archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,2.4861e-06,1.2013,1.0116,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,3.0905e-06,1.0644,0.8522,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.2538e-08,0.98963,0.82572,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,3.9717e-11,0.91991,0.89471,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.1789e-06,0.90901,0.69951,1,1
1,GO BLEB ASSEMBLY,3.6361e-10,0.87874,0.99781,1,1
1,GO RESPONSE TO INTERFERON ALPHA,8.0815e-10,0.85574,0.8851,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,5.4701e-07,0.81081,0.64467,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.6001e-09,0.79855,0.74308,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.2565e-10,0.78241,0.74756,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,3.4296e-07,0.78149,0.62021,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,4.0343e-10,0.78019,0.64487,1,1
1,GO RESPONSE TO INTERFERON BETA,3.5606e-08,0.7641,0.70694,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,4.1552e-07,0.76387,0.69865,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,3.4296e-07,0.76294,0.72305,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.7309e-08,0.73395,0.74173,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.2864e-09,0.7282,0.64304,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.1245e-09,0.7277,0.70653,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,1.1579e-08,0.71943,0.63766,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,6.0979e-10,0.71615,0.68006,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,1.5604e-09,0.71615,0.69919,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,5.3647e-09,0.71454,0.64386,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,2.634e-09,0.70732,0.66698,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.7909e-10,0.69843,0.67323,1,1
1,GO HYALURONAN CATABOLIC PROCESS,4.5526e-11,0.68333,0.72561,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,1.9563e-06,0.66669,0.56798,1,1
1,GO FIBRINOLYSIS,3.0296e-10,0.66339,0.6279,1,1
1,GO RESPONSE TO TYPE I INTERFERON,2.5359e-06,0.65482,0.51739,1,1
1,GO HEMIDESMOSOME ASSEMBLY,9.404e-07,0.6544,0.73944,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,9.1996e-11,0.65422,0.69523,1,1
1,GO NEUTROPHIL HOMEOSTASIS,4.4749e-10,0.64981,0.64797,1,1
1,GO MEMBRANE RAFT ORGANIZATION,2.4586e-08,0.63974,0.65216,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.094e-05,0.6375,0.45678,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,6.5125e-09,0.6344,0.57354,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,4.3082e-09,0.62964,0.6169,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,2.65e-07,0.62701,0.48973,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,1.8419e-06,0.62207,0.5788,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,3.094e-05,0.61647,0.54315,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.6362e-08,0.61583,0.58525,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,9.03e-05,0.6148,0.46719,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,1.9064e-09,0.61055,0.64021,1,1
1,GO CYTOLYSIS,9.028e-08,0.60793,0.48166,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.155e-06,0.60244,0.47937,1,1
1,GO LEUKOCYTE AGGREGATION,1.9175e-06,0.59916,0.51275,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,5.0922e-10,0.59818,0.5887,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,4.31e-06,0.59535,0.47555,1,1
1,GO PROSTATIC BUD FORMATION,1.9749e-05,0.59483,0.49578,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.9602e-08,0.59099,0.5316,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.4877e-09,0.59036,0.51473,1,1
1,GO SKIN MORPHOGENESIS,3.247e-08,0.59022,0.62451,1,1
1,GO TOLERANCE INDUCTION,2.9332e-05,0.58871,0.451,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,4.4285e-07,0.58604,0.52209,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,1.0804e-10,0.57758,0.62169,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,6.0759e-07,0.57525,0.53275,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,5.6245e-08,0.57122,0.48947,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,5.1356e-08,0.57031,0.52977,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.8135e-09,0.56885,0.53804,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,4.3606e-10,0.56833,0.56189,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.3784e-07,0.56785,0.5806,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,7.4177e-11,0.56725,0.6162,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,5.1101e-09,0.56571,0.53473,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,1.0554e-07,0.56372,0.46683,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,1.9064e-09,0.5609,0.58921,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,7.1121e-10,0.55849,0.63132,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,6.4434e-08,0.55433,0.44902,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,7.0337e-07,0.55344,0.48136,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,1.9546e-09,0.55066,0.57014,1,1
1,GO DETECTION OF BIOTIC STIMULUS,3.1004e-08,0.55008,0.49877,1,1
1,GO RESPONSE TO INTERFERON GAMMA,2.8271e-07,0.54647,0.44248,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.0527e-08,0.54585,0.47786,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,3.8118e-09,0.53954,0.50643,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.342e-06,0.53527,0.53594,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.457e-10,0.53513,0.55452,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.188e-08,0.5334,0.48528,1,1
1,GO T CELL EXTRAVASATION,2.65e-07,0.53213,0.48214,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,4.5233e-07,0.53141,0.49285,1,1
1,GO ELASTIC FIBER ASSEMBLY,8.3066e-07,0.5311,0.65247,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.5756e-08,0.52735,0.50098,1,1
1,GO EPIBOLY,6.757e-10,0.52558,0.54642,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,8.6328e-08,0.52395,0.50847,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,3.8161e-07,0.52219,0.63026,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.3274e-07,0.51957,0.49176,1,1
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,2.2505e-06,0.5192,0.44544,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,1.1041e-08,0.5188,0.55369,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,8.2864e-09,0.51876,0.47948,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.7154e-07,0.51668,0.39341,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,8.6328e-08,0.51559,0.40754,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,2.65e-07,0.51488,0.52707,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.6907e-08,0.51309,0.44835,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.9546e-09,0.51146,0.53793,1,1
1,GO MUCUS SECRETION,3.5646e-05,0.50977,0.46774,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,3.7195e-09,0.50857,0.5642,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,9.5999e-07,0.50707,0.53938,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,1.3878e-06,0.5058,0.49159,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,2.6386e-06,0.50546,0.48713,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0028118,0.50513,0.33145,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,4.8416e-06,0.50492,0.552,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,6.2993e-08,0.50477,0.50455,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.6352e-05,0.50171,0.43792,1,1
1,GO ZYMOGEN ACTIVATION,2.8001e-06,0.50093,0.40939,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.3312e-10,0.49861,0.50282,1,1
1,GO ETHANOL OXIDATION,0.0041031,0.49769,0.32599,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,9.4407e-08,0.49644,0.48368,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.2775e-07,0.4959,0.4397,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.9558e-07,0.49441,0.35921,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,1.2604e-07,0.4942,0.52297,1,1
1,GO RESPONSE TO INTERLEUKIN 18,4.7172e-05,0.49255,0.5009,1,1
1,GO ENDODERM FORMATION,5.7923e-10,0.49199,0.5069,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,1.2027e-05,0.49053,0.43194,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.3878e-06,0.49026,0.36509,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,6.545e-05,0.48947,0.52554,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,2.0364e-06,0.48921,0.45188,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.3174e-07,0.48882,0.44277,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,2.0881e-08,0.48837,0.47795,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,3.6435e-08,0.48563,0.4808,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.2585e-06,0.48524,0.34202,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,6.3359e-07,0.48359,0.39481,1,1
1,GO INTERLEUKIN 1 PRODUCTION,8.8282e-08,0.48,0.39157,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,1.2534e-06,0.4796,0.51281,1,1
1,GO APOPTOTIC CELL CLEARANCE,3.2764e-10,0.47931,0.50687,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.6914e-06,0.47759,0.32995,1,1
1,GO ZYMOGEN INHIBITION,7.1726e-09,0.47454,0.52959,1,1
1,GO PROTEIN OXIDATION,2.2416e-05,0.47324,0.4261,1,1
1,GO TYPE 2 IMMUNE RESPONSE,3.6435e-08,0.47078,0.44991,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,2.971e-06,0.46875,0.39705,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,3.0811e-07,0.46791,0.468,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,4.9694e-05,0.46527,0.34707,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.7536e-08,0.46503,0.41283,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,3.2859e-07,0.46399,0.44317,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,2.1064e-09,0.46299,0.50146,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9834e-06,0.46166,0.33338,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,4.4285e-07,0.46096,0.41494,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.7319e-10,0.45829,0.47653,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.1101e-09,0.45674,0.4381,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.7582e-06,0.45641,0.37155,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.6981e-08,0.45556,0.42011,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,3.9941e-08,0.45493,0.4542,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.892e-08,0.45125,0.35811,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.6321e-06,0.4498,0.3793,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,2.1338e-07,0.44933,0.4267,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,7.0522e-08,0.44828,0.39449,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,1.3948e-05,0.44807,0.40695,1,1
1,GO REGULATION OF FIBRINOLYSIS,4.6202e-07,0.44782,0.41634,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,2.3891e-06,0.44767,0.4364,1,1
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,4.3997e-05,0.44724,0.36937,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.65e-07,0.44601,0.50437,1,1
1,GO VAGINA DEVELOPMENT,9.3415e-09,0.44564,0.43203,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.9859e-05,0.44503,0.329,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.7442e-10,0.4448,0.52214,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,4.0314e-05,0.44466,0.42974,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.4285e-07,0.44459,0.38494,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.536e-06,0.44323,0.3425,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,7.8778e-10,0.44104,0.45786,1,1
1,GO PROTEIN ACTIVATION CASCADE,9.7991e-09,0.43739,0.42175,1,1
1,GO BONE TRABECULA MORPHOGENESIS,3.758e-05,0.43725,0.41439,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,5.0278e-07,0.43676,0.40253,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,4.0033e-09,0.43577,0.5707,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.8262e-08,0.43494,0.38091,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,3.2057e-05,0.43485,0.42805,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,2.1375e-08,0.43398,0.41623,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,2.4837e-07,0.43375,0.3786,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,3.5427e-10,0.43371,0.44455,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,1.0557e-05,0.43368,0.35099,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,1.6321e-06,0.43255,0.42054,1,1
1,GO DEFENSE RESPONSE TO VIRUS,7.4873e-07,0.43226,0.32651,1,1
1,GO TRABECULA FORMATION,2.4861e-06,0.43225,0.38857,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.152e-06,0.43215,0.30881,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,3.1494e-05,0.43187,0.3454,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.5412e-09,0.43025,0.45684,1,1
1,GO INTERLEUKIN 13 PRODUCTION,1.6761e-05,0.43007,0.37023,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,1.0964e-09,0.4295,0.45812,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00046872,0.4295,0.30353,1,1
1,GO ENDODERM DEVELOPMENT,9.658e-10,0.42907,0.44486,1,1
1,GO T CELL MEDIATED IMMUNITY,1.155e-06,0.42886,0.3401,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,2.342e-06,0.42822,0.44153,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.3747e-08,0.42781,0.39761,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.5359e-06,0.42754,0.37011,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,8.4262e-06,0.42741,0.2908,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.8856e-08,0.4272,0.43532,1,1
1,GO VASCULOGENESIS,2.1543e-10,0.42595,0.44208,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.00027716,0.42437,0.40996,1,1
1,GO LATERAL MESODERM DEVELOPMENT,1.2534e-06,0.42434,0.41054,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.3419e-09,0.42421,0.43505,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.2733e-08,0.42341,0.43682,1,1
1,GO PINOCYTOSIS,2.2926e-08,0.42327,0.38666,1,1
1,GO BIOLOGICAL PHASE,2.5884e-05,0.42287,0.40509,1,1
1,GO HIPPO SIGNALING,5.0278e-07,0.42267,0.41723,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.4305e-07,0.42248,0.3252,1,1
1,GO DNA DEAMINATION,2.2015e-05,0.42234,0.42557,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.3351e-08,0.42212,0.41983,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,3.0811e-07,0.42141,0.39787,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,4.3774e-08,0.42123,0.3698,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,5.1356e-08,0.42099,0.36692,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,1.6654e-06,0.42093,0.44524,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.402e-08,0.42041,0.38549,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,9.4959e-05,0.41823,0.26869,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.2058e-07,0.41807,0.38002,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.0169e-05,0.41789,0.36247,1,1
1,GO RETINAL METABOLIC PROCESS,5.7059e-05,0.41781,0.35192,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,5.9498e-07,0.41682,0.41466,1,1
1,GO POSITIVE REGULATION OF COAGULATION,3.2146e-06,0.41653,0.33855,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.2271e-06,0.4164,0.28732,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,6.5906e-08,0.41631,0.38447,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00026438,0.41583,0.28873,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,8.8282e-08,0.41552,0.48448,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,6.8885e-07,0.41537,0.42122,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00068191,0.41522,0.2812,1,1
1,GO CERAMIDE CATABOLIC PROCESS,1.2954e-05,0.41514,0.3443,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.0323e-06,0.41396,0.31404,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,6.0205e-08,0.4137,0.56118,1,1
1,GO PLASMINOGEN ACTIVATION,1.0212e-06,0.4137,0.42475,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,3.152e-06,0.41353,0.45809,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,1.7693e-06,0.4129,0.33395,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,5.7051e-07,0.41167,0.36401,1,1
1,GO REGULATION OF PINOCYTOSIS,1.475e-06,0.41064,0.32238,1,1
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,3.3806e-05,0.41021,0.39396,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.3891e-06,0.40891,0.33124,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,6.545e-05,0.40874,0.32599,1,1
1,GO ENTRY INTO HOST,2.188e-08,0.4086,0.38498,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.0337e-07,0.4057,0.42008,1,1
1,GO INTERLEUKIN 8 PRODUCTION,1.6062e-07,0.4044,0.36217,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,5.02e-08,0.40439,0.48002,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,5.8262e-07,0.40401,0.4152,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.00032916,0.404,0.30994,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,2.6352e-05,0.40374,0.35175,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00023667,0.40232,0.29434,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,3.9822e-07,0.40144,0.42878,1,1
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.016027,0.40055,0.23569,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.996e-06,0.40042,0.43954,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,2.1196e-06,0.4,0.3887,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,5.4701e-07,0.39962,0.39805,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,6.7461e-07,0.39953,0.35916,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,3.0295e-08,0.39948,0.40174,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,2.8925e-08,0.39921,0.38672,1,1
1,GO GAP JUNCTION ASSEMBLY,1.6782e-07,0.39815,0.4244,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,2.2015e-05,0.39815,0.35566,1,1
1,GO SALIVARY GLAND DEVELOPMENT,9.028e-08,0.39747,0.44816,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,4.1552e-07,0.39741,0.47563,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.3174e-07,0.39712,0.34283,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.2328e-07,0.39538,0.36701,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,2.5359e-06,0.39449,0.42611,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.6581e-10,0.39349,0.45551,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.3599e-06,0.39334,0.31207,1,1
1,GO CYTOKINE METABOLIC PROCESS,1.6782e-07,0.39332,0.33086,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,1.6321e-06,0.39288,0.37426,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,3.3214e-05,0.39226,0.28665,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,2.5868e-06,0.39215,0.35905,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.00088789,0.3914,0.24244,1,1
1,GO CELLULAR RESPONSE TO DSRNA,2.7676e-09,0.39077,0.39888,1,1
1,GO AMYLOID FIBRIL FORMATION,0.00015083,0.3904,0.35579,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,6.1583e-08,0.39038,0.50244,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,3.3713e-09,0.38995,0.42078,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00049053,0.38974,0.35871,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00022208,0.38972,0.33249,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,3.0395e-05,0.38898,0.4773,1,1
1,GO AMYLOID BETA CLEARANCE,4.0678e-07,0.38887,0.32295,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,2.6352e-05,0.38852,0.39159,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.3693e-05,0.38825,0.31315,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.2015e-05,0.38793,0.37053,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,5.7536e-08,0.38785,0.32856,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.0212e-06,0.38717,0.40608,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.856e-06,0.3864,0.31083,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00010673,0.38628,0.28111,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.2482e-05,0.38554,0.38695,1,1
1,GO VIRAL GENOME REPLICATION,7.0522e-08,0.38468,0.33961,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,1.1086e-06,0.38399,0.41426,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,7.9617e-06,0.38314,0.39647,1,1
1,GO MACROPHAGE PROLIFERATION,1.3196e-05,0.38297,0.37743,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,8.5858e-05,0.38178,0.30941,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,7.2414e-06,0.38064,0.37097,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,3.2784e-06,0.37959,0.33162,1,1
1,GO MYOBLAST PROLIFERATION,7.3739e-05,0.37936,0.28467,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,8.1138e-06,0.37927,0.38887,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,8.8389e-07,0.3792,0.367,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,6.5837e-06,0.37833,0.34918,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,5.0563e-05,0.37828,0.32968,1,1
1,GO RESPONSE TO INTERLEUKIN 12,1.5713e-07,0.37818,0.32164,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.3891e-06,0.37748,0.32397,1,1
1,GO T CELL APOPTOTIC PROCESS,9.8716e-08,0.37727,0.30057,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.6202e-07,0.37725,0.34224,1,1
1,GO REGULATION OF TRANSPOSITION,1.1588e-05,0.37674,0.37846,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,7.3739e-05,0.37662,0.32478,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,2.913e-06,0.37637,0.42313,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.4837e-07,0.37604,0.32247,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,2.6362e-08,0.37529,0.4226,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,8.0256e-05,0.37457,0.34822,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,2.2416e-05,0.37409,0.26206,1,1
1,GO INTERLEUKIN 2 PRODUCTION,2.9602e-08,0.37391,0.33279,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.1858e-08,0.37322,0.41519,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,3.9822e-07,0.3731,0.42829,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.9064e-09,0.37081,0.43084,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,8.4805e-07,0.37069,0.27494,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.0811e-07,0.37066,0.31862,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.2958e-06,0.3697,0.3806,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,5.8698e-06,0.36904,0.31028,1,1
1,GO HEME METABOLIC PROCESS,2.1375e-08,0.36867,0.34928,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.996e-06,0.36805,0.42598,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.6881e-08,0.36765,0.37768,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,3.6567e-07,0.36668,0.41482,1,1
1,GO SERTOLI CELL DEVELOPMENT,4.8416e-06,0.36576,0.35791,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,6.9323e-10,0.36571,0.39669,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.00020178,0.36488,0.27019,1,1
1,GO GENITALIA MORPHOGENESIS,6.8888e-05,0.36449,0.31239,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,2.6981e-08,0.3641,0.35301,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.3769e-07,0.36329,0.37142,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,1.1034e-07,0.36324,0.40357,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,1.7534e-07,0.36303,0.36746,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,2.7804e-05,0.36252,0.34439,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,2.5934e-07,0.36217,0.37987,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.9361e-06,0.36148,0.28515,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.0429e-07,0.36039,0.35046,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.1819e-07,0.36039,0.29055,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,8.4415e-08,0.35991,0.39649,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,1.1165e-05,0.35985,0.27615,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00015583,0.35984,0.28521,1,1
1,GO RESPONSE TO VIRUS,7.333e-07,0.35982,0.27844,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,3.357e-07,0.35971,0.40375,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,2.7804e-05,0.35899,0.25278,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,1.2032e-06,0.35857,0.3145,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.5713e-07,0.3585,0.32503,1,1
1,GO CHEMOKINE PRODUCTION,1.1806e-05,0.35849,0.26952,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.5037e-07,0.35812,0.43341,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.9175e-06,0.35788,0.35148,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,9.2118e-07,0.3578,0.44172,1,1
1,GO PLATELET AGGREGATION,4.6881e-08,0.35755,0.35445,1,1
1,GO TROPHOBLAST CELL MIGRATION,2.4371e-06,0.35689,0.38792,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,3.0395e-05,0.35669,0.45205,1,1
1,GO T CELL CYTOKINE PRODUCTION,6.8396e-06,0.35632,0.27707,1,1
1,GO REGULATION OF COAGULATION,1.2886e-07,0.35577,0.38737,1,1
1,GO MUSCLE CELL FATE COMMITMENT,4.4285e-07,0.35522,0.3709,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,9.795e-06,0.35479,0.31024,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,2.402e-08,0.35418,0.36432,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.457e-10,0.35367,0.38844,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.00084997,0.35365,0.29849,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,8.1623e-05,0.35347,0.26864,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,5.6245e-08,0.35275,0.3865,1,1
1,GO HYALURONAN METABOLIC PROCESS,9.4157e-10,0.35268,0.363,1,1
1,GO INTERFERON BETA PRODUCTION,3.5461e-06,0.35204,0.27011,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00018323,0.35194,0.27511,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,8.1623e-05,0.35191,0.41177,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,9.9844e-05,0.35084,0.25048,1,1
1,GO CD40 SIGNALING PATHWAY,7.5451e-08,0.35071,0.37463,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,5.332e-06,0.35035,0.29273,1,1
1,GO COLLAGEN CATABOLIC PROCESS,5.4982e-08,0.34996,0.35834,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.0322e-07,0.34975,0.34841,1,1
1,GO PROSTANOID METABOLIC PROCESS,2.5868e-06,0.34947,0.29751,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00043435,0.34931,0.27901,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.9749e-05,0.34884,0.26375,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.0364e-06,0.34882,0.339,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0025961,0.34855,0.2569,1,1
1,GO PROSTATE GLAND DEVELOPMENT,1.5994e-06,0.3477,0.36842,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.7059e-05,0.34768,0.30865,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.2444e-07,0.34722,0.3301,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,1.0094e-07,0.34715,0.40708,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,2.0879e-07,0.34634,0.34605,1,1
1,GO RENAL FILTRATION,0.0001179,0.34606,0.3849,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,2.0364e-06,0.34576,0.31515,1,1
1,GO ENAMEL MINERALIZATION,6.1119e-05,0.34551,0.37478,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,2.5868e-06,0.34532,0.29887,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.8318e-07,0.3453,0.32532,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.5037e-07,0.34506,0.2975,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,1.5037e-07,0.34495,0.35912,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00022927,0.34469,0.24572,1,1
1,GO AORTIC VALVE DEVELOPMENT,8.8389e-07,0.34387,0.39924,1,1
1,GO PLATELET DEGRANULATION,1.8723e-07,0.34366,0.35774,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.004156,0.34352,0.24213,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,9.2118e-07,0.3435,0.27949,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.000286,0.34334,0.31378,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.6446e-07,0.34256,0.33264,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,5.1446e-05,0.34168,0.27299,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2281e-06,0.34152,0.29164,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,3.0905e-06,0.34138,0.25871,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,1.2032e-06,0.34125,0.32866,1,1
1,GO I KAPPAB PHOSPHORYLATION,2.3274e-07,0.34121,0.30172,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,2.4972e-05,0.3412,0.33863,1,1
1,GO TYPE I INTERFERON PRODUCTION,1.475e-06,0.34086,0.26161,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,1.1282e-07,0.3408,0.28909,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,6.4699e-07,0.34078,0.36742,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,6.337e-06,0.34031,0.33331,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.7693e-06,0.33969,0.27557,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.3693e-05,0.3393,0.31762,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.3946e-06,0.33905,0.29475,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,9.5999e-07,0.33905,0.26863,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.9136e-07,0.33901,0.31044,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.1196e-06,0.33828,0.27835,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.00034485,0.33805,0.2669,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.2958e-06,0.33803,0.35266,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,2.856e-06,0.33768,0.29789,1,1
1,GO GLAND MORPHOGENESIS,1.5674e-06,0.33718,0.35434,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,4.4787e-08,0.33704,0.38153,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,4.9694e-05,0.33678,0.29206,1,1
1,GO RESPONSE TO DSRNA,2.3784e-07,0.33621,0.2885,1,1
1,GO REGULATION OF MYOBLAST FUSION,6.4592e-06,0.33602,0.3632,1,1
1,GO PIGMENT ACCUMULATION,3.1494e-05,0.33571,0.31555,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.9014e-08,0.33553,0.31927,1,1
1,GO STORE OPERATED CALCIUM ENTRY,2.4528e-05,0.33551,0.26152,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.0025277,0.33498,0.25464,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,9.2321e-08,0.33483,0.38355,1,1
1,GO LYMPHANGIOGENESIS,1.9465e-08,0.33456,0.37191,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.00013451,0.33452,0.37882,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.8001e-06,0.33409,0.25262,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0021798,0.33404,0.37043,1,1
1,GO MACROPHAGE CHEMOTAXIS,3.8161e-07,0.33342,0.30494,1,1
1,GO MACROPHAGE MIGRATION,2.9602e-08,0.33331,0.31823,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,4.8839e-05,0.33287,0.34595,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,6.5837e-06,0.33233,0.30424,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,8.8282e-08,0.33154,0.31893,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,5.8262e-07,0.33131,0.35722,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.9941e-08,0.33092,0.36833,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,6.7105e-06,0.33079,0.40666,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00023667,0.32953,0.23319,1,1
1,GO PERICARDIUM DEVELOPMENT,7.5001e-05,0.32953,0.3084,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,4.4807e-06,0.32947,0.29413,1,1
1,GO PHAGOCYTOSIS RECOGNITION,2.1624e-06,0.32914,0.35141,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,9.6538e-08,0.32907,0.38449,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,2.9514e-07,0.32861,0.29671,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00015838,0.32831,0.34211,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,3.094e-05,0.32818,0.30516,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,3.8983e-07,0.32797,0.34773,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,8.1361e-07,0.32733,0.26545,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,3.6162e-06,0.32666,0.36589,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,5.8856e-08,0.32599,0.29494,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.00013232,0.32588,0.25119,1,1
1,GO REGULATION OF STEROL TRANSPORT,1.3599e-06,0.32503,0.31079,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,6.4341e-05,0.32485,0.28226,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,1.0036e-08,0.32483,0.38772,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00016901,0.32418,0.25224,1,1
1,GO TRANSPOSITION,1.8701e-05,0.32359,0.32581,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.00049053,0.32356,0.33485,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.3056e-06,0.32346,0.27946,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00048316,0.32329,0.36197,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00020178,0.3229,0.25339,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,2.0881e-08,0.32279,0.28228,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.538e-07,0.32256,0.38924,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,2.1624e-06,0.32225,0.34074,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,2.2416e-05,0.32188,0.25311,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,1.7687e-09,0.32127,0.35196,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,6.1119e-05,0.32126,0.35781,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,5.7059e-05,0.32113,0.23806,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,1.7534e-07,0.32093,0.2929,1,1
1,GO OSTEOBLAST DEVELOPMENT,7.2414e-06,0.32077,0.29409,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.5038e-07,0.32038,0.25682,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,4.8839e-05,0.32021,0.32068,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.3355e-07,0.31989,0.28797,1,1
1,GO P38MAPK CASCADE,9.795e-06,0.31949,0.25336,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,5.8698e-06,0.31935,0.38156,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00045468,0.31897,0.2308,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.5412e-06,0.31878,0.28132,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,2.5164e-08,0.31795,0.27384,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,8.7237e-10,0.31794,0.34027,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00034485,0.31771,0.32808,1,1
1,GO EMBRYO IMPLANTATION,3.4296e-07,0.31711,0.31467,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.7452e-06,0.31644,0.2528,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,4.6359e-05,0.31629,0.25774,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.4837e-07,0.31625,0.33594,1,1
1,GO HYPOTONIC RESPONSE,2.011e-05,0.3161,0.28773,1,1
1,GO ODONTOGENESIS,9.1829e-05,0.31601,0.25261,1,1
1,GO FIBROBLAST MIGRATION,4.1815e-08,0.31573,0.33802,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,5.7059e-05,0.31556,0.26644,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.8419e-06,0.31543,0.24308,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,7.6657e-06,0.31492,0.35121,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,6.4592e-06,0.31469,0.30084,1,1
1,GO PROSTATE GLAND MORPHOGENESIS,0.00033432,0.31462,0.35333,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0025277,0.31439,0.35879,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,3.4409e-05,0.31422,0.28561,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,2.3467e-08,0.31407,0.33768,1,1
1,GO TRABECULA MORPHOGENESIS,2.4528e-05,0.31395,0.28676,1,1
1,GO REGULATION OF PLATELET ACTIVATION,0.00012594,0.31393,0.33407,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,6.2169e-06,0.31357,0.27776,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,5.8049e-05,0.31355,0.25331,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.6129e-08,0.31345,0.39497,1,1
1,GO RESPONSE TO ESTROGEN,3.8118e-09,0.31318,0.30803,1,1
1,GO FOCAL ADHESION ASSEMBLY,2.1338e-07,0.31291,0.35171,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,2.4305e-07,0.31247,0.33624,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.00041488,0.31176,0.27336,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.00039622,0.31169,0.23189,1,1
1,GO RESPONSE TO ANGIOTENSIN,2.0429e-07,0.31097,0.3177,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.152e-06,0.31071,0.24899,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.105e-06,0.31061,0.26686,1,1
1,GO CELL SUBSTRATE ADHESION,3.4796e-08,0.31016,0.34292,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,9.0235e-07,0.31002,0.3309,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.9617e-06,0.30977,0.38865,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.00019857,0.30945,0.3179,1,1
1,GO COPPER ION HOMEOSTASIS,3.5038e-07,0.30873,0.31465,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,0.00012804,0.30812,0.33964,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.00053704,0.30809,0.35866,1,1
1,GO LIVER REGENERATION,4.6356e-09,0.30798,0.30841,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.2444e-07,0.30785,0.32988,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0033361,0.30722,0.31324,1,1
1,GO PHOSPHOLIPID HOMEOSTASIS,0.0023009,0.30701,0.23172,1,1
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.00042777,0.307,0.32967,1,1
1,GO MEMBRANE INVAGINATION,9.4407e-08,0.30697,0.30086,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0001862,0.30677,0.35187,1,1
1,GO ARGININE METABOLIC PROCESS,1.8419e-06,0.30653,0.31202,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9102e-06,0.30602,0.28099,1,1
1,GO REGULATION OF PHAGOCYTOSIS,9.4407e-08,0.30588,0.33401,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,7.2497e-05,0.30582,0.32584,1,1
1,GO VIRAL LIFE CYCLE,5.4982e-08,0.30545,0.27379,1,1
1,GO VITAMIN D METABOLIC PROCESS,0.0020092,0.30542,0.23358,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,6.8885e-07,0.30537,0.28414,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,1.6782e-07,0.30524,0.28188,1,1
1,GO RESPONSE TO TUMOR CELL,0.0019285,0.30522,0.25385,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00033432,0.30505,0.20782,1,1
1,GO PROTEIN DEGLYCOSYLATION,1.1588e-05,0.30487,0.29848,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.001483,0.30485,0.31841,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,0.00016098,0.30332,0.31113,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0011021,0.30303,0.25023,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00019857,0.303,0.30035,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,1.0169e-05,0.30284,0.23847,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,3.3214e-05,0.30266,0.28425,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00025215,0.30081,0.26684,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0010259,0.30042,0.32445,1,1
1,GO RESPONSE TO CYTOKINE,9.5999e-07,0.30033,0.23899,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.9822e-07,0.3003,0.27367,1,1
1,GO RESPONSE TO HYDROPEROXIDE,0.024947,0.30025,0.20861,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.4972e-05,0.30021,0.24809,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,2.538e-07,0.30013,0.29554,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.1535e-07,0.29973,0.39795,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.4305e-07,0.29946,0.25777,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,8.6579e-07,0.29938,0.32463,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,2.1196e-06,0.29926,0.38374,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.0364e-06,0.29727,0.26407,1,1
1,GO INTERACTION WITH SYMBIONT,2.4837e-07,0.29709,0.24693,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.8701e-05,0.29707,0.26086,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.0478e-05,0.29677,0.22712,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,2.9859e-05,0.29644,0.24305,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,1.2792e-06,0.29643,0.29864,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.5868e-06,0.2964,0.36742,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.5994e-06,0.29629,0.31931,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,8.4805e-07,0.29627,0.29126,1,1
1,GO REGULATION OF VASCULOGENESIS,0.0016122,0.29601,0.26924,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,6.2993e-08,0.29588,0.2635,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,7.6446e-07,0.29574,0.27306,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.5372e-07,0.29564,0.25898,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.3599e-06,0.29549,0.29038,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.475e-06,0.29527,0.30907,1,1
1,GO LIPOPROTEIN LOCALIZATION,4.31e-06,0.29525,0.32174,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,1.5576e-05,0.29518,0.25758,1,1
1,GO INTERFERON ALPHA PRODUCTION,5.1446e-05,0.29487,0.26154,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00033955,0.29467,0.24127,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.001776,0.29452,0.35933,1,1
1,GO OSTEOCLAST DEVELOPMENT,2.8001e-06,0.2943,0.33344,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,5.9498e-07,0.29417,0.36006,1,1
1,GO CELLULAR RESPONSE TO IRON ION,6.4341e-05,0.2941,0.30483,1,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0034692,0.29355,0.21636,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,2.65e-07,0.29351,0.28309,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,6.8888e-05,0.29345,0.30738,1,1
1,GO REGULATION OF GASTRULATION,1.2886e-07,0.29341,0.28902,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,5.1304e-06,0.29276,0.24391,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.2328e-07,0.29276,0.33507,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,3.5646e-05,0.29276,0.29116,1,1
1,GO RESPONSE TO MANGANESE ION,9.028e-08,0.29252,0.26725,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00092737,0.29226,0.23564,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,1.6062e-07,0.29193,0.38157,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.00026438,0.29188,0.27858,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00070238,0.29176,0.23563,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0005789,0.29164,0.24169,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,3.8246e-05,0.29134,0.27298,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.010522,0.29106,0.25746,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,4.7999e-05,0.29041,0.23809,1,1
1,GO RESPONSE TO UV B,0.0038977,0.29034,0.24049,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,1.1034e-07,0.28999,0.34686,1,1
1,GO NATURAL KILLER CELL ACTIVATION,3.2784e-06,0.28962,0.2605,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00028155,0.2894,0.25512,1,1
1,GO WOUND HEALING,2.9514e-07,0.28887,0.28096,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00026024,0.28886,0.28679,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.001422,0.28872,0.24292,1,1
1,GO MYOBLAST DIFFERENTIATION,9.4407e-08,0.2887,0.2979,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00015331,0.28848,0.21628,1,1
1,GO BONE GROWTH,6.7105e-06,0.28846,0.35248,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,2.0853e-05,0.28824,0.22143,1,1
1,GO VIRAL RNA GENOME REPLICATION,2.2958e-06,0.28808,0.27046,1,1
1,GO COAGULATION,3.1479e-07,0.28803,0.26176,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,9.4959e-05,0.28794,0.30057,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,3.6435e-08,0.28775,0.27487,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.6578e-05,0.28774,0.44696,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,6.7461e-07,0.28765,0.29613,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0011341,0.28763,0.20949,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,1.6761e-05,0.28762,0.28026,1,1
1,GO CELL MATRIX ADHESION,3.6567e-07,0.28754,0.31059,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,1.8363e-05,0.28706,0.25435,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.0361e-05,0.28704,0.25224,1,1
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,6.6578e-05,0.2867,0.29079,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.3769e-07,0.2864,0.33879,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,6.7105e-06,0.28635,0.30327,1,1
1,GO REGULATION OF BONE MINERALIZATION,0.000662,0.28571,0.23315,1,1
1,GO ENDOTHELIAL CELL MIGRATION,2.65e-07,0.28567,0.31412,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00029052,0.28567,0.26775,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,3.3435e-06,0.28563,0.26888,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.00071283,0.28542,0.3408,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.1588e-05,0.28527,0.33278,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,6.4592e-06,0.28524,0.28462,1,1
1,GO RESPONSE TO X RAY,6.5906e-08,0.28467,0.33682,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,4.8198e-07,0.28437,0.29635,1,1
1,GO INTERACTION WITH HOST,2.2775e-07,0.28403,0.26339,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,4.5558e-05,0.284,0.27095,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,7.1819e-07,0.284,0.27115,1,1
1,GO SERTOLI CELL DIFFERENTIATION,5.8049e-05,0.28387,0.27454,1,1
1,GO AMINE CATABOLIC PROCESS,0.0016347,0.28387,0.19398,1,1
1,GO LYMPH VESSEL DEVELOPMENT,2.5424e-05,0.28385,0.3208,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,4.0314e-05,0.28385,0.22575,1,1
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0046018,0.28372,0.24993,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,4.9228e-07,0.28362,0.27574,1,1
1,GO NIK NF KAPPAB SIGNALING,1.2434e-08,0.28356,0.27867,1,1
1,GO MUSCLE CELL MIGRATION,5.2344e-05,0.28338,0.26302,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.1751e-05,0.28332,0.35191,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.7051e-07,0.28317,0.25067,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.001071,0.28294,0.22956,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00033432,0.28275,0.33724,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00012804,0.28242,0.2168,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,8.2864e-09,0.28227,0.27883,1,1
1,GO RESPONSE TO RETINOIC ACID,2.342e-06,0.28218,0.25271,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0011503,0.28194,0.16882,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,1.6321e-06,0.28164,0.20972,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,1.8419e-06,0.28156,0.30679,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,3.0156e-07,0.28102,0.36593,1,1
1,GO TISSUE REGENERATION,6.0991e-06,0.28072,0.24107,1,1
1,GO RESPONSE TO INTERLEUKIN 1,1.0791e-07,0.28041,0.23911,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.3196e-05,0.27979,0.27115,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,3.357e-07,0.27943,0.36517,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,2.971e-06,0.27937,0.2929,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,3.628e-05,0.27923,0.25497,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,1.2027e-05,0.2792,0.29529,1,1
1,GO TISSUE MIGRATION,1.7693e-06,0.27898,0.28166,1,1
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0073682,0.2789,0.19014,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,5.3256e-05,0.27887,0.35492,1,1
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.8796e-05,0.27886,0.27985,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.3435e-06,0.27848,0.26029,1,1
1,GO RESPONSE TO VITAMIN,0.00012186,0.27832,0.21782,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,6.6066e-07,0.27826,0.27612,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,2.8814e-05,0.278,0.23831,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,7.6446e-07,0.27741,0.33598,1,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0048405,0.2773,0.25563,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,1.1165e-05,0.27702,0.267,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.001776,0.27683,0.26726,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.6924e-05,0.27636,0.23114,1,1
1,GO IMMUNE EFFECTOR PROCESS,2.8001e-06,0.27623,0.24651,1,1
1,GO CHONDROCYTE DEVELOPMENT,6.9711e-06,0.27573,0.31342,1,1
1,GO HAIR FOLLICLE MATURATION,0.00024045,0.2757,0.25246,1,1
1,GO POSITIVE REGULATION OF WOUND HEALING,0.0019023,0.27519,0.23413,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.7154e-07,0.27517,0.2736,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.9872e-06,0.27504,0.23598,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,7.4873e-07,0.27493,0.3035,1,1
1,GO MACROPHAGE DIFFERENTIATION,8.3066e-07,0.27473,0.28915,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,9.5999e-07,0.27445,0.30101,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,6.2169e-06,0.27393,0.3014,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.4454e-06,0.27392,0.28756,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,3.357e-07,0.27383,0.28121,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,8.2686e-06,0.27349,0.30826,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.0062108,0.27335,0.23351,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,1.0361e-05,0.2733,0.29152,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,2.0364e-06,0.27299,0.27935,1,1
1,GO MYOBLAST FUSION,5.5412e-06,0.27296,0.33548,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00016629,0.27292,0.30442,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,1.4454e-06,0.27253,0.27203,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.0072e-05,0.27248,0.2001,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,2.8305e-05,0.27205,0.31474,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,3.3435e-06,0.27186,0.22807,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.9166e-06,0.27181,0.22737,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.9102e-06,0.27142,0.2389,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,1.1588e-05,0.27083,0.25895,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00052901,0.27029,0.19791,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0034692,0.27012,0.20705,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0042636,0.27004,0.19295,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,3.6924e-05,0.26992,0.20975,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,3.0905e-06,0.26988,0.24482,1,1
1,GO REGULATION OF CELL SHAPE,2.011e-05,0.26979,0.22731,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,4.6359e-05,0.26916,0.25607,1,1
1,GO VASCULATURE DEVELOPMENT,2.4837e-07,0.26915,0.26959,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,1.9044e-05,0.26895,0.28062,1,1
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,9.03e-05,0.2689,0.22066,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.5934e-07,0.26885,0.27672,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00033432,0.26865,0.21808,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.2416e-05,0.26865,0.22047,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,3.5646e-05,0.26862,0.492,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,4.5822e-08,0.26829,0.27823,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,5.0563e-05,0.26824,0.27097,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,8.3066e-07,0.26814,0.25997,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,2.1624e-06,0.26809,0.26546,1,1
1,GO POSITIVE CHEMOTAXIS,0.00015083,0.26798,0.23729,1,1
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0001803,0.26752,0.23128,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.2032e-06,0.26732,0.28177,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,2.6352e-05,0.26718,0.33513,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.1351e-07,0.26665,0.25682,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00036686,0.26658,0.18931,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,5.2303e-06,0.26646,0.31521,1,1
1,GO REGULATION OF WOUND HEALING,8.5867e-06,0.26628,0.28218,1,1
1,GO PHAGOCYTOSIS,1.9136e-07,0.26602,0.28387,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,6.4434e-08,0.26597,0.27176,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,1.2253e-05,0.2657,0.31021,1,1
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,6.8396e-06,0.26549,0.33618,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.5794e-07,0.26535,0.25349,1,1
1,GO MESENCHYME MORPHOGENESIS,0.0011503,0.26526,0.23189,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,3.4098e-06,0.2652,0.27765,1,1
1,GO LIPID STORAGE,5.7582e-06,0.26481,0.22037,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.5022e-05,0.26466,0.19388,1,1
1,GO NECROTIC CELL DEATH,3.5646e-05,0.26456,0.24381,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,1.1375e-05,0.26383,0.27482,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,2.9859e-05,0.26364,0.25801,1,1
1,GO ERK1 AND ERK2 CASCADE,8.1361e-07,0.26318,0.24773,1,1
1,GO GALACTOSE METABOLIC PROCESS,7.2497e-05,0.26272,0.27592,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,3.247e-08,0.26261,0.30329,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,3.4409e-05,0.26251,0.26404,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.8793e-06,0.26244,0.25536,1,1
1,GO CARDIOBLAST DIFFERENTIATION,6.7724e-05,0.26173,0.28575,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,1.2032e-06,0.26129,0.25276,1,1
1,GO CERAMIDE TRANSPORT,2.1621e-05,0.2612,0.26337,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00040857,0.2603,0.29365,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,1.5576e-05,0.26022,0.31764,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0022095,0.25985,0.2946,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00091404,0.25979,0.31164,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.758e-05,0.25967,0.19526,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,8.7316e-05,0.25951,0.26223,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,2.1338e-07,0.25946,0.27729,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00022565,0.25938,0.29628,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,7.9617e-06,0.25925,0.27178,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0026663,0.2592,0.18757,1,1
1,GO RESPONSE TO SALT STRESS,7.8052e-07,0.25843,0.2713,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,1.6457e-05,0.25835,0.27998,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,9.6562e-05,0.25828,0.24262,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,7.6283e-05,0.25814,0.21494,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,9.795e-06,0.25803,0.25662,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.00044103,0.25765,0.21976,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.6782e-07,0.25708,0.25411,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,2.913e-06,0.25662,0.2997,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,8.4424e-05,0.25619,0.2533,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,2.4528e-05,0.25588,0.26012,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00015331,0.25562,0.18062,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,9.2585e-06,0.25551,0.23306,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,4.4807e-06,0.25542,0.2069,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00042128,0.25521,0.24092,1,1
1,GO REGULATION OF OSSIFICATION,0.0001862,0.25519,0.21614,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00015583,0.25456,0.3302,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.6654e-06,0.25439,0.24009,1,1
1,GO ARTERY DEVELOPMENT,0.00073415,0.25433,0.2209,1,1
1,GO PODOSOME ASSEMBLY,3.8924e-05,0.25416,0.31435,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.000662,0.25415,0.22349,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0011021,0.25388,0.21537,1,1
1,GO RESPONSE TO CORTICOSTEROID,1.0557e-05,0.25384,0.21659,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00025215,0.25374,0.18947,1,1
1,GO URETER DEVELOPMENT,0.00022208,0.25372,0.2406,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,3.6567e-07,0.25371,0.34138,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,5.1351e-07,0.2537,0.2459,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,2.1624e-06,0.25369,0.27587,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,5.5412e-06,0.25318,0.23734,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.011e-05,0.25283,0.20865,1,1
1,GO NEURAL CREST CELL MIGRATION,0.00033955,0.25277,0.24475,1,1
1,GO REGULATION OF LIPID STORAGE,3.758e-05,0.25252,0.21262,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.6457e-05,0.2521,0.22108,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0001862,0.25161,0.26675,1,1
1,GO FOREGUT MORPHOGENESIS,3.3214e-05,0.25159,0.27742,1,1
1,GO RIG I SIGNALING PATHWAY,2.7312e-05,0.2515,0.24127,1,1
1,GO OSTEOBLAST DIFFERENTIATION,8.4805e-07,0.25092,0.26538,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0024609,0.25086,0.26583,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,2.0879e-07,0.25014,0.24013,1,1
1,GO MUSCLE CELL PROLIFERATION,1.2604e-07,0.25012,0.26301,1,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.020385,0.2499,0.15662,1,1
1,GO SEQUESTERING OF METAL ION,9.4959e-05,0.24984,0.21247,1,1
1,GO KERATINOCYTE MIGRATION,3.5461e-06,0.24899,0.25199,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.4454e-06,0.24883,0.25018,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,3.1494e-05,0.24865,0.20552,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.0478e-05,0.24781,0.20558,1,1
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,9.6562e-05,0.24744,0.21809,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.0361e-05,0.24715,0.30056,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.017699,0.24705,0.20207,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,2.1621e-05,0.24678,0.28244,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,4.7488e-06,0.24651,0.3117,1,1
1,GO MICROVILLUS ASSEMBLY,0.014332,0.24645,0.16949,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,5.7059e-05,0.24609,0.25765,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,0.003607,0.24594,0.1792,1,1
1,GO STEROL TRANSPORT,9.1829e-05,0.2458,0.21221,1,1
1,GO GASTRULATION,3.0156e-07,0.24577,0.26723,1,1
1,GO ASTROCYTE DEVELOPMENT,6.7105e-06,0.24574,0.26502,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.00015331,0.24569,0.21226,1,1
1,GO GLIAL CELL ACTIVATION,0.00013451,0.24533,0.22866,1,1
1,GO RESPONSE TO VITAMIN D,0.044722,0.24521,0.15223,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,1.6158e-05,0.24498,0.26617,1,1
1,GO RECEPTOR CATABOLIC PROCESS,1.9749e-05,0.24418,0.26252,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.019523,0.24376,0.19327,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0039481,0.24292,0.22145,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.00023294,0.24225,0.20694,1,1
1,GO CHONDROCYTE DIFFERENTIATION,1.2534e-06,0.24196,0.28796,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,4.0657e-06,0.24165,0.28987,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,4.0314e-05,0.24165,0.27078,1,1
1,GO PLASMA MEMBRANE FUSION,0.01829,0.2416,0.18813,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.00034485,0.24156,0.2548,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00013016,0.24114,0.16879,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00055343,0.2406,0.26264,1,1
1,GO SYNCYTIUM FORMATION,4.5233e-07,0.2405,0.32259,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.9613e-05,0.24046,0.25331,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,3.5646e-05,0.2398,0.22617,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.9613e-05,0.23946,0.19324,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,6.0991e-06,0.23943,0.21139,1,1
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.0027381,0.23932,0.21472,1,1
1,GO ERBB2 SIGNALING PATHWAY,1.8701e-05,0.23901,0.22527,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,5.9056e-05,0.23889,0.30589,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.2784e-06,0.23843,0.26652,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0011341,0.23823,0.20014,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,3.628e-05,0.23808,0.23749,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00031414,0.23807,0.22409,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,4.2444e-07,0.23758,0.25556,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.7105e-06,0.23758,0.23116,1,1
1,GO TERPENOID METABOLIC PROCESS,0.003166,0.23686,0.14511,1,1
1,GO DECIDUALIZATION,0.0002117,0.2365,0.31015,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.00011033,0.23615,0.29919,1,1
1,GO CHOLESTEROL EFFLUX,7.7586e-05,0.23615,0.2193,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,8.7502e-06,0.23592,0.29332,1,1
1,GO BONE DEVELOPMENT,1.6761e-05,0.23588,0.22171,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.006444,0.2356,0.16082,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.00026858,0.23559,0.22381,1,1
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.011151,0.23552,0.20589,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,1.0169e-05,0.2354,0.2618,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,1.4472e-05,0.23474,0.226,1,1
1,GO ANIMAL ORGAN REGENERATION,1.0527e-08,0.23441,0.28506,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,6.2175e-05,0.23375,0.22979,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00030449,0.23374,0.23166,1,1
1,GO ERBB SIGNALING PATHWAY,4.8839e-05,0.23374,0.19409,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.9056e-05,0.23337,0.19467,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,1.0557e-05,0.23332,0.27313,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,3.5461e-06,0.23308,0.25943,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,4.2444e-07,0.23303,0.23751,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,2.4091e-05,0.23288,0.20975,1,1
1,GO REGENERATION,2.4305e-07,0.23285,0.2204,1,1
1,GO RESPONSE TO WOUNDING,9.7998e-07,0.23259,0.24657,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,3.5461e-06,0.23205,0.3209,1,1
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.013856,0.23185,0.16678,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,5.1446e-05,0.2318,0.23455,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.8416e-06,0.2318,0.20074,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.00019541,0.23169,0.21023,1,1
1,GO CELLULAR RESPONSE TO LIPID,1.0361e-05,0.23122,0.18783,1,1
1,GO PLATELET ACTIVATION,1.9749e-05,0.23118,0.24327,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,3.3214e-05,0.23117,0.24715,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,1.0361e-05,0.23105,0.23608,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00040857,0.23104,0.17783,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0018256,0.23083,0.20263,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.4771e-05,0.23061,0.21488,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,2.0853e-05,0.23055,0.25799,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,8.5867e-06,0.23037,0.19607,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,7.3803e-06,0.2302,0.20875,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,2.2958e-06,0.22958,0.27637,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,5.4184e-05,0.22957,0.22946,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,4.2271e-06,0.22956,0.23938,1,1
1,GO VESICLE CARGO LOADING,2.7312e-05,0.22942,0.22895,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,3.0395e-05,0.22914,0.17425,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,8.4424e-05,0.22907,0.21225,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,7.3739e-05,0.22839,0.20147,1,1
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00057029,0.22833,0.23187,1,1
1,GO ASTROCYTE ACTIVATION,6.2175e-05,0.22822,0.22181,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,7.6283e-05,0.22794,0.21229,1,1
1,GO UV PROTECTION,0.0021505,0.22784,0.21662,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0046604,0.22777,0.29698,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00024045,0.22744,0.18023,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00032408,0.22736,0.18673,1,1
1,GO FACE DEVELOPMENT,3.2631e-05,0.22717,0.25319,1,1
1,GO REGULATION OF LIPASE ACTIVITY,2.8001e-06,0.22707,0.22258,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.000286,0.22705,0.22895,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,2.342e-06,0.22689,0.22479,1,1
1,GO RETINOL METABOLIC PROCESS,0.00024819,0.22641,0.19396,1,1
1,GO RESPONSE TO VITAMIN A,0.00046165,0.22597,0.20737,1,1
1,GO BONE MORPHOGENESIS,1.9749e-05,0.22581,0.24695,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.00044103,0.22577,0.19252,1,1
1,GO MESENCHYME DEVELOPMENT,4.7172e-05,0.22563,0.20332,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,1.9393e-05,0.22551,0.21674,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00091404,0.2254,0.18776,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.00029976,0.22516,0.18519,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.3256e-05,0.22484,0.21206,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00039622,0.2247,0.24612,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0027381,0.22453,0.28889,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,9.819e-05,0.22448,0.19016,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,4.0314e-05,0.2244,0.31901,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,6.7105e-06,0.22406,0.23854,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00076726,0.22405,0.19069,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,4.3946e-06,0.22394,0.26045,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,2.5884e-05,0.22363,0.28719,1,1
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00042777,0.22335,0.2159,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,4.3997e-05,0.22289,0.18338,1,1
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00092737,0.22276,0.19719,1,1
1,GO ACUTE PHASE RESPONSE,0.012087,0.22253,0.14662,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,6.0079e-05,0.22202,0.3014,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,7.2497e-05,0.222,0.23847,1,1
1,GO IRON ION HOMEOSTASIS,1.2534e-06,0.22194,0.20476,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00039622,0.22188,0.20312,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,6.4434e-08,0.22181,0.25608,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,6.7105e-06,0.22154,0.24297,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,1.4472e-05,0.22057,0.24815,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00046165,0.22044,0.25881,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00047589,0.21923,0.27446,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,8.7316e-05,0.21841,0.28099,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.6994e-06,0.21835,0.2103,1,1
1,GO OSSIFICATION,4.1026e-05,0.21832,0.20663,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.6202e-07,0.21799,0.23029,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00013899,0.2178,0.27199,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00059648,0.21715,0.19951,1,1
1,GO BONE MATURATION,0.03006,0.21704,0.12006,1,1
1,GO CARNITINE METABOLIC PROCESS,0.0018006,0.21674,0.20382,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0014624,0.21623,0.2459,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.795e-06,0.21609,0.2343,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.8793e-06,0.21605,0.24923,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0012005,0.21549,0.17006,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0018764,0.21541,0.25999,1,1
1,GO TUBE MORPHOGENESIS,1.7385e-05,0.21472,0.2064,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00095459,0.21415,0.25044,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00044103,0.21385,0.2242,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.996e-06,0.21376,0.27437,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,9.4959e-05,0.21367,0.20173,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00037257,0.21367,0.22866,1,1
1,GO LIVER MORPHOGENESIS,0.01585,0.21354,0.17552,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00044781,0.21345,0.19396,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00082553,0.21333,0.18437,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,2.8305e-05,0.21331,0.24083,1,1
1,GO REGULATION OF BODY FLUID LEVELS,6.7724e-05,0.21301,0.18435,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,7.105e-06,0.21288,0.26787,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0007786,0.21255,0.14005,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,7.6283e-05,0.21244,0.22036,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0028872,0.2123,0.1997,1,1
1,GO REPLACEMENT OSSIFICATION,0.00040235,0.21211,0.26383,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0002443,0.21197,0.16411,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,1.4207e-05,0.2119,0.20626,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,7.2414e-06,0.21187,0.2236,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.1316e-06,0.21177,0.23642,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.011813,0.21163,0.1585,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00015838,0.2116,0.22205,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.9393e-05,0.21082,0.29737,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0005133,0.21081,0.22638,1,1
1,GO FLUID TRANSPORT,0.00037835,0.2108,0.19357,1,1
1,GO LAMELLIPODIUM ORGANIZATION,9.03e-05,0.21067,0.20005,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00020504,0.21022,0.17979,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,4.9694e-05,0.21014,0.194,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0002443,0.21009,0.17778,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0056255,0.2098,0.13796,1,1
1,GO REGULATION OF HEMOPOIESIS,2.8001e-06,0.20947,0.1917,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.00010323,0.20912,0.18507,1,1
1,GO NEGATIVE CHEMOTAXIS,0.0049019,0.20898,0.2178,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,5.7051e-07,0.20882,0.21516,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00020178,0.20872,0.16092,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0020929,0.20867,0.18791,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00025617,0.20854,0.22349,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0047198,0.20852,0.17289,1,1
1,GO ISOPRENOID METABOLIC PROCESS,0.0022095,0.20847,0.13233,1,1
1,GO PLACENTA DEVELOPMENT,0.00014839,0.20845,0.18313,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0087156,0.20799,0.17563,1,1
1,GO REGULATION OF HEART GROWTH,9.9844e-05,0.20778,0.19791,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,6.1119e-05,0.20778,0.20538,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,2.4972e-05,0.20749,0.23603,1,1
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.017315,0.20722,0.1815,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.31e-06,0.20721,0.2196,1,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.010645,0.20707,0.17445,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.4163e-06,0.20692,0.22224,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0007786,0.20677,0.17736,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.7172e-05,0.20671,0.19719,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.0361e-05,0.20645,0.20556,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.00027716,0.20645,0.19648,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0068504,0.20624,0.18042,1,1
1,GO ERAD PATHWAY,4.7999e-05,0.2058,0.15797,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00073415,0.20575,0.20421,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.003607,0.2056,0.20692,1,1
1,GO SYMBIOTIC PROCESS,2.2775e-07,0.20557,0.17385,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0010259,0.20546,0.17324,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,4.2487e-05,0.20522,0.21912,1,1
1,GO CARTILAGE DEVELOPMENT,1.9563e-06,0.20479,0.25421,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.0041031,0.20476,0.27026,1,1
1,GO MUSCLE FILAMENT SLIDING,1.3442e-05,0.20449,0.21944,1,1
1,GO REGULATION OF CELL FATE SPECIFICATION,0.040981,0.20428,0.17481,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0005133,0.20423,0.27195,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0022095,0.20392,0.18844,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,9.404e-07,0.20377,0.19339,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00012388,0.20368,0.23761,1,1
1,GO TRACHEA MORPHOGENESIS,1.9749e-05,0.20358,0.31232,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,9.03e-05,0.20336,0.16775,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0013633,0.20334,0.16658,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.00095459,0.20281,0.20531,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0054872,0.20281,0.14799,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,9.03e-05,0.20223,0.23411,1,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0043184,0.2018,0.18097,1,1
1,GO PROSTATE GLAND GROWTH,0.034984,0.20115,0.21959,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00044103,0.20106,0.15607,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.010041,0.20043,0.18224,1,1
1,GO HINDLIMB MORPHOGENESIS,0.0023637,0.19993,0.20132,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00030449,0.19954,0.19444,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00067188,0.19953,0.129,1,1
1,GO RESPONSE TO ANTIBIOTIC,4.1456e-06,0.19917,0.18903,1,1
1,GO RESPONSE TO UV C,0.0025961,0.1991,0.15576,1,1
1,GO AMELOGENESIS,0.019523,0.19895,0.16768,1,1
1,GO PEPTIDE CATABOLIC PROCESS,5.9834e-06,0.19884,0.24932,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0068504,0.19843,0.13227,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,0.00010152,0.19757,0.21973,1,1
1,GO BIOLOGICAL ADHESION,0.0021505,0.19754,0.15149,1,1
1,GO MYOTUBE DIFFERENTIATION,0.0032078,0.19713,0.14781,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.5884e-05,0.19712,0.17223,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,1.8701e-05,0.1971,0.22773,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00025215,0.1966,0.18994,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00010673,0.1965,0.19113,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,4.2271e-06,0.19592,0.29614,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,5.1304e-06,0.1958,0.24055,1,1
1,GO FATTY ACID BETA OXIDATION,0.0005211,0.19557,0.16025,1,1
1,GO BIOMINERALIZATION,0.0062877,0.19554,0.16172,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.1375e-05,0.19545,0.22749,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0010259,0.19508,0.18136,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0005618,0.19508,0.19979,1,1
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.018693,0.19477,0.16041,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00067188,0.19465,0.18363,1,1
1,GO VIRAL TRANSLATION,0.0020092,0.19421,0.18662,1,1
1,GO GLIAL CELL MIGRATION,0.0028492,0.19409,0.17315,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,5.7582e-06,0.19402,0.19849,1,1
1,GO PROTEIN KINASE B SIGNALING,2.0853e-05,0.19376,0.18692,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.7312e-05,0.19361,0.19449,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.00019857,0.19298,0.18285,1,1
1,GO RECEPTOR RECYCLING,0.0010259,0.19294,0.14491,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.7385e-05,0.19293,0.2077,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.033948,0.19249,0.13735,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00013016,0.19241,0.19426,1,1
1,GO VIRAL GENE EXPRESSION,0.0050269,0.19208,0.13252,1,1
1,GO STRESS FIBER ASSEMBLY,0.00032408,0.19204,0.21861,1,1
1,GO ANIMAL ORGAN FORMATION,0.0013255,0.19194,0.18634,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00091404,0.19161,0.17151,1,1
1,GO PROTEIN KINASE A SIGNALING,0.0002117,0.19144,0.16482,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00064263,0.19133,0.22295,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00036686,0.19131,0.14598,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.013856,0.1912,0.14751,1,1
1,GO AUTOPHAGOSOME MATURATION,2.7312e-05,0.19093,0.1818,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.00011218,0.1909,0.16665,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0005056,0.1906,0.18115,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0018006,0.19022,0.21271,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,6.2175e-05,0.18981,0.17303,1,1
1,GO DETOXIFICATION,0.00084997,0.18971,0.13878,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.037509,0.18971,0.13882,1,1
1,GO PLATELET MORPHOGENESIS,0.0010113,0.18963,0.20697,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.0037985,0.18956,0.13723,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,6.7105e-06,0.18929,0.21517,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.00022565,0.18912,0.16716,1,1
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.011411,0.18909,0.1424,1,1
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.036409,0.18897,0.11921,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,0.0007786,0.18871,0.20842,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,7.6283e-05,0.18853,0.22406,1,1
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00094089,0.18837,0.17453,1,1
1,GO SELECTIVE AUTOPHAGY,3.2146e-06,0.18828,0.19109,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.002702,0.18826,0.16843,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0025617,0.18819,0.16806,1,1
1,GO RESPONSE TO LIPID,0.00014599,0.18815,0.16094,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,3.2146e-06,0.18784,0.16981,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.8983e-07,0.18783,0.18386,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.0060595,0.18779,0.1566,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.001422,0.18743,0.17822,1,1
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0052197,0.18739,0.15365,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,6.545e-05,0.18732,0.16185,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0013633,0.18675,0.1374,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,1.996e-06,0.18651,0.18399,1,1
1,GO LIPID OXIDATION,0.00045468,0.18611,0.15389,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0044298,0.18589,0.14997,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00012594,0.18582,0.15423,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,2.9859e-05,0.1856,0.22309,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.4207e-05,0.1851,0.22395,1,1
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0028872,0.18504,0.18751,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,4.2487e-05,0.18463,0.1865,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.1806e-05,0.1846,0.16118,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,7.2414e-06,0.18444,0.20086,1,1
1,GO RESPONSE TO IONIZING RADIATION,4.0314e-05,0.18402,0.16264,1,1
1,GO POSITIVE REGULATION OF OSSIFICATION,0.001442,0.18399,0.22238,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00010497,0.18349,0.15279,1,1
1,GO MESODERM MORPHOGENESIS,7.6657e-06,0.18319,0.2158,1,1
1,GO PRIMARY MIRNA PROCESSING,0.0029645,0.18315,0.15815,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,8.3013e-05,0.1829,0.13578,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.0011341,0.18289,0.1752,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.022686,0.18243,0.11838,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0012705,0.18243,0.16572,1,1
1,GO TOXIN TRANSPORT,0.0039992,0.18238,0.12952,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.2631e-05,0.18219,0.18386,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00020178,0.18205,0.22117,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00038422,0.18198,0.18818,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.0047798,0.18187,0.14352,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0003557,0.1817,0.18807,1,1
1,GO HEAD MORPHOGENESIS,0.00060545,0.1817,0.23671,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00018323,0.18165,0.16533,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0005133,0.18146,0.17769,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,8.0256e-05,0.1814,0.17597,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0022095,0.18117,0.21136,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,1.1165e-05,0.18078,0.22082,1,1
1,GO RESPONSE TO AMYLOID BETA,0.056652,0.18072,0.10864,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.2281e-06,0.18063,0.21373,1,1
1,GO RESPONSE TO ISCHEMIA,0.00068191,0.18028,0.1735,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,9.6129e-06,0.18003,0.1569,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,1.0958e-05,0.17991,0.19978,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00025617,0.1799,0.22123,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00060545,0.1799,0.17547,1,1
1,GO PORE COMPLEX ASSEMBLY,0.0052854,0.17987,0.12532,1,1
1,GO MATURATION OF LSU RRNA,0.021053,0.17973,0.142,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,3.8246e-05,0.1797,0.17118,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0005133,0.17968,0.19736,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.00019541,0.17957,0.21078,1,1
1,GO REGULATION OF MRNA BINDING,0.019735,0.17876,0.1415,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00020835,0.1787,0.14516,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.0094686,0.17817,0.17172,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00080175,0.17811,0.18146,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.012087,0.17808,0.13085,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,9.6562e-05,0.17801,0.16516,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00054518,0.17772,0.22869,1,1
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.021053,0.17764,0.17588,1,1
1,GO PENTOSE METABOLIC PROCESS,0.01251,0.1773,0.15014,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0018508,0.17727,0.18036,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.013243,0.17726,0.1335,1,1
1,GO REGULATION OF URINE VOLUME,2.2416e-05,0.17706,0.21795,1,1
1,GO FEMALE GENITALIA DEVELOPMENT,0.0070192,0.17649,0.18011,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.0003557,0.17643,0.1952,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,4.3997e-05,0.17634,0.16979,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00028155,0.17634,0.17329,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00016901,0.17591,0.16897,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.00064263,0.17578,0.15643,1,1
1,GO REGULATION OF PROTEOLYSIS,1.6457e-05,0.17573,0.16691,1,1
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0022095,0.17554,0.15119,1,1
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0032078,0.17519,0.15372,1,1
1,GO PIGMENT METABOLIC PROCESS,0.00011986,0.17494,0.15822,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00096848,0.17476,0.15824,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,8.0256e-05,0.17461,0.18759,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,4.7999e-05,0.17433,0.21322,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.5014e-05,0.17428,0.20744,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,2.2015e-05,0.17416,0.185,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,8.2686e-06,0.17415,0.16189,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0003557,0.17415,0.14199,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00072342,0.17404,0.20969,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.00043435,0.17399,0.20923,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00062378,0.17378,0.1401,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0022396,0.17368,0.16691,1,1
1,GO REGULATION OF VASOCONSTRICTION,7.5001e-05,0.17365,0.21921,1,1
1,GO TUBE DEVELOPMENT,0.00021857,0.17363,0.17103,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.00048316,0.17328,0.16041,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00095459,0.17326,0.1833,1,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.027686,0.17319,0.15741,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0023321,0.17289,0.14252,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.03429,0.17277,0.12523,1,1
1,GO RESPONSE TO CORTICOSTERONE,0.031953,0.17247,0.1346,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0098086,0.1723,0.16909,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0023957,0.17202,0.15922,1,1
1,GO REGULATION OF FATTY ACID OXIDATION,0.0098086,0.17195,0.14357,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,4.7172e-05,0.17189,0.16548,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.00055343,0.17186,0.15259,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.4207e-05,0.17166,0.1679,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,2.6352e-05,0.17148,0.22077,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.0063654,0.17134,0.14132,1,1
1,GO REGULATION OF ORGAN GROWTH,9.6129e-06,0.1713,0.20681,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00087508,0.17091,0.26118,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0016806,0.1707,0.18175,1,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0047198,0.17066,0.21341,1,1
1,GO CELLULAR RESPONSE TO FATTY ACID,0.056128,0.17059,0.11454,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0087156,0.17047,0.15201,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0024609,0.17023,0.16025,1,1
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.027973,0.16999,0.11576,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0031247,0.16991,0.19339,1,1
1,GO MANGANESE ION TRANSPORT,0.0015038,0.16951,0.16699,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0001862,0.16942,0.15877,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00049802,0.1693,0.19896,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0020929,0.16921,0.15796,1,1
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.0011503,0.16868,0.1641,1,1
1,GO ORGAN GROWTH,0.0001803,0.16852,0.18071,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.5646e-05,0.16816,0.2334,1,1
1,GO LAMELLIPODIUM ASSEMBLY,0.00017741,0.16803,0.18501,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0025617,0.16795,0.17356,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0024281,0.16792,0.21061,1,1
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0021215,0.16783,0.17535,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00055343,0.1677,0.15599,1,1
1,GO REGULATION OF CELL AGING,2.5424e-05,0.16707,0.17504,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00074504,0.16707,0.20451,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.6828e-05,0.16706,0.2175,1,1
1,GO MRNA TRANSCRIPTION,0.00030928,0.16702,0.21057,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.1165e-05,0.16672,0.18991,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00095459,0.16671,0.15689,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.02174,0.16638,0.13303,1,1
1,GO RESPONSE TO GAMMA RADIATION,0.00016629,0.16624,0.15973,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,8.3013e-05,0.16592,0.18108,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0011836,0.1659,0.13656,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.0095807,0.16588,0.11023,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00082553,0.16586,0.17556,1,1
1,GO CELL MOTILITY,0.0021798,0.16582,0.13409,1,1
1,GO BONE REMODELING,0.00061456,0.1657,0.20829,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,2.3661e-05,0.16562,0.18084,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0013255,0.1656,0.12471,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.035336,0.16558,0.11178,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0053519,0.16555,0.15624,1,1
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.041789,0.16536,0.157,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00075607,0.16522,0.15159,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00024045,0.16519,0.17488,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.01995,0.16515,0.16638,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0098086,0.16492,0.1384,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.0054192,0.16462,0.12458,1,1
1,GO HISTONE H2B UBIQUITINATION,0.033271,0.16454,0.091089,1,1
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0019819,0.16417,0.18503,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.031953,0.16414,0.17453,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00052901,0.16413,0.15129,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00022208,0.16406,0.18935,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00032916,0.16367,0.18608,1,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0023957,0.16338,0.14614,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0031247,0.16336,0.18997,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0021505,0.16323,0.17718,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.002631,0.16317,0.21688,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,8.9166e-06,0.16308,0.16313,1,1
1,GO HISTONE PHOSPHORYLATION,0.0012177,0.16306,0.13283,1,1
1,GO RESPONSE TO NUTRIENT,0.00081356,0.16282,0.16288,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0059852,0.16278,0.24668,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,6.8396e-06,0.16259,0.1662,1,1
1,GO HEART MORPHOGENESIS,0.0032928,0.162,0.14478,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.012945,0.16166,0.14582,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00019857,0.16166,0.15974,1,1
1,GO MEMBRANE DISASSEMBLY,0.018091,0.16153,0.14285,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0059116,0.16102,0.14724,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00159,0.16067,0.11156,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0021215,0.16062,0.11985,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0086125,0.16051,0.1393,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0016575,0.1604,0.14178,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,1.9749e-05,0.16039,0.17874,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.00016098,0.16005,0.14318,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.0083098,0.16004,0.22695,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.011813,0.15968,0.10497,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00060545,0.15956,0.15404,1,1
1,GO CELL AGING,6.6578e-05,0.15954,0.14911,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.00026024,0.15915,0.16032,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0032928,0.15914,0.13831,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0080166,0.15899,0.17633,1,1
1,GO MUSCLE ADAPTATION,0.010279,0.15847,0.12686,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0011341,0.15826,0.10521,1,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0063654,0.15808,0.15611,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.012945,0.15792,0.18225,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.035691,0.15777,0.12155,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.02945,0.15758,0.12025,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0081133,0.15743,0.15727,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0030038,0.15732,0.11947,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00026438,0.15731,0.16279,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,4.5558e-05,0.15726,0.17525,1,1
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.043444,0.1572,0.15919,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.001235,0.15719,0.19873,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.9393e-05,0.15702,0.17943,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0032928,0.15692,0.13228,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0037016,0.15685,0.19962,1,1
1,GO REGULATION OF MAPK CASCADE,0.00013451,0.15666,0.16111,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0003557,0.15644,0.13722,1,1
1,GO STEM CELL DIFFERENTIATION,2.5424e-05,0.15643,0.15939,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0043184,0.15637,0.12493,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.4262e-06,0.15625,0.15939,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0016806,0.15621,0.12278,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00036686,0.15619,0.14345,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.001071,0.15609,0.12918,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.013394,0.15604,0.10496,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00069207,0.1558,0.14038,1,1
1,GO VESICLE TARGETING,0.0028118,0.15574,0.12313,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0005618,0.15562,0.15171,1,1
1,GO CELLULAR RESPONSE TO KETONE,0.019104,0.15538,0.1151,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0018764,0.15487,0.12132,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00014362,0.15484,0.16422,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.00039622,0.15466,0.13118,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.001955,0.15466,0.15041,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.00022208,0.15465,0.14885,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0093576,0.1546,0.14151,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.0011341,0.15458,0.16785,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.01995,0.15457,0.12249,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00090088,0.15449,0.1514,1,1
1,GO PROTEIN PROCESSING,0.00033955,0.15417,0.15149,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.00031414,0.15411,0.13588,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.00030449,0.15385,0.24828,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.001071,0.15363,0.15053,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,3.628e-05,0.15344,0.21576,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.01829,0.1532,0.08894,1,1
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.015674,0.153,0.18968,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0010113,0.15295,0.12048,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.015501,0.15295,0.12069,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.027401,0.15291,0.12853,1,1
1,GO CELL CELL RECOGNITION,2.4528e-05,0.15286,0.14847,1,1
1,GO HEART TRABECULA FORMATION,0.010522,0.15255,0.21994,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,3.9872e-06,0.15242,0.17127,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0021505,0.15242,0.15424,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00087508,0.15241,0.18359,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0072795,0.15222,0.15096,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.011022,0.1518,0.10486,1,1
1,GO MEMBRANE BIOGENESIS,0.0085105,0.15165,0.17209,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00083767,0.15149,0.12736,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0005211,0.15145,0.13161,1,1
1,GO MYELOID CELL DEVELOPMENT,0.031953,0.1513,0.11378,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00020835,0.15087,0.14332,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00049053,0.1508,0.14364,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,2.8814e-05,0.15065,0.14439,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,2.011e-05,0.15061,0.14915,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.0071051,0.15055,0.13329,1,1
1,GO RESPONSE TO BMP,0.024947,0.15001,0.13084,1,1
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0029645,0.14992,0.1466,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,1.5865e-05,0.14986,0.15116,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0020929,0.14976,0.13429,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.00069207,0.14961,0.16722,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0075485,0.14956,0.16004,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00034485,0.14946,0.13569,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00031414,0.14931,0.15478,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0023637,0.14927,0.16502,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.00081356,0.14902,0.13442,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00029511,0.14894,0.13963,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,7.6283e-05,0.14882,0.17501,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0015463,0.14857,0.13509,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00019541,0.14857,0.16193,1,1
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.022686,0.1485,0.11594,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.0050904,0.14839,0.11883,1,1
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.03902,0.14817,0.12828,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00068191,0.14813,0.13057,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00026858,0.14777,0.14228,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.0098086,0.14773,0.15885,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0027381,0.14771,0.16482,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.014823,0.14763,0.13913,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.022209,0.14735,0.13165,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0069343,0.14726,0.17825,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0066039,0.14695,0.12448,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0050904,0.14658,0.11532,1,1
1,GO MAMMARY GLAND DEVELOPMENT,0.013394,0.14656,0.12894,1,1
1,GO LYSOSOMAL TRANSPORT,0.0014022,0.14638,0.13185,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0030038,0.14571,0.15339,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,9.03e-05,0.14555,0.18956,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0010865,0.14554,0.14594,1,1
1,GO RESPONSE TO ESTRADIOL,0.001955,0.14521,0.14341,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,6.4341e-05,0.14501,0.12335,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00058763,0.1449,0.1377,1,1
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.038258,0.14476,0.10883,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.010041,0.14473,0.15176,1,1
1,GO CELLULAR RESPONSE TO DRUG,0.0029645,0.14433,0.11515,1,1
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.027401,0.14416,0.1315,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.059331,0.14394,0.12811,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0035605,0.14348,0.12578,1,1
1,GO RESPONSE TO GROWTH FACTOR,0.0005133,0.14335,0.15113,1,1
1,GO HEART GROWTH,0.00090088,0.14334,0.15668,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0016806,0.14323,0.12344,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.0018256,0.14306,0.12136,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00029976,0.14284,0.13794,1,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.033608,0.14275,0.14658,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0023321,0.1427,0.12366,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.0039481,0.14254,0.1374,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.002631,0.14241,0.11674,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00087508,0.1423,0.10262,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0044298,0.14214,0.11769,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.01251,0.14206,0.12848,1,1
1,GO JNK CASCADE,0.014658,0.14203,0.095648,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.0025961,0.14168,0.15491,1,1
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.02521,0.1416,0.11044,1,1
1,GO HISTONE H4 DEACETYLATION,0.025475,0.1413,0.15197,1,1
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.025743,0.14075,0.11497,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0096941,0.14064,0.11731,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.0027747,0.1405,0.15208,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.049212,0.1403,0.11353,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,7.5001e-05,0.14025,0.13996,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.002631,0.13985,0.12813,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.0065235,0.13981,0.15967,1,1
1,GO CYTOKINETIC PROCESS,0.00071283,0.13971,0.1575,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,8.2686e-06,0.13939,0.17357,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00017176,0.13928,0.14051,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0042636,0.13892,0.10899,1,1
1,GO REGULATION OF RESPONSE TO STRESS,8.1623e-05,0.13857,0.13215,1,1
1,GO RIBOSOME ASSEMBLY,0.035691,0.13854,0.10379,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.0085105,0.13844,0.11277,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00021857,0.1384,0.18097,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0016347,0.13831,0.1297,1,1
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.011022,0.13774,0.1316,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00049802,0.13744,0.12108,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.001422,0.13713,0.1363,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00039018,0.13697,0.11561,1,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.050154,0.13696,0.10507,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0077327,0.13682,0.098771,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0032078,0.13676,0.093677,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,9.4959e-05,0.13667,0.14315,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0056958,0.13666,0.10608,1,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.023419,0.13658,0.10116,1,1
1,GO CAMP METABOLIC PROCESS,0.013093,0.13651,0.18751,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.014494,0.13649,0.15002,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.8701e-05,0.13648,0.16386,1,1
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0007786,0.13634,0.16714,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0016806,0.13628,0.153,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00065224,0.13582,0.14658,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00064263,0.13564,0.11933,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0005211,0.13535,0.12886,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.018091,0.13529,0.09615,1,1
1,GO RESPONSE TO KETONE,0.0054192,0.13511,0.12386,1,1
1,GO MULTI ORGANISM LOCALIZATION,0.00015838,0.13499,0.15349,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.055093,0.13478,0.090225,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0007901,0.13468,0.13963,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.2487e-05,0.13463,0.1462,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00062378,0.13459,0.12015,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.016568,0.13431,0.14564,1,1
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.027118,0.13427,0.13985,1,1
1,GO REGULATION OF CELL DEATH,0.00059648,0.1337,0.11625,1,1
1,GO CELLULAR PIGMENTATION,0.0050269,0.13321,0.11844,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0034243,0.13321,0.16947,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0066851,0.13315,0.12571,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,8.7316e-05,0.1331,0.13208,1,1
1,GO DNA LIGATION,0.046921,0.13285,0.093881,1,1
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.0027747,0.1328,0.12667,1,1
1,GO INACTIVATION OF MAPK ACTIVITY,0.0031247,0.13258,0.21323,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,3.628e-05,0.13229,0.14089,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0085105,0.13211,0.094127,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030928,0.13167,0.13422,1,1
1,GO RESPONSE TO HORMONE,0.0028492,0.1316,0.11149,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.0087156,0.13155,0.12793,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0087156,0.1314,0.15645,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0065235,0.13108,0.11019,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.0022396,0.13068,0.12647,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00015331,0.13053,0.1243,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0028872,0.13048,0.11067,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.01251,0.13047,0.10532,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.0075485,0.13033,0.14688,1,1
1,GO NEURAL TUBE FORMATION,0.015501,0.13024,0.11354,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00025215,0.13023,0.13414,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0069343,0.13009,0.14486,1,1
1,GO TRANSLATIONAL INITIATION,0.01995,0.13006,0.11135,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00011596,0.12992,0.1478,1,1
1,GO SULFATION,0.010279,0.12982,0.15908,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.027973,0.12965,0.10566,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00049053,0.12954,0.13684,1,1
1,GO MUSCLE TISSUE DEVELOPMENT,0.055093,0.12953,0.084577,1,1
1,GO REGULATION OF PROTEIN BINDING,0.00087508,0.12921,0.13345,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.05063,0.12902,0.066023,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00073415,0.12895,0.16314,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0011341,0.1289,0.13036,1,1
1,GO AGING,0.00015331,0.12886,0.13321,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0033799,0.12841,0.10947,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.014494,0.12828,0.1399,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0054872,0.12821,0.1128,1,1
1,GO MAINTENANCE OF LOCATION,9.03e-05,0.12818,0.13968,1,1
1,GO EXOCYTOSIS,0.0025617,0.12813,0.12746,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0047198,0.12781,0.10571,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.015329,0.12744,0.12472,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0054872,0.12743,0.14968,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0063654,0.12732,0.21868,1,1
1,GO VACUOLAR ACIDIFICATION,0.046921,0.12722,0.090435,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0022095,0.12688,0.11645,1,1
1,GO RESPONSE TO UV,0.0010408,0.12602,0.11443,1,1
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0059116,0.1258,0.17475,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.0017517,0.12568,0.10708,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.001422,0.12558,0.13776,1,1
1,GO REGULATION OF PROTEIN SUMOYLATION,0.00065224,0.12547,0.13057,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.0033361,0.12519,0.11477,1,1
1,GO REGULATION OF GENE SILENCING,0.0074579,0.12518,0.094658,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.021973,0.12476,0.11938,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.001483,0.12443,0.16803,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0016347,0.1241,0.14434,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.031631,0.12392,0.10269,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.017506,0.12388,0.10454,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.014332,0.12362,0.093665,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0028118,0.1236,0.089402,1,1
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.038637,0.12261,0.11604,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.00016629,0.12227,0.13536,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,7.6283e-05,0.12221,0.11175,1,1
1,GO LIPID CATABOLIC PROCESS,0.001568,0.12209,0.11387,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00020504,0.12206,0.10291,1,1
1,GO MATURATION OF 5 8S RRNA,0.058787,0.12202,0.092751,1,1
1,GO PROTEIN POLYUBIQUITINATION,0.0074579,0.12197,0.074813,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00159,0.12179,0.10012,1,1
1,GO HEART DEVELOPMENT,0.0011503,0.12166,0.13953,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.018693,0.12152,0.079034,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.0018256,0.12099,0.14174,1,1
1,GO GOLGI VESICLE TRANSPORT,0.00019541,0.12087,0.11762,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.01251,0.12082,0.10487,1,1
1,GO GOLGI VESICLE BUDDING,0.0056255,0.12039,0.10624,1,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.010041,0.12037,0.12392,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.0052854,0.12032,0.080057,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0005211,0.12015,0.11089,1,1
1,GO COPII COATED VESICLE BUDDING,0.0068504,0.11982,0.10291,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0007786,0.11969,0.13265,1,1
1,GO ENDOCYTOSIS,0.0030839,0.11968,0.10821,1,1
1,GO ENDOCYTIC RECYCLING,0.037882,0.11965,0.093414,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.0024609,0.11958,0.10742,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0005618,0.11957,0.18032,1,1
1,GO BODY FLUID SECRETION,0.0005618,0.11956,0.13451,1,1
1,GO VIRION ASSEMBLY,0.0045438,0.11882,0.10288,1,1
1,GO LIPID MODIFICATION,0.0065235,0.11857,0.099552,1,1
1,GO PROTEIN AUTOPHOSPHORYLATION,0.032607,0.11803,0.088608,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.016752,0.118,0.13415,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.009139,0.1173,0.13916,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.0023321,0.11729,0.11682,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.023919,0.11725,0.13999,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0013069,0.11709,0.12436,1,1
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.040582,0.11684,0.11033,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0001803,0.11669,0.15078,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.027401,0.1162,0.11212,1,1
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.040981,0.11614,0.1091,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00059648,0.11578,0.1201,1,1
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.027401,0.11524,0.097794,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0013633,0.11511,0.10601,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.014172,0.1151,0.092808,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0015249,0.11478,0.099792,1,1
1,GO VACUOLAR TRANSPORT,0.0034692,0.11446,0.10272,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0042636,0.11439,0.10368,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,0.0048405,0.11428,0.11314,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.013093,0.11423,0.11254,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.039406,0.11392,0.10061,1,1
1,GO DNA DEALKYLATION,0.02174,0.11352,0.11116,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00099681,0.1135,0.19015,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0076401,0.11344,0.099455,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,8.1623e-05,0.11342,0.15353,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00075607,0.1134,0.10142,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0062877,0.11338,0.10253,1,1
1,GO RNA DESTABILIZATION,0.006444,0.11336,0.12034,1,1
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0027381,0.11282,0.14066,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,7.5001e-05,0.11264,0.10887,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0032078,0.11255,0.11248,1,1
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0094686,0.11226,0.1408,1,1
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.01585,0.11201,0.091318,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0045438,0.11152,0.09426,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00023294,0.11072,0.10545,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.026286,0.11066,0.12992,1,1
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.020385,0.11024,0.10754,1,1
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.010522,0.11011,0.11184,1,1
1,GO REGULATION OF CATABOLIC PROCESS,0.00020835,0.10986,0.098122,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0026663,0.10981,0.077837,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0021505,0.10972,0.1065,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.015501,0.10969,0.10297,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.010645,0.10962,0.11577,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.0048405,0.10934,0.16797,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.011151,0.10921,0.098538,1,1
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.028556,0.10915,0.094253,1,1
1,GO RESPONSE TO CAMP,0.016568,0.10894,0.12565,1,1
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.017894,0.10879,0.11935,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0071918,0.10869,0.099377,1,1
1,GO PROTEIN DESTABILIZATION,0.045155,0.10823,0.084306,1,1
1,GO MITOTIC CYTOKINESIS,0.036048,0.10777,0.082002,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.016027,0.10758,0.20832,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.018693,0.10737,0.12034,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,8.3013e-05,0.10639,0.11632,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.00099681,0.10615,0.11273,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.012227,0.10596,0.086188,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.003607,0.10534,0.10961,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00082553,0.10516,0.1458,1,1
1,GO MATURATION OF SSU RRNA,0.036409,0.10472,0.12238,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.023919,0.10429,0.048934,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0023009,0.10359,0.11903,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.004964,0.10306,0.09821,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.02174,0.10191,0.093695,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0030038,0.10176,0.10296,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.037139,0.10132,0.12784,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0031247,0.1008,0.08946,1,1
1,GO WHITE FAT CELL DIFFERENTIATION,0.046921,0.098864,0.098154,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.024947,0.098413,0.078281,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.021973,0.097073,0.11504,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,0.013546,0.096797,0.078763,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.033608,0.096433,0.079777,1,1
1,GO MUSCLE CELL DIFFERENTIATION,0.02521,0.096338,0.099459,1,1
1,GO BLASTOCYST FORMATION,0.01829,0.095974,0.085217,1,1
1,GO PEPTIDE METABOLIC PROCESS,0.0024609,0.09431,0.086053,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.015159,0.094128,0.16872,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0010259,0.093734,0.09261,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0034243,0.09284,0.14258,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.059331,0.092803,0.0955,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.009139,0.092253,0.13605,1,1
1,GO MITOPHAGY,0.031631,0.091996,0.1074,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.028264,0.091204,0.086818,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.019104,0.091171,0.052128,1,1
1,GO HORMONE METABOLIC PROCESS,0.033608,0.089974,0.085917,1,1
1,GO MODIFIED AMINO ACID TRANSPORT,0.046921,0.089758,0.091948,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.05063,0.089511,0.076946,1,1
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.048746,0.089476,0.095793,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.036048,0.088997,0.072305,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.016568,0.088575,0.079718,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.045591,0.088246,0.049797,1,1
1,GO RESPONSE TO HEAT,0.0087156,0.087508,0.090157,1,1
1,GO NCRNA PROCESSING,0.046031,0.087071,0.087281,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.016205,0.087037,0.088515,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0037498,0.086732,0.10784,1,1
1,GO SULFATE TRANSPORT,0.041789,0.086067,0.061825,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0021798,0.085929,0.079188,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.00072342,0.085899,0.088224,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0016122,0.085743,0.086112,1,1
1,GO RNA MODIFICATION,0.047372,0.083781,0.075161,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.024173,0.083619,0.083206,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0026663,0.083134,0.10091,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0077327,0.082487,0.099957,1,1
1,GO CELLULAR SENESCENCE,0.0026663,0.080169,0.11688,1,1
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.025743,0.079463,0.094651,1,1
1,GO RNA CATABOLIC PROCESS,0.008211,0.079154,0.087331,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0047798,0.07856,0.12122,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0089251,0.078326,0.079425,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0041031,0.078055,0.096533,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0055559,0.077779,0.079913,1,1
1,GO SPINDLE LOCALIZATION,0.061549,0.077776,0.081615,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.048285,0.077539,0.066446,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,0.001704,0.077234,0.082161,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.050154,0.077116,0.072802,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.060988,0.075706,0.059258,1,1
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.022686,0.073837,0.089924,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.060432,0.073634,0.03472,1,1
1,GO NUCLEAR TRANSPORT,0.049212,0.07299,0.04487,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.040582,0.072539,0.10639,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.039406,0.07175,0.072626,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.046921,0.071628,0.0642,1,1
1,GO NUCLEAR EXPORT,0.05357,0.071586,0.052474,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,0.0032501,0.071524,0.078156,1,1
1,GO ENDOSOMAL TRANSPORT,0.032938,0.071288,0.063717,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.042197,0.070898,0.10937,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.039406,0.069135,0.13882,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.050154,0.068655,0.07375,1,1
1,GO MEMBRANE ORGANIZATION,0.03006,0.068493,0.068547,1,1
1,GO PROTEIN FOLDING,0.048285,0.066629,0.088188,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.034636,0.066477,0.060874,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.041383,0.060824,0.056875,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.037882,0.060814,0.077811,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.021053,0.060771,0.060084,1,1
1,GO PROTEIN TARGETING,0.014494,0.060471,0.072545,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.059879,0.058338,0.037094,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.026286,0.055255,0.074983,1,1
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.00060545,0.51034,0.46943,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00013899,0.47745,0.38582,1,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,2.4091e-05,0.45091,0.48424,1,0
1,GO DETECTION OF OTHER ORGANISM,8.7316e-05,0.41773,0.39633,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.0314e-05,0.40873,0.39178,1,0
1,GO DENDRITIC CELL APOPTOTIC PROCESS,1.8363e-05,0.40519,0.46801,1,0
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.1751e-05,0.40402,0.33662,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00029976,0.40286,0.36843,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.8885e-07,0.39909,0.43088,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00070238,0.39777,0.28419,1,0
1,GO PEPTIDE CROSS LINKING,3.3806e-05,0.39456,0.32447,1,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00042128,0.39228,0.38536,1,0
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,3.6924e-05,0.38966,0.42149,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,2.8305e-05,0.38892,0.39407,1,0
1,GO NOTOCHORD DEVELOPMENT,3.2162e-07,0.38681,0.4633,1,0
1,GO GERMINAL CENTER FORMATION,1.4472e-05,0.38389,0.3888,1,0
1,GO MONOCYTE CHEMOTAXIS,1.7071e-05,0.37962,0.28353,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,7.3803e-06,0.37288,0.34104,1,0
1,GO REGULATION OF CELL KILLING,0.00052901,0.36238,0.2313,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.475e-06,0.35986,0.32532,1,0
1,GO ETHANOL METABOLIC PROCESS,0.0019023,0.35453,0.2517,1,0
1,GO KERATAN SULFATE CATABOLIC PROCESS,4.3946e-06,0.35408,0.41042,1,0
1,GO REGULATION OF TOLERANCE INDUCTION,0.00083767,0.35379,0.29343,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.000286,0.3521,0.35781,1,0
1,GO MACROPHAGE CYTOKINE PRODUCTION,4.3997e-05,0.35166,0.4048,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0028872,0.34377,0.29094,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,2.0478e-05,0.34276,0.36747,1,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.007921,0.34034,0.28723,1,0
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,2.8305e-05,0.33946,0.3943,1,0
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,8.4424e-05,0.3381,0.32978,1,0
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.4972e-05,0.33706,0.27099,1,0
1,GO ALPHA BETA T CELL PROLIFERATION,0.0137,0.33316,0.18998,1,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,9.819e-05,0.33101,0.30247,1,0
1,GO RESPONSE TO PROTOZOAN,5.6085e-05,0.32919,0.32167,1,0
1,GO COMPLEMENT ACTIVATION,4.5233e-07,0.32737,0.40867,1,0
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,7.4873e-07,0.32586,0.31396,1,0
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.5684e-06,0.31808,0.37339,1,0
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00076726,0.31805,0.23482,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.0364e-06,0.31604,0.37773,1,0
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.856e-06,0.31586,0.27788,1,0
1,GO MONONUCLEAR CELL MIGRATION,1.3599e-06,0.31559,0.28551,1,0
1,GO RESPONSE TO HYPEROXIA,2.1338e-07,0.31537,0.3634,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.3806e-05,0.31456,0.2325,1,0
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.1119e-05,0.31121,0.26339,1,0
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0001862,0.3099,0.26104,1,0
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,2.6828e-05,0.30983,0.24299,1,0
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0028118,0.30945,0.28293,1,0
1,GO B CELL MEDIATED IMMUNITY,4.31e-06,0.3094,0.3197,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,1.4741e-05,0.30717,0.37665,1,0
1,GO T CELL MIGRATION,4.31e-06,0.30545,0.27823,1,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,4.6578e-06,0.30413,0.32386,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00013016,0.3041,0.30144,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,7.9617e-06,0.30266,0.26628,1,0
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00024045,0.30173,0.44807,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.4959e-05,0.30158,0.24328,1,0
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.1819e-07,0.29783,0.31396,1,0
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,1.0169e-05,0.29704,0.31492,1,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0085105,0.29598,0.27644,1,0
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.4773e-06,0.29468,0.26311,1,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.014494,0.29436,0.25342,1,0
1,GO INNATE IMMUNE RESPONSE,4.8416e-06,0.29366,0.25206,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00013899,0.2935,0.21332,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.3056e-06,0.29319,0.2805,1,0
1,GO TRACHEA DEVELOPMENT,0.00011406,0.28921,0.31432,1,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0011503,0.28893,0.24054,1,0
1,GO RESPONSE TO PEPTIDOGLYCAN,7.8124e-06,0.28802,0.26105,1,0
1,GO T CELL PROLIFERATION,9.9844e-05,0.28778,0.21741,1,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.00046872,0.28589,0.33866,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00021511,0.2854,0.22937,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.8305e-05,0.28527,0.26753,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.011e-05,0.28465,0.28077,1,0
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0019819,0.28423,0.24665,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00072342,0.28392,0.25803,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00025617,0.28157,0.33155,1,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.0071918,0.28075,0.18485,1,0
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00036124,0.28046,0.23374,1,0
1,GO GLOMERULUS DEVELOPMENT,0.0001179,0.27988,0.29598,1,0
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,9.404e-07,0.27904,0.28393,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.8001e-06,0.27875,0.29732,1,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,8.3013e-05,0.27853,0.23071,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.4773e-06,0.27839,0.30994,1,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.01128,0.27714,0.30782,1,0
1,GO REGULATION OF SPROUTING ANGIOGENESIS,2.538e-07,0.27668,0.31888,1,0
1,GO LYMPHOCYTE MEDIATED IMMUNITY,4.8416e-06,0.2759,0.27695,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00024819,0.27451,0.25043,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0065235,0.27447,0.17905,1,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,1.5576e-05,0.27416,0.29164,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.8049e-05,0.27371,0.24832,1,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.010769,0.27303,0.25019,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0020367,0.27196,0.27745,1,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00019229,0.27178,0.31603,1,0
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.00080175,0.27172,0.26593,1,0
1,GO GRANULOCYTE MIGRATION,1.2716e-05,0.27034,0.23962,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0015249,0.27013,0.22116,1,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.036772,0.2698,0.20531,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00032916,0.2694,0.2075,1,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.00091404,0.26884,0.23495,1,0
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00039622,0.26866,0.22328,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00028155,0.2671,0.27449,1,0
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.001483,0.26562,0.21321,1,0
1,GO STEROID ESTERIFICATION,0.0056958,0.26472,0.21144,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.038637,0.26377,0.17308,1,0
1,GO SPROUTING ANGIOGENESIS,1.0554e-07,0.26324,0.31509,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,2.9859e-05,0.26293,0.26974,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.3442e-05,0.26287,0.25629,1,0
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00027284,0.26256,0.27754,1,0
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00068191,0.26176,0.22646,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,2.8305e-05,0.25956,0.25846,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.6562e-05,0.25952,0.24585,1,0
1,GO ALPHA BETA T CELL ACTIVATION,0.00027716,0.25855,0.21418,1,0
1,GO PARAXIAL MESODERM DEVELOPMENT,6.2175e-05,0.25829,0.29987,1,0
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.5884e-05,0.25787,0.22098,1,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0053519,0.2575,0.22565,1,0
1,GO ACTIN FILAMENT SEVERING,0.0034243,0.25554,0.24992,1,0
1,GO STEM CELL DIVISION,0.0025277,0.25522,0.19704,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,5.7582e-06,0.25496,0.29905,1,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.012653,0.25449,0.25401,1,0
1,GO BLOOD VESSEL REMODELING,0.00011033,0.25445,0.27963,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,4.4771e-05,0.25444,0.24634,1,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0037985,0.2543,0.20261,1,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0013633,0.25374,0.31943,1,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00028155,0.2537,0.2322,1,0
1,GO LEUKOCYTE CELL CELL ADHESION,6.2175e-05,0.25362,0.22557,1,0
1,GO T CELL ACTIVATION,3.6924e-05,0.25276,0.21384,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00028155,0.25265,0.21857,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,1.6761e-05,0.2523,0.22876,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,1.2482e-05,0.25211,0.32538,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00013673,0.25187,0.25424,1,0
1,GO RESPONSE TO THYROID HORMONE,0.00049802,0.25157,0.27214,1,0
1,GO MAMMARY GLAND MORPHOGENESIS,6.9711e-06,0.25139,0.32891,1,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.0007786,0.25131,0.20662,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0012705,0.25071,0.18998,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00047589,0.25059,0.19189,1,0
1,GO RESPONSE TO BACTERIUM,3.4098e-06,0.2497,0.24179,1,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.001704,0.24961,0.2615,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,6.545e-05,0.2489,0.24568,1,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00087508,0.24888,0.2323,1,0
1,GO AORTA DEVELOPMENT,0.0019285,0.24797,0.219,1,0
1,GO FOAM CELL DIFFERENTIATION,5.4184e-05,0.24737,0.29513,1,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.014823,0.24699,0.14729,1,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0059852,0.24675,0.24945,1,0
1,GO REGULATION OF T CELL ACTIVATION,0.00015583,0.24508,0.19759,1,0
1,GO TOOTH MINERALIZATION,0.00034485,0.24465,0.28034,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00012804,0.24349,0.22184,1,0
1,GO MIDGUT DEVELOPMENT,0.0013069,0.24296,0.2696,1,0
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00039018,0.24116,0.31277,1,0
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,1.8363e-05,0.241,0.19772,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.2487e-05,0.24054,0.223,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0019819,0.24041,0.23747,1,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,3.1494e-05,0.24003,0.29414,1,0
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013451,0.23976,0.21286,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00039018,0.23955,0.30728,1,0
1,GO GRANULOCYTE CHEMOTAXIS,0.00012594,0.23912,0.22278,1,0
1,GO PROTEIN DEMANNOSYLATION,0.0014624,0.23908,0.20921,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00084997,0.23901,0.2144,1,0
1,GO RESPONSE TO BIOTIC STIMULUS,4.5684e-06,0.23874,0.21677,1,0
1,GO REPLICATIVE SENESCENCE,0.0044298,0.23736,0.18087,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00096848,0.23592,0.20359,1,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0034692,0.23558,0.34148,1,0
1,GO FIBROBLAST PROLIFERATION,5.8698e-06,0.23531,0.26405,1,0
1,GO LEUKOCYTE PROLIFERATION,0.0001862,0.2353,0.20975,1,0
1,GO CYTOKINE PRODUCTION,2.8001e-06,0.23522,0.23659,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.030368,0.23507,0.22312,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.0015038,0.23412,0.20414,1,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.8396e-06,0.23402,0.26364,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.012798,0.23378,0.20697,1,0
1,GO REGULATION OF PLATELET AGGREGATION,0.040187,0.2337,0.20686,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00071283,0.2331,0.23869,1,0
1,GO LUNG MORPHOGENESIS,0.00013016,0.23283,0.27973,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0050904,0.23274,0.18826,1,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.002702,0.23205,0.24325,1,0
1,GO EOSINOPHIL MIGRATION,0.0021215,0.23194,0.28133,1,0
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,7.7586e-05,0.23192,0.26276,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,2.6828e-05,0.23168,0.22398,1,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010645,0.2312,0.26372,1,0
1,GO HOMOTYPIC CELL CELL ADHESION,0.00022208,0.23112,0.24233,1,0
1,GO REGULATION OF LEUKOCYTE MIGRATION,1.3878e-06,0.2311,0.26861,1,0
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00023667,0.23061,0.21812,1,0
1,GO INTERLEUKIN 17 PRODUCTION,4.1751e-05,0.2303,0.28495,1,0
1,GO CYCLOOXYGENASE PATHWAY,0.023419,0.23022,0.23698,1,0
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00011033,0.23011,0.1813,1,0
1,GO MYOBLAST MIGRATION,0.0018256,0.23004,0.30414,1,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0055559,0.22957,0.2059,1,0
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00017741,0.22955,0.20186,1,0
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0039992,0.22927,0.24314,1,0
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00049802,0.22878,0.19667,1,0
1,GO T CELL CHEMOTAXIS,0.00012388,0.2285,0.19075,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0010865,0.2283,0.22298,1,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,5.7059e-05,0.22732,0.21889,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0013633,0.22715,0.20983,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,2.7452e-06,0.22698,0.26031,1,0
1,GO NADPH REGENERATION,0.0005056,0.22697,0.2023,1,0
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,4.0657e-06,0.2266,0.24145,1,0
1,GO RESPONSE TO DEXAMETHASONE,0.00048316,0.22654,0.20043,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,2.3239e-05,0.22641,0.22286,1,0
1,GO REGULATION OF IMMUNE RESPONSE,9.795e-06,0.22598,0.2087,1,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0024281,0.22562,0.30474,1,0
1,GO CELLULAR EXTRAVASATION,1.6761e-05,0.22533,0.23894,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0071918,0.22518,0.26716,1,0
1,GO POSITIVE REGULATION OF CELL ACTIVATION,4.1751e-05,0.22424,0.21573,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.9102e-06,0.2239,0.21277,1,0
1,GO TISSUE REMODELING,0.00020504,0.22379,0.2346,1,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.022446,0.22282,0.2189,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00034485,0.22282,0.17568,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00076726,0.22256,0.27925,1,0
1,GO REGULATION OF CALCIUM ION IMPORT,4.3236e-05,0.222,0.22726,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.1621e-05,0.2217,0.23313,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.020166,0.2197,0.1179,1,0
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0013633,0.21866,0.24953,1,0
1,GO DEFENSE RESPONSE,1.7706e-05,0.21821,0.20119,1,0
1,GO TONGUE DEVELOPMENT,0.0022396,0.21751,0.21987,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0012005,0.21659,0.20094,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00032408,0.2164,0.23278,1,0
1,GO ACTIVATION OF IMMUNE RESPONSE,1.3196e-05,0.21631,0.19841,1,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.0053519,0.21579,0.18289,1,0
1,GO LEUKOCYTE HOMEOSTASIS,2.8305e-05,0.21555,0.22377,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.9859e-05,0.21543,0.25872,1,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0017277,0.21444,0.22967,1,0
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,2.0776e-06,0.21439,0.24044,1,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.050154,0.21398,0.13841,1,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0012705,0.21391,0.24336,1,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.01585,0.21377,0.17389,1,0
1,GO REGULATION OF BONE DEVELOPMENT,0.00014839,0.21374,0.24159,1,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,1.4207e-05,0.21367,0.23732,1,0
1,GO REGULATION OF CELL ADHESION,0.00018323,0.21345,0.20325,1,0
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0054192,0.21333,0.1942,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00025617,0.21305,0.20441,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.7071e-05,0.21293,0.24989,1,0
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00017176,0.21233,0.19241,1,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0042636,0.21215,0.25997,1,0
1,GO REGULATION OF CELL CELL ADHESION,0.00082553,0.21204,0.17931,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00036686,0.21202,0.20646,1,0
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00029052,0.21161,0.21629,1,0
1,GO NEGATIVE T CELL SELECTION,0.0023009,0.21134,0.21948,1,0
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0048405,0.21118,0.2146,1,0
1,GO INTERFERON GAMMA PRODUCTION,0.00013016,0.21106,0.22519,1,0
1,GO OSTEOCLAST DIFFERENTIATION,2.6386e-06,0.21062,0.2302,1,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0052854,0.21043,0.20008,1,0
1,GO CELL ACTIVATION,6.4592e-06,0.20895,0.20854,1,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.3256e-05,0.20885,0.22145,1,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.034636,0.20869,0.12525,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,5.4356e-06,0.20865,0.26108,1,0
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0032501,0.20821,0.18631,1,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.055609,0.20807,0.1899,1,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,4.0314e-05,0.20791,0.20933,1,0
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,6.4341e-05,0.2076,0.2717,1,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,1.5293e-05,0.20705,0.22734,1,0
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,3.3806e-05,0.20648,0.20232,1,0
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,5.7059e-05,0.20599,0.22289,1,0
1,GO CELLULAR RESPONSE TO VIRUS,0.00025215,0.20563,0.18932,1,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.022686,0.20406,0.1806,1,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.011151,0.20391,0.13877,1,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0027381,0.20363,0.19802,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.013856,0.20363,0.1645,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0013633,0.20362,0.26402,1,0
1,GO INFLAMMATORY RESPONSE,4.1026e-05,0.20341,0.21317,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.0033361,0.20291,0.26873,1,0
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00027716,0.20265,0.26289,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.017125,0.20249,0.14716,1,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0029256,0.2019,0.19245,1,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00090088,0.20141,0.24022,1,0
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,6.4341e-05,0.20141,0.23446,1,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.019312,0.20099,0.20035,1,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00024045,0.19965,0.1788,1,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0034692,0.19896,0.20353,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.2344e-05,0.19874,0.2216,1,0
1,GO DENDRITIC CELL CHEMOTAXIS,0.0104,0.19712,0.16843,1,0
1,GO IMMUNOGLOBULIN PRODUCTION,3.5022e-05,0.19682,0.17208,1,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0030038,0.19681,0.24338,1,0
1,GO HEART VALVE DEVELOPMENT,8.4424e-05,0.19669,0.2768,1,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.021053,0.19651,0.20018,1,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.0034243,0.19621,0.30728,1,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.01251,0.19548,0.19013,1,0
1,GO LYMPHOCYTE CHEMOTAXIS,2.2824e-05,0.19521,0.2184,1,0
1,GO CELL KILLING,0.0016347,0.19413,0.17815,1,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00046872,0.19374,0.18049,1,0
1,GO LEFT RIGHT AXIS SPECIFICATION,0.021973,0.19305,0.19296,1,0
1,GO SECRETION BY TISSUE,0.0085105,0.19286,0.13919,1,0
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.0395e-05,0.1914,0.21697,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00049802,0.19085,0.18355,1,0
1,GO CELL CHEMOTAXIS,0.00023667,0.19072,0.20209,1,0
1,GO REGULATION OF CELL ACTIVATION,4.8839e-05,0.18971,0.20052,1,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,6.6578e-05,0.18969,0.21358,1,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.002631,0.18959,0.15737,1,0
1,GO NEUROBLAST DIVISION,0.049212,0.18956,0.16036,1,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.016568,0.18923,0.19224,1,0
1,GO MYELOID CELL HOMEOSTASIS,8.2686e-06,0.18884,0.18334,1,0
1,GO NEUTROPHIL MIGRATION,0.00029511,0.18879,0.20622,1,0
1,GO LAMELLIPODIUM MORPHOGENESIS,0.022209,0.18866,0.18567,1,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.048746,0.18825,0.15394,1,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0015249,0.18816,0.30045,1,0
1,GO LEUKOCYTE DIFFERENTIATION,9.4959e-05,0.18781,0.18512,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.0015038,0.18769,0.15916,1,0
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,8.4424e-05,0.18701,0.18329,1,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.016568,0.18694,0.16495,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00082553,0.18678,0.19801,1,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0024941,0.18677,0.17602,1,0
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00014362,0.18671,0.1787,1,0
1,GO REGULATION OF DEFENSE RESPONSE,5.6085e-05,0.18663,0.18027,1,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.057711,0.18617,0.27841,1,0
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.003654,0.18537,0.13881,1,0
1,GO RESPONSE TO PROSTAGLANDIN,0.01016,0.18537,0.17674,1,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.043025,0.18535,0.18496,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0012177,0.18529,0.22041,1,0
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00015583,0.18487,0.29576,1,0
1,GO COPPER ION TRANSPORT,0.00015083,0.18454,0.21206,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.052575,0.18418,0.13662,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00061456,0.18394,0.18184,1,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.01585,0.1828,0.16651,1,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0065235,0.1828,0.26647,1,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0085105,0.18271,0.15486,1,0
1,GO LYMPHOCYTE ACTIVATION,3.6924e-05,0.18231,0.19239,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00011218,0.18216,0.18086,1,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0013633,0.1819,0.21423,1,0
1,GO RESPONSE TO PROGESTERONE,0.0045438,0.18189,0.18249,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.011678,0.18172,0.24743,1,0
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.028556,0.18147,0.17037,1,0
1,GO RESPONSE TO INTERLEUKIN 7,0.011813,0.18115,0.12274,1,0
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.00038422,0.18103,0.16366,1,0
1,GO LYMPHOCYTE MIGRATION,3.6924e-05,0.18098,0.22101,1,0
1,GO DENDRITIC CELL MIGRATION,0.028556,0.1808,0.16098,1,0
1,GO ARTERY MORPHOGENESIS,0.026013,0.18072,0.1569,1,0
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0050904,0.18045,0.14549,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0015038,0.18043,0.20495,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0023009,0.1797,0.18345,1,0
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,7.5217e-06,0.17926,0.23115,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,1.1588e-05,0.17798,0.24084,1,0
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00014839,0.17768,0.20072,1,0
1,GO PROTEIN HYDROXYLATION,0.0065235,0.17761,0.2266,1,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.036048,0.17738,0.13959,1,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.00014839,0.17727,0.1569,1,0
1,GO INTERLEUKIN 6 PRODUCTION,0.019735,0.17546,0.14981,1,0
1,GO GLUTATHIONE METABOLIC PROCESS,0.0015463,0.17507,0.15687,1,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.015159,0.17499,0.16888,1,0
1,GO INTERMEMBRANE LIPID TRANSFER,0.00040857,0.17481,0.18358,1,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.039406,0.17477,0.17609,1,0
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00023294,0.17467,0.16137,1,0
1,GO CELL REDOX HOMEOSTASIS,2.8305e-05,0.17434,0.17947,1,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.049212,0.17427,0.15999,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.022209,0.17422,0.18718,1,0
1,GO TETRAPYRROLE METABOLIC PROCESS,4.4771e-05,0.17418,0.1643,1,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0041031,0.17398,0.20058,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0032928,0.17341,0.11924,1,0
1,GO MYELOID CELL DIFFERENTIATION,8.9166e-06,0.17338,0.18313,1,0
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0137,0.17296,0.18021,1,0
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0005211,0.17213,0.15218,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0073682,0.17211,0.12903,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.02174,0.17183,0.12209,1,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00010497,0.17149,0.15426,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00070238,0.17131,0.14507,1,0
1,GO HEPARIN METABOLIC PROCESS,0.00030449,0.17122,0.31928,1,0
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0001179,0.17108,0.22927,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0052197,0.17102,0.20538,1,0
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,6.4341e-05,0.17092,0.20423,1,0
1,GO ACTIVATED T CELL PROLIFERATION,0.0071918,0.17025,0.14572,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.00025617,0.16998,0.18429,1,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.026561,0.16946,0.14698,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,7.3739e-05,0.16933,0.14863,1,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.022209,0.16929,0.1463,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.00043435,0.16913,0.19343,1,0
1,GO ASYMMETRIC CELL DIVISION,0.00019229,0.16913,0.23349,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0055559,0.16905,0.15411,1,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.0021215,0.16837,0.17614,1,0
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00040857,0.16813,0.21705,1,0
1,GO AMYLOID BETA METABOLIC PROCESS,0.0028492,0.16806,0.16478,1,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.017894,0.16795,0.21307,1,0
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00017741,0.16778,0.19523,1,0
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.2954e-05,0.16774,0.19887,1,0
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.4207e-05,0.16728,0.22099,1,0
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.021973,0.16715,0.1861,1,0
1,GO PROGESTERONE METABOLIC PROCESS,0.024428,0.16683,0.16993,1,0
1,GO INTRACELLULAR MRNA LOCALIZATION,0.0013443,0.16633,0.18038,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.01829,0.16614,0.21008,1,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.050154,0.16592,0.19557,1,0
1,GO INTERLEUKIN 4 PRODUCTION,0.0034243,0.1658,0.15928,1,0
1,GO ERYTHROCYTE HOMEOSTASIS,0.00019857,0.16503,0.15005,1,0
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,8.4262e-06,0.16492,0.19271,1,0
1,GO REGULATION OF AMYLOID BETA FORMATION,0.004964,0.16439,0.17802,1,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.035691,0.16409,0.22838,1,0
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,3.152e-06,0.16376,0.18205,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.023173,0.16372,0.14217,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00044781,0.16372,0.15784,1,0
1,GO AXIS ELONGATION,0.010041,0.16335,0.19797,1,0
1,GO ETHER METABOLIC PROCESS,0.0023321,0.16329,0.17263,1,0
1,GO RENAL ABSORPTION,0.035336,0.16315,0.21689,1,0
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00058763,0.16297,0.1541,1,0
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0024941,0.16281,0.20306,1,0
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00092737,0.16274,0.19899,1,0
1,GO TISSUE MORPHOGENESIS,0.00020835,0.16236,0.15118,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.000286,0.16235,0.16064,1,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.013856,0.16209,0.14457,1,0
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0016575,0.16204,0.19607,1,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0022701,0.1613,0.13995,1,0
1,GO SUPEROXIDE ANION GENERATION,0.0048405,0.16039,0.19476,1,0
1,GO METANEPHROS DEVELOPMENT,0.0003557,0.16009,0.18468,1,0
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.052083,0.16002,0.11718,1,0
1,GO T CELL DIFFERENTIATION IN THYMUS,8.0256e-05,0.15776,0.18938,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.01016,0.15774,0.14103,1,0
1,GO AMYLOID BETA FORMATION,0.0052854,0.15766,0.15814,1,0
1,GO GENITALIA DEVELOPMENT,0.0043737,0.15757,0.14204,1,0
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,4.0314e-05,0.15723,0.2285,1,0
1,GO MESODERM DEVELOPMENT,2.9859e-05,0.157,0.15598,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0010259,0.1569,0.1421,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00044781,0.15671,0.1936,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.055093,0.15622,0.16635,1,0
1,GO BODY MORPHOGENESIS,0.0020092,0.15617,0.20035,1,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.01128,0.15607,0.11704,1,0
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0044298,0.15559,0.21674,1,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0041031,0.15542,0.18909,1,0
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,7.6283e-05,0.15531,0.15648,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.00039622,0.15524,0.18449,1,0
1,GO OSTEOBLAST PROLIFERATION,0.028556,0.15504,0.18487,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.1829e-05,0.15501,0.15362,1,0
1,GO LYMPHOCYTE COSTIMULATION,0.0052854,0.15501,0.16675,1,0
1,GO EMBRYONIC EYE MORPHOGENESIS,0.0043184,0.15499,0.20052,1,0
1,GO ENDOTHELIAL CELL PROLIFERATION,6.1119e-05,0.15485,0.23844,1,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.011544,0.15463,0.13129,1,0
1,GO REGULATION OF ANOIKIS,0.03902,0.15437,0.15337,1,0
1,GO IMMUNE SYSTEM DEVELOPMENT,2.8305e-05,0.15406,0.15486,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.00070238,0.15381,0.15944,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.012945,0.15375,0.15173,1,0
1,GO T CELL DIFFERENTIATION,0.0010259,0.15329,0.15527,1,0
1,GO B CELL HOMEOSTASIS,0.028852,0.15318,0.15876,1,0
1,GO ENDOTHELIUM DEVELOPMENT,0.007921,0.15299,0.15721,1,0
1,GO FAT CELL DIFFERENTIATION,0.0024281,0.15226,0.14124,1,0
1,GO GLIAL CELL APOPTOTIC PROCESS,0.00053704,0.15201,0.29754,1,0
1,GO NEUTROPHIL CHEMOTAXIS,0.0044298,0.15159,0.18,1,0
1,GO BONE MINERALIZATION,0.054582,0.15155,0.13612,1,0
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.014823,0.15149,0.10795,1,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.026561,0.15148,0.15452,1,0
1,GO RESPONSE TO CHEMOKINE,0.00040857,0.15136,0.16209,1,0
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00013673,0.15103,0.14848,1,0
1,GO FIBROBLAST ACTIVATION,0.0032501,0.15072,0.20916,1,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.02174,0.1507,0.12941,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0050904,0.15032,0.17438,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,8.3013e-05,0.15024,0.18097,1,0
1,GO LEUKOCYTE MIGRATION,0.00023294,0.14997,0.20439,1,0
1,GO RESPONSE TO INTERLEUKIN 6,0.012227,0.14908,0.13144,1,0
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.026561,0.14872,0.17252,1,0
1,GO RESPONSE TO PH,0.0019023,0.14787,0.16084,1,0
1,GO RESPONSE TO GROWTH HORMONE,0.010895,0.14779,0.17015,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0043737,0.1477,0.18971,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.003607,0.14752,0.19104,1,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.045591,0.14729,0.17711,1,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.024428,0.14723,0.14635,1,0
1,GO EOSINOPHIL CHEMOTAXIS,0.016205,0.14664,0.24926,1,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.0063654,0.14648,0.17467,1,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00159,0.14632,0.16307,1,0
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.2497e-05,0.14575,0.16079,1,0
1,GO REGULATION OF HAIR CYCLE,0.009139,0.14573,0.15346,1,0
1,GO REGULATION OF ODONTOGENESIS,0.0054872,0.14566,0.22224,1,0
1,GO LEUKOCYTE CHEMOTAXIS,0.0042095,0.14542,0.1734,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0032928,0.14535,0.1321,1,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.043866,0.14494,0.18989,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0023321,0.14493,0.14468,1,0
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.001118,0.14482,0.17858,1,0
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0022095,0.14406,0.1733,1,0
1,GO INTERLEUKIN 12 PRODUCTION,0.016568,0.14355,0.16291,1,0
1,GO REGULATION OF TISSUE REMODELING,0.0071051,0.1435,0.16174,1,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.045591,0.14299,0.17169,1,0
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.01016,0.14292,0.15229,1,0
1,GO RESPONSE TO INTERLEUKIN 4,0.00036686,0.14268,0.15167,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0020646,0.14267,0.12558,1,0
1,GO NEPHRON DEVELOPMENT,0.014172,0.14251,0.1401,1,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.041383,0.14244,0.18305,1,0
1,GO CELLULAR IRON ION HOMEOSTASIS,0.00025215,0.14227,0.13361,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00011596,0.14223,0.1865,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.014658,0.14222,0.19919,1,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0013633,0.14194,0.15889,1,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.023668,0.14194,0.14731,1,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.055609,0.14183,0.17332,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00016629,0.1417,0.1784,1,0
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0104,0.14132,0.1487,1,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,9.9844e-05,0.14117,0.19102,1,0
1,GO NEUROINFLAMMATORY RESPONSE,0.0046018,0.14114,0.16043,1,0
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0062108,0.14043,0.12775,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0033799,0.13931,0.1628,1,0
1,GO CELL JUNCTION DISASSEMBLY,0.0024941,0.13915,0.19357,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0022095,0.13891,0.13304,1,0
1,GO CELLULAR KETONE METABOLIC PROCESS,0.00010323,0.13864,0.13509,1,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00049802,0.13857,0.15385,1,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0015249,0.13839,0.14539,1,0
1,GO LIPID IMPORT INTO CELL,0.017506,0.13819,0.14004,1,0
1,GO REGULATION OF VIRAL TRANSCRIPTION,0.00018323,0.13746,0.15243,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0010865,0.13732,0.13082,1,0
1,GO APOPTOTIC SIGNALING PATHWAY,0.001071,0.13714,0.11723,1,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0020367,0.13675,0.13341,1,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0098086,0.13669,0.16846,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0062877,0.1366,0.14548,1,0
1,GO POSITIVE REGULATION OF CELL DEATH,0.0012886,0.13652,0.12338,1,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.012087,0.13565,0.14878,1,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.061549,0.13529,0.11131,1,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02915,0.13521,0.098437,1,0
1,GO GAS TRANSPORT,0.045591,0.13517,0.15248,1,0
1,GO OUTFLOW TRACT MORPHOGENESIS,0.0033799,0.1349,0.21601,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,0.00054518,0.13461,0.14896,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.0046604,0.13457,0.18696,1,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.024428,0.13441,0.11255,1,0
1,GO CELL CELL ADHESION,0.025475,0.13411,0.11157,1,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.043444,0.13365,0.17149,1,0
1,GO NEURAL TUBE DEVELOPMENT,0.0084096,0.13362,0.12248,1,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0088198,0.13353,0.12618,1,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00061456,0.13313,0.15349,1,0
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0038977,0.13281,0.16961,1,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.03006,0.13262,0.19619,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0096941,0.13233,0.13449,1,0
1,GO XENOBIOTIC TRANSPORT,0.0047798,0.13227,0.142,1,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.053071,0.13223,0.11067,1,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.060432,0.1319,0.11909,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.045155,0.13153,0.20325,1,0
1,GO EPITHELIUM DEVELOPMENT,0.027973,0.13121,0.092976,1,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0032078,0.13093,0.18253,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0044298,0.13035,0.12008,1,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.028852,0.12996,0.11534,1,0
1,GO AUTOPHAGOSOME ORGANIZATION,0.00029976,0.12958,0.15309,1,0
1,GO STEROL HOMEOSTASIS,0.0062877,0.12908,0.17308,1,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.0095807,0.12905,0.14183,1,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.011022,0.12895,0.12166,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0089251,0.12801,0.12915,1,0
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.023919,0.12717,0.16554,1,0
1,GO CYTOKINE SECRETION,0.040187,0.12695,0.12159,1,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.02945,0.1267,0.12484,1,0
1,GO B CELL DIFFERENTIATION,0.013394,0.12647,0.14269,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.001118,0.12646,0.15089,1,0
1,GO TONGUE MORPHOGENESIS,0.043025,0.12605,0.15704,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0017517,0.12602,0.12563,1,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0058389,0.12572,0.15837,1,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.033608,0.12513,0.12269,1,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.048285,0.12438,0.10093,1,0
1,GO GTP METABOLIC PROCESS,0.0020646,0.12432,0.17403,1,0
1,GO REGULATION OF B CELL ACTIVATION,0.0033361,0.12424,0.16003,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0013826,0.12361,0.14812,1,0
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0014022,0.12343,0.14661,1,0
1,GO FATTY ACID CATABOLIC PROCESS,0.031311,0.12332,0.092139,1,0
1,GO REGULATION OF HYDROLASE ACTIVITY,0.0032501,0.12321,0.10713,1,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0007901,0.12309,0.19935,1,0
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0038977,0.12277,0.11695,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0053519,0.12238,0.13838,1,0
1,GO REGULATION OF CHEMOTAXIS,0.00088789,0.1223,0.16681,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0022701,0.12202,0.13883,1,0
1,GO ENDOCRINE PROCESS,0.0043184,0.12153,0.1441,1,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.011022,0.12145,0.11494,1,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0010865,0.12113,0.1278,1,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.028852,0.12101,0.1264,1,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.025743,0.12097,0.13287,1,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0044864,0.12094,0.11751,1,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.046031,0.12086,0.10387,1,0
1,GO RUFFLE ORGANIZATION,0.0093576,0.12022,0.11853,1,0
1,GO MITOTIC CELL CYCLE ARREST,0.019104,0.11995,0.12615,1,0
1,GO HUMORAL IMMUNE RESPONSE,0.0054192,0.11979,0.19129,1,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.016027,0.11971,0.1262,1,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.053071,0.11967,0.14838,1,0
1,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0013633,0.11942,0.10705,1,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0057669,0.11877,0.11351,1,0
1,GO MUSCLE ORGAN MORPHOGENESIS,0.028852,0.11876,0.10678,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0016575,0.11823,0.24559,1,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.015159,0.1181,0.11445,1,0
1,GO TRANSCYTOSIS,0.055609,0.11796,0.12324,1,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.001071,0.11785,0.13738,1,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0033361,0.1177,0.10582,1,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0024941,0.11766,0.10702,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0013826,0.1174,0.11197,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.003654,0.11728,0.10499,1,0
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.002631,0.11714,0.13472,1,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.022446,0.11706,0.10743,1,0
1,GO RENAL VESICLE DEVELOPMENT,0.054074,0.11692,0.11777,1,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.022209,0.11692,0.10484,1,0
1,GO DRUG METABOLIC PROCESS,0.019735,0.1168,0.10336,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0016806,0.11626,0.11587,1,0
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.031311,0.11575,0.086091,1,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.056652,0.11571,0.13896,1,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.036772,0.11564,0.10938,1,0
1,GO REGULATION OF MUSCLE ADAPTATION,0.037882,0.11528,0.10599,1,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.028852,0.11523,0.10468,1,0
1,GO CELLULAR RESPONSE TO UV,0.0020092,0.11483,0.11696,1,0
1,GO VACUOLE ORGANIZATION,0.00062378,0.11481,0.12515,1,0
1,GO DENDRITIC SPINE MAINTENANCE,0.032938,0.11481,0.16482,1,0
1,GO RESPONSE TO PEPTIDE,0.0044298,0.11479,0.098498,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.033608,0.11434,0.11531,1,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0010408,0.11432,0.11481,1,0
1,GO TUBE FORMATION,0.044292,0.11401,0.086054,1,0
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0021505,0.11397,0.161,1,0
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0020646,0.1139,0.13409,1,0
1,GO MALE SEX DIFFERENTIATION,0.040187,0.11381,0.089731,1,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.05063,0.11378,0.1125,1,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.016938,0.1129,0.18283,1,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.011813,0.1128,0.11172,1,0
1,GO PROTEIN MATURATION,0.00084997,0.11273,0.11386,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.035336,0.11247,0.11233,1,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.032938,0.11181,0.16745,1,0
1,GO INTEGRIN ACTIVATION,0.0030436,0.11159,0.18809,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00041488,0.1114,0.13299,1,0
1,GO EPITHELIAL TUBE FORMATION,0.056652,0.11129,0.083699,1,0
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0077327,0.11128,0.10567,1,0
1,GO APOPTOTIC PROCESS,0.0013069,0.11105,0.10304,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.017125,0.11072,0.12584,1,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00099681,0.11072,0.14986,1,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.026013,0.1101,0.14191,1,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0015463,0.10971,0.15879,1,0
1,GO ERYTHROCYTE DEVELOPMENT,0.017315,0.10933,0.12318,1,0
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0013443,0.10891,0.16991,1,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.0016347,0.10874,0.15852,1,0
1,GO RESPONSE TO DRUG,0.0083098,0.10852,0.10834,1,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0075485,0.10757,0.11268,1,0
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0053519,0.10735,0.10003,1,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0056958,0.10731,0.13652,1,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.002631,0.10723,0.10327,1,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.011678,0.10721,0.10467,1,0
1,GO REGULATION OF LIPID LOCALIZATION,0.00064263,0.10716,0.16061,1,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0072795,0.10697,0.10564,1,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0042636,0.10694,0.096957,1,0
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.01499,0.10688,0.14216,1,0
1,GO B CELL ACTIVATION,0.0011503,0.10663,0.1629,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0056255,0.10653,0.10497,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.010769,0.10624,0.1001,1,0
1,GO INTRACELLULAR STEROL TRANSPORT,0.02174,0.10616,0.15679,1,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00099681,0.106,0.15595,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0011341,0.10596,0.12359,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.031953,0.10561,0.16782,1,0
1,GO ESTROGEN METABOLIC PROCESS,0.0044298,0.10553,0.12212,1,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.02174,0.1055,0.11148,1,0
1,GO FATTY ACID METABOLIC PROCESS,0.004156,0.105,0.10238,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.026838,0.10424,0.10983,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0015463,0.10422,0.11985,1,0
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.007921,0.1041,0.13526,1,0
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0030038,0.10397,0.10379,1,0
1,GO OVULATION,0.039406,0.10384,0.13407,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0092477,0.10372,0.13263,1,0
1,GO BONE RESORPTION,0.0039992,0.10319,0.18353,1,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.058247,0.10312,0.1165,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.058247,0.10261,0.14794,1,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.042609,0.10261,0.11462,1,0
1,GO TISSUE HOMEOSTASIS,0.043866,0.1024,0.091833,1,0
1,GO NEURAL TUBE PATTERNING,0.019312,0.10237,0.11982,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,0.0058389,0.10196,0.098722,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.02521,0.10195,0.083008,1,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.023919,0.10185,0.12342,1,0
1,GO REGULATION OF GTP BINDING,0.031631,0.10148,0.16136,1,0
1,GO EMBRYONIC MORPHOGENESIS,0.010645,0.10145,0.11032,1,0
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034243,0.10134,0.092373,1,0
1,GO PROTEOLYSIS,0.00091404,0.10098,0.097649,1,0
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.014823,0.10088,0.13332,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.006444,0.10076,0.11727,1,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0088198,0.1007,0.15712,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0023957,0.10063,0.17769,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0052197,0.10045,0.091435,1,0
1,GO ICOSANOID METABOLIC PROCESS,0.040981,0.10006,0.11915,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.025743,0.099589,0.07617,1,0
1,GO IMPORT INTO NUCLEUS,0.01849,0.099515,0.067581,1,0
1,GO LYTIC VACUOLE ORGANIZATION,0.033948,0.099428,0.088317,1,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.048746,0.099252,0.1084,1,0
1,GO LIPID HOMEOSTASIS,0.0062877,0.099003,0.11926,1,0
1,GO FATTY ACID TRANSPORT,0.023668,0.09861,0.1024,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.022928,0.098274,0.12851,1,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.03429,0.097448,0.13886,1,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.035336,0.097223,0.090783,1,0
1,GO PROTEIN IMPORT,0.0067673,0.096992,0.081857,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.013546,0.096913,0.11008,1,0
1,GO RNA DECAPPING,0.0035605,0.096849,0.12346,1,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.017699,0.096478,0.085194,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00081356,0.09626,0.14301,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.027973,0.09619,0.087247,1,0
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00159,0.096184,0.093057,1,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.039795,0.096119,0.068227,1,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.019312,0.096099,0.20212,1,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.05063,0.096004,0.097695,1,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.046474,0.095258,0.10265,1,0
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00015838,0.094936,0.10355,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0018764,0.094808,0.090201,1,0
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.0039481,0.094549,0.11642,1,0
1,GO REGULATION OF TUBE SIZE,0.0077327,0.094372,0.1215,1,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.021053,0.094274,0.074956,1,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.055093,0.094018,0.17246,1,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.044292,0.094007,0.10755,1,0
1,GO REGULATION OF BINDING,0.0024609,0.093619,0.10473,1,0
1,GO NADP METABOLIC PROCESS,0.059331,0.093585,0.093454,1,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.03902,0.093439,0.065191,1,0
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.017125,0.093425,0.12356,1,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.03006,0.093259,0.085987,1,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.045591,0.093218,0.10543,1,0
1,GO RNA 5 END PROCESSING,0.037882,0.093123,0.11715,1,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.028264,0.092865,0.13696,1,0
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.011949,0.092845,0.10328,1,0
1,GO PROTEIN CATABOLIC PROCESS,0.00083767,0.092552,0.086387,1,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.054074,0.091729,0.074622,1,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.036048,0.091687,0.1441,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0086125,0.091592,0.084492,1,0
1,GO REGULATION OF MYELINATION,0.017315,0.090921,0.13123,1,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.032278,0.090891,0.098927,1,0
1,GO REGULATION OF PROTON TRANSPORT,0.060988,0.090644,0.097728,1,0
1,GO TRNA 5 LEADER REMOVAL,0.05063,0.090621,0.11184,1,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.032278,0.090119,0.10625,1,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.021509,0.090088,0.092397,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.023173,0.089726,0.082863,1,0
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.021509,0.089291,0.11342,1,0
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0024941,0.089223,0.21775,1,0
1,GO TAXIS,0.041789,0.089184,0.096014,1,0
1,GO CELLULAR RESPONSE TO RADIATION,0.0034692,0.088962,0.096453,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0047198,0.088894,0.11387,1,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.038637,0.088736,0.090227,1,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.052575,0.088513,0.080518,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.022209,0.088379,0.11145,1,0
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0066851,0.088346,0.12791,1,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.018091,0.088137,0.080872,1,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.045155,0.08812,0.17546,1,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.012227,0.087778,0.14456,1,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.022686,0.087666,0.18382,1,0
1,GO CYTOPLASMIC TRANSLATION,0.057179,0.087489,0.081404,1,0
1,GO TRNA 5 END PROCESSING,0.035691,0.08745,0.11795,1,0
1,GO OVULATION CYCLE,0.047372,0.087393,0.10263,1,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.017125,0.086941,0.20932,1,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.051111,0.086212,0.16346,1,0
1,GO BLASTOCYST GROWTH,0.033948,0.085369,0.12607,1,0
1,GO REGULATION OF ENDOCYTOSIS,0.023668,0.0848,0.089096,1,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0067673,0.084614,0.14792,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.024173,0.084576,0.097189,1,0
1,GO MACROPHAGE ACTIVATION,0.012653,0.083906,0.15572,1,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0071918,0.083829,0.084432,1,0
1,GO LIPID METABOLIC PROCESS,0.016386,0.083416,0.080795,1,0
1,GO ORGANIC ACID METABOLIC PROCESS,0.0038478,0.0824,0.086534,1,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.019312,0.08233,0.1089,1,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.032938,0.082069,0.10081,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.028556,0.081726,0.10111,1,0
1,GO MACROMOLECULE CATABOLIC PROCESS,0.00015838,0.081357,0.093867,1,0
1,GO LIPID LOCALIZATION,0.015501,0.081099,0.10402,1,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.025743,0.080958,0.11213,1,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.039795,0.080825,0.061843,1,0
1,GO REGULATION OF ERAD PATHWAY,0.0016122,0.080593,0.12347,1,0
1,GO REGULATION OF SENSORY PERCEPTION,0.020605,0.080479,0.08847,1,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0046018,0.080425,0.099922,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.025743,0.079258,0.066389,1,0
1,GO POSITIVE REGULATION OF SIGNALING,0.024428,0.079108,0.080453,1,0
1,GO NUCLEOSIDE METABOLIC PROCESS,0.012945,0.079103,0.10096,1,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0059852,0.079009,0.082769,1,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.027686,0.078484,0.13287,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.014013,0.078419,0.084404,1,0
1,GO ANION HOMEOSTASIS,0.011411,0.078077,0.12612,1,0
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.037509,0.0779,0.098218,1,0
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.003654,0.077652,0.072975,1,0
1,GO POSITIVE REGULATION OF CELL AGING,0.051111,0.07759,0.12462,1,0
1,GO REGULATION OF LIPID TRANSPORT,0.0020929,0.07752,0.15364,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.044722,0.077449,0.069077,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.027118,0.077353,0.076455,1,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.032278,0.076933,0.13143,1,0
1,GO REGULATION OF PROTEIN STABILITY,0.0042636,0.076928,0.086256,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.037882,0.076605,0.062216,1,0
1,GO RESPONSE TO ABIOTIC STIMULUS,0.01829,0.075842,0.068757,1,0
1,GO PEROXISOMAL TRANSPORT,0.0066851,0.075805,0.11678,1,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0081133,0.07565,0.089786,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.002702,0.075089,0.094979,1,0
1,GO RESPONSE TO ATP,0.0042636,0.074169,0.10723,1,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.010522,0.074068,0.069797,1,0
1,GO B CELL PROLIFERATION,0.043444,0.074005,0.13961,1,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.033608,0.073059,0.075977,1,0
1,GO REGULATION OF T CELL MIGRATION,0.021053,0.072876,0.14493,1,0
1,GO POSITIVE REGULATION OF BINDING,0.013546,0.072439,0.089805,1,0
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.014823,0.072436,0.12086,1,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.031311,0.071875,0.1448,1,0
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0024941,0.071868,0.082385,1,0
1,GO GOLGI ORGANIZATION,0.036409,0.071666,0.076591,1,0
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.027973,0.071295,0.060829,1,0
1,GO ORGAN INDUCTION,0.059879,0.071134,0.13556,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.008211,0.071071,0.090418,1,0
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0020367,0.070794,0.074928,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.05063,0.070735,0.054167,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.024687,0.070295,0.062734,1,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.016205,0.070128,0.10273,1,0
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.023668,0.069738,0.054677,1,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.040187,0.069684,0.11298,1,0
1,GO OXIDATION REDUCTION PROCESS,0.018693,0.068858,0.069741,1,0
1,GO ECTODERM DEVELOPMENT,0.013546,0.068669,0.10893,1,0
1,GO PROTEIN STABILIZATION,0.0060595,0.067926,0.090418,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.059879,0.067655,0.10827,1,0
1,GO ALCOHOL METABOLIC PROCESS,0.022928,0.067492,0.076842,1,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.058247,0.066952,0.063816,1,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.033271,0.066523,0.10497,1,0
1,GO DNA BIOSYNTHETIC PROCESS,0.037882,0.066453,0.05037,1,0
1,GO NEGATIVE REGULATION OF GROWTH,0.021053,0.066279,0.095368,1,0
1,GO REGULATION OF AUTOPHAGY,0.0042095,0.065536,0.082768,1,0
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.042197,0.065457,0.070735,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.032938,0.065327,0.07136,1,0
1,GO PEROXISOME ORGANIZATION,0.0063654,0.065295,0.10906,1,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.024428,0.06438,0.07563,1,0
1,GO PROTEIN TETRAMERIZATION,0.0099244,0.063432,0.091245,1,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.05063,0.063108,0.12784,1,0
1,GO REGULATION OF BONE REMODELING,0.058787,0.062437,0.12271,1,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.033948,0.062375,0.087078,1,0
1,GO PLASMA MEMBRANE ORGANIZATION,0.039406,0.061725,0.11412,1,0
1,GO NEGATIVE REGULATION OF BINDING,0.0137,0.061144,0.092637,1,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.050154,0.06072,0.1349,1,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.036772,0.060322,0.085228,1,0
1,GO SEQUESTERING OF CALCIUM ION,0.058787,0.059877,0.087606,1,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.01128,0.059465,0.13687,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0095807,0.057508,0.065895,1,0
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.060988,0.056564,0.047197,1,0
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.041789,0.056164,0.064129,1,0
1,GO AUTOPHAGY OF MITOCHONDRION,0.032278,0.055799,0.073536,1,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.032607,0.055096,0.079416,1,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.059331,0.053967,0.17917,1,0
1,GO EMBRYO DEVELOPMENT,0.059879,0.052806,0.071533,1,0
1,GO MYELIN ASSEMBLY,0.054582,0.051924,0.14791,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.027118,0.050952,0.070813,1,0
1,GO ENDOSOME ORGANIZATION,0.022686,0.049982,0.081506,1,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.044292,0.048598,0.094785,1,0
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0090315,0.048469,0.070944,1,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.03068,0.048359,0.18328,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.027973,0.047417,0.067876,1,0
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.022686,0.04667,0.054961,1,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.03902,0.0466,0.097944,1,0
1,GO SPERM EGG RECOGNITION,0.056652,0.046252,0.067374,1,0
1,GO MACROAUTOPHAGY,0.013856,0.045121,0.074914,1,0
1,GO CHOLESTEROL STORAGE,0.019312,0.044154,0.22503,1,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.039406,0.043482,0.083872,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.051595,0.041341,0.06825,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.042609,0.040957,0.063586,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042609,0.037381,0.076538,1,0
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.039795,0.034061,0.055186,1,0
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.043025,0.033372,0.0489,1,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.046921,0.033071,0.075129,1,0
1,GO REGULATION OF RNA SPLICING,0.05357,-0.029587,-0.068001,1,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.054074,-0.033192,-0.068435,1,0
1,GO TRANSFERRIN TRANSPORT,0.046031,-0.037269,-0.08473,1,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.056128,-0.038851,-0.099323,1,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.046031,-0.040685,-0.12923,1,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.038637,-0.040847,-0.07703,1,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.034984,-0.046468,-0.21626,1,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.056652,-0.046788,-0.051118,1,0
1,GO DNA PACKAGING,0.015674,-0.048964,-0.10082,1,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.046921,-0.048991,-0.058699,1,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.056652,-0.049479,-0.06725,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.055093,-0.050409,-0.087557,1,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.057179,-0.050864,-0.086512,1,0
1,GO POLYOL CATABOLIC PROCESS,0.015329,-0.051432,-0.10733,1,0
1,GO PROTEIN ACETYLATION,0.0093576,-0.051695,-0.071914,1,0
1,GO MICROTUBULE BASED PROCESS,0.043866,-0.054346,-0.063667,1,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.055609,-0.054703,-0.061587,1,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.020828,-0.055399,-0.092295,1,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.048746,-0.055754,-0.068675,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.019523,-0.057982,-0.091093,1,0
1,GO CELL CELL SIGNALING,0.056128,-0.062955,-0.049454,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.042609,-0.063005,-0.14992,1,0
1,GO DNA REPLICATION INITIATION,0.038258,-0.064262,-0.14631,1,0
1,GO PROTEIN ACYLATION,0.0016122,-0.064528,-0.078931,1,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.060988,-0.06483,-0.10567,1,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.041789,-0.06529,-0.069181,1,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.022686,-0.066296,-0.084508,1,0
1,GO DEVELOPMENTAL CELL GROWTH,0.051595,-0.066398,-0.064369,1,0
1,GO SISTER CHROMATID COHESION,0.038258,-0.066978,-0.10998,1,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.060988,-0.067046,-0.06788,1,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0034243,-0.067418,-0.096088,1,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.033271,-0.068024,-0.085978,1,0
1,GO HISTONE H3 K9 METHYLATION,0.03068,-0.068669,-0.094269,1,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.022446,-0.069186,-0.081929,1,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.017699,-0.069207,-0.097686,1,0
1,GO NUCLEOSOME ORGANIZATION,0.014332,-0.069578,-0.10541,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.043444,-0.070673,-0.085549,1,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.049212,-0.070739,-0.067858,1,0
1,GO REGULATION OF MRNA PROCESSING,0.055609,-0.070768,-0.069742,1,0
1,GO DETECTION OF STIMULUS,0.027118,-0.070814,-0.063448,1,0
1,GO FOREBRAIN CELL MIGRATION,0.055093,-0.07084,-0.098096,1,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.014658,-0.070847,-0.069458,1,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.048746,-0.071018,-0.098543,1,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.044292,-0.073022,-0.077518,1,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.027973,-0.07354,-0.11944,1,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.030994,-0.073567,-0.11232,1,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.045591,-0.073768,-0.083005,1,0
1,GO NEUROGENESIS,0.055609,-0.074454,-0.059464,1,0
1,GO REGULATION OF BEHAVIOR,0.059879,-0.074901,-0.074574,1,0
1,GO SENSORY PERCEPTION,0.0050269,-0.075406,-0.079858,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.026013,-0.075623,-0.18613,1,0
1,GO MEMBRANE DOCKING,0.0095807,-0.075744,-0.072754,1,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.028264,-0.075905,-0.071656,1,0
1,GO OOCYTE DIFFERENTIATION,0.0017277,-0.077162,-0.12401,1,0
1,GO CHROMATIN REMODELING,0.030994,-0.078301,-0.08867,1,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.017125,-0.078575,-0.068464,1,0
1,GO OOCYTE MATURATION,0.046031,-0.07904,-0.090423,1,0
1,GO CIRCADIAN RHYTHM,0.051111,-0.079718,-0.053169,1,0
1,GO DNA REPLICATION CHECKPOINT,0.02915,-0.080004,-0.15669,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0032501,-0.080985,-0.11098,1,0
1,GO GERM CELL DEVELOPMENT,0.01995,-0.081053,-0.070085,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.033948,-0.081821,-0.051867,1,0
1,GO REGULATION OF CELL CYCLE ARREST,0.022686,-0.081922,-0.073293,1,0
1,GO PH REDUCTION,0.057179,-0.083315,-0.062891,1,0
1,GO CELL CYCLE DNA REPLICATION,0.014823,-0.084743,-0.13329,1,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0060595,-0.085009,-0.073324,1,0
1,GO CILIUM ORGANIZATION,0.051595,-0.08526,-0.064175,1,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.031953,-0.085617,-0.10843,1,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.054582,-0.086395,-0.06895,1,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.0047798,-0.086432,-0.13162,1,0
1,GO PHOTOTRANSDUCTION,0.0020646,-0.087438,-0.10192,1,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.023419,-0.088331,-0.10937,1,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.02945,-0.088488,-0.081284,1,0
1,GO NUCLEOSOME ASSEMBLY,0.0062108,-0.088655,-0.13186,1,0
1,GO MICROTUBULE BASED TRANSPORT,0.023419,-0.088676,-0.074976,1,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.017699,-0.088787,-0.11309,1,0
1,GO TRANSPORT ALONG MICROTUBULE,0.010769,-0.089024,-0.087452,1,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.048746,-0.08908,-0.079307,1,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.059879,-0.089117,-0.098483,1,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.031953,-0.089148,-0.12351,1,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0063654,-0.089172,-0.10515,1,0
1,GO HEAD DEVELOPMENT,0.018091,-0.090375,-0.079416,1,0
1,GO REGULATION OF HORMONE LEVELS,0.042197,-0.090419,-0.061382,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,0.036772,-0.09054,-0.075568,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.016205,-0.090654,-0.15206,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.030994,-0.090661,-0.085526,1,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.038258,-0.091001,-0.078673,1,0
1,GO PALLIUM DEVELOPMENT,0.0039992,-0.091163,-0.12381,1,0
1,GO TELENCEPHALON DEVELOPMENT,0.014494,-0.091351,-0.092387,1,0
1,GO ION TRANSPORT,0.056652,-0.091521,-0.046787,1,0
1,GO AXIS SPECIFICATION,0.036772,-0.091688,-0.082528,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.036409,-0.091948,-0.072962,1,0
1,GO NEURON PROJECTION EXTENSION,0.045591,-0.092024,-0.078465,1,0
1,GO MICROTUBULE BASED MOVEMENT,0.0088198,-0.092042,-0.087345,1,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.046031,-0.092334,-0.068291,1,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.022209,-0.092599,-0.13662,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.015674,-0.093014,-0.10956,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.028264,-0.093378,-0.05995,1,0
1,GO PROTEIN DEMETHYLATION,0.017506,-0.093711,-0.11137,1,0
1,GO IMPORT INTO CELL,0.056128,-0.094347,-0.064304,1,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0019023,-0.09439,-0.11079,1,0
1,GO HINDBRAIN MORPHOGENESIS,0.011813,-0.094642,-0.082525,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.00057029,-0.094775,-0.103,1,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.036772,-0.094775,-0.097883,1,0
1,GO CELL PART MORPHOGENESIS,0.028852,-0.095773,-0.082182,1,0
1,GO CILIUM MOVEMENT,0.043025,-0.095861,-0.077105,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.032278,-0.096203,-0.065717,1,0
1,GO AXO DENDRITIC TRANSPORT,0.0027747,-0.096358,-0.12602,1,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.052083,-0.097661,-0.10227,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0021505,-0.098226,-0.10582,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.014172,-0.099376,-0.078538,1,0
1,GO REGULATION OF RESPONSE TO FOOD,0.010895,-0.10083,-0.12017,1,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0083098,-0.10101,-0.11395,1,0
1,GO CELL MATURATION,0.010769,-0.10194,-0.076444,1,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.043444,-0.10195,-0.12186,1,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.052083,-0.10198,-0.099141,1,0
1,GO DOSAGE COMPENSATION,0.061549,-0.10222,-0.10068,1,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.0025617,-0.10262,-0.13558,1,0
1,GO EATING BEHAVIOR,0.011151,-0.10375,-0.090276,1,0
1,GO PROTEIN DEPOLYMERIZATION,0.0065235,-0.1039,-0.095562,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.003654,-0.10457,-0.12482,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.048285,-0.10479,-0.061404,1,0
1,GO HISTONE METHYLATION,0.0062877,-0.10497,-0.098103,1,0
1,GO PEPTIDYL LYSINE METHYLATION,0.008211,-0.106,-0.10319,1,0
1,GO ENERGY HOMEOSTASIS,0.058787,-0.10659,-0.10008,1,0
1,GO NEURON DIFFERENTIATION,0.014172,-0.10664,-0.085681,1,0
1,GO G0 TO G1 TRANSITION,0.028852,-0.10683,-0.0999,1,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.031953,-0.10696,-0.089484,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.059879,-0.10708,-0.097821,1,0
1,GO CATION TRANSPORT,0.014332,-0.10802,-0.069619,1,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.0016347,-0.10832,-0.12069,1,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.056652,-0.10868,-0.12625,1,0
1,GO DIGESTION,0.046031,-0.10873,-0.090059,1,0
1,GO DETECTION OF LIGHT STIMULUS,0.00029052,-0.10975,-0.12635,1,0
1,GO FUCOSYLATION,0.035336,-0.11035,-0.093598,1,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0081133,-0.11042,-0.12776,1,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.01995,-0.11079,-0.1236,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.013394,-0.11089,-0.16908,1,0
1,GO FOREBRAIN DEVELOPMENT,0.012653,-0.11098,-0.096494,1,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.011022,-0.11117,-0.12586,1,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.034984,-0.11129,-0.079681,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,0.015501,-0.11162,-0.072253,1,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.016386,-0.11166,-0.11347,1,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.022928,-0.11194,-0.095553,1,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.012367,-0.11203,-0.093795,1,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.036048,-0.11285,-0.077869,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.060432,-0.1133,-0.090851,1,0
1,GO SPERM MOTILITY,0.0086125,-0.11368,-0.092114,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,0.0018256,-0.11408,-0.10507,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.014013,-0.11419,-0.073227,1,0
1,GO REGULATION OF CELL MATURATION,0.0039992,-0.11431,-0.13415,1,0
1,GO HISTONE H3 K36 METHYLATION,0.042609,-0.11436,-0.11377,1,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0062108,-0.11559,-0.15734,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.045591,-0.1156,-0.13479,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031311,-0.11573,-0.075856,1,0
1,GO RESPONSE TO CATECHOLAMINE,0.0033799,-0.11602,-0.10597,1,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.013394,-0.11654,-0.1352,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.022209,-0.1174,-0.086575,1,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0137,-0.11749,-0.13762,1,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.040981,-0.11796,-0.11652,1,0
1,GO REGULATION OF SECRETION,0.015329,-0.11798,-0.070196,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.03429,-0.1182,-0.096842,1,0
1,GO MATING,0.05357,-0.11857,-0.068159,1,0
1,GO REGULATION OF HISTONE METHYLATION,0.015501,-0.11891,-0.089408,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0076401,-0.11917,-0.079647,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.0059852,-0.11922,-0.10547,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.0050904,-0.11935,-0.11153,1,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0023321,-0.11941,-0.13279,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.000662,-0.12021,-0.1219,1,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0046018,-0.12024,-0.18169,1,0
1,GO LIMBIC SYSTEM DEVELOPMENT,0.016386,-0.12054,-0.10703,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.045591,-0.12114,-0.11062,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.017315,-0.12145,-0.080635,1,0
1,GO PROTEIN METHYLATION,0.0025277,-0.12189,-0.10327,1,0
1,GO HISTONE H4 ACETYLATION,0.0012886,-0.12208,-0.10691,1,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.030994,-0.12221,-0.079243,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.014823,-0.12234,-0.088156,1,0
1,GO HISTONE H2A ACETYLATION,0.017125,-0.12235,-0.10706,1,0
1,GO NEURON DEVELOPMENT,0.013546,-0.12251,-0.085066,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,0.0035605,-0.12344,-0.13799,1,0
1,GO HISTONE H4 K16 ACETYLATION,0.0002443,-0.12354,-0.16468,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.03902,-0.12381,-0.11743,1,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.058787,-0.12503,-0.067829,1,0
1,GO SPERMATID DIFFERENTIATION,0.0068504,-0.12552,-0.090196,1,0
1,GO RESPONSE TO FOOD,0.0039481,-0.12603,-0.10888,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.012945,-0.12605,-0.097618,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0023321,-0.12636,-0.11221,1,0
1,GO CHROMATIN SILENCING,0.0021505,-0.12643,-0.11902,1,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.041383,-0.12657,-0.12086,1,0
1,GO TOXIN METABOLIC PROCESS,0.057711,-0.12681,-0.1448,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,3.2631e-05,-0.1269,-0.16103,1,0
1,GO SODIUM ION TRANSPORT,0.019312,-0.12747,-0.08998,1,0
1,GO COGNITION,0.017315,-0.12757,-0.091424,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0023637,-0.12762,-0.14004,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.02521,-0.1281,-0.090525,1,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.0052854,-0.12825,-0.13839,1,0
1,GO NERVOUS SYSTEM PROCESS,0.0010259,-0.12853,-0.10903,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.019523,-0.12865,-0.076731,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.018898,-0.12884,-0.089959,1,0
1,GO DETECTION OF VISIBLE LIGHT,0.00020835,-0.12886,-0.13469,1,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.055609,-0.12908,-0.059551,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0098086,-0.12908,-0.10149,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0016347,-0.12913,-0.113,1,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0137,-0.12945,-0.16289,1,0
1,GO MICROTUBULE POLYMERIZATION,0.00023667,-0.12975,-0.15333,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0011668,-0.12986,-0.16332,1,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.013243,-0.13036,-0.10712,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.055093,-0.13168,-0.16122,1,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0023637,-0.13169,-0.1327,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.03068,-0.13225,-0.10202,1,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.001422,-0.13276,-0.1718,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0062877,-0.13332,-0.11603,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0069343,-0.13366,-0.1805,1,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.0013255,-0.13374,-0.16059,1,0
1,GO SEX DETERMINATION,0.012087,-0.13474,-0.12864,1,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.051595,-0.13507,-0.082914,1,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.028852,-0.13519,-0.08304,1,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.019735,-0.1355,-0.13063,1,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.033948,-0.13552,-0.16548,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.032607,-0.13573,-0.090194,1,0
1,GO SECRETORY GRANULE ORGANIZATION,0.03006,-0.13575,-0.092077,1,0
1,GO HISTONE H3 K4 METHYLATION,0.0030839,-0.136,-0.15694,1,0
1,GO RESPONSE TO NICOTINE,0.010279,-0.13619,-0.1384,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00025215,-0.13661,-0.12941,1,0
1,GO ACROSOME ASSEMBLY,0.0066039,-0.13712,-0.14557,1,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.033271,-0.13747,-0.11211,1,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.00022565,-0.13764,-0.17858,1,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0081133,-0.13807,-0.11295,1,0
1,GO MATING BEHAVIOR,0.016386,-0.13832,-0.11308,1,0
1,GO AXONAL TRANSPORT,0.0013826,-0.13883,-0.14298,1,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00013232,-0.14038,-0.15262,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00087508,-0.14116,-0.14758,1,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.05063,-0.14146,-0.10161,1,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0072795,-0.14193,-0.16963,1,0
1,GO REGULATION OF ION TRANSPORT,0.019735,-0.14249,-0.075513,1,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0019819,-0.1431,-0.12468,1,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.0012705,-0.1434,-0.14676,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.0043737,-0.14344,-0.12231,1,0
1,GO COCHLEA DEVELOPMENT,0.01829,-0.14368,-0.12315,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00031414,-0.14373,-0.13179,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.015329,-0.14409,-0.11104,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00016098,-0.14413,-0.175,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.041383,-0.14421,-0.099112,1,0
1,GO POSTSYNAPSE ORGANIZATION,0.0086125,-0.14452,-0.12532,1,0
1,GO TUBULIN DEACETYLATION,0.026838,-0.14462,-0.1418,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.046921,-0.14516,-0.11399,1,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0033361,-0.14524,-0.14075,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00062378,-0.14537,-0.16294,1,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0029645,-0.14548,-0.11506,1,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0032078,-0.14576,-0.13499,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0081133,-0.14602,-0.10615,1,0
1,GO GENETIC IMPRINTING,0.059879,-0.14638,-0.066668,1,0
1,GO ACROSOME REACTION,0.0052197,-0.14642,-0.13277,1,0
1,GO DEVELOPMENTAL MATURATION,0.0037016,-0.14659,-0.10144,1,0
1,GO MAINTENANCE OF CELL POLARITY,0.026286,-0.14713,-0.10434,1,0
1,GO RESPONSE TO AMPHETAMINE,0.010769,-0.14751,-0.14885,1,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.004156,-0.14773,-0.1591,1,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.0028872,-0.14828,-0.083977,1,0
1,GO MAST CELL MIGRATION,0.032278,-0.14836,-0.19687,1,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.012945,-0.14896,-0.11484,1,0
1,GO WALKING BEHAVIOR,6.1119e-05,-0.14932,-0.2211,1,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.053071,-0.15,-0.11156,1,0
1,GO VESICLE DOCKING,0.00099681,-0.15034,-0.12141,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.016938,-0.1508,-0.13395,1,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.016386,-0.1514,-0.12842,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0030436,-0.15165,-0.19414,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0033799,-0.15166,-0.17593,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.001422,-0.1517,-0.15211,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00083767,-0.15194,-0.14286,1,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00011596,-0.15207,-0.18735,1,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.011544,-0.15211,-0.13572,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00096848,-0.15259,-0.13809,1,0
1,GO VISUAL BEHAVIOR,0.00049802,-0.15264,-0.12072,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0063654,-0.15323,-0.16001,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00016098,-0.15344,-0.16159,1,0
1,GO ACID SECRETION,0.0034243,-0.15384,-0.11372,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.022446,-0.15421,-0.13953,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,0.0042095,-0.15452,-0.12414,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.014494,-0.15467,-0.16438,1,0
1,GO MEMBRANE FISSION,0.0090315,-0.15546,-0.14591,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0026663,-0.15572,-0.14163,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00043435,-0.1558,-0.19253,1,0
1,GO NEUROMUSCULAR PROCESS,0.0065235,-0.15586,-0.118,1,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.018091,-0.15633,-0.11238,1,0
1,GO ASSOCIATIVE LEARNING,0.0017517,-0.15662,-0.12851,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.001235,-0.157,-0.22652,1,0
1,GO RESPONSE TO ALKALOID,0.0001179,-0.15712,-0.13162,1,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.0072795,-0.15722,-0.15447,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.041383,-0.1575,-0.067382,1,0
1,GO SKELETAL MUSCLE ADAPTATION,0.056128,-0.15772,-0.1053,1,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.022928,-0.16013,-0.095371,1,0
1,GO MEMORY,0.0098086,-0.16041,-0.10904,1,0
1,GO FAT CELL PROLIFERATION,0.012367,-0.16083,-0.17365,1,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00052901,-0.16118,-0.16551,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0015038,-0.1612,-0.18233,1,0
1,GO DNA STRAND ELONGATION,0.0016122,-0.16132,-0.19305,1,0
1,GO HORMONE TRANSPORT,0.00023294,-0.16138,-0.14668,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.017315,-0.16144,-0.10801,1,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.026286,-0.16168,-0.11183,1,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00087508,-0.16174,-0.13024,1,0
1,GO REGULATION OF HORMONE SECRETION,0.000286,-0.16202,-0.1402,1,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.017125,-0.16202,-0.1459,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.035336,-0.16203,-0.11073,1,0
1,GO SENSORY PERCEPTION OF PAIN,0.002631,-0.16279,-0.11562,1,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0035605,-0.16303,-0.20132,1,0
1,GO RESPONSE TO LEUCINE,0.019523,-0.16305,-0.16597,1,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.028264,-0.16374,-0.14523,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0047198,-0.16407,-0.13055,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.049212,-0.16428,-0.096985,1,0
1,GO PHAGOSOME ACIDIFICATION,0.0087156,-0.16451,-0.11747,1,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00036686,-0.16453,-0.12723,1,0
1,GO FOREBRAIN REGIONALIZATION,0.016205,-0.16462,-0.16896,1,0
1,GO MALE SEX DETERMINATION,0.017125,-0.1647,-0.17812,1,0
1,GO REGULATION OF HEART RATE,0.014494,-0.16506,-0.11507,1,0
1,GO PRESYNAPSE ORGANIZATION,0.014658,-0.16519,-0.13507,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.0054872,-0.16596,-0.2074,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,4.9694e-05,-0.16616,-0.21809,1,0
1,GO REGULATION OF HEAT GENERATION,0.0059116,-0.16621,-0.20272,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0086125,-0.16796,-0.092256,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.01849,-0.16818,-0.16713,1,0
1,GO REGULATION OF INSULIN SECRETION,0.00015583,-0.16819,-0.16534,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.037509,-0.16828,-0.12833,1,0
1,GO RESPONSE TO DOPAMINE,0.00026438,-0.1683,-0.13325,1,0
1,GO BEHAVIOR,0.0016347,-0.16859,-0.11784,1,0
1,GO POTASSIUM ION HOMEOSTASIS,0.0099244,-0.16965,-0.13642,1,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,1.6761e-05,-0.16972,-0.17696,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00044781,-0.16988,-0.14234,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.03429,-0.17033,-0.14953,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.0069343,-0.17057,-0.1519,1,0
1,GO INTRACILIARY TRANSPORT,0.0094686,-0.17092,-0.1371,1,0
1,GO OXIDATIVE DEMETHYLATION,0.00011986,-0.17095,-0.14942,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.0056255,-0.1711,-0.12222,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.00070238,-0.1713,-0.15018,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0044864,-0.17224,-0.1669,1,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.0047198,-0.1724,-0.16542,1,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0021505,-0.17276,-0.20382,1,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.05063,-0.17293,-0.13736,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.0013255,-0.17313,-0.15371,1,0
1,GO SPINAL CORD DEVELOPMENT,0.0018256,-0.17315,-0.15266,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.055093,-0.1739,-0.079833,1,0
1,GO NUCLEAR BODY ORGANIZATION,0.016568,-0.17391,-0.12004,1,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,5.7582e-06,-0.1741,-0.20774,1,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.0053519,-0.17419,-0.22985,1,0
1,GO DENDRITE MORPHOGENESIS,0.00082553,-0.17471,-0.16298,1,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.058247,-0.17477,-0.080284,1,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0024281,-0.17486,-0.16769,1,0
1,GO CELL JUNCTION MAINTENANCE,0.026838,-0.17578,-0.12643,1,0
1,GO LONG TERM SYNAPTIC DEPRESSION,0.010279,-0.1766,-0.1557,1,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.015674,-0.17693,-0.16496,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.024947,-0.17722,-0.092139,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0037985,-0.17889,-0.1405,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.03006,-0.17908,-0.15128,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0039992,-0.17911,-0.25291,1,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0042636,-0.17911,-0.17661,1,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,7.6657e-06,-0.17939,-0.21497,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.023668,-0.17979,-0.11732,1,0
1,GO MALE MEIOSIS I,0.015159,-0.17986,-0.17299,1,0
1,GO EMBRYONIC AXIS SPECIFICATION,6.7724e-05,-0.1804,-0.18762,1,0
1,GO CELL FATE SPECIFICATION,0.0053519,-0.18066,-0.16877,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0005618,-0.18073,-0.17637,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0016122,-0.18087,-0.12549,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.034984,-0.18088,-0.16975,1,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.016568,-0.18123,-0.13971,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.013093,-0.18143,-0.14203,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0035605,-0.18164,-0.1441,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.0041031,-0.18208,-0.2262,1,0
1,GO REGULATION OF CILIUM MOVEMENT,0.0030436,-0.18225,-0.13287,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0056255,-0.18305,-0.15359,1,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0010113,-0.18316,-0.12551,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.037882,-0.18413,-0.13032,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0021215,-0.18422,-0.1263,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,1.7706e-05,-0.18439,-0.19151,1,0
1,GO PANCREAS DEVELOPMENT,0.035336,-0.18502,-0.10106,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,2.6828e-05,-0.18535,-0.1653,1,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.0088198,-0.18605,-0.14964,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00013232,-0.18746,-0.17539,1,0
1,GO SPERM AXONEME ASSEMBLY,0.0037498,-0.18846,-0.1556,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0071051,-0.1887,-0.17627,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0050904,-0.18893,-0.17916,1,0
1,GO NEURON MIGRATION,0.00094089,-0.18913,-0.18714,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00016629,-0.18919,-0.14317,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0025961,-0.18931,-0.15615,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00159,-0.18982,-0.12972,1,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.05357,-0.19052,-0.12963,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0071918,-0.1909,-0.13605,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00022565,-0.19145,-0.19194,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.0033799,-0.19166,-0.16973,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0073682,-0.19172,-0.17259,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0062108,-0.1918,-0.19728,1,0
1,GO AMINO ACID TRANSPORT,0.00023294,-0.19191,-0.15583,1,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0016122,-0.192,-0.1954,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0089251,-0.19241,-0.17671,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0056255,-0.19307,-0.21569,1,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.014172,-0.19364,-0.17062,1,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.015674,-0.1938,-0.19612,1,0
1,GO PARENTAL BEHAVIOR,0.01829,-0.19477,-0.17196,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.020385,-0.1974,-0.11716,1,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,1.0361e-05,-0.19774,-0.18293,1,0
1,GO SIGNAL RELEASE,7.2497e-05,-0.19786,-0.1554,1,0
1,GO SECRETORY GRANULE LOCALIZATION,0.00029511,-0.19923,-0.31202,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00071283,-0.20003,-0.19573,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00099681,-0.20033,-0.15786,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.01995,-0.20091,-0.11523,1,0
1,GO DETECTION OF MECHANICAL STIMULUS,0.01251,-0.20104,-0.14763,1,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.0025617,-0.20128,-0.26306,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0037498,-0.20223,-0.1751,1,0
1,GO DENDRITE DEVELOPMENT,0.0010259,-0.20237,-0.14389,1,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00040857,-0.20258,-0.14588,1,0
1,GO MITOCHONDRION LOCALIZATION,8.5867e-06,-0.2027,-0.20689,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00015331,-0.20277,-0.17712,1,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0062108,-0.20293,-0.24188,1,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0065235,-0.20311,-0.14316,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0071918,-0.20342,-0.16697,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.018091,-0.20366,-0.13881,1,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,5.3256e-05,-0.2039,-0.18412,1,0
1,GO LEARNING,0.00053704,-0.20431,-0.16839,1,0
1,GO STRIATUM DEVELOPMENT,0.00037835,-0.20449,-0.20489,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.013546,-0.20559,-0.13215,1,0
1,GO HINDBRAIN DEVELOPMENT,0.00020504,-0.20578,-0.16672,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0073682,-0.20659,-0.1517,1,0
1,GO ACTION POTENTIAL,0.00047589,-0.20683,-0.19059,1,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.024173,-0.20762,-0.17799,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0074579,-0.2088,-0.14996,1,0
1,GO CARDIAC CONDUCTION,0.003166,-0.21054,-0.14087,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0025961,-0.21191,-0.21063,1,0
1,GO MICROTUBULE DEPOLYMERIZATION,2.2416e-05,-0.21193,-0.26398,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.012798,-0.21223,-0.15077,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.00022565,-0.21248,-0.22567,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,8.8796e-05,-0.21271,-0.15779,1,0
1,GO MICROTUBULE BUNDLE FORMATION,0.00072342,-0.21331,-0.14689,1,0
1,GO LYSINE METABOLIC PROCESS,0.023419,-0.21387,-0.13342,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.043025,-0.21446,-0.1904,1,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,3.5646e-05,-0.2148,-0.29294,1,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00023294,-0.21533,-0.21534,1,0
1,GO NEURAL RETINA DEVELOPMENT,6.2175e-05,-0.21553,-0.25272,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0021215,-0.2156,-0.17808,1,0
1,GO NEURON RECOGNITION,0.00083767,-0.21629,-0.25278,1,0
1,GO SYNAPSE ORGANIZATION,0.0019023,-0.21649,-0.15127,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071051,-0.21669,-0.18548,1,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0046604,-0.21672,-0.16317,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.0048405,-0.21681,-0.2068,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.012798,-0.21732,-0.13287,1,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0043184,-0.21741,-0.19212,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00043435,-0.2176,-0.23767,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.8814e-05,-0.21796,-0.18782,1,0
1,GO OTIC VESICLE DEVELOPMENT,0.010522,-0.21826,-0.22565,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.475e-06,-0.21848,-0.22046,1,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.0030839,-0.22106,-0.23057,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0025277,-0.22118,-0.13021,1,0
1,GO FEEDING BEHAVIOR,2.1234e-05,-0.22121,-0.1766,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,5.4184e-05,-0.22183,-0.18668,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.042197,-0.22266,-0.1731,1,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0039992,-0.22328,-0.23252,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.9056e-05,-0.22341,-0.22316,1,0
1,GO REGULATION OF MICROTUBULE BINDING,5.3256e-05,-0.22345,-0.19792,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0077327,-0.22346,-0.17332,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.00018323,-0.22426,-0.2136,1,0
1,GO AXONEME ASSEMBLY,0.0028118,-0.22447,-0.17552,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.013243,-0.22487,-0.19276,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.045155,-0.22499,-0.12776,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,2.538e-07,-0.2254,-0.23428,1,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0042095,-0.22561,-0.12162,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0087156,-0.22595,-0.18895,1,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0012886,-0.22621,-0.2025,1,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0047798,-0.22699,-0.17464,1,0
1,GO INSULIN SECRETION,3.3806e-05,-0.22808,-0.18637,1,0
1,GO REGULATION OF SYNAPSE MATURATION,0.0020092,-0.22809,-0.33131,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00080175,-0.22967,-0.24469,1,0
1,GO NOREPINEPHRINE TRANSPORT,0.0043737,-0.23113,-0.17323,1,0
1,GO PROTEIN PALMITOYLATION,0.00074504,-0.23264,-0.1553,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00039018,-0.23443,-0.24201,1,0
1,GO ADRENAL GLAND DEVELOPMENT,0.0017277,-0.23677,-0.17816,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.00055343,-0.23738,-0.17288,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0025617,-0.23739,-0.22616,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0001803,-0.23863,-0.18732,1,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.037139,-0.23889,-0.13627,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,3.4409e-05,-0.23895,-0.2226,1,0
1,GO CELL MIGRATION IN HINDBRAIN,0.0137,-0.23936,-0.15534,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.025743,-0.23941,-0.19868,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0010259,-0.24018,-0.28116,1,0
1,GO DIENCEPHALON DEVELOPMENT,0.0016347,-0.24147,-0.18811,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0067673,-0.24209,-0.19418,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.001442,-0.24243,-0.21499,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0010865,-0.24371,-0.22892,1,0
1,GO PEPTIDE HORMONE SECRETION,1.6457e-05,-0.24374,-0.19211,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.0098086,-0.24422,-0.16624,1,0
1,GO SYNAPTIC VESICLE TRANSPORT,1.9393e-05,-0.24423,-0.21923,1,0
1,GO SEGMENT SPECIFICATION,0.001235,-0.24442,-0.2439,1,0
1,GO SYNAPTIC VESICLE RECYCLING,6.9711e-06,-0.24552,-0.22542,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,6.6578e-05,-0.24554,-0.20627,1,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.002702,-0.24693,-0.18542,1,0
1,GO METENCEPHALON DEVELOPMENT,4.8416e-06,-0.24817,-0.24117,1,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.015501,-0.24834,-0.21804,1,0
1,GO CHROMATIN SILENCING AT TELOMERE,5.8856e-08,-0.24857,-0.25982,1,0
1,GO MEMBRANE DEPOLARIZATION,0.0038977,-0.24897,-0.1535,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,1.6158e-05,-0.24931,-0.20217,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00037257,-0.24943,-0.24874,1,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.5052e-06,-0.25004,-0.27708,1,0
1,GO NOREPINEPHRINE SECRETION,0.016386,-0.25022,-0.13746,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,3.8924e-05,-0.25026,-0.24269,1,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00074504,-0.25039,-0.21682,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,5.6085e-05,-0.25125,-0.21664,1,0
1,GO NERVE DEVELOPMENT,0.019312,-0.25325,-0.14318,1,0
1,GO HISTONE H4 K5 ACETYLATION,1.475e-06,-0.2543,-0.23481,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,7.2414e-06,-0.25561,-0.26376,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00010323,-0.25664,-0.26857,1,0
1,GO EPITHELIAL CELL MATURATION,0.00010323,-0.2591,-0.26598,1,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0011836,-0.25975,-0.26852,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,1.0557e-05,-0.26015,-0.22693,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.4091e-05,-0.26195,-0.24013,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,3.7605e-06,-0.26298,-0.23636,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,1.5293e-05,-0.26339,-0.23716,1,0
1,GO LOCOMOTORY BEHAVIOR,5.8049e-05,-0.26376,-0.20639,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,6.4592e-06,-0.26389,-0.2203,1,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,0.00060545,-0.26466,-0.2059,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.7059e-05,-0.26479,-0.26251,1,0
1,GO NEUROTRANSMITTER UPTAKE,8.4424e-05,-0.26528,-0.2197,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0018508,-0.26583,-0.23918,1,0
1,GO CEREBELLAR CORTEX FORMATION,4.6578e-06,-0.26668,-0.28188,1,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0012527,-0.2682,-0.18651,1,0
1,GO DICARBOXYLIC ACID TRANSPORT,1.4472e-05,-0.26848,-0.19126,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00026024,-0.27005,-0.18543,1,0
1,GO MRNA SPLICE SITE SELECTION,5.1351e-07,-0.27115,-0.28113,1,0
1,GO RESPONSE TO ACETYLCHOLINE,0.0050904,-0.27152,-0.17843,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0016575,-0.27582,-0.24966,1,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,7.105e-06,-0.27678,-0.24119,1,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00031907,-0.27737,-0.26346,1,0
1,GO REGULATION OF EXOCYTOSIS,9.9803e-06,-0.27862,-0.1945,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,1.8701e-05,-0.27878,-0.26757,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,4.8839e-05,-0.27887,-0.24187,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0071918,-0.28096,-0.2306,1,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,0.0054872,-0.2816,-0.24849,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0024609,-0.28166,-0.18813,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0003557,-0.28413,-0.20176,1,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,0.0005618,-0.28497,-0.36806,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,1.5576e-05,-0.28524,-0.20336,1,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00030928,-0.28605,-0.31154,1,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,2.2824e-05,-0.28808,-0.21424,1,0
1,GO PROTEIN POLYGLUTAMYLATION,9.086e-06,-0.28923,-0.25626,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,5.4184e-05,-0.28996,-0.21378,1,0
1,GO PRESYNAPTIC ENDOCYTOSIS,5.5412e-06,-0.29035,-0.24815,1,0
1,GO SUCKLING BEHAVIOR,0.001442,-0.29194,-0.26055,1,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.00046165,-0.29308,-0.26001,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.004964,-0.29361,-0.2089,1,0
1,GO SYNAPTIC SIGNALING,9.795e-06,-0.29425,-0.20826,1,0
1,GO GLIAL CELL FATE COMMITMENT,0.017125,-0.29566,-0.26361,1,0
1,GO POTASSIUM ION TRANSPORT,1.2253e-05,-0.29754,-0.20827,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.026838,-0.29816,-0.13832,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0021798,-0.30001,-0.24443,1,0
1,GO SYNAPSE ASSEMBLY,6.2175e-05,-0.30025,-0.24419,1,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0095807,-0.30048,-0.18933,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,2.0364e-06,-0.30116,-0.25037,1,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.031631,-0.30288,-0.27274,1,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.00060545,-0.30367,-0.2548,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0016575,-0.30501,-0.24597,1,0
1,GO ACIDIC AMINO ACID TRANSPORT,4.9361e-06,-0.30519,-0.22349,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,3.1494e-05,-0.30599,-0.29822,1,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,1.7154e-07,-0.30663,-0.30641,1,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00020178,-0.30882,-0.21373,1,0
1,GO RESPONSE TO L GLUTAMATE,0.00010852,-0.30889,-0.31699,1,0
1,GO NEUROTRANSMITTER REUPTAKE,0.00012388,-0.3091,-0.25188,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,8.0256e-05,-0.31133,-0.29029,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0080166,-0.3118,-0.25473,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.013856,-0.31246,-0.25156,1,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,7.8052e-07,-0.31331,-0.31139,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,3.9872e-06,-0.31534,-0.29172,1,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,0.00081356,-0.31617,-0.23028,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.014172,-0.3167,-0.18734,1,0
1,GO SEROTONIN SECRETION,0.0054872,-0.31756,-0.28711,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0023637,-0.31881,-0.35043,1,0
1,GO DENDRITIC TRANSPORT,0.00021857,-0.31888,-0.24937,1,0
1,GO REFLEX,0.0013633,-0.319,-0.28952,1,0
1,GO RESPONSE TO COCAINE,2.8271e-07,-0.3198,-0.28444,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00048316,-0.3234,-0.21983,1,0
1,GO REGULATION OF NEURON MATURATION,0.00025215,-0.32444,-0.30961,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,2.5359e-06,-0.32542,-0.29789,1,0
1,GO NEURON MATURATION,7.3803e-06,-0.3257,-0.27528,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.9044e-05,-0.32628,-0.4185,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,6.4592e-06,-0.32893,-0.37712,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00014129,-0.32919,-0.23513,1,0
1,GO REGULATION OF VESICLE FUSION,9.086e-06,-0.32954,-0.33666,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.0098086,-0.3313,-0.21038,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,2.0776e-06,-0.33212,-0.26648,1,0
1,GO EXOCYTIC PROCESS,1.6994e-06,-0.33353,-0.25892,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.996e-06,-0.3348,-0.25723,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.0169e-05,-0.33664,-0.2847,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.012653,-0.33726,-0.2207,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00052901,-0.33744,-0.30116,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.001776,-0.33773,-0.30188,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.015329,-0.33812,-0.26549,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0016347,-0.33827,-0.22746,1,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0030038,-0.33912,-0.23319,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,1.6654e-06,-0.33994,-0.2996,1,0
1,GO GROOMING BEHAVIOR,1.4454e-06,-0.34043,-0.32174,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00012388,-0.34359,-0.31362,1,0
1,GO NEURON FATE COMMITMENT,5.2303e-06,-0.34546,-0.37973,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.010645,-0.34928,-0.20028,1,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.047372,-0.35123,-0.13777,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,2.1621e-05,-0.35185,-0.29985,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,8.4424e-05,-0.3561,-0.30289,1,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00018323,-0.35701,-0.29348,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,4.4771e-05,-0.35716,-0.30849,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00012804,-0.35989,-0.38759,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,4.5233e-07,-0.36029,-0.37987,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,5.1446e-05,-0.36101,-0.29164,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,2.0478e-05,-0.36389,-0.29567,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,3.5646e-05,-0.36546,-0.28907,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,1.5994e-06,-0.36579,-0.30043,1,0
1,GO SPINAL CORD PATTERNING,8.8796e-05,-0.36616,-0.32475,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0039481,-0.36673,-0.32172,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00043435,-0.36711,-0.23994,1,0
1,GO STARTLE RESPONSE,3.3214e-05,-0.36722,-0.3311,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.5674e-06,-0.36823,-0.31876,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,2.4091e-05,-0.37177,-0.33654,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00073415,-0.3723,-0.28759,1,0
1,GO SEROTONIN TRANSPORT,0.0014022,-0.37573,-0.28358,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,2.5934e-07,-0.37734,-0.31432,1,0
1,GO PREPULSE INHIBITION,5.8698e-06,-0.37777,-0.44412,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.6782e-07,-0.37793,-0.31349,1,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,2.0776e-06,-0.37815,-0.38231,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00015331,-0.38018,-0.36975,1,0
1,GO ADULT BEHAVIOR,2.5934e-07,-0.38094,-0.3055,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.00012804,-0.3811,-0.34424,1,0
1,GO CGMP METABOLIC PROCESS,8.1623e-05,-0.3812,-0.33743,1,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,1.4741e-05,-0.38256,-0.38631,1,0
1,GO SUBPALLIUM DEVELOPMENT,8.4424e-05,-0.38343,-0.29965,1,0
1,GO RESPONSE TO INSECTICIDE,1.7706e-05,-0.38386,-0.29997,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS,0.00012594,-0.38547,-0.34809,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.3442e-05,-0.3868,-0.37539,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00013673,-0.38895,-0.31037,1,0
1,GO DOPAMINE METABOLIC PROCESS,1.6654e-06,-0.39094,-0.36118,1,0
1,GO PITUITARY GLAND DEVELOPMENT,0.0011668,-0.39195,-0.24266,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.2631e-05,-0.39775,-0.27308,1,0
1,GO CATECHOLAMINE UPTAKE,9.795e-06,-0.40042,-0.32409,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,1.1165e-05,-0.40076,-0.36429,1,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,8.1623e-05,-0.40577,-0.28646,1,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,4.2784e-08,-0.40632,-0.34509,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0021798,-0.40787,-0.26971,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,2.7312e-05,-0.41026,-0.34174,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0016806,-0.41527,-0.33885,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,2.5868e-06,-0.41529,-0.33106,1,0
1,GO SYNAPSE MATURATION,0.00022208,-0.41884,-0.3871,1,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,4.4787e-08,-0.42318,-0.3522,1,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,2.2958e-06,-0.42473,-0.41838,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,0.00048316,-0.42648,-0.37666,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0030038,-0.42877,-0.32432,1,0
1,GO RESPONSE TO LITHIUM ION,7.6283e-05,-0.43297,-0.30951,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00029511,-0.43336,-0.3229,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00024819,-0.43788,-0.28925,1,0
1,GO RETINA LAYER FORMATION,7.5217e-06,-0.43904,-0.43278,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,3.0811e-07,-0.43996,-0.3703,1,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00064263,-0.44117,-0.34224,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,4.0657e-06,-0.44487,-0.41342,1,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0013443,-0.45101,-0.35162,1,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,3.7282e-08,-0.45264,-0.50914,1,0
1,GO GLUTAMATE SECRETION,1.6062e-07,-0.45597,-0.36674,1,0
1,GO NEURONAL ACTION POTENTIAL,2.5359e-06,-0.45719,-0.4284,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00082553,-0.46335,-0.34116,1,0
1,GO DENSE CORE GRANULE TRANSPORT,1.2328e-07,-0.46702,-0.57838,1,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,2.8262e-08,-0.47241,-0.39136,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,6.0079e-05,-0.47275,-0.41624,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,2.9859e-05,-0.47367,-0.31651,1,0
1,GO DETECTION OF CALCIUM ION,4.1552e-07,-0.4755,-0.42816,1,0
1,GO REGULATION OF GLUTAMATE SECRETION,8.8389e-07,-0.47561,-0.39123,1,0
1,GO INNERVATION,0.00082553,-0.47702,-0.32865,1,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00011406,-0.47703,-0.39243,1,0
1,GO NEUROTRANSMITTER TRANSPORT,1.2733e-08,-0.47986,-0.39607,1,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,3.0905e-06,-0.4804,-0.44798,1,0
1,GO GROWTH HORMONE SECRETION,4.7999e-05,-0.48255,-0.36075,1,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,6.6066e-07,-0.48493,-0.41592,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.0958e-05,-0.48547,-0.39332,1,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,1.6158e-05,-0.48918,-0.45351,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.00072342,-0.49523,-0.33314,1,0
1,GO THALAMUS DEVELOPMENT,2.3239e-05,-0.49877,-0.36579,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,8.3013e-05,-0.49973,-0.34796,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,2.5868e-06,-0.50037,-0.46185,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,2.8001e-06,-0.50228,-0.53984,1,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,1.6321e-06,-0.50647,-0.48411,1,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,1.3351e-08,-0.50764,-0.43722,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,5.1351e-07,-0.51183,-0.42649,1,0
1,GO NEUROTRANSMITTER SECRETION,1.2143e-08,-0.51697,-0.42732,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,5.9056e-05,-0.51771,-0.41971,1,0
1,GO PROTEIN LOCALIZATION TO AXON,4.3997e-05,-0.518,-0.50629,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,0.00046872,-0.52244,-0.50933,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,1.3999e-08,-0.52265,-0.53906,1,0
1,GO VOCALIZATION BEHAVIOR,3.2057e-05,-0.52528,-0.44574,1,0
1,GO AMINE TRANSPORT,4.5822e-08,-0.52909,-0.42981,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.2253e-05,-0.53713,-0.54206,1,0
1,GO NEURON FATE SPECIFICATION,2.7668e-07,-0.53955,-0.57794,1,0
1,GO SYNAPTIC VESICLE MATURATION,4.1552e-07,-0.5466,-0.53614,1,0
1,GO MONOAMINE TRANSPORT,1.6782e-07,-0.54704,-0.44091,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,9.6538e-08,-0.54726,-0.44534,1,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0067673,-0.55718,-0.34063,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,3.2162e-07,-0.55891,-0.52265,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,1.0756e-05,-0.55982,-0.43087,1,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,1.3196e-05,-0.56204,-0.46392,1,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,5.2359e-09,-0.56308,-0.46122,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,1.0527e-08,-0.56815,-0.49117,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,1.3999e-08,-0.57135,-0.477,1,0
1,GO NEURON CELL CELL ADHESION,9.2585e-06,-0.58011,-0.48708,1,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,7.3476e-09,-0.59548,-0.49948,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,1.2441e-09,-0.60876,-0.58554,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,2.538e-07,-0.61231,-0.52458,1,0
1,GO CATECHOLAMINE SECRETION,2.5164e-08,-0.62285,-0.55768,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,6.9711e-06,-0.63034,-0.46497,1,0
1,GO GANGLION DEVELOPMENT,3.3806e-05,-0.63333,-0.47573,1,0
1,GO NOSE DEVELOPMENT,6.3249e-05,-0.64404,-0.47776,1,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.1583e-08,-0.65389,-0.51669,1,0
1,GO DENDRITE EXTENSION,2.1064e-09,-0.65556,-0.52232,1,0
1,GO SYNAPTIC VESICLE PRIMING,2.9078e-09,-0.65734,-0.54694,1,0
1,GO SYNAPTIC VESICLE DOCKING,1.9926e-08,-0.67399,-0.57784,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.6823e-09,-0.67471,-0.58309,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00091404,-0.67844,-0.37507,1,0
1,GO DOPAMINE TRANSPORT,4.2042e-09,-0.69135,-0.59655,1,0
1,GO REGULATION OF DENDRITE EXTENSION,2.5066e-09,-0.69901,-0.58309,1,0
1,GO SYNAPTIC VESICLE CLUSTERING,1.6654e-06,-0.72361,-0.56058,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,6.6717e-09,-0.72642,-0.60595,1,0
1,GO REGULATION OF DOPAMINE SECRETION,1.5604e-09,-0.74051,-0.72818,1,0
1,GO GABAERGIC NEURON DIFFERENTIATION,5.4356e-06,-0.76821,-0.56309,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,3.1098e-10,-0.78171,-0.76727,1,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,5.6487e-06,-0.78955,-0.59341,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,1.2733e-08,-0.79836,-0.69637,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.9064e-09,-0.84901,-0.77556,1,0
1,GO MECHANOSENSORY BEHAVIOR,1.3599e-06,-0.86431,-0.68599,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,1.2441e-09,-0.8738,-0.76154,1,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,1.3468e-07,-0.87498,-0.73243,1,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,6.3359e-07,-0.95908,-0.78509,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,1.8135e-09,-1.1726,-1.0643,1,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.063836,0.34047,0.1481,0,1
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.12421,0.31635,0.19929,0,1
1,GO CELLULAR RESPONSE TO VITAMIN D,0.12924,0.20233,0.13032,0,1
1,GO RESPONSE TO FATTY ACID,0.10385,0.19624,0.087323,0,1
1,GO ACTIN FILAMENT NETWORK FORMATION,0.22971,0.19283,0.086921,0,1
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.17669,0.18487,0.10904,0,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.095518,0.17624,0.089624,0,1
1,GO RESPONSE TO MUSCLE STRETCH,0.26964,0.17532,0.10291,0,1
1,GO PSEUDOURIDINE SYNTHESIS,0.086237,0.17453,0.084664,0,1
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.15447,0.16766,0.11276,0,1
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.14983,0.16719,0.09361,0,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.17156,0.15656,0.087564,0,1
1,GO HORMONE CATABOLIC PROCESS,0.14308,0.14973,0.12148,0,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.10558,0.1488,0.086622,0,1
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.17029,0.13822,0.07962,0,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.16904,0.1357,0.070242,0,1
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.082591,0.13435,0.068129,0,1
1,GO CARTILAGE MORPHOGENESIS,0.21587,0.12978,0.16087,0,1
1,GO PIGMENT CELL DIFFERENTIATION,0.13338,0.12975,0.083295,0,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.090011,0.12841,0.085903,0,1
1,GO ANIMAL ORGAN MATURATION,0.078382,0.12665,0.096991,0,1
1,GO MUSCLE HYPERTROPHY,0.077018,0.12586,0.097428,0,1
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.13444,0.12492,0.14131,0,1
1,GO RETINOIC ACID METABOLIC PROCESS,0.068006,0.1243,0.10445,0,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.066192,0.12133,0.11516,0,1
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.15565,0.12111,0.09239,0,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.10646,0.12109,0.089951,0,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.093126,0.11819,0.070401,0,1
1,GO RRNA MODIFICATION,0.087731,0.11749,0.078569,0,1
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.17411,0.11609,0.091305,0,1
1,GO REGULATION OF RNA BINDING,0.072397,0.11527,0.089106,0,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.10558,0.11487,0.089381,0,1
1,GO TELOMERASE RNA LOCALIZATION,0.077018,0.11323,0.075812,0,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.075674,0.11313,0.082114,0,1
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.34008,0.11213,0.049509,0,1
1,GO NUCLEUS LOCALIZATION,0.1754,0.11182,0.088784,0,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.10734,0.11168,0.084198,0,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.069238,0.11164,0.07293,0,1
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.31604,0.11012,0.096211,0,1
1,GO NUCLEAR MIGRATION,0.40743,0.10987,0.067527,0,1
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.13763,0.1089,0.10686,0,1
1,GO HISTONE DEACETYLATION,0.065005,0.10803,0.065957,0,1
1,GO CARNITINE SHUTTLE,0.24416,0.107,0.068328,0,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.068006,0.10653,0.075695,0,1
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.22503,0.10634,0.066456,0,1
1,GO REGULATION OF GTPASE ACTIVITY,0.084034,0.10506,0.079162,0,1
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.26964,0.10358,0.083643,0,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.062684,0.10242,0.075993,0,1
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.2458,0.10072,0.057555,0,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.10471,0.10029,0.12091,0,1
1,GO DE NOVO PROTEIN FOLDING,0.29689,0.099629,0.04841,0,1
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.15683,0.099528,0.092048,0,1
1,GO ROOF OF MOUTH DEVELOPMENT,0.50258,0.099,0.049033,0,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.20992,0.0988,0.041545,0,1
1,GO SCHWANN CELL DEVELOPMENT,0.1313,0.098371,0.091197,0,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.21288,0.097813,0.061347,0,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.077698,0.095889,0.083355,0,1
1,GO NUCLEAR PORE ORGANIZATION,0.1873,0.094999,0.064801,0,1
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.24252,0.094859,0.0618,0,1
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.098784,0.094582,0.073544,0,1
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.18866,0.094185,0.081269,0,1
1,GO ENERGY RESERVE METABOLIC PROCESS,0.30637,0.094105,0.049146,0,1
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.11275,0.093862,0.080941,0,1
1,GO REGULATION OF CELL DIFFERENTIATION,0.13549,0.09362,0.064788,0,1
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.17283,0.093267,0.092991,0,1
1,GO NUCLEOSIDE SALVAGE,0.16904,0.092157,0.11229,0,1
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.21288,0.090061,0.043618,0,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.47211,0.089962,0.023544,0,1
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.2114,0.089724,0.085311,0,1
1,GO DNA DEMETHYLATION,0.20554,0.088436,0.07059,0,1
1,GO LACTATION,0.10912,0.0876,0.077659,0,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.36311,0.086618,0.026648,0,1
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.22348,0.085821,0.04984,0,1
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.32393,0.085221,0.041585,0,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.73517,0.085089,-0.0023351,0,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.45727,0.085013,0.025714,0,1
1,GO MUSCLE SYSTEM PROCESS,0.10734,0.084148,0.072745,0,1
1,GO TRNA METHYLATION,0.11367,0.083818,0.075155,0,1
1,GO LOCOMOTOR RHYTHM,0.17411,0.083749,0.071631,0,1
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.092339,0.082894,0.091383,0,1
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.35463,0.082465,0.04256,0,1
1,GO RIBOSOME BIOGENESIS,0.062684,0.08233,0.089593,0,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.13338,0.082303,0.053772,0,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.33803,0.082106,0.035421,0,1
1,GO SARCOMERE ORGANIZATION,0.26267,0.081312,0.084111,0,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.23927,0.07987,0.061587,0,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.24416,0.079491,0.051188,0,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.13549,0.079447,0.052036,0,1
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.12924,0.077788,0.11744,0,1
1,GO CYTOSKELETON ORGANIZATION,0.096327,0.077689,0.054798,0,1
1,GO REGULATION OF AXON GUIDANCE,0.15565,0.076218,0.10599,0,1
1,GO TELOMERE ORGANIZATION,0.37173,0.075131,0.0026742,0,1
1,GO CELL CYCLE PHASE TRANSITION,0.088486,0.073003,0.028405,0,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.318,0.070255,0.022664,0,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.15098,0.069907,0.052762,0,1
1,GO REGULATION OF PROTEIN TARGETING,0.11183,0.069617,0.060077,0,1
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.16285,0.069394,0.049577,0,1
1,GO TRNA METABOLIC PROCESS,0.33803,0.069307,0.031125,0,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.079765,0.068392,0.024062,0,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.094715,0.066837,0.037216,0,1
1,GO RNA METHYLATION,0.18866,0.066489,0.057908,0,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.16163,0.066168,0.037354,0,1
1,GO POSITIVE REGULATION OF FERTILIZATION,0.7814,0.066068,0.012568,0,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.47963,0.06562,0.020431,0,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.36741,0.064093,0.025552,0,1
1,GO GROWTH,0.086237,0.064011,0.064277,0,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.39156,0.06392,0.045938,0,1
1,GO SNRNA PROCESSING,0.27495,0.062461,0.16979,0,1
1,GO PROTEIN SUMOYLATION,0.13549,0.062411,0.037924,0,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.19003,0.062139,0.050918,0,1
1,GO GENE SILENCING,0.20409,0.060903,0.033011,0,1
1,GO MITOTIC CELL CYCLE,0.13338,0.060694,0.025005,0,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.12224,0.060511,0.022857,0,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.064418,0.059096,0.08339,0,1
1,GO REGULATION OF CELL CYCLE,0.1313,0.058988,0.019756,0,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.34835,0.05855,0.027944,0,1
1,GO CYTOKINESIS,0.3739,0.058105,0.024586,0,1
1,GO CELL CYCLE PROCESS,0.23766,0.057577,0.012338,0,1
1,GO PROTEIN MONOUBIQUITINATION,0.31215,0.057366,0.023603,0,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.50258,0.05634,0.024767,0,1
1,GO SPINDLE ORGANIZATION,1,0.055837,-0.015865,0,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.063836,0.055564,0.035972,0,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.38488,0.055274,0.025307,0,1
1,GO REGULATION OF GLUCONEOGENESIS,0.3871,0.054605,0.022068,0,1
1,GO REGULATION OF NUCLEAR DIVISION,0.31215,0.053041,0.0099893,0,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.26614,0.052799,0.039552,0,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.24252,0.052523,0.042896,0,1
1,GO CELL DIVISION,0.1754,0.051958,0.025857,0,1
1,GO MACROMOLECULE DEACYLATION,0.16778,0.049123,0.044425,0,1
1,GO ORGANELLE INHERITANCE,0.40286,0.047863,0.037613,0,1
1,GO NON RECOMBINATIONAL REPAIR,0.25078,0.046356,0.021299,0,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.57476,0.042726,0.0075378,0,1
1,GO MRNA TRANSPORT,0.1754,0.042715,0.043408,0,1
1,GO INOSITOL METABOLIC PROCESS,0.84107,0.041875,-0.018342,0,1
1,GO RNA PROCESSING,0.43075,0.041028,0.024039,0,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.65442,0.038552,0.012361,0,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.17411,0.034411,0.033375,0,1
1,GO DNA CATABOLIC PROCESS,0.49231,0.028042,0.012861,0,1
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.10558,0.26824,0.16856,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.25924,0.21738,0.16566,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.066792,0.21327,0.11557,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.081877,0.20946,0.19811,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.58585,0.20068,0.050765,0,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.098784,0.17758,0.098442,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.091558,0.1735,0.13289,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.22042,0.17261,0.079122,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.30446,0.17073,0.093303,0,0
1,GO RESPIRATORY BURST,0.14419,0.16648,0.096083,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.075009,0.16534,0.13808,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.067397,0.16453,0.16315,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.27853,0.16345,0.078091,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.18595,0.15987,0.1617,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.072397,0.15888,0.10577,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.572,0.15823,0.051966,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.077018,0.15671,0.11216,0,0
1,GO FATTY ACID HOMEOSTASIS,0.081877,0.15587,0.11635,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.095518,0.15539,0.15484,0,0
1,GO HISTAMINE SECRETION,0.3739,0.15516,0.078524,0,0
1,GO MYELIN MAINTENANCE,0.19003,0.15257,0.10919,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.15802,0.15156,0.16322,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.1146,0.14571,0.10302,0,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.067397,0.14352,0.12556,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.073043,0.14206,0.18549,0,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.11742,0.13953,0.12276,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.090011,0.1395,0.14295,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.091558,0.13674,0.14923,0,0
1,GO BRONCHUS DEVELOPMENT,0.23286,0.13629,0.14948,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.20122,0.13494,0.10785,0,0
1,GO REGULATION OF T CELL CHEMOTAXIS,0.08331,0.13381,0.076693,0,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.21437,0.13347,0.060829,0,0
1,GO SOMATIC STEM CELL DIVISION,0.4355,0.13316,0.076624,0,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.92416,0.13311,-0.054944,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.16407,0.13294,0.092012,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.36526,0.13259,0.086223,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.092339,0.13226,0.11168,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.52874,0.13197,0.017517,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.32592,0.13164,0.043323,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.21288,0.1305,0.090989,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.071119,0.12987,0.11397,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.23766,0.12948,0.085864,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.12322,0.12855,0.12104,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.080464,0.12711,0.099013,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.56103,0.127,0.026746,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.11092,0.12629,0.072664,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.24089,0.12604,0.088059,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.067397,0.12558,0.20616,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.10045,0.12558,0.11238,0,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.064418,0.12506,0.14574,0,0
1,GO RESPONSE TO CADMIUM ION,0.088486,0.12493,0.091471,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.21587,0.12483,0.084509,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.26614,0.12467,0.073268,0,0
1,GO BLASTODERM SEGMENTATION,0.11002,0.12362,0.14108,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.13549,0.12349,0.074599,0,0
1,GO L GLUTAMATE IMPORT,0.19003,0.12225,0.090602,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.074349,0.12104,0.12012,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.39156,0.12082,0.075907,0,0
1,GO SKIN DEVELOPMENT,0.098784,0.11979,0.10488,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.10912,0.11849,0.11462,0,0
1,GO NEPHRON TUBULE FORMATION,0.23766,0.11656,0.093309,0,0
1,GO GLIAL CELL PROLIFERATION,0.21889,0.11621,0.083103,0,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.11092,0.11604,0.13383,0,0
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.10045,0.11579,0.10996,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.10558,0.11579,0.10792,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.40286,0.11577,0.10861,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.086237,0.11527,0.10201,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.15921,0.11442,0.11674,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.56925,0.11366,0.0027653,0,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.11183,0.11361,0.096302,0,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.066792,0.1136,0.12164,0,0
1,GO HEART VALVE FORMATION,0.1793,0.11276,0.11869,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.15214,0.11186,0.098325,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.32792,0.11127,0.085986,0,0
1,GO FORELIMB MORPHOGENESIS,0.42602,0.10966,0.056681,0,0
1,GO OXYGEN TRANSPORT,0.32592,0.10929,0.074757,0,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.079765,0.10799,0.090862,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.31215,0.10753,0.049084,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.067397,0.10718,0.1459,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.087731,0.10677,0.09809,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.11742,0.10437,0.16561,0,0
1,GO ACETYL COA METABOLIC PROCESS,0.16407,0.10418,0.067744,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.23605,0.10399,0.071456,0,0
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.1146,0.10365,0.06303,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.080464,0.10355,0.099277,0,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.10823,0.10345,0.069557,0,0
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.063258,0.10342,0.1192,0,0
1,GO ESTROUS CYCLE,0.12822,0.10332,0.11079,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.062684,0.10331,0.076391,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.1793,0.10307,0.11029,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.572,0.10304,0.035623,0,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.089246,0.10257,0.067895,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.33396,0.10228,0.075516,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.065005,0.10173,0.20761,0,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.22814,0.10101,0.061822,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.34213,0.10092,0.05348,0,0
1,GO NUCLEOTIDE SALVAGE,0.081168,0.10022,0.14719,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.14419,0.099826,0.074173,0,0
1,GO B CELL APOPTOTIC PROCESS,0.10385,0.099705,0.1058,0,0
1,GO MOLTING CYCLE,0.084763,0.099651,0.10133,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.35463,0.099468,0.054514,0,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.20845,0.098839,0.057753,0,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.10129,0.098568,0.1132,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.11183,0.097444,0.11685,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.068006,0.0974,0.10596,0,0
1,GO TRNA CATABOLIC PROCESS,0.25924,0.097221,0.095255,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.071756,0.096981,0.14676,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.12421,0.096912,0.076099,0,0
1,GO BICARBONATE TRANSPORT,0.13027,0.096648,0.063805,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.66616,0.095399,0.038398,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.13338,0.095278,0.1014,0,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.094715,0.095109,0.072384,0,0
1,GO BONE CELL DEVELOPMENT,0.13027,0.094507,0.11753,0,0
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.076344,0.094482,0.10532,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.18327,0.093847,0.064928,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.41899,0.093819,0.06589,0,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.15565,0.093816,0.093077,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.084034,0.093472,0.078674,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.28033,0.09317,0.15664,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.14308,0.092924,0.0921,0,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.085497,0.092384,0.070824,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.72907,0.092346,0.054799,0,0
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.086237,0.09229,0.091494,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.29877,0.092272,0.093794,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.37608,0.09222,0.059308,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.178,0.092168,0.083973,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.17029,0.091628,0.09514,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.49743,0.091172,0.031969,0,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.12322,0.091164,0.10059,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.17029,0.090269,0.12427,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.26964,0.090233,0.07685,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.19838,0.090098,0.066978,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.21587,0.089975,0.071631,0,0
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.1262,0.089439,0.074846,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.12721,0.089407,0.076842,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.16407,0.089243,0.11846,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.58585,0.089135,0.0037718,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.066192,0.088657,0.082515,0,0
1,GO GLIAL CELL DEVELOPMENT,0.095518,0.088536,0.085549,0,0
1,GO DRUG CATABOLIC PROCESS,0.5314,0.088187,0.021254,0,0
1,GO MAINTENANCE OF CELL NUMBER,0.08331,0.08816,0.076558,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.21738,0.088067,0.18663,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11553,0.087932,0.12152,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.082591,0.087868,0.081349,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.099614,0.087835,0.094105,0,0
1,GO RESPONSE TO STEROL,0.17411,0.087669,0.080479,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.16163,0.087634,0.10271,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.20409,0.08747,0.068098,0,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.17156,0.087457,0.081377,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.12224,0.087032,0.083504,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.13763,0.086339,0.08637,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.34008,0.086205,0.041417,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.086237,0.085807,0.088036,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.079071,0.085251,0.13422,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.70787,0.085038,0.064265,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.30637,0.084693,0.042341,0,0
1,GO RRNA METHYLATION,0.11933,0.084688,0.071799,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.12924,0.084629,0.079365,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.2114,0.084613,0.089808,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.20409,0.084473,0.05206,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.1262,0.084402,0.10415,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.073043,0.083479,0.10657,0,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.089246,0.083413,0.081341,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.22658,0.083411,0.047454,0,0
1,GO REGULATION OF RUFFLE ASSEMBLY,0.16778,0.083257,0.084262,0,0
1,GO GOLGI RIBBON FORMATION,0.10045,0.08324,0.087185,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.38267,0.083116,0.084088,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.92094,0.08292,-0.026018,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17283,0.082742,0.049394,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.34627,0.082118,0.098388,0,0
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.091558,0.081961,0.13133,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.067397,0.081952,0.079055,0,0
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.1387,0.081941,0.062469,0,0
1,GO PROTEIN NITROSYLATION,0.12924,0.08189,0.089336,0,0
1,GO AORTA MORPHOGENESIS,0.23766,0.081596,0.10481,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.28761,0.080973,0.07939,0,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.39606,0.080831,0.038142,0,0
1,GO WATER TRANSPORT,0.15802,0.080592,0.10507,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.49487,0.080483,0.055715,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.44752,0.080419,0.030345,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.20122,0.079595,0.044162,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.21288,0.079414,0.052908,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.062684,0.079314,0.070072,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.12126,0.079154,0.075881,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.076344,0.079124,0.078295,0,0
1,GO PROTEIN TRIMERIZATION,0.44269,0.079096,0.04519,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.68094,0.079091,0.0018999,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.17029,0.079003,0.070864,0,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.17029,0.079001,0.062631,0,0
1,GO MITOTIC RECOMBINATION,0.44028,0.078999,0.038449,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.25753,0.078545,0.10111,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.38488,0.078137,0.079374,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.36098,0.078054,0.10528,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.090011,0.077983,0.064984,0,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.070488,0.077812,0.10624,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.14308,0.07763,0.084029,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.32993,0.077582,0.064799,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.31215,0.077461,0.078355,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.090782,0.077212,0.065267,0,0
1,GO GLAND DEVELOPMENT,0.098784,0.076903,0.079178,0,0
1,GO NCRNA EXPORT FROM NUCLEUS,0.15214,0.076825,0.057749,0,0
1,GO NCRNA METABOLIC PROCESS,0.086237,0.075927,0.069119,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.20992,0.07568,0.080727,0,0
1,GO APPENDAGE DEVELOPMENT,0.092339,0.075411,0.094442,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.090011,0.075135,0.080572,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.1914,0.07493,0.077459,0,0
1,GO VESICLE ORGANIZATION,0.091558,0.074703,0.060335,0,0
1,GO REGULATION OF HISTONE DEACETYLATION,0.11092,0.073862,0.088002,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.12322,0.073707,0.064751,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.13979,0.073634,0.070382,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.48722,0.073554,0.10803,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.52874,0.073513,0.037806,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.17283,0.073018,0.084895,0,0
1,GO RRNA METABOLIC PROCESS,0.075009,0.072678,0.082463,0,0
1,GO EPIDERMIS DEVELOPMENT,0.17156,0.072472,0.083282,0,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.21437,0.072152,0.03972,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.33599,0.071728,0.090743,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.1252,0.07168,0.075706,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.21889,0.071634,0.098187,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.090782,0.071557,0.067091,0,0
1,GO SMOOTHENED SIGNALING PATHWAY,0.071119,0.071483,0.085205,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.25246,0.071421,0.049835,0,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.073043,0.07086,0.060422,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.24911,0.070724,0.056976,0,0
1,GO RESPONSE TO LEAD ION,0.16407,0.070657,0.073446,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.59144,0.070631,0.045232,0,0
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.1653,0.070547,0.021341,0,0
1,GO CELL VOLUME HOMEOSTASIS,0.079765,0.070534,0.074571,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.22814,0.070529,0.089453,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.41203,0.070517,0.075092,0,0
1,GO APPENDAGE MORPHOGENESIS,0.14088,0.070367,0.085754,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.12924,0.070352,0.11441,0,0
1,GO VASCULAR WOUND HEALING,0.80012,0.070102,0.0073996,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.34835,0.069984,0.053571,0,0
1,GO CELL AGGREGATION,0.70787,0.069796,0.061071,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.78763,0.069698,-0.033081,0,0
1,GO PANCREATIC JUICE SECRETION,0.49231,0.069697,0.040185,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.71996,0.069468,0.034328,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.11837,0.069432,0.08921,0,0
1,GO MIDBODY ABSCISSION,0.11367,0.069312,0.081025,0,0
1,GO VASODILATION,0.51819,0.069292,0.021313,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.35253,0.068743,0.03537,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.15565,0.068742,0.052101,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.094715,0.068728,0.11178,0,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.1313,0.06831,0.047906,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.17669,0.068079,0.059308,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.42133,0.067991,0.060682,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.22971,0.067924,0.07825,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.31021,0.067795,0.039637,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.20122,0.067618,0.060586,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.19557,0.067549,0.12855,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.082591,0.067506,0.088557,0,0
1,GO HYPEROSMOTIC RESPONSE,0.10912,0.067452,0.070286,0,0
1,GO RECEPTOR INTERNALIZATION,0.14088,0.06736,0.067938,0,0
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.47211,0.067079,0.048251,0,0
1,GO FOLIC ACID METABOLIC PROCESS,0.22971,0.066817,0.059016,0,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.090011,0.066677,0.14221,0,0
1,GO REGULATION OF DNA BINDING,0.38267,0.066589,0.033687,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.089246,0.066548,0.06109,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.22971,0.066403,0.074677,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.52082,0.06638,0.050767,0,0
1,GO VIRAL BUDDING,0.18194,0.066087,0.05518,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.69885,0.066034,0.030541,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.2644,0.065772,0.039345,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.2644,0.065743,0.068153,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.40286,0.065673,0.074754,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.2714,0.065575,0.05337,0,0
1,GO ARACHIDONIC ACID SECRETION,0.75356,0.065453,0.0075177,0,0
1,GO RESPONSE TO ALCOHOL,0.24416,0.065304,0.054655,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.34008,0.065278,0.040014,0,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.94671,0.065067,-0.052855,0,0
1,GO PIGMENTATION,0.46962,0.065043,0.037874,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.32993,0.064974,0.14702,0,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.18194,0.064486,0.070524,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.2458,0.064357,0.049079,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.6515,0.064206,0.026879,0,0
1,GO RESPONSE TO INSULIN,0.15098,0.064142,0.05407,0,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.1252,0.064036,0.055505,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.35043,0.063802,0.059315,0,0
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.30446,0.06357,0.067264,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.62258,0.063471,0.0085897,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.32393,0.063462,0.069374,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.11092,0.063409,0.193,0,0
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.088486,0.063359,0.067326,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.85059,0.063281,0.0064429,0,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.067397,0.063273,0.072104,0,0
1,GO GLIOGENESIS,0.31215,0.062981,0.054135,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.21587,0.06296,0.055288,0,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.14419,0.062937,0.042752,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.59705,0.062792,0.038435,0,0
1,GO RESPONSE TO ACTIVITY,0.26095,0.062755,0.042127,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.35463,0.062737,0.076198,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.35886,0.062673,0.063631,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.52082,0.062463,0.056517,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.87606,0.062396,0.038026,0,0
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.23128,0.062366,0.073778,0,0
1,GO HISTAMINE TRANSPORT,0.62545,0.061956,0.035547,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.91772,0.061945,0.0049586,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.23927,0.061526,0.12075,0,0
1,GO PEPTIDYL THREONINE MODIFICATION,0.38047,0.061497,0.027393,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.12421,0.061236,0.077275,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.43075,0.061169,0.067896,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.065596,0.061088,0.077647,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.098784,0.060987,0.073277,0,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.26095,0.060982,0.063852,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.24911,0.060695,0.083873,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.23128,0.060539,0.10183,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.13444,0.060515,0.05931,0,0
1,GO STEM CELL PROLIFERATION,0.3871,0.060366,0.039705,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.19838,0.060232,0.090681,0,0
1,GO REGULATION OF MRNA 3 END PROCESSING,0.088486,0.060016,0.069761,0,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.096327,0.059999,0.05147,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.47461,0.05995,0.084926,0,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.085497,0.059828,0.11618,0,0
1,GO RESPONSE TO ZINC ION,0.19003,0.059823,0.06642,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.34213,0.059723,0.050755,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.09714,0.059704,0.069141,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.33396,0.05928,0.082355,0,0
1,GO REGULATION OF GROWTH,0.14308,0.05922,0.055569,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.24416,0.059087,0.047357,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.29502,0.058882,0.07914,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.5665,0.058772,0.014455,0,0
1,GO RENAL SYSTEM PROCESS,0.17156,0.058675,0.095223,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.51296,0.058527,0.12088,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.39381,0.058455,0.079767,0,0
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.12721,0.058451,0.043492,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.572,0.058439,0.030552,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.55558,0.058198,0.0071384,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.36956,0.058153,0.037101,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.47211,0.058102,0.02545,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.10912,0.05801,0.061484,0,0
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.36526,0.057963,0.037242,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.10558,0.057958,0.082813,0,0
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.31215,0.057913,0.061877,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.17156,0.057909,0.10275,0,0
1,GO TRNA PROCESSING,0.21587,0.057521,0.042898,0,0
1,GO RESPONSE TO FUNGUS,0.5665,0.057426,0.033864,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.23128,0.057404,0.057101,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.22042,0.057336,0.054772,0,0
1,GO OVULATION CYCLE PROCESS,0.31604,0.057297,0.04987,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.52082,0.057284,0.037659,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.28761,0.057236,0.071177,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.43075,0.057115,0.065074,0,0
1,GO NEURON PROJECTION REGENERATION,0.1453,0.05699,0.088163,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.079071,0.056982,0.0783,0,0
1,GO AMINE METABOLIC PROCESS,0.178,0.056902,0.042051,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.084763,0.056866,0.12975,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.14419,0.056697,0.16519,0,0
1,GO RESPONSE TO IRON ION,0.20554,0.056611,0.073528,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.46962,0.056446,0.034822,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.41434,0.056373,0.040875,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.25078,0.056154,0.053491,0,0
1,GO REGULATION OF NUCLEASE ACTIVITY,0.067397,0.056097,0.080931,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.17411,0.055979,0.11106,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.35463,0.055894,0.035304,0,0
1,GO MICROVILLUS ORGANIZATION,0.86649,0.055829,0.0066564,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.071756,0.055689,0.064505,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.17669,0.055638,0.086704,0,0
1,GO ANOIKIS,0.2714,0.05563,0.07392,0,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.58307,0.055572,0.012866,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.42367,0.055548,0.025061,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.47712,0.055296,0.073239,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.16407,0.055163,0.054208,0,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.94026,0.055158,-0.00036004,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.33803,0.054949,0.048533,0,0
1,GO REGULATION OF CELL DIVISION,0.09714,0.054738,0.062786,0,0
1,GO RRNA TRANSCRIPTION,0.29877,0.054738,0.042629,0,0
1,GO RNA LOCALIZATION,0.13549,0.054704,0.050349,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.27853,0.054602,0.043698,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.67501,0.054263,0.032675,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.43789,0.05412,0.039747,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.28761,0.05378,0.10115,0,0
1,GO SECRETION,0.095518,0.053732,0.071047,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.18194,0.053543,0.051902,0,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.87926,0.052854,-0.01387,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.084034,0.052796,0.11992,0,0
1,GO STEROID METABOLIC PROCESS,0.10734,0.052667,0.062702,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.43312,0.052648,0.039923,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.20554,0.052536,0.091899,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.34213,0.052519,0.050585,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.38488,0.052412,0.073201,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.28761,0.052159,0.049176,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.19003,0.052099,0.064898,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.51035,0.051776,0.045237,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.14197,0.051606,0.050406,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.18595,0.051542,0.053943,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.30637,0.05151,0.04692,0,0
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.22348,0.051501,0.054471,0,0
1,GO VITAMIN METABOLIC PROCESS,0.15214,0.051448,0.064287,0,0
1,GO PRO B CELL DIFFERENTIATION,0.52609,0.051061,0.048912,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.46962,0.051035,0.02434,0,0
1,GO RESPONSE TO AXON INJURY,0.47461,0.050964,0.047357,0,0
1,GO SHORT TERM MEMORY,0.68689,0.050674,0.033611,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.28761,0.050651,0.13644,0,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.094715,0.050535,0.051019,0,0
1,GO RUFFLE ASSEMBLY,0.14983,0.050534,0.074632,0,0
1,GO AMINO ACID IMPORT,0.86331,0.050513,0.025837,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.31215,0.050403,0.04369,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.25583,0.050394,0.085477,0,0
1,GO TRANSITION METAL ION TRANSPORT,0.079071,0.050199,0.052253,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.56376,0.05018,0.022062,0,0
1,GO VITAMIN TRANSPORT,0.64567,0.050133,0.018773,0,0
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.079071,0.050098,0.057848,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.065596,0.050045,0.10643,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.15214,0.049895,0.095307,0,0
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.92094,0.049886,-0.007746,0,0
1,GO REGULATION OF EXCRETION,0.17283,0.049881,0.083808,0,0
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.24911,0.04983,0.061307,0,0
1,GO GDP METABOLIC PROCESS,0.26964,0.04981,-0.08427,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.1313,0.049632,0.076866,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.84424,0.049553,0.033308,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.33803,0.049522,0.023199,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.43075,0.049491,0.057817,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.74435,0.049463,-0.0053795,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.61402,0.049399,0.033727,0,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.42367,0.049381,0.031207,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.32195,0.049287,0.039103,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.20845,0.049275,0.061498,0,0
1,GO ALDITOL METABOLIC PROCESS,0.45482,0.049246,0.029221,0,0
1,GO PROTEASOME ASSEMBLY,0.087731,0.049162,0.094238,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.28033,0.049139,0.092656,0,0
1,GO NEPHRON MORPHOGENESIS,0.48215,0.049114,0.044342,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.20699,0.049098,0.11139,0,0
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.45727,0.048932,0.048183,0,0
1,GO ATP TRANSPORT,0.55558,0.048855,0.030196,0,0
1,GO LIPID DIGESTION,0.69885,0.048712,0.0094421,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.20992,0.048684,0.074373,0,0
1,GO TRNA MODIFICATION,0.18866,0.048635,0.050764,0,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.076344,0.048628,0.11856,0,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.12224,0.048592,0.058034,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.17029,0.048538,0.10301,0,0
1,GO O GLYCAN PROCESSING,0.46713,0.048134,0.038869,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.30637,0.048083,0.040623,0,0
1,GO PROTEIN KINASE C SIGNALING,0.36741,0.047989,0.066799,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.41899,0.047737,0.028618,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.40058,0.047678,0.035557,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.37608,0.047579,0.037629,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.69286,0.047564,0.01866,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.20845,0.047451,0.047323,0,0
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.10385,0.04733,0.084392,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.23128,0.047252,0.071559,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.26964,0.047172,0.062841,0,0
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.084034,0.047035,0.073077,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.10214,0.046903,0.085606,0,0
1,GO RENAL SODIUM EXCRETION,0.40058,0.046855,0.054355,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.39606,0.04685,0.028225,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.52345,0.046818,0.063645,0,0
1,GO POSTREPLICATION REPAIR,0.35886,0.046714,0.021242,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.48215,0.046667,0.049223,0,0
1,GO LACTATE METABOLIC PROCESS,0.25414,0.046639,0.057044,0,0
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.91772,0.04658,-0.0036209,0,0
1,GO MUSCLE CONTRACTION,0.23766,0.046524,0.059485,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.3871,0.046431,0.038488,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.35674,0.046408,0.043489,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.52082,0.046384,0.055577,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.28578,0.046328,0.061347,0,0
1,GO HISTONE MRNA METABOLIC PROCESS,0.40743,0.045936,0.013905,0,0
1,GO COENZYME A METABOLIC PROCESS,0.31997,0.045933,0.051802,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.28033,0.045871,0.061593,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.26095,0.045863,0.098484,0,0
1,GO STEROL METABOLIC PROCESS,0.12924,0.045806,0.066451,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.39606,0.045797,0.064997,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.38267,0.045635,0.07661,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.86649,0.045559,-0.04352,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.74741,0.045556,0.0073154,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.9306,0.045369,0.020213,0,0
1,GO RESPONSE TO ACID CHEMICAL,0.11092,0.0453,0.078543,0,0
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.16778,0.045144,0.029391,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.85376,0.045121,0.030159,0,0
1,GO RESPONSE TO INACTIVITY,0.5394,0.044854,0.042364,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.30637,0.044792,0.04426,0,0
1,GO CELL GROWTH,0.30829,0.04469,0.044212,0,0
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.54477,0.044513,0.018214,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.11553,0.044496,0.062843,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.38933,0.044454,0.066814,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.23445,0.044384,0.044369,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.22503,0.044378,0.076252,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.61972,0.044366,0.012372,0,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.18461,0.044305,0.041043,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.77519,0.044304,0.014831,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.28761,0.04419,0.024375,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.10646,0.044188,0.070802,0,0
1,GO CARBOHYDRATE TRANSPORT,0.60268,0.04354,0.018637,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.37827,0.043246,0.033402,0,0
1,GO RESPONSE TO RADIATION,0.21587,0.043053,0.029331,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.75664,0.042959,-0.015934,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.12721,0.042597,0.066673,0,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.11367,0.042424,0.056254,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.97899,0.042375,-0.02713,0,0
1,GO THIOESTER METABOLIC PROCESS,0.10734,0.042362,0.074577,0,0
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.40058,0.042348,0.032936,0,0
1,GO PIRNA METABOLIC PROCESS,0.60268,0.042186,0.032191,0,0
1,GO DNA INTEGRITY CHECKPOINT,0.81581,0.042127,-0.0049594,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.62545,0.042125,0.030871,0,0
1,GO CELL CYCLE,0.20554,0.042063,0.012411,0,0
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.52345,0.041942,0.021792,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.69586,0.041934,0.038091,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.5314,0.04176,0.03328,0,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.797,0.041631,0.0010557,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.082591,0.041569,0.056519,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.26964,0.041475,0.065565,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.56925,0.041253,0.045997,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.24911,0.04102,0.063037,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.36956,0.041,0.053283,0,0
1,GO RESPONSE TO GONADOTROPIN,0.10734,0.040963,0.11168,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.60834,0.040951,0.037384,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.47712,0.040773,0.041507,0,0
1,GO DEVELOPMENTAL GROWTH,0.41434,0.040377,0.037713,0,0
1,GO TRANSLESION SYNTHESIS,0.31604,0.04028,0.030641,0,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.20122,0.040022,0.062698,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.20122,0.040006,0.041223,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.91772,0.03997,0.033495,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.52345,0.039954,0.031341,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.6515,0.039868,0.052593,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.28578,0.039865,0.11234,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.30066,0.039803,0.06139,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.84424,0.039734,0.007056,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.5,0.039471,0.11598,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.090011,0.039332,0.066413,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.28945,0.039315,0.042342,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.81267,0.039311,0.0098712,0,0
1,GO PHAGOSOME MATURATION,0.7659,0.039228,0.023644,0,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.094715,0.039197,0.050679,0,0
1,GO GONADOTROPIN SECRETION,0.14088,0.039168,0.095273,0,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.58585,0.039053,0.0275,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.42838,0.038901,0.030519,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.32195,0.038897,0.034379,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.69286,0.038828,0.017081,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.75356,0.03876,0.014411,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.70486,0.038748,0.034697,0,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.25246,0.038521,0.026457,0,0
1,GO REGULATION OF DNA RECOMBINATION,0.178,0.038494,0.047635,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.797,0.038355,0.01492,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.3739,0.038307,0.045501,0,0
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.31409,0.038226,0.01156,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.098784,0.038222,0.046446,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.64276,0.038056,0.017504,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.9113,0.037882,-0.0059513,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.36098,0.037832,0.079587,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.11183,0.03771,0.096913,0,0
1,GO CELL JUNCTION ASSEMBLY,0.61972,0.037294,0.035496,0,0
1,GO EXPLORATION BEHAVIOR,0.65442,0.037214,0.0066444,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.45482,0.037195,0.040648,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.089246,0.037131,0.065906,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.88885,0.037115,-0.019353,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE,0.63986,0.037088,0.010637,0,0
1,GO RNA SURVEILLANCE,0.66321,0.037047,0.009952,0,0
1,GO LYMPH NODE DEVELOPMENT,0.44994,0.036953,0.078927,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.36741,0.036859,0.028217,0,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.24416,0.036759,0.035438,0,0
1,GO TRNA TRANSPORT,0.47461,0.03671,0.020323,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.41203,0.036673,0.064853,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.14642,0.036599,0.043444,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.48722,0.036546,0.017586,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.30829,0.03652,0.045599,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.43075,0.036508,0.031574,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.58585,0.036357,0.040741,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.49743,0.036327,0.020386,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.94671,0.036249,-0.0028417,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.96284,0.03599,0.0092244,0,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.42602,0.035975,0.064512,0,0
1,GO POSITIVE REGULATION OF DNA BINDING,0.54477,0.035873,0.022412,0,0
1,GO REPRODUCTION,0.53406,0.035863,0.022204,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.50258,0.03586,0.051798,0,0
1,GO NUCLEUS ORGANIZATION,0.18062,0.035763,0.037242,0,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.1252,0.035733,0.068692,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.77209,0.035698,-0.00055986,0,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.83158,0.035672,-0.0073237,0,0
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.44994,0.035624,1.377e-05,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.43312,0.035623,0.039826,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.4355,0.035551,0.027017,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.61972,0.035525,0.02734,0,0
1,GO MRNA METABOLIC PROCESS,0.41666,0.035297,0.022984,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.59144,0.035277,0.042159,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.11367,0.035185,0.15449,0,0
1,GO GLYCINE METABOLIC PROCESS,0.61117,0.035051,0.026152,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.32592,0.035022,0.057506,0,0
1,GO RESPONSE TO COPPER ION,0.35253,0.035022,0.050149,0,0
1,GO ENSHEATHMENT OF NEURONS,0.092339,0.034975,0.089409,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.41666,0.034916,0.025374,0,0
1,GO CELL CYCLE ARREST,0.23766,0.034709,0.032796,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.5314,0.034662,0.052802,0,0
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.12721,0.034516,0.032004,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.26964,0.034305,0.098471,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.52345,0.034015,0.024195,0,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.40973,0.033844,0.038534,0,0
1,GO LIPID PHOSPHORYLATION,0.35043,0.033828,0.042711,0,0
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.15921,0.033798,0.035564,0,0
1,GO PROTEIN POLYMERIZATION,0.27317,0.033618,0.036794,0,0
1,GO DNA METABOLIC PROCESS,0.55287,0.033618,-0.0044835,0,0
1,GO THYROID GLAND DEVELOPMENT,0.89846,0.033595,0.025322,0,0
1,GO REGULATION OF CHROMOSOME SEPARATION,0.45727,0.033577,0.0029344,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.90809,0.03357,-0.016915,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.37173,0.033556,0.012291,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.38267,0.033555,0.096082,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.48468,0.033462,0.036419,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.16285,0.033405,0.049014,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.19979,0.033377,0.065504,0,0
1,GO POLYOL METABOLIC PROCESS,0.47461,0.033352,0.026589,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.99192,0.033318,-0.0011177,0,0
1,GO NCRNA 3 END PROCESSING,0.35886,0.033214,0.10267,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.68392,0.033128,0.022566,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.26095,0.03309,0.03659,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.572,0.032998,0.019978,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42367,0.032959,0.065938,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.91451,0.032827,0.0079881,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.71391,0.032535,0.014293,0,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.69286,0.032413,0.01645,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.75972,0.032314,-0.0058032,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.89526,0.032279,0.004083,0,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.12822,0.032226,0.055205,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.33194,0.032208,0.033067,0,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.71693,0.03219,0.013105,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.28213,0.032167,0.037582,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.56103,0.032157,0.036978,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.61972,0.032055,-0.038961,0,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.68392,0.031778,0.026665,0,0
1,GO REGULATION OF CELL SIZE,0.35043,0.031761,0.041001,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.3739,0.031746,0.031235,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.15565,0.031716,0.074018,0,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.32792,0.031642,0.028478,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.43075,0.031618,0.033046,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.74741,0.031602,0.0015036,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.37608,0.03151,0.046408,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.65442,0.031498,0.018459,0,0
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.3442,0.031485,0.024256,0,0
1,GO G2 DNA DAMAGE CHECKPOINT,0.75664,0.031282,0.00096924,0,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.41434,0.031236,0.027867,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.43312,0.0312,0.051852,0,0
1,GO REGULATION OF CENTROSOME CYCLE,0.82211,0.031159,-0.0064695,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.89205,0.03106,-0.040052,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.90488,0.031028,-0.0074666,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.61117,0.030925,-0.021389,0,0
1,GO SPINDLE ASSEMBLY,0.81896,0.030911,-0.030672,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.61972,0.030711,0.035808,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.82211,0.030685,0.04078,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.94026,0.03043,0.015002,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.62832,0.029982,0.016445,0,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.73517,0.029931,-0.016337,0,0
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.318,0.029741,0.016474,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.67206,0.029695,0.027345,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.80012,0.029633,0.015041,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.72603,0.029607,-0.022928,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.24089,0.029549,0.053659,0,0
1,GO RNA 3 END PROCESSING,0.572,0.029454,0.016898,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.80953,0.029428,0.0053748,0,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.87926,0.029326,0.0077888,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.75664,0.029189,0.0089173,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.69885,0.028978,0.039495,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.2913,0.028977,0.043427,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.35253,0.028764,0.032886,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.29502,0.028707,0.079846,0,0
1,GO HOMEOSTATIC PROCESS,0.18595,0.028677,0.044132,0,0
1,GO NODAL SIGNALING PATHWAY,0.63408,0.02867,-0.041968,0,0
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.31215,0.028537,0.018754,0,0
1,GO MEIOTIC SPINDLE ORGANIZATION,0.49487,0.028493,0.014947,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.43312,0.02844,0.046196,0,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.24745,0.0284,0.0404,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.54746,0.028307,0.053037,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.23445,0.028212,0.052042,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.82842,0.028098,-0.0076904,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.46962,0.028024,0.041122,0,0
1,GO MULTIVESICULAR BODY ORGANIZATION,0.26614,0.027864,0.040533,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.58029,0.02779,0.033091,0,0
1,GO REGULATION OF DNA METABOLIC PROCESS,0.38267,0.027694,0.014177,0,0
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.57476,0.02754,0.030621,0,0
1,GO LEFT RIGHT PATTERN FORMATION,0.20409,0.027284,0.095602,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.28033,0.027197,0.068092,0,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.48976,0.02705,0.021992,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.29315,0.026972,0.055693,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.7814,0.026931,0.011069,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.4355,0.026913,0.032706,0,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.84741,0.02688,-0.037307,0,0
1,GO RESPONSE TO ACIDIC PH,0.24416,0.026816,0.073053,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.95961,0.026726,-0.0030952,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.51035,0.026637,0.036029,0,0
1,GO AEROBIC RESPIRATION,0.67206,0.026635,0.0085951,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.43312,0.026605,0.044713,0,0
1,GO TRNA WOBBLE BASE MODIFICATION,0.52082,0.026545,0.035164,0,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.1754,0.026424,0.048861,0,0
1,GO SEGMENTATION,0.78451,0.026265,0.01604,0,0
1,GO SPHINGOID METABOLIC PROCESS,0.34835,0.026253,0.049502,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.72299,0.02625,0.013296,0,0
1,GO CELLULAR HOMEOSTASIS,0.40743,0.026199,0.035704,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.48722,0.026166,0.067145,0,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.95316,0.026161,-0.029655,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.75972,0.02615,-0.031787,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.6691,0.026094,0.022295,0,0
1,GO SEX DIFFERENTIATION,0.68094,0.026039,0.018331,0,0
1,GO GLYCOSYLATION,0.66028,0.025828,0.018336,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.75356,0.025724,0.02092,0,0
1,GO DNA GEOMETRIC CHANGE,0.5314,0.025628,0.010239,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.47963,0.025442,0.039504,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.5583,0.025436,0.029491,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.96607,0.025425,-0.010632,0,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.47963,0.025125,0.027499,0,0
1,GO AMINO ACID ACTIVATION,0.92416,0.025043,-0.0057198,0,0
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.42133,0.024779,0.012999,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.31997,0.024777,0.029021,0,0
1,GO TRANSLATIONAL TERMINATION,0.25753,0.024764,0.04675,0,0
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.52874,0.024739,0.01543,0,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.9693,0.024624,-0.0054117,0,0
1,GO ADAPTIVE THERMOGENESIS,0.44994,0.024596,0.038945,0,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.42367,0.024508,0.043011,0,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.45727,0.024475,0.037678,0,0
1,GO EXTRACELLULAR TRANSPORT,0.9306,0.024436,-0.0027375,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.20845,0.024212,0.049243,0,0
1,GO RESPONSE TO WATER,0.59705,0.024133,0.045166,0,0
1,GO CELL MORPHOGENESIS,0.99192,0.02404,0.014956,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.64276,0.02396,0.023225,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.86649,0.023915,0.030876,0,0
1,GO SNRNA METABOLIC PROCESS,0.35463,0.023912,0.12187,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.9693,0.023851,-0.041008,0,0
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.63408,0.023659,0.010273,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.15447,0.023634,0.08437,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.52609,0.023572,0.02878,0,0
1,GO FEVER GENERATION,0.35253,0.02348,-0.075413,0,0
1,GO SPLEEN DEVELOPMENT,0.70486,0.023463,0.021938,0,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.59986,0.023121,0.037963,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.7814,0.023072,-0.0049663,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.64276,0.022976,0.029518,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.56376,0.02291,0.031304,0,0
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.66616,0.02277,-0.024867,0,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.21437,0.022761,0.038344,0,0
1,GO AXON EXTENSION,0.97576,0.022734,0.015293,0,0
1,GO CELL CYCLE CHECKPOINT,0.81267,0.022715,-0.018993,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.73517,0.022583,0.01161,0,0
1,GO MESONEPHROS DEVELOPMENT,0.45238,0.022566,0.057842,0,0
1,GO REGULATION OF FERTILIZATION,0.81267,0.0225,0.0048156,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.36311,0.02249,0.034294,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.11837,0.022452,0.045679,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.94348,0.022301,0.0019583,0,0
1,GO MITOTIC NUCLEAR DIVISION,0.87606,0.022248,-0.019902,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.13027,0.022154,0.054352,0,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.23605,0.022049,0.028948,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.81896,0.021655,-0.0095336,0,0
1,GO ORGANELLE DISASSEMBLY,0.12822,0.021601,0.052366,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.63697,0.021567,0.026873,0,0
1,GO MITOCHONDRIAL DNA REPLICATION,0.55016,0.021508,0.021519,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.92738,0.021475,-0.018205,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.43789,0.021447,0.036561,0,0
1,GO INTRACELLULAR TRANSPORT,0.14088,0.021353,0.034523,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.69286,0.021168,0.020132,0,0
1,GO HEART INDUCTION,0.90167,0.021137,0.0068533,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.68988,0.021053,0.034214,0,0
1,GO IRON ION TRANSPORT,0.24252,0.020993,0.040435,0,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.41203,0.020988,0.036658,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.44752,0.020747,0.050127,0,0
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.35886,0.020627,0.050646,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.87606,0.020625,0.013751,0,0
1,GO GOLGI LOCALIZATION,0.6515,0.020437,-0.012033,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.1387,0.020173,0.095271,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.73822,0.020069,-0.00058649,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.58029,0.020028,0.013314,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.73517,0.019965,0.0072731,0,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.81267,0.019944,0.012007,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.22195,0.019886,0.042506,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.35674,0.01966,0.070201,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.5583,0.019584,-0.04048,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.73822,0.019512,-0.010156,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.30829,0.019469,0.05287,0,0
1,GO METAPHASE PLATE CONGRESSION,0.77519,0.019347,-0.038692,0,0
1,GO METAL ION HOMEOSTASIS,0.20122,0.019323,0.05417,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.16904,0.019132,0.059474,0,0
1,GO CHROMOSOME SEGREGATION,0.70486,0.019034,-0.044264,0,0
1,GO SPECIFICATION OF SYMMETRY,0.29315,0.018964,0.043766,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.90488,0.018833,0.0044609,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.59424,0.018815,0.029045,0,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.16407,0.018611,0.035322,0,0
1,GO FEMALE GAMETE GENERATION,0.96284,0.01845,-0.0087406,0,0
1,GO CYTOSOLIC TRANSPORT,0.28945,0.018427,0.042474,0,0
1,GO EYE MORPHOGENESIS,0.96607,0.018395,0.011403,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.9113,0.018358,-0.040369,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.44994,0.018356,0.059577,0,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.66321,0.018353,0.017417,0,0
1,GO PROTEIN DENEDDYLATION,0.64276,0.018221,0.023674,0,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.67206,0.017752,0.0040024,0,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.66616,0.017739,0.015397,0,0
1,GO MIRNA METABOLIC PROCESS,0.73212,0.017704,0.016047,0,0
1,GO CENTRIOLE ASSEMBLY,0.97899,0.017676,-0.012719,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.63697,0.017532,0.019212,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.89526,0.017508,0.0018852,0,0
1,GO MAST CELL ACTIVATION,0.60834,0.017226,0.045798,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.60268,0.017204,0.026722,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.5583,0.017178,0.043598,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.28945,0.017135,0.057334,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.92738,0.017093,0.017712,0,0
1,GO REGULATION OF MITOPHAGY,0.40743,0.016981,0.071385,0,0
1,GO RESPONSE TO EPINEPHRINE,0.70787,0.016955,0.034311,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.28395,0.01685,0.085803,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.63408,0.016616,0.0371,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.48215,0.016491,0.036436,0,0
1,GO MITOCHONDRIAL TRANSLATION,0.55016,0.016403,0.015197,0,0
1,GO ORGANELLE ASSEMBLY,0.86331,0.016229,0.0053862,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.39606,0.016197,0.038574,0,0
1,GO REGULATION OF DNA REPAIR,0.91451,0.016184,-0.014502,0,0
1,GO RNA EXPORT FROM NUCLEUS,0.94671,0.016121,-0.0074312,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.99838,0.016009,0.0060787,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.1262,0.015987,0.066986,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.56376,0.015942,0.039992,0,0
1,GO ION HOMEOSTASIS,0.28761,0.015932,0.04787,0,0
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.49743,0.015917,0.025807,0,0
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.75972,0.015914,-0.0021882,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.93704,0.015474,0.0064844,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.20409,0.015286,0.096902,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.90488,0.015144,0.0047936,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.35674,0.014974,0.045769,0,0
1,GO VIRAL LATENCY,0.92094,0.014954,-0.020091,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.30829,0.01491,0.054902,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.55016,0.014843,0.06406,0,0
1,GO THYMIC T CELL SELECTION,0.38047,0.014702,0.079671,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.67501,0.014596,0.039632,0,0
1,GO CELLULAR RESPONSE TO PH,0.83474,0.014555,0.012245,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.86331,0.014434,0.00032521,0,0
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.45238,0.014433,0.038277,0,0
1,GO RELAXATION OF MUSCLE,0.82526,0.014431,0.00070321,0,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.572,0.014246,0.013122,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.81896,0.014201,-0.0093432,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.797,0.014191,-0.00039949,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.75972,0.01419,0.017898,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.87926,0.014028,-0.01414,0,0
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.82526,0.013866,-0.0013679,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.72603,0.013754,0.0039491,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.88565,0.013743,0.0198,0,0
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.37827,0.01367,0.040405,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.97576,0.013644,-0.0072446,0,0
1,GO ORGANELLE FISSION,0.93382,0.013594,-0.023057,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.88245,0.013588,-0.016846,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.98869,0.013551,-0.001376,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.52345,0.01351,0.051856,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.95961,0.013391,0.014187,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.73517,0.013156,0.031034,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.97253,0.013153,0.010648,0,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.18595,0.013064,0.096546,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.46713,0.012987,0.040096,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.26789,0.012852,0.055045,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.60268,0.012847,0.026445,0,0
1,GO KIDNEY MORPHOGENESIS,0.92416,0.012599,0.014134,0,0
1,GO ACTIN NUCLEATION,0.59424,0.012534,0.014059,0,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.36741,0.012489,0.035218,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.95639,0.012448,0.0045314,0,0
1,GO HISTONE MONOUBIQUITINATION,0.93382,0.012409,7.0532e-05,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.57752,0.012347,0.030712,0,0
1,GO DNA RECOMBINATION,0.9693,0.012298,-0.017827,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.19417,0.012296,-0.056893,0,0
1,GO ATP METABOLIC PROCESS,0.94671,0.012287,0.00055949,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.91451,0.012262,0.018696,0,0
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.97253,0.012235,-0.0060019,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.49231,0.01223,-0.049722,0,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.30829,0.012137,0.045635,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.93704,0.012084,0.030364,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.89846,0.01207,0.0047639,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.30255,0.01201,0.037138,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.99515,0.011745,-0.0014842,0,0
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.49487,0.011685,0.012388,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.74435,0.011494,0.004852,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.95316,0.011425,0.0085156,0,0
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.83474,0.011395,-0.019928,0,0
1,GO RESPONSE TO ETHANOL,0.90488,0.011229,0.01723,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.12126,0.011192,0.088497,0,0
1,GO DOUBLE STRAND BREAK REPAIR,0.81581,0.011142,-0.030471,0,0
1,GO ERYTHROCYTE MATURATION,0.31215,0.011045,0.086004,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.93382,0.010945,0.0068736,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.88565,0.010927,0.0067354,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.68392,0.010891,0.026193,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.84424,0.01088,0.0044954,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.50776,0.010759,0.023449,0,0
1,GO NOTCH SIGNALING PATHWAY,0.84107,0.010745,0.0066264,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.75972,0.010582,0.032495,0,0
1,GO REGULATION OF DNA REPLICATION,0.6515,0.010495,-0.0035242,0,0
1,GO REGULATION OF MACROAUTOPHAGY,0.10471,0.01046,0.067008,0,0
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.8379,0.010429,0.0035065,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.93704,0.010392,-0.0008141,0,0
1,GO AMP METABOLIC PROCESS,0.48215,0.010379,0.057515,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.43075,0.010354,0.07116,0,0
1,GO NUCLEOTIDE EXCISION REPAIR,0.84107,0.010294,0.0055792,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.73822,0.01011,0.024171,0,0
1,GO APOPTOTIC DNA FRAGMENTATION,0.60268,0.01008,0.009683,0,0
1,GO CELL PROJECTION ASSEMBLY,0.71693,0.010052,0.021434,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.31021,0.0098758,0.044059,0,0
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.97576,0.0098654,-0.0052328,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.51557,0.0098208,0.051849,0,0
1,GO LIPID EXPORT FROM CELL,0.64858,0.009736,0.037267,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.89205,0.0097297,-0.0043929,0,0
1,GO DNA MODIFICATION,0.75972,0.0097001,0.0067457,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.34008,0.009497,0.04417,0,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.28761,0.009401,0.041728,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.69885,0.0093789,0.024267,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.94348,0.0090231,0.010462,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.47712,0.0090101,0.031264,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.26964,0.0089216,0.045476,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.86649,0.0088843,0.030491,0,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.94348,0.0087954,-0.046955,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.24416,0.0086385,0.067002,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,0.96284,0.0085361,-0.012609,0,0
1,GO CHROMOSOME LOCALIZATION,0.73517,0.0084323,-0.030841,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.86012,0.0083998,0.026131,0,0
1,GO MRNA CLEAVAGE,0.91772,0.0083701,-0.0061815,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.71391,0.0083292,0.025412,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.58029,0.0083074,-0.018146,0,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.35886,0.0082469,0.090073,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.70185,0.0079327,-0.02161,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.66321,0.0079145,0.04243,0,0
1,GO MEMBRANE FUSION,0.93382,0.0078766,0.011837,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.97899,0.0078601,0.012242,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.31409,0.0075852,0.070753,0,0
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.56925,0.0072416,-0.054076,0,0
1,GO NEURON PROJECTION GUIDANCE,0.39606,0.0070085,-0.041793,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.72299,0.0069865,-0.0060735,0,0
1,GO P BODY ASSEMBLY,0.88565,0.0069616,-0.0040322,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.31215,0.0069371,0.045027,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.35043,0.0069231,-0.027367,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.22658,0.0068637,0.066922,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.85376,0.0068569,0.0041277,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.35886,0.0068564,-0.035396,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.52345,0.0067299,0.037467,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.80639,0.0066289,-0.07622,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.60268,0.0066142,0.01242,0,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.23128,0.0065692,0.070035,0,0
1,GO ALANINE TRANSPORT,0.95961,0.006479,-0.0031779,0,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.96284,0.0059926,-0.0059465,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.45727,0.0058697,0.040189,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.56925,0.005737,0.056594,0,0
1,GO PROTEIN NEDDYLATION,0.62545,0.0056831,0.033108,0,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.87287,0.0056806,-0.0037089,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.45972,0.0056731,0.056827,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.72907,0.0056475,0.027874,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.92738,0.0055785,-0.013205,0,0
1,GO DNA REPAIR,0.71996,0.0054886,-0.028752,0,0
1,GO RRNA 3 END PROCESSING,0.90167,0.0052623,-0.010314,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.90488,0.0051477,0.0020168,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.50516,0.0050855,-0.016415,0,0
1,GO NCRNA CATABOLIC PROCESS,0.55016,0.0050677,0.034399,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.96284,0.0047172,0.0088863,0,0
1,GO TOR SIGNALING,0.77519,0.0047095,0.002487,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.56925,0.0044298,0.023655,0,0
1,GO ZINC ION TRANSPORT,0.84107,0.0043676,0.034082,0,0
1,GO GLUCOSE IMPORT,0.7659,0.0042578,0.017167,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.80639,0.004078,-0.0060239,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.70787,0.0040647,0.01755,0,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.6312,0.0038941,-0.023408,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.35886,0.0038931,0.070684,0,0
1,GO MIDBRAIN DEVELOPMENT,0.59705,0.0037418,0.029823,0,0
1,GO PHOSPHATE ION TRANSPORT,0.96284,0.0036739,0.0077033,0,0
1,GO SISTER CHROMATID SEGREGATION,0.38933,0.00361,-0.066777,0,0
1,GO SNORNA 3 END PROCESSING,0.572,0.0035141,-0.045508,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.98546,0.0033005,-0.014656,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.58864,0.0031084,0.023056,0,0
1,GO REGULATION OF ATPASE ACTIVITY,0.50776,0.0029486,0.028373,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.62258,0.002895,0.027329,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.52609,0.002705,-0.028101,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.72907,0.0024941,0.026548,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.43075,0.0023567,0.043625,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.71089,0.0023437,-0.0038325,0,0
1,GO RETINA HOMEOSTASIS,0.69286,0.0022836,-0.017013,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.80326,0.002283,0.03829,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.73212,0.0020531,0.025999,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.54208,0.001939,0.053568,0,0
1,GO MULTI ORGANISM PROCESS,0.82526,0.0018923,0.0099477,0,0
1,GO CHROMOSOME SEPARATION,0.90167,0.0018077,-0.020502,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.6515,0.0017885,0.022009,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.66616,0.0016727,0.031449,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.38047,0.0016644,-0.031198,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.90167,0.0014478,0.018934,0,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.84424,0.0012594,-0.0038765,0,0
1,GO RESPONSE TO LEPTIN,0.5314,0.0010894,0.047343,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.80953,0.00085655,0.0075854,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.48722,0.00055814,-0.012373,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.77829,0.00046026,-0.019852,0,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.8379,0.00043279,-0.022068,0,0
1,GO TRANSLATIONAL ELONGATION,0.38488,0.00042855,0.030535,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.25246,0.0003318,0.076173,0,0
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.83474,0.00028201,0.0081283,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.98546,0.00021694,0.013024,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.61402,8.1573e-05,0.081502,0,0
1,GO NEURON DEATH,0.98222,1.9234e-05,0.015778,0,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.27317,-7.385e-06,-0.072665,0,0
1,GO REGULATION OF CYTOKINESIS,0.99838,-0.00011526,-0.017993,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.56103,-0.00023367,-0.030731,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.86649,-0.0003274,-0.016405,0,0
1,GO DIET INDUCED THERMOGENESIS,0.92094,-0.00057642,0.011288,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.60834,-0.00059499,-0.0036915,0,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.91451,-0.00071677,-0.0085555,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.50516,-0.00078066,-0.026632,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.58585,-0.00079908,-0.032748,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.90809,-0.0010434,0.009495,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.96284,-0.0011577,-0.0096432,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.80953,-0.0012167,0.03892,0,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.47963,-0.0012917,-0.058226,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.73822,-0.0013738,-0.016609,0,0
1,GO PROSTAGLANDIN SECRETION,0.18327,-0.0014778,0.094523,0,0
1,GO CGMP MEDIATED SIGNALING,0.74128,-0.0016679,-0.010388,0,0
1,GO CENTROSOME DUPLICATION,0.75972,-0.00169,-0.020325,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.80012,-0.0019021,0.032312,0,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.36311,-0.0020785,0.050034,0,0
1,GO CELL RECOGNITION,0.77209,-0.0021004,-0.0017307,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.46962,-0.0022113,0.056976,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.94348,-0.0022542,0.053219,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.25583,-0.0023273,0.069147,0,0
1,GO STEROID CATABOLIC PROCESS,0.73822,-0.0023861,0.034479,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.98869,-0.0023907,0.012046,0,0
1,GO DEPHOSPHORYLATION,0.88565,-0.0025534,0.00040914,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.45972,-0.0026699,0.070319,0,0
1,GO HISTONE H3 ACETYLATION,0.66616,-0.0027373,-0.0081534,0,0
1,GO ACTIN CROSSLINK FORMATION,0.83158,-0.0029055,-0.030191,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.90488,-0.0029893,-0.00038793,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.80953,-0.0030953,-0.002464,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.89526,-0.0032805,0.010818,0,0
1,GO RESPONSE TO REDOX STATE,0.58585,-0.0033155,0.035479,0,0
1,GO IMP METABOLIC PROCESS,0.95639,-0.0034245,-0.025829,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.77209,-0.0034896,-0.027528,0,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.82526,-0.0036204,0.013694,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.82526,-0.0036258,-0.036893,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.80326,-0.0037097,0.0028258,0,0
1,GO DEVELOPMENTAL INDUCTION,0.86331,-0.0037662,-0.00026352,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.70185,-0.0038473,0.035189,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.9113,-0.0038481,0.0076305,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.92094,-0.0041461,0.015081,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.7814,-0.0042326,-0.0033135,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.6691,-0.0042493,-0.010184,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.50258,-0.0044557,0.059341,0,0
1,GO COCHLEA MORPHOGENESIS,0.71089,-0.0045388,0.015651,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.797,-0.0046973,0.039537,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.97253,-0.004743,0.0022366,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.7814,-0.004777,0.019663,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.37173,-0.0048073,0.078553,0,0
1,GO MRNA EXPORT FROM NUCLEUS,0.58307,-0.0048191,-0.028854,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.8379,-0.0049434,-0.009078,0,0
1,GO CELLULAR RESPIRATION,0.58864,-0.0050009,0.012099,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.59705,-0.0052628,-0.022974,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.89526,-0.0053912,0.027264,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.81581,-0.0055032,0.0076414,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.61687,-0.0056473,-0.013412,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.70787,-0.0058929,-0.013304,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.38488,-0.0059673,-0.06169,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.88245,-0.0060875,-0.017634,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.41666,-0.0061621,0.032027,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.67798,-0.006292,-0.0088768,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.45482,-0.0064674,-0.037968,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.58864,-0.0065084,-0.019942,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.50258,-0.0065551,-0.021253,0,0
1,GO MRNA 3 END PROCESSING,0.77829,-0.0067126,-0.019744,0,0
1,GO REGULATION OF TOR SIGNALING,0.318,-0.0067776,-0.017727,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.32393,-0.0067922,-0.048991,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.81896,-0.0068834,0.043795,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.92094,-0.0068967,0.010224,0,0
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.57752,-0.0071409,0.035143,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.75356,-0.0072907,0.039334,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.90809,-0.0074998,0.011835,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.47712,-0.0077353,0.046015,0,0
1,GO CENTRIOLE CENTRIOLE COHESION,0.63408,-0.0077581,0.033587,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.68392,-0.0078024,0.02594,0,0
1,GO DNA REPLICATION,0.62545,-0.0078415,-0.044014,0,0
1,GO METHIONINE METABOLIC PROCESS,0.35674,-0.0079334,-0.043885,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.67501,-0.0079608,-0.0030683,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.78763,-0.0079628,-0.006294,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.8379,-0.0080087,0.03338,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.34008,-0.0081643,-0.029613,0,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.50776,-0.0082058,0.050753,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.87606,-0.0084658,-0.0061552,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.67501,-0.0085137,0.034919,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.81896,-0.0085994,0.0080903,0,0
1,GO RESPONSE TO METAL ION,0.70185,-0.0086038,0.0036275,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.50776,-0.0086751,0.055069,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.71693,-0.0087432,0.089544,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.65442,-0.0088532,-0.03905,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.25583,-0.0088702,-0.03588,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.90167,-0.0089146,-0.019328,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.34627,-0.0089363,-0.039114,0,0
1,GO RNA INTERFERENCE,0.79387,-0.0089492,-0.023119,0,0
1,GO NUCLEOTIDE TRANSPORT,0.99192,-0.0091298,0.0017095,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.78451,-0.0092805,-0.0036206,0,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.77519,-0.0093341,-0.0016398,0,0
1,GO ZINC ION HOMEOSTASIS,0.70787,-0.0094515,0.037863,0,0
1,GO PARTURITION,0.75048,-0.0095347,0.016237,0,0
1,GO CORNIFICATION,0.78451,-0.0095725,-0.032291,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.74741,-0.009914,-0.01466,0,0
1,GO DNA CONFORMATION CHANGE,0.49487,-0.0099987,-0.042922,0,0
1,GO FERTILIZATION,0.26789,-0.010028,-0.03104,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.66321,-0.010092,-0.015091,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.9693,-0.010262,0.030553,0,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.87606,-0.010271,0.0043725,0,0
1,GO CALCIUM ION IMPORT,0.30066,-0.010373,-0.028111,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.68988,-0.010707,0.029085,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.5665,-0.010721,-0.029769,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.94026,-0.010821,0.0064529,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.35463,-0.010854,0.078278,0,0
1,GO MITOCHONDRION ORGANIZATION,0.86649,-0.010905,0.0023426,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.83158,-0.010924,-0.007361,0,0
1,GO CRISTAE FORMATION,0.71089,-0.01094,0.00036046,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.67798,-0.010978,-0.026666,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.89205,-0.011039,-0.041211,0,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.7659,-0.0112,0.021522,0,0
1,GO REGULATION OF HISTONE UBIQUITINATION,0.89205,-0.011321,0.010128,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.42602,-0.011327,-0.014353,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.88565,-0.011484,0.013177,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.96607,-0.011579,0.010902,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.55558,-0.01174,-0.019352,0,0
1,GO RESPONSE TO STARVATION,0.59705,-0.011758,0.00022776,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.29502,-0.011883,-0.095545,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.99515,-0.01193,0.023904,0,0
1,GO PHOTOPERIODISM,0.87926,-0.01216,-0.0074539,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.64858,-0.012192,0.079225,0,0
1,GO UTERUS DEVELOPMENT,0.42838,-0.012271,-0.040634,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.6691,-0.012272,-0.029864,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.83158,-0.012279,0.023291,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.52874,-0.012281,-0.024,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.9113,-0.01231,-0.014043,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.85694,-0.012389,-0.0015813,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.94348,-0.012408,0.013398,0,0
1,GO SNRNA TRANSCRIPTION,0.58029,-0.012436,-0.010369,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.84741,-0.012531,0.018774,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.9693,-0.012571,0.01307,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.64858,-0.012598,-0.0087226,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.35043,-0.012741,-0.038065,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.42133,-0.012823,-0.047173,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.59424,-0.013035,0.090062,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.49487,-0.013044,-0.013888,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.68689,-0.013163,-0.023951,0,0
1,GO RNA STABILIZATION,0.4355,-0.013166,-0.028864,0,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.9113,-0.013181,-0.010901,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.39381,-0.013191,-0.037636,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.54208,-0.013401,-0.030602,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.36098,-0.013449,-0.020418,0,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.30446,-0.013528,-0.05188,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.9306,-0.01353,0.010784,0,0
1,GO REGULATION OF DNA METHYLATION,0.59705,-0.013554,-0.028299,0,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.40743,-0.013579,-0.04066,0,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.56103,-0.013726,-0.029895,0,0
1,GO SEXUAL REPRODUCTION,0.16778,-0.013877,-0.032979,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.64858,-0.014032,0.02888,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.80953,-0.014182,-0.035565,0,0
1,GO SECONDARY METABOLIC PROCESS,0.83474,-0.014198,-0.0017903,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.76281,-0.014775,-0.0075464,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.47712,-0.014808,-0.0084841,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.18194,-0.014841,0.073417,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.90167,-0.014859,0.019006,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.45972,-0.014879,-0.062184,0,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.84424,-0.014908,0.012867,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.69586,-0.014931,-0.02417,0,0
1,GO GMP METABOLIC PROCESS,0.68094,-0.015003,-0.012608,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.96284,-0.015005,0.018369,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.87287,-0.01516,-0.013271,0,0
1,GO RNA POLYADENYLATION,0.92416,-0.015342,0.0043645,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.39606,-0.015357,0.062968,0,0
1,GO RENAL WATER HOMEOSTASIS,0.83158,-0.015588,0.0019799,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.22195,-0.015607,-0.11332,0,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.96607,-0.015646,0.0070508,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.88885,-0.01565,0.006139,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.67501,-0.016096,-0.04337,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.99192,-0.016101,-0.0015151,0,0
1,GO L AMINO ACID TRANSPORT,0.48722,-0.016178,-0.02084,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.9113,-0.016254,0.034875,0,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.87287,-0.016359,-0.00019347,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.095518,-0.016396,-0.15293,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.86968,-0.016541,-0.0056395,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.70787,-0.016599,0.0051253,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.55016,-0.016703,-0.041887,0,0
1,GO REGULATION OF SPINDLE ORGANIZATION,0.71391,-0.016718,-0.035993,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.6312,-0.016927,-0.0064943,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.58585,-0.017054,-0.020764,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.48468,-0.017182,0.035131,0,0
1,GO MEIOTIC CELL CYCLE,0.13444,-0.017353,-0.067775,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.5665,-0.017358,-0.022555,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.70185,-0.017455,0.031915,0,0
1,GO GASTRIC ACID SECRETION,0.69885,-0.017532,-0.011739,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.52345,-0.017555,-0.045117,0,0
1,GO RNA CAPPING,0.88565,-0.017734,0.010456,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.45482,-0.017803,-0.051096,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.76281,-0.017942,-0.012426,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.30255,-0.018095,-0.038558,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.72299,-0.018105,0.028094,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.48215,-0.018195,0.061725,0,0
1,GO MITOCHONDRIAL TRANSPORT,0.55016,-0.018248,-0.012022,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.73822,-0.018405,-0.0097016,0,0
1,GO MICROTUBULE ANCHORING,0.62258,-0.018462,-0.0015398,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.5394,-0.018477,-0.024895,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.47712,-0.018528,-0.070622,0,0
1,GO CHROMOSOME ORGANIZATION,0.37827,-0.018528,-0.040262,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.25753,-0.018631,-0.052,0,0
1,GO HISTONE UBIQUITINATION,0.71996,-0.018757,-0.016681,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.81581,-0.0188,-0.0029712,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.72907,-0.018924,-0.02061,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.6515,-0.018938,-0.006639,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.22658,-0.018967,-0.062383,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.88565,-0.019083,0.037295,0,0
1,GO V D J RECOMBINATION,0.97899,-0.019128,0.0058806,0,0
1,GO EXCRETION,0.97899,-0.019294,0.02001,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.48215,-0.019513,0.038863,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.5583,-0.019796,-0.00926,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.71089,-0.019808,0.0213,0,0
1,GO METHYLATION,0.29502,-0.020136,-0.032345,0,0
1,GO CELL JUNCTION ORGANIZATION,0.50516,-0.020137,-0.010621,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.48722,-0.020342,-0.030449,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.6515,-0.020374,0.030909,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.17029,-0.020451,-0.081147,0,0
1,GO LIPID DROPLET ORGANIZATION,0.83158,-0.020677,0.00049421,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.63986,-0.020685,-0.036364,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.60268,-0.020916,-0.01806,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.6312,-0.021069,-0.010299,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.74741,-0.021078,-0.027112,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.32993,-0.021158,-0.029338,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.91772,-0.021234,0.022347,0,0
1,GO HEART FIELD SPECIFICATION,0.30446,-0.02125,-0.082171,0,0
1,GO HISTONE H2A UBIQUITINATION,0.87926,-0.021473,-0.0040632,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.52609,-0.021477,-0.032973,0,0
1,GO RNA SPLICING,0.14983,-0.021489,-0.050136,0,0
1,GO RHYTHMIC BEHAVIOR,0.26267,-0.02169,-0.050069,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.28761,-0.022032,-0.027219,0,0
1,GO SNORNA METABOLIC PROCESS,0.45727,-0.022303,-0.047681,0,0
1,GO FUCOSE METABOLIC PROCESS,0.61972,-0.022334,-0.034015,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.99838,-0.022354,0.01624,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.7814,-0.022389,-0.012058,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.52345,-0.022395,-0.029689,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.30637,-0.0224,-0.02576,0,0
1,GO LYSOSOME LOCALIZATION,0.45972,-0.022505,0.048545,0,0
1,GO HISTONE H3 K27 METHYLATION,0.28945,-0.022648,-0.061883,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.55016,-0.022671,-0.016366,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.81581,-0.02274,0.0051213,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.2714,-0.023269,-0.033106,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.5,-0.023469,-0.020779,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.35253,-0.023477,-0.036879,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.56376,-0.02391,-0.0048013,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.77209,-0.024183,-0.0082646,0,0
1,GO SOMITOGENESIS,0.4451,-0.024299,-0.02368,0,0
1,GO T CELL HOMEOSTASIS,0.98869,-0.024472,0.028268,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.57476,-0.024507,-0.041345,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.31997,-0.024523,-0.033005,0,0
1,GO RHYTHMIC PROCESS,0.26267,-0.024689,-0.02442,0,0
1,GO INORGANIC ANION TRANSPORT,0.68988,-0.024709,0.0012756,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.51296,-0.024967,0.069393,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.31409,-0.025026,-0.039816,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.71391,-0.025043,0.033141,0,0
1,GO DEMETHYLATION,0.32592,-0.025052,-0.034291,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.77209,-0.025061,0.024685,0,0
1,GO OOGENESIS,0.065005,-0.025097,-0.077028,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.59424,-0.025121,-0.024648,0,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.2114,-0.025203,-0.032519,0,0
1,GO RESPONSE TO GLUCAGON,0.6312,-0.025212,-0.01323,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.92094,-0.025253,-0.001647,0,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.55287,-0.02527,-0.0034848,0,0
1,GO T CELL LINEAGE COMMITMENT,0.59705,-0.025339,0.043247,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.89526,-0.025354,0.019966,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.43312,-0.025395,-0.047489,0,0
1,GO BLASTOCYST DEVELOPMENT,0.43789,-0.025457,-0.02107,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.61687,-0.025491,0.038891,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.81581,-0.02561,0.028509,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.16904,-0.025632,-0.037977,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.65442,-0.025634,-0.02319,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.43075,-0.025723,-0.040562,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.88565,-0.025732,0.02905,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.14088,-0.025817,-0.070029,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.15447,-0.025835,-0.060823,0,0
1,GO REGIONALIZATION,0.21738,-0.025953,-0.043457,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.67501,-0.026046,0.018175,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.91772,-0.026319,0.026314,0,0
1,GO CHEMICAL HOMEOSTASIS,0.76899,-0.026535,0.025931,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.60834,-0.026559,-0.012421,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.76281,-0.026678,0.006738,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.96284,-0.026741,-0.0053005,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.65442,-0.026771,-0.023829,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.86012,-0.026897,0.0080721,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.72907,-0.026906,-0.013757,0,0
1,GO NEUROBLAST PROLIFERATION,0.39156,-0.027113,-0.049125,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.97899,-0.027352,0.021506,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.86968,-0.027356,0.0035088,0,0
1,GO MYOFIBRIL ASSEMBLY,0.50516,-0.027535,0.062105,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.70486,-0.027907,0.024768,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.8379,-0.028008,0.0022981,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.74435,-0.028184,0.0028847,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.84741,-0.028201,-0.033306,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.66321,-0.028255,-0.029659,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.51819,-0.028307,0.057847,0,0
1,GO TORC1 SIGNALING,0.25078,-0.028373,-0.032904,0,0
1,GO CELL FATE COMMITMENT,0.32195,-0.028463,-0.045041,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.14308,-0.028471,-0.040452,0,0
1,GO NCRNA TRANSCRIPTION,0.49743,-0.028608,-0.020129,0,0
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.75048,-0.028665,0.056775,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.67206,-0.028851,7.7804e-05,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.15683,-0.028857,-0.032349,0,0
1,GO HISTONE H3 DEACETYLATION,0.73822,-0.028892,0.028325,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.91451,-0.028897,0.0016132,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.30637,-0.029002,-0.074483,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.41666,-0.029296,-0.0147,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.6055,-0.029345,-0.014616,0,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.46713,-0.029785,-0.029872,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.70787,-0.029859,0.017422,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.71996,-0.02998,-0.016386,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.98222,-0.030065,0.012813,0,0
1,GO GAMETE GENERATION,0.18461,-0.030353,-0.034967,0,0
1,GO COVALENT CHROMATIN MODIFICATION,0.24416,-0.030496,-0.035356,0,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.81896,-0.030507,-0.0036515,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.22042,-0.030597,-0.050308,0,0
1,GO MRNA PROCESSING,0.18595,-0.030717,-0.045811,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.84424,-0.030725,0.010334,0,0
1,GO MISMATCH REPAIR,0.44269,-0.030923,-0.03505,0,0
1,GO CARDIAC CHAMBER FORMATION,0.36956,-0.031211,-0.040978,0,0
1,GO ORGANELLE LOCALIZATION,0.11837,-0.031282,-0.0364,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.97253,-0.031283,-0.0098299,0,0
1,GO ADULT HEART DEVELOPMENT,0.32993,-0.031367,-0.047496,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.86649,-0.031505,-0.0088407,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.75664,-0.031623,0.0081001,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.52082,-0.031888,-0.016572,0,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.39381,-0.031935,-0.066562,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.33194,-0.03199,-0.059211,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.52082,-0.032106,-0.014743,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.14869,-0.03248,-0.059939,0,0
1,GO SINGLE FERTILIZATION,0.24416,-0.032681,-0.034111,0,0
1,GO ER OVERLOAD RESPONSE,0.65442,-0.03296,-0.019617,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.66028,-0.033101,-0.024676,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.30829,-0.033543,-0.05737,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19003,-0.033558,-0.088844,0,0
1,GO CHROMOSOME CONDENSATION,0.47461,-0.033942,-0.057852,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.61687,-0.03398,-0.0079348,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.77209,-0.034043,0.038462,0,0
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.47963,-0.034044,-0.054336,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.22814,-0.034529,-0.063312,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.4355,-0.034538,-0.044055,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.58864,-0.034576,0.031529,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.33803,-0.034577,-0.039465,0,0
1,GO SPERM CAPACITATION,0.85376,-0.034597,0.0011538,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.36741,-0.03472,-0.029762,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.41203,-0.03476,-0.03315,0,0
1,GO BASE EXCISION REPAIR,0.16285,-0.034965,-0.054513,0,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.40286,-0.035014,-0.032769,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.54208,-0.035149,-0.012628,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.57752,-0.035158,-0.01604,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.29689,-0.035337,-0.075849,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.30637,-0.035427,-0.049702,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.95639,-0.035449,0.036948,0,0
1,GO REGULATION OF TRANSPORT,0.45972,-0.035495,-0.0065908,0,0
1,GO REGULATION OF ACROSOME REACTION,0.73212,-0.035635,-0.028991,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.68988,-0.035643,-0.015194,0,0
1,GO MITOCHONDRIAL FISSION,0.56376,-0.035722,-0.013261,0,0
1,GO REGULATION OF GLIOGENESIS,0.35886,-0.03586,-0.025185,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.57752,-0.035966,-0.022344,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.27853,-0.035977,-0.032141,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.3871,-0.036324,-0.037853,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.067397,-0.036384,-0.046213,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.67798,-0.036448,-0.006123,0,0
1,GO VESICLE LOCALIZATION,0.36741,-0.036507,-0.018499,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.46962,-0.03665,-0.027801,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.52609,-0.036936,-0.021034,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.32592,-0.037142,-0.030771,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.59144,-0.037281,0.00034021,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.6691,-0.037292,-0.0089115,0,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.17283,-0.037318,-0.037176,0,0
1,GO PENILE ERECTION,0.61687,-0.037442,-0.036127,0,0
1,GO AXONAL FASCICULATION,0.090011,-0.037493,-0.15945,0,0
1,GO REGULATION OF NEURON MIGRATION,0.37173,-0.037562,-0.05424,0,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.096327,-0.037574,-0.081721,0,0
1,GO RESPONSE TO CARBOHYDRATE,0.47461,-0.03761,-0.004039,0,0
1,GO REGULATION OF PH,0.97576,-0.03774,0.0051464,0,0
1,GO METANEPHROS MORPHOGENESIS,0.54477,-0.037906,-0.032781,0,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.57476,-0.038383,-0.045202,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.32993,-0.038399,-0.053989,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.38047,-0.03844,-0.046774,0,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.19838,-0.038568,-0.034187,0,0
1,GO STRESS GRANULE ASSEMBLY,0.24911,-0.038598,-0.049971,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.22814,-0.038876,-0.069253,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.572,-0.038965,-0.022008,0,0
1,GO SENSORY PERCEPTION OF TASTE,0.063258,-0.039034,-0.1071,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.58585,-0.039247,0.053338,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.24416,-0.039411,-0.070853,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.19979,-0.039508,-0.059861,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.27853,-0.03973,-0.037248,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.19697,-0.039804,-0.032348,0,0
1,GO AUTOPHAGIC CELL DEATH,0.797,-0.03988,0.0091509,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.55016,-0.040448,-0.0085,0,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.48468,-0.04072,-0.025614,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.5394,-0.040775,-0.015114,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.10045,-0.040948,-0.043651,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.55016,-0.041154,-0.0098839,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.28395,-0.041451,-0.025283,0,0
1,GO DIOL METABOLIC PROCESS,0.63408,-0.04161,-0.028575,0,0
1,GO RESPONSE TO CALCIUM ION,0.62258,-0.041661,-0.011333,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.29315,-0.041761,-0.068647,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.18327,-0.041942,-0.042365,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.91451,-0.041969,0.0098655,0,0
1,GO EXIT FROM MITOSIS,0.29315,-0.042139,-0.043382,0,0
1,GO MALE GAMETE GENERATION,0.1262,-0.042308,-0.040697,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.077698,-0.042477,-0.047757,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.64276,-0.042482,0.045726,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.14088,-0.042519,-0.069125,0,0
1,GO RECOMBINATIONAL REPAIR,0.085497,-0.042592,-0.078742,0,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.81267,-0.042737,-0.020289,0,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.35886,-0.042757,-0.084297,0,0
1,GO CENTROSOME SEPARATION,0.73822,-0.043104,-0.040318,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.40743,-0.043667,-0.048125,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.53672,-0.043679,-0.041359,0,0
1,GO THYMUS DEVELOPMENT,0.36311,-0.043769,-0.029697,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.61972,-0.043849,0.054211,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.17669,-0.044013,-0.12024,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.53672,-0.044101,-0.022681,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.30066,-0.044349,-0.027677,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.1252,-0.044357,-0.095488,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.32195,-0.04443,-0.047415,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.78763,-0.044482,0.024012,0,0
1,GO STEROID HORMONE SECRETION,0.99838,-0.044503,0.0089084,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.16904,-0.044522,-0.070009,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.47211,-0.044966,-0.054577,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.83158,-0.045159,0.064175,0,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.086981,-0.045204,-0.055547,0,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.49487,-0.045312,-0.016064,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.71996,-0.045462,-0.01778,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.14419,-0.04551,-0.04989,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.36956,-0.045638,-0.033342,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.71089,-0.045742,0.001516,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.22971,-0.04577,-0.051941,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.36311,-0.04603,-0.03298,0,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.20992,-0.046103,-0.033714,0,0
1,GO REGULATION OF CELLULAR PH,0.83158,-0.046547,-0.003311,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.7659,-0.046633,0.038724,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.11647,-0.046799,-0.046218,0,0
1,GO EAR DEVELOPMENT,0.21437,-0.046871,-0.057764,0,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.24911,-0.046875,-0.027791,0,0
1,GO FEAR RESPONSE,0.1387,-0.04691,-0.05733,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.78451,-0.046917,-0.0042483,0,0
1,GO INCLUSION BODY ASSEMBLY,0.16042,-0.046932,-0.11404,0,0
1,GO DENDRITE SELF AVOIDANCE,0.94026,-0.04701,0.0022804,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.56376,-0.047083,0.05295,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.26267,-0.047264,-0.045325,0,0
1,GO SOMITE DEVELOPMENT,0.11933,-0.047325,-0.059942,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.34835,-0.047358,-0.047092,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.61402,-0.047675,-0.017778,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.10214,-0.047773,-0.10822,0,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.25583,-0.048027,-0.050388,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.09796,-0.048105,-0.10599,0,0
1,GO TELOMERE CAPPING,0.093126,-0.048237,-0.055966,0,0
1,GO AXON DEVELOPMENT,0.10385,-0.048283,-0.066602,0,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.41666,-0.048314,-0.035502,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.12924,-0.048333,-0.080139,0,0
1,GO L SERINE METABOLIC PROCESS,0.85376,-0.048407,-0.037245,0,0
1,GO RESPONSE TO SALT,0.33803,-0.048537,-0.051832,0,0
1,GO EAR MORPHOGENESIS,0.3871,-0.048571,-0.039019,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.41899,-0.048703,-0.037863,0,0
1,GO RESPONSE TO ETHER,0.30446,-0.048711,-0.070951,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.27853,-0.048752,-0.039142,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.14642,-0.04876,-0.12781,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.25753,-0.049078,-0.04774,0,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.33599,-0.049185,-0.064103,0,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.096327,-0.049737,-0.094214,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.92738,-0.049918,0.021174,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.71089,-0.049997,-0.032829,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.16407,-0.050254,-0.03696,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.59144,-0.050376,-0.0098932,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.39156,-0.050438,-0.04781,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.33396,-0.050619,-0.063184,0,0
1,GO KINETOCHORE ORGANIZATION,0.32592,-0.050769,-0.10313,0,0
1,GO FILOPODIUM ASSEMBLY,0.26095,-0.05085,-0.039006,0,0
1,GO CELL PROJECTION ORGANIZATION,0.14419,-0.050852,-0.031313,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.10823,-0.051086,-0.065863,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.59986,-0.051347,-0.0057645,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.25414,-0.051376,-0.047931,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.22195,-0.051807,-0.038171,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.38267,-0.052191,-0.049888,0,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.75664,-0.052248,-0.01523,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.15214,-0.052443,-0.062645,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.19557,-0.052535,-0.0227,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.30066,-0.052621,-0.047107,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.22814,-0.052824,-0.052916,0,0
1,GO NEURAL CREST FORMATION,0.70787,-0.053153,-0.019812,0,0
1,GO HEART FORMATION,0.60268,-0.053347,-0.026818,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.57752,-0.053886,-0.036697,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.41666,-0.053968,-0.014848,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.59705,-0.054008,-0.011685,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.50516,-0.054033,-0.016576,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.33194,-0.054157,-0.051675,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.1252,-0.054295,-0.086044,0,0
1,GO NEURON APOPTOTIC PROCESS,0.34213,-0.054356,-0.021034,0,0
1,GO CHROMATIN ORGANIZATION,0.10558,-0.054437,-0.052019,0,0
1,GO MANNOSYLATION,0.26789,-0.054472,-0.029951,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.77519,-0.054564,0.0049431,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.33599,-0.054783,-0.027659,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.25583,-0.05485,-0.035511,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.60834,-0.054932,-0.039973,0,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.18327,-0.055081,-0.050461,0,0
1,GO T CELL SELECTION,0.84424,-0.055275,0.025974,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.98546,-0.055313,0.011472,0,0
1,GO REGULATION OF APPETITE,0.1313,-0.05532,-0.059003,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.52345,-0.055396,-0.013991,0,0
1,GO HISTONE EXCHANGE,0.15447,-0.055508,-0.081342,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.26964,-0.055533,-0.038633,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.20409,-0.055927,-0.065072,0,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.14088,-0.055961,-0.04706,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.97899,-0.056158,0.026978,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.42838,-0.056381,-0.035446,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.24745,-0.056403,-0.050237,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.54477,-0.056451,-0.015345,0,0
1,GO QUINONE METABOLIC PROCESS,0.9306,-0.056484,-0.016047,0,0
1,GO MEMBRANE REPOLARIZATION,0.10471,-0.056496,-0.073173,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.29689,-0.056727,-0.033848,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.25753,-0.056917,-0.030628,0,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.31215,-0.057009,-0.030634,0,0
1,GO ANION TRANSPORT,0.39156,-0.057025,-0.0111,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.14088,-0.057053,-0.087818,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.25078,-0.057153,-0.039196,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.39381,-0.057349,-0.035929,0,0
1,GO RESPONSE TO COLD,0.75664,-0.057482,-0.010103,0,0
1,GO NADH METABOLIC PROCESS,0.32195,-0.057505,-0.048605,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.1453,-0.057507,-0.078061,0,0
1,GO REGULATION OF ACTIN NUCLEATION,0.18194,-0.05762,-0.063828,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.7814,-0.057908,0.0069581,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.36741,-0.058052,-0.053398,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.16163,-0.058255,-0.051528,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.41666,-0.058318,-0.037272,0,0
1,GO RESPONSE TO CAFFEINE,0.36098,-0.058378,-0.045858,0,0
1,GO DNA METHYLATION,0.42838,-0.058954,-0.031509,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.23605,-0.059042,-0.057285,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.76281,-0.059149,-0.022061,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.12822,-0.059558,-0.056778,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.075674,-0.059587,-0.10605,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.14088,-0.059874,-0.043485,0,0
1,GO CELL FATE DETERMINATION,0.17669,-0.059883,-0.071736,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.16407,-0.060181,-0.076334,0,0
1,GO TRANSMEMBRANE TRANSPORT,0.15447,-0.060352,-0.02607,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.30255,-0.060665,-0.030558,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.318,-0.060705,-0.03855,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.20122,-0.060937,-0.076823,0,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.075674,-0.061132,-0.089097,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.075674,-0.061425,-0.038064,0,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.19278,-0.06149,-0.069941,0,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.52345,-0.061678,-0.0084521,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.61117,-0.061718,-0.03217,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.58307,-0.062132,-0.01056,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.36741,-0.062183,-0.032599,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.23927,-0.062275,-0.0719,0,0
1,GO REPLICATION FORK PROCESSING,0.1754,-0.062366,-0.065529,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.72299,-0.062492,-0.10007,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.30255,-0.062558,-0.070778,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.67206,-0.062631,-0.010295,0,0
1,GO ORGANELLE FUSION,0.20265,-0.062691,-0.029637,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.22503,-0.062861,-0.080565,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.54746,-0.062937,-0.0264,0,0
1,GO MULTICELLULAR ORGANISM AGING,0.12029,-0.062949,-0.069928,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.44269,-0.063269,-0.02716,0,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.068006,-0.063388,-0.068963,0,0
1,GO CONVERGENT EXTENSION,0.41666,-0.063462,-0.03869,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.61972,-0.063514,-0.0047451,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.25078,-0.063534,-0.03446,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.093126,-0.063648,-0.097332,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.30637,-0.063841,-0.055369,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.085497,-0.06385,-0.077409,0,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.098784,-0.064201,-0.072998,0,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.15214,-0.064311,-0.052766,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.24911,-0.064392,-0.063521,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.084763,-0.065157,-0.099966,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.063258,-0.065462,-0.085497,0,0
1,GO MICROTUBULE NUCLEATION,0.1387,-0.0655,-0.054898,0,0
1,GO RECEPTOR CLUSTERING,0.2458,-0.065841,-0.055129,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.27673,-0.065843,-0.047977,0,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.62832,-0.067012,-0.0033351,0,0
1,GO RESPONSE TO MONOSACCHARIDE,0.21738,-0.068408,-0.024396,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.11367,-0.068475,-0.037407,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.10214,-0.068595,-0.078909,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.2114,-0.068792,-0.04556,0,0
1,GO ORGANIC ANION TRANSPORT,0.34835,-0.06895,-0.013008,0,0
1,GO KINETOCHORE ASSEMBLY,0.70486,-0.06919,-0.043451,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.39156,-0.069356,-0.044009,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.25924,-0.0695,-0.06847,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.23445,-0.069577,-0.12771,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.42602,-0.069699,-0.062775,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.076344,-0.069737,-0.063021,0,0
1,GO KERATINIZATION,0.44994,-0.070193,-0.053628,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.18327,-0.070241,-0.025468,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.62832,-0.070343,-0.011268,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.080464,-0.070611,-0.07095,0,0
1,GO POSITIVE T CELL SELECTION,0.88565,-0.070613,0.016311,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.12126,-0.070615,-0.039101,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.10045,-0.070635,-0.066469,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.15214,-0.070761,-0.058516,0,0
1,GO MRNA METHYLATION,0.077018,-0.070872,-0.08666,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.093126,-0.070916,-0.1058,0,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.08331,-0.07098,-0.053441,0,0
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.28033,-0.071133,-0.041727,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.27673,-0.071992,-0.036926,0,0
1,GO PEPTIDYL ARGININE METHYLATION,0.49231,-0.072008,-0.035238,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.14869,-0.072402,-0.05706,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.4451,-0.072524,-0.059765,0,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.35886,-0.072568,-0.048393,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.074349,-0.072801,-0.054283,0,0
1,GO REGULATION OF OOGENESIS,0.26614,-0.072922,-0.039278,0,0
1,GO WATER HOMEOSTASIS,0.71089,-0.073433,-0.010904,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.64858,-0.073748,-0.0048142,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.40058,-0.073895,-0.054247,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.16778,-0.073936,-0.079257,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.15683,-0.074229,-0.061517,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.40973,-0.074359,-0.0085221,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.23766,-0.074456,-0.055831,0,0
1,GO HEAT GENERATION,0.079071,-0.074481,-0.097445,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.19979,-0.074686,-0.07477,0,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.09714,-0.074884,-0.084679,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.19003,-0.074894,-0.060905,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.48722,-0.074954,-0.02876,0,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.21587,-0.075123,-0.032984,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.58307,-0.075194,-0.028888,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.10646,-0.075412,-0.064108,0,0
1,GO MAGNESIUM ION TRANSPORT,0.18461,-0.076361,-0.056761,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.22658,-0.076436,-0.052597,0,0
1,GO BRAIN MORPHOGENESIS,0.071119,-0.076933,-0.085588,0,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.071756,-0.076961,-0.052257,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.48722,-0.076991,-0.022934,0,0
1,GO HISTONE DEUBIQUITINATION,0.28213,-0.077251,-0.028189,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.1146,-0.077305,-0.13372,0,0
1,GO LONG TERM MEMORY,0.68392,-0.07737,-0.016663,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.21587,-0.077454,-0.075756,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.22195,-0.077475,-0.058317,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.15921,-0.077552,-0.059163,0,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.32195,-0.077753,-0.024889,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.38047,-0.077788,-0.03836,0,0
1,GO PROTEIN REFOLDING,0.45238,-0.078356,-0.035426,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.99192,-0.078433,0.012591,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.10385,-0.07867,-0.060512,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.58585,-0.078889,-0.051274,0,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.15447,-0.079473,-0.038183,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.15565,-0.079838,-0.073816,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.31215,-0.080742,-0.023237,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.062114,-0.080777,-0.039028,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.10385,-0.08094,-0.040026,0,0
1,GO NAD METABOLIC PROCESS,0.36311,-0.081046,-0.036345,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.67798,-0.081095,-0.0070104,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.23927,-0.08115,-0.051945,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.15447,-0.081184,-0.070148,0,0
1,GO REGULATION OF PEPTIDE SECRETION,0.18595,-0.08149,-0.031538,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.079765,-0.081595,-0.084353,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.47963,-0.081684,-0.021238,0,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.25078,-0.081773,-0.031377,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.067397,-0.081914,-0.17692,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.34213,-0.082332,-0.083895,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.086237,-0.083497,-0.12573,0,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.29877,-0.083584,-0.027348,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.13763,-0.083923,-0.091812,0,0
1,GO STRIATED MUSCLE CONTRACTION,0.079071,-0.083978,-0.068708,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.21587,-0.084526,-0.084234,0,0
1,GO ORGANIC ACID TRANSPORT,0.084763,-0.084658,-0.039487,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.081877,-0.084731,-0.069702,0,0
1,GO RRNA CATABOLIC PROCESS,0.61117,-0.084828,-0.024954,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.17411,-0.085073,-0.053236,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.16163,-0.086007,-0.084477,0,0
1,GO REGULATION OF AXONOGENESIS,0.080464,-0.086689,-0.065425,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.11183,-0.086974,-0.04935,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.11002,-0.087075,-0.062012,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.13027,-0.087749,-0.08045,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.51557,-0.08798,-0.022712,0,0
1,GO RESPONSE TO POTASSIUM ION,0.21437,-0.089026,-0.10229,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.11092,-0.09012,-0.10023,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.098784,-0.090384,-0.073738,0,0
1,GO CHROMATIN DISASSEMBLY,0.2458,-0.090533,-0.07622,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.064418,-0.0907,-0.086372,0,0
1,GO LIPOXYGENASE PATHWAY,0.96607,-0.090857,-0.0019007,0,0
1,GO GLUTAMATE METABOLIC PROCESS,0.21738,-0.090996,-0.052157,0,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.066792,-0.09109,-0.066959,0,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.073043,-0.091129,-0.091086,0,0
1,GO CHLORIDE TRANSPORT,0.12822,-0.091137,-0.040453,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.089246,-0.091463,-0.071538,0,0
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.2714,-0.09187,-0.08984,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.91451,-0.092414,0.0040104,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.30637,-0.092716,-0.071156,0,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.08331,-0.092896,-0.11948,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.15565,-0.093103,-0.066504,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.26095,-0.093231,-0.061968,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.10214,-0.09345,-0.069794,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.15683,-0.093455,-0.086904,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.088486,-0.093719,-0.097969,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.52874,-0.093848,-0.11008,0,0
1,GO INTESTINAL ABSORPTION,0.44752,-0.094049,-0.050479,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.19417,-0.094239,-0.056015,0,0
1,GO INNER EAR MORPHOGENESIS,0.23766,-0.09469,-0.064768,0,0
1,GO MITOTIC DNA REPLICATION,0.21437,-0.094726,-0.10275,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.075674,-0.094754,-0.086412,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.062114,-0.094964,-0.086771,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.15802,-0.095104,-0.084326,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.091558,-0.095376,-0.097751,0,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.82526,-0.095377,0.041721,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.33599,-0.095476,-0.037321,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.25078,-0.095959,-0.047076,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.14088,-0.09758,-0.043187,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.7814,-0.09829,0.0071182,0,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.19557,-0.098675,-0.051077,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.50776,-0.099076,-0.016123,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.33599,-0.099309,-0.044156,0,0
1,GO HEART PROCESS,0.11933,-0.099428,-0.05207,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.49231,-0.099542,-0.016366,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.33599,-0.099751,-0.029612,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.093126,-0.099997,-0.06055,0,0
1,GO REGULATION OF RESPIRATORY BURST,0.11183,-0.10009,-0.11889,0,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.084034,-0.10021,-0.081438,0,0
1,GO PROTEIN MANNOSYLATION,0.16163,-0.10033,-0.047194,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.55287,-0.10039,-0.015605,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.33194,-0.10044,-0.043603,0,0
1,GO REGULATION OF ANION TRANSPORT,0.088486,-0.10044,-0.043181,0,0
1,GO POSITIVE REGULATION OF SECRETION,0.10385,-0.10098,-0.042488,0,0
1,GO RESPONSE TO AMINE,0.1262,-0.10121,-0.064671,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.079071,-0.1013,-0.061451,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.10471,-0.10132,-0.10832,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.11553,-0.10139,-0.058022,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.075009,-0.1014,-0.14181,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.090782,-0.10159,-0.099671,0,0
1,GO PROTEIN AUTOPROCESSING,0.22348,-0.10211,-0.05142,0,0
1,GO MICROTUBULE SEVERING,0.06986,-0.10296,-0.083963,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.1252,-0.10328,-0.14105,0,0
1,GO MITOCHONDRIAL FUSION,0.070488,-0.10333,-0.054969,0,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.069238,-0.10349,-0.093058,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.54208,-0.10352,-0.070697,0,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.087731,-0.10371,-0.056959,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.20265,-0.10416,-0.049652,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.25078,-0.10424,-0.029951,0,0
1,GO MRNA MODIFICATION,0.13979,-0.10446,-0.071265,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.09714,-0.10466,-0.098884,0,0
1,GO METAL ION TRANSPORT,0.079765,-0.10488,-0.045059,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.23128,-0.1051,-0.079946,0,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.084763,-0.10544,-0.048693,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.37827,-0.1064,-0.032769,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.13763,-0.10649,-0.062417,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.64858,-0.10665,-0.020526,0,0
1,GO DENTATE GYRUS DEVELOPMENT,0.081168,-0.1067,-0.18474,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.067397,-0.10674,-0.062437,0,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.68392,-0.10699,-0.055161,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.13444,-0.10721,-0.14654,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.11647,-0.10761,-0.1182,0,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.14197,-0.10776,-0.09439,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.15098,-0.10844,-0.076955,0,0
1,GO RESPONSE TO FORSKOLIN,0.32393,-0.1085,-0.063154,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.25924,-0.10862,-0.1626,0,0
1,GO PEPTIDE SECRETION,0.081168,-0.10886,-0.044502,0,0
1,GO REGULATION OF SYSTEM PROCESS,0.094715,-0.10934,-0.048827,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.24911,-0.10966,-0.05694,0,0
1,GO DIGESTIVE SYSTEM PROCESS,0.13444,-0.10981,-0.06948,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.66321,-0.10984,-0.0065341,0,0
1,GO ENDOCARDIUM DEVELOPMENT,0.10823,-0.1101,-0.092152,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.093126,-0.11012,-0.065262,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.074349,-0.11083,-0.05222,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.10385,-0.11095,-0.062055,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.11367,-0.11154,-0.087889,0,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.75972,-0.11188,0.015487,0,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.090782,-0.1119,-0.065568,0,0
1,GO NEURON REMODELING,0.39606,-0.11214,-0.050608,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.46466,-0.11273,-0.047193,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.065596,-0.11319,-0.071719,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.091558,-0.1154,-0.11139,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.068619,-0.11668,-0.08362,0,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.34213,-0.11762,-0.058221,0,0
1,GO BILE ACID METABOLIC PROCESS,0.22658,-0.11797,-0.065426,0,0
1,GO CARDIAC VENTRICLE FORMATION,0.14755,-0.1202,-0.11389,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.079765,-0.12028,-0.078761,0,0
1,GO DIVALENT METAL ION EXPORT,0.25078,-0.12148,-0.084487,0,0
1,GO REGULATION OF BLOOD CIRCULATION,0.12029,-0.12396,-0.049772,0,0
1,GO ORGANIC CATION TRANSPORT,0.076344,-0.12405,-0.084406,0,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.1387,-0.12626,-0.051822,0,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.5394,-0.12644,-0.029657,0,0
1,GO RESPONSE TO INTERLEUKIN 2,0.53406,-0.12662,-0.025337,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.26095,-0.12664,-0.060923,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.16042,-0.12671,-0.084313,0,0
1,GO SODIUM ION HOMEOSTASIS,0.10385,-0.12827,-0.091243,0,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.14869,-0.12891,-0.072892,0,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.33599,-0.12941,-0.050597,0,0
1,GO RESPONSE TO PAIN,0.21738,-0.13043,-0.066938,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.11367,-0.13049,-0.1031,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.073694,-0.13156,-0.098458,0,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.16904,-0.13172,-0.076613,0,0
1,GO COPULATION,0.40286,-0.13209,-0.038666,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.28578,-0.13253,-0.088991,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.73822,-0.13625,-0.026311,0,0
1,GO SLEEP,0.071119,-0.13641,-0.08238,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.071119,-0.13677,-0.075952,0,0
1,GO GLYCINE TRANSPORT,0.57752,-0.13737,-0.04877,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.26095,-0.13769,-0.042537,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.10558,-0.13934,-0.081118,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.063836,-0.13943,-0.1281,0,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.066792,-0.14054,-0.099455,0,0
1,GO SECONDARY PALATE DEVELOPMENT,0.22348,-0.14131,-0.039474,0,0
1,GO LIPID TRANSLOCATION,0.18461,-0.14295,-0.068702,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.27673,-0.14352,-0.047187,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.36741,-0.14497,-0.078595,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.064418,-0.14524,-0.1248,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.22042,-0.14538,-0.085875,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.30066,-0.14614,-0.071879,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.081877,-0.14723,-0.074098,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.10385,-0.15215,-0.10198,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.46962,-0.15419,-0.060418,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.19417,-0.15444,-0.072244,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.3871,-0.15674,-0.063668,0,0
1,GO HAIR CELL DIFFERENTIATION,0.067397,-0.15754,-0.1047,0,0
1,GO CYTOPLASM ORGANIZATION,0.064418,-0.15802,-0.11496,0,0
1,GO RESPONSE TO MAGNESIUM ION,0.1387,-0.15804,-0.11818,0,0
1,GO COLLATERAL SPROUTING,0.073694,-0.16107,-0.092346,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.089246,-0.16351,-0.085275,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.65734,-0.16616,-0.020985,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.10646,-0.16658,-0.09459,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.1653,-0.16731,-0.08572,0,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.075009,-0.16804,-0.13632,0,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.20265,-0.16856,-0.07843,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.22042,-0.17535,-0.12943,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.071756,-0.1764,-0.126,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.087731,-0.17688,-0.076485,0,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.13234,-0.18579,-0.10298,0,0
1,GO CRANIAL NERVE DEVELOPMENT,0.063258,-0.1872,-0.095716,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.068006,-0.18817,-0.11468,0,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.41899,-0.18902,-0.045303,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.42367,-0.19009,-0.11345,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.13979,-0.19972,-0.16468,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.19557,-0.19985,-0.096129,0,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.076344,-0.22074,-0.15013,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.178,-0.2242,-0.11822,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.063836,-0.2268,-0.13799,0,0
1,GO SIALYLATION,0.18062,-0.22701,-0.10611,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.1793,-0.23245,-0.094737,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.52874,-0.23963,-0.09475,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.066192,-0.24221,-0.12536,0,0
1,GO LIMB BUD FORMATION,0.16285,-0.24411,-0.093478,0,0
1,GO N GLYCAN PROCESSING,0.40743,-0.25429,-0.042049,0,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.077698,-0.25601,-0.17601,0,0
1,GO LUNG CELL DIFFERENTIATION,0.095518,-0.30685,-0.13293,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,1.2281e-06,1.2443,1.0153,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.1316e-06,1.1308,0.86079,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.1729e-08,0.85374,0.76605,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.1456e-06,0.83447,0.62634,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,3.9035e-08,0.82247,0.63923,1,1
2,GO ETHANOL OXIDATION,2.0509e-11,0.81594,0.81777,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.0979e-10,0.81216,0.73438,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.9185e-12,0.74363,0.70832,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,2.2912e-11,0.73251,0.64634,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,3.8149e-08,0.704,0.59307,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,1.9136e-07,0.70166,0.62766,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,2.2926e-08,0.70076,0.56347,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,4.9069e-08,0.69228,0.55458,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,5.6487e-06,0.68424,0.54168,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,2.1196e-06,0.67079,0.52026,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,1.9546e-09,0.66928,0.73024,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.3697e-11,0.66169,0.6384,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,9.2118e-07,0.65325,0.58052,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,2.7676e-09,0.61977,0.5623,1,1
2,GO MUCUS SECRETION,5.0278e-07,0.60833,0.60468,1,1
2,GO MYOBLAST MIGRATION,6.1119e-05,0.60232,0.47736,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,3.0811e-07,0.59536,0.5535,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,8.4805e-07,0.59258,0.52202,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.2328e-07,0.57958,0.47746,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,3.2859e-07,0.57953,0.5391,1,1
2,GO RESPONSE TO INTERFERON BETA,0.0005056,0.57709,0.38013,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.6579e-07,0.571,0.52296,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,1.0554e-07,0.56979,0.56408,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,5.9056e-05,0.56895,0.42808,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,7.5266e-09,0.5671,0.61708,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,1.1794e-07,0.56703,0.51152,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,4.0868e-08,0.56225,0.53948,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,4.3946e-06,0.55605,0.40023,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.2281e-06,0.55461,0.43787,1,1
2,GO PROSTATE GLAND GROWTH,2.2926e-08,0.55415,0.58062,1,1
2,GO RESPONSE TO INTERLEUKIN 18,5.4701e-07,0.54153,0.58503,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,2.7078e-07,0.54023,0.50008,1,1
2,GO OTIC VESICLE DEVELOPMENT,1.8032e-05,0.53871,0.436,1,1
2,GO CYCLOOXYGENASE PATHWAY,6.7105e-06,0.53652,0.43955,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,2.6386e-06,0.5365,0.45112,1,1
2,GO TOLERANCE INDUCTION,3.628e-05,0.53201,0.42042,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.2131e-09,0.53013,0.49509,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00010852,0.52874,0.39172,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.5052e-06,0.52544,0.53692,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,2.4586e-08,0.52424,0.46404,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.8135e-09,0.52242,0.44862,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.1064e-09,0.51682,0.49492,1,1
2,GO ETHANOL METABOLIC PROCESS,3.7319e-10,0.51622,0.55044,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.3784e-07,0.51559,0.44136,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,9.404e-07,0.51436,0.39191,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,1.2281e-06,0.50787,0.49877,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,1.6761e-05,0.50639,0.38419,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,4.8198e-07,0.50297,0.40082,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.9393e-05,0.50166,0.46387,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,9.4157e-10,0.5013,0.51333,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,3.6162e-06,0.49973,0.42541,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.5868e-06,0.49769,0.37822,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,5.4967e-09,0.4967,0.54816,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,8.9047e-09,0.49594,0.43604,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,2.6352e-05,0.49242,0.37739,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.00013673,0.48886,0.37457,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,2.5934e-07,0.48805,0.3607,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.8124e-06,0.48707,0.35947,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.7536e-08,0.48664,0.47704,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.2926e-08,0.47985,0.38973,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,8.7502e-06,0.47928,0.461,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,9.0235e-07,0.47927,0.47247,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,6.337e-06,0.47603,0.34267,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,4.1552e-07,0.47349,0.42453,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.1533e-09,0.47099,0.45565,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,1.6994e-06,0.46977,0.40376,1,1
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.00036686,0.46909,0.35518,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.8001e-06,0.46669,0.36658,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,5.1304e-06,0.46447,0.45399,1,1
2,GO ACTIN FILAMENT SEVERING,6.7724e-05,0.46013,0.40913,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.5027e-08,0.45894,0.41235,1,1
2,GO HEPATOCYTE DIFFERENTIATION,1.0361e-05,0.45862,0.39071,1,1
2,GO RETINAL METABOLIC PROCESS,0.00033432,0.45685,0.35298,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.1588e-05,0.45606,0.42151,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.5037e-07,0.45532,0.40717,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,2.1375e-08,0.45156,0.38731,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.2543e-08,0.45052,0.36597,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,2.0429e-07,0.44871,0.35456,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.0094e-07,0.448,0.39258,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,3.1729e-08,0.44374,0.43427,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,3.5461e-06,0.44201,0.42056,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,7.9617e-06,0.44041,0.39943,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.3325e-06,0.43564,0.38122,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.5646e-05,0.43417,0.38321,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00037835,0.43411,0.43267,1,1
2,GO TYPE 2 IMMUNE RESPONSE,1.064e-06,0.43347,0.36176,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.00016361,0.43137,0.29999,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.9069e-08,0.43114,0.39601,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00010673,0.42991,0.35922,1,1
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00026858,0.42592,0.35729,1,1
2,GO PROSTANOID METABOLIC PROCESS,3.8118e-09,0.42553,0.4481,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.5293e-05,0.42449,0.38796,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,3.094e-05,0.42449,0.31044,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,5.0278e-07,0.42376,0.44051,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,2.7452e-06,0.42311,0.32526,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00025215,0.42279,0.34064,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,1.0094e-07,0.42158,0.42768,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.1375e-05,0.41958,0.3234,1,1
2,GO DENDRITIC CELL MIGRATION,8.0712e-08,0.41871,0.39561,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,4.6881e-08,0.41869,0.39767,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.7282e-08,0.41867,0.33876,1,1
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.052575,0.41855,0.3722,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,6.4592e-06,0.41757,0.36398,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00011596,0.41701,0.40725,1,1
2,GO BIOLOGICAL PHASE,1.3693e-05,0.41638,0.47516,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,4.8416e-06,0.41607,0.39062,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0014624,0.41594,0.31976,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,2.1234e-05,0.4142,0.34261,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.471e-07,0.41187,0.36749,1,1
2,GO T CELL MEDIATED IMMUNITY,8.6328e-08,0.41097,0.35091,1,1
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0099244,0.41029,0.24005,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.8983e-07,0.40896,0.35653,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.8262e-07,0.40728,0.35536,1,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.012798,0.40693,0.27621,1,1
2,GO PEPTIDE CROSS LINKING,4.3997e-05,0.40664,0.30663,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.8698e-06,0.40595,0.33826,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.00010673,0.40307,0.29994,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,2.7804e-05,0.40125,0.39428,1,1
2,GO LYSINE METABOLIC PROCESS,0.00013899,0.40119,0.41552,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00044781,0.40054,0.29139,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.5606e-08,0.39884,0.35772,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,1.9749e-05,0.39852,0.44651,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,6.3359e-07,0.39828,0.36849,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,7.0522e-08,0.39628,0.38779,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00026858,0.39569,0.38921,1,1
2,GO PSEUDOPODIUM ORGANIZATION,1.9393e-05,0.39557,0.40551,1,1
2,GO INTERLEUKIN 13 PRODUCTION,2.206e-06,0.39521,0.42665,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,7.6446e-07,0.39516,0.38218,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.0161e-09,0.39239,0.41771,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.012367,0.39103,0.20547,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,4.0314e-05,0.38894,0.4233,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,2.2926e-08,0.38826,0.38127,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,1.6457e-05,0.38267,0.3057,1,1
2,GO INTERLEUKIN 2 PRODUCTION,7.892e-08,0.38172,0.33845,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,5.8049e-05,0.38136,0.37995,1,1
2,GO T CELL APOPTOTIC PROCESS,9.404e-07,0.38104,0.28368,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.4773e-06,0.37975,0.29292,1,1
2,GO INTERLEUKIN 8 PRODUCTION,7.8052e-07,0.37972,0.34464,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0005133,0.37916,0.32748,1,1
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.01016,0.37855,0.22383,1,1
2,GO REGULATION OF CELL KILLING,1.5674e-06,0.37767,0.30713,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.2146e-06,0.37749,0.33412,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.2143e-08,0.37702,0.34146,1,1
2,GO NOTOCHORD DEVELOPMENT,9.795e-06,0.37665,0.43448,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00049802,0.3728,0.34504,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,5.9056e-05,0.37187,0.36578,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,9.7998e-07,0.37141,0.37664,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,2.4861e-06,0.3714,0.31539,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,1.7693e-06,0.37025,0.32107,1,1
2,GO FRUCTOSE METABOLIC PROCESS,3.9613e-05,0.36939,0.40852,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.0678e-07,0.36937,0.37808,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,9.5999e-07,0.3692,0.41013,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,6.7411e-08,0.3688,0.40708,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,7.3803e-06,0.36706,0.32425,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.4861e-06,0.36698,0.28876,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.014332,0.36594,0.19569,1,1
2,GO RESPONSE TO HYDROPEROXIDE,0.0043737,0.36449,0.26132,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,6.205e-09,0.36399,0.37938,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.00033432,0.36288,0.26893,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,4.2444e-07,0.36269,0.35328,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.332e-06,0.36243,0.31327,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,1.3442e-05,0.36201,0.43254,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,1.3693e-05,0.36193,0.29159,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.2253e-05,0.3607,0.28499,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,1.6654e-06,0.35853,0.29616,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.00086244,0.35842,0.21413,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.3661e-05,0.35779,0.27517,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,1.734e-06,0.35714,0.32263,1,1
2,GO LIMB BUD FORMATION,0.00087508,0.35677,0.41781,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00014599,0.35625,0.36579,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.0791e-07,0.35618,0.31948,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,3.3435e-06,0.35584,0.33223,1,1
2,GO LEUKOCYTE AGGREGATION,0.019523,0.35444,0.23095,1,1
2,GO MONOCYTE CHEMOTAXIS,4.3946e-06,0.35245,0.30582,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.0076401,0.35164,0.26983,1,1
2,GO AMINE CATABOLIC PROCESS,9.0235e-07,0.35091,0.34908,1,1
2,GO REGULATION OF DNA METHYLATION,5.8698e-06,0.34986,0.28257,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,1.3325e-06,0.34971,0.29945,1,1
2,GO RESPONSE TO TUMOR CELL,3.5461e-06,0.34834,0.32745,1,1
2,GO RETINOL METABOLIC PROCESS,9.2321e-08,0.34644,0.32352,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00029511,0.3455,0.27958,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,2.1196e-06,0.34498,0.32608,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.4091e-05,0.34367,0.30967,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00039622,0.33941,0.28815,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,1.8053e-06,0.33748,0.35807,1,1
2,GO INTERLEUKIN 1 PRODUCTION,2.5424e-05,0.3365,0.30813,1,1
2,GO CHONDROCYTE PROLIFERATION,5.1446e-05,0.33529,0.35968,1,1
2,GO OXYGEN TRANSPORT,0.0035605,0.33521,0.30177,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,5.7582e-06,0.33393,0.27524,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0028872,0.33344,0.27658,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.3228e-08,0.33287,0.32197,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.00016629,0.33273,0.29405,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00028155,0.33228,0.28543,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,4.5684e-06,0.33202,0.23952,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.00052901,0.33164,0.37144,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00036124,0.33112,0.31191,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.0657e-06,0.33096,0.27018,1,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00042128,0.33053,0.26328,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,6.1119e-05,0.33025,0.31986,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,9.086e-06,0.32907,0.25246,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.001955,0.32869,0.21331,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,5.0563e-05,0.32821,0.35148,1,1
2,GO ETHER METABOLIC PROCESS,2.7668e-07,0.32811,0.36159,1,1
2,GO RESPONSE TO INTERLEUKIN 15,8.1138e-06,0.32779,0.29377,1,1
2,GO NEURAL CREST FORMATION,0.00017176,0.32765,0.29946,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,5.8698e-06,0.32749,0.31496,1,1
2,GO HAIR FOLLICLE MATURATION,6.0079e-05,0.32699,0.31897,1,1
2,GO MATURE B CELL DIFFERENTIATION,3.4409e-05,0.32684,0.31455,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,1.7154e-07,0.3263,0.31553,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00010497,0.326,0.28791,1,1
2,GO GRANULOCYTE DIFFERENTIATION,9.4341e-06,0.32574,0.26568,1,1
2,GO EPIBOLY,0.0085105,0.3256,0.20893,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.0021798,0.3253,0.21192,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.2445e-07,0.32446,0.33439,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,2.8262e-08,0.32406,0.35199,1,1
2,GO PSEUDOURIDINE SYNTHESIS,2.1624e-06,0.32343,0.28722,1,1
2,GO T CELL CHEMOTAXIS,8.6579e-07,0.32342,0.28178,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,2.206e-06,0.32317,0.28394,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.65e-07,0.32179,0.32616,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0012005,0.32096,0.22231,1,1
2,GO POSITIVE REGULATION OF COAGULATION,5.332e-06,0.32063,0.29392,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00012186,0.32048,0.256,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,5.3562e-07,0.31948,0.26962,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.4207e-05,0.31947,0.27449,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,1.5293e-05,0.31907,0.24508,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0029645,0.31897,0.27478,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,1.2716e-05,0.31885,0.30043,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.2162e-07,0.31836,0.29422,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,6.9711e-06,0.31808,0.27746,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,3.5022e-05,0.31795,0.23776,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.00025617,0.31757,0.31447,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,9.6129e-06,0.31752,0.26891,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,5.2303e-06,0.31738,0.2902,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.4472e-05,0.31708,0.25746,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.439e-07,0.31615,0.29546,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.6761e-05,0.3157,0.27192,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00014362,0.31516,0.28062,1,1
2,GO MONONUCLEAR CELL MIGRATION,5.0278e-07,0.31509,0.2987,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,7.5217e-06,0.31473,0.27995,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00084997,0.31442,0.23806,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,9.03e-05,0.31398,0.25035,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.00038422,0.31395,0.29525,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,2.2505e-06,0.31353,0.29322,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.0061347,0.31338,0.22451,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.206e-06,0.31282,0.3041,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00036124,0.31189,0.28782,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,1.9989e-07,0.31109,0.29554,1,1
2,GO NAD BIOSYNTHETIC PROCESS,0.00041488,0.31062,0.23759,1,1
2,GO I KAPPAB PHOSPHORYLATION,1.0756e-05,0.31056,0.26285,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.00022927,0.31018,0.31564,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,3.8161e-07,0.30935,0.28431,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,3.8347e-06,0.30878,0.39857,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00025215,0.30857,0.29981,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,3.758e-05,0.3081,0.26285,1,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.007921,0.30802,0.21189,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00019229,0.30752,0.33577,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00026858,0.30743,0.26041,1,1
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,6.3249e-05,0.30716,0.23873,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,5.8049e-05,0.30603,0.27979,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,2.0853e-05,0.3051,0.25758,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00012804,0.30485,0.36905,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,5.6487e-06,0.3048,0.28389,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.7051e-07,0.30468,0.26311,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,4.8416e-06,0.30435,0.32783,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,9.6562e-05,0.30433,0.31997,1,1
2,GO MUSCLE CELL FATE COMMITMENT,0.00023667,0.30407,0.24638,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00016098,0.30301,0.27606,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0003557,0.30247,0.2686,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,5.2303e-06,0.30171,0.34574,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.00012594,0.30159,0.23936,1,1
2,GO RESPONSE TO INTERLEUKIN 12,5.6487e-06,0.30123,0.26081,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.819e-05,0.30039,0.27462,1,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0012527,0.30018,0.27204,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,1.2954e-05,0.29997,0.37309,1,1
2,GO RIG I SIGNALING PATHWAY,5.2445e-07,0.29958,0.26798,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0028118,0.29918,0.27014,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.00023294,0.29901,0.2443,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,7.3803e-06,0.29873,0.27493,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.8419e-06,0.29857,0.29164,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,2.8001e-06,0.29847,0.30611,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,8.1623e-05,0.2977,0.30119,1,1
2,GO HIPPO SIGNALING,0.00095459,0.29769,0.28386,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.00013673,0.29717,0.30181,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00032408,0.2968,0.2637,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,7.0522e-08,0.29646,0.30808,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,8.1138e-06,0.29638,0.27554,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00083767,0.2959,0.27709,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.1794e-07,0.29548,0.27516,1,1
2,GO ZYMOGEN ACTIVATION,0.001422,0.29463,0.28057,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7804e-05,0.29439,0.26965,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,4.8416e-06,0.29421,0.27314,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.2162e-07,0.29376,0.25967,1,1
2,GO RESPONSE TO PROTOZOAN,3.8246e-05,0.29339,0.30804,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0068504,0.29302,0.2058,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,7.9617e-06,0.29216,0.27124,1,1
2,GO SEQUESTERING OF METAL ION,0.0011341,0.29213,0.23438,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00037257,0.29181,0.21311,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0002443,0.29148,0.24549,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.0094e-07,0.2912,0.28491,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,4.6359e-05,0.29115,0.23233,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0024281,0.29095,0.3049,1,1
2,GO PODOSOME ASSEMBLY,0.0005618,0.29072,0.27161,1,1
2,GO CHEMOKINE PRODUCTION,9.1829e-05,0.29062,0.2283,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,1.3056e-06,0.29039,0.28602,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.0012527,0.29027,0.23493,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.00032916,0.28923,0.20859,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,1.6761e-05,0.28904,0.21481,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00021511,0.28856,0.27364,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00013232,0.28822,0.30158,1,1
2,GO PORE COMPLEX ASSEMBLY,9.7991e-09,0.28708,0.28874,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,1.0036e-08,0.28706,0.3287,1,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.014494,0.28681,0.19883,1,1
2,GO T CELL PROLIFERATION,1.3442e-05,0.28641,0.23184,1,1
2,GO ETHANOL CATABOLIC PROCESS,0.00055343,0.28637,0.28279,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,2.011e-05,0.28615,0.2197,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00074504,0.28599,0.21288,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.00053704,0.28562,0.25158,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,8.7316e-05,0.28528,0.25659,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0085105,0.28518,0.22031,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,9.6129e-06,0.28499,0.26587,1,1
2,GO VIRAL GENOME REPLICATION,0.0037016,0.28489,0.18375,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,6.5125e-09,0.28475,0.30051,1,1
2,GO REGULATION OF B CELL PROLIFERATION,2.9332e-05,0.28382,0.24859,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,7.5217e-06,0.28377,0.24702,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,6.4434e-08,0.28362,0.27125,1,1
2,GO RESPONSE TO ANGIOTENSIN,6.2175e-05,0.28328,0.25238,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.5837e-06,0.28291,0.24514,1,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.034984,0.28231,0.19,1,1
2,GO B CELL PROLIFERATION,2.0478e-05,0.28083,0.23922,1,1
2,GO BLASTODERM SEGMENTATION,0.0005789,0.28063,0.27014,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,2.0776e-06,0.28062,0.32065,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00040857,0.28038,0.31657,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00084997,0.28029,0.24117,1,1
2,GO INTERFERON ALPHA PRODUCTION,0.00025617,0.28028,0.24423,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,1.5014e-05,0.28006,0.25491,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.913e-06,0.28003,0.28488,1,1
2,GO TRNA CATABOLIC PROCESS,0.038637,0.27951,0.18526,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,9.6129e-06,0.27807,0.25973,1,1
2,GO KERATINOCYTE PROLIFERATION,0.0084096,0.2767,0.23685,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,2.2824e-05,0.27657,0.23765,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.00010673,0.27628,0.22656,1,1
2,GO INTERACTION WITH SYMBIONT,6.8885e-07,0.27552,0.23448,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,2.3891e-06,0.27538,0.29991,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.5359e-06,0.27498,0.24235,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,8.2686e-06,0.27473,0.24362,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.00058763,0.27457,0.23575,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0021505,0.27457,0.19515,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0025617,0.27447,0.17937,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.8924e-05,0.27444,0.24746,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00057029,0.27437,0.24596,1,1
2,GO CHROMATIN DISASSEMBLY,0.00013899,0.27404,0.20691,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0012005,0.27383,0.25849,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,2.6828e-05,0.27373,0.24754,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,8.1361e-07,0.27369,0.2594,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,8.4262e-06,0.2736,0.29851,1,1
2,GO INNATE IMMUNE RESPONSE,4.3236e-05,0.27359,0.21846,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,3.758e-05,0.27307,0.24247,1,1
2,GO TONGUE MORPHOGENESIS,0.0062877,0.27302,0.24581,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,9.03e-05,0.27234,0.23192,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,4.4807e-06,0.27208,0.21549,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0031247,0.27185,0.20231,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,5.0323e-06,0.27179,0.26846,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0039992,0.27175,0.31156,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.011022,0.27171,0.21789,1,1
2,GO RESPONSE TO VIRUS,0.00091404,0.27166,0.18631,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00022208,0.27157,0.262,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,1.0424e-06,0.27142,0.26309,1,1
2,GO ERYTHROCYTE MATURATION,4.7999e-05,0.27127,0.29046,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00010152,0.27102,0.2169,1,1
2,GO FIBROBLAST ACTIVATION,8.6579e-07,0.27086,0.32149,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,8.1361e-07,0.27057,0.3057,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,1.0791e-07,0.27042,0.2739,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,2.8001e-06,0.27014,0.21571,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00022927,0.27011,0.24216,1,1
2,GO LAMELLIPODIUM ORGANIZATION,3.2162e-07,0.2701,0.25759,1,1
2,GO NIK NF KAPPAB SIGNALING,3.0905e-06,0.26973,0.21751,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,1.4207e-05,0.26947,0.24881,1,1
2,GO GAS TRANSPORT,0.00055343,0.26898,0.29312,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,1.9563e-06,0.26834,0.25011,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0012005,0.26816,0.23419,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,4.0314e-05,0.26801,0.21957,1,1
2,GO PIGMENT ACCUMULATION,0.0005618,0.26797,0.26515,1,1
2,GO PROTEIN DEMANNOSYLATION,0.00039622,0.26749,0.23058,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.00015838,0.26746,0.26418,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.00091404,0.26686,0.25941,1,1
2,GO CORNIFICATION,0.00020835,0.26663,0.32203,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0052197,0.26644,0.19208,1,1
2,GO TRACHEA DEVELOPMENT,0.00045468,0.2661,0.23981,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00020504,0.26538,0.26558,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.3661e-05,0.26479,0.26131,1,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.0050269,0.26467,0.23837,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,3.5461e-06,0.26461,0.32397,1,1
2,GO ALPHA BETA T CELL ACTIVATION,2.3661e-05,0.26453,0.24672,1,1
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.034984,0.26432,0.15617,1,1
2,GO PROTEIN ADP RIBOSYLATION,1.0169e-05,0.26388,0.24468,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.00013016,0.26316,0.21428,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.5127e-05,0.26315,0.25737,1,1
2,GO MICROVILLUS ORGANIZATION,0.00022565,0.26259,0.29056,1,1
2,GO NEUROBLAST DIVISION,0.00057029,0.26245,0.25272,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00029052,0.26225,0.2373,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,8.5867e-06,0.26188,0.25078,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,1.0424e-06,0.26151,0.22047,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00067188,0.26134,0.19612,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00092737,0.26129,0.21063,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,1.7071e-05,0.26104,0.24329,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0050269,0.26077,0.1946,1,1
2,GO MICROVILLUS ASSEMBLY,0.00042777,0.26063,0.26872,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,7.2414e-06,0.26061,0.2435,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0062877,0.26041,0.23082,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00013232,0.25958,0.22533,1,1
2,GO ERBB2 SIGNALING PATHWAY,5.7051e-07,0.25873,0.28141,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,1.1535e-07,0.25867,0.24882,1,1
2,GO ARACHIDONIC ACID SECRETION,1.1806e-05,0.25844,0.2501,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.0005618,0.25817,0.38597,1,1
2,GO RESPIRATORY BURST,0.00021511,0.25795,0.22953,1,1
2,GO RESPONSE TO INTERLEUKIN 1,1.2534e-06,0.25784,0.20983,1,1
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0050269,0.25749,0.24347,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,1.4741e-05,0.25724,0.24236,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.342e-06,0.25681,0.26613,1,1
2,GO BRONCHUS DEVELOPMENT,0.0063654,0.25665,0.22631,1,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.018693,0.25663,0.13739,1,1
2,GO T CELL CYTOKINE PRODUCTION,2.4861e-06,0.25639,0.26021,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.00024045,0.25615,0.26047,1,1
2,GO ARGININE METABOLIC PROCESS,0.00096848,0.25597,0.21737,1,1
2,GO ACETYL COA METABOLIC PROCESS,6.8888e-05,0.25586,0.24408,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.024687,0.25575,0.17564,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.00091404,0.25551,0.2617,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.2027e-05,0.25547,0.21805,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0016122,0.25515,0.18855,1,1
2,GO RESPONSE TO STEROL DEPLETION,2.4091e-05,0.25501,0.26387,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,7.8911e-05,0.25498,0.22901,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.3946e-06,0.2548,0.25667,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00023294,0.25406,0.22374,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.4424e-05,0.25387,0.20945,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,1.0557e-05,0.25368,0.25436,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,3.3435e-06,0.25326,0.22635,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0087156,0.25317,0.22795,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,4.2784e-08,0.25304,0.23037,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0028872,0.25296,0.20947,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00044781,0.25295,0.24542,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0022396,0.25208,0.25169,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.9056e-05,0.25183,0.2402,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,5.0278e-07,0.25162,0.25418,1,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.009139,0.25115,0.23335,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,3.2057e-05,0.25112,0.22816,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,8.8796e-05,0.25099,0.21659,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,5.2344e-05,0.25061,0.24286,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.1621e-05,0.25,0.21747,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00062378,0.24998,0.21275,1,1
2,GO INTERFERON BETA PRODUCTION,0.0005211,0.24948,0.20944,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.00026858,0.24921,0.22599,1,1
2,GO CYTOPLASM ORGANIZATION,5.4184e-05,0.24869,0.31881,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,4.3997e-05,0.24782,0.21018,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.1282e-07,0.24779,0.23969,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00055343,0.24745,0.21048,1,1
2,GO REGULATION OF GASTRULATION,0.012087,0.24734,0.14487,1,1
2,GO NEGATIVE T CELL SELECTION,0.00014599,0.24708,0.21841,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,4.7963e-08,0.24706,0.25334,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,6.3249e-05,0.24703,0.25614,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.628e-05,0.24703,0.24688,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,1.7071e-05,0.24698,0.22968,1,1
2,GO FOREGUT MORPHOGENESIS,0.00087508,0.24698,0.24747,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.052575,0.24697,0.14705,1,1
2,GO ERYTHROCYTE DEVELOPMENT,1.9749e-05,0.24695,0.21415,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.001442,0.24687,0.25726,1,1
2,GO SECRETION BY TISSUE,0.00011033,0.24664,0.22067,1,1
2,GO REGULATION OF FIBRINOLYSIS,0.0044864,0.2462,0.18692,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001568,0.24618,0.24182,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00049802,0.24547,0.23325,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,1.1034e-07,0.24546,0.23737,1,1
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0053519,0.245,0.2163,1,1
2,GO REGULATION OF T CELL ACTIVATION,4.2487e-05,0.24495,0.20907,1,1
2,GO URETER DEVELOPMENT,0.00071283,0.2449,0.22557,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,4.2271e-06,0.24462,0.32088,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.2497e-05,0.24425,0.21239,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.0089251,0.24425,0.16752,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.0041031,0.24401,0.18697,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.048746,0.2437,0.15249,1,1
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0058389,0.24322,0.19471,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0047798,0.24319,0.17063,1,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.001483,0.24302,0.2258,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,8.5858e-05,0.24254,0.24991,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.016568,0.24234,0.1549,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,1.7922e-07,0.24186,0.2478,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0020929,0.24171,0.20057,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0095807,0.2413,0.15432,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00033955,0.24122,0.19698,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00099681,0.24109,0.23955,1,1
2,GO NEPHRON TUBULE FORMATION,0.00014839,0.24069,0.31478,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,2.8001e-06,0.24023,0.22004,1,1
2,GO VIRAL LIFE CYCLE,0.00033955,0.24008,0.1779,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,6.7105e-06,0.24002,0.23363,1,1
2,GO CELLULAR RESPONSE TO VIRUS,9.819e-05,0.23968,0.21672,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,2.4972e-05,0.23955,0.22632,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00015838,0.23934,0.21848,1,1
2,GO MACROPHAGE MIGRATION,0.00045468,0.23896,0.20205,1,1
2,GO EPIDERMAL CELL DIFFERENTIATION,0.0003557,0.23848,0.21791,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.0020092,0.23841,0.38036,1,1
2,GO B CELL HOMEOSTASIS,0.00025617,0.2384,0.22593,1,1
2,GO LEUKOCYTE PROLIFERATION,1.6457e-05,0.23824,0.22242,1,1
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.024947,0.23822,0.21173,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,2.9859e-05,0.23815,0.23463,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00018323,0.23812,0.23421,1,1
2,GO ENAMEL MINERALIZATION,0.0029256,0.23807,0.3105,1,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.022446,0.23787,0.19659,1,1
2,GO TERPENOID METABOLIC PROCESS,0.00095459,0.23753,0.16858,1,1
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.032278,0.23751,0.14979,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00047589,0.23671,0.18905,1,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.002631,0.23654,0.1849,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00022565,0.23652,0.22153,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00031414,0.23595,0.21043,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,5.7582e-06,0.23581,0.26242,1,1
2,GO RESPONSE TO X RAY,1.3442e-05,0.23577,0.27603,1,1
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.010522,0.23562,0.25228,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,4.6881e-08,0.23559,0.23406,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,0.00031907,0.23558,0.19754,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,5.7059e-05,0.23549,0.23061,1,1
2,GO HISTONE H4 DEACETYLATION,0.00014839,0.23549,0.22405,1,1
2,GO MAMMARY GLAND MORPHOGENESIS,0.00035024,0.23546,0.26903,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,7.5001e-05,0.23519,0.19948,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,3.1494e-05,0.23519,0.23545,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00063314,0.23503,0.21302,1,1
2,GO PENTOSE METABOLIC PROCESS,2.3891e-06,0.23487,0.32909,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.0011341,0.23448,0.1937,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.0314e-05,0.23419,0.20676,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0030839,0.23389,0.19424,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00015083,0.23371,0.19499,1,1
2,GO STEM CELL DIVISION,0.0013069,0.23367,0.21153,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,2.2015e-05,0.23367,0.21485,1,1
2,GO INTERFERON GAMMA PRODUCTION,2.7804e-05,0.23345,0.22906,1,1
2,GO VESICLE CARGO LOADING,6.1119e-05,0.23345,0.19904,1,1
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.002702,0.23325,0.25408,1,1
2,GO PLATELET MORPHOGENESIS,2.1234e-05,0.23266,0.2717,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,8.1623e-05,0.2326,0.23023,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.00018323,0.23225,0.21065,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0013633,0.23219,0.1807,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00018323,0.23206,0.28023,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.7316e-05,0.23148,0.22054,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,9.03e-05,0.23116,0.21284,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,2.2958e-06,0.23087,0.21737,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00011406,0.23079,0.29544,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.043866,0.23077,0.15741,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,1.8363e-05,0.23054,0.27291,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,3.094e-05,0.23039,0.22038,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.0015249,0.22995,0.21585,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0002117,0.2295,0.1999,1,1
2,GO RRNA MODIFICATION,1.3693e-05,0.22934,0.19663,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0037016,0.22931,0.21252,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0023637,0.22922,0.19466,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.011e-05,0.22892,0.20101,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00043435,0.22889,0.19987,1,1
2,GO L SERINE METABOLIC PROCESS,0.010895,0.22836,0.19498,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013633,0.22825,0.22797,1,1
2,GO BEHAVIORAL RESPONSE TO PAIN,0.031631,0.22822,0.18657,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00031907,0.22819,0.27005,1,1
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0024609,0.22798,0.19973,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,7.8911e-05,0.2278,0.191,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.00049053,0.22775,0.27499,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,1.9175e-06,0.22712,0.26588,1,1
2,GO MUSCLE CELL MIGRATION,0.002631,0.22698,0.17386,1,1
2,GO ACUTE INFLAMMATORY RESPONSE,0.0046604,0.22682,0.13954,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0043737,0.22669,0.17627,1,1
2,GO RENAL VESICLE DEVELOPMENT,0.00086244,0.22626,0.20048,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,1.2253e-05,0.22626,0.20334,1,1
2,GO REPLICATIVE SENESCENCE,0.034636,0.22613,0.13595,1,1
2,GO IMP METABOLIC PROCESS,0.0037498,0.22607,0.19902,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.00069207,0.22604,0.22884,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.0958e-05,0.22602,0.19484,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,9.3381e-05,0.22576,0.20577,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,9.4341e-06,0.22558,0.25812,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0010408,0.22537,0.16829,1,1
2,GO REPLACEMENT OSSIFICATION,0.018693,0.22512,0.18439,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,1.4472e-05,0.22498,0.22059,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,6.4592e-06,0.22495,0.1968,1,1
2,GO DETOXIFICATION,4.1456e-06,0.22435,0.22348,1,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0015249,0.2242,0.19375,1,1
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.032938,0.22415,0.21781,1,1
2,GO T CELL ACTIVATION,0.00010673,0.22407,0.20322,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0011668,0.22355,0.18195,1,1
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.017315,0.22323,0.18016,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,1.3948e-05,0.2228,0.23127,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00011033,0.22216,0.22588,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00030928,0.22186,0.18955,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0012177,0.2214,0.17662,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00024045,0.22114,0.18839,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00048316,0.22104,0.22376,1,1
2,GO ZINC ION HOMEOSTASIS,0.0055559,0.22068,0.21493,1,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0077327,0.22065,0.18232,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0034692,0.22055,0.16044,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,4.0314e-05,0.22039,0.22374,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.031631,0.22013,0.16404,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,2.3239e-05,0.22012,0.20196,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,3.9872e-06,0.22008,0.23635,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.0776e-06,0.22007,0.22566,1,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.011022,0.21992,0.19152,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.002702,0.21977,0.16605,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.536e-06,0.21967,0.24415,1,1
2,GO MRNA MODIFICATION,0.00035024,0.21939,0.19232,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.004156,0.21922,0.1836,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.00014129,0.21906,0.26193,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00064263,0.219,0.39455,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.00030928,0.21883,0.19855,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1.0557e-05,0.21864,0.20989,1,1
2,GO LAMELLIPODIUM ASSEMBLY,7.3803e-06,0.21856,0.20631,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00023294,0.21833,0.20444,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.4972e-05,0.21808,0.19678,1,1
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.046921,0.21746,0.13028,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,6.8885e-07,0.21737,0.24513,1,1
2,GO REGULATION OF PROTEIN MATURATION,0.00071283,0.21722,0.17899,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0042095,0.21679,0.18142,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,2.3891e-06,0.21662,0.20043,1,1
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.030994,0.2164,0.16708,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00049053,0.2164,0.18003,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00080175,0.21639,0.24871,1,1
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0032078,0.21618,0.1668,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,7.0072e-05,0.21611,0.22174,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.094e-05,0.216,0.22025,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0014624,0.21546,0.27595,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00010497,0.21505,0.21088,1,1
2,GO INTERACTION WITH HOST,0.0002117,0.21483,0.18696,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,3.8924e-05,0.21452,0.19801,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0063654,0.21451,0.22816,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,2.6386e-06,0.21448,0.21327,1,1
2,GO CYTOKINE PRODUCTION,0.00014599,0.21445,0.19329,1,1
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0075485,0.21435,0.17998,1,1
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0046604,0.21416,0.18778,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0020092,0.21413,0.25951,1,1
2,GO RNA DECAPPING,2.1621e-05,0.21357,0.18832,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,1.2253e-05,0.21349,0.18712,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00010152,0.21347,0.21423,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00098255,0.21279,0.20724,1,1
2,GO B CELL APOPTOTIC PROCESS,0.0005056,0.21269,0.20317,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,7.6283e-05,0.21257,0.19864,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.001118,0.21236,0.17616,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.0022396,0.21234,0.27312,1,1
2,GO ALDITOL METABOLIC PROCESS,1.0958e-05,0.21232,0.28326,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,5.5412e-06,0.21231,0.21397,1,1
2,GO PIGMENT GRANULE ORGANIZATION,3.758e-05,0.21229,0.2484,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.00022208,0.21212,0.17062,1,1
2,GO LYMPH VESSEL DEVELOPMENT,0.0024941,0.21212,0.24441,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00014839,0.21187,0.19377,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,6.9711e-06,0.21183,0.28629,1,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0072795,0.21164,0.16786,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.016752,0.21133,0.14107,1,1
2,GO MITRAL VALVE DEVELOPMENT,0.0059852,0.21131,0.28148,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00012594,0.21087,0.19866,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,1.7922e-07,0.21005,0.23107,1,1
2,GO ICOSANOID METABOLIC PROCESS,3.6924e-05,0.21004,0.2132,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00010152,0.21002,0.17799,1,1
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.02174,0.20987,0.17217,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00029052,0.20986,0.23858,1,1
2,GO REGULATION OF PROTEIN IMPORT,7.2414e-06,0.20982,0.22661,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,2.342e-06,0.20971,0.19613,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.2487e-05,0.20967,0.22282,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00010152,0.20962,0.20286,1,1
2,GO RNA INTERFERENCE,0.00027716,0.20947,0.18835,1,1
2,GO RESPONSE TO CYTOKINE,0.00027716,0.20925,0.17298,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00026024,0.20919,0.16371,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00013232,0.20917,0.22529,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0005211,0.20915,0.27563,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,6.545e-05,0.209,0.22068,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0028492,0.20852,0.18689,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.00013016,0.20839,0.23566,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.001704,0.20835,0.18087,1,1
2,GO OVULATION,9.9844e-05,0.20816,0.23507,1,1
2,GO REGULATION OF B CELL ACTIVATION,0.00019857,0.20813,0.19614,1,1
2,GO SPROUTING ANGIOGENESIS,0.00071283,0.20802,0.18125,1,1
2,GO RESPONSE TO GONADOTROPIN,0.001442,0.2079,0.19333,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00010852,0.20779,0.21298,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0012705,0.20738,0.22961,1,1
2,GO REGULATION OF CELL CELL ADHESION,0.00012388,0.20698,0.19597,1,1
2,GO FIBROBLAST PROLIFERATION,0.015501,0.20687,0.13834,1,1
2,GO LYMPHANGIOGENESIS,0.0025277,0.20669,0.2073,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0038977,0.20664,0.14988,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.010279,0.20658,0.14833,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0020646,0.20643,0.23024,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.001704,0.20627,0.18197,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0030436,0.20608,0.18,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,6.2169e-06,0.20605,0.21334,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0032928,0.20598,0.17754,1,1
2,GO PLASMA MEMBRANE FUSION,0.032607,0.20575,0.1552,1,1
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0053519,0.20551,0.17608,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.0011503,0.20491,0.19985,1,1
2,GO RESPONSE TO IONIZING RADIATION,2.8814e-05,0.20489,0.18766,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.00010323,0.20463,0.18841,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,5.0323e-06,0.20442,0.25166,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.014172,0.2044,0.15674,1,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00040235,0.20432,0.24447,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.003654,0.20431,0.15382,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00081356,0.20429,0.21673,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0013443,0.2042,0.25073,1,1
2,GO GTP METABOLIC PROCESS,4.8839e-05,0.20413,0.21522,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,2.7804e-05,0.20385,0.28813,1,1
2,GO RESPONSE TO ANTIBIOTIC,1.2716e-05,0.20329,0.20052,1,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.004156,0.20298,0.16431,1,1
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.01829,0.20264,0.18209,1,1
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.024947,0.20258,0.20181,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,1.2792e-06,0.20186,0.20759,1,1
2,GO REGULATION OF IMMUNE RESPONSE,2.5884e-05,0.20173,0.1957,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00046872,0.20161,0.17033,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.5359e-06,0.20134,0.19801,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0005056,0.20121,0.18328,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00021511,0.20093,0.18463,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,3.6162e-06,0.20076,0.19427,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,9.4341e-06,0.20076,0.19397,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.7999e-05,0.20059,0.21613,1,1
2,GO LIPID IMPORT INTO CELL,0.0032078,0.20023,0.17011,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0012005,0.2001,0.2225,1,1
2,GO RESPONSE TO BACTERIUM,0.00037257,0.20006,0.17144,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,7.8911e-05,0.1999,0.20941,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00015838,0.19982,0.21962,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0019285,0.19931,0.19591,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.0059852,0.19922,0.24842,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0013069,0.19899,0.16623,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0014624,0.1989,0.17215,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.00016901,0.19854,0.18692,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.00026858,0.19851,0.17228,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00030449,0.19842,0.17017,1,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.042609,0.19837,0.16607,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00034485,0.19822,0.18622,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0016122,0.19811,0.16022,1,1
2,GO EPIDERMIS DEVELOPMENT,0.0010259,0.19802,0.18529,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00019229,0.1978,0.17163,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00024819,0.19735,0.16461,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.0030436,0.19732,0.16143,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0007901,0.19727,0.18512,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.00068191,0.19705,0.16611,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.000286,0.19698,0.16728,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,9.086e-06,0.19642,0.20306,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,8.9166e-06,0.19636,0.2081,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0018764,0.1963,0.15457,1,1
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.011949,0.19572,0.1715,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00016361,0.19555,0.2161,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0023637,0.19551,0.20277,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,9.4959e-05,0.19542,0.19489,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,8.1138e-06,0.19529,0.20554,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0005211,0.19498,0.19266,1,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.004964,0.19494,0.16967,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,9.6562e-05,0.19475,0.17315,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,2.0853e-05,0.19452,0.1837,1,1
2,GO BLASTOCYST FORMATION,2.3784e-07,0.19445,0.21235,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00098255,0.19442,0.27918,1,1
2,GO MESODERMAL CELL DIFFERENTIATION,0.004964,0.1944,0.16064,1,1
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.012653,0.19414,0.17108,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.01128,0.19413,0.20568,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00043435,0.1941,0.15442,1,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.0052854,0.1941,0.16513,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.025475,0.1941,0.14574,1,1
2,GO PRIMARY MIRNA PROCESSING,9.086e-06,0.19407,0.25929,1,1
2,GO CARNITINE SHUTTLE,8.1623e-05,0.19403,0.23344,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,1.0958e-05,0.19394,0.19999,1,1
2,GO KERATINIZATION,0.0045438,0.19389,0.21575,1,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.016938,0.19385,0.10983,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,1.0756e-05,0.1936,0.198,1,1
2,GO ASYMMETRIC CELL DIVISION,0.0018006,0.19353,0.18436,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00040235,0.19338,0.18751,1,1
2,GO T HELPER CELL LINEAGE COMMITMENT,0.0089251,0.19328,0.15869,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00088789,0.19305,0.23921,1,1
2,GO FATTY ACID TRANSPORT,3.4773e-06,0.19303,0.18278,1,1
2,GO REGULATION OF HEMOPOIESIS,4.7999e-05,0.19294,0.18516,1,1
2,GO SKIN DEVELOPMENT,0.0025277,0.19288,0.18426,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.3196e-05,0.19276,0.17133,1,1
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0035605,0.19271,0.15572,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00043435,0.19235,0.1692,1,1
2,GO GASTRIC ACID SECRETION,2.3661e-05,0.19222,0.22542,1,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0067673,0.19172,0.17967,1,1
2,GO TISSUE REGENERATION,0.0014022,0.19168,0.17548,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,1.6761e-05,0.19141,0.19352,1,1
2,GO HYPOTONIC RESPONSE,0.016386,0.19131,0.16063,1,1
2,GO REGULATION OF CELL ACTIVATION,6.4341e-05,0.19129,0.1915,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00015083,0.19121,0.28712,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00057029,0.19086,0.17873,1,1
2,GO REGULATION OF CELL ADHESION,0.0017517,0.1908,0.16257,1,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.011678,0.19052,0.13914,1,1
2,GO MYOBLAST DIFFERENTIATION,0.0011503,0.19051,0.18039,1,1
2,GO ERBB SIGNALING PATHWAY,4.0314e-05,0.19042,0.18596,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0030038,0.1904,0.14111,1,1
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0014022,0.19039,0.21158,1,1
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.01849,0.19016,0.16067,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.00091404,0.18946,0.21916,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.020385,0.18934,0.15425,1,1
2,GO HISTONE H2B UBIQUITINATION,0.00047589,0.18927,0.15791,1,1
2,GO T CELL DIFFERENTIATION,8.8796e-05,0.18908,0.19874,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,1.2716e-05,0.1881,0.19776,1,1
2,GO GLYCINE METABOLIC PROCESS,0.001704,0.18785,0.18826,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0005211,0.18778,0.17196,1,1
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.053071,0.18775,0.15438,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0020929,0.18733,0.1999,1,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.0046604,0.18731,0.15711,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00088789,0.18686,0.22627,1,1
2,GO AMINO ACID ACTIVATION,8.8796e-05,0.18677,0.18232,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00034485,0.18654,0.18481,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0083098,0.18629,0.14272,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.001442,0.18621,0.22565,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0018006,0.18611,0.193,1,1
2,GO PHAGOCYTOSIS RECOGNITION,0.0020367,0.18602,0.20423,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00011986,0.18573,0.19638,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,9.819e-05,0.1853,0.17516,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.2057e-05,0.18522,0.22162,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,9.9844e-05,0.18511,0.21717,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,8.7316e-05,0.1851,0.16607,1,1
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.054582,0.18478,0.15354,1,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0037985,0.18477,0.14523,1,1
2,GO GRANULOCYTE MIGRATION,0.001235,0.18467,0.1776,1,1
2,GO SOMATIC STEM CELL DIVISION,0.016386,0.18453,0.26924,1,1
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.056128,0.18423,0.17688,1,1
2,GO MRNA TRANSCRIPTION,0.00052901,0.18368,0.18671,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.0012886,0.18354,0.16732,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,1.6761e-05,0.1832,0.17588,1,1
2,GO ARTERY MORPHOGENESIS,0.007921,0.18316,0.16725,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0043737,0.18305,0.15042,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00057029,0.18287,0.19659,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,8.1623e-05,0.18274,0.20718,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,2.3239e-05,0.18267,0.21334,1,1
2,GO FATTY ACID METABOLIC PROCESS,2.5424e-05,0.18265,0.15765,1,1
2,GO V D J RECOMBINATION,0.012227,0.1826,0.17597,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.00017176,0.18249,0.18893,1,1
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.032607,0.18238,0.19088,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.00022565,0.18229,0.20301,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00042128,0.18221,0.16076,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0104,0.18209,0.24181,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.7071e-05,0.18143,0.20225,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0047198,0.18134,0.15625,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00032916,0.18095,0.13116,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0001862,0.18081,0.16251,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,2.5884e-05,0.18069,0.16511,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.6877e-06,0.18048,0.20515,1,1
2,GO RESPONSE TO UV C,0.0069343,0.18041,0.19162,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,2.2824e-05,0.18027,0.18741,1,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.017315,0.18023,0.16787,1,1
2,GO RESPONSE TO ESTROGEN,0.0016806,0.18019,0.17593,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00031907,0.18017,0.18996,1,1
2,GO REGULATION OF HAIR CYCLE,0.0017517,0.17987,0.20826,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,4.5233e-07,0.17957,0.1878,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00062378,0.17945,0.14767,1,1
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.011022,0.1793,0.14488,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0010259,0.17913,0.21534,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0053519,0.17906,0.12694,1,1
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0104,0.17888,0.21734,1,1
2,GO LIPID HOMEOSTASIS,0.00061456,0.17861,0.14873,1,1
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.017125,0.17822,0.16746,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0052197,0.17816,0.16584,1,1
2,GO NUCLEAR PORE ORGANIZATION,6.545e-05,0.17792,0.20868,1,1
2,GO TOXIN TRANSPORT,0.00023294,0.17785,0.17086,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00032408,0.17762,0.1855,1,1
2,GO NADP METABOLIC PROCESS,0.0017277,0.17756,0.16507,1,1
2,GO PIGMENT METABOLIC PROCESS,8.5858e-05,0.17734,0.15875,1,1
2,GO SYMBIOTIC PROCESS,1.5293e-05,0.17718,0.15388,1,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.0096941,0.17713,0.16104,1,1
2,GO B CELL DIFFERENTIATION,0.00011986,0.17704,0.20215,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,1.5576e-05,0.17686,0.20441,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0019819,0.1763,0.22803,1,1
2,GO COLLAGEN CATABOLIC PROCESS,0.011022,0.17609,0.15457,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0016122,0.17605,0.16588,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0037985,0.17589,0.17672,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.019312,0.17589,0.1575,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.00015083,0.17588,0.18223,1,1
2,GO ACUTE PHASE RESPONSE,0.0005789,0.17585,0.17321,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,6.4341e-05,0.1757,0.19588,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0022396,0.17556,0.13168,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0016122,0.17545,0.16285,1,1
2,GO AMELOGENESIS,0.015674,0.17542,0.19817,1,1
2,GO HISTONE H3 K9 ACETYLATION,0.00031907,0.17515,0.17937,1,1
2,GO LEUKOCYTE HOMEOSTASIS,0.0039481,0.17494,0.15442,1,1
2,GO MAINTENANCE OF CELL NUMBER,6.3249e-05,0.17489,0.1803,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00029511,0.17481,0.14443,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0098086,0.1748,0.13789,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.0019285,0.1746,0.17722,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,1.8363e-05,0.17447,0.15494,1,1
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.059879,0.17413,0.0969,1,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0063654,0.174,0.15145,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,4.5558e-05,0.17383,0.17859,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00034485,0.17373,0.16147,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,4.3946e-06,0.17343,0.17808,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,1.5293e-05,0.17343,0.18384,1,1
2,GO GLAND MORPHOGENESIS,0.032278,0.17321,0.17322,1,1
2,GO PERICARDIUM DEVELOPMENT,0.033271,0.17317,0.1557,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.00025617,0.17303,0.17649,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0089251,0.17303,0.12043,1,1
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0056255,0.17301,0.14734,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0030038,0.17299,0.15655,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0031247,0.1729,0.2424,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.00019229,0.17262,0.1655,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.037509,0.17247,0.13048,1,1
2,GO LUNG MORPHOGENESIS,0.02128,0.17244,0.18926,1,1
2,GO AXIS ELONGATION,0.0010113,0.17231,0.26375,1,1
2,GO RESPONSE TO VITAMIN A,0.0069343,0.17204,0.17439,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00011406,0.17197,0.22557,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0013443,0.17144,0.15131,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,3.9102e-06,0.17141,0.22323,1,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.028852,0.17123,0.19828,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.017125,0.17122,0.13811,1,1
2,GO LYMPHOCYTE ACTIVATION,0.0002117,0.17115,0.17748,1,1
2,GO LIPID OXIDATION,0.00064263,0.17075,0.14258,1,1
2,GO REGULATORY T CELL DIFFERENTIATION,0.0042095,0.17064,0.20368,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.015329,0.17064,0.15387,1,1
2,GO REGULATION OF GENE SILENCING,1.6158e-05,0.17013,0.15421,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,8.4424e-05,0.17005,0.14919,1,1
2,GO GOLGI LOCALIZATION,0.00049802,0.17,0.17349,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.0029256,0.16984,0.13232,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.996e-06,0.16976,0.1765,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.001442,0.16968,0.1973,1,1
2,GO SYNCYTIUM FORMATION,0.0084096,0.16927,0.15156,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.017506,0.16899,0.14622,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.00032408,0.16898,0.27689,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.00030449,0.16896,0.15993,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.011e-05,0.16872,0.15798,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,3.094e-05,0.16822,0.18807,1,1
2,GO RESPONSE TO GAMMA RADIATION,1.0361e-05,0.16789,0.2125,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.012945,0.16783,0.14506,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.0033799,0.16776,0.17992,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.001235,0.16768,0.18609,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.003607,0.16755,0.13804,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.03006,0.167,0.13135,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0078263,0.16691,0.15291,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.00020835,0.16677,0.17299,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00029511,0.1666,0.18917,1,1
2,GO AMP METABOLIC PROCESS,0.0015463,0.16656,0.22715,1,1
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.006444,0.16649,0.19924,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.001776,0.16601,0.19463,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.018693,0.16595,0.11346,1,1
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.042197,0.16587,0.15018,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0093576,0.16569,0.15439,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.002631,0.16546,0.16328,1,1
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.012367,0.16529,0.17488,1,1
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.008211,0.16501,0.16957,1,1
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.036409,0.16494,0.13506,1,1
2,GO TRNA PROCESSING,0.00024819,0.16485,0.13948,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00014839,0.16483,0.18271,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00013451,0.16466,0.16394,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,7.5217e-06,0.16466,0.18172,1,1
2,GO MIRNA METABOLIC PROCESS,0.0007786,0.16456,0.14846,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.002702,0.16453,0.16967,1,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.00027284,0.16449,0.2163,1,1
2,GO MANGANESE ION TRANSPORT,0.050154,0.1644,0.097281,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.003607,0.16431,0.13681,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0046018,0.16431,0.14767,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0016122,0.16424,0.13775,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.00045468,0.16421,0.18433,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.027401,0.16416,0.13733,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.00031414,0.16409,0.1749,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0057669,0.16404,0.15388,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.052083,0.16399,0.12614,1,1
2,GO B CELL ACTIVATION,0.00028155,0.16387,0.18037,1,1
2,GO TRNA METABOLIC PROCESS,0.00014839,0.16376,0.14584,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00065224,0.16374,0.14766,1,1
2,GO RESPONSE TO SALT STRESS,0.0043737,0.16334,0.17815,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,5.4184e-05,0.16328,0.16167,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.030368,0.16326,0.11936,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.027973,0.16312,0.11891,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,6.545e-05,0.16303,0.13926,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00047589,0.16268,0.17366,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0071051,0.16263,0.1316,1,1
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0050269,0.16262,0.19478,1,1
2,GO RESPONSE TO RETINOIC ACID,0.012653,0.16262,0.14389,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.001422,0.16243,0.18578,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0015463,0.16242,0.18732,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00018323,0.16218,0.19897,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.001955,0.16213,0.15878,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00038422,0.16207,0.15349,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,9.819e-05,0.16166,0.17306,1,1
2,GO RRNA METHYLATION,0.0001179,0.16161,0.17418,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00033955,0.16138,0.15754,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00033432,0.16121,0.17882,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00023294,0.16119,0.14467,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0012886,0.16088,0.16421,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.00092737,0.16061,0.132,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00061456,0.16057,0.17109,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0038977,0.16054,0.13925,1,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0104,0.16052,0.14005,1,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.023173,0.1605,0.11461,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0073682,0.16029,0.11471,1,1
2,GO SPLEEN DEVELOPMENT,0.0021798,0.16014,0.13932,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0080166,0.15977,0.11628,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0024941,0.15964,0.15603,1,1
2,GO LYMPH VESSEL MORPHOGENESIS,0.016386,0.15961,0.17701,1,1
2,GO PROTEIN NITROSYLATION,0.0053519,0.15954,0.1867,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0025617,0.15952,0.15888,1,1
2,GO PLACENTA DEVELOPMENT,0.0045438,0.15926,0.13371,1,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0048405,0.15879,0.13517,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00082553,0.15865,0.15707,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.0086125,0.15853,0.17223,1,1
2,GO TISSUE MIGRATION,0.0054192,0.15824,0.15288,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,9.3381e-05,0.15816,0.15165,1,1
2,GO BILE ACID METABOLIC PROCESS,0.0013826,0.15802,0.16967,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.008211,0.15784,0.13699,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.00044781,0.15778,0.20164,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.00016629,0.15742,0.1599,1,1
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0059852,0.15711,0.1491,1,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.001118,0.15707,0.16852,1,1
2,GO REGULATION OF CELL MATURATION,0.0047798,0.157,0.13758,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.00095459,0.15672,0.16127,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0012177,0.15629,0.1445,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00084997,0.1561,0.17306,1,1
2,GO REGULATION OF CELL SHAPE,0.0014624,0.15583,0.17256,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,0.0019285,0.15556,0.17933,1,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.0047198,0.15555,0.16789,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0039481,0.15554,0.12073,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.01499,0.1555,0.15625,1,1
2,GO ASTROCYTE DEVELOPMENT,0.030368,0.15547,0.13289,1,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.011678,0.15546,0.12911,1,1
2,GO LIPID MODIFICATION,0.0010558,0.15545,0.12316,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00021857,0.15536,0.14234,1,1
2,GO THIOESTER METABOLIC PROCESS,9.819e-05,0.15526,0.19262,1,1
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.026013,0.15518,0.1285,1,1
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.057179,0.15488,0.09203,1,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0104,0.15465,0.13184,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,1.6761e-05,0.15432,0.1591,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.00016901,0.15376,0.15342,1,1
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.021509,0.15349,0.10494,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.00037257,0.15323,0.18075,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00028155,0.15277,0.15964,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.1588e-05,0.15275,0.1902,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.01128,0.15272,0.14114,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00016629,0.1525,0.13889,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.0013069,0.15241,0.12601,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00022927,0.15234,0.15809,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0065235,0.15219,0.12364,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.040582,0.15207,0.11911,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,4.8839e-05,0.15187,0.15946,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.7059e-05,0.15114,0.18026,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.00035024,0.15096,0.13613,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.4262e-06,0.15093,0.15685,1,1
2,GO PROTEIN KINASE B SIGNALING,0.0054872,0.15086,0.12014,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00058763,0.15075,0.14673,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,2.8305e-05,0.15066,0.15059,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057669,0.15063,0.14571,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.0169e-05,0.15057,0.15687,1,1
2,GO BLOOD VESSEL MORPHOGENESIS,0.041383,0.15027,0.11441,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.00027284,0.15026,0.17588,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.017125,0.15017,0.10404,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00067188,0.15008,0.16628,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.010041,0.14998,0.1432,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0040509,0.14986,0.23288,1,1
2,GO GOLGI RIBBON FORMATION,0.00069207,0.14975,0.17124,1,1
2,GO MAST CELL MEDIATED IMMUNITY,0.052575,0.14971,0.13072,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.020166,0.14954,0.15543,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.016027,0.14947,0.13122,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,2.7312e-05,0.14946,0.15946,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.016568,0.14904,0.12401,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001568,0.14871,0.12893,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0046604,0.14856,0.13703,1,1
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.014823,0.1481,0.094697,1,1
2,GO EMBRYONIC HEMOPOIESIS,0.031311,0.14798,0.12814,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0016806,0.14768,0.17126,1,1
2,GO P BODY ASSEMBLY,0.0037985,0.14733,0.11262,1,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.006444,0.14731,0.11581,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00014129,0.14728,0.16197,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,9.9844e-05,0.14721,0.13696,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,0.00010852,0.14717,0.1662,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.0023009,0.14713,0.15896,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0014624,0.14702,0.1875,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0034692,0.14698,0.1395,1,1
2,GO ALCOHOL METABOLIC PROCESS,1.7071e-05,0.14692,0.15843,1,1
2,GO OXIDATIVE DEMETHYLATION,0.010522,0.14678,0.094131,1,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.0092477,0.14678,0.14491,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.021509,0.14673,0.12261,1,1
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.059879,0.14648,0.12113,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00037835,0.14644,0.13468,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00016629,0.14634,0.14559,1,1
2,GO VASCULATURE DEVELOPMENT,0.023173,0.14609,0.12426,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00067188,0.14602,0.16534,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.052575,0.14572,0.1065,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00068191,0.14571,0.12237,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,5.2344e-05,0.14545,0.16274,1,1
2,GO GOLGI VESICLE BUDDING,0.00044781,0.14543,0.13123,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.03006,0.14534,0.12902,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0021505,0.14508,0.16324,1,1
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.027401,0.14507,0.14684,1,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.018091,0.14497,0.12272,1,1
2,GO HISTONE DEUBIQUITINATION,0.0011503,0.14489,0.13907,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0074579,0.1448,0.11799,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.060432,0.14472,0.098584,1,1
2,GO REGULATION OF FATTY ACID OXIDATION,0.021053,0.14469,0.12772,1,1
2,GO STEM CELL DIFFERENTIATION,0.0024609,0.14458,0.12273,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0005618,0.14457,0.14513,1,1
2,GO BONE MORPHOGENESIS,0.01829,0.14444,0.14598,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,1.5576e-05,0.14442,0.17805,1,1
2,GO BONE GROWTH,0.0083098,0.14415,0.19261,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00031414,0.14406,0.13496,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,8.7316e-05,0.144,0.15069,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.00024045,0.1438,0.16994,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00084997,0.14375,0.15075,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.0002117,0.14352,0.16267,1,1
2,GO RNA DESTABILIZATION,0.0023957,0.14295,0.1467,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0066851,0.14236,0.14903,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0089251,0.14208,0.15122,1,1
2,GO CELLULAR RESPONSE TO LIPID,0.0031247,0.1419,0.1299,1,1
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.032278,0.1418,0.20618,1,1
2,GO MAMMARY GLAND DEVELOPMENT,0.040187,0.14177,0.10973,1,1
2,GO LIPID METABOLIC PROCESS,0.00055343,0.1417,0.11962,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.016752,0.14153,0.16768,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.048285,0.1415,0.12861,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.5014e-05,0.14126,0.1458,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0013069,0.14109,0.12213,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.010279,0.141,0.10637,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00049802,0.14077,0.16557,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00012388,0.14063,0.13508,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0087156,0.14015,0.13145,1,1
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.042609,0.14005,0.08107,1,1
2,GO LIVER MORPHOGENESIS,0.0071051,0.13987,0.16779,1,1
2,GO DETERMINATION OF ADULT LIFESPAN,0.01016,0.13984,0.16522,1,1
2,GO RESPONSE TO SALT,2.6352e-05,0.1398,0.20252,1,1
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.043025,0.13973,0.093115,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.00088789,0.13961,0.14428,1,1
2,GO MULTI ORGANISM LOCALIZATION,8.7316e-05,0.13922,0.14328,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0073682,0.13922,0.19162,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00020835,0.1392,0.18269,1,1
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.016205,0.13917,0.11522,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.9044e-05,0.13905,0.15492,1,1
2,GO MALE SEX DIFFERENTIATION,0.012653,0.13902,0.11867,1,1
2,GO MUSCLE CELL PROLIFERATION,0.013856,0.13885,0.12161,1,1
2,GO COPII COATED VESICLE BUDDING,0.00043435,0.13866,0.12863,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.026838,0.13863,0.10273,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0012705,0.13835,0.12265,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,0.012945,0.13786,0.14209,1,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.011411,0.13782,0.11529,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.001955,0.1378,0.11034,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0083098,0.13772,0.15981,1,1
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.023919,0.13768,0.11472,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.030368,0.1376,0.13252,1,1
2,GO REGULATION OF GTP BINDING,0.041789,0.1374,0.14217,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.027973,0.13729,0.11236,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.0007786,0.13724,0.15494,1,1
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.037139,0.1371,0.14509,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.026838,0.13677,0.14168,1,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.011022,0.13657,0.16751,1,1
2,GO PROTEIN O LINKED GLYCOSYLATION,0.038258,0.13654,0.10143,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.0010408,0.13635,0.12117,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.017125,0.13625,0.11954,1,1
2,GO RESPONSE TO UV,0.0019023,0.13595,0.12381,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.00030928,0.13579,0.13284,1,1
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.011411,0.13522,0.15674,1,1
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.011411,0.13516,0.16032,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0001803,0.13513,0.17567,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.0062108,0.1349,0.11612,1,1
2,GO STEROL METABOLIC PROCESS,0.00026858,0.13467,0.15362,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.025743,0.13457,0.092967,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0024281,0.13451,0.11485,1,1
2,GO STEROID METABOLIC PROCESS,0.00076726,0.13437,0.12641,1,1
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.041789,0.13422,0.12325,1,1
2,GO CELL CELL RECOGNITION,6.1119e-05,0.13415,0.15182,1,1
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.01128,0.13415,0.11651,1,1
2,GO CELLULAR RESPONSE TO UV,0.001483,0.13402,0.13132,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.0027381,0.13394,0.10986,1,1
2,GO HISTONE MONOUBIQUITINATION,0.025475,0.13374,0.085476,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00036124,0.13347,0.13285,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0015038,0.13323,0.17417,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0023009,0.13317,0.11572,1,1
2,GO RNA POLYADENYLATION,0.0071918,0.13316,0.11055,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.00036124,0.13304,0.1515,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00070238,0.13293,0.1356,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.027401,0.13287,0.091067,1,1
2,GO TRNA TRANSPORT,8.7316e-05,0.13276,0.16199,1,1
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.021509,0.13268,0.11122,1,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.021973,0.13267,0.12963,1,1
2,GO TISSUE HOMEOSTASIS,0.012653,0.13266,0.10066,1,1
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0037985,0.13233,0.1422,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0071051,0.13232,0.14365,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00016098,0.13216,0.11471,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.041383,0.13204,0.1302,1,1
2,GO CELLULAR PIGMENTATION,0.014494,0.13201,0.12906,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.02128,0.13191,0.11076,1,1
2,GO POSITIVE REGULATION OF URINE VOLUME,0.01585,0.13183,0.18805,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.00074504,0.13181,0.15785,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.00064263,0.13164,0.11568,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.00046165,0.13158,0.1492,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,3.628e-05,0.13152,0.15782,1,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.03068,0.13149,0.12086,1,1
2,GO ENDOTHELIAL CELL MIGRATION,0.02521,0.13129,0.12375,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.1165e-05,0.13129,0.15775,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0007901,0.13128,0.12901,1,1
2,GO RESPONSE TO STEROID HORMONE,0.021973,0.13118,0.10257,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.017315,0.13116,0.12208,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.001071,0.13052,0.13807,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.038637,0.13029,0.10071,1,1
2,GO REGULATION OF LIPID TRANSPORT,0.010895,0.13018,0.12093,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.001071,0.12986,0.13517,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00018323,0.1293,0.12381,1,1
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.039406,0.12914,0.094946,1,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0032928,0.12909,0.13067,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0022701,0.12908,0.12552,1,1
2,GO ACTIN NUCLEATION,0.00034485,0.12905,0.14077,1,1
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.031311,0.12899,0.1333,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.011813,0.12853,0.13999,1,1
2,GO LIPID STORAGE,0.052575,0.1285,0.099156,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.013243,0.12844,0.11038,1,1
2,GO RESPONSE TO LIPID,0.014823,0.128,0.10407,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.01128,0.12791,0.11523,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.001955,0.12767,0.15429,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.016752,0.12732,0.13607,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,5.7059e-05,0.12731,0.11901,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.011813,0.12721,0.28879,1,1
2,GO THYROID HORMONE METABOLIC PROCESS,0.048746,0.12717,0.083106,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,3.094e-05,0.12701,0.14458,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,7.5001e-05,0.12686,0.11971,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0137,0.12682,0.12571,1,1
2,GO RESPONSE TO OXYGEN LEVELS,0.0069343,0.12668,0.098187,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,6.3249e-05,0.12667,0.13508,1,1
2,GO SPERM EGG RECOGNITION,0.0024941,0.12657,0.10922,1,1
2,GO GMP METABOLIC PROCESS,0.0137,0.12625,0.12518,1,1
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.041383,0.1259,0.14539,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00054518,0.12568,0.12041,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0040509,0.12546,0.153,1,1
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.0137,0.12544,0.14879,1,1
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.00022927,0.12542,0.13499,1,1
2,GO COCHLEA MORPHOGENESIS,0.01995,0.12513,0.13157,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0094686,0.12495,0.13275,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.026013,0.12468,0.12895,1,1
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.010279,0.12464,0.12434,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0044864,0.12463,0.13214,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0023321,0.12454,0.12743,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.0065235,0.12446,0.12059,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.059331,0.12441,0.11042,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0057669,0.12434,0.10362,1,1
2,GO MRNA CLEAVAGE,0.00038422,0.12427,0.12378,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0029645,0.12408,0.12141,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.002631,0.12405,0.10689,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00067188,0.12404,0.12949,1,1
2,GO VITAMIN METABOLIC PROCESS,0.013546,0.12388,0.098435,1,1
2,GO MYOTUBE DIFFERENTIATION,0.040582,0.12379,0.10368,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.03429,0.12373,0.10674,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.03006,0.12334,0.094203,1,1
2,GO PROTEIN SUMOYLATION,0.00069207,0.12319,0.12426,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.008211,0.12313,0.14805,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION,0.043444,0.12307,0.10281,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,5.0563e-05,0.12278,0.1459,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,5.6085e-05,0.12271,0.13835,1,1
2,GO RUFFLE ORGANIZATION,0.019312,0.12255,0.10541,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.00036124,0.12231,0.11949,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.014658,0.12219,0.13994,1,1
2,GO RESPONSE TO INTERLEUKIN 4,0.00087508,0.12207,0.16134,1,1
2,GO REGULATION OF PROTEOLYSIS,0.0083098,0.12172,0.11278,1,1
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.041383,0.12165,0.11044,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0031247,0.12161,0.12871,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.0031247,0.1214,0.1395,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0035146,0.12123,0.1604,1,1
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.059879,0.12118,0.11634,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0021798,0.12115,0.098075,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00081356,0.12105,0.17969,1,1
2,GO REGULATION OF URINE VOLUME,0.0035605,0.12102,0.15928,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0080166,0.12099,0.12197,1,1
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.037882,0.12075,0.13235,1,1
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.042609,0.12068,0.10226,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.017125,0.12067,0.16996,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.00091404,0.12046,0.12912,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.025743,0.12037,0.14199,1,1
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.00159,0.12036,0.12872,1,1
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.055093,0.12023,0.11736,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00010152,0.11988,0.12083,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.02128,0.11961,0.13513,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.0010558,0.11916,0.1286,1,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.03068,0.11916,0.11121,1,1
2,GO ANION HOMEOSTASIS,0.0063654,0.11915,0.13936,1,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.05357,0.11869,0.085986,1,1
2,GO DIGESTION,0.0042636,0.11865,0.11781,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.018693,0.11864,0.086016,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.047372,0.11855,0.094366,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.052083,0.11792,0.098522,1,1
2,GO REGULATION OF CELL MATRIX ADHESION,0.047372,0.11781,0.12839,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00080175,0.11772,0.16389,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.011678,0.1177,0.097471,1,1
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.049212,0.11751,0.097344,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.015501,0.11701,0.11887,1,1
2,GO NCRNA CATABOLIC PROCESS,0.0086125,0.11642,0.13131,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.052083,0.11617,0.087766,1,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.046474,0.11607,0.098436,1,1
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.027973,0.11591,0.11164,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00011406,0.11587,0.13808,1,1
2,GO THYMUS DEVELOPMENT,0.0007901,0.11562,0.15791,1,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.036048,0.11561,0.088291,1,1
2,GO LIPID PHOSPHORYLATION,0.024173,0.1156,0.099759,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00064263,0.11545,0.11323,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.0049019,0.11525,0.09317,1,1
2,GO LIPID CATABOLIC PROCESS,0.0043184,0.11512,0.10967,1,1
2,GO GENITALIA DEVELOPMENT,0.058247,0.11498,0.087251,1,1
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.017315,0.11479,0.10759,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0016806,0.1145,0.14523,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0010113,0.11436,0.11657,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.002631,0.11436,0.16144,1,1
2,GO DNA METHYLATION,0.00033955,0.1141,0.13291,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0031247,0.11392,0.11169,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.030368,0.1138,0.085177,1,1
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.047827,0.1138,0.14818,1,1
2,GO RESPONSE TO TESTOSTERONE,0.01849,0.11373,0.12416,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.017125,0.11369,0.13996,1,1
2,GO RESPONSE TO KETONE,0.033608,0.11365,0.095042,1,1
2,GO FOCAL ADHESION ASSEMBLY,0.01995,0.11346,0.16458,1,1
2,GO IMPORT INTO NUCLEUS,0.0087156,0.11332,0.10269,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0013443,0.11326,0.11371,1,1
2,GO EPITHELIAL TUBE FORMATION,0.020166,0.11306,0.11708,1,1
2,GO TUBE FORMATION,0.023668,0.11291,0.11345,1,1
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011022,0.11284,0.092406,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0066851,0.11267,0.09573,1,1
2,GO RESPONSE TO CHEMOKINE,0.0043737,0.11262,0.1255,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0033799,0.11254,0.11326,1,1
2,GO FEVER GENERATION,0.016027,0.11227,0.13217,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0005056,0.11211,0.13111,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.00087508,0.11196,0.13113,1,1
2,GO GENE SILENCING,0.00026858,0.11177,0.10843,1,1
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.052575,0.11125,0.092037,1,1
2,GO HISTONE DEACETYLATION,0.023419,0.1112,0.072643,1,1
2,GO HYPEROSMOTIC RESPONSE,0.018898,0.11119,0.10963,1,1
2,GO RESPONSE TO NUTRIENT,0.05063,0.11117,0.097656,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.00070238,0.11107,0.16713,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0025961,0.11082,0.14786,1,1
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.025743,0.11079,0.12041,1,1
2,GO TELOMERE ORGANIZATION,0.0013255,0.11075,0.1147,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0077327,0.11054,0.10007,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00049802,0.11022,0.10302,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.0045438,0.11016,0.10502,1,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.056128,0.10983,0.10177,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00014839,0.10973,0.12775,1,1
2,GO FATTY ACYL COA METABOLIC PROCESS,0.0032928,0.10969,0.16991,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.02521,0.10964,0.11284,1,1
2,GO REGULATION OF CELL DEATH,0.011411,0.10947,0.09343,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00032916,0.10938,0.12941,1,1
2,GO MOLTING CYCLE,0.056128,0.10916,0.11627,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00011986,0.10905,0.13102,1,1
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.050154,0.10854,0.10221,1,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.012367,0.10851,0.11513,1,1
2,GO HISTONE UBIQUITINATION,0.047372,0.10848,0.064577,1,1
2,GO RESPONSE TO DRUG,0.024687,0.10848,0.094335,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00048316,0.10848,0.13442,1,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.027686,0.10848,0.1071,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0056958,0.10843,0.11691,1,1
2,GO PROTEIN IMPORT,0.0019023,0.10837,0.10931,1,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.03902,0.10834,0.10332,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.012367,0.10827,0.082576,1,1
2,GO MACROPHAGE ACTIVATION,0.0048405,0.1082,0.14288,1,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.020605,0.10799,0.098256,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0025961,0.1079,0.11333,1,1
2,GO MRNA METHYLATION,0.033608,0.10708,0.12598,1,1
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.033948,0.10698,0.086408,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.0024609,0.10656,0.10976,1,1
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.053071,0.10633,0.084111,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.022686,0.10625,0.093909,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0045438,0.10609,0.17581,1,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.039795,0.10606,0.11218,1,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.046474,0.10594,0.10697,1,1
2,GO RNA CATABOLIC PROCESS,0.00013016,0.10582,0.11103,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00084997,0.10515,0.10603,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.01849,0.10507,0.11261,1,1
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.017699,0.10462,0.12758,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.048746,0.10456,0.1293,1,1
2,GO REGULATION OF ORGAN GROWTH,0.036048,0.10436,0.10331,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00019857,0.10417,0.12539,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.003166,0.10392,0.15327,1,1
2,GO DNA GEOMETRIC CHANGE,0.003654,0.10373,0.10512,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.00032408,0.1037,0.11743,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.013394,0.10369,0.12461,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00159,0.10364,0.11111,1,1
2,GO TRACHEA MORPHOGENESIS,0.036772,0.10339,0.11991,1,1
2,GO RESPONSE TO NITRIC OXIDE,0.058787,0.10311,0.073843,1,1
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.05063,0.10293,0.089969,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0021505,0.1029,0.095181,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0018764,0.10275,0.10552,1,1
2,GO RESPONSE TO ALCOHOL,0.021973,0.10269,0.089804,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0026663,0.10252,0.14468,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0090315,0.1021,0.10893,1,1
2,GO REGULATION OF LIPID STORAGE,0.045591,0.10209,0.10506,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.013243,0.10207,0.11111,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0099244,0.10175,0.12295,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.003654,0.10165,0.10569,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0098086,0.10136,0.09687,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.016386,0.10111,0.088601,1,1
2,GO RESPONSE TO ACTIVITY,0.014332,0.10065,0.093981,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0043184,0.10061,0.088762,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.034636,0.10007,0.11982,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0089251,0.099686,0.097901,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.023419,0.099444,0.14264,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0072795,0.099351,0.10174,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0005211,0.099142,0.11107,1,1
2,GO PROTEIN DESTABILIZATION,0.01849,0.099071,0.1067,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0029645,0.098871,0.095362,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.00028155,0.098572,0.11634,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.03006,0.098486,0.090302,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.038637,0.098481,0.11462,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.012087,0.098381,0.095785,1,1
2,GO NODAL SIGNALING PATHWAY,0.02128,0.098205,0.10671,1,1
2,GO RNA PROCESSING,0.00098255,0.098189,0.10926,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0034243,0.098128,0.11418,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.03429,0.097941,0.092989,1,1
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.056652,0.097889,0.088797,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0013826,0.097798,0.10116,1,1
2,GO MRNA 3 END PROCESSING,0.010895,0.097143,0.10092,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.01128,0.096567,0.10921,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00058763,0.096183,0.11155,1,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0012886,0.096123,0.11641,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.041789,0.096059,0.094413,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.056128,0.095851,0.091203,1,1
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.054074,0.095851,0.091675,1,1
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0024609,0.095835,0.098675,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.037139,0.095814,0.068607,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.001442,0.095801,0.10782,1,1
2,GO MULTIVESICULAR BODY ORGANIZATION,0.030994,0.095507,0.096172,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0076401,0.095374,0.083646,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0066039,0.095298,0.080156,1,1
2,GO RNA 3 END PROCESSING,0.010279,0.094921,0.088149,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0027747,0.094368,0.10418,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.013093,0.094199,0.099362,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0038478,0.094187,0.087244,1,1
2,GO CELLULAR RESPONSE TO RADIATION,0.015501,0.093963,0.091862,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00063314,0.093906,0.10759,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.043025,0.093855,0.084191,1,1
2,GO RNA LOCALIZATION,0.0022095,0.093387,0.10762,1,1
2,GO HORMONE METABOLIC PROCESS,0.042609,0.093302,0.078481,1,1
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0039992,0.092838,0.1642,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001704,0.092553,0.10252,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.0032501,0.092037,0.10976,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0059852,0.091616,0.11272,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0076401,0.091568,0.093508,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0020929,0.091336,0.10736,1,1
2,GO DNA MODIFICATION,0.0061347,0.091331,0.094589,1,1
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0016347,0.091036,0.14055,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00033432,0.090962,0.11559,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.03006,0.090679,0.080467,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.015501,0.09024,0.14076,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0071051,0.0901,0.080675,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.053071,0.090088,0.074802,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0019285,0.089914,0.10495,1,1
2,GO PIGMENT GRANULE LOCALIZATION,0.038258,0.088699,0.11476,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0044298,0.088605,0.088251,1,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.017315,0.088318,0.083292,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.026561,0.088219,0.076671,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.039406,0.087799,0.079332,1,1
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.052575,0.08756,0.097774,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0024941,0.087519,0.096286,1,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0069343,0.087402,0.09454,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.022686,0.08704,0.085872,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00099681,0.086512,0.10431,1,1
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0066039,0.08643,0.11365,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.017699,0.086246,0.085391,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.0022095,0.086045,0.090605,1,1
2,GO MRNA METABOLIC PROCESS,0.0024281,0.085985,0.090686,1,1
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.046474,0.085701,0.13559,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.003607,0.085207,0.084989,1,1
2,GO PROTEOLYSIS,0.035336,0.084417,0.075083,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.044292,0.084413,0.069012,1,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.018693,0.084318,0.12614,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.010895,0.084201,0.14612,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.019312,0.083731,0.12654,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0035605,0.083726,0.099312,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.01849,0.083148,0.091678,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.01128,0.083052,0.088584,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.040582,0.082925,0.082714,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.055093,0.082821,0.088437,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.03006,0.08276,0.070469,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.016568,0.082712,0.076595,1,1
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.026838,0.081637,0.090728,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.033271,0.081518,0.11062,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.054582,0.081228,0.077734,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0088198,0.08096,0.099636,1,1
2,GO HISTONE H3 ACETYLATION,0.0085105,0.080085,0.080785,1,1
2,GO APOPTOTIC PROCESS,0.047827,0.079846,0.072477,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0052197,0.079683,0.099399,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.01995,0.078919,0.096683,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.03429,0.078621,0.072034,1,1
2,GO CELL AGING,0.012798,0.077787,0.097313,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0023637,0.077424,0.10464,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.0084096,0.077273,0.075485,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0020646,0.076595,0.10494,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.027973,0.076343,0.074777,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.030994,0.07569,0.090047,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.013546,0.074808,0.13517,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.046031,0.074719,0.092964,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0013255,0.074538,0.10425,1,1
2,GO PROTEIN MONOUBIQUITINATION,0.023668,0.074256,0.066173,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.012945,0.073682,0.091684,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.051111,0.071267,0.066789,1,1
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.032607,0.071151,0.065737,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.041383,0.069726,0.071787,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0019285,0.069221,0.098428,1,1
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.040187,0.068915,0.11374,1,1
2,GO REGULATION OF ATP METABOLIC PROCESS,0.035691,0.068794,0.073385,1,1
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0063654,0.068589,0.081523,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0070192,0.068242,0.085155,1,1
2,GO CHROMATIN REMODELING,0.011411,0.068231,0.077212,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.019312,0.067772,0.077494,1,1
2,GO MRNA PROCESSING,0.038258,0.067588,0.071603,1,1
2,GO METHYLATION,0.010279,0.066418,0.075617,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.038258,0.065998,0.084246,1,1
2,GO MRNA TRANSPORT,0.0081133,0.065838,0.096035,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.059331,0.065801,0.069874,1,1
2,GO DNA METABOLIC PROCESS,0.024947,0.065778,0.059877,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0094686,0.065484,0.097142,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.016027,0.064742,0.10785,1,1
2,GO RESPONSE TO RADIATION,0.037139,0.064509,0.06469,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0044298,0.064496,0.089198,1,1
2,GO BLASTOCYST DEVELOPMENT,0.046474,0.064202,0.056497,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.059879,0.063875,0.059793,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.037509,0.063445,0.061854,1,1
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.061549,0.062847,0.077104,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.061549,0.06093,0.058373,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.0062108,0.060886,0.085027,1,1
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.039795,0.060524,0.074566,1,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.042197,0.060439,0.066787,1,1
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.046921,0.060386,0.087691,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.02174,0.059306,0.075285,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.009139,0.058584,0.069452,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.051595,0.057008,0.061888,1,1
2,GO ENDOSOME ORGANIZATION,0.046921,0.055639,0.080248,1,1
2,GO MITOCHONDRIAL TRANSPORT,0.058787,0.055451,0.064629,1,1
2,GO RNA SPLICING,0.043866,0.054956,0.071799,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.029754,0.054746,0.066713,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.036048,0.054287,0.081081,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.026561,0.053665,0.063701,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.03902,0.053321,0.055429,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.012798,0.050871,0.082054,1,1
2,GO MACROAUTOPHAGY,0.014332,0.049852,0.072909,1,1
2,GO DNA METHYLATION OR DEMETHYLATION,0.014332,0.047323,0.093427,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0061347,0.047048,0.078884,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.059331,0.043012,0.099767,1,1
2,GO NCRNA TRANSCRIPTION,0.054582,0.042752,0.065831,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.041383,0.04249,0.058373,1,1
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.058247,0.041574,0.074063,1,1
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.050154,0.033208,0.064611,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00017457,0.61584,0.45242,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.0016122,0.5074,0.35541,1,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0016347,0.47616,0.40126,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.000662,0.4738,0.37394,1,0
2,GO RESPONSE TO TYPE I INTERFERON,0.00047589,0.47163,0.33718,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00084997,0.46235,0.37434,1,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00033432,0.43317,0.37215,1,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00019229,0.42923,0.363,1,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00011033,0.42129,0.33815,1,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,4.1456e-06,0.40515,0.46449,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.7706e-05,0.37596,0.31938,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.8246e-05,0.36949,0.30563,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0037016,0.36885,0.272,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,2.5424e-05,0.36326,0.37205,1,0
2,GO BLEB ASSEMBLY,0.0061347,0.35521,0.32346,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,2.2015e-05,0.34799,0.31591,1,0
2,GO HEMIDESMOSOME ASSEMBLY,0.0062877,0.34368,0.37116,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.0051547,0.33652,0.25293,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.9056e-05,0.32978,0.29351,1,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0020929,0.32732,0.26086,1,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.00026858,0.32564,0.29822,1,0
2,GO HEME METABOLIC PROCESS,5.5864e-07,0.3249,0.29565,1,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.00062378,0.32392,0.2795,1,0
2,GO HYALURONAN CATABOLIC PROCESS,0.028852,0.32352,0.17186,1,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00012804,0.31875,0.37578,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0035605,0.31784,0.23799,1,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0045438,0.31647,0.30106,1,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,8.3013e-05,0.31424,0.30354,1,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00014129,0.31074,0.29724,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00011406,0.3093,0.24425,1,0
2,GO DENDRITIC CELL DIFFERENTIATION,0.0057669,0.30593,0.22038,1,0
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0021215,0.30461,0.30378,1,0
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00159,0.30124,0.20783,1,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0005211,0.30081,0.27566,1,0
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.010769,0.29689,0.26539,1,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,3.758e-05,0.2954,0.26437,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0011021,0.29446,0.25383,1,0
2,GO GERMINAL CENTER FORMATION,0.0066039,0.29399,0.22666,1,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.0032501,0.28479,0.2111,1,0
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.7693e-06,0.28434,0.29218,1,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.002631,0.283,0.24582,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00021511,0.28282,0.24223,1,0
2,GO CYTOLYSIS,0.0040509,0.28212,0.25605,1,0
2,GO CYSTEINE METABOLIC PROCESS,0.0015249,0.28046,0.25657,1,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0062108,0.27922,0.17205,1,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00082553,0.27889,0.30289,1,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0075485,0.27763,0.19181,1,0
2,GO DETECTION OF OTHER ORGANISM,0.0011341,0.27685,0.29417,1,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.035336,0.2764,0.16476,1,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0005618,0.2762,0.32615,1,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00013232,0.27571,0.26357,1,0
2,GO DETECTION OF BIOTIC STIMULUS,0.0010558,0.27406,0.28556,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.003607,0.27256,0.23725,1,0
2,GO ENTRY INTO HOST,0.00017176,0.27195,0.23737,1,0
2,GO PROTEIN ACTIVATION CASCADE,0.0027381,0.27119,0.1946,1,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.014332,0.27026,0.26868,1,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.003607,0.26967,0.24178,1,0
2,GO RENAL ABSORPTION,0.014332,0.26964,0.22492,1,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00019229,0.25623,0.22827,1,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.0028492,0.25551,0.20704,1,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0037016,0.25415,0.20647,1,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0023009,0.25376,0.21269,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0005133,0.25337,0.24205,1,0
2,GO REGULATION OF PLATELET ACTIVATION,0.002631,0.25331,0.2435,1,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0027747,0.25208,0.26092,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.03006,0.25163,0.20313,1,0
2,GO OSTEOBLAST DEVELOPMENT,3.5646e-05,0.24808,0.26619,1,0
2,GO PLASMINOGEN ACTIVATION,0.0023321,0.24663,0.23003,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0018256,0.24661,0.23046,1,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.00019541,0.24592,0.22504,1,0
2,GO APOPTOTIC CELL CLEARANCE,0.00018923,0.24559,0.22933,1,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0024609,0.2453,0.19548,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0033799,0.24414,0.20944,1,0
2,GO PINOCYTOSIS,0.00090088,0.2418,0.21309,1,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.00073415,0.24158,0.22318,1,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0007901,0.2408,0.27955,1,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.001568,0.23965,0.30111,1,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.00021511,0.23939,0.21095,1,0
2,GO HETEROTYPIC CELL CELL ADHESION,0.001071,0.2369,0.19162,1,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.00017176,0.23398,0.21736,1,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00033432,0.23294,0.20372,1,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.025743,0.23209,0.19438,1,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0070192,0.23194,0.22501,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.033948,0.22923,0.15189,1,0
2,GO REGULATION OF RECEPTOR BINDING,0.023173,0.22859,0.18879,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010673,0.22735,0.20428,1,0
2,GO CELL KILLING,4.1026e-05,0.22732,0.21952,1,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.020828,0.22324,0.19109,1,0
2,GO NADPH REGENERATION,0.00072342,0.22305,0.21048,1,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0024609,0.22265,0.2486,1,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00076726,0.22262,0.28201,1,0
2,GO TROPHOBLAST CELL MIGRATION,0.0039481,0.2225,0.18445,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00041488,0.22191,0.23577,1,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.003654,0.22186,0.18228,1,0
2,GO INTESTINAL ABSORPTION,0.0011021,0.2215,0.22813,1,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0011021,0.22146,0.21589,1,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0059116,0.2211,0.20504,1,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0037498,0.22049,0.18823,1,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0019819,0.22046,0.22316,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0043184,0.21981,0.17958,1,0
2,GO RESPONSE TO MANGANESE ION,0.00010852,0.21947,0.18858,1,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00062378,0.21894,0.21002,1,0
2,GO ZYMOGEN INHIBITION,0.00071283,0.21879,0.25652,1,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.022209,0.2165,0.17855,1,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.2015e-05,0.21588,0.23179,1,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00039018,0.21545,0.25652,1,0
2,GO CD40 SIGNALING PATHWAY,0.00046165,0.215,0.1889,1,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.024687,0.21476,0.19652,1,0
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.2954e-05,0.21465,0.29631,1,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0028492,0.21419,0.20743,1,0
2,GO DNA DEAMINATION,0.017315,0.21419,0.2064,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0066851,0.21337,0.2521,1,0
2,GO INTERLEUKIN 17 PRODUCTION,0.00023294,0.21296,0.23324,1,0
2,GO B CELL MEDIATED IMMUNITY,0.00019229,0.21291,0.23301,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.019523,0.2122,0.22711,1,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.00029511,0.21213,0.16841,1,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0049019,0.21084,0.18266,1,0
2,GO COLLAGEN METABOLIC PROCESS,0.025475,0.20927,0.138,1,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.00019857,0.20832,0.17673,1,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.012653,0.20777,0.2119,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0019285,0.20748,0.18057,1,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,2.1621e-05,0.2073,0.23085,1,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024819,0.20621,0.21145,1,0
2,GO OLIGOPEPTIDE TRANSPORT,0.023668,0.20569,0.17168,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00022927,0.20509,0.20859,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00029052,0.20399,0.21669,1,0
2,GO ENDODERM FORMATION,0.035336,0.2033,0.16647,1,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0030839,0.20265,0.16432,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0010408,0.20255,0.19949,1,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.001442,0.20226,0.18951,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.010645,0.20177,0.1865,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.00029511,0.20115,0.20213,1,0
2,GO STEROL HOMEOSTASIS,0.00026438,0.20079,0.20629,1,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0056255,0.20026,0.16227,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00040857,0.20021,0.18813,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00011033,0.19993,0.20593,1,0
2,GO NUCLEOTIDE SALVAGE,0.020605,0.19914,0.13802,1,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.018693,0.19912,0.16667,1,0
2,GO INTERLEUKIN 5 PRODUCTION,0.0049019,0.19871,0.2564,1,0
2,GO ENDODERM DEVELOPMENT,0.030994,0.19771,0.15789,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00013016,0.19723,0.22882,1,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.9694e-05,0.19577,0.21045,1,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.001704,0.1955,0.14664,1,0
2,GO RESPONSE TO THYROID HORMONE,0.011949,0.19548,0.18251,1,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0016575,0.19528,0.18001,1,0
2,GO VIRAL TRANSLATION,0.00022927,0.19479,0.20278,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0061347,0.19445,0.19946,1,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00082553,0.19413,0.17545,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.019312,0.19383,0.12652,1,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.020385,0.19367,0.29217,1,0
2,GO VASCULOGENESIS,0.026286,0.19352,0.14387,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.000662,0.19345,0.21292,1,0
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.003607,0.19318,0.18253,1,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0028492,0.19312,0.19943,1,0
2,GO GLUTATHIONE METABOLIC PROCESS,5.332e-06,0.18956,0.24207,1,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.031953,0.18916,0.16955,1,0
2,GO CELLULAR DEFENSE RESPONSE,0.003607,0.18884,0.16052,1,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.000662,0.18783,0.17855,1,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0071918,0.18767,0.21644,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00031414,0.18732,0.17912,1,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,1.9563e-06,0.18721,0.23779,1,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.026013,0.18666,0.14309,1,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.011678,0.18608,0.1456,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0022396,0.18505,0.17678,1,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.028852,0.18481,0.15719,1,0
2,GO IMMUNE EFFECTOR PROCESS,0.00013899,0.18436,0.19285,1,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.00045468,0.18406,0.18822,1,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.038258,0.18388,0.24977,1,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.048285,0.18384,0.1645,1,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.014494,0.18383,0.20697,1,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.060432,0.18382,0.1314,1,0
2,GO CELL AGGREGATION,0.00017457,0.18374,0.24182,1,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00014362,0.18339,0.27467,1,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.02174,0.18301,0.15021,1,0
2,GO ARTERY DEVELOPMENT,0.032607,0.18274,0.14744,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00069207,0.18274,0.19265,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0005056,0.18251,0.19204,1,0
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00046872,0.18237,0.22673,1,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.043866,0.18226,0.13557,1,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.017506,0.18178,0.21153,1,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00159,0.1817,0.26628,1,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00084997,0.1811,0.18247,1,0
2,GO MYOBLAST FUSION,0.010041,0.18108,0.1697,1,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0019285,0.18096,0.17702,1,0
2,GO PROTEASOME ASSEMBLY,0.001568,0.1807,0.14479,1,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.050154,0.18047,0.12217,1,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.000286,0.17954,0.18693,1,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.036409,0.17907,0.17023,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00099681,0.17881,0.17064,1,0
2,GO TRNA 5 LEADER REMOVAL,0.00016098,0.17866,0.16733,1,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.022446,0.17857,0.13781,1,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0046604,0.17856,0.17796,1,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.049212,0.17814,0.17877,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.00012186,0.178,0.19332,1,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.015159,0.1778,0.19797,1,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00060545,0.17715,0.17991,1,0
2,GO COPPER ION TRANSPORT,0.00027284,0.17628,0.20526,1,0
2,GO REGULATION OF DEFENSE RESPONSE,9.3381e-05,0.17626,0.17369,1,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0028872,0.17605,0.17926,1,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00073415,0.17573,0.17488,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.018091,0.17552,0.14503,1,0
2,GO MATURATION OF LSU RRNA,0.00039622,0.17519,0.20605,1,0
2,GO DEFENSE RESPONSE,0.00069207,0.17515,0.1556,1,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00032408,0.17447,0.24231,1,0
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00010152,0.17446,0.1997,1,0
2,GO COMPLEMENT ACTIVATION,0.0089251,0.17422,0.16461,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0044298,0.17422,0.18354,1,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.035336,0.17399,0.1246,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0090315,0.17359,0.15556,1,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.036409,0.17347,0.24099,1,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.019104,0.17317,0.14417,1,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.004156,0.173,0.14554,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.042609,0.17288,0.14794,1,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.012653,0.17288,0.13193,1,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.047372,0.17263,0.24079,1,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.016752,0.1719,0.14298,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.016386,0.17186,0.18606,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0060595,0.1717,0.16831,1,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.036772,0.17166,0.16611,1,0
2,GO TONGUE DEVELOPMENT,0.0066851,0.17129,0.2033,1,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.046474,0.17117,0.21822,1,0
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.00099681,0.17091,0.23106,1,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00029511,0.17043,0.16587,1,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.054582,0.1702,0.11316,1,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00038422,0.17012,0.23659,1,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0030436,0.17003,0.20938,1,0
2,GO AMYLOID BETA CLEARANCE,0.00058763,0.16877,0.19694,1,0
2,GO RESPONSE TO CADMIUM ION,0.0010259,0.16845,0.20194,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.021053,0.16837,0.19939,1,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.03006,0.16793,0.13844,1,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.0028118,0.16775,0.17313,1,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00083767,0.16754,0.15863,1,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.029754,0.16713,0.19691,1,0
2,GO CELL CHEMOTAXIS,0.0018764,0.16652,0.15573,1,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.00049053,0.16603,0.17907,1,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.0137,0.16564,0.2038,1,0
2,GO T CELL MIGRATION,0.018693,0.16537,0.14768,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0018508,0.16528,0.20154,1,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.034636,0.16527,0.15429,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0022095,0.16514,0.21998,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0020646,0.16428,0.15498,1,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0001179,0.164,0.19141,1,0
2,GO PROTEIN HYDROXYLATION,0.027118,0.16357,0.12257,1,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.058787,0.16356,0.10097,1,0
2,GO GLOMERULUS DEVELOPMENT,0.0094686,0.16343,0.20063,1,0
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00080175,0.16332,0.18593,1,0
2,GO MATURATION OF SSU RRNA,0.00010673,0.16323,0.20235,1,0
2,GO EMBRYO IMPLANTATION,0.008211,0.16308,0.15284,1,0
2,GO NATURAL KILLER CELL ACTIVATION,0.032607,0.16305,0.12767,1,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.030994,0.16293,0.19393,1,0
2,GO INTERLEUKIN 12 PRODUCTION,0.0027381,0.16237,0.18293,1,0
2,GO POSITIVE REGULATION OF CELL AGING,0.01849,0.16222,0.11884,1,0
2,GO CELL REDOX HOMEOSTASIS,1.6158e-05,0.16212,0.18585,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.000286,0.16194,0.16279,1,0
2,GO SERTOLI CELL DIFFERENTIATION,0.0013826,0.16184,0.21644,1,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.0084096,0.16169,0.13029,1,0
2,GO REGULATION OF WOUND HEALING,0.03429,0.16146,0.12979,1,0
2,GO STEROID ESTERIFICATION,0.037509,0.16142,0.11937,1,0
2,GO RIBOSOME BIOGENESIS,3.094e-05,0.16132,0.1738,1,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.001118,0.1608,0.15357,1,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.022446,0.16055,0.24107,1,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.010041,0.15997,0.15142,1,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.040582,0.1595,0.11674,1,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.0028492,0.1594,0.15799,1,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0051547,0.15931,0.14162,1,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0042636,0.15916,0.17598,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.006444,0.15896,0.16354,1,0
2,GO NCRNA PROCESSING,5.7059e-05,0.15838,0.15985,1,0
2,GO ERK1 AND ERK2 CASCADE,0.0015038,0.1582,0.15055,1,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0020929,0.1581,0.17847,1,0
2,GO STORE OPERATED CALCIUM ENTRY,0.0059852,0.15771,0.15525,1,0
2,GO POSITIVE REGULATION OF TRANSLATION,1.2716e-05,0.1571,0.15377,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00026858,0.15705,0.1966,1,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.055093,0.15642,0.093757,1,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.027686,0.15578,0.10443,1,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,6.8888e-05,0.15552,0.15889,1,0
2,GO METANEPHROS DEVELOPMENT,0.0034692,0.15535,0.16427,1,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.003654,0.15531,0.13404,1,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.010895,0.15523,0.25664,1,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.060432,0.15474,0.12001,1,0
2,GO PHAGOCYTOSIS,0.00012388,0.15427,0.20825,1,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.023919,0.1542,0.20494,1,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.051595,0.1542,0.14024,1,0
2,GO MATURATION OF 5 8S RRNA,0.00071283,0.15372,0.18326,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.061549,0.15367,0.15776,1,0
2,GO IRON ION HOMEOSTASIS,0.00033955,0.15354,0.15909,1,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0005211,0.15346,0.16048,1,0
2,GO RESPONSE TO DEXAMETHASONE,0.023173,0.15338,0.13907,1,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0094686,0.15272,0.14749,1,0
2,GO REGULATION OF ODONTOGENESIS,0.032278,0.15262,0.10709,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0005133,0.15251,0.17763,1,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.022209,0.15204,0.13947,1,0
2,GO CELLULAR RESPONSE TO DSRNA,0.0104,0.15204,0.15037,1,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.036772,0.15113,0.13577,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0011503,0.15112,0.1466,1,0
2,GO FATTY ACID BETA OXIDATION,0.0067673,0.15098,0.10646,1,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.038637,0.1505,0.12968,1,0
2,GO RECEPTOR CATABOLIC PROCESS,0.0025617,0.15039,0.18523,1,0
2,GO AUTOPHAGY OF NUCLEUS,0.05063,0.15028,0.10184,1,0
2,GO HUMORAL IMMUNE RESPONSE,0.00080175,0.15022,0.15751,1,0
2,GO RNA METHYLATION,0.00025215,0.15013,0.15243,1,0
2,GO WOUND HEALING,0.026013,0.15008,0.1269,1,0
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0094686,0.14995,0.17369,1,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.040981,0.14995,0.14354,1,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.037882,0.14878,0.1196,1,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.03006,0.14826,0.10995,1,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.033948,0.14807,0.11724,1,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.00012186,0.14798,0.15481,1,0
2,GO NCRNA METABOLIC PROCESS,0.00011406,0.14768,0.14483,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0043737,0.14755,0.13766,1,0
2,GO LEUKOCYTE CHEMOTAXIS,0.001442,0.14725,0.15972,1,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0020646,0.14714,0.13451,1,0
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00094089,0.14708,0.15279,1,0
2,GO RNA 5 END PROCESSING,0.00059648,0.14695,0.15122,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.016386,0.14653,0.17757,1,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0083098,0.14631,0.14824,1,0
2,GO CYTOKINE SECRETION,0.014172,0.14611,0.12208,1,0
2,GO RRNA METABOLIC PROCESS,6.545e-05,0.1461,0.16236,1,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.014494,0.14558,0.13319,1,0
2,GO RNA MODIFICATION,7.0072e-05,0.1455,0.1503,1,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.9694e-05,0.1454,0.14562,1,0
2,GO TRNA MODIFICATION,0.0014022,0.14515,0.13155,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.010041,0.14414,0.22362,1,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,7.0072e-05,0.14405,0.16365,1,0
2,GO VIRAL GENE EXPRESSION,0.00062378,0.1438,0.13672,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00043435,0.14356,0.15885,1,0
2,GO REGULATION OF PHAGOCYTOSIS,0.00042777,0.14344,0.20395,1,0
2,GO INTERLEUKIN 4 PRODUCTION,0.0024609,0.14342,0.16758,1,0
2,GO AORTA MORPHOGENESIS,0.035691,0.14342,0.14772,1,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.0073682,0.14337,0.18059,1,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.014658,0.14305,0.12474,1,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00031414,0.14234,0.16121,1,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0083098,0.14199,0.13184,1,0
2,GO REGULATION OF STEROL TRANSPORT,0.013243,0.14196,0.16125,1,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.058787,0.1419,0.098843,1,0
2,GO INFLAMMATORY RESPONSE,0.004156,0.14174,0.13692,1,0
2,GO CELL ACTIVATION,0.00046872,0.14172,0.15938,1,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.013394,0.14139,0.12928,1,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00063314,0.1413,0.1401,1,0
2,GO NECROTIC CELL DEATH,0.0027747,0.14099,0.15515,1,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0003557,0.14094,0.19881,1,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.022928,0.14073,0.15828,1,0
2,GO TRNA METHYLATION,0.0016806,0.14069,0.15943,1,0
2,GO RESPONSE TO FATTY ACID,0.034636,0.14025,0.099031,1,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0028872,0.13989,0.13664,1,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.043025,0.13954,0.12012,1,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.2497e-05,0.13946,0.13746,1,0
2,GO POSITIVE CHEMOTAXIS,0.0073682,0.13941,0.13696,1,0
2,GO NUCLEAR MIGRATION,0.021973,0.13931,0.12994,1,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.0071051,0.13923,0.12076,1,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.029754,0.13903,0.12042,1,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00046872,0.13864,0.18497,1,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.012945,0.13824,0.14685,1,0
2,GO NUCLEUS LOCALIZATION,0.024173,0.13786,0.12087,1,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.002631,0.13758,0.14839,1,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00046165,0.13751,0.19895,1,0
2,GO LIVER REGENERATION,0.0029645,0.13734,0.14138,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0063654,0.13635,0.27751,1,0
2,GO RIBOSOME ASSEMBLY,0.0013255,0.13594,0.13848,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.011151,0.13573,0.13432,1,0
2,GO INTERLEUKIN 6 PRODUCTION,0.0092477,0.13531,0.14345,1,0
2,GO REGULATION OF MYOBLAST FUSION,0.031311,0.13445,0.14796,1,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00010323,0.13424,0.1907,1,0
2,GO RENAL TUBULE DEVELOPMENT,0.032278,0.13369,0.13099,1,0
2,GO NUCLEOBASE METABOLIC PROCESS,2.0853e-05,0.13346,0.16091,1,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0013069,0.13346,0.18436,1,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001442,0.13321,0.14044,1,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.009139,0.1332,0.12251,1,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.02915,0.13318,0.11208,1,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.035691,0.13315,0.13594,1,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0028118,0.13314,0.12416,1,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.010522,0.13297,0.15005,1,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0005789,0.13288,0.18183,1,0
2,GO DEFENSE RESPONSE TO BACTERIUM,0.00076726,0.13279,0.16605,1,0
2,GO TRANSITION METAL ION HOMEOSTASIS,8.1623e-05,0.13201,0.16579,1,0
2,GO TRNA 5 END PROCESSING,0.0050904,0.13179,0.11722,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00055343,0.13152,0.18541,1,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.0023009,0.13146,0.1211,1,0
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0027381,0.13133,0.16787,1,0
2,GO MAST CELL ACTIVATION,0.042197,0.1309,0.13085,1,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.046921,0.13042,0.10815,1,0
2,GO NEPHRON DEVELOPMENT,0.021973,0.13041,0.13512,1,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.034984,0.13031,0.11757,1,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.013243,0.13015,0.11449,1,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.017699,0.12973,0.12749,1,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.035691,0.12937,0.12055,1,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.017506,0.12888,0.15431,1,0
2,GO TELOMERASE RNA LOCALIZATION,0.0022701,0.12838,0.15442,1,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.0067673,0.12836,0.1938,1,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.013093,0.12799,0.11887,1,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.011949,0.1278,0.15102,1,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0018508,0.12749,0.16045,1,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.033948,0.12707,0.096057,1,0
2,GO MITOCHONDRIAL TRANSLATION,0.00059648,0.12639,0.14591,1,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.031953,0.12619,0.10607,1,0
2,GO VIRAL RNA GENOME REPLICATION,0.026838,0.12612,0.12008,1,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0052854,0.12611,0.16062,1,0
2,GO PLATELET ACTIVATION,0.0071051,0.1259,0.14544,1,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0028872,0.12552,0.15851,1,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.027401,0.1248,0.1336,1,0
2,GO ANIMAL ORGAN REGENERATION,0.0095807,0.12454,0.1117,1,0
2,GO PROGRAMMED NECROTIC CELL DEATH,0.014494,0.12447,0.14095,1,0
2,GO MYELOID CELL DEVELOPMENT,0.014332,0.12431,0.14288,1,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.046921,0.12394,0.11983,1,0
2,GO POLYAMINE METABOLIC PROCESS,0.0072795,0.12394,0.12018,1,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.00026438,0.12389,0.1369,1,0
2,GO AUTOPHAGOSOME MATURATION,0.034636,0.12381,0.092078,1,0
2,GO GDP METABOLIC PROCESS,0.052083,0.12374,0.12922,1,0
2,GO CELL CELL ADHESION,0.041789,0.12366,0.098365,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.0053519,0.12328,0.11055,1,0
2,GO O GLYCAN PROCESSING,0.022446,0.12314,0.14226,1,0
2,GO VESICLE TARGETING,0.0051547,0.12205,0.1178,1,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.01499,0.12204,0.10756,1,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.013546,0.12177,0.12539,1,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0095807,0.12165,0.16142,1,0
2,GO RESPONSE TO DSRNA,0.010769,0.12157,0.13226,1,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00057029,0.12143,0.14321,1,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.03429,0.1214,0.10282,1,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.00031907,0.12128,0.14265,1,0
2,GO LIPID LOCALIZATION,0.014494,0.121,0.10277,1,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.021509,0.12098,0.094142,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.014172,0.12013,0.095165,1,0
2,GO LEUKOCYTE MIGRATION,0.014013,0.1201,0.12695,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010279,0.12006,0.12151,1,0
2,GO RESPONSE TO HYPEROXIA,0.058247,0.11976,0.12639,1,0
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0023321,0.1197,0.11797,1,0
2,GO NEUTROPHIL CHEMOTAXIS,0.0025617,0.11942,0.14379,1,0
2,GO CHOLESTEROL STORAGE,0.011813,0.11895,0.20479,1,0
2,GO SNRNA PROCESSING,0.0022396,0.11882,0.07832,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0039992,0.11867,0.16614,1,0
2,GO MACROPHAGE DIFFERENTIATION,0.0038977,0.11784,0.16246,1,0
2,GO NEUTROPHIL MIGRATION,0.0044298,0.11784,0.14241,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.002631,0.11717,0.12467,1,0
2,GO ENDOCRINE PROCESS,0.012087,0.11704,0.11654,1,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.057179,0.11667,0.10454,1,0
2,GO RRNA TRANSCRIPTION,0.0016347,0.11659,0.16543,1,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.029754,0.11618,0.10156,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0137,0.11613,0.1114,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0024941,0.1161,0.14545,1,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0051547,0.11604,0.11108,1,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.019735,0.116,0.20186,1,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.01995,0.1159,0.10166,1,0
2,GO GENITALIA MORPHOGENESIS,0.036772,0.11588,0.14112,1,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.033271,0.11547,0.14699,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.055609,0.11533,0.1167,1,0
2,GO MYOBLAST PROLIFERATION,0.043025,0.11513,0.12302,1,0
2,GO COAGULATION,0.030368,0.1151,0.11172,1,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0016806,0.11508,0.11039,1,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.059879,0.11487,0.17916,1,0
2,GO REGULATION OF NECROTIC CELL DEATH,0.002631,0.11404,0.16563,1,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.01849,0.11379,0.18296,1,0
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0066039,0.11343,0.12247,1,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.023173,0.11342,0.096939,1,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.030994,0.11336,0.12868,1,0
2,GO EPIDERMIS MORPHOGENESIS,0.028556,0.11334,0.20772,1,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0047798,0.11319,0.14054,1,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0029645,0.11237,0.17269,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0011341,0.11231,0.18649,1,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.053071,0.1122,0.10125,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.036409,0.11203,0.081129,1,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.058247,0.11197,0.085904,1,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.012227,0.11162,0.14745,1,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.043444,0.11085,0.15907,1,0
2,GO RESPONSE TO CORTICOSTEROID,0.019312,0.11081,0.11125,1,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.030368,0.11081,0.13323,1,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0028872,0.11078,0.17315,1,0
2,GO CELLULAR EXTRAVASATION,0.0035605,0.11076,0.14949,1,0
2,GO LYMPHOCYTE MIGRATION,0.060432,0.11073,0.1054,1,0
2,GO COPPER ION HOMEOSTASIS,0.0098086,0.11068,0.1362,1,0
2,GO TRANSEPITHELIAL TRANSPORT,0.0075485,0.11035,0.13121,1,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0014624,0.10971,0.13188,1,0
2,GO VIRAL LATENCY,0.040187,0.10941,0.094432,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0033799,0.10927,0.12558,1,0
2,GO VIRAL RELEASE FROM HOST CELL,0.0018508,0.10874,0.13945,1,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.01995,0.10862,0.14201,1,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.050154,0.10781,0.081008,1,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.050154,0.10678,0.09771,1,0
2,GO PEPTIDE CATABOLIC PROCESS,0.0085105,0.10606,0.1475,1,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.032607,0.10552,0.13259,1,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.014823,0.10548,0.12543,1,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.013093,0.10542,0.096398,1,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.034636,0.10521,0.15158,1,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.060432,0.10506,0.091146,1,0
2,GO BODY FLUID SECRETION,0.0016806,0.10502,0.13445,1,0
2,GO RESPONSE TO OSMOTIC STRESS,0.0044864,0.105,0.12125,1,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.021053,0.10492,0.11661,1,0
2,GO CELLULAR RESPONSE TO X RAY,0.056652,0.10477,0.14941,1,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.017699,0.10443,0.1275,1,0
2,GO CELL SUBSTRATE ADHESION,0.048285,0.10433,0.12662,1,0
2,GO REGULATION OF BODY FLUID LEVELS,0.049681,0.1036,0.092921,1,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.012653,0.10351,0.1355,1,0
2,GO RESPONSE TO ISCHEMIA,0.027401,0.10344,0.11661,1,0
2,GO TRANSLATIONAL TERMINATION,0.002631,0.10283,0.12598,1,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.02521,0.10223,0.12443,1,0
2,GO HISTONE PHOSPHORYLATION,0.021509,0.1022,0.085404,1,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.0096941,0.1019,0.1199,1,0
2,GO SELECTIVE AUTOPHAGY,0.012653,0.10189,0.10607,1,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.01829,0.1018,0.25614,1,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00036686,0.10152,0.10177,1,0
2,GO NAD METABOLIC PROCESS,0.030368,0.10138,0.12656,1,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.027686,0.10062,0.10053,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.014172,0.099604,0.14013,1,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.056652,0.099461,0.10692,1,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0074579,0.099219,0.12972,1,0
2,GO VIRION ASSEMBLY,0.01128,0.098948,0.10014,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.011949,0.09885,0.095336,1,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.019735,0.09883,0.090127,1,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.02945,0.098773,0.11464,1,0
2,GO REGENERATION,0.029754,0.098313,0.10401,1,0
2,GO SNORNA METABOLIC PROCESS,0.047372,0.098057,0.078726,1,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.024173,0.097928,0.11181,1,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0062108,0.097422,0.13805,1,0
2,GO STRESS GRANULE ASSEMBLY,0.051111,0.097222,0.089218,1,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.020605,0.097153,0.13822,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0089251,0.096715,0.187,1,0
2,GO PROGESTERONE METABOLIC PROCESS,0.050154,0.096679,0.1703,1,0
2,GO SNRNA METABOLIC PROCESS,0.0054192,0.096203,0.067839,1,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.0052197,0.095347,0.11208,1,0
2,GO PEPTIDE METABOLIC PROCESS,0.00049053,0.095088,0.093806,1,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0093576,0.094815,0.099298,1,0
2,GO RESPONSE TO VITAMIN,0.056128,0.094527,0.1172,1,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.040187,0.094368,0.14492,1,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.0084096,0.093977,0.18907,1,0
2,GO PEROXISOMAL TRANSPORT,0.0025961,0.09281,0.11279,1,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0035146,0.092671,0.1005,1,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.033608,0.092489,0.07998,1,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.056652,0.092428,0.085233,1,0
2,GO PLATELET AGGREGATION,0.0093576,0.092272,0.17058,1,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.031953,0.092155,0.11504,1,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.038637,0.091892,0.12715,1,0
2,GO PEROXISOME ORGANIZATION,0.0023957,0.091522,0.10657,1,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.023173,0.091366,0.15388,1,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.001442,0.091055,0.10069,1,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00042777,0.09087,0.10012,1,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.042609,0.090865,0.078789,1,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.057711,0.090259,0.097283,1,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.014494,0.090099,0.20105,1,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.01585,0.089837,0.10398,1,0
2,GO CYTOKINETIC PROCESS,0.048285,0.08977,0.095851,1,0
2,GO ESTROGEN METABOLIC PROCESS,0.037882,0.089671,0.11009,1,0
2,GO TRANSLATIONAL INITIATION,0.023668,0.089408,0.086896,1,0
2,GO NCRNA 3 END PROCESSING,0.046921,0.089283,0.04852,1,0
2,GO GLIAL CELL ACTIVATION,0.025743,0.088883,0.12326,1,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.049212,0.088824,0.11201,1,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.03429,0.088475,0.086411,1,0
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.043444,0.088474,0.072354,1,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.017894,0.087202,0.13074,1,0
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0034243,0.087093,0.098398,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0018508,0.086932,0.12413,1,0
2,GO RNA SURVEILLANCE,0.016386,0.086588,0.10252,1,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.024947,0.086444,0.085509,1,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.033271,0.086365,0.10124,1,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.011813,0.085785,0.11371,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.047372,0.085633,0.11589,1,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0083098,0.085531,0.0808,1,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.011678,0.084568,0.13419,1,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.037509,0.084239,0.14421,1,0
2,GO AEROBIC RESPIRATION,0.00092737,0.084154,0.1357,1,0
2,GO CELLULAR RESPONSE TO STEROL,0.017506,0.083719,0.15248,1,0
2,GO BLASTOCYST GROWTH,0.026838,0.083185,0.10068,1,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.044292,0.083024,0.097483,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.035691,0.082602,0.10055,1,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00052901,0.082592,0.089853,1,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.012087,0.082486,0.11971,1,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.036409,0.082154,0.10553,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.017894,0.081839,0.081749,1,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.00026438,0.080225,0.10187,1,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.048285,0.079926,0.12655,1,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0099244,0.079904,0.11763,1,0
2,GO CELLULAR RESPONSE TO IRON ION,0.012798,0.079842,0.1858,1,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.059331,0.079587,0.076735,1,0
2,GO DNA LIGATION,0.0058389,0.079347,0.14557,1,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0085105,0.079324,0.12612,1,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.060988,0.078914,0.059327,1,0
2,GO PROTEIN MATURATION,0.051111,0.078314,0.077092,1,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.050154,0.078265,0.15486,1,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.041383,0.0782,0.10111,1,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.050154,0.078051,0.11833,1,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.040582,0.077653,0.11311,1,0
2,GO REGULATION OF PROTEIN STABILITY,0.0070192,0.077546,0.087377,1,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.055609,0.07718,0.068395,1,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.028852,0.076387,0.11094,1,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.033271,0.076354,0.1519,1,0
2,GO RNA STABILIZATION,0.058247,0.076053,0.075097,1,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.055093,0.075804,0.091039,1,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.012798,0.075138,0.10007,1,0
2,GO NEPHRON MORPHOGENESIS,0.044292,0.074847,0.095643,1,0
2,GO NUCLEAR TRANSPORT,0.0066039,0.074839,0.092182,1,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0034243,0.07444,0.09135,1,0
2,GO MEMBRANE INVAGINATION,0.023173,0.073575,0.12847,1,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0021505,0.073383,0.078887,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.045591,0.072744,0.094886,1,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.037139,0.072057,0.08824,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.013093,0.071513,0.089536,1,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0067673,0.071108,0.13063,1,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.016568,0.071046,0.098905,1,0
2,GO NUCLEAR EXPORT,0.0025617,0.070847,0.11103,1,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.032938,0.07076,0.14089,1,0
2,GO RESPONSE TO STEROL,0.05357,0.070716,0.11725,1,0
2,GO LIPID EXPORT FROM CELL,0.028264,0.070203,0.09991,1,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.027118,0.070111,0.076278,1,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.010522,0.068201,0.072634,1,0
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.014332,0.068148,0.13609,1,0
2,GO REGULATION OF T CELL MIGRATION,0.033271,0.06811,0.11485,1,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.023173,0.067388,0.30718,1,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.022446,0.067168,0.069307,1,0
2,GO NEGATIVE REGULATION OF SECRETION,0.039795,0.067121,0.072719,1,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.024428,0.0669,0.10413,1,0
2,GO EAR MORPHOGENESIS,0.050154,0.066214,0.081386,1,0
2,GO PROTEIN CATABOLIC PROCESS,0.045591,0.066058,0.064194,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.037509,0.06461,0.13286,1,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.052575,0.064525,0.13391,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.016027,0.06396,0.10414,1,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0058389,0.062876,0.073995,1,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.033271,0.06174,0.073355,1,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0092477,0.0616,0.12592,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.052083,0.061379,0.061504,1,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.053071,0.060644,0.093514,1,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.021053,0.060084,0.10644,1,0
2,GO CELLULAR RESPIRATION,0.022446,0.05997,0.087495,1,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.014013,0.059582,0.14124,1,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.03006,0.05869,0.11404,1,0
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.028264,0.058009,0.10687,1,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.048746,0.05731,0.13304,1,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.02174,0.057061,0.066856,1,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.024687,0.056659,0.069258,1,0
2,GO CELLULAR RESPONSE TO HEAT,0.042609,0.054888,0.090234,1,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.047372,0.054798,0.064436,1,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.026013,0.053382,0.11032,1,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.032938,0.053124,0.10974,1,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.018693,0.052853,0.099534,1,0
2,GO POLYOL METABOLIC PROCESS,0.0090315,0.05283,0.10559,1,0
2,GO TRANSLATIONAL ELONGATION,0.044722,0.052477,0.078453,1,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.047827,0.051425,0.055007,1,0
2,GO ERAD PATHWAY,0.056128,0.049416,0.079837,1,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.055609,0.049369,0.07538,1,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.010769,0.04934,0.12826,1,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.060988,0.048904,0.067911,1,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0137,0.048577,0.087745,1,0
2,GO RESPONSE TO HEAT,0.019735,0.045879,0.093938,1,0
2,GO ELECTRON TRANSPORT CHAIN,0.022686,0.045751,0.081276,1,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.043866,0.044453,0.083418,1,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.049681,0.042271,0.11018,1,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.05063,0.04134,0.072542,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.042197,0.032429,0.054925,1,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.039406,0.032351,0.075626,1,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.02521,-0.038139,-0.073552,1,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.057711,-0.045843,-0.055047,1,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.034984,-0.050774,-0.074829,1,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.038637,-0.052128,-0.065316,1,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.056128,-0.052512,-0.06514,1,0
2,GO REGULATION OF CELL DEVELOPMENT,0.050154,-0.053252,-0.054836,1,0
2,GO CELL PROJECTION ORGANIZATION,0.023668,-0.055857,-0.06287,1,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.046921,-0.057662,-0.049754,1,0
2,GO AXON EXTENSION,0.038258,-0.058181,-0.088482,1,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.015674,-0.058304,-0.072777,1,0
2,GO CIRCADIAN RHYTHM,0.032607,-0.05898,-0.04877,1,0
2,GO ION TRANSPORT,0.042197,-0.060306,-0.041389,1,0
2,GO HINDBRAIN MORPHOGENESIS,0.026286,-0.061589,-0.091227,1,0
2,GO RESPONSE TO COLD,0.060988,-0.061824,-0.090604,1,0
2,GO CELL MATURATION,0.016027,-0.063476,-0.072825,1,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.047827,-0.064172,-0.068451,1,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.032607,-0.064254,-0.066857,1,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.048746,-0.065005,-0.060324,1,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.040981,-0.065317,-0.065787,1,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.017894,-0.067335,-0.11515,1,0
2,GO MICROTUBULE BASED PROCESS,0.023173,-0.067363,-0.061964,1,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0081133,-0.067805,-0.074203,1,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.026838,-0.068127,-0.10578,1,0
2,GO REGULATION OF NEURON MIGRATION,0.056128,-0.069778,-0.11553,1,0
2,GO REGULATION OF GLUCOSE IMPORT,0.022209,-0.07029,-0.074606,1,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.036048,-0.073007,-0.069608,1,0
2,GO AXON DEVELOPMENT,0.01128,-0.074117,-0.10327,1,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.05357,-0.074453,-0.042134,1,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.003654,-0.074622,-0.11626,1,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.061549,-0.07496,-0.060749,1,0
2,GO REGULATION OF LYASE ACTIVITY,0.046474,-0.075952,-0.085187,1,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.028852,-0.076072,-0.063112,1,0
2,GO NEUROGENESIS,0.0068504,-0.076148,-0.080313,1,0
2,GO REGULATION OF HORMONE LEVELS,0.043444,-0.076214,-0.057504,1,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0066039,-0.076407,-0.099798,1,0
2,GO RESPONSE TO MONOSACCHARIDE,0.034984,-0.07669,-0.052105,1,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.02915,-0.077322,-0.13812,1,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.0049019,-0.077688,-0.098957,1,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.058247,-0.078455,-0.073485,1,0
2,GO SENSORY PERCEPTION OF SMELL,0.02128,-0.078946,-0.10537,1,0
2,GO SPERMATID DIFFERENTIATION,0.031953,-0.078968,-0.078548,1,0
2,GO HEART PROCESS,0.027118,-0.079071,-0.061695,1,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.025475,-0.080089,-0.084159,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.011022,-0.080573,-0.075333,1,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.051111,-0.080833,-0.082279,1,0
2,GO MICROTUBULE BASED TRANSPORT,0.0071051,-0.081445,-0.087273,1,0
2,GO GERM CELL DEVELOPMENT,0.010769,-0.081654,-0.079294,1,0
2,GO CELL CELL SIGNALING,0.001442,-0.081668,-0.084438,1,0
2,GO PROTEIN DEPOLYMERIZATION,0.033948,-0.081728,-0.058937,1,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.040187,-0.081766,-0.072208,1,0
2,GO REGULATION OF ANION TRANSPORT,0.044722,-0.082122,-0.066196,1,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.023919,-0.082426,-0.084241,1,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.01585,-0.082727,-0.075193,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.013243,-0.082924,-0.11421,1,0
2,GO ENERGY HOMEOSTASIS,0.043866,-0.083358,-0.093506,1,0
2,GO REGULATION OF BLOOD CIRCULATION,0.01016,-0.083502,-0.078117,1,0
2,GO MATING,0.028852,-0.083526,-0.080767,1,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.0062877,-0.083569,-0.068663,1,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.024947,-0.083788,-0.081988,1,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.039795,-0.084285,-0.043322,1,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.060432,-0.084498,-0.10733,1,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.059879,-0.085275,-0.085533,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.015159,-0.085797,-0.083519,1,0
2,GO RESPONSE TO ALKALOID,0.0018508,-0.085879,-0.10489,1,0
2,GO METAL ION TRANSPORT,0.0095807,-0.087451,-0.061835,1,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.0028118,-0.087792,-0.06803,1,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0013826,-0.087903,-0.09793,1,0
2,GO NEURON PROJECTION GUIDANCE,0.030368,-0.088635,-0.096127,1,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.059879,-0.088742,-0.05661,1,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.032607,-0.089255,-0.056741,1,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.024947,-0.089776,-0.071042,1,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0068504,-0.090103,-0.081484,1,0
2,GO RESPONSE TO FOOD,0.0028872,-0.090368,-0.11188,1,0
2,GO CATION TRANSPORT,0.0056958,-0.090407,-0.068198,1,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.018693,-0.090458,-0.098638,1,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.028852,-0.091211,-0.08848,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.027401,-0.092157,-0.1126,1,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.055093,-0.092198,-0.061229,1,0
2,GO TRANSPORT ALONG MICROTUBULE,0.0032501,-0.092402,-0.091228,1,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0040509,-0.093008,-0.11908,1,0
2,GO CELL PART MORPHOGENESIS,0.001955,-0.093025,-0.11402,1,0
2,GO RESPONSE TO GLUCAGON,0.033608,-0.093058,-0.079202,1,0
2,GO DEVELOPMENTAL CELL GROWTH,0.0011668,-0.093283,-0.11588,1,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.044292,-0.093443,-0.08544,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.027973,-0.094674,-0.055193,1,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.055093,-0.094719,-0.11731,1,0
2,GO RESPONSE TO AXON INJURY,0.02128,-0.095613,-0.096112,1,0
2,GO SPERM MOTILITY,0.013546,-0.096524,-0.10476,1,0
2,GO MEMBRANE FISSION,0.031953,-0.096559,-0.12667,1,0
2,GO MULTICELLULAR ORGANISM AGING,0.056652,-0.09777,-0.06382,1,0
2,GO HEAD DEVELOPMENT,0.0028118,-0.098307,-0.096123,1,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.0061347,-0.09891,-0.10582,1,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.032278,-0.099326,-0.064473,1,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.01499,-0.099425,-0.087582,1,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0092477,-0.099448,-0.1041,1,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00159,-0.10007,-0.1211,1,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0037016,-0.10017,-0.11703,1,0
2,GO PEPTIDE SECRETION,0.012653,-0.10028,-0.072098,1,0
2,GO CHLORIDE TRANSPORT,0.0018256,-0.10175,-0.098486,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.010041,-0.10203,-0.12589,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0022095,-0.10242,-0.072601,1,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.028264,-0.10307,-0.081132,1,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.037882,-0.1031,-0.084261,1,0
2,GO REGULATION OF SECRETION,0.004964,-0.10312,-0.075685,1,0
2,GO MEMBRANE DOCKING,0.00032916,-0.10366,-0.097501,1,0
2,GO NEURON DIFFERENTIATION,0.001483,-0.10401,-0.10289,1,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0077327,-0.10428,-0.087408,1,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.032938,-0.10486,-0.058389,1,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.01995,-0.10501,-0.075895,1,0
2,GO IMPORT INTO CELL,0.017506,-0.10536,-0.078883,1,0
2,GO MEMBRANE REPOLARIZATION,0.0056958,-0.10585,-0.1202,1,0
2,GO NEURON DEVELOPMENT,0.00073415,-0.10617,-0.11442,1,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.011544,-0.10636,-0.10016,1,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.0015463,-0.10637,-0.13319,1,0
2,GO DETECTION OF VISIBLE LIGHT,0.0019023,-0.10662,-0.11458,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.040187,-0.10672,-0.10572,1,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.03068,-0.10687,-0.13098,1,0
2,GO AXO DENDRITIC TRANSPORT,0.0048405,-0.10746,-0.10096,1,0
2,GO CILIUM MOVEMENT,0.013093,-0.10752,-0.10879,1,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.026013,-0.10767,-0.059542,1,0
2,GO MICROTUBULE POLYMERIZATION,0.0025961,-0.10798,-0.12717,1,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.024428,-0.10805,-0.099749,1,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.024687,-0.10809,-0.11707,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.013856,-0.10851,-0.13571,1,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0040509,-0.10888,-0.088093,1,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.056652,-0.1089,-0.14947,1,0
2,GO REGULATION OF RESPONSE TO FOOD,0.0052854,-0.10917,-0.13953,1,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.059331,-0.10927,-0.069949,1,0
2,GO EPITHELIAL CELL MATURATION,0.0052854,-0.1093,-0.17417,1,0
2,GO NEUROBLAST PROLIFERATION,0.01128,-0.10934,-0.1354,1,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.018898,-0.10937,-0.081946,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.030994,-0.1097,-0.095394,1,0
2,GO DENDRITE DEVELOPMENT,0.0029645,-0.10993,-0.11842,1,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.0027381,-0.11002,-0.077865,1,0
2,GO MITOCHONDRION LOCALIZATION,0.0026663,-0.11053,-0.12384,1,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0037985,-0.11067,-0.12666,1,0
2,GO MICROTUBULE BASED MOVEMENT,0.0016122,-0.11091,-0.10353,1,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.051595,-0.11102,-0.092382,1,0
2,GO SPERM CAPACITATION,0.022686,-0.11125,-0.11734,1,0
2,GO CALCIUM ION IMPORT,0.0007901,-0.11133,-0.13328,1,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.01585,-0.11181,-0.098604,1,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0070192,-0.11188,-0.071123,1,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.0024609,-0.11197,-0.10578,1,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0099244,-0.11346,-0.079889,1,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.025475,-0.1143,-0.090332,1,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0019819,-0.11498,-0.10371,1,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0090315,-0.11503,-0.13714,1,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0012005,-0.11544,-0.089149,1,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0104,-0.11554,-0.092541,1,0
2,GO CILIUM ORGANIZATION,0.0030038,-0.11618,-0.10691,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0071051,-0.11625,-0.096879,1,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0015038,-0.11652,-0.11637,1,0
2,GO RECEPTOR CLUSTERING,0.030368,-0.11657,-0.11708,1,0
2,GO REGULATION OF SYSTEM PROCESS,0.0010865,-0.11713,-0.094257,1,0
2,GO CELL JUNCTION MAINTENANCE,0.049681,-0.11739,-0.10277,1,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.019523,-0.11833,-0.1057,1,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.035336,-0.11882,-0.14773,1,0
2,GO DEVELOPMENTAL INDUCTION,0.021973,-0.11882,-0.12732,1,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.001955,-0.1189,-0.091237,1,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0069343,-0.11939,-0.077306,1,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.004964,-0.11945,-0.13864,1,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.0094686,-0.11975,-0.099874,1,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.011151,-0.12022,-0.10264,1,0
2,GO NERVOUS SYSTEM PROCESS,0.00065224,-0.12082,-0.095902,1,0
2,GO AXONAL TRANSPORT,0.0039481,-0.12096,-0.11374,1,0
2,GO RESPONSE TO CALCIUM ION,0.0057669,-0.1211,-0.095994,1,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.027686,-0.12181,-0.087409,1,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.014332,-0.12205,-0.15722,1,0
2,GO FEAR RESPONSE,0.0055559,-0.12226,-0.11136,1,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0011668,-0.12229,-0.12915,1,0
2,GO MICROTUBULE SEVERING,0.017125,-0.1234,-0.1416,1,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.011022,-0.12383,-0.12759,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00082553,-0.12408,-0.11688,1,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.03902,-0.12411,-0.13626,1,0
2,GO POSTSYNAPSE ORGANIZATION,0.0020092,-0.12427,-0.13777,1,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.059331,-0.12427,-0.066531,1,0
2,GO REGULATION OF ION TRANSPORT,0.0028118,-0.12427,-0.08566,1,0
2,GO REGULATION OF AXONOGENESIS,0.0039992,-0.12479,-0.13334,1,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0059852,-0.125,-0.14929,1,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0023321,-0.12519,-0.14644,1,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0081133,-0.12542,-0.11049,1,0
2,GO DENDRITE MORPHOGENESIS,0.003654,-0.1258,-0.13288,1,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0034243,-0.12633,-0.15226,1,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.0095807,-0.12653,-0.12145,1,0
2,GO CELL FATE SPECIFICATION,0.026561,-0.12687,-0.099141,1,0
2,GO REGULATION OF FERTILIZATION,0.014172,-0.12831,-0.10604,1,0
2,GO SODIUM ION TRANSPORT,0.0030038,-0.12846,-0.10011,1,0
2,GO FAT CELL PROLIFERATION,0.014658,-0.12866,-0.13554,1,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0104,-0.12929,-0.099214,1,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00072342,-0.12966,-0.19478,1,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.013394,-0.12978,-0.11558,1,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00073415,-0.12984,-0.18106,1,0
2,GO COLLATERAL SPROUTING,0.0096941,-0.13009,-0.16317,1,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0056255,-0.1305,-0.13819,1,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.043866,-0.13065,-0.11185,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0071918,-0.13141,-0.16804,1,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.0024941,-0.13148,-0.13992,1,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.02915,-0.13212,-0.1511,1,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0023009,-0.13221,-0.15198,1,0
2,GO ACTION POTENTIAL,0.003607,-0.13237,-0.10548,1,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.012945,-0.13249,-0.11143,1,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0086125,-0.1327,-0.10414,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0016806,-0.13299,-0.14908,1,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0070192,-0.13311,-0.11065,1,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0022396,-0.13338,-0.099347,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0015463,-0.13427,-0.13128,1,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,5.6085e-05,-0.13483,-0.16643,1,0
2,GO NEURON PROJECTION EXTENSION,0.00037257,-0.13503,-0.14315,1,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.0023321,-0.13537,-0.15497,1,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0057669,-0.13593,-0.1175,1,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0046604,-0.13645,-0.13633,1,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.057711,-0.13696,-0.12872,1,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.0018006,-0.13753,-0.11756,1,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.027686,-0.13853,-0.16556,1,0
2,GO DETECTION OF ABIOTIC STIMULUS,9.4959e-05,-0.13888,-0.12736,1,0
2,GO SKELETAL MUSCLE CONTRACTION,0.0092477,-0.13888,-0.12713,1,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.013546,-0.13895,-0.1962,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.017315,-0.13895,-0.11438,1,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,6.0079e-05,-0.1391,-0.13088,1,0
2,GO SENSORY PERCEPTION OF PAIN,0.0020092,-0.14009,-0.11706,1,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0020367,-0.14086,-0.15588,1,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.051595,-0.14091,-0.12308,1,0
2,GO RESPONSE TO NICOTINE,0.048285,-0.14123,-0.085363,1,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.036409,-0.14275,-0.11846,1,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00019229,-0.14308,-0.17083,1,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.030994,-0.14322,-0.097346,1,0
2,GO COGNITION,0.00044103,-0.14386,-0.13227,1,0
2,GO REPRODUCTIVE BEHAVIOR,0.0011503,-0.14438,-0.14092,1,0
2,GO DEVELOPMENTAL MATURATION,8.3013e-05,-0.14441,-0.1375,1,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.045591,-0.14508,-0.07173,1,0
2,GO PROTEIN KINASE C SIGNALING,0.002631,-0.14513,-0.17017,1,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00087508,-0.14519,-0.14569,1,0
2,GO TELENCEPHALON DEVELOPMENT,0.00053704,-0.14566,-0.12583,1,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.044292,-0.14631,-0.10301,1,0
2,GO REGULATION OF APPETITE,4.0314e-05,-0.14644,-0.14898,1,0
2,GO ACROSOME ASSEMBLY,0.0053519,-0.14705,-0.177,1,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.055609,-0.14724,-0.12831,1,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00083767,-0.14743,-0.14942,1,0
2,GO FEEDING BEHAVIOR,0.00013451,-0.14813,-0.14195,1,0
2,GO HORMONE TRANSPORT,0.00015583,-0.14899,-0.13081,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.1806e-05,-0.14911,-0.15741,1,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.00013016,-0.14921,-0.1494,1,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00014129,-0.14954,-0.1521,1,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.0018508,-0.14989,-0.13597,1,0
2,GO FOREBRAIN DEVELOPMENT,0.00028155,-0.15005,-0.13466,1,0
2,GO CAMP METABOLIC PROCESS,0.019735,-0.15038,-0.13,1,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.00076726,-0.15048,-0.1273,1,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.017699,-0.15164,-0.16521,1,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.0066039,-0.15218,-0.13994,1,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.028264,-0.15221,-0.10836,1,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.042609,-0.1523,-0.12889,1,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.046474,-0.15235,-0.09105,1,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0025617,-0.15239,-0.16027,1,0
2,GO CRANIAL NERVE DEVELOPMENT,0.023668,-0.15446,-0.11605,1,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.016205,-0.15498,-0.13497,1,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.00072342,-0.15514,-0.13329,1,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.023668,-0.15534,-0.10861,1,0
2,GO PALLIUM DEVELOPMENT,0.00071283,-0.15563,-0.11938,1,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.058787,-0.15587,-0.12143,1,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00092737,-0.15591,-0.138,1,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0098086,-0.15624,-0.16394,1,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.056128,-0.15637,-0.14698,1,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0016347,-0.15656,-0.15444,1,0
2,GO NEURAL RETINA DEVELOPMENT,0.00054518,-0.1567,-0.17991,1,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0029256,-0.15708,-0.15252,1,0
2,GO DORSAL AORTA DEVELOPMENT,0.041383,-0.1588,-0.124,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00042777,-0.15901,-0.16937,1,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00014362,-0.15961,-0.15482,1,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016205,-0.15995,-0.20413,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00011986,-0.16029,-0.18312,1,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0012705,-0.16044,-0.16351,1,0
2,GO REGULATION OF HORMONE SECRETION,0.000286,-0.16046,-0.12413,1,0
2,GO REGULATION OF INSULIN SECRETION,0.00029976,-0.1607,-0.13077,1,0
2,GO LONG TERM MEMORY,0.011678,-0.16115,-0.11864,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0089251,-0.16129,-0.15776,1,0
2,GO HINDBRAIN DEVELOPMENT,0.00014129,-0.16167,-0.16799,1,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.052575,-0.16277,-0.12796,1,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0049019,-0.16406,-0.13498,1,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.0048405,-0.16443,-0.14207,1,0
2,GO MEMORY,0.00025617,-0.16451,-0.14757,1,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.00074504,-0.16462,-0.17037,1,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.01251,-0.16475,-0.12065,1,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0023009,-0.16498,-0.11729,1,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.021973,-0.16533,-0.12289,1,0
2,GO STRIATUM DEVELOPMENT,0.0078263,-0.16609,-0.16159,1,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00095459,-0.16649,-0.14212,1,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00073415,-0.16675,-0.14145,1,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.02128,-0.16842,-0.13808,1,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.0013069,-0.16891,-0.28074,1,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.00012804,-0.16901,-0.14998,1,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.060432,-0.16904,-0.13434,1,0
2,GO ADULT HEART DEVELOPMENT,0.0033799,-0.16967,-0.18286,1,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.0023321,-0.16971,-0.13351,1,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.006444,-0.16972,-0.19668,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00032916,-0.17006,-0.14347,1,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0061347,-0.17087,-0.13531,1,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.02128,-0.17096,-0.1434,1,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00083767,-0.17131,-0.11579,1,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.001071,-0.17213,-0.18034,1,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.1165e-05,-0.17227,-0.18117,1,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0068504,-0.17247,-0.22576,1,0
2,GO CARDIAC CONDUCTION,0.0012005,-0.17263,-0.13407,1,0
2,GO ASSOCIATIVE LEARNING,0.00076726,-0.17295,-0.14058,1,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,9.6562e-05,-0.17313,-0.16148,1,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0014022,-0.17359,-0.18,1,0
2,GO CELLULAR RESPONSE TO PH,0.014823,-0.17407,-0.096687,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.040582,-0.17437,-0.10899,1,0
2,GO REGULATION OF ACROSOME REACTION,0.0069343,-0.17483,-0.16898,1,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0026663,-0.17503,-0.18662,1,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0048405,-0.17561,-0.18195,1,0
2,GO COCHLEA DEVELOPMENT,0.0020367,-0.1758,-0.13614,1,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00019229,-0.1759,-0.14771,1,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,4.7999e-05,-0.17599,-0.16074,1,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.014494,-0.17615,-0.1584,1,0
2,GO AMINO ACID TRANSPORT,2.8814e-05,-0.17691,-0.1618,1,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.00018923,-0.17701,-0.16258,1,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00015838,-0.17757,-0.14547,1,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0016575,-0.17942,-0.13812,1,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.01829,-0.17985,-0.1916,1,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,5.5127e-05,-0.1799,-0.19885,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.011544,-0.18003,-0.14868,1,0
2,GO RESPONSE TO COCAINE,0.00010497,-0.18038,-0.1736,1,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0022396,-0.18043,-0.22928,1,0
2,GO REGULATION OF OOGENESIS,1.1588e-05,-0.18055,-0.16918,1,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.001704,-0.18066,-0.17739,1,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,3.5022e-05,-0.1809,-0.1523,1,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00027284,-0.18155,-0.14426,1,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0038977,-0.18161,-0.17982,1,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00023667,-0.18227,-0.22714,1,0
2,GO SKELETAL MUSCLE ADAPTATION,0.02945,-0.18269,-0.14097,1,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.024947,-0.18307,-0.10993,1,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00014839,-0.18309,-0.16374,1,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,9.795e-06,-0.18401,-0.17319,1,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00019229,-0.18482,-0.19817,1,0
2,GO THALAMUS DEVELOPMENT,0.0015038,-0.18518,-0.22218,1,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00014599,-0.18568,-0.20178,1,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,2.2505e-06,-0.18591,-0.22292,1,0
2,GO NEUROTRANSMITTER UPTAKE,0.0051547,-0.18614,-0.16468,1,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00036686,-0.18778,-0.15895,1,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00023667,-0.1896,-0.14898,1,0
2,GO MALE MEIOSIS I,0.00095459,-0.19009,-0.20084,1,0
2,GO RESPONSE TO POTASSIUM ION,0.0050904,-0.19019,-0.19969,1,0
2,GO SPINAL CORD DEVELOPMENT,0.00027716,-0.19074,-0.16573,1,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.0094686,-0.19084,-0.22988,1,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.026561,-0.19105,-0.21646,1,0
2,GO REGULATION OF EXOCYTOSIS,0.00010323,-0.19171,-0.1643,1,0
2,GO BEHAVIOR,1.3442e-05,-0.19182,-0.15608,1,0
2,GO SECRETORY GRANULE LOCALIZATION,0.0018256,-0.19291,-0.25472,1,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.040582,-0.19333,-0.10129,1,0
2,GO LEARNING,8.4424e-05,-0.19358,-0.1911,1,0
2,GO SIGNAL RELEASE,8.5867e-06,-0.19389,-0.14782,1,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.014172,-0.19396,-0.14069,1,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00039622,-0.19402,-0.13052,1,0
2,GO MAINTENANCE OF CELL POLARITY,0.00046165,-0.19412,-0.22786,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,2.4972e-05,-0.19422,-0.20829,1,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.038637,-0.19435,-0.15784,1,0
2,GO SYNAPSE ORGANIZATION,0.00036686,-0.19466,-0.16073,1,0
2,GO CELL MIGRATION IN HINDBRAIN,0.0039481,-0.19489,-0.20178,1,0
2,GO HEART FORMATION,0.00094089,-0.19574,-0.24555,1,0
2,GO INSULIN SECRETION,0.00013451,-0.19714,-0.14543,1,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0021215,-0.1974,-0.19736,1,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0062877,-0.19752,-0.17783,1,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,1.0756e-05,-0.19851,-0.25942,1,0
2,GO NEUROMUSCULAR PROCESS,0.00019541,-0.1993,-0.15849,1,0
2,GO METENCEPHALON DEVELOPMENT,1.7706e-05,-0.19937,-0.20092,1,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.012945,-0.19952,-0.15177,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,6.7724e-05,-0.19954,-0.20397,1,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00031414,-0.19955,-0.22102,1,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00040235,-0.19987,-0.16431,1,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.049681,-0.20044,-0.15877,1,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.002631,-0.20061,-0.23942,1,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,1.0557e-05,-0.20103,-0.17441,1,0
2,GO FOREBRAIN CELL MIGRATION,0.0010113,-0.20248,-0.15802,1,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0104,-0.20352,-0.20396,1,0
2,GO CELL FATE DETERMINATION,0.011544,-0.20524,-0.14046,1,0
2,GO MITOCHONDRION DISTRIBUTION,0.001483,-0.20621,-0.17961,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.0557e-05,-0.20677,-0.18986,1,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.0075485,-0.20859,-0.1454,1,0
2,GO DIVALENT METAL ION EXPORT,0.003607,-0.20888,-0.19664,1,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00036124,-0.21015,-0.19159,1,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.001422,-0.21108,-0.27939,1,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,1.536e-06,-0.2112,-0.23839,1,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00024045,-0.21185,-0.25268,1,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,5.8698e-06,-0.212,-0.18963,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.026286,-0.21251,-0.19014,1,0
2,GO RESPONSE TO DOPAMINE,4.0868e-08,-0.21404,-0.22915,1,0
2,GO SECONDARY PALATE DEVELOPMENT,0.0034692,-0.215,-0.19633,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00028155,-0.21505,-0.18178,1,0
2,GO TUBULIN DEACETYLATION,0.00032916,-0.21728,-0.20266,1,0
2,GO PEPTIDE HORMONE SECRETION,5.5412e-06,-0.21815,-0.18183,1,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0050269,-0.2185,-0.2175,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.011411,-0.21854,-0.18235,1,0
2,GO ACROSOME REACTION,2.5884e-05,-0.219,-0.19541,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0043184,-0.21974,-0.19105,1,0
2,GO COPULATION,0.0099244,-0.22092,-0.14515,1,0
2,GO MICROTUBULE DEPOLYMERIZATION,3.6162e-06,-0.22169,-0.27404,1,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0067673,-0.22268,-0.14969,1,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00023294,-0.22312,-0.19188,1,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,2.4528e-05,-0.22342,-0.26285,1,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.00046872,-0.22358,-0.25242,1,0
2,GO NEURON MIGRATION,9.4959e-05,-0.22392,-0.20492,1,0
2,GO SECRETORY GRANULE ORGANIZATION,0.00027716,-0.22442,-0.19139,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.001235,-0.22465,-0.15804,1,0
2,GO RESPONSE TO CATECHOLAMINE,1.4163e-06,-0.22661,-0.1998,1,0
2,GO NOTCH RECEPTOR PROCESSING,0.00024045,-0.22699,-0.26067,1,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.00083767,-0.22731,-0.18095,1,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.00020504,-0.22762,-0.18681,1,0
2,GO MEMBRANE DEPOLARIZATION,1.2027e-05,-0.22839,-0.22784,1,0
2,GO SEROTONIN TRANSPORT,0.0044298,-0.22912,-0.18032,1,0
2,GO CARDIAC CELL FATE COMMITMENT,0.01829,-0.22945,-0.19789,1,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00037835,-0.23017,-0.29892,1,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00012388,-0.23026,-0.19203,1,0
2,GO REGULATION OF CILIUM MOVEMENT,0.00040857,-0.23055,-0.17163,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00021511,-0.23115,-0.229,1,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.000286,-0.2318,-0.1769,1,0
2,GO EXPLORATION BEHAVIOR,1.7385e-05,-0.23212,-0.28793,1,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00015583,-0.23215,-0.26501,1,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.01995,-0.23357,-0.20248,1,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.00012388,-0.23479,-0.20401,1,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0027381,-0.23526,-0.20559,1,0
2,GO POTASSIUM ION TRANSPORT,1.4163e-06,-0.23539,-0.20897,1,0
2,GO PRESYNAPSE ORGANIZATION,1.2954e-05,-0.23544,-0.26009,1,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.012945,-0.23589,-0.19995,1,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0011021,-0.2359,-0.19491,1,0
2,GO NEUROTRANSMITTER REUPTAKE,0.00049053,-0.23696,-0.21575,1,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.003607,-0.2375,-0.17056,1,0
2,GO VESICLE DOCKING,2.011e-05,-0.23765,-0.18834,1,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0033361,-0.23803,-0.21207,1,0
2,GO RETINA LAYER FORMATION,0.002631,-0.23823,-0.22389,1,0
2,GO INTRACILIARY TRANSPORT,0.00044103,-0.23888,-0.2126,1,0
2,GO NEURON PROJECTION ARBORIZATION,0.0018764,-0.23996,-0.21135,1,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.0026663,-0.24031,-0.20673,1,0
2,GO DENDRITIC TRANSPORT,0.00054518,-0.24085,-0.22511,1,0
2,GO OPTIC NERVE DEVELOPMENT,0.000286,-0.24107,-0.27299,1,0
2,GO SYNAPSE ASSEMBLY,4.2487e-05,-0.24114,-0.20746,1,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,7.0072e-05,-0.24227,-0.22263,1,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0011021,-0.24239,-0.26237,1,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,9.03e-05,-0.24257,-0.2364,1,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0023637,-0.24268,-0.24205,1,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,8.6328e-08,-0.2428,-0.26219,1,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00010152,-0.24294,-0.23217,1,0
2,GO RESPONSE TO MUSCLE STRETCH,0.032938,-0.24368,-0.17919,1,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00065224,-0.2439,-0.20997,1,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,6.337e-06,-0.24399,-0.22568,1,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00029511,-0.24401,-0.29188,1,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0059852,-0.24404,-0.24859,1,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,3.5461e-06,-0.24498,-0.24821,1,0
2,GO REGULATION OF MICROTUBULE BINDING,9.0235e-07,-0.24501,-0.28059,1,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.024173,-0.24566,-0.14955,1,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.001118,-0.24659,-0.20962,1,0
2,GO MICROTUBULE BUNDLE FORMATION,5.9498e-07,-0.24755,-0.24494,1,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0005133,-0.24862,-0.26855,1,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,1.1789e-06,-0.2488,-0.28663,1,0
2,GO SYNAPTIC VESICLE TRANSPORT,2.5868e-06,-0.2491,-0.24414,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.6321e-06,-0.24984,-0.26055,1,0
2,GO MEMBRANE BIOGENESIS,0.0011341,-0.25073,-0.1917,1,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,1.2032e-06,-0.25161,-0.24057,1,0
2,GO INCLUSION BODY ASSEMBLY,0.00026024,-0.25231,-0.24359,1,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0090315,-0.25282,-0.20578,1,0
2,GO GROOMING BEHAVIOR,6.2169e-06,-0.25305,-0.27131,1,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.002631,-0.25315,-0.18815,1,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.009139,-0.25323,-0.21238,1,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00025617,-0.2535,-0.21335,1,0
2,GO ADULT LOCOMOTORY BEHAVIOR,3.5038e-07,-0.25368,-0.25138,1,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,1.2253e-05,-0.25442,-0.24081,1,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,5.7536e-08,-0.25461,-0.28831,1,0
2,GO AMMONIUM ION METABOLIC PROCESS,4.1026e-05,-0.25511,-0.26046,1,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,8.1138e-06,-0.25574,-0.27407,1,0
2,GO NEURAL NUCLEUS DEVELOPMENT,2.5359e-06,-0.2559,-0.25315,1,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.0025277,-0.25632,-0.21926,1,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,3.1494e-05,-0.25653,-0.18147,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00016361,-0.2579,-0.23186,1,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.054582,-0.25797,-0.15915,1,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0023957,-0.2586,-0.24438,1,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,9.795e-06,-0.25983,-0.27303,1,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,3.6162e-06,-0.26169,-0.26005,1,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,8.5867e-06,-0.26192,-0.25223,1,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.016568,-0.26206,-0.17484,1,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0062877,-0.26226,-0.24323,1,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0011668,-0.26343,-0.24129,1,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,3.3228e-08,-0.26377,-0.28115,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,2.4371e-06,-0.26398,-0.22852,1,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00022208,-0.2643,-0.31592,1,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.00017176,-0.26563,-0.28465,1,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00021857,-0.2675,-0.22074,1,0
2,GO REGULATION OF MEMBRANE POTENTIAL,7.969e-07,-0.26796,-0.21748,1,0
2,GO SYNAPTIC SIGNALING,2.4305e-07,-0.26957,-0.24683,1,0
2,GO MYELIN MAINTENANCE,0.0076401,-0.27002,-0.19248,1,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0012705,-0.27085,-0.2568,1,0
2,GO NEURON MATURATION,4.9694e-05,-0.27092,-0.20748,1,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,6.0079e-05,-0.27121,-0.2993,1,0
2,GO DORSAL VENTRAL PATTERN FORMATION,1.9393e-05,-0.27208,-0.25166,1,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.00069207,-0.27214,-0.32426,1,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,4.9694e-05,-0.27274,-0.26052,1,0
2,GO SYNAPTIC VESICLE RECYCLING,7.333e-07,-0.27324,-0.26509,1,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.00074504,-0.27434,-0.18138,1,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00049053,-0.27505,-0.24075,1,0
2,GO DICARBOXYLIC ACID TRANSPORT,4.719e-07,-0.27543,-0.22922,1,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,2.5424e-05,-0.27664,-0.36599,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00054518,-0.27668,-0.25708,1,0
2,GO NERVE DEVELOPMENT,4.0314e-05,-0.27727,-0.23957,1,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.1351e-07,-0.2782,-0.28267,1,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,8.6579e-07,-0.27837,-0.26786,1,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.0005789,-0.27843,-0.20336,1,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.00018323,-0.27937,-0.24696,1,0
2,GO RESPONSE TO ACETYLCHOLINE,0.00055343,-0.27966,-0.23356,1,0
2,GO ADRENAL GLAND DEVELOPMENT,0.00010323,-0.28049,-0.26755,1,0
2,GO REGULATION OF SYNAPSE MATURATION,0.00028155,-0.2806,-0.32883,1,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00011596,-0.28081,-0.30439,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00020504,-0.28086,-0.32723,1,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,9.7998e-07,-0.28094,-0.26476,1,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,2.971e-06,-0.28141,-0.24232,1,0
2,GO LONG TERM SYNAPTIC DEPRESSION,1.9749e-05,-0.28301,-0.26771,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.1316e-06,-0.28302,-0.34417,1,0
2,GO LOCOMOTORY BEHAVIOR,7.4873e-07,-0.28377,-0.2346,1,0
2,GO DIENCEPHALON DEVELOPMENT,5.9834e-06,-0.28406,-0.26411,1,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.00034485,-0.28419,-0.28348,1,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,1.2281e-06,-0.28427,-0.29888,1,0
2,GO NEURON RECOGNITION,9.6562e-05,-0.28439,-0.24802,1,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,2.7312e-05,-0.28454,-0.29483,1,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0022095,-0.2851,-0.21019,1,0
2,GO CEREBELLAR CORTEX FORMATION,5.7582e-06,-0.28721,-0.26746,1,0
2,GO RESPONSE TO FORSKOLIN,0.004964,-0.29001,-0.22695,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,1.8701e-05,-0.29075,-0.29083,1,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.00026438,-0.29108,-0.29652,1,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.1034e-07,-0.29146,-0.24333,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00044781,-0.29163,-0.30666,1,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,2.65e-07,-0.29345,-0.32235,1,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,3.4098e-06,-0.29392,-0.25642,1,0
2,GO REGULATION OF AMINO ACID TRANSPORT,1.7922e-07,-0.29688,-0.28862,1,0
2,GO PROTEIN POLYGLUTAMYLATION,2.2505e-06,-0.29712,-0.26804,1,0
2,GO RESPONSE TO LITHIUM ION,0.0011021,-0.29781,-0.23226,1,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,9.086e-06,-0.29786,-0.23759,1,0
2,GO SUCKLING BEHAVIOR,9.3381e-05,-0.29792,-0.30348,1,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,2.2286e-07,-0.29796,-0.26985,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00010152,-0.30016,-0.29915,1,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0031247,-0.30126,-0.25247,1,0
2,GO PROTEIN PALMITOYLATION,1.6654e-06,-0.30141,-0.25286,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,2.206e-06,-0.3016,-0.27125,1,0
2,GO EXOCYTIC PROCESS,1.8793e-06,-0.30278,-0.24626,1,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,4.5558e-05,-0.30291,-0.34054,1,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,7.0072e-05,-0.30397,-0.33549,1,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,9.9803e-06,-0.3059,-0.30945,1,0
2,GO PRESYNAPTIC ENDOCYTOSIS,1.2534e-06,-0.3079,-0.27976,1,0
2,GO MOTILE CILIUM ASSEMBLY,0.00046872,-0.30804,-0.24706,1,0
2,GO ACIDIC AMINO ACID TRANSPORT,1.2886e-07,-0.31007,-0.27702,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00024819,-0.31211,-0.2811,1,0
2,GO RESPONSE TO DIETARY EXCESS,0.00020835,-0.31584,-0.26662,1,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.00014839,-0.31623,-0.23516,1,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,3.7356e-07,-0.31668,-0.33986,1,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,1.0212e-06,-0.3181,-0.30933,1,0
2,GO ADULT BEHAVIOR,3.9035e-08,-0.31913,-0.28663,1,0
2,GO TOXIN METABOLIC PROCESS,0.0007901,-0.31966,-0.24945,1,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.5674e-06,-0.32243,-0.32121,1,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0042636,-0.32262,-0.24894,1,0
2,GO AXONEME ASSEMBLY,2.6386e-06,-0.32291,-0.29876,1,0
2,GO REGULATION OF VESICLE FUSION,0.00029976,-0.32552,-0.2539,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,3.1494e-05,-0.32567,-0.3161,1,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,4.31e-06,-0.32748,-0.32236,1,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,5.1351e-07,-0.32902,-0.31975,1,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00022208,-0.32928,-0.30218,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,2.2958e-06,-0.32947,-0.37911,1,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00027716,-0.33022,-0.25653,1,0
2,GO SYNAPTIC VESICLE LOCALIZATION,4.4807e-06,-0.33143,-0.30645,1,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,7.105e-06,-0.3315,-0.31999,1,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,2.1621e-05,-0.33151,-0.31564,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,6.5837e-06,-0.33544,-0.35929,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,8.4424e-05,-0.33769,-0.23498,1,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.0018764,-0.33772,-0.2364,1,0
2,GO OLFACTORY LOBE DEVELOPMENT,6.2169e-06,-0.33775,-0.30861,1,0
2,GO SPERM AXONEME ASSEMBLY,0.00076726,-0.34064,-0.22573,1,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,4.4285e-07,-0.34139,-0.27315,1,0
2,GO PARENTAL BEHAVIOR,1.475e-06,-0.34249,-0.34968,1,0
2,GO CGMP METABOLIC PROCESS,9.9844e-05,-0.34422,-0.3012,1,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.7385e-05,-0.34962,-0.27632,1,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,3.7356e-07,-0.35347,-0.3508,1,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,3.0156e-07,-0.35559,-0.38464,1,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,7.6657e-06,-0.35952,-0.3377,1,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,9.5999e-07,-0.36022,-0.33416,1,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,1.0361e-05,-0.36234,-0.32389,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00067188,-0.36337,-0.28073,1,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.2445e-07,-0.36441,-0.40977,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS,7.969e-07,-0.37123,-0.41919,1,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,1.2482e-05,-0.37136,-0.27382,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.206e-06,-0.37187,-0.31368,1,0
2,GO REFLEX,7.7586e-05,-0.37204,-0.36689,1,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.1041e-08,-0.37272,-0.36759,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.1621e-05,-0.37285,-0.33541,1,0
2,GO TELENCEPHALON REGIONALIZATION,0.00010497,-0.37324,-0.32871,1,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,2.1234e-05,-0.37401,-0.36962,1,0
2,GO CATECHOLAMINE METABOLIC PROCESS,1.0036e-08,-0.37554,-0.36907,1,0
2,GO NOREPINEPHRINE SECRETION,1.8419e-06,-0.37743,-0.32091,1,0
2,GO NEURONAL ACTION POTENTIAL,3.7605e-06,-0.37787,-0.33706,1,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,1.8723e-07,-0.37874,-0.3368,1,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.4003e-08,-0.37965,-0.33509,1,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,1.471e-07,-0.38032,-0.31903,1,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,1.3468e-07,-0.38072,-0.34122,1,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,3.628e-05,-0.38082,-0.35037,1,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,8.8389e-07,-0.38288,-0.37696,1,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,6.545e-05,-0.38483,-0.34566,1,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,6.8888e-05,-0.38503,-0.31689,1,0
2,GO FOREBRAIN REGIONALIZATION,4.9228e-07,-0.38729,-0.37218,1,0
2,GO FOREBRAIN GENERATION OF NEURONS,3.6877e-06,-0.38755,-0.31648,1,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,3.7605e-06,-0.38794,-0.35269,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,2.5868e-06,-0.38984,-0.3646,1,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.013243,-0.39008,-0.28644,1,0
2,GO SPINAL CORD PATTERNING,5.6487e-06,-0.3901,-0.37947,1,0
2,GO DENDRITE EXTENSION,3.8149e-08,-0.39061,-0.40113,1,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00012804,-0.39275,-0.38502,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,2.8271e-07,-0.39482,-0.35068,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,9.4407e-08,-0.39882,-0.36156,1,0
2,GO HEART INDUCTION,0.00088789,-0.40663,-0.38934,1,0
2,GO TRANSMISSION OF NERVE IMPULSE,3.5606e-08,-0.40776,-0.36022,1,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.00016361,-0.40906,-0.29945,1,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,2.7668e-07,-0.41854,-0.407,1,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,5.9056e-05,-0.42105,-0.36208,1,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.8363e-05,-0.42151,-0.46865,1,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,3.9872e-06,-0.42174,-0.46463,1,0
2,GO NEUROTRANSMITTER TRANSPORT,1.4076e-07,-0.42332,-0.35254,1,0
2,GO NOREPINEPHRINE TRANSPORT,6.7461e-07,-0.42417,-0.31319,1,0
2,GO GLUTAMATE SECRETION,1.1034e-07,-0.42617,-0.38223,1,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,9.2118e-07,-0.4278,-0.38244,1,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,3.1479e-07,-0.42943,-0.35866,1,0
2,GO CATECHOLAMINE UPTAKE,1.3325e-06,-0.42977,-0.35175,1,0
2,GO DETECTION OF CALCIUM ION,2.3274e-07,-0.43016,-0.39864,1,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,1.1588e-05,-0.4319,-0.40588,1,0
2,GO GLIAL CELL FATE COMMITMENT,0.00069207,-0.4336,-0.34939,1,0
2,GO DOPAMINE METABOLIC PROCESS,5.6317e-09,-0.43516,-0.40905,1,0
2,GO STARTLE RESPONSE,1.3468e-07,-0.44096,-0.425,1,0
2,GO NEURON FATE COMMITMENT,2.5868e-06,-0.44391,-0.33629,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,1.9926e-08,-0.44522,-0.41906,1,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,9.404e-07,-0.44897,-0.38628,1,0
2,GO PITUITARY GLAND DEVELOPMENT,1.3056e-06,-0.44928,-0.38919,1,0
2,GO NEUROTRANSMITTER SECRETION,1.7922e-07,-0.45172,-0.38279,1,0
2,GO SYNAPSE MATURATION,9.7998e-07,-0.45729,-0.48897,1,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,4.0657e-06,-0.4579,-0.46401,1,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,3.5794e-07,-0.46485,-0.39459,1,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,1.6994e-06,-0.46597,-0.4676,1,0
2,GO NEURONAL ION CHANNEL CLUSTERING,1.155e-06,-0.46727,-0.47075,1,0
2,GO PROTEIN LOCALIZATION TO AXON,3.758e-05,-0.46745,-0.46018,1,0
2,GO DENSE CORE GRANULE TRANSPORT,2.9514e-07,-0.46892,-0.51231,1,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,2.6362e-08,-0.4699,-0.46707,1,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.1196e-06,-0.4726,-0.40596,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,3.758e-05,-0.47361,-0.4377,1,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,4.7488e-06,-0.47447,-0.48367,1,0
2,GO PREPULSE INHIBITION,1.6158e-05,-0.4786,-0.466,1,0
2,GO SYNAPTIC MEMBRANE ADHESION,1.1034e-07,-0.4853,-0.48977,1,0
2,GO SUBPALLIUM DEVELOPMENT,2.971e-06,-0.48627,-0.39972,1,0
2,GO RESPONSE TO AUDITORY STIMULUS,1.0424e-06,-0.48644,-0.42752,1,0
2,GO POSTSYNAPSE ASSEMBLY,1.4076e-07,-0.49202,-0.49029,1,0
2,GO SYNAPTIC VESICLE PRIMING,2.342e-06,-0.49222,-0.44833,1,0
2,GO SECONDARY HEART FIELD SPECIFICATION,4.3236e-05,-0.49492,-0.44569,1,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.3419e-09,-0.50398,-0.49707,1,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,1.5865e-05,-0.5118,-0.42283,1,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,6.7724e-05,-0.51574,-0.43499,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,1.2032e-06,-0.51762,-0.407,1,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,2.913e-06,-0.52225,-0.51392,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,2.0546e-09,-0.5307,-0.48057,1,0
2,GO AMINE TRANSPORT,3.8118e-09,-0.53767,-0.45792,1,0
2,GO RESPONSE TO INSECTICIDE,1.3761e-09,-0.53777,-0.51949,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00012594,-0.53851,-0.40442,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.5674e-06,-0.54244,-0.51427,1,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,8.4805e-07,-0.5459,-0.45862,1,0
2,GO VOCALIZATION BEHAVIOR,5.7051e-07,-0.55119,-0.53607,1,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.7534e-07,-0.55371,-0.5282,1,0
2,GO NEURON FATE SPECIFICATION,2.5868e-06,-0.55811,-0.40107,1,0
2,GO REGULATION OF DENDRITE EXTENSION,1.0036e-08,-0.56016,-0.52445,1,0
2,GO REGULATION OF GLUTAMATE SECRETION,7.5266e-09,-0.56237,-0.46062,1,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,3.4296e-07,-0.56474,-0.42442,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.6386e-06,-0.57024,-0.54459,1,0
2,GO MONOAMINE TRANSPORT,7.3476e-09,-0.57339,-0.47198,1,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,5.2445e-07,-0.57664,-0.514,1,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.8924e-05,-0.5805,-0.4348,1,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,2.5756e-08,-0.5888,-0.52171,1,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,7.4854e-10,-0.59159,-0.53669,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,1.2328e-07,-0.59203,-0.52143,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,2.971e-06,-0.5932,-0.52796,1,0
2,GO HEART FIELD SPECIFICATION,7.3803e-06,-0.59471,-0.46138,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,1.5372e-07,-0.59669,-0.5745,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.7534e-07,-0.60057,-0.51726,1,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.00013016,-0.60108,-0.48915,1,0
2,GO SYNAPTIC VESICLE CLUSTERING,1.9393e-05,-0.60579,-0.53073,1,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.5604e-09,-0.608,-0.57817,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,1.1034e-07,-0.61252,-0.55021,1,0
2,GO NOSE DEVELOPMENT,9.9803e-06,-0.61291,-0.45572,1,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.5934e-07,-0.61387,-0.6274,1,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,2.1595e-09,-0.6249,-0.59889,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,7.3476e-09,-0.62777,-0.55,1,0
2,GO DOPAMINE TRANSPORT,1.1307e-08,-0.63066,-0.57563,1,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,3.3713e-09,-0.64269,-0.57504,1,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,3.1729e-08,-0.64311,-0.58013,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,1.8135e-09,-0.64354,-0.54982,1,0
2,GO NEURON CELL CELL ADHESION,3.3228e-08,-0.64398,-0.6278,1,0
2,GO INNERVATION,1.3351e-08,-0.64695,-0.59472,1,0
2,GO GROWTH HORMONE SECRETION,5.1101e-09,-0.64874,-0.57335,1,0
2,GO SYNAPTIC VESICLE DOCKING,1.9175e-06,-0.65102,-0.55284,1,0
2,GO CATECHOLAMINE SECRETION,1.5753e-08,-0.66516,-0.56385,1,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,9.4407e-08,-0.67979,-0.56722,1,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.5223e-10,-0.68855,-0.61925,1,0
2,GO REGULATION OF DOPAMINE SECRETION,1.439e-07,-0.68872,-0.6455,1,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,3.2859e-07,-0.70101,-0.66061,1,0
2,GO MECHANOSENSORY BEHAVIOR,3.5794e-07,-0.70684,-0.63386,1,0
2,GO GANGLION DEVELOPMENT,3.8983e-07,-0.7076,-0.54826,1,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,5.9116e-09,-0.7126,-0.61026,1,0
2,GO SYNAPTIC VESICLE MATURATION,1.3039e-08,-0.71581,-0.65578,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,3.055e-09,-0.72728,-0.71244,1,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,1.7721e-08,-0.74498,-0.69791,1,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,7.4854e-10,-0.7475,-0.68803,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,6.0759e-07,-0.84709,-0.6356,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.6907e-08,-0.87407,-0.80104,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,8.0815e-10,-0.8742,-0.78968,1,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,6.895e-08,-0.88953,-0.93679,1,0
2,GO GABAERGIC NEURON DIFFERENTIATION,1.0036e-08,-0.91948,-0.80731,1,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,3.1004e-08,-0.96622,-0.80154,1,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,2.4091e-05,-1.0207,-0.79687,1,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,6.0565e-09,-1.0679,-0.9961,1,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.11647,0.2763,0.19211,0,1
2,GO BONE TRABECULA MORPHOGENESIS,0.1533,0.24245,0.1729,0,1
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.073043,0.21091,0.2058,0,1
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.21437,0.20682,0.18276,0,1
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.084034,0.2023,0.1151,0,1
2,GO CELLULAR RESPONSE TO COPPER ION,0.070488,0.20025,0.21768,0,1
2,GO PROSTATE GLAND MORPHOGENESIS,0.078382,0.1991,0.1787,0,1
2,GO PARAXIAL MESODERM DEVELOPMENT,0.1793,0.19438,0.12011,0,1
2,GO RESPONSE TO UV B,0.080464,0.19203,0.12449,0,1
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.064418,0.18841,0.13053,0,1
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.098784,0.18656,0.10758,0,1
2,GO GLYCOSIDE METABOLIC PROCESS,0.068006,0.17962,0.13795,0,1
2,GO CERAMIDE TRANSPORT,0.10129,0.17828,0.13128,0,1
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.2114,0.17721,0.068135,0,1
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.10646,0.17696,0.094912,0,1
2,GO FIBROBLAST MIGRATION,0.30829,0.17141,0.075117,0,1
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.077018,0.16601,0.12178,0,1
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.062114,0.16595,0.12615,0,1
2,GO GASTRULATION,0.068006,0.16475,0.10913,0,1
2,GO ACTIVATED T CELL PROLIFERATION,0.1387,0.16471,0.092485,0,1
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.11837,0.16299,0.14008,0,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.12924,0.16212,0.089067,0,1
2,GO TOOTH MINERALIZATION,0.10385,0.15899,0.16025,0,1
2,GO PRO B CELL DIFFERENTIATION,0.06986,0.15437,0.15908,0,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.10214,0.15346,0.12441,0,1
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.10646,0.15241,0.10907,0,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15447,0.14983,0.1028,0,1
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.10558,0.14418,0.11418,0,1
2,GO TRANSCYTOSIS,0.062684,0.14281,0.10986,0,1
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10129,0.13761,0.10501,0,1
2,GO NEURAL TUBE FORMATION,0.063258,0.13673,0.10786,0,1
2,GO CELLULAR RESPONSE TO KETONE,0.063836,0.1366,0.093147,0,1
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.082591,0.13616,0.086953,0,1
2,GO RECEPTOR RECYCLING,0.24089,0.13392,0.058796,0,1
2,GO STRESS FIBER ASSEMBLY,0.062114,0.13179,0.1123,0,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.34213,0.13134,0.038016,0,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.062114,0.13087,0.12353,0,1
2,GO TUBE MORPHOGENESIS,0.076344,0.12934,0.097758,0,1
2,GO REGULATION OF WATER LOSS VIA SKIN,0.1653,0.12888,0.10857,0,1
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.28033,0.128,0.067907,0,1
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.32195,0.12729,0.051883,0,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.063836,0.12705,0.10159,0,1
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.087731,0.12668,0.084136,0,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.10299,0.1261,0.105,0,1
2,GO REGULATION OF CELL FATE COMMITMENT,0.14869,0.12484,0.11896,0,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.178,0.12434,0.069691,0,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.67206,0.1239,0.021938,0,1
2,GO RESPONSE TO INACTIVITY,0.1146,0.12331,0.11123,0,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.14197,0.12177,0.12234,0,1
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.3739,0.12121,0.060775,0,1
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.10734,0.11875,0.10726,0,1
2,GO EPITHELIUM DEVELOPMENT,0.12126,0.11749,0.07567,0,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.25583,0.11683,0.051411,0,1
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.072397,0.1168,0.14034,0,1
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.075674,0.11644,0.080073,0,1
2,GO REGULATION OF JUN KINASE ACTIVITY,0.16285,0.11611,0.078632,0,1
2,GO TISSUE MORPHOGENESIS,0.24089,0.11507,0.06219,0,1
2,GO BONE DEVELOPMENT,0.070488,0.11499,0.11256,0,1
2,GO PROTEIN PROCESSING,0.071756,0.11429,0.087094,0,1
2,GO DRUG CATABOLIC PROCESS,0.09796,0.11295,0.10353,0,1
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.1533,0.1129,0.068058,0,1
2,GO MESODERM DEVELOPMENT,0.15565,0.11227,0.070786,0,1
2,GO RESPONSE TO IRON ION,0.1653,0.112,0.10099,0,1
2,GO NEURAL CREST CELL DIFFERENTIATION,0.25414,0.11051,0.076012,0,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.081877,0.10943,0.070769,0,1
2,GO JNK CASCADE,0.071119,0.10895,0.080574,0,1
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.23927,0.10724,0.098105,0,1
2,GO FAT CELL DIFFERENTIATION,0.084763,0.10643,0.083255,0,1
2,GO CARTILAGE DEVELOPMENT,0.20992,0.10586,0.071061,0,1
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.066192,0.10562,0.08772,0,1
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.47461,0.10549,0.046434,0,1
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.13979,0.10539,0.047884,0,1
2,GO TUBE DEVELOPMENT,0.21437,0.10511,0.075023,0,1
2,GO RRNA CATABOLIC PROCESS,0.23128,0.10357,0.054585,0,1
2,GO PHOTOPERIODISM,0.098784,0.10347,0.065941,0,1
2,GO HAIR CELL DIFFERENTIATION,0.080464,0.10273,0.10718,0,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.077698,0.10177,0.090951,0,1
2,GO ER OVERLOAD RESPONSE,0.36526,0.101,0.059025,0,1
2,GO CERAMIDE METABOLIC PROCESS,0.1262,0.099899,0.061067,0,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.14308,0.099707,0.066056,0,1
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.081168,0.099701,0.10525,0,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.35463,0.099432,0.043736,0,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.093126,0.098811,0.079309,0,1
2,GO MATERNAL PLACENTA DEVELOPMENT,0.25753,0.098663,0.065892,0,1
2,GO SEGMENTATION,0.10471,0.098227,0.082911,0,1
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.54746,0.097699,0.037707,0,1
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.13656,0.097267,0.0656,0,1
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.12126,0.096949,0.082615,0,1
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.14869,0.096798,0.083262,0,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.27495,0.096703,0.051572,0,1
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.08331,0.096549,0.07094,0,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.20845,0.096447,0.042688,0,1
2,GO ASTROCYTE ACTIVATION,0.33194,0.09619,0.052885,0,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.19979,0.094823,0.061257,0,1
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.068006,0.094368,0.081036,0,1
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.085497,0.093614,0.068852,0,1
2,GO SKIN EPIDERMIS DEVELOPMENT,0.12924,0.092061,0.10295,0,1
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.066192,0.091757,0.10382,0,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.11275,0.091307,0.085757,0,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.096327,0.091113,0.082483,0,1
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.062114,0.091,0.075249,0,1
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.14308,0.090683,0.068288,0,1
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.2458,0.09041,0.11625,0,1
2,GO CELLULAR RESPONSE TO FATTY ACID,0.29877,0.089843,0.052073,0,1
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.36956,0.088788,0.074946,0,1
2,GO REGULATION OF MUSCLE ADAPTATION,0.94993,0.088649,0.0066502,0,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.071756,0.088563,0.065093,0,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.069238,0.088555,0.060123,0,1
2,GO SPHINGOID METABOLIC PROCESS,0.1146,0.08808,0.10704,0,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.063836,0.087517,0.085283,0,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.1387,0.08666,0.071315,0,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.11933,0.086248,0.13077,0,1
2,GO GLUCOSE CATABOLIC PROCESS,0.17411,0.085012,0.096737,0,1
2,GO REGULATION OF HISTONE DEACETYLATION,0.12721,0.084033,0.076647,0,1
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.16778,0.083853,0.060188,0,1
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.14869,0.083546,0.063365,0,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.12126,0.08325,0.079843,0,1
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.1653,0.083131,0.081402,0,1
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.13763,0.082621,0.060413,0,1
2,GO RESPONSE TO ESTRADIOL,0.11092,0.082042,0.061439,0,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.068619,0.081702,0.074624,0,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.13549,0.081491,0.081048,0,1
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.10214,0.081472,0.067002,0,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.22195,0.081366,0.084424,0,1
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.24745,0.080308,0.043508,0,1
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.41899,0.07841,0.068593,0,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11002,0.0773,0.066886,0,1
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.13234,0.076392,0.058714,0,1
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.18595,0.075682,0.053041,0,1
2,GO REGULATION OF PHOSPHORYLATION,0.1533,0.075658,0.056504,0,1
2,GO POLYOL CATABOLIC PROCESS,0.32195,0.07554,0.03251,0,1
2,GO AUTOPHAGOSOME ORGANIZATION,0.10299,0.075253,0.075949,0,1
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.18461,0.074412,0.05463,0,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.31997,0.074115,0.039173,0,1
2,GO PYRUVATE METABOLIC PROCESS,0.075009,0.073321,0.079363,0,1
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.44994,0.072705,0.058311,0,1
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.12224,0.072658,0.05446,0,1
2,GO RECEPTOR METABOLIC PROCESS,0.17156,0.072549,0.06045,0,1
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.15214,0.072049,0.061374,0,1
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.071119,0.070962,0.069753,0,1
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.062684,0.070939,0.062766,0,1
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.086237,0.070382,0.073782,0,1
2,GO REGULATION OF HELICASE ACTIVITY,0.47461,0.070307,0.030417,0,1
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.19417,0.069738,0.052462,0,1
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.34008,0.069711,0.027895,0,1
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.31021,0.06881,0.055657,0,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.072397,0.067824,0.069329,0,1
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.11002,0.067309,0.057003,0,1
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.08331,0.067144,0.045301,0,1
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.11933,0.065948,0.050675,0,1
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.20992,0.065127,0.028534,0,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.096327,0.064819,0.10839,0,1
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.21437,0.064476,0.050771,0,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.095518,0.064005,0.070545,0,1
2,GO PEPTIDYL THREONINE MODIFICATION,0.068619,0.063925,0.070974,0,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.10912,0.063192,0.086843,0,1
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.13027,0.062648,0.072352,0,1
2,GO LACTATION,0.093126,0.062632,0.087753,0,1
2,GO POSITIVE REGULATION OF NEURON DEATH,0.34008,0.062029,0.054568,0,1
2,GO DNA CONFORMATION CHANGE,0.068619,0.061854,0.058024,0,1
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.067397,0.061833,0.057079,0,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.06986,0.061165,0.060239,0,1
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.078382,0.060944,0.056395,0,1
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.39156,0.060939,0.05106,0,1
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.45972,0.060855,0.02803,0,1
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.46713,0.060698,0.049873,0,1
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.2913,0.060358,0.042695,0,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.076344,0.056451,0.07693,0,1
2,GO BASE EXCISION REPAIR,0.079765,0.056049,0.064546,0,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.24252,0.054661,0.04928,0,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11275,0.054496,0.067367,0,1
2,GO CALCINEURIN MEDIATED SIGNALING,0.10558,0.054258,0.077141,0,1
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.26789,0.053602,0.060206,0,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.28395,0.053586,0.041892,0,1
2,GO CHROMOSOME SEPARATION,0.27673,0.053054,0.043861,0,1
2,GO RESPONSE TO ABIOTIC STIMULUS,0.1914,0.053049,0.051313,0,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.10646,0.052387,0.047236,0,1
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.10045,0.051995,0.051075,0,1
2,GO ENDOSOMAL TRANSPORT,0.10385,0.051325,0.054737,0,1
2,GO GPI ANCHOR METABOLIC PROCESS,0.54746,0.051046,0.030409,0,1
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.12924,0.050391,0.058804,0,1
2,GO REGULATION OF SPINDLE ASSEMBLY,0.2644,0.050172,0.074981,0,1
2,GO COVALENT CHROMATIN MODIFICATION,0.13979,0.04925,0.038391,0,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.11183,0.049209,0.058263,0,1
2,GO PROTEIN POLYMERIZATION,0.18194,0.04916,0.046265,0,1
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.53406,0.048895,0.027206,0,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.16407,0.046965,0.048566,0,1
2,GO MACROMOLECULE DEACYLATION,0.26267,0.045767,0.035127,0,1
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.1533,0.045058,0.048067,0,1
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.10299,0.044753,0.047753,0,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.096327,0.044317,0.051874,0,1
2,GO MITOTIC CELL CYCLE,0.10299,0.044078,0.04857,0,1
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.33803,0.043518,0.047906,0,1
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.48722,0.04339,0.025885,0,1
2,GO CYTOSOLIC TRANSPORT,0.63986,0.043266,0.017566,0,1
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.26964,0.039909,0.043381,0,1
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.26789,0.039438,0.036729,0,1
2,GO REGULATION OF MACROAUTOPHAGY,0.075009,0.03775,0.054812,0,1
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.27853,0.035394,0.030095,0,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.46218,0.034625,0.025131,0,1
2,GO DNA REPAIR,0.10385,0.033199,0.048593,0,1
2,GO GLUCOSE METABOLIC PROCESS,0.32592,0.031976,0.040636,0,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.13234,0.0314,0.054516,0,1
2,GO PEPTIDYL LYSINE MODIFICATION,0.1754,0.03135,0.03939,0,1
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.51557,0.030723,0.028595,0,1
2,GO CELL CYCLE CHECKPOINT,0.18461,0.029519,0.049611,0,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.76899,0.023814,0.026061,0,1
2,GO REGULATION OF HISTONE MODIFICATION,0.35674,0.023109,0.025234,0,1
2,GO FIBRINOLYSIS,0.1533,0.26807,0.12518,0,0
2,GO T CELL EXTRAVASATION,0.098784,0.26337,0.14904,0,0
2,GO GAP JUNCTION ASSEMBLY,0.12822,0.20813,0.11916,0,0
2,GO REGULATION OF PLATELET AGGREGATION,0.17156,0.20792,0.12683,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.11092,0.20522,0.10932,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.078382,0.20405,0.12181,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.21587,0.19784,0.095635,0,0
2,GO SKIN MORPHOGENESIS,0.10299,0.19492,0.18287,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.068006,0.19435,0.20405,0,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.067397,0.19337,0.14068,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.26095,0.19144,0.10748,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.069238,0.18856,0.13261,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.20122,0.18776,0.11611,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.13234,0.18326,0.12568,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.071119,0.18148,0.11835,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.13979,0.17904,0.093038,0,0
2,GO PROSTATIC BUD FORMATION,0.14197,0.17788,0.10953,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.11002,0.17679,0.18474,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.093918,0.17459,0.1372,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.23445,0.17115,0.10986,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.077018,0.16853,0.14843,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.14642,0.16808,0.11316,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.21738,0.16634,0.086543,0,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.091558,0.1657,0.088711,0,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.06986,0.16184,0.14207,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.21587,0.16127,0.099205,0,0
2,GO LIPID DIGESTION,0.22042,0.15525,0.090224,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.08331,0.15443,0.10174,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.081877,0.15367,0.13994,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.39832,0.15358,0.054799,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.23605,0.15087,0.052372,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.079071,0.14915,0.14128,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.35674,0.14792,0.046109,0,0
2,GO REGULATION OF COAGULATION,0.072397,0.14742,0.12155,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1754,0.14704,0.089215,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.32993,0.14495,0.0754,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.43789,0.14337,0.039575,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.068619,0.14287,0.11458,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.066792,0.1418,0.13591,0,0
2,GO REGULATION OF PINOCYTOSIS,0.12126,0.14167,0.11735,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.30829,0.14127,0.063006,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.085497,0.14053,0.11105,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.068619,0.14034,0.10757,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.080464,0.1383,0.083544,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.063258,0.13762,0.14118,0,0
2,GO P38MAPK CASCADE,0.068619,0.13664,0.10774,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.08331,0.13616,0.1059,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.43312,0.13382,0.085082,0,0
2,GO CELL CELL JUNCTION ASSEMBLY,0.10823,0.1334,0.09079,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.066792,0.13257,0.11232,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.10558,0.13213,0.092303,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.22042,0.13184,0.097202,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.13656,0.13106,0.1429,0,0
2,GO HISTAMINE SECRETION,0.2114,0.13094,0.082218,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.077018,0.12965,0.12615,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.1313,0.1294,0.10922,0,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.068619,0.12923,0.11941,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.25078,0.12848,0.06844,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.1387,0.12822,0.11373,0,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.078382,0.12747,0.10965,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.073043,0.12719,0.099484,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.19417,0.12671,0.078922,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.26964,0.12655,0.058078,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.08331,0.12626,0.1167,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.4355,0.12605,0.073267,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.066792,0.126,0.12542,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.078382,0.12565,0.15067,0,0
2,GO CELL CELL JUNCTION ORGANIZATION,0.069238,0.1255,0.10363,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.79387,0.12422,0.011532,0,0
2,GO OSTEOBLAST PROLIFERATION,0.087731,0.12386,0.129,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.11553,0.1232,0.11679,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.13338,0.12318,0.1212,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.14308,0.12277,0.142,0,0
2,GO REGULATION OF ANOIKIS,0.09796,0.12255,0.12644,0,0
2,GO SNORNA 3 END PROCESSING,0.090782,0.12241,0.075004,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.12421,0.12241,0.10943,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.48976,0.12205,0.076636,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.069238,0.12187,0.11399,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.093918,0.12116,0.13286,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.10734,0.1199,0.11101,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.090011,0.11959,0.1106,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.065596,0.11916,0.13226,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.065005,0.11914,0.12128,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.1262,0.11893,0.12358,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.68094,0.11884,0.058701,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.40058,0.11868,0.073801,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.24252,0.11828,0.050187,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.21738,0.1181,0.079435,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.096327,0.11666,0.08409,0,0
2,GO PANCREATIC JUICE SECRETION,0.13979,0.11648,0.099205,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.26789,0.11625,0.1008,0,0
2,GO PROTEIN TRIMERIZATION,0.077698,0.11624,0.095777,0,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.1533,0.11598,0.089919,0,0
2,GO AXONAL FASCICULATION,0.68988,0.11558,0.0038406,0,0
2,GO AORTA DEVELOPMENT,0.13027,0.1155,0.10757,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.22042,0.11538,0.080415,0,0
2,GO PROTEIN OXIDATION,0.33599,0.11453,0.057026,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.13338,0.11402,0.095805,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.10558,0.11397,0.10186,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.33599,0.11358,0.065841,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.13444,0.11312,0.081828,0,0
2,GO MUSCLE ADAPTATION,0.30637,0.11302,0.057284,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.25924,0.11295,0.071148,0,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.31021,0.11288,0.060615,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.09714,0.11267,0.11304,0,0
2,GO SUPEROXIDE ANION GENERATION,0.10734,0.1125,0.10874,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.22348,0.11229,0.080415,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.18327,0.11136,0.08409,0,0
2,GO MEMBRANE DISASSEMBLY,0.3442,0.10943,0.05907,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.096327,0.10928,0.10481,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.18866,0.10916,0.084494,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.28395,0.10847,0.07594,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.1873,0.10821,0.11658,0,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.10558,0.10811,0.23401,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.13549,0.10693,0.093889,0,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.13027,0.10686,0.10799,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.20992,0.10685,0.061254,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.42602,0.10675,0.049213,0,0
2,GO FILOPODIUM ASSEMBLY,0.082591,0.10672,0.091395,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.19278,0.10628,0.07211,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.099614,0.10578,0.088002,0,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.10129,0.10564,0.10283,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.16163,0.10551,0.08101,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.15921,0.10512,0.18016,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.12822,0.10504,0.11864,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.20845,0.10489,0.069141,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.42133,0.10477,0.042537,0,0
2,GO FLUID TRANSPORT,0.15098,0.10449,0.066759,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.077698,0.10399,0.082798,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.12029,0.10395,0.096642,0,0
2,GO HISTAMINE TRANSPORT,0.52082,0.10374,0.027601,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.064418,0.10311,0.12785,0,0
2,GO PLATELET DEGRANULATION,0.24252,0.10215,0.06962,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.27853,0.10205,0.072869,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.65734,0.10196,0.014254,0,0
2,GO TISSUE REMODELING,0.17156,0.10167,0.085586,0,0
2,GO EOSINOPHIL MIGRATION,0.20699,0.10145,0.087438,0,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.074349,0.10144,0.089345,0,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.066192,0.1013,0.17151,0,0
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.2913,0.10094,0.099922,0,0
2,GO HEART VALVE FORMATION,0.094715,0.10083,0.13635,0,0
2,GO RESPONSE TO WOUNDING,0.073043,0.10042,0.097731,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.19417,0.10031,0.080381,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.071756,0.099217,0.096302,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.44269,0.098996,0.035188,0,0
2,GO RESPONSE TO COPPER ION,0.13338,0.098754,0.12608,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.073694,0.098274,0.10014,0,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.068619,0.09792,0.073772,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.20122,0.097908,0.076781,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.47712,0.097827,0.032251,0,0
2,GO REGULATION OF NEURON MATURATION,0.08331,0.097761,0.1446,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.24745,0.09763,0.068871,0,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.29502,0.097611,0.075866,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.23605,0.097581,0.13504,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.084763,0.097564,0.081568,0,0
2,GO MESONEPHROS DEVELOPMENT,0.1387,0.097449,0.08178,0,0
2,GO CELL MATRIX ADHESION,0.071119,0.097124,0.11347,0,0
2,GO MIDGUT DEVELOPMENT,0.36526,0.096835,0.069466,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.093126,0.096835,0.076921,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.29502,0.096623,0.053232,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.41899,0.096404,0.084807,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.35886,0.09629,0.059958,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.091558,0.096167,0.11682,0,0
2,GO AMYLOID BETA FORMATION,0.073043,0.095915,0.10059,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.19697,0.095822,0.090289,0,0
2,GO VAGINA DEVELOPMENT,0.5394,0.095793,0.024474,0,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.062114,0.095421,0.10295,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.47211,0.094978,0.049091,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.19557,0.094934,0.07447,0,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.075009,0.094616,0.080589,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.20845,0.094307,0.11851,0,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.18194,0.094216,0.075031,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.35463,0.093736,0.082959,0,0
2,GO REGULATION OF TISSUE REMODELING,0.44752,0.093717,0.053273,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.15565,0.093649,0.1129,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.14755,0.093361,0.131,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.1653,0.0932,0.071461,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.51819,0.093143,0.059325,0,0
2,GO SIGNAL PEPTIDE PROCESSING,0.077698,0.09298,0.11042,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.10646,0.092872,0.078823,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.14088,0.092707,0.089028,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.15921,0.092646,0.094282,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.23766,0.092344,0.063973,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.11367,0.092303,0.076457,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.17283,0.092062,0.085461,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.4355,0.091654,0.023749,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.1793,0.091217,0.10649,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.1453,0.090881,0.094251,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.11647,0.090861,0.07771,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.15447,0.090378,0.12841,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.23605,0.090216,0.058182,0,0
2,GO BIOLOGICAL ADHESION,0.073694,0.089701,0.08941,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.43075,0.089571,0.046133,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.086237,0.089135,0.13917,0,0
2,GO NEURAL TUBE DEVELOPMENT,0.16285,0.088712,0.092036,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.37608,0.088476,0.068202,0,0
2,GO MACROPHAGE PROLIFERATION,0.2644,0.088404,0.079149,0,0
2,GO AGING,0.11553,0.088114,0.062954,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.22348,0.087811,0.063467,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.13444,0.087795,0.086192,0,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.093126,0.087777,0.067435,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.087731,0.087596,0.066874,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.33396,0.087581,0.065591,0,0
2,GO QUINONE METABOLIC PROCESS,0.096327,0.087506,0.080748,0,0
2,GO UV PROTECTION,0.12126,0.087371,0.092605,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.23286,0.087361,0.091099,0,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.36526,0.087241,0.074376,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.35253,0.087108,0.093089,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.26964,0.087005,0.078413,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.10823,0.087001,0.065534,0,0
2,GO RESPONSE TO PROGESTERONE,0.10129,0.086973,0.12146,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.22971,0.086889,0.15665,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.10214,0.08669,0.098679,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.13656,0.086522,0.071165,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.61972,0.086301,0.043698,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.12029,0.086159,0.069499,0,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.09796,0.085987,0.0758,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.22503,0.085902,0.045779,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.15098,0.085473,0.11824,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.34835,0.085399,0.021107,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.17029,0.085319,0.055743,0,0
2,GO ODONTOGENESIS,0.18327,0.084997,0.091718,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.2114,0.084902,0.10453,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.40286,0.084773,0.027827,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.065005,0.084754,0.086274,0,0
2,GO BONE REMODELING,0.37173,0.084725,0.064201,0,0
2,GO MESENCHYME MORPHOGENESIS,0.91451,0.084217,0.012072,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.29689,0.084196,0.067421,0,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.070488,0.083984,0.086388,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.18595,0.083884,0.087876,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.32393,0.083873,0.083959,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.11742,0.083858,0.07799,0,0
2,GO MEMBRANE RAFT ORGANIZATION,0.18866,0.08378,0.13915,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.1252,0.083629,0.070794,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.13444,0.083562,0.12585,0,0
2,GO BONE CELL DEVELOPMENT,0.23128,0.083363,0.10957,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.20845,0.08334,0.085053,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.11933,0.083244,0.067812,0,0
2,GO REGULATION OF MAPK CASCADE,0.063836,0.083166,0.079528,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.19278,0.083052,0.067326,0,0
2,GO REPLICATION FORK PROCESSING,0.11933,0.082945,0.079607,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.22814,0.082856,0.028919,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.17029,0.082561,0.12766,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.093918,0.082536,0.08302,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.091558,0.08249,0.082414,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.24745,0.082434,0.071897,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.19979,0.082351,0.071457,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.19003,0.08231,0.053571,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.25078,0.082207,0.073714,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.75664,0.082156,0.01896,0,0
2,GO MALE SEX DETERMINATION,0.32792,0.082055,0.070658,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.36956,0.081987,0.031118,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.43789,0.081902,0.058768,0,0
2,GO LIPOXYGENASE PATHWAY,0.31409,0.081638,0.089499,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.066192,0.081596,0.11177,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.10646,0.081554,0.064895,0,0
2,GO PHOSPHOLIPID TRANSPORT,0.13979,0.081494,0.077765,0,0
2,GO LIPID DROPLET ORGANIZATION,0.20409,0.081474,0.056932,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.10558,0.081382,0.067475,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.13234,0.08126,0.069644,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.075674,0.081156,0.08467,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.23445,0.080842,0.064242,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.10214,0.080507,0.072377,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.62832,0.080066,0.021294,0,0
2,GO KERATINOCYTE MIGRATION,0.075674,0.079379,0.10921,0,0
2,GO RESPONSE TO VITAMIN D,0.090782,0.079272,0.098738,0,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.087731,0.079165,0.084887,0,0
2,GO INTEGRIN ACTIVATION,0.12322,0.078957,0.1039,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.084763,0.07894,0.083631,0,0
2,GO XENOBIOTIC TRANSPORT,0.21889,0.078921,0.079104,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.1313,0.07876,0.075006,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.16654,0.078677,0.070689,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.12322,0.078604,0.06276,0,0
2,GO GLIAL CELL PROLIFERATION,0.077698,0.078301,0.0972,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.22348,0.078151,0.092936,0,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.15921,0.077936,0.076895,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.21437,0.077651,0.065134,0,0
2,GO RESPONSE TO HORMONE,0.089246,0.077578,0.069077,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.26614,0.077449,0.049464,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.59144,0.077416,0.011934,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.1387,0.077193,0.094908,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.51035,0.077115,0.068361,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.36741,0.077113,0.11117,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.13549,0.077068,0.094182,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.11933,0.077033,0.069712,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.069238,0.076792,0.1263,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.09796,0.076661,0.089875,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.13234,0.076487,0.079628,0,0
2,GO DECIDUALIZATION,0.2458,0.076285,0.075907,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.12322,0.076268,0.071301,0,0
2,GO OSSIFICATION,0.55287,0.076154,0.040133,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.30446,0.075674,0.086047,0,0
2,GO RUFFLE ASSEMBLY,0.093126,0.075669,0.081422,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.089246,0.075557,0.076211,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.080464,0.075534,0.070975,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.12224,0.075433,0.080577,0,0
2,GO REGULATION OF OSSIFICATION,0.28395,0.075304,0.066478,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.086981,0.075181,0.07679,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.13234,0.075165,0.11442,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.14419,0.074899,0.055526,0,0
2,GO SHORT TERM MEMORY,0.21288,0.0748,0.084463,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.13234,0.074707,0.064029,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.35674,0.07446,0.039949,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.41666,0.074388,0.053332,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.22042,0.074279,0.058248,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.10385,0.074178,0.091356,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.51819,0.07409,0.048396,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.34835,0.074051,0.048225,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.28945,0.073914,0.056883,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.14308,0.073796,0.088702,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.15921,0.07377,0.074777,0,0
2,GO PROSTAGLANDIN SECRETION,0.12322,0.073737,0.087941,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.13027,0.073363,0.054657,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.26964,0.073234,0.060625,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.44269,0.073113,0.054733,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.7814,0.072782,0.028337,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.38267,0.07266,0.067051,0,0
2,GO RENAL SYSTEM PROCESS,0.22348,0.072489,0.070383,0,0
2,GO GLYCOSYLATION,0.22814,0.072384,0.044182,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.10129,0.072251,0.14228,0,0
2,GO REGULATION OF CELL AGING,0.22658,0.072098,0.048209,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.063258,0.071763,0.1172,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.41899,0.07175,0.060591,0,0
2,GO MESODERM MORPHOGENESIS,0.20409,0.07163,0.068795,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.15683,0.071619,0.06414,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.28395,0.071557,0.076419,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.41666,0.071543,0.028808,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.4451,0.071018,0.043749,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.077018,0.070993,0.072572,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.06986,0.070973,0.072776,0,0
2,GO PIGMENTATION,0.29502,0.070882,0.044382,0,0
2,GO HINDLIMB MORPHOGENESIS,0.20699,0.070828,0.089294,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.32195,0.070778,0.10066,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.16904,0.070356,0.05917,0,0
2,GO RESPONSE TO INSULIN,0.13234,0.070351,0.06173,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.5,0.070309,0.030132,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.081168,0.070224,0.13299,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.15214,0.070031,0.08473,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.65442,0.06992,0.060929,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.2714,0.069872,0.10079,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.11647,0.069773,0.10213,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.47963,0.069759,0.03862,0,0
2,GO POSITIVE T CELL SELECTION,0.096327,0.069752,0.10707,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.35674,0.069715,0.050252,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.16654,0.069643,0.082688,0,0
2,GO BONE RESORPTION,0.33599,0.069572,0.063622,0,0
2,GO HEART MORPHOGENESIS,0.46713,0.069358,0.044493,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.35043,0.069317,0.066719,0,0
2,GO RENAL FILTRATION,0.37173,0.069119,0.086592,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.17029,0.068714,0.11984,0,0
2,GO DE NOVO PROTEIN FOLDING,0.53406,0.068526,0.022308,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.20409,0.068356,0.069271,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.16163,0.068266,0.069501,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.063836,0.068163,0.14058,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.18461,0.068156,0.082528,0,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.17283,0.068141,0.054344,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.20409,0.067979,0.050014,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.12421,0.067784,0.098681,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.10299,0.067733,0.056765,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.1252,0.06768,0.068165,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.22971,0.067596,0.066944,0,0
2,GO CYTOPLASMIC TRANSLATION,0.068006,0.06743,0.061878,0,0
2,GO PROTEIN AUTOUBIQUITINATION,0.18327,0.06738,0.041858,0,0
2,GO HISTONE H2A UBIQUITINATION,0.26614,0.067278,0.046545,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.12126,0.067278,0.082246,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.47211,0.067252,0.035773,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.073694,0.067234,0.078085,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.086981,0.067117,0.1138,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.34627,0.06698,0.055478,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.1793,0.066832,0.071038,0,0
2,GO INNER EAR MORPHOGENESIS,0.081877,0.066808,0.078169,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.12029,0.066737,0.11577,0,0
2,GO VACUOLAR TRANSPORT,0.55016,0.066718,0.03332,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.20554,0.066627,0.081003,0,0
2,GO CELLULAR SENESCENCE,0.095518,0.066478,0.060192,0,0
2,GO GLAND DEVELOPMENT,0.48976,0.066172,0.043613,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.25583,0.066162,0.09136,0,0
2,GO RESPONSE TO ZINC ION,0.19697,0.06606,0.079274,0,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.34835,0.065931,0.069327,0,0
2,GO FACE DEVELOPMENT,0.13338,0.065888,0.11041,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.23605,0.065886,0.060756,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.61687,0.065881,0.022864,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.37827,0.065586,0.076425,0,0
2,GO RESPONSE TO WATER,0.31604,0.065218,0.087837,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.22658,0.065078,0.063987,0,0
2,GO ORGAN GROWTH,0.082591,0.065057,0.098798,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.29315,0.064866,0.060411,0,0
2,GO STEROL TRANSPORT,0.064418,0.064788,0.10877,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.27495,0.064647,0.049486,0,0
2,GO VESICLE ORGANIZATION,0.40514,0.064345,0.036524,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.5,0.064241,0.048498,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.12924,0.064153,0.087161,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.13234,0.064108,0.077392,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.24252,0.063778,0.043147,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.10129,0.063589,0.070184,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.36098,0.063533,0.043538,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.065596,0.063478,0.067346,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.090011,0.063315,0.062326,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.1453,0.063303,0.08955,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.09714,0.063233,0.075276,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.14197,0.063227,0.071575,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.51819,0.063197,0.052361,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.14197,0.063194,0.076914,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.24089,0.06304,0.053066,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.26789,0.062892,0.060499,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.53406,0.062736,0.024893,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.32195,0.062672,0.047867,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.077698,0.062627,0.059474,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.090782,0.062626,0.12983,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.19838,0.062408,0.045284,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.23766,0.062349,0.056342,0,0
2,GO HEART DEVELOPMENT,0.49231,0.062341,0.040939,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.085497,0.062339,0.11854,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.18327,0.062314,0.064197,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.40743,0.062273,0.13407,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.26964,0.062146,0.07667,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.21738,0.062143,0.055825,0,0
2,GO REGULATION OF BINDING,0.74741,0.06206,0.023017,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.12322,0.061683,0.086935,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.15802,0.061678,0.059239,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.11742,0.061607,0.068992,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.26267,0.061577,0.08761,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.36098,0.06136,0.053207,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.12322,0.061335,0.13006,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.1453,0.061314,0.063296,0,0
2,GO ANOIKIS,0.1313,0.061283,0.10092,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.14088,0.061147,0.079837,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.071756,0.061134,0.093377,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.72299,0.061078,0.020205,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.24911,0.060863,0.045424,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.19838,0.060717,0.069206,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.1453,0.060673,0.060615,0,0
2,GO FEMALE GAMETE GENERATION,0.14983,0.060607,0.041287,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.57476,0.060587,0.043923,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.80953,0.06049,0.0056265,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.082591,0.060422,0.079408,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.76899,0.06024,0.044336,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.090011,0.060121,0.089615,0,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.31215,0.060052,0.065075,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.32993,0.059594,0.052998,0,0
2,GO EXOCYTOSIS,0.087731,0.059515,0.073962,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.075009,0.059487,0.090159,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.10299,0.059484,0.075851,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.23286,0.059424,0.068491,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.1754,0.059416,0.056438,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.1754,0.059413,0.071078,0,0
2,GO REGULATION OF PROTEIN BINDING,0.11933,0.059306,0.070196,0,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.20992,0.059191,0.062019,0,0
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.20122,0.059139,0.057266,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.95961,0.059131,-0.0099227,0,0
2,GO SARCOMERE ORGANIZATION,0.1313,0.058943,0.088018,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.11837,0.058849,0.07687,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.75664,0.058845,0.034164,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.94671,0.058656,0.0042365,0,0
2,GO FUCOSE METABOLIC PROCESS,0.68392,0.058585,0.028835,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.13656,0.058526,0.11214,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.20992,0.058343,0.062344,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.093126,0.058332,0.065807,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.6515,0.058292,0.035168,0,0
2,GO RESPONSE TO ETHANOL,0.2114,0.058235,0.060447,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.33803,0.058219,0.035019,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.080464,0.05799,0.062851,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.28578,0.057873,0.072892,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.27317,0.057848,0.069906,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.10214,0.057756,0.069406,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.10129,0.057751,0.10479,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.28578,0.057687,0.049609,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.39606,0.057578,0.039223,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.37827,0.056939,0.043631,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.39156,0.056675,0.028044,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.797,0.056606,0.00097851,0,0
2,GO BLOOD VESSEL REMODELING,0.11275,0.056478,0.091549,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.14869,0.056424,0.059913,0,0
2,GO CELL MOTILITY,0.23445,0.056333,0.061214,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.14869,0.056314,0.10731,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.59705,0.056284,0.03006,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.24252,0.056229,0.042526,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.18461,0.05611,0.08329,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.1387,0.056018,0.088142,0,0
2,GO T CELL SELECTION,0.10299,0.055727,0.096656,0,0
2,GO MYOFIBRIL ASSEMBLY,0.12421,0.055691,0.077926,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.10912,0.055465,0.10522,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.318,0.055346,0.053122,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.32792,0.055324,0.042864,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.10214,0.05528,0.06075,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.25414,0.055234,0.086109,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.12224,0.055154,0.084419,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.74741,0.054826,0.011469,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.25583,0.054804,0.063814,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.84424,0.054788,0.018803,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.30637,0.054786,0.06852,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.27853,0.054759,0.086071,0,0
2,GO KIDNEY MORPHOGENESIS,0.11183,0.054701,0.080573,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.65734,0.054646,0.052598,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.073694,0.054558,0.095891,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.59144,0.054342,0.034599,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.21587,0.054121,0.076853,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.28395,0.054029,0.048216,0,0
2,GO PROTEIN KINASE A SIGNALING,0.13979,0.05401,0.068927,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.28213,0.053962,0.079993,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.14983,0.053739,0.094272,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.30066,0.05358,0.047266,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.44028,0.05353,0.050926,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.33194,0.053507,0.045926,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.33194,0.053382,0.050888,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.094715,0.053298,0.065116,0,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.46218,0.053282,0.059866,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.59144,0.053263,0.043966,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.30829,0.053253,0.070257,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.14419,0.053084,0.065581,0,0
2,GO SULFATION,0.27495,0.052926,0.081425,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.25583,0.052894,0.06851,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.13549,0.052868,0.05953,0,0
2,GO EMBRYO DEVELOPMENT,0.22348,0.052806,0.053206,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.28945,0.052798,0.042029,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.58307,0.052796,0.045206,0,0
2,GO PROTEIN REFOLDING,0.72907,0.052792,0.015533,0,0
2,GO DIOL METABOLIC PROCESS,0.35253,0.052781,0.051268,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.41434,0.052703,0.052537,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.50516,0.052555,0.050308,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.32592,0.052486,0.038683,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.19417,0.05239,0.037956,0,0
2,GO CYTOSKELETON ORGANIZATION,0.3871,0.05235,0.03621,0,0
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.11553,0.052295,0.059078,0,0
2,GO PROTEIN STABILIZATION,0.11092,0.052208,0.063184,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.16904,0.052194,0.072792,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.45727,0.052133,0.036106,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.82211,0.052109,0.024491,0,0
2,GO REGULATION OF CELL DIVISION,0.50776,0.052022,0.028755,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.1754,0.051947,0.068705,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.9113,0.051789,-0.0053943,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.71996,0.051784,0.024801,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.61117,0.051667,0.026813,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.065596,0.051625,0.084006,0,0
2,GO HEART VALVE DEVELOPMENT,0.72603,0.051594,0.035252,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.10912,0.051558,0.069549,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.33396,0.051484,0.056987,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.14642,0.051392,0.064776,0,0
2,GO ANIMAL ORGAN FORMATION,0.98546,0.051377,0.0015578,0,0
2,GO CELL CYCLE ARREST,0.22658,0.051264,0.039889,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.23766,0.05126,0.047583,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.49487,0.051251,0.047149,0,0
2,GO MESENCHYME DEVELOPMENT,0.68988,0.051206,0.036314,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.077018,0.051094,0.051334,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.21889,0.051002,0.057237,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.18327,0.050995,0.073463,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.41666,0.05093,0.066765,0,0
2,GO DNA STRAND ELONGATION,0.5314,0.050839,0.035756,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.09714,0.050741,0.054995,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.40743,0.050695,0.033099,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.11002,0.050654,0.086301,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.11553,0.050606,0.069728,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.49231,0.050506,0.046583,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.077698,0.050493,0.073416,0,0
2,GO DNA DEALKYLATION,0.27673,0.050389,0.062518,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.53672,0.05034,0.019926,0,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.42602,0.050283,0.091955,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.41203,0.050221,0.059904,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.24745,0.050118,0.071524,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.97253,0.050111,0.011264,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.11092,0.050099,0.064555,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.30066,0.050089,0.10761,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.15802,0.049878,0.07258,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15802,0.049802,0.052842,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.22658,0.04967,0.084212,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.25583,0.049583,0.064065,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.49231,0.049539,0.047582,0,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.21587,0.049449,0.050539,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.63408,0.049419,0.030176,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.57476,0.049397,0.028146,0,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.52609,0.049339,0.045058,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.39381,0.049159,0.062917,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.52609,0.049155,0.044003,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.1914,0.049052,0.044316,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.48976,0.049006,0.046896,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.33194,0.048875,0.049879,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.17029,0.048853,0.084478,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.92738,0.048775,-0.014237,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.40286,0.048734,0.025938,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.6515,0.048691,0.025558,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.19697,0.048681,0.064999,0,0
2,GO NEURAL CREST CELL MIGRATION,0.47712,0.048585,0.049606,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.14088,0.048499,0.082861,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.63408,0.04848,0.030245,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.25414,0.048427,0.060813,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.12224,0.048222,0.084318,0,0
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.29877,0.048121,0.043812,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.06986,0.048031,0.051394,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.09796,0.047967,0.07302,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.1873,0.047911,0.064314,0,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.076344,0.047864,0.081326,0,0
2,GO LYSOSOMAL TRANSPORT,0.82526,0.047815,0.021974,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.32792,0.047596,0.047623,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.56103,0.047589,0.04059,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.46713,0.047548,0.028476,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.63986,0.047495,-0.036082,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.28213,0.047492,0.065242,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.073694,0.047397,0.079457,0,0
2,GO LACTATE METABOLIC PROCESS,0.32792,0.047396,0.053,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.26789,0.047337,0.056186,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.21587,0.047234,0.058096,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.49231,0.047119,0.04759,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.14419,0.047118,0.062771,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.32792,0.046982,0.040171,0,0
2,GO DNA RECOMBINATION,0.064418,0.046963,0.066799,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.21587,0.046861,0.049095,0,0
2,GO RETINA HOMEOSTASIS,0.11647,0.046782,0.046268,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.11647,0.046712,0.043333,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.42602,0.046712,0.031778,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.88885,0.046597,-0.00043055,0,0
2,GO POSTREPLICATION REPAIR,0.16778,0.046597,0.05256,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.23445,0.046563,0.094722,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.22814,0.046467,0.046728,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.797,0.046364,0.038819,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.6312,0.046279,0.038,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.75972,0.046152,0.02976,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.27495,0.046148,0.065073,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.22195,0.04612,0.054889,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.68988,0.046093,0.02409,0,0
2,GO HOMEOSTATIC PROCESS,0.17411,0.046049,0.046256,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.28945,0.045959,0.048883,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.80012,0.045943,0.0043109,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.95639,0.04594,-0.018617,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.51819,0.045686,0.027543,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.52609,0.045672,0.033942,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.40743,0.045652,0.044448,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.61402,0.045641,0.033193,0,0
2,GO APPENDAGE DEVELOPMENT,0.18461,0.045474,0.076716,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.4451,0.045374,0.030384,0,0
2,GO POSITIVE REGULATION OF SIGNALING,0.572,0.045267,0.028998,0,0
2,GO ACTIN CROSSLINK FORMATION,0.75048,0.045261,-0.03941,0,0
2,GO EXIT FROM MITOSIS,0.5,0.045175,0.013216,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.10214,0.045139,0.082852,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.19979,0.045107,0.063604,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.28945,0.045106,0.10352,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.74435,0.044974,0.023911,0,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.26964,0.044921,0.045387,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.1793,0.044843,0.12155,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.16654,0.044812,0.055569,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.92416,0.0448,-0.0094674,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.1914,0.044794,0.071316,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.76899,0.044739,0.030196,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.318,0.044573,0.061061,0,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.17411,0.044456,0.055784,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.50776,0.044428,0.031589,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.19838,0.044421,0.051514,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.48722,0.044335,0.033512,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.24745,0.044312,0.056197,0,0
2,GO NADH METABOLIC PROCESS,0.36526,0.044119,0.062658,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.2714,0.044083,0.063339,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.073043,0.043967,0.077119,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42133,0.043888,0.039579,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.22042,0.043884,0.071425,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.37608,0.043729,0.044065,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.15098,0.043594,0.08551,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.51557,0.043588,0.034153,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.318,0.043425,0.048205,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.72603,0.04335,0.028125,0,0
2,GO REGULATION OF AUTOPHAGY,0.063836,0.043312,0.061516,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.11933,0.043203,0.092388,0,0
2,GO MITOTIC CYTOKINESIS,0.25414,0.043182,0.051369,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.47211,0.042992,0.046615,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.54477,0.042915,0.040349,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.80953,0.042885,-0.01659,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.25414,0.042798,0.048643,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.97899,0.042686,0.0064814,0,0
2,GO RNA CAPPING,0.079071,0.042645,0.05476,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.74435,0.042538,0.011113,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.80326,0.042492,0.035372,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.31215,0.042487,0.04663,0,0
2,GO CHOLESTEROL EFFLUX,0.11275,0.042471,0.091251,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.70486,0.042463,0.027388,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.35886,0.042258,0.040916,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.32792,0.04224,0.048689,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.54746,0.042181,0.066243,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.11275,0.042151,0.074122,0,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.21437,0.042089,0.049495,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.79387,0.042051,0.013639,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.1873,0.041781,0.059833,0,0
2,GO REGULATION OF MRNA BINDING,0.41899,0.041751,0.035547,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.53406,0.041749,0.03782,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.178,0.041701,0.078525,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.40973,0.041632,0.038752,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.13656,0.041224,0.063852,0,0
2,GO MUSCLE HYPERTROPHY,0.58864,0.041207,0.038624,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.19697,0.041102,0.047939,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.30637,0.040756,0.060943,0,0
2,GO SEX DIFFERENTIATION,0.39381,0.04071,0.031753,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.32792,0.040661,0.048603,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.24416,0.040607,0.05493,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.13338,0.040481,0.1049,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.19557,0.040401,0.054641,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.5,0.040357,-0.043866,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.55016,0.040238,0.023041,0,0
2,GO DRUG METABOLIC PROCESS,0.6312,0.040108,0.03412,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.58864,0.040078,0.031971,0,0
2,GO URONIC ACID METABOLIC PROCESS,0.067397,0.040077,0.073213,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.5,0.040064,0.038165,0,0
2,GO REGULATION OF MYELINATION,0.27495,0.040054,0.060421,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.5314,0.03989,0.047796,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.25753,0.039862,0.034935,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.50258,0.039824,0.034106,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.58307,0.039824,0.031544,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.97576,0.039791,0.00086493,0,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.51035,0.0395,0.038779,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.90167,0.039475,0.025951,0,0
2,GO BICARBONATE TRANSPORT,0.42133,0.03943,0.034448,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.2913,0.039231,0.057229,0,0
2,GO VASCULAR WOUND HEALING,0.74741,0.039188,0.035968,0,0
2,GO TRANSLESION SYNTHESIS,0.178,0.039182,0.053817,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.58864,0.039069,0.0323,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.16407,0.039066,0.11169,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.9306,0.0388,0.0049854,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.21587,0.038585,0.046491,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.67206,0.038491,0.023117,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.17411,0.038403,0.10771,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.25924,0.038375,0.075872,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.50776,0.038371,0.037422,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.23766,0.03834,0.044218,0,0
2,GO BODY MORPHOGENESIS,0.94348,0.038279,0.022931,0,0
2,GO FOAM CELL DIFFERENTIATION,0.09714,0.038269,0.1157,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.45482,0.038209,0.038046,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.10214,0.038097,0.09633,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.36741,0.038042,0.041987,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.15921,0.037939,0.07503,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.3871,0.037898,0.056949,0,0
2,GO MANNOSYLATION,0.93704,0.03783,0.008055,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.93382,0.037735,0.0002371,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.49487,0.037628,0.05001,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.1262,0.037527,0.061975,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.34835,0.037497,0.060227,0,0
2,GO VIRAL BUDDING,0.12721,0.037479,0.073163,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.34627,0.037468,0.050827,0,0
2,GO TAXIS,0.56376,0.037325,0.033454,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.084763,0.037315,0.048496,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.40973,0.037314,0.040374,0,0
2,GO LYSOSOME LOCALIZATION,0.54208,0.0373,0.032976,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.46713,0.037245,0.043012,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.36956,0.037231,0.047592,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.48468,0.037203,0.043811,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.38933,0.037151,0.049901,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.33396,0.037127,0.045499,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.40743,0.037119,0.044277,0,0
2,GO TRANSPOSITION,0.44028,0.036873,0.053847,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.70787,0.036683,0.025446,0,0
2,GO RESPONSE TO ACIDIC PH,0.89846,0.036607,0.00064738,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.572,0.036509,0.030442,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.14983,0.036398,0.058711,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.59705,0.036383,0.030355,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.40058,0.036372,0.045652,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.35886,0.036335,0.080523,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.90167,0.03632,0.018035,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.39381,0.036262,0.062492,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.080464,0.036207,0.078247,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.82526,0.035938,0.019512,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.572,0.035934,0.032089,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.38267,0.035927,0.040122,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.12029,0.035901,0.048995,0,0
2,GO HISTONE H3 DEACETYLATION,0.25414,0.03575,0.0592,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.78763,0.035746,0.04189,0,0
2,GO G0 TO G1 TRANSITION,0.24089,0.035718,0.045892,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.90488,0.035654,-0.00023015,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.59986,0.035647,0.054032,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.47712,0.035595,0.035037,0,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.09714,0.035527,0.09365,0,0
2,GO REGULATION OF DNA REPAIR,0.46466,0.035463,0.031188,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.49743,0.035418,0.0434,0,0
2,GO T CELL HOMEOSTASIS,0.19417,0.03515,0.064841,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.1914,0.035123,0.04706,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.65442,0.035107,0.012853,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.77209,0.035029,0.014023,0,0
2,GO MAGNESIUM ION TRANSPORT,0.92738,0.035004,-0.01813,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.65442,0.034873,0.024135,0,0
2,GO REGULATION OF EXCRETION,0.59424,0.034846,0.045799,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.27853,0.034817,0.056447,0,0
2,GO RENAL SODIUM EXCRETION,0.75048,0.034743,0.02959,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.14983,0.034597,0.046543,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21437,0.034485,0.074803,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.25078,0.034448,0.099279,0,0
2,GO GOLGI ORGANIZATION,0.30446,0.03442,0.050352,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.25078,0.034302,0.10555,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.84741,0.034263,0.011574,0,0
2,GO DIET INDUCED THERMOGENESIS,0.94671,0.034172,0.00099566,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.42133,0.034147,0.058456,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.318,0.034059,0.051037,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.41899,0.033984,0.034864,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.13234,0.033926,0.04666,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.10823,0.033701,0.061956,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.67501,0.033556,0.02744,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.68689,0.033147,-0.012046,0,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.47461,0.033133,0.032781,0,0
2,GO REGULATION OF RNA SPLICING,0.318,0.033029,0.038299,0,0
2,GO CELL CYCLE PROCESS,0.12322,0.033011,0.042124,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.70787,0.032935,0.020981,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.39832,0.0329,0.051578,0,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.34627,0.032876,0.069193,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.43312,0.032873,0.041625,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.30066,0.032761,0.048749,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.71391,0.032705,0.022023,0,0
2,GO REGULATION OF CHEMOTAXIS,0.15802,0.032562,0.073879,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.81896,0.032478,-0.039622,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.89846,0.032446,0.012106,0,0
2,GO SECRETION,0.45727,0.032371,0.031568,0,0
2,GO MUSCLE FILAMENT SLIDING,0.53672,0.032356,0.026537,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.95639,0.032332,0.017527,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.91772,0.032168,0.013825,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.55558,0.032166,0.028816,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.28395,0.032115,0.047955,0,0
2,GO OXIDATIVE PHOSPHORYLATION,0.19003,0.032072,0.057149,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.44269,0.032006,0.038843,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.5,0.03199,0.072629,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.34213,0.03196,0.045682,0,0
2,GO RRNA 3 END PROCESSING,0.32195,0.031626,0.048016,0,0
2,GO VESICLE LOCALIZATION,0.52609,0.03124,0.017659,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.063258,0.031136,0.096648,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.78763,0.031121,0.028182,0,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.45727,0.030846,0.05626,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.96607,0.030814,0.018488,0,0
2,GO RECEPTOR INTERNALIZATION,0.63697,0.030784,0.034357,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.63986,0.030767,0.035023,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.64858,0.030753,-0.038584,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.29689,0.030729,0.071198,0,0
2,GO ENDOCYTIC RECYCLING,0.46713,0.0307,0.049556,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.1754,0.030559,0.047652,0,0
2,GO PROTEIN NEDDYLATION,0.29877,0.030501,0.040796,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.71391,0.030492,0.027718,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.14869,0.030425,0.07977,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.82211,0.030398,0.013491,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.36526,0.030392,0.087754,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.22503,0.030371,0.064632,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.10214,0.030366,0.041709,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.6055,0.030353,0.029616,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.31215,0.030319,0.039276,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.73212,0.03031,-0.015386,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.95639,0.030275,0.010472,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.22348,0.030268,0.10073,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.54208,0.030167,0.020618,0,0
2,GO RESPONSE TO EPINEPHRINE,0.58864,0.030119,0.061189,0,0
2,GO CHROMATIN ORGANIZATION,0.22195,0.029921,0.030827,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.14419,0.029921,0.04939,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.72603,0.029629,0.029403,0,0
2,GO HISTONE H3 K9 METHYLATION,0.44028,0.029474,0.037334,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.47461,0.029397,0.014282,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.77829,0.029392,0.022837,0,0
2,GO REGULATION OF HEART GROWTH,0.36526,0.029365,0.048875,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.87287,0.029362,0.010447,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.50258,0.029358,0.043536,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.6515,0.029335,0.036118,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.2114,0.029203,0.079383,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.67206,0.029192,0.035766,0,0
2,GO ORGANELLE INHERITANCE,0.20122,0.029113,0.051624,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.63697,0.028878,0.034073,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.8379,0.028817,-0.017177,0,0
2,GO SNRNA TRANSCRIPTION,0.10129,0.02867,0.056921,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.45972,0.028643,0.043879,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.76899,0.028635,-0.028515,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.22195,0.028594,0.057469,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.26095,0.028522,0.044199,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.78451,0.028502,0.028955,0,0
2,GO CHEMICAL HOMEOSTASIS,0.94026,0.028441,0.013299,0,0
2,GO METHIONINE METABOLIC PROCESS,0.75972,0.028342,0.010549,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.090782,0.028318,0.093943,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.79387,0.028293,0.0027613,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.38488,0.028189,0.038048,0,0
2,GO CHROMOSOME ORGANIZATION,0.095518,0.028176,0.04425,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.7659,0.028159,-0.011541,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.22814,0.028127,0.049694,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.68392,0.028067,0.032511,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.71089,0.028035,-0.036218,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.90488,0.027984,0.020802,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.70486,0.027969,0.036934,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.32993,0.027962,0.073335,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.29689,0.02796,0.057244,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.94026,0.027915,0.018858,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.38933,0.02783,0.039031,0,0
2,GO COENZYME A METABOLIC PROCESS,0.63697,0.027785,0.034194,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.67206,0.027729,0.014031,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.36526,0.027727,0.074761,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.7659,0.027724,0.021479,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.62545,0.027644,0.027803,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.79387,0.02755,0.030131,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.59144,0.027541,0.028029,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.82526,0.027527,0.04018,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.23766,0.027421,0.060685,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.60268,0.027311,0.04024,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.46962,0.027305,0.043733,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.88565,0.027236,-0.0075792,0,0
2,GO MIDBODY ABSCISSION,0.5314,0.027204,0.059922,0,0
2,GO REGULATION OF CELLULAR PH,0.49743,0.026943,0.027192,0,0
2,GO APPENDAGE MORPHOGENESIS,0.32792,0.026901,0.067042,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.93704,0.026885,0.0087585,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.79075,0.026854,0.017728,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.16163,0.026736,0.066724,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.64276,0.026709,0.024777,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.58585,0.026631,0.034211,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.34008,0.026611,0.040466,0,0
2,GO VACUOLAR ACIDIFICATION,0.34835,0.026442,0.043171,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.78451,0.026417,0.02217,0,0
2,GO MITOCHONDRION ORGANIZATION,0.19697,0.02641,0.042873,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.74128,0.026409,-0.04183,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.14983,0.026335,0.044288,0,0
2,GO ORGANELLE DISASSEMBLY,0.51296,0.026136,0.026911,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.1914,0.026042,0.098807,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.12924,0.025931,0.088113,0,0
2,GO REGULATION OF RNA BINDING,0.47712,0.025919,0.030037,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.78763,0.025809,-0.02489,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10646,0.025618,0.051567,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.71693,0.025583,0.025208,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.62545,0.025437,-0.026179,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.75048,0.025338,-0.013997,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.1387,0.025308,0.068763,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.13549,0.025272,0.18259,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.64276,0.025149,0.024746,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.70787,0.025142,0.0218,0,0
2,GO PROTEIN TETRAMERIZATION,0.2714,0.024992,0.048205,0,0
2,GO WATER TRANSPORT,0.61402,0.024975,0.0091007,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.95316,0.02494,0.0080309,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.17156,0.024909,0.064372,0,0
2,GO RESPONSE TO PEPTIDE,0.18194,0.024887,0.053699,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.73822,0.024831,-0.027752,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.88565,0.02463,0.014295,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.50776,0.024505,0.026826,0,0
2,GO CELL CELL SIGNALING BY WNT,0.61402,0.024505,0.036065,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.63408,0.024336,0.029196,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.79387,0.024076,0.0070379,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.42602,0.023995,-0.0442,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.67501,0.023994,0.02453,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.80953,0.023974,-0.037014,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.22971,0.023941,0.033354,0,0
2,GO CENTRIOLE ASSEMBLY,0.3871,0.023851,0.038597,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.75356,0.023818,0.030119,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.96284,0.023817,0.023355,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.75356,0.023567,0.035261,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.22195,0.023524,0.043491,0,0
2,GO IMMUNOGLOBULIN SECRETION,0.41203,0.023316,0.047947,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.33599,0.023266,0.061895,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.76281,0.023143,0.032369,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.35043,0.022971,0.038024,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.28761,0.02288,0.059744,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.36741,0.022876,0.03352,0,0
2,GO THYMIC T CELL SELECTION,0.2644,0.022842,0.064335,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.42367,0.022787,0.03153,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.9306,0.022747,0.0087678,0,0
2,GO CELL CYCLE,0.15098,0.022743,0.036845,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.87287,0.022692,0.021123,0,0
2,GO SPINDLE ASSEMBLY,0.67206,0.022595,0.014715,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.23286,0.022511,0.089421,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.64276,0.022485,0.028394,0,0
2,GO SISTER CHROMATID COHESION,0.59705,0.022443,0.026997,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.47963,0.022388,0.037067,0,0
2,GO AMINE METABOLIC PROCESS,0.31409,0.022332,0.03787,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.30066,0.022318,0.055906,0,0
2,GO HISTONE H3 K4 METHYLATION,0.3871,0.022206,0.040085,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.81896,0.022192,-0.0063684,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.40743,0.022179,0.038491,0,0
2,GO VACUOLE ORGANIZATION,0.31604,0.022141,0.048383,0,0
2,GO PENILE ERECTION,0.68689,0.022111,-0.0028156,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.13444,0.022068,0.071191,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.60268,0.022043,0.025937,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.92416,0.021986,0.016144,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.64567,0.021964,-0.003018,0,0
2,GO T CELL LINEAGE COMMITMENT,0.19557,0.021833,0.078169,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.64276,0.021816,0.025507,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.76899,0.021797,0.027344,0,0
2,GO L GLUTAMATE IMPORT,0.92094,0.021588,-0.014072,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.54208,0.021587,0.088071,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.30255,0.021538,0.12092,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.63408,0.021537,0.039487,0,0
2,GO PHOTOTRANSDUCTION,0.5,0.021241,0.0037551,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.69885,0.021241,0.023733,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.90488,0.021176,0.010396,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.33396,0.020943,0.037348,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.88245,0.020841,0.020703,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.98869,0.020622,0.016218,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.92094,0.020543,0.022467,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.90167,0.020437,-0.0029746,0,0
2,GO REGULATION OF ERAD PATHWAY,0.084034,0.020268,0.089973,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.16407,0.019996,0.049636,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.47712,0.019979,0.033957,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.48976,0.019965,0.052157,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.6515,0.019919,-0.024764,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.56376,0.01984,0.045317,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.71391,0.019631,0.022642,0,0
2,GO IRON ION TRANSPORT,0.48722,0.019173,0.036837,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.72907,0.018997,0.019513,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.80012,0.01898,0.012088,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.1262,0.018967,0.057576,0,0
2,GO REGULATION OF CELL CYCLE,0.24416,0.01892,0.033703,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.94993,0.018842,0.015885,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.89526,0.018692,-0.0088048,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.39381,0.018651,0.040252,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.59424,0.018628,0.026613,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.61972,0.018377,0.029655,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.45972,0.01837,0.0745,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.49231,0.018359,0.064101,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.68392,0.018051,0.017627,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.86649,0.0178,0.020765,0,0
2,GO PROTEIN TARGETING,0.4451,0.017762,0.02952,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.32393,0.01776,0.04458,0,0
2,GO ATP METABOLIC PROCESS,0.2114,0.017545,0.050909,0,0
2,GO RESPONSE TO ATP,0.61402,0.017435,0.032783,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.78763,0.017352,0.025412,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.99838,0.017195,-0.0094694,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.5,0.017176,0.042963,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.6055,0.016998,0.019058,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.76281,0.016967,0.016276,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.97253,0.016904,0.016047,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.46466,0.016793,0.062949,0,0
2,GO MAINTENANCE OF LOCATION,0.15214,0.016723,0.066811,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.97253,0.016684,0.0065576,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.5394,0.016583,0.034777,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.32592,0.016533,0.063682,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.79387,0.016512,0.010445,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.86331,0.016507,-0.012054,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.75048,0.016263,0.023166,0,0
2,GO CARTILAGE MORPHOGENESIS,0.82526,0.016258,0.019948,0,0
2,GO CARNITINE METABOLIC PROCESS,0.45727,0.016147,0.046548,0,0
2,GO INTRACELLULAR TRANSPORT,0.25924,0.016136,0.032764,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.68988,0.016082,0.02217,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.53406,0.015967,0.047588,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.16407,0.01583,0.10375,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.82211,0.015769,0.018253,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.87926,0.015729,0.022603,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.81581,0.015723,0.019878,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.99515,0.015669,-0.0028933,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.73212,0.015654,0.013393,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.45727,0.015481,-0.085294,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.2913,0.015461,-0.075487,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.65734,0.01546,0.017727,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.67798,0.015451,0.026212,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.48976,0.015377,0.068221,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.2714,0.015356,0.086924,0,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.37827,0.015205,0.04871,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.88565,0.015094,0.027984,0,0
2,GO NUCLEOSOME ORGANIZATION,0.74435,0.015063,0.016863,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.7814,0.014997,-0.0078298,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.21889,0.014983,0.035803,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.44994,0.01498,0.048645,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.72603,0.014768,0.027355,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.63697,0.014683,0.045746,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.47211,0.014627,0.048637,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.71391,0.014488,0.028596,0,0
2,GO MEMBRANE ORGANIZATION,0.88885,0.014437,0.018317,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.50258,0.014338,0.034575,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.62258,0.014248,0.014617,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.83474,0.014233,0.017809,0,0
2,GO ENDOCYTOSIS,0.38488,0.014196,0.043315,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.86968,0.014042,0.012219,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.63986,0.01399,0.033025,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.34835,0.013987,0.054733,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.89846,0.013897,0.0085564,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.5665,0.01389,0.027998,0,0
2,GO REGULATION OF MRNA PROCESSING,0.93704,0.013887,0.012339,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.6312,0.01388,-0.034474,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.64567,0.013877,0.026564,0,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.29877,0.013856,0.032244,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.89526,0.013832,0.023075,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.87606,0.0138,0.028834,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.97899,0.013718,-0.004157,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.26267,0.013474,0.042008,0,0
2,GO CELLULAR RESPONSE TO ATP,0.87606,0.013363,0.0077349,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.76899,0.013168,0.0059152,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.87606,0.013153,0.01206,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.73212,0.012989,-0.018515,0,0
2,GO HEAD MORPHOGENESIS,0.67206,0.012849,0.049749,0,0
2,GO ADAPTIVE THERMOGENESIS,0.88245,0.012849,0.016661,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.76899,0.012691,0.021847,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.31604,0.012373,0.042785,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.88565,0.012203,0.0074091,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.42367,0.012055,-0.04185,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.76899,0.01192,-0.020141,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.40743,0.011826,0.044078,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.99515,0.011752,0.012965,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.071119,0.011621,0.075628,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.78451,0.011603,0.01347,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.84741,0.01155,0.021911,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.69286,0.011457,0.040265,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.81267,0.011326,0.004095,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.55287,0.011301,0.035407,0,0
2,GO NUCLEUS ORGANIZATION,0.52345,0.01126,0.015239,0,0
2,GO DEPHOSPHORYLATION,0.87287,0.011202,0.01531,0,0
2,GO POSITIVE REGULATION OF BINDING,0.83158,0.011031,0.019507,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.19278,0.010964,0.063533,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.51557,0.010912,-0.018074,0,0
2,GO CHROMOSOME CONDENSATION,0.98869,0.01084,0.01113,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.42602,0.010803,0.053603,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.9306,0.010785,0.013064,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.86331,0.010737,0.018314,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.84424,0.010592,0.019209,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,0.91772,0.01045,0.033723,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.22814,0.010366,0.052694,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.64567,0.010348,-0.0084244,0,0
2,GO PROTEIN DEMETHYLATION,0.61117,0.010319,0.039648,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.84107,0.010228,0.0095827,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.83474,0.01012,0.023202,0,0
2,GO PH REDUCTION,0.58029,0.010046,0.020339,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.30066,0.010008,-0.093666,0,0
2,GO HISTONE METHYLATION,0.91772,0.0099942,0.012185,0,0
2,GO TOR SIGNALING,0.80953,0.0099208,0.014443,0,0
2,GO CELL JUNCTION ASSEMBLY,0.81896,0.0098969,0.003262,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.78763,0.0098753,-0.013264,0,0
2,GO SEX DETERMINATION,0.76899,0.0097427,-0.0082407,0,0
2,GO SISTER CHROMATID SEGREGATION,0.3871,0.009641,0.034685,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.51035,0.0094726,-0.067414,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.68988,0.0094181,0.033585,0,0
2,GO DNA PACKAGING,0.85694,0.009367,0.0080247,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.39606,0.0093484,0.040995,0,0
2,GO SPECIFICATION OF SYMMETRY,0.51557,0.0090838,0.023311,0,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.14308,0.0089833,-0.11723,0,0
2,GO SLEEP,0.43075,0.0089658,0.055999,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.73212,0.008934,0.040796,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.56103,0.0086587,-0.0034279,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.5665,0.0086248,-0.023813,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.96284,0.0085277,0.011989,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,1,0.0084307,0.0017754,0,0
2,GO TRABECULA FORMATION,0.2458,0.0082874,0.074977,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.81581,0.0082633,-0.0034887,0,0
2,GO MISMATCH REPAIR,0.92094,0.0081954,0.0038246,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.28213,0.0080081,0.05644,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.81267,0.0079557,0.0025637,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.28945,0.0078097,0.086502,0,0
2,GO REPRODUCTION,0.93704,0.0078025,0.0047713,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.59986,0.0077421,-0.048998,0,0
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.42133,0.0077311,0.031526,0,0
2,GO PIRNA METABOLIC PROCESS,0.6691,0.0076428,-0.056218,0,0
2,GO REGULATION OF TRANSPOSITION,0.35463,0.0074572,0.065298,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.797,0.0074354,-0.017583,0,0
2,GO GONADOTROPIN SECRETION,0.38933,0.0074098,0.055952,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.77519,0.0073764,0.0030815,0,0
2,GO PROTEIN ACETYLATION,0.97576,0.007363,0.0076365,0,0
2,GO MITOCHONDRIAL FUSION,0.90809,0.0072582,0.0054645,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.90488,0.0071212,0.016638,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.75664,0.0071031,0.024165,0,0
2,GO REGULATION OF BONE REMODELING,0.74741,0.0070863,0.020744,0,0
2,GO RECOMBINATIONAL REPAIR,0.59705,0.0070689,0.040241,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.96607,0.0070536,0.016086,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.69885,0.0070182,0.025149,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.65442,0.0069406,-0.0088468,0,0
2,GO GROWTH,0.96607,0.0069298,0.015778,0,0
2,GO REGULATION OF PH,0.91772,0.0068837,0.0081209,0,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.73212,0.0068098,0.041104,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.94026,0.006803,0.0096698,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.4355,0.0067882,0.032517,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.88245,0.00675,-3.3928e-05,0,0
2,GO CELL DIVISION,0.3871,0.0067289,0.036251,0,0
2,GO RESPONSE TO ETHER,0.32993,0.0066853,0.051665,0,0
2,GO REGULATION OF TOR SIGNALING,0.93382,0.0066367,0.0097874,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.55558,0.006556,0.033928,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.77209,0.0065067,0.019292,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.81581,0.0063174,0.0059323,0,0
2,GO ORGANELLE FUSION,0.6312,0.0062899,-0.0044941,0,0
2,GO AUTOPHAGIC CELL DEATH,0.43075,0.0062886,0.059388,0,0
2,GO MEMBRANE FUSION,0.99515,0.0062388,0.0076799,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.94348,0.0061056,0.009095,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.89526,0.0059321,0.021025,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.75356,0.0058892,0.004579,0,0
2,GO DNA REPLICATION INITIATION,0.73822,0.0058724,0.037864,0,0
2,GO SPINDLE LOCALIZATION,0.70787,0.0057468,0.013566,0,0
2,GO HEART GROWTH,0.86968,0.0055724,0.02018,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.84107,0.0055409,0.029452,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.60834,0.005508,-0.00027466,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.90167,0.0054749,-0.0014831,0,0
2,GO MUSCLE SYSTEM PROCESS,0.84741,0.0053499,0.0038072,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.52874,0.0053471,0.04293,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.93704,0.0053087,-0.00074404,0,0
2,GO MYELIN ASSEMBLY,0.80639,0.0051872,-0.0047524,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.84424,0.0051597,0.0063838,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.72907,0.0051283,0.031939,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.80326,0.0049469,0.021301,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.9306,0.0047831,0.017286,0,0
2,GO CHROMATIN SILENCING,0.61972,0.0045566,0.030596,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.5394,0.004421,0.041673,0,0
2,GO STEROID CATABOLIC PROCESS,0.93382,0.0041927,0.00072323,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.39156,0.0039956,0.028827,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.81896,0.0039627,-0.01793,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.72603,0.003829,-0.00017603,0,0
2,GO SODIUM ION HOMEOSTASIS,0.46713,0.0037658,-0.025444,0,0
2,GO AMYLOID FIBRIL FORMATION,0.60834,0.0036957,0.057721,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.71693,0.0036822,-0.044374,0,0
2,GO PHOSPHATE ION TRANSPORT,0.96284,0.0036739,0.011582,0,0
2,GO MICROTUBULE NUCLEATION,0.63408,0.0035966,-0.034695,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.36526,0.0033715,0.050037,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.98546,0.0031456,0.0042166,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.73212,0.0030168,-0.035838,0,0
2,GO DEVELOPMENTAL GROWTH,0.62545,0.0029852,-0.0046617,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.74435,0.0028836,0.028044,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.81581,0.0028084,0.021721,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.9693,0.0027343,0.01965,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.51557,0.002686,0.044833,0,0
2,GO GLIAL CELL MIGRATION,0.61972,0.0024984,0.04122,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.92416,0.0023435,0.0092013,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.77209,0.002311,0.019006,0,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.31997,0.002244,0.056059,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.84424,0.0022047,-0.0071864,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.88565,0.002195,0.0062281,0,0
2,GO ANDROGEN METABOLIC PROCESS,0.86012,0.0021109,-0.00033459,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.7814,0.0020735,-0.015009,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.55558,0.0018811,-0.026122,0,0
2,GO CYTOKINESIS,0.64567,0.0017996,-0.011109,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.9306,0.0017968,0.0085459,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.92416,0.0016775,0.0029638,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.48215,0.0016537,0.055852,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.81896,0.0016361,0.0027844,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.95316,0.0016052,0.0018332,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.40743,0.0013321,-0.026652,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.95639,0.0012927,0.0045735,0,0
2,GO NEGATIVE CHEMOTAXIS,0.46466,0.0011404,-0.057549,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.79387,0.0010973,0.01955,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.97899,0.0010608,0.014893,0,0
2,GO RESPONSE TO AMINE,0.4355,0.0010512,-0.031309,0,0
2,GO CENTROSOME SEPARATION,0.91772,0.0010494,0.0046728,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.95961,0.0010437,0.013147,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.52609,0.0009008,-0.039159,0,0
2,GO MITOPHAGY,0.82842,0.00075554,0.021952,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.95639,0.00073383,0.012158,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.83474,0.00060027,0.018842,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.52345,0.00045859,0.04755,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.7659,0.00034118,-0.0032908,0,0
2,GO ORGANELLE ASSEMBLY,0.52082,0.00029465,-0.0090728,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.68392,0.00027903,0.035201,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.89846,0.00026294,-0.0048217,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.85376,0.00018252,0.0049648,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.68392,0.00011985,0.027687,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.99192,0.00010554,0.0039731,0,0
2,GO CELLULAR HOMEOSTASIS,0.99192,-0.00026648,0.017131,0,0
2,GO DEMETHYLATION,0.60834,-0.00036213,0.033569,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.79075,-0.00072677,0.025653,0,0
2,GO HEAT GENERATION,0.56925,-0.00085095,0.038552,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.98869,-0.00087804,0.0010885,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.66321,-0.00099769,0.029645,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.88885,-0.0010566,0.010778,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.67798,-0.0010864,0.030948,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.74741,-0.001098,-0.027701,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.9113,-0.0011186,0.0023957,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.91772,-0.0012469,0.019261,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.84424,-0.0016066,0.017545,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.46218,-0.0017452,0.045814,0,0
2,GO EAR DEVELOPMENT,0.80953,-0.0017889,0.015722,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.99192,-0.0018796,0.0081248,0,0
2,GO RESPONSE TO L GLUTAMATE,0.70185,-0.0019074,0.026023,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.67206,-0.001945,-0.012093,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.74128,-0.0020547,-0.001185,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.55558,-0.002151,0.046235,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.47461,-0.0022607,-0.014306,0,0
2,GO HISTONE H3 K27 METHYLATION,0.66321,-0.0022992,-0.020212,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.76281,-0.0024349,-0.0056669,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.96607,-0.002543,-0.0032168,0,0
2,GO ORGANIC ANION TRANSPORT,0.9693,-0.002669,0.014206,0,0
2,GO TELOMERE CAPPING,0.55558,-0.0027938,0.028912,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.70185,-0.0028395,-0.011672,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.70185,-0.0031801,0.028035,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.82842,-0.0032374,0.0068724,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.71089,-0.0035951,-0.0010363,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.83474,-0.0037451,0.017203,0,0
2,GO REGULATION OF DNA REPLICATION,0.87926,-0.0038099,0.020934,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.97253,-0.0038109,0.025883,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.87287,-0.0038307,0.012991,0,0
2,GO METANEPHROS MORPHOGENESIS,0.5583,-0.0038525,-0.024236,0,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.2714,-0.0038754,0.035955,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.9693,-0.0039935,0.013734,0,0
2,GO FERTILIZATION,0.52082,-0.0040259,-0.021982,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.99192,-0.004116,0.0080639,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.96607,-0.0041483,0.0096281,0,0
2,GO CHROMOSOME SEGREGATION,0.61972,-0.0042011,0.02068,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.80326,-0.0043285,-0.0001312,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.81581,-0.0043483,0.023358,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.94026,-0.0043755,-0.012394,0,0
2,GO DNA REPLICATION,0.73822,-0.0044042,0.034835,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.91772,-0.0044091,0.01861,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.94671,-0.0045291,0.0085439,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.84107,-0.0047537,0.0051729,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.92738,-0.0047998,0.02454,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.69286,-0.0048901,0.016713,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.24911,-0.0050858,-0.075324,0,0
2,GO SOMITOGENESIS,0.81896,-0.005126,0.026323,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.47712,-0.0052702,-0.020521,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.69885,-0.0054696,-0.0050689,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.67206,-0.0055835,0.050725,0,0
2,GO WATER HOMEOSTASIS,0.83158,-0.0057538,-0.0053954,0,0
2,GO GLIAL CELL DEVELOPMENT,0.60268,-0.0058048,-0.0075851,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.54477,-0.0058569,-0.019896,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35253,-0.0058841,0.069045,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.5583,-0.0059263,0.049495,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.66321,-0.0060059,0.029236,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.66616,-0.0060591,-0.008955,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.43789,-0.0063893,-0.03551,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.84107,-0.0064264,-0.00011687,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.98222,-0.0064385,0.0051078,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.65734,-0.0065728,0.048053,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.92738,-0.0065961,0.0064567,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.35886,-0.0066057,-0.041649,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.64858,-0.0066107,-0.015994,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.51819,-0.006813,0.039764,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.89526,-0.0068463,0.00922,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.91772,-0.0068839,0.033665,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.75664,-0.0069183,0.054183,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.5,-0.0069386,0.052566,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.94348,-0.0069603,0.013764,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.4451,-0.0070381,-0.021748,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.49231,-0.0071315,0.045546,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.98869,-0.0072538,0.01835,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.32592,-0.007345,-0.056854,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.94993,-0.007411,-0.00040795,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.4355,-0.0074182,-0.032095,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.51557,-0.0074527,-0.023556,0,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.59705,-0.0074935,0.050527,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.9113,-0.0075776,0.0090825,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.46713,-0.0077652,-0.045061,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.91772,-0.0077754,0.011941,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.9113,-0.0078046,0.0030047,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.81581,-0.0078149,0.024087,0,0
2,GO MIDBRAIN DEVELOPMENT,0.83474,-0.0078658,0.039078,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.89526,-0.0082971,0.0083845,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.91451,-0.0083474,0.0129,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.92738,-0.0084222,-0.0011122,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.38488,-0.0085831,-0.024777,0,0
2,GO REGULATION OF GROWTH,0.61972,-0.0086091,-0.0017675,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.67206,-0.0086111,0.028288,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.47712,-0.0086191,-0.020895,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.80326,-0.0086207,0.0095371,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.88885,-0.0086588,-0.0073349,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.80326,-0.0086727,-0.030381,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.47461,-0.0089374,-0.016898,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,1,-0.0092386,0.009529,0,0
2,GO METAPHASE PLATE CONGRESSION,0.91772,-0.0092423,0.018026,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.8379,-0.0093635,0.016509,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.56103,-0.0094421,-0.013395,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,1,-0.0094934,0.0055939,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.74435,-0.0095468,-0.0002047,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.51035,-0.0096227,0.068237,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.94348,-0.0098179,0.016966,0,0
2,GO RESPONSE TO STARVATION,0.40514,-0.009895,-0.01421,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.88565,-0.0099865,-0.026703,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.65442,-0.010211,0.0001762,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.66616,-0.010282,-0.034391,0,0
2,GO ION HOMEOSTASIS,0.97576,-0.01041,0.016188,0,0
2,GO NEURON APOPTOTIC PROCESS,0.46466,-0.010888,-0.0093633,0,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.95639,-0.011121,0.012671,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.60268,-0.011167,-0.030544,0,0
2,GO NEURON DEATH,0.4451,-0.011178,-0.007661,0,0
2,GO RESPONSE TO INTERLEUKIN 6,0.83474,-0.011301,0.0057595,0,0
2,GO METAL ION HOMEOSTASIS,0.93704,-0.011416,0.015873,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.87926,-0.011469,0.0057504,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.50516,-0.01195,0.066362,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.64567,-0.012008,-0.010021,0,0
2,GO UTERUS DEVELOPMENT,0.49231,-0.012446,-0.040625,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.48976,-0.012468,-0.01949,0,0
2,GO OOCYTE DIFFERENTIATION,0.69885,-0.012536,-0.015396,0,0
2,GO ORGANELLE FISSION,0.61687,-0.012632,-0.0062397,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.37173,-0.012674,-0.044631,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.67501,-0.012688,-0.017809,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.89526,-0.012843,0.021579,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.81896,-0.012892,0.032807,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.82211,-0.012896,0.02401,0,0
2,GO PROTEIN ACYLATION,0.21587,-0.012905,-0.023577,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.87606,-0.013009,-0.0085778,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.72907,-0.013084,-0.00081923,0,0
2,GO ANION TRANSPORT,0.63697,-0.013095,-0.002148,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.95316,-0.013107,0.018836,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.80953,-0.013151,0.019526,0,0
2,GO BIOMINERALIZATION,0.69586,-0.013339,0.033536,0,0
2,GO CELL GROWTH,0.26614,-0.013544,-0.02251,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.23927,-0.013656,-0.057417,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.25583,-0.013981,0.10633,0,0
2,GO ORGANELLE LOCALIZATION,0.34213,-0.014085,-0.018007,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.83158,-0.014175,0.0055587,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.86012,-0.014248,-5.9714e-05,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.86331,-0.014489,-0.0089136,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.8379,-0.014672,0.00060846,0,0
2,GO CRISTAE FORMATION,0.66321,-0.014704,0.042454,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.68094,-0.014844,-0.021451,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.28213,-0.015106,-0.033532,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.53672,-0.015157,-0.018757,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.91772,-0.015283,0.014639,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.9306,-0.015656,0.00034672,0,0
2,GO REGULATION OF AXON GUIDANCE,0.86331,-0.015731,0.0057513,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.36526,-0.015752,-0.037625,0,0
2,GO MULTI ORGANISM PROCESS,0.32993,-0.015771,-0.018131,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.81581,-0.015939,-0.0068668,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.96284,-0.015941,0.011051,0,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.49231,-0.015973,0.038919,0,0
2,GO AMINO ACID IMPORT,0.85376,-0.016069,0.0094334,0,0
2,GO BONE MINERALIZATION,0.89846,-0.016181,0.0092526,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.62545,-0.016241,0.052751,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.88885,-0.016294,-0.0098788,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.86649,-0.016302,0.0041426,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.6691,-0.016487,-0.0073336,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.48976,-0.016535,-0.0074663,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.54477,-0.016541,-0.023916,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.89846,-0.01657,0.019422,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.26267,-0.016601,-0.032425,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.90488,-0.01679,0.0058402,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.6312,-0.016817,-0.00091611,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.33396,-0.016899,-0.016744,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.76281,-0.017009,0.021183,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.97253,-0.017115,0.0099484,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.32195,-0.01719,-0.027694,0,0
2,GO THYROID GLAND DEVELOPMENT,0.78763,-0.017387,0.002117,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42838,-0.017484,-0.035044,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.41666,-0.017539,-0.020098,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.90488,-0.017632,0.02631,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.75048,-0.01772,-0.023398,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.69586,-0.017855,-0.0080102,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.80012,-0.018061,-0.0098385,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.77209,-0.018097,-0.002009,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.49743,-0.018112,-0.018317,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.90167,-0.018148,0.0077426,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.42838,-0.018161,-0.032727,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.96284,-0.018266,0.0067827,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.30066,-0.018407,-0.080974,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.88245,-0.01844,0.024398,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.5394,-0.018512,-0.01958,0,0
2,GO NOTCH SIGNALING PATHWAY,0.59986,-0.018559,-0.0091003,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.56925,-0.018603,0.042202,0,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.42602,-0.018678,0.067419,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.54746,-0.018765,-0.02316,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.74741,-0.018816,-0.018665,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.62258,-0.018894,0.028522,0,0
2,GO PROTEIN METHYLATION,0.87606,-0.018905,0.0055699,0,0
2,GO INOSITOL METABOLIC PROCESS,0.15447,-0.018967,-0.072215,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.83158,-0.018987,0.0183,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.53672,-0.018993,-0.013205,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.95639,-0.019119,0.016038,0,0
2,GO SINGLE FERTILIZATION,0.16407,-0.019291,-0.038265,0,0
2,GO EXCRETION,0.49743,-0.019548,-0.01846,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.66321,-0.019649,0.029104,0,0
2,GO PROTEIN FOLDING,0.5583,-0.019788,-0.0040906,0,0
2,GO SULFATE TRANSPORT,0.47211,-0.020211,-0.024312,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.61972,-0.020278,0.025861,0,0
2,GO DNA REPLICATION CHECKPOINT,0.84741,-0.020305,0.041605,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.33396,-0.020318,-0.033033,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.082591,-0.020558,-0.057119,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.48215,-0.02057,-0.011025,0,0
2,GO RESPONSE TO BMP,0.73822,-0.020767,0.0010942,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.91451,-0.020822,0.012725,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.1453,-0.02088,-0.082144,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.93382,-0.020973,0.039013,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.85694,-0.021003,0.01867,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.35674,-0.021089,-0.057292,0,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.25246,-0.021091,-0.04478,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.26614,-0.021095,-0.037798,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.68689,-0.021369,-0.011883,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.54208,-0.021606,-0.024961,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.99838,-0.021658,0.0017973,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.50258,-0.021722,-0.053354,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.67501,-0.021845,-0.00097152,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.45727,-0.021859,0.043681,0,0
2,GO LIPID TRANSLOCATION,0.85059,-0.021916,0.0019605,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.49231,-0.022118,-0.051508,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.6515,-0.022478,0.056086,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.10214,-0.022481,-0.064237,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.58307,-0.022563,0.049576,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.85376,-0.022593,0.010211,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.95316,-0.022736,-0.00026669,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.23927,-0.02276,-0.032479,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.39381,-0.022916,-0.014678,0,0
2,GO EYE MORPHOGENESIS,0.86331,-0.023001,0.022846,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.48722,-0.023107,-0.023349,0,0
2,GO SPINDLE ORGANIZATION,0.75048,-0.023391,-0.0067826,0,0
2,GO STEM CELL PROLIFERATION,0.75356,-0.023617,-0.0079282,0,0
2,GO ORGANIC ACID TRANSPORT,0.47211,-0.023639,-0.004473,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.73212,-0.023791,0.04149,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.65734,-0.023803,-0.011741,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.44028,-0.024084,-0.01724,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.65442,-0.024308,0.048067,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.35253,-0.024361,-0.0049245,0,0
2,GO PROTEIN DENEDDYLATION,0.70787,-0.024456,-0.013037,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.41434,-0.024536,-0.026647,0,0
2,GO SENSORY PERCEPTION,0.25246,-0.02486,-0.02193,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.18327,-0.024882,-0.0435,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.572,-0.025019,-0.013592,0,0
2,GO VISUAL BEHAVIOR,0.26789,-0.025027,-0.044849,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.44269,-0.025243,-0.022603,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.70185,-0.025305,0.045844,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.96607,-0.025374,0.0057487,0,0
2,GO NEURAL TUBE PATTERNING,0.77519,-0.025845,0.0089648,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.14755,-0.026018,-0.061188,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.73517,-0.026022,-0.00050816,0,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.54477,-0.026063,-0.007249,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.59424,-0.026079,-0.0089348,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.68392,-0.026124,0.058254,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.36311,-0.026207,-0.044102,0,0
2,GO PROTEIN AUTOPROCESSING,0.65442,-0.026257,-0.031692,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.32195,-0.026286,-0.051339,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.89846,-0.026381,-0.00095551,0,0
2,GO REGULATION OF MITOPHAGY,0.42838,-0.026437,-0.021465,0,0
2,GO REGULATION OF CYTOKINESIS,0.74435,-0.026505,-0.010379,0,0
2,GO OOGENESIS,0.48722,-0.026535,-0.034264,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.46713,-0.02669,-0.013405,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.089246,-0.026718,-0.058419,0,0
2,GO REGULATION OF CELL SIZE,0.28578,-0.02676,-0.027153,0,0
2,GO CENTROSOME DUPLICATION,0.62832,-0.026805,-0.0074153,0,0
2,GO VITAMIN TRANSPORT,0.65442,-0.027017,-0.017623,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.10912,-0.027028,-0.05243,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.73212,-0.027804,0.0077173,0,0
2,GO RESPONSE TO LEAD ION,0.66321,-0.027965,0.001764,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.92416,-0.028112,0.019912,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.25753,-0.028138,-0.021199,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.32195,-0.028256,-0.02772,0,0
2,GO DOSAGE COMPENSATION,0.6691,-0.02855,0.012485,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.30637,-0.02885,-0.051491,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.75664,-0.028865,0.0036375,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.30637,-0.028964,-0.03811,0,0
2,GO DNA CATABOLIC PROCESS,0.58029,-0.02906,-0.011233,0,0
2,GO SECONDARY METABOLIC PROCESS,0.42367,-0.029092,-0.050298,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.47211,-0.029109,0.036641,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.35043,-0.02914,-0.080996,0,0
2,GO RHYTHMIC PROCESS,0.20992,-0.029152,-0.02405,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.94348,-0.029251,0.011831,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.96284,-0.029315,0.0053654,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.45727,-0.029387,-0.015152,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.38267,-0.029408,-0.013191,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.21738,-0.029459,-0.059118,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.6515,-0.029636,-0.0004027,0,0
2,GO CELL CYCLE DNA REPLICATION,0.81581,-0.029729,0.011894,0,0
2,GO KINETOCHORE ASSEMBLY,0.39381,-0.029802,-0.043484,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.6312,-0.030014,-0.0084846,0,0
2,GO CELL MORPHOGENESIS,0.19697,-0.030027,-0.038727,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.94026,-0.030044,0.018331,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.77519,-0.030078,-0.020693,0,0
2,GO LEYDIG CELL DIFFERENTIATION,0.572,-0.030215,-0.11891,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.89846,-0.03033,0.0059907,0,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.76281,-0.030334,0.028807,0,0
2,GO MALE GAMETE GENERATION,0.1914,-0.030583,-0.040952,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.22503,-0.030726,-0.049684,0,0
2,GO MEIOTIC CELL CYCLE,0.15683,-0.030797,-0.038111,0,0
2,GO CHROMOSOME LOCALIZATION,0.32993,-0.030842,-0.017437,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.38267,-0.030951,-0.012137,0,0
2,GO CELL RECOGNITION,0.26964,-0.031122,-0.026313,0,0
2,GO HISTONE H2A ACETYLATION,0.78763,-0.031166,-0.0060288,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.34835,-0.031337,-0.036648,0,0
2,GO DETECTION OF STIMULUS,0.34213,-0.031471,-0.016141,0,0
2,GO MUSCLE CONTRACTION,0.40058,-0.031818,-0.01653,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.77519,-0.031823,0.003833,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.318,-0.031852,-0.038163,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.98222,-0.031871,-0.0015735,0,0
2,GO OVULATION CYCLE,0.69586,-0.03193,-0.0083044,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.10045,-0.032015,-0.093445,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.24252,-0.03204,-0.066328,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.9306,-0.032096,0.0087192,0,0
2,GO RENAL WATER HOMEOSTASIS,0.56103,-0.032136,-0.014018,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.42367,-0.032237,-0.054434,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.67206,-0.032285,0.058734,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.37608,-0.032288,-0.019054,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.75048,-0.032312,0.01368,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.15565,-0.032361,-0.051046,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.2714,-0.032453,-0.041203,0,0
2,GO AXIS SPECIFICATION,0.55287,-0.032536,-0.025368,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.86968,-0.03258,0.012426,0,0
2,GO REGULATION OF VASCULOGENESIS,0.52082,-0.032645,-0.031787,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.94348,-0.033107,0.0063367,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.71996,-0.033237,-0.014601,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.20265,-0.033254,-0.027627,0,0
2,GO REGULATION OF HEAT GENERATION,0.99838,-0.033356,0.021911,0,0
2,GO ORGAN INDUCTION,0.21738,-0.033488,-0.078542,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.6055,-0.033657,-0.038985,0,0
2,GO SEXUAL REPRODUCTION,0.13444,-0.033681,-0.037772,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.94348,-0.033873,0.0055832,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.83474,-0.033907,-0.0026729,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.5394,-0.034032,-0.0014715,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.16163,-0.034078,-0.044199,0,0
2,GO HISTONE H3 K36 METHYLATION,0.92738,-0.034081,0.017528,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.66028,-0.034195,-0.012325,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.1754,-0.034586,-0.043339,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.20699,-0.034754,-0.048991,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.48976,-0.034923,-0.019912,0,0
2,GO REGULATION OF TRANSPORT,0.16904,-0.034975,-0.023732,0,0
2,GO MITOCHONDRIAL FISSION,0.23128,-0.035026,-0.039729,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.40514,-0.03504,-0.030018,0,0
2,GO NEURON REMODELING,0.81581,-0.035125,-0.0071991,0,0
2,GO ZINC ION TRANSPORT,0.98869,-0.035181,0.025297,0,0
2,GO OVULATION CYCLE PROCESS,0.57476,-0.035218,-0.017188,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.96284,-0.035239,0.0062503,0,0
2,GO PHAGOSOME ACIDIFICATION,0.49743,-0.035255,-0.028418,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.15802,-0.035263,-0.067802,0,0
2,GO OOCYTE MATURATION,0.62545,-0.035303,-0.034456,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.071119,-0.035315,-0.060806,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.29689,-0.035463,-0.025603,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.4355,-0.035511,-0.015115,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.17156,-0.035566,-0.038748,0,0
2,GO RESPONSE TO LEPTIN,0.9306,-0.035744,0.018734,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.68392,-0.035749,-0.0074929,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.572,-0.035794,-0.010806,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.42602,-0.035807,-0.024866,0,0
2,GO NUCLEOSIDE SALVAGE,0.86968,-0.03632,-0.0049611,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.95316,-0.036395,0.0090601,0,0
2,GO CELL JUNCTION ORGANIZATION,0.16042,-0.036404,-0.038941,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.26964,-0.036449,0.074597,0,0
2,GO HISTONE H4 ACETYLATION,0.42602,-0.036677,-0.02136,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.36956,-0.036721,-0.026557,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.74741,-0.036914,-0.018289,0,0
2,GO CONVERGENT EXTENSION,0.62258,-0.036986,0.060863,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.99515,-0.037558,0.0088751,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.31997,-0.037747,-0.046311,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.25414,-0.03776,-0.023511,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.6515,-0.037815,-0.010441,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.21587,-0.037825,-0.063282,0,0
2,GO CELL PROJECTION ASSEMBLY,0.63697,-0.037931,-0.0029253,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.178,-0.038033,-0.029218,0,0
2,GO SOMITE DEVELOPMENT,0.52609,-0.038137,-0.015793,0,0
2,GO RESPONSE TO CAMP,0.51296,-0.03834,-0.011237,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.90809,-0.038479,0.010259,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.94348,-0.038514,0.018999,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.38933,-0.038873,-0.035345,0,0
2,GO INORGANIC ANION TRANSPORT,0.11647,-0.038887,-0.034385,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.19697,-0.039133,-0.042672,0,0
2,GO RESPONSE TO FUNGUS,0.34627,-0.039179,-0.028148,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.6312,-0.039287,-0.0017467,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.87926,-0.03929,0.015691,0,0
2,GO GAMETE GENERATION,0.21889,-0.039547,-0.035945,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.17156,-0.039556,-0.040795,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.35043,-0.039887,-0.045164,0,0
2,GO GENETIC IMPRINTING,0.71391,-0.039969,-0.0097328,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.86968,-0.03997,-0.0026809,0,0
2,GO CELL FATE COMMITMENT,0.19003,-0.040083,-0.041119,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.082591,-0.040118,-0.046581,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.11183,-0.040282,-0.04594,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.69286,-0.040333,0.034257,0,0
2,GO HISTONE EXCHANGE,0.52345,-0.040387,-0.020344,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.30829,-0.040398,-0.034804,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.75972,-0.040491,0.0025473,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.36956,-0.040937,-0.050649,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.095518,-0.041001,-0.087233,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.19838,-0.041091,-0.050153,0,0
2,GO WALKING BEHAVIOR,0.1653,-0.0411,-0.063328,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.35886,-0.041213,-0.067748,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.3442,-0.041393,-0.022574,0,0
2,GO REGULATION OF GLIOGENESIS,0.47461,-0.041416,-0.016933,0,0
2,GO BONE MATURATION,0.82526,-0.041566,-0.0032689,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.28578,-0.042002,-0.023238,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.5,-0.042181,-0.016952,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.22814,-0.042394,-0.063224,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.20554,-0.042475,-0.051716,0,0
2,GO DNA DEMETHYLATION,0.7814,-0.04252,0.0023016,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.19697,-0.04255,-0.025065,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.11183,-0.042642,-0.050844,0,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.1873,-0.042702,-0.031803,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.87926,-0.042817,0.0093986,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.30446,-0.042948,-0.076528,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.17411,-0.043074,-0.055892,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.94993,-0.043128,0.027232,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.42602,-0.043203,-0.026111,0,0
2,GO FUCOSYLATION,0.51035,-0.043484,-0.023446,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.095518,-0.043505,-0.028669,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.41899,-0.043641,-0.02978,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.94671,-0.043692,0.012161,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.52874,-0.04374,0.1022,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.63408,-0.043764,0.072398,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.95961,-0.043795,0.01814,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.67206,-0.043971,-0.0056032,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.83158,-0.044277,-0.01123,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.318,-0.044336,-0.038317,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.28033,-0.04435,-0.024251,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.13338,-0.044435,-0.023568,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.40514,-0.044624,-0.028859,0,0
2,GO REGULATION OF DNA BINDING,0.086981,-0.044896,-0.069356,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.41899,-0.045057,-0.027204,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.080464,-0.045105,-0.10314,0,0
2,GO HEPARIN METABOLIC PROCESS,0.60834,-0.045323,0.069892,0,0
2,GO NUCLEOTIDE TRANSPORT,0.2114,-0.045509,-0.040569,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.20845,-0.045619,-0.048888,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.17283,-0.045704,-0.067788,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.79387,-0.045777,-0.0029639,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.31409,-0.045781,-0.038945,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.31997,-0.046043,-0.01436,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.17411,-0.046113,-0.027646,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.58307,-0.046119,-0.027269,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.41666,-0.046357,-0.022015,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.52609,-0.046625,-0.041751,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.41434,-0.046707,-0.021582,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.26964,-0.046846,-0.082561,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.3739,-0.046965,-0.038339,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.69586,-0.047004,-0.0030697,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.36956,-0.047157,-0.019472,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.43312,-0.04736,-0.061924,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.48468,-0.047499,-0.044498,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.29502,-0.047548,-0.047703,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.31409,-0.047602,-0.066274,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.32792,-0.047667,-0.024215,0,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.1387,-0.047669,-0.053304,0,0
2,GO ACID SECRETION,0.69885,-0.047786,0.005003,0,0
2,GO ATP TRANSPORT,0.44994,-0.04794,-0.015303,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.068006,-0.048091,-0.052585,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.20699,-0.04834,-0.063187,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.41899,-0.048478,-0.016102,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.1533,-0.048571,-0.09341,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.093918,-0.048805,-0.099661,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.48722,-0.048887,-0.02037,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.19003,-0.049058,-0.026417,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.84424,-0.049326,0.016251,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.27317,-0.049407,-0.022829,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.35886,-0.049582,-0.097356,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.52082,-0.04988,-0.025681,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.073043,-0.049888,-0.055385,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.21288,-0.050092,-0.016287,0,0
2,GO REGIONALIZATION,0.11837,-0.050304,-0.055141,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.50776,-0.050554,-0.026482,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.066192,-0.050589,-0.047281,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.25246,-0.050686,-0.07244,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.9306,-0.05104,0.010657,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.85376,-0.051433,-0.017104,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.53406,-0.051916,-0.033508,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.19557,-0.052299,-0.07731,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.062114,-0.052611,-0.07342,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.14088,-0.052857,-0.05341,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.12721,-0.053294,-0.15026,0,0
2,GO ENSHEATHMENT OF NEURONS,0.28945,-0.053675,-0.030568,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.066192,-0.054074,-0.091976,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.15447,-0.054219,-0.078799,0,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.13338,-0.0543,-0.04093,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.17669,-0.054381,-0.053173,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.16407,-0.054459,-0.033905,0,0
2,GO CARBOHYDRATE TRANSPORT,0.24089,-0.054624,-0.024994,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.48722,-0.055162,-0.015011,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.25924,-0.055512,-0.035826,0,0
2,GO ESTROUS CYCLE,0.797,-0.055583,-0.011348,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.22503,-0.055647,-0.021331,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.95961,-0.055784,-0.013586,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.46962,-0.055827,-0.025963,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.50516,-0.055915,-0.032435,0,0
2,GO BRAIN MORPHOGENESIS,0.28033,-0.056005,-0.056603,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.36741,-0.056217,-0.04761,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.077698,-0.056243,-0.070284,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.57476,-0.05643,-0.041512,0,0
2,GO FORELIMB MORPHOGENESIS,0.67206,-0.056587,-0.027733,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.49487,-0.056717,-0.0027334,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.16285,-0.056761,-0.056877,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.11002,-0.056781,-0.074242,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.1873,-0.056797,-0.051554,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.22814,-0.056938,-0.056785,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.40973,-0.056956,-0.037503,0,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.45727,-0.057204,-0.021021,0,0
2,GO RESPONSE TO AMPHETAMINE,0.178,-0.057398,-0.062569,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.93382,-0.057694,0.021189,0,0
2,GO NUCLEOSOME ASSEMBLY,0.19557,-0.057969,-0.039214,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.37608,-0.058115,-0.025295,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.54746,-0.058162,-0.022596,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.178,-0.058385,-0.045935,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.18062,-0.058436,-0.055405,0,0
2,GO TORC1 SIGNALING,0.26789,-0.058566,-0.029042,0,0
2,GO RESPONSE TO METAL ION,0.19417,-0.058917,-0.024559,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.38267,-0.059797,-0.043503,0,0
2,GO HEART TRABECULA FORMATION,0.23286,-0.059831,-0.083289,0,0
2,GO MICROTUBULE ANCHORING,0.15802,-0.059869,-0.058968,0,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.74435,-0.060159,-0.024808,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.077018,-0.060429,-0.077213,0,0
2,GO TRABECULA MORPHOGENESIS,0.88885,-0.060511,0.039361,0,0
2,GO REGULATION OF TUBE SIZE,0.073043,-0.060634,-0.058467,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.21587,-0.060824,-0.097228,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.099614,-0.061089,-0.070561,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.063836,-0.061315,-0.080565,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.65734,-0.061507,-0.016051,0,0
2,GO GLUCOSE IMPORT,0.086237,-0.061604,-0.044401,0,0
2,GO LUNG CELL DIFFERENTIATION,0.28033,-0.061672,-0.11751,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.43075,-0.061676,-0.029304,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.13338,-0.062104,-0.09878,0,0
2,GO ECTODERM DEVELOPMENT,0.38047,-0.062239,-0.030185,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.52874,-0.062261,0.005078,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.22042,-0.062321,-0.030998,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.59986,-0.062338,-0.035838,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.18327,-0.062518,-0.046614,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.14983,-0.06253,-0.041124,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.16285,-0.062681,-0.05986,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.17669,-0.062725,-0.028436,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.062684,-0.062902,-0.075699,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.60834,-0.063101,-0.020977,0,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.1262,-0.063248,-0.029678,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.10129,-0.063302,-0.044588,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.077018,-0.063898,-0.089678,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.10214,-0.063925,-0.064808,0,0
2,GO N GLYCAN PROCESSING,0.48976,-0.06401,-0.041693,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.572,-0.064076,0.076911,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.35253,-0.064141,-0.057023,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.11275,-0.064347,-0.05314,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.1146,-0.064589,-0.077789,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.077698,-0.064659,-0.038244,0,0
2,GO MRNA SPLICE SITE SELECTION,0.062684,-0.064839,-0.10506,0,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.42367,-0.064917,-0.037383,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.26614,-0.064942,-0.020411,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.20992,-0.065368,-0.042208,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.21288,-0.065443,-0.029922,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.3739,-0.065503,-0.027803,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.092339,-0.065876,-0.040871,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.093126,-0.065888,-0.078099,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.19278,-0.065982,-0.047656,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.16654,-0.066034,-0.050319,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.5583,-0.066309,-0.034188,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.1914,-0.066607,-0.058129,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.62258,-0.066736,0.00036635,0,0
2,GO PARTURITION,0.22814,-0.06701,-0.081909,0,0
2,GO GLIOGENESIS,0.31409,-0.067375,-0.029713,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.18866,-0.067392,-0.036587,0,0
2,GO RESPONSE TO PAIN,0.27495,-0.067605,-0.067957,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.35463,-0.067902,-0.05208,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.087731,-0.067912,-0.052479,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.12721,-0.068163,-0.071166,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.41434,-0.068532,-0.036099,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.12224,-0.068653,-0.068177,0,0
2,GO REGULATION OF HEART RATE,0.086981,-0.068808,-0.058185,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.10385,-0.068835,-0.055312,0,0
2,GO EATING BEHAVIOR,0.28033,-0.068845,-0.038949,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.089246,-0.068956,-0.064808,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.10734,-0.069057,-0.075005,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.46962,-0.069066,-0.031352,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.40973,-0.069187,-0.021384,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.21587,-0.069423,-0.06634,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.12822,-0.069608,-0.036047,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.27673,-0.069722,-0.041711,0,0
2,GO REGULATION OF BEHAVIOR,0.2114,-0.070061,-0.046232,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.7659,-0.07016,-0.0052656,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.13979,-0.070266,-0.056299,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.24911,-0.070366,-0.043953,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.50258,-0.070447,-0.034783,0,0
2,GO RHYTHMIC BEHAVIOR,0.21889,-0.070564,-0.044972,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.14983,-0.070576,-0.071118,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.4451,-0.070881,-0.032319,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.066792,-0.071181,-0.062344,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.10129,-0.071543,-0.045665,0,0
2,GO PHAGOSOME MATURATION,0.53672,-0.072263,-0.012803,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.068006,-0.072531,-0.065527,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.53406,-0.072558,-0.071047,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.16778,-0.072765,-0.053394,0,0
2,GO HORMONE CATABOLIC PROCESS,0.45482,-0.072834,-0.057396,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.99838,-0.072854,0.020541,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.51557,-0.072999,-0.015358,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.98222,-0.073016,0.003359,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.82842,-0.073022,-0.0029455,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.28395,-0.073023,-0.0233,0,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.28945,-0.073134,-0.02682,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.4451,-0.073468,-0.059298,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.13549,-0.073594,-0.066408,0,0
2,GO L AMINO ACID TRANSPORT,0.14983,-0.073893,-0.052765,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.24416,-0.074118,-0.099208,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.065596,-0.07425,-0.12733,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.70486,-0.074258,0.041923,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.21889,-0.074788,-0.03389,0,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.41434,-0.074922,-0.022931,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.67501,-0.075128,-0.00078649,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.33194,-0.075632,-0.046893,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.086981,-0.07604,-0.10299,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.18327,-0.076286,-0.10427,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.51557,-0.076584,-0.067901,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.21738,-0.076633,-0.057619,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.43789,-0.076791,-0.043201,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.85059,-0.076879,0.011147,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.30637,-0.076934,-0.048404,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.54208,-0.077069,-0.0059631,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.28578,-0.077189,-0.023459,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.093126,-0.077552,-0.057275,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.13444,-0.077744,-0.056601,0,0
2,GO TRANSFERRIN TRANSPORT,0.095518,-0.077939,-0.054709,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.11002,-0.078892,-0.093457,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.10734,-0.078907,-0.056391,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.14755,-0.078969,-0.033039,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.086237,-0.079082,-0.059981,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.15214,-0.079328,-0.069,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.59144,-0.079362,-0.0423,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.068619,-0.079496,-0.040219,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.51296,-0.079801,-0.049331,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.57476,-0.080276,-0.018199,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.178,-0.080367,-0.044656,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.61402,-0.080439,-0.002283,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.30829,-0.080521,-0.031973,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.40973,-0.080576,-0.042674,0,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.1653,-0.080763,-0.062599,0,0
2,GO VASODILATION,0.18461,-0.080837,-0.081681,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.09796,-0.080906,-0.066086,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.66616,-0.081024,-0.023747,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.13444,-0.081246,-0.085761,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.098784,-0.081512,-0.077777,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.11002,-0.081643,-0.064579,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.47963,-0.081706,-0.042079,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.26267,-0.081866,-0.034019,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.2714,-0.08196,-0.049196,0,0
2,GO RESPONSE TO LEUCINE,0.14983,-0.082205,-0.098335,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.62832,-0.082432,-0.0017216,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.14308,-0.082734,-0.090018,0,0
2,GO FACIAL NERVE MORPHOGENESIS,0.21437,-0.082959,-0.12122,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.18327,-0.083276,-0.058049,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.10558,-0.083457,-0.044264,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.26614,-0.083543,-0.026966,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.75972,-0.083658,-0.0044444,0,0
2,GO MATING BEHAVIOR,0.14642,-0.083766,-0.065223,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.12924,-0.083827,-0.10498,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.27853,-0.084072,-0.039328,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.074349,-0.084352,-0.077266,0,0
2,GO RESPONSE TO PH,0.099614,-0.084592,-0.075327,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.15565,-0.084932,-0.054914,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.16407,-0.08594,-0.042675,0,0
2,GO ALANINE TRANSPORT,0.20699,-0.085953,-0.072209,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.4355,-0.085967,-0.070127,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.1533,-0.086243,-0.069818,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.62545,-0.088085,-0.021836,0,0
2,GO RELAXATION OF MUSCLE,0.20409,-0.088097,-0.065345,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.26789,-0.088153,-0.078544,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.1387,-0.088167,-0.054399,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.58029,-0.088271,-0.057133,0,0
2,GO CGMP MEDIATED SIGNALING,0.096327,-0.088302,-0.083916,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.20122,-0.088468,-0.031235,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.31215,-0.089138,-0.019196,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.25246,-0.08946,-0.040551,0,0
2,GO STEROID HORMONE SECRETION,0.77519,-0.089629,-0.016568,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.46713,-0.089896,-0.039007,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.70787,-0.090869,-0.016288,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.29315,-0.090927,-0.060173,0,0
2,GO MITOTIC RECOMBINATION,0.47712,-0.091214,-0.010524,0,0
2,GO LOCOMOTOR RHYTHM,0.40514,-0.091508,-0.026028,0,0
2,GO SEGMENT SPECIFICATION,0.68094,-0.091642,-0.018218,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.27673,-0.093201,-0.10131,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.090782,-0.09358,-0.10684,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.17156,-0.094595,-0.049264,0,0
2,GO EXTRACELLULAR TRANSPORT,0.37608,-0.094869,-0.050654,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.1873,-0.095604,-0.094383,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.088486,-0.09583,-0.055707,0,0
2,GO LYMPH NODE DEVELOPMENT,0.22195,-0.096743,-0.061913,0,0
2,GO PANCREAS DEVELOPMENT,0.078382,-0.097258,-0.084738,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.35674,-0.097525,-0.065435,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.32792,-0.097915,-0.045442,0,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.10471,-0.098636,-0.1039,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.1262,-0.10017,-0.099402,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.13979,-0.10052,-0.066675,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.18866,-0.10089,-0.079968,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.38933,-0.1009,-0.033101,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.1533,-0.1011,-0.080462,0,0
2,GO PROTEIN MANNOSYLATION,0.18595,-0.10112,-0.06593,0,0
2,GO ANIMAL ORGAN MATURATION,0.45727,-0.10132,-0.029547,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.076344,-0.10148,-0.083671,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.31409,-0.10183,-0.054851,0,0
2,GO MAST CELL MIGRATION,0.24745,-0.10217,-0.074172,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.064418,-0.10229,-0.061635,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.13979,-0.10289,-0.10723,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.22971,-0.10526,-0.058985,0,0
2,GO MITOTIC DNA REPLICATION,0.23286,-0.10604,-0.030881,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.13549,-0.10678,-0.095434,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.13234,-0.10698,-0.05959,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.11933,-0.10736,-0.082595,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.14642,-0.10782,-0.084679,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.2114,-0.1092,-0.097967,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.54208,-0.10945,-0.034505,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.10558,-0.11046,-0.055732,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.088486,-0.11054,-0.086626,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.15565,-0.11058,-0.12219,0,0
2,GO RESPONSE TO REDOX STATE,0.11933,-0.1114,-0.08018,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.09796,-0.11224,-0.059819,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.17669,-0.11442,-0.073324,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.090011,-0.11454,-0.15941,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.079071,-0.11471,-0.08731,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.23927,-0.11562,-0.061944,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.12322,-0.11675,-0.10115,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.40973,-0.11801,-0.043892,0,0
2,GO RESPONSE TO AMYLOID BETA,0.06986,-0.11909,-0.072157,0,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.10045,-0.12007,-0.078691,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.25078,-0.12018,-0.04406,0,0
2,GO KINETOCHORE ORGANIZATION,0.071756,-0.12065,-0.088622,0,0
2,GO CARDIAC CHAMBER FORMATION,0.14755,-0.12101,-0.11788,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.12224,-0.12113,-0.11613,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.18194,-0.12124,-0.044234,0,0
2,GO ORGANIC CATION TRANSPORT,0.062114,-0.1215,-0.072311,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.084763,-0.12205,-0.072431,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.079071,-0.12214,-0.11025,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.77519,-0.12233,-0.0074622,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.71996,-0.12263,-0.019856,0,0
2,GO DENDRITE SELF AVOIDANCE,0.073043,-0.12263,-0.11676,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.13656,-0.12371,-0.089369,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.14197,-0.1247,-0.084402,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.063836,-0.12649,-0.080049,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.11367,-0.12709,-0.060102,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.22042,-0.12816,-0.080104,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.11367,-0.12841,-0.093335,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.10299,-0.12923,-0.061284,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.090782,-0.13118,-0.082295,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.15683,-0.13544,-0.069384,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.10734,-0.13581,-0.10554,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.20265,-0.13647,-0.12289,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.21437,-0.13919,-0.055046,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.13444,-0.13994,-0.11447,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.063836,-0.14015,-0.096724,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.64276,-0.14171,-0.0089052,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.10823,-0.14334,-0.11174,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.079765,-0.14443,-0.081943,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.14869,-0.14503,-0.086842,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.93704,-0.14613,0.01541,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.064418,-0.14618,-0.084674,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.06986,-0.14709,-0.09603,0,0
2,GO GLYCINE TRANSPORT,0.31021,-0.14753,-0.082549,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.41203,-0.14907,-0.014969,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.47461,-0.14912,-0.0092618,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.22658,-0.14972,-0.049374,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.11002,-0.15117,-0.15027,0,0
2,GO RESPONSE TO CAFFEINE,0.20265,-0.15151,-0.052135,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.11367,-0.15153,-0.09103,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.12721,-0.15446,-0.10866,0,0
2,GO SEROTONIN SECRETION,0.093918,-0.16061,-0.10272,0,0
2,GO VITAMIN CATABOLIC PROCESS,0.10558,-0.16196,-0.14115,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.096327,-0.16231,-0.13445,0,0
2,GO NEURON PROJECTION REGENERATION,0.068006,-0.16411,-0.08104,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.1387,-0.16831,-0.10237,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.13444,-0.16853,-0.10198,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.19838,-0.17989,-0.07732,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.10214,-0.18594,-0.096315,0,0
2,GO SIALYLATION,0.12924,-0.20155,-0.10173,0,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.16407,-0.3142,-0.092254,0,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.0437e-10,0.94793,0.89569,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.8118e-09,0.82367,0.76157,1,1
3,GO SYNAPSE MATURATION,8.3066e-07,0.60479,0.53275,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,4.2784e-08,0.59681,0.71706,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,1.6514e-08,0.5772,0.552,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,6.5837e-06,0.57716,0.52987,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,1.155e-06,0.55921,0.48753,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,4.4787e-08,0.5563,0.56012,1,1
3,GO REGULATION OF SYNAPSE MATURATION,2.3661e-05,0.54817,0.43776,1,1
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,2.3891e-06,0.54062,0.47435,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,7.0337e-07,0.54047,0.53144,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.856e-06,0.5356,0.43406,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,2.8886e-07,0.5246,0.49893,1,1
3,GO RESPONSE TO L GLUTAMATE,5.4967e-09,0.51224,0.48125,1,1
3,GO NEURON CELLULAR HOMEOSTASIS,8.7237e-10,0.50929,0.49989,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,6.9711e-06,0.49992,0.40188,1,1
3,GO DENSE CORE GRANULE TRANSPORT,2.5424e-05,0.49672,0.43062,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,4.9228e-07,0.44706,0.3842,1,1
3,GO POSTSYNAPSE ASSEMBLY,1.1086e-06,0.44362,0.4895,1,1
3,GO SYNAPTIC VESICLE MATURATION,2.971e-06,0.42834,0.43758,1,1
3,GO GLYCINE TRANSPORT,0.00099681,0.42547,0.32992,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,3.9822e-07,0.4222,0.51165,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,2.2505e-06,0.41687,0.47472,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,2.0398e-08,0.41566,0.44855,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,1.8793e-06,0.40191,0.3195,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.6457e-05,0.399,0.43255,1,1
3,GO CYTOPLASMIC TRANSLATION,2.971e-06,0.39893,0.3258,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,4.7172e-05,0.39866,0.35687,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,4.3946e-06,0.3979,0.33975,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,1.1789e-06,0.39179,0.38478,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,5.1446e-05,0.39157,0.41705,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,2.6386e-06,0.39123,0.40795,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00059648,0.38668,0.33541,1,1
3,GO SYNAPTIC MEMBRANE ADHESION,0.0010865,0.38275,0.31764,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,2.2397e-08,0.38257,0.43039,1,1
3,GO DENTATE GYRUS DEVELOPMENT,2.8001e-06,0.38012,0.43184,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,4.4807e-06,0.37872,0.35447,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,1.439e-07,0.3776,0.40629,1,1
3,GO MYOBLAST PROLIFERATION,8.0712e-08,0.37653,0.35587,1,1
3,GO ANATOMICAL STRUCTURE REGRESSION,0.001118,0.3748,0.29343,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,9.1829e-05,0.37181,0.31187,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.8888e-05,0.37126,0.32152,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,1.8701e-05,0.36892,0.35532,1,1
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00083767,0.36427,0.31702,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00032408,0.36395,0.3343,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,7.0072e-05,0.36352,0.31559,1,1
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.7071e-05,0.36135,0.37852,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00042128,0.35873,0.332,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.069e-09,0.35748,0.36415,1,1
3,GO SYNAPTIC VESICLE CLUSTERING,0.0011836,0.3572,0.38439,1,1
3,GO IMP METABOLIC PROCESS,1.1806e-05,0.35647,0.37257,1,1
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.0395e-05,0.3558,0.32497,1,1
3,GO SUCKLING BEHAVIOR,1.536e-06,0.35507,0.37864,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00083767,0.35385,0.35713,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0050269,0.35052,0.23758,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,1.3878e-06,0.3502,0.29695,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.9514e-07,0.3472,0.38478,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.0361e-05,0.34409,0.32341,1,1
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.00012594,0.34347,0.30979,1,1
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,3.6877e-06,0.34346,0.30318,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,4.9361e-06,0.34094,0.37444,1,1
3,GO TRANSLATIONAL INITIATION,3.0395e-05,0.34035,0.27869,1,1
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,9.795e-06,0.33832,0.31244,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001071,0.33772,0.2631,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00031414,0.33749,0.29827,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,1.6514e-08,0.33426,0.317,1,1
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00019857,0.33219,0.41567,1,1
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.0323e-06,0.33205,0.29645,1,1
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.1815e-08,0.33163,0.38507,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.001071,0.33097,0.30538,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0030839,0.33055,0.35553,1,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,4.5684e-06,0.32954,0.41574,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00060545,0.32914,0.3312,1,1
3,GO L GLUTAMATE IMPORT,0.0002443,0.32698,0.21632,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.00057029,0.32619,0.40663,1,1
3,GO MATURATION OF LSU RRNA,4.5684e-06,0.32595,0.33385,1,1
3,GO NEUROTRANSMITTER REUPTAKE,3.9102e-06,0.32363,0.30504,1,1
3,GO UV PROTECTION,8.9166e-06,0.3233,0.32379,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00043435,0.32325,0.29837,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.3803e-06,0.32109,0.35733,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.0156e-07,0.31903,0.33102,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,1.3056e-06,0.31669,0.30858,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.2784e-06,0.31255,0.34613,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,7.3739e-05,0.31196,0.35775,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.001422,0.3118,0.29787,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,5.7051e-07,0.3109,0.32715,1,1
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.004964,0.31033,0.251,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,6.4341e-05,0.30878,0.314,1,1
3,GO REGULATION OF VESICLE FUSION,5.332e-06,0.30679,0.32973,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,7.8124e-06,0.30495,0.29364,1,1
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,9.3381e-05,0.30424,0.2563,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1.9749e-05,0.30354,0.32199,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,6.8396e-06,0.30211,0.30746,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,4.4787e-08,0.30175,0.28811,1,1
3,GO RIBOSOME ASSEMBLY,1.3442e-05,0.30149,0.30724,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,1.5994e-06,0.30046,0.36988,1,1
3,GO GLYCINE METABOLIC PROCESS,0.0044298,0.29865,0.20009,1,1
3,GO REGULATION OF MRNA BINDING,1.0557e-05,0.29533,0.2836,1,1
3,GO DIVALENT METAL ION EXPORT,6.7105e-06,0.29514,0.35919,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00030928,0.29464,0.268,1,1
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,6.7105e-06,0.29443,0.28144,1,1
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00031414,0.29417,0.29674,1,1
3,GO DENDRITIC SPINE MORPHOGENESIS,3.2057e-05,0.29382,0.27283,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,6.8396e-06,0.2932,0.28035,1,1
3,GO PHAGOCYTOSIS RECOGNITION,5.5127e-05,0.29263,0.25105,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,6.545e-05,0.2926,0.28563,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0002117,0.29252,0.2578,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.2926e-08,0.292,0.36048,1,1
3,GO NEURON PROJECTION ORGANIZATION,1.8053e-06,0.29185,0.27072,1,1
3,GO REGULATION OF NEURON MIGRATION,0.0034243,0.29166,0.19266,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0010558,0.29028,0.25351,1,1
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00014362,0.29012,0.36389,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,2.0478e-05,0.28791,0.35714,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,2.2824e-05,0.28754,0.33858,1,1
3,GO OXYGEN TRANSPORT,0.016386,0.28705,0.28345,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001422,0.28161,0.25364,1,1
3,GO ADULT HEART DEVELOPMENT,8.0256e-05,0.27979,0.32806,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.014658,0.27885,0.22041,1,1
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,6.3249e-05,0.27851,0.26411,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00017741,0.27832,0.27166,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0002443,0.27794,0.25306,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.0016575,0.27627,0.24672,1,1
3,GO CGMP METABOLIC PROCESS,0.0014022,0.27425,0.28054,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,4.5684e-06,0.27407,0.26018,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.00071283,0.27224,0.27399,1,1
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.1789e-06,0.27045,0.31878,1,1
3,GO TELOMERASE RNA LOCALIZATION,5.8049e-05,0.26961,0.26241,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,3.3806e-05,0.26911,0.21826,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,9.9844e-05,0.26893,0.2648,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.011022,0.26878,0.27109,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00059648,0.26818,0.2643,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,2.2416e-05,0.26811,0.2697,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,1.5576e-05,0.26686,0.28018,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,1.1165e-05,0.26669,0.31182,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0013443,0.26612,0.20396,1,1
3,GO ELASTIC FIBER ASSEMBLY,0.011949,0.26454,0.25592,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00090088,0.26367,0.26422,1,1
3,GO AMP METABOLIC PROCESS,0.0018764,0.26201,0.20436,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.0038977,0.26158,0.19822,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.012653,0.25724,0.20805,1,1
3,GO VIRAL TRANSLATION,5.8049e-05,0.25599,0.25136,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.042609,0.25541,0.14392,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,3.758e-05,0.25529,0.2637,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,6.7105e-06,0.25501,0.25595,1,1
3,GO NEUROTRANSMITTER UPTAKE,1.2027e-05,0.25494,0.24763,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,7.3739e-05,0.25458,0.20427,1,1
3,GO SIALYLATION,0.00086244,0.25456,0.33356,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1588e-05,0.25362,0.32229,1,1
3,GO PENTOSE METABOLIC PROCESS,0.00039622,0.2531,0.19799,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0021798,0.25218,0.24257,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00049053,0.25214,0.35551,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,3.3435e-06,0.25213,0.25698,1,1
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.011678,0.2521,0.20787,1,1
3,GO MATURATION OF SSU RRNA,4.3997e-05,0.25207,0.2678,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.001776,0.24994,0.20181,1,1
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00011033,0.24915,0.25375,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,9.795e-06,0.2487,0.24128,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0025277,0.24863,0.18945,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00019857,0.24847,0.26839,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,9.9844e-05,0.24843,0.19001,1,1
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.014494,0.24773,0.16512,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,2.7312e-05,0.24764,0.2018,1,1
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.023668,0.24712,0.19216,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,3.2057e-05,0.24701,0.26448,1,1
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00029511,0.24693,0.24556,1,1
3,GO NEURON REMODELING,8.0256e-05,0.24593,0.25498,1,1
3,GO REGULATION OF RNA BINDING,4.0314e-05,0.2453,0.22662,1,1
3,GO HEART VALVE FORMATION,0.00086244,0.2451,0.25995,1,1
3,GO GLUTAMATE SECRETION,1.5014e-05,0.24502,0.26724,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00015838,0.24492,0.26229,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,7.105e-06,0.24323,0.22928,1,1
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0010558,0.24276,0.25706,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00021511,0.24263,0.26719,1,1
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0010113,0.24241,0.21451,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0018764,0.24119,0.19079,1,1
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00091404,0.24055,0.23384,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00046872,0.24034,0.28624,1,1
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.00055343,0.24023,0.26213,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.086e-06,0.24015,0.19943,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00036686,0.24011,0.22577,1,1
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0046018,0.23969,0.19173,1,1
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.00076726,0.23952,0.2754,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00042777,0.23769,0.22728,1,1
3,GO PROTEIN TRIMERIZATION,5.7059e-05,0.23732,0.24358,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00026438,0.23714,0.23351,1,1
3,GO LONG TERM MEMORY,2.4528e-05,0.23646,0.24125,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00059648,0.2361,0.19656,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00026438,0.23606,0.28501,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,9.1829e-05,0.23568,0.26907,1,1
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0067673,0.23305,0.30183,1,1
3,GO GTP METABOLIC PROCESS,2.9859e-05,0.23303,0.2277,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0019285,0.23159,0.21184,1,1
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,7.0072e-05,0.23065,0.22954,1,1
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,9.03e-05,0.23042,0.26723,1,1
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.033948,0.22774,0.17139,1,1
3,GO GAS TRANSPORT,0.0038977,0.22462,0.25574,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.3435e-06,0.22457,0.23396,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00030449,0.22432,0.23085,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.006444,0.22332,0.18734,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00047589,0.22308,0.1865,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00030449,0.2229,0.18903,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00017176,0.22236,0.24068,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0011668,0.22175,0.2087,1,1
3,GO VOCALIZATION BEHAVIOR,0.024687,0.22156,0.24725,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00010497,0.2213,0.19495,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00075607,0.22068,0.21401,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.012945,0.22067,0.13309,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.059331,0.22058,0.19263,1,1
3,GO NAD METABOLIC PROCESS,1.7693e-06,0.22049,0.28163,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.05063,0.2197,0.13973,1,1
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0011503,0.21875,0.18839,1,1
3,GO ARGININE METABOLIC PROCESS,0.0015038,0.21847,0.23033,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.00067188,0.21843,0.26154,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.00042128,0.21832,0.20387,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.01016,0.21756,0.20766,1,1
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,6.8396e-06,0.21664,0.26383,1,1
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.05063,0.21643,0.14479,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.00063314,0.21561,0.25121,1,1
3,GO CHEMOSENSORY BEHAVIOR,4.6359e-05,0.2153,0.20593,1,1
3,GO LEARNING,0.00015838,0.21523,0.20029,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00067188,0.21459,0.21671,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0084096,0.21423,0.17987,1,1
3,GO VIRAL GENE EXPRESSION,0.00057029,0.21417,0.19236,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0054192,0.21345,0.17744,1,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.023419,0.21296,0.16327,1,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,8.4262e-06,0.21246,0.25062,1,1
3,GO SYNAPSE ORGANIZATION,0.00031414,0.21225,0.17526,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0012177,0.21219,0.19426,1,1
3,GO MECHANOSENSORY BEHAVIOR,0.0084096,0.21211,0.33796,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00011406,0.21206,0.21096,1,1
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00010673,0.21194,0.20851,1,1
3,GO STRESS GRANULE ASSEMBLY,0.00040857,0.21173,0.16975,1,1
3,GO MATURATION OF 5 8S RRNA,0.00068191,0.21149,0.22144,1,1
3,GO LONG TERM SYNAPTIC DEPRESSION,0.00057029,0.21115,0.21933,1,1
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.00035024,0.21107,0.20822,1,1
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.819e-05,0.21057,0.24141,1,1
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0019023,0.20962,0.22799,1,1
3,GO REGULATION OF DOPAMINE SECRETION,0.016027,0.20923,0.24769,1,1
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.00044103,0.20923,0.18331,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.5293e-05,0.20869,0.26246,1,1
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00015583,0.20862,0.24157,1,1
3,GO SYNAPTIC VESICLE EXOCYTOSIS,3.2057e-05,0.20784,0.24491,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.014823,0.20784,0.14411,1,1
3,GO PEPTIDYL ARGININE METHYLATION,2.3661e-05,0.20768,0.22797,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00030449,0.20682,0.18975,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0056958,0.20681,0.15919,1,1
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00090088,0.20641,0.32746,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00011986,0.20627,0.19572,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0025961,0.20573,0.26249,1,1
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.001776,0.20449,0.19141,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00082553,0.20437,0.19954,1,1
3,GO CGMP MEDIATED SIGNALING,0.00036124,0.20427,0.19379,1,1
3,GO TRNA MODIFICATION,0.00010497,0.20381,0.19736,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0040509,0.20237,0.1938,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0044864,0.20142,0.19437,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0013069,0.20017,0.1875,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0028118,0.19998,0.17236,1,1
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0047798,0.19918,0.15994,1,1
3,GO TRANSLATIONAL ELONGATION,5.9056e-05,0.19918,0.18994,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0012177,0.19832,0.1753,1,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.042609,0.19764,0.10197,1,1
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.001071,0.19751,0.18077,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0012527,0.19737,0.20368,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.030994,0.19708,0.16537,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.024173,0.197,0.13514,1,1
3,GO MITOCHONDRION LOCALIZATION,5.7059e-05,0.19665,0.17782,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,9.4341e-06,0.19656,0.22769,1,1
3,GO REGULATION OF DENDRITE MORPHOGENESIS,7.5001e-05,0.1959,0.20264,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,5.1304e-06,0.19583,0.23227,1,1
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00011986,0.19575,0.1919,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,4.7172e-05,0.19541,0.18961,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,1.536e-06,0.19461,0.2112,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0048405,0.19393,0.20445,1,1
3,GO MEMBRANE REPOLARIZATION,0.00028155,0.19352,0.18161,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00011986,0.19346,0.16657,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00023294,0.19305,0.19396,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0055559,0.19177,0.1595,1,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.017506,0.19072,0.17676,1,1
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,2.6352e-05,0.19065,0.17312,1,1
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00040235,0.18993,0.17415,1,1
3,GO REGULATION OF AXONOGENESIS,0.0020929,0.1893,0.16733,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.001071,0.18921,0.14321,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0023321,0.18874,0.17454,1,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.032938,0.18866,0.19611,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.6487e-06,0.18861,0.20042,1,1
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00048316,0.18831,0.2257,1,1
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,7.2497e-05,0.18812,0.17592,1,1
3,GO REGULATION OF CATION CHANNEL ACTIVITY,5.3256e-05,0.18788,0.19655,1,1
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.020166,0.18758,0.17443,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0018006,0.1868,0.18075,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00049802,0.18668,0.19406,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,3.758e-05,0.18622,0.20106,1,1
3,GO NEUROTRANSMITTER TRANSPORT,0.00039018,0.18621,0.2046,1,1
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.01016,0.18547,0.18708,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0088198,0.18405,0.15325,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00018923,0.18394,0.21132,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0096941,0.18387,0.15061,1,1
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0054872,0.1838,0.15212,1,1
3,GO ACIDIC AMINO ACID TRANSPORT,3.3214e-05,0.18353,0.19202,1,1
3,GO LIPID IMPORT INTO CELL,0.032938,0.18324,0.12001,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0044864,0.18297,0.19683,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00053704,0.18245,0.20501,1,1
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.0023321,0.18148,0.16404,1,1
3,GO SNORNA 3 END PROCESSING,9.6562e-05,0.18113,0.28441,1,1
3,GO NEURON RECOGNITION,0.0022396,0.18111,0.21181,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00052901,0.18026,0.23236,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00015583,0.17811,0.1709,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0029645,0.17756,0.13941,1,1
3,GO SHORT TERM MEMORY,0.0095807,0.17752,0.26052,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,1.4472e-05,0.17679,0.18259,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,2.1621e-05,0.17664,0.17973,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.013394,0.17599,0.13034,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0032501,0.1759,0.17142,1,1
3,GO HEPARIN METABOLIC PROCESS,0.020605,0.1758,0.18837,1,1
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0012705,0.17563,0.18874,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0014624,0.17561,0.17643,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0022095,0.17561,0.18979,1,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0034243,0.17509,0.17528,1,1
3,GO AEROBIC RESPIRATION,0.0023637,0.17482,0.13692,1,1
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.036409,0.17438,0.1204,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00011033,0.17373,0.15941,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,9.6562e-05,0.1737,0.19712,1,1
3,GO WALKING BEHAVIOR,6.4592e-06,0.17293,0.26574,1,1
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.014494,0.17252,0.16589,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.044722,0.17218,0.1305,1,1
3,GO AMINO ACID IMPORT,0.014332,0.17138,0.14025,1,1
3,GO NEUROTRANSMITTER SECRETION,0.0010865,0.17092,0.20015,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0020929,0.17081,0.19351,1,1
3,GO TRANSLATIONAL TERMINATION,0.0032928,0.17057,0.16328,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00069207,0.17055,0.18783,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.00033432,0.1705,0.20997,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0043737,0.17007,0.20891,1,1
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0011021,0.17002,0.1785,1,1
3,GO POSTSYNAPSE ORGANIZATION,6.545e-05,0.16991,0.21524,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.0044298,0.16969,0.10698,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0078263,0.16968,0.14161,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0010408,0.16915,0.19265,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00090088,0.16893,0.21377,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0018508,0.16871,0.27359,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.024173,0.16851,0.13593,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00011596,0.1682,0.14169,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0037985,0.16819,0.14285,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.0085105,0.16814,0.14813,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00012594,0.16797,0.18572,1,1
3,GO AXON EXTENSION,0.001071,0.16676,0.16449,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0076401,0.16675,0.1553,1,1
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0050269,0.16666,0.21329,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0014022,0.16652,0.14908,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00032408,0.16602,0.177,1,1
3,GO SYNAPTIC VESICLE LOCALIZATION,0.022686,0.16525,0.15375,1,1
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.025743,0.16512,0.12449,1,1
3,GO RIBOSOME BIOGENESIS,0.00020504,0.16477,0.21864,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00099681,0.16445,0.18771,1,1
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.0005789,0.16409,0.16016,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,3.3806e-05,0.16383,0.18625,1,1
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0032928,0.16381,0.17571,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0005056,0.16307,0.20833,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00083767,0.16307,0.14383,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0005211,0.16285,0.1424,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0029645,0.16263,0.12892,1,1
3,GO FATTY ACID HOMEOSTASIS,0.0030038,0.16232,0.21835,1,1
3,GO NADH METABOLIC PROCESS,5.2344e-05,0.16223,0.23471,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0038977,0.16184,0.17467,1,1
3,GO NEURON PROJECTION GUIDANCE,0.012798,0.16184,0.13982,1,1
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.021509,0.16133,0.19332,1,1
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00067188,0.1605,0.16105,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.0031247,0.16047,0.19715,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.001955,0.16008,0.17305,1,1
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.02521,0.15919,0.12285,1,1
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00022565,0.15888,0.16377,1,1
3,GO RRNA TRANSCRIPTION,0.00015583,0.15853,0.18635,1,1
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0043184,0.15851,0.16142,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0043737,0.15807,0.15647,1,1
3,GO REGULATION OF TUBULIN DEACETYLATION,0.036048,0.15746,0.15298,1,1
3,GO RELAXATION OF MUSCLE,0.0052854,0.15699,0.15141,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0030436,0.15669,0.16021,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.0067673,0.15658,0.10753,1,1
3,GO DENDRITE MORPHOGENESIS,0.0071051,0.15638,0.14659,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.02945,0.15609,0.16645,1,1
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0023009,0.15594,0.15721,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0015463,0.15536,0.13773,1,1
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.030994,0.15504,0.13499,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0035146,0.15498,0.16894,1,1
3,GO MRNA MODIFICATION,0.00060545,0.15496,0.20589,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0019023,0.15465,0.15605,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00022208,0.15462,0.17481,1,1
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.022928,0.15361,0.15562,1,1
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0067673,0.15351,0.1507,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00069207,0.15304,0.12446,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0092477,0.15279,0.13757,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0073682,0.15223,0.12881,1,1
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.012367,0.15201,0.17624,1,1
3,GO RRNA METABOLIC PROCESS,0.00022565,0.1516,0.20017,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00039622,0.15137,0.12866,1,1
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00033432,0.15049,0.20351,1,1
3,GO NEURON PROJECTION EXTENSION,0.0005789,0.15045,0.16081,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.033948,0.15026,0.18423,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00057029,0.14996,0.14153,1,1
3,GO ASSOCIATIVE LEARNING,0.00083767,0.14981,0.15276,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00159,0.14976,0.17484,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00015331,0.14976,0.14676,1,1
3,GO RESPONSE TO AMINE,0.0083098,0.14969,0.12278,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00016098,0.14967,0.15018,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0025617,0.14951,0.1536,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00013016,0.14932,0.17293,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,4.7488e-06,0.14913,0.17911,1,1
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0096941,0.14909,0.15732,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010113,0.14885,0.22135,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.004156,0.1488,0.14264,1,1
3,GO NUCLEOBASE METABOLIC PROCESS,0.0001803,0.14828,0.19324,1,1
3,GO L AMINO ACID TRANSPORT,0.00092737,0.14798,0.17295,1,1
3,GO TRNA METHYLATION,0.00084997,0.14767,0.17442,1,1
3,GO CRISTAE FORMATION,0.007921,0.14711,0.17852,1,1
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00075607,0.14693,0.15461,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0013826,0.14685,0.16255,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,4.4771e-05,0.14635,0.16719,1,1
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.003654,0.14604,0.13906,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00099681,0.14589,0.14558,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.013093,0.14537,0.13419,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.003654,0.14422,0.16445,1,1
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0084096,0.14388,0.16846,1,1
3,GO DENDRITIC SPINE DEVELOPMENT,0.00023294,0.14382,0.20007,1,1
3,GO ALDEHYDE CATABOLIC PROCESS,0.019735,0.14308,0.092611,1,1
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0104,0.14279,0.21248,1,1
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0035146,0.14253,0.14379,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00010673,0.14243,0.16796,1,1
3,GO DENDRITE DEVELOPMENT,0.0035146,0.14207,0.13994,1,1
3,GO ONE CARBON METABOLIC PROCESS,0.0096941,0.14147,0.12057,1,1
3,GO CARDIAC CONDUCTION,0.0029256,0.14127,0.1449,1,1
3,GO FOREBRAIN CELL MIGRATION,0.0020367,0.14031,0.16332,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00068191,0.13985,0.11235,1,1
3,GO DEVELOPMENTAL CELL GROWTH,0.0017517,0.13967,0.13128,1,1
3,GO GLUTAMINE METABOLIC PROCESS,6.1119e-05,0.13946,0.1937,1,1
3,GO IMPORT INTO CELL,7.8911e-05,0.13923,0.16171,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0052197,0.13884,0.15024,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0085105,0.13867,0.14903,1,1
3,GO AXON DEVELOPMENT,0.0057669,0.13812,0.13957,1,1
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.007921,0.13739,0.17593,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.046921,0.13727,0.14297,1,1
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.013546,0.13703,0.11739,1,1
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.047372,0.137,0.13545,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0020646,0.13635,0.1221,1,1
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.01251,0.1361,0.13471,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.00041488,0.13531,0.11636,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0037016,0.13454,0.16855,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.01585,0.13453,0.1139,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00073415,0.13436,0.19993,1,1
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0024281,0.13432,0.1547,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.00016361,0.13428,0.11714,1,1
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0063654,0.13359,0.15368,1,1
3,GO DENDRITIC SPINE MAINTENANCE,0.035336,0.13353,0.13289,1,1
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.026013,0.1335,0.14678,1,1
3,GO SNORNA METABOLIC PROCESS,0.00011033,0.13333,0.28274,1,1
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.031631,0.1329,0.12856,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.024687,0.13266,0.23125,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0046018,0.13243,0.16199,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,3.3806e-05,0.13243,0.14116,1,1
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.031311,0.13243,0.11021,1,1
3,GO RRNA MODIFICATION,0.0035605,0.13235,0.19523,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.022928,0.13179,0.12908,1,1
3,GO NUCLEOTIDE SALVAGE,0.031311,0.1314,0.18303,1,1
3,GO TRANSEPITHELIAL TRANSPORT,0.0027747,0.13123,0.12456,1,1
3,GO RNA POLYADENYLATION,0.0043184,0.13097,0.10954,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.012227,0.12938,0.11279,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00096848,0.1293,0.13038,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0023957,0.12859,0.13465,1,1
3,GO RNA SURVEILLANCE,0.0089251,0.12831,0.13219,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.026838,0.12824,0.12609,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0071918,0.12816,0.15095,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0046018,0.12752,0.16472,1,1
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016568,0.12688,0.11195,1,1
3,GO AXO DENDRITIC TRANSPORT,0.022209,0.12645,0.10253,1,1
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00039018,0.12608,0.12949,1,1
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.032938,0.12585,0.10865,1,1
3,GO CELLULAR RESPIRATION,0.001483,0.12581,0.12977,1,1
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0052197,0.12571,0.14752,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0030839,0.12411,0.14904,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.038258,0.12314,0.15893,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.040981,0.12245,0.10209,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.013546,0.1224,0.12136,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.037882,0.12233,0.11821,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0077327,0.12228,0.13041,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00094089,0.12146,0.1677,1,1
3,GO NCRNA PROCESSING,0.00072342,0.121,0.16863,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.016205,0.11924,0.13575,1,1
3,GO SYNAPTIC SIGNALING,0.0035605,0.1187,0.13916,1,1
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.028264,0.11852,0.13649,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0005211,0.11851,0.1291,1,1
3,GO BONE GROWTH,0.057179,0.11721,0.13654,1,1
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0022095,0.11532,0.12605,1,1
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.016386,0.11437,0.099064,1,1
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.011411,0.1142,0.13638,1,1
3,GO AMINO ACID TRANSPORT,0.00019857,0.11408,0.15251,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0012177,0.11402,0.1399,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0057669,0.11358,0.095175,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.023173,0.11315,0.15887,1,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.055609,0.11312,0.11689,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.0019819,0.11258,0.097746,1,1
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00024045,0.11192,0.15094,1,1
3,GO TUBULIN DEACETYLATION,0.023919,0.11086,0.1543,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0062877,0.11065,0.14865,1,1
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0088198,0.1096,0.10826,1,1
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0046018,0.10935,0.13592,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.023668,0.10868,0.103,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.027973,0.10852,0.1035,1,1
3,GO MEMBRANE HYPERPOLARIZATION,0.039406,0.10787,0.14377,1,1
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0051547,0.10692,0.1214,1,1
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0014022,0.1068,0.10896,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0078263,0.10667,0.13393,1,1
3,GO REGULATION OF MEMBRANE POTENTIAL,0.013093,0.10663,0.11645,1,1
3,GO COCHLEA DEVELOPMENT,0.022446,0.10613,0.10556,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.012945,0.10565,0.099129,1,1
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.019104,0.10544,0.090809,1,1
3,GO CERAMIDE TRANSPORT,0.014658,0.10518,0.12744,1,1
3,GO CELLULAR RESPONSE TO PH,0.010041,0.1047,0.10083,1,1
3,GO PROTEIN TARGETING,0.00015331,0.10423,0.10867,1,1
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.0046604,0.10401,0.12063,1,1
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0093576,0.10396,0.11398,1,1
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.040582,0.1039,0.10984,1,1
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0071051,0.10359,0.13701,1,1
3,GO TRNA PROCESSING,0.0014022,0.10318,0.15178,1,1
3,GO MRNA METHYLATION,0.037882,0.10279,0.13391,1,1
3,GO RNA METHYLATION,0.0055559,0.10199,0.12392,1,1
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0037016,0.10159,0.084806,1,1
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.012798,0.10082,0.13156,1,1
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0047198,0.099909,0.11394,1,1
3,GO STRIATED MUSCLE CONTRACTION,0.044292,0.099809,0.084131,1,1
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.020385,0.099807,0.085835,1,1
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0038478,0.099347,0.12333,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.036409,0.09932,0.1773,1,1
3,GO PRESYNAPTIC ENDOCYTOSIS,0.042197,0.099191,0.11172,1,1
3,GO RNA CATABOLIC PROCESS,0.0030839,0.098794,0.10639,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.012087,0.098576,0.10845,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0015249,0.097699,0.10363,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.023668,0.097607,0.12176,1,1
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.050154,0.096388,0.1069,1,1
3,GO SKELETAL MUSCLE CONTRACTION,0.010279,0.0958,0.13646,1,1
3,GO RESPONSE TO AMYLOID BETA,0.010769,0.095579,0.12321,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.018898,0.094643,0.12746,1,1
3,GO NCRNA METABOLIC PROCESS,0.0023009,0.093617,0.1417,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.01995,0.093316,0.084551,1,1
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0089251,0.092511,0.17303,1,1
3,GO RESPONSE TO NITRIC OXIDE,0.017506,0.091914,0.082731,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.013243,0.091483,0.10253,1,1
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0020929,0.089074,0.11437,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.015674,0.089051,0.098154,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.012087,0.088621,0.10566,1,1
3,GO CELL RECOGNITION,0.0063654,0.088376,0.10273,1,1
3,GO TRNA 5 END PROCESSING,0.016938,0.087996,0.13094,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0030436,0.087544,0.089881,1,1
3,GO RNA 5 END PROCESSING,0.0088198,0.086892,0.16606,1,1
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0035146,0.08612,0.11091,1,1
3,GO PROTEIN TETRAMERIZATION,0.0051547,0.085451,0.095473,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.017894,0.085321,0.094385,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0031247,0.084634,0.11337,1,1
3,GO RRNA METHYLATION,0.027686,0.084319,0.13326,1,1
3,GO MRNA METABOLIC PROCESS,0.0031247,0.084215,0.087569,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.026286,0.083937,0.073863,1,1
3,GO REGULATION OF CELL SIZE,0.017894,0.082711,0.10064,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.0073682,0.082565,0.096887,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00038422,0.081828,0.12093,1,1
3,GO COGNITION,0.0084096,0.08141,0.11837,1,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.004156,0.081292,0.1248,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.034636,0.081087,0.10723,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.048746,0.080546,0.096944,1,1
3,GO RECEPTOR INTERNALIZATION,0.018091,0.080252,0.10511,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.004156,0.08019,0.08373,1,1
3,GO PROTEIN NITROSYLATION,0.059331,0.080055,0.12607,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0073682,0.079939,0.11589,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.014172,0.079721,0.11303,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0072795,0.079548,0.11195,1,1
3,GO ATP METABOLIC PROCESS,0.0029256,0.079302,0.092352,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0037016,0.079265,0.087485,1,1
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.014172,0.078407,0.13811,1,1
3,GO RNA 3 END PROCESSING,0.041383,0.077498,0.064902,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0033799,0.076384,0.074196,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.05063,0.075522,0.066975,1,1
3,GO RNA PROCESSING,0.0053519,0.074425,0.095293,1,1
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.019312,0.074275,0.087172,1,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0041031,0.073202,0.12789,1,1
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.019735,0.071752,0.091949,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.015329,0.07011,0.087191,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.020166,0.069013,0.08728,1,1
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0073682,0.067994,0.11282,1,1
3,GO MEMORY,0.042197,0.066017,0.094069,1,1
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.013856,0.063196,0.079158,1,1
3,GO RNA MODIFICATION,0.0069343,0.06175,0.11843,1,1
3,GO CATECHOLAMINE SECRETION,0.042197,0.059232,0.18623,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.059331,0.054455,0.054175,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.011813,0.048769,0.11416,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.015501,0.048189,0.076129,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0037498,0.33659,0.36592,1,0
3,GO PREPULSE INHIBITION,0.0024281,0.32617,0.3038,1,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.01016,0.25393,0.21423,1,0
3,GO INNERVATION,0.0071051,0.24678,0.25968,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0043184,0.2465,0.19901,1,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.034636,0.23543,0.26978,1,0
3,GO AXONAL FASCICULATION,0.013093,0.23285,0.23157,1,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.026013,0.22019,0.19204,1,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.010769,0.21424,0.15888,1,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.013546,0.21379,0.13358,1,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0038977,0.20839,0.17897,1,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.036048,0.20287,0.1852,1,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.012653,0.19808,0.22746,1,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.019312,0.19672,0.23585,1,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0034692,0.1936,0.18332,1,0
3,GO SYNAPTIC VESICLE DOCKING,0.021053,0.19065,0.22753,1,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0057669,0.18958,0.18874,1,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.010769,0.18795,0.20112,1,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.036772,0.18235,0.18033,1,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0012005,0.18221,0.21089,1,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.03006,0.18066,0.16576,1,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.023419,0.17529,0.18931,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.028264,0.17133,0.14033,1,0
3,GO DENDRITIC TRANSPORT,0.0021505,0.16759,0.2126,1,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.019523,0.16377,0.1587,1,0
3,GO COLLATERAL SPROUTING,0.0023637,0.16115,0.19505,1,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.034636,0.16008,0.17451,1,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0137,0.15848,0.16833,1,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.059879,0.15618,0.12305,1,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.047372,0.15603,0.17269,1,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.037139,0.15541,0.13741,1,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.02128,0.15309,0.16638,1,0
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.000662,0.15054,0.16637,1,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.043444,0.15053,0.11858,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.019104,0.14884,0.19698,1,0
3,GO RESPIRATORY SYSTEM PROCESS,0.00049053,0.14847,0.20881,1,0
3,GO PRESYNAPSE ORGANIZATION,0.032607,0.14811,0.1276,1,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.053071,0.14722,0.18322,1,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.014494,0.14699,0.24559,1,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.037509,0.14312,0.15775,1,0
3,GO RESPONSE TO CAFFEINE,0.0038478,0.13704,0.15322,1,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.025743,0.1357,0.1283,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0073682,0.13314,0.16315,1,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.004156,0.13247,0.1608,1,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0065235,0.13176,0.16143,1,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0021798,0.13056,0.1365,1,0
3,GO NEUROMUSCULAR PROCESS,0.0020929,0.12789,0.1453,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.011022,0.12605,0.19156,1,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.059879,0.12474,0.10727,1,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0030839,0.12448,0.1701,1,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.051111,0.12435,0.13807,1,0
3,GO SYNAPSE ASSEMBLY,0.048746,0.12359,0.10573,1,0
3,GO SEROTONIN TRANSPORT,0.051595,0.12326,0.14324,1,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.026561,0.12319,0.16159,1,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.019735,0.12293,0.1972,1,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.03429,0.12264,0.15822,1,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.016205,0.1225,0.10668,1,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0052197,0.11995,0.13861,1,0
3,GO AXONAL TRANSPORT,0.036048,0.11992,0.10838,1,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0059116,0.11942,0.24799,1,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.026838,0.11879,0.16083,1,0
3,GO MICROTUBULE POLYMERIZATION,0.032278,0.11755,0.098539,1,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.033948,0.11728,0.11827,1,0
3,GO RESPONSE TO ACETYLCHOLINE,0.052083,0.11676,0.15667,1,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0051547,0.11514,0.25329,1,0
3,GO DNA REPLICATION INITIATION,0.032938,0.11501,0.095124,1,0
3,GO SYNAPTIC VESICLE RECYCLING,0.056128,0.115,0.10058,1,0
3,GO CELL PART MORPHOGENESIS,0.0078263,0.11464,0.12313,1,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.036772,0.11223,0.11791,1,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.036048,0.10926,0.13803,1,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.031953,0.10668,0.09504,1,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.020166,0.10656,0.12523,1,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.023419,0.10652,0.099478,1,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.037139,0.10632,0.13599,1,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.0015249,0.10571,0.12347,1,0
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0085105,0.10406,0.1487,1,0
3,GO TRICARBOXYLIC ACID CYCLE,0.027118,0.10391,0.10578,1,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.033271,0.10364,0.12249,1,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0043737,0.10357,0.12255,1,0
3,GO REGULATION OF AXON GUIDANCE,0.02945,0.10348,0.14227,1,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0074579,0.10132,0.12553,1,0
3,GO RESPONSE TO DOPAMINE,0.025475,0.10001,0.104,1,0
3,GO STRIATUM DEVELOPMENT,0.052575,0.098815,0.12622,1,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.046921,0.09875,0.080628,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.047372,0.09758,0.099581,1,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.058787,0.097435,0.11083,1,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.012087,0.097383,0.13332,1,0
3,GO DETECTION OF VISIBLE LIGHT,0.043025,0.096792,0.18476,1,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0039481,0.096601,0.11738,1,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.045155,0.096489,0.093317,1,0
3,GO METENCEPHALON DEVELOPMENT,0.016205,0.094238,0.11305,1,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.048285,0.094142,0.1534,1,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.03068,0.09194,0.1206,1,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.0080166,0.091568,0.12137,1,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.032938,0.090797,0.10332,1,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.045591,0.090726,0.088706,1,0
3,GO PROTEIN DENEDDYLATION,0.049212,0.089512,0.093139,1,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.012798,0.088318,0.10988,1,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.057711,0.088042,0.099444,1,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.012367,0.087923,0.14763,1,0
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0025277,0.086905,0.13915,1,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.046031,0.086636,0.11944,1,0
3,GO NEURON DEVELOPMENT,0.044292,0.086626,0.088203,1,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0063654,0.08497,0.08994,1,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.014172,0.084922,0.28297,1,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0056958,0.084136,0.093667,1,0
3,GO ADULT BEHAVIOR,0.056652,0.083388,0.11082,1,0
3,GO ALDITOL METABOLIC PROCESS,0.027973,0.0816,0.1408,1,0
3,GO POTASSIUM ION TRANSPORT,0.015329,0.080961,0.10924,1,0
3,GO ANION HOMEOSTASIS,0.046031,0.080777,0.10376,1,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.026013,0.080037,0.11084,1,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.012945,0.0799,0.095636,1,0
3,GO TRNA METABOLIC PROCESS,0.0074579,0.079414,0.11971,1,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.026286,0.078631,0.075616,1,0
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.042609,0.07835,0.12302,1,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.050154,0.077223,0.1116,1,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.012945,0.076667,0.271,1,0
3,GO EXPLORATION BEHAVIOR,0.048746,0.075652,0.17059,1,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.055093,0.073333,0.13893,1,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.046921,0.072802,0.11475,1,0
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.014332,0.071946,0.082326,1,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.020605,0.071253,0.079678,1,0
3,GO PYRUVATE METABOLIC PROCESS,0.038258,0.070475,0.091209,1,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.030994,0.070391,0.093375,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.037139,0.070323,0.095531,1,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.043866,0.069225,0.067879,1,0
3,GO RESPONSE TO CATECHOLAMINE,0.050154,0.068397,0.091413,1,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.030994,0.067194,0.10874,1,0
3,GO REGULATION OF METAL ION TRANSPORT,0.042197,0.066193,0.074487,1,0
3,GO REGULATION OF PROTEIN TARGETING,0.015159,0.064797,0.088872,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.026013,0.064671,0.13387,1,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.056652,0.064222,0.099424,1,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.061549,0.063713,0.085118,1,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.049681,0.063464,0.085605,1,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.008211,0.063346,0.15963,1,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.03068,0.062973,0.091474,1,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.014494,0.061458,0.072564,1,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.03429,0.060319,0.10276,1,0
3,GO FEEDING BEHAVIOR,0.044722,0.06005,0.083062,1,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.010522,0.059011,0.1092,1,0
3,GO THIOESTER METABOLIC PROCESS,0.059879,0.057626,0.081255,1,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.027686,0.056692,0.090117,1,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.028264,0.054784,0.063884,1,0
3,GO MIRNA METABOLIC PROCESS,0.057179,0.052082,0.073841,1,0
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.042197,0.051983,0.081987,1,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0078263,0.051958,0.10293,1,0
3,GO NCRNA 3 END PROCESSING,0.044292,0.051891,0.079749,1,0
3,GO RNA CAPPING,0.053071,0.049006,0.063445,1,0
3,GO BEHAVIOR,0.059879,0.048872,0.078836,1,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.025475,0.048088,0.074662,1,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.023668,0.047326,0.12669,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.045591,0.045959,0.06655,1,0
3,GO PROTEIN NEDDYLATION,0.049681,0.044566,0.079309,1,0
3,GO NCRNA TRANSCRIPTION,0.022446,0.044366,0.074144,1,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.026286,0.041623,0.084613,1,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.05063,0.033936,0.087903,1,0
3,GO NUCLEOTIDE PHOSPHORYLATION,0.024428,0.032808,0.095543,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.045155,0.028693,0.095547,1,0
3,GO RESPONSE TO IONIZING RADIATION,0.030368,-0.01285,-0.071321,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.056652,-0.015375,-0.034892,1,0
3,GO SISTER CHROMATID SEGREGATION,0.032938,-0.02466,-0.055346,1,0
3,GO CELLULAR RESPONSE TO STARVATION,0.025743,-0.031614,-0.060278,1,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.046031,-0.032347,-0.035232,1,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.017315,-0.033577,-0.044176,1,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.054074,-0.035855,-0.041528,1,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.03429,-0.036129,-0.093445,1,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.030994,-0.036194,-0.031893,1,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.049681,-0.036737,-0.046108,1,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.061549,-0.038116,-0.064673,1,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.05357,-0.038923,-0.037891,1,0
3,GO CYTOSOLIC TRANSPORT,0.032938,-0.03911,-0.038137,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.040582,-0.039178,-0.032378,1,0
3,GO CELL JUNCTION ASSEMBLY,0.046921,-0.03921,-0.062472,1,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.055609,-0.039318,-0.033161,1,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.030368,-0.039327,-0.041339,1,0
3,GO MEMBRANE FUSION,0.041383,-0.041314,-0.055129,1,0
3,GO ORGANELLE LOCALIZATION,0.01128,-0.041381,-0.041446,1,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.043025,-0.041869,-0.041187,1,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.016386,-0.04194,-0.033828,1,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.05063,-0.041957,-0.071274,1,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.056652,-0.042102,-0.069739,1,0
3,GO ORGANELLE ASSEMBLY,0.0077327,-0.042174,-0.044397,1,0
3,GO REGULATION OF APPETITE,0.049212,-0.042877,-0.082116,1,0
3,GO RESPONSE TO GROWTH FACTOR,0.049212,-0.042947,-0.05666,1,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.014823,-0.043465,-0.035426,1,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.051595,-0.0437,-0.030282,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.010895,-0.043952,-0.054075,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.03006,-0.044142,-0.11225,1,0
3,GO MANNOSYLATION,0.055609,-0.044329,-0.075305,1,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.044722,-0.044568,-0.04154,1,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.011813,-0.045,-0.039894,1,0
3,GO CHROMOSOME SEGREGATION,0.053071,-0.045025,-0.044972,1,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.059331,-0.045135,-0.044683,1,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.046474,-0.04559,-0.042093,1,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.019523,-0.045625,-0.034647,1,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.054074,-0.045646,-0.064207,1,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.039795,-0.04617,-0.11831,1,0
3,GO REGULATION OF PHOSPHORYLATION,0.019735,-0.04627,-0.045447,1,0
3,GO HISTONE H3 K9 METHYLATION,0.037882,-0.046578,-0.065863,1,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0042636,-0.046803,-0.057388,1,0
3,GO PEPTIDYL SERINE MODIFICATION,0.044722,-0.047161,-0.037026,1,0
3,GO CERAMIDE METABOLIC PROCESS,0.052575,-0.047188,-0.055317,1,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.013394,-0.047371,-0.041028,1,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.027973,-0.048056,-0.049294,1,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.028556,-0.048125,-0.04991,1,0
3,GO REGULATION OF CELL CYCLE,0.0078263,-0.048142,-0.038083,1,0
3,GO HISTONE H3 K9 MODIFICATION,0.033948,-0.049097,-0.068105,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0078263,-0.049279,-0.060962,1,0
3,GO SINGLE FERTILIZATION,0.044722,-0.049354,-0.042227,1,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.045591,-0.049545,-0.048227,1,0
3,GO MITOTIC CELL CYCLE,0.021509,-0.049566,-0.041332,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.030368,-0.049586,-0.052243,1,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.038637,-0.049757,-0.035004,1,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.015501,-0.050036,-0.085728,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.041383,-0.050638,-0.0402,1,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.061549,-0.051311,-0.033222,1,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.031311,-0.051337,-0.043031,1,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.02174,-0.051345,-0.044644,1,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.017699,-0.051838,-0.041648,1,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.054074,-0.052017,-0.036678,1,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.054074,-0.0523,-0.10668,1,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.033608,-0.052311,-0.050497,1,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.040981,-0.052536,-0.057004,1,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.027973,-0.052629,-0.040615,1,0
3,GO SISTER CHROMATID COHESION,0.054074,-0.052734,-0.057956,1,0
3,GO CELL CYCLE,0.0059116,-0.053624,-0.040472,1,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0056255,-0.05384,-0.10748,1,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.031631,-0.053941,-0.046421,1,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.003607,-0.054004,-0.049524,1,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.035691,-0.054093,-0.040832,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.049212,-0.054473,-0.084821,1,0
3,GO TOR SIGNALING,0.050154,-0.054663,-0.031157,1,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.0088198,-0.054929,-0.062665,1,0
3,GO REGULATION OF MAPK CASCADE,0.055093,-0.055256,-0.045268,1,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.032278,-0.055661,-0.044231,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.040187,-0.055762,-0.037592,1,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.01849,-0.055866,-0.078039,1,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.02521,-0.056223,-0.048473,1,0
3,GO NEGATIVE REGULATION OF GROWTH,0.057179,-0.056659,-0.039106,1,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.031953,-0.056768,-0.043222,1,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.012087,-0.056874,-0.050287,1,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.048746,-0.056967,-0.041536,1,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.033271,-0.057302,-0.038233,1,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0069343,-0.057326,-0.063573,1,0
3,GO MEMBRANE DOCKING,0.032938,-0.05752,-0.046888,1,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.052575,-0.05758,-0.037147,1,0
3,GO CELLULAR LIPID METABOLIC PROCESS,0.023419,-0.057741,-0.053796,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.020385,-0.057954,-0.063117,1,0
3,GO VESICLE ORGANIZATION,0.0058389,-0.058036,-0.069176,1,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.046921,-0.058119,-0.037696,1,0
3,GO HISTONE UBIQUITINATION,0.0085105,-0.058154,-0.067087,1,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.011949,-0.058515,-0.053654,1,0
3,GO DNA INTEGRITY CHECKPOINT,0.010645,-0.058578,-0.064889,1,0
3,GO REGULATION OF TUBE SIZE,0.036409,-0.058759,-0.063138,1,0
3,GO LIPID METABOLIC PROCESS,0.026561,-0.058957,-0.050338,1,0
3,GO SPINDLE ASSEMBLY,0.013243,-0.059346,-0.058708,1,0
3,GO RESPONSE TO HORMONE,0.054074,-0.059865,-0.040439,1,0
3,GO ERAD PATHWAY,0.012227,-0.059997,-0.070344,1,0
3,GO HISTONE H4 ACETYLATION,0.052083,-0.060094,-0.038535,1,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0037016,-0.060166,-0.090102,1,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0074579,-0.060489,-0.053563,1,0
3,GO MALE GAMETE GENERATION,0.00091404,-0.060685,-0.076848,1,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.027401,-0.060746,-0.054826,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.009139,-0.060886,-0.045441,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.057179,-0.060886,-0.067565,1,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.052575,-0.060937,-0.086345,1,0
3,GO CYTOKINESIS,0.0012886,-0.061254,-0.082119,1,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.022928,-0.061285,-0.097537,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.022446,-0.061324,-0.051998,1,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.061549,-0.061915,-0.043097,1,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.024428,-0.061936,-0.060452,1,0
3,GO REGULATION OF TOR SIGNALING,0.042197,-0.062138,-0.04323,1,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.047372,-0.062156,-0.056737,1,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.027973,-0.062282,-0.074495,1,0
3,GO POSITIVE REGULATION OF SIGNALING,0.0060595,-0.062376,-0.058341,1,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.045155,-0.062506,-0.032824,1,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.026013,-0.062572,-0.060334,1,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.026838,-0.06269,-0.0491,1,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0104,-0.063131,-0.047476,1,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.0080166,-0.063185,-0.12125,1,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.057711,-0.063299,-0.042169,1,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.0038478,-0.063352,-0.075452,1,0
3,GO SPECIFICATION OF SYMMETRY,0.0021505,-0.063548,-0.08465,1,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.054582,-0.063565,-0.083063,1,0
3,GO NEUTROPHIL CHEMOTAXIS,0.052575,-0.063755,-0.067462,1,0
3,GO ACTIN FILAMENT BASED PROCESS,0.01499,-0.063757,-0.060004,1,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.023919,-0.063865,-0.057597,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.0070192,-0.06392,-0.077865,1,0
3,GO SPINDLE ORGANIZATION,0.029754,-0.063941,-0.048382,1,0
3,GO MITOTIC NUCLEAR DIVISION,0.010769,-0.063998,-0.061991,1,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.021509,-0.064419,-0.054254,1,0
3,GO REGULATION OF PHAGOCYTOSIS,0.038258,-0.064899,-0.085713,1,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.014332,-0.065103,-0.071093,1,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.013546,-0.065373,-0.10433,1,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.033608,-0.065398,-0.042509,1,0
3,GO BLASTOCYST DEVELOPMENT,0.030994,-0.065636,-0.045253,1,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.055609,-0.066024,-0.058896,1,0
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.0050904,-0.066055,-0.059366,1,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.033608,-0.066102,-0.1138,1,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.027118,-0.066102,-0.05588,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.040981,-0.066641,-0.074682,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.054074,-0.066642,-0.11137,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.049681,-0.066823,-0.057681,1,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.023919,-0.066872,-0.040817,1,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.03068,-0.067044,-0.04466,1,0
3,GO PROTEIN CATABOLIC PROCESS,0.011544,-0.067159,-0.044273,1,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.023419,-0.067265,-0.044936,1,0
3,GO LYSOSOME LOCALIZATION,0.03068,-0.067284,-0.084007,1,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.014172,-0.067394,-0.074793,1,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.013546,-0.067465,-0.068429,1,0
3,GO SEXUAL REPRODUCTION,0.0020646,-0.067531,-0.064188,1,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.023668,-0.067552,-0.054613,1,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0012177,-0.067561,-0.09401,1,0
3,GO DEMETHYLATION,0.031311,-0.067563,-0.045048,1,0
3,GO HUMORAL IMMUNE RESPONSE,0.0039481,-0.067769,-0.12386,1,0
3,GO GLYCOSYLATION,0.013856,-0.067851,-0.076866,1,0
3,GO PIGMENT CELL DIFFERENTIATION,0.042609,-0.067851,-0.075648,1,0
3,GO LIPID MODIFICATION,0.016205,-0.067886,-0.06046,1,0
3,GO SENSORY ORGAN DEVELOPMENT,0.043444,-0.067948,-0.049808,1,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.012653,-0.068207,-0.066898,1,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.013093,-0.068251,-0.059812,1,0
3,GO FATTY ACID METABOLIC PROCESS,0.031311,-0.068378,-0.06334,1,0
3,GO ORGANELLE FISSION,0.00080175,-0.068392,-0.065555,1,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.052083,-0.06845,-0.080221,1,0
3,GO SPERM MOTILITY,0.057711,-0.068718,-0.059637,1,0
3,GO REGULATION OF SECRETION,0.036048,-0.068739,-0.051488,1,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.040187,-0.06884,-0.055587,1,0
3,GO AMINE METABOLIC PROCESS,0.046474,-0.068967,-0.063324,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.017125,-0.069013,-0.045309,1,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.053071,-0.06903,-0.058327,1,0
3,GO MACROAUTOPHAGY,0.0015463,-0.069083,-0.059497,1,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.019312,-0.06925,-0.088913,1,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.019312,-0.069438,-0.056124,1,0
3,GO CELL DIVISION,0.01251,-0.069447,-0.050128,1,0
3,GO NUCLEUS ORGANIZATION,0.007921,-0.069546,-0.049459,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.03902,-0.0696,-0.04521,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.045591,-0.069605,-0.069359,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0038977,-0.069879,-0.077788,1,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.012653,-0.069887,-0.054533,1,0
3,GO CYTOSKELETON ORGANIZATION,0.013093,-0.069936,-0.04879,1,0
3,GO OOGENESIS,0.022209,-0.069979,-0.077087,1,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.056652,-0.070074,-0.060444,1,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.010769,-0.070097,-0.069345,1,0
3,GO SYMBIOTIC PROCESS,0.006444,-0.070287,-0.06784,1,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.032607,-0.070314,-0.066065,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.027118,-0.070334,-0.045202,1,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.060432,-0.070582,-0.042254,1,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0083098,-0.070604,-0.062622,1,0
3,GO BIOLOGICAL ADHESION,0.023668,-0.070607,-0.074153,1,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.018693,-0.070609,-0.066216,1,0
3,GO CIRCADIAN RHYTHM,0.013546,-0.070687,-0.046446,1,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.011151,-0.070824,-0.05342,1,0
3,GO CELL CYCLE CHECKPOINT,0.0011021,-0.070838,-0.077946,1,0
3,GO DNA MODIFICATION,0.055093,-0.071004,-0.041271,1,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.01251,-0.071022,-0.079729,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.00067188,-0.071081,-0.065785,1,0
3,GO NON RECOMBINATIONAL REPAIR,0.001071,-0.071083,-0.077318,1,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00026438,-0.071157,-0.099526,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0019819,-0.071202,-0.067373,1,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.047372,-0.071518,-0.038754,1,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.00028155,-0.071647,-0.06576,1,0
3,GO RESPONSE TO ALCOHOL,0.027973,-0.071724,-0.05588,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0023637,-0.071757,-0.051731,1,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.025475,-0.07177,-0.099891,1,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.010895,-0.071812,-0.054987,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.027973,-0.071828,-0.053538,1,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00061456,-0.072186,-0.067805,1,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.01995,-0.072224,-0.049529,1,0
3,GO VASCULATURE DEVELOPMENT,0.051111,-0.072399,-0.062341,1,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00084997,-0.0724,-0.059788,1,0
3,GO VACUOLE ORGANIZATION,0.024687,-0.072518,-0.053401,1,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.056128,-0.072534,-0.056114,1,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.012945,-0.072791,-0.055896,1,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0060595,-0.07285,-0.064643,1,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.022446,-0.072871,-0.08219,1,0
3,GO QUINONE METABOLIC PROCESS,0.023668,-0.073053,-0.14634,1,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.012945,-0.073098,-0.049074,1,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.026561,-0.073244,-0.059481,1,0
3,GO MULTI ORGANISM PROCESS,0.001955,-0.073276,-0.059764,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.020828,-0.073316,-0.044989,1,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.027686,-0.073451,-0.076389,1,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0071051,-0.07349,-0.07018,1,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.00013451,-0.074317,-0.09858,1,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.047827,-0.074375,-0.10022,1,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.020828,-0.074395,-0.090348,1,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00027716,-0.074412,-0.06796,1,0
3,GO GERM CELL DEVELOPMENT,0.0033361,-0.074939,-0.078366,1,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.0054872,-0.075164,-0.10722,1,0
3,GO EMBRYO DEVELOPMENT,0.0032928,-0.075307,-0.066501,1,0
3,GO RESPONSE TO FOOD,0.019735,-0.075411,-0.098094,1,0
3,GO REGULATION OF CELL MATURATION,0.017894,-0.075572,-0.0702,1,0
3,GO ORGANELLE DISASSEMBLY,0.0104,-0.075578,-0.05645,1,0
3,GO PROTEIN AUTOUBIQUITINATION,0.0070192,-0.075954,-0.068381,1,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.023419,-0.076258,-0.06243,1,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.012087,-0.076363,-0.070294,1,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.05063,-0.076375,-0.099264,1,0
3,GO HETEROCHROMATIN ORGANIZATION,0.0059852,-0.076378,-0.061718,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0043184,-0.076421,-0.087665,1,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.048285,-0.076442,-0.044874,1,0
3,GO PATTERN SPECIFICATION PROCESS,0.037509,-0.076599,-0.055747,1,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.013093,-0.076707,-0.059791,1,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.041383,-0.076968,-0.16793,1,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.032278,-0.077049,-0.04883,1,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0044864,-0.077279,-0.095248,1,0
3,GO NEGATIVE REGULATION OF SECRETION,0.043866,-0.077326,-0.052549,1,0
3,GO CELL MOTILITY,0.0071918,-0.077337,-0.072261,1,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.021053,-0.077587,-0.077076,1,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.027401,-0.077644,-0.104,1,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.027973,-0.07781,-0.11574,1,0
3,GO APOPTOTIC PROCESS,0.0093576,-0.077864,-0.05272,1,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.018693,-0.078134,-0.050366,1,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.026013,-0.078343,-0.063514,1,0
3,GO MUSCLE CELL DIFFERENTIATION,0.01499,-0.078437,-0.071208,1,0
3,GO RESPONSE TO BMP,0.020385,-0.078481,-0.093032,1,0
3,GO GOLGI VESICLE TRANSPORT,0.0073682,-0.078665,-0.057246,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.006444,-0.078891,-0.068151,1,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.013093,-0.078965,-0.14407,1,0
3,GO REGULATION OF HYDROLASE ACTIVITY,0.0048405,-0.078988,-0.067011,1,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.041789,-0.079142,-0.080861,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00094089,-0.079145,-0.072527,1,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.031311,-0.079221,-0.13272,1,0
3,GO DNA DEALKYLATION,0.018898,-0.079357,-0.091567,1,0
3,GO NIK NF KAPPAB SIGNALING,0.027973,-0.07945,-0.082278,1,0
3,GO APPENDAGE DEVELOPMENT,0.0086125,-0.07947,-0.10155,1,0
3,GO DETECTION OF STIMULUS,0.010041,-0.079509,-0.060381,1,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0034692,-0.07955,-0.0698,1,0
3,GO THYMIC T CELL SELECTION,0.03068,-0.079595,-0.096024,1,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0092477,-0.079698,-0.076733,1,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.01016,-0.079906,-0.077151,1,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.017699,-0.080195,-0.067457,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.026561,-0.080234,-0.060735,1,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.039795,-0.080443,-0.091782,1,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.042197,-0.081081,-0.087031,1,0
3,GO RESPONSE TO KETONE,0.018693,-0.081258,-0.067353,1,0
3,GO ERYTHROCYTE MATURATION,0.037509,-0.081685,-0.090752,1,0
3,GO REGULATION OF CYTOKINESIS,0.022686,-0.081719,-0.060599,1,0
3,GO AMINE CATABOLIC PROCESS,0.045591,-0.081735,-0.11379,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0059852,-0.081773,-0.081072,1,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.0021505,-0.081777,-0.099573,1,0
3,GO GLYCEROLIPID METABOLIC PROCESS,0.0042636,-0.08186,-0.063841,1,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.049681,-0.082095,-0.075443,1,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.032938,-0.082101,-0.066086,1,0
3,GO HISTONE H2B UBIQUITINATION,0.011678,-0.08227,-0.10653,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0018006,-0.082278,-0.068983,1,0
3,GO CELL AGING,0.010769,-0.082357,-0.090929,1,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00098255,-0.082531,-0.0815,1,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0039992,-0.082777,-0.090646,1,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00076726,-0.083113,-0.11277,1,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.026286,-0.083237,-0.069129,1,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0027381,-0.083284,-0.11752,1,0
3,GO CELLULAR KETONE METABOLIC PROCESS,0.037882,-0.083286,-0.061998,1,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0037016,-0.083331,-0.092039,1,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.025475,-0.08345,-0.047295,1,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.050154,-0.083691,-0.054311,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.032607,-0.08374,-0.066182,1,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.0053519,-0.083821,-0.066001,1,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0067673,-0.08383,-0.070663,1,0
3,GO REGULATION OF OSSIFICATION,0.024173,-0.083881,-0.08728,1,0
3,GO MESODERM DEVELOPMENT,0.026286,-0.083892,-0.06574,1,0
3,GO APPENDAGE MORPHOGENESIS,0.0065235,-0.08393,-0.1182,1,0
3,GO LIPID BIOSYNTHETIC PROCESS,0.0087156,-0.083962,-0.05921,1,0
3,GO REGULATION OF VASOCONSTRICTION,0.01251,-0.084122,-0.083566,1,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0032928,-0.084181,-0.098575,1,0
3,GO GLUCOSE METABOLIC PROCESS,0.019735,-0.084186,-0.050567,1,0
3,GO POLYOL CATABOLIC PROCESS,0.038258,-0.084267,-0.07879,1,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.032607,-0.084351,-0.085122,1,0
3,GO RNA DECAPPING,0.0088198,-0.084462,-0.069308,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.032607,-0.084531,-0.050095,1,0
3,GO DEPHOSPHORYLATION,0.0062877,-0.084693,-0.054389,1,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.00037835,-0.084696,-0.16515,1,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0137,-0.085104,-0.055383,1,0
3,GO REGULATION OF CILIUM MOVEMENT,0.055609,-0.085118,-0.088932,1,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.030994,-0.085294,-0.059602,1,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.041383,-0.085306,-0.072615,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.036772,-0.085391,-0.082927,1,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.00024819,-0.085425,-0.086449,1,0
3,GO DOSAGE COMPENSATION,0.018091,-0.085452,-0.094737,1,0
3,GO GAMETE GENERATION,0.00033955,-0.0855,-0.081095,1,0
3,GO RESPONSE TO STEROID HORMONE,0.0086125,-0.085573,-0.076665,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0065235,-0.085581,-0.067166,1,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00064263,-0.085655,-0.071454,1,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.011411,-0.085877,-0.10574,1,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00159,-0.08588,-0.10643,1,0
3,GO CELL MATURATION,0.011813,-0.086135,-0.066185,1,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.0029645,-0.086281,-0.076757,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.0018508,-0.086387,-0.060713,1,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.009139,-0.086485,-0.070389,1,0
3,GO FATTY ACID CATABOLIC PROCESS,0.034636,-0.086518,-0.073353,1,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.030368,-0.086629,-0.051052,1,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.0062108,-0.086734,-0.11384,1,0
3,GO KINETOCHORE ORGANIZATION,0.052575,-0.086894,-0.098319,1,0
3,GO RESPONSE TO INTERLEUKIN 1,0.012798,-0.086903,-0.085409,1,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.022209,-0.087027,-0.10364,1,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.040187,-0.087029,-0.098251,1,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0078263,-0.087095,-0.082855,1,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.05063,-0.087294,-0.053395,1,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.02915,-0.087394,-0.084177,1,0
3,GO REGULATION OF CELL DEATH,0.0062877,-0.087468,-0.059499,1,0
3,GO RENAL SYSTEM PROCESS,0.0050904,-0.087615,-0.10463,1,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.011949,-0.087913,-0.08797,1,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0041031,-0.088022,-0.11843,1,0
3,GO ACTIN FILAMENT ORGANIZATION,0.0028872,-0.088037,-0.08633,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0076401,-0.08811,-0.1407,1,0
3,GO RESPONSE TO CORTICOSTEROID,0.03429,-0.088279,-0.072482,1,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0052854,-0.088459,-0.12738,1,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0039992,-0.088632,-0.076231,1,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.00073415,-0.088715,-0.082989,1,0
3,GO REGULATION OF IMMUNE RESPONSE,0.0016806,-0.088734,-0.10691,1,0
3,GO PLATELET MORPHOGENESIS,0.01016,-0.08878,-0.1496,1,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.048285,-0.088957,-0.061624,1,0
3,GO PIGMENTATION,0.03006,-0.088958,-0.06677,1,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.0071918,-0.088967,-0.066421,1,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.0062108,-0.089083,-0.093407,1,0
3,GO ECTODERM DEVELOPMENT,0.011949,-0.089116,-0.10183,1,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.024687,-0.089147,-0.060591,1,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.015329,-0.089344,-0.11316,1,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.041789,-0.089482,-0.080628,1,0
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00036686,-0.089568,-0.078592,1,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0033799,-0.089872,-0.081969,1,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.021973,-0.09,-0.069012,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.026286,-0.090099,-0.057922,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.040187,-0.0901,-0.094902,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0062108,-0.090136,-0.083985,1,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.020828,-0.090244,-0.066216,1,0
3,GO POSITIVE REGULATION OF SECRETION,0.0030839,-0.090337,-0.085046,1,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.010645,-0.090402,-0.11238,1,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00084997,-0.090403,-0.10425,1,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.055093,-0.090574,-0.12932,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.027118,-0.090666,-0.070714,1,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0024281,-0.090697,-0.078753,1,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.014494,-0.090704,-0.086312,1,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.043025,-0.090712,-0.060319,1,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.046031,-0.090903,-0.11827,1,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.016205,-0.090935,-0.051809,1,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0095807,-0.091024,-0.065416,1,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0047798,-0.091064,-0.079268,1,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.027686,-0.091089,-0.057466,1,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0061347,-0.091162,-0.061734,1,0
3,GO TISSUE MORPHOGENESIS,0.0021798,-0.091237,-0.089024,1,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.0023637,-0.09127,-0.073948,1,0
3,GO SECRETION,0.0035605,-0.091272,-0.067955,1,0
3,GO LEUKOCYTE DIFFERENTIATION,0.00070238,-0.091322,-0.10719,1,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.017315,-0.091453,-0.065157,1,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0044298,-0.091635,-0.078367,1,0
3,GO CELLULAR SENESCENCE,0.0062108,-0.091776,-0.10562,1,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.010041,-0.091854,-0.10269,1,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00053704,-0.091918,-0.10235,1,0
3,GO MEIOTIC CELL CYCLE,2.0478e-05,-0.091929,-0.10064,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.014658,-0.091948,-0.069352,1,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.053071,-0.092134,-0.17118,1,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0014624,-0.092177,-0.085599,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.004156,-0.092203,-0.10325,1,0
3,GO RESPONSE TO FUNGUS,0.031953,-0.092206,-0.08379,1,0
3,GO NEUTROPHIL MIGRATION,0.024428,-0.092469,-0.085532,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.018693,-0.092597,-0.074055,1,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.026561,-0.092616,-0.087342,1,0
3,GO FIBROBLAST MIGRATION,0.011022,-0.092784,-0.11751,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0062877,-0.092808,-0.10818,1,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0023637,-0.092953,-0.072678,1,0
3,GO B CELL HOMEOSTASIS,0.016938,-0.093056,-0.11733,1,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0056255,-0.093187,-0.090787,1,0
3,GO LIPID LOCALIZATION,0.012945,-0.093223,-0.077261,1,0
3,GO TUBE MORPHOGENESIS,0.0040509,-0.09323,-0.095754,1,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.015329,-0.093436,-0.087613,1,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0074579,-0.093526,-0.098618,1,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.0104,-0.09358,-0.059838,1,0
3,GO REGULATION OF CELL DIVISION,0.0043737,-0.093844,-0.070432,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0094686,-0.09385,-0.057691,1,0
3,GO P38MAPK CASCADE,0.02174,-0.093914,-0.10935,1,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.02521,-0.094208,-0.1041,1,0
3,GO CELLULAR RESPONSE TO LIPID,0.012367,-0.094336,-0.073199,1,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.0078263,-0.094345,-0.075603,1,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0059116,-0.09439,-0.064792,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.010279,-0.094394,-0.097797,1,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00064263,-0.094414,-0.10792,1,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0023321,-0.094452,-0.088165,1,0
3,GO REGULATION OF PROTEOLYSIS,0.001422,-0.09452,-0.087299,1,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.021509,-0.094575,-0.10561,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0030038,-0.094589,-0.074593,1,0
3,GO MUSCLE HYPERTROPHY,0.047827,-0.094776,-0.065967,1,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.040582,-0.094785,-0.074715,1,0
3,GO DEVELOPMENTAL PIGMENTATION,0.020166,-0.094918,-0.081024,1,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.036772,-0.094975,-0.05129,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.02521,-0.095011,-0.078265,1,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.004156,-0.095136,-0.11699,1,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.001704,-0.095145,-0.10053,1,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.026561,-0.095151,-0.06141,1,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.014823,-0.09527,-0.086434,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0012886,-0.095507,-0.097965,1,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.041789,-0.095527,-0.072533,1,0
3,GO REGULATION OF ERAD PATHWAY,0.0038977,-0.095621,-0.067336,1,0
3,GO PROTEIN POLYUBIQUITINATION,2.6828e-05,-0.095707,-0.09884,1,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.017699,-0.095724,-0.12466,1,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,6.6578e-05,-0.095805,-0.11172,1,0
3,GO RESPONSE TO ISCHEMIA,0.040981,-0.095807,-0.071403,1,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.00032916,-0.095973,-0.079415,1,0
3,GO EXOCYTOSIS,0.0037016,-0.09598,-0.08244,1,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.057179,-0.096135,-0.069955,1,0
3,GO TUBE DEVELOPMENT,0.0021505,-0.096159,-0.093831,1,0
3,GO CD40 SIGNALING PATHWAY,0.019312,-0.096201,-0.11744,1,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.0047798,-0.096239,-0.091136,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.03902,-0.096366,-0.06658,1,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0022701,-0.096417,-0.099732,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0038977,-0.096513,-0.093915,1,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0019285,-0.096582,-0.11023,1,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0023321,-0.096737,-0.059488,1,0
3,GO THYMUS DEVELOPMENT,0.020605,-0.096782,-0.1058,1,0
3,GO NEGATIVE T CELL SELECTION,0.0063654,-0.096806,-0.10964,1,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0088198,-0.096868,-0.087517,1,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.0058389,-0.097157,-0.10662,1,0
3,GO MELANOCYTE DIFFERENTIATION,0.03902,-0.097171,-0.095743,1,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.017506,-0.097336,-0.10261,1,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.030994,-0.097338,-0.11782,1,0
3,GO HORMONE TRANSPORT,0.024947,-0.097506,-0.066881,1,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0054872,-0.09751,-0.097409,1,0
3,GO LYMPHOCYTE ACTIVATION,0.0016122,-0.097556,-0.10043,1,0
3,GO AGING,0.0022396,-0.097573,-0.078118,1,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.026838,-0.097583,-0.10574,1,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.042609,-0.097712,-0.084526,1,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.016752,-0.097741,-0.0781,1,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.006444,-0.097874,-0.13246,1,0
3,GO ENDOSOMAL TRANSPORT,5.1446e-05,-0.097896,-0.091272,1,0
3,GO RETINA HOMEOSTASIS,0.034636,-0.097909,-0.047135,1,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.012227,-0.097956,-0.087133,1,0
3,GO SEX DIFFERENTIATION,0.01016,-0.098104,-0.068325,1,0
3,GO CELL FATE COMMITMENT,0.0066851,-0.098127,-0.081098,1,0
3,GO LIPID EXPORT FROM CELL,0.024173,-0.098237,-0.10341,1,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.028264,-0.098242,-0.05954,1,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.0017517,-0.098251,-0.099615,1,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0018006,-0.098308,-0.093635,1,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0039481,-0.098377,-0.095794,1,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.0041031,-0.098386,-0.084949,1,0
3,GO CARDIAC CELL DEVELOPMENT,0.017699,-0.098502,-0.07904,1,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0037016,-0.098557,-0.1198,1,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00029511,-0.098572,-0.11094,1,0
3,GO LEUKOCYTE HOMEOSTASIS,0.012227,-0.098595,-0.092465,1,0
3,GO REPLACEMENT OSSIFICATION,0.032938,-0.098725,-0.11854,1,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.01585,-0.098772,-0.11073,1,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.024947,-0.098833,-0.097596,1,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00098255,-0.098878,-0.11284,1,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.043866,-0.098883,-0.064809,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.010769,-0.098899,-0.074005,1,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.023173,-0.098912,-0.09703,1,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0042636,-0.09915,-0.093223,1,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.051595,-0.099188,-0.1087,1,0
3,GO RESPONSE TO VITAMIN,0.051595,-0.099194,-0.087228,1,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.035336,-0.099572,-0.069005,1,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.039795,-0.099624,-0.079318,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0088198,-0.099732,-0.083658,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0062108,-0.099735,-0.099805,1,0
3,GO CARBOHYDRATE TRANSPORT,0.0018508,-0.09979,-0.080811,1,0
3,GO PROTEIN MATURATION,0.00080175,-0.099827,-0.084905,1,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.016938,-0.099844,-0.072993,1,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0057669,-0.099878,-0.10212,1,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.017506,-0.099879,-0.12669,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0052197,-0.099895,-0.096339,1,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.033948,-0.099925,-0.080099,1,0
3,GO PROTEOLYSIS,0.00016361,-0.10005,-0.082566,1,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.025475,-0.10028,-0.091715,1,0
3,GO ERBB SIGNALING PATHWAY,0.0062877,-0.10031,-0.092797,1,0
3,GO COPII COATED VESICLE BUDDING,0.001422,-0.1005,-0.085759,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.018693,-0.10069,-0.12886,1,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.01016,-0.1007,-0.11095,1,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.0005133,-0.10078,-0.10527,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.016027,-0.10087,-0.095901,1,0
3,GO RESPONSE TO LIPID,0.014172,-0.10094,-0.065144,1,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00096848,-0.10098,-0.11395,1,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0025277,-0.10123,-0.093666,1,0
3,GO REGIONALIZATION,0.0052197,-0.10135,-0.085449,1,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0088198,-0.10159,-0.10271,1,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0035605,-0.10163,-0.09339,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.011949,-0.10181,-0.086374,1,0
3,GO REGULATION OF HORMONE SECRETION,0.030368,-0.10205,-0.066849,1,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.019735,-0.10219,-0.054414,1,0
3,GO PEPTIDE SECRETION,0.0078263,-0.10226,-0.073175,1,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0035146,-0.10259,-0.070084,1,0
3,GO MICROTUBULE BUNDLE FORMATION,0.026013,-0.1026,-0.092629,1,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.060432,-0.10266,-0.086305,1,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.056128,-0.10271,-0.089761,1,0
3,GO METAPHASE PLATE CONGRESSION,5.4184e-05,-0.10275,-0.12226,1,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0075485,-0.1028,-0.12306,1,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.019523,-0.10292,-0.077901,1,0
3,GO TUBE FORMATION,0.00038422,-0.10313,-0.12218,1,0
3,GO METANEPHROS DEVELOPMENT,0.0052197,-0.10319,-0.13254,1,0
3,GO REGULATION OF HORMONE LEVELS,0.008211,-0.10329,-0.076844,1,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.0069343,-0.1033,-0.066854,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0013633,-0.10369,-0.079297,1,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.0096941,-0.1037,-0.11553,1,0
3,GO SPROUTING ANGIOGENESIS,0.018693,-0.10395,-0.088652,1,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.03006,-0.10414,-0.07091,1,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.00020835,-0.10421,-0.11315,1,0
3,GO HORMONE METABOLIC PROCESS,0.01251,-0.1043,-0.097827,1,0
3,GO RESPONSE TO BACTERIUM,0.004964,-0.10432,-0.10892,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0019285,-0.10443,-0.084158,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00015838,-0.1045,-0.083864,1,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.048746,-0.10458,-0.080293,1,0
3,GO REGULATION OF HEMOPOIESIS,0.00040235,-0.10469,-0.11055,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00096848,-0.10474,-0.069733,1,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0003557,-0.10494,-0.11848,1,0
3,GO RESPONSE TO ACTIVITY,0.028556,-0.105,-0.072932,1,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.013243,-0.10515,-0.1132,1,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00073415,-0.1053,-0.11378,1,0
3,GO RESPONSE TO ESTRADIOL,0.011949,-0.1053,-0.078066,1,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.4341e-05,-0.10534,-0.12141,1,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0073682,-0.10539,-0.10289,1,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00080175,-0.10546,-0.084293,1,0
3,GO MITOCHONDRIAL FUSION,0.047827,-0.10554,-0.050779,1,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.0017277,-0.10565,-0.098349,1,0
3,GO CILIUM MOVEMENT,0.007921,-0.10574,-0.087327,1,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.028852,-0.10575,-0.092603,1,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0092477,-0.1058,-0.12661,1,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00081356,-0.1058,-0.095777,1,0
3,GO NUCLEOTIDE TRANSPORT,0.015501,-0.10584,-0.073018,1,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.010895,-0.10587,-0.080457,1,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.001442,-0.1059,-0.11365,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0023637,-0.10596,-0.096781,1,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.051595,-0.10603,-0.076406,1,0
3,GO MUSCLE CELL DEVELOPMENT,0.0069343,-0.10605,-0.080619,1,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011678,-0.1061,-0.073619,1,0
3,GO RESPONSE TO ANTIBIOTIC,0.011678,-0.10626,-0.091657,1,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.014013,-0.10634,-0.093762,1,0
3,GO EAR DEVELOPMENT,0.0037985,-0.10636,-0.096747,1,0
3,GO EMBRYONIC MORPHOGENESIS,0.0005618,-0.10643,-0.1035,1,0
3,GO PROTEIN MONOUBIQUITINATION,0.00040235,-0.10652,-0.079821,1,0
3,GO VIRAL LATENCY,0.016752,-0.10655,-0.082927,1,0
3,GO EYE MORPHOGENESIS,0.017125,-0.10667,-0.080794,1,0
3,GO REGULATION OF GASTRULATION,0.018091,-0.10692,-0.097343,1,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.00025617,-0.10694,-0.1155,1,0
3,GO SECRETION BY TISSUE,0.040187,-0.10733,-0.09943,1,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.003654,-0.10736,-0.15092,1,0
3,GO COAGULATION,0.0018256,-0.10742,-0.11543,1,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.03429,-0.10755,-0.086353,1,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.018898,-0.10763,-0.069869,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0016575,-0.1077,-0.12349,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.043025,-0.10781,-0.11767,1,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0051547,-0.10783,-0.14738,1,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.014013,-0.10816,-0.11892,1,0
3,GO SECONDARY PALATE DEVELOPMENT,0.046921,-0.1084,-0.11782,1,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0026663,-0.1087,-0.08228,1,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.00084997,-0.10882,-0.11903,1,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.0065235,-0.10896,-0.13043,1,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.0046018,-0.10914,-0.085144,1,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.019104,-0.1092,-0.10083,1,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.032278,-0.1094,-0.078431,1,0
3,GO STEROID METABOLIC PROCESS,0.0071051,-0.10944,-0.084252,1,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0043737,-0.10961,-0.11892,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.053071,-0.10962,-0.13496,1,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0094686,-0.10966,-0.1201,1,0
3,GO MAINTENANCE OF CELL NUMBER,0.0017517,-0.10966,-0.098249,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,4.7999e-05,-0.1097,-0.11841,1,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.040187,-0.10985,-0.078698,1,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0098086,-0.10987,-0.15397,1,0
3,GO EPITHELIAL CELL PROLIFERATION,0.0022095,-0.10988,-0.11961,1,0
3,GO RESPONSE TO IRON ION,0.0030038,-0.10999,-0.14437,1,0
3,GO REPRODUCTION,0.00010152,-0.11012,-0.087051,1,0
3,GO TONGUE DEVELOPMENT,0.038637,-0.11018,-0.1563,1,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.003607,-0.11025,-0.11801,1,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,7.8911e-05,-0.11031,-0.093296,1,0
3,GO NEPHRON MORPHOGENESIS,0.0069343,-0.11036,-0.12011,1,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.0016575,-0.11042,-0.086208,1,0
3,GO RESPONSE TO CADMIUM ION,0.03429,-0.11068,-0.10473,1,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00061456,-0.11069,-0.10199,1,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0005211,-0.11084,-0.10439,1,0
3,GO PROSTATE GLAND DEVELOPMENT,0.052083,-0.11092,-0.12642,1,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.034636,-0.11105,-0.068171,1,0
3,GO MICROTUBULE SEVERING,0.02915,-0.11109,-0.10525,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.03006,-0.11111,-0.097269,1,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.0088198,-0.11133,-0.098243,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.017894,-0.11139,-0.077733,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.011678,-0.11139,-0.14793,1,0
3,GO LYMPHOCYTE COSTIMULATION,0.0081133,-0.1114,-0.10776,1,0
3,GO SPERMATID DIFFERENTIATION,0.016205,-0.11144,-0.088165,1,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.054582,-0.11154,-0.18376,1,0
3,GO REGULATION OF PH,0.00055343,-0.11157,-0.088166,1,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.043025,-0.11165,-0.079812,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0067673,-0.1117,-0.11213,1,0
3,GO IMMUNE SYSTEM DEVELOPMENT,5.7059e-05,-0.1117,-0.10991,1,0
3,GO RESPONSE TO ETHER,0.0073682,-0.11185,-0.10421,1,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.054582,-0.11187,-0.065247,1,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.014013,-0.1122,-0.13709,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.010041,-0.11244,-0.12096,1,0
3,GO PINOCYTOSIS,0.0083098,-0.11264,-0.12481,1,0
3,GO MACROPHAGE MIGRATION,0.022209,-0.1127,-0.10551,1,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0053519,-0.11272,-0.10046,1,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.00042128,-0.11288,-0.15275,1,0
3,GO GOLGI VESICLE BUDDING,0.00081356,-0.11311,-0.093851,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.00058763,-0.11316,-0.12958,1,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.0030436,-0.1132,-0.099879,1,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.0011836,-0.11321,-0.15667,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.013093,-0.11334,-0.071015,1,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.00096848,-0.11336,-0.10497,1,0
3,GO RESPONSE TO NUTRIENT,0.035336,-0.11346,-0.070517,1,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.027401,-0.11353,-0.090086,1,0
3,GO STEM CELL PROLIFERATION,0.0021505,-0.1136,-0.11352,1,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.013093,-0.11368,-0.12628,1,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.00099681,-0.11372,-0.13205,1,0
3,GO CELL MATRIX ADHESION,0.0062108,-0.11386,-0.10939,1,0
3,GO MESODERM MORPHOGENESIS,0.0090315,-0.11388,-0.10565,1,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.031631,-0.11397,-0.12709,1,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.01499,-0.11399,-0.10017,1,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.001704,-0.11414,-0.083218,1,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00044103,-0.11428,-0.12855,1,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.010279,-0.11436,-0.13216,1,0
3,GO FEMALE GAMETE GENERATION,0.0083098,-0.11448,-0.067776,1,0
3,GO CHROMOSOME LOCALIZATION,3.3806e-05,-0.11452,-0.12371,1,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.019104,-0.11455,-0.071782,1,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.010522,-0.11464,-0.21845,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.046474,-0.11468,-0.094838,1,0
3,GO REGULATION OF CELLULAR PH,0.00048316,-0.11485,-0.090843,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0037498,-0.11506,-0.12778,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.027973,-0.11525,-0.11277,1,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.004156,-0.11526,-0.10013,1,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.037509,-0.11536,-0.079894,1,0
3,GO MAMMARY GLAND DEVELOPMENT,0.0058389,-0.1154,-0.10137,1,0
3,GO REGULATION OF NUCLEAR DIVISION,5.8049e-05,-0.11541,-0.094536,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00088789,-0.11544,-0.13638,1,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.059331,-0.11574,-0.07945,1,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0070192,-0.1158,-0.133,1,0
3,GO MUSCLE ADAPTATION,0.001704,-0.11583,-0.10294,1,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0030839,-0.11597,-0.12219,1,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.057179,-0.11617,-0.086461,1,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,3.5022e-05,-0.11629,-0.10454,1,0
3,GO REGULATION OF RESPONSE TO STRESS,0.00036124,-0.11647,-0.085574,1,0
3,GO REGULATION OF BODY FLUID LEVELS,0.00027284,-0.11672,-0.11842,1,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0013633,-0.11676,-0.10168,1,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0020646,-0.1168,-0.12392,1,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0013443,-0.11684,-0.10095,1,0
3,GO REGULATION OF CELL ACTIVATION,0.0005618,-0.11687,-0.11891,1,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00022565,-0.11696,-0.13322,1,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.002702,-0.11697,-0.1251,1,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0042095,-0.11704,-0.10464,1,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.05357,-0.11708,-0.084003,1,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.032278,-0.11723,-0.12861,1,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0014022,-0.11725,-0.14375,1,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.033948,-0.11734,-0.085787,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0019819,-0.11743,-0.093639,1,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.046031,-0.11759,-0.11475,1,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.036048,-0.11763,-0.13556,1,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.030994,-0.11768,-0.088129,1,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0062877,-0.11783,-0.083623,1,0
3,GO FACE DEVELOPMENT,0.0028872,-0.11783,-0.12869,1,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00011033,-0.11801,-0.10949,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0020646,-0.11816,-0.10462,1,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.022209,-0.11819,-0.075826,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0088198,-0.11826,-0.14378,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00018923,-0.11827,-0.089315,1,0
3,GO GOLGI ORGANIZATION,6.5837e-06,-0.11827,-0.11944,1,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.01128,-0.11827,-0.086473,1,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.0017517,-0.11847,-0.10492,1,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.0087156,-0.11879,-0.098251,1,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0012705,-0.11908,-0.10386,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0052854,-0.11929,-0.12893,1,0
3,GO MOLTING CYCLE,0.0040509,-0.11949,-0.12036,1,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.00026024,-0.11954,-0.10547,1,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,8.0256e-05,-0.1196,-0.12459,1,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0066851,-0.1199,-0.11299,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0057669,-0.12001,-0.13739,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00083767,-0.12027,-0.19619,1,0
3,GO CELL CELL ADHESION,0.00096848,-0.12047,-0.11562,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0060595,-0.12055,-0.1028,1,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0056255,-0.12063,-0.12104,1,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.024428,-0.12069,-0.11557,1,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.0037016,-0.12069,-0.096337,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.036772,-0.1207,-0.1344,1,0
3,GO RESPONSE TO GAMMA RADIATION,0.002631,-0.12073,-0.097189,1,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.00052901,-0.1208,-0.12331,1,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0001179,-0.12083,-0.09567,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.02128,-0.12084,-0.12939,1,0
3,GO MULTICELLULAR ORGANISM AGING,0.00159,-0.1211,-0.12646,1,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.023173,-0.12116,-0.14859,1,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.029754,-0.12129,-0.1008,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0065235,-0.1213,-0.13871,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.012945,-0.12131,-0.13502,1,0
3,GO RESPONSE TO WOUNDING,0.001776,-0.12138,-0.1177,1,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.012367,-0.12147,-0.085454,1,0
3,GO MITOTIC CYTOKINESIS,0.00029511,-0.12158,-0.1207,1,0
3,GO HISTONE H2A UBIQUITINATION,0.00092737,-0.12175,-0.10595,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0012886,-0.12182,-0.096683,1,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.055093,-0.12182,-0.10256,1,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0013826,-0.122,-0.14514,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00017741,-0.12207,-0.13319,1,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.021509,-0.12225,-0.078301,1,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0020367,-0.12229,-0.11248,1,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,9.9844e-05,-0.12252,-0.092044,1,0
3,GO RESPIRATORY BURST,0.0037498,-0.12256,-0.1711,1,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0093576,-0.12258,-0.10655,1,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.055609,-0.1226,-0.14918,1,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00063314,-0.12262,-0.1285,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0055559,-0.12269,-0.10263,1,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.059331,-0.12273,-0.12275,1,0
3,GO EXECUTION PHASE OF APOPTOSIS,1.0958e-05,-0.12275,-0.118,1,0
3,GO POSTREPLICATION REPAIR,0.00015083,-0.1228,-0.095898,1,0
3,GO T CELL DIFFERENTIATION,9.819e-05,-0.12282,-0.13866,1,0
3,GO RESPONSE TO SALT STRESS,0.010769,-0.12284,-0.10886,1,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.0014022,-0.12293,-0.098217,1,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.038637,-0.12293,-0.14939,1,0
3,GO ANIMAL ORGAN FORMATION,0.011949,-0.12294,-0.11391,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.058787,-0.12301,-0.067206,1,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.027118,-0.1232,-0.16512,1,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.0093576,-0.12321,-0.11039,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0018764,-0.12326,-0.14706,1,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,1.9749e-05,-0.12327,-0.1095,1,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,1.5014e-05,-0.12339,-0.12594,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,7.7586e-05,-0.12344,-0.12869,1,0
3,GO FAT CELL DIFFERENTIATION,8.4424e-05,-0.12349,-0.1389,1,0
3,GO CELL ACTIVATION,0.00039622,-0.12352,-0.11825,1,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.0001862,-0.1236,-0.11468,1,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.0104,-0.12361,-0.096236,1,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,6.545e-05,-0.12378,-0.096411,1,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0019023,-0.12385,-0.12096,1,0
3,GO CENTRIOLE ASSEMBLY,0.00034485,-0.12394,-0.14668,1,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.033271,-0.12404,-0.065964,1,0
3,GO INFLAMMATORY RESPONSE,0.00029976,-0.1242,-0.12648,1,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.0025617,-0.12429,-0.16209,1,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00040235,-0.12434,-0.15249,1,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.011411,-0.12435,-0.1197,1,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00037835,-0.12441,-0.12158,1,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.01499,-0.12448,-0.085924,1,0
3,GO DEVELOPMENTAL INDUCTION,0.0021215,-0.12455,-0.16622,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0007786,-0.12467,-0.11048,1,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0087156,-0.12478,-0.11915,1,0
3,GO PHOSPHOLIPID TRANSPORT,0.0015038,-0.12478,-0.12366,1,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.016205,-0.12481,-0.11485,1,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.00026024,-0.12484,-0.093973,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.020605,-0.12514,-0.0625,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0066039,-0.1252,-0.11813,1,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0073682,-0.12521,-0.10165,1,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.037139,-0.12526,-0.068694,1,0
3,GO LEUKOCYTE PROLIFERATION,0.00024819,-0.12532,-0.14128,1,0
3,GO REGULATION OF DEFENSE RESPONSE,2.9332e-05,-0.12615,-0.13958,1,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0077327,-0.1262,-0.077984,1,0
3,GO MACROPHAGE DIFFERENTIATION,0.0073682,-0.12621,-0.12844,1,0
3,GO PROTEIN DESTABILIZATION,0.00011986,-0.12622,-0.12257,1,0
3,GO OOCYTE DIFFERENTIATION,0.0058389,-0.12645,-0.10867,1,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.0089251,-0.12649,-0.1044,1,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.042197,-0.1265,-0.10702,1,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,4.3997e-05,-0.12686,-0.12535,1,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.024173,-0.12692,-0.14707,1,0
3,GO REGULATION OF PROTEIN IMPORT,0.0053519,-0.12702,-0.10165,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.4424e-05,-0.12708,-0.10334,1,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0021215,-0.12709,-0.11579,1,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00042777,-0.12711,-0.12132,1,0
3,GO GLAND MORPHOGENESIS,0.0092477,-0.12737,-0.15364,1,0
3,GO GLAND DEVELOPMENT,7.3739e-05,-0.12743,-0.1301,1,0
3,GO VACUOLAR TRANSPORT,0.0025961,-0.12758,-0.083303,1,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.034636,-0.1276,-0.10964,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.00086244,-0.12783,-0.097151,1,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0029256,-0.12802,-0.12779,1,0
3,GO VESICLE TARGETING,9.819e-05,-0.12803,-0.12363,1,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.052083,-0.12807,-0.15658,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.003166,-0.1281,-0.11322,1,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.027686,-0.12826,-0.13161,1,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,6.8888e-05,-0.12827,-0.15412,1,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00087508,-0.12836,-0.12377,1,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.011544,-0.12839,-0.10922,1,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.041383,-0.12844,-0.13879,1,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.020166,-0.12857,-0.14261,1,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.011813,-0.1286,-0.095136,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.00049802,-0.12878,-0.10163,1,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.00062378,-0.12879,-0.11604,1,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0013255,-0.1288,-0.095483,1,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.012367,-0.12893,-0.11859,1,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0081133,-0.12898,-0.11211,1,0
3,GO TEMPERATURE HOMEOSTASIS,0.0039481,-0.12916,-0.070912,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00015583,-0.12925,-0.1547,1,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0027381,-0.12934,-0.13525,1,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00080175,-0.12935,-0.15018,1,0
3,GO REGULATION OF PEPTIDE SECRETION,0.00099681,-0.12942,-0.095653,1,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.00045468,-0.12946,-0.11361,1,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0023321,-0.12955,-0.11092,1,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.0040509,-0.1296,-0.15543,1,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0090315,-0.12966,-0.13548,1,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0005211,-0.12978,-0.13402,1,0
3,GO REGULATION OF CHEMOTAXIS,0.0024609,-0.13005,-0.09802,1,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.022928,-0.13018,-0.12128,1,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.0037985,-0.13018,-0.13187,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0025277,-0.13038,-0.10224,1,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.00054518,-0.13044,-0.11101,1,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.026561,-0.13045,-0.14753,1,0
3,GO EXIT FROM MITOSIS,0.0062108,-0.13045,-0.089594,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00094089,-0.13048,-0.11263,1,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0059116,-0.1305,-0.13952,1,0
3,GO HISTONE MONOUBIQUITINATION,8.1138e-06,-0.13053,-0.13173,1,0
3,GO T CELL PROLIFERATION,0.00081356,-0.13062,-0.14063,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.021973,-0.13073,-0.15442,1,0
3,GO REGULATION OF T CELL ACTIVATION,0.000286,-0.13077,-0.13299,1,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0053519,-0.13078,-0.090509,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00017176,-0.13094,-0.12589,1,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0020646,-0.13095,-0.15474,1,0
3,GO DIGESTIVE SYSTEM PROCESS,0.0013069,-0.13096,-0.12848,1,0
3,GO T CELL ACTIVATION,0.00014129,-0.13103,-0.13997,1,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.010769,-0.13108,-0.12939,1,0
3,GO NOTCH SIGNALING PATHWAY,1.8363e-05,-0.13132,-0.14493,1,0
3,GO CILIUM ORGANIZATION,0.00087508,-0.13136,-0.11229,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.0019285,-0.13147,-0.15542,1,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0037985,-0.13149,-0.10398,1,0
3,GO ENDOCRINE HORMONE SECRETION,0.000662,-0.13163,-0.13853,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.010645,-0.13181,-0.13132,1,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00159,-0.13198,-0.095287,1,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,5.7059e-05,-0.1321,-0.15462,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.002631,-0.13211,-0.13664,1,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0005618,-0.13218,-0.12218,1,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.0071918,-0.13222,-0.1257,1,0
3,GO CELL JUNCTION MAINTENANCE,0.055609,-0.13224,-0.10677,1,0
3,GO MEMBRANE FISSION,0.023919,-0.13241,-0.088549,1,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00021857,-0.13259,-0.12081,1,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.031631,-0.13266,-0.10923,1,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0022701,-0.13273,-0.11282,1,0
3,GO RESPONSE TO CYTOKINE,0.00019857,-0.13275,-0.13226,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,8.1623e-05,-0.13279,-0.15497,1,0
3,GO PODOSOME ASSEMBLY,0.056652,-0.13287,-0.10462,1,0
3,GO AMYLOID BETA CLEARANCE,0.0062108,-0.13287,-0.13627,1,0
3,GO NATURAL KILLER CELL ACTIVATION,0.00055343,-0.13305,-0.15064,1,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00037835,-0.13326,-0.14411,1,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00086244,-0.13327,-0.22013,1,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00022208,-0.13352,-0.10692,1,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0032928,-0.13353,-0.10406,1,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.0037985,-0.13353,-0.11311,1,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0060595,-0.13368,-0.11145,1,0
3,GO MYOTUBE DIFFERENTIATION,0.0010259,-0.13369,-0.13127,1,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.00020835,-0.13381,-0.14304,1,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.05063,-0.13387,-0.14137,1,0
3,GO PH REDUCTION,0.0001862,-0.13391,-0.12624,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.042609,-0.134,-0.14587,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.03429,-0.13405,-0.085355,1,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0080166,-0.13408,-0.13046,1,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0104,-0.13425,-0.15468,1,0
3,GO NEURAL TUBE DEVELOPMENT,3.6924e-05,-0.13428,-0.13526,1,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.0059852,-0.13436,-0.11603,1,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.026013,-0.13443,-0.17416,1,0
3,GO REGULATION OF HAIR CYCLE,0.0023957,-0.13444,-0.1602,1,0
3,GO MYELOID CELL DIFFERENTIATION,4.6359e-05,-0.13447,-0.11776,1,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0012177,-0.13462,-0.12946,1,0
3,GO RESPONSE TO TESTOSTERONE,0.053071,-0.13466,-0.085034,1,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.03429,-0.13488,-0.11167,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.8049e-05,-0.13496,-0.1741,1,0
3,GO WOUND HEALING,0.001071,-0.13499,-0.13207,1,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00027284,-0.13514,-0.11013,1,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.021053,-0.13551,-0.14601,1,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.0068504,-0.13552,-0.08797,1,0
3,GO RESPONSE TO COLD,0.0011836,-0.13567,-0.15666,1,0
3,GO CELLULAR RESPONSE TO ALKALOID,7.7586e-05,-0.13569,-0.17692,1,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.004156,-0.13574,-0.088571,1,0
3,GO TISSUE HOMEOSTASIS,5.1304e-06,-0.13594,-0.14873,1,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0071918,-0.13597,-0.14842,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00063314,-0.13598,-0.15888,1,0
3,GO REGULATION OF CHROMATIN BINDING,0.0003557,-0.13605,-0.17181,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0030436,-0.13609,-0.12053,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.013546,-0.13613,-0.16134,1,0
3,GO MALE MEIOSIS I,0.059879,-0.13614,-0.16574,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.8049e-05,-0.1362,-0.15371,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0089251,-0.1362,-0.10966,1,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0045438,-0.13623,-0.12096,1,0
3,GO CELLULAR PIGMENTATION,0.00019541,-0.13636,-0.13197,1,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0059116,-0.1366,-0.11368,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.031631,-0.13678,-0.12252,1,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00046165,-0.13719,-0.13701,1,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.00026858,-0.1372,-0.13383,1,0
3,GO ADAPTIVE THERMOGENESIS,0.00094089,-0.13723,-0.090728,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.00075607,-0.13743,-0.14633,1,0
3,GO TRANSLESION SYNTHESIS,1.6457e-05,-0.13747,-0.12793,1,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0040509,-0.13752,-0.12791,1,0
3,GO CYTOKINE PRODUCTION,5.0563e-05,-0.13754,-0.1527,1,0
3,GO REGULATION OF CELL ADHESION,0.00053704,-0.13765,-0.13625,1,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.02128,-0.13769,-0.13385,1,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0043184,-0.13771,-0.11012,1,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.4184e-05,-0.13796,-0.17263,1,0
3,GO RETINOL METABOLIC PROCESS,0.0092477,-0.13797,-0.14858,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.5001e-05,-0.13799,-0.10121,1,0
3,GO INTERLEUKIN 17 PRODUCTION,0.013546,-0.13806,-0.13436,1,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,7.9617e-06,-0.1381,-0.187,1,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00019857,-0.13813,-0.17173,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001483,-0.13817,-0.12278,1,0
3,GO CELL PROJECTION ASSEMBLY,9.6562e-05,-0.13825,-0.10396,1,0
3,GO DEFENSE RESPONSE,7.5001e-05,-0.13829,-0.14049,1,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.004156,-0.13837,-0.16212,1,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.001776,-0.13873,-0.10429,1,0
3,GO TYPE 2 IMMUNE RESPONSE,0.036772,-0.13893,-0.15544,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,5.5127e-05,-0.13893,-0.13701,1,0
3,GO POSITIVE CHEMOTAXIS,0.0013443,-0.139,-0.16378,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0015463,-0.13905,-0.13611,1,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.011813,-0.13907,-0.17742,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00014839,-0.1392,-0.13389,1,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.020605,-0.13923,-0.16544,1,0
3,GO GRANULOCYTE MIGRATION,0.0018764,-0.13928,-0.12705,1,0
3,GO CARDIOCYTE DIFFERENTIATION,0.012087,-0.13929,-0.087761,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.3214e-05,-0.1394,-0.14569,1,0
3,GO INNATE IMMUNE RESPONSE,0.00022208,-0.13949,-0.15298,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.001704,-0.1395,-0.17606,1,0
3,GO KIDNEY MORPHOGENESIS,0.0011341,-0.1398,-0.14578,1,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,9.6562e-05,-0.14007,-0.14264,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00014599,-0.14008,-0.11266,1,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00016361,-0.14009,-0.13035,1,0
3,GO T CELL CYTOKINE PRODUCTION,0.026013,-0.14017,-0.10261,1,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00053704,-0.14048,-0.15051,1,0
3,GO LIPID STORAGE,0.032938,-0.14056,-0.078313,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0001862,-0.14073,-0.15181,1,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,8.1623e-05,-0.14075,-0.12449,1,0
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0015038,-0.14082,-0.11708,1,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0054192,-0.14088,-0.13373,1,0
3,GO POLYAMINE METABOLIC PROCESS,0.013546,-0.14096,-0.10132,1,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0034243,-0.14101,-0.14153,1,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.012367,-0.14122,-0.13425,1,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00033432,-0.14137,-0.13349,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0083098,-0.14164,-0.14066,1,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.0016122,-0.14167,-0.12183,1,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.012367,-0.14171,-0.11063,1,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.023173,-0.14187,-0.20091,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.01128,-0.14194,-0.093711,1,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.5884e-05,-0.14196,-0.15639,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0023637,-0.14197,-0.11907,1,0
3,GO ENDOCYTIC RECYCLING,0.00043435,-0.14207,-0.11835,1,0
3,GO RNA DESTABILIZATION,0.0074579,-0.14216,-0.084486,1,0
3,GO PEPTIDYL THREONINE MODIFICATION,1.9393e-05,-0.1424,-0.11905,1,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0029256,-0.14242,-0.13025,1,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.022928,-0.14245,-0.17218,1,0
3,GO PROTEIN KINASE B SIGNALING,0.00010673,-0.14247,-0.1337,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.8246e-05,-0.14249,-0.17347,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00040857,-0.14249,-0.13465,1,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0020367,-0.14249,-0.14393,1,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0011503,-0.14264,-0.15671,1,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0037498,-0.1427,-0.13575,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00096848,-0.14291,-0.12659,1,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,5.7051e-07,-0.14302,-0.14505,1,0
3,GO EPITHELIUM DEVELOPMENT,4.719e-07,-0.14303,-0.16393,1,0
3,GO RESPONSE TO REDOX STATE,0.014172,-0.14307,-0.11993,1,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00080175,-0.14309,-0.12727,1,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0011503,-0.14312,-0.12156,1,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.010522,-0.14312,-0.11931,1,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00026024,-0.14326,-0.13114,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,4.5558e-05,-0.14343,-0.17446,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.012798,-0.14347,-0.11638,1,0
3,GO ACTIN NUCLEATION,0.00029511,-0.14351,-0.11512,1,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.023668,-0.14352,-0.086129,1,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,2.6828e-05,-0.14361,-0.13838,1,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.004964,-0.14364,-0.21062,1,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0005789,-0.14366,-0.14536,1,0
3,GO TISSUE MIGRATION,0.0041031,-0.14392,-0.11016,1,0
3,GO AUTOPHAGIC CELL DEATH,0.010645,-0.14393,-0.12195,1,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.036409,-0.14406,-0.096194,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,6.4592e-06,-0.14407,-0.15103,1,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.0047198,-0.14411,-0.1154,1,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.049212,-0.14423,-0.10814,1,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00036124,-0.14428,-0.12758,1,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,2.4972e-05,-0.14436,-0.14694,1,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0022701,-0.14452,-0.13113,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0016122,-0.14456,-0.1726,1,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.00013899,-0.14479,-0.13567,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00021857,-0.1448,-0.1357,1,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.021053,-0.14488,-0.081442,1,0
3,GO B CELL ACTIVATION,2.1621e-05,-0.14514,-0.14117,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.01499,-0.14538,-0.089591,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00042777,-0.14539,-0.1128,1,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0047798,-0.14544,-0.12495,1,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0086125,-0.1455,-0.12481,1,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.0014022,-0.14558,-0.15638,1,0
3,GO PROTEIN DEGLYCOSYLATION,0.016938,-0.14563,-0.13207,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.002702,-0.14565,-0.14491,1,0
3,GO EAR MORPHOGENESIS,0.00038422,-0.14574,-0.1292,1,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00053704,-0.1458,-0.14709,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.1165e-05,-0.14582,-0.1505,1,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.03902,-0.14585,-0.10102,1,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0041031,-0.14587,-0.12811,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0023637,-0.146,-0.20842,1,0
3,GO REGULATION OF SPINDLE ORGANIZATION,5.9056e-05,-0.14601,-0.12866,1,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.001483,-0.14612,-0.18019,1,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.023919,-0.14624,-0.13713,1,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,2.3661e-05,-0.14642,-0.14346,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00092737,-0.14651,-0.1467,1,0
3,GO ETHER METABOLIC PROCESS,0.0019023,-0.14677,-0.18897,1,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0043737,-0.14698,-0.10346,1,0
3,GO DIENCEPHALON DEVELOPMENT,0.0019023,-0.147,-0.16416,1,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.013546,-0.14702,-0.11672,1,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.0061347,-0.14702,-0.12073,1,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0029256,-0.1471,-0.13374,1,0
3,GO REGULATION OF CELL SHAPE,0.0019819,-0.14716,-0.11005,1,0
3,GO DENDRITIC CELL MIGRATION,0.015159,-0.14765,-0.15131,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0007901,-0.14765,-0.17998,1,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0032928,-0.14785,-0.14528,1,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.02174,-0.14793,-0.13874,1,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0020367,-0.14798,-0.18944,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.00059648,-0.14809,-0.13754,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.0010408,-0.14825,-0.14375,1,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,8.7502e-06,-0.14827,-0.16278,1,0
3,GO PHAGOSOME ACIDIFICATION,0.0057669,-0.14828,-0.12023,1,0
3,GO LEUKOCYTE CHEMOTAXIS,0.00015331,-0.14838,-0.15087,1,0
3,GO REGULATION OF PINOCYTOSIS,0.001071,-0.14845,-0.15935,1,0
3,GO CYTOKINE SECRETION,0.00023294,-0.14855,-0.13725,1,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0013069,-0.14862,-0.12246,1,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.027401,-0.14863,-0.19653,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00022927,-0.14866,-0.17775,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00041488,-0.14882,-0.13954,1,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00025215,-0.14886,-0.13331,1,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.003607,-0.14891,-0.14837,1,0
3,GO RESPONSE TO INTERLEUKIN 2,0.0078263,-0.14894,-0.12525,1,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00081356,-0.14912,-0.15426,1,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00067188,-0.14918,-0.14257,1,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00011986,-0.14927,-0.12238,1,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.056128,-0.1493,-0.15361,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00088789,-0.14933,-0.14079,1,0
3,GO TELOMERE CAPPING,0.0005056,-0.14936,-0.11328,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0061347,-0.14941,-0.11322,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00036124,-0.14951,-0.1505,1,0
3,GO HEMOGLOBIN METABOLIC PROCESS,9.3381e-05,-0.1496,-0.15506,1,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0092477,-0.1497,-0.14231,1,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.028264,-0.14982,-0.17035,1,0
3,GO MALE SEX DIFFERENTIATION,7.0072e-05,-0.14989,-0.14347,1,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.036409,-0.14991,-0.07368,1,0
3,GO INTERLEUKIN 4 PRODUCTION,0.0011668,-0.14995,-0.16035,1,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0034243,-0.14998,-0.13066,1,0
3,GO ANIMAL ORGAN MATURATION,0.02521,-0.15,-0.10391,1,0
3,GO RESPONSE TO DSRNA,0.0012705,-0.1501,-0.12577,1,0
3,GO FORELIMB MORPHOGENESIS,0.017125,-0.15018,-0.14417,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.00037257,-0.15025,-0.13819,1,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00016361,-0.15032,-0.2537,1,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0010558,-0.15043,-0.15425,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,4.0314e-05,-0.15045,-0.17627,1,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.012227,-0.15048,-0.1053,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0043737,-0.15056,-0.13315,1,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.036409,-0.15064,-0.11966,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.016938,-0.15067,-0.14621,1,0
3,GO RESPONSE TO OSMOTIC STRESS,0.00023667,-0.15071,-0.11309,1,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.014494,-0.15077,-0.17529,1,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00016629,-0.15079,-0.12183,1,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,2.3661e-05,-0.15085,-0.14934,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.4472e-05,-0.15086,-0.14946,1,0
3,GO CRANIAL NERVE DEVELOPMENT,0.016386,-0.15089,-0.13707,1,0
3,GO B CELL PROLIFERATION,0.0022396,-0.15106,-0.13254,1,0
3,GO PEPTIDE CROSS LINKING,0.001422,-0.15119,-0.19953,1,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.031311,-0.15149,-0.12814,1,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.016027,-0.15155,-0.097067,1,0
3,GO LEUKOCYTE MIGRATION,7.8911e-05,-0.15162,-0.14922,1,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.01016,-0.15163,-0.10177,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00090088,-0.15195,-0.18177,1,0
3,GO ACUTE PHASE RESPONSE,0.0013255,-0.15207,-0.15101,1,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.006444,-0.15216,-0.13826,1,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0045438,-0.15224,-0.11565,1,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0027747,-0.15233,-0.10535,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00088789,-0.15236,-0.15022,1,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0071918,-0.1525,-0.11892,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00019857,-0.15264,-0.18755,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.00032916,-0.15287,-0.16585,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.03902,-0.15289,-0.15163,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,9.819e-05,-0.15291,-0.17284,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,7.5001e-05,-0.15292,-0.20322,1,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,5.7059e-05,-0.15307,-0.15723,1,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,3.8347e-06,-0.15317,-0.19119,1,0
3,GO MYOTUBE CELL DEVELOPMENT,0.0090315,-0.15331,-0.12797,1,0
3,GO EPITHELIAL TUBE FORMATION,3.0302e-06,-0.15334,-0.16326,1,0
3,GO INTERACTION WITH HOST,5.2344e-05,-0.15339,-0.15942,1,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.043444,-0.15339,-0.15053,1,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0022095,-0.15364,-0.20973,1,0
3,GO PROTEIN PROCESSING,2.1234e-05,-0.15367,-0.14512,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,8.5858e-05,-0.15369,-0.15193,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00030449,-0.15411,-0.14028,1,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.014494,-0.15411,-0.1168,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00022208,-0.1545,-0.14264,1,0
3,GO RESPONSE TO UV C,0.00018323,-0.1547,-0.19183,1,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0053519,-0.15481,-0.092436,1,0
3,GO ARTERY MORPHOGENESIS,0.00038422,-0.15488,-0.15418,1,0
3,GO DIOL METABOLIC PROCESS,0.015674,-0.15508,-0.11904,1,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0089251,-0.1551,-0.12,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00047589,-0.15516,-0.16611,1,0
3,GO SPINDLE LOCALIZATION,0.00021857,-0.15537,-0.126,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0067673,-0.15546,-0.11969,1,0
3,GO ENDOTHELIAL CELL MIGRATION,0.0020646,-0.15555,-0.12599,1,0
3,GO EPIDERMIS MORPHOGENESIS,0.020166,-0.15562,-0.17155,1,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,7.3739e-05,-0.15563,-0.18131,1,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,4.1552e-07,-0.1557,-0.14775,1,0
3,GO DNA DEMETHYLATION,0.0020929,-0.15588,-0.12897,1,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0002443,-0.15589,-0.17247,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0058389,-0.15589,-0.1172,1,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0029256,-0.15594,-0.11654,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00015583,-0.15603,-0.16791,1,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0084096,-0.15611,-0.13656,1,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0072795,-0.15614,-0.1122,1,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0053519,-0.15615,-0.16108,1,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0067673,-0.15618,-0.1908,1,0
3,GO RIG I SIGNALING PATHWAY,0.0003557,-0.15619,-0.15757,1,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,1.3693e-05,-0.15619,-0.18994,1,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.010279,-0.15621,-0.12327,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0002443,-0.1563,-0.15484,1,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.052083,-0.15633,-0.15503,1,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,7.3739e-05,-0.15635,-0.15658,1,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0071918,-0.15702,-0.17313,1,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.038637,-0.15719,-0.10438,1,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.050154,-0.15722,-0.11811,1,0
3,GO INNER EAR MORPHOGENESIS,0.0012527,-0.15746,-0.12853,1,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.023173,-0.15751,-0.12621,1,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.040187,-0.15759,-0.1297,1,0
3,GO IMMUNOGLOBULIN SECRETION,0.0015249,-0.15771,-0.18443,1,0
3,GO REGULATION OF NEURON MATURATION,0.045591,-0.15775,-0.10141,1,0
3,GO MESENCHYME MORPHOGENESIS,0.0017517,-0.15791,-0.14588,1,0
3,GO PIGMENT GRANULE LOCALIZATION,0.0018006,-0.15796,-0.14455,1,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0018256,-0.15801,-0.13138,1,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0026663,-0.15816,-0.14073,1,0
3,GO FOAM CELL DIFFERENTIATION,0.011544,-0.15824,-0.1406,1,0
3,GO MESONEPHROS DEVELOPMENT,0.00016361,-0.15825,-0.1735,1,0
3,GO GRANULOCYTE CHEMOTAXIS,0.0037985,-0.15825,-0.11676,1,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0007901,-0.15834,-0.21675,1,0
3,GO REGULATION OF CELL CELL ADHESION,7.3739e-05,-0.1584,-0.1606,1,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0072795,-0.15846,-0.19306,1,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00016098,-0.15847,-0.15623,1,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.1119e-05,-0.15847,-0.16807,1,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.6578e-05,-0.15851,-0.12762,1,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.4091e-05,-0.15871,-0.15827,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00013451,-0.15871,-0.18528,1,0
3,GO DIGESTION,4.8839e-05,-0.15877,-0.16277,1,0
3,GO SUBPALLIUM DEVELOPMENT,0.048285,-0.15879,-0.11597,1,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,6.2175e-05,-0.15897,-0.16704,1,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0013255,-0.15903,-0.16775,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.002702,-0.1591,-0.13072,1,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.016386,-0.15914,-0.23066,1,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.0001179,-0.15917,-0.15135,1,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00012594,-0.1592,-0.16048,1,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0066851,-0.15929,-0.15969,1,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0089251,-0.15944,-0.10298,1,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.01251,-0.1597,-0.14159,1,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,4.8839e-05,-0.15984,-0.19271,1,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.0012886,-0.15998,-0.12705,1,0
3,GO MONOCYTE CHEMOTAXIS,0.00024045,-0.16001,-0.19743,1,0
3,GO SEX DETERMINATION,0.0010865,-0.16015,-0.19455,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00012804,-0.16028,-0.15458,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.00082553,-0.16037,-0.14839,1,0
3,GO MALE GENITALIA DEVELOPMENT,0.02174,-0.16045,-0.14842,1,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0033799,-0.16057,-0.14214,1,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.0052854,-0.16066,-0.17146,1,0
3,GO INTEGRIN ACTIVATION,0.0089251,-0.16105,-0.12153,1,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.014013,-0.16109,-0.12966,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0014624,-0.1611,-0.21743,1,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.0007901,-0.16133,-0.17377,1,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00031414,-0.16138,-0.16902,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00032408,-0.16145,-0.20609,1,0
3,GO REGULATION OF RUFFLE ASSEMBLY,4.3236e-05,-0.16152,-0.16166,1,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.014332,-0.16178,-0.17463,1,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.00029052,-0.16202,-0.15722,1,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.042197,-0.16207,-0.15099,1,0
3,GO RESPONSE TO OXYGEN RADICAL,0.0032501,-0.16211,-0.10725,1,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00094089,-0.1622,-0.19159,1,0
3,GO CELL CHEMOTAXIS,3.5022e-05,-0.1623,-0.16719,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00081356,-0.16231,-0.12346,1,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0020367,-0.16232,-0.14281,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.00015331,-0.16237,-0.15351,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00036124,-0.16261,-0.14288,1,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.018693,-0.16273,-0.18915,1,0
3,GO CYTOKINE METABOLIC PROCESS,0.00014362,-0.16289,-0.17508,1,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.001422,-0.16319,-0.14374,1,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00020835,-0.16324,-0.1643,1,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.021509,-0.1633,-0.1836,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0099244,-0.16349,-0.16743,1,0
3,GO VIRAL LIFE CYCLE,6.0079e-05,-0.16351,-0.15189,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00010323,-0.16369,-0.16396,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00032408,-0.16385,-0.18007,1,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,3.8924e-05,-0.16385,-0.17579,1,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.1829e-05,-0.16398,-0.20822,1,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.055093,-0.16408,-0.1628,1,0
3,GO IMMUNE EFFECTOR PROCESS,7.7586e-05,-0.16414,-0.1583,1,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.0083098,-0.16418,-0.24561,1,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00034485,-0.16443,-0.15542,1,0
3,GO RESPONSE TO LEPTIN,0.00030928,-0.16451,-0.2081,1,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.2716e-05,-0.16457,-0.17747,1,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,9.9844e-05,-0.16461,-0.17002,1,0
3,GO MAST CELL MEDIATED IMMUNITY,0.00041488,-0.16504,-0.21685,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.003654,-0.16529,-0.13159,1,0
3,GO ENDOCRINE PROCESS,0.0003557,-0.1653,-0.15605,1,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.012367,-0.16538,-0.15151,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.03902,-0.16552,-0.17832,1,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.02128,-0.16563,-0.18359,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.2585e-06,-0.16575,-0.18485,1,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.052083,-0.16579,-0.16027,1,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.020605,-0.16609,-0.17949,1,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0016575,-0.16616,-0.15669,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00015838,-0.16632,-0.21029,1,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0052197,-0.1664,-0.15131,1,0
3,GO MATURE B CELL DIFFERENTIATION,0.0077327,-0.16658,-0.17407,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00013673,-0.1666,-0.19759,1,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00012594,-0.16666,-0.14721,1,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.057179,-0.16707,-0.13649,1,0
3,GO REPLICATIVE SENESCENCE,0.013546,-0.16712,-0.1519,1,0
3,GO CYTOPLASM ORGANIZATION,0.00159,-0.1675,-0.19985,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,2.8305e-05,-0.1675,-0.18864,1,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.043444,-0.16751,-0.15802,1,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00086244,-0.16754,-0.17844,1,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00044781,-0.16754,-0.15585,1,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00032916,-0.1676,-0.20803,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.1119e-05,-0.16787,-0.17853,1,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00060545,-0.16791,-0.13527,1,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.0011668,-0.16791,-0.19479,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00026024,-0.16794,-0.18327,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.0756e-05,-0.16809,-0.20828,1,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.009139,-0.16809,-0.18254,1,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0054872,-0.16809,-0.18905,1,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.01251,-0.16841,-0.13633,1,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.021973,-0.16845,-0.15076,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.007921,-0.16859,-0.16336,1,0
3,GO RESPONSE TO ANGIOTENSIN,0.00018323,-0.16877,-0.18071,1,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0099244,-0.16878,-0.14531,1,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0056255,-0.16883,-0.37403,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,7.8911e-05,-0.16886,-0.17678,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012804,-0.16895,-0.15697,1,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0016575,-0.16903,-0.20444,1,0
3,GO V D J RECOMBINATION,0.0012005,-0.16918,-0.19799,1,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.054074,-0.16919,-0.12575,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0014624,-0.16927,-0.19755,1,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00088789,-0.16941,-0.14781,1,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.013243,-0.16982,-0.13807,1,0
3,GO REGULATION OF ICOSANOID SECRETION,0.0066039,-0.16984,-0.14486,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0020929,-0.16999,-0.13941,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.01016,-0.17004,-0.10754,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,1.9749e-05,-0.1703,-0.21127,1,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,3.3806e-05,-0.17049,-0.15507,1,0
3,GO DEFENSE RESPONSE TO BACTERIUM,2.4528e-05,-0.17051,-0.17797,1,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,3.2784e-06,-0.17067,-0.15519,1,0
3,GO PROTEIN DEMANNOSYLATION,0.00060545,-0.17081,-0.1755,1,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0073682,-0.17104,-0.16778,1,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.037139,-0.1711,-0.11492,1,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.056652,-0.17127,-0.10536,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0053519,-0.17145,-0.10938,1,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0053519,-0.17148,-0.20236,1,0
3,GO NEURAL TUBE FORMATION,7.8052e-07,-0.17158,-0.18166,1,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.031311,-0.17184,-0.08546,1,0
3,GO MYOBLAST DIFFERENTIATION,0.00019857,-0.17189,-0.17614,1,0
3,GO CELL KILLING,0.00012594,-0.172,-0.18281,1,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.035691,-0.17207,-0.11032,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00011406,-0.17212,-0.16722,1,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00024819,-0.17222,-0.21989,1,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,9.3381e-05,-0.17229,-0.17567,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0025961,-0.1723,-0.18667,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,5.4184e-05,-0.1724,-0.15361,1,0
3,GO ETHANOL METABOLIC PROCESS,0.01016,-0.17242,-0.1859,1,0
3,GO VITAMIN D METABOLIC PROCESS,0.0062877,-0.17258,-0.18711,1,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.026286,-0.17286,-0.1801,1,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.3693e-05,-0.17303,-0.15563,1,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,7.7586e-05,-0.17309,-0.21443,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00088789,-0.1732,-0.17304,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0026663,-0.1733,-0.13848,1,0
3,GO REGULATION OF ACTIN NUCLEATION,0.00029511,-0.1733,-0.16372,1,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0035605,-0.17339,-0.13978,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,1.2716e-05,-0.17374,-0.17489,1,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.02945,-0.17376,-0.11,1,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,4.6359e-05,-0.17403,-0.13464,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00065224,-0.17407,-0.14489,1,0
3,GO LUNG MORPHOGENESIS,0.00059648,-0.17418,-0.19649,1,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00010152,-0.17422,-0.18152,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00015331,-0.17428,-0.21163,1,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00020504,-0.17436,-0.17967,1,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.0013443,-0.1745,-0.15268,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00087508,-0.17451,-0.18454,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00014362,-0.17458,-0.20187,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0017277,-0.17462,-0.14519,1,0
3,GO O GLYCAN PROCESSING,3.8924e-05,-0.17526,-0.25068,1,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,9.2585e-06,-0.17532,-0.15023,1,0
3,GO CARNITINE METABOLIC PROCESS,0.027401,-0.17533,-0.10724,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0002443,-0.17545,-0.18356,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,7.6283e-05,-0.17554,-0.13905,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,6.4341e-05,-0.17629,-0.19266,1,0
3,GO KERATINOCYTE PROLIFERATION,0.0013826,-0.17673,-0.21168,1,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0019285,-0.17674,-0.31703,1,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.001235,-0.17681,-0.14365,1,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.9749e-05,-0.17684,-0.18355,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00071283,-0.17699,-0.20921,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,7.7586e-05,-0.177,-0.19155,1,0
3,GO INTRACILIARY TRANSPORT,0.0044298,-0.17717,-0.15064,1,0
3,GO REGULATION OF B CELL ACTIVATION,2.8305e-05,-0.17726,-0.16227,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00073415,-0.17731,-0.18373,1,0
3,GO CYTOLYSIS,0.015159,-0.17755,-0.17562,1,0
3,GO ENDOTHELIUM DEVELOPMENT,9.3381e-05,-0.17791,-0.16967,1,0
3,GO N GLYCAN PROCESSING,0.043025,-0.17792,-0.14059,1,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0011668,-0.17796,-0.11225,1,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.3196e-05,-0.17805,-0.18823,1,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0017277,-0.17806,-0.19214,1,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.011151,-0.17853,-0.12195,1,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.00075607,-0.17863,-0.17601,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0017517,-0.17876,-0.11851,1,0
3,GO EPITHELIAL CELL MATURATION,0.013394,-0.17884,-0.13302,1,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.01585,-0.17893,-0.13094,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0015038,-0.17893,-0.1409,1,0
3,GO ERYTHROCYTE DEVELOPMENT,3.4409e-05,-0.17895,-0.15832,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00017176,-0.17907,-0.12618,1,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,1.2482e-05,-0.17908,-0.17267,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0041031,-0.17923,-0.16387,1,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,9.3381e-05,-0.17939,-0.16245,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0046604,-0.1794,-0.14598,1,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.0022396,-0.17951,-0.17711,1,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00011986,-0.17957,-0.1579,1,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.8032e-05,-0.17979,-0.21837,1,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00026438,-0.18004,-0.18602,1,0
3,GO CHEMOKINE PRODUCTION,3.2057e-05,-0.18005,-0.19611,1,0
3,GO REGULATION OF TELOMERE CAPPING,0.0028492,-0.18006,-0.12067,1,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.001422,-0.18023,-0.18452,1,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,3.8161e-07,-0.18032,-0.16815,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0012886,-0.18053,-0.17606,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0040509,-0.18055,-0.13412,1,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.00045468,-0.18083,-0.18146,1,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,5.3256e-05,-0.18092,-0.1746,1,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.033271,-0.18097,-0.14992,1,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.000662,-0.18105,-0.16608,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00086244,-0.18126,-0.17502,1,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.00015838,-0.18138,-0.15279,1,0
3,GO BONE RESORPTION,9.03e-05,-0.18142,-0.17992,1,0
3,GO GOLGI RIBBON FORMATION,0.0016806,-0.18175,-0.15189,1,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0065235,-0.18185,-0.15869,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.0759e-07,-0.18204,-0.21678,1,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,2.8305e-05,-0.18219,-0.16083,1,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0048405,-0.18226,-0.17308,1,0
3,GO GENETIC IMPRINTING,0.0050269,-0.18229,-0.13621,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.2344e-05,-0.18233,-0.16638,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019229,-0.18234,-0.195,1,0
3,GO RENAL TUBULE DEVELOPMENT,7.2497e-05,-0.18255,-0.18057,1,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00074504,-0.1826,-0.14692,1,0
3,GO ALPHA BETA T CELL ACTIVATION,5.7051e-07,-0.18268,-0.21188,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00012186,-0.18277,-0.19436,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00036124,-0.18278,-0.16232,1,0
3,GO ICOSANOID METABOLIC PROCESS,1.1588e-05,-0.1829,-0.22207,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.6446e-07,-0.18309,-0.23445,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0043184,-0.1831,-0.20648,1,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0018764,-0.18314,-0.16568,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0011341,-0.18332,-0.15537,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00027284,-0.18333,-0.19855,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.4262e-06,-0.1835,-0.23375,1,0
3,GO NEPHRON DEVELOPMENT,3.8924e-05,-0.18422,-0.17744,1,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0059116,-0.18423,-0.16829,1,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,5.2344e-05,-0.18431,-0.16284,1,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00017176,-0.18469,-0.20372,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0049019,-0.18482,-0.25757,1,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.03068,-0.18484,-0.19833,1,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0065235,-0.18498,-0.14365,1,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0055559,-0.18504,-0.14981,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.036409,-0.18511,-0.12334,1,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.6994e-06,-0.18538,-0.22492,1,0
3,GO SENSORY PERCEPTION OF TASTE,3.2146e-06,-0.18586,-0.21517,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0010408,-0.18629,-0.19599,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.00041488,-0.1863,-0.18572,1,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0013255,-0.18654,-0.18638,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00025215,-0.18672,-0.19056,1,0
3,GO CELLULAR RESPONSE TO VIRUS,1.8032e-05,-0.18696,-0.19197,1,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00014599,-0.18708,-0.15913,1,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.004964,-0.18714,-0.15613,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0005211,-0.18748,-0.22754,1,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.1234e-05,-0.18791,-0.15365,1,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.010895,-0.18795,-0.24963,1,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0017517,-0.18807,-0.17482,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00011596,-0.18807,-0.15493,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,7.5001e-05,-0.18826,-0.23001,1,0
3,GO B CELL DIFFERENTIATION,2.8001e-06,-0.18866,-0.17059,1,0
3,GO BIOLOGICAL PHASE,0.058787,-0.18874,-0.18513,1,0
3,GO REGULATION OF TISSUE REMODELING,0.00024819,-0.18907,-0.17941,1,0
3,GO TYPE I INTERFERON PRODUCTION,6.4341e-05,-0.18911,-0.17163,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,8.4262e-06,-0.18912,-0.16978,1,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.024428,-0.18922,-0.11084,1,0
3,GO APICAL PROTEIN LOCALIZATION,0.00052901,-0.18931,-0.15032,1,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0013443,-0.18953,-0.25863,1,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0021215,-0.18961,-0.19222,1,0
3,GO ENTRY INTO HOST,0.00019541,-0.18972,-0.2057,1,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0072795,-0.18974,-0.21758,1,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.00043435,-0.18976,-0.19353,1,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00063314,-0.19044,-0.17127,1,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.2253e-05,-0.19051,-0.17772,1,0
3,GO RESPONSE TO INACTIVITY,0.0083098,-0.19057,-0.14337,1,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00019857,-0.19081,-0.197,1,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0005211,-0.19091,-0.17688,1,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.00055343,-0.19092,-0.19971,1,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,3.8161e-07,-0.19104,-0.17197,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,7.6657e-06,-0.19113,-0.19214,1,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,5.5127e-05,-0.19118,-0.1865,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.5994e-06,-0.19136,-0.22895,1,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0042636,-0.19142,-0.22927,1,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,4.9694e-05,-0.19144,-0.17186,1,0
3,GO ETHANOL OXIDATION,0.027973,-0.19153,-0.21718,1,0
3,GO SEGMENT SPECIFICATION,0.003654,-0.19163,-0.22672,1,0
3,GO ORGAN INDUCTION,0.00095459,-0.19168,-0.18491,1,0
3,GO RESPONSE TO PROGESTERONE,0.00015583,-0.1917,-0.21344,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.037139,-0.19201,-0.14422,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,1.7706e-05,-0.19208,-0.21906,1,0
3,GO REGULATION OF B CELL PROLIFERATION,0.00036124,-0.19209,-0.16475,1,0
3,GO RESPONSE TO MECHANICAL STIMULUS,8.7316e-05,-0.19263,-0.15737,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00070238,-0.19301,-0.14611,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,2.6828e-05,-0.19304,-0.22069,1,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.0063654,-0.19312,-0.27543,1,0
3,GO MYELOID CELL DEVELOPMENT,1.0169e-05,-0.19343,-0.15384,1,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00054518,-0.19359,-0.1386,1,0
3,GO B CELL MEDIATED IMMUNITY,0.00019541,-0.19385,-0.19287,1,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,4.9694e-05,-0.19392,-0.22925,1,0
3,GO BONE CELL DEVELOPMENT,0.00030449,-0.19398,-0.15382,1,0
3,GO CELLULAR DEFENSE RESPONSE,4.8198e-07,-0.19411,-0.25606,1,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.2281e-06,-0.19441,-0.18867,1,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.020828,-0.19442,-0.17242,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,3.3435e-06,-0.19454,-0.22644,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00012804,-0.19486,-0.21945,1,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00012388,-0.19492,-0.22183,1,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0012705,-0.19501,-0.19391,1,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.0088198,-0.19515,-0.19897,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,1.8363e-05,-0.19516,-0.19644,1,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,2.3891e-06,-0.19521,-0.17994,1,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,5.3256e-05,-0.19522,-0.17239,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0019819,-0.19526,-0.15971,1,0
3,GO HISTAMINE TRANSPORT,0.0015038,-0.19574,-0.27438,1,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.051111,-0.19574,-0.1781,1,0
3,GO T CELL MEDIATED IMMUNITY,0.00058763,-0.1958,-0.20473,1,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0013443,-0.19588,-0.18252,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00061456,-0.19605,-0.19455,1,0
3,GO ERBB2 SIGNALING PATHWAY,0.00012804,-0.19606,-0.17626,1,0
3,GO RESPONSE TO VIRUS,1.0756e-05,-0.19616,-0.18967,1,0
3,GO SECONDARY METABOLIC PROCESS,0.00017176,-0.1962,-0.18077,1,0
3,GO ENDOSOME ORGANIZATION,9.7998e-07,-0.19622,-0.16153,1,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.0087156,-0.19629,-0.12556,1,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001442,-0.19638,-0.21792,1,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.0088198,-0.19699,-0.16827,1,0
3,GO MYELOID CELL HOMEOSTASIS,1.475e-06,-0.19711,-0.18498,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.2253e-05,-0.19716,-0.18793,1,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.0029645,-0.19721,-0.17715,1,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,4.7172e-05,-0.19722,-0.2,1,0
3,GO AORTA MORPHOGENESIS,0.0030436,-0.19725,-0.1939,1,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0011021,-0.19726,-0.19209,1,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,1.1375e-05,-0.19739,-0.17759,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.6761e-05,-0.19739,-0.22362,1,0
3,GO OLIGOPEPTIDE TRANSPORT,0.00060545,-0.19756,-0.24584,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,8.7316e-05,-0.1978,-0.17704,1,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00041488,-0.19795,-0.19573,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9361e-06,-0.19821,-0.18769,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00039018,-0.19826,-0.1863,1,0
3,GO VIRAL RELEASE FROM HOST CELL,1.1316e-06,-0.19839,-0.18429,1,0
3,GO AXIS ELONGATION,0.024687,-0.19863,-0.16274,1,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0081133,-0.19875,-0.14321,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0018764,-0.19876,-0.18721,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,1.7385e-05,-0.19892,-0.20078,1,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0038478,-0.19939,-0.28626,1,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.054582,-0.1996,-0.13914,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00098255,-0.19974,-0.22845,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,6.3249e-05,-0.19986,-0.19984,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.2716e-05,-0.20011,-0.2136,1,0
3,GO HEART FORMATION,0.0052854,-0.20017,-0.15341,1,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0005133,-0.20019,-0.14,1,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.0049019,-0.20024,-0.15224,1,0
3,GO CENTROSOME DUPLICATION,1.1282e-07,-0.20039,-0.20764,1,0
3,GO CELL FATE SPECIFICATION,2.6352e-05,-0.20052,-0.20178,1,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.001568,-0.20056,-0.17842,1,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.014172,-0.20075,-0.16691,1,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00020178,-0.2009,-0.22038,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00042777,-0.20117,-0.25648,1,0
3,GO EPITHELIAL CELL DEVELOPMENT,4.2444e-07,-0.20122,-0.22128,1,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,1.0756e-05,-0.20162,-0.21438,1,0
3,GO HEART FIELD SPECIFICATION,0.0081133,-0.20186,-0.18637,1,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0050269,-0.20209,-0.13372,1,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.016568,-0.2021,-0.18916,1,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.011813,-0.20255,-0.20025,1,0
3,GO INTERLEUKIN 6 PRODUCTION,2.2775e-07,-0.20281,-0.22704,1,0
3,GO INTERLEUKIN 13 PRODUCTION,0.012798,-0.2034,-0.18171,1,0
3,GO PLATELET ACTIVATION,8.0256e-05,-0.20343,-0.17059,1,0
3,GO AUTOPHAGOSOME MATURATION,4.6359e-05,-0.20358,-0.16254,1,0
3,GO VIRION ASSEMBLY,1.9989e-07,-0.20375,-0.17973,1,0
3,GO MICROVILLUS ASSEMBLY,0.020166,-0.20382,-0.14903,1,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0010259,-0.20399,-0.18298,1,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00036124,-0.2043,-0.19961,1,0
3,GO T CELL EXTRAVASATION,0.016386,-0.20447,-0.19438,1,0
3,GO CELLULAR RESPONSE TO IRON ION,0.004964,-0.20451,-0.20244,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,3.2057e-05,-0.20456,-0.20335,1,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00018323,-0.2052,-0.17621,1,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0032078,-0.20524,-0.20496,1,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.2015e-05,-0.20527,-0.19559,1,0
3,GO RESPONSE TO INTERLEUKIN 6,6.5837e-06,-0.20565,-0.22079,1,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.0066039,-0.20582,-0.16896,1,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.0001862,-0.20622,-0.15445,1,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,3.8924e-05,-0.20623,-0.18314,1,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00047589,-0.20644,-0.16782,1,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.00011596,-0.20656,-0.21237,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,4.9694e-05,-0.20681,-0.18372,1,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.0879e-07,-0.20757,-0.21834,1,0
3,GO INTERLEUKIN 8 PRODUCTION,1.3693e-05,-0.20788,-0.22803,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0016122,-0.20798,-0.16881,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0013633,-0.20805,-0.24054,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00023294,-0.20821,-0.23298,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.094e-05,-0.20829,-0.17766,1,0
3,GO TISSUE REMODELING,5.1446e-05,-0.20841,-0.19079,1,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.05063,-0.20866,-0.11032,1,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.010769,-0.20867,-0.1882,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0005211,-0.20869,-0.21454,1,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00069207,-0.20884,-0.20612,1,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.048746,-0.2096,-0.15267,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00027716,-0.20975,-0.21502,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.023173,-0.20983,-0.16,1,0
3,GO ACTIVATED T CELL PROLIFERATION,0.00012388,-0.20987,-0.18639,1,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.027401,-0.20999,-0.12524,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,7.969e-07,-0.21007,-0.25597,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00017741,-0.21007,-0.26819,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00011033,-0.21043,-0.25717,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.3891e-06,-0.21044,-0.20239,1,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00036686,-0.21063,-0.25577,1,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.00026438,-0.21068,-0.17035,1,0
3,GO RESPONSE TO INTERFERON GAMMA,0.00069207,-0.21078,-0.22196,1,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,5.5127e-05,-0.21097,-0.27292,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0073682,-0.21099,-0.18565,1,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0014624,-0.21105,-0.16229,1,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.0040509,-0.21129,-0.15249,1,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.00087508,-0.21132,-0.23907,1,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,5.8856e-08,-0.21132,-0.24885,1,0
3,GO NEUTROPHIL HOMEOSTASIS,0.0068504,-0.2115,-0.19055,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,1.4472e-05,-0.21157,-0.23039,1,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0070192,-0.21161,-0.13749,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0010259,-0.21168,-0.14853,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0011503,-0.21193,-0.219,1,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00083767,-0.21193,-0.18406,1,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0023009,-0.21231,-0.19639,1,0
3,GO REGULATION OF RECEPTOR BINDING,0.0081133,-0.21317,-0.15916,1,0
3,GO NEURON FATE COMMITMENT,0.0041031,-0.21378,-0.18152,1,0
3,GO GLOMERULUS DEVELOPMENT,7.2497e-05,-0.21414,-0.23416,1,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.002702,-0.21438,-0.22261,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00037835,-0.21472,-0.19764,1,0
3,GO REGULATION OF VASCULOGENESIS,0.012227,-0.21473,-0.15926,1,0
3,GO ER OVERLOAD RESPONSE,0.016568,-0.21486,-0.15052,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.719e-07,-0.21508,-0.2024,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.8305e-05,-0.21508,-0.22809,1,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.010041,-0.21515,-0.15894,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,2.011e-05,-0.21552,-0.23606,1,0
3,GO BONE REMODELING,0.00059648,-0.21555,-0.15848,1,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.014172,-0.21564,-0.1617,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00044103,-0.21588,-0.22432,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.0080166,-0.21598,-0.19227,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00034485,-0.21598,-0.22174,1,0
3,GO SPERM CAPACITATION,0.00011406,-0.21634,-0.18803,1,0
3,GO MAST CELL ACTIVATION,0.00022565,-0.21647,-0.21961,1,0
3,GO LIPID DIGESTION,0.0017517,-0.21693,-0.30777,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.016386,-0.21708,-0.20396,1,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00044103,-0.21722,-0.20059,1,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.0054192,-0.2178,-0.16783,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,8.4424e-05,-0.21809,-0.26032,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,3.9872e-06,-0.21847,-0.20057,1,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0012005,-0.21859,-0.19581,1,0
3,GO REGULATION OF CENTROSOME DUPLICATION,8.2543e-08,-0.21893,-0.21497,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.105e-06,-0.21903,-0.19823,1,0
3,GO PIGMENT ACCUMULATION,0.0052854,-0.21932,-0.18697,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.032607,-0.2197,-0.13515,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00023667,-0.21988,-0.17922,1,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,6.5837e-06,-0.21998,-0.22623,1,0
3,GO HEART INDUCTION,0.048285,-0.2204,-0.13082,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0028872,-0.22046,-0.22398,1,0
3,GO SUPEROXIDE ANION GENERATION,0.00029511,-0.22051,-0.22654,1,0
3,GO B CELL APOPTOTIC PROCESS,1.3693e-05,-0.2207,-0.25605,1,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.0756e-05,-0.22071,-0.22142,1,0
3,GO PROSTANOID METABOLIC PROCESS,6.7724e-05,-0.22115,-0.28062,1,0
3,GO REGULATION OF CENTROSOME CYCLE,3.8149e-08,-0.22133,-0.20439,1,0
3,GO INTERLEUKIN 12 PRODUCTION,1.3769e-07,-0.22137,-0.27501,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00040857,-0.22173,-0.207,1,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.7502e-06,-0.22195,-0.223,1,0
3,GO DEFENSE RESPONSE TO VIRUS,9.404e-07,-0.22227,-0.24719,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.014494,-0.22317,-0.15352,1,0
3,GO MAGNESIUM ION TRANSPORT,3.8246e-05,-0.22331,-0.21314,1,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,2.3274e-07,-0.22332,-0.20318,1,0
3,GO REGULATION OF MYOBLAST FUSION,0.0047798,-0.2236,-0.17333,1,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,6.6578e-05,-0.22438,-0.17063,1,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00086244,-0.22477,-0.15594,1,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00019541,-0.22497,-0.22102,1,0
3,GO ESCRT COMPLEX DISASSEMBLY,1.7706e-05,-0.22581,-0.2541,1,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0023009,-0.22593,-0.22099,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0050904,-0.2261,-0.21318,1,0
3,GO AXONEME ASSEMBLY,0.0005618,-0.22678,-0.20118,1,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,8.2686e-06,-0.22711,-0.21704,1,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0019285,-0.22744,-0.18272,1,0
3,GO INTERLEUKIN 10 PRODUCTION,1.5994e-06,-0.22757,-0.2633,1,0
3,GO ADRENAL GLAND DEVELOPMENT,3.758e-05,-0.22771,-0.26901,1,0
3,GO NECROTIC CELL DEATH,3.8347e-06,-0.22779,-0.21051,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.00010323,-0.22781,-0.21507,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0001803,-0.22841,-0.18567,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,6.7724e-05,-0.22861,-0.18736,1,0
3,GO MYOFIBRIL ASSEMBLY,5.6085e-05,-0.22897,-0.18203,1,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,1.3442e-05,-0.22923,-0.21985,1,0
3,GO REGULATION OF COAGULATION,0.0003557,-0.22927,-0.21887,1,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0069343,-0.22941,-0.19344,1,0
3,GO VASCULAR WOUND HEALING,0.002702,-0.22956,-0.2265,1,0
3,GO POSITIVE REGULATION OF CELL KILLING,5.6487e-06,-0.22978,-0.26204,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,6.0079e-05,-0.22997,-0.27448,1,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00021857,-0.23027,-0.18809,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,2.3853e-09,-0.23051,-0.2335,1,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0039992,-0.23066,-0.30201,1,0
3,GO REGULATION OF B CELL DIFFERENTIATION,9.1829e-05,-0.23145,-0.2201,1,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0015249,-0.23173,-0.21818,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.0522e-08,-0.23185,-0.27282,1,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0042095,-0.2322,-0.27084,1,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,1.3878e-06,-0.23282,-0.21989,1,0
3,GO INTERFERON BETA PRODUCTION,2.5424e-05,-0.23288,-0.19381,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,1.9749e-05,-0.23312,-0.29232,1,0
3,GO REGULATION OF RESPONSE TO WOUNDING,2.3661e-05,-0.23317,-0.20426,1,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00016361,-0.23321,-0.25354,1,0
3,GO PANCREAS DEVELOPMENT,9.2585e-06,-0.23324,-0.23186,1,0
3,GO REGULATION OF CELL KILLING,8.5867e-06,-0.23336,-0.24549,1,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.0030436,-0.23342,-0.20586,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00021511,-0.23393,-0.16875,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,1.1806e-05,-0.23428,-0.19155,1,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.7312e-05,-0.2347,-0.185,1,0
3,GO RUFFLE ORGANIZATION,5.1356e-08,-0.23512,-0.19895,1,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.7586e-05,-0.23517,-0.19366,1,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.023173,-0.23548,-0.22582,1,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,5.3256e-05,-0.23599,-0.21471,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0057669,-0.23629,-0.16881,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.6562e-05,-0.23635,-0.26802,1,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0032928,-0.23703,-0.16619,1,0
3,GO CYTOKINETIC PROCESS,4.0033e-09,-0.23714,-0.24288,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.5014e-05,-0.23757,-0.3231,1,0
3,GO CARDIOBLAST DIFFERENTIATION,0.0029645,-0.23769,-0.19611,1,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,1.0361e-05,-0.23786,-0.22389,1,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.036048,-0.2379,-0.13165,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.00057029,-0.23833,-0.24389,1,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0081133,-0.23856,-0.20014,1,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,1.8032e-05,-0.23879,-0.23628,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.2958e-06,-0.2395,-0.20926,1,0
3,GO CELL FATE DETERMINATION,6.0991e-06,-0.23963,-0.2328,1,0
3,GO ZYMOGEN INHIBITION,3.3214e-05,-0.23963,-0.31588,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0001803,-0.23993,-0.23369,1,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00032916,-0.23994,-0.25333,1,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00029976,-0.24031,-0.18926,1,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00017741,-0.24084,-0.24419,1,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00015083,-0.24127,-0.22008,1,0
3,GO RUFFLE ASSEMBLY,4.719e-07,-0.24143,-0.18366,1,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0013069,-0.24152,-0.17055,1,0
3,GO MUSCLE CELL MIGRATION,1.0557e-05,-0.24167,-0.23118,1,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.01251,-0.24172,-0.18904,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.011544,-0.24173,-0.17801,1,0
3,GO PLACENTA DEVELOPMENT,4.3355e-07,-0.24187,-0.20796,1,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,3.152e-06,-0.24218,-0.23015,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0012886,-0.24282,-0.30942,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.0302e-06,-0.24282,-0.26567,1,0
3,GO PLATELET AGGREGATION,9.4341e-06,-0.24319,-0.23917,1,0
3,GO VIRAL GENOME REPLICATION,7.105e-06,-0.24328,-0.22364,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0016575,-0.24383,-0.31268,1,0
3,GO POSITIVE T CELL SELECTION,1.5865e-05,-0.24447,-0.21006,1,0
3,GO MICROVILLUS ORGANIZATION,0.00033432,-0.24459,-0.23292,1,0
3,GO REGULATORY T CELL DIFFERENTIATION,2.6352e-05,-0.24463,-0.29664,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.6914e-06,-0.24474,-0.24741,1,0
3,GO BLOOD VESSEL REMODELING,6.4341e-05,-0.24501,-0.20672,1,0
3,GO EOSINOPHIL CHEMOTAXIS,0.024428,-0.24547,-0.20366,1,0
3,GO BROWN FAT CELL DIFFERENTIATION,4.31e-06,-0.24609,-0.25589,1,0
3,GO REGULATION OF RESPIRATORY BURST,1.1806e-05,-0.24618,-0.2295,1,0
3,GO EMBRYONIC HEMOPOIESIS,1.6158e-05,-0.2478,-0.25865,1,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.0522e-08,-0.24882,-0.25982,1,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,3.758e-05,-0.24896,-0.21105,1,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0062877,-0.24908,-0.1894,1,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,6.2993e-08,-0.24941,-0.25288,1,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.003607,-0.24959,-0.16894,1,0
3,GO INTERLEUKIN 1 PRODUCTION,1.6158e-05,-0.25011,-0.24862,1,0
3,GO REGULATION OF WOUND HEALING,7.3803e-06,-0.25065,-0.2423,1,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.6359e-05,-0.25099,-0.19818,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9332e-05,-0.25104,-0.24079,1,0
3,GO LIPOXYGENASE PATHWAY,0.0052197,-0.25122,-0.25638,1,0
3,GO EOSINOPHIL MIGRATION,0.0087156,-0.25185,-0.21169,1,0
3,GO SMOOTH MUSCLE CELL MIGRATION,4.7999e-05,-0.25191,-0.22351,1,0
3,GO ZYMOGEN ACTIVATION,0.00046872,-0.25191,-0.23532,1,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,8.6579e-07,-0.25212,-0.23671,1,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.0039992,-0.25243,-0.17578,1,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0054192,-0.25258,-0.23395,1,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.0047798,-0.25274,-0.2305,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0062877,-0.25281,-0.24205,1,0
3,GO ESTROUS CYCLE,0.0019023,-0.25281,-0.20378,1,0
3,GO BILE ACID METABOLIC PROCESS,1.2032e-06,-0.25287,-0.2469,1,0
3,GO MALE SEX DETERMINATION,1.2716e-05,-0.25298,-0.31367,1,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00076726,-0.25347,-0.21566,1,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,2.0776e-06,-0.25353,-0.27321,1,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00010323,-0.25406,-0.21585,1,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.0016347,-0.25467,-0.29556,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00030928,-0.2548,-0.29915,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,2.0429e-07,-0.25481,-0.25869,1,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.01499,-0.2551,-0.20445,1,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0013443,-0.25567,-0.17655,1,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.00012186,-0.2557,-0.3141,1,0
3,GO T CELL SELECTION,9.086e-06,-0.25573,-0.19527,1,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.020605,-0.25574,-0.16153,1,0
3,GO POSITIVE REGULATION OF COAGULATION,6.4592e-06,-0.25588,-0.27626,1,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,1.3442e-05,-0.25588,-0.23599,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.0478e-05,-0.25624,-0.2473,1,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.2775e-07,-0.25636,-0.25284,1,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0020367,-0.25681,-0.18201,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,1.0094e-07,-0.25698,-0.2348,1,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0092477,-0.25708,-0.21518,1,0
3,GO SPLEEN DEVELOPMENT,6.0205e-08,-0.25737,-0.23837,1,0
3,GO MOTILE CILIUM ASSEMBLY,0.0032078,-0.25738,-0.22313,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,4.9361e-06,-0.25748,-0.23564,1,0
3,GO GERMINAL CENTER FORMATION,0.00082553,-0.25754,-0.27124,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00030928,-0.2578,-0.22977,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,7.0072e-05,-0.25789,-0.26744,1,0
3,GO PROTEIN ADP RIBOSYLATION,1.2027e-05,-0.25802,-0.22531,1,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,4.2487e-05,-0.2585,-0.24665,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,1.0212e-06,-0.25872,-0.24408,1,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,3.8347e-06,-0.25888,-0.24823,1,0
3,GO SPINAL CORD PATTERNING,0.0005133,-0.25903,-0.24446,1,0
3,GO REGULATION OF SPINDLE ASSEMBLY,3.5794e-07,-0.25904,-0.22547,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0012005,-0.25961,-0.30404,1,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.0958e-05,-0.2598,-0.22251,1,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0050904,-0.26009,-0.2551,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.5837e-06,-0.26009,-0.23196,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION,5.2538e-08,-0.26082,-0.23972,1,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0016122,-0.26165,-0.18197,1,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,7.3739e-05,-0.26204,-0.32241,1,0
3,GO REGULATION OF BONE REMODELING,0.0001803,-0.26283,-0.19775,1,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,4.8839e-05,-0.26286,-0.27019,1,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.009139,-0.26383,-0.31803,1,0
3,GO MYOBLAST MIGRATION,0.0033361,-0.26409,-0.26953,1,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.0364e-06,-0.26429,-0.24991,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,4.1552e-07,-0.26435,-0.28963,1,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.8419e-06,-0.26498,-0.23298,1,0
3,GO ALPHA BETA T CELL PROLIFERATION,5.1304e-06,-0.26541,-0.29581,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,6.895e-08,-0.26565,-0.30709,1,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,5.3256e-05,-0.26602,-0.26963,1,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.048285,-0.26772,-0.18879,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00017741,-0.26793,-0.19691,1,0
3,GO EXTRACELLULAR TRANSPORT,0.00013016,-0.26913,-0.23437,1,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.0023957,-0.26928,-0.25519,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.3239e-05,-0.26934,-0.23106,1,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0028492,-0.26943,-0.22316,1,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.00073415,-0.27129,-0.19089,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0005211,-0.27188,-0.29026,1,0
3,GO INTESTINAL LIPID ABSORPTION,0.00071283,-0.27194,-0.34571,1,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00013232,-0.2721,-0.21205,1,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.3236e-05,-0.27242,-0.22895,1,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,4.31e-06,-0.2726,-0.25804,1,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,6.7724e-05,-0.27306,-0.23948,1,0
3,GO OTIC VESICLE DEVELOPMENT,0.0059116,-0.27381,-0.25603,1,0
3,GO TRANSCYTOSIS,1.3325e-06,-0.27387,-0.2235,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,9.5999e-07,-0.27518,-0.26384,1,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.001483,-0.27532,-0.21269,1,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00073415,-0.27533,-0.22309,1,0
3,GO HOMOTYPIC CELL CELL ADHESION,1.0861e-06,-0.27542,-0.28424,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.00012804,-0.27572,-0.22793,1,0
3,GO GDP METABOLIC PROCESS,0.0028872,-0.27594,-0.18701,1,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.001483,-0.27597,-0.30206,1,0
3,GO CENTROSOME SEPARATION,3.2631e-05,-0.27613,-0.22787,1,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.0067673,-0.27631,-0.20213,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00018923,-0.27652,-0.26294,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00069207,-0.27727,-0.24536,1,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.5372e-07,-0.27758,-0.26783,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,9.4341e-06,-0.27798,-0.24419,1,0
3,GO ACTIN FILAMENT BASED TRANSPORT,9.6562e-05,-0.27821,-0.2341,1,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0030038,-0.27824,-0.27894,1,0
3,GO MYELOID CELL APOPTOTIC PROCESS,2.6828e-05,-0.2783,-0.24186,1,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,9.0235e-07,-0.27833,-0.27779,1,0
3,GO HORMONE CATABOLIC PROCESS,2.9859e-05,-0.27851,-0.28264,1,0
3,GO LEFT RIGHT AXIS SPECIFICATION,7.6283e-05,-0.27938,-0.26746,1,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,1.6321e-06,-0.27975,-0.21249,1,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,3.1729e-08,-0.28041,-0.27877,1,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0069343,-0.2809,-0.26181,1,0
3,GO RENAL ABSORPTION,0.0012177,-0.28092,-0.28819,1,0
3,GO GANGLION DEVELOPMENT,0.0060595,-0.28176,-0.19703,1,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,2.4091e-05,-0.28281,-0.27324,1,0
3,GO LEFT RIGHT PATTERN FORMATION,2.4371e-06,-0.2832,-0.26709,1,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,1.5052e-06,-0.2832,-0.27856,1,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.333e-07,-0.28337,-0.28955,1,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00022208,-0.2838,-0.32985,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,1.1316e-06,-0.28446,-0.26377,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,2.4972e-05,-0.28476,-0.28989,1,0
3,GO HEPATOCYTE DIFFERENTIATION,9.4341e-06,-0.28511,-0.31437,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.8246e-05,-0.2852,-0.29376,1,0
3,GO SIGNAL PEPTIDE PROCESSING,5.9834e-06,-0.28545,-0.28069,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.001118,-0.28571,-0.27832,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0037016,-0.28594,-0.2256,1,0
3,GO LIVER MORPHOGENESIS,0.0001803,-0.28665,-0.23668,1,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,1.6761e-05,-0.28802,-0.22427,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.8118e-09,-0.28835,-0.31615,1,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,3.2057e-05,-0.28838,-0.29387,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00021857,-0.28895,-0.30977,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.4296e-07,-0.29046,-0.29352,1,0
3,GO REGULATION OF PLATELET ACTIVATION,8.7316e-05,-0.29092,-0.28951,1,0
3,GO REGULATION OF CELL FATE COMMITMENT,3.1479e-07,-0.29198,-0.307,1,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,1.9563e-06,-0.29247,-0.27699,1,0
3,GO CELL CELL JUNCTION ORGANIZATION,1.3468e-07,-0.2927,-0.24649,1,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.8419e-06,-0.29298,-0.28233,1,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,4.4285e-07,-0.29319,-0.25152,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0012886,-0.29346,-0.25333,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,6.2169e-06,-0.29547,-0.31023,1,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00081356,-0.29581,-0.29389,1,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.0212e-06,-0.29711,-0.33711,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.2631e-05,-0.2973,-0.22556,1,0
3,GO BRONCHUS DEVELOPMENT,0.0011021,-0.29801,-0.30091,1,0
3,GO T HELPER CELL LINEAGE COMMITMENT,7.1819e-07,-0.29902,-0.27096,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,4.1751e-05,-0.29952,-0.24094,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,5.9056e-05,-0.30047,-0.34102,1,0
3,GO PRO B CELL DIFFERENTIATION,1.3693e-05,-0.30065,-0.26758,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.6924e-05,-0.30066,-0.24659,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00031414,-0.30113,-0.26035,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,1.9546e-09,-0.30119,-0.2921,1,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.00069207,-0.30127,-0.21214,1,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,2.65e-07,-0.30135,-0.3086,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00021857,-0.30182,-0.24139,1,0
3,GO FRUCTOSE METABOLIC PROCESS,0.0029645,-0.30194,-0.26759,1,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.010895,-0.30344,-0.21337,1,0
3,GO REGULATION OF EXOSOMAL SECRETION,3.8161e-07,-0.30393,-0.25626,1,0
3,GO GONADOTROPIN SECRETION,3.7356e-07,-0.30458,-0.31154,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,5.6245e-08,-0.30479,-0.27924,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00014362,-0.30482,-0.29093,1,0
3,GO CELL CELL JUNCTION ASSEMBLY,4.3774e-08,-0.3049,-0.25877,1,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.00022565,-0.3058,-0.24244,1,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.0019819,-0.30593,-0.25342,1,0
3,GO EPIDERMIS DEVELOPMENT,2.6981e-08,-0.30637,-0.2793,1,0
3,GO DECIDUALIZATION,0.0010113,-0.30715,-0.25201,1,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,2.0478e-05,-0.30809,-0.31635,1,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.4409e-05,-0.3083,-0.35516,1,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.014013,-0.30836,-0.22398,1,0
3,GO SKIN DEVELOPMENT,3.4003e-08,-0.3091,-0.28387,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.9563e-06,-0.30924,-0.28876,1,0
3,GO SARCOMERE ORGANIZATION,1.6158e-05,-0.30926,-0.23582,1,0
3,GO WATER HOMEOSTASIS,7.6446e-07,-0.30945,-0.27547,1,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.7452e-06,-0.30973,-0.3151,1,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0024609,-0.31244,-0.27758,1,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00028155,-0.31247,-0.33252,1,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,1.0781e-08,-0.3136,-0.31275,1,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,3.758e-05,-0.31396,-0.24424,1,0
3,GO LIPID TRANSLOCATION,9.795e-06,-0.31472,-0.25544,1,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,9.5999e-07,-0.31546,-0.34046,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.0020646,-0.31668,-0.32338,1,0
3,GO REGULATION OF INTEGRIN ACTIVATION,2.4837e-07,-0.31767,-0.28428,1,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00037257,-0.31838,-0.26578,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,1.069e-09,-0.31847,-0.32864,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.4741e-05,-0.3188,-0.39688,1,0
3,GO ACTIN FILAMENT SEVERING,3.2057e-05,-0.31886,-0.32925,1,0
3,GO T CELL LINEAGE COMMITMENT,6.8348e-09,-0.3191,-0.30662,1,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,9.1829e-05,-0.31924,-0.28845,1,0
3,GO HETEROTYPIC CELL CELL ADHESION,4.3774e-08,-0.31971,-0.31128,1,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.011022,-0.32144,-0.27884,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,9.0235e-07,-0.32148,-0.3051,1,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.00063314,-0.3217,-0.32073,1,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,4.7172e-05,-0.3228,-0.36914,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,4.3997e-05,-0.32354,-0.32531,1,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00018323,-0.32395,-0.24426,1,0
3,GO OSTEOBLAST PROLIFERATION,2.7668e-07,-0.32466,-0.33674,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0012527,-0.32531,-0.36499,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,4.6359e-05,-0.32532,-0.37196,1,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,2.5359e-06,-0.32626,-0.34119,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,7.6283e-05,-0.32643,-0.3959,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00021857,-0.32768,-0.30219,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.7605e-06,-0.32774,-0.28711,1,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00040235,-0.32809,-0.3063,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.2058e-07,-0.32814,-0.37714,1,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00098255,-0.32839,-0.32333,1,0
3,GO PARAXIAL MESODERM DEVELOPMENT,2.0478e-05,-0.33036,-0.30297,1,0
3,GO RESPONSE TO INTERFERON BETA,0.00036124,-0.3307,-0.37655,1,0
3,GO INNER DYNEIN ARM ASSEMBLY,3.0395e-05,-0.33267,-0.36992,1,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,1.3948e-05,-0.33318,-0.35577,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,8.5858e-05,-0.33408,-0.32869,1,0
3,GO RETINA LAYER FORMATION,0.004964,-0.33445,-0.2293,1,0
3,GO NOTCH RECEPTOR PROCESSING,9.9803e-06,-0.33494,-0.35703,1,0
3,GO RESPONSE TO WATER,1.1588e-05,-0.33499,-0.31627,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.65e-07,-0.33626,-0.2979,1,0
3,GO VIRAL BUDDING,4.1025e-09,-0.3363,-0.27833,1,0
3,GO TRANSPOSITION,1.1316e-06,-0.3372,-0.36159,1,0
3,GO INTERFERON ALPHA PRODUCTION,4.0657e-06,-0.33731,-0.27181,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.4771e-05,-0.33836,-0.35671,1,0
3,GO LUNG EPITHELIUM DEVELOPMENT,2.1624e-06,-0.33877,-0.31287,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,2.971e-06,-0.33939,-0.38602,1,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00021857,-0.34069,-0.25287,1,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.5684e-06,-0.34098,-0.32655,1,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,2.2775e-07,-0.34105,-0.33682,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,3.152e-06,-0.3413,-0.29155,1,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.011022,-0.34174,-0.18345,1,0
3,GO GAP JUNCTION ASSEMBLY,1.0861e-06,-0.3424,-0.38459,1,0
3,GO BARBED END ACTIN FILAMENT CAPPING,7.5451e-08,-0.34241,-0.37912,1,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.7385e-05,-0.34244,-0.31655,1,0
3,GO HISTAMINE SECRETION,4.3997e-05,-0.34321,-0.38765,1,0
3,GO ENDOCARDIUM DEVELOPMENT,1.4163e-06,-0.34383,-0.3496,1,0
3,GO TOXIN METABOLIC PROCESS,3.1494e-05,-0.34394,-0.31784,1,0
3,GO ANOIKIS,1.9014e-08,-0.34487,-0.32811,1,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,4.3997e-05,-0.34538,-0.34138,1,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00090088,-0.34568,-0.40897,1,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,9.086e-06,-0.34594,-0.2951,1,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00014839,-0.34794,-0.28822,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,2.3467e-08,-0.34898,-0.37286,1,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00012186,-0.34939,-0.27068,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00068191,-0.34981,-0.28571,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,5.815e-11,-0.35015,-0.32236,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,7.8911e-05,-0.35023,-0.27437,1,0
3,GO REGULATION OF CELL FATE SPECIFICATION,3.0302e-06,-0.35032,-0.33736,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.4516e-10,-0.35199,-0.40123,1,0
3,GO DETECTION OF OTHER ORGANISM,1.3693e-05,-0.35299,-0.35962,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.9989e-07,-0.35318,-0.37299,1,0
3,GO INTESTINAL ABSORPTION,4.31e-06,-0.35342,-0.34151,1,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.7309e-08,-0.3557,-0.40216,1,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.0052197,-0.35644,-0.35886,1,0
3,GO HAIR CELL DIFFERENTIATION,3.7605e-06,-0.35687,-0.26627,1,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,8.3013e-05,-0.3582,-0.35099,1,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00063314,-0.35864,-0.36819,1,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,4.8839e-05,-0.35977,-0.31632,1,0
3,GO DNA DEAMINATION,0.00081356,-0.36145,-0.28716,1,0
3,GO GLIAL CELL APOPTOTIC PROCESS,3.9613e-05,-0.36149,-0.33588,1,0
3,GO TOLERANCE INDUCTION,4.1751e-05,-0.36248,-0.39294,1,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,2.8262e-08,-0.36285,-0.35395,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,2.6914e-06,-0.36337,-0.40608,1,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00049053,-0.36365,-0.29952,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00019229,-0.36387,-0.28869,1,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,6.6717e-09,-0.36411,-0.35706,1,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0035605,-0.3644,-0.32041,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00043435,-0.36469,-0.36039,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.6162e-06,-0.36628,-0.38357,1,0
3,GO LYSINE METABOLIC PROCESS,1.5576e-05,-0.36632,-0.32228,1,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.1041e-08,-0.36685,-0.34365,1,0
3,GO RETINAL METABOLIC PROCESS,0.0066851,-0.36809,-0.25231,1,0
3,GO REGULATION OF PLATELET AGGREGATION,5.0323e-06,-0.3681,-0.41901,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00039018,-0.37079,-0.24126,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.8814e-05,-0.37576,-0.38334,1,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00052901,-0.37591,-0.31637,1,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0028872,-0.37653,-0.38257,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0010558,-0.37778,-0.33106,1,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0017517,-0.37824,-0.41056,1,0
3,GO BILE ACID AND BILE SALT TRANSPORT,2.342e-06,-0.3783,-0.34058,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.8052e-07,-0.37924,-0.37978,1,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,3.2146e-06,-0.37991,-0.33263,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.5052e-06,-0.38147,-0.36789,1,0
3,GO PROGESTERONE METABOLIC PROCESS,1.4454e-06,-0.38205,-0.4617,1,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00011218,-0.38349,-0.26407,1,0
3,GO RESPONSE TO INTERFERON ALPHA,3.094e-05,-0.38355,-0.42956,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,1.0554e-07,-0.38489,-0.35777,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00029052,-0.38699,-0.2772,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,9.7998e-07,-0.38747,-0.32567,1,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00010497,-0.38857,-0.35338,1,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,1.2441e-09,-0.38905,-0.33224,1,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0018764,-0.38951,-0.30567,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0001803,-0.39089,-0.46374,1,0
3,GO REFLEX,8.0256e-05,-0.39229,-0.34529,1,0
3,GO REGULATION OF TRANSPOSITION,1.2032e-06,-0.39345,-0.38853,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.0881e-08,-0.3937,-0.47682,1,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.00049802,-0.39482,-0.33274,1,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,2.4861e-06,-0.39635,-0.40745,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00028155,-0.39746,-0.44615,1,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.1086e-06,-0.40002,-0.36132,1,0
3,GO REGULATION OF RECEPTOR CLUSTERING,5.5127e-05,-0.40378,-0.36525,1,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,2.6981e-08,-0.40607,-0.34034,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,2.8305e-05,-0.40699,-0.34576,1,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,4.1456e-06,-0.40844,-0.37477,1,0
3,GO REGULATION OF ANOIKIS,2.4586e-08,-0.40844,-0.41293,1,0
3,GO PITUITARY GLAND DEVELOPMENT,3.2146e-06,-0.40928,-0.36237,1,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,1.6994e-06,-0.41292,-0.41341,1,0
3,GO RESPONSE TO FORSKOLIN,2.9859e-05,-0.4141,-0.31445,1,0
3,GO POSITIVE REGULATION OF CELL MATURATION,4.1815e-08,-0.41612,-0.40077,1,0
3,GO MEGAKARYOCYTE DEVELOPMENT,1.0424e-06,-0.41617,-0.35476,1,0
3,GO RESPONSE TO INTERLEUKIN 18,3.9872e-06,-0.41989,-0.43427,1,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00039018,-0.42131,-0.30369,1,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,1.6994e-06,-0.42215,-0.3752,1,0
3,GO REGULATION OF TOLERANCE INDUCTION,8.4415e-08,-0.42237,-0.43284,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,7.2129e-08,-0.42382,-0.44501,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.4967e-09,-0.42432,-0.38178,1,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,7.6792e-10,-0.42496,-0.39797,1,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.7071e-05,-0.43336,-0.37309,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.5674e-06,-0.43403,-0.40283,1,0
3,GO RESPONSE TO TYPE I INTERFERON,1.2534e-06,-0.43565,-0.45133,1,0
3,GO KERATINOCYTE DIFFERENTIATION,2.1595e-09,-0.43809,-0.40556,1,0
3,GO POSITIVE REGULATION OF WOUND HEALING,7.1726e-09,-0.43895,-0.4065,1,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00023667,-0.4406,-0.3458,1,0
3,GO EPIDERMAL CELL DIFFERENTIATION,5.9116e-09,-0.44073,-0.37308,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00011596,-0.44088,-0.41139,1,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,1.996e-06,-0.44135,-0.41592,1,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.0343e-10,-0.44342,-0.45216,1,0
3,GO MIDBODY ABSCISSION,4.1948e-11,-0.44451,-0.41517,1,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,4.1403e-10,-0.44506,-0.43168,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.4076e-07,-0.44648,-0.49131,1,0
3,GO NEURON FATE SPECIFICATION,3.2057e-05,-0.44932,-0.34704,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,2.4837e-07,-0.45856,-0.49488,1,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0031247,-0.46094,-0.33652,1,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,1.0212e-06,-0.46235,-0.39978,1,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,1.1794e-07,-0.46443,-0.4139,1,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.8198e-07,-0.46496,-0.4434,1,0
3,GO RESPONSE TO LITHIUM ION,5.1356e-08,-0.46597,-0.42671,1,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.00024819,-0.46602,-0.33054,1,0
3,GO MUCUS SECRETION,0.00017176,-0.46675,-0.4219,1,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.8142e-08,-0.46702,-0.41423,1,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,5.9116e-09,-0.47171,-0.51373,1,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.4787e-08,-0.4742,-0.46674,1,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,1.2759e-09,-0.4779,-0.43752,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.6321e-06,-0.48054,-0.44526,1,0
3,GO LEYDIG CELL DIFFERENTIATION,3.2146e-06,-0.48494,-0.44315,1,0
3,GO APICAL JUNCTION ASSEMBLY,1.4107e-10,-0.4861,-0.44697,1,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.0156e-07,-0.487,-0.41063,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.8701e-05,-0.50021,-0.34861,1,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,2.2775e-07,-0.50289,-0.37888,1,0
3,GO NEGATIVE REGULATION OF ANOIKIS,4.7501e-09,-0.50749,-0.5596,1,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,1.3174e-07,-0.51317,-0.399,1,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,1.439e-07,-0.51579,-0.48134,1,0
3,GO KERATINOCYTE DEVELOPMENT,0.00028155,-0.51868,-0.37952,1,0
3,GO LUNG CELL DIFFERENTIATION,2.2397e-08,-0.52764,-0.52974,1,0
3,GO GLIAL CELL FATE COMMITMENT,1.5293e-05,-0.5281,-0.47829,1,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,5.5412e-06,-0.53688,-0.44317,1,0
3,GO CARDIAC CELL FATE COMMITMENT,3.5038e-07,-0.5398,-0.46453,1,0
3,GO KERATINIZATION,1.3999e-08,-0.54062,-0.47197,1,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.3774e-08,-0.54171,-0.46474,1,0
3,GO PSEUDOPODIUM ORGANIZATION,1.3056e-06,-0.54946,-0.44111,1,0
3,GO GAMMA DELTA T CELL ACTIVATION,9.028e-08,-0.55023,-0.44113,1,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,2.856e-06,-0.57272,-0.53835,1,0
3,GO EPITHELIAL CELL CELL ADHESION,6.0979e-10,-0.57402,-0.62321,1,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.5753e-08,-0.58399,-0.51053,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,6.2169e-06,-0.58914,-0.6067,1,0
3,GO CORNIFICATION,3.1729e-08,-0.58971,-0.5227,1,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,3.1004e-08,-0.61562,-0.57253,1,0
3,GO REGULATION OF WATER LOSS VIA SKIN,3.9941e-08,-0.61696,-0.54169,1,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,4.0868e-08,-0.63258,-0.56279,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,2.8262e-08,-0.63303,-0.55508,1,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,5.2253e-10,-0.63697,-0.59894,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.9069e-08,-0.63714,-0.54638,1,0
3,GO EPITHELIAL CELL MORPHOGENESIS,8.9047e-09,-0.63848,-0.56418,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.7687e-09,-0.67222,-0.66597,1,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,1.9926e-08,-0.72296,-0.58453,1,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,5.4967e-09,-0.74822,-0.65984,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,1.9905e-10,-0.77526,-0.68103,1,0
3,GO NOSE DEVELOPMENT,1.3056e-06,-0.82284,-0.5728,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.734e-06,-0.84583,-0.7935,1,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,1.5968e-11,-0.85308,-0.89935,1,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,4.9624e-10,-0.86067,-0.74346,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,1.7693e-06,-1.0174,-0.94576,1,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,5.7923e-10,-1.0261,-0.89395,1,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.068619,0.33331,0.22525,0,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.12126,0.22799,0.17187,0,1
3,GO FACIAL NERVE MORPHOGENESIS,0.093918,0.22194,0.16344,0,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.086981,0.20191,0.108,0,1
3,GO PROTEIN OXIDATION,0.090011,0.19614,0.1153,0,1
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.077698,0.17807,0.1601,0,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.079765,0.17699,0.13451,0,1
3,GO MIDGUT DEVELOPMENT,0.28033,0.17077,0.077277,0,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.089246,0.1695,0.10597,0,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.10214,0.16652,0.11182,0,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.15921,0.16565,0.080469,0,1
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.09796,0.16059,0.17175,0,1
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.45727,0.15901,0.071982,0,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.090782,0.15501,0.14058,0,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.13549,0.14963,0.057564,0,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.26614,0.14593,0.086896,0,1
3,GO GLIAL CELL MIGRATION,0.064418,0.14068,0.10909,0,1
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.14088,0.14036,0.11094,0,1
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.11933,0.13825,0.099339,0,1
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.22814,0.1373,0.10834,0,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.34627,0.13488,0.086203,0,1
3,GO MEMBRANE DISASSEMBLY,0.11742,0.12918,0.082659,0,1
3,GO CARTILAGE MORPHOGENESIS,0.16285,0.12912,0.11863,0,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12721,0.12845,0.13041,0,1
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.11002,0.12167,0.11116,0,1
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.18062,0.1198,0.094514,0,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.1313,0.11801,0.10745,0,1
3,GO POST ANAL TAIL MORPHOGENESIS,0.15802,0.11742,0.092205,0,1
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.14308,0.11217,0.061865,0,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.070488,0.11019,0.12498,0,1
3,GO L SERINE METABOLIC PROCESS,0.081877,0.10917,0.15464,0,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.12029,0.10913,0.098075,0,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.075009,0.10889,0.077022,0,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.090782,0.10469,0.1212,0,1
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.4355,0.10006,0.043291,0,1
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.18866,0.099865,0.069107,0,1
3,GO CARDIAC MUSCLE CONTRACTION,0.093918,0.096832,0.079619,0,1
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.22348,0.096503,0.068905,0,1
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.093918,0.094639,0.07107,0,1
3,GO NADPH REGENERATION,0.61117,0.093897,0.028299,0,1
3,GO RENAL VESICLE DEVELOPMENT,0.12421,0.093138,0.11248,0,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.28033,0.092322,0.041975,0,1
3,GO NEUROBLAST DIVISION,0.075009,0.092005,0.15184,0,1
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.096327,0.091804,0.093436,0,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.11837,0.089564,0.068948,0,1
3,GO TOOTH MINERALIZATION,0.15921,0.089134,0.10358,0,1
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.13444,0.089029,0.078895,0,1
3,GO MUSCLE FILAMENT SLIDING,0.25078,0.088855,0.064428,0,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.13027,0.083393,0.078293,0,1
3,GO ACETYL COA METABOLIC PROCESS,0.12822,0.083223,0.085426,0,1
3,GO REGULATION OF CELL CYCLE ARREST,0.076344,0.082876,0.046291,0,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.19838,0.079665,0.053858,0,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.29689,0.079475,0.064369,0,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.86649,0.078258,0.024103,0,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.58029,0.077971,-0.010173,0,1
3,GO FEAR RESPONSE,0.46962,0.077915,0.018129,0,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.48468,0.07712,0.045066,0,1
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.20845,0.075513,0.063011,0,1
3,GO PROTEIN KINASE A SIGNALING,0.68392,0.074581,0.012794,0,1
3,GO REGULATION OF SYSTEM PROCESS,0.090782,0.071823,0.071565,0,1
3,GO BLASTOCYST FORMATION,0.10558,0.070922,0.044327,0,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.44028,0.069661,0.04388,0,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.071119,0.069455,0.059956,0,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.079071,0.06942,0.070405,0,1
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.19417,0.067906,0.047131,0,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.1252,0.067261,0.049628,0,1
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.090011,0.06664,0.10776,0,1
3,GO RENAL SODIUM EXCRETION,0.13656,0.064136,0.059902,0,1
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.10912,0.063286,0.04774,0,1
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.14983,0.062602,0.07963,0,1
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.16163,0.062263,0.059368,0,1
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.11275,0.061099,0.047535,0,1
3,GO REGULATION OF EXCRETION,0.096327,0.060804,0.08895,0,1
3,GO PEPTIDYL ARGININE MODIFICATION,0.074349,0.060461,0.072826,0,1
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.063258,0.060365,0.083236,0,1
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.22503,0.060274,0.054247,0,1
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.19838,0.058703,0.079582,0,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.093918,0.057684,0.047897,0,1
3,GO HYPOTONIC RESPONSE,0.073043,0.057039,0.1088,0,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.42133,0.055636,0.024564,0,1
3,GO GMP METABOLIC PROCESS,0.34008,0.054694,0.062632,0,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.12924,0.053944,0.080554,0,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.096327,0.053332,0.077729,0,1
3,GO ELECTRON TRANSPORT CHAIN,0.18062,0.05325,0.045657,0,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.094715,0.053019,0.054274,0,1
3,GO APOPTOTIC DNA FRAGMENTATION,0.1754,0.052516,0.042397,0,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.27317,0.049295,0.032245,0,1
3,GO HISTONE H3 K36 METHYLATION,0.91451,0.049069,-0.0038586,0,1
3,GO CELLULAR RESPONSE TO ATP,0.11837,0.048956,0.071997,0,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.16778,0.048562,0.050556,0,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.10129,0.04772,0.13942,0,1
3,GO RESPONSE TO ATP,0.16163,0.046819,0.054923,0,1
3,GO CELL GROWTH,0.45238,0.045082,0.034266,0,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.13027,0.044726,0.075866,0,1
3,GO ZINC ION HOMEOSTASIS,0.66616,0.039478,-0.039902,0,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.18595,0.037494,0.043418,0,1
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.68988,0.034565,0.016243,0,1
3,GO RESPONSE TO CAMP,0.1252,0.034057,0.071824,0,1
3,GO NCRNA CATABOLIC PROCESS,0.31604,0.032361,0.049554,0,1
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.41666,0.023697,0.024992,0,1
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.086981,0.20924,0.11818,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.10646,0.177,0.10891,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.1453,0.17312,0.11595,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.21587,0.15827,0.081951,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.12224,0.15637,0.11257,0,0
3,GO THALAMUS DEVELOPMENT,0.42838,0.15409,0.059469,0,0
3,GO LIMB BUD FORMATION,0.14755,0.1537,0.16981,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.19557,0.1501,0.091962,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.082591,0.14593,0.204,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.20122,0.14582,0.12543,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.086237,0.1448,0.11554,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.070488,0.14346,0.12516,0,0
3,GO REGULATION OF HIPPO SIGNALING,0.13338,0.14047,0.13393,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.10299,0.14002,0.13443,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.30255,0.13733,0.086215,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.066192,0.13688,0.17009,0,0
3,GO RESPONSE TO POTASSIUM ION,0.20845,0.1345,0.093337,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.065596,0.13389,0.096417,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.081168,0.13179,0.10756,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.079071,0.12985,0.15504,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.11002,0.12558,0.12138,0,0
3,GO FIBRINOLYSIS,0.35886,0.1251,0.016761,0,0
3,GO RECEPTOR CLUSTERING,0.081168,0.12265,0.13704,0,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.10646,0.12119,0.089388,0,0
3,GO DENDRITE SELF AVOIDANCE,0.095518,0.12091,0.12902,0,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.079071,0.11847,0.090192,0,0
3,GO PROSTAGLANDIN SECRETION,0.10045,0.1175,0.077172,0,0
3,GO DOPAMINE TRANSPORT,0.18866,0.11675,0.13595,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.10823,0.11608,0.16168,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.11742,0.11563,0.12761,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.44269,0.11557,0.049688,0,0
3,GO CATECHOLAMINE UPTAKE,0.090011,0.11465,0.13966,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.11647,0.11354,0.091047,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.23927,0.11149,0.070999,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.082591,0.11133,0.11652,0,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.079765,0.11102,0.12924,0,0
3,GO SEQUESTERING OF METAL ION,0.21738,0.11066,0.037998,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.22658,0.10941,0.065556,0,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.086237,0.10933,0.10058,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.15214,0.10737,0.090052,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.08331,0.10736,0.12685,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.1453,0.10538,0.095137,0,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.079765,0.10529,0.096252,0,0
3,GO MATING BEHAVIOR,0.08331,0.10525,0.097743,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.095518,0.10489,0.097363,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.071756,0.10411,0.09815,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.066792,0.10373,0.10052,0,0
3,GO GROOMING BEHAVIOR,0.077018,0.10368,0.095636,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.090782,0.10316,0.076278,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.19417,0.10265,0.094655,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.46962,0.10195,0.048999,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.42838,0.10173,0.064205,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.16654,0.10144,0.090986,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.10471,0.10063,0.19783,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.12421,0.10044,0.095158,0,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.31409,0.098525,0.039998,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.088486,0.098471,0.086754,0,0
3,GO ALANINE TRANSPORT,0.1533,0.09802,0.14119,0,0
3,GO NEURON MIGRATION,0.079071,0.097778,0.11224,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.4451,0.097264,0.088298,0,0
3,GO REPLICATION FORK PROCESSING,0.26267,0.096981,0.059179,0,0
3,GO REPRODUCTIVE BEHAVIOR,0.22658,0.096724,0.07333,0,0
3,GO NEURON CELL CELL ADHESION,0.71391,0.096033,0.070636,0,0
3,GO PROTEIN DEMETHYLATION,0.23605,0.095705,0.063369,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.4451,0.095091,0.06592,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.16778,0.09462,0.090044,0,0
3,GO LEUKOCYTE AGGREGATION,0.52345,0.092434,0.021863,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.10129,0.092411,0.094552,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.34008,0.092325,0.081845,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.36526,0.092281,0.10833,0,0
3,GO ACTION POTENTIAL,0.091558,0.090532,0.083371,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.24252,0.089957,0.069038,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.13338,0.08987,0.082256,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.67798,0.089258,0.028981,0,0
3,GO BASIC AMINO ACID TRANSPORT,0.56103,0.088959,0.074141,0,0
3,GO MRNA SPLICE SITE SELECTION,0.1914,0.087638,0.064631,0,0
3,GO NOREPINEPHRINE SECRETION,0.11553,0.087281,0.098312,0,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.27317,0.085555,0.052629,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.48976,0.085443,0.076403,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.81267,0.085328,0.019117,0,0
3,GO ENAMEL MINERALIZATION,0.55016,0.085145,0.059622,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.11183,0.08493,0.075752,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.23286,0.084589,0.088755,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.089246,0.083951,0.10866,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16904,0.083628,0.084727,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.49743,0.083539,0.042488,0,0
3,GO AORTA DEVELOPMENT,0.31997,0.083326,0.069153,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.31021,0.083138,0.060981,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.30255,0.082898,0.059854,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.178,0.082535,0.084845,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.21437,0.08126,0.061076,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.1146,0.080834,0.15311,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.27495,0.08065,0.077167,0,0
3,GO REGULATION OF ACROSOME REACTION,0.39606,0.080468,0.057839,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.1754,0.08038,0.093958,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.19979,0.080376,0.0819,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.68988,0.07996,0.019002,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.09714,0.079952,0.12381,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.38047,0.079918,0.091573,0,0
3,GO MEMBRANE DEPOLARIZATION,0.11092,0.079859,0.088729,0,0
3,GO STARTLE RESPONSE,0.17283,0.079188,0.11113,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.10385,0.079094,0.10162,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.30637,0.079019,0.051848,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.13656,0.078824,0.098136,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.54208,0.078027,0.030882,0,0
3,GO SNRNA PROCESSING,0.20265,0.07777,0.025679,0,0
3,GO REGULATION OF HEART RATE,0.21288,0.077091,0.062588,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.18327,0.076744,0.10729,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.15802,0.075883,0.11263,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.40743,0.075814,0.040695,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.26964,0.07578,0.049738,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.56925,0.075306,0.035886,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.16163,0.075247,0.084744,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.55287,0.07522,0.065046,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.14308,0.075174,0.10369,0,0
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.075674,0.075025,0.071346,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.90488,0.074924,0.0089894,0,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.081877,0.074478,0.12251,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.062684,0.073607,0.075901,0,0
3,GO NEURAL CREST CELL MIGRATION,0.080464,0.073363,0.12491,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE,0.068006,0.073314,0.070465,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.25078,0.073129,0.029541,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.16904,0.073125,0.081741,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.1653,0.073098,0.1203,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.19003,0.072887,0.077892,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.23766,0.072765,0.069765,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.21587,0.072424,0.053065,0,0
3,GO XENOBIOTIC TRANSPORT,0.30637,0.072306,0.056946,0,0
3,GO LIVER REGENERATION,0.079071,0.072155,0.07691,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.14419,0.072069,0.11114,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.38488,0.071898,0.029523,0,0
3,GO ENDODERM FORMATION,0.44752,0.071556,0.042241,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.69885,0.071338,-0.00074605,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.32792,0.071142,0.060049,0,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.29877,0.071101,0.066751,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.093126,0.071047,0.069538,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.24416,0.070964,0.10362,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.29877,0.070742,0.04163,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.22195,0.070017,0.077249,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.2714,0.069922,0.057528,0,0
3,GO BONE MORPHOGENESIS,0.55558,0.069823,0.028488,0,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.10734,0.06965,0.077825,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.1252,0.069306,0.066755,0,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.15098,0.069176,0.043587,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.068006,0.069166,0.098141,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.61117,0.069157,0.017281,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.18595,0.069036,0.068651,0,0
3,GO MATING,0.25753,0.068799,0.042923,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.41203,0.068362,0.034574,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.61972,0.068263,0.040717,0,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.19278,0.067939,0.093077,0,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.12126,0.067798,0.093481,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.19278,0.067686,0.073373,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.16042,0.067431,0.085348,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.27673,0.067033,0.072532,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.1653,0.066766,0.1385,0,0
3,GO COPPER ION HOMEOSTASIS,0.318,0.066696,0.054913,0,0
3,GO COCHLEA MORPHOGENESIS,0.30829,0.066664,0.058917,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.068006,0.066579,0.12092,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.58307,0.066465,0.032013,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.11092,0.066313,0.065544,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.22814,0.066123,0.055117,0,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.2714,0.065917,0.050507,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.062684,0.065882,0.12008,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.16407,0.065808,0.096827,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.13338,0.065625,0.080024,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.09714,0.065567,0.075836,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.086981,0.065554,0.090059,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.94993,0.065182,-0.016273,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.12924,0.065164,0.070872,0,0
3,GO ACROSOME REACTION,0.38933,0.064762,0.042794,0,0
3,GO LOCOMOTORY BEHAVIOR,0.062684,0.064549,0.10122,0,0
3,GO NUCLEUS LOCALIZATION,0.18866,0.064518,0.078535,0,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.15683,0.064175,0.061634,0,0
3,GO RESPONSE TO LEAD ION,0.12421,0.064106,0.076575,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.46218,0.064086,0.057141,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.12224,0.063748,0.12767,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.24745,0.063702,0.053294,0,0
3,GO NEURON MATURATION,0.072397,0.063614,0.11823,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.21437,0.063429,0.062893,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.12421,0.063247,0.072732,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.29877,0.063169,0.081406,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.60268,0.062837,0.047195,0,0
3,GO NUCLEAR PORE ORGANIZATION,0.1146,0.062771,0.087577,0,0
3,GO RESPONSE TO COCAINE,0.29877,0.0624,0.064787,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.43789,0.062378,0.037437,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.071756,0.062155,0.060307,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.20845,0.062053,0.065948,0,0
3,GO NEURON DIFFERENTIATION,0.093918,0.06189,0.071191,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.75664,0.061887,0.02138,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.20699,0.061885,0.057975,0,0
3,GO COENZYME A METABOLIC PROCESS,0.075674,0.061663,0.08436,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.12224,0.0614,0.074143,0,0
3,GO TELENCEPHALON REGIONALIZATION,0.49231,0.061294,0.065179,0,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.21587,0.060862,0.052538,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.17411,0.060464,0.070777,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.3871,0.060409,0.063572,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.41899,0.060218,0.050236,0,0
3,GO REGULATION OF MRNA PROCESSING,0.077698,0.060197,0.060866,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.078382,0.060175,0.086935,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.16285,0.060116,0.094895,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.16654,0.060085,0.046593,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.14983,0.060044,0.10531,0,0
3,GO HEART PROCESS,0.10214,0.059905,0.068989,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.22042,0.059824,0.11107,0,0
3,GO SODIUM ION TRANSPORT,0.31409,0.059548,0.041909,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.28945,0.059475,0.066263,0,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.18866,0.059225,0.057823,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.2458,0.058972,0.0425,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.51557,0.058871,0.048645,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.31997,0.05875,0.058597,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.28578,0.05866,0.068417,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.62258,0.058581,0.035128,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.26267,0.058514,0.039369,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.19979,0.05844,0.050789,0,0
3,GO MRNA PROCESSING,0.067397,0.05835,0.058904,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.5,0.058264,0.052417,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.178,0.05825,0.086354,0,0
3,GO CELL AGGREGATION,0.23445,0.058194,0.056512,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.51819,0.058072,0.043793,0,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.072397,0.058015,0.07766,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.25924,0.057645,0.081083,0,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.1313,0.057546,0.078792,0,0
3,GO HEME METABOLIC PROCESS,0.14419,0.057432,0.09235,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.14755,0.057353,0.067654,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.31409,0.057101,0.086754,0,0
3,GO DNA REPLICATION CHECKPOINT,0.41899,0.057091,0.039674,0,0
3,GO RRNA 3 END PROCESSING,0.26614,0.057078,0.056168,0,0
3,GO METAL ION TRANSPORT,0.093126,0.056979,0.058619,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.99515,0.056952,0.0061896,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.2644,0.056769,0.055575,0,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.21889,0.056512,0.094525,0,0
3,GO RESPONSE TO MANGANESE ION,0.55016,0.056497,0.024259,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.24745,0.05638,0.078874,0,0
3,GO RRNA CATABOLIC PROCESS,0.40973,0.056222,0.049488,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.13027,0.056157,0.08462,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.15447,0.056004,0.1079,0,0
3,GO OXIDATIVE DEMETHYLATION,0.12029,0.055567,0.057428,0,0
3,GO CATION TRANSPORT,0.14755,0.055032,0.054786,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.19979,0.05483,0.055555,0,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.093918,0.054669,0.071707,0,0
3,GO MICROTUBULE ANCHORING,0.85059,0.054572,0.0027578,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.1653,0.054341,0.083957,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.77209,0.054022,0.034765,0,0
3,GO ORGANIC CATION TRANSPORT,0.19003,0.053815,0.06549,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.079765,0.053748,0.078505,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.32393,0.053609,0.075308,0,0
3,GO ZINC ION TRANSPORT,0.31997,0.053534,0.047696,0,0
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.063258,0.053482,0.087902,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.43789,0.053309,0.049302,0,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.18461,0.053255,0.079608,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.35886,0.053212,0.054228,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.11933,0.053154,0.093399,0,0
3,GO RESPONSE TO CALCIUM ION,0.19003,0.053082,0.064407,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.1146,0.053018,0.070541,0,0
3,GO RNA STABILIZATION,0.36741,0.052981,0.031402,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.081877,0.052704,0.061118,0,0
3,GO CELL CYCLE DNA REPLICATION,0.57476,0.052383,0.019258,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.29689,0.052223,0.05079,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.10646,0.052053,0.051472,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.58585,0.052015,0.024169,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.12029,0.051994,0.049863,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.16042,0.05194,0.078994,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.89526,0.051842,0.0041159,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.5314,0.051799,0.04691,0,0
3,GO NEUROGENESIS,0.2114,0.051728,0.053063,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.11837,0.051689,0.078241,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.10129,0.051587,0.060119,0,0
3,GO VITAMIN TRANSPORT,0.10045,0.051201,0.11665,0,0
3,GO REGULATION OF EXOCYTOSIS,0.33396,0.051058,0.049261,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.178,0.050985,0.080356,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.5583,0.050863,0.02213,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.84424,0.050826,-0.0069395,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.23766,0.050372,0.0571,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.40286,0.050334,0.040271,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.10734,0.050044,0.096236,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.14869,0.050014,0.077271,0,0
3,GO TRNA TRANSPORT,0.076344,0.049912,0.093515,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.12721,0.049896,0.066656,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.1793,0.049513,0.047833,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.87926,0.049406,-0.017053,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.2458,0.049331,0.057657,0,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.13338,0.049193,0.10317,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.43075,0.049192,0.06702,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.55287,0.049115,0.036666,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.42367,0.049036,0.064303,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.1533,0.049001,0.086189,0,0
3,GO MONOAMINE TRANSPORT,0.39381,0.048887,0.096032,0,0
3,GO REGULATION OF ION TRANSPORT,0.10299,0.048726,0.065693,0,0
3,GO PHOSPHATE ION TRANSPORT,0.13234,0.048639,0.055757,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.27853,0.048471,0.061804,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.40058,0.04835,0.040332,0,0
3,GO CAMP METABOLIC PROCESS,0.33599,0.048303,0.065096,0,0
3,GO NERVOUS SYSTEM PROCESS,0.20554,0.048276,0.048224,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.88885,0.048269,-0.004849,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.18595,0.048211,0.058855,0,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.1262,0.048194,0.069413,0,0
3,GO TOXIN TRANSPORT,0.36098,0.048121,0.046398,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.44028,0.048069,0.032592,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.34008,0.048068,0.041377,0,0
3,GO RESPONSE TO SALT,0.30637,0.048068,0.044606,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.22348,0.04763,0.050953,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.75664,0.047585,0.022936,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.17029,0.04754,0.049771,0,0
3,GO RESPONSE TO LEUCINE,0.91772,0.046975,0.016074,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.32792,0.04691,0.058762,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.28578,0.04673,0.050513,0,0
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.59705,0.046156,0.026205,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.74741,0.046148,-0.0095231,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.56376,0.046129,0.026345,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.22195,0.046121,0.058878,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.48468,0.046045,0.042347,0,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.51035,0.045829,0.023456,0,0
3,GO RNA LOCALIZATION,0.082591,0.045808,0.069009,0,0
3,GO POSITIVE REGULATION OF HEART RATE,0.90809,0.045764,0.016478,0,0
3,GO WATER TRANSPORT,0.82842,0.045648,0.00085836,0,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.088486,0.045422,0.070832,0,0
3,GO RNA SPLICING,0.10734,0.045172,0.052885,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.28033,0.045166,0.082426,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.55558,0.045137,0.040494,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.47963,0.045081,0.068492,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.44028,0.045013,0.06167,0,0
3,GO MRNA 3 END PROCESSING,0.12721,0.044964,0.050513,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.64276,0.04449,0.031741,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.94348,0.044337,-0.0033676,0,0
3,GO CELL JUNCTION ORGANIZATION,0.64858,0.044211,0.028493,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.18327,0.044157,0.043034,0,0
3,GO PROTEIN PALMITOYLATION,0.9306,0.044072,0.012413,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.79387,0.043913,0.0040996,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.63697,0.043675,0.013322,0,0
3,GO VAGINA DEVELOPMENT,0.34008,0.0434,0.089122,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.61117,0.043325,-0.022809,0,0
3,GO EXCRETION,0.066192,0.043138,0.080961,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.13338,0.042873,0.13334,0,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.48722,0.042682,0.058801,0,0
3,GO PALLIUM DEVELOPMENT,0.20409,0.042657,0.062704,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.2458,0.042534,0.05947,0,0
3,GO PLASMINOGEN ACTIVATION,0.6312,0.042513,0.013172,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.58864,0.042486,0.044362,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.1262,0.042174,0.095029,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.27853,0.042111,0.075831,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.19278,0.042044,0.063342,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.96607,0.042029,0.016968,0,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.1653,0.041756,0.057953,0,0
3,GO LACTATION,0.15098,0.041647,0.090574,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.69286,0.041628,-0.035623,0,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.23766,0.041575,0.087669,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.43075,0.041514,0.027136,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.28033,0.041317,0.052382,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.18194,0.041285,0.071736,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.33803,0.041276,0.053107,0,0
3,GO TELOMERE ORGANIZATION,0.23927,0.04126,0.040167,0,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.74741,0.041245,0.022369,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.15565,0.041124,0.063262,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.51819,0.04101,0.060888,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.20409,0.040925,0.082702,0,0
3,GO VESICLE DOCKING,0.67501,0.040924,0.03254,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.10912,0.040877,0.064306,0,0
3,GO AMYLOID BETA FORMATION,0.57752,0.040716,0.04738,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.47712,0.040522,0.044302,0,0
3,GO PROTEIN FOLDING,0.12822,0.040401,0.053778,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.12322,0.040385,0.036651,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.84107,0.04037,-0.012847,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.93704,0.040211,-0.033877,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.36526,0.040135,0.065518,0,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.10823,0.040082,0.058948,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.7659,0.039995,0.020655,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.39832,0.039952,0.041228,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.23927,0.03991,0.065543,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27673,0.039793,0.087942,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.6691,0.039738,0.036317,0,0
3,GO MITOCHONDRIAL FISSION,0.59424,0.039719,0.045733,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.19557,0.039489,0.049868,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.58307,0.039334,0.029426,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.36956,0.039305,0.057453,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.49743,0.039286,0.027946,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.19417,0.039164,0.070344,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.46466,0.039025,0.047242,0,0
3,GO SNRNA METABOLIC PROCESS,0.68094,0.038946,0.010037,0,0
3,GO BICARBONATE TRANSPORT,0.28945,0.038943,0.039442,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.55016,0.03875,0.028093,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.32792,0.038746,0.0464,0,0
3,GO ENDODERM DEVELOPMENT,0.96607,0.038371,-0.00064568,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.61687,0.038316,0.038166,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.098784,0.03789,0.065519,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.2644,0.037768,0.047396,0,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.1262,0.037616,0.05892,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.39832,0.037444,0.039649,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.28395,0.037387,0.11322,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.22042,0.037383,0.051055,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.69586,0.037347,-0.027962,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.20845,0.037322,0.062311,0,0
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.36311,0.037266,0.030534,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.34835,0.037246,0.043736,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.29315,0.037153,0.087847,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.99838,0.037092,0.006773,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.45482,0.037076,0.053336,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.39606,0.03697,0.04165,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.81267,0.036913,0.028893,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.46218,0.036702,0.049755,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.72603,0.036578,0.029519,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.64858,0.036565,-0.025664,0,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.10299,0.036492,0.11231,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.68689,0.036453,0.026141,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.12924,0.036366,0.046244,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.23605,0.03623,0.050709,0,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.1914,0.036221,0.11016,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.19278,0.036141,0.10336,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.35886,0.036072,0.054015,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.08331,0.035824,0.081982,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.5394,0.035718,0.025512,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.80012,0.035657,0.0035675,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.72603,0.035476,0.031799,0,0
3,GO FUCOSYLATION,0.52874,0.035376,-0.03356,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.21288,0.034891,0.090468,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.37173,0.034825,0.043907,0,0
3,GO DE NOVO PROTEIN FOLDING,0.74128,0.034737,0.04109,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.1262,0.034726,0.066828,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.86331,0.034654,0.013668,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.93382,0.034625,0.0054935,0,0
3,GO CELLULAR RESPONSE TO UV,0.6312,0.034365,0.022385,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.63697,0.034361,0.025368,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.87606,0.034259,0.036975,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.64858,0.034252,0.012472,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.72299,0.034242,0.027253,0,0
3,GO DEVELOPMENTAL GROWTH,0.59424,0.034221,0.027459,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.23286,0.034009,0.051211,0,0
3,GO MRNA CLEAVAGE,0.13027,0.033997,0.056313,0,0
3,GO NUCLEAR MIGRATION,0.40973,0.033936,0.056735,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.38047,0.0339,0.056599,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.50516,0.033786,0.056233,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.81896,0.033689,0.019309,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.62832,0.033651,0.047482,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.37173,0.033376,0.046575,0,0
3,GO CHOLESTEROL EFFLUX,0.8379,0.03302,0.0060415,0,0
3,GO NUCLEAR TRANSPORT,0.34627,0.032912,0.026534,0,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.22658,0.03286,0.089312,0,0
3,GO CHROMATIN SILENCING,0.73212,0.03284,0.020224,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.73822,0.032741,0.024976,0,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.32393,0.03273,0.041953,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.77209,0.032596,0.016617,0,0
3,GO RESPONSE TO HEAT,0.15098,0.03257,0.055512,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.11933,0.032281,0.087054,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.14197,0.03225,0.080819,0,0
3,GO DENDRITE EXTENSION,0.25246,0.032236,0.10251,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.81896,0.032158,0.018501,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.31215,0.032058,0.042418,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.24911,0.03202,0.072977,0,0
3,GO PROTEASOME ASSEMBLY,0.4355,0.032015,0.046707,0,0
3,GO CELL MORPHOGENESIS,0.30829,0.031902,0.048602,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.61972,0.031814,0.083971,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.75972,0.031706,0.007524,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.82526,0.031654,0.019094,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.797,0.031016,0.014337,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.31215,0.030983,0.1049,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.53406,0.030756,0.024975,0,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.85694,0.030753,0.014331,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.5314,0.030648,0.035119,0,0
3,GO RESPONSE TO AMPHETAMINE,0.55558,0.030627,0.025708,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.54477,0.030552,0.01787,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.68392,0.030549,-0.023809,0,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.30255,0.030433,0.034764,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.35463,0.030415,0.038139,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.28395,0.030288,0.060704,0,0
3,GO RNA INTERFERENCE,0.57752,0.030267,0.036209,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.45238,0.030137,0.029788,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.94671,0.030091,0.0084209,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.22658,0.029782,0.045419,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.32195,0.02971,0.037592,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.6691,0.029673,0.038408,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.13979,0.029542,0.070132,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.5,0.029381,0.047896,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.68094,0.029176,-0.02756,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.50776,0.029161,0.017335,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.84424,0.029138,0.023125,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.97899,0.029132,0.0081718,0,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.12126,0.029115,0.050603,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.52082,0.029024,0.038752,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.22042,0.028302,0.035996,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.25583,0.028246,0.12234,0,0
3,GO GLIAL CELL ACTIVATION,0.86649,0.028112,0.012031,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.94026,0.028031,-0.0004175,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.91772,0.028016,0.0054947,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.72603,0.027929,-0.033121,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.74741,0.027805,0.017824,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.94026,0.027749,-0.0033586,0,0
3,GO FOREBRAIN REGIONALIZATION,0.75664,0.027264,0.013031,0,0
3,GO PROTEIN STABILIZATION,0.75048,0.027228,0.02099,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.3739,0.026922,0.042822,0,0
3,GO MITOCHONDRION ORGANIZATION,0.21587,0.026769,0.037324,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.75048,0.026466,0.021487,0,0
3,GO HISTONE DEUBIQUITINATION,0.37608,0.026318,0.037588,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.58307,0.0263,0.017893,0,0
3,GO CHLORIDE TRANSPORT,0.33803,0.02626,0.037401,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.27317,0.025862,0.055464,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.72299,0.0258,-0.025711,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.74128,0.025787,0.023136,0,0
3,GO MRNA TRANSPORT,0.54746,0.025487,0.035317,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.16163,0.025473,0.053938,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.49487,0.025456,0.096838,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.16042,0.025424,0.043007,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.85376,0.025414,0.0090231,0,0
3,GO FUCOSE METABOLIC PROCESS,0.29689,0.02538,-0.074453,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.32393,0.025379,0.053784,0,0
3,GO RESPONSE TO GLUCAGON,0.59424,0.025335,0.042111,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.61687,0.025267,0.028241,0,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.68392,0.025189,0.0093746,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.79075,0.025166,0.11579,0,0
3,GO REGULATION OF RESPONSE TO FOOD,0.95961,0.025156,-0.01492,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.40514,0.025105,0.026441,0,0
3,GO TRNA 5 LEADER REMOVAL,0.31604,0.025042,0.066603,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.093918,0.025005,0.18535,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.27317,0.024896,0.06589,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.33803,0.024765,0.041374,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.35886,0.024751,0.044952,0,0
3,GO NUCLEAR EXPORT,0.37827,0.024729,0.031852,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.64567,0.024555,0.023068,0,0
3,GO BASE EXCISION REPAIR,0.27317,0.024538,0.041641,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.33599,0.024525,0.039999,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.94993,0.024518,0.012298,0,0
3,GO PROTEIN REFOLDING,0.86331,0.024317,0.01743,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.31021,0.024298,0.048806,0,0
3,GO INTRACELLULAR LIPID TRANSPORT,0.74435,0.024121,0.032811,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.35043,0.024069,0.028283,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.10045,0.023871,0.063512,0,0
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.28578,0.023821,0.057783,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.76899,0.023782,-0.02045,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.61117,0.023681,0.014725,0,0
3,GO AMINO ACID ACTIVATION,0.084034,0.023635,0.11027,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.92416,0.023634,0.011948,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.58585,0.023596,0.073366,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.38047,0.023491,0.053818,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.71996,0.023379,0.045992,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.1653,0.023356,0.16331,0,0
3,GO RNA EXPORT FROM NUCLEUS,0.26964,0.02326,0.053635,0,0
3,GO MUSCLE CONTRACTION,0.29315,0.023161,0.046781,0,0
3,GO TORC1 SIGNALING,0.40973,0.023094,0.042917,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.75048,0.02285,-0.064497,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.19979,0.022685,0.047682,0,0
3,GO ION TRANSPORT,0.34008,0.022588,0.035755,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.72603,0.022563,0.024939,0,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.56925,0.022518,0.032977,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.94026,0.022518,0.0075861,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.85376,0.022504,0.032893,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.2458,0.022491,0.049568,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.85376,0.022475,-0.01679,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.94026,0.022323,-0.0056498,0,0
3,GO NEUROBLAST PROLIFERATION,0.56376,0.022142,0.031233,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.59986,0.022134,0.030815,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.87926,0.022125,-0.014058,0,0
3,GO CHROMATIN DISASSEMBLY,0.50258,0.022032,0.071396,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.25246,0.022,0.060645,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.23766,0.021964,0.061945,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.70185,0.021919,0.038755,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.39156,0.021912,0.045712,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.42602,0.021663,0.068987,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.78763,0.021579,0.010933,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.87287,0.021566,-0.0052523,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.27317,0.021522,0.10899,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.88885,0.021413,0.0028084,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.1754,0.021276,0.096848,0,0
3,GO CHROMOSOME CONDENSATION,0.8379,0.021235,-0.0095722,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.94993,0.021121,0.0088315,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.51819,0.021079,0.027065,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.5394,0.021069,-0.027996,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.61117,0.02104,-0.02363,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.38267,0.020958,0.045122,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.5583,0.020896,0.082115,0,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.12421,0.020603,0.049907,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.88885,0.020597,0.018203,0,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.17156,0.020555,0.07583,0,0
3,GO COPPER ION TRANSPORT,0.86649,0.020489,-0.00021047,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.67206,0.020282,0.0080482,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.75048,0.020268,0.010052,0,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.80639,0.020187,-0.019527,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.97899,0.020079,0.0060038,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.076344,0.020033,0.08423,0,0
3,GO POLYOL METABOLIC PROCESS,0.44994,0.020027,0.034875,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.44752,0.019999,0.061208,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.99838,0.019629,0.029159,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.94671,0.019502,0.004338,0,0
3,GO CELL CELL SIGNALING,0.48722,0.019408,0.031135,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.96284,0.019357,-0.033802,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.26789,0.019271,0.07474,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.62832,0.019173,-0.0099467,0,0
3,GO ENSHEATHMENT OF NEURONS,0.73517,0.019128,0.00098685,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.49231,0.01895,0.049098,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.86012,0.018894,0.02388,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.54746,0.018872,0.035583,0,0
3,GO NADP METABOLIC PROCESS,0.97576,0.018842,-0.0033132,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.572,0.018811,0.031874,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.33599,0.018696,0.034211,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.35043,0.018663,0.086049,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.92094,0.018576,-0.01351,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.59144,0.018519,0.042553,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.97253,0.018204,0.0041151,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.85376,0.018099,0.0099342,0,0
3,GO LEUKOCYTE TETHERING OR ROLLING,0.35253,0.017981,0.039298,0,0
3,GO DNA GEOMETRIC CHANGE,0.94671,0.017671,0.0074518,0,0
3,GO TRABECULA FORMATION,0.74741,0.017567,0.017152,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.22348,0.017402,0.052816,0,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.066192,0.017358,0.10742,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.26267,0.017187,0.040832,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.68392,0.017052,0.022002,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.98869,0.016937,-0.00047266,0,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.65442,0.016839,0.033774,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.72907,0.016751,0.016447,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.20992,0.016694,0.04774,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.91451,0.016675,-0.019,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.86968,0.016639,0.024182,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.3442,0.016447,0.034801,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.24089,0.016272,0.079279,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.69885,0.016177,0.015729,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.93382,0.01613,-0.049899,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.90809,0.016043,-0.0033289,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.87287,0.015948,-0.0053278,0,0
3,GO PROTEIN HYDROXYLATION,0.82211,0.015906,0.0051242,0,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.70185,0.015426,-0.028692,0,0
3,GO MYELIN MAINTENANCE,0.81896,0.015255,0.02816,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.85059,0.015249,0.027025,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.51035,0.015226,0.042084,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.69286,0.015226,0.027028,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.22814,0.014823,0.062892,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.70185,0.014807,0.019113,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.40514,0.014773,0.035878,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.97576,0.014762,-0.00070261,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.73517,0.014751,0.018011,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.74128,0.014729,-0.019952,0,0
3,GO IRON ION HOMEOSTASIS,0.72603,0.014593,0.026097,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.55287,0.014309,0.02989,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.85376,0.014298,0.0094374,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.34213,0.014084,0.048737,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.7659,0.013806,0.031842,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.26964,0.013802,0.065231,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.49487,0.013793,0.042633,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.7659,0.013663,-0.024992,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.49743,0.01363,0.029291,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.84741,0.013588,0.014298,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.63408,0.013422,-0.098503,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.70486,0.013369,0.0016529,0,0
3,GO STEROID HORMONE SECRETION,0.2714,0.013155,-0.080815,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.80953,0.013134,-0.037372,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.89526,0.012974,0.014406,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.54208,0.012953,0.028466,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.70787,0.01293,0.031817,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.26614,0.012829,-0.044813,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.8379,0.012822,0.020696,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.41434,0.012778,0.047686,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.88565,0.012547,0.010212,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.76899,0.012459,-0.0055183,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.97576,0.012396,0.0087027,0,0
3,GO METHIONINE METABOLIC PROCESS,0.73212,0.012386,0.0015315,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.81896,0.012294,-0.018113,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.96607,0.012286,0.0057888,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.80326,0.012086,0.0026915,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.69586,0.012054,0.0098365,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.77519,0.01198,-0.00097799,0,0
3,GO METHYLATION,0.30637,0.011956,0.037591,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.65734,0.011905,-0.042149,0,0
3,GO DEVELOPMENTAL MATURATION,0.68094,0.011826,0.030275,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.99515,0.011769,-0.0016577,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.46713,0.011755,-0.042982,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.71391,0.011691,0.019999,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.42602,0.011574,0.063236,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.21288,0.011527,0.063466,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.86968,0.011482,0.093456,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.59705,0.011464,-0.0047167,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.46713,0.011462,0.03036,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.92738,0.011456,0.011931,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.3442,0.011326,0.066736,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.84741,0.011292,-0.031987,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.81581,0.01128,0.027786,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.74128,0.011181,-0.018745,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.75048,0.011159,0.011076,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.45482,0.011144,0.070034,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.062114,0.011141,0.11148,0,0
3,GO PROTEIN IMPORT,0.82211,0.011094,0.0053981,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.93704,0.01108,-0.014278,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.75356,0.011027,0.021472,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.8379,0.011022,0.0016051,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.93382,0.010938,-0.0052241,0,0
3,GO REGULATION OF FERTILIZATION,0.76899,0.01078,0.010034,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.65734,0.010588,0.056487,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.35463,0.010441,0.057527,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.6515,0.01027,0.021205,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.5583,0.01023,0.030567,0,0
3,GO NERVE DEVELOPMENT,0.98869,0.010211,0.0050354,0,0
3,GO RESPONSE TO ZINC ION,0.99838,0.010149,-0.012527,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.61402,0.010052,0.026463,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.8379,0.010044,-0.014636,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.45727,0.0097506,-0.026032,0,0
3,GO DNA REPAIR,0.97576,0.0097141,0.0032095,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.27853,0.009685,0.060451,0,0
3,GO RESPONSE TO UV,0.92738,0.0096167,0.0051113,0,0
3,GO CELLULAR HOMEOSTASIS,0.43789,0.0093054,0.033054,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.77519,0.0091788,-0.035809,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.56103,0.0090633,0.046028,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.68689,0.0088733,0.037348,0,0
3,GO REGULATION OF GENE SILENCING,0.73212,0.0087923,0.018766,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.70787,0.0086267,0.025326,0,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.26964,0.0085924,0.049995,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.47712,0.0083768,0.029574,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.87926,0.0083367,0.01247,0,0
3,GO ION HOMEOSTASIS,0.80953,0.008326,0.019381,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.46962,0.0082927,0.027539,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.50258,0.0082259,-0.038506,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.69586,0.0082256,0.0095442,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.68392,0.0082183,0.028289,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.85059,0.0078583,0.019896,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.79075,0.0078508,0.0050565,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.76281,0.0075226,0.005344,0,0
3,GO VESICLE CARGO LOADING,0.84741,0.0075038,0.0081719,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.99515,0.0073814,0.0036054,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.69586,0.0071205,0.024446,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.63697,0.0071133,-0.014574,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.85059,0.0070905,0.024244,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.98222,0.0070728,-0.0016,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.97253,0.0069837,0.0055741,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.89205,0.0069117,0.07742,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.94993,0.0067931,-0.00042462,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.80639,0.0067686,0.013452,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.20122,0.0066796,0.055867,0,0
3,GO ODONTOGENESIS,0.47211,0.0066563,0.043715,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.64858,0.0066477,0.026857,0,0
3,GO FOREBRAIN DEVELOPMENT,0.88245,0.0063951,0.020629,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.96284,0.0063312,-0.010911,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.73212,0.0061902,0.0036643,0,0
3,GO ENDOCYTOSIS,0.86649,0.0060884,0.011526,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.79075,0.0058914,-0.012527,0,0
3,GO CHROMATIN REMODELING,0.72299,0.0058551,-0.004233,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.88245,0.0057639,0.011474,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.37608,0.0054834,-0.043137,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.28578,0.0054508,0.046707,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.36098,0.0054251,0.029296,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.66616,0.0054148,-0.0092854,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.71693,0.005315,0.042879,0,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.87287,0.0053123,0.011004,0,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.86331,0.0052967,0.026091,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.70787,0.0052107,0.024485,0,0
3,GO HEART TRABECULA FORMATION,0.32195,0.0051986,-0.099938,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.63986,0.0051573,-0.0091756,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.55287,0.0048173,0.033514,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.61972,0.0047453,-0.017259,0,0
3,GO ORGANIC ACID TRANSPORT,0.27673,0.0047316,0.043566,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.93382,0.0047069,0.0072489,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.90809,0.0047043,0.013485,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.90809,0.0046356,-0.025524,0,0
3,GO NEURON DEATH,0.58029,0.0044968,-0.0045728,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.82842,0.004477,0.018519,0,0
3,GO INORGANIC ANION TRANSPORT,0.72603,0.0043809,0.013183,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.33396,0.004364,0.054812,0,0
3,GO VASODILATION,0.70486,0.0043593,0.014946,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.22195,0.0043547,-0.087581,0,0
3,GO CELL PROJECTION ORGANIZATION,0.82211,0.0043321,0.017702,0,0
3,GO MACROPHAGE PROLIFERATION,0.85694,0.0042576,0.023747,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.82842,0.0042242,0.025941,0,0
3,GO PIGMENT METABOLIC PROCESS,0.24416,0.0042015,0.070509,0,0
3,GO RESPONSE TO THYROID HORMONE,0.58029,0.0042,-0.044314,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.68689,0.0041954,-0.020933,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.46218,0.0041804,0.032095,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.74128,0.004143,0.0019759,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.87926,0.0041297,0.015437,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.92738,0.004084,0.016642,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.77519,0.0038946,0.024155,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.78451,0.0037919,0.0096827,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.84424,0.0037276,0.0045977,0,0
3,GO REGULATION OF OOGENESIS,0.8379,0.0036989,-0.0091562,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.34008,0.0036099,-0.036362,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.83474,0.0033293,-0.0098653,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.96607,0.0033111,0.031078,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.75048,0.0032833,-0.021718,0,0
3,GO ANIMAL ORGAN REGENERATION,0.64858,0.0032011,-0.0062293,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.98546,0.0031335,0.018216,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.91772,0.0030768,0.0034065,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.94026,0.0030097,0.015038,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.82842,0.0029446,0.0039112,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.84107,0.0029326,0.021014,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.52609,0.0028358,-0.015334,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.97899,0.0028287,0.0056354,0,0
3,GO NUCLEOSIDE SALVAGE,0.55287,0.0028108,0.03017,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.60268,0.0027991,0.031447,0,0
3,GO SPINAL CORD DEVELOPMENT,0.79387,0.0027507,-0.0062068,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.59986,0.0027424,0.037164,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.70486,0.0027263,-0.017364,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.63986,0.0026627,-0.0071833,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.91451,0.0026406,0.0040448,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.36311,0.0026023,-0.02973,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.6312,0.0025959,-0.0045492,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.99515,0.0024763,0.010347,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.67798,0.0021783,-0.026044,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.1653,0.002142,0.13742,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.55287,0.0020558,0.034882,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.91451,0.0020163,0.024885,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.92094,0.001915,0.015152,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.85376,0.0018462,-0.007969,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.94026,0.0018165,0.0042673,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.63408,0.0017476,0.028514,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.76899,0.0014515,0.024412,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.5665,0.00139,0.059139,0,0
3,GO T CELL HOMEOSTASIS,0.99192,0.0011311,-0.0023816,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.89846,0.0009983,0.0031707,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.32393,0.00097723,-0.10805,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.47461,0.00090815,0.037936,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.67206,0.00090029,0.021422,0,0
3,GO RHYTHMIC BEHAVIOR,0.97576,0.00075685,0.018341,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.3739,0.00069329,0.045419,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.50516,0.00065938,0.039391,0,0
3,GO METAL ION HOMEOSTASIS,0.84107,0.00046769,0.0066706,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.7659,0.00043338,0.0267,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.89846,0.00040192,0.0064644,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.86012,0.0003881,0.0019377,0,0
3,GO MICROTUBULE NUCLEATION,0.9306,0.00029682,0.027732,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.79387,0.00028471,0.021558,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.85376,0.00018645,-0.0039648,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.38267,0.00016754,-0.030962,0,0
3,GO SOMITE DEVELOPMENT,0.67206,-0.00037488,-0.013164,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.33803,-0.00042017,-0.035758,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.58864,-0.00043523,0.038775,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.74435,-0.00046988,0.0055586,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.29877,-0.0004792,0.067157,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.70486,-0.00062242,-0.026816,0,0
3,GO VISUAL BEHAVIOR,0.76899,-0.00068863,0.024176,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.50776,-0.00069713,-0.026671,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.79075,-0.00070429,0.033078,0,0
3,GO GROWTH,0.61117,-0.0008187,0.00093014,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.69586,-0.00096574,0.044379,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.88565,-0.0010011,0.032385,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.80639,-0.0010298,0.04153,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.75664,-0.0012987,0.031108,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.69286,-0.0013417,0.041247,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.82211,-0.0014295,-0.0082923,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.80639,-0.0014311,0.0061251,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.78451,-0.0014985,0.0045556,0,0
3,GO REGULATION OF GROWTH,0.3739,-0.0015642,-0.0084131,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.47712,-0.0016699,-0.048743,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.94671,-0.0016725,-0.010975,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.69885,-0.0016902,-0.034504,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.42838,-0.0016941,0.041228,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.85694,-0.0017448,0.0015201,0,0
3,GO PORE COMPLEX ASSEMBLY,0.9693,-0.001837,-0.00011273,0,0
3,GO GROWTH HORMONE SECRETION,0.64567,-0.0018379,-0.008442,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.78763,-0.0019148,-0.0031335,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.61972,-0.001915,-0.012387,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.70486,-0.0019815,-0.0093582,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.93704,-0.0020435,0.0072789,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.84741,-0.0020562,-0.0047939,0,0
3,GO HISTONE H3 K27 METHYLATION,0.86331,-0.0020703,0.01894,0,0
3,GO DETOXIFICATION,0.80326,-0.0021286,-0.0075024,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.86968,-0.0021441,0.01173,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.48215,-0.0021595,0.046662,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.61687,-0.0022353,-0.012926,0,0
3,GO CELL CYCLE ARREST,0.76281,-0.0022627,0.0021581,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.95316,-0.0023176,0.049588,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.95639,-0.0023744,0.013755,0,0
3,GO THYROID GLAND DEVELOPMENT,0.43075,-0.0024086,-0.084617,0,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.94348,-0.0024493,0.013833,0,0
3,GO HINDBRAIN DEVELOPMENT,0.94993,-0.002592,0.016883,0,0
3,GO SEGMENTATION,0.82211,-0.0027189,-0.0041186,0,0
3,GO SENSORY PERCEPTION,0.44028,-0.0027334,-0.012494,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.89205,-0.002819,0.0057457,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.92094,-0.0028318,0.012703,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.73212,-0.0028495,0.018545,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.66321,-0.00291,-0.0061648,0,0
3,GO HISTONE METHYLATION,0.98869,-0.0030807,0.010973,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.97899,-0.0031456,0.025502,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.65442,-0.0031506,0.056923,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.67501,-0.0032354,-0.034649,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.63986,-0.0033709,0.0024487,0,0
3,GO REGULATION OF RNA SPLICING,0.92738,-0.0035634,0.0065149,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.94993,-0.0035996,0.018783,0,0
3,GO CONVERGENT EXTENSION,0.68094,-0.0036517,0.033936,0,0
3,GO MUSCLE SYSTEM PROCESS,0.65734,-0.0036611,0.02798,0,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.79387,-0.0036836,0.024533,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.96607,-0.0037427,0.011035,0,0
3,GO RESPONSE TO AXON INJURY,0.95639,-0.0040122,0.012819,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.61117,-0.0040376,-0.0017152,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.6691,-0.0040378,-0.0032499,0,0
3,GO BONE DEVELOPMENT,0.51819,-0.0040552,-0.018057,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.79387,-0.0041365,-0.0076704,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.89526,-0.0041694,0.012081,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.178,-0.0042983,-0.098871,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.98546,-0.0043648,0.012427,0,0
3,GO PROTEIN ACYLATION,0.70787,-0.00442,0.0020845,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.57476,-0.0044305,0.060017,0,0
3,GO BODY FLUID SECRETION,0.89205,-0.0044448,0.011952,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.94671,-0.0046619,0.014763,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.44994,-0.0046733,-0.015057,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.46713,-0.0047487,-0.028696,0,0
3,GO HISTONE EXCHANGE,0.797,-0.0048008,0.0016222,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.92738,-0.0049573,0.025783,0,0
3,GO G0 TO G1 TRANSITION,0.77209,-0.0050273,-0.0038545,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.64858,-0.0051186,-0.024989,0,0
3,GO OVULATION CYCLE PROCESS,0.67501,-0.0051437,0.029933,0,0
3,GO DNA METABOLIC PROCESS,0.5583,-0.0052383,-0.0042207,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.81896,-0.0052742,0.012462,0,0
3,GO PENILE ERECTION,0.9693,-0.0054286,0.0037307,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.80639,-0.0054934,-0.02991,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.49743,-0.0055225,0.044876,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.74435,-0.0055476,-0.018569,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.7659,-0.0056029,-0.024105,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.79075,-0.0056087,-0.011669,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.80639,-0.0058675,0.026209,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.95639,-0.00589,-0.034189,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.88565,-0.0059395,0.019119,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.45238,-0.0060001,0.041004,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.89205,-0.0060482,0.018032,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.81896,-0.006206,-0.0071313,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.39606,-0.0062191,-0.04272,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.37173,-0.0062511,-0.0054136,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.35886,-0.0062844,-0.054097,0,0
3,GO COMPLEMENT ACTIVATION,0.73212,-0.0062865,-0.04364,0,0
3,GO REGULATION OF URINE VOLUME,0.69286,-0.0063157,0.030273,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.79387,-0.00653,0.034463,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.83474,-0.0065357,0.0068656,0,0
3,GO RECOMBINATIONAL REPAIR,0.69586,-0.0065683,-0.010504,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.79387,-0.0066004,0.027059,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.89205,-0.0068442,0.028816,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.92738,-0.0068609,0.0006087,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.89526,-0.0069875,-0.017402,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.77519,-0.0070976,-0.015037,0,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.58029,-0.0071039,-0.052963,0,0
3,GO RESPONSE TO ETHANOL,0.51035,-0.007157,-0.0086601,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.93704,-0.0071755,0.012266,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.29502,-0.0072092,-0.038616,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.95316,-0.0072096,0.0068041,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.90809,-0.0072203,0.021381,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.86649,-0.0074835,0.020893,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.84107,-0.0075455,0.0058896,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.51557,-0.0076487,-0.0056044,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.99192,-0.0076884,0.020336,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.91451,-0.0077033,0.017502,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.98869,-0.0077131,0.016216,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.55287,-0.0077936,-0.00087435,0,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.73822,-0.0078936,0.041052,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.38488,-0.0079047,-0.01098,0,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.43075,-0.0079368,-0.020946,0,0
3,GO ACROSOME ASSEMBLY,0.52874,-0.0080463,0.071516,0,0
3,GO NEURON APOPTOTIC PROCESS,0.33599,-0.0080491,-0.013691,0,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.36741,-0.008107,0.068399,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.38267,-0.0082051,-0.020025,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.68094,-0.0082236,-0.023633,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.71089,-0.0082269,-0.023059,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.67501,-0.0082569,-0.0099412,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.6055,-0.0084786,-0.012488,0,0
3,GO RESPONSE TO PROTOZOAN,0.38488,-0.0085138,-0.060958,0,0
3,GO MEMBRANE BIOGENESIS,0.8379,-0.008528,-0.0060084,0,0
3,GO EXOCYTIC PROCESS,0.72299,-0.0086324,0.041795,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.80012,-0.0086716,-0.0024721,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.90167,-0.0088259,-0.0037393,0,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.97253,-0.0088626,0.018635,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.66321,-0.0089217,-0.0046705,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.24911,-0.0089465,-0.13266,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.75972,-0.0089563,0.0039175,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.75048,-0.0089856,0.021896,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.78451,-0.0089867,0.009659,0,0
3,GO REGULATION OF MITOPHAGY,0.35674,-0.0090326,-0.032623,0,0
3,GO REGULATION OF DNA REPAIR,0.80012,-0.0091265,-0.00062511,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.58029,-0.0091499,-0.02943,0,0
3,GO REGULATION OF BEHAVIOR,0.85694,-0.0092747,0.029714,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.84107,-0.0092847,-0.0065195,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.92416,-0.009299,0.0074171,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.85694,-0.0093633,-0.014425,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.2714,-0.0093886,-0.036024,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.69586,-0.0093896,-0.016664,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.57476,-0.0093998,0.050054,0,0
3,GO DRUG METABOLIC PROCESS,0.63697,-0.0094058,-0.028322,0,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.81896,-0.0094264,-0.030599,0,0
3,GO TERPENOID METABOLIC PROCESS,0.47211,-0.009505,-0.032635,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.40743,-0.0095617,-0.010084,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.96607,-0.0098096,0.017697,0,0
3,GO HEART VALVE DEVELOPMENT,0.74741,-0.0098478,0.032239,0,0
3,GO PHOTOPERIODISM,0.72299,-0.009888,-0.011313,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.22348,-0.0099202,-0.026361,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.45727,-0.010137,-0.040416,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.56925,-0.010185,-0.01013,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.90488,-0.01021,0.021008,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.92094,-0.010226,0.01255,0,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.78451,-0.01024,0.023406,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.88245,-0.010243,-0.015648,0,0
3,GO ARTERY DEVELOPMENT,0.97899,-0.010393,0.0034731,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.797,-0.010515,0.0098736,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.74128,-0.010547,0.00099444,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.79387,-0.010712,0.020745,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.7814,-0.010759,-0.0021332,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.35253,-0.010849,-0.073988,0,0
3,GO MIDBRAIN DEVELOPMENT,0.30637,-0.010902,-0.032391,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.2714,-0.010935,-0.018117,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.32592,-0.01095,-0.041059,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.72299,-0.011104,-0.018187,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.48215,-0.011106,-0.036228,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.65734,-0.011218,-0.0029682,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.92416,-0.011285,0.013677,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.59705,-0.011314,-0.0068773,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.68988,-0.011432,0.033187,0,0
3,GO RESPONSE TO VITAMIN A,0.76281,-0.011454,0.021023,0,0
3,GO IRON ION TRANSPORT,0.6055,-0.011481,-0.0029866,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.61687,-0.01154,0.031865,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.93704,-0.011614,0.012504,0,0
3,GO PROTEIN POLYMERIZATION,0.59424,-0.011691,-0.0018586,0,0
3,GO CARTILAGE DEVELOPMENT,0.45482,-0.011751,-0.024089,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.92416,-0.011903,-0.0032869,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.20992,-0.011953,-0.051732,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.95316,-0.011966,0.015711,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.90167,-0.011999,0.017205,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.88245,-0.012093,0.0021577,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.35463,-0.012103,-0.068625,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.95316,-0.012222,0.020069,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.66616,-0.012405,-0.0034912,0,0
3,GO GLIOGENESIS,0.31021,-0.012411,-0.023715,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.79075,-0.012485,0.0040428,0,0
3,GO LIPID PHOSPHORYLATION,0.70185,-0.012616,0.0019463,0,0
3,GO OVULATION CYCLE,0.67798,-0.012651,0.032103,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.64276,-0.012708,-0.032539,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.12721,-0.012737,-0.023728,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.78763,-0.012848,0.027202,0,0
3,GO DNA RECOMBINATION,0.28578,-0.012864,-0.025263,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.43075,-0.012962,-0.036956,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.42133,-0.012964,-0.043449,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.45972,-0.013086,-0.041062,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.52345,-0.013172,0.046673,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.80012,-0.013178,0.0022616,0,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.13234,-0.013226,-0.025154,0,0
3,GO RESPONSE TO STEROL,0.78763,-0.013332,0.011858,0,0
3,GO TAXIS,0.3442,-0.013422,-0.014583,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.80953,-0.013472,-0.0040003,0,0
3,GO PROTEIN ACETYLATION,0.58307,-0.013508,-0.0029407,0,0
3,GO DNA PACKAGING,0.52082,-0.013559,-0.0082924,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.6515,-0.013598,-0.0075081,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.73212,-0.013685,0.0059381,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.67206,-0.013803,-0.010064,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.27673,-0.013978,-0.017164,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.85376,-0.014117,0.011111,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.58307,-0.014119,0.039082,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.68689,-0.014157,0.04161,0,0
3,GO ANION TRANSPORT,0.94026,-0.014183,0.0097923,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.97253,-0.014264,0.014448,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.65734,-0.014335,0.035951,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.5583,-0.014357,0.021037,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.98869,-0.014372,0.011944,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.46713,-0.014396,-0.011498,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.68689,-0.014453,-0.024676,0,0
3,GO BIOMINERALIZATION,0.33599,-0.014488,-0.032785,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.55287,-0.014511,-0.00064306,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.45238,-0.01453,-0.044075,0,0
3,GO RESPONSE TO RADIATION,0.36098,-0.01453,-0.0054345,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.90809,-0.014615,0.010455,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.50258,-0.014642,-0.014001,0,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.59705,-0.014682,-0.014148,0,0
3,GO MAINTENANCE OF LOCATION,0.97253,-0.014704,0.022417,0,0
3,GO DNA STRAND ELONGATION,0.5,-0.014838,-0.012384,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.5394,-0.014852,-0.012146,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.91451,-0.014894,0.005587,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.75972,-0.014925,0.021794,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.32393,-0.015004,-0.086301,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.71391,-0.015008,-0.015806,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.9693,-0.015087,-0.02858,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.70486,-0.015093,-0.019529,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.30637,-0.015096,-0.0090621,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.74128,-0.015187,-0.012895,0,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.89205,-0.01521,0.0031349,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.5314,-0.015263,-0.010788,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.4355,-0.015402,-0.034784,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.68988,-0.015419,0.048437,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.89205,-0.015427,0.0013544,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.69586,-0.015476,0.001915,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.90488,-0.015534,0.015787,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.11553,-0.015538,-0.049217,0,0
3,GO MISMATCH REPAIR,0.65734,-0.015598,-0.00083123,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.5314,-0.015818,-0.011561,0,0
3,GO CALCIUM ION IMPORT,0.58585,-0.015878,0.042618,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.92416,-0.015881,0.018414,0,0
3,GO PHAGOSOME MATURATION,0.35253,-0.01593,-0.025844,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.84107,-0.015967,0.0092156,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.68988,-0.01602,-0.013293,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.70486,-0.016097,-0.012708,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.20699,-0.016128,-0.030938,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.6515,-0.016179,-0.01726,0,0
3,GO HAIR FOLLICLE MATURATION,0.1914,-0.016302,-0.075192,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.73822,-0.016305,-0.012131,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.68094,-0.016321,0.00086134,0,0
3,GO MACROMOLECULE DEACYLATION,0.9693,-0.016347,0.015869,0,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.55558,-0.016351,0.050948,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.29502,-0.016414,-0.040515,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.85376,-0.016437,-0.0049172,0,0
3,GO INTRACELLULAR TRANSPORT,0.44994,-0.016457,-0.00085766,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.66028,-0.016483,0.0042971,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.6691,-0.016503,-0.0083004,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.87287,-0.016556,0.016167,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.19557,-0.016566,-0.030308,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.40286,-0.016591,0.041022,0,0
3,GO REGULATION OF DNA BINDING,0.60834,-0.016941,-0.0056283,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.32592,-0.017143,-0.025676,0,0
3,GO MITOTIC RECOMBINATION,0.99192,-0.017269,0.0015704,0,0
3,GO SYNCYTIUM FORMATION,0.29877,-0.017285,-0.047679,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.75356,-0.017301,0.025232,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.79387,-0.01755,0.027728,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.77829,-0.017604,0.03845,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.86012,-0.017666,0.014223,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.73212,-0.017747,-0.012906,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.86968,-0.017848,0.0033179,0,0
3,GO DRUG CATABOLIC PROCESS,0.90809,-0.017873,-0.00514,0,0
3,GO CELL CELL SIGNALING BY WNT,0.52874,-0.017886,-0.0064661,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.6055,-0.01797,-0.048511,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.75664,-0.018018,0.02638,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.20122,-0.018315,-0.015377,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.51819,-0.018456,0.014748,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.67206,-0.0185,-0.14197,0,0
3,GO NUCLEOSOME ORGANIZATION,1,-0.018531,0.01021,0,0
3,GO CHROMOSOME SEPARATION,0.72907,-0.018591,-0.0041311,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.10214,-0.018667,-0.098782,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.32195,-0.018894,-0.051321,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.93704,-0.018946,0.03583,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.91772,-0.01895,0.016104,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.95639,-0.019022,0.032161,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.75972,-0.019039,0.0025551,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.98869,-0.019107,0.014022,0,0
3,GO RESPONSE TO ESTROGEN,0.62545,-0.019191,-0.014312,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.42133,-0.019228,-0.0066546,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.40514,-0.019284,-0.049794,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.9113,-0.019355,0.0039235,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.39381,-0.019414,-0.041518,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.51819,-0.019486,-0.018844,0,0
3,GO SNRNA TRANSCRIPTION,0.96284,-0.019682,0.010879,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.30829,-0.019723,-0.0073341,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.59424,-0.019724,0.0052843,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,1,-0.019903,0.028266,0,0
3,GO URETER DEVELOPMENT,0.34627,-0.019923,-0.10133,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.30066,-0.019992,-0.10684,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.84107,-0.020062,0.035373,0,0
3,GO OOCYTE MATURATION,0.58307,-0.020077,-0.010491,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.63697,-0.020086,0.029753,0,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.43075,-0.020135,0.059306,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.572,-0.020195,-0.010503,0,0
3,GO IMPORT INTO NUCLEUS,0.26964,-0.020242,-0.023654,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.73212,-0.020247,0.0096936,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.066792,-0.020264,-0.057218,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.51557,-0.020358,-0.019736,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.48722,-0.020414,-0.0037516,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.22503,-0.020436,-0.020843,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.095518,-0.020484,-0.024505,0,0
3,GO POSITIVE REGULATION OF BINDING,0.34213,-0.020528,-0.0041552,0,0
3,GO CELL REDOX HOMEOSTASIS,0.797,-0.020589,-0.014822,0,0
3,GO DNA CONFORMATION CHANGE,0.64276,-0.020656,-0.004417,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.51296,-0.020665,-0.034823,0,0
3,GO RESPONSE TO HYPEROXIA,0.86649,-0.020694,0.017761,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.84741,-0.020748,-0.0098311,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.41899,-0.021021,-0.084795,0,0
3,GO GLUCOSE IMPORT,0.30829,-0.021088,-0.017583,0,0
3,GO PANCREATIC JUICE SECRETION,0.48468,-0.021166,-0.033413,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.26964,-0.021221,-0.023705,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.99515,-0.021245,0.013628,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.56925,-0.021408,0.056473,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.61402,-0.02143,-0.0013536,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.27317,-0.021432,-0.04203,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.85059,-0.021474,-0.0003178,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.69586,-0.021533,0.04642,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.76899,-0.021653,-0.0099119,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.29689,-0.021669,-0.062152,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.48215,-0.021675,0.056228,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.48468,-0.021699,-0.027422,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.2644,-0.021872,-0.048889,0,0
3,GO SLEEP,0.47712,-0.021913,-0.023196,0,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.33803,-0.022026,-0.093604,0,0
3,GO HISTONE H3 K4 METHYLATION,0.16904,-0.022029,-0.033976,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.572,-0.02203,-0.037775,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.39606,-0.022036,0.063052,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.67501,-0.022036,-0.016584,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.28578,-0.022239,-0.007826,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.78763,-0.022279,0.035305,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.65734,-0.022437,0.0068227,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.43312,-0.022438,-0.014634,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.98869,-0.022502,0.017288,0,0
3,GO MITOPHAGY,0.34627,-0.022518,-0.024659,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.23445,-0.022561,-0.023282,0,0
3,GO BRAIN MORPHOGENESIS,0.89846,-0.02258,0.00018182,0,0
3,GO TRACHEA DEVELOPMENT,0.85059,-0.022597,-0.0081485,0,0
3,GO FOREGUT MORPHOGENESIS,0.38488,-0.022606,-0.05921,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.26789,-0.022638,-0.013319,0,0
3,GO PROTEIN METHYLATION,0.38488,-0.022649,-0.0064166,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.28945,-0.022714,-0.007436,0,0
3,GO ORGANIC ANION TRANSPORT,0.87606,-0.022724,0.005564,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.72603,-0.02274,-0.00033659,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.54208,-0.022821,-0.024242,0,0
3,GO OXIDATION REDUCTION PROCESS,0.88885,-0.022856,0.015506,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.64276,-0.02306,0.0040386,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.46218,-0.023068,-0.0045179,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.90809,-0.023265,0.015644,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.67501,-0.023268,-0.0098729,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.72299,-0.023288,0.005976,0,0
3,GO HEART MORPHOGENESIS,0.20845,-0.023304,-0.036896,0,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.58029,-0.023319,-0.022255,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.084034,-0.023497,-0.038054,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.87926,-0.023539,-0.050426,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.26964,-0.023681,-0.037887,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.45482,-0.023685,-0.040423,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.35043,-0.02371,-0.061997,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.35463,-0.02375,-0.020879,0,0
3,GO REGULATION OF T CELL MIGRATION,0.30255,-0.023763,-0.041034,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.35886,-0.023791,-0.050839,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.58029,-0.02391,-0.022589,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.33599,-0.023931,-0.026604,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.079765,-0.023944,-0.04773,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.72907,-0.024011,-0.0018201,0,0
3,GO DNA REPLICATION,0.55016,-0.024029,-0.020319,0,0
3,GO PEROXISOMAL TRANSPORT,0.59986,-0.024107,-0.010119,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.48976,-0.024137,-0.0067813,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.088486,-0.02416,-0.033259,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.91451,-0.024298,0.020048,0,0
3,GO HEAD DEVELOPMENT,0.74435,-0.024382,0.0055254,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.68988,-0.024386,0.047317,0,0
3,GO NEURAL TUBE PATTERNING,0.16407,-0.024391,-0.071097,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.21587,-0.024454,-0.015319,0,0
3,GO VESICLE LOCALIZATION,0.18595,-0.024488,-0.026968,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.18866,-0.024515,-0.046718,0,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.48722,-0.024529,-0.0070087,0,0
3,GO PROTEIN SUMOYLATION,0.35674,-0.024531,-0.01318,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.47461,-0.024554,-0.027176,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.28578,-0.024598,-0.014843,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.98222,-0.024665,0.02479,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.12224,-0.024699,-0.061905,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.10214,-0.024772,-0.041425,0,0
3,GO FATTY ACID TRANSPORT,0.84741,-0.024934,0.0052537,0,0
3,GO RESPONSE TO STARVATION,0.14197,-0.025043,-0.036002,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.31021,-0.025062,-0.046044,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.48215,-0.025153,-0.01255,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.1653,-0.025193,-0.0278,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.90488,-0.025295,0.0096673,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.47963,-0.025432,0.083721,0,0
3,GO ACID SECRETION,0.69286,-0.02549,-0.013045,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.090011,-0.025518,-0.028934,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.93382,-0.025726,0.0065039,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.45727,-0.025817,-0.016345,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.89846,-0.025994,0.0072635,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.55287,-0.025997,-0.0081859,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.43789,-0.026073,-0.016777,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.18194,-0.026131,-0.010639,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.22658,-0.026208,-0.054098,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.47963,-0.026216,-0.040013,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.86649,-0.026299,0.0050562,0,0
3,GO HEART GROWTH,0.61117,-0.026314,-0.0030177,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.77829,-0.02646,-0.015179,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.78451,-0.026497,-0.00042177,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.84424,-0.026618,0.032892,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.43789,-0.026627,-0.023585,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.80953,-0.026628,0.0098604,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.24745,-0.026663,-0.043924,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.44269,-0.026686,-0.038778,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.37608,-0.0267,-0.017514,0,0
3,GO INCLUSION BODY ASSEMBLY,0.67798,-0.026714,0.072241,0,0
3,GO REGULATION OF DNA METHYLATION,0.50516,-0.026751,-0.044651,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.30446,-0.026801,-0.040379,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.43789,-0.026836,-0.0044616,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.58585,-0.026874,0.078915,0,0
3,GO CHROMATIN ORGANIZATION,0.085497,-0.026887,-0.028214,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.52345,-0.026918,-0.020342,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.31604,-0.026935,-0.01888,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.46466,-0.026982,-0.033998,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.6691,-0.027012,-0.0067898,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.60268,-0.027099,-0.0071243,0,0
3,GO ENERGY HOMEOSTASIS,0.45482,-0.027127,-0.034423,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.23286,-0.02719,-0.027529,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.26789,-0.027252,-0.048939,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.11553,-0.027265,-0.049448,0,0
3,GO DNA CATABOLIC PROCESS,0.091558,-0.02729,-0.046774,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.90488,-0.027569,0.0053222,0,0
3,GO RESPONSE TO DRUG,0.78451,-0.027569,0.012185,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.26789,-0.02761,-0.039667,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.077018,-0.027646,-0.03768,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.51296,-0.027697,0.059102,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.28395,-0.027718,-0.022219,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.94993,-0.02782,0.0094952,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.14419,-0.027845,-0.036141,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.38933,-0.027855,-0.033188,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.25924,-0.027966,-0.057184,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.55287,-0.028007,-0.051146,0,0
3,GO ISOPRENOID METABOLIC PROCESS,0.35043,-0.028057,-0.034711,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.90809,-0.028075,0.015468,0,0
3,GO BONE MINERALIZATION,0.37173,-0.028103,-0.030463,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.70185,-0.02814,0.019141,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.51296,-0.028149,-0.0091846,0,0
3,GO T CELL MIGRATION,0.29877,-0.02815,-0.048675,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.77209,-0.028292,0.033675,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.39381,-0.028318,-0.001484,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.77519,-0.02841,-0.053722,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.71996,-0.028449,-0.011456,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.52874,-0.028506,-0.013979,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.93382,-0.028526,-0.0043502,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.97253,-0.028641,0.012853,0,0
3,GO RESPONSE TO CHEMOKINE,0.40514,-0.02873,-0.030848,0,0
3,GO MEMBRANE ORGANIZATION,0.13338,-0.028738,-0.02179,0,0
3,GO CHEMICAL HOMEOSTASIS,0.50776,-0.028808,-0.0068152,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.60834,-0.028809,-0.0030306,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.28033,-0.028889,-0.012235,0,0
3,GO INTERACTION WITH SYMBIONT,0.84107,-0.028911,-0.006856,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.24911,-0.028956,-0.032572,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.96284,-0.029076,0.013606,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.86331,-0.029096,0.010024,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.57752,-0.029128,-0.011186,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.66616,-0.029328,0.032922,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.94671,-0.029858,0.026311,0,0
3,GO BLASTOCYST GROWTH,0.40973,-0.029924,-0.038441,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.29877,-0.030059,-0.032045,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.66321,-0.03008,-0.00522,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.58864,-0.030112,-0.0087462,0,0
3,GO HEAT GENERATION,0.20554,-0.030156,-0.087876,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.44994,-0.030186,-0.011936,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.21889,-0.030247,-0.052735,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.071119,-0.030261,-0.062279,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.50258,-0.030294,-0.11211,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.14755,-0.030322,-0.036498,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.33396,-0.030329,-0.033762,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.42838,-0.030364,-0.021298,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.54208,-0.030397,-0.022031,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.18327,-0.030448,-0.027967,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.79387,-0.030586,0.0044347,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.25753,-0.030596,-0.044453,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.2644,-0.030687,-0.023708,0,0
3,GO RESPONSE TO FATTY ACID,0.66321,-0.030793,-0.0042142,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.25583,-0.030858,-0.04339,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.22814,-0.03089,-0.054073,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.6515,-0.030956,0.0014109,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.47712,-0.031087,0.012156,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.25078,-0.03111,-0.014035,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.15802,-0.031178,-0.068705,0,0
3,GO PEROXISOME ORGANIZATION,0.51819,-0.031266,-0.013761,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.31997,-0.031322,-0.016187,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.35253,-0.031364,-0.031715,0,0
3,GO LYMPH NODE DEVELOPMENT,0.33599,-0.031392,-0.045394,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.16042,-0.031483,-0.061488,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.61117,-0.031521,-0.0023071,0,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.14983,-0.031596,-0.058613,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.83474,-0.031711,-0.0017222,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.79075,-0.031727,0.051981,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.87287,-0.031763,-0.0034675,0,0
3,GO REGULATION OF TRANSPORT,0.31215,-0.031812,-0.010457,0,0
3,GO GENE SILENCING,0.23927,-0.031854,-0.015588,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.20265,-0.031886,-0.062976,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.7659,-0.031992,-0.019551,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.33396,-0.032099,-0.028354,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.56103,-0.03214,-0.0046879,0,0
3,GO STEM CELL DIVISION,0.41203,-0.032164,-0.039555,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.63408,-0.032195,-0.010723,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.23128,-0.032343,-0.06997,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.16778,-0.032446,-0.043413,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.40514,-0.032547,-0.048238,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.53406,-0.032628,-0.020812,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.20699,-0.0327,-0.032461,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.31604,-0.032738,-0.075562,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.89846,-0.033102,-0.0019442,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.40286,-0.033257,-0.032607,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.11002,-0.033263,-0.090023,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.23286,-0.033322,-0.015607,0,0
3,GO HISTONE DEACETYLATION,0.572,-0.033422,-0.003381,0,0
3,GO PROTEIN AUTOPROCESSING,0.43075,-0.033434,-0.024921,0,0
3,GO RECEPTOR RECYCLING,0.70185,-0.033443,-0.00066939,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.39832,-0.033529,-0.05276,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.72299,-0.033574,-0.014645,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.44994,-0.033626,-0.080805,0,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.17156,-0.033632,-0.067274,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.38488,-0.033694,-0.017767,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.50776,-0.03377,-0.010888,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.16904,-0.033771,-0.04835,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.82526,-0.034044,0.00086687,0,0
3,GO HEAD MORPHOGENESIS,0.11553,-0.034049,-0.07597,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.54477,-0.034069,-0.025512,0,0
3,GO PIRNA METABOLIC PROCESS,0.29689,-0.034135,-0.076403,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.36956,-0.034217,-0.020466,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.74741,-0.034302,-0.0057107,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.95316,-0.034352,-0.0037677,0,0
3,GO REGULATION OF ODONTOGENESIS,0.65442,-0.034376,-0.043009,0,0
3,GO STEROID ESTERIFICATION,0.60268,-0.034391,-0.056948,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.55558,-0.034402,-0.03198,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.62258,-0.034685,-0.0093292,0,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.77519,-0.034707,0.028427,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.20845,-0.03474,-0.030473,0,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.63408,-0.034819,0.0022446,0,0
3,GO RESPONSE TO NICOTINE,0.64858,-0.034857,-0.034132,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.96284,-0.034932,0.012365,0,0
3,GO CHROMOSOME ORGANIZATION,0.09714,-0.034958,-0.023381,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.36526,-0.034966,-0.010057,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.55287,-0.03502,-0.010542,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.064418,-0.035151,-0.033948,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.1873,-0.035162,-0.014676,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.13027,-0.035181,-0.022876,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.11553,-0.035286,-0.035309,0,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.85059,-0.035316,-0.0046226,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.074349,-0.035344,-0.091737,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.24416,-0.035371,-0.028122,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.14983,-0.035372,-0.03322,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.35253,-0.035507,-0.024042,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.078382,-0.035637,-0.070251,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.10558,-0.035677,-0.026794,0,0
3,GO REGULATION OF HEART GROWTH,0.81896,-0.035711,0.022184,0,0
3,GO RHYTHMIC PROCESS,0.21288,-0.035722,-0.014434,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.068619,-0.035805,-0.035642,0,0
3,GO ORGANELLE FUSION,0.34213,-0.035822,-0.015129,0,0
3,GO FERTILIZATION,0.1754,-0.035845,-0.018408,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.16163,-0.035873,-0.03968,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.42838,-0.035889,-0.018406,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.18194,-0.036246,-0.098558,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.94348,-0.036258,0.0064007,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.44269,-0.036266,-0.02074,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.35043,-0.036267,-0.02156,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.4355,-0.036529,-0.028586,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.48976,-0.036549,-0.062169,0,0
3,GO VITAMIN METABOLIC PROCESS,0.43075,-0.036676,-0.021351,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.28213,-0.036753,-0.036033,0,0
3,GO HOMEOSTATIC PROCESS,0.065005,-0.036764,-0.028259,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.34008,-0.036785,-0.067079,0,0
3,GO REGULATION OF MYELINATION,0.77209,-0.036836,0.0079175,0,0
3,GO SULFATION,0.27495,-0.036872,-0.08037,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.33396,-0.036887,-0.011756,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.67798,-0.037052,-0.029306,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.23286,-0.037062,-0.032989,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.068619,-0.037071,-0.030233,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.24911,-0.037132,-0.058535,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.13979,-0.037149,-0.027275,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.084034,-0.037245,-0.041465,0,0
3,GO STEM CELL DIFFERENTIATION,0.12924,-0.037274,-0.037191,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.14088,-0.037355,-0.021221,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.86649,-0.037355,-0.0021446,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.23286,-0.037359,-0.067959,0,0
3,GO SODIUM ION HOMEOSTASIS,0.2458,-0.037378,-0.031168,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.2114,-0.037386,-0.049504,0,0
3,GO OPTIC NERVE DEVELOPMENT,0.88565,-0.037496,-0.0036811,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.94993,-0.037606,-0.002793,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.28578,-0.037783,-0.037322,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.40514,-0.037793,-0.025615,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.18062,-0.038003,-0.013444,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.33194,-0.038021,-0.010029,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.10646,-0.038034,-0.10815,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.14642,-0.038061,-0.02738,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.3442,-0.038069,-0.017223,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.55016,-0.038123,-0.036395,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.56376,-0.038139,0.053442,0,0
3,GO ASYMMETRIC CELL DIVISION,0.58029,-0.038237,-0.031548,0,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.1262,-0.038265,-0.056661,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.071756,-0.03832,-0.07576,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.74435,-0.038327,-0.0042722,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.10558,-0.038372,-0.084881,0,0
3,GO REGULATION OF CELL AGING,0.14983,-0.03838,-0.065187,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.22658,-0.038397,-0.084356,0,0
3,GO DNA LIGATION,0.1873,-0.0384,-0.069344,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.16163,-0.038477,-0.038576,0,0
3,GO REGULATION OF BINDING,0.16654,-0.038508,-0.0219,0,0
3,GO SOMITOGENESIS,0.35674,-0.038515,-0.026492,0,0
3,GO REGULATION OF AUTOPHAGY,0.087731,-0.038621,-0.02134,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.22814,-0.038653,-0.050396,0,0
3,GO CHOLESTEROL STORAGE,0.94993,-0.038749,0.0083591,0,0
3,GO PHOTOTRANSDUCTION,0.26614,-0.0388,0.066782,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.36098,-0.039008,-0.0041688,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.83474,-0.039043,-0.005505,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.42838,-0.039057,-0.035961,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.079765,-0.039207,-0.046673,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.10045,-0.039286,-0.025428,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.11002,-0.039296,-0.037247,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.24252,-0.039317,-0.049259,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.33803,-0.039416,-0.012583,0,0
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.46713,-0.039457,-0.0088145,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.084763,-0.039465,-0.029988,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.06986,-0.039473,-0.043731,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.25078,-0.039499,-0.082451,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.15921,-0.039551,-0.028357,0,0
3,GO ATP TRANSPORT,0.75972,-0.039692,0.0078759,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.55287,-0.039718,-0.022127,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.36098,-0.039767,-0.020305,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.089246,-0.040002,-0.037713,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.18866,-0.040009,-0.040919,0,0
3,GO CELL CYCLE PROCESS,0.066192,-0.040076,-0.027488,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.90809,-0.040322,0.018123,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.14983,-0.040331,-0.045452,0,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.29689,-0.040336,-0.028112,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.1252,-0.04034,-0.047653,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.38488,-0.040351,-0.01068,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.077698,-0.040368,-0.064083,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.31215,-0.04038,-0.025428,0,0
3,GO REGULATION OF DENDRITE EXTENSION,0.5583,-0.040442,0.095663,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.52609,-0.040532,-0.026336,0,0
3,GO STEROID CATABOLIC PROCESS,0.30255,-0.040591,-0.062187,0,0
3,GO REGULATION OF FATTY ACID OXIDATION,0.66321,-0.04061,-0.010781,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.3739,-0.040661,-0.012035,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.13234,-0.040731,-0.030806,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.14755,-0.040759,-0.027513,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.34835,-0.040806,-0.065106,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.1146,-0.040822,0.11462,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.70486,-0.041,-0.024203,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.35043,-0.04101,-0.049403,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.30446,-0.04103,-0.061406,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.90167,-0.041201,0.018851,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.44269,-0.041332,-0.076388,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.1313,-0.04136,-0.026482,0,0
3,GO ORGANELLE INHERITANCE,0.18866,-0.041413,-0.02896,0,0
3,GO ARACHIDONIC ACID SECRETION,0.44752,-0.041467,-0.034401,0,0
3,GO MEMBRANE INVAGINATION,0.091558,-0.041494,-0.061528,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.09714,-0.041495,-0.034949,0,0
3,GO HISTONE H3 ACETYLATION,0.15447,-0.041633,-0.028027,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.22195,-0.041699,-0.037261,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.11092,-0.041755,-0.10384,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.70486,-0.041816,0.010803,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.11742,-0.041828,-0.04421,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.17156,-0.041885,-0.021016,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.42602,-0.041927,-0.088649,0,0
3,GO RESPONSE TO RETINOIC ACID,0.11553,-0.041981,-0.056882,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.1313,-0.042017,-0.084783,0,0
3,GO LIPID CATABOLIC PROCESS,0.30066,-0.042025,-0.022051,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.12924,-0.042025,-0.02034,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.26614,-0.042154,-0.049268,0,0
3,GO HEART DEVELOPMENT,0.10045,-0.042166,-0.043334,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.9693,-0.042254,0.014051,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.25924,-0.042273,-0.011934,0,0
3,GO SULFATE TRANSPORT,0.15802,-0.042329,-0.030663,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.12822,-0.0424,-0.047962,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.40058,-0.042527,-0.024132,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.13763,-0.04257,-0.085796,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.37827,-0.042586,-0.032155,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.49487,-0.042679,0.00054293,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.15683,-0.042804,-0.033554,0,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.51557,-0.042953,-0.039891,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.17411,-0.042965,-0.046273,0,0
3,GO GENITALIA DEVELOPMENT,0.2714,-0.04297,-0.045079,0,0
3,GO HISTONE H2A ACETYLATION,0.22348,-0.043034,-0.039047,0,0
3,GO RESPONSE TO ALKALOID,0.58585,-0.043069,-0.011261,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.61972,-0.04316,-0.0063199,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.44752,-0.043263,-0.026181,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.17156,-0.043317,-0.051271,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.40973,-0.043485,-0.077995,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.2458,-0.043501,-0.033932,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.85694,-0.043507,-0.025496,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.76281,-0.043592,-0.0033099,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.35253,-0.043699,-0.014468,0,0
3,GO RESPONSE TO INSULIN,0.071119,-0.043731,-0.033243,0,0
3,GO REGULATION OF PROTEIN BINDING,0.17156,-0.043789,-0.024987,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.12126,-0.044175,-0.055739,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.35674,-0.044394,-0.095144,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.57476,-0.044452,-0.025951,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.1387,-0.044509,-0.027491,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.070488,-0.044584,-0.019953,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.086237,-0.044726,-0.027717,0,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.28761,-0.044747,-0.027549,0,0
3,GO FEVER GENERATION,0.91451,-0.044757,-0.013341,0,0
3,GO TISSUE REGENERATION,0.086981,-0.044808,-0.078985,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.82842,-0.044808,0.044403,0,0
3,GO PLATELET DEGRANULATION,0.30066,-0.044834,-0.053344,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.16407,-0.044884,-0.074445,0,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.86331,-0.044947,0.01755,0,0
3,GO RESPONSE TO PEPTIDE,0.079765,-0.045144,-0.028917,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.073694,-0.045154,-0.033574,0,0
3,GO FIBROBLAST ACTIVATION,0.41434,-0.045245,-0.04919,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.062114,-0.045371,-0.043896,0,0
3,GO INTERFERON GAMMA PRODUCTION,0.12224,-0.045403,-0.070526,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.11183,-0.045451,-0.028325,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10823,-0.045525,-0.042511,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.6691,-0.045552,-0.013365,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.31997,-0.045581,-0.018797,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.23445,-0.045642,-0.086919,0,0
3,GO HISTONE PHOSPHORYLATION,0.15098,-0.045683,-0.046472,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.19557,-0.045723,-0.033825,0,0
3,GO BLASTODERM SEGMENTATION,0.67501,-0.045791,0.065189,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.75664,-0.045895,-0.0027584,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.74741,-0.045951,-0.0043328,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.43789,-0.046035,-0.034042,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.17156,-0.046035,-0.036091,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.15447,-0.046114,-0.020312,0,0
3,GO REGULATION OF GLIOGENESIS,0.1387,-0.046147,-0.042288,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.1252,-0.046248,-0.068285,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.19003,-0.046321,-0.067426,0,0
3,GO ALCOHOL METABOLIC PROCESS,0.2714,-0.046341,-0.02279,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.56376,-0.046407,0.097195,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.19417,-0.04645,-0.035787,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.69286,-0.046485,0.0023805,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.31215,-0.046543,-0.018972,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.068006,-0.046641,-0.058301,0,0
3,GO STEROL TRANSPORT,0.35674,-0.046695,-0.025928,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.92094,-0.046743,0.0025812,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.68392,-0.04675,-0.013927,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.20265,-0.046877,-0.018584,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.52874,-0.046885,-0.058934,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.76281,-0.046911,0.048394,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.5665,-0.046965,-0.0054489,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.33599,-0.046999,-0.063348,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.50258,-0.047086,-0.011357,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.33803,-0.047133,-0.02543,0,0
3,GO FILOPODIUM ASSEMBLY,0.48976,-0.047175,0.049703,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.085497,-0.047206,-0.065866,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.57752,-0.047215,0.029954,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.41203,-0.047264,-0.030839,0,0
3,GO REGULATION OF DNA REPLICATION,0.067397,-0.047332,-0.046311,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.15802,-0.047411,-0.028043,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.24745,-0.047418,-0.034082,0,0
3,GO P BODY ASSEMBLY,0.064418,-0.047556,-0.048614,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.11002,-0.047616,-0.10285,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.1262,-0.047772,-0.035542,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.24911,-0.047813,-0.04107,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.2458,-0.047844,-0.028454,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.29315,-0.047844,-0.060475,0,0
3,GO NEURON PROJECTION REGENERATION,0.72603,-0.047845,-0.0010144,0,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.1252,-0.047853,-0.021366,0,0
3,GO CELL SUBSTRATE ADHESION,0.16778,-0.047875,-0.050107,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.26789,-0.047915,-0.044029,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.42133,-0.047931,-0.023831,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.318,-0.048191,-0.023271,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.36098,-0.048307,-0.038793,0,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.12421,-0.048368,-0.036873,0,0
3,GO TRANSFERRIN TRANSPORT,0.16904,-0.048467,-0.037782,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.55287,-0.0486,-0.014065,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.54208,-0.048785,-0.0015264,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.11367,-0.048838,-0.023265,0,0
3,GO MICROTUBULE BASED PROCESS,0.32592,-0.048846,-0.019453,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.71391,-0.049008,-0.01693,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.11275,-0.049157,-0.042228,0,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.53672,-0.049389,-0.017644,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.42133,-0.04945,-0.022654,0,0
3,GO AMINE TRANSPORT,0.85376,-0.049457,0.056872,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.21738,-0.049544,-0.072544,0,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.34213,-0.049554,-0.028272,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.082591,-0.049595,-0.038607,0,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.086981,-0.049628,-0.094885,0,0
3,GO MYELIN ASSEMBLY,0.75356,-0.049728,0.043055,0,0
3,GO ASTROCYTE DEVELOPMENT,0.63408,-0.049847,-0.016796,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.1793,-0.049851,-0.035616,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.22503,-0.049924,-0.07561,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.2114,-0.049952,-0.032982,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.20122,-0.049974,-0.016372,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.318,-0.049984,-0.033168,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.27673,-0.050131,-0.030214,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.31604,-0.050142,-0.04441,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.85059,-0.050347,-0.0070057,0,0
3,GO MESENCHYME DEVELOPMENT,0.28213,-0.050467,-0.035141,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.062684,-0.05059,-0.037935,0,0
3,GO REGULATION OF ORGAN GROWTH,0.71996,-0.050606,-0.0011511,0,0
3,GO NUCLEOSOME ASSEMBLY,0.43789,-0.05078,-0.021798,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.38488,-0.050816,-0.011167,0,0
3,GO REGULATION OF ANION TRANSPORT,0.11092,-0.050959,-0.049627,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.20554,-0.051129,-0.063199,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.57476,-0.05131,-0.016971,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.14869,-0.051434,-0.021991,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.38488,-0.051439,-0.013753,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.1262,-0.051459,-0.056408,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.31997,-0.051549,-0.025566,0,0
3,GO REGULATION OF INSULIN SECRETION,0.44752,-0.051566,-0.010562,0,0
3,GO MANGANESE ION TRANSPORT,0.34627,-0.051577,-0.041418,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.32993,-0.051684,-0.096406,0,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.1387,-0.051735,-0.070784,0,0
3,GO SPERM EGG RECOGNITION,0.29315,-0.05178,-0.023544,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.32993,-0.051912,-0.07848,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.087731,-0.052003,-0.053419,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.1653,-0.052045,-0.01816,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.062684,-0.052108,-0.046872,0,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.071119,-0.052288,-0.04804,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.066192,-0.052351,-0.034779,0,0
3,GO LYMPHANGIOGENESIS,0.43312,-0.05237,-0.042395,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.28395,-0.052433,-0.06417,0,0
3,GO MACROPHAGE ACTIVATION,0.31215,-0.05251,-0.032678,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.1252,-0.052543,-0.0339,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.3442,-0.05255,-0.061455,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.95961,-0.052581,0.036799,0,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.25753,-0.052695,-0.019879,0,0
3,GO RESPONSE TO METAL ION,0.082591,-0.052714,-0.040118,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.32592,-0.052759,-0.020017,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.18327,-0.052783,-0.032955,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.33599,-0.052792,-0.047274,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.087731,-0.05289,-0.052825,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.073043,-0.05293,-0.031182,0,0
3,GO HIPPO SIGNALING,0.53406,-0.052936,-0.039385,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.22195,-0.052984,-0.040907,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.23605,-0.05304,-0.038913,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.95316,-0.053143,0.00025022,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.2458,-0.053145,-0.047881,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.13763,-0.05317,-0.058714,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.34008,-0.053241,-0.014506,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.28033,-0.053294,-0.034187,0,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.12721,-0.053346,-0.081412,0,0
3,GO CARNITINE SHUTTLE,0.62832,-0.053431,-0.0033535,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.10558,-0.053529,-0.047475,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.4451,-0.053627,-0.021403,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.11367,-0.053659,-0.094899,0,0
3,GO JNK CASCADE,0.090782,-0.053711,-0.034085,0,0
3,GO CELLULAR RESPONSE TO KETONE,0.081168,-0.053755,-0.057392,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.59424,-0.053809,-0.026745,0,0
3,GO PROSTATE GLAND GROWTH,0.49231,-0.053817,-0.10102,0,0
3,GO SIGNAL RELEASE,0.28213,-0.054059,-0.016098,0,0
3,GO CELLULAR EXTRAVASATION,0.19979,-0.054065,-0.038709,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.16904,-0.054108,-0.05293,0,0
3,GO MAST CELL MIGRATION,0.17669,-0.054382,-0.12019,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.1873,-0.054482,-0.056414,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.27317,-0.054518,-0.049399,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.4355,-0.054596,-0.020808,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.13338,-0.054944,-0.080409,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.36311,-0.054995,-0.021161,0,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.073043,-0.055039,-0.067035,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.44028,-0.055056,-0.048079,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.084763,-0.05513,-0.099976,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.46218,-0.055224,-0.035674,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.33599,-0.055392,-0.0049982,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.41899,-0.055651,-0.026188,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.34213,-0.055764,-0.035755,0,0
3,GO RESPONSE TO PAIN,0.25414,-0.055871,-0.076643,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.25414,-0.055966,-0.037617,0,0
3,GO RESPONSE TO EPINEPHRINE,0.9113,-0.056046,-0.008091,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.3442,-0.056218,-0.074411,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.077698,-0.056268,-0.076191,0,0
3,GO OSSIFICATION,0.10646,-0.056357,-0.056484,0,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.10471,-0.056361,-0.064025,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.28395,-0.056512,-0.091687,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.18327,-0.056591,-0.032008,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.45727,-0.056647,-0.021006,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.098784,-0.056687,-0.02839,0,0
3,GO CELL CELL RECOGNITION,0.24745,-0.056757,-0.028215,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.086237,-0.05684,-0.039699,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.32792,-0.056849,-0.011852,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.14983,-0.056894,-0.033258,0,0
3,GO TRABECULA MORPHOGENESIS,0.17411,-0.057015,-0.054209,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.080464,-0.057105,-0.063486,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.14197,-0.057259,-0.032632,0,0
3,GO HINDLIMB MORPHOGENESIS,0.28578,-0.057334,-0.059484,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.14983,-0.057391,-0.062349,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.096327,-0.057466,-0.03418,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.22814,-0.057494,-0.046577,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.15921,-0.057499,-0.020618,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.08331,-0.057521,-0.042612,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.50258,-0.057558,-0.033426,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.1262,-0.057733,-0.042604,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.28945,-0.057772,-0.060281,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.48215,-0.057896,-0.0010426,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.59424,-0.057911,-0.028109,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.12029,-0.05795,-0.05405,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.33803,-0.058072,-0.086161,0,0
3,GO REGENERATION,0.15921,-0.058092,-0.03804,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.13656,-0.058379,-0.061275,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.25246,-0.058498,-0.045421,0,0
3,GO RESPONSE TO X RAY,0.16904,-0.058598,-0.07208,0,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.91451,-0.058631,0.0082912,0,0
3,GO LIPID DROPLET ORGANIZATION,0.20554,-0.058635,-0.043581,0,0
3,GO LYMPHOCYTE MIGRATION,0.11837,-0.058663,-0.059426,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.1453,-0.058823,-0.019053,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.52345,-0.05891,-0.03345,0,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.086981,-0.058941,-0.030143,0,0
3,GO RESPONSE TO INTERLEUKIN 15,0.068619,-0.058979,-0.099901,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.12822,-0.058997,-0.042021,0,0
3,GO REGULATION OF HEAT GENERATION,0.17669,-0.059174,-0.11097,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.068006,-0.059328,-0.053014,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.5394,-0.059395,-0.025665,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.20554,-0.05941,-0.06269,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.20992,-0.059473,-0.077146,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.090782,-0.059576,-0.05,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.3739,-0.059708,-0.066341,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.72299,-0.059867,-0.0030082,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.33599,-0.060037,-0.069628,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.92094,-0.060116,0.032171,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.65734,-0.06014,-0.047602,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.14308,-0.060197,-0.049312,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.20122,-0.060205,-0.036106,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.26095,-0.060249,-0.062527,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.28578,-0.060362,-0.0079298,0,0
3,GO ERK1 AND ERK2 CASCADE,0.16042,-0.060368,-0.043095,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.1387,-0.060557,-0.0441,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.81896,-0.060612,-0.010049,0,0
3,GO GLIAL CELL DEVELOPMENT,0.24252,-0.060755,-0.026814,0,0
3,GO LIPID OXIDATION,0.10385,-0.060864,-0.054417,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.21889,-0.06093,-0.05196,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.68689,-0.061171,-0.0088264,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.38933,-0.061204,-0.026274,0,0
3,GO PROTEIN MANNOSYLATION,0.084034,-0.061276,-0.060812,0,0
3,GO DIET INDUCED THERMOGENESIS,0.66616,-0.061502,-0.0021662,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.13549,-0.061779,-0.035888,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.1313,-0.061913,-0.033164,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.26095,-0.061964,-0.055,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.67798,-0.062109,-0.019649,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.073694,-0.062159,-0.088136,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.76899,-0.062203,0.01937,0,0
3,GO OVULATION,0.15565,-0.06222,-0.076703,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.26789,-0.062238,-0.066806,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.17029,-0.062242,-0.050541,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.13234,-0.062271,-0.036078,0,0
3,GO GASTRULATION,0.21288,-0.062292,-0.040517,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.36956,-0.062309,-0.057547,0,0
3,GO AMELOGENESIS,0.52345,-0.062332,-0.034903,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.86331,-0.062375,-0.010978,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.19697,-0.062557,-0.03441,0,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.10299,-0.062661,-0.074017,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.18327,-0.062738,-0.034896,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.21738,-0.062741,-0.071362,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.14983,-0.062927,-0.07285,0,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.093126,-0.062937,-0.068469,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.77519,-0.062998,0.0036655,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.55016,-0.063103,0.011597,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.25414,-0.063403,-0.046182,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.15921,-0.063408,-0.037901,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.21288,-0.06343,-0.075981,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.17156,-0.063451,-0.078223,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.16654,-0.063475,-0.073581,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.20265,-0.064176,-0.072413,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.081877,-0.064182,-0.058834,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.12029,-0.064212,-0.028342,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.082591,-0.064298,-0.075228,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.32195,-0.064335,-0.051238,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.33194,-0.064396,-0.034745,0,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.068006,-0.064577,-0.043455,0,0
3,GO T CELL APOPTOTIC PROCESS,0.12721,-0.064692,-0.079807,0,0
3,GO SELECTIVE AUTOPHAGY,0.062684,-0.064749,-0.05276,0,0
3,GO HISTONE H3 DEACETYLATION,0.66616,-0.064807,-0.0023275,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.26614,-0.064997,-0.052831,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.11092,-0.065519,-0.040817,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.35886,-0.065566,-0.02732,0,0
3,GO PROTEIN KINASE C SIGNALING,0.37827,-0.065622,-0.028439,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.56925,-0.066147,-0.020196,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.31021,-0.066224,-0.024665,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.15214,-0.066385,-0.037534,0,0
3,GO NODAL SIGNALING PATHWAY,0.318,-0.0665,-0.067627,0,0
3,GO PRIMARY MIRNA PROCESSING,0.22503,-0.0665,-0.048451,0,0
3,GO FATTY ACID BETA OXIDATION,0.14088,-0.066505,-0.048823,0,0
3,GO TONGUE MORPHOGENESIS,0.18866,-0.066615,-0.15575,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.17411,-0.066684,-0.040453,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.43075,-0.066924,-0.049668,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.21889,-0.067037,-0.036825,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.06986,-0.067078,-0.06713,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.23128,-0.067182,-0.060368,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.25078,-0.067248,-0.053458,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.10214,-0.067419,-0.068244,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.1914,-0.067437,-0.076474,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.44269,-0.067624,-0.052177,0,0
3,GO BODY MORPHOGENESIS,0.066192,-0.067667,-0.081559,0,0
3,GO GLIAL CELL PROLIFERATION,0.074349,-0.067696,-0.095062,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.2114,-0.067782,-0.061756,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.064418,-0.067924,-0.059626,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.39832,-0.067994,-0.055503,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.33396,-0.068009,-0.034825,0,0
3,GO STEROL HOMEOSTASIS,0.18062,-0.068133,-0.063531,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.19979,-0.068167,-0.082712,0,0
3,GO AXIS SPECIFICATION,0.24416,-0.06823,-0.027226,0,0
3,GO STEROL METABOLIC PROCESS,0.32195,-0.06828,-0.021612,0,0
3,GO STRESS FIBER ASSEMBLY,0.14983,-0.068385,-0.046085,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.16042,-0.068573,-0.056376,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.69286,-0.0686,-0.018584,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.1146,-0.068682,-0.092632,0,0
3,GO NEURAL CREST FORMATION,0.53672,-0.068934,-0.048708,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.21288,-0.068935,-0.046397,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.318,-0.068952,-0.015267,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.14088,-0.069277,-0.07388,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.27853,-0.069373,-0.037072,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.22658,-0.069623,-0.073179,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.2714,-0.06972,-0.017912,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.12126,-0.069741,-0.068625,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.45972,-0.069929,-0.037302,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.72299,-0.069935,0.0089067,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.34835,-0.070327,-0.053126,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.56376,-0.070328,-0.052959,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.38047,-0.07053,-0.028688,0,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.45972,-0.070707,-0.032197,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.37827,-0.071017,-0.035497,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.080464,-0.071032,-0.041581,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.2644,-0.071326,-0.03377,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.090782,-0.071557,-0.060328,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.23445,-0.071682,-0.032385,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.081168,-0.071751,-0.091742,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.80639,-0.07178,0.0050029,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.30255,-0.071989,-0.050667,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.09714,-0.072001,-0.10052,0,0
3,GO HISTONE H4 DEACETYLATION,0.11002,-0.072279,-0.082985,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.61687,-0.072309,-0.0055727,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.36526,-0.072698,-0.02911,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.13338,-0.072715,-0.057411,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.4451,-0.073004,-0.055714,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.92738,-0.073172,0.017444,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.51035,-0.073479,-0.031077,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.14419,-0.073513,-0.044459,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.10558,-0.073555,-0.080185,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.33396,-0.07367,-0.049715,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.092339,-0.07386,-0.079929,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.14755,-0.073876,-0.036053,0,0
3,GO REGULATION OF LIPID STORAGE,0.092339,-0.073947,-0.050782,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12924,-0.074085,-0.084303,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.24416,-0.074192,-0.026908,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.31215,-0.074318,-0.02737,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.11837,-0.074379,-0.023911,0,0
3,GO LIPID HOMEOSTASIS,0.20992,-0.074381,-0.039449,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.18595,-0.074555,-0.11054,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.24252,-0.074679,-0.07941,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.36526,-0.074758,-0.030721,0,0
3,GO HYPEROSMOTIC RESPONSE,0.064418,-0.074836,-0.062857,0,0
3,GO EMBRYO IMPLANTATION,0.19697,-0.075027,-0.06683,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.33396,-0.075085,-0.080229,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.12421,-0.0753,-0.04883,0,0
3,GO MYOBLAST FUSION,0.21437,-0.075439,-0.068419,0,0
3,GO ACTIN CROSSLINK FORMATION,0.86012,-0.075458,0.033716,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.39381,-0.075787,-0.027144,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.34627,-0.075846,-0.017013,0,0
3,GO FLUID TRANSPORT,0.11183,-0.075867,-0.075798,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.16654,-0.075977,-0.042146,0,0
3,GO VASCULOGENESIS,0.43075,-0.076166,-0.035451,0,0
3,GO MUSCLE CELL PROLIFERATION,0.090782,-0.07625,-0.060287,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.3442,-0.076289,-0.054958,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.6055,-0.076434,-0.0073674,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.077698,-0.076545,-0.091331,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.73517,-0.076641,-0.0063249,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.58585,-0.076757,-0.05388,0,0
3,GO NEURONAL ACTION POTENTIAL,0.11002,-0.076811,-0.11733,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.20554,-0.076826,-0.032788,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.17283,-0.076831,-0.08348,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.36956,-0.076926,-0.096499,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.19417,-0.077115,-0.092706,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.17411,-0.07745,-0.11061,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.076344,-0.077481,-0.074375,0,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.081168,-0.077505,-0.032262,0,0
3,GO LYSOSOMAL TRANSPORT,0.080464,-0.077579,-0.049903,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.15683,-0.077843,-0.075395,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.52609,-0.077927,-0.039905,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.089246,-0.0781,-0.031247,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.41666,-0.078738,-0.035661,0,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.11933,-0.079128,-0.042577,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.13656,-0.079226,-0.040607,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.16163,-0.079478,-0.069584,0,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.090782,-0.079588,-0.077134,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.13656,-0.079739,-0.079684,0,0
3,GO PLASMA MEMBRANE FUSION,0.10823,-0.079785,-0.12853,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.073043,-0.079795,-0.092461,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.089246,-0.080158,-0.087014,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.42367,-0.08016,-0.017456,0,0
3,GO ASTROCYTE ACTIVATION,0.11933,-0.080358,-0.068283,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.13027,-0.080437,-0.048023,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.070488,-0.080595,-0.036402,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.77209,-0.08063,0.014818,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.096327,-0.080768,-0.042168,0,0
3,GO T CELL CHEMOTAXIS,0.064418,-0.080897,-0.07677,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.54477,-0.080935,-0.0061004,0,0
3,GO RESPONSE TO PH,0.14088,-0.081224,-0.042253,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.99515,-0.081406,0.012585,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.27495,-0.08143,-0.091651,0,0
3,GO PHAGOCYTOSIS,0.10214,-0.081562,-0.057872,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.26964,-0.081692,-0.11562,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.089246,-0.081733,-0.074422,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.12224,-0.081834,-0.05119,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.066192,-0.081847,-0.057434,0,0
3,GO INSULIN SECRETION,0.15802,-0.082257,-0.040384,0,0
3,GO ORGAN GROWTH,0.18866,-0.082362,-0.037196,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.56925,-0.082709,-0.058287,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.13027,-0.08284,-0.060369,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.1914,-0.082852,-0.02679,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.6055,-0.083417,-0.021389,0,0
3,GO GASTRIC ACID SECRETION,0.075009,-0.083664,-0.074024,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.13979,-0.083744,-0.051302,0,0
3,GO PEPTIDE HORMONE SECRETION,0.16285,-0.083773,-0.034925,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.13444,-0.083924,-0.07177,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.077018,-0.083968,-0.16492,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.31604,-0.084063,-0.034214,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.069238,-0.084517,-0.10636,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.2913,-0.084614,-0.059824,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.073694,-0.084634,-0.048687,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.59705,-0.084678,-0.06512,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.24416,-0.084749,-0.074002,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.12322,-0.084829,-0.067956,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.068619,-0.084839,-0.064862,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.40973,-0.08487,-0.034105,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.76899,-0.08492,0.11098,0,0
3,GO GENITALIA MORPHOGENESIS,0.77829,-0.085031,-0.01997,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.2714,-0.085129,-0.059027,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.14088,-0.085182,-0.062045,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.079765,-0.085494,-0.084013,0,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.081168,-0.085523,-0.061632,0,0
3,GO VACUOLAR ACIDIFICATION,0.078382,-0.085543,-0.075807,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.10912,-0.085682,-0.077918,0,0
3,GO CHONDROCYTE PROLIFERATION,0.38267,-0.0858,-0.061729,0,0
3,GO BONE MATURATION,0.3442,-0.085927,-0.040685,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.10299,-0.085974,-0.078618,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.12924,-0.086198,-0.077983,0,0
3,GO RESPONSE TO TUMOR CELL,0.15683,-0.086531,-0.091335,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.086237,-0.086742,-0.063467,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.16407,-0.086785,-0.10039,0,0
3,GO COPULATION,0.093918,-0.086826,-0.086268,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.1146,-0.086834,-0.062675,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.073043,-0.086852,-0.074361,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.12822,-0.086967,-0.054252,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.12924,-0.087198,-0.057683,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.38047,-0.087272,-0.045574,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.5665,-0.087438,-0.010977,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.23605,-0.088098,-0.031711,0,0
3,GO FIBROBLAST PROLIFERATION,0.5583,-0.088161,-0.0097797,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.63986,-0.08817,-0.019742,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.92094,-0.08828,0.023608,0,0
3,GO DNA METHYLATION,0.23128,-0.08838,-0.032112,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.1533,-0.088447,-0.043093,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.17669,-0.088488,-0.06787,0,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.09796,-0.088618,-0.069757,0,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.089246,-0.088798,-0.049754,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.12924,-0.089111,-0.042904,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.10214,-0.08929,-0.080892,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.096327,-0.089318,-0.072239,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.27673,-0.089519,-0.044586,0,0
3,GO GOLGI LOCALIZATION,0.074349,-0.089774,-0.062191,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.1313,-0.09014,-0.04838,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.92738,-0.090185,0.016628,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.61972,-0.09035,-0.037294,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.099614,-0.090858,-0.07411,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.092339,-0.090935,-0.048415,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.37173,-0.091215,-0.08862,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.094715,-0.091361,-0.082093,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.13338,-0.091501,-0.15475,0,0
3,GO INOSITOL METABOLIC PROCESS,0.078382,-0.091573,-0.066952,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.088486,-0.091631,-0.079241,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.17029,-0.091827,-0.092265,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.25078,-0.092163,-0.091489,0,0
3,GO SKIN MORPHOGENESIS,0.40743,-0.092181,-0.071797,0,0
3,GO PROSTATIC BUD FORMATION,0.30446,-0.092451,-0.11812,0,0
3,GO SPERM AXONEME ASSEMBLY,0.11647,-0.092538,-0.098995,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.1313,-0.092557,-0.056665,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.14088,-0.092567,-0.044155,0,0
3,GO RECEPTOR CATABOLIC PROCESS,0.073694,-0.092775,-0.060298,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.10823,-0.092846,-0.07266,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.072397,-0.092988,-0.05088,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.23128,-0.093073,-0.092831,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.098784,-0.093114,-0.094049,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.20699,-0.093171,-0.060661,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.11002,-0.093208,-0.058731,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.17283,-0.093773,-0.044068,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.1793,-0.093798,-0.082286,0,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.11183,-0.094227,-0.045133,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.082591,-0.094497,-0.10575,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.14419,-0.094522,-0.064635,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.078382,-0.094587,-0.068559,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.52082,-0.095164,-0.029587,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.19278,-0.095167,-0.1127,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.24089,-0.095695,-0.062476,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.12126,-0.096054,-0.13865,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.24089,-0.096072,-0.038473,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.16285,-0.096326,-0.11282,0,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.072397,-0.096417,-0.059673,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.089246,-0.096688,-0.074038,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.45238,-0.097111,-0.031224,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.19417,-0.097242,-0.059872,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.30446,-0.097252,-0.070737,0,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.092339,-0.097295,-0.071307,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.078382,-0.097571,-0.073498,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.11647,-0.097695,-0.049566,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.10299,-0.098428,-0.067932,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.072397,-0.099337,-0.057612,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.14419,-0.09951,-0.051954,0,0
3,GO PERICARDIUM DEVELOPMENT,0.25924,-0.099572,-0.060401,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.1754,-0.099951,-0.10487,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.12721,-0.099998,-0.065389,0,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.093918,-0.10017,-0.066977,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.23605,-0.10089,-0.088379,0,0
3,GO KERATINOCYTE MIGRATION,0.062114,-0.10108,-0.066092,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.22658,-0.10134,-0.088987,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.10912,-0.1014,-0.06875,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.31997,-0.10195,-0.076704,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.16042,-0.10211,-0.049236,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.22971,-0.10285,-0.0956,0,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.12421,-0.10294,-0.07572,0,0
3,GO METANEPHROS MORPHOGENESIS,0.10646,-0.10343,-0.090853,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.10299,-0.1049,-0.10723,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.1146,-0.10505,-0.062098,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.12822,-0.10663,-0.039812,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.10471,-0.10674,-0.069654,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.13549,-0.10708,-0.073931,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.12822,-0.10717,-0.069375,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.073043,-0.10717,-0.073916,0,0
3,GO AMYLOID FIBRIL FORMATION,0.36098,-0.10756,-0.065497,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.17156,-0.10782,-0.061931,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.20992,-0.10793,-0.058838,0,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.23128,-0.10828,-0.068174,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.065596,-0.10848,-0.11641,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.068619,-0.10855,-0.11541,0,0
3,GO KINETOCHORE ASSEMBLY,0.087731,-0.10893,-0.07961,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.59705,-0.10903,-0.046651,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.27673,-0.1095,-0.035765,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.54477,-0.10956,-0.057271,0,0
3,GO RESPONSE TO COPPER ION,0.089246,-0.11062,-0.11296,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.11183,-0.11066,-0.081733,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.34213,-0.11096,-0.062386,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.56103,-0.11105,-0.049706,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.45972,-0.11109,-0.046372,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.067397,-0.1111,-0.057296,0,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.1453,-0.11151,-0.13734,0,0
3,GO RENAL FILTRATION,0.22971,-0.11216,-0.073393,0,0
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.14869,-0.11282,-0.052685,0,0
3,GO MRNA TRANSCRIPTION,0.11933,-0.11346,-0.052226,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.1146,-0.11347,-0.069853,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.099614,-0.11382,-0.083584,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.26789,-0.11382,-0.05434,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.2714,-0.11419,-0.068457,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.14869,-0.11434,-0.0964,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.4451,-0.11467,-0.017589,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.073043,-0.11482,-0.064334,0,0
3,GO RESPONSE TO GONADOTROPIN,0.070488,-0.11515,-0.089676,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.18461,-0.11528,-0.10279,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.17669,-0.1158,-0.075139,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.10129,-0.11614,-0.065165,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.67798,-0.11617,-0.026362,0,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.084763,-0.11706,-0.096934,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.2714,-0.11722,-0.099222,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.24911,-0.1176,-0.060917,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.16407,-0.11797,-0.077895,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.065005,-0.11826,-0.070715,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.063258,-0.11831,-0.051643,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.14197,-0.11832,-0.066495,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.098784,-0.11844,-0.070652,0,0
3,GO FAT CELL PROLIFERATION,0.11742,-0.11848,-0.11393,0,0
3,GO LOCOMOTOR RHYTHM,0.42367,-0.11865,-0.026454,0,0
3,GO EATING BEHAVIOR,0.077018,-0.11878,-0.059275,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.20699,-0.11899,-0.049445,0,0
3,GO RESPONSE TO INSECTICIDE,0.56925,-0.119,-0.026048,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.50258,-0.11903,-0.062263,0,0
3,GO RESPONSE TO VITAMIN D,0.21738,-0.11911,-0.052292,0,0
3,GO NOTOCHORD DEVELOPMENT,0.078382,-0.11918,-0.13879,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.067397,-0.11936,-0.11978,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.067397,-0.11942,-0.066924,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.1313,-0.11948,-0.092171,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.10823,-0.11978,-0.10828,0,0
3,GO TRNA CATABOLIC PROCESS,0.11092,-0.12034,-0.12354,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.17029,-0.1205,-0.094278,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.094715,-0.12115,-0.091882,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.15447,-0.12172,-0.095622,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.11367,-0.12268,-0.13169,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.10646,-0.12302,-0.08644,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.25078,-0.12339,-0.054826,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.1793,-0.12423,-0.094406,0,0
3,GO MITOTIC DNA REPLICATION,0.11933,-0.12505,-0.072662,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.1914,-0.12555,-0.106,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.072397,-0.12583,-0.089058,0,0
3,GO RESPONSE TO ACIDIC PH,0.10129,-0.12683,-0.095292,0,0
3,GO UTERUS DEVELOPMENT,0.30255,-0.12722,-0.040024,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.32195,-0.12814,-0.053383,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.12126,-0.12819,-0.1441,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.15802,-0.12834,-0.11756,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.24089,-0.12904,-0.056286,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.16407,-0.12969,-0.10019,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.066192,-0.12978,-0.10044,0,0
3,GO REGULATION OF GTP BINDING,0.27853,-0.13063,-0.060158,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.2644,-0.13103,-0.046145,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.093126,-0.13192,-0.072681,0,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.25583,-0.13225,-0.07337,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.091558,-0.13258,-0.090292,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.28761,-0.13268,-0.05523,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.16778,-0.1334,-0.074636,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.14869,-0.13365,-0.082978,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.15098,-0.13391,-0.076713,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.081877,-0.13424,-0.11166,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.15098,-0.13435,-0.14014,0,0
3,GO SEROTONIN SECRETION,0.16042,-0.13435,-0.062162,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.096327,-0.13489,-0.090639,0,0
3,GO EPIBOLY,0.11367,-0.13501,-0.10023,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.16042,-0.13728,-0.08908,0,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.13027,-0.13746,-0.15721,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.075674,-0.13801,-0.11631,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.096327,-0.13836,-0.088489,0,0
3,GO LACTATE METABOLIC PROCESS,0.10385,-0.13942,-0.090435,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.14308,-0.13951,-0.10248,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.2114,-0.13997,-0.066111,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.065005,-0.14,-0.10319,0,0
3,GO RENAL WATER HOMEOSTASIS,0.06986,-0.14337,-0.071778,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.11092,-0.14361,-0.17335,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.16654,-0.14388,-0.0798,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.49231,-0.14391,-0.036777,0,0
3,GO PARENTAL BEHAVIOR,0.074349,-0.1448,-0.15158,0,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.065596,-0.14484,-0.15038,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.093918,-0.14612,-0.10631,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.20122,-0.14625,-0.061986,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.12421,-0.14671,-0.1054,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.09714,-0.14713,-0.12291,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.12822,-0.14733,-0.10135,0,0
3,GO TRACHEA MORPHOGENESIS,0.10471,-0.15025,-0.088229,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.068006,-0.1507,-0.10447,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.40973,-0.15303,-0.032994,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.12721,-0.15396,-0.042449,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.11837,-0.15444,-0.11423,0,0
3,GO PARTURITION,0.067397,-0.15603,-0.11505,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.30255,-0.15764,-0.083593,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.081168,-0.15767,-0.095652,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.15683,-0.15809,-0.079494,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.51035,-0.15822,-0.030946,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.080464,-0.15939,-0.090037,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.15214,-0.16041,-0.11277,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.31215,-0.16078,-0.045084,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.09796,-0.1627,-0.1308,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.13027,-0.16537,-0.095294,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.16778,-0.16581,-0.050446,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.065005,-0.1693,-0.099537,0,0
3,GO DETECTION OF CALCIUM ION,0.12322,-0.16982,-0.12504,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.092339,-0.17436,-0.12558,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.26789,-0.17541,-0.073829,0,0
3,GO RESPONSE TO UV B,0.072397,-0.17553,-0.15119,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.064418,-0.17575,-0.18431,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.079765,-0.17723,-0.15974,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.28761,-0.17878,-0.08935,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.26614,-0.18,-0.076249,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.093918,-0.18674,-0.10622,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.1146,-0.18953,-0.10765,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.089246,-0.19095,-0.12796,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.20409,-0.19253,-0.070107,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.06986,-0.19525,-0.14117,0,0
3,GO BLEB ASSEMBLY,0.11275,-0.19558,-0.2177,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.26964,-0.20371,-0.034267,0,0
3,GO SOMATIC STEM CELL DIVISION,0.063836,-0.20642,-0.14748,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.16163,-0.21689,-0.093028,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.069238,-0.22784,-0.14147,0,0
3,GO NEPHRON TUBULE FORMATION,0.074349,-0.23304,-0.17329,0,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.075674,-0.2461,-0.12005,0,0
3,GO INTERLEUKIN 5 PRODUCTION,0.089246,-0.24825,-0.11401,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.13444,-0.26311,-0.089938,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.21288,-0.26832,-0.081884,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.091558,-0.45433,-0.12605,0,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1.1588e-05,0.70576,0.74612,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,6.3359e-07,0.62532,0.60025,1,1
4,GO HISTAMINE SECRETION,1.6321e-06,0.60845,0.5042,1,1
4,GO HISTAMINE TRANSPORT,3.9822e-07,0.52796,0.47793,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,1.2886e-07,0.51046,0.57356,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,7.1726e-09,0.50996,0.50441,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,9.2321e-08,0.50612,0.49491,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,6.6717e-09,0.49774,0.53368,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00075607,0.48753,0.42793,1,1
4,GO REFLEX,2.3239e-05,0.47881,0.39321,1,1
4,GO REGULATION OF PLATELET AGGREGATION,3.5794e-07,0.47817,0.48277,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,4.3355e-07,0.47269,0.47256,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,5.1101e-09,0.46065,0.46501,1,1
4,GO O GLYCAN PROCESSING,3.4003e-08,0.45906,0.39383,1,1
4,GO INTESTINAL LIPID ABSORPTION,1.996e-06,0.45716,0.49602,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,4.0343e-10,0.45453,0.4491,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,5.7582e-06,0.45346,0.42367,1,1
4,GO RESPONSE TO TYPE I INTERFERON,0.00047589,0.44607,0.32181,1,1
4,GO INTESTINAL ABSORPTION,5.6317e-09,0.44279,0.46034,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,1.2032e-06,0.43458,0.49518,1,1
4,GO REGULATION OF ANOIKIS,4.3355e-07,0.43111,0.42978,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00025617,0.42923,0.39786,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00029511,0.42807,0.3109,1,1
4,GO TOXIN METABOLIC PROCESS,2.3784e-07,0.4252,0.39414,1,1
4,GO MUCUS SECRETION,0.001235,0.42406,0.37735,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00063314,0.41816,0.3617,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,5.4184e-05,0.41632,0.38236,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.0712e-08,0.4161,0.43297,1,1
4,GO STABILIZATION OF MEMBRANE POTENTIAL,7.3739e-05,0.41551,0.37333,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,9.5999e-07,0.41175,0.51069,1,1
4,GO REGULATION OF PLATELET ACTIVATION,2.1196e-06,0.4107,0.37534,1,1
4,GO ADRENAL GLAND DEVELOPMENT,6.2993e-08,0.40923,0.40961,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,3.628e-05,0.40798,0.40687,1,1
4,GO RENAL ABSORPTION,2.8305e-05,0.40795,0.40693,1,1
4,GO DENDRITIC CELL APOPTOTIC PROCESS,5.0563e-05,0.40735,0.37405,1,1
4,GO RESPONSE TO INTERFERON BETA,0.0021505,0.40569,0.2859,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.00012186,0.39703,0.31393,1,1
4,GO CELLULAR RESPONSE TO ZINC ION,0.0050904,0.39492,0.37886,1,1
4,GO LIPOXYGENASE PATHWAY,0.00022565,0.39334,0.35039,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,3.0156e-07,0.39306,0.46449,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00026024,0.39288,0.31077,1,1
4,GO RESPONSE TO MAGNESIUM ION,1.734e-06,0.38825,0.4066,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0035146,0.38563,0.27347,1,1
4,GO DETECTION OF OTHER ORGANISM,0.00037835,0.38436,0.32138,1,1
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.043866,0.38022,0.46029,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,6.0991e-06,0.3789,0.33934,1,1
4,GO TOLERANCE INDUCTION,0.001071,0.37845,0.33037,1,1
4,GO CELLULAR RESPONSE TO COPPER ION,0.009139,0.37834,0.33976,1,1
4,GO ADHESION OF SYMBIONT TO HOST,2.5868e-06,0.37779,0.3966,1,1
4,GO REGULATION OF VASCULOGENESIS,2.2015e-05,0.37774,0.34618,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,1.5014e-05,0.37733,0.41554,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0084096,0.37642,0.22531,1,1
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.6994e-06,0.37457,0.39479,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00014362,0.37304,0.30668,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.1375e-05,0.37224,0.31799,1,1
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.00016629,0.36804,0.30904,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,5.7582e-06,0.3667,0.37933,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,9.7991e-09,0.36614,0.41623,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.1751e-05,0.36595,0.38331,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.00018923,0.3659,0.30936,1,1
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00031414,0.36576,0.33028,1,1
4,GO RESPONSE TO PAIN,4.0868e-08,0.36005,0.36009,1,1
4,GO MECHANOSENSORY BEHAVIOR,0.019312,0.35972,0.24826,1,1
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,8.5858e-05,0.35959,0.35471,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.971e-06,0.35101,0.4159,1,1
4,GO GERMINAL CENTER FORMATION,0.00033955,0.35055,0.29922,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00020178,0.34568,0.36092,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,3.8246e-05,0.34437,0.29427,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,2.5884e-05,0.34315,0.40832,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.8701e-05,0.3419,0.34306,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00010323,0.34128,0.29388,1,1
4,GO RESPONSE TO INTERFERON ALPHA,0.019312,0.34115,0.21391,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,2.8814e-05,0.34079,0.33337,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,1.5293e-05,0.34013,0.34563,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,1.4207e-05,0.33931,0.32372,1,1
4,GO MEMBRANE RAFT ORGANIZATION,0.00043435,0.33836,0.31647,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,4.0657e-06,0.33725,0.44722,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,3.6877e-06,0.33432,0.30952,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.0011836,0.33351,0.28581,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.0004e-06,0.33271,0.39734,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.001483,0.33255,0.2869,1,1
4,GO RESPONSE TO DIETARY EXCESS,3.0905e-06,0.33232,0.3234,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.001235,0.33207,0.26631,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,9.0235e-07,0.33109,0.32924,1,1
4,GO NEURONAL ACTION POTENTIAL,1.0004e-06,0.33105,0.39554,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,1.9563e-06,0.33102,0.30209,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,3.3228e-08,0.33063,0.30231,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.00040235,0.32865,0.26012,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00057029,0.32549,0.29421,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,4.8673e-09,0.32477,0.35887,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00015331,0.32475,0.3102,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,6.0991e-06,0.32385,0.26043,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00048316,0.32317,0.32458,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0011021,0.32248,0.33809,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.00021857,0.32218,0.33174,1,1
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.02174,0.32204,0.23599,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00057029,0.32174,0.30628,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.4262e-06,0.31917,0.32742,1,1
4,GO REGULATION OF DENDRITE EXTENSION,5.1351e-07,0.31861,0.35102,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,1.5372e-07,0.31827,0.37478,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,4.6578e-06,0.31745,0.31199,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,9.7998e-07,0.31696,0.31288,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00040857,0.31636,0.27916,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,2.9859e-05,0.31629,0.31194,1,1
4,GO CORNIFICATION,5.3256e-05,0.31582,0.2748,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0020929,0.31448,0.24875,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00036686,0.31446,0.27252,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,1.9175e-06,0.31311,0.37993,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0050904,0.31253,0.20481,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00016361,0.31029,0.24666,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0033799,0.30936,0.24106,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00021511,0.30899,0.35162,1,1
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,5.8049e-05,0.30876,0.35274,1,1
4,GO PLASMA MEMBRANE FUSION,0.00010152,0.30817,0.29518,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00015083,0.30772,0.2846,1,1
4,GO REGULATION OF DOPAMINE SECRETION,7.105e-06,0.30766,0.42208,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,1.3948e-05,0.30679,0.37845,1,1
4,GO EOSINOPHIL CHEMOTAXIS,6.545e-05,0.30652,0.35291,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00022208,0.30541,0.25861,1,1
4,GO KERATINIZATION,5.8698e-06,0.30527,0.2757,1,1
4,GO RESPONSE TO COLD,7.0337e-07,0.30501,0.28892,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,3.094e-05,0.30446,0.29599,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,3.9872e-06,0.30403,0.37404,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,4.8416e-06,0.30399,0.36205,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,7.5217e-06,0.30274,0.2756,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.6761e-05,0.30194,0.29965,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,8.1138e-06,0.30158,0.26622,1,1
4,GO RESPONSE TO COPPER ION,0.00018323,0.30152,0.33004,1,1
4,GO NOTCH RECEPTOR PROCESSING,0.00061456,0.30101,0.30606,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,1.1086e-06,0.30016,0.35159,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,6.337e-06,0.29872,0.32835,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,1.5052e-06,0.29854,0.29815,1,1
4,GO SEQUESTERING OF ACTIN MONOMERS,0.00049053,0.29826,0.31765,1,1
4,GO RESPONSE TO REDOX STATE,1.3325e-06,0.29817,0.29133,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0050269,0.298,0.20439,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,8.0256e-05,0.29688,0.25677,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00022565,0.2967,0.31762,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.003607,0.29648,0.2196,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.0010408,0.29633,0.20849,1,1
4,GO RESPONSE TO FORSKOLIN,0.0011503,0.29629,0.25715,1,1
4,GO REGULATION OF RESPIRATORY BURST,1.1041e-08,0.29563,0.36063,1,1
4,GO ACTIN FILAMENT SEVERING,0.0001179,0.29524,0.29657,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0002117,0.29369,0.23756,1,1
4,GO CELLULAR DEFENSE RESPONSE,1.8363e-05,0.2934,0.23706,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0021215,0.29277,0.29002,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.011544,0.29178,0.26924,1,1
4,GO ANOIKIS,7.969e-07,0.29166,0.33155,1,1
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.0022701,0.2916,0.26411,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00016901,0.29109,0.24981,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00017176,0.2882,0.38012,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,4.2487e-05,0.28793,0.27149,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,6.2046e-07,0.28721,0.27776,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.7693e-06,0.28674,0.26599,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0012886,0.28574,0.23518,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.00067188,0.28559,0.27309,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00020178,0.28552,0.30231,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,1.5576e-05,0.28515,0.27812,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.0010408,0.28509,0.25671,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,6.6578e-05,0.28454,0.27981,1,1
4,GO LIPID TRANSLOCATION,5.4701e-07,0.2844,0.30354,1,1
4,GO DOPAMINE TRANSPORT,2.0364e-06,0.2843,0.38746,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00084997,0.28381,0.29238,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0020367,0.28374,0.22421,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,2.5868e-06,0.28267,0.27374,1,1
4,GO DETECTION OF CALCIUM ION,7.3803e-06,0.28227,0.355,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00015083,0.28208,0.2545,1,1
4,GO RESPONSE TO AUDITORY STIMULUS,0.0051547,0.2816,0.22312,1,1
4,GO EOSINOPHIL MIGRATION,0.00018923,0.28071,0.32265,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,6.7461e-07,0.28034,0.32448,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0044864,0.27921,0.20168,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0075485,0.27817,0.25347,1,1
4,GO B CELL APOPTOTIC PROCESS,1.4741e-05,0.27799,0.26526,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.00016629,0.27624,0.26249,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0023321,0.27581,0.26669,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,0.00024819,0.27541,0.29809,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0020646,0.27488,0.18969,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,1.0004e-06,0.27385,0.29096,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00094089,0.27292,0.20872,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00045468,0.27284,0.2639,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,9.4341e-06,0.27144,0.26651,1,1
4,GO VASODILATION,6.8888e-05,0.271,0.20762,1,1
4,GO REGULATION OF NEURON MATURATION,0.00019541,0.27075,0.24392,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0042636,0.26941,0.2437,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,1.1375e-05,0.26931,0.30409,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0032078,0.26877,0.25088,1,1
4,GO ZYMOGEN ACTIVATION,0.00027284,0.26793,0.25201,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0001803,0.26786,0.35333,1,1
4,GO RESPONSE TO EPINEPHRINE,0.00010152,0.2676,0.34669,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,6.545e-05,0.26648,0.23194,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00029511,0.26579,0.26432,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0026663,0.26562,0.27258,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00033432,0.26558,0.2073,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.0005789,0.26548,0.24451,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,7.3739e-05,0.26524,0.30352,1,1
4,GO REGULATION OF VESICLE FUSION,0.0029645,0.2652,0.21813,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00013232,0.26436,0.26018,1,1
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.00015838,0.26426,0.37241,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00016629,0.26371,0.28626,1,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0022396,0.26281,0.23643,1,1
4,GO RESPIRATORY BURST,1.0756e-05,0.26274,0.26279,1,1
4,GO MYELIN MAINTENANCE,0.001071,0.26241,0.27861,1,1
4,GO PANCREATIC JUICE SECRETION,0.00073415,0.26236,0.18496,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,3.357e-07,0.26231,0.29682,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0047198,0.26214,0.16236,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.014658,0.26143,0.15204,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.0051547,0.26085,0.19668,1,1
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0030038,0.26082,0.27236,1,1
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.0063654,0.26058,0.20878,1,1
4,GO REGULATION OF TISSUE REMODELING,1.2954e-05,0.26036,0.24749,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,9.6129e-06,0.2591,0.23834,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.0079e-05,0.25904,0.3429,1,1
4,GO BLOOD VESSEL REMODELING,0.0005056,0.25837,0.21451,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.00083767,0.25798,0.24062,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.019312,0.25795,0.2072,1,1
4,GO NEPHRIC DUCT DEVELOPMENT,0.003654,0.25781,0.21982,1,1
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.0012886,0.25695,0.1798,1,1
4,GO REGULATION OF BONE REMODELING,8.1138e-06,0.25659,0.25354,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,5.5127e-05,0.2564,0.23547,1,1
4,GO REGULATION OF CELL KILLING,0.0012005,0.25632,0.18724,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.001704,0.25566,0.20859,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,6.8888e-05,0.25524,0.24082,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00022927,0.25519,0.23169,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00016361,0.25471,0.27781,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00011218,0.25471,0.22801,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.8053e-06,0.2547,0.26806,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.002631,0.2544,0.21347,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,3.3435e-06,0.25428,0.31057,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.7693e-06,0.25325,0.27027,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,1.5576e-05,0.25317,0.24003,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00030449,0.25263,0.24117,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,3.9102e-06,0.25259,0.24338,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,5.0563e-05,0.25208,0.2662,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00010323,0.25179,0.22419,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00083767,0.25162,0.22121,1,1
4,GO RESPONSE TO LITHIUM ION,2.971e-06,0.25127,0.32154,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.014172,0.25122,0.17456,1,1
4,GO NEURON CELL CELL ADHESION,0.015159,0.25087,0.23135,1,1
4,GO PHAGOSOME ACIDIFICATION,3.6435e-08,0.25057,0.25674,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0056958,0.25032,0.21844,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,4.4285e-07,0.24988,0.27322,1,1
4,GO RESPONSE TO STEROL DEPLETION,1.9175e-06,0.24955,0.2776,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.00090088,0.2495,0.19642,1,1
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00080175,0.24917,0.26917,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0062108,0.24897,0.1866,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0029256,0.24821,0.28184,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.026013,0.24744,0.17229,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00041488,0.24693,0.22109,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.2604e-07,0.24654,0.29363,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00055343,0.2464,0.25567,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.0012705,0.24608,0.24368,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.0563e-05,0.24586,0.23917,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0054192,0.24569,0.16955,1,1
4,GO RESPONSE TO GONADOTROPIN,4.1026e-05,0.24553,0.21302,1,1
4,GO DOPAMINE METABOLIC PROCESS,2.4861e-06,0.24544,0.29353,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.00014129,0.24491,0.21423,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.0056958,0.24461,0.20672,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,3.6924e-05,0.24378,0.21783,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,4.7172e-05,0.24295,0.24661,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00095459,0.24273,0.21148,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.0012705,0.24252,0.19167,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00015083,0.2425,0.20286,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.0069343,0.24241,0.26574,1,1
4,GO APICAL JUNCTION ASSEMBLY,1.5576e-05,0.24193,0.24917,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0030436,0.24189,0.23958,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.0001179,0.2418,0.24705,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.5038e-07,0.2416,0.28074,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.5646e-05,0.24152,0.26601,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.012227,0.24132,0.19421,1,1
4,GO CATECHOLAMINE UPTAKE,8.1623e-05,0.24099,0.27861,1,1
4,GO REGULATION OF ICOSANOID SECRETION,4.1552e-07,0.24057,0.26803,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.0032078,0.24025,0.22303,1,1
4,GO REGULATION OF COAGULATION,0.00053704,0.24023,0.21577,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.00063314,0.23994,0.1843,1,1
4,GO INTERLEUKIN 12 PRODUCTION,0.00025617,0.23967,0.2083,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,2.1621e-05,0.23843,0.23642,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,2.4528e-05,0.23833,0.26685,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0088198,0.23786,0.211,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.00068191,0.23712,0.19464,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0007786,0.23701,0.19938,1,1
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0032078,0.23643,0.32278,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,3.628e-05,0.23582,0.25683,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.1086e-06,0.23578,0.23252,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0020367,0.23564,0.22134,1,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0033799,0.23505,0.18231,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.010522,0.23504,0.19236,1,1
4,GO SUPEROXIDE ANION GENERATION,0.0005789,0.23458,0.2203,1,1
4,GO N GLYCAN PROCESSING,0.0019023,0.23327,0.24687,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.2253e-05,0.23273,0.21981,1,1
4,GO MAST CELL ACTIVATION,1.9393e-05,0.23245,0.26343,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,1.536e-06,0.23177,0.23491,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00013451,0.23166,0.20748,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.3256e-05,0.23161,0.23083,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0024609,0.23157,0.2498,1,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.015159,0.23146,0.18376,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0037498,0.23138,0.15364,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.000662,0.23097,0.25306,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.055093,0.23082,0.11957,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,1.0958e-05,0.23061,0.2288,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00084997,0.23055,0.24942,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0019285,0.23039,0.16368,1,1
4,GO T CELL MEDIATED IMMUNITY,0.0081133,0.23014,0.13873,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.4972e-05,0.2297,0.25859,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,2.6828e-05,0.22956,0.19636,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,4.6359e-05,0.22946,0.20975,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.3381e-05,0.22878,0.18077,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00044781,0.22872,0.21514,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00084997,0.22866,0.20303,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.00046872,0.22786,0.25127,1,1
4,GO STEROID ESTERIFICATION,0.0104,0.2278,0.15512,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.015159,0.22776,0.23855,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00068191,0.22739,0.18568,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0099244,0.22693,0.12831,1,1
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.061549,0.22679,0.14635,1,1
4,GO RESPONSE TO INTERLEUKIN 2,1.4207e-05,0.22643,0.23411,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,4.3236e-05,0.22589,0.21005,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00027284,0.22578,0.17882,1,1
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0046604,0.22553,0.2211,1,1
4,GO DIGESTIVE SYSTEM PROCESS,1.5052e-06,0.22475,0.21376,1,1
4,GO PROTEIN DEMANNOSYLATION,9.4959e-05,0.22463,0.2387,1,1
4,GO MAGNESIUM ION TRANSPORT,1.4207e-05,0.22415,0.24847,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,2.2824e-05,0.224,0.32797,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,6.337e-06,0.22293,0.23338,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00018923,0.22287,0.23276,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.0020092,0.22274,0.2376,1,1
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0054872,0.22262,0.27298,1,1
4,GO MYOBLAST FUSION,0.00065224,0.22261,0.19981,1,1
4,GO POSITIVE REGULATION OF HEART CONTRACTION,1.1806e-05,0.2226,0.238,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00064263,0.22215,0.25158,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.6321e-06,0.22173,0.30545,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.001568,0.22137,0.21853,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00074504,0.22131,0.21889,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,5.4184e-05,0.22102,0.23856,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.027118,0.22101,0.1173,1,1
4,GO CELL KILLING,0.00065224,0.22042,0.16921,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00012388,0.2203,0.18941,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00046165,0.22007,0.18953,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0073682,0.21996,0.1836,1,1
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00052901,0.21989,0.19902,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0012705,0.21932,0.24595,1,1
4,GO VACUOLAR ACIDIFICATION,1.536e-06,0.21931,0.20594,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0016122,0.21931,0.23376,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.1789e-06,0.21897,0.2094,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.0089251,0.2188,0.1585,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0013069,0.21843,0.19648,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.0005211,0.21838,0.17344,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.00046872,0.21818,0.19767,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.00011218,0.21817,0.19944,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,2.4091e-05,0.21797,0.23406,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.014332,0.21779,0.13543,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00065224,0.21777,0.15683,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.043866,0.21748,0.10244,1,1
4,GO MEMBRANE DEPOLARIZATION,8.8796e-05,0.21737,0.20836,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.0028492,0.21733,0.21268,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0861e-06,0.21705,0.24792,1,1
4,GO PHOSPHOLIPID TRANSPORT,4.31e-06,0.21693,0.21677,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0081133,0.21598,0.16169,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,1.4741e-05,0.21593,0.23089,1,1
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0066039,0.21548,0.22329,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,7.7586e-05,0.21531,0.1944,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00044103,0.21529,0.21645,1,1
4,GO INOSITOL METABOLIC PROCESS,0.00029511,0.21521,0.19835,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00021857,0.2152,0.25171,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,7.9617e-06,0.21514,0.24646,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00021511,0.21433,0.20298,1,1
4,GO REGULATION OF MYOBLAST FUSION,0.00029976,0.21428,0.23142,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00029511,0.21388,0.21574,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.032938,0.21374,0.21031,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0022701,0.21348,0.22111,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.00012594,0.21288,0.23522,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,5.4356e-06,0.21287,0.24723,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00099681,0.21266,0.17469,1,1
4,GO ETHER METABOLIC PROCESS,0.00044781,0.21199,0.17523,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0056255,0.2117,0.22375,1,1
4,GO REGULATION OF B CELL PROLIFERATION,8.1623e-05,0.21135,0.21583,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.000286,0.21134,0.23191,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00025215,0.21134,0.23844,1,1
4,GO SECRETION BY TISSUE,0.00037257,0.2108,0.19312,1,1
4,GO MATURE B CELL DIFFERENTIATION,0.002631,0.21079,0.22555,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.018693,0.21042,0.14339,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,5.2344e-05,0.20973,0.21458,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.3878e-06,0.20945,0.251,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.7385e-05,0.20943,0.24765,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,5.1446e-05,0.20931,0.23366,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,4.4771e-05,0.20915,0.27986,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,6.8888e-05,0.20895,0.21952,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00046165,0.2089,0.20818,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,4.6578e-06,0.2087,0.19313,1,1
4,GO DNA DEAMINATION,0.0015249,0.20848,0.29321,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,1.5865e-05,0.20843,0.22874,1,1
4,GO OSTEOBLAST PROLIFERATION,0.00054518,0.20842,0.22462,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00049802,0.20833,0.19185,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,1.4207e-05,0.20823,0.18769,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0039481,0.20775,0.17331,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00016901,0.20765,0.18343,1,1
4,GO DIOL METABOLIC PROCESS,5.5127e-05,0.20765,0.22916,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00022927,0.20763,0.16417,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0018508,0.20762,0.22787,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0028492,0.20737,0.17158,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0007901,0.20658,0.1783,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.012798,0.20655,0.19237,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,4.5558e-05,0.2062,0.21559,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.009139,0.20608,0.15231,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,2.1621e-05,0.20594,0.17983,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0067673,0.20593,0.1817,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0001803,0.2059,0.19949,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.0010259,0.20566,0.22051,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.015674,0.20537,0.17393,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,1.6158e-05,0.20508,0.20822,1,1
4,GO ORGANELLE MEMBRANE FUSION,5.7582e-06,0.20473,0.18544,1,1
4,GO TISSUE REMODELING,6.7724e-05,0.20457,0.21482,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,9.6562e-05,0.20442,0.23505,1,1
4,GO PLATELET AGGREGATION,0.00018923,0.20392,0.21966,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.027401,0.20388,0.14538,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0066039,0.20346,0.26347,1,1
4,GO LYTIC VACUOLE ORGANIZATION,2.0879e-07,0.2034,0.22906,1,1
4,GO RESPONSE TO GROWTH HORMONE,0.00011033,0.20319,0.21818,1,1
4,GO BONE REMODELING,8.4424e-05,0.20304,0.20708,1,1
4,GO GLYCOSYLATION,1.8053e-06,0.20285,0.19271,1,1
4,GO PLATELET DEGRANULATION,0.0011836,0.2028,0.18603,1,1
4,GO B CELL PROLIFERATION,0.00026858,0.20221,0.17837,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.042197,0.20212,0.11975,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00029976,0.20198,0.17522,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00042128,0.20194,0.19197,1,1
4,GO REGULATION OF WOUND HEALING,0.00014839,0.2009,0.21328,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.00012594,0.20079,0.1913,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00048316,0.20076,0.17001,1,1
4,GO SNARE COMPLEX ASSEMBLY,3.3214e-05,0.20051,0.23176,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00083767,0.20045,0.21162,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.0047198,0.20042,0.17782,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,2.0879e-07,0.2004,0.20357,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.1623e-05,0.20003,0.19637,1,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.022446,0.20002,0.16079,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00058763,0.19996,0.25353,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.00045468,0.19972,0.1959,1,1
4,GO METHIONINE METABOLIC PROCESS,0.0020646,0.19955,0.14831,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0025277,0.19944,0.17741,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0010558,0.1993,0.17634,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,2.011e-05,0.19927,0.18752,1,1
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0016806,0.19904,0.24731,1,1
4,GO LIVER MORPHOGENESIS,0.00021511,0.19852,0.25005,1,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.049212,0.19851,0.17124,1,1
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.010279,0.19828,0.16937,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.00030928,0.19772,0.25962,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.0034243,0.19749,0.16734,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00019229,0.19745,0.2314,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.3739e-05,0.19709,0.18248,1,1
4,GO REGULATION OF ACTIN NUCLEATION,1.9749e-05,0.19702,0.22175,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.020385,0.19694,0.15258,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,1.6994e-06,0.19686,0.22627,1,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0061347,0.19659,0.20391,1,1
4,GO BONE RESORPTION,2.3661e-05,0.19652,0.20698,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,4.9228e-07,0.19644,0.20239,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0010408,0.19643,0.17717,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0005211,0.19642,0.1968,1,1
4,GO DEFENSE RESPONSE TO FUNGUS,8.7316e-05,0.19617,0.16946,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,1.4454e-06,0.19609,0.18312,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00021857,0.19589,0.21044,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0005056,0.19589,0.20598,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00087508,0.19584,0.16609,1,1
4,GO TRANSCYTOSIS,0.003166,0.19558,0.15519,1,1
4,GO FUCOSYLATION,0.0045438,0.19497,0.14542,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00045468,0.19448,0.22664,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00080175,0.19447,0.18888,1,1
4,GO HEART TRABECULA MORPHOGENESIS,0.0098086,0.19411,0.13774,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.00011596,0.19363,0.22818,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.011949,0.19315,0.15956,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00027284,0.19305,0.19078,1,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00086244,0.19264,0.22428,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00015583,0.19248,0.26276,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.020605,0.19242,0.18371,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00029976,0.19239,0.1901,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.033948,0.19238,0.12106,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,4.1456e-06,0.19177,0.21333,1,1
4,GO PHAGOSOME MATURATION,2.4972e-05,0.19097,0.19799,1,1
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00092737,0.19093,0.24982,1,1
4,GO MICROVILLUS ASSEMBLY,0.017125,0.19078,0.17139,1,1
4,GO HAIR CELL DIFFERENTIATION,0.0038478,0.19049,0.15844,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0046018,0.19033,0.15371,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,6.5837e-06,0.19031,0.22523,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,1.536e-06,0.19026,0.19063,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00062378,0.19025,0.21355,1,1
4,GO HEART TRABECULA FORMATION,0.0063654,0.19011,0.21771,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.003166,0.1901,0.2034,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0013255,0.18988,0.1657,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.013093,0.18948,0.16213,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,3.628e-05,0.18942,0.18534,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0018006,0.18929,0.26897,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.0021505,0.18888,0.17052,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00037257,0.18833,0.16603,1,1
4,GO LEUKOCYTE MIGRATION,8.3013e-05,0.18826,0.17889,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,0.00013673,0.18762,0.19843,1,1
4,GO REGULATION OF B CELL ACTIVATION,0.00029511,0.18758,0.16398,1,1
4,GO CERAMIDE METABOLIC PROCESS,1.3693e-05,0.18732,0.17381,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,5.0323e-06,0.1872,0.19346,1,1
4,GO SIGNAL PEPTIDE PROCESSING,3.3214e-05,0.18683,0.24396,1,1
4,GO MAST CELL MEDIATED IMMUNITY,0.00017741,0.18671,0.2323,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,5.1446e-05,0.18648,0.22588,1,1
4,GO ICOSANOID METABOLIC PROCESS,0.0005618,0.18637,0.177,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0013443,0.18635,0.17301,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.00015331,0.18629,0.214,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00013232,0.1861,0.188,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.0022701,0.18607,0.16051,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.00073415,0.18589,0.18084,1,1
4,GO MEMBRANE FUSION,5.8698e-06,0.18588,0.18218,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0054192,0.1858,0.1226,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.026013,0.18578,0.14962,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0005056,0.18577,0.22871,1,1
4,GO DIET INDUCED THERMOGENESIS,5.5127e-05,0.18573,0.21802,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00022927,0.18561,0.17864,1,1
4,GO TRANSPOSITION,0.0013069,0.18546,0.24317,1,1
4,GO TRANSFERRIN TRANSPORT,2.9514e-07,0.18509,0.21008,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0087156,0.18502,0.15888,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0022095,0.18497,0.19112,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0030839,0.18494,0.15653,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00025215,0.1848,0.18169,1,1
4,GO NERVE DEVELOPMENT,0.001704,0.18475,0.18496,1,1
4,GO CYTOPLASM ORGANIZATION,0.0040509,0.18471,0.1786,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0058389,0.18449,0.14411,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0013443,0.18442,0.16372,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.001704,0.18425,0.20248,1,1
4,GO INSULIN SECRETION,7.105e-06,0.18421,0.18138,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00017176,0.18417,0.24395,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.004964,0.18415,0.15849,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0005618,0.18368,0.17448,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00092737,0.18342,0.21251,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00035024,0.18318,0.16053,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00018323,0.18305,0.17947,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00062378,0.183,0.1941,1,1
4,GO DETECTION OF BIOTIC STIMULUS,0.037882,0.18291,0.12277,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,6.3249e-05,0.18272,0.15333,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0016575,0.1827,0.17648,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0033799,0.18268,0.1469,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,4.2271e-06,0.18261,0.19407,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00017741,0.18248,0.16788,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00036124,0.18234,0.24576,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.015329,0.18221,0.10998,1,1
4,GO GAP JUNCTION ASSEMBLY,0.01499,0.18205,0.17091,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0074579,0.182,0.16682,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.001483,0.1817,0.16099,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0063654,0.18158,0.1351,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,6.2169e-06,0.18144,0.20163,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00032408,0.18144,0.19222,1,1
4,GO GROOMING BEHAVIOR,0.0050269,0.18073,0.16376,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.9711e-06,0.18054,0.18777,1,1
4,GO HUMORAL IMMUNE RESPONSE,0.00036124,0.18036,0.13948,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.010279,0.18024,0.27219,1,1
4,GO RESPONSE TO LEPTIN,0.00018923,0.17997,0.18653,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.0046604,0.17935,0.12831,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001483,0.17922,0.20633,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0078263,0.17906,0.24094,1,1
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0062108,0.17897,0.15604,1,1
4,GO RESPONSE TO THYROID HORMONE,0.022928,0.17861,0.15947,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0054192,0.17849,0.12064,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,9.819e-05,0.17822,0.17903,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,0.0002117,0.17819,0.16257,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0049019,0.17766,0.1495,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0063654,0.17727,0.13267,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,0.00053704,0.17698,0.14506,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.001235,0.17694,0.16178,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.00024045,0.17692,0.17915,1,1
4,GO REGULATION OF HEART RATE,0.00016629,0.17686,0.18093,1,1
4,GO POLYOL CATABOLIC PROCESS,0.00040235,0.17675,0.16275,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,1.7071e-05,0.17666,0.1974,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.001955,0.17661,0.13896,1,1
4,GO MICROVILLUS ORGANIZATION,0.00036686,0.17648,0.27646,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,1.1165e-05,0.17636,0.18216,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,3.2057e-05,0.17608,0.22173,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.001776,0.17598,0.20153,1,1
4,GO CHEMOKINE PRODUCTION,0.01499,0.17596,0.12367,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.00016629,0.17586,0.1698,1,1
4,GO PODOSOME ASSEMBLY,0.01585,0.17576,0.15532,1,1
4,GO NEURON MATURATION,0.004156,0.17574,0.16113,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0024281,0.17549,0.20323,1,1
4,GO ENDOTHELIUM DEVELOPMENT,0.01585,0.17545,0.12609,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0059852,0.17534,0.18341,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.00025617,0.17533,0.18332,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.0040509,0.17528,0.17633,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00014129,0.17518,0.18562,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0031247,0.17471,0.14239,1,1
4,GO DIGESTION,4.31e-06,0.17455,0.20571,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00010323,0.17435,0.17718,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.048285,0.17432,0.13264,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.001776,0.17361,0.14518,1,1
4,GO EXOCYTIC PROCESS,0.00012594,0.1735,0.19376,1,1
4,GO PLASMINOGEN ACTIVATION,0.01829,0.17348,0.15914,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0011836,0.17345,0.16126,1,1
4,GO LIPID EXPORT FROM CELL,0.0021505,0.17295,0.13623,1,1
4,GO STEROID METABOLIC PROCESS,0.00016629,0.17281,0.14943,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.018898,0.17254,0.14425,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0005789,0.1725,0.18082,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0022701,0.17247,0.22379,1,1
4,GO REGULATION OF CELL PROJECTION SIZE,0.0023957,0.17243,0.22266,1,1
4,GO ZINC ION HOMEOSTASIS,0.017125,0.1724,0.19084,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0038478,0.17234,0.12821,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0027381,0.17226,0.13115,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0028492,0.17214,0.19275,1,1
4,GO SKIN DEVELOPMENT,0.00081356,0.17213,0.15371,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0089251,0.17191,0.13764,1,1
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0068504,0.17116,0.21408,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.00082553,0.17108,0.18162,1,1
4,GO RESPONSE TO METAL ION,4.9361e-06,0.17107,0.1647,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00022565,0.17095,0.17445,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,4.7172e-05,0.17093,0.15916,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0016122,0.17078,0.14224,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.018898,0.1707,0.14172,1,1
4,GO CYTOKINE METABOLIC PROCESS,0.0013255,0.17048,0.13519,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0007901,0.17045,0.15403,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0046604,0.17035,0.16773,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,5.2344e-05,0.17023,0.1858,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00014839,0.17023,0.18158,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0013826,0.16998,0.15251,1,1
4,GO NUCLEOTIDE TRANSPORT,0.00011596,0.16998,0.15163,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.011949,0.16984,0.16867,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0030436,0.16973,0.14405,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.0010113,0.16946,0.1749,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00064263,0.16943,0.13658,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0020929,0.16922,0.16722,1,1
4,GO MULTIVESICULAR BODY SORTING PATHWAY,1.8701e-05,0.1692,0.17904,1,1
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.012367,0.16865,0.17566,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.032938,0.16859,0.11535,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.059879,0.16831,0.097595,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0040509,0.16821,0.13586,1,1
4,GO RESPONSE TO AMPHETAMINE,0.0051547,0.16816,0.17902,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00042128,0.16777,0.20053,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00027284,0.16774,0.1633,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0033799,0.16762,0.14175,1,1
4,GO BONE CELL DEVELOPMENT,0.02945,0.16762,0.13021,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.012798,0.16759,0.11513,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.1138e-06,0.1675,0.1864,1,1
4,GO PROTEIN HYDROXYLATION,0.011544,0.16744,0.18281,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0094686,0.16719,0.19702,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.03902,0.16714,0.1069,1,1
4,GO SKELETAL MUSCLE ADAPTATION,0.0016806,0.16707,0.18006,1,1
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00095459,0.16703,0.1664,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.001955,0.16678,0.15157,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00021857,0.16671,0.16785,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00070238,0.16639,0.14971,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,4.1751e-05,0.16613,0.18103,1,1
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.018898,0.16598,0.17108,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.0002443,0.16583,0.19958,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00061456,0.16571,0.17317,1,1
4,GO PROTEIN DEGLYCOSYLATION,0.00048316,0.1655,0.21364,1,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0024941,0.16538,0.15238,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00068191,0.16525,0.18329,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,3.5022e-05,0.16505,0.19537,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.01995,0.16483,0.10589,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.059879,0.16411,0.10156,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0010558,0.16391,0.1603,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0023957,0.16349,0.14473,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,0.00048316,0.16345,0.16252,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0010558,0.1633,0.16496,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0011021,0.16275,0.18164,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0001179,0.16256,0.18206,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00029052,0.16224,0.15747,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0098086,0.16206,0.17092,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.00058763,0.16201,0.14518,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00054518,0.1619,0.13903,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0032928,0.16154,0.13413,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00061456,0.16137,0.27897,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.013546,0.16129,0.16414,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.021509,0.16106,0.1303,1,1
4,GO VIRAL GENOME REPLICATION,0.0018508,0.161,0.15698,1,1
4,GO RESPONSE TO AMINE,0.054074,0.16099,0.091032,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0061347,0.16071,0.15977,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0011341,0.16071,0.18412,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0014624,0.16069,0.1752,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.027401,0.16055,0.17367,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,8.5858e-05,0.16046,0.17234,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0010259,0.16038,0.13513,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.014332,0.16027,0.11856,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0013255,0.1601,0.19044,1,1
4,GO MANNOSYLATION,0.00040857,0.16009,0.15927,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00062378,0.15989,0.16742,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0007901,0.15962,0.15571,1,1
4,GO PEPTIDE HORMONE SECRETION,4.1751e-05,0.15924,0.16878,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0024609,0.15921,0.14291,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00016361,0.15919,0.15155,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.003654,0.15919,0.14375,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00088789,0.15914,0.12629,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0024941,0.15831,0.15834,1,1
4,GO ACTION POTENTIAL,0.00036686,0.1582,0.16398,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0003557,0.15816,0.21729,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0020367,0.15815,0.15031,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.001071,0.1581,0.16613,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.059879,0.15793,0.18928,1,1
4,GO RESPONSE TO FUNGUS,4.9694e-05,0.15776,0.16316,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.043866,0.15749,0.16618,1,1
4,GO CATECHOLAMINE SECRETION,0.00040857,0.15724,0.27375,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.0022095,0.15694,0.12148,1,1
4,GO PH REDUCTION,2.0853e-05,0.15659,0.15224,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,6.1119e-05,0.15651,0.17328,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0072795,0.15639,0.14071,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.002702,0.15634,0.16244,1,1
4,GO REGULATION OF TRANSPOSITION,0.0060595,0.15584,0.22645,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0137,0.15576,0.13712,1,1
4,GO NECROTIC CELL DEATH,0.001118,0.15566,0.16065,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.017894,0.15538,0.12222,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,1.8363e-05,0.15535,0.18153,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.00016361,0.15523,0.14076,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0010558,0.15506,0.16617,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.011022,0.15497,0.15019,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.046474,0.15446,0.12605,1,1
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.043444,0.15439,0.12937,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0046018,0.15429,0.15331,1,1
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00010852,0.15383,0.17862,1,1
4,GO RESPONSE TO TUMOR CELL,0.016938,0.15381,0.14959,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0018256,0.15358,0.11599,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.010522,0.15318,0.10943,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00039622,0.15304,0.13737,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,9.6562e-05,0.15293,0.16929,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.00082553,0.15269,0.17489,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.011949,0.15265,0.15672,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.022209,0.1525,0.15506,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0053519,0.15244,0.12975,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00033955,0.1521,0.13775,1,1
4,GO NEURAL NUCLEUS DEVELOPMENT,0.0046604,0.15185,0.17306,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0060595,0.15184,0.10101,1,1
4,GO SODIUM ION HOMEOSTASIS,0.0020092,0.15176,0.12726,1,1
4,GO SECONDARY METABOLIC PROCESS,0.0046018,0.15167,0.15393,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,8.0256e-05,0.15138,0.1346,1,1
4,GO LEUKOCYTE PROLIFERATION,0.001776,0.15138,0.13419,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.034984,0.15136,0.097357,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0005056,0.15115,0.16951,1,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.025743,0.15094,0.15814,1,1
4,GO REGULATION OF INSULIN SECRETION,5.7059e-05,0.15063,0.15948,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0062108,0.1506,0.14237,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,0.00026858,0.15055,0.13848,1,1
4,GO MEMBRANE HYPERPOLARIZATION,0.016938,0.15044,0.12329,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0015463,0.15021,0.17742,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0093576,0.15018,0.12066,1,1
4,GO RESPONSE TO STEROL,0.0032078,0.15014,0.15901,1,1
4,GO FOAM CELL DIFFERENTIATION,0.0011836,0.14993,0.18098,1,1
4,GO NEUTROPHIL MIGRATION,0.0018508,0.14992,0.12836,1,1
4,GO EXOCYTOSIS,3.8246e-05,0.14987,0.1593,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.012945,0.14983,0.13823,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.019312,0.14981,0.13759,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0024941,0.14979,0.15719,1,1
4,GO LIPID LOCALIZATION,4.2487e-05,0.14967,0.16076,1,1
4,GO STEROL TRANSPORT,0.0020092,0.14963,0.15308,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00087508,0.14954,0.1551,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0076401,0.14944,0.13594,1,1
4,GO EPIDERMIS DEVELOPMENT,0.0011836,0.14921,0.14477,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00015583,0.14897,0.21705,1,1
4,GO REGULATION OF T CELL CHEMOTAXIS,0.0044864,0.14891,0.12625,1,1
4,GO REGULATION OF T CELL MIGRATION,0.0015038,0.14874,0.16875,1,1
4,GO CELL JUNCTION ASSEMBLY,0.011151,0.14868,0.11122,1,1
4,GO AMINE TRANSPORT,0.00020835,0.1485,0.23167,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00011218,0.14839,0.14376,1,1
4,GO MUSCLE HYPERTROPHY,0.00021511,0.14828,0.17322,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00035024,0.14827,0.15083,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.002702,0.14821,0.1735,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,9.9844e-05,0.14811,0.14831,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.0019285,0.14789,0.1616,1,1
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0046018,0.14787,0.15163,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.015674,0.14782,0.12987,1,1
4,GO REGULATION OF RUFFLE ASSEMBLY,0.015674,0.14778,0.13009,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.00034485,0.1477,0.13945,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0083098,0.14756,0.12069,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0013826,0.14754,0.14686,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0011021,0.14747,0.13353,1,1
4,GO BONE MINERALIZATION,0.0090315,0.14734,0.12751,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00048316,0.14722,0.15824,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.023173,0.14708,0.13396,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.0044298,0.14706,0.12946,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.0013633,0.14706,0.18296,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00047589,0.14701,0.14712,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0075485,0.14688,0.14616,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.026838,0.14676,0.12099,1,1
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00067188,0.14672,0.1564,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.00058763,0.14667,0.20898,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0033361,0.14652,0.14089,1,1
4,GO DENDRITE EXTENSION,7.2497e-05,0.14579,0.25116,1,1
4,GO PIGMENTATION,0.0071918,0.14579,0.10189,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.0030038,0.14557,0.13714,1,1
4,GO GRANULOCYTE MIGRATION,0.0014624,0.14534,0.13443,1,1
4,GO RESPONSE TO CALCIUM ION,0.00029976,0.14493,0.15154,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,6.1119e-05,0.14474,0.15896,1,1
4,GO RESPONSE TO CADMIUM ION,0.0062877,0.14451,0.16533,1,1
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0013443,0.14449,0.13583,1,1
4,GO POSITIVE REGULATION OF MYELINATION,0.00083767,0.14449,0.14462,1,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0037016,0.14388,0.13765,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.050154,0.14379,0.087085,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0024941,0.14378,0.15946,1,1
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0037498,0.14371,0.17505,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.003654,0.14369,0.14423,1,1
4,GO ORGANELLE FUSION,6.4341e-05,0.14314,0.14082,1,1
4,GO PROTEIN PROCESSING,3.3214e-05,0.14305,0.16366,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.013243,0.14301,0.13352,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.013093,0.14276,0.12109,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.00023294,0.14274,0.12396,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.0046604,0.14266,0.12342,1,1
4,GO LYSOSOME LOCALIZATION,0.00072342,0.1426,0.15206,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.00013232,0.14254,0.14708,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0056255,0.14242,0.20185,1,1
4,GO REGULATION OF HORMONE LEVELS,7.5001e-05,0.14236,0.14051,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00026024,0.14229,0.14745,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.0038977,0.14195,0.11031,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.054582,0.14182,0.12802,1,1
4,GO ACTIN NUCLEATION,7.8124e-06,0.14156,0.1763,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00092737,0.14153,0.15763,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.011022,0.14128,0.11703,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0019285,0.14097,0.13777,1,1
4,GO STEROL METABOLIC PROCESS,0.0005133,0.14089,0.14154,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0137,0.14083,0.10953,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.00074504,0.14073,0.15093,1,1
4,GO CARBOHYDRATE TRANSPORT,1.8363e-05,0.14053,0.14758,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0030839,0.14034,0.13242,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.02521,0.13999,0.14576,1,1
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.017699,0.13977,0.14375,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00016901,0.13968,0.11859,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0016575,0.13966,0.15847,1,1
4,GO ARACHIDONIC ACID SECRETION,0.0080166,0.13951,0.13164,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,3.9872e-06,0.13892,0.14175,1,1
4,GO GDP METABOLIC PROCESS,0.010769,0.13891,0.19168,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0083098,0.1389,0.090612,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.003654,0.13885,0.11892,1,1
4,GO B CELL HOMEOSTASIS,0.0088198,0.1384,0.13999,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0022701,0.13837,0.16697,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,1.3948e-05,0.13836,0.13842,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.00081356,0.13818,0.15581,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0067673,0.13806,0.1615,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0012705,0.13751,0.14658,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0018256,0.13727,0.12591,1,1
4,GO MEMBRANE REPOLARIZATION,0.0087156,0.13712,0.13405,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0003557,0.13699,0.14513,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.035336,0.13668,0.11163,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.00015583,0.13635,0.15461,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.013856,0.13624,0.1477,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0011341,0.13619,0.16027,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.0056255,0.13603,0.12452,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0020646,0.13574,0.14558,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,8.0256e-05,0.13537,0.15708,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.026561,0.13527,0.109,1,1
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.031311,0.13526,0.13257,1,1
4,GO REGULATION OF CELLULAR PH,1.0361e-05,0.13518,0.13491,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.00094089,0.13502,0.16861,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.014013,0.13467,0.10994,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0037016,0.13428,0.13441,1,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.019735,0.13409,0.13516,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0096941,0.13407,0.12765,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.0084096,0.13401,0.1458,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.047827,0.13397,0.10333,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.0024281,0.13387,0.19643,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0059852,0.13382,0.18069,1,1
4,GO VIRION ASSEMBLY,0.00084997,0.13375,0.11038,1,1
4,GO INFLAMMATORY RESPONSE,0.00070238,0.13317,0.13331,1,1
4,GO REGULATION OF MUSCLE CONTRACTION,0.001776,0.13298,0.11598,1,1
4,GO ENDOCRINE PROCESS,0.0037016,0.13295,0.13309,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00019857,0.1328,0.16486,1,1
4,GO VACUOLE ORGANIZATION,2.8814e-05,0.13256,0.14733,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0043737,0.13256,0.12724,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.00026858,0.13246,0.13254,1,1
4,GO CALCIUM ION IMPORT,0.0062877,0.13203,0.11028,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.0023957,0.13183,0.12329,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0089251,0.13135,0.1487,1,1
4,GO CELLULAR PIGMENTATION,0.017315,0.13033,0.097878,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0048405,0.13033,0.14088,1,1
4,GO AMINE METABOLIC PROCESS,6.7105e-06,0.13016,0.14421,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.031953,0.12996,0.12911,1,1
4,GO PLATELET MORPHOGENESIS,0.02128,0.1298,0.13775,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.055093,0.12964,0.080872,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.015674,0.12962,0.12161,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.0013826,0.12926,0.1285,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0048405,0.12921,0.13438,1,1
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.029754,0.12886,0.20996,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0068504,0.12878,0.12014,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.016205,0.12877,0.13397,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00046165,0.12857,0.14523,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0028118,0.12856,0.1063,1,1
4,GO REGULATION OF CELL ACTIVATION,0.006444,0.12848,0.10395,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.01849,0.12839,0.14469,1,1
4,GO SECRETION,5.0563e-05,0.12833,0.13496,1,1
4,GO ACUTE PHASE RESPONSE,0.0015249,0.1281,0.14154,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0088198,0.12801,0.10493,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0010558,0.1276,0.15503,1,1
4,GO UBIQUINONE METABOLIC PROCESS,0.0032928,0.12748,0.12073,1,1
4,GO T CELL PROLIFERATION,0.0029256,0.12725,0.13487,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.024428,0.12701,0.12791,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0019285,0.12673,0.15617,1,1
4,GO REGULATION OF EXOCYTOSIS,0.00029976,0.12671,0.15129,1,1
4,GO CELLULAR RESPONSE TO STARVATION,0.00019541,0.12612,0.13799,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.024428,0.12585,0.10502,1,1
4,GO REGULATION OF HEAT GENERATION,0.015501,0.12534,0.15625,1,1
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.0096941,0.12527,0.14711,1,1
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.019523,0.12504,0.11988,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.010769,0.12432,0.10865,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.5001e-05,0.12426,0.16042,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,3.2631e-05,0.12391,0.16693,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.032607,0.12383,0.10957,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.027686,0.12377,0.11951,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.00060545,0.12361,0.16333,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.012367,0.12333,0.095262,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00081356,0.12329,0.11814,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.0034243,0.12303,0.1559,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.043866,0.12255,0.10992,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.023668,0.12233,0.17007,1,1
4,GO REGULATION OF PH,1.1165e-05,0.12226,0.1313,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0072795,0.12214,0.097205,1,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.010769,0.1221,0.11314,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.0017277,0.12188,0.13601,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0022095,0.12175,0.10865,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0054872,0.12173,0.087309,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0078263,0.12129,0.11375,1,1
4,GO RELAXATION OF MUSCLE,0.009139,0.12123,0.14124,1,1
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.02945,0.1201,0.10302,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.001568,0.11995,0.12577,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,0.01829,0.11924,0.16453,1,1
4,GO T CELL SELECTION,0.0039992,0.11923,0.11481,1,1
4,GO MACROPHAGE ACTIVATION,0.0032501,0.11889,0.12853,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.003166,0.11875,0.16498,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.0027747,0.1185,0.12321,1,1
4,GO STRIATED MUSCLE CONTRACTION,0.0035146,0.11813,0.11803,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0021798,0.11797,0.14534,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0137,0.11789,0.11104,1,1
4,GO REGULATION OF FERTILIZATION,0.0034692,0.11761,0.12664,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.052083,0.11715,0.095572,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0028118,0.11714,0.14076,1,1
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0022701,0.11675,0.13706,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.033271,0.1165,0.085621,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,4.3236e-05,0.1163,0.14361,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.014494,0.11602,0.12646,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0057669,0.11577,0.13262,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0072795,0.11549,0.12389,1,1
4,GO POSITIVE T CELL SELECTION,0.017125,0.1151,0.10517,1,1
4,GO CARNITINE SHUTTLE,0.053071,0.11479,0.10553,1,1
4,GO IRON ION TRANSPORT,5.9056e-05,0.11428,0.12617,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.0094686,0.1142,0.093422,1,1
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.014823,0.11369,0.14586,1,1
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.02174,0.11361,0.14334,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.013856,0.113,0.12353,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.00049053,0.11299,0.10769,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.055093,0.11296,0.078222,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.051111,0.11288,0.092679,1,1
4,GO PROTEIN PALMITOYLATION,0.047827,0.11283,0.1032,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.007921,0.11282,0.09279,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0090315,0.11278,0.10251,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.00026858,0.1123,0.14461,1,1
4,GO RESPONSE TO ZINC ION,0.022928,0.11229,0.15681,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0046604,0.11213,0.10122,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0034243,0.1121,0.11976,1,1
4,GO T CELL ACTIVATION,0.0060595,0.11191,0.10894,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.03429,0.11184,0.14709,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.018693,0.11179,0.092484,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.014494,0.11167,0.12047,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.037139,0.11166,0.11023,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0092477,0.11133,0.10245,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.013394,0.11121,0.13338,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0073682,0.11075,0.10041,1,1
4,GO PROTEIN MATURATION,0.00011986,0.10998,0.12503,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.057179,0.10963,0.090132,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0083098,0.10943,0.10414,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0051547,0.1087,0.16165,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00096848,0.10817,0.13779,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.036409,0.10809,0.11149,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0078263,0.10806,0.11004,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00010852,0.10804,0.12614,1,1
4,GO RESPONSE TO TESTOSTERONE,0.027686,0.10775,0.10301,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.011e-05,0.10754,0.1354,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.020385,0.10746,0.10204,1,1
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.012367,0.10671,0.11631,1,1
4,GO LIPID DROPLET ORGANIZATION,0.007921,0.10634,0.10325,1,1
4,GO REGULATION OF OSSIFICATION,0.026013,0.10621,0.095985,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0014022,0.10616,0.12343,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.032278,0.10616,0.1213,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.0044864,0.10604,0.12237,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.00021857,0.10603,0.12216,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.016027,0.10603,0.10053,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.053071,0.1059,0.093488,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.014823,0.10586,0.16581,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.0090315,0.10553,0.10227,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.046031,0.10539,0.11241,1,1
4,GO CHOLESTEROL EFFLUX,0.027973,0.10535,0.098199,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0011836,0.10527,0.1819,1,1
4,GO RESPONSE TO COCAINE,0.028264,0.10526,0.11157,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0043737,0.10499,0.096519,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0052197,0.10492,0.13018,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.011151,0.10477,0.12842,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,0.0013069,0.10438,0.12431,1,1
4,GO DETECTION OF STIMULUS,4.3236e-05,0.10422,0.12041,1,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.0043184,0.10417,0.11301,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015038,0.10413,0.10941,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.002702,0.10372,0.12402,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.03902,0.10362,0.094567,1,1
4,GO PHOTOTRANSDUCTION,0.003654,0.10359,0.06981,1,1
4,GO CYTOKINETIC PROCESS,0.0015249,0.10357,0.12719,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00075607,0.10334,0.10382,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00090088,0.10272,0.11804,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0085105,0.10171,0.11227,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0054192,0.10157,0.13287,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.046474,0.10118,0.10933,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.0043737,0.10115,0.11901,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.01251,0.10109,0.10115,1,1
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.016027,0.099619,0.13543,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.060988,0.099583,0.11124,1,1
4,GO RESPONSE TO ALKALOID,0.003166,0.098944,0.11961,1,1
4,GO PROTEIN DESTABILIZATION,0.0018256,0.0987,0.12296,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.01016,0.098516,0.1003,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.0084096,0.098228,0.1358,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00073415,0.097858,0.1111,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0029645,0.097842,0.10133,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.038258,0.09761,0.096664,1,1
4,GO VIRAL RELEASE FROM HOST CELL,0.015159,0.097575,0.097111,1,1
4,GO SELECTIVE AUTOPHAGY,0.0060595,0.096669,0.098908,1,1
4,GO AGING,0.014332,0.096358,0.078179,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.049212,0.095914,0.097609,1,1
4,GO GOLGI RIBBON FORMATION,0.036048,0.095784,0.11106,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.027973,0.095631,0.1123,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.046031,0.095477,0.099325,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00045468,0.095475,0.10237,1,1
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.0071918,0.094193,0.10913,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.012227,0.092908,0.11687,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0021215,0.092798,0.099055,1,1
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0068504,0.092238,0.12656,1,1
4,GO ENDOSOME ORGANIZATION,0.0019819,0.091681,0.11422,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.034984,0.091565,0.14685,1,1
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.045155,0.091561,0.1099,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.026013,0.091481,0.077077,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.0059852,0.090813,0.1006,1,1
4,GO NADP METABOLIC PROCESS,0.039795,0.089699,0.10965,1,1
4,GO LYMPH NODE DEVELOPMENT,0.021973,0.089564,0.10833,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.037882,0.087891,0.07737,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.020828,0.087023,0.11125,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.012945,0.086731,0.09048,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.001422,0.086199,0.11468,1,1
4,GO POLYOL METABOLIC PROCESS,0.016386,0.085476,0.080584,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.003654,0.085271,0.085812,1,1
4,GO GOLGI ORGANIZATION,0.0021505,0.08509,0.097718,1,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.040187,0.084808,0.11832,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.059331,0.084549,0.064939,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.040981,0.083448,0.08148,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.011411,0.083354,0.080788,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.023173,0.082834,0.071334,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.040981,0.081783,0.075654,1,1
4,GO BICARBONATE TRANSPORT,0.01585,0.081262,0.10918,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0024609,0.080926,0.11296,1,1
4,GO CHOLESTEROL STORAGE,0.041789,0.079207,0.14402,1,1
4,GO ELECTRON TRANSPORT CHAIN,0.0080166,0.079148,0.071365,1,1
4,GO REGULATION OF TOR SIGNALING,0.004964,0.077913,0.10299,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0048405,0.077902,0.10657,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.016568,0.076915,0.089775,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.003166,0.074949,0.095276,1,1
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.052575,0.074584,0.0867,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.040582,0.073676,0.091965,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.014823,0.073067,0.098745,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.034636,0.07105,0.073382,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0090315,0.068916,0.072324,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.016205,0.061466,0.091712,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.033948,0.060014,0.074975,1,1
4,GO BLASTOCYST DEVELOPMENT,0.012798,0.058034,0.069469,1,1
4,GO ORGANELLE DISASSEMBLY,0.0034243,0.057782,0.087995,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.016205,0.057573,0.069466,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.023919,0.057149,0.071894,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.015159,0.054884,0.091429,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.055093,0.050414,0.059084,1,1
4,GO ORGANELLE INHERITANCE,0.037139,0.050319,0.079488,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.037509,0.04931,0.10067,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.017125,0.50117,0.49122,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.01251,0.45464,0.42206,1,0
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00012186,0.36284,0.3285,1,0
4,GO LIPID DIGESTION,6.3249e-05,0.3508,0.37802,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.003607,0.3181,0.20138,1,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,6.4592e-06,0.31429,0.43812,1,0
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,7.9617e-06,0.29638,0.38358,1,0
4,GO HEART INDUCTION,0.000286,0.29385,0.32291,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00083767,0.29333,0.29155,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0065235,0.29135,0.21069,1,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0030839,0.27396,0.25839,1,0
4,GO STEROID HORMONE SECRETION,0.001483,0.26489,0.1888,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0016122,0.2586,0.27878,1,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0020367,0.25759,0.25203,1,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00099681,0.25568,0.23466,1,0
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00019541,0.25369,0.27641,1,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.036772,0.25107,0.1802,1,0
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00096848,0.24649,0.29325,1,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.0053519,0.24628,0.25302,1,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0059116,0.24535,0.21798,1,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.022209,0.24302,0.20205,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.019312,0.24096,0.2632,1,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,3.5022e-05,0.23706,0.21772,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0066851,0.23642,0.19718,1,0
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.03068,0.23607,0.15461,1,0
4,GO REGULATION OF INTEGRIN ACTIVATION,5.332e-06,0.23186,0.26682,1,0
4,GO RESPONSE TO MUSCLE STRETCH,0.00016361,0.23132,0.32257,1,0
4,GO PROGESTERONE METABOLIC PROCESS,0.011022,0.23006,0.22816,1,0
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.014823,0.22916,0.1678,1,0
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0013255,0.22904,0.24149,1,0
4,GO PROTEIN KINASE C SIGNALING,0.00044103,0.22892,0.23011,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0020929,0.22575,0.20932,1,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00027284,0.2248,0.22713,1,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.011022,0.22328,0.21906,1,0
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00013016,0.22289,0.19969,1,0
4,GO KERATINOCYTE DEVELOPMENT,0.0038977,0.22051,0.2751,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0035605,0.22017,0.17033,1,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00035024,0.21907,0.19346,1,0
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.004156,0.2177,0.21611,1,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0001803,0.21722,0.19205,1,0
4,GO PLATELET ACTIVATION,0.0005211,0.21233,0.17673,1,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.02128,0.21112,0.18148,1,0
4,GO WATER HOMEOSTASIS,2.1621e-05,0.20958,0.22341,1,0
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.0029645,0.2095,0.20852,1,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.035336,0.20787,0.23614,1,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.020605,0.20596,0.23605,1,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00067188,0.20439,0.23566,1,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.011813,0.20278,0.13812,1,0
4,GO GLOMERULUS DEVELOPMENT,0.0040509,0.20125,0.18274,1,0
4,GO ACTIN FILAMENT NETWORK FORMATION,0.012653,0.20021,0.22033,1,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.036048,0.19957,0.24215,1,0
4,GO COPULATION,0.0027381,0.19931,0.17149,1,0
4,GO EPITHELIAL CELL MORPHOGENESIS,0.00081356,0.19751,0.3084,1,0
4,GO REGULATION OF AMINO ACID TRANSPORT,0.014658,0.19716,0.13677,1,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0049019,0.19517,0.24581,1,0
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00033955,0.19472,0.16616,1,0
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.019523,0.19287,0.15682,1,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.024687,0.18881,0.15194,1,0
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,1.0557e-05,0.1871,0.17778,1,0
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,6.4341e-05,0.1865,0.1994,1,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.0137,0.18583,0.19712,1,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.012945,0.18573,0.2424,1,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00054518,0.18569,0.17678,1,0
4,GO EPITHELIAL CELL CELL ADHESION,0.024947,0.1854,0.19865,1,0
4,GO RESPONSE TO WATER,0.0005133,0.18527,0.23957,1,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.027118,0.18513,0.22932,1,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.016205,0.18455,0.19936,1,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0067673,0.18371,0.17762,1,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.0052197,0.18345,0.1954,1,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00043435,0.18271,0.19493,1,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.023919,0.18108,0.15615,1,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0023637,0.1807,0.23337,1,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.033608,0.18053,0.10915,1,0
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00046872,0.18052,0.26391,1,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.043444,0.18042,0.14146,1,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.026838,0.18009,0.16208,1,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.047372,0.18001,0.12163,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0030038,0.1798,0.25157,1,0
4,GO LUNG CELL DIFFERENTIATION,0.0033799,0.1793,0.25351,1,0
4,GO INTEGRIN ACTIVATION,0.00031414,0.17868,0.19736,1,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.032607,0.17792,0.14021,1,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0028872,0.17751,0.22136,1,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.016938,0.17623,0.19556,1,0
4,GO AMYLOID BETA METABOLIC PROCESS,0.0035605,0.17541,0.15096,1,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0054192,0.17485,0.19875,1,0
4,GO ENDOCARDIUM DEVELOPMENT,0.0039481,0.17478,0.18593,1,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.039795,0.17458,0.12403,1,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.037139,0.17349,0.12767,1,0
4,GO ALANINE TRANSPORT,0.052575,0.17343,0.098052,1,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.026561,0.17306,0.17575,1,0
4,GO ENTRY INTO HOST,0.0024609,0.17277,0.16967,1,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.037509,0.17277,0.26445,1,0
4,GO B CELL MEDIATED IMMUNITY,0.0051547,0.17267,0.13565,1,0
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0012177,0.17178,0.17214,1,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0055559,0.17092,0.17601,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0098086,0.17044,0.17449,1,0
4,GO MALE MEIOSIS I,0.024428,0.16994,0.21154,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0073682,0.16993,0.12339,1,0
4,GO POSITIVE CHEMOTAXIS,0.008211,0.16908,0.12745,1,0
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.3214e-05,0.16877,0.16215,1,0
4,GO AMYLOID FIBRIL FORMATION,0.02521,0.16849,0.15695,1,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.0050904,0.16843,0.21479,1,0
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00058763,0.16738,0.18218,1,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.035336,0.16738,0.10013,1,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.036409,0.16649,0.18162,1,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0038977,0.16636,0.13488,1,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0031247,0.16568,0.15979,1,0
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,8.7316e-05,0.16519,0.2048,1,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.0011021,0.16462,0.22533,1,0
4,GO GLIAL CELL FATE COMMITMENT,0.049681,0.16439,0.20889,1,0
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.0024941,0.16424,0.1306,1,0
4,GO INNERVATION,0.025743,0.16254,0.22095,1,0
4,GO SMOOTH MUSCLE CELL MIGRATION,0.027686,0.16164,0.12812,1,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.003654,0.16152,0.1954,1,0
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00035024,0.16141,0.1675,1,0
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.024687,0.16125,0.11197,1,0
4,GO AMYLOID BETA FORMATION,0.024428,0.16092,0.12638,1,0
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0023009,0.16079,0.14492,1,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0012705,0.16064,0.2009,1,0
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.011151,0.1603,0.18723,1,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.049681,0.16003,0.12786,1,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0050269,0.15995,0.16671,1,0
4,GO MIDBODY ABSCISSION,4.5558e-05,0.159,0.18957,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.012227,0.15872,0.13124,1,0
4,GO INNATE IMMUNE RESPONSE,0.00058763,0.15838,0.14844,1,0
4,GO METANEPHROS MORPHOGENESIS,0.017699,0.15761,0.14387,1,0
4,GO MYELIN ASSEMBLY,0.0013443,0.15738,0.20703,1,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.040582,0.15714,0.10649,1,0
4,GO LEUKOTRIENE METABOLIC PROCESS,0.0028118,0.15701,0.1643,1,0
4,GO ENDOCYTIC RECYCLING,0.001776,0.15699,0.14135,1,0
4,GO DENDRITIC CELL MIGRATION,0.011678,0.15654,0.13144,1,0
4,GO RESPONSE TO INSECTICIDE,0.011949,0.15649,0.18833,1,0
4,GO DEVELOPMENTAL INDUCTION,0.0025617,0.15632,0.15728,1,0
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0015463,0.15573,0.24476,1,0
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00048316,0.15559,0.14537,1,0
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,7.2497e-05,0.15559,0.16408,1,0
4,GO MYOTUBE DIFFERENTIATION,0.00033955,0.15537,0.16457,1,0
4,GO BIOMINERALIZATION,0.0032078,0.15527,0.14099,1,0
4,GO FLUID TRANSPORT,0.020605,0.15524,0.10524,1,0
4,GO PITUITARY GLAND DEVELOPMENT,0.0052854,0.15504,0.22678,1,0
4,GO MONOCYTE CHEMOTAXIS,0.0088198,0.1549,0.13649,1,0
4,GO DEFENSE RESPONSE TO VIRUS,0.0056255,0.15475,0.14087,1,0
4,GO VASCULAR WOUND HEALING,0.0013069,0.15435,0.25597,1,0
4,GO REGULATION OF CARDIAC CONDUCTION,0.00065224,0.15433,0.14504,1,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.05357,0.15425,0.1092,1,0
4,GO PARTURITION,0.012945,0.1539,0.16801,1,0
4,GO MONOAMINE TRANSPORT,0.00033432,0.15387,0.24901,1,0
4,GO ENERGY HOMEOSTASIS,0.001955,0.15364,0.17753,1,0
4,GO CRANIAL NERVE DEVELOPMENT,0.010279,0.15354,0.15228,1,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.022446,0.15296,0.11272,1,0
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00022927,0.15294,0.15966,1,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.026013,0.1526,0.17217,1,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0037498,0.15256,0.13397,1,0
4,GO REGULATION OF BODY FLUID LEVELS,0.0013633,0.1525,0.13606,1,0
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.011813,0.15236,0.12921,1,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.025475,0.15227,0.13518,1,0
4,GO PURINE NUCLEOTIDE TRANSPORT,0.00026024,0.15214,0.15675,1,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.033608,0.15163,0.16133,1,0
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.0018764,0.15135,0.22828,1,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.023173,0.15123,0.10107,1,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.011813,0.15116,0.13894,1,0
4,GO WOUND HEALING,0.011678,0.15108,0.12276,1,0
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.031631,0.15053,0.13934,1,0
4,GO PEPTIDE SECRETION,1.2716e-05,0.15044,0.15903,1,0
4,GO TYPE I INTERFERON PRODUCTION,0.0032928,0.15044,0.13797,1,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.045591,0.15043,0.16916,1,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.018091,0.15019,0.10607,1,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.014494,0.15014,0.1121,1,0
4,GO HORMONE TRANSPORT,4.6359e-05,0.15002,0.16239,1,0
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0041031,0.14974,0.19701,1,0
4,GO RESPONSE TO PH,0.0035146,0.14954,0.15522,1,0
4,GO RESPONSE TO ACIDIC PH,0.0065235,0.14917,0.21718,1,0
4,GO CELL CHEMOTAXIS,0.0011503,0.14863,0.14422,1,0
4,GO RESPONSE TO IRON ION,0.0054872,0.1484,0.14176,1,0
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00029052,0.14827,0.13222,1,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.006444,0.14824,0.1419,1,0
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.01016,0.14795,0.13025,1,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.061549,0.14776,0.12157,1,0
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.011544,0.14574,0.11763,1,0
4,GO ZYMOGEN INHIBITION,0.013394,0.14553,0.14967,1,0
4,GO REGULATION OF B CELL DIFFERENTIATION,0.014172,0.14512,0.12439,1,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.058787,0.14491,0.18928,1,0
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.049212,0.14489,0.099849,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0055559,0.14437,0.125,1,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.016752,0.14402,0.11315,1,0
4,GO PROTEIN LOCALIZATION TO AXON,0.014332,0.14359,0.25893,1,0
4,GO CELL CELL ADHESION,0.0033799,0.14352,0.13101,1,0
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0085105,0.14345,0.13213,1,0
4,GO MEMBRANE FISSION,0.057179,0.14331,0.12914,1,0
4,GO INTRACELLULAR STEROL TRANSPORT,0.0011668,0.14294,0.21086,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.014494,0.14252,0.14422,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.023419,0.14231,0.095518,1,0
4,GO REGULATION OF HORMONE SECRETION,8.4424e-05,0.14224,0.15243,1,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.0016347,0.14222,0.14037,1,0
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00040857,0.1422,0.17712,1,0
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,1.3693e-05,0.14204,0.16738,1,0
4,GO INTERACTION WITH HOST,0.0038977,0.14158,0.1273,1,0
4,GO SYNCYTIUM FORMATION,0.008211,0.14145,0.13782,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00015838,0.14144,0.14452,1,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0019819,0.1414,0.17169,1,0
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0034692,0.14095,0.15975,1,0
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0088198,0.14069,0.13637,1,0
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0057669,0.1405,0.13668,1,0
4,GO DEFENSE RESPONSE,0.00038422,0.14011,0.14009,1,0
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.020385,0.14004,0.14531,1,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.043444,0.13956,0.10252,1,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.027118,0.13929,0.11328,1,0
4,GO KERATINOCYTE PROLIFERATION,0.045155,0.13903,0.11584,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.018693,0.13903,0.1115,1,0
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,7.5001e-05,0.13902,0.16936,1,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.056652,0.13895,0.11804,1,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0074579,0.13867,0.13717,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.010645,0.13848,0.12507,1,0
4,GO SPERM CAPACITATION,0.0137,0.138,0.11462,1,0
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0043184,0.13759,0.12211,1,0
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0022396,0.1375,0.16208,1,0
4,GO RESPONSE TO WOUNDING,0.016938,0.1373,0.11342,1,0
4,GO RESPONSE TO MECHANICAL STIMULUS,8.1623e-05,0.13714,0.17613,1,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.032938,0.137,0.15946,1,0
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,3.8246e-05,0.13699,0.16644,1,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.042609,0.13697,0.10527,1,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.001568,0.13696,0.14824,1,0
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0040509,0.13685,0.12146,1,0
4,GO IMMUNE EFFECTOR PROCESS,0.00053704,0.13684,0.14981,1,0
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0038478,0.1367,0.15439,1,0
4,GO REGULATION OF MUSCLE ADAPTATION,0.0021798,0.13643,0.14919,1,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.031311,0.1361,0.10648,1,0
4,GO BILE ACID METABOLIC PROCESS,0.0035605,0.13572,0.14408,1,0
4,GO LYMPHOCYTE MIGRATION,0.0041031,0.1357,0.12194,1,0
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00068191,0.1354,0.15707,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0069343,0.13526,0.13898,1,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.011949,0.13519,0.16704,1,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0037016,0.13487,0.16228,1,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.016752,0.13469,0.12024,1,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.035336,0.13427,0.16147,1,0
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.01016,0.13426,0.13398,1,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.02128,0.13424,0.17921,1,0
4,GO ACID SECRETION,0.00046165,0.13417,0.14195,1,0
4,GO REGULATION OF PEPTIDE SECRETION,2.2015e-05,0.13405,0.15236,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.010522,0.13398,0.14375,1,0
4,GO REGULATION OF CELL MATRIX ADHESION,0.01251,0.13344,0.15321,1,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00068191,0.13341,0.13203,1,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.017699,0.13311,0.11629,1,0
4,GO COAGULATION,0.0071918,0.13304,0.12117,1,0
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0028872,0.13279,0.11269,1,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.037139,0.13259,0.11139,1,0
4,GO RESPONSE TO BACTERIUM,0.0012705,0.13247,0.12522,1,0
4,GO REGULATION OF BIOMINERALIZATION,0.056128,0.13239,0.090424,1,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.014823,0.13236,0.14639,1,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0072795,0.13235,0.17675,1,0
4,GO SUBPALLIUM DEVELOPMENT,0.043025,0.13195,0.16453,1,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.033271,0.13171,0.10804,1,0
4,GO HORMONE CATABOLIC PROCESS,0.016205,0.13142,0.14236,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0054872,0.13138,0.12096,1,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.013394,0.13118,0.1112,1,0
4,GO VIRAL RNA GENOME REPLICATION,0.0054192,0.13118,0.13181,1,0
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00030449,0.13111,0.13271,1,0
4,GO ORGANIC ANION TRANSPORT,0.00011218,0.1309,0.12355,1,0
4,GO AMYLOID BETA CLEARANCE,0.012653,0.13069,0.13301,1,0
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0050904,0.13059,0.10892,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0055559,0.13051,0.17699,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.017125,0.13003,0.10898,1,0
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0089251,0.12967,0.15229,1,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.034636,0.12964,0.22022,1,0
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0024281,0.12963,0.16895,1,0
4,GO GLAND DEVELOPMENT,0.012945,0.12953,0.098325,1,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0027747,0.12944,0.191,1,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.016205,0.12931,0.12258,1,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.01128,0.1293,0.11625,1,0
4,GO REGULATION OF ENDOCRINE PROCESS,0.0012886,0.12919,0.14945,1,0
4,GO NOTCH SIGNALING PATHWAY,0.00014839,0.12914,0.16653,1,0
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.0063654,0.12897,0.13366,1,0
4,GO VESICLE BUDDING FROM MEMBRANE,0.011544,0.1289,0.099321,1,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.012367,0.12849,0.13238,1,0
4,GO EPITHELIAL CELL DEVELOPMENT,0.0093576,0.12838,0.12932,1,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.036772,0.12829,0.17367,1,0
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0029256,0.12827,0.11561,1,0
4,GO B CELL ACTIVATION,0.0018508,0.12826,0.12136,1,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0049019,0.1282,0.14671,1,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.048746,0.12814,0.1149,1,0
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,8.8796e-05,0.12754,0.1594,1,0
4,GO RESPONSE TO PEPTIDOGLYCAN,0.0093576,0.12741,0.12383,1,0
4,GO RESPONSE TO CAFFEINE,0.0093576,0.12704,0.14103,1,0
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00020178,0.12691,0.15837,1,0
4,GO MUSCLE ADAPTATION,0.00080175,0.12617,0.15414,1,0
4,GO REGULATION OF SECRETION,7.0072e-05,0.12608,0.13438,1,0
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0021798,0.12603,0.13849,1,0
4,GO HEART PROCESS,0.0062877,0.12597,0.10331,1,0
4,GO RESPONSE TO INORGANIC SUBSTANCE,2.8305e-05,0.12591,0.13816,1,0
4,GO REGULATION OF ACROSOME REACTION,0.0137,0.12588,0.1538,1,0
4,GO SENSORY PERCEPTION OF TASTE,0.00014362,0.12577,0.14948,1,0
4,GO B CELL DIFFERENTIATION,0.0022396,0.12548,0.12095,1,0
4,GO BIOLOGICAL ADHESION,0.015159,0.1254,0.10588,1,0
4,GO CELL ACTIVATION,0.001442,0.12522,0.12688,1,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.017699,0.12518,0.12842,1,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.0060595,0.12516,0.12342,1,0
4,GO COLLAGEN CATABOLIC PROCESS,0.031953,0.12501,0.12588,1,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.040582,0.12465,0.089722,1,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.014332,0.12439,0.15444,1,0
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.002702,0.12424,0.12644,1,0
4,GO RENAL SYSTEM PROCESS,0.017506,0.12408,0.12342,1,0
4,GO MONONUCLEAR CELL MIGRATION,0.028852,0.12386,0.095473,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.042609,0.12384,0.10934,1,0
4,GO PLASMA MEMBRANE ORGANIZATION,0.00036124,0.12377,0.17862,1,0
4,GO CYTOKINE PRODUCTION,0.004964,0.1237,0.11993,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0062877,0.12353,0.12041,1,0
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.1119e-05,0.12318,0.13621,1,0
4,GO RESPONSE TO INACTIVITY,0.060988,0.12288,0.16338,1,0
4,GO VESICLE ORGANIZATION,0.00042128,0.12285,0.12524,1,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0012527,0.12281,0.13425,1,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.060432,0.12279,0.091513,1,0
4,GO REGULATION OF CELL ADHESION,0.0060595,0.12276,0.12701,1,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.014332,0.12261,0.11555,1,0
4,GO POSITIVE REGULATION OF CELL ADHESION,0.006444,0.12229,0.12972,1,0
4,GO POSITIVE REGULATION OF SECRETION,2.4528e-05,0.12208,0.14891,1,0
4,GO RESPONSE TO BMP,0.055609,0.12208,0.091638,1,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.046921,0.12206,0.1641,1,0
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.017315,0.1218,0.10126,1,0
4,GO VITAMIN TRANSPORT,0.0072795,0.12158,0.13541,1,0
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.022686,0.12155,0.10649,1,0
4,GO PROSTAGLANDIN SECRETION,0.0076401,0.12151,0.13215,1,0
4,GO ADAPTIVE THERMOGENESIS,0.0001179,0.12145,0.1429,1,0
4,GO TYPE 2 IMMUNE RESPONSE,0.024687,0.12115,0.12401,1,0
4,GO MUSCLE CELL DEVELOPMENT,0.016752,0.12099,0.093924,1,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.014658,0.12089,0.099339,1,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.0020092,0.12087,0.13567,1,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.054074,0.12066,0.1161,1,0
4,GO RESPONSE TO INTERLEUKIN 1,0.010645,0.12066,0.080511,1,0
4,GO REGULATION OF HISTONE DEACETYLATION,0.0052197,0.12051,0.15051,1,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.003654,0.12023,0.12151,1,0
4,GO T CELL DIFFERENTIATION,0.012227,0.12003,0.091446,1,0
4,GO REGULATION OF ANION TRANSPORT,0.0018256,0.12002,0.11876,1,0
4,GO REGULATION OF BLOOD CIRCULATION,0.0047798,0.11988,0.11012,1,0
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.044292,0.11954,0.096717,1,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.010895,0.11936,0.1033,1,0
4,GO REGULATION OF GLUCONEOGENESIS,0.0014022,0.11936,0.12127,1,0
4,GO LIPID STORAGE,0.0078263,0.11908,0.13041,1,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.022446,0.11901,0.21494,1,0
4,GO REGULATION OF DEFENSE RESPONSE,0.0012177,0.11895,0.11968,1,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.032938,0.11891,0.1272,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.026286,0.11862,0.10601,1,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.011813,0.11847,0.12697,1,0
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0095807,0.11845,0.1127,1,0
4,GO HYALURONAN METABOLIC PROCESS,0.02521,0.11831,0.10464,1,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.020166,0.11821,0.13025,1,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0070192,0.11801,0.20724,1,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.035336,0.11779,0.11287,1,0
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0069343,0.11768,0.10391,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.004156,0.1175,0.16909,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.018091,0.11743,0.12557,1,0
4,GO EPITHELIUM DEVELOPMENT,0.0086125,0.11716,0.10139,1,0
4,GO REGULATION OF SODIUM ION TRANSPORT,0.0047798,0.11714,0.13295,1,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.02174,0.11675,0.15557,1,0
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0030839,0.11669,0.11466,1,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.034636,0.11659,0.11894,1,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.025743,0.11652,0.15751,1,0
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.041789,0.11643,0.11485,1,0
4,GO DNA DEMETHYLATION,0.0069343,0.11641,0.13413,1,0
4,GO PROTEIN MANNOSYLATION,0.0090315,0.11629,0.13552,1,0
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0052854,0.11618,0.12578,1,0
4,GO SIGNAL RELEASE,0.00028155,0.1161,0.13536,1,0
4,GO AUTOPHAGOSOME MATURATION,0.0022095,0.11601,0.13362,1,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0024281,0.11599,0.13434,1,0
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00059648,0.11553,0.11753,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.009139,0.11548,0.12587,1,0
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.007921,0.11545,0.14919,1,0
4,GO INTERLEUKIN 6 PRODUCTION,0.0005618,0.11543,0.15765,1,0
4,GO FUCOSE METABOLIC PROCESS,0.048746,0.11526,0.11045,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.013394,0.11511,0.11711,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.040187,0.115,0.1053,1,0
4,GO ANION TRANSPORT,0.00020178,0.11495,0.11382,1,0
4,GO RESPONSE TO VIRUS,0.0047798,0.11495,0.12546,1,0
4,GO DIENCEPHALON DEVELOPMENT,0.013394,0.11482,0.16428,1,0
4,GO FAT CELL DIFFERENTIATION,0.0090315,0.11475,0.11342,1,0
4,GO VIRAL BUDDING,0.00031414,0.11473,0.14297,1,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.017699,0.11468,0.10817,1,0
4,GO RESPONSE TO STARVATION,0.00061456,0.11455,0.12541,1,0
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0043737,0.11453,0.16967,1,0
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.006444,0.1145,0.12962,1,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0025961,0.11429,0.11053,1,0
4,GO RESPONSE TO CYTOKINE,0.0025277,0.11429,0.11954,1,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0012527,0.11401,0.10601,1,0
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.009139,0.11393,0.11836,1,0
4,GO STEROID CATABOLIC PROCESS,0.0021505,0.11385,0.19633,1,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.015674,0.11368,0.10767,1,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00019229,0.11339,0.13362,1,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.014172,0.11324,0.095237,1,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.021509,0.11311,0.12761,1,0
4,GO CYTOKINE SECRETION,0.0011021,0.11292,0.13879,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0070192,0.11274,0.10925,1,0
4,GO RESPONSE TO CORTICOSTEROID,0.057711,0.11268,0.085245,1,0
4,GO RESPONSE TO PROTOZOAN,0.027686,0.11215,0.10855,1,0
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00036124,0.11212,0.11784,1,0
4,GO CELLULAR RESPONSE TO KETONE,0.031953,0.11208,0.096043,1,0
4,GO BROWN FAT CELL DIFFERENTIATION,0.00098255,0.112,0.17024,1,0
4,GO GLUCOSE METABOLIC PROCESS,0.00011986,0.11182,0.13318,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.02915,0.11178,0.13175,1,0
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.00061456,0.11172,0.10442,1,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.031631,0.1117,0.19947,1,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.01016,0.1116,0.11193,1,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.011022,0.11137,0.11773,1,0
4,GO T CELL MIGRATION,0.021053,0.11133,0.11975,1,0
4,GO GLIAL CELL DEVELOPMENT,0.027686,0.11131,0.099689,1,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.010522,0.11127,0.11533,1,0
4,GO ENGULFMENT OF APOPTOTIC CELL,0.032938,0.11127,0.10144,1,0
4,GO RESPONSE TO BIOTIC STIMULUS,0.0011021,0.11125,0.12445,1,0
4,GO SODIUM ION TRANSPORT,0.00061456,0.11089,0.126,1,0
4,GO CELLULAR LIPID METABOLIC PROCESS,0.001483,0.11084,0.10214,1,0
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00040857,0.1108,0.12357,1,0
4,GO RESPONSE TO INSULIN,0.000662,0.11066,0.11819,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0013633,0.11045,0.12274,1,0
4,GO REGULATION OF CHEMOTAXIS,0.0083098,0.11032,0.10679,1,0
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0053519,0.1101,0.14584,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0066851,0.11006,0.135,1,0
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0010408,0.10994,0.11879,1,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.055609,0.10991,0.17199,1,0
4,GO CHEMICAL HOMEOSTASIS,0.00036124,0.1099,0.11139,1,0
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.012367,0.10986,0.08666,1,0
4,GO TISSUE HOMEOSTASIS,0.0061347,0.10986,0.10691,1,0
4,GO REGULATION OF TUBE SIZE,0.013546,0.10965,0.091583,1,0
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.004156,0.10954,0.12367,1,0
4,GO ADIPOSE TISSUE DEVELOPMENT,0.024687,0.10952,0.11663,1,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.036048,0.1095,0.12837,1,0
4,GO LYMPHOCYTE DIFFERENTIATION,0.013856,0.10949,0.084368,1,0
4,GO RESPONSE TO ISCHEMIA,0.030994,0.10918,0.099038,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.044722,0.10918,0.10138,1,0
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.021973,0.10912,0.099933,1,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.05357,0.10894,0.09899,1,0
4,GO REGULATION OF SYSTEM PROCESS,0.01251,0.10858,0.08999,1,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.0078263,0.10858,0.11275,1,0
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.054582,0.10846,0.091425,1,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.047827,0.10845,0.10052,1,0
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0013069,0.10821,0.10403,1,0
4,GO RESPONSE TO KETONE,0.02945,0.10819,0.087508,1,0
4,GO LEUKOCYTE DIFFERENTIATION,0.0062108,0.10766,0.099052,1,0
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00159,0.10762,0.11147,1,0
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.011151,0.10754,0.10583,1,0
4,GO RESPONSE TO ALCOHOL,0.0065235,0.10753,0.10509,1,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.026286,0.10738,0.11363,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.052575,0.10702,0.11008,1,0
4,GO STEROL HOMEOSTASIS,0.0066851,0.1069,0.13202,1,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.006444,0.10667,0.13379,1,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.03902,0.10638,0.10395,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.017315,0.10636,0.091973,1,0
4,GO ZINC ION TRANSPORT,0.050154,0.10622,0.077419,1,0
4,GO REGULATION OF ION TRANSPORT,0.003654,0.10601,0.10202,1,0
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.022928,0.10596,0.11874,1,0
4,GO MULTICELLULAR ORGANISM AGING,0.0030839,0.10593,0.13312,1,0
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.004964,0.10584,0.10412,1,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.019523,0.10577,0.1151,1,0
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.017506,0.10564,0.1097,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00061456,0.1056,0.11236,1,0
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.034636,0.10559,0.1058,1,0
4,GO POSITIVE REGULATION OF CELL GROWTH,0.0093576,0.10555,0.09083,1,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.017315,0.10546,0.10351,1,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.03429,0.10537,0.10662,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.027973,0.10534,0.14111,1,0
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00036686,0.10532,0.13078,1,0
4,GO CIRCULATORY SYSTEM PROCESS,0.00159,0.10527,0.11117,1,0
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0043184,0.10525,0.1042,1,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.014494,0.10514,0.1038,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.030994,0.1051,0.097234,1,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.016938,0.10498,0.11361,1,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.049681,0.10493,0.10297,1,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.020385,0.10492,0.12771,1,0
4,GO ORGANIC ACID TRANSPORT,0.001235,0.10482,0.099587,1,0
4,GO ACTIVATION OF IMMUNE RESPONSE,0.0037498,0.10477,0.10546,1,0
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0039992,0.10465,0.10856,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0094686,0.10445,0.099144,1,0
4,GO LIPID METABOLIC PROCESS,0.0011341,0.10431,0.10303,1,0
4,GO ENERGY RESERVE METABOLIC PROCESS,0.003607,0.10417,0.12853,1,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.01849,0.1041,0.13129,1,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.012945,0.1037,0.090371,1,0
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.024687,0.10355,0.096855,1,0
4,GO ION TRANSPORT,0.00025215,0.10346,0.1113,1,0
4,GO MATING,0.0043737,0.10339,0.11682,1,0
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.016752,0.10338,0.092496,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.7586e-05,0.10335,0.13002,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.041789,0.1033,0.088497,1,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.032938,0.1032,0.15,1,0
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.017506,0.10287,0.11145,1,0
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.01499,0.10279,0.13458,1,0
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.023919,0.10277,0.10213,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.015674,0.10266,0.098696,1,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.058787,0.10248,0.13826,1,0
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.0038478,0.10224,0.12277,1,0
4,GO DNA DEALKYLATION,0.01016,0.10217,0.11418,1,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0057669,0.10216,0.13236,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.03006,0.102,0.12827,1,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0073682,0.10191,0.13986,1,0
4,GO METAL ION HOMEOSTASIS,0.0028872,0.10162,0.09388,1,0
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0012527,0.10157,0.13372,1,0
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.001235,0.10142,0.12117,1,0
4,GO TRANSITION METAL ION TRANSPORT,0.00026024,0.10141,0.104,1,0
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.010522,0.10118,0.11274,1,0
4,GO CELL MATRIX ADHESION,0.026561,0.10114,0.1189,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0048405,0.10096,0.12012,1,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.030368,0.10084,0.07275,1,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.013243,0.10084,0.11917,1,0
4,GO RESPONSE TO PEPTIDE HORMONE,0.0062108,0.10077,0.09329,1,0
4,GO ANIMAL ORGAN MATURATION,0.032938,0.1005,0.11628,1,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.034636,0.10041,0.078271,1,0
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.007921,0.10027,0.11966,1,0
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0055559,0.10025,0.1119,1,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.017699,0.10023,0.11406,1,0
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.00025617,0.10019,0.1345,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.01995,0.10011,0.096833,1,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.02128,0.099933,0.095918,1,0
4,GO CELLULAR RESPONSE TO PEPTIDE,0.017125,0.099795,0.08592,1,0
4,GO DETECTION OF MECHANICAL STIMULUS,0.058787,0.099667,0.12382,1,0
4,GO GOLGI VESICLE BUDDING,0.0046604,0.099605,0.10262,1,0
4,GO ION TRANSMEMBRANE TRANSPORT,0.001118,0.09955,0.10348,1,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.054074,0.099543,0.092721,1,0
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.014332,0.099466,0.14894,1,0
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.043025,0.099409,0.0865,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0028118,0.098929,0.08917,1,0
4,GO CELL REDOX HOMEOSTASIS,0.023419,0.098882,0.085732,1,0
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0037498,0.098767,0.13117,1,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.009139,0.098691,0.10052,1,0
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0025617,0.098535,0.10096,1,0
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0029256,0.098428,0.10975,1,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.054582,0.098264,0.11961,1,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.017506,0.098107,0.1111,1,0
4,GO ENDOCRINE HORMONE SECRETION,0.004156,0.098086,0.11883,1,0
4,GO TEMPERATURE HOMEOSTASIS,0.00081356,0.098007,0.12706,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.035336,0.097799,0.094855,1,0
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.011949,0.097539,0.088761,1,0
4,GO EXECUTION PHASE OF APOPTOSIS,0.00019857,0.097464,0.10941,1,0
4,GO CHLORIDE TRANSPORT,0.0013633,0.097113,0.11445,1,0
4,GO LYMPHOCYTE COSTIMULATION,0.059331,0.097013,0.089264,1,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.050154,0.097003,0.10371,1,0
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.026286,0.096829,0.10536,1,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.043025,0.096816,0.1007,1,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.02174,0.096714,0.092047,1,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.020605,0.096582,0.091695,1,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0077327,0.096381,0.094641,1,0
4,GO REGULATION OF PROTEOLYSIS,0.0065235,0.096337,0.093971,1,0
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.002702,0.096286,0.09713,1,0
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0020646,0.096051,0.094403,1,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0090315,0.095861,0.15298,1,0
4,GO REGULATION OF LIPID STORAGE,0.011411,0.095765,0.12112,1,0
4,GO VIRAL LIFE CYCLE,0.0049019,0.095752,0.11057,1,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0096941,0.095639,0.10303,1,0
4,GO DETECTION OF ABIOTIC STIMULUS,0.022686,0.095556,0.083822,1,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.015674,0.095522,0.1202,1,0
4,GO EATING BEHAVIOR,0.0024941,0.095499,0.14312,1,0
4,GO ACROSOME REACTION,0.049681,0.095363,0.10531,1,0
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0019819,0.095218,0.10909,1,0
4,GO CD40 SIGNALING PATHWAY,0.05063,0.095169,0.088243,1,0
4,GO CELL MATURATION,0.0067673,0.095149,0.097169,1,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0013069,0.095128,0.14409,1,0
4,GO RESPONSE TO CATECHOLAMINE,0.029754,0.095126,0.10022,1,0
4,GO TRANSMEMBRANE TRANSPORT,0.0005211,0.095071,0.096182,1,0
4,GO RESPONSE TO HORMONE,0.019735,0.095065,0.083463,1,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.049681,0.095026,0.10218,1,0
4,GO OOCYTE DIFFERENTIATION,0.031953,0.095004,0.087393,1,0
4,GO NIK NF KAPPAB SIGNALING,0.03006,0.094876,0.072434,1,0
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.033948,0.094869,0.09262,1,0
4,GO REPRODUCTIVE BEHAVIOR,0.032278,0.094757,0.097639,1,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.031953,0.094755,0.10799,1,0
4,GO MEMBRANE ORGANIZATION,0.001955,0.094713,0.099033,1,0
4,GO RESPONSE TO ETHANOL,0.009139,0.09457,0.089763,1,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.043025,0.094514,0.1202,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.032938,0.094501,0.10404,1,0
4,GO CIRCADIAN RHYTHM,0.0017277,0.094099,0.10986,1,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.053071,0.093937,0.11248,1,0
4,GO REGULATION OF T CELL DIFFERENTIATION,0.032607,0.093872,0.078636,1,0
4,GO GLUTAMATE METABOLIC PROCESS,0.020166,0.093789,0.09208,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.041383,0.093389,0.090364,1,0
4,GO REGULATION OF CELL MATURATION,0.026561,0.093244,0.085699,1,0
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0041031,0.093235,0.09666,1,0
4,GO LYMPHOCYTE ACTIVATION,0.014013,0.093097,0.089451,1,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.014013,0.093,0.09241,1,0
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0070192,0.092826,0.089296,1,0
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0037016,0.092789,0.11975,1,0
4,GO SULFUR COMPOUND TRANSPORT,0.013243,0.092709,0.10278,1,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.038258,0.092518,0.10015,1,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.055609,0.0924,0.099052,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.03068,0.092394,0.11168,1,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.027401,0.092352,0.088364,1,0
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00042128,0.092344,0.12636,1,0
4,GO ION HOMEOSTASIS,0.0023009,0.092341,0.093218,1,0
4,GO FATTY ACID METABOLIC PROCESS,0.0054192,0.092286,0.094561,1,0
4,GO CELL MOTILITY,0.035691,0.092262,0.08403,1,0
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.008211,0.092237,0.091479,1,0
4,GO REGULATION OF PEPTIDE TRANSPORT,0.00012594,0.092226,0.11583,1,0
4,GO ANION TRANSMEMBRANE TRANSPORT,0.0029645,0.092029,0.090715,1,0
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0096941,0.091974,0.093234,1,0
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0054872,0.091875,0.10274,1,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.009139,0.091489,0.095111,1,0
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.040582,0.091388,0.13976,1,0
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.048746,0.091298,0.079482,1,0
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.034984,0.091188,0.081695,1,0
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0059116,0.091162,0.089859,1,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.037509,0.091139,0.079297,1,0
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.035336,0.090948,0.094684,1,0
4,GO CATION TRANSPORT,0.0016122,0.090808,0.1003,1,0
4,GO VESICLE DOCKING,0.05063,0.09073,0.09334,1,0
4,GO SECRETORY GRANULE ORGANIZATION,0.040582,0.090694,0.11188,1,0
4,GO REGULATION OF PROTEIN BINDING,0.028852,0.090497,0.088646,1,0
4,GO REGULATION OF IMMUNE RESPONSE,0.0088198,0.090145,0.097637,1,0
4,GO MANGANESE ION TRANSPORT,0.041789,0.090142,0.092192,1,0
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.016938,0.090027,0.12205,1,0
4,GO OSSIFICATION,0.049212,0.089828,0.079751,1,0
4,GO AUTOPHAGOSOME ORGANIZATION,0.0038977,0.089823,0.11433,1,0
4,GO DEVELOPMENTAL MATURATION,0.043025,0.089796,0.082461,1,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0093576,0.08979,0.10369,1,0
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.002631,0.089636,0.097041,1,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.022446,0.089441,0.11292,1,0
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.01849,0.088935,0.10234,1,0
4,GO REGULATION OF LIPID LOCALIZATION,0.0078263,0.088882,0.10778,1,0
4,GO PROTEIN DEPOLYMERIZATION,0.056652,0.088765,0.087208,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.037882,0.088713,0.11719,1,0
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00036686,0.088684,0.14053,1,0
4,GO RESPONSE TO DSRNA,0.013394,0.088608,0.10449,1,0
4,GO RESPONSE TO OXIDATIVE STRESS,0.01849,0.088599,0.08472,1,0
4,GO RESPONSE TO PEPTIDE,0.0080166,0.088535,0.091232,1,0
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0073682,0.088103,0.094626,1,0
4,GO VESICLE TARGETING,0.013856,0.088076,0.10419,1,0
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.008211,0.087924,0.09784,1,0
4,GO REGULATION OF HYDROLASE ACTIVITY,0.051111,0.087902,0.075037,1,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.040582,0.087875,0.077689,1,0
4,GO REGULATION OF GROWTH,0.055093,0.087808,0.067877,1,0
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0018508,0.087757,0.1022,1,0
4,GO GLYCEROLIPID METABOLIC PROCESS,0.0020092,0.087529,0.094053,1,0
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02521,0.087509,0.084269,1,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.021973,0.087403,0.086323,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0030436,0.087396,0.10163,1,0
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.00037835,0.087273,0.1204,1,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.01829,0.087182,0.082699,1,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.020605,0.087095,0.082195,1,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.022928,0.087074,0.1149,1,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.018898,0.086947,0.1085,1,0
4,GO CELLULAR ION HOMEOSTASIS,0.0038478,0.086902,0.086254,1,0
4,GO REGULATION OF CIRCADIAN RHYTHM,0.037509,0.086848,0.072749,1,0
4,GO COPPER ION HOMEOSTASIS,0.032278,0.086641,0.11442,1,0
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.024173,0.086636,0.080167,1,0
4,GO RESPONSE TO NUTRIENT,0.032938,0.086406,0.095469,1,0
4,GO ENDOTHELIAL CELL MIGRATION,0.047827,0.086316,0.10526,1,0
4,GO CALCIUM MEDIATED SIGNALING,0.0028492,0.086109,0.082084,1,0
4,GO RECEPTOR RECYCLING,0.032278,0.086065,0.10115,1,0
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.047827,0.085995,0.082876,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.023668,0.085841,0.11038,1,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.013243,0.08582,0.097811,1,0
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.001704,0.085741,0.10544,1,0
4,GO SKELETAL MUSCLE CONTRACTION,0.027118,0.085627,0.10233,1,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.0095807,0.085507,0.095777,1,0
4,GO JNK CASCADE,0.015329,0.085386,0.09231,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.022686,0.085382,0.09299,1,0
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.057711,0.085199,0.067027,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.03068,0.085191,0.098227,1,0
4,GO VACUOLAR TRANSPORT,0.014494,0.085155,0.087708,1,0
4,GO RESPONSE TO DEXAMETHASONE,0.022686,0.085019,0.10297,1,0
4,GO POTASSIUM ION TRANSPORT,0.0090315,0.084853,0.11824,1,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.022209,0.084563,0.086154,1,0
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.047827,0.084537,0.099427,1,0
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.033948,0.084523,0.079407,1,0
4,GO REGULATION OF VACUOLE ORGANIZATION,0.022209,0.084502,0.09988,1,0
4,GO LIPID CATABOLIC PROCESS,0.0016122,0.084378,0.11183,1,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.040981,0.084366,0.095196,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.016027,0.08412,0.10638,1,0
4,GO RESPONSE TO MONOSACCHARIDE,0.0012177,0.08402,0.11549,1,0
4,GO RESPONSE TO CARBOHYDRATE,0.002631,0.084008,0.10565,1,0
4,GO LIPID HOMEOSTASIS,0.027686,0.083992,0.090528,1,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.056652,0.08391,0.090911,1,0
4,GO ANATOMICAL STRUCTURE MATURATION,0.027686,0.08372,0.08034,1,0
4,GO TRANSITION METAL ION HOMEOSTASIS,0.040582,0.083636,0.085373,1,0
4,GO REGULATION OF TRANSPORT,0.0034692,0.083624,0.086197,1,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.016027,0.083571,0.10006,1,0
4,GO REGULATION OF PROTEIN DEACETYLATION,0.025743,0.083456,0.10603,1,0
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0070192,0.083446,0.097448,1,0
4,GO MUSCLE SYSTEM PROCESS,0.026561,0.083112,0.07657,1,0
4,GO PROTEIN TARGETING TO VACUOLE,0.019312,0.082976,0.11204,1,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.051595,0.082965,0.16111,1,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.038258,0.082877,0.083212,1,0
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.031953,0.082721,0.090637,1,0
4,GO REVERSE CHOLESTEROL TRANSPORT,0.024687,0.082398,0.18523,1,0
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0078263,0.082357,0.093522,1,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.028852,0.082141,0.11081,1,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0056255,0.082111,0.13034,1,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.046474,0.082011,0.080427,1,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.037139,0.081995,0.080517,1,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.040187,0.081868,0.10255,1,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0137,0.081678,0.10661,1,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.033271,0.081661,0.095551,1,0
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0037016,0.08162,0.092982,1,0
4,GO APOPTOTIC SIGNALING PATHWAY,0.001483,0.081561,0.10432,1,0
4,GO SENSORY PERCEPTION OF PAIN,0.01016,0.081355,0.1123,1,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.03902,0.081275,0.1025,1,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.037139,0.081249,0.10107,1,0
4,GO METAL ION TRANSPORT,0.003654,0.080978,0.092395,1,0
4,GO COPII COATED VESICLE BUDDING,0.0086125,0.080872,0.093561,1,0
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0031247,0.080847,0.11601,1,0
4,GO RESPONSE TO TOXIC SUBSTANCE,0.017894,0.080796,0.083533,1,0
4,GO POSITIVE REGULATION OF SIGNALING,0.0051547,0.080242,0.08807,1,0
4,GO ENDOCYTOSIS,0.041789,0.080125,0.081911,1,0
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.026838,0.080085,0.079295,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.055609,0.080007,0.082403,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0035605,0.079647,0.09296,1,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.033271,0.079614,0.080355,1,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.030994,0.079574,0.074397,1,0
4,GO FATTY ACID TRANSPORT,0.030368,0.079499,0.089064,1,0
4,GO PROTEOLYSIS,0.0041031,0.079435,0.088228,1,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.036772,0.079272,0.08134,1,0
4,GO HEAT GENERATION,0.014332,0.079128,0.12422,1,0
4,GO MAINTENANCE OF LOCATION IN CELL,0.0054872,0.078895,0.097604,1,0
4,GO HOMEOSTATIC PROCESS,0.0040509,0.078384,0.083081,1,0
4,GO POSITIVE REGULATION OF TRANSPORT,0.0044864,0.078357,0.087976,1,0
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.010522,0.078337,0.093796,1,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.024173,0.078288,0.09653,1,0
4,GO CARDIAC MUSCLE CONTRACTION,0.022446,0.078271,0.098688,1,0
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0084096,0.078032,0.098855,1,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.056652,0.077951,0.059572,1,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.05063,0.077889,0.078024,1,0
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0052854,0.077852,0.10633,1,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.026838,0.077762,0.088066,1,0
4,GO COPPER ION TRANSPORT,0.018693,0.077564,0.11707,1,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.041383,0.07735,0.069186,1,0
4,GO CARBOHYDRATE METABOLIC PROCESS,0.0012177,0.077235,0.098504,1,0
4,GO PHAGOCYTOSIS,0.01995,0.07715,0.10987,1,0
4,GO INORGANIC ANION TRANSPORT,0.001955,0.077119,0.094595,1,0
4,GO RESPONSE TO OXYGEN LEVELS,0.040187,0.077043,0.07706,1,0
4,GO VITAMIN METABOLIC PROCESS,0.056652,0.076972,0.077798,1,0
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0090315,0.076845,0.096977,1,0
4,GO SYMBIOTIC PROCESS,0.035691,0.076759,0.061273,1,0
4,GO ENDOSOMAL TRANSPORT,0.012227,0.076593,0.076035,1,0
4,GO VISUAL BEHAVIOR,0.053071,0.076549,0.081738,1,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.040187,0.076401,0.077258,1,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.03902,0.076373,0.086513,1,0
4,GO REGULATION OF MAP KINASE ACTIVITY,0.020828,0.076189,0.099657,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.047827,0.076147,0.096497,1,0
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.016205,0.076039,0.08329,1,0
4,GO CARDIAC CONDUCTION,0.018091,0.076007,0.10927,1,0
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.014332,0.07596,0.088376,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0041031,0.075835,0.12696,1,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.011544,0.07529,0.087752,1,0
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.049212,0.075036,0.066556,1,0
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0013443,0.074943,0.09535,1,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.033948,0.074896,0.074494,1,0
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.060988,0.074865,0.073277,1,0
4,GO MALE SEX DIFFERENTIATION,0.057711,0.074803,0.080409,1,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.051111,0.074631,0.07366,1,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.026561,0.074498,0.16514,1,0
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0045438,0.074482,0.092088,1,0
4,GO MYOFIBRIL ASSEMBLY,0.035336,0.074454,0.10151,1,0
4,GO HORMONE METABOLIC PROCESS,0.0095807,0.074146,0.1136,1,0
4,GO INTRACELLULAR LIPID TRANSPORT,0.032938,0.07402,0.12152,1,0
4,GO SENSORY PERCEPTION,0.0069343,0.074006,0.077834,1,0
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.024428,0.073989,0.10775,1,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0054872,0.073901,0.11252,1,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.025475,0.073887,0.10126,1,0
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.013856,0.073844,0.08158,1,0
4,GO MALE GENITALIA DEVELOPMENT,0.052083,0.073823,0.11668,1,0
4,GO TOR SIGNALING,0.0071918,0.073818,0.086049,1,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.054582,0.073722,0.075986,1,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.040981,0.073666,0.077217,1,0
4,GO MESONEPHROS DEVELOPMENT,0.026286,0.073651,0.10058,1,0
4,GO REGULATION OF MITOPHAGY,0.051595,0.073461,0.10563,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.027401,0.073155,0.086403,1,0
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.022209,0.072708,0.11128,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.039795,0.07259,0.078942,1,0
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.030368,0.072399,0.086385,1,0
4,GO FATTY ACID CATABOLIC PROCESS,0.0050904,0.072292,0.10974,1,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.05357,0.072254,0.10403,1,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.054074,0.072139,0.071774,1,0
4,GO POSITIVE REGULATION OF MITOPHAGY,0.033948,0.072117,0.12577,1,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.031311,0.071973,0.083834,1,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.037139,0.071589,0.085565,1,0
4,GO ACTIVATION OF MAPK ACTIVITY,0.014658,0.071539,0.090683,1,0
4,GO ANIMAL ORGAN REGENERATION,0.054074,0.071429,0.081006,1,0
4,GO CELLULAR HOMEOSTASIS,0.0096941,0.070912,0.073979,1,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.036409,0.0708,0.086524,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.036409,0.070523,0.086085,1,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.022686,0.070185,0.086092,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0104,0.070013,0.096,1,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.027118,0.069856,0.08891,1,0
4,GO POSITIVE REGULATION OF CELL DEATH,0.054074,0.069807,0.072462,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.036048,0.069732,0.083675,1,0
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0090315,0.069709,0.10817,1,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.015159,0.069638,0.082457,1,0
4,GO GLUCOSE IMPORT,0.02521,0.06963,0.084788,1,0
4,GO MUSCLE CONTRACTION,0.043866,0.069315,0.068445,1,0
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.038637,0.069008,0.070608,1,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.047372,0.068963,0.081057,1,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0094686,0.068898,0.10282,1,0
4,GO OXIDATIVE PHOSPHORYLATION,0.014823,0.068743,0.070269,1,0
4,GO RESPONSE TO NITROGEN COMPOUND,0.0062877,0.068701,0.085671,1,0
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019285,0.068646,0.12229,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.038637,0.068614,0.086616,1,0
4,GO REGULATION OF HEMOPOIESIS,0.028556,0.068552,0.079621,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.050154,0.068401,0.10517,1,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.037882,0.068353,0.078016,1,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.042197,0.06835,0.1043,1,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.034636,0.068232,0.084917,1,0
4,GO SINGLE FERTILIZATION,0.043444,0.068164,0.065369,1,0
4,GO RESPONSE TO CHEMOKINE,0.020385,0.068153,0.071643,1,0
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.045591,0.068051,0.096063,1,0
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0025277,0.068043,0.090811,1,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.05357,0.067945,0.078224,1,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.03006,0.067889,0.090557,1,0
4,GO REGULATION OF RESPONSE TO STRESS,0.023919,0.067447,0.074725,1,0
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.043866,0.067388,0.074803,1,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.017699,0.067133,0.072265,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.013856,0.066543,0.08157,1,0
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.052083,0.066404,0.069226,1,0
4,GO MEMBRANE INVAGINATION,0.050154,0.066323,0.097561,1,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.02521,0.066319,0.087414,1,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.043025,0.066021,0.079854,1,0
4,GO REGULATION OF GLUCOSE IMPORT,0.032938,0.065853,0.080724,1,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.043025,0.065824,0.095634,1,0
4,GO REGULATION OF APPETITE,0.059879,0.065816,0.07568,1,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.035691,0.0658,0.095933,1,0
4,GO PEPTIDYL SERINE MODIFICATION,0.035691,0.065741,0.069203,1,0
4,GO CELL CELL RECOGNITION,0.0011503,0.065657,0.12913,1,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.049681,0.065616,0.094398,1,0
4,GO RESPONSE TO DRUG,0.027401,0.065547,0.086779,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.02521,0.065545,0.093657,1,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.043866,0.065474,0.070572,1,0
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.037882,0.065461,0.063298,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.017125,0.065299,0.085645,1,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.054582,0.065109,0.064323,1,0
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.024173,0.065061,0.076417,1,0
4,GO DRUG METABOLIC PROCESS,0.039406,0.064548,0.11915,1,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.040981,0.064293,0.088931,1,0
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0090315,0.064011,0.10901,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.05063,0.063411,0.062704,1,0
4,GO OXIDATION REDUCTION PROCESS,0.012798,0.06334,0.075023,1,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.061549,0.06311,0.091579,1,0
4,GO RHYTHMIC BEHAVIOR,0.054074,0.063097,0.10245,1,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.018898,0.063087,0.10931,1,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.02915,0.062882,0.073007,1,0
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.028264,0.062784,0.088935,1,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.060432,0.062746,0.07242,1,0
4,GO LIPID MODIFICATION,0.035336,0.062602,0.074061,1,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.021973,0.062449,0.08479,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.039795,0.062442,0.077472,1,0
4,GO APOPTOTIC PROCESS,0.024687,0.062117,0.071301,1,0
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.024428,0.062093,0.14834,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.041789,0.061586,0.11829,1,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.011678,0.061459,0.095076,1,0
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.02915,0.061406,0.074964,1,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.049212,0.06131,0.088039,1,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.010522,0.061244,0.10492,1,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.054582,0.060325,0.068191,1,0
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.058247,0.05976,0.07762,1,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.026838,0.059717,0.09242,1,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.060988,0.058933,0.064553,1,0
4,GO MAINTENANCE OF LOCATION,0.026013,0.058897,0.082669,1,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.055609,0.058736,0.079459,1,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.061549,0.057574,0.057416,1,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.051111,0.057514,0.11161,1,0
4,GO RESPONSE TO ACID CHEMICAL,0.043444,0.057081,0.078815,1,0
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.054074,0.05705,0.069835,1,0
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0066039,0.05667,0.088962,1,0
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.051111,0.056184,0.083829,1,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.060432,0.055644,0.065229,1,0
4,GO RESPONSE TO LIPID,0.039795,0.055191,0.078587,1,0
4,GO DEPHOSPHORYLATION,0.036409,0.054748,0.0638,1,0
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.014823,0.054745,0.070163,1,0
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.055609,0.054514,0.071346,1,0
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.038637,0.053857,0.067913,1,0
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.023668,0.053834,0.076034,1,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.039795,0.053833,0.074694,1,0
4,GO RESPONSE TO ABIOTIC STIMULUS,0.03429,0.053733,0.064238,1,0
4,GO REGULATION OF CELL DEATH,0.054582,0.053677,0.065922,1,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.032607,0.053449,0.074941,1,0
4,GO PROTEIN CATABOLIC PROCESS,0.027401,0.053224,0.06132,1,0
4,GO KETONE BIOSYNTHETIC PROCESS,0.042609,0.053027,0.11367,1,0
4,GO PROTEIN AUTOPROCESSING,0.060432,0.052549,0.091303,1,0
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.046921,0.052457,0.086719,1,0
4,GO ALCOHOL CATABOLIC PROCESS,0.046921,0.05237,0.066018,1,0
4,GO CYTOSOLIC TRANSPORT,0.034636,0.052355,0.073824,1,0
4,GO RHYTHMIC PROCESS,0.05063,0.052116,0.066612,1,0
4,GO NEGATIVE REGULATION OF GROWTH,0.038637,0.052092,0.086815,1,0
4,GO MYELOID CELL DIFFERENTIATION,0.022928,0.051857,0.08472,1,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.037882,0.051816,0.077762,1,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.049212,0.051346,0.10471,1,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.036409,0.050819,0.071384,1,0
4,GO IMMUNE SYSTEM DEVELOPMENT,0.01128,0.050319,0.084225,1,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.040187,0.048859,0.069339,1,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.059331,0.048804,0.061047,1,0
4,GO ERYTHROCYTE HOMEOSTASIS,0.056652,0.04869,0.084805,1,0
4,GO SPERM EGG RECOGNITION,0.05357,0.04848,0.072436,1,0
4,GO REGULATION OF AUTOPHAGY,0.0062108,0.048005,0.088717,1,0
4,GO PEROXISOMAL TRANSPORT,0.02128,0.047498,0.085516,1,0
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.027686,0.047022,0.057049,1,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.01829,0.046668,0.072432,1,0
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.02521,0.045816,0.067882,1,0
4,GO DETECTION OF LIGHT STIMULUS,0.057711,0.045627,0.035687,1,0
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.046921,0.045438,0.063251,1,0
4,GO ORGANIC ACID METABOLIC PROCESS,0.020605,0.04481,0.070609,1,0
4,GO GOLGI VESICLE TRANSPORT,0.042609,0.043602,0.067249,1,0
4,GO MITOPHAGY,0.028852,0.043518,0.10281,1,0
4,GO MACROAUTOPHAGY,0.0029256,0.042642,0.084406,1,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.016752,0.04153,0.078155,1,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.059879,0.039951,0.09254,1,0
4,GO PEROXISOME ORGANIZATION,0.037882,0.037271,0.073015,1,0
4,GO REGULATION OF MACROAUTOPHAGY,0.042609,0.025396,0.068339,1,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.050154,0.013786,0.089314,1,0
4,GO MULTI ORGANISM LOCALIZATION,0.058787,-0.026251,-0.054617,1,0
4,GO NUCLEAR EXPORT,0.02128,-0.035945,-0.056733,1,0
4,GO NUCLEAR TRANSPORT,0.056652,-0.037149,-0.038763,1,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.043444,-0.037343,-0.057785,1,0
4,GO DNA METABOLIC PROCESS,0.037882,-0.038705,-0.035289,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.041383,-0.039059,-0.040577,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.043866,-0.040615,-0.05125,1,0
4,GO REGULATION OF GENE SILENCING,0.035691,-0.040728,-0.059472,1,0
4,GO RNA POLYADENYLATION,0.036772,-0.040862,-0.070337,1,0
4,GO DNA BIOSYNTHETIC PROCESS,0.019312,-0.04102,-0.040162,1,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.031953,-0.041908,-0.074759,1,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.060432,-0.042955,-0.069216,1,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.049212,-0.044678,-0.088721,1,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.023419,-0.045081,-0.046141,1,0
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.057711,-0.045156,-0.063807,1,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.050154,-0.045651,-0.055492,1,0
4,GO CHROMATIN REMODELING,0.034984,-0.046041,-0.049578,1,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.03006,-0.046435,-0.064233,1,0
4,GO SNRNA TRANSCRIPTION,0.037139,-0.050846,-0.050775,1,0
4,GO CHROMOSOME SEGREGATION,0.031631,-0.051102,-0.051459,1,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.052083,-0.051219,-0.042772,1,0
4,GO DNA REPAIR,0.014332,-0.051254,-0.049386,1,0
4,GO PROTEIN NEDDYLATION,0.038637,-0.05173,-0.078321,1,0
4,GO MRNA METABOLIC PROCESS,0.0058389,-0.052234,-0.066938,1,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.057711,-0.05224,-0.085524,1,0
4,GO RNA SURVEILLANCE,0.060432,-0.052444,-0.0669,1,0
4,GO REGULATION OF RNA SPLICING,0.023173,-0.053706,-0.055602,1,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.057179,-0.053901,-0.052098,1,0
4,GO SNRNA PROCESSING,0.019312,-0.056109,-0.092882,1,0
4,GO BASE EXCISION REPAIR,0.0085105,-0.056497,-0.071882,1,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0089251,-0.05741,-0.095858,1,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.058787,-0.057537,-0.057875,1,0
4,GO DNA CONFORMATION CHANGE,0.039406,-0.057596,-0.051895,1,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.042197,-0.057994,-0.062856,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.056652,-0.058035,-0.048943,1,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.045591,-0.058042,-0.051232,1,0
4,GO RESPONSE TO UV,0.02521,-0.058369,-0.058536,1,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.016938,-0.058428,-0.046627,1,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.046921,-0.059505,-0.069251,1,0
4,GO MRNA TRANSPORT,0.0066851,-0.059725,-0.074294,1,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.032938,-0.059977,-0.055344,1,0
4,GO RNA MODIFICATION,0.048285,-0.06045,-0.060996,1,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.040582,-0.060468,-0.079354,1,0
4,GO DOUBLE STRAND BREAK REPAIR,0.0061347,-0.061455,-0.072449,1,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0092477,-0.061499,-0.068939,1,0
4,GO LYMPHANGIOGENESIS,0.032938,-0.06162,-0.12089,1,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.03068,-0.062596,-0.099427,1,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.0042636,-0.062685,-0.093543,1,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.0039992,-0.063188,-0.075379,1,0
4,GO HISTONE H3 ACETYLATION,0.043866,-0.063238,-0.047104,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.045591,-0.063979,-0.065486,1,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.046921,-0.064203,-0.10327,1,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.041789,-0.065897,-0.053481,1,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.022928,-0.066617,-0.10792,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.043866,-0.067131,-0.085543,1,0
4,GO MRNA PROCESSING,0.0029645,-0.06745,-0.07558,1,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.020385,-0.067915,-0.075699,1,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.020828,-0.068103,-0.053505,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.017506,-0.068518,-0.058523,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.051595,-0.068526,-0.076447,1,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.036048,-0.069268,-0.043717,1,0
4,GO RIBOSOME ASSEMBLY,0.024173,-0.069526,-0.11962,1,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.012227,-0.069604,-0.078928,1,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.022209,-0.070074,-0.10426,1,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.02945,-0.071225,-0.08923,1,0
4,GO TELOMERE ORGANIZATION,0.0017517,-0.071235,-0.081004,1,0
4,GO TRANSLATIONAL INITIATION,0.052083,-0.072284,-0.094432,1,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.017894,-0.07246,-0.075576,1,0
4,GO SNRNA METABOLIC PROCESS,0.02521,-0.072608,-0.072866,1,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.022686,-0.072714,-0.054221,1,0
4,GO RNA SPLICING,0.0015249,-0.072773,-0.081607,1,0
4,GO DNA REPLICATION CHECKPOINT,0.014823,-0.073018,-0.11865,1,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.028852,-0.073234,-0.06167,1,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.053071,-0.07389,-0.067057,1,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.043866,-0.073956,-0.16286,1,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.010522,-0.074006,-0.069675,1,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.046921,-0.07478,-0.072822,1,0
4,GO RNA LOCALIZATION,0.0018764,-0.074866,-0.084944,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0024609,-0.075087,-0.080092,1,0
4,GO NCRNA TRANSCRIPTION,0.0031247,-0.075172,-0.074629,1,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.054582,-0.075245,-0.052735,1,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.036048,-0.07532,-0.060913,1,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.01128,-0.075331,-0.07583,1,0
4,GO BRAIN MORPHOGENESIS,0.034636,-0.076124,-0.10364,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.055093,-0.07617,-0.063896,1,0
4,GO CELLULAR RESPONSE TO HEAT,0.057179,-0.076481,-0.039895,1,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0025961,-0.076489,-0.09745,1,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0094686,-0.077015,-0.068243,1,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.019312,-0.077201,-0.056664,1,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.027686,-0.077362,-0.14859,1,0
4,GO CELL CYCLE DNA REPLICATION,0.0046604,-0.077369,-0.10017,1,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0137,-0.077646,-0.06161,1,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.045591,-0.077685,-0.075147,1,0
4,GO CHROMOSOME CONDENSATION,0.048285,-0.077845,-0.069866,1,0
4,GO TRNA METABOLIC PROCESS,0.032607,-0.078184,-0.073058,1,0
4,GO MITOCHONDRION LOCALIZATION,0.02128,-0.078187,-0.0664,1,0
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0023957,-0.07831,-0.081197,1,0
4,GO DNA GEOMETRIC CHANGE,0.015674,-0.078406,-0.072751,1,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.036409,-0.078628,-0.093242,1,0
4,GO MRNA CLEAVAGE,0.011813,-0.078672,-0.076603,1,0
4,GO DNA REPLICATION,0.010645,-0.078727,-0.064434,1,0
4,GO PROTEIN SUMOYLATION,0.017125,-0.078921,-0.049901,1,0
4,GO PORE COMPLEX ASSEMBLY,0.028264,-0.07915,-0.080268,1,0
4,GO NCRNA METABOLIC PROCESS,0.016205,-0.079961,-0.082399,1,0
4,GO RNA PROCESSING,0.0019285,-0.080326,-0.083551,1,0
4,GO RNA 3 END PROCESSING,0.0063654,-0.080649,-0.074567,1,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.036409,-0.080692,-0.074137,1,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.036048,-0.080816,-0.11403,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.058787,-0.081008,-0.095668,1,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.056652,-0.081147,-0.060719,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.0029645,-0.081489,-0.055444,1,0
4,GO RRNA METABOLIC PROCESS,0.0092477,-0.082283,-0.099809,1,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.013093,-0.082432,-0.066971,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.020828,-0.082503,-0.090294,1,0
4,GO LIVER REGENERATION,0.040981,-0.082808,-0.083404,1,0
4,GO HISTONE H3 K9 ACETYLATION,0.0077327,-0.083216,-0.10255,1,0
4,GO CHROMOSOME SEPARATION,0.0070192,-0.083224,-0.08229,1,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.060988,-0.083624,-0.098255,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00040235,-0.083796,-0.090989,1,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.038637,-0.084156,-0.13822,1,0
4,GO MRNA EXPORT FROM NUCLEUS,0.002702,-0.084381,-0.085484,1,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0043184,-0.084501,-0.087199,1,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.036772,-0.084843,-0.074601,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0057669,-0.08494,-0.070745,1,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0028118,-0.085335,-0.10242,1,0
4,GO MATURATION OF 5 8S RRNA,0.022209,-0.085503,-0.11804,1,0
4,GO RNA STABILIZATION,0.020828,-0.085731,-0.063666,1,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.02128,-0.086432,-0.05606,1,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.0098086,-0.086457,-0.096768,1,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.003654,-0.086861,-0.10024,1,0
4,GO MRNA 3 END PROCESSING,0.0043737,-0.08821,-0.080001,1,0
4,GO NEURAL TUBE PATTERNING,0.021053,-0.088522,-0.10728,1,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0035605,-0.088599,-0.090414,1,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.013243,-0.088641,-0.062807,1,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.048746,-0.08917,-0.095971,1,0
4,GO CELLULAR RESPONSE TO UV,0.0038478,-0.090253,-0.087963,1,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.057711,-0.090453,-0.049891,1,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.038258,-0.090591,-0.10793,1,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.051111,-0.091603,-0.11748,1,0
4,GO RESPONSE TO X RAY,0.056652,-0.091849,-0.09316,1,0
4,GO RNA EXPORT FROM NUCLEUS,0.0027381,-0.091911,-0.089978,1,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.031953,-0.092018,-0.14035,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.000662,-0.092137,-0.11298,1,0
4,GO G0 TO G1 TRANSITION,0.022446,-0.092165,-0.078446,1,0
4,GO OXIDATIVE DEMETHYLATION,0.037882,-0.092267,-0.064334,1,0
4,GO CENTRIOLE ASSEMBLY,0.012367,-0.092874,-0.087498,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0028872,-0.093048,-0.078808,1,0
4,GO DNA STRAND ELONGATION,0.0137,-0.093146,-0.097724,1,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.049681,-0.093581,-0.085999,1,0
4,GO TRNA PROCESSING,0.0023009,-0.093722,-0.11255,1,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00039018,-0.093776,-0.098534,1,0
4,GO DNA RECOMBINATION,0.0066039,-0.094845,-0.062964,1,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0068504,-0.094985,-0.087846,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0057669,-0.095166,-0.09177,1,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.042197,-0.096001,-0.056979,1,0
4,GO NCRNA PROCESSING,0.0037985,-0.096007,-0.1086,1,0
4,GO CYTOPLASMIC TRANSLATION,0.0099244,-0.096432,-0.11947,1,0
4,GO BONE MORPHOGENESIS,0.039406,-0.096863,-0.093823,1,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.021973,-0.09741,-0.098318,1,0
4,GO SULFATION,0.057711,-0.097458,-0.097285,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.010769,-0.097578,-0.065375,1,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.041789,-0.097599,-0.13373,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.016205,-0.098706,-0.12417,1,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.01251,-0.099038,-0.1253,1,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.012367,-0.099069,-0.068961,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0068504,-0.099208,-0.12018,1,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.041789,-0.099425,-0.11815,1,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.055093,-0.099818,-0.077982,1,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.01995,-0.099988,-0.10859,1,0
4,GO RETROGRADE AXONAL TRANSPORT,0.022928,-0.10002,-0.13334,1,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.027118,-0.10073,-0.086991,1,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0048405,-0.10086,-0.096541,1,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.015674,-0.1015,-0.075284,1,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0062108,-0.10219,-0.10092,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.001483,-0.10231,-0.093585,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0077327,-0.10298,-0.075437,1,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0027381,-0.10329,-0.15416,1,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00042128,-0.10329,-0.095666,1,0
4,GO RECOMBINATIONAL REPAIR,0.0023637,-0.10338,-0.095916,1,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.00095459,-0.10371,-0.1045,1,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.043025,-0.10385,-0.081012,1,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0071918,-0.10418,-0.087657,1,0
4,GO REGULATION OF DNA REPAIR,0.00094089,-0.10435,-0.083734,1,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.050154,-0.10445,-0.09094,1,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.039406,-0.10446,-0.0919,1,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.017699,-0.10459,-0.17362,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0072795,-0.1046,-0.094687,1,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0065235,-0.10474,-0.087762,1,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.049681,-0.1052,-0.085305,1,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0022396,-0.10525,-0.081786,1,0
4,GO RIBOSOME BIOGENESIS,0.0060595,-0.10562,-0.11583,1,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.058787,-0.1057,-0.08437,1,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.026561,-0.10577,-0.12869,1,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.040981,-0.1058,-0.084621,1,0
4,GO NEURAL CREST CELL MIGRATION,0.032607,-0.10597,-0.11404,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0087156,-0.10677,-0.10039,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0026663,-0.10698,-0.11868,1,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.03068,-0.10704,-0.09604,1,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0024281,-0.10723,-0.10334,1,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.008211,-0.10758,-0.093031,1,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.015674,-0.10826,-0.10786,1,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.042609,-0.10867,-0.098583,1,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.037509,-0.10868,-0.11663,1,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.032938,-0.10889,-0.10664,1,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.02521,-0.109,-0.085553,1,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.013394,-0.10917,-0.1009,1,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.012087,-0.10944,-0.119,1,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.045591,-0.10965,-0.12552,1,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.0038478,-0.10969,-0.11371,1,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.007921,-0.11066,-0.080957,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0013069,-0.11115,-0.1228,1,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0010558,-0.11145,-0.091936,1,0
4,GO STRESS GRANULE ASSEMBLY,0.0017517,-0.11209,-0.122,1,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.021973,-0.11232,-0.095545,1,0
4,GO ERYTHROCYTE MATURATION,0.0055559,-0.11239,-0.14489,1,0
4,GO RNA METHYLATION,0.013243,-0.11252,-0.090897,1,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.02521,-0.11267,-0.091274,1,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0047798,-0.11271,-0.15599,1,0
4,GO TRNA METHYLATION,0.0075485,-0.11293,-0.11425,1,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.019312,-0.11294,-0.14146,1,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.022209,-0.11301,-0.09709,1,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0071918,-0.11304,-0.10847,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.01585,-0.11305,-0.10449,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0014624,-0.11339,-0.16468,1,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0005133,-0.1138,-0.111,1,0
4,GO REGULATION OF MRNA PROCESSING,0.0012527,-0.1138,-0.092886,1,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.016386,-0.11425,-0.11712,1,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.020166,-0.11454,-0.11524,1,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.022686,-0.11617,-0.10342,1,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.016938,-0.1166,-0.10642,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.00054518,-0.11673,-0.10202,1,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0039481,-0.11675,-0.13481,1,0
4,GO TRNA TRANSPORT,0.0022396,-0.11678,-0.11414,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0067673,-0.11691,-0.12948,1,0
4,GO MITOTIC RECOMBINATION,0.025475,-0.11736,-0.1028,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.010895,-0.11813,-0.16677,1,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.031311,-0.11832,-0.11734,1,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.017315,-0.11879,-0.097476,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.046921,-0.11889,-0.090852,1,0
4,GO REGULATION OF NEURON MIGRATION,0.019735,-0.11908,-0.13993,1,0
4,GO RRNA TRANSCRIPTION,0.001955,-0.11935,-0.12923,1,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.03902,-0.12069,-0.12761,1,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.054074,-0.12082,-0.1138,1,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.00026858,-0.12095,-0.1126,1,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.022928,-0.12138,-0.066239,1,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.016027,-0.12223,-0.10465,1,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.042197,-0.12227,-0.1216,1,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.011678,-0.12306,-0.19053,1,0
4,GO PROTEIN DEMETHYLATION,0.033608,-0.12331,-0.098644,1,0
4,GO ETHANOL CATABOLIC PROCESS,0.03068,-0.12371,-0.15259,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0044864,-0.12393,-0.11547,1,0
4,GO MEMBRANE DISASSEMBLY,0.032278,-0.12446,-0.10775,1,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.0050904,-0.12718,-0.18518,1,0
4,GO DNA DEPENDENT DNA REPLICATION,0.00016629,-0.12813,-0.11605,1,0
4,GO TONGUE DEVELOPMENT,0.026838,-0.12816,-0.1582,1,0
4,GO MATURATION OF SSU RRNA,0.0061347,-0.12859,-0.14168,1,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.01995,-0.12926,-0.11007,1,0
4,GO RESPIRATORY SYSTEM PROCESS,0.0042095,-0.12931,-0.12715,1,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.052083,-0.12955,-0.088045,1,0
4,GO RRNA METHYLATION,0.0056255,-0.1298,-0.11095,1,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.030368,-0.12981,-0.090343,1,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.0080166,-0.12997,-0.15382,1,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.007921,-0.13003,-0.11403,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0019819,-0.13005,-0.14705,1,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00013016,-0.13038,-0.099869,1,0
4,GO DNA REPLICATION INITIATION,0.00033432,-0.13052,-0.14194,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.018091,-0.13064,-0.10114,1,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.041383,-0.13111,-0.12275,1,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.054582,-0.13115,-0.14321,1,0
4,GO PSEUDOURIDINE SYNTHESIS,0.015159,-0.13168,-0.13528,1,0
4,GO RRNA MODIFICATION,0.0042636,-0.13334,-0.12492,1,0
4,GO BLASTOCYST GROWTH,0.0012177,-0.13379,-0.12894,1,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.015501,-0.13408,-0.094761,1,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0034243,-0.13476,-0.10018,1,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.015159,-0.13573,-0.14727,1,0
4,GO REPLICATION FORK PROCESSING,0.00011406,-0.136,-0.17275,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012804,-0.1366,-0.12624,1,0
4,GO ADULT HEART DEVELOPMENT,0.0098086,-0.13667,-0.1742,1,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.037882,-0.13683,-0.10954,1,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00075607,-0.13695,-0.11634,1,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.033608,-0.13725,-0.10238,1,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0089251,-0.13734,-0.14337,1,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0043737,-0.13738,-0.11389,1,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00054518,-0.1377,-0.11894,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0040509,-0.13777,-0.12899,1,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.012653,-0.13799,-0.13612,1,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0024609,-0.1384,-0.12945,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00098255,-0.13861,-0.12159,1,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.011813,-0.13872,-0.17334,1,0
4,GO HINDLIMB MORPHOGENESIS,0.046921,-0.13924,-0.10619,1,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.031953,-0.13932,-0.12344,1,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,2.3239e-05,-0.13937,-0.15565,1,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.00057029,-0.13959,-0.16087,1,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0011021,-0.1401,-0.15758,1,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,3.758e-05,-0.14031,-0.21276,1,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.01016,-0.14093,-0.14333,1,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0005211,-0.14111,-0.14346,1,0
4,GO DNA LIGATION,0.019735,-0.1412,-0.10825,1,0
4,GO REGULATION OF HIPPO SIGNALING,0.027118,-0.14159,-0.14152,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.011022,-0.1417,-0.15328,1,0
4,GO MRNA METHYLATION,0.003166,-0.14197,-0.12892,1,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0048405,-0.14224,-0.11045,1,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.011151,-0.14243,-0.12874,1,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00046165,-0.14272,-0.11153,1,0
4,GO CARTILAGE MORPHOGENESIS,0.016386,-0.14331,-0.19969,1,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.0059852,-0.14341,-0.092172,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,1.4472e-05,-0.14348,-0.11988,1,0
4,GO CARDIOBLAST DIFFERENTIATION,0.024947,-0.14423,-0.14375,1,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.012227,-0.14505,-0.16993,1,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.0083098,-0.14529,-0.14416,1,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.046921,-0.1459,-0.13069,1,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.012945,-0.14603,-0.16826,1,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.02521,-0.14604,-0.16894,1,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.014823,-0.14618,-0.1383,1,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0032928,-0.14622,-0.12113,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,9.819e-05,-0.14643,-0.12258,1,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0014022,-0.14689,-0.17507,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00075607,-0.14694,-0.14883,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0010259,-0.14698,-0.17165,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00026024,-0.14705,-0.14155,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0024609,-0.14729,-0.19425,1,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0005056,-0.14747,-0.19745,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00032408,-0.14789,-0.12231,1,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.00016901,-0.14838,-0.15134,1,0
4,GO MRNA SPLICE SITE SELECTION,0.00159,-0.14911,-0.15561,1,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.01995,-0.14979,-0.10017,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00027716,-0.14998,-0.14591,1,0
4,GO TRNA MODIFICATION,0.00096848,-0.15023,-0.13096,1,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.018693,-0.1503,-0.16519,1,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00064263,-0.15071,-0.18655,1,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.05063,-0.15082,-0.1013,1,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.017699,-0.15213,-0.12917,1,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.037139,-0.15243,-0.19516,1,0
4,GO MICROTUBULE SEVERING,0.023419,-0.15243,-0.13041,1,0
4,GO HISTONE DEUBIQUITINATION,0.0074579,-0.15256,-0.087587,1,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.019735,-0.15274,-0.14856,1,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.011411,-0.15389,-0.14589,1,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00053704,-0.1539,-0.14311,1,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.020828,-0.15396,-0.10752,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0015463,-0.15398,-0.18878,1,0
4,GO MUSCLE CELL FATE COMMITMENT,0.016568,-0.15414,-0.15077,1,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.5576e-05,-0.15433,-0.17961,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0019285,-0.15574,-0.17436,1,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0020092,-0.15622,-0.11948,1,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.00036686,-0.1565,-0.16322,1,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.034984,-0.15756,-0.21933,1,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.014494,-0.15761,-0.10577,1,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0066851,-0.15886,-0.20385,1,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.047372,-0.15935,-0.12234,1,0
4,GO HIPPO SIGNALING,0.0098086,-0.15982,-0.16001,1,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.016027,-0.16014,-0.14538,1,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.00017176,-0.16082,-0.16747,1,0
4,GO GLYCINE METABOLIC PROCESS,0.037509,-0.16093,-0.12312,1,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.035336,-0.16093,-0.14689,1,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0039992,-0.16271,-0.17042,1,0
4,GO MATURATION OF LSU RRNA,0.0075485,-0.16289,-0.16795,1,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.049212,-0.16431,-0.11143,1,0
4,GO TRACHEA DEVELOPMENT,0.0051547,-0.16707,-0.18152,1,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0023009,-0.16762,-0.16199,1,0
4,GO TELOMERASE RNA LOCALIZATION,0.00047589,-0.168,-0.18886,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.014658,-0.16801,-0.19096,1,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.014494,-0.16816,-0.11579,1,0
4,GO GTP METABOLIC PROCESS,0.0011021,-0.1683,-0.17319,1,0
4,GO CELLULAR RESPONSE TO X RAY,0.0022701,-0.17116,-0.14886,1,0
4,GO DENDRITE SELF AVOIDANCE,0.01251,-0.17196,-0.16601,1,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.043444,-0.17219,-0.16278,1,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0010113,-0.17323,-0.20746,1,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.0037985,-0.17463,-0.22854,1,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0071051,-0.17509,-0.12234,1,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.0058389,-0.17656,-0.19085,1,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0011668,-0.17742,-0.20808,1,0
4,GO MRNA MODIFICATION,0.00043435,-0.17855,-0.16189,1,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.012227,-0.1786,-0.15681,1,0
4,GO CHROMATIN DISASSEMBLY,0.00031414,-0.17894,-0.1844,1,0
4,GO MYOBLAST MIGRATION,0.042609,-0.18053,-0.17585,1,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.001568,-0.18075,-0.15379,1,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0137,-0.18087,-0.15057,1,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0026663,-0.18102,-0.21241,1,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.012227,-0.18126,-0.14489,1,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0021505,-0.18222,-0.23633,1,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0086125,-0.18241,-0.23131,1,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.026561,-0.18268,-0.15136,1,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.0032078,-0.18292,-0.1412,1,0
4,GO CELL PROLIFERATION IN FOREBRAIN,0.001704,-0.18314,-0.18897,1,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.048285,-0.18379,-0.11511,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0052197,-0.18721,-0.18683,1,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,1.8363e-05,-0.18905,-0.19225,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00067188,-0.1892,-0.23042,1,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,5.7582e-06,-0.18976,-0.16171,1,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.037882,-0.19098,-0.11589,1,0
4,GO HEART VALVE FORMATION,0.026561,-0.19144,-0.1881,1,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.042609,-0.1945,-0.15581,1,0
4,GO UV PROTECTION,0.0059116,-0.19473,-0.17212,1,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0065235,-0.19547,-0.14303,1,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0061347,-0.1961,-0.14669,1,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.055609,-0.19714,-0.15619,1,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00016629,-0.19777,-0.19636,1,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0010408,-0.19842,-0.18361,1,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00080175,-0.1986,-0.25126,1,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00030449,-0.19901,-0.20654,1,0
4,GO TRNA WOBBLE BASE MODIFICATION,7.2497e-05,-0.19905,-0.16629,1,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.0016575,-0.19943,-0.18148,1,0
4,GO BONE GROWTH,0.017125,-0.19961,-0.13992,1,0
4,GO V D J RECOMBINATION,0.0023321,-0.20047,-0.18756,1,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,4.7172e-05,-0.20475,-0.19034,1,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.052083,-0.20501,-0.15622,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00049802,-0.20544,-0.22063,1,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.0005789,-0.20718,-0.16382,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00036686,-0.20808,-0.2188,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.014172,-0.20945,-0.23593,1,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.055609,-0.21085,-0.13127,1,0
4,GO NEUROBLAST DIVISION,0.015159,-0.21139,-0.16845,1,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.00095459,-0.21261,-0.17186,1,0
4,GO VIRAL TRANSLATION,0.0026663,-0.2134,-0.17681,1,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.044292,-0.2134,-0.197,1,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.0018006,-0.21515,-0.22823,1,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0044298,-0.21549,-0.23064,1,0
4,GO LIMB BUD FORMATION,0.024947,-0.21564,-0.21875,1,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,5.9834e-06,-0.21797,-0.23949,1,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0069343,-0.2188,-0.23322,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,7.5001e-05,-0.21939,-0.21774,1,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.013093,-0.21996,-0.21431,1,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,5.3256e-05,-0.22078,-0.20394,1,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0062877,-0.22147,-0.20987,1,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.02915,-0.22176,-0.17454,1,0
4,GO NUCLEAR PORE ORGANIZATION,0.00099681,-0.22222,-0.17256,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.022209,-0.22444,-0.152,1,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0001862,-0.22547,-0.17947,1,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.013243,-0.22582,-0.18779,1,0
4,GO NEURAL CREST FORMATION,0.0027381,-0.22624,-0.2186,1,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00017457,-0.22811,-0.22038,1,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.00094089,-0.2283,-0.2107,1,0
4,GO CENTRIOLE CENTRIOLE COHESION,0.0012705,-0.22926,-0.16981,1,0
4,GO CHONDROCYTE PROLIFERATION,0.0075485,-0.23078,-0.18699,1,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.011813,-0.23519,-0.13422,1,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0025277,-0.23545,-0.21519,1,0
4,GO PHAGOCYTOSIS RECOGNITION,0.0035146,-0.23656,-0.19022,1,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.0010408,-0.24197,-0.22051,1,0
4,GO TELENCEPHALON REGIONALIZATION,0.045155,-0.24414,-0.16286,1,0
4,GO MYOBLAST PROLIFERATION,8.5867e-06,-0.24523,-0.25798,1,0
4,GO PROSTATE GLAND GROWTH,9.9844e-05,-0.25052,-0.28982,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00024819,-0.25352,-0.24789,1,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.003166,-0.2603,-0.25484,1,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,8.1361e-07,-0.26174,-0.20913,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0016806,-0.26753,-0.20771,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00027716,-0.2742,-0.26213,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00017176,-0.2791,-0.30686,1,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,1.5865e-05,-0.28059,-0.23675,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,1.2253e-05,-0.29584,-0.25766,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0030839,-0.30234,-0.3492,1,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.00036124,-0.30299,-0.28409,1,0
4,GO LATERAL MESODERM DEVELOPMENT,5.7059e-05,-0.30473,-0.28703,1,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0080166,-0.30737,-0.24106,1,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.015501,-0.31548,-0.30363,1,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0078263,-0.32902,-0.29577,1,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0011503,-0.36531,-0.29411,1,0
4,GO CARDIAC VENTRICLE FORMATION,0.00010497,-0.36632,-0.3643,1,0
4,GO CARDIAC CHAMBER FORMATION,4.4771e-05,-0.36832,-0.36126,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0010865,-0.37596,-0.31378,1,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,9.2118e-07,-0.38214,-0.37501,1,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.00036124,-0.40373,-0.34814,1,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.074349,0.27542,0.18557,0,1
4,GO NEPHRIC DUCT MORPHOGENESIS,0.089246,0.2397,0.12118,0,1
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.12924,0.23498,0.16914,0,1
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.10129,0.21218,0.1676,0,1
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.15214,0.19676,0.13936,0,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.08331,0.19199,0.08606,0,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.074349,0.18736,0.132,0,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.11742,0.17726,0.13591,0,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.066192,0.17651,0.096958,0,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.063258,0.1743,0.13231,0,1
4,GO AMELOGENESIS,0.063836,0.16736,0.14286,0,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.21889,0.16573,0.11776,0,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.066192,0.15386,0.098248,0,1
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.078382,0.14699,0.0988,0,1
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.062684,0.14478,0.10063,0,1
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.22195,0.14374,0.077142,0,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.069238,0.14185,0.10619,0,1
4,GO PARENTAL BEHAVIOR,0.079765,0.1417,0.12752,0,1
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.33194,0.14065,0.060571,0,1
4,GO PROTEIN ADP RIBOSYLATION,0.068006,0.13955,0.098097,0,1
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.26964,0.13913,0.079325,0,1
4,GO LINOLEIC ACID METABOLIC PROCESS,0.062684,0.13628,0.096231,0,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.081168,0.13621,0.11203,0,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.14419,0.13617,0.075627,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.073043,0.13492,0.11449,0,1
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.31021,0.13386,0.039638,0,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.11837,0.12696,0.10242,0,1
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.49743,0.12619,0.049945,0,1
4,GO RESPONSE TO PROGESTERONE,0.063258,0.12524,0.094015,0,1
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.12322,0.12489,0.1029,0,1
4,GO NATURAL KILLER CELL ACTIVATION,0.075674,0.12326,0.078399,0,1
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.082591,0.12317,0.093025,0,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.084034,0.11982,0.10344,0,1
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.082591,0.11869,0.1039,0,1
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.35253,0.11861,0.061212,0,1
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.12126,0.11847,0.080266,0,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.077698,0.1175,0.090787,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.10129,0.11747,0.11606,0,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.10646,0.11473,0.12047,0,1
4,GO HEXOSE CATABOLIC PROCESS,0.10558,0.11174,0.089169,0,1
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.082591,0.11026,0.096038,0,1
4,GO CERAMIDE TRANSPORT,0.064418,0.10987,0.10636,0,1
4,GO RESPONSE TO UV B,0.36956,0.10904,0.061871,0,1
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.064418,0.10874,0.091343,0,1
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.062684,0.10709,0.097068,0,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.12322,0.10672,0.072817,0,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.16163,0.10629,0.089694,0,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.17669,0.10515,0.079141,0,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.063258,0.10428,0.094848,0,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.18595,0.10119,0.058807,0,1
4,GO T CELL CYTOKINE PRODUCTION,0.11367,0.101,0.072471,0,1
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.062114,0.097378,0.087933,0,1
4,GO ALDEHYDE CATABOLIC PROCESS,0.14983,0.095078,0.054081,0,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.21437,0.091766,0.062924,0,1
4,GO REGULATION OF GASTRIC ACID SECRETION,0.18062,0.091734,0.078778,0,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.10912,0.091509,0.082488,0,1
4,GO LIPID IMPORT INTO CELL,0.27317,0.089409,0.071724,0,1
4,GO SCHWANN CELL DEVELOPMENT,0.18595,0.089332,0.06717,0,1
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.079071,0.088972,0.080779,0,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.10045,0.087788,0.070504,0,1
4,GO CELL RECOGNITION,0.20845,0.087136,0.052705,0,1
4,GO VAGINA DEVELOPMENT,0.25078,0.085458,0.056893,0,1
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.11933,0.082688,0.064648,0,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.1873,0.079453,0.078467,0,1
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.3871,0.079294,0.043854,0,1
4,GO AUTOPHAGIC CELL DEATH,0.14983,0.079198,0.087476,0,1
4,GO CONVERGENT EXTENSION,0.40743,0.077569,0.049529,0,1
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.2913,0.077516,0.03502,0,1
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.11933,0.075683,0.060978,0,1
4,GO REGULATION OF LIGASE ACTIVITY,0.14869,0.071721,0.066634,0,1
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.20554,0.070645,0.052536,0,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.084034,0.070487,0.088079,0,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.15214,0.066476,0.061962,0,1
4,GO TRNA CATABOLIC PROCESS,0.1146,0.06623,0.13868,0,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.28033,0.065728,0.075503,0,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.14419,0.061299,0.031127,0,1
4,GO HISTONE H2B UBIQUITINATION,0.077698,0.060553,0.074131,0,1
4,GO ATP METABOLIC PROCESS,0.066192,0.059053,0.054539,0,1
4,GO DNA MODIFICATION,0.16778,0.057753,0.042315,0,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.20845,0.055787,0.056601,0,1
4,GO MITOTIC CYTOKINESIS,0.32195,0.053788,0.0404,0,1
4,GO GLUCOSE CATABOLIC PROCESS,0.22814,0.052277,0.084382,0,1
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.067397,0.050489,0.081094,0,1
4,GO MEMBRANE DOCKING,0.40514,0.048163,0.033693,0,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.76281,0.043025,0.0097862,0,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.089246,0.0397,0.048755,0,1
4,GO MITOCHONDRIAL TRANSPORT,0.28033,0.033357,0.031052,0,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.13979,0.025864,0.037553,0,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.066792,0.36356,0.22541,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.089246,0.32942,0.17911,0,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.19697,0.25264,0.081593,0,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.15921,0.247,0.1285,0,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.33194,0.20099,0.0971,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.28945,0.18611,0.046759,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.19697,0.18329,0.058768,0,0
4,GO T CELL EXTRAVASATION,0.16163,0.18304,0.086606,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.15214,0.17458,0.21144,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.066792,0.16542,0.1182,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.070488,0.16432,0.13679,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.2913,0.16271,0.089296,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.16042,0.16044,0.23065,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.10471,0.1592,0.099521,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.062684,0.1579,0.12504,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.19838,0.15377,0.12764,0,0
4,GO HEMIDESMOSOME ASSEMBLY,0.81267,0.15206,-0.037278,0,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.068006,0.14948,0.08071,0,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.089246,0.14885,0.11206,0,0
4,GO INCLUSION BODY ASSEMBLY,0.11002,0.14765,0.11894,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.20122,0.14758,0.1386,0,0
4,GO BASEMENT MEMBRANE ORGANIZATION,0.13549,0.14654,0.1133,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.72299,0.14584,0.034443,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.10214,0.1454,0.17916,0,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.099614,0.14502,0.093509,0,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.11742,0.14487,0.084983,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.26095,0.14468,0.099929,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.16042,0.14457,0.11352,0,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.10823,0.14333,0.08263,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.23286,0.14272,0.055602,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.099614,0.14261,0.099759,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.088486,0.13939,0.11471,0,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.066192,0.1393,0.10819,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.068619,0.13874,0.10126,0,0
4,GO INTERLEUKIN 5 PRODUCTION,0.13763,0.13826,0.13518,0,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.11367,0.13739,0.098284,0,0
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.067397,0.13548,0.081634,0,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.06986,0.13442,0.13117,0,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.093126,0.13439,0.13153,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10558,0.13409,0.13711,0,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.22503,0.13335,0.10369,0,0
4,GO CHLORIDE ION HOMEOSTASIS,0.1793,0.13306,0.075483,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.18866,0.13228,0.13772,0,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.13979,0.13189,0.13148,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.22042,0.13181,0.095818,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.080464,0.13116,0.10392,0,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.090011,0.13098,0.093839,0,0
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.063258,0.13082,0.10725,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.22042,0.12917,0.055223,0,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.10558,0.1282,0.064107,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.24745,0.12738,0.082712,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.23286,0.12645,0.049895,0,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.31997,0.12625,0.076001,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.11553,0.12544,0.1021,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.13979,0.12438,0.24924,0,0
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.077698,0.12437,0.11541,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.50258,0.12385,0.046273,0,0
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.10214,0.12288,0.090963,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.087731,0.12251,0.13217,0,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.12822,0.12163,0.079658,0,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.082591,0.12155,0.098999,0,0
4,GO RENAL FILTRATION,0.24416,0.12133,0.1188,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.18595,0.12107,0.086519,0,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.14642,0.12051,0.085976,0,0
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.071119,0.11987,0.098177,0,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.062114,0.11934,0.11728,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.39606,0.11901,0.049462,0,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.11553,0.11871,0.088271,0,0
4,GO STARTLE RESPONSE,0.09796,0.11848,0.10693,0,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.1653,0.11773,0.091568,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.2114,0.11734,0.077198,0,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.075674,0.11732,0.14416,0,0
4,GO SEGMENT SPECIFICATION,0.071756,0.11731,0.13353,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.17669,0.11711,0.09965,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.15921,0.11689,0.11141,0,0
4,GO CAMP METABOLIC PROCESS,0.14869,0.11617,0.091354,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.18194,0.11613,0.04531,0,0
4,GO HEART FIELD SPECIFICATION,0.075674,0.11509,0.14852,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.56376,0.1147,0.030111,0,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.070488,0.11466,0.084724,0,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.1873,0.11445,0.067174,0,0
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.12224,0.11433,0.080044,0,0
4,GO TERPENOID METABOLIC PROCESS,0.078382,0.11401,0.088471,0,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.090782,0.11392,0.082099,0,0
4,GO GLYCINE TRANSPORT,0.35886,0.11344,0.074905,0,0
4,GO PLACENTA DEVELOPMENT,0.17283,0.11302,0.069927,0,0
4,GO NEPHRON DEVELOPMENT,0.075674,0.11295,0.087992,0,0
4,GO BLEB ASSEMBLY,0.52609,0.11277,0.001177,0,0
4,GO ACTIN FILAMENT ORGANIZATION,0.063836,0.11253,0.084021,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.29877,0.11214,0.098229,0,0
4,GO NEUTRAL AMINO ACID TRANSPORT,0.06986,0.11198,0.094926,0,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.6312,0.11186,0.019389,0,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.11092,0.11114,0.11012,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.14869,0.11101,0.069436,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.1252,0.11082,0.10497,0,0
4,GO MEMBRANE BIOGENESIS,0.13027,0.11017,0.084199,0,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.090782,0.1098,0.13937,0,0
4,GO MAST CELL MIGRATION,0.39832,0.10973,0.058064,0,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.12421,0.10946,0.0824,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.15447,0.1094,0.080132,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.15921,0.10888,0.10079,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.1262,0.10854,0.12029,0,0
4,GO LOCOMOTORY BEHAVIOR,0.079071,0.10834,0.094568,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.32393,0.10826,0.055033,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.1793,0.10822,0.18612,0,0
4,GO NOSE DEVELOPMENT,0.30829,0.10744,0.16022,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.18327,0.10742,0.10897,0,0
4,GO BLASTODERM SEGMENTATION,0.40058,0.10722,0.059737,0,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.16654,0.10687,0.072197,0,0
4,GO TRABECULA MORPHOGENESIS,0.25414,0.10686,0.057483,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.31409,0.10683,0.04095,0,0
4,GO EPIBOLY,0.1262,0.10674,0.096602,0,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.14197,0.10669,0.075799,0,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.11933,0.10664,0.075239,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.08331,0.10624,0.10011,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.098784,0.10587,0.090422,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.12822,0.10566,0.091836,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.15802,0.10558,0.084299,0,0
4,GO SYNAPSE MATURATION,0.51819,0.1055,0.053624,0,0
4,GO PROSTANOID METABOLIC PROCESS,0.27317,0.10545,0.068762,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.15565,0.10529,0.079154,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.10045,0.10489,0.074167,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.37827,0.10453,0.042072,0,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.062114,0.10427,0.10123,0,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.09796,0.10406,0.10773,0,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.2458,0.10374,0.047304,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.19979,0.10371,0.075703,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.15447,0.10358,0.077969,0,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.46218,0.10336,0.042339,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.091558,0.10304,0.099783,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.065005,0.1029,0.11751,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.19417,0.10284,0.12712,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.069238,0.10278,0.14719,0,0
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.22042,0.10257,0.059405,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.089246,0.10248,0.096121,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.17669,0.10244,0.089709,0,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.26614,0.10239,0.067042,0,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.10646,0.10235,0.093617,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.73517,0.10208,-0.020968,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.066192,0.10205,0.16147,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.21437,0.10199,0.10466,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.18866,0.10191,0.080805,0,0
4,GO ACTIVATION OF GTPASE ACTIVITY,0.073043,0.10153,0.078463,0,0
4,GO SEROTONIN SECRETION,0.28213,0.10129,0.079828,0,0
4,GO ARTERY MORPHOGENESIS,0.073043,0.10124,0.074564,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.085497,0.10071,0.10831,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.14755,0.10069,0.084207,0,0
4,GO ESTROUS CYCLE,0.15565,0.10049,0.095574,0,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.19838,0.1,0.088291,0,0
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.1146,0.099965,0.091278,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.071119,0.09941,0.068973,0,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.12126,0.099193,0.082567,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.076344,0.099074,0.092347,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.13027,0.099051,0.089216,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.21889,0.098859,0.086167,0,0
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.069238,0.098808,0.071663,0,0
4,GO DEVELOPMENTAL PIGMENTATION,0.16163,0.098657,0.064522,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.10823,0.098648,0.078945,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.12029,0.098621,0.098672,0,0
4,GO MYELOID CELL DEVELOPMENT,0.080464,0.098284,0.084079,0,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.075009,0.098122,0.084966,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.71996,0.098095,0.020217,0,0
4,GO EMBRYONIC BODY MORPHOGENESIS,0.095518,0.097544,0.09244,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.082591,0.097534,0.10462,0,0
4,GO ORGANIC CATION TRANSPORT,0.06986,0.097328,0.094565,0,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.19417,0.097292,0.11691,0,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.081877,0.096505,0.12418,0,0
4,GO CELL JUNCTION ORGANIZATION,0.13338,0.096469,0.064962,0,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.089246,0.096264,0.088268,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.17283,0.0961,0.067801,0,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.079071,0.095926,0.1036,0,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.065005,0.095814,0.095582,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.30446,0.095795,0.064683,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.26095,0.095693,0.090137,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.18194,0.095521,0.1019,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.17283,0.095337,0.14236,0,0
4,GO COLLATERAL SPROUTING,0.28578,0.095301,0.051058,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.11837,0.095163,0.057839,0,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.1146,0.095071,0.10247,0,0
4,GO ACTIN FILAMENT BASED PROCESS,0.14869,0.094528,0.066914,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.067397,0.094497,0.082789,0,0
4,GO MAMMARY GLAND DEVELOPMENT,0.13549,0.094226,0.077872,0,0
4,GO ER OVERLOAD RESPONSE,0.10129,0.0942,0.099721,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.1793,0.094139,0.10293,0,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.099614,0.094066,0.072579,0,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.10912,0.093978,0.14143,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.22503,0.09395,0.074696,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.21587,0.093399,0.10153,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.19003,0.093394,0.046722,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.20122,0.093354,0.072457,0,0
4,GO CYCLOOXYGENASE PATHWAY,0.47712,0.092916,0.052806,0,0
4,GO REGULATION OF GTP BINDING,0.42133,0.09289,0.042695,0,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.066192,0.092731,0.10105,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.096327,0.092635,0.10761,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.22814,0.092516,0.055403,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.47461,0.092454,0.042941,0,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.30829,0.092435,0.049481,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.09714,0.092237,0.07583,0,0
4,GO MUSCLE CELL MIGRATION,0.16904,0.091524,0.077461,0,0
4,GO LEUKOCYTE AGGREGATION,0.85376,0.091358,-0.015927,0,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.18595,0.091342,0.097198,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.1262,0.091324,0.11314,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.10385,0.09129,0.08939,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.13979,0.091226,0.076988,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.89846,0.090904,-0.024859,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.22503,0.090741,0.18964,0,0
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.092339,0.090609,0.089294,0,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.18866,0.090597,0.047055,0,0
4,GO INTERFERON BETA PRODUCTION,0.10214,0.090382,0.083317,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.088486,0.090376,0.11424,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.20845,0.090355,0.051428,0,0
4,GO STRESS FIBER ASSEMBLY,0.1914,0.090194,0.081322,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.31215,0.090142,0.034382,0,0
4,GO EPITHELIAL CELL MATURATION,0.065596,0.089985,0.11667,0,0
4,GO ENAMEL MINERALIZATION,0.53406,0.089962,0.067183,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.075009,0.089838,0.10133,0,0
4,GO BODY MORPHOGENESIS,0.18062,0.089733,0.074952,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.1146,0.089722,0.10643,0,0
4,GO FAT CELL PROLIFERATION,0.1653,0.089309,0.089079,0,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.11367,0.089166,0.085881,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.064418,0.088872,0.13687,0,0
4,GO MUSCLE CELL DIFFERENTIATION,0.075009,0.088621,0.066244,0,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.090011,0.088383,0.072662,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.11742,0.088296,0.10108,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.45727,0.08827,0.032775,0,0
4,GO PANCREAS DEVELOPMENT,0.087731,0.088136,0.098121,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.178,0.088112,0.1018,0,0
4,GO ADULT BEHAVIOR,0.06986,0.08796,0.10307,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.41203,0.087765,0.074777,0,0
4,GO EPITHELIAL CELL PROLIFERATION,0.093918,0.087569,0.073344,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.22503,0.087497,0.053442,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.1653,0.087489,0.07446,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.086981,0.087226,0.14177,0,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.069238,0.08714,0.10903,0,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.12421,0.087119,0.072269,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.078382,0.087069,0.076069,0,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.14197,0.086732,0.060725,0,0
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.079765,0.086513,0.078511,0,0
4,GO SARCOMERE ORGANIZATION,0.064418,0.086325,0.095319,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.066192,0.086123,0.069826,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.078382,0.086046,0.10138,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.10646,0.085947,0.079788,0,0
4,GO MOLTING CYCLE,0.08331,0.085887,0.070318,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.3739,0.085874,0.06137,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.09714,0.085851,0.077929,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.30446,0.085833,0.068993,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.2714,0.08576,0.043241,0,0
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23605,0.085484,0.055929,0,0
4,GO AUTOPHAGY OF NUCLEUS,0.12421,0.084961,0.077764,0,0
4,GO LEUKOCYTE HOMEOSTASIS,0.10646,0.084536,0.071176,0,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.092339,0.084518,0.065751,0,0
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.15921,0.084206,0.060124,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.59986,0.084203,0.021487,0,0
4,GO REGULATION OF PROTEIN MATURATION,0.1914,0.084186,0.058644,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.092339,0.084041,0.1036,0,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.065596,0.083951,0.093894,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.12029,0.083706,0.093085,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.44028,0.083686,0.041289,0,0
4,GO EMBRYO IMPLANTATION,0.55016,0.083679,0.039493,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.38488,0.083545,0.056392,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.17669,0.083144,0.085596,0,0
4,GO GANGLION DEVELOPMENT,0.31409,0.083141,0.1416,0,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.090782,0.083013,0.083353,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.25078,0.082968,0.056347,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.94026,0.082953,0.015805,0,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.26964,0.082629,0.087996,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.08331,0.082629,0.13817,0,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.073694,0.082584,0.09366,0,0
4,GO LOCOMOTOR RHYTHM,0.20265,0.082438,0.07799,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.20554,0.082338,0.058327,0,0
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.068006,0.082138,0.066264,0,0
4,GO REPLICATIVE SENESCENCE,0.2913,0.082004,0.067526,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.11367,0.08195,0.07761,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.27853,0.081858,0.079301,0,0
4,GO QUINONE METABOLIC PROCESS,0.12224,0.081683,0.10963,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.17669,0.081477,0.085965,0,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.35886,0.081107,0.099883,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.6691,0.081106,0.05292,0,0
4,GO PROTEIN KINASE B SIGNALING,0.090011,0.081092,0.076541,0,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.086237,0.081044,0.06394,0,0
4,GO PROTEIN OXIDATION,0.23286,0.080895,0.080589,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.1387,0.080725,0.09351,0,0
4,GO SOMITE DEVELOPMENT,0.15802,0.080681,0.056831,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.14983,0.080265,0.097907,0,0
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.072397,0.080021,0.094856,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.28033,0.079691,0.069584,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.35043,0.079684,0.05938,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.099614,0.079635,0.072038,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.073694,0.079628,0.097923,0,0
4,GO AMINE CATABOLIC PROCESS,0.15683,0.079617,0.054233,0,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.20845,0.079213,0.066851,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.29315,0.079151,0.070068,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.178,0.079109,0.065815,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.61972,0.079044,0.02896,0,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.15683,0.078878,0.064303,0,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.19979,0.078797,0.097192,0,0
4,GO STRIATUM DEVELOPMENT,0.071119,0.078738,0.10165,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.065005,0.078536,0.074584,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.32592,0.078447,0.052558,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.23766,0.078287,0.040324,0,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.30829,0.078157,0.069778,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.090782,0.07808,0.080987,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.13234,0.077884,0.105,0,0
4,GO RETINAL METABOLIC PROCESS,0.36956,0.077794,0.097885,0,0
4,GO CELL SUBSTRATE ADHESION,0.23766,0.07765,0.06562,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.10214,0.077633,0.070961,0,0
4,GO ORGAN INDUCTION,0.092339,0.077557,0.082928,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.48976,0.077509,0.12549,0,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.16042,0.077206,0.10211,0,0
4,GO SPINAL CORD PATTERNING,0.28213,0.07719,0.10033,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.21437,0.077184,0.06825,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.78763,0.076945,0.013602,0,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.18327,0.076896,0.13309,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.14642,0.076896,0.064019,0,0
4,GO REGULATION OF STEROL TRANSPORT,0.11837,0.076606,0.072068,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.54208,0.076449,0.067811,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.16654,0.076401,0.089593,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.37608,0.076393,0.054057,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.11933,0.076215,0.068353,0,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.47461,0.076167,0.054419,0,0
4,GO POSITIVE REGULATION OF CELL AGING,0.25583,0.076005,0.073698,0,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.1252,0.075954,0.065308,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.30066,0.07593,0.060974,0,0
4,GO GLIAL CELL ACTIVATION,0.21288,0.075796,0.055589,0,0
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.075009,0.075695,0.07991,0,0
4,GO RESPONSE TO AXON INJURY,0.1146,0.075622,0.079218,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.22503,0.075565,0.064563,0,0
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.14869,0.07553,0.069334,0,0
4,GO KERATINOCYTE MIGRATION,0.081877,0.075117,0.075375,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.32993,0.075091,0.032924,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.22503,0.075012,0.048329,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.45482,0.074942,0.031889,0,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.093918,0.074934,0.08542,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.094715,0.074818,0.085511,0,0
4,GO PROTEIN ACTIVATION CASCADE,0.74128,0.074655,0.009227,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.10734,0.074461,0.095437,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.27853,0.074444,0.057341,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.56376,0.074439,0.046357,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.30637,0.074359,0.051311,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.1387,0.074333,0.064171,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.29315,0.074193,0.076326,0,0
4,GO DORSAL AORTA DEVELOPMENT,0.16163,0.074016,0.095995,0,0
4,GO SEX DETERMINATION,0.26095,0.073964,0.049827,0,0
4,GO GLIAL CELL MIGRATION,0.3739,0.073827,0.043258,0,0
4,GO GLAND MORPHOGENESIS,0.20845,0.073798,0.069731,0,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.10045,0.073477,0.088423,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.47461,0.073403,0.034898,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.14419,0.073391,0.12975,0,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.099614,0.073302,0.086759,0,0
4,GO ETHANOL OXIDATION,0.30637,0.073296,0.054582,0,0
4,GO REGULATION OF BONE DEVELOPMENT,0.19979,0.072948,0.068183,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.15447,0.072904,0.11005,0,0
4,GO NEURAL TUBE FORMATION,0.2644,0.072876,0.049258,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.32792,0.072693,0.067419,0,0
4,GO PIGMENT GRANULE LOCALIZATION,0.079765,0.072645,0.082336,0,0
4,GO TISSUE MIGRATION,0.071119,0.072619,0.094021,0,0
4,GO RESPONSE TO STEROID HORMONE,0.081168,0.072615,0.070313,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.066792,0.072594,0.10322,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.089246,0.072538,0.06772,0,0
4,GO NEURON REMODELING,0.077018,0.072397,0.13236,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.091558,0.07215,0.13303,0,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.14869,0.072068,0.070862,0,0
4,GO RESPONSE TO VITAMIN,0.47461,0.071926,0.04251,0,0
4,GO PRO B CELL DIFFERENTIATION,0.15921,0.07181,0.089684,0,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.10299,0.071728,0.066818,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.5,0.07169,0.031277,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.24416,0.071587,0.066407,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.69586,0.071558,0.050266,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.16285,0.071547,0.06279,0,0
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.099614,0.071365,0.12937,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.14197,0.071328,0.093433,0,0
4,GO SOMITOGENESIS,0.062114,0.071292,0.076672,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.40743,0.071175,0.045524,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.5,0.07109,0.041233,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.16407,0.071002,0.081233,0,0
4,GO LYSOSOMAL TRANSPORT,0.13656,0.070944,0.067518,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.20265,0.070702,0.054072,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.25924,0.070651,0.084137,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.14869,0.070642,0.14498,0,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.1252,0.070212,0.090037,0,0
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.093918,0.070135,0.091232,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.079071,0.070123,0.075848,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.28578,0.07007,0.064836,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.41899,0.069928,0.039464,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.13027,0.069803,0.056793,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.72907,0.069783,0.011288,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.44752,0.069733,0.02383,0,0
4,GO T CELL HOMEOSTASIS,0.071756,0.069624,0.067832,0,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.44269,0.069618,0.020356,0,0
4,GO ASSOCIATIVE LEARNING,0.23605,0.069607,0.058113,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.086237,0.069595,0.096988,0,0
4,GO CARNITINE METABOLIC PROCESS,0.16654,0.069502,0.096489,0,0
4,GO TISSUE MORPHOGENESIS,0.1754,0.069489,0.050654,0,0
4,GO SYNAPSE ASSEMBLY,0.14197,0.069471,0.082199,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.75048,0.069468,0.034908,0,0
4,GO REGULATION OF PHOSPHORYLATION,0.065596,0.069457,0.064257,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.15921,0.069414,0.058464,0,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.06986,0.069278,0.072434,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.80326,0.069258,0.0022515,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.32195,0.069233,0.091485,0,0
4,GO INTERLEUKIN 13 PRODUCTION,0.31215,0.069213,0.093455,0,0
4,GO PREPULSE INHIBITION,0.55558,0.069153,0.043449,0,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.068006,0.069118,0.169,0,0
4,GO REGULATION OF FATTY ACID OXIDATION,0.32792,0.069091,0.056624,0,0
4,GO CELLULAR RESPONSE TO VIRUS,0.12721,0.068894,0.069898,0,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.4451,0.068787,0.087484,0,0
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.19838,0.068762,0.064961,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.48215,0.068742,0.058681,0,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.19697,0.068736,0.066121,0,0
4,GO RESPONSE TO ANGIOTENSIN,0.15683,0.068664,0.079144,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.20265,0.06862,0.04821,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.31604,0.068426,0.058282,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.14308,0.068323,0.083011,0,0
4,GO TRABECULA FORMATION,0.72603,0.068275,0.025678,0,0
4,GO CELLULAR RESPONSE TO FATTY ACID,0.13979,0.068245,0.084239,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.12924,0.068026,0.099926,0,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.19003,0.068011,0.083879,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.60834,0.06801,0.037397,0,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.15802,0.06799,0.071893,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.46713,0.067854,0.045382,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.20409,0.067773,0.086212,0,0
4,GO GENETIC IMPRINTING,0.20992,0.067723,0.075859,0,0
4,GO FEEDING BEHAVIOR,0.093126,0.067721,0.065468,0,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.11647,0.067655,0.058622,0,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.063258,0.067653,0.058613,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.48722,0.067473,0.065396,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.28213,0.067209,0.060147,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.13444,0.067186,0.047316,0,0
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.58585,0.067166,0.027749,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.34627,0.067079,0.03312,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.12224,0.066995,0.079038,0,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.1453,0.066893,0.088521,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.2714,0.066685,0.060325,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.59705,0.066643,0.040519,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.064418,0.0666,0.11413,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.09796,0.066567,0.060916,0,0
4,GO RETINOL METABOLIC PROCESS,0.18062,0.066545,0.071455,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.42838,0.066538,0.027665,0,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.21288,0.066513,0.048823,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.15921,0.06651,0.07087,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.42133,0.066507,0.024471,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.81267,0.066442,0.028825,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.095518,0.066389,0.087551,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.10045,0.066298,0.054058,0,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.31997,0.066173,0.076335,0,0
4,GO METANEPHROS DEVELOPMENT,0.42838,0.066107,0.049307,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.31997,0.066095,0.049895,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.081877,0.066078,0.064555,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.14308,0.066059,0.07957,0,0
4,GO MACROPHAGE MIGRATION,0.1252,0.065956,0.059605,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.19979,0.065894,0.048622,0,0
4,GO HYALURONAN CATABOLIC PROCESS,0.61117,0.065727,0.0075695,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.24089,0.065437,0.054478,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.16778,0.065311,0.065265,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.68094,0.065275,0.02171,0,0
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.1533,0.065142,0.075612,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.14088,0.065057,0.078511,0,0
4,GO EXCRETION,0.073694,0.065047,0.079054,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.17283,0.065027,0.15205,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.26789,0.06499,0.065493,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.31604,0.064974,0.09115,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.20845,0.064911,0.063324,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.35043,0.064868,0.030689,0,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.10646,0.064794,0.065759,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.12721,0.064757,0.060713,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.074349,0.064479,0.080989,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.13338,0.064256,0.084548,0,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.090011,0.064217,0.054877,0,0
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.067397,0.064089,0.067252,0,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.22042,0.064081,0.058974,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.098784,0.064016,0.079455,0,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.10646,0.063931,0.060171,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.18595,0.06392,0.081799,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.075009,0.063896,0.0712,0,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.26095,0.063838,0.12772,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.34627,0.063629,0.045377,0,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.12126,0.063433,0.073206,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.14197,0.063323,0.080766,0,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.10385,0.06331,0.067919,0,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.85694,0.063226,-0.0099923,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.13763,0.063216,0.058903,0,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.088486,0.063199,0.06676,0,0
4,GO EPITHELIAL TUBE FORMATION,0.13549,0.063191,0.051761,0,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.091558,0.063113,0.059288,0,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.085497,0.063093,0.064176,0,0
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.065596,0.062974,0.070524,0,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.22195,0.062924,0.057077,0,0
4,GO NEUROTRANSMITTER SECRETION,0.37173,0.062848,0.083007,0,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.16904,0.062734,0.07836,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.071119,0.06268,0.082539,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.095518,0.062651,0.11104,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.25414,0.062553,0.071967,0,0
4,GO PROTEIN REFOLDING,0.20845,0.062369,0.062346,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.66321,0.062264,0.0036027,0,0
4,GO SPLEEN DEVELOPMENT,0.12322,0.062246,0.068148,0,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.40973,0.062234,0.068457,0,0
4,GO PEPTIDE CROSS LINKING,0.34627,0.062196,0.048072,0,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.15683,0.062175,0.058198,0,0
4,GO RNA INTERFERENCE,0.77519,0.062136,0.001454,0,0
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.085497,0.062082,0.05985,0,0
4,GO ENSHEATHMENT OF NEURONS,0.10823,0.062068,0.072147,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.16654,0.062048,0.049857,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.11367,0.061894,0.060427,0,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.12421,0.061572,0.062673,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.56925,0.061492,0.027392,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.21288,0.061373,0.06998,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.090011,0.061297,0.16124,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.079765,0.061297,0.080222,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.59986,0.061286,0.029643,0,0
4,GO NERVOUS SYSTEM PROCESS,0.1146,0.060977,0.054851,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.24252,0.060893,0.092807,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.077018,0.060873,0.14807,0,0
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.10558,0.060819,0.058096,0,0
4,GO CELL GROWTH,0.16285,0.060799,0.053848,0,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.13979,0.06079,0.0989,0,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.27495,0.06077,0.048444,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.09796,0.060684,0.11094,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.072397,0.060584,0.064316,0,0
4,GO RUFFLE ORGANIZATION,0.11647,0.060522,0.082261,0,0
4,GO CGMP MEDIATED SIGNALING,0.29689,0.060517,0.064661,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.09714,0.060399,0.071577,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.25414,0.060389,0.074476,0,0
4,GO XENOBIOTIC TRANSPORT,0.13656,0.060373,0.076276,0,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.068619,0.060373,0.090141,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.43075,0.060344,0.034775,0,0
4,GO CELL CELL SIGNALING,0.091558,0.060265,0.057683,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.35253,0.060124,0.036361,0,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.26614,0.060057,0.040396,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.49231,0.06002,0.027722,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.19003,0.059956,0.086862,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.14308,0.059793,0.062238,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.37827,0.059685,0.044035,0,0
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.065596,0.059673,0.077224,0,0
4,GO TUBE DEVELOPMENT,0.095518,0.059564,0.066014,0,0
4,GO AMINO ACID IMPORT,0.39156,0.059443,0.039092,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.10214,0.059401,0.074782,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.14983,0.059302,0.077816,0,0
4,GO POTASSIUM ION HOMEOSTASIS,0.18194,0.059298,0.063269,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.44028,0.059257,0.030828,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.3442,0.059208,0.040707,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.14869,0.05907,0.057402,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.44269,0.059055,0.038088,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.33194,0.058911,0.079293,0,0
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.068619,0.058908,0.065333,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.61117,0.058898,0.023034,0,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.1453,0.058872,0.064575,0,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.2644,0.058853,0.035175,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.34008,0.058834,0.04996,0,0
4,GO RESPONSE TO AMYLOID BETA,0.14983,0.058815,0.083722,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.14419,0.058807,0.059292,0,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.093126,0.05875,0.060142,0,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.84107,0.058729,0.040935,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.23128,0.05869,0.05629,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.064418,0.058481,0.072339,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.084763,0.058416,0.10171,0,0
4,GO EAR DEVELOPMENT,0.14642,0.058186,0.05915,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.22503,0.058168,0.058851,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.9306,0.058154,0.0078258,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.2913,0.057946,0.042814,0,0
4,GO RUFFLE ASSEMBLY,0.52345,0.057777,0.048945,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.22971,0.057772,0.053915,0,0
4,GO NEURON FATE SPECIFICATION,0.70787,0.057649,0.064886,0,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.29689,0.057561,0.056316,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.1252,0.057546,0.095066,0,0
4,GO FEAR RESPONSE,0.1914,0.05746,0.058418,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.6691,0.057435,0.0086506,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.42838,0.057288,0.04918,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.23766,0.057238,0.054783,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.50516,0.057199,0.029238,0,0
4,GO RESPONSE TO ACTIVITY,0.11092,0.057076,0.067114,0,0
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.10646,0.057035,0.084541,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.39606,0.057012,0.046924,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.26964,0.056994,0.086605,0,0
4,GO PIGMENT ACCUMULATION,0.51035,0.056875,0.044874,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.23286,0.056841,0.057342,0,0
4,GO UTERUS DEVELOPMENT,0.81267,0.056812,-0.026404,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.1146,0.056799,0.10409,0,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.30446,0.056783,0.036,0,0
4,GO SYNAPTIC VESICLE PRIMING,0.20699,0.056685,0.13464,0,0
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.14642,0.056659,0.044843,0,0
4,GO FACE DEVELOPMENT,0.47712,0.056372,0.046651,0,0
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.072397,0.056368,0.075106,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.22195,0.056217,0.059697,0,0
4,GO RESPONSE TO NICOTINE,0.26614,0.05613,0.063152,0,0
4,GO COMPLEMENT ACTIVATION,0.23128,0.056081,0.050579,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.065005,0.055945,0.081739,0,0
4,GO REPRODUCTION,0.072397,0.05593,0.057551,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.080464,0.055898,0.11005,0,0
4,GO NUCLEOTIDE SALVAGE,0.36741,0.055889,0.053754,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.61972,0.055869,0.027308,0,0
4,GO GLUTATHIONE METABOLIC PROCESS,0.4355,0.055866,0.037605,0,0
4,GO RESPONSE TO UV C,0.46713,0.055857,0.036014,0,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.37608,0.055828,0.03783,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.48976,0.055801,0.055811,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.2458,0.055732,0.066128,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.11092,0.055727,0.10667,0,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.20265,0.055688,0.055671,0,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.2458,0.055558,0.054745,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.5583,0.055547,0.016428,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.15214,0.055543,0.057081,0,0
4,GO REGENERATION,0.24745,0.055521,0.052229,0,0
4,GO GROWTH,0.24252,0.055356,0.045473,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.063836,0.055291,0.065446,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.14197,0.05528,0.073438,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.085497,0.055199,0.080559,0,0
4,GO ERBB SIGNALING PATHWAY,0.5,0.055185,0.034161,0,0
4,GO KIDNEY MORPHOGENESIS,0.15802,0.055124,0.066203,0,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.29689,0.055032,0.061657,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.64858,0.054981,0.014721,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.13027,0.054888,0.066321,0,0
4,GO TUBE MORPHOGENESIS,0.25246,0.054741,0.049774,0,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.092339,0.054667,0.070127,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.22195,0.054526,0.066388,0,0
4,GO BODY FLUID SECRETION,0.12224,0.054523,0.065805,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.12322,0.054522,0.048067,0,0
4,GO GROWTH HORMONE SECRETION,0.44994,0.054396,0.097143,0,0
4,GO RESPONSE TO OXYGEN RADICAL,0.091558,0.054291,0.074933,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.1387,0.054282,0.051705,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.080464,0.054279,0.075934,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.19557,0.054251,0.051687,0,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.38267,0.054246,0.04408,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.36741,0.054218,0.028732,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.18866,0.054193,0.07006,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.67798,0.054104,0.026901,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.71693,0.05402,-0.00082758,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.76899,0.05391,0.026704,0,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.95961,0.053854,0.0062427,0,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.23605,0.053717,0.065694,0,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.064418,0.05369,0.078217,0,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.14197,0.053664,0.072651,0,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.36526,0.053616,0.04215,0,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.1453,0.053525,0.049726,0,0
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.082591,0.053516,0.060693,0,0
4,GO AXONEME ASSEMBLY,0.17411,0.053432,0.075961,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.15921,0.053414,0.054109,0,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.45482,0.053309,0.026316,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.09796,0.053206,0.093534,0,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.11183,0.053144,0.075203,0,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.70787,0.052958,-0.028266,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.32993,0.052839,0.077575,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.36098,0.052698,0.027969,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.15565,0.052694,0.07569,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.1453,0.052619,0.085605,0,0
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.09796,0.052516,0.063807,0,0
4,GO RESPONSE TO ESTRADIOL,0.32195,0.052471,0.038144,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.57752,0.052463,0.027232,0,0
4,GO REGULATION OF MAPK CASCADE,0.066192,0.052442,0.073285,0,0
4,GO DEVELOPMENTAL CELL GROWTH,0.64276,0.052372,0.022233,0,0
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.075009,0.052338,0.06222,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.39606,0.05226,0.058421,0,0
4,GO FIBROBLAST PROLIFERATION,0.31409,0.052133,0.052475,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.7659,0.052063,0.015938,0,0
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.12421,0.052063,0.071612,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.46218,0.052004,0.039793,0,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.25246,0.051974,0.054416,0,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.44269,0.051918,0.043699,0,0
4,GO ERAD PATHWAY,0.071119,0.051835,0.057509,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.572,0.051803,-0.055721,0,0
4,GO PRESYNAPSE ORGANIZATION,0.28033,0.051784,0.060403,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.77519,0.051771,-0.0014019,0,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.15214,0.051697,0.070077,0,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.59144,0.05159,0.023676,0,0
4,GO NEGATIVE REGULATION OF CELL DEATH,0.13444,0.05152,0.053419,0,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.13338,0.051486,0.057466,0,0
4,GO HEART FORMATION,0.42838,0.05146,0.058083,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.17156,0.051374,0.070089,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.52874,0.051368,0.028301,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.2644,0.051258,0.058832,0,0
4,GO ASTROCYTE ACTIVATION,0.40286,0.051242,0.052707,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.40058,0.051194,0.035439,0,0
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.16042,0.051068,0.07752,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.26095,0.051025,0.066729,0,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.10823,0.051,0.064508,0,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.2644,0.050896,0.080689,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.318,0.050828,0.042661,0,0
4,GO MACROPHAGE DIFFERENTIATION,0.39381,0.050792,0.039075,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.1754,0.050638,0.13269,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.23128,0.050631,0.051119,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.078382,0.05057,0.078294,0,0
4,GO PIGMENT CELL DIFFERENTIATION,0.35463,0.050543,0.052423,0,0
4,GO NEUROMUSCULAR PROCESS,0.66321,0.05051,0.02903,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.63408,0.050477,0.025934,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.10646,0.050424,0.067349,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.15683,0.050364,0.069927,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.69586,0.050324,-0.0064674,0,0
4,GO SPERM AXONEME ASSEMBLY,0.59424,0.050256,0.037757,0,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.26614,0.050127,0.052926,0,0
4,GO LIPID OXIDATION,0.079071,0.050118,0.065337,0,0
4,GO RENAL WATER HOMEOSTASIS,0.52874,0.049935,0.03858,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.39156,0.049872,0.037047,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.17283,0.04977,0.075001,0,0
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.36956,0.049768,0.060305,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.28945,0.049708,0.055544,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.44994,0.049686,0.03824,0,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.15683,0.049678,0.079186,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.13338,0.049677,0.060019,0,0
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.075009,0.049633,0.07185,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.10734,0.049631,0.060241,0,0
4,GO THYMIC T CELL SELECTION,0.081168,0.049552,0.060608,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.2114,0.049532,0.061157,0,0
4,GO VESICLE LOCALIZATION,0.079765,0.049431,0.059675,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.88245,0.049422,-0.029686,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.17283,0.049355,0.083859,0,0
4,GO HEAD MORPHOGENESIS,0.63697,0.049264,0.027204,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.54746,0.04923,0.042121,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.29689,0.049206,0.0442,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.6312,0.049152,0.020073,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.39606,0.049144,0.047951,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.31021,0.049064,0.044139,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.45482,0.049059,0.044329,0,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.22503,0.04899,0.044247,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.16904,0.048985,0.065731,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.2644,0.048887,0.049873,0,0
4,GO NEGATIVE T CELL SELECTION,0.51035,0.048828,0.0055175,0,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.15447,0.048814,0.065428,0,0
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.13338,0.048719,0.061965,0,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.50258,0.048701,0.041204,0,0
4,GO REGULATION OF ENDOCYTOSIS,0.35674,0.048637,0.046867,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.17411,0.048465,0.046567,0,0
4,GO ORGANIC ACID CATABOLIC PROCESS,0.11837,0.048464,0.051822,0,0
4,GO BEHAVIOR,0.27317,0.048383,0.048616,0,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.23605,0.048359,0.069559,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.14419,0.048326,0.060657,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.065005,0.048283,0.059315,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.71089,0.04828,0.05811,0,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.25924,0.048274,0.062172,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.098784,0.048243,0.091913,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.14755,0.048082,0.087949,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.6312,0.048048,-0.024127,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.23445,0.048026,0.051167,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.2114,0.048024,0.055704,0,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.14755,0.048,0.063959,0,0
4,GO REGULATION OF NUCLEASE ACTIVITY,0.23445,0.04799,0.049638,0,0
4,GO GMP METABOLIC PROCESS,0.28761,0.047962,0.061723,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.13656,0.047939,0.078595,0,0
4,GO PIGMENT GRANULE ORGANIZATION,0.34627,0.047793,0.039689,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.43312,0.047768,0.038365,0,0
4,GO VASCULOGENESIS,0.85059,0.047683,-0.0066301,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.090011,0.047683,0.092786,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.28033,0.047614,0.03879,0,0
4,GO RRNA CATABOLIC PROCESS,0.18327,0.047605,0.075636,0,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.6055,0.047545,0.022103,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.59424,0.04754,0.02799,0,0
4,GO FIBROBLAST MIGRATION,0.40058,0.047421,0.048249,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.30066,0.047379,0.11516,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY,0.14869,0.047369,0.045909,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.59424,0.047337,0.021327,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.66028,0.047267,0.055163,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.71391,0.047263,0.022815,0,0
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.18194,0.047176,0.062676,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.94348,0.047173,0.0076977,0,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.10558,0.04713,0.073212,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.33194,0.047064,0.059269,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.35886,0.047048,0.059901,0,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.22348,0.046933,0.064184,0,0
4,GO PHOTOPERIODISM,0.20122,0.046875,0.068681,0,0
4,GO REGIONALIZATION,0.12126,0.046839,0.068621,0,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.10299,0.04683,0.063296,0,0
4,GO SEGMENTATION,0.36098,0.046771,0.044395,0,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.17156,0.046697,0.051572,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.17029,0.04661,0.098166,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.22814,0.046518,0.05129,0,0
4,GO TUBE FORMATION,0.23927,0.046445,0.039536,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.77209,0.046292,0.032646,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.94993,0.046287,-0.0076925,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.53672,0.046282,0.031508,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.39156,0.046153,0.04794,0,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.18062,0.04602,0.042812,0,0
4,GO CELLULAR RESPIRATION,0.10646,0.046005,0.047816,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.16407,0.045996,0.064087,0,0
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.12322,0.045845,0.060141,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.46466,0.045755,0.030846,0,0
4,GO HYPOTONIC RESPONSE,0.78451,0.045608,0.0048668,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.24745,0.045514,0.04553,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.51035,0.045389,0.036876,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.30637,0.045351,0.076332,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.60834,0.045277,0.029262,0,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.11367,0.045238,0.057018,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.38047,0.045216,0.10125,0,0
4,GO PROTEIN HOMOOLIGOMERIZATION,0.1146,0.045205,0.049595,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.39832,0.045105,0.12867,0,0
4,GO MESENCHYME MORPHOGENESIS,0.50776,0.045005,0.029746,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.13763,0.044831,0.076641,0,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.24416,0.044744,0.061722,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.75664,0.044715,0.032583,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.50258,0.044661,0.033091,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.98869,0.04445,0.0016182,0,0
4,GO SULFATE TRANSPORT,0.28578,0.044428,0.062823,0,0
4,GO REGULATION OF PROTEIN FOLDING,0.11367,0.044352,0.069054,0,0
4,GO DRUG CATABOLIC PROCESS,0.28395,0.044291,0.055466,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.80326,0.04428,0.019526,0,0
4,GO RESPONSE TO INTERLEUKIN 7,0.20845,0.044069,0.068022,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.79075,0.044068,0.012239,0,0
4,GO PERICARDIUM DEVELOPMENT,0.89205,0.044023,-0.010479,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.25924,0.044013,0.066272,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.23766,0.043973,0.068746,0,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.30066,0.043942,0.071297,0,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.23605,0.043807,0.035353,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.17029,0.043788,0.052043,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.44752,0.043758,0.041895,0,0
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.10045,0.043728,0.055577,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.44028,0.043585,0.046725,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.092339,0.043579,0.067092,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.56376,0.043469,0.036696,0,0
4,GO CELLULAR RESPONSE TO LIPID,0.1453,0.043456,0.058595,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.40973,0.043367,0.038805,0,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.53406,0.043342,0.032467,0,0
4,GO TETRAPYRROLE METABOLIC PROCESS,0.62258,0.043319,0.02268,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.6055,0.043219,0.027314,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.91451,0.043207,0.019879,0,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.84741,0.043175,0.01799,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.54208,0.043103,0.038906,0,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.10045,0.043098,0.062271,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.77519,0.042995,0.038841,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.30637,0.042994,0.027007,0,0
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.066192,0.042951,0.072162,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.20122,0.042872,0.053132,0,0
4,GO CHEMOSENSORY BEHAVIOR,0.31604,0.042765,0.019425,0,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.73822,0.042752,0.038088,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.26614,0.04264,0.076559,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.96284,0.042534,-0.043387,0,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.42367,0.042517,0.040611,0,0
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.14197,0.042452,0.046543,0,0
4,GO MYELOID CELL HOMEOSTASIS,0.088486,0.042271,0.081778,0,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.16778,0.042248,0.064399,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.90809,0.042197,0.0082601,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.36311,0.042191,0.051169,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.62258,0.042181,0.032189,0,0
4,GO SYNAPTIC SIGNALING,0.67798,0.042129,0.028307,0,0
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.68988,0.042054,0.014704,0,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.52082,0.042016,0.017998,0,0
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.062684,0.041877,0.057159,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.62832,0.041856,0.026327,0,0
4,GO REGULATION OF PROTEIN STABILITY,0.08331,0.041789,0.05319,0,0
4,GO IRON ION HOMEOSTASIS,0.35043,0.041787,0.037795,0,0
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.10299,0.041785,0.064644,0,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.96607,0.04178,-0.0038247,0,0
4,GO REGULATION OF HAIR CYCLE,0.39381,0.041779,0.046848,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.69885,0.041752,0.021306,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.25924,0.041742,0.058289,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.19557,0.041699,0.077735,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.94993,0.041663,0.017084,0,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.64858,0.041616,-0.048691,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.41434,0.041544,0.038111,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.28578,0.041478,0.036054,0,0
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.12126,0.041391,0.062629,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.33803,0.041364,0.046008,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.28033,0.041265,0.047888,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.80012,0.041252,0.0043883,0,0
4,GO WATER TRANSPORT,0.31215,0.041227,0.045712,0,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.11092,0.041166,0.0739,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.28761,0.041144,0.055933,0,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.32592,0.041021,0.052342,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.09796,0.040999,0.086853,0,0
4,GO MATING BEHAVIOR,0.17029,0.040979,0.066096,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.95316,0.040743,0.005127,0,0
4,GO HINDBRAIN DEVELOPMENT,0.12029,0.040694,0.077539,0,0
4,GO EMBRYO DEVELOPMENT,0.46218,0.040676,0.029114,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.34213,0.040669,0.053539,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.22195,0.040592,0.053079,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.7659,0.040584,0.018561,0,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.318,0.040566,0.046691,0,0
4,GO MACROPHAGE PROLIFERATION,0.39606,0.04056,0.063487,0,0
4,GO TISSUE REGENERATION,0.12924,0.040506,0.073356,0,0
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.41666,0.040492,0.06798,0,0
4,GO RESPONSE TO ETHER,0.18062,0.040485,0.067602,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.88565,0.040408,0.017101,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.41899,0.040392,0.050824,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.44752,0.040219,0.060013,0,0
4,GO MEMORY,0.26964,0.040207,0.051765,0,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.37608,0.040177,0.044022,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.33599,0.040064,0.042765,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.17029,0.040057,0.053115,0,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.10734,0.039966,0.06046,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.89846,0.039957,0.0022617,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.67206,0.03994,0.033774,0,0
4,GO IMPORT INTO CELL,0.14308,0.039871,0.067998,0,0
4,GO ARTERY DEVELOPMENT,0.84424,0.039862,0.0040217,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.35043,0.039802,0.064194,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.20265,0.039735,0.056713,0,0
4,GO NEGATIVE REGULATION OF TRANSPORT,0.086237,0.03965,0.055032,0,0
4,GO REGULATION OF VASOCONSTRICTION,0.20699,0.039382,0.055601,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.16904,0.03937,0.045788,0,0
4,GO TAXIS,0.44269,0.039333,0.038004,0,0
4,GO REGULATION OF GTPASE ACTIVITY,0.25583,0.039318,0.05478,0,0
4,GO CELL FATE DETERMINATION,0.27853,0.039304,0.0732,0,0
4,GO MITOTIC DNA REPLICATION,0.86968,0.039262,0.011175,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.40286,0.03925,0.059162,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.75972,0.039125,-0.0033819,0,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.27853,0.039109,0.073921,0,0
4,GO RESPONSE TO CAMP,0.13763,0.039087,0.065646,0,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.093918,0.039061,0.053244,0,0
4,GO THALAMUS DEVELOPMENT,0.25078,0.039053,0.10525,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.44269,0.038939,0.066798,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.065596,0.038899,0.12166,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.85059,0.03887,0.01809,0,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.39156,0.038844,0.037455,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.61402,0.038795,0.024851,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.15447,0.038777,0.084813,0,0
4,GO HAIR FOLLICLE MATURATION,0.9113,0.038684,0.0068936,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.69885,0.038633,-0.011682,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.51819,0.038608,0.025387,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.42838,0.03858,0.037032,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.14197,0.038576,0.11182,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.12924,0.038538,0.061499,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.25246,0.038469,0.073039,0,0
4,GO PIRNA METABOLIC PROCESS,0.16904,0.038462,0.12217,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.32393,0.038433,0.049254,0,0
4,GO MESODERM MORPHOGENESIS,0.3739,0.038398,0.044631,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.55287,0.038396,0.025558,0,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.37608,0.038382,0.062408,0,0
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.1252,0.038375,0.088086,0,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.178,0.038301,0.057321,0,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.79075,0.038214,0.015585,0,0
4,GO HETEROCHROMATIN ORGANIZATION,0.49743,0.0382,0.02313,0,0
4,GO MEIOTIC CELL CYCLE,0.35674,0.038178,0.026929,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.45727,0.038131,0.0441,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.61972,0.03809,0.023879,0,0
4,GO POSITIVE REGULATION OF BINDING,0.30446,0.038082,0.046019,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.31997,0.037974,0.066761,0,0
4,GO REGULATION OF CELL SHAPE,0.16285,0.037887,0.071612,0,0
4,GO SERTOLI CELL DIFFERENTIATION,0.15565,0.037862,0.085412,0,0
4,GO GASTRULATION,0.58029,0.03777,0.033225,0,0
4,GO INNER EAR MORPHOGENESIS,0.48976,0.037645,0.030151,0,0
4,GO ARGININE METABOLIC PROCESS,0.99515,0.037566,0.0026686,0,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.093918,0.037502,0.052381,0,0
4,GO NEURON PROJECTION EXTENSION,0.97899,0.037481,0.0057679,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.33803,0.037377,0.047312,0,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.15921,0.037368,0.055078,0,0
4,GO REGULATION OF BINDING,0.15921,0.037303,0.056911,0,0
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.23445,0.037224,0.063852,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.40514,0.037136,0.046218,0,0
4,GO EAR MORPHOGENESIS,0.47211,0.03712,0.02377,0,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.13027,0.037092,0.097697,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.19557,0.037052,0.064054,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.52345,0.037052,0.034073,0,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.572,0.037003,0.02335,0,0
4,GO CELL CELL SIGNALING BY WNT,0.34213,0.036918,0.041849,0,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.48215,0.036873,0.040991,0,0
4,GO AORTA DEVELOPMENT,0.71089,0.036869,-0.021161,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.1653,0.036868,0.041286,0,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.088486,0.036836,0.077343,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.64567,0.036806,0.024909,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.48468,0.036749,0.053506,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.42367,0.036735,0.025553,0,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.13549,0.036704,0.062267,0,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.20554,0.036662,0.038969,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.65734,0.036635,0.025904,0,0
4,GO MIDGUT DEVELOPMENT,0.53672,0.036552,0.059725,0,0
4,GO GONADOTROPIN SECRETION,0.31021,0.036403,0.058212,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.93382,0.03634,0.011434,0,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.29877,0.036292,0.030332,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.4355,0.036255,0.044288,0,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.3739,0.036247,0.041334,0,0
4,GO MALE SEX DETERMINATION,0.50258,0.036236,0.045804,0,0
4,GO TUBULIN DEACETYLATION,0.54208,0.036128,0.04587,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.86331,0.035991,0.0035968,0,0
4,GO MULTI ORGANISM PROCESS,0.10045,0.035954,0.051396,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.82842,0.035948,0.014329,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.15921,0.035873,0.056661,0,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.59705,0.035832,0.017321,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.41666,0.035742,0.037699,0,0
4,GO SLEEP,0.12126,0.035665,0.083652,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.56376,0.03566,0.031824,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.55287,0.035597,0.03208,0,0
4,GO PHOSPHOLIPID HOMEOSTASIS,0.71391,0.035536,0.022584,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.94671,0.03552,-0.022918,0,0
4,GO T CELL APOPTOTIC PROCESS,0.29877,0.03547,0.049311,0,0
4,GO FERTILIZATION,0.11837,0.035306,0.046231,0,0
4,GO CELLULAR RESPONSE TO ALCOHOL,0.14419,0.035268,0.077727,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.34627,0.035267,0.044397,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.5394,0.035202,0.017674,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.572,0.03519,0.031327,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.46962,0.03515,0.027705,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.88885,0.035144,0.017671,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.71089,0.035066,0.021522,0,0
4,GO ORGANELLE LOCALIZATION,0.22814,0.034954,0.03391,0,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.32195,0.034946,0.0336,0,0
4,GO REGULATION OF CATABOLIC PROCESS,0.14983,0.034945,0.046202,0,0
4,GO RESPONSE TO LEUCINE,0.39156,0.034908,0.073945,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.27673,0.034785,0.060512,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.58307,0.034781,0.032315,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.28213,0.034761,0.065395,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.82211,0.034736,0.029456,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.33396,0.034719,0.044237,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.78451,0.034583,0.01396,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.17411,0.034495,0.049579,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.40973,0.034475,0.046043,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.32195,0.034417,0.04578,0,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.070488,0.034329,0.072688,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.797,0.034164,0.021533,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.80012,0.034051,0.011961,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.15447,0.03398,0.072965,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.86968,0.033964,0.010833,0,0
4,GO BONE MATURATION,0.57476,0.033919,-0.022436,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.99192,0.033865,0.0077666,0,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.32195,0.033846,0.03356,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.35043,0.033846,0.057899,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.95961,0.033805,0.0047923,0,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.21587,0.033801,0.089687,0,0
4,GO RESPONSE TO RETINOIC ACID,0.64276,0.033771,0.034611,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.93382,0.033625,0.0067047,0,0
4,GO CYTOKINESIS,0.50776,0.033597,0.028941,0,0
4,GO GLIAL CELL PROLIFERATION,0.49743,0.033458,0.038871,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.9693,0.033408,0.010582,0,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.4451,0.033387,0.032214,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.20554,0.033376,0.046227,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.31021,0.03335,0.052795,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.81896,0.033343,0.053794,0,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.21437,0.033297,0.059563,0,0
4,GO RETINA LAYER FORMATION,0.2458,0.03324,0.11577,0,0
4,GO POLYAMINE METABOLIC PROCESS,0.76899,0.033221,0.024283,0,0
4,GO RESPONSE TO ESTROGEN,0.92416,0.033143,0.001115,0,0
4,GO SEROTONIN TRANSPORT,0.6515,0.033015,0.059136,0,0
4,GO SYNAPSE ORGANIZATION,0.92416,0.032918,0.0033285,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.39606,0.032769,0.04708,0,0
4,GO METENCEPHALON DEVELOPMENT,0.43789,0.032746,0.047767,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.35674,0.032714,0.054217,0,0
4,GO RESPONSE TO HYPEROXIA,0.99515,0.032686,-0.0021069,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.28033,0.032675,0.059826,0,0
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.74435,0.032594,0.037451,0,0
4,GO DEVELOPMENTAL GROWTH,0.77209,0.032577,0.019201,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.5665,0.032539,0.013508,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.31604,0.032499,0.050433,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.71996,0.032372,0.027425,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.29315,0.03236,0.050389,0,0
4,GO DETOXIFICATION,0.23605,0.032337,0.04958,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.31409,0.032312,0.060248,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.81896,0.032251,-0.027806,0,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.28033,0.031909,0.047531,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.27853,0.031843,0.091108,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.51819,0.031841,0.038611,0,0
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.071756,0.03184,0.058087,0,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.88565,0.031809,0.0041527,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.5394,0.031795,0.037816,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.6691,0.031698,0.04116,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.73212,0.031679,-0.0072842,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.35463,0.031676,0.036655,0,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.26095,0.031506,0.080862,0,0
4,GO RESPONSE TO ANTIBIOTIC,0.40286,0.031376,0.03713,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.86649,0.031334,-0.0037675,0,0
4,GO AXIS SPECIFICATION,0.33194,0.031321,0.049311,0,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.20265,0.031312,0.0529,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.69885,0.031281,0.031092,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.44028,0.031269,0.035359,0,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.26964,0.031211,0.060503,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.62545,0.03115,0.029612,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.6312,0.031055,0.026268,0,0
4,GO RESPONSE TO INTERLEUKIN 4,0.24089,0.031028,0.051615,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.19417,0.030918,0.046401,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.74128,0.030801,-0.020941,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.68392,0.03078,0.028758,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.74435,0.030692,0.020316,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.53672,0.030657,0.030012,0,0
4,GO AORTA MORPHOGENESIS,0.33194,0.030648,0.060319,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.47211,0.030616,0.042884,0,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.68689,0.03046,0.012771,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.23927,0.030434,0.054032,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.52082,0.03041,0.05624,0,0
4,GO RESPONSE TO FATTY ACID,0.20554,0.030319,0.063106,0,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.1873,0.030269,0.087312,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.6691,0.030208,0.021213,0,0
4,GO GLIOGENESIS,0.24911,0.030185,0.05432,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.25753,0.030151,0.10647,0,0
4,GO ACYLGLYCEROL HOMEOSTASIS,0.57476,0.030151,0.023422,0,0
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.13979,0.030144,0.057043,0,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.27673,0.030052,0.041901,0,0
4,GO NEURON DEVELOPMENT,0.95961,0.029983,0.0095657,0,0
4,GO REGULATION OF ATP METABOLIC PROCESS,0.11647,0.029972,0.063822,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.25583,0.02985,0.029525,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.65734,0.029809,0.02555,0,0
4,GO HISTONE H3 K36 METHYLATION,0.90167,0.029729,-0.0099895,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.68988,0.029695,-0.021388,0,0
4,GO SEXUAL REPRODUCTION,0.1387,0.029567,0.042131,0,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.22348,0.029473,0.038118,0,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.19278,0.029454,0.090337,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.46962,0.029403,0.047284,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.53672,0.029296,0.025713,0,0
4,GO HISTONE MONOUBIQUITINATION,0.43075,0.029247,0.032858,0,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.39606,0.029241,0.033997,0,0
4,GO VASCULATURE DEVELOPMENT,0.44752,0.029132,0.038593,0,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.18461,0.029052,0.063442,0,0
4,GO RESPONSE TO MISFOLDED PROTEIN,0.17283,0.029039,0.075199,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.80953,0.02896,-0.0067683,0,0
4,GO GASTRIC ACID SECRETION,0.34627,0.02893,0.047759,0,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.81267,0.028873,-0.018666,0,0
4,GO AEROBIC RESPIRATION,0.19979,0.02885,0.041232,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.74128,0.028835,0.02003,0,0
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.44994,0.02876,0.032616,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.19979,0.028719,0.10522,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.60834,0.028698,0.027719,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.28033,0.028674,0.051364,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.17029,0.028611,0.081007,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.64276,0.028606,0.026885,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.19557,0.028588,0.06397,0,0
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.14308,0.028478,0.057797,0,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.64567,0.028474,0.040456,0,0
4,GO CELLULAR EXTRAVASATION,0.37827,0.028456,0.048868,0,0
4,GO REGULATION OF METAL ION TRANSPORT,0.18327,0.028373,0.048129,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.35674,0.028364,0.040452,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.72299,0.028332,0.023982,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.36098,0.028261,0.046047,0,0
4,GO EYE MORPHOGENESIS,0.797,0.028239,0.019345,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.20409,0.028195,0.049178,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.59424,0.028125,0.031772,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.75664,0.02812,-0.05835,0,0
4,GO MIDBRAIN DEVELOPMENT,0.51819,0.027988,0.030054,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.97253,0.02798,0.0094303,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.96607,0.027972,-0.00039187,0,0
4,GO HEART DEVELOPMENT,0.76899,0.027964,0.019741,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.68094,0.027914,0.021486,0,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.10299,0.027791,0.08283,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.23128,0.027718,0.053215,0,0
4,GO RIG I SIGNALING PATHWAY,0.51296,0.027656,0.02726,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.85694,0.027602,0.015721,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.57752,0.027569,0.024606,0,0
4,GO CELL PROJECTION ORGANIZATION,0.81581,0.027486,0.015752,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.42367,0.027402,0.045928,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.20992,0.027397,0.057358,0,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.41434,0.027332,0.045175,0,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.11553,0.027294,0.041073,0,0
4,GO MACROPHAGE CHEMOTAXIS,0.19003,0.027276,0.049035,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.47211,0.027255,0.040402,0,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.6312,0.02724,0.020648,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.97899,0.02718,-0.011145,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.57752,0.02698,0.023794,0,0
4,GO ERK1 AND ERK2 CASCADE,0.75664,0.026947,0.0257,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.98869,0.026914,0.01307,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.98546,0.026831,0.009709,0,0
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.077018,0.026796,0.061377,0,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.33194,0.026782,0.033541,0,0
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.28395,0.026708,0.05806,0,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.26267,0.026591,0.071755,0,0
4,GO TRANSLESION SYNTHESIS,0.21587,0.02648,0.047499,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.36311,0.026452,0.016552,0,0
4,GO CYTOSKELETON ORGANIZATION,0.67206,0.026413,0.025372,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.5314,0.026411,0.029689,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.40286,0.026354,0.02919,0,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.75664,0.0262,0.002014,0,0
4,GO GENITALIA DEVELOPMENT,0.17411,0.026169,0.061749,0,0
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.44994,0.026139,0.037678,0,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.19697,0.026076,0.04952,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.70185,0.026029,0.0261,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.69286,0.025984,0.020049,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.41434,0.025927,0.045729,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.14308,0.025911,0.037379,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.9306,0.025809,0.0037435,0,0
4,GO PROTEIN POLYMERIZATION,0.3739,0.025764,0.038618,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.84424,0.025742,0.021491,0,0
4,GO INTRACELLULAR TRANSPORT,0.13338,0.025727,0.039417,0,0
4,GO FATTY ACID BETA OXIDATION,0.29877,0.025675,0.038581,0,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.1914,0.025487,0.039837,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23927,0.025403,0.0926,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.12029,0.025397,0.099631,0,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.99515,0.025315,-0.0034127,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.36526,0.025245,0.036109,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.40058,0.025235,0.0378,0,0
4,GO PROTEIN NITROSYLATION,0.6312,0.025156,-0.0028777,0,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.41434,0.025141,0.029592,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.28033,0.025134,0.04063,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.25924,0.024933,0.069723,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.90809,0.024907,0.0088092,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.80326,0.024834,0.018167,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.88245,0.024819,0.020068,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.89846,0.024805,-0.039232,0,0
4,GO PROTEIN TRIMERIZATION,0.69885,0.024736,0.027828,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.98222,0.024698,0.012008,0,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.23445,0.024666,0.047653,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.22814,0.024633,0.050056,0,0
4,GO MUSCLE FILAMENT SLIDING,0.84107,0.024624,-0.014493,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.49487,0.024516,0.028884,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.96607,0.024432,0.012006,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.3739,0.024423,0.039684,0,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.50258,0.024416,0.021853,0,0
4,GO NEUROGENESIS,0.94026,0.024415,0.010627,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.40514,0.024234,0.038319,0,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.75048,0.024228,0.028111,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.74435,0.024202,-0.023926,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.67206,0.024197,0.026743,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.31409,0.02409,0.04086,0,0
4,GO NEURON DEATH,0.21437,0.023979,0.047781,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.70486,0.023922,0.02937,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.37827,0.023885,0.043191,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.2458,0.023879,0.050261,0,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.73517,0.023838,0.013258,0,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.41434,0.023786,0.025749,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.87287,0.023721,0.023968,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.79075,0.02359,0.012614,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.49743,0.023524,0.063281,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.58029,0.023451,-0.03053,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.9113,0.023405,-0.0017015,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.25753,0.023344,0.060014,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.42602,0.023322,0.063926,0,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.92738,0.023307,-0.001433,0,0
4,GO ESTROGEN METABOLIC PROCESS,0.47461,0.023277,0.029218,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.44994,0.023185,0.025996,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.86012,0.023171,0.0153,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.69286,0.023158,-0.025458,0,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.86331,0.023071,0.0032414,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.93382,0.022927,-0.0032863,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.26964,0.022809,0.062398,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.31409,0.022781,0.072136,0,0
4,GO MUSCLE CELL PROLIFERATION,0.44269,0.022732,0.038769,0,0
4,GO HISTONE H3 DEACETYLATION,0.72603,0.02273,0.022457,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.70185,0.022692,-0.0046766,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.74128,0.022633,0.025705,0,0
4,GO RETINA HOMEOSTASIS,0.43789,0.022607,0.018063,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.96607,0.022603,0.015886,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.20845,0.022521,0.058123,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.65734,0.022443,0.026387,0,0
4,GO NEPHRON MORPHOGENESIS,0.52874,0.022441,0.027689,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.1754,0.022406,0.075779,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.67206,0.02238,-0.023945,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.6312,0.022319,0.031979,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.73822,0.022289,0.021648,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.21288,0.022188,0.083222,0,0
4,GO REGULATION OF PINOCYTOSIS,0.99192,0.022183,-0.0073742,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.71391,0.022121,0.03111,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.3739,0.022085,0.044469,0,0
4,GO NADH METABOLIC PROCESS,0.43075,0.02208,0.056174,0,0
4,GO SOMATIC STEM CELL DIVISION,0.62832,0.022063,-0.032874,0,0
4,GO THIOESTER METABOLIC PROCESS,0.25583,0.022037,0.050046,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.5314,0.021855,0.051437,0,0
4,GO INTERFERON GAMMA PRODUCTION,0.14308,0.021676,0.069565,0,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.27673,0.021676,0.040196,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.84107,0.021673,0.008874,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.94993,0.021626,-0.020078,0,0
4,GO DNA CATABOLIC PROCESS,0.084034,0.021597,0.066533,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.58307,0.021555,0.044081,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.39606,0.021449,0.055659,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.72907,0.021312,0.02572,0,0
4,GO RENAL SODIUM EXCRETION,0.44028,0.021197,0.039973,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.84741,0.021184,0.010025,0,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.70185,0.02115,0.02558,0,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.99515,0.02108,-0.0023604,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.48976,0.021004,0.066513,0,0
4,GO MITOCHONDRION ORGANIZATION,0.20699,0.020993,0.035767,0,0
4,GO SEX DIFFERENTIATION,0.27673,0.020908,0.046612,0,0
4,GO T CELL CHEMOTAXIS,0.48468,0.020865,0.030402,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.36956,0.020784,0.039907,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.67206,0.020755,0.083365,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.94026,0.020663,0.027424,0,0
4,GO RESPONSE TO LIGHT STIMULUS,0.99515,0.02066,0.0053221,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.22042,0.020625,0.065574,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.42133,0.020597,0.034227,0,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.11183,0.020569,0.090533,0,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.21738,0.020562,0.036121,0,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.22971,0.02056,0.031588,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.83474,0.02053,0.017137,0,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.9306,0.020519,0.0088034,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.92416,0.020391,0.011809,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.41203,0.020383,0.022988,0,0
4,GO ODONTOGENESIS,0.3871,0.020319,-0.040397,0,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.40743,0.020319,0.054118,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.53672,0.020282,0.029427,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.73822,0.020261,0.020506,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.37173,0.020186,0.04088,0,0
4,GO REGULATION OF CELL DEVELOPMENT,0.96284,0.020145,0.013285,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.86649,0.020138,0.0085321,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.34835,0.020119,0.043834,0,0
4,GO OVULATION,0.91772,0.01997,-0.010542,0,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.47963,0.019912,0.040678,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.90809,0.019905,0.0068643,0,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.46962,0.019878,0.025722,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.55016,0.019816,0.050763,0,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.90809,0.019708,0.003778,0,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.59144,0.019482,0.040398,0,0
4,GO REGULATION OF CYTOKINESIS,0.67501,0.019455,0.0010863,0,0
4,GO RESPONSE TO RADIATION,0.86331,0.019436,0.011204,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.34627,0.019424,0.064149,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.797,0.019399,-0.0027539,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.68689,0.019302,0.021122,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.47461,0.019145,-0.018282,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.83474,0.019138,0.025906,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.59424,0.019134,0.025922,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.57752,0.019039,0.028134,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.53672,0.018835,0.028652,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.46466,0.01878,-0.0030062,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.86331,0.018523,0.019395,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.62545,0.018439,0.035471,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.34008,0.018399,0.074024,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.54746,0.018385,0.031749,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.84424,0.018344,-0.019082,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.45238,0.01826,0.045452,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.9306,0.018174,0.0027824,0,0
4,GO HEPATOCYTE DIFFERENTIATION,0.31997,0.018157,0.052009,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.97253,0.018148,0.0053483,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.86968,0.018051,-0.0080998,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.76899,0.018048,0.031756,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.66321,0.01793,0.022977,0,0
4,GO MALE GAMETE GENERATION,0.32592,0.017882,0.030909,0,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.99192,0.017882,0.0014402,0,0
4,GO CELL MORPHOGENESIS,0.96284,0.017772,0.012242,0,0
4,GO AMP METABOLIC PROCESS,0.65442,0.017754,-0.050421,0,0
4,GO PROSTATIC BUD FORMATION,0.69286,0.017668,-0.078889,0,0
4,GO ASTROCYTE DEVELOPMENT,0.9306,0.01762,0.016889,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.94993,0.017615,0.011546,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.41434,0.01757,0.059523,0,0
4,GO OVULATION CYCLE,0.80326,0.01753,-0.0013941,0,0
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.62545,0.0175,0.025439,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.63986,0.0175,0.01805,0,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.13444,0.017306,0.086378,0,0
4,GO GAMETE GENERATION,0.32993,0.017255,0.030676,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.85694,0.017165,0.011476,0,0
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.36741,0.017117,0.03956,0,0
4,GO DEMETHYLATION,0.42838,0.016985,0.036057,0,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.93382,0.016855,0.0048275,0,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.86649,0.016756,0.005506,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.69286,0.016695,0.01769,0,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.69586,0.01669,0.022957,0,0
4,GO THYROID GLAND DEVELOPMENT,0.87287,0.016661,0.0039903,0,0
4,GO MITOCHONDRIAL FUSION,0.61117,0.016645,-0.0082924,0,0
4,GO MESENCHYME DEVELOPMENT,0.93704,0.016637,-0.0054134,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.47712,0.016454,0.04535,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.99515,0.016443,0.010269,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.47461,0.016323,0.04354,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.62545,0.016295,-0.0022462,0,0
4,GO MACROMOLECULE DEACYLATION,0.75664,0.016242,0.022891,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.64858,0.016186,0.038037,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.32393,0.016067,0.045986,0,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.16904,0.015995,0.044193,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.61687,0.015954,0.020872,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.50258,0.015749,0.051808,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.40973,0.015741,0.047902,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.53406,0.015737,0.043993,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.81896,0.015642,0.023255,0,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.70486,0.015515,0.03842,0,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.95316,0.015492,0.016455,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.32993,0.015424,0.048587,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.56103,0.015419,0.034754,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.20699,0.015402,0.06779,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.56103,0.015377,0.029185,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.89846,0.015249,0.010626,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.44269,0.015234,0.045491,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.88885,0.015202,0.034961,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.98546,0.015166,0.0065691,0,0
4,GO LUNG MORPHOGENESIS,0.72299,0.015052,0.016349,0,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.9693,0.015002,0.0086108,0,0
4,GO PEPTIDYL ARGININE METHYLATION,0.5394,0.014973,0.030446,0,0
4,GO NOREPINEPHRINE TRANSPORT,0.68094,0.014924,0.039484,0,0
4,GO CILIUM MOVEMENT,0.49487,0.014824,0.022446,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.75048,0.014822,-0.031226,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.68988,0.014762,-0.0020302,0,0
4,GO PINOCYTOSIS,0.69885,0.014753,0.011281,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.61687,0.014715,0.022935,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.55287,0.014621,0.05353,0,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.23605,0.014613,0.053272,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.86012,0.014594,0.0034521,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.94026,0.014553,0.0024531,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.69286,0.014498,0.04224,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.82526,0.014488,-0.0020123,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.30637,0.014477,0.063701,0,0
4,GO NAD METABOLIC PROCESS,0.7659,0.014296,0.032569,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.30066,0.014184,0.052934,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.87926,0.014151,0.03068,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.84424,0.014076,0.012713,0,0
4,GO THYMUS DEVELOPMENT,0.66321,0.014047,0.024264,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.99515,0.01399,0.0069654,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.55287,0.013985,0.051848,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.74741,0.013796,0.017151,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.71996,0.013693,0.022287,0,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.57476,0.013423,0.023602,0,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.86968,0.013205,0.0018344,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.44994,0.013189,0.036035,0,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.93382,0.013042,0.0068562,0,0
4,GO CYTOLYSIS,0.72299,0.013041,0.0082759,0,0
4,GO CELL PART MORPHOGENESIS,0.63408,0.013032,-0.015724,0,0
4,GO NEURON APOPTOTIC PROCESS,0.65442,0.013004,0.024679,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.60268,0.012936,0.043483,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.9113,0.012741,0.012402,0,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.89846,0.012739,0.0079016,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.63408,0.012733,0.018159,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.85694,0.012724,-0.0052827,0,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.50776,0.012637,0.033641,0,0
4,GO INTERLEUKIN 17 PRODUCTION,0.11183,0.012635,0.10714,0,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.89526,0.012552,0.015276,0,0
4,GO ANION HOMEOSTASIS,0.85059,0.012511,0.02019,0,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.13763,0.012442,0.049339,0,0
4,GO OOGENESIS,0.89205,0.012346,0.0053773,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.63697,0.01233,-0.012839,0,0
4,GO HEART MORPHOGENESIS,0.82526,0.012274,-0.0069396,0,0
4,GO PROTEASOME ASSEMBLY,0.56376,0.012155,-0.030164,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.84107,0.012144,0.0053745,0,0
4,GO NEURON DIFFERENTIATION,0.92094,0.011971,0.0045481,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.75048,0.011888,-0.016769,0,0
4,GO COCHLEA DEVELOPMENT,0.85059,0.011853,-0.015998,0,0
4,GO TRNA 5 LEADER REMOVAL,0.86012,0.011805,0.00026439,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.65734,0.011708,0.00056388,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.71996,0.011556,-0.0056977,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.66028,0.011504,0.021969,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.53672,0.011414,-0.027492,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.98869,0.011405,0.010959,0,0
4,GO NEURON PROJECTION REGENERATION,1,0.011212,0.014376,0,0
4,GO HEART GROWTH,0.91451,0.01118,0.0037628,0,0
4,GO HEAD DEVELOPMENT,0.58307,0.011154,0.02868,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.89846,0.011002,0.014226,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.98869,0.010969,0.033282,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.92416,0.010939,0.013525,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.99838,0.010931,0.019028,0,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1,0.010914,0.0036638,0,0
4,GO CELL FATE COMMITMENT,0.95316,0.010723,0.01024,0,0
4,GO PROTEIN STABILIZATION,0.572,0.010678,0.027812,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.79387,0.010635,0.00971,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.97576,0.010614,-0.026771,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.62258,0.010545,-0.0098847,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.6691,0.010461,-0.018904,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.77209,0.010413,0.028049,0,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.35463,0.010395,0.083468,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.85694,0.010393,-0.0071276,0,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.85059,0.010364,0.016416,0,0
4,GO LIPID PHOSPHORYLATION,0.4451,0.01036,0.047262,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.84741,0.010323,0.015506,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.82526,0.010309,-0.025383,0,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.34213,0.010301,0.039602,0,0
4,GO AXON DEVELOPMENT,0.37827,0.010273,-0.035589,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.77209,0.010159,0.0040712,0,0
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.6691,0.010154,0.031237,0,0
4,GO URONIC ACID METABOLIC PROCESS,0.90167,0.010072,-0.0087771,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.38047,0.010008,0.044823,0,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.15802,0.010001,0.061863,0,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.94993,0.0099994,0.0045829,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.82842,0.0099778,0.026265,0,0
4,GO ORGANELLE FISSION,0.61402,0.0099512,-0.0013882,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.58585,0.0099106,0.029146,0,0
4,GO METHYLATION,0.41899,0.0098793,-0.022427,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.87287,0.0098457,-0.003162,0,0
4,GO CARTILAGE DEVELOPMENT,0.71089,0.0097527,0.024637,0,0
4,GO FIBRINOLYSIS,0.60834,0.0097181,0.013175,0,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.58307,0.0096755,-0.023195,0,0
4,GO NUCLEOSIDE SALVAGE,0.6691,0.009601,0.012356,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.97253,0.0093759,0.018254,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.90809,0.0093459,-0.0024944,0,0
4,GO AMINO ACID ACTIVATION,0.96284,0.0092536,0.0038635,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.99838,0.0092334,-0.0040459,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.98869,0.0092297,0.022764,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.3442,0.0092002,0.033492,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.84741,0.0091328,-0.0085695,0,0
4,GO COGNITION,0.89526,0.0090793,0.001093,0,0
4,GO REGULATION OF CELL SIZE,0.99515,0.0090463,0.0057721,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.52082,0.0090137,-0.023064,0,0
4,GO ATP TRANSPORT,0.42602,0.008865,0.041338,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.62832,0.008864,0.019045,0,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.87606,0.0087587,-0.0047689,0,0
4,GO PROTEIN FOLDING,0.38267,0.0086331,0.041304,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.6515,0.0086244,0.026226,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.5314,0.0085133,0.037968,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.82211,0.0084955,0.015921,0,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.88565,0.0084615,0.011776,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.72907,0.0083838,0.014833,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.66321,0.0083677,0.029912,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.34008,0.0082889,0.05287,0,0
4,GO INTERACTION WITH SYMBIONT,0.86012,0.0081789,-0.015107,0,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.27495,0.0081668,0.031129,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.74741,0.0080782,-0.00041688,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.79075,0.0080435,0.010398,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.92416,0.0080298,-0.0061395,0,0
4,GO DECIDUALIZATION,0.63986,0.0080286,-0.037744,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.89846,0.0079975,0.0063158,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.97576,0.0079328,0.011612,0,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.51296,0.0078105,0.05675,0,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.6312,0.0077635,0.020262,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.35463,0.0077514,0.040257,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.99515,0.0076602,0.0095256,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.72907,0.0076419,-0.0080859,0,0
4,GO HORMONE BIOSYNTHETIC PROCESS,0.37827,0.0076059,0.045818,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.81896,0.0075724,0.012413,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.54208,0.0075218,0.050412,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.68988,0.0075031,-0.0087832,0,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.83474,0.007475,-0.014519,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.86331,0.007359,0.01872,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.99192,0.0071261,-0.0028034,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.82842,0.0071067,0.017461,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.9306,0.0069861,0.014217,0,0
4,GO PROTEIN MONOUBIQUITINATION,0.88565,0.0069801,0.0058734,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.22195,0.0069037,0.071065,0,0
4,GO GERM CELL DEVELOPMENT,0.65734,0.0068865,0.017077,0,0
4,GO CELL FATE SPECIFICATION,0.6515,0.0068657,-0.014132,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.70185,0.0068342,-0.010116,0,0
4,GO AMINO ACID TRANSPORT,0.26614,0.0067705,0.058077,0,0
4,GO RESPONSE TO SALT,0.75664,0.0065199,0.02588,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.87606,0.0065062,-0.028417,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.94993,0.0064863,0.0016696,0,0
4,GO CGMP METABOLIC PROCESS,0.79387,0.006482,0.025338,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.73517,0.0064252,-0.036371,0,0
4,GO HISTONE H2A ACETYLATION,0.72603,0.0063953,-0.012317,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.91772,0.0062044,0.016163,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.99515,0.0061994,0.0023789,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.60268,0.0061508,0.033521,0,0
4,GO PIGMENT METABOLIC PROCESS,0.83474,0.0061493,-0.0033595,0,0
4,GO CELL AGING,0.94348,0.0060473,0.0057531,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.59705,0.0059976,0.026815,0,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.58585,0.0059881,-0.027807,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.71089,0.0059006,0.0043735,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.68094,0.0056892,-0.0029019,0,0
4,GO RESPONSE TO DOPAMINE,0.50258,0.0056643,0.043132,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.6515,0.0055921,0.040101,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.73517,0.0055761,0.022635,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.45972,0.005543,-0.0098611,0,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.99838,0.0055099,0.011683,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.75972,0.0054998,0.019063,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.59424,0.0054216,0.027037,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.79075,0.0051649,0.026094,0,0
4,GO HISTONE H4 ACETYLATION,0.89526,0.0049689,0.014916,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.68689,0.0047665,0.035761,0,0
4,GO PROTEIN TARGETING,0.75048,0.0047256,0.013475,0,0
4,GO REGULATION OF CELL CYCLE,0.89846,0.0045685,0.0058058,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.79075,0.0044823,0.0092268,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.65442,0.0044253,-0.017582,0,0
4,GO SPINAL CORD DEVELOPMENT,0.63408,0.0044232,-0.023899,0,0
4,GO SKIN MORPHOGENESIS,0.98546,0.004418,-0.022028,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.75972,0.0043997,0.021,0,0
4,GO FEMALE SEX DIFFERENTIATION,0.71996,0.0043537,0.027219,0,0
4,GO NOREPINEPHRINE SECRETION,0.67206,0.004277,-0.022531,0,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.52345,0.0042084,0.036792,0,0
4,GO TOOTH MINERALIZATION,0.87606,0.0041755,0.034409,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.97576,0.0038316,-0.019177,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.56925,0.0037831,0.0022624,0,0
4,GO RNA DESTABILIZATION,0.29689,0.0037163,-0.033246,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.40743,0.0036732,0.010489,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.74128,0.0036164,0.026569,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.42602,0.0035707,0.063576,0,0
4,GO CELL CYCLE,0.55558,0.0035314,-0.0020658,0,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.99838,0.0034966,0.013588,0,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.68392,0.0034854,0.019147,0,0
4,GO BLASTOCYST FORMATION,0.61402,0.0032779,0.028197,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.85694,0.0032557,0.01407,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.76899,0.0030969,0.003917,0,0
4,GO ETHANOL METABOLIC PROCESS,0.89205,0.0030309,-0.018196,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.81896,0.003003,0.00029257,0,0
4,GO POSTREPLICATION REPAIR,0.69885,0.0029281,0.017554,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.7659,0.0028379,0.0015583,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.94671,0.0027766,0.032121,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.46218,0.0027599,-0.056649,0,0
4,GO SPROUTING ANGIOGENESIS,0.51296,0.0027086,-0.018363,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.43789,0.0026453,-0.020422,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.36741,0.0025482,-0.027453,0,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.70486,0.0025249,0.018987,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.71391,0.00247,0.038049,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.80012,0.0024402,-0.007694,0,0
4,GO PROTEIN ACYLATION,0.78763,0.00243,-0.0005094,0,0
4,GO CELL JUNCTION MAINTENANCE,0.9306,0.0023687,0.018802,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.83158,0.0019378,0.0037756,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.77519,0.0018435,0.024389,0,0
4,GO L AMINO ACID TRANSPORT,0.87606,0.0017955,0.0045564,0,0
4,GO P38MAPK CASCADE,0.52609,0.001715,0.055535,0,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.63408,0.0016811,-0.011541,0,0
4,GO PROTEIN METHYLATION,0.88885,0.0016789,-0.00049764,0,0
4,GO MYOBLAST DIFFERENTIATION,0.71391,0.0016417,-0.016681,0,0
4,GO CELLULAR RESPONSE TO ATP,0.99515,0.0015908,0.0126,0,0
4,GO TOXIN TRANSPORT,0.9693,0.001542,0.013844,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.87926,0.001495,0.015664,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.94026,0.0013574,0.011466,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.49743,0.0012273,0.04504,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.85694,0.001217,0.022063,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.92738,0.0010799,-0.0015494,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.52082,0.0010721,-0.015817,0,0
4,GO CRISTAE FORMATION,0.97899,0.0010472,0.0014084,0,0
4,GO BIOLOGICAL PHASE,0.99838,0.00096703,-0.0068157,0,0
4,GO FEVER GENERATION,0.80953,0.00083564,0.01306,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.50258,0.00080587,0.035298,0,0
4,GO CELL PROJECTION ASSEMBLY,0.77829,0.0006977,0.017741,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.87287,0.00058112,0.0046291,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.46466,0.00054593,-0.018074,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.75972,0.00054407,-0.012995,0,0
4,GO PROTEIN TETRAMERIZATION,0.67206,0.00049395,0.0015629,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.87606,0.00047004,0.006469,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.39606,0.00037058,-0.11457,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.94671,0.0002064,0.015265,0,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.97576,0.00018771,-0.0084414,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.92416,2.3244e-05,0.0072402,0,0
4,GO FATTY ACID HOMEOSTASIS,0.96284,-3.7751e-05,-0.00025847,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.77519,-7.8571e-05,-0.0089842,0,0
4,GO CELL CYCLE ARREST,0.99838,-0.00020624,0.014232,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.77829,-0.0002448,0.035031,0,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.91772,-0.00026341,0.020003,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.99192,-0.00032436,0.0046456,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.80012,-0.00039715,-0.039265,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.94993,-0.00049132,0.014675,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.797,-0.00049592,0.01031,0,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.5665,-0.00050587,0.0481,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.73212,-0.0005194,0.016479,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.52345,-0.00063428,-0.030644,0,0
4,GO EXPLORATION BEHAVIOR,0.62258,-0.00066029,-0.05286,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.86331,-0.00075913,-0.0097424,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.63986,-0.000762,-0.038711,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.39832,-0.0010261,0.063372,0,0
4,GO HEME METABOLIC PROCESS,0.47712,-0.0011075,-0.045897,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.38488,-0.0011419,0.13283,0,0
4,GO STEM CELL PROLIFERATION,0.76899,-0.0011522,0.00054055,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.65734,-0.0011641,0.040445,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.4451,-0.0012111,0.061255,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.5394,-0.0012144,0.049856,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.42367,-0.0013855,-0.027566,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.76899,-0.0014952,0.014912,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.97253,-0.0015264,0.0025572,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.69885,-0.0015344,-0.058464,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.78451,-0.0015533,0.018281,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.3442,-0.001593,0.054117,0,0
4,GO PROTEIN IMPORT,0.43075,-0.0017259,-0.011574,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.91772,-0.0017407,0.028505,0,0
4,GO ENDODERM DEVELOPMENT,0.96284,-0.0017609,-0.0079197,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.41434,-0.0018418,-0.045791,0,0
4,GO CELL AGGREGATION,0.95961,-0.0019016,-0.008451,0,0
4,GO ALDITOL METABOLIC PROCESS,0.69286,-0.0019397,-0.021297,0,0
4,GO INTRACILIARY TRANSPORT,0.60834,-0.002018,-0.019923,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.91451,-0.0020485,0.0023635,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.60834,-0.0022083,0.049278,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.69286,-0.0022322,-0.0038874,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.68988,-0.0024021,0.029894,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.96607,-0.0025377,0.012825,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.84741,-0.0027188,-0.0078341,0,0
4,GO SPERMATID DIFFERENTIATION,0.80012,-0.0027347,0.013799,0,0
4,GO CENTROSOME SEPARATION,0.72299,-0.0027622,0.042584,0,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.67501,-0.0030241,0.02756,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.38488,-0.0030725,-0.026247,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.66028,-0.0030763,-0.0040394,0,0
4,GO RESPONSE TO FOOD,0.71089,-0.0031012,-0.016646,0,0
4,GO HISTONE H2A UBIQUITINATION,0.76899,-0.0031106,-0.0071148,0,0
4,GO ORGANELLE ASSEMBLY,0.98869,-0.0031893,0.007114,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.77209,-0.0033251,-0.011126,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.68689,-0.0033435,0.027765,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.89205,-0.0035383,0.0033315,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.73212,-0.0035739,-0.0010318,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.31021,-0.0036244,-0.062933,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.86012,-0.0036795,0.0048578,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.99192,-0.003872,0.0055109,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.73212,-0.003898,0.022736,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.66616,-0.0039657,0.024943,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.89846,-0.0040024,0.0049291,0,0
4,GO PYRUVATE METABOLIC PROCESS,0.54208,-0.0042064,0.037644,0,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.62832,-0.004228,0.044569,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.92094,-0.0042366,0.014028,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.67798,-0.0043159,0.026383,0,0
4,GO INTERLEUKIN 4 PRODUCTION,0.15098,-0.0043323,0.092151,0,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.86331,-0.004408,0.01422,0,0
4,GO HISTONE METHYLATION,0.73822,-0.0044237,-0.010108,0,0
4,GO IMPORT INTO NUCLEUS,0.3871,-0.0045718,-0.019281,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.56925,-0.0046195,-0.023507,0,0
4,GO CILIUM ORGANIZATION,0.71996,-0.0047337,-0.0063638,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.26964,-0.0047576,-0.10787,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.62258,-0.0047637,-0.011837,0,0
4,GO MESODERM DEVELOPMENT,0.81896,-0.0048582,-0.0056698,0,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.83158,-0.0048889,0.020325,0,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.94671,-0.0048938,0.01954,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.30446,-0.0049035,-0.090825,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.70486,-0.0049352,-0.016456,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.48976,-0.0049797,0.04156,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.73517,-0.0049875,-0.0024966,0,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.5665,-0.0050021,-0.018976,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.94993,-0.0051213,0.011272,0,0
4,GO NADPH REGENERATION,0.74435,-0.0051871,-0.011277,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.77829,-0.0052242,-0.0054016,0,0
4,GO REGULATION OF GLIOGENESIS,0.28395,-0.0052254,0.05679,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.46218,-0.0052792,-0.07228,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.78451,-0.0052848,0.015253,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.43789,-0.0054983,-0.010944,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.3442,-0.0055535,0.032858,0,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.86968,-0.0055618,0.023838,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.44269,-0.0056221,-0.021275,0,0
4,GO MICROTUBULE POLYMERIZATION,0.49487,-0.005699,-0.020879,0,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.61972,-0.0057528,0.0025488,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.86649,-0.0057994,0.017305,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.43075,-0.0058261,-0.011933,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.98869,-0.0058456,-0.0018597,0,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.64858,-0.0058502,-0.019967,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.75356,-0.0059148,-0.015006,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.73212,-0.0059317,0.038553,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.97576,-0.0059535,0.020473,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.6312,-0.0059928,0.061011,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.81267,-0.0060248,0.027135,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.53406,-0.0060708,0.049247,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.6055,-0.0060848,0.032378,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.99192,-0.0061306,0.0058677,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.68988,-0.0061751,-0.0037178,0,0
4,GO PEPTIDE METABOLIC PROCESS,0.48976,-0.0061778,-0.014955,0,0
4,GO ECTODERM DEVELOPMENT,0.57476,-0.0061798,0.029317,0,0
4,GO RESPONSE TO LEAD ION,0.37173,-0.0062097,-0.030801,0,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.53672,-0.0063998,-0.0056794,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.95316,-0.0065861,0.024346,0,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.56103,-0.0066569,-0.032135,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.78451,-0.0066728,0.037075,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.62258,-0.00672,-0.024443,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.84741,-0.0068085,0.0052964,0,0
4,GO RESPONSE TO ATP,0.98869,-0.006822,0.0086119,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.6515,-0.0068983,-0.030837,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.56103,-0.0071064,-0.032597,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.88245,-0.0071361,0.012769,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.33396,-0.0072479,-0.044765,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.64567,-0.0072507,0.022022,0,0
4,GO CHROMATIN ORGANIZATION,0.32993,-0.0073296,-0.018067,0,0
4,GO PEPTIDYL LYSINE METHYLATION,0.47211,-0.0073438,-0.023503,0,0
4,GO DENDRITE DEVELOPMENT,0.6691,-0.0076596,-0.0084736,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.39156,-0.007672,-0.033488,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1,-0.0076814,0.0094017,0,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.95961,-0.0076948,0.013808,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.95639,-0.0076983,0.0090189,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.97576,-0.0077255,0.016379,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.23286,-0.0077703,-0.026516,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.88565,-0.0079647,0.0044488,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.95961,-0.0080174,-0.0047918,0,0
4,GO TORC1 SIGNALING,0.82526,-0.008083,0.032574,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.47963,-0.0080951,-0.01151,0,0
4,GO TRNA 5 END PROCESSING,0.68988,-0.0081067,-0.021409,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5665,-0.0082773,0.03352,0,0
4,GO NOTOCHORD DEVELOPMENT,0.78451,-0.0082889,-0.040565,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.89205,-0.008317,-0.011327,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.84741,-0.0083863,0.019752,0,0
4,GO HISTONE DEACETYLATION,0.84107,-0.0085547,0.02087,0,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.6312,-0.0087091,-0.054334,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.26964,-0.0087391,-0.028713,0,0
4,GO CELLULAR SENESCENCE,0.76281,-0.0088603,0.00049808,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.13979,-0.0089455,-0.022355,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.33194,-0.009009,-0.039021,0,0
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.99515,-0.0090231,0.016636,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.86968,-0.009102,0.035013,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.86012,-0.0092135,-0.0056138,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.63408,-0.0092167,0.0022649,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.65442,-0.009218,0.027306,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.6515,-0.0094929,-0.00065351,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.99192,-0.0095434,0.0055399,0,0
4,GO REGULATION OF URINE VOLUME,0.56103,-0.0095536,-0.018977,0,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.38933,-0.0095796,-0.040765,0,0
4,GO HEART VALVE DEVELOPMENT,0.72603,-0.0095969,-0.017053,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.94026,-0.0096635,-0.015711,0,0
4,GO LACTATE METABOLIC PROCESS,0.89846,-0.0097226,0.015884,0,0
4,GO EXTRACELLULAR TRANSPORT,0.51035,-0.0097978,0.038041,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.51035,-0.0098278,0.029047,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.59424,-0.0098667,-0.0051359,0,0
4,GO SPERM MOTILITY,0.75972,-0.0099462,0.018834,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.75664,-0.010004,-0.0053251,0,0
4,GO NUCLEUS ORGANIZATION,0.87287,-0.010119,0.003503,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.87926,-0.010232,0.020149,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.80639,-0.010286,0.021555,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.78763,-0.010306,0.02273,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.77519,-0.010341,-0.038961,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.90809,-0.010367,-0.0049265,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.94026,-0.010417,-0.0031085,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.7814,-0.010496,0.026572,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.88245,-0.010501,0.0093031,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.36956,-0.010525,-0.057872,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.18327,-0.010569,-0.026821,0,0
4,GO VESICLE CARGO LOADING,0.68988,-0.010719,-0.012276,0,0
4,GO NEURON RECOGNITION,0.91772,-0.010727,0.013007,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.58864,-0.010751,-0.038612,0,0
4,GO CELL DIVISION,0.26964,-0.010757,-0.019016,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.49487,-0.010797,-0.025017,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.85059,-0.010821,-0.011784,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.52345,-0.010879,0.058336,0,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.89526,-0.010917,0.0020382,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.67798,-0.010943,-0.0047635,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.77519,-0.010976,0.026703,0,0
4,GO METAPHASE PLATE CONGRESSION,0.67501,-0.011003,-0.00082987,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.93382,-0.011047,-0.032557,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.55558,-0.011161,-0.018776,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.572,-0.011199,-0.02009,0,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.6312,-0.011326,0.0033111,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.78763,-0.011382,0.0014562,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.71089,-0.011587,0.0044224,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.71693,-0.011637,0.045561,0,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.84424,-0.011638,0.014669,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.5665,-0.011647,0.046641,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.94993,-0.011749,-0.0025213,0,0
4,GO GENE SILENCING,0.46713,-0.011776,-0.016364,0,0
4,GO LEARNING,0.55016,-0.011843,-0.023434,0,0
4,GO HISTONE H3 K9 METHYLATION,0.6055,-0.011845,-0.020815,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.89205,-0.011864,-0.0035362,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.84424,-0.011966,0.039077,0,0
4,GO REGULATION OF CELL AGING,0.32393,-0.012003,-0.028416,0,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.69885,-0.01203,-0.036219,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.23128,-0.012038,-0.039037,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.51819,-0.012111,-0.027267,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.94671,-0.012116,0.022401,0,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.65442,-0.012151,-0.021676,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.76281,-0.012194,-0.0059732,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.5,-0.012222,-0.0090972,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.80326,-0.012265,0.0023893,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.55287,-0.012274,-0.018962,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.75664,-0.012595,0.0044681,0,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.94026,-0.01267,0.011418,0,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.94671,-0.012675,0.0062184,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.95316,-0.012769,0.020261,0,0
4,GO NEURON MIGRATION,0.44994,-0.012823,-0.025727,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.99192,-0.013159,0.017059,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.1262,-0.013172,-0.061253,0,0
4,GO GOLGI TO VACUOLE TRANSPORT,0.83474,-0.013175,0.02191,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.56103,-0.01321,-0.026023,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.20845,-0.013286,-0.078144,0,0
4,GO ACROSOME ASSEMBLY,0.4451,-0.013328,-0.043889,0,0
4,GO PEPTIDE CATABOLIC PROCESS,0.94348,-0.013365,0.0087787,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.75356,-0.01342,0.061303,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.88565,-0.013421,0.01103,0,0
4,GO FILOPODIUM ASSEMBLY,0.62545,-0.013535,-0.0055731,0,0
4,GO REGULATION OF DNA BINDING,0.797,-0.013576,0.011177,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.36956,-0.013607,-0.039758,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.56376,-0.013629,-0.024009,0,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.91451,-0.013689,0.0223,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.68392,-0.013692,0.0045878,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.54746,-0.013822,-0.020445,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.8379,-0.014039,-0.0023597,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.88565,-0.014145,0.017486,0,0
4,GO ACTIN CROSSLINK FORMATION,0.24745,-0.014156,-0.06686,0,0
4,GO DE NOVO PROTEIN FOLDING,0.39156,-0.014213,0.041135,0,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.74741,-0.014255,0.029697,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.35674,-0.014292,-0.048982,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.80326,-0.014368,0.02906,0,0
4,GO CELL CYCLE CHECKPOINT,0.27853,-0.014486,-0.021388,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.46962,-0.014523,-0.059181,0,0
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.71391,-0.014591,-0.021522,0,0
4,GO TONGUE MORPHOGENESIS,0.47712,-0.014623,-0.068055,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.61972,-0.014755,-0.0025273,0,0
4,GO CELL CYCLE PROCESS,0.18194,-0.014773,-0.016725,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.35674,-0.014856,-0.020635,0,0
4,GO POSTSYNAPSE ORGANIZATION,0.21738,-0.014908,-0.068281,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.89846,-0.014985,-0.0046361,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.69286,-0.015263,-0.0098563,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.30255,-0.015449,-0.01347,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.65442,-0.015548,-0.050471,0,0
4,GO GLUTAMATE SECRETION,0.99515,-0.015551,0.036652,0,0
4,GO ORGAN GROWTH,0.40514,-0.015672,-0.025016,0,0
4,GO DENDRITE MORPHOGENESIS,0.2913,-0.015682,-0.045711,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.29877,-0.015776,-0.022318,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.54477,-0.015823,-0.048285,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.6312,-0.015828,-0.016666,0,0
4,GO COVALENT CHROMATIN MODIFICATION,0.30829,-0.015863,-0.016945,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.3739,-0.01596,-0.0062142,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.59705,-0.015964,-0.02462,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.67206,-0.016004,-0.028447,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.88245,-0.016065,0.024969,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.7814,-0.016146,0.007773,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.73212,-0.016194,-0.03644,0,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.40743,-0.016231,-0.04465,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.29689,-0.016269,-0.024955,0,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.33803,-0.0163,-0.044635,0,0
4,GO MITOTIC CELL CYCLE,0.26964,-0.016421,-0.014373,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.55016,-0.016488,-0.0046629,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.65734,-0.016532,0.033777,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.46713,-0.016553,-0.030652,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.087731,-0.016596,-0.085674,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.5665,-0.016624,-0.045155,0,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.1793,-0.016634,0.091078,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.7814,-0.016682,0.0028013,0,0
4,GO HYPEROSMOTIC RESPONSE,0.40514,-0.016746,-0.026989,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.74435,-0.01685,-0.026488,0,0
4,GO LACTATION,0.68689,-0.016867,0.0023747,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.90167,-0.016933,0.0052261,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.93704,-0.016951,0.0014386,0,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.39156,-0.017005,-0.011474,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.66616,-0.01704,-0.0063356,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.39832,-0.017046,-0.018787,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.53672,-0.017095,-0.02444,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.58029,-0.017098,0.0095013,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.58864,-0.017113,-0.038903,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.52874,-0.01726,-0.012357,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.797,-0.017271,-0.0011511,0,0
4,GO RECEPTOR INTERNALIZATION,0.58029,-0.017342,-0.0092951,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.44994,-0.017354,-0.043934,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.74741,-0.017415,0.021967,0,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.8379,-0.017444,0.0039657,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.84741,-0.017508,-0.00058741,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.91772,-0.017671,0.0037748,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.64276,-0.017787,-0.0086764,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.6515,-0.01779,-0.01628,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.67206,-0.017804,0.037712,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.34835,-0.017809,-0.076842,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.9113,-0.017904,0.012824,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.59144,-0.017917,-0.015911,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.89205,-0.017991,-0.0031776,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.44269,-0.018066,-0.033585,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.38933,-0.018156,-0.042464,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.88885,-0.018253,0.00068147,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.80012,-0.018316,-0.016859,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.61402,-0.018361,0.026595,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.79387,-0.018518,0.019849,0,0
4,GO NEURON FATE COMMITMENT,0.56103,-0.018581,-0.010132,0,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.29502,-0.018733,-0.015954,0,0
4,GO NEGATIVE CHEMOTAXIS,0.48976,-0.018754,-0.044377,0,0
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.61402,-0.01877,0.025984,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.68392,-0.018822,0.004773,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.33194,-0.01894,0.091917,0,0
4,GO HISTONE H4 K5 ACETYLATION,0.69885,-0.019027,0.0023695,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.44752,-0.019039,-0.010624,0,0
4,GO MITOCHONDRIAL FISSION,0.68689,-0.019276,-0.0027624,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.34835,-0.019295,-0.017667,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.60834,-0.019324,-0.029367,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.3871,-0.019691,-0.0096929,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.37827,-0.01971,-0.012391,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.75048,-0.020006,0.028629,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.36741,-0.020048,-0.019167,0,0
4,GO MRNA TRANSCRIPTION,0.5394,-0.020092,-0.011173,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.94671,-0.020202,0.01783,0,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.52082,-0.020217,-0.027259,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.42367,-0.020235,-0.0154,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.99838,-0.020337,-0.013676,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.93704,-0.020351,0.011819,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.46466,-0.020582,-0.049928,0,0
4,GO REGULATION OF AXONOGENESIS,0.54477,-0.020642,-0.030707,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.50258,-0.020705,-0.010692,0,0
4,GO PROTEIN ACETYLATION,0.21437,-0.020876,-0.017101,0,0
4,GO MISMATCH REPAIR,0.54208,-0.020947,-0.014762,0,0
4,GO FOREBRAIN DEVELOPMENT,0.77519,-0.021017,0.0045571,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.97899,-0.021132,0.017366,0,0
4,GO CELLULAR RESPONSE TO PH,0.69286,-0.021176,0.039584,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.74741,-0.021281,-0.004935,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.65442,-0.0215,0.0054472,0,0
4,GO EXIT FROM MITOSIS,0.71391,-0.021512,0.0015611,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.44028,-0.021587,-0.054939,0,0
4,GO ATP BIOSYNTHETIC PROCESS,0.32993,-0.021738,0.061504,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.85376,-0.02177,0.012021,0,0
4,GO REGULATION OF BEHAVIOR,0.96284,-0.021799,0.0023383,0,0
4,GO SECRETORY GRANULE LOCALIZATION,0.52345,-0.021804,-0.04094,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.54746,-0.021937,-0.014713,0,0
4,GO HISTONE H4 DEACETYLATION,0.36311,-0.022211,-0.053425,0,0
4,GO GENITALIA MORPHOGENESIS,0.82842,-0.022329,-0.027612,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.97253,-0.022456,0.0083273,0,0
4,GO GOLGI LOCALIZATION,0.85376,-0.022541,0.0061574,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.63986,-0.022614,-0.016525,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.61402,-0.022687,-0.031904,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.69586,-0.022702,-0.058715,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.51557,-0.022702,-0.041954,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.78451,-0.02282,0.025407,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.63697,-0.022886,0.040358,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.42602,-0.022949,-0.037799,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.93382,-0.022952,0.0054969,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.52874,-0.023146,-0.040249,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.45972,-0.023202,-0.031465,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.25583,-0.023215,-0.033116,0,0
4,GO NUCLEOSOME ASSEMBLY,0.25246,-0.023327,-0.040645,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.82211,-0.023365,-0.015912,0,0
4,GO DNA METHYLATION,0.68988,-0.023517,-0.0038377,0,0
4,GO TELENCEPHALON DEVELOPMENT,0.45482,-0.023551,-0.013748,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.47963,-0.023568,-0.025716,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.46713,-0.023568,-0.012548,0,0
4,GO MICROTUBULE BASED PROCESS,0.30066,-0.023638,-0.022081,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.62832,-0.023674,-0.026204,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.572,-0.023801,-0.037235,0,0
4,GO TRICARBOXYLIC ACID CYCLE,0.95961,-0.024123,0.023432,0,0
4,GO REGULATION OF CELL DIVISION,0.56925,-0.024352,-0.0057792,0,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.80639,-0.024419,0.0014105,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.094715,-0.024468,-0.081092,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.80326,-0.024492,0.0036194,0,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.87926,-0.024669,0.01361,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.72907,-0.024702,-0.031391,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.13027,-0.024831,-0.050194,0,0
4,GO NUCLEOTIDE PHOSPHORYLATION,0.71693,-0.02484,0.031183,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.92094,-0.02485,0.0039099,0,0
4,GO SMOOTHENED SIGNALING PATHWAY,0.25078,-0.024894,-0.033038,0,0
4,GO OVULATION CYCLE PROCESS,0.65442,-0.024911,-0.009198,0,0
4,GO FEMALE GAMETE GENERATION,0.48722,-0.024919,-0.011359,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.89846,-0.025002,0.0092249,0,0
4,GO PROTEIN KINASE A SIGNALING,0.75048,-0.025136,-0.0066262,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.62258,-0.025152,-0.012752,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.98222,-0.025164,0.012647,0,0
4,GO RESPONSE TO GLUCAGON,0.75664,-0.025189,-0.0075438,0,0
4,GO BONE DEVELOPMENT,0.27495,-0.025205,-0.033405,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.70486,-0.025208,-0.042595,0,0
4,GO DOSAGE COMPENSATION,0.59144,-0.025546,-0.015916,0,0
4,GO REGULATION OF DNA METHYLATION,0.64858,-0.025797,-0.0039609,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.797,-0.025885,0.037157,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.21889,-0.025902,-0.025093,0,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.178,-0.026094,-0.07002,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.37608,-0.026106,-0.031779,0,0
4,GO NCRNA CATABOLIC PROCESS,0.68988,-0.026183,0.029758,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.80639,-0.026191,0.0029108,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.73212,-0.02629,-0.010273,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.46713,-0.026406,-0.012949,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.38267,-0.026566,-0.036902,0,0
4,GO REGULATION OF RESPONSE TO FOOD,0.59424,-0.026881,0.020813,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.15447,-0.027088,-0.035488,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.37827,-0.027207,-0.036924,0,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.18327,-0.027239,-0.047382,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.22348,-0.027428,-0.026214,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.85694,-0.027429,-0.0032449,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.47211,-0.027483,-0.010734,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.34213,-0.027494,-0.022342,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.9306,-0.027555,0.0099035,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.3442,-0.02763,-0.051505,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.67798,-0.027784,-0.0061616,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.84424,-0.027792,-0.01662,0,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.12421,-0.027967,-0.022281,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.38047,-0.028029,-0.017707,0,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.797,-0.028062,0.040843,0,0
4,GO BRONCHUS DEVELOPMENT,0.40286,-0.028098,-0.042174,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.27853,-0.028207,-0.016384,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.40286,-0.028443,-0.02367,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.43075,-0.028479,-0.051439,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.71089,-0.028618,-0.053626,0,0
4,GO AXON EXTENSION,0.21587,-0.028622,-0.051641,0,0
4,GO APPENDAGE DEVELOPMENT,0.73517,-0.028682,-0.0037649,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.35463,-0.028717,-0.034611,0,0
4,GO ACETYL COA METABOLIC PROCESS,0.96607,-0.028836,0.0064025,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.70185,-0.028849,0.0019212,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.82211,-0.029003,-0.011983,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.24745,-0.029003,-0.056954,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.45238,-0.029034,-0.0077002,0,0
4,GO SPECIFICATION OF SYMMETRY,0.19417,-0.02904,-0.035928,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.54477,-0.029113,-0.077738,0,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.34835,-0.029308,-0.025333,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.84107,-0.02935,0.00030655,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.10129,-0.029366,-0.048046,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.66616,-0.029371,-0.0097537,0,0
4,GO PALLIUM DEVELOPMENT,0.47211,-0.029441,-0.012726,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.60834,-0.029471,-0.02154,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.5665,-0.029514,-0.046337,0,0
4,GO VIRAL LATENCY,0.081168,-0.029572,-0.082402,0,0
4,GO ANIMAL ORGAN FORMATION,0.55558,-0.029599,-0.024888,0,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.23766,-0.029766,-0.033634,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.56376,-0.029833,0.00085144,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.89205,-0.030046,0.0027247,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.40973,-0.030334,-0.0089789,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.20992,-0.030363,-0.026143,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.86649,-0.030422,0.0094588,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.36098,-0.030544,-0.032917,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.4355,-0.030623,-0.0082648,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.31215,-0.03078,-0.019878,0,0
4,GO REGULATION OF ORGAN GROWTH,0.21437,-0.030792,-0.038706,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.14419,-0.030949,-0.076153,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.16163,-0.030965,-0.019546,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.13234,-0.031032,-0.13412,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.64567,-0.031079,-0.007828,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.58029,-0.031114,-0.021676,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.5,-0.031248,-0.026318,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.08331,-0.031289,-0.072561,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.46218,-0.031364,-0.030622,0,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.30066,-0.031391,-0.035135,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.51035,-0.031466,-0.024859,0,0
4,GO STEM CELL DIFFERENTIATION,0.29502,-0.031469,-0.020977,0,0
4,GO RESPONSE TO MANGANESE ION,0.60268,-0.031615,-0.01326,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.79075,-0.031821,0.032745,0,0
4,GO PROTEIN DENEDDYLATION,0.40514,-0.032202,-0.03718,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.41203,-0.032282,-0.0092682,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.68094,-0.032399,-0.019348,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.88245,-0.032469,0.0077278,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.082591,-0.032716,-0.049748,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.87926,-0.032728,0.032227,0,0
4,GO NCRNA 3 END PROCESSING,0.18194,-0.032829,-0.055822,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.56925,-0.032836,-0.016959,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.39606,-0.032838,-0.037257,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.7814,-0.032856,0.0088165,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.93704,-0.032882,0.0032629,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61972,-0.032897,0.069897,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.094715,-0.032962,-0.034582,0,0
4,GO APPENDAGE MORPHOGENESIS,0.5,-0.033097,-0.022161,0,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.5665,-0.033122,-0.015734,0,0
4,GO COENZYME A METABOLIC PROCESS,0.99192,-0.033151,0.018053,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.54208,-0.033294,-0.021234,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.62832,-0.03332,-0.0023787,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.60834,-0.033362,-0.017333,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.87926,-0.033425,0.0158,0,0
4,GO P BODY ASSEMBLY,0.17156,-0.033454,-0.037034,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.30446,-0.033481,-0.01522,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.48976,-0.033578,-0.014165,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.54208,-0.033743,-0.016056,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.32393,-0.033755,-0.019521,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.28945,-0.03376,-0.06181,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.39381,-0.033878,-0.035513,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.76281,-0.034011,-0.018173,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.66028,-0.034058,-0.0036414,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.82211,-0.03411,-0.00061385,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.25414,-0.034207,-0.037406,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.33194,-0.034219,0.048934,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.99838,-0.034221,0.010446,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.18194,-0.034245,-0.085383,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.90809,-0.034319,0.00080404,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.66028,-0.034392,-0.0051994,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.3871,-0.034465,-0.032199,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.94671,-0.034548,0.032125,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.81896,-0.034573,-0.0085202,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.19838,-0.034597,-0.076228,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.72299,-0.034624,0.023725,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.20845,-0.034811,-0.043257,0,0
4,GO RECEPTOR CLUSTERING,0.21738,-0.034877,-0.068411,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.57752,-0.035018,-0.016589,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.23128,-0.035038,-0.065249,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.59424,-0.035191,-0.017384,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.6515,-0.03528,-0.013513,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.68392,-0.035322,-0.020281,0,0
4,GO AXONAL FASCICULATION,0.89526,-0.035395,0.016643,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.87926,-0.035415,-0.034757,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.12721,-0.035499,-0.03855,0,0
4,GO HISTONE H3 K4 METHYLATION,0.35674,-0.035543,-0.028638,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.32195,-0.035575,-0.031691,0,0
4,GO CHROMOSOME ORGANIZATION,0.10734,-0.035651,-0.027994,0,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.14197,-0.035678,-0.0658,0,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.36956,-0.035728,-0.028069,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.38933,-0.035838,-0.024713,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.67501,-0.035932,-0.011198,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.39832,-0.035942,-0.03106,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.5314,-0.035999,-0.01305,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.61117,-0.036105,-0.07019,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.1754,-0.036119,-0.040866,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.11742,-0.036157,-0.034478,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.36311,-0.036206,-0.015088,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.092339,-0.036234,-0.036382,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.25583,-0.036248,-0.038069,0,0
4,GO OOCYTE MATURATION,0.65734,-0.036477,-0.015584,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.96607,-0.036525,-0.00078885,0,0
4,GO HISTONE UBIQUITINATION,0.37827,-0.036673,-0.016045,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.18062,-0.036889,-0.027451,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.28945,-0.036925,-0.048544,0,0
4,GO NUCLEOSOME ORGANIZATION,0.079765,-0.036934,-0.052105,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.34835,-0.036966,-0.025985,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.98869,-0.036978,0.014775,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.24745,-0.037027,-0.056769,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.51296,-0.037052,-0.038537,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.52345,-0.037126,-0.034195,0,0
4,GO NEURON PROJECTION GUIDANCE,0.18461,-0.037156,-0.057178,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.37173,-0.037181,-0.031994,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.69885,-0.03722,-0.018119,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.3739,-0.037231,-0.05148,0,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.27495,-0.037272,-0.041697,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.40514,-0.03733,-0.038187,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.34835,-0.037455,-0.08056,0,0
4,GO RNA CATABOLIC PROCESS,0.11367,-0.037489,-0.041565,0,0
4,GO MIRNA METABOLIC PROCESS,0.11742,-0.037579,-0.049892,0,0
4,GO REGULATION OF ERAD PATHWAY,0.96284,-0.037756,0.019134,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.78451,-0.037894,0.017807,0,0
4,GO HISTONE EXCHANGE,0.16042,-0.037904,-0.056807,0,0
4,GO SPINDLE LOCALIZATION,0.22658,-0.037918,-0.027039,0,0
4,GO DNA PACKAGING,0.085497,-0.037967,-0.043409,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.2114,-0.038077,-0.041441,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35253,-0.038271,-0.07109,0,0
4,GO HISTONE PHOSPHORYLATION,0.20265,-0.038383,-0.041087,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.76899,-0.038424,-0.016928,0,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.42133,-0.038454,-0.026136,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.086237,-0.038473,-0.025068,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.33194,-0.038488,-0.029797,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.37608,-0.038516,-0.023959,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.18194,-0.03878,-0.017632,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.078382,-0.038836,-0.070564,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.95316,-0.038932,0.0075059,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.12421,-0.039039,-0.053631,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.2714,-0.039346,-0.043331,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.36956,-0.039531,-0.031171,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.1873,-0.039538,-0.039121,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.51296,-0.039727,-0.01346,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.87926,-0.039835,-0.00076637,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.36956,-0.040307,-0.026036,0,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.14419,-0.040352,-0.02827,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.318,-0.040485,-0.037793,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.44269,-0.040772,-0.0084725,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.58307,-0.041024,-0.023583,0,0
4,GO CHROMOSOME LOCALIZATION,0.53672,-0.041102,-0.0013862,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.45238,-0.041167,-0.028116,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.2458,-0.041218,-0.053756,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.16904,-0.041506,-0.020566,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.064418,-0.041645,-0.026943,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.85059,-0.041676,0.014065,0,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.797,-0.041724,-0.0049693,0,0
4,GO MITOCHONDRIAL TRANSLATION,0.14869,-0.041727,-0.053325,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.22348,-0.041894,-0.096313,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.82211,-0.042459,0.0039134,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.85376,-0.042788,0.016754,0,0
4,GO VOCALIZATION BEHAVIOR,0.63986,-0.042822,-0.06257,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.063258,-0.042886,-0.034744,0,0
4,GO SPINDLE ORGANIZATION,0.094715,-0.042914,-0.035568,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.42838,-0.042925,-0.031041,0,0
4,GO MICROTUBULE ANCHORING,0.32592,-0.042984,-0.037203,0,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.20409,-0.043202,-0.045555,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.29315,-0.043287,-0.041341,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.58585,-0.043586,-0.0086891,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.64858,-0.043749,-0.035539,0,0
4,GO PENILE ERECTION,0.36098,-0.043826,-0.062527,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.35463,-0.043862,-0.078105,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.84741,-0.043893,0.020905,0,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.10129,-0.043907,-0.07445,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.13656,-0.043955,-0.053973,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.22658,-0.044014,-0.047628,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.52609,-0.044045,-0.024795,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.38933,-0.044107,-0.036674,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.23445,-0.044109,-0.036528,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.25924,-0.044123,-0.049774,0,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.24911,-0.044131,-0.048529,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.43075,-0.044136,-0.021088,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.37827,-0.04434,-0.030005,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.26267,-0.044373,-0.075925,0,0
4,GO PRIMARY MIRNA PROCESSING,0.52082,-0.044393,-0.029408,0,0
4,GO FOREGUT MORPHOGENESIS,0.52082,-0.044394,-0.032261,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.29877,-0.044396,-0.064868,0,0
4,GO SISTER CHROMATID SEGREGATION,0.063836,-0.044416,-0.043719,0,0
4,GO TELOMERE CAPPING,0.31997,-0.044644,-0.014216,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.77829,-0.044766,0.013465,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.26095,-0.044814,-0.050084,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.20554,-0.044874,-0.069751,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.1262,-0.044906,-0.047658,0,0
4,GO URETER DEVELOPMENT,0.26095,-0.045147,-0.084831,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.39606,-0.045311,-0.039872,0,0
4,GO REGULATION OF MRNA BINDING,0.18194,-0.045316,-0.076881,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.088486,-0.045379,-0.045079,0,0
4,GO RNA CAPPING,0.16285,-0.045434,-0.035549,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.41434,-0.045457,-0.011108,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,1,-0.045611,0.015113,0,0
4,GO HEPARIN METABOLIC PROCESS,0.9693,-0.046031,1.7874e-07,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.28578,-0.046098,-0.050673,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.85376,-0.046169,-0.0055684,0,0
4,GO ENDODERM FORMATION,0.67798,-0.04619,-0.038299,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.20992,-0.046342,-0.02901,0,0
4,GO FOREBRAIN CELL MIGRATION,0.41203,-0.046363,-0.029543,0,0
4,GO TRANSLATIONAL ELONGATION,0.073694,-0.046395,-0.057263,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.57476,-0.046528,-0.01864,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.52082,-0.046812,-0.036302,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.85694,-0.046872,8.7745e-05,0,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.28761,-0.04698,-0.045185,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.35674,-0.047008,-0.037983,0,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.66321,-0.047054,-0.0036898,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.23128,-0.047228,-0.10119,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.80326,-0.047337,0.026209,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.23128,-0.047488,-0.065228,0,0
4,GO CHROMATIN SILENCING,0.12322,-0.047496,-0.046229,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.10471,-0.047773,-0.024329,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.62545,-0.047826,-0.013927,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.29689,-0.047851,-0.027729,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.067397,-0.047918,-0.052177,0,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.13027,-0.047954,-0.064438,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.31997,-0.047977,-0.029009,0,0
4,GO RESPONSE TO ACETYLCHOLINE,0.44269,-0.048016,-0.049004,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.13549,-0.048097,-0.061022,0,0
4,GO CENTROSOME DUPLICATION,0.44028,-0.048605,-0.016328,0,0
4,GO RESPONSE TO HEAT,0.22971,-0.048739,-0.016939,0,0
4,GO RESPONSE TO VITAMIN D,0.34213,-0.048927,-0.067927,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.74128,-0.049005,-0.021797,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.46466,-0.049026,-0.043872,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.94993,-0.049048,0.0086707,0,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.39381,-0.049111,-0.032208,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.12721,-0.04915,-0.090966,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.36956,-0.049459,-0.089798,0,0
4,GO FIBROBLAST ACTIVATION,0.75356,-0.049597,-0.0054528,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.50258,-0.049625,-0.037205,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.61687,-0.049656,-0.021181,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.1754,-0.049984,-0.053067,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.2114,-0.050019,-0.050019,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.82526,-0.050074,-0.026801,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.19003,-0.050191,-0.024677,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.28578,-0.050509,-0.033951,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.17029,-0.050519,-0.025406,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.069238,-0.050648,-0.064149,0,0
4,GO OXYGEN TRANSPORT,0.57752,-0.050712,-0.068319,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.60834,-0.050887,-0.010577,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.74435,-0.050902,-0.024802,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.84107,-0.050921,-0.0019512,0,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.31409,-0.050995,-0.050162,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.089246,-0.051047,-0.066151,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.17669,-0.05111,-0.067298,0,0
4,GO NUCLEAR MIGRATION,0.178,-0.051275,-0.06494,0,0
4,GO REGULATION OF GASTRULATION,0.61687,-0.051349,-0.010631,0,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.063836,-0.051467,-0.07222,0,0
4,GO REPLACEMENT OSSIFICATION,0.46466,-0.051481,-0.026996,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.52345,-0.051534,-0.041493,0,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.51035,-0.051693,-0.014518,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.43075,-0.051731,-0.034266,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.69286,-0.051755,0.0039329,0,0
4,GO REGULATION OF OOGENESIS,0.41666,-0.052039,-0.019003,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.27495,-0.052225,-0.036132,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.13027,-0.052357,-0.041068,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.797,-0.052427,-0.0063333,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.50258,-0.052429,-0.027839,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.92738,-0.052526,0.0064244,0,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.1793,-0.052526,-0.061972,0,0
4,GO STORE OPERATED CALCIUM ENTRY,0.24252,-0.052541,-0.059063,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.79075,-0.052822,-0.0082804,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.17156,-0.0529,-0.097956,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.80326,-0.052935,0.033663,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.50258,-0.052941,-0.056933,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.21587,-0.053138,-0.083102,0,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.3871,-0.053316,-0.026194,0,0
4,GO REGULATION OF RNA BINDING,0.099614,-0.053319,-0.071558,0,0
4,GO AXO DENDRITIC TRANSPORT,0.18461,-0.053491,-0.037692,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.25924,-0.053499,-0.031074,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.79387,-0.053559,-0.032486,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.13027,-0.053852,-0.043925,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.43075,-0.053913,-0.016995,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.23445,-0.05395,-0.085902,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.23445,-0.054214,-0.038884,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.94026,-0.054269,0.020855,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.39832,-0.054424,-0.02971,0,0
4,GO REGULATION OF MYELINATION,0.11933,-0.054616,-0.046184,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.98869,-0.054628,-0.0025914,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.29502,-0.054988,-0.11988,0,0
4,GO NODAL SIGNALING PATHWAY,0.98222,-0.054993,0.028836,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.1313,-0.055046,-0.058582,0,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.081877,-0.05511,-0.042947,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.29689,-0.055258,-0.030901,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.68392,-0.055375,-0.0096666,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.18866,-0.055571,-0.066924,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.067397,-0.055658,-0.046248,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.21738,-0.055766,-0.067851,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.15683,-0.056043,-0.0582,0,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.068006,-0.056282,-0.045862,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.70486,-0.056622,-0.022046,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.90488,-0.057106,0.072069,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.53406,-0.05714,-0.011967,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.52345,-0.057181,-0.087236,0,0
4,GO TRANSLATIONAL TERMINATION,0.13656,-0.057284,-0.054033,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.46713,-0.057323,-0.020842,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.55287,-0.057354,-0.024507,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.10214,-0.05741,-0.094476,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.068006,-0.057466,-0.046911,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.86331,-0.05752,1.1386e-05,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.318,-0.057721,-0.050372,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.22503,-0.057876,-0.05066,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.20554,-0.057955,-0.084396,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.66028,-0.058198,-0.0051392,0,0
4,GO STEM CELL DIVISION,0.20992,-0.058202,-0.061466,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.10299,-0.058224,-0.029664,0,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.079071,-0.058519,-0.045806,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.078382,-0.058519,-0.031107,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.32393,-0.058618,-0.021456,0,0
4,GO HISTONE H4 K16 ACETYLATION,0.37173,-0.05862,-0.023933,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.23445,-0.058671,-0.045619,0,0
4,GO PHOSPHATE ION TRANSPORT,0.90167,-0.058905,0.019685,0,0
4,GO MAINTENANCE OF CELL NUMBER,0.15098,-0.058913,-0.050031,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.68392,-0.058987,-0.0056339,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.1914,-0.059117,-0.048426,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.20409,-0.059212,-0.054928,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.67501,-0.059244,-0.025562,0,0
4,GO SPINDLE ASSEMBLY,0.11647,-0.059353,-0.030764,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.19838,-0.05937,-0.045471,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.75048,-0.059407,-0.033789,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.34835,-0.059463,-0.030212,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.13656,-0.059721,-0.07021,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.087731,-0.059992,-0.0667,0,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.11837,-0.06009,-0.054722,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.31604,-0.060099,-0.054763,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.094715,-0.060172,-0.055238,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.58585,-0.060599,-0.013898,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.36311,-0.06061,-0.041949,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.24911,-0.060675,-0.022522,0,0
4,GO LYSINE METABOLIC PROCESS,0.80639,-0.06111,0.010829,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.098784,-0.061247,-0.10216,0,0
4,GO LONG TERM MEMORY,0.19979,-0.061392,-0.059249,0,0
4,GO SEQUESTERING OF METAL ION,0.82526,-0.061427,-0.056311,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.68392,-0.061436,-0.023983,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.090011,-0.061462,-0.052445,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.38488,-0.061575,-0.027554,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.13444,-0.061721,-0.063115,0,0
4,GO NEUROBLAST PROLIFERATION,0.17156,-0.061792,-0.047687,0,0
4,GO REGULATION OF DNA REPLICATION,0.092339,-0.061893,-0.038478,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.77519,-0.061997,-0.018189,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.1793,-0.062179,-0.0657,0,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.31409,-0.062183,-0.064165,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.52082,-0.062378,0.011107,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.51819,-0.062464,-0.024675,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.062114,-0.062512,-0.06764,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.75356,-0.062628,0.014053,0,0
4,GO RNA DECAPPING,0.09796,-0.062727,-0.046711,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.64276,-0.062751,-0.0066042,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.17283,-0.062754,-0.050074,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.50516,-0.062817,-0.0023246,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.27317,-0.063426,-0.046885,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.80012,-0.063741,-0.014936,0,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.21738,-0.06391,-0.046984,0,0
4,GO RNA 5 END PROCESSING,0.2913,-0.064221,-0.045494,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.40058,-0.064401,-0.060255,0,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.10823,-0.064528,-0.07946,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.29315,-0.064559,-0.036977,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.26267,-0.064784,-0.053199,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.31215,-0.064903,-0.050937,0,0
4,GO RESPONSE TO POTASSIUM ION,0.18194,-0.064972,-0.093876,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.29502,-0.065003,-0.068173,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.73517,-0.065042,-0.0080809,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.52345,-0.065128,-0.025328,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.20265,-0.065241,-0.062251,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.077018,-0.06546,-0.0925,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.23445,-0.06554,-0.12269,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.069238,-0.065588,-0.051209,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.30637,-0.0656,-0.069038,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.39606,-0.065602,-0.12226,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.66616,-0.065869,-0.0029189,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.20699,-0.06617,-0.066901,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.2644,-0.066646,-0.041773,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.29502,-0.067019,-0.059067,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.41899,-0.067134,-0.022071,0,0
4,GO DENDRITIC TRANSPORT,0.23766,-0.06714,-0.058411,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.56925,-0.067506,-0.019876,0,0
4,GO NUCLEUS LOCALIZATION,0.11275,-0.067605,-0.072276,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.33396,-0.067803,-0.10432,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.72299,-0.067843,-0.0062635,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.17156,-0.067854,-0.051147,0,0
4,GO VIRAL GENE EXPRESSION,0.090011,-0.068269,-0.068469,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.25414,-0.068412,-0.049537,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.31021,-0.068484,-0.042531,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.46713,-0.068523,-0.047192,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.13338,-0.068715,-0.087287,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.078382,-0.068802,-0.043952,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.065005,-0.068821,-0.045894,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.10823,-0.068826,-0.056082,0,0
4,GO GAS TRANSPORT,0.30255,-0.068992,-0.084183,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.22348,-0.068998,-0.037259,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.42133,-0.069038,-0.023426,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.10385,-0.069044,-0.052342,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.41203,-0.06915,-0.051261,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.23605,-0.069228,-0.052755,0,0
4,GO MICROTUBULE NUCLEATION,0.36311,-0.069326,-0.018257,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.17411,-0.06935,-0.07768,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.16042,-0.069561,-0.056607,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.20554,-0.069821,-0.098201,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.093918,-0.06984,-0.049628,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.1653,-0.070012,-0.034355,0,0
4,GO TRACHEA MORPHOGENESIS,0.21738,-0.070136,-0.060956,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.12322,-0.070452,-0.068838,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.96607,-0.070546,0.092393,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.068619,-0.070781,-0.082621,0,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.36526,-0.071126,-0.048639,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.11837,-0.071251,-0.10673,0,0
4,GO WALKING BEHAVIOR,0.084763,-0.071276,-0.07217,0,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.35463,-0.071294,-0.07907,0,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.15098,-0.071432,-0.063948,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.10385,-0.071523,-0.073087,0,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.88885,-0.072023,-0.012248,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.31604,-0.072315,-0.041792,0,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.3442,-0.072522,-0.033621,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.318,-0.072618,-0.020512,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.43075,-0.072806,-0.051528,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.35674,-0.072935,-0.069139,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.27317,-0.072959,-0.048281,0,0
4,GO FORELIMB MORPHOGENESIS,0.16654,-0.073168,-0.085121,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.94671,-0.07325,0.012097,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.072397,-0.073302,-0.049925,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.19417,-0.073546,-0.10483,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.1313,-0.073693,-0.085942,0,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.20409,-0.073867,-0.077511,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.074349,-0.07454,-0.056434,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.86012,-0.074712,0.0058355,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.19417,-0.07514,-0.055397,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.14308,-0.075159,-0.074489,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.11367,-0.0752,-0.086505,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.39606,-0.075609,-0.051319,0,0
4,GO SHORT TERM MEMORY,0.35463,-0.075613,-0.05558,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.13656,-0.075621,-0.070246,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.24745,-0.075658,-0.088441,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.073694,-0.075709,-0.044208,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.19697,-0.076834,-0.068888,0,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.1252,-0.076884,-0.11427,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.57752,-0.077088,-0.047634,0,0
4,GO HISTONE H3 K27 METHYLATION,0.1754,-0.077173,-0.062303,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.08331,-0.077261,-0.10824,0,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.15098,-0.077472,-0.13158,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.36311,-0.077518,-0.044179,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.21288,-0.07756,-0.059619,0,0
4,GO RESPONSE TO VITAMIN A,0.062114,-0.077691,-0.094591,0,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.11367,-0.077738,-0.07755,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.15565,-0.077984,-0.079755,0,0
4,GO AXIS ELONGATION,0.37608,-0.078416,-0.071908,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.11647,-0.078606,-0.090623,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.11275,-0.078649,-0.098571,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.91772,-0.078675,0.0072713,0,0
4,GO SYNAPTIC VESICLE MATURATION,0.57752,-0.078709,-0.015573,0,0
4,GO SNORNA METABOLIC PROCESS,0.081877,-0.078832,-0.086119,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.28761,-0.079523,-0.11314,0,0
4,GO REGULATION OF LYASE ACTIVITY,0.10471,-0.080609,-0.056852,0,0
4,GO L GLUTAMATE IMPORT,0.2114,-0.08091,-0.063774,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.094715,-0.08092,-0.087225,0,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.23605,-0.081042,-0.034336,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.64276,-0.081168,-0.017235,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.58864,-0.081367,-0.023665,0,0
4,GO SUCKLING BEHAVIOR,0.36098,-0.081693,-0.054741,0,0
4,GO SISTER CHROMATID COHESION,0.14419,-0.082008,-0.044362,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.69286,-0.082026,0.0067408,0,0
4,GO REGULATION OF HEART GROWTH,0.22042,-0.08231,-0.0475,0,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.10471,-0.082966,-0.081433,0,0
4,GO RRNA 3 END PROCESSING,0.39156,-0.083186,-0.034317,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.30829,-0.083379,-0.053642,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.073694,-0.083629,-0.091648,0,0
4,GO FOREBRAIN REGIONALIZATION,0.29315,-0.083636,-0.051686,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.099614,-0.083757,-0.1154,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.1453,-0.083921,-0.037265,0,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.48468,-0.083943,-0.046705,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.15447,-0.084101,-0.06671,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.19417,-0.084358,-0.074858,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.47461,-0.084376,-0.028834,0,0
4,GO AXONAL TRANSPORT,0.10734,-0.084446,-0.051485,0,0
4,GO REGULATION OF ODONTOGENESIS,0.19278,-0.084553,-0.089749,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.27317,-0.084646,-0.068679,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.16407,-0.08481,-0.046353,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.063836,-0.084885,-0.099199,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.075009,-0.085252,-0.045713,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.063836,-0.08532,-0.067917,0,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.20409,-0.086484,-0.045589,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.38267,-0.087198,-0.073791,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.082591,-0.088483,-0.15732,0,0
4,GO SNORNA 3 END PROCESSING,0.079765,-0.088709,-0.092467,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.28761,-0.089797,-0.048476,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.41203,-0.089838,-0.023718,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.34213,-0.090125,-0.066087,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.36526,-0.091089,-0.036851,0,0
4,GO REGULATION OF EXCRETION,0.25246,-0.091391,-0.047707,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.72299,-0.091479,-0.0063287,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.42838,-0.091877,-0.033122,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.077698,-0.09195,-0.071381,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.21437,-0.093576,-0.088482,0,0
4,GO COCHLEA MORPHOGENESIS,0.15098,-0.093716,-0.078156,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.066792,-0.094041,-0.10269,0,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.12126,-0.094042,-0.072265,0,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.06986,-0.094421,-0.097512,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.60834,-0.09468,-0.046324,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.1754,-0.09532,-0.059398,0,0
4,GO MITOCHONDRION DISTRIBUTION,0.070488,-0.096102,-0.071094,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.077018,-0.096162,-0.12921,0,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.068619,-0.096317,-0.11532,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.086981,-0.097305,-0.07996,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.10646,-0.097504,-0.042562,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.44028,-0.098149,-0.043201,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.42602,-0.098662,-0.030504,0,0
4,GO RESPONSE TO SALT STRESS,0.062114,-0.098824,-0.084991,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.1873,-0.098825,-0.067141,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.1754,-0.099131,-0.11946,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.10558,-0.099299,-0.057252,0,0
4,GO NEURON PROJECTION ORGANIZATION,0.069238,-0.099873,-0.090009,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.091558,-0.1002,-0.055705,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.18461,-0.10051,-0.063111,0,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.22814,-0.10125,-0.076257,0,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.20265,-0.10144,-0.079478,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.23286,-0.1021,-0.055616,0,0
4,GO PENTOSE METABOLIC PROCESS,0.16285,-0.1022,-0.079683,0,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.22658,-0.1027,-0.075411,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.5314,-0.10281,-0.047071,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.24416,-0.10283,-0.016957,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.14419,-0.10375,-0.076114,0,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.068619,-0.10387,-0.073902,0,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.12421,-0.10432,-0.13499,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.2644,-0.10475,-0.055529,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.33194,-0.10489,-0.05184,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.13234,-0.10521,-0.057659,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.16407,-0.10549,-0.061786,0,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.96607,-0.10552,0.024049,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.12721,-0.10576,-0.093144,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.15921,-0.10625,-0.06241,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.13234,-0.10626,-0.14984,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.12224,-0.10634,-0.1003,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.066192,-0.10638,-0.12031,0,0
4,GO REGULATION OF AXON GUIDANCE,0.091558,-0.10664,-0.076111,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.065596,-0.10671,-0.1041,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.35253,-0.10673,-0.06001,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.14308,-0.10674,-0.042089,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.33194,-0.10763,-0.04965,0,0
4,GO EMBRYONIC EYE MORPHOGENESIS,0.086237,-0.108,-0.082517,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.19838,-0.10891,-0.080594,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.11367,-0.11085,-0.082685,0,0
4,GO ASYMMETRIC CELL DIVISION,0.25414,-0.11256,-0.048284,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.16285,-0.11303,-0.099754,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.17411,-0.11328,-0.10652,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.2114,-0.11388,-0.060405,0,0
4,GO SIALYLATION,0.47461,-0.11407,-0.041717,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.10912,-0.11412,-0.14551,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.09796,-0.11511,-0.089296,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.19278,-0.11577,-0.10561,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.28578,-0.11696,-0.10975,0,0
4,GO NEPHRON TUBULE FORMATION,0.15447,-0.11774,-0.10211,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.12224,-0.11938,-0.1064,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.30255,-0.12027,-0.049853,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.19417,-0.12236,-0.11786,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.11183,-0.12343,-0.073024,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.11002,-0.12358,-0.097154,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.26614,-0.12372,-0.025318,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.075009,-0.12384,-0.08765,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.1262,-0.12506,-0.12675,0,0
4,GO IMP METABOLIC PROCESS,0.086237,-0.12537,-0.12382,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.089246,-0.12543,-0.094548,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.070488,-0.12567,-0.08855,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.13549,-0.12594,-0.10391,0,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.13979,-0.12672,-0.078389,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.22503,-0.12822,-0.078839,0,0
4,GO CYSTEINE METABOLIC PROCESS,0.13234,-0.13009,-0.14517,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.1313,-0.13063,-0.12304,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.49487,-0.1309,-0.018508,0,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.28761,-0.13207,-0.059968,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.59424,-0.13466,-0.078476,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.10129,-0.13582,-0.11369,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.096327,-0.13726,-0.09784,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.080464,-0.13828,-0.13637,0,0
4,GO KINETOCHORE ASSEMBLY,0.21889,-0.14261,-0.056386,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.13338,-0.14269,-0.096714,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.088486,-0.14503,-0.11776,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.099614,-0.14533,-0.14353,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.25414,-0.14584,-0.076359,0,0
4,GO DIVALENT METAL ION EXPORT,0.12126,-0.14891,-0.13274,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.086237,-0.15114,-0.09461,0,0
4,GO KINETOCHORE ORGANIZATION,0.1146,-0.15121,-0.063655,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.20845,-0.15207,-0.098932,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.11553,-0.15268,-0.094248,0,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.066792,-0.15556,-0.15064,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.063258,-0.15569,-0.14103,0,0
4,GO ELASTIC FIBER ASSEMBLY,0.16407,-0.15659,-0.13238,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.062684,-0.15696,-0.17782,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.2114,-0.16017,-0.091652,0,0
4,GO RESPONSE TO L GLUTAMATE,0.062114,-0.1629,-0.13634,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.068619,-0.16378,-0.11754,0,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.063836,-0.16426,-0.15547,0,0
4,GO L SERINE METABOLIC PROCESS,0.12721,-0.16838,-0.1444,0,0
4,GO POSTSYNAPSE ASSEMBLY,0.10385,-0.18109,-0.16223,0,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.078382,-0.18912,-0.1524,0,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.016752,0.21354,0.18193,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.022446,0.16968,0.1386,1,1
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.047827,-0.028501,-0.14686,1,0
5,GO AMINO ACID ACTIVATION,0.019312,-0.040232,-0.16487,1,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.016938,-0.042576,-0.14311,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.051111,-0.046301,-0.13941,1,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.019104,-0.049073,-0.093435,1,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.0081133,-0.049797,-0.17973,1,0
5,GO TRNA PROCESSING,0.023419,-0.050405,-0.14202,1,0
5,GO SNORNA METABOLIC PROCESS,0.054074,-0.051642,-0.14504,1,0
5,GO METHIONINE METABOLIC PROCESS,0.027973,-0.05505,-0.14481,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.039795,-0.058048,-0.12682,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.02128,-0.05819,-0.11354,1,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0066039,-0.05826,-0.15201,1,0
5,GO SNRNA PROCESSING,0.048746,-0.062211,-0.10234,1,0
5,GO QUINONE METABOLIC PROCESS,0.046474,-0.062827,-0.13876,1,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.048746,-0.062986,-0.12932,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.029754,-0.063725,-0.1393,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.032278,-0.063972,-0.16834,1,0
5,GO RNA 3 END PROCESSING,0.002702,-0.064151,-0.16897,1,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.026013,-0.064994,-0.16887,1,0
5,GO UBIQUINONE METABOLIC PROCESS,0.0093576,-0.065059,-0.16338,1,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.019104,-0.065579,-0.17505,1,0
5,GO ELECTRON TRANSPORT CHAIN,0.016752,-0.065601,-0.093065,1,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.035336,-0.067145,-0.11109,1,0
5,GO SPERM AXONEME ASSEMBLY,0.056128,-0.067927,-0.13115,1,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.014823,-0.068165,-0.1044,1,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.00067188,-0.068347,-0.18416,1,0
5,GO TRNA METABOLIC PROCESS,0.010279,-0.068586,-0.15436,1,0
5,GO NCRNA PROCESSING,0.020385,-0.070129,-0.1438,1,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0024281,-0.070171,-0.19254,1,0
5,GO NUCLEOSOME ASSEMBLY,0.03068,-0.071031,-0.12822,1,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.018898,-0.074522,-0.15733,1,0
5,GO RRNA METABOLIC PROCESS,0.022928,-0.075558,-0.14205,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.035336,-0.077047,-0.13999,1,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.011678,-0.077208,-0.22418,1,0
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0098086,-0.077664,-0.16119,1,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.041789,-0.078466,-0.11484,1,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.058247,-0.078642,-0.17527,1,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.02128,-0.079185,-0.10921,1,0
5,GO VITAMIN CATABOLIC PROCESS,0.059879,-0.079871,-0.18651,1,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.023173,-0.080094,-0.15595,1,0
5,GO RNA SPLICING,0.00096848,-0.081198,-0.17556,1,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.0013633,-0.081777,-0.21266,1,0
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.014172,-0.083104,-0.10849,1,0
5,GO CHROMATIN SILENCING,0.0040509,-0.083386,-0.17162,1,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0089251,-0.084257,-0.16584,1,0
5,GO PENTOSE METABOLIC PROCESS,0.061549,-0.084408,-0.13987,1,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.041789,-0.085264,-0.19399,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.022928,-0.085787,-0.12866,1,0
5,GO SNRNA METABOLIC PROCESS,0.031631,-0.087259,-0.11372,1,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.043025,-0.088033,-0.14394,1,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015674,-0.088628,-0.157,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.021509,-0.088718,-0.1393,1,0
5,GO RESPONSE TO LITHIUM ION,0.025475,-0.08914,-0.18399,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.00042777,-0.089468,-0.1584,1,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.017894,-0.089554,-0.17594,1,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.0047198,-0.089702,-0.16877,1,0
5,GO BASE EXCISION REPAIR,0.0092477,-0.089705,-0.14201,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.052575,-0.089809,-0.21731,1,0
5,GO NCRNA METABOLIC PROCESS,0.0066851,-0.090032,-0.15493,1,0
5,GO NEGATIVE T CELL SELECTION,0.0021798,-0.090656,-0.22824,1,0
5,GO MIDBODY ABSCISSION,0.037139,-0.090666,-0.13585,1,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0028492,-0.090878,-0.17805,1,0
5,GO TRNA MODIFICATION,0.0083098,-0.092405,-0.16987,1,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.020605,-0.092573,-0.17727,1,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.027401,-0.092687,-0.18335,1,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.0051547,-0.093183,-0.15094,1,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.023173,-0.094228,-0.11672,1,0
5,GO SPINDLE ASSEMBLY,0.00031414,-0.094546,-0.216,1,0
5,GO MRNA PROCESSING,0.00035024,-0.095162,-0.19125,1,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.011949,-0.095231,-0.13185,1,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,9.03e-05,-0.095286,-0.14501,1,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.0047198,-0.095354,-0.12078,1,0
5,GO DETECTION OF VISIBLE LIGHT,0.000286,-0.09542,-0.18974,1,0
5,GO HISTONE H4 K16 ACETYLATION,0.019523,-0.096304,-0.17472,1,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.003607,-0.097339,-0.17807,1,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.0016122,-0.097674,-0.17629,1,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.017506,-0.097836,-0.13542,1,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.027401,-0.098347,-0.13952,1,0
5,GO NUCLEOSOME ORGANIZATION,0.0012005,-0.098552,-0.16929,1,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.0067673,-0.099082,-0.18282,1,0
5,GO POSITIVE REGULATION OF RNA SPLICING,6.1119e-05,-0.099084,-0.22771,1,0
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.040981,-0.09927,-0.16615,1,0
5,GO REGULATION OF MRNA BINDING,0.0065235,-0.099477,-0.18199,1,0
5,GO CELL CYCLE DNA REPLICATION,0.045155,-0.099532,-0.14138,1,0
5,GO MEIOTIC CELL CYCLE,9.6562e-05,-0.099533,-0.20321,1,0
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.047372,-0.099786,-0.25334,1,0
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0019023,-0.099854,-0.21995,1,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.020605,-0.10051,-0.14504,1,0
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0092477,-0.10089,-0.17475,1,0
5,GO CARDIOLIPIN METABOLIC PROCESS,0.000286,-0.10096,-0.22032,1,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0089251,-0.101,-0.15503,1,0
5,GO CHROMOSOME SEGREGATION,0.0019023,-0.10181,-0.17747,1,0
5,GO URONIC ACID METABOLIC PROCESS,0.01128,-0.10183,-0.11364,1,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0057669,-0.1023,-0.16118,1,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.01829,-0.10261,-0.1697,1,0
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0013255,-0.10343,-0.19406,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0055559,-0.10345,-0.18438,1,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.026561,-0.10347,-0.14628,1,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0044864,-0.10389,-0.16764,1,0
5,GO RNA PROCESSING,0.00035024,-0.10453,-0.18404,1,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.031631,-0.1046,-0.085271,1,0
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.001071,-0.10469,-0.20431,1,0
5,GO AEROBIC RESPIRATION,0.0019819,-0.10493,-0.15822,1,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.018091,-0.10494,-0.19225,1,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.0010865,-0.10564,-0.16321,1,0
5,GO TRNA METHYLATION,0.0027747,-0.10567,-0.20447,1,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.011544,-0.10571,-0.12859,1,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0081133,-0.10596,-0.1757,1,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0089251,-0.10611,-0.16691,1,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.002631,-0.10612,-0.20117,1,0
5,GO CRISTAE FORMATION,0.0018764,-0.1062,-0.26971,1,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.001235,-0.1064,-0.17165,1,0
5,GO MITOCHONDRIAL FUSION,0.015674,-0.10647,-0.20986,1,0
5,GO REGULATION OF RNA SPLICING,1.5014e-05,-0.10652,-0.2385,1,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00021857,-0.1071,-0.14991,1,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.045591,-0.10757,-0.13706,1,0
5,GO RNA CAPPING,0.01585,-0.10804,-0.12153,1,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0065235,-0.10875,-0.16195,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.001483,-0.10885,-0.21024,1,0
5,GO SISTER CHROMATID COHESION,0.0046018,-0.10899,-0.18157,1,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.00060545,-0.10906,-0.23745,1,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.010279,-0.10938,-0.10963,1,0
5,GO METAPHASE PLATE CONGRESSION,0.029754,-0.10949,-0.14428,1,0
5,GO RECOMBINATIONAL REPAIR,0.0020367,-0.10975,-0.20645,1,0
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.03006,-0.10981,-0.13569,1,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.033271,-0.10987,-0.17148,1,0
5,GO CENTROSOME DUPLICATION,0.0030038,-0.10999,-0.22123,1,0
5,GO RRNA MODIFICATION,0.013546,-0.11023,-0.16849,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0032928,-0.11113,-0.16518,1,0
5,GO PSEUDOURIDINE SYNTHESIS,0.02521,-0.11122,-0.17573,1,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.0016806,-0.11125,-0.19328,1,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.044292,-0.11153,-0.12603,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0015038,-0.1117,-0.1709,1,0
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.012653,-0.11208,-0.15601,1,0
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0044864,-0.1121,-0.18018,1,0
5,GO SNRNA TRANSCRIPTION,0.00054518,-0.11232,-0.17999,1,0
5,GO REGULATION OF SISTER CHROMATID COHESION,0.0081133,-0.11233,-0.20452,1,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0005789,-0.1133,-0.18432,1,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.0095807,-0.1135,-0.17045,1,0
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0098086,-0.1135,-0.16576,1,0
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00026858,-0.11352,-0.18546,1,0
5,GO RRNA METHYLATION,0.0094686,-0.11378,-0.17242,1,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.033948,-0.11398,-0.12171,1,0
5,GO ORGANELLE FISSION,6.545e-05,-0.1143,-0.2174,1,0
5,GO MATURATION OF SSU RRNA,0.026286,-0.11436,-0.16051,1,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.00095459,-0.11454,-0.20977,1,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.0018764,-0.11474,-0.16836,1,0
5,GO PHOTOTRANSDUCTION,0.00016098,-0.11491,-0.20088,1,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00031414,-0.11505,-0.30108,1,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00029976,-0.11514,-0.17336,1,0
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0069343,-0.11518,-0.14863,1,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00094089,-0.11532,-0.17877,1,0
5,GO CELLULAR RESPIRATION,0.012653,-0.11538,-0.11948,1,0
5,GO VIRAL BUDDING,0.00086244,-0.11547,-0.18639,1,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0048405,-0.11564,-0.18452,1,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.0039481,-0.11574,-0.15528,1,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0096941,-0.11617,-0.15586,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0012705,-0.11639,-0.17404,1,0
5,GO RNA MODIFICATION,0.00012388,-0.11701,-0.21345,1,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0024609,-0.1172,-0.18485,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0067673,-0.11741,-0.15711,1,0
5,GO SISTER CHROMATID SEGREGATION,0.0077327,-0.11752,-0.16552,1,0
5,GO MITOTIC RECOMBINATION,0.0011021,-0.1178,-0.23905,1,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.05357,-0.118,-0.17568,1,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.0093576,-0.11825,-0.16198,1,0
5,GO MITOCHONDRION MORPHOGENESIS,0.00059648,-0.11846,-0.21953,1,0
5,GO SPINDLE ORGANIZATION,4.5558e-05,-0.1185,-0.23725,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0047798,-0.11852,-0.17025,1,0
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0061347,-0.11858,-0.16913,1,0
5,GO DNA PACKAGING,0.0019819,-0.11875,-0.18092,1,0
5,GO MRNA MODIFICATION,0.0018764,-0.11935,-0.22284,1,0
5,GO POSTREPLICATION REPAIR,0.00015331,-0.11946,-0.17527,1,0
5,GO VIRAL TRANSLATION,0.0070192,-0.11992,-0.19405,1,0
5,GO MULTIVESICULAR BODY ORGANIZATION,0.0034692,-0.11996,-0.17725,1,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.018091,-0.12007,-0.17599,1,0
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0041031,-0.12043,-0.25295,1,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0050904,-0.12044,-0.13497,1,0
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.042609,-0.12048,-0.18897,1,0
5,GO MRNA METABOLIC PROCESS,4.6359e-05,-0.12058,-0.16497,1,0
5,GO SPERM EGG RECOGNITION,0.00072342,-0.12079,-0.15046,1,0
5,GO PROTEIN INSERTION INTO MEMBRANE,0.00055343,-0.12141,-0.18291,1,0
5,GO HISTONE H4 K5 ACETYLATION,0.0029645,-0.12171,-0.18812,1,0
5,GO RNA CATABOLIC PROCESS,8.7316e-05,-0.12176,-0.13644,1,0
5,GO AMIDE BIOSYNTHETIC PROCESS,3.2146e-06,-0.12212,-0.17669,1,0
5,GO MIDDLE EAR MORPHOGENESIS,0.0095807,-0.12227,-0.17775,1,0
5,GO REGULATION OF DNA METHYLATION,0.0011503,-0.12237,-0.28346,1,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0041031,-0.12253,-0.1821,1,0
5,GO MRNA 3 END PROCESSING,0.00044103,-0.12255,-0.20404,1,0
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.010279,-0.12304,-0.18646,1,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.049212,-0.12328,-0.17059,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,1.3693e-05,-0.12336,-0.23062,1,0
5,GO MANNOSYLATION,0.00016361,-0.12337,-0.24846,1,0
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,4.7488e-06,-0.12348,-0.22327,1,0
5,GO REPLICATION FORK PROCESSING,0.0038977,-0.12349,-0.22236,1,0
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.028264,-0.12349,-0.14646,1,0
5,GO G0 TO G1 TRANSITION,0.00083767,-0.12357,-0.22454,1,0
5,GO DNA GEOMETRIC CHANGE,0.00070238,-0.1237,-0.20975,1,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00036124,-0.12388,-0.21435,1,0
5,GO DNA REPAIR,0.00010852,-0.12389,-0.20879,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00072342,-0.12407,-0.18551,1,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,1.4741e-05,-0.12407,-0.25313,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.6981e-08,-0.12412,-0.26479,1,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.011678,-0.12423,-0.24324,1,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,9.3381e-05,-0.12425,-0.17718,1,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,8.4424e-05,-0.12448,-0.20093,1,0
5,GO MRNA EXPORT FROM NUCLEUS,0.00094089,-0.12456,-0.19604,1,0
5,GO REGULATION OF LIGASE ACTIVITY,0.02945,-0.12471,-0.15426,1,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.019104,-0.12477,-0.13806,1,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.026286,-0.12479,-0.11269,1,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00012804,-0.12485,-0.21334,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0013069,-0.12497,-0.18674,1,0
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0003557,-0.12499,-0.2331,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0038478,-0.12515,-0.21467,1,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.001704,-0.12522,-0.18789,1,0
5,GO REGULATION OF MRNA PROCESSING,0.00013232,-0.12593,-0.23644,1,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.0096941,-0.12606,-0.19267,1,0
5,GO DNA METABOLIC PROCESS,3.3435e-06,-0.12617,-0.22504,1,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.014172,-0.12719,-0.18091,1,0
5,GO DNA CONFORMATION CHANGE,0.000662,-0.12762,-0.20396,1,0
5,GO CENTROSOME SEPARATION,0.0068504,-0.12769,-0.19522,1,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.060988,-0.12776,-0.19484,1,0
5,GO REGULATION OF ATPASE ACTIVITY,4.7172e-05,-0.12811,-0.19717,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0020646,-0.1285,-0.27663,1,0
5,GO REGULATION OF TELOMERE CAPPING,2.2416e-05,-0.12885,-0.2776,1,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.0018006,-0.12889,-0.1813,1,0
5,GO PROTEIN MONOUBIQUITINATION,1.4741e-05,-0.129,-0.24741,1,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0023009,-0.12914,-0.16718,1,0
5,GO RESPONSE TO ETHER,0.00024045,-0.1292,-0.20614,1,0
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00082553,-0.12943,-0.18702,1,0
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00070238,-0.12958,-0.29797,1,0
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,8.4424e-05,-0.13,-0.26758,1,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0066039,-0.13012,-0.16559,1,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00070238,-0.13028,-0.22429,1,0
5,GO RNA METHYLATION,0.00025617,-0.13041,-0.22074,1,0
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0034243,-0.13056,-0.20933,1,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.020166,-0.13077,-0.14459,1,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.00042128,-0.13088,-0.20815,1,0
5,GO RESPONSE TO FOOD,0.030994,-0.13099,-0.11999,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,1.4207e-05,-0.13118,-0.19685,1,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0071918,-0.13123,-0.21644,1,0
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,4.6578e-06,-0.13134,-0.19183,1,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00029976,-0.13137,-0.18097,1,0
5,GO DNA REPLICATION CHECKPOINT,0.010041,-0.13144,-0.15716,1,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.0958e-05,-0.1318,-0.19712,1,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0086125,-0.13194,-0.20565,1,0
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,7.6446e-07,-0.13214,-0.2442,1,0
5,GO DNA MODIFICATION,9.5999e-07,-0.13223,-0.23312,1,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.484e-09,-0.13235,-0.27519,1,0
5,GO HISTONE H3 K9 ACETYLATION,7.8124e-06,-0.13254,-0.26687,1,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0037985,-0.13263,-0.20683,1,0
5,GO DNA METHYLATION OR DEMETHYLATION,1.7071e-05,-0.13278,-0.23891,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,2.8271e-07,-0.13287,-0.25298,1,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0027747,-0.13296,-0.13826,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0011021,-0.13306,-0.17227,1,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0032928,-0.13315,-0.18856,1,0
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.02945,-0.1332,-0.1601,1,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,9.4959e-05,-0.13325,-0.20059,1,0
5,GO HISTONE H3 K27 METHYLATION,4.3236e-05,-0.13337,-0.27359,1,0
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0025617,-0.1334,-0.1862,1,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.0027747,-0.13354,-0.15881,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.015674,-0.13393,-0.2296,1,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.00075607,-0.13422,-0.21529,1,0
5,GO MITOTIC CYTOKINETIC PROCESS,0.0029645,-0.13443,-0.18973,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00019541,-0.13457,-0.26855,1,0
5,GO RESPONSE TO OXYGEN RADICAL,0.00013899,-0.13462,-0.19713,1,0
5,GO OXIDATIVE DEMETHYLATION,0.0055559,-0.13466,-0.1545,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,1.7385e-05,-0.13484,-0.1346,1,0
5,GO IMP METABOLIC PROCESS,0.025743,-0.13504,-0.24467,1,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.01251,-0.13509,-0.1682,1,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.5424e-05,-0.13528,-0.20837,1,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.6418e-07,-0.13533,-0.17508,1,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,2.1543e-10,-0.13544,-0.29267,1,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0016575,-0.13556,-0.16152,1,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,6.7411e-08,-0.13608,-0.29627,1,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.2505e-06,-0.13638,-0.24348,1,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0037016,-0.13663,-0.2018,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.475e-06,-0.13663,-0.22948,1,0
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.00098255,-0.13669,-0.23802,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,2.2775e-07,-0.13708,-0.25764,1,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,3.9941e-08,-0.13726,-0.26105,1,0
5,GO HISTONE MONOUBIQUITINATION,0.00053704,-0.13728,-0.23057,1,0
5,GO MITOTIC SISTER CHROMATID COHESION,0.019312,-0.13733,-0.16636,1,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00048316,-0.13754,-0.22205,1,0
5,GO METHYLATION,4.1552e-07,-0.13758,-0.24331,1,0
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00019857,-0.13805,-0.2247,1,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,1.5994e-06,-0.13829,-0.27529,1,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,3.4553e-09,-0.13857,-0.23256,1,0
5,GO DOUBLE STRAND BREAK REPAIR,0.00017457,-0.13879,-0.23077,1,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0017517,-0.13939,-0.18085,1,0
5,GO GROOMING BEHAVIOR,0.0054192,-0.13962,-0.1936,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0029645,-0.13973,-0.15061,1,0
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.010645,-0.14024,-0.17332,1,0
5,GO PORE COMPLEX ASSEMBLY,9.9844e-05,-0.14047,-0.25814,1,0
5,GO TELOMERE CAPPING,3.8246e-05,-0.14057,-0.26648,1,0
5,GO RNA POLYADENYLATION,9.086e-06,-0.1406,-0.27783,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0068504,-0.14076,-0.16455,1,0
5,GO HOMOLOGOUS RECOMBINATION,0.007921,-0.14094,-0.17645,1,0
5,GO OOCYTE MATURATION,0.0010408,-0.14114,-0.18838,1,0
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,7.8052e-07,-0.14119,-0.22949,1,0
5,GO GPI ANCHOR METABOLIC PROCESS,0.00018923,-0.14149,-0.21366,1,0
5,GO RNA INTERFERENCE,0.0024941,-0.14169,-0.1733,1,0
5,GO LIPID DIGESTION,0.010522,-0.14175,-0.25073,1,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0020929,-0.14183,-0.19978,1,0
5,GO REGULATION OF EXIT FROM MITOSIS,0.0015249,-0.14233,-0.19342,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0011503,-0.14234,-0.15748,1,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,4.5558e-05,-0.14238,-0.23364,1,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.001071,-0.14238,-0.28291,1,0
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,1.2716e-05,-0.14269,-0.224,1,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.00072342,-0.14299,-0.19468,1,0
5,GO DETECTION OF LIGHT STIMULUS,4.9694e-05,-0.14329,-0.21051,1,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00060545,-0.14336,-0.18169,1,0
5,GO REGULATION OF RNA BINDING,0.002631,-0.14342,-0.18661,1,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00025617,-0.14354,-0.18193,1,0
5,GO HISTONE UBIQUITINATION,4.0314e-05,-0.14372,-0.24053,1,0
5,GO RNA STABILIZATION,0.00030449,-0.1441,-0.22136,1,0
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,7.2202e-11,-0.14426,-0.29712,1,0
5,GO CYTOKINESIS,2.8001e-06,-0.14451,-0.27424,1,0
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,7.333e-07,-0.14472,-0.22267,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,2.2286e-07,-0.14481,-0.25442,1,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.012227,-0.14489,-0.20885,1,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00090088,-0.14499,-0.30151,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0005618,-0.14504,-0.29072,1,0
5,GO ORGANELLE INHERITANCE,5.8049e-05,-0.14541,-0.23073,1,0
5,GO GENE SILENCING,8.4805e-07,-0.14545,-0.2458,1,0
5,GO POSITIVE REGULATION OF CELL AGING,0.00042128,-0.14553,-0.1893,1,0
5,GO REGULATION OF ERAD PATHWAY,2.2505e-06,-0.14569,-0.32357,1,0
5,GO DNA DEPENDENT DNA REPLICATION,0.011813,-0.14583,-0.17153,1,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.00016629,-0.14584,-0.19474,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.002631,-0.14593,-0.20897,1,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00036124,-0.1462,-0.17778,1,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0028872,-0.14635,-0.23243,1,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.00080175,-0.14647,-0.19453,1,0
5,GO PEPTIDE METABOLIC PROCESS,3.0156e-07,-0.14664,-0.18344,1,0
5,GO MRNA METHYLATION,0.0007901,-0.14671,-0.2682,1,0
5,GO AMINE METABOLIC PROCESS,4.3946e-06,-0.14677,-0.19561,1,0
5,GO MITOCHONDRIAL TRANSPORT,6.6066e-07,-0.14693,-0.22387,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0015249,-0.14693,-0.19414,1,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.00159,-0.14702,-0.25332,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.017894,-0.14709,-0.18602,1,0
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.00059648,-0.14714,-0.20248,1,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00026858,-0.14726,-0.17714,1,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00012388,-0.14732,-0.20264,1,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,9.6562e-05,-0.14775,-0.19777,1,0
5,GO POLYAMINE METABOLIC PROCESS,0.00044781,-0.14781,-0.21991,1,0
5,GO RNA EXPORT FROM NUCLEUS,0.00090088,-0.14791,-0.19431,1,0
5,GO NADPH REGENERATION,0.0013826,-0.14795,-0.24753,1,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0060595,-0.14817,-0.17399,1,0
5,GO RNA LOCALIZATION,8.8796e-05,-0.1482,-0.21842,1,0
5,GO TRICARBOXYLIC ACID CYCLE,0.00044781,-0.14829,-0.23517,1,0
5,GO NON RECOMBINATIONAL REPAIR,8.5867e-06,-0.14862,-0.25341,1,0
5,GO CHROMOSOME ORGANIZATION,4.7488e-06,-0.14866,-0.24627,1,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.000662,-0.14869,-0.19295,1,0
5,GO NCRNA TRANSCRIPTION,0.00019857,-0.14875,-0.19544,1,0
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,8.7502e-06,-0.14882,-0.25666,1,0
5,GO MITOTIC NUCLEAR DIVISION,0.00047589,-0.14899,-0.21093,1,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.00054518,-0.14899,-0.19655,1,0
5,GO MRNA SPLICE SITE SELECTION,0.0030839,-0.149,-0.20721,1,0
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.001568,-0.14918,-0.26143,1,0
5,GO PROTEIN ACYLATION,1.3351e-08,-0.1492,-0.29649,1,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.0013069,-0.14929,-0.19672,1,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.00010673,-0.14931,-0.24895,1,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0012177,-0.1497,-0.17338,1,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.014332,-0.14984,-0.15989,1,0
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00040857,-0.14991,-0.20957,1,0
5,GO MULTI ORGANISM LOCALIZATION,3.5794e-07,-0.15002,-0.26032,1,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,6.1119e-05,-0.15015,-0.25975,1,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,2.2958e-06,-0.15019,-0.2238,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0047198,-0.15025,-0.17146,1,0
5,GO TELOMERE ORGANIZATION,9.819e-05,-0.15064,-0.21236,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.03902,-0.15066,-0.118,1,0
5,GO PIGMENT GRANULE LOCALIZATION,0.0001179,-0.15109,-0.24533,1,0
5,GO REGULATION OF DNA REPAIR,5.5412e-06,-0.15138,-0.26,1,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,1.9393e-05,-0.15164,-0.18933,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,5.0766e-11,-0.15164,-0.29106,1,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0021798,-0.15173,-0.21414,1,0
5,GO TRANSLESION SYNTHESIS,0.00012388,-0.15185,-0.19257,1,0
5,GO CHROMOSOME CONDENSATION,0.0052197,-0.15197,-0.17602,1,0
5,GO PROTEIN POLYGLUTAMYLATION,0.0026663,-0.15242,-0.22382,1,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.00099681,-0.15252,-0.2519,1,0
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00068191,-0.15279,-0.20028,1,0
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,3.6877e-06,-0.15325,-0.2402,1,0
5,GO FOREBRAIN REGIONALIZATION,0.060988,-0.15329,-0.15187,1,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,7.8124e-06,-0.15356,-0.20201,1,0
5,GO POSITIVE REGULATION OF FERTILIZATION,0.00061456,-0.15365,-0.26793,1,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,2.8886e-07,-0.15369,-0.30684,1,0
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00084997,-0.15375,-0.22769,1,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00053704,-0.15401,-0.18562,1,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.0094686,-0.15407,-0.16557,1,0
5,GO DNA RECOMBINATION,0.00012594,-0.1542,-0.21827,1,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,8.4424e-05,-0.15439,-0.17461,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,5.3562e-07,-0.15445,-0.26144,1,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.0013633,-0.15446,-0.1758,1,0
5,GO REPLICATIVE SENESCENCE,0.0014624,-0.15461,-0.25507,1,0
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0071918,-0.15469,-0.14782,1,0
5,GO CHROMOSOME LOCALIZATION,0.013856,-0.15474,-0.1643,1,0
5,GO DRUG CATABOLIC PROCESS,0.00011986,-0.15486,-0.21135,1,0
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.000286,-0.15504,-0.18433,1,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.059331,-0.15526,-0.12423,1,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00036686,-0.1553,-0.22989,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0037985,-0.1555,-0.18751,1,0
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00075607,-0.15564,-0.16181,1,0
5,GO REGULATION OF FERTILIZATION,0.00048316,-0.15594,-0.2003,1,0
5,GO SENSORY PERCEPTION OF TASTE,0.00064263,-0.15622,-0.15576,1,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0066851,-0.15624,-0.22437,1,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,7.8911e-05,-0.15644,-0.23414,1,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.00016901,-0.15653,-0.20852,1,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0030839,-0.15654,-0.17605,1,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.8032e-05,-0.15658,-0.20898,1,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.0013069,-0.15678,-0.18603,1,0
5,GO RESPONSE TO SALT,0.0013069,-0.15708,-0.19912,1,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,1.8793e-06,-0.15714,-0.25366,1,0
5,GO MITOCHONDRION ORGANIZATION,8.4415e-08,-0.15728,-0.22411,1,0
5,GO ORGANELLE LOCALIZATION,1.725e-09,-0.15736,-0.31308,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00057029,-0.15739,-0.25747,1,0
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,5.332e-06,-0.15745,-0.22193,1,0
5,GO CHROMOSOME SEPARATION,0.00096848,-0.15787,-0.19043,1,0
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00020178,-0.15788,-0.18137,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.014332,-0.15803,-0.15474,1,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.4207e-05,-0.15832,-0.2977,1,0
5,GO HISTONE H2A MONOUBIQUITINATION,0.0030038,-0.15842,-0.21053,1,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.0554e-07,-0.15861,-0.29241,1,0
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,3.9102e-06,-0.15864,-0.30007,1,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,3.094e-05,-0.15866,-0.21317,1,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,5.2165e-11,-0.15869,-0.26535,1,0
5,GO CENTRIOLE ASSEMBLY,0.00076726,-0.15876,-0.26004,1,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.9014e-08,-0.15877,-0.18687,1,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,1.3671e-08,-0.15888,-0.21673,1,0
5,GO NUCLEAR EXPORT,5.6487e-06,-0.15915,-0.24664,1,0
5,GO MIRNA METABOLIC PROCESS,2.9332e-05,-0.15928,-0.25911,1,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0024281,-0.15935,-0.18167,1,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,4.7488e-06,-0.1594,-0.28504,1,0
5,GO PEPTIDYL PROLINE MODIFICATION,1.3948e-05,-0.15949,-0.26542,1,0
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00058763,-0.15949,-0.22918,1,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,4.5558e-05,-0.15969,-0.22393,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,2.1678e-11,-0.15983,-0.2918,1,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.00030449,-0.15987,-0.18517,1,0
5,GO REGULATION OF CYTOKINESIS,0.00010152,-0.15991,-0.26353,1,0
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,8.4262e-06,-0.15999,-0.2385,1,0
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.00044103,-0.16011,-0.25792,1,0
5,GO COBALAMIN METABOLIC PROCESS,3.6924e-05,-0.16015,-0.24938,1,0
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,9.7998e-07,-0.16017,-0.29438,1,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,1.1316e-06,-0.16017,-0.23858,1,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0010408,-0.16019,-0.20757,1,0
5,GO MITOTIC CYTOKINESIS,1.9749e-05,-0.16023,-0.257,1,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.00046872,-0.16029,-0.21677,1,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,4.5558e-05,-0.16049,-0.22905,1,0
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.8695e-12,-0.16068,-0.31708,1,0
5,GO PEPTIDYL LYSINE MODIFICATION,1.9175e-06,-0.16073,-0.27725,1,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,4.7172e-05,-0.16082,-0.22707,1,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00040235,-0.16084,-0.24434,1,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.00025215,-0.16113,-0.22822,1,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.8594e-09,-0.16128,-0.2784,1,0
5,GO HISTONE H2B UBIQUITINATION,6.6066e-07,-0.16169,-0.28534,1,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.0043184,-0.16192,-0.27866,1,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.002631,-0.16192,-0.22236,1,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.4787e-08,-0.16202,-0.25173,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,5.1446e-05,-0.16222,-0.2161,1,0
5,GO OTIC VESICLE DEVELOPMENT,0.055609,-0.16226,-0.15548,1,0
5,GO REGULATION OF PROTEIN FOLDING,9.4959e-05,-0.16234,-0.24332,1,0
5,GO ZINC ION TRANSPORT,5.1304e-06,-0.16259,-0.27139,1,0
5,GO MRNA CLEAVAGE,5.6085e-05,-0.16265,-0.23314,1,0
5,GO VIRION ASSEMBLY,4.7172e-05,-0.16275,-0.19579,1,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,1.734e-06,-0.16297,-0.21013,1,0
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.5576e-05,-0.16328,-0.30175,1,0
5,GO NUCLEAR TRANSPORT,8.8282e-08,-0.16333,-0.26297,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,4.9694e-05,-0.16343,-0.22746,1,0
5,GO SINGLE STRAND BREAK REPAIR,0.016205,-0.16346,-0.19627,1,0
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.00018323,-0.16348,-0.226,1,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.011022,-0.16379,-0.22924,1,0
5,GO NUCLEUS ORGANIZATION,2.2286e-07,-0.16387,-0.28398,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00022927,-0.16388,-0.24257,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00015331,-0.16422,-0.27823,1,0
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,4.0314e-05,-0.16426,-0.20243,1,0
5,GO CELL CYCLE PHASE TRANSITION,1.8793e-06,-0.16429,-0.23694,1,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0038977,-0.16488,-0.25223,1,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,2.6828e-05,-0.16489,-0.23319,1,0
5,GO SEXUAL REPRODUCTION,3.5427e-10,-0.16495,-0.26806,1,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.00010673,-0.16523,-0.17602,1,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,1.5674e-06,-0.1653,-0.20846,1,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,5.1351e-07,-0.16542,-0.25463,1,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00010673,-0.16544,-0.20343,1,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,7.6205e-11,-0.16552,-0.26388,1,0
5,GO REGULATION OF DNA REPLICATION,0.00013899,-0.16552,-0.24121,1,0
5,GO PEPTIDYL ARGININE METHYLATION,0.00092737,-0.16573,-0.22936,1,0
5,GO CIRCADIAN RHYTHM,4.9872e-09,-0.16586,-0.32319,1,0
5,GO REGULATION OF CILIUM MOVEMENT,0.0003557,-0.16592,-0.15113,1,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,1.0424e-06,-0.16617,-0.24462,1,0
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.0072795,-0.16618,-0.21926,1,0
5,GO NUCLEAR ENVELOPE ORGANIZATION,9.7998e-07,-0.16643,-0.31592,1,0
5,GO PHAGOSOME ACIDIFICATION,8.0256e-05,-0.1665,-0.24152,1,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00092737,-0.16668,-0.19731,1,0
5,GO PROTEIN ACETYLATION,1.0861e-06,-0.16671,-0.28057,1,0
5,GO CELL CYCLE PROCESS,9.028e-08,-0.16677,-0.26467,1,0
5,GO PROTEIN N LINKED GLYCOSYLATION,7.1819e-07,-0.16692,-0.2865,1,0
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.015329,-0.16698,-0.2411,1,0
5,GO CELL CYCLE,7.1726e-09,-0.16705,-0.27404,1,0
5,GO CELL CYCLE CHECKPOINT,4.7488e-06,-0.16711,-0.25518,1,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,4.4771e-05,-0.16713,-0.29986,1,0
5,GO GAMETE GENERATION,2.004e-09,-0.16716,-0.26108,1,0
5,GO DETOXIFICATION,2.4091e-05,-0.16729,-0.21947,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,5.8262e-07,-0.16731,-0.25983,1,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00025215,-0.16734,-0.18689,1,0
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00057029,-0.1676,-0.21241,1,0
5,GO MICROTUBULE BASED PROCESS,5.1356e-08,-0.1676,-0.28609,1,0
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,9.4959e-05,-0.16772,-0.22939,1,0
5,GO REGULATION OF CIRCADIAN RHYTHM,1.0424e-06,-0.16779,-0.28594,1,0
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00016098,-0.16785,-0.20757,1,0
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00033955,-0.16792,-0.25173,1,0
5,GO REGULATION OF MICROTUBULE BINDING,0.00082553,-0.168,-0.30976,1,0
5,GO REGULATION OF CELL CYCLE PROCESS,4.0678e-07,-0.16801,-0.25517,1,0
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00023667,-0.16804,-0.1603,1,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0041031,-0.16819,-0.15896,1,0
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0041031,-0.16855,-0.20969,1,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0033799,-0.16863,-0.30725,1,0
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.027401,-0.16877,-0.14077,1,0
5,GO KERATINIZATION,0.034984,-0.1688,-0.13885,1,0
5,GO REGULATION OF CELL CYCLE,1.0964e-09,-0.16896,-0.28499,1,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,1.2027e-05,-0.16909,-0.20447,1,0
5,GO SENSORY PERCEPTION OF SMELL,1.5865e-05,-0.16912,-0.22309,1,0
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0067673,-0.16916,-0.15287,1,0
5,GO CELLULAR RESPONSE TO COPPER ION,0.027118,-0.16919,-0.29463,1,0
5,GO ATP METABOLIC PROCESS,2.0364e-06,-0.16928,-0.20708,1,0
5,GO DNA BIOSYNTHETIC PROCESS,3.7356e-07,-0.16931,-0.25481,1,0
5,GO REGULATION OF MITOTIC CELL CYCLE,6.4434e-08,-0.16947,-0.26331,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,4.5233e-07,-0.1697,-0.28219,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,3.5461e-06,-0.16976,-0.23881,1,0
5,GO HISTONE H4 ACETYLATION,0.00011033,-0.16985,-0.2571,1,0
5,GO MRNA TRANSPORT,7.1274e-05,-0.17006,-0.23371,1,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,3.1494e-05,-0.17035,-0.26853,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,4.3997e-05,-0.17065,-0.25948,1,0
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00065224,-0.17075,-0.28023,1,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.00058763,-0.17082,-0.22587,1,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,3.5794e-07,-0.17088,-0.26575,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE,5.6317e-09,-0.17095,-0.28286,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,3.5646e-05,-0.17095,-0.18406,1,0
5,GO MALE GAMETE GENERATION,7.1726e-09,-0.17097,-0.24812,1,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,2.0478e-05,-0.17111,-0.24752,1,0
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,6.8348e-09,-0.17146,-0.25664,1,0
5,GO PROTEIN FOLDING,8.6579e-07,-0.17155,-0.2631,1,0
5,GO REGULATION OF GLUTAMATE SECRETION,0.011151,-0.17171,-0.20754,1,0
5,GO SPINAL CORD PATTERNING,0.0060595,-0.17175,-0.27717,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,2.1621e-05,-0.1718,-0.20665,1,0
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.6828e-05,-0.17197,-0.28868,1,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,4.249e-10,-0.17199,-0.25042,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00012594,-0.17209,-0.22737,1,0
5,GO CELL CELL RECOGNITION,7.1819e-07,-0.17233,-0.23621,1,0
5,GO REGULATION OF CENTROSOME CYCLE,0.0035605,-0.17241,-0.20041,1,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,3.152e-06,-0.17273,-0.27717,1,0
5,GO INTRACILIARY TRANSPORT,0.00059648,-0.17291,-0.23472,1,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.00037835,-0.17302,-0.26112,1,0
5,GO DNA CATABOLIC PROCESS,4.7488e-06,-0.17312,-0.21878,1,0
5,GO HISTONE H3 ACETYLATION,1.0861e-06,-0.17348,-0.2813,1,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,9.6562e-05,-0.17359,-0.31959,1,0
5,GO NUCLEOSIDE METABOLIC PROCESS,1.9175e-06,-0.1736,-0.22138,1,0
5,GO TRNA TRANSPORT,0.00059648,-0.17368,-0.22547,1,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.014658,-0.17374,-0.25889,1,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,1.2143e-08,-0.17376,-0.28496,1,0
5,GO REGULATION OF DNA METABOLIC PROCESS,3.0811e-07,-0.17387,-0.26743,1,0
5,GO POSITIVE REGULATION OF DNA BINDING,6.337e-06,-0.17394,-0.24396,1,0
5,GO CHROMATIN ORGANIZATION,3.0156e-07,-0.17395,-0.28118,1,0
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,2.0478e-05,-0.17402,-0.20189,1,0
5,GO PEPTIDYL LYSINE ACETYLATION,7.2414e-06,-0.17405,-0.27581,1,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00015583,-0.17406,-0.21394,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.4972e-05,-0.1742,-0.23134,1,0
5,GO REGULATION OF NUCLEAR DIVISION,7.2414e-06,-0.17422,-0.22826,1,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00021857,-0.17425,-0.29429,1,0
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,1.785e-11,-0.17428,-0.32907,1,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,2.2958e-06,-0.17431,-0.23603,1,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.0554e-07,-0.17465,-0.26479,1,0
5,GO MITOTIC CELL CYCLE,6.8885e-07,-0.17468,-0.25664,1,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.001704,-0.17472,-0.17595,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,9.3381e-05,-0.17479,-0.21135,1,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00086244,-0.17491,-0.25972,1,0
5,GO PROTEIN AUTOPROCESSING,0.0021798,-0.17505,-0.18797,1,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.9175e-06,-0.17537,-0.29266,1,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,3.9872e-06,-0.17538,-0.27011,1,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00044781,-0.17538,-0.26231,1,0
5,GO T HELPER CELL LINEAGE COMMITMENT,0.00044781,-0.17539,-0.22241,1,0
5,GO PROTEIN CATABOLIC PROCESS,4.1125e-12,-0.17544,-0.32545,1,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00071283,-0.17555,-0.23556,1,0
5,GO ZINC ION HOMEOSTASIS,0.026561,-0.17557,-0.20102,1,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00010497,-0.1756,-0.22012,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0030436,-0.17625,-0.23575,1,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,3.094e-05,-0.1763,-0.29394,1,0
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,1.484e-09,-0.17647,-0.31451,1,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,2.2775e-07,-0.17661,-0.29452,1,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,1.3056e-06,-0.17663,-0.25391,1,0
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,9.5999e-07,-0.17676,-0.25384,1,0
5,GO ENDOSOMAL TRANSPORT,1.5604e-09,-0.17718,-0.33025,1,0
5,GO DNA INTEGRITY CHECKPOINT,1.4454e-06,-0.17722,-0.27403,1,0
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,5.3747e-08,-0.17728,-0.22984,1,0
5,GO RRNA TRANSCRIPTION,0.00082553,-0.17751,-0.2285,1,0
5,GO MACROMOLECULE CATABOLIC PROCESS,7.479e-12,-0.17762,-0.28795,1,0
5,GO POSITIVE THYMIC T CELL SELECTION,3.5646e-05,-0.17769,-0.26352,1,0
5,GO NUCLEOSIDE SALVAGE,0.013394,-0.17789,-0.12846,1,0
5,GO TRANSFERRIN TRANSPORT,6.2046e-07,-0.17796,-0.29134,1,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.004964,-0.17819,-0.25964,1,0
5,GO PHOTORECEPTOR CELL MAINTENANCE,7.5001e-05,-0.17827,-0.21767,1,0
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,1.0519e-10,-0.17832,-0.31924,1,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,5.4184e-05,-0.17863,-0.26757,1,0
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.001422,-0.17868,-0.19781,1,0
5,GO POSITIVE REGULATION OF HORMONE SECRETION,2.1624e-06,-0.17892,-0.26675,1,0
5,GO AXONEME ASSEMBLY,0.00014129,-0.17905,-0.24425,1,0
5,GO SLEEP,0.00062378,-0.17941,-0.20898,1,0
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.014172,-0.17951,-0.155,1,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,4.1456e-06,-0.17967,-0.28656,1,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,9.086e-06,-0.17973,-0.30112,1,0
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00010323,-0.17973,-0.28682,1,0
5,GO PROTEIN METHYLATION,5.5412e-06,-0.18006,-0.26567,1,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00020178,-0.18016,-0.26089,1,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.00012186,-0.18019,-0.2155,1,0
5,GO DNA METHYLATION,8.5858e-05,-0.18024,-0.23735,1,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.007921,-0.1804,-0.30152,1,0
5,GO NUCLEAR PORE ORGANIZATION,0.0071051,-0.18065,-0.22228,1,0
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0012886,-0.18076,-0.19624,1,0
5,GO CELL DIVISION,5.2445e-07,-0.18078,-0.2675,1,0
5,GO INTRACELLULAR TRANSPORT,2.559e-11,-0.181,-0.28482,1,0
5,GO CHROMATIN REMODELING,4.0314e-05,-0.18123,-0.23203,1,0
5,GO PROTEIN TARGETING,4.1552e-07,-0.18151,-0.16775,1,0
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.2027e-05,-0.18174,-0.21977,1,0
5,GO AMINE BIOSYNTHETIC PROCESS,0.00043435,-0.18184,-0.24162,1,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0063654,-0.18198,-0.15521,1,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.00030449,-0.182,-0.25037,1,0
5,GO POLYOL CATABOLIC PROCESS,1.6994e-06,-0.18201,-0.31099,1,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.0013069,-0.18246,-0.16553,1,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0049019,-0.1827,-0.18353,1,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,7.2414e-06,-0.18275,-0.26692,1,0
5,GO PHOTOPERIODISM,4.5684e-06,-0.18283,-0.26876,1,0
5,GO GOLGI LOCALIZATION,9.6129e-06,-0.18285,-0.29508,1,0
5,GO RESPONSE TO UV C,9.819e-05,-0.18287,-0.27903,1,0
5,GO DIGESTION,9.795e-06,-0.1829,-0.22513,1,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,6.2993e-08,-0.18296,-0.23754,1,0
5,GO MEMBRANE DOCKING,2.3784e-07,-0.18303,-0.29865,1,0
5,GO FAT CELL PROLIFERATION,0.0029256,-0.1834,-0.23898,1,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00019857,-0.18378,-0.21692,1,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,2.4861e-06,-0.18409,-0.254,1,0
5,GO NODAL SIGNALING PATHWAY,0.001568,-0.18448,-0.17185,1,0
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,1.6321e-06,-0.18478,-0.36125,1,0
5,GO COVALENT CHROMATIN MODIFICATION,2.6362e-08,-0.18491,-0.29941,1,0
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00053704,-0.18498,-0.24279,1,0
5,GO EXIT FROM MITOSIS,4.8839e-05,-0.18499,-0.23515,1,0
5,GO BLASTOCYST DEVELOPMENT,1.3468e-07,-0.18507,-0.22948,1,0
5,GO MITOCHONDRION LOCALIZATION,1.9044e-05,-0.1851,-0.29514,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,8.1623e-05,-0.18516,-0.24617,1,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.016205,-0.18523,-0.14734,1,0
5,GO CELL FATE SPECIFICATION,0.00064263,-0.18532,-0.21589,1,0
5,GO CEREBELLAR CORTEX FORMATION,0.0013826,-0.18542,-0.26383,1,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.001955,-0.18545,-0.18533,1,0
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,8.8282e-08,-0.18556,-0.25849,1,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,2.9332e-05,-0.18559,-0.32671,1,0
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,5.3617e-10,-0.18565,-0.25319,1,0
5,GO HISTONE H2A UBIQUITINATION,7.8911e-05,-0.18576,-0.24438,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE,1.1245e-09,-0.18587,-0.287,1,0
5,GO CELLULAR MACROMOLECULE LOCALIZATION,1.2417e-11,-0.18595,-0.30338,1,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,1.7442e-10,-0.18615,-0.26013,1,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,2.971e-06,-0.18618,-0.33069,1,0
5,GO ALDITOL METABOLIC PROCESS,0.00025617,-0.18619,-0.27444,1,0
5,GO DNA REPLICATION,0.00042128,-0.18619,-0.22105,1,0
5,GO ATP BIOSYNTHETIC PROCESS,0.00095459,-0.1862,-0.25755,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,1.5372e-07,-0.18623,-0.23889,1,0
5,GO PEPTIDYL ASPARAGINE MODIFICATION,5.2344e-05,-0.18625,-0.22447,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,7.2964e-10,-0.18629,-0.28712,1,0
5,GO ORGANELLE DISASSEMBLY,1.1307e-08,-0.18629,-0.28662,1,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,8.6328e-08,-0.1863,-0.25117,1,0
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,6.4592e-06,-0.18635,-0.2291,1,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,1.7706e-05,-0.18635,-0.23641,1,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,2.2397e-08,-0.18646,-0.25001,1,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0023637,-0.18649,-0.16376,1,0
5,GO NCRNA EXPORT FROM NUCLEUS,9.4959e-05,-0.1865,-0.25219,1,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.0029256,-0.18655,-0.1612,1,0
5,GO REGULATION OF PROTEIN SUMOYLATION,1.5713e-07,-0.18669,-0.32287,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE,1.2253e-05,-0.18672,-0.25564,1,0
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.0030038,-0.18681,-0.19449,1,0
5,GO PEPTIDYL ARGININE MODIFICATION,1.0361e-05,-0.18691,-0.23028,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,3.2057e-05,-0.18704,-0.27612,1,0
5,GO CELLULAR RESPONSE TO ATP,1.2328e-07,-0.18709,-0.26488,1,0
5,GO ERAD PATHWAY,9.028e-08,-0.18729,-0.33946,1,0
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,3.9309e-10,-0.18729,-0.3165,1,0
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,3.8645e-11,-0.18753,-0.32546,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,6.8348e-09,-0.18771,-0.2055,1,0
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.7797e-11,-0.18774,-0.32054,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION,2.004e-09,-0.18782,-0.31781,1,0
5,GO REGULATION OF PROSTAGLANDIN SECRETION,5.6085e-05,-0.18814,-0.26001,1,0
5,GO CYTOKINETIC PROCESS,4.7172e-05,-0.18819,-0.26697,1,0
5,GO RESPONSE TO DOPAMINE,7.3803e-06,-0.18821,-0.28493,1,0
5,GO SEQUESTERING OF METAL ION,0.00013899,-0.18825,-0.22426,1,0
5,GO REGULATION OF CELL MATURATION,5.1351e-07,-0.18834,-0.25047,1,0
5,GO MAINTENANCE OF ORGANELLE LOCATION,3.2057e-05,-0.18875,-0.2895,1,0
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,1.8135e-09,-0.18889,-0.30907,1,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.00013899,-0.18903,-0.22903,1,0
5,GO NCRNA CATABOLIC PROCESS,6.6066e-07,-0.18932,-0.28902,1,0
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00010852,-0.18938,-0.2194,1,0
5,GO ORGANELLE ASSEMBLY,2.3312e-10,-0.18962,-0.29309,1,0
5,GO RESPONSE TO ALKALOID,5.3562e-07,-0.18966,-0.27474,1,0
5,GO REGULATION OF MEMBRANE PERMEABILITY,1.8032e-05,-0.1897,-0.24558,1,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.0302e-06,-0.18971,-0.24447,1,0
5,GO REGULATION OF TELOMERASE ACTIVITY,8.5858e-05,-0.18983,-0.26427,1,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,3.4003e-08,-0.18983,-0.24808,1,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00012594,-0.18999,-0.28806,1,0
5,GO REGULATION OF GENE SILENCING,1.3599e-06,-0.19015,-0.25837,1,0
5,GO ARACHIDONIC ACID SECRETION,6.7105e-06,-0.1902,-0.29134,1,0
5,GO PROTEIN HETEROOLIGOMERIZATION,2.5868e-06,-0.19046,-0.27412,1,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.0005618,-0.19052,-0.24831,1,0
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,6.3088e-12,-0.19052,-0.342,1,0
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,6.3249e-05,-0.19066,-0.28872,1,0
5,GO ANDROGEN METABOLIC PROCESS,0.001776,-0.19067,-0.21276,1,0
5,GO EXECUTION PHASE OF APOPTOSIS,5.2538e-08,-0.19074,-0.277,1,0
5,GO HEPATOCYTE DIFFERENTIATION,1.8701e-05,-0.19074,-0.29026,1,0
5,GO CELLULAR RESPONSE TO MANGANESE ION,1.9749e-05,-0.19077,-0.27244,1,0
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,1.7154e-07,-0.19092,-0.27309,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,6.7105e-06,-0.19099,-0.21655,1,0
5,GO FOLIC ACID METABOLIC PROCESS,1.1165e-05,-0.19119,-0.28993,1,0
5,GO PEPTIDE HORMONE SECRETION,2.4837e-07,-0.19119,-0.31662,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,6.4341e-05,-0.19121,-0.2147,1,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,3.2631e-05,-0.19133,-0.21031,1,0
5,GO CILIUM ORGANIZATION,4.8198e-07,-0.1914,-0.29019,1,0
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,4.1026e-05,-0.19143,-0.309,1,0
5,GO REGULATION OF CILIUM ASSEMBLY,4.2271e-06,-0.1915,-0.2826,1,0
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,6.337e-06,-0.19165,-0.30174,1,0
5,GO DORSAL VENTRAL PATTERN FORMATION,3.3214e-05,-0.19173,-0.25494,1,0
5,GO GLYCOSIDE METABOLIC PROCESS,0.026013,-0.19173,-0.22282,1,0
5,GO EAR MORPHOGENESIS,2.1338e-07,-0.19174,-0.29267,1,0
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,5.9834e-06,-0.19193,-0.26375,1,0
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,9.0235e-07,-0.19207,-0.24356,1,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,1.9136e-07,-0.19209,-0.26985,1,0
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,8.8282e-08,-0.19209,-0.25233,1,0
5,GO REGULATION OF PH,6.0979e-10,-0.19211,-0.28398,1,0
5,GO CELLULAR RESPONSE TO HEAT,3.9822e-07,-0.19215,-0.29255,1,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,2.5359e-06,-0.19221,-0.25092,1,0
5,GO BLASTOCYST GROWTH,0.0001862,-0.19226,-0.25707,1,0
5,GO PROTEIN POLYUBIQUITINATION,1.4112e-09,-0.19229,-0.29316,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,3.4773e-06,-0.19233,-0.24423,1,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00096848,-0.1924,-0.26199,1,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.00026858,-0.1926,-0.21251,1,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.00052901,-0.19263,-0.22082,1,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00010852,-0.19273,-0.21051,1,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0015463,-0.19278,-0.19567,1,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,1.0527e-08,-0.19282,-0.28955,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,1.6823e-09,-0.19308,-0.28738,1,0
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,1.1415e-11,-0.19318,-0.32745,1,0
5,GO POSITIVE REGULATION OF DNA REPAIR,6.8888e-05,-0.1934,-0.26702,1,0
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.001071,-0.19361,-0.21055,1,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00054518,-0.1941,-0.20936,1,0
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,1.0554e-07,-0.19432,-0.26279,1,0
5,GO TRANSPORT ALONG MICROTUBULE,2.5359e-06,-0.19444,-0.29907,1,0
5,GO MULTICELLULAR ORGANISM AGING,2.9332e-05,-0.1945,-0.25262,1,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015038,-0.19466,-0.26833,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,8.3747e-12,-0.19472,-0.34581,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00020835,-0.19525,-0.25365,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,5.1356e-08,-0.19527,-0.3288,1,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,1.0791e-07,-0.19527,-0.26071,1,0
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.7452e-06,-0.19547,-0.25972,1,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,3.8149e-08,-0.19556,-0.28045,1,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,8.6937e-09,-0.19564,-0.26553,1,0
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,4.3606e-10,-0.19569,-0.31369,1,0
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,4.31e-06,-0.19569,-0.30106,1,0
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,4.9403e-11,-0.19571,-0.32671,1,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.0756e-05,-0.19586,-0.24754,1,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.00059648,-0.19588,-0.27931,1,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,4.7999e-05,-0.19613,-0.27225,1,0
5,GO DNA DEALKYLATION,0.00010323,-0.19621,-0.23768,1,0
5,GO RETINA HOMEOSTASIS,1.3468e-07,-0.19626,-0.20346,1,0
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,2.801e-10,-0.19636,-0.31906,1,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0049019,-0.19638,-0.19654,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,3.9102e-06,-0.19653,-0.23122,1,0
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00074504,-0.19668,-0.24884,1,0
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.00058763,-0.19678,-0.23785,1,0
5,GO OOGENESIS,6.8885e-07,-0.19692,-0.24296,1,0
5,GO DOPAMINE METABOLIC PROCESS,0.00015331,-0.19728,-0.27595,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00073415,-0.19729,-0.19335,1,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00037835,-0.19733,-0.23717,1,0
5,GO RESPONSE TO LIGHT STIMULUS,8.9487e-10,-0.19734,-0.29171,1,0
5,GO STEROL BIOSYNTHETIC PROCESS,0.00061456,-0.19758,-0.23159,1,0
5,GO GLYCINE METABOLIC PROCESS,0.0019285,-0.1976,-0.21608,1,0
5,GO CILIUM MOVEMENT,1.5372e-07,-0.19771,-0.2421,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.6542e-10,-0.19778,-0.33441,1,0
5,GO SENSORY PERCEPTION,1.3085e-09,-0.19786,-0.26915,1,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.0018508,-0.19793,-0.18217,1,0
5,GO RESPONSE TO RADIATION,2.457e-10,-0.19795,-0.29391,1,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00053704,-0.19795,-0.24789,1,0
5,GO OUTER DYNEIN ARM ASSEMBLY,0.0003557,-0.19795,-0.25879,1,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,6.4699e-07,-0.19807,-0.26204,1,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,3.152e-06,-0.19814,-0.22159,1,0
5,GO PROTEIN K48 LINKED UBIQUITINATION,6.5125e-09,-0.19821,-0.29649,1,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,1.6158e-05,-0.19824,-0.25824,1,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,6.4699e-07,-0.19826,-0.30148,1,0
5,GO HISTONE H2A ACETYLATION,0.012653,-0.19833,-0.15398,1,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00032916,-0.19834,-0.27085,1,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,4.1026e-05,-0.19838,-0.2744,1,0
5,GO HISTONE H3 K9 TRIMETHYLATION,0.00025617,-0.19863,-0.27431,1,0
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,5.6245e-08,-0.19863,-0.29575,1,0
5,GO RESPONSE TO COCAINE,3.4409e-05,-0.19871,-0.28479,1,0
5,GO AXO DENDRITIC TRANSPORT,2.342e-06,-0.19875,-0.34061,1,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,7.6657e-06,-0.19879,-0.2569,1,0
5,GO CELLULAR KETONE METABOLIC PROCESS,1.5753e-08,-0.19884,-0.26449,1,0
5,GO FEEDING BEHAVIOR,5.7582e-06,-0.19895,-0.25928,1,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0040509,-0.19901,-0.21128,1,0
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,5.1351e-07,-0.19912,-0.34494,1,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.000286,-0.19919,-0.22231,1,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.032607,-0.19966,-0.19973,1,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.011151,-0.19972,-0.1838,1,0
5,GO REGULATION OF MRNA POLYADENYLATION,7.9617e-06,-0.19976,-0.29627,1,0
5,GO RESPONSE TO FUNGUS,2.9859e-05,-0.19993,-0.21985,1,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00058763,-0.19996,-0.26102,1,0
5,GO GLYCOSYLATION,1.6407e-09,-0.19996,-0.33649,1,0
5,GO PROTEIN MANNOSYLATION,0.00015583,-0.20014,-0.27247,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00013451,-0.20026,-0.25062,1,0
5,GO ORGANIC ACID TRANSPORT,1.2348e-10,-0.20029,-0.33478,1,0
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.001235,-0.20036,-0.18538,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,4.2271e-06,-0.20037,-0.23509,1,0
5,GO REGULATION OF ICOSANOID SECRETION,9.03e-05,-0.20037,-0.27514,1,0
5,GO MULTI ORGANISM PROCESS,5.0766e-11,-0.20039,-0.2947,1,0
5,GO MICROTUBULE NUCLEATION,0.000662,-0.20042,-0.32081,1,0
5,GO GERM CELL DEVELOPMENT,3.6435e-08,-0.20052,-0.2515,1,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,4.6202e-07,-0.2007,-0.28072,1,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00011596,-0.20087,-0.24078,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,2.8886e-07,-0.20101,-0.27336,1,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.8389e-07,-0.20109,-0.31018,1,0
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0019285,-0.20111,-0.20966,1,0
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.5884e-05,-0.20118,-0.21784,1,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,2.6914e-06,-0.20119,-0.25795,1,0
5,GO RNA DECAPPING,4.7488e-06,-0.20122,-0.29038,1,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0011021,-0.20134,-0.26009,1,0
5,GO MICROTUBULE BASED MOVEMENT,1.439e-07,-0.20137,-0.28044,1,0
5,GO RESPONSE TO NITRIC OXIDE,3.7356e-07,-0.20155,-0.25435,1,0
5,GO DETECTION OF STIMULUS,6.4434e-08,-0.20156,-0.23535,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.014332,-0.20157,-0.14274,1,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.8076e-11,-0.20157,-0.30868,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,7.3772e-08,-0.20168,-0.2286,1,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0045438,-0.20186,-0.27975,1,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.00010323,-0.20199,-0.2898,1,0
5,GO PROTEIN O LINKED GLYCOSYLATION,2.7078e-07,-0.202,-0.33345,1,0
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,5.0922e-10,-0.20201,-0.32477,1,0
5,GO INTERACTION WITH SYMBIONT,3.4003e-08,-0.20215,-0.28534,1,0
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,7.0522e-08,-0.20228,-0.26483,1,0
5,GO RESPONSE TO ATP,2.2139e-09,-0.20235,-0.29629,1,0
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,7.1121e-10,-0.2024,-0.30863,1,0
5,GO APOPTOTIC DNA FRAGMENTATION,2.4091e-05,-0.20253,-0.20131,1,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.4701e-07,-0.20256,-0.27413,1,0
5,GO SINGLE FERTILIZATION,1.1307e-08,-0.20261,-0.26306,1,0
5,GO HETEROCHROMATIN ORGANIZATION,5.6487e-06,-0.20272,-0.29461,1,0
5,GO SPERMATID DIFFERENTIATION,4.2444e-07,-0.20279,-0.23324,1,0
5,GO MACROMOLECULE DEACYLATION,1.3761e-09,-0.2028,-0.33821,1,0
5,GO REGULATION OF DNA BINDING,5.8856e-08,-0.20283,-0.26574,1,0
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.5027e-08,-0.20317,-0.26959,1,0
5,GO MULTICELLULAR ORGANISM REPRODUCTION,1.2023e-10,-0.20324,-0.28944,1,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.9514e-07,-0.20339,-0.30292,1,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,4.5684e-06,-0.20346,-0.24723,1,0
5,GO REGULATION OF ORGANELLE ORGANIZATION,1.887e-11,-0.2035,-0.33711,1,0
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,1.0212e-06,-0.20364,-0.28537,1,0
5,GO POSITIVE REGULATION OF TRANSLATION,1.9465e-08,-0.20371,-0.27034,1,0
5,GO VESICLE BUDDING FROM MEMBRANE,6.4192e-10,-0.20374,-0.33625,1,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,3.1729e-08,-0.20381,-0.28536,1,0
5,GO HISTONE METHYLATION,4.7488e-06,-0.20384,-0.27752,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,5.1304e-06,-0.20392,-0.26117,1,0
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00042777,-0.20393,-0.25626,1,0
5,GO DNA DEMETHYLATION,0.00031414,-0.20394,-0.24227,1,0
5,GO ACETYL COA METABOLIC PROCESS,2.8886e-07,-0.20402,-0.3276,1,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,6.4699e-07,-0.2041,-0.3418,1,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00073415,-0.20419,-0.28982,1,0
5,GO MYOBLAST PROLIFERATION,8.5867e-06,-0.20435,-0.29965,1,0
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,5.3647e-09,-0.20451,-0.35545,1,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,2.2286e-07,-0.20466,-0.30472,1,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,8.2543e-08,-0.20472,-0.35866,1,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,8.4805e-07,-0.20476,-0.28788,1,0
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.8305e-05,-0.20493,-0.2563,1,0
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00013232,-0.20495,-0.18663,1,0
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,1.5604e-09,-0.20526,-0.28213,1,0
5,GO SYMBIOTIC PROCESS,3.8301e-10,-0.20528,-0.27238,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.3249e-05,-0.20557,-0.25741,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,9.6431e-12,-0.20562,-0.34675,1,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00026858,-0.20563,-0.23172,1,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,7.2414e-06,-0.20563,-0.26703,1,0
5,GO HISTONE H3 K4 METHYLATION,9.4959e-05,-0.20573,-0.22583,1,0
5,GO WALKING BEHAVIOR,0.00075607,-0.20575,-0.25168,1,0
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.001422,-0.20578,-0.31299,1,0
5,GO CELL REDOX HOMEOSTASIS,9.9844e-05,-0.20579,-0.19444,1,0
5,GO REGULATION OF PROTON TRANSPORT,0.00031907,-0.20579,-0.23778,1,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.028e-08,-0.20583,-0.27569,1,0
5,GO P BODY ASSEMBLY,3.0811e-07,-0.20613,-0.31489,1,0
5,GO OXIDATION REDUCTION PROCESS,6.205e-09,-0.20636,-0.26583,1,0
5,GO EATING BEHAVIOR,1.0361e-05,-0.20655,-0.2322,1,0
5,GO SIGNAL RELEASE,1.2143e-08,-0.20655,-0.31813,1,0
5,GO FATTY ACID BETA OXIDATION,5.4982e-08,-0.20663,-0.31591,1,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0022701,-0.2067,-0.24139,1,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,2.7668e-07,-0.20676,-0.31702,1,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION,2.9514e-07,-0.20689,-0.28617,1,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,3.9102e-06,-0.20689,-0.28746,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.2926e-08,-0.20689,-0.28717,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00044781,-0.2069,-0.29899,1,0
5,GO AXONAL TRANSPORT,6.9711e-06,-0.20699,-0.34327,1,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.013546,-0.20704,-0.25435,1,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,3.5597e-11,-0.20719,-0.33077,1,0
5,GO REGULATION OF TRANSPORT,5.1691e-12,-0.20731,-0.35007,1,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,4.8198e-07,-0.20732,-0.28743,1,0
5,GO SPERM MOTILITY,1.6782e-07,-0.20738,-0.2365,1,0
5,GO O GLYCAN PROCESSING,9.9803e-06,-0.20767,-0.33827,1,0
5,GO RETINOIC ACID METABOLIC PROCESS,0.00029052,-0.20769,-0.21235,1,0
5,GO DENDRITE EXTENSION,0.0014624,-0.20771,-0.24623,1,0
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,3.8118e-09,-0.20778,-0.30984,1,0
5,GO HORMONE TRANSPORT,6.0205e-08,-0.20784,-0.31476,1,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.0042095,-0.2081,-0.21257,1,0
5,GO REGULATION OF MEIOTIC CELL CYCLE,1.0958e-05,-0.20812,-0.24803,1,0
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00074504,-0.2082,-0.27047,1,0
5,GO OOCYTE DIFFERENTIATION,2.5424e-05,-0.20823,-0.23016,1,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.5604e-09,-0.20838,-0.32606,1,0
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,9.1793e-10,-0.20852,-0.31544,1,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.00011986,-0.20855,-0.28621,1,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,1.1034e-07,-0.20868,-0.33728,1,0
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,2.6306e-11,-0.20885,-0.33711,1,0
5,GO SUBPALLIUM DEVELOPMENT,0.0040509,-0.20887,-0.29441,1,0
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,1.3671e-08,-0.20906,-0.32024,1,0
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00020504,-0.2091,-0.25667,1,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,6.5125e-09,-0.20916,-0.2998,1,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,1.0424e-06,-0.20916,-0.30944,1,0
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,4.1815e-08,-0.20923,-0.24915,1,0
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,2.8305e-05,-0.20937,-0.33384,1,0
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.9465e-08,-0.2094,-0.31734,1,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0052854,-0.20952,-0.18709,1,0
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0001179,-0.20958,-0.27696,1,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,9.03e-05,-0.20967,-0.21169,1,0
5,GO INTESTINAL LIPID ABSORPTION,0.0042095,-0.20969,-0.31195,1,0
5,GO NIK NF KAPPAB SIGNALING,1.9989e-07,-0.20986,-0.27259,1,0
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00037835,-0.20998,-0.22789,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.0958e-05,-0.21018,-0.37005,1,0
5,GO MITOCHONDRIAL FISSION,1.3769e-07,-0.21023,-0.36008,1,0
5,GO IMPORT INTO NUCLEUS,2.9805e-09,-0.21033,-0.2941,1,0
5,GO HISTONE PHOSPHORYLATION,9.7991e-09,-0.21036,-0.28625,1,0
5,GO ONE CARBON METABOLIC PROCESS,5.0278e-07,-0.21039,-0.26965,1,0
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00032916,-0.21051,-0.25373,1,0
5,GO REGULATION OF DNA RECOMBINATION,2.1338e-07,-0.2107,-0.29895,1,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.5424e-05,-0.21071,-0.44067,1,0
5,GO DOSAGE COMPENSATION,0.0001862,-0.21076,-0.27814,1,0
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00041488,-0.2108,-0.23465,1,0
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,1.5994e-06,-0.2108,-0.36851,1,0
5,GO TRANSITION METAL ION TRANSPORT,2.2117e-10,-0.21083,-0.28271,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.9127e-12,-0.21085,-0.33003,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,3.6162e-06,-0.21086,-0.30717,1,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,1.9749e-05,-0.21103,-0.24846,1,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.00025617,-0.21119,-0.24933,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,3.4296e-07,-0.21135,-0.29838,1,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,1.4207e-05,-0.2114,-0.27705,1,0
5,GO VACUOLAR ACIDIFICATION,3.2859e-07,-0.2116,-0.29611,1,0
5,GO PEPTIDYL LYSINE METHYLATION,3.2631e-05,-0.21168,-0.26518,1,0
5,GO LIPOXYGENASE PATHWAY,0.03006,-0.21178,-0.18768,1,0
5,GO NERVOUS SYSTEM PROCESS,4.8359e-10,-0.21182,-0.3122,1,0
5,GO REGULATION OF OOGENESIS,1.1165e-05,-0.21182,-0.23996,1,0
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,6.6578e-05,-0.21184,-0.26485,1,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,2.8262e-08,-0.21188,-0.33928,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0026663,-0.2119,-0.32624,1,0
5,GO FEMALE GAMETE GENERATION,3.3713e-09,-0.2119,-0.27023,1,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.7356e-07,-0.21192,-0.27633,1,0
5,GO PROTEIN SUMOYLATION,2.5868e-06,-0.21197,-0.28385,1,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00017176,-0.21201,-0.34577,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.1234e-05,-0.21212,-0.23978,1,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,4.7999e-05,-0.21214,-0.24952,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,9.086e-06,-0.21227,-0.26133,1,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.3196e-05,-0.21247,-0.30257,1,0
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,9.6562e-05,-0.21265,-0.30251,1,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,9.6562e-05,-0.21267,-0.26177,1,0
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,3.0302e-06,-0.21272,-0.20359,1,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1.0322e-07,-0.21274,-0.34523,1,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,2.2958e-06,-0.2128,-0.2624,1,0
5,GO VESICLE LOCALIZATION,1.0241e-10,-0.21282,-0.36271,1,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,9.2118e-07,-0.21292,-0.2754,1,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.6283e-05,-0.21293,-0.21513,1,0
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,1.4163e-06,-0.21303,-0.27469,1,0
5,GO RESPONSE TO GAMMA RADIATION,8.0712e-08,-0.21306,-0.3041,1,0
5,GO MITOTIC CHROMOSOME CONDENSATION,0.0055559,-0.21311,-0.22178,1,0
5,GO DENDRITE SELF AVOIDANCE,0.002702,-0.21325,-0.2404,1,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,6.5837e-06,-0.21336,-0.38451,1,0
5,GO HUMORAL IMMUNE RESPONSE,6.205e-09,-0.21357,-0.30246,1,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,9.2585e-06,-0.21377,-0.36368,1,0
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.2253e-05,-0.21381,-0.29245,1,0
5,GO REGULATION OF CGMP MEDIATED SIGNALING,3.7605e-06,-0.21399,-0.46219,1,0
5,GO REGULATION OF HISTONE UBIQUITINATION,1.064e-06,-0.21409,-0.2584,1,0
5,GO PROTEIN LOCALIZATION TO MEMBRANE,4.5526e-11,-0.21411,-0.28121,1,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.011022,-0.21429,-0.22739,1,0
5,GO ORGANIC ACID METABOLIC PROCESS,1.4487e-10,-0.21429,-0.30029,1,0
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.0429e-07,-0.21452,-0.31571,1,0
5,GO DENSE CORE GRANULE TRANSPORT,0.0081133,-0.21469,-0.34661,1,0
5,GO PROTEIN HOMOTETRAMERIZATION,1.0161e-09,-0.21488,-0.30349,1,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,3.7356e-07,-0.21499,-0.26463,1,0
5,GO GLUTATHIONE METABOLIC PROCESS,8.7316e-05,-0.215,-0.24914,1,0
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00023667,-0.21504,-0.25037,1,0
5,GO PIGMENT METABOLIC PROCESS,4.6202e-07,-0.21505,-0.29187,1,0
5,GO MICROTUBULE BUNDLE FORMATION,1.3599e-06,-0.21508,-0.27856,1,0
5,GO REGULATION OF HORMONE LEVELS,1.0279e-08,-0.21509,-0.30233,1,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,6.7105e-06,-0.21511,-0.30336,1,0
5,GO HEART FIELD SPECIFICATION,0.00020504,-0.21512,-0.34866,1,0
5,GO STEROID BIOSYNTHETIC PROCESS,2.9514e-07,-0.21541,-0.28132,1,0
5,GO NEURON APOPTOTIC PROCESS,5.3647e-09,-0.21546,-0.32386,1,0
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00036686,-0.21547,-0.27569,1,0
5,GO GLUTAMATE METABOLIC PROCESS,1.7693e-06,-0.21586,-0.26386,1,0
5,GO PEPTIDYL AMINO ACID MODIFICATION,1.8863e-12,-0.21587,-0.35065,1,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,8.1623e-05,-0.2159,-0.30671,1,0
5,GO CELL FATE COMMITMENT,9.028e-08,-0.21594,-0.29804,1,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,4.9069e-08,-0.21599,-0.257,1,0
5,GO RHYTHMIC PROCESS,2.2707e-10,-0.21599,-0.3426,1,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,3.8924e-05,-0.21601,-0.25401,1,0
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0063654,-0.21613,-0.30444,1,0
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.00063314,-0.21616,-0.24508,1,0
5,GO REGULATION OF ORGANIC ACID TRANSPORT,1.9558e-07,-0.2163,-0.32636,1,0
5,GO DIGESTIVE SYSTEM PROCESS,4.0678e-07,-0.21638,-0.25936,1,0
5,GO FATTY ACID DERIVATIVE TRANSPORT,3.6435e-08,-0.21651,-0.33328,1,0
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,1.4677e-08,-0.21654,-0.41507,1,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,6.6717e-09,-0.21658,-0.33908,1,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.00022565,-0.21659,-0.22905,1,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.028556,-0.21666,-0.22622,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,1.2032e-06,-0.21672,-0.32529,1,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.2344e-05,-0.21679,-0.29852,1,0
5,GO DIOL BIOSYNTHETIC PROCESS,0.0005618,-0.21686,-0.26719,1,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.00011033,-0.21689,-0.28141,1,0
5,GO RESPONSE TO IMMOBILIZATION STRESS,4.6359e-05,-0.21702,-0.27957,1,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.1034e-07,-0.21707,-0.26464,1,0
5,GO SPERM CAPACITATION,2.1621e-05,-0.21707,-0.22956,1,0
5,GO PROTEOLYSIS,6.6774e-12,-0.21711,-0.32711,1,0
5,GO PEPTIDYL LYSINE TRIMETHYLATION,1.734e-06,-0.21722,-0.30874,1,0
5,GO RETINOL METABOLIC PROCESS,3.2631e-05,-0.21728,-0.24018,1,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.0028872,-0.21749,-0.21822,1,0
5,GO HEMOGLOBIN METABOLIC PROCESS,1.2792e-06,-0.21762,-0.34936,1,0
5,GO LYSINE METABOLIC PROCESS,0.0083098,-0.21763,-0.21394,1,0
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0049019,-0.21776,-0.24982,1,0
5,GO PROTEIN IMPORT,2.0437e-10,-0.21776,-0.30673,1,0
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,2.856e-06,-0.21784,-0.33513,1,0
5,GO HISTONE H4 DEACETYLATION,4.4285e-07,-0.21784,-0.31441,1,0
5,GO HISTONE H3 K14 ACETYLATION,1.3442e-05,-0.21788,-0.2732,1,0
5,GO MACROAUTOPHAGY,1.9402e-11,-0.21791,-0.33979,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,3.2057e-05,-0.21798,-0.31141,1,0
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,1.9563e-06,-0.21811,-0.28394,1,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,8.6937e-09,-0.21811,-0.33999,1,0
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00043435,-0.21817,-0.25142,1,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,4.8673e-09,-0.21824,-0.2967,1,0
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,6.757e-10,-0.21831,-0.3023,1,0
5,GO PHOSPHATE ION TRANSPORT,3.357e-07,-0.21835,-0.29081,1,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,1.3671e-08,-0.21838,-0.30629,1,0
5,GO MITOCHONDRIAL DNA REPLICATION,3.8246e-05,-0.21839,-0.24943,1,0
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,5.6317e-09,-0.21848,-0.34022,1,0
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,1.3196e-05,-0.21851,-0.26461,1,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,7.3739e-05,-0.21852,-0.20985,1,0
5,GO PROTEIN POLYMERIZATION,2.1085e-11,-0.21872,-0.36999,1,0
5,GO SMALL MOLECULE CATABOLIC PROCESS,1.3761e-09,-0.21882,-0.295,1,0
5,GO INTERLEUKIN 12 PRODUCTION,1.5674e-06,-0.21885,-0.30561,1,0
5,GO ORGAN INDUCTION,3.9102e-06,-0.21885,-0.29031,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.0958e-05,-0.21893,-0.26968,1,0
5,GO NADP METABOLIC PROCESS,1.2954e-05,-0.21896,-0.29697,1,0
5,GO MISMATCH REPAIR,1.4207e-05,-0.21899,-0.25233,1,0
5,GO MICROTUBULE SEVERING,6.6578e-05,-0.21908,-0.29193,1,0
5,GO CELLULAR COMPONENT DISASSEMBLY,7.0279e-11,-0.21908,-0.29909,1,0
5,GO EPIDERMAL CELL DIFFERENTIATION,1.0756e-05,-0.21912,-0.28608,1,0
5,GO MICROTUBULE BASED TRANSPORT,1.2281e-06,-0.21919,-0.30305,1,0
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,7.5001e-05,-0.21937,-0.23548,1,0
5,GO ENDOSOME ORGANIZATION,4.9069e-08,-0.21938,-0.30615,1,0
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,4.3606e-10,-0.21941,-0.33319,1,0
5,GO MAINTENANCE OF CELL NUMBER,4.6356e-09,-0.21955,-0.34394,1,0
5,GO POSITIVE REGULATION OF SECRETION,3.1098e-10,-0.21958,-0.33221,1,0
5,GO SULFATE TRANSPORT,4.7172e-05,-0.2196,-0.24661,1,0
5,GO ORGANIC ACID CATABOLIC PROCESS,9.1793e-10,-0.21967,-0.29789,1,0
5,GO RESPONSE TO XENOBIOTIC STIMULUS,2.3891e-06,-0.21975,-0.22222,1,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.0964e-09,-0.22003,-0.34417,1,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,9.2118e-07,-0.2201,-0.31472,1,0
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,3.0811e-07,-0.2202,-0.34896,1,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00026858,-0.22024,-0.27106,1,0
5,GO TOR SIGNALING,8.8611e-12,-0.22027,-0.34977,1,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,2.4371e-06,-0.2203,-0.26745,1,0
5,GO CELLULAR HOMEOSTASIS,7.2702e-12,-0.2204,-0.32032,1,0
5,GO TRANSMEMBRANE TRANSPORT,1.1415e-11,-0.22047,-0.32253,1,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00015331,-0.2205,-0.24964,1,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,5.1446e-05,-0.2205,-0.25126,1,0
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,1.7922e-07,-0.22057,-0.27592,1,0
5,GO HORMONE CATABOLIC PROCESS,0.0023321,-0.22061,-0.24147,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.0522e-08,-0.22062,-0.27662,1,0
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,1.2886e-07,-0.2208,-0.28224,1,0
5,GO RESPONSE TO ABIOTIC STIMULUS,1.1099e-11,-0.2208,-0.32775,1,0
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,3.2785e-11,-0.22091,-0.33766,1,0
5,GO REGULATION OF CATABOLIC PROCESS,2.521e-12,-0.22092,-0.33485,1,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,2.5884e-05,-0.22113,-0.25415,1,0
5,GO TRANSPOSITION,0.0011836,-0.22123,-0.27132,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.3647e-09,-0.22138,-0.31764,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,2.4452e-09,-0.22144,-0.33858,1,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,1.8032e-05,-0.22159,-0.26806,1,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,6.3569e-09,-0.22174,-0.29038,1,0
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.734e-06,-0.22195,-0.25479,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.8723e-07,-0.22207,-0.31537,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,1.6654e-06,-0.22213,-0.3315,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.996e-06,-0.22217,-0.32968,1,0
5,GO GOLGI ORGANIZATION,9.1793e-10,-0.22229,-0.36708,1,0
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,1.3056e-06,-0.2223,-0.29079,1,0
5,GO PROTEIN TETRAMERIZATION,5.3617e-10,-0.22231,-0.30084,1,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.8161e-07,-0.22234,-0.28601,1,0
5,GO REGULATION OF HORMONE SECRETION,3.1729e-08,-0.22238,-0.31161,1,0
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,5.2165e-11,-0.22251,-0.32678,1,0
5,GO NEUTRAL AMINO ACID TRANSPORT,1.0004e-06,-0.22251,-0.37197,1,0
5,GO EAR DEVELOPMENT,1.4334e-08,-0.22263,-0.32871,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,3.8149e-08,-0.22263,-0.31099,1,0
5,GO REGULATION OF CELL FATE COMMITMENT,2.7312e-05,-0.22268,-0.26273,1,0
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,1.4334e-08,-0.22271,-0.2508,1,0
5,GO REGULATION OF PEPTIDE TRANSPORT,3.1032e-11,-0.22271,-0.33737,1,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.3355e-07,-0.22275,-0.35004,1,0
5,GO DETERMINATION OF ADULT LIFESPAN,0.00061456,-0.2228,-0.27235,1,0
5,GO GLIAL CELL FATE COMMITMENT,0.0092477,-0.22283,-0.26231,1,0
5,GO REGULATION OF HISTONE MODIFICATION,3.6293e-09,-0.22286,-0.31501,1,0
5,GO PROTEIN AUTOUBIQUITINATION,8.9558e-11,-0.22297,-0.32066,1,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,6.4699e-07,-0.22298,-0.30128,1,0
5,GO CELLULAR OXIDANT DETOXIFICATION,4.4285e-07,-0.22302,-0.2343,1,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,2.9859e-05,-0.22302,-0.259,1,0
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,6.2175e-05,-0.22321,-0.3101,1,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,3.6293e-09,-0.22338,-0.29636,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,2.9602e-08,-0.22353,-0.30348,1,0
5,GO REGULATION OF PROTEIN ACETYLATION,1.3599e-06,-0.22357,-0.27771,1,0
5,GO CELL CYCLE ARREST,1.3133e-11,-0.2238,-0.34193,1,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.00071283,-0.22382,-0.19024,1,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,4.1552e-07,-0.22385,-0.29174,1,0
5,GO ANION TRANSPORT,1.2074e-11,-0.22387,-0.34361,1,0
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,2.457e-10,-0.22397,-0.29943,1,0
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,1.8793e-06,-0.22404,-0.32155,1,0
5,GO ENDODERMAL CELL FATE COMMITMENT,8.4424e-05,-0.22412,-0.24711,1,0
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,3.055e-09,-0.22425,-0.34612,1,0
5,GO RESPONSE TO HEAT,2.2926e-08,-0.22439,-0.30839,1,0
5,GO ADULT BEHAVIOR,1.6321e-06,-0.22442,-0.3194,1,0
5,GO AUTOPHAGY OF MITOCHONDRION,5.6451e-10,-0.22448,-0.32568,1,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,1.8135e-09,-0.22464,-0.31345,1,0
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.337e-06,-0.22464,-0.32506,1,0
5,GO LEYDIG CELL DIFFERENTIATION,0.0016575,-0.22466,-0.3252,1,0
5,GO VACUOLAR TRANSPORT,6.3074e-11,-0.22468,-0.38062,1,0
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,3.6162e-06,-0.22469,-0.33273,1,0
5,GO HEME METABOLIC PROCESS,1.4741e-05,-0.22485,-0.3076,1,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,3.7605e-06,-0.22485,-0.28421,1,0
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,3.5597e-11,-0.22489,-0.32523,1,0
5,GO REGULATION OF ORGANELLE ASSEMBLY,8.7184e-11,-0.22494,-0.35326,1,0
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,3.1032e-11,-0.22504,-0.34653,1,0
5,GO ANTEROGRADE AXONAL TRANSPORT,2.913e-06,-0.22508,-0.33975,1,0
5,GO FERTILIZATION,1.9064e-09,-0.22509,-0.26601,1,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0019023,-0.22509,-0.23088,1,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00040235,-0.2251,-0.28518,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,2.9371e-11,-0.22511,-0.34184,1,0
5,GO CELLULAR PIGMENTATION,1.5713e-07,-0.22513,-0.29767,1,0
5,GO T CELL APOPTOTIC PROCESS,4.2444e-07,-0.22517,-0.29338,1,0
5,GO SIGNAL PEPTIDE PROCESSING,0.010041,-0.2252,-0.17635,1,0
5,GO CYTOSOLIC TRANSPORT,1.2348e-10,-0.22521,-0.39892,1,0
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,6.757e-10,-0.22522,-0.34306,1,0
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,2.5424e-05,-0.22533,-0.35005,1,0
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,4.6202e-07,-0.22537,-0.26241,1,0
5,GO HOMEOSTATIC PROCESS,3.6667e-12,-0.22546,-0.33122,1,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.0010259,-0.2255,-0.26203,1,0
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,6.8348e-09,-0.22553,-0.33447,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.0958e-05,-0.2256,-0.28449,1,0
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,8.4871e-11,-0.22574,-0.33124,1,0
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,4.3606e-10,-0.22575,-0.37384,1,0
5,GO MACROPHAGE CHEMOTAXIS,5.2445e-07,-0.22577,-0.28524,1,0
5,GO CATECHOLAMINE METABOLIC PROCESS,4.4771e-05,-0.22586,-0.28079,1,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,4.4807e-06,-0.22591,-0.29187,1,0
5,GO DE NOVO PROTEIN FOLDING,0.00018923,-0.22593,-0.25897,1,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00073415,-0.22593,-0.26374,1,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,5.2303e-06,-0.22606,-0.25578,1,0
5,GO CD40 SIGNALING PATHWAY,3.3435e-06,-0.22612,-0.31403,1,0
5,GO NUCLEOTIDE TRANSPORT,1.996e-06,-0.22638,-0.3063,1,0
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,1.6823e-09,-0.2265,-0.36159,1,0
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,7.8052e-07,-0.22651,-0.34349,1,0
5,GO HISTONE DEACETYLATION,1.1041e-08,-0.22654,-0.34746,1,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.4285e-07,-0.22656,-0.34963,1,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.0361e-05,-0.22659,-0.31782,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,7.1274e-05,-0.22659,-0.31687,1,0
5,GO REGULATION OF INSULIN SECRETION,1.1041e-08,-0.22668,-0.33544,1,0
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,9.1146e-12,-0.22669,-0.324,1,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,2.9127e-12,-0.22673,-0.34002,1,0
5,GO TRANSCYTOSIS,6.8396e-06,-0.22678,-0.33194,1,0
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00024819,-0.22684,-0.28854,1,0
5,GO PROTEIN REFOLDING,0.0020929,-0.22695,-0.21477,1,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00019541,-0.22697,-0.25304,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.3351e-08,-0.22699,-0.36174,1,0
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,3.6567e-07,-0.22714,-0.33928,1,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,4.5684e-06,-0.22721,-0.29173,1,0
5,GO REGULATION OF MACROAUTOPHAGY,1.785e-11,-0.22723,-0.35841,1,0
5,GO REGULATION OF TOR SIGNALING,3.3697e-11,-0.22724,-0.36651,1,0
5,GO VIRAL RELEASE FROM HOST CELL,1.439e-07,-0.22748,-0.28856,1,0
5,GO CELL MATURATION,2.634e-09,-0.2276,-0.31138,1,0
5,GO REPRODUCTION,3.7602e-11,-0.22775,-0.3095,1,0
5,GO VISUAL BEHAVIOR,1.9989e-07,-0.22776,-0.32592,1,0
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,2.0478e-05,-0.22778,-0.30908,1,0
5,GO TETRAPYRROLE METABOLIC PROCESS,2.9514e-07,-0.22781,-0.28345,1,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,7.892e-08,-0.22785,-0.32695,1,0
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,2.3933e-10,-0.22799,-0.335,1,0
5,GO MACROPHAGE MIGRATION,1.0791e-07,-0.228,-0.31469,1,0
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,4.9624e-10,-0.22803,-0.37876,1,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,3.1004e-08,-0.22812,-0.30687,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,8.0712e-08,-0.22817,-0.32711,1,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,8.4415e-08,-0.22823,-0.30521,1,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,6.8396e-06,-0.22827,-0.30239,1,0
5,GO ECTODERM DEVELOPMENT,1.5037e-07,-0.22844,-0.28777,1,0
5,GO VITAMIN METABOLIC PROCESS,1.2733e-08,-0.22855,-0.29171,1,0
5,GO CELL AGING,5.9432e-10,-0.22855,-0.3143,1,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.009139,-0.22873,-0.17151,1,0
5,GO CELLULAR RESPONSE TO ALKALOID,2.206e-06,-0.22874,-0.25654,1,0
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,6.8406e-11,-0.2288,-0.3111,1,0
5,GO XENOBIOTIC CATABOLIC PROCESS,0.022686,-0.22881,-0.26484,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,9.9803e-06,-0.22884,-0.27474,1,0
5,GO RESPONSE TO INTERLEUKIN 1,4.8673e-09,-0.22891,-0.27845,1,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,2.206e-06,-0.22897,-0.27961,1,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,8.0712e-08,-0.22897,-0.23385,1,0
5,GO PH REDUCTION,1.5713e-07,-0.22903,-0.25465,1,0
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,1.2604e-07,-0.22904,-0.29268,1,0
5,GO REGULATION OF ACROSOME REACTION,0.0012886,-0.2291,-0.26769,1,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,2.2958e-06,-0.22913,-0.40467,1,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,6.6578e-05,-0.22926,-0.25055,1,0
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.1032e-11,-0.22927,-0.36833,1,0
5,GO PROTEIN HOMOOLIGOMERIZATION,1.9402e-11,-0.22957,-0.32118,1,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,8.0712e-08,-0.22962,-0.3109,1,0
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,5.815e-11,-0.22969,-0.31861,1,0
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,8.2903e-10,-0.22974,-0.2875,1,0
5,GO CELL CELL SIGNALING,7.2202e-11,-0.22975,-0.3419,1,0
5,GO THIOESTER METABOLIC PROCESS,2.7668e-07,-0.23025,-0.28203,1,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00022565,-0.23026,-0.2438,1,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,7.6657e-06,-0.23026,-0.35683,1,0
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,9.2118e-07,-0.23029,-0.30958,1,0
5,GO CARBOHYDRATE TRANSPORT,5.3617e-10,-0.23031,-0.34865,1,0
5,GO RIG I SIGNALING PATHWAY,2.8271e-07,-0.23057,-0.31858,1,0
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00058763,-0.23059,-0.25479,1,0
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,5.9748e-11,-0.23066,-0.36768,1,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,5.3256e-05,-0.23069,-0.28866,1,0
5,GO SENSORY ORGAN MORPHOGENESIS,1.1041e-08,-0.23073,-0.33544,1,0
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,2.0879e-07,-0.23074,-0.32772,1,0
5,GO INTRA S DNA DAMAGE CHECKPOINT,2.971e-06,-0.23076,-0.30064,1,0
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,7.0279e-11,-0.23081,-0.34718,1,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,3.7356e-07,-0.23105,-0.32357,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.536e-06,-0.23106,-0.39267,1,0
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,5.8698e-06,-0.23112,-0.34347,1,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,3.2057e-05,-0.23117,-0.25974,1,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,1.0202e-11,-0.23117,-0.36433,1,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.8286e-11,-0.2312,-0.3049,1,0
5,GO INNER EAR MORPHOGENESIS,1.8318e-07,-0.23129,-0.31193,1,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.7184e-11,-0.23136,-0.34907,1,0
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,1.0527e-08,-0.23137,-0.35176,1,0
5,GO INSULIN SECRETION,3.4796e-08,-0.23141,-0.33585,1,0
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,6.6578e-05,-0.23142,-0.23298,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0098086,-0.23146,-0.24892,1,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,1.0094e-07,-0.23148,-0.27603,1,0
5,GO RESPONSE TO IONIZING RADIATION,4.6356e-09,-0.23148,-0.31639,1,0
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,1.1034e-07,-0.23149,-0.34267,1,0
5,GO REGULATION OF GLIOGENESIS,1.5037e-07,-0.23149,-0.29547,1,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,8.5867e-06,-0.23154,-0.29076,1,0
5,GO REGULATION OF CELLULAR PH,1.2131e-09,-0.23158,-0.29247,1,0
5,GO GLUTAMINE METABOLIC PROCESS,5.0278e-07,-0.23162,-0.30533,1,0
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,4.249e-10,-0.23184,-0.38094,1,0
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.7676e-09,-0.23185,-0.35051,1,0
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00049053,-0.23188,-0.33281,1,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,7.8778e-10,-0.23211,-0.31227,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.0161e-09,-0.23215,-0.2936,1,0
5,GO CELLULAR RESPONSE TO PH,5.7051e-07,-0.23216,-0.2783,1,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,7.1121e-10,-0.23217,-0.29963,1,0
5,GO PEPTIDYL CYSTEINE MODIFICATION,6.2993e-08,-0.23218,-0.3053,1,0
5,GO GOLGI VESICLE TRANSPORT,1.642e-11,-0.23222,-0.35354,1,0
5,GO PEROXISOME ORGANIZATION,1.6782e-07,-0.23229,-0.26625,1,0
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0023637,-0.23237,-0.20835,1,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00028155,-0.23244,-0.22029,1,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.6877e-06,-0.23252,-0.2452,1,0
5,GO SEX DETERMINATION,3.6162e-06,-0.2326,-0.27361,1,0
5,GO LIVER REGENERATION,1.3039e-08,-0.23261,-0.30089,1,0
5,GO ALCOHOL CATABOLIC PROCESS,3.055e-09,-0.23261,-0.31999,1,0
5,GO RESPONSE TO CHEMOKINE,3.9309e-10,-0.23265,-0.26722,1,0
5,GO LIPOPROTEIN METABOLIC PROCESS,8.0424e-11,-0.23267,-0.33204,1,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,2.5066e-09,-0.2327,-0.33498,1,0
5,GO CELLULAR DEFENSE RESPONSE,3.0156e-07,-0.23272,-0.31218,1,0
5,GO PEROXISOMAL TRANSPORT,2.8886e-07,-0.23273,-0.27257,1,0
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0042636,-0.23276,-0.19133,1,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.8318e-07,-0.23277,-0.30534,1,0
5,GO DETECTION OF CALCIUM ION,0.01829,-0.2328,-0.21924,1,0
5,GO NUCLEAR BODY ORGANIZATION,9.6129e-06,-0.23286,-0.33691,1,0
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,1.785e-11,-0.23317,-0.3781,1,0
5,GO COPII COATED VESICLE BUDDING,2.7286e-10,-0.23325,-0.33311,1,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,1.6654e-06,-0.23343,-0.32395,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,6.3569e-09,-0.23344,-0.3123,1,0
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,1.7687e-09,-0.23354,-0.30238,1,0
5,GO MUSCLE TISSUE DEVELOPMENT,1.0519e-10,-0.23357,-0.36502,1,0
5,GO T CELL RECEPTOR SIGNALING PATHWAY,1.3999e-08,-0.23387,-0.31187,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,2.1595e-09,-0.23394,-0.32227,1,0
5,GO REGULATION OF SECRETION,1.3737e-10,-0.23396,-0.3373,1,0
5,GO REGULATION OF CELL AGING,1.3419e-09,-0.23402,-0.33058,1,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,1.0322e-07,-0.23408,-0.24523,1,0
5,GO NEGATIVE REGULATION OF NEURON DEATH,3.3629e-10,-0.23413,-0.35057,1,0
5,GO MICROTUBULE POLYMERIZATION,8.3066e-07,-0.23417,-0.34638,1,0
5,GO AMINO ACID TRANSPORT,1.3671e-08,-0.23418,-0.34012,1,0
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.5427e-10,-0.23419,-0.3252,1,0
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00029511,-0.2343,-0.31535,1,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00013673,-0.23432,-0.31506,1,0
5,GO SPLEEN DEVELOPMENT,1.3999e-08,-0.23435,-0.31737,1,0
5,GO ANION TRANSMEMBRANE TRANSPORT,1.3133e-11,-0.23441,-0.35068,1,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.00029052,-0.23443,-0.2533,1,0
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,7.0279e-11,-0.23443,-0.36141,1,0
5,GO CELLULAR RESPONSE TO RADIATION,5.1356e-08,-0.23478,-0.28272,1,0
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,5.4356e-06,-0.23484,-0.32551,1,0
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.0868e-08,-0.23484,-0.2902,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.7309e-08,-0.23492,-0.32899,1,0
5,GO PROTEIN STABILIZATION,2.457e-10,-0.23492,-0.30395,1,0
5,GO RESPONSE TO VIRUS,3.4796e-08,-0.23494,-0.3404,1,0
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.3693e-05,-0.23517,-0.26034,1,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,1.8723e-07,-0.23528,-0.34671,1,0
5,GO RESPONSE TO NITROGEN COMPOUND,2.1188e-12,-0.23533,-0.36419,1,0
5,GO ESTABLISHMENT OF TISSUE POLARITY,9.028e-08,-0.23545,-0.28345,1,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,1.5102e-11,-0.23547,-0.3637,1,0
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0005618,-0.2355,-0.26719,1,0
5,GO FEVER GENERATION,4.5233e-07,-0.23565,-0.22926,1,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,4.7488e-06,-0.23566,-0.35499,1,0
5,GO ION TRANSPORT,1.1099e-11,-0.23572,-0.33724,1,0
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,2.1595e-09,-0.23576,-0.35114,1,0
5,GO HINDBRAIN DEVELOPMENT,1.1034e-07,-0.23578,-0.33367,1,0
5,GO RESPONSE TO ZINC ION,0.00014129,-0.23579,-0.24283,1,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,7.3772e-08,-0.23582,-0.36206,1,0
5,GO CATION TRANSPORT,3.8645e-11,-0.2359,-0.33356,1,0
5,GO DRUG METABOLIC PROCESS,1.3056e-06,-0.23595,-0.26534,1,0
5,GO CELLULAR RESPONSE TO UV,1.8318e-07,-0.23595,-0.30776,1,0
5,GO KERATINOCYTE DIFFERENTIATION,5.9056e-05,-0.23601,-0.27675,1,0
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.003654,-0.23601,-0.21361,1,0
5,GO SODIUM ION HOMEOSTASIS,4.2444e-07,-0.23603,-0.28516,1,0
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,2.2707e-10,-0.23603,-0.34657,1,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,1.1588e-05,-0.23604,-0.3252,1,0
5,GO INORGANIC ANION TRANSPORT,7.6205e-11,-0.23613,-0.32615,1,0
5,GO DIOL METABOLIC PROCESS,3.4409e-05,-0.23621,-0.30922,1,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,7.2414e-06,-0.2363,-0.27511,1,0
5,GO ER OVERLOAD RESPONSE,0.0011836,-0.2363,-0.24465,1,0
5,GO POSITIVE REGULATION OF TRANSPORT,6.8695e-12,-0.23633,-0.35991,1,0
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,7.2202e-11,-0.23637,-0.31038,1,0
5,GO KETONE BODY METABOLIC PROCESS,0.0012527,-0.23641,-0.21113,1,0
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,1.2328e-07,-0.23643,-0.34659,1,0
5,GO LATERAL MESODERM DEVELOPMENT,0.00026858,-0.23648,-0.29799,1,0
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.00011033,-0.23655,-0.27212,1,0
5,GO NON MOTILE CILIUM ASSEMBLY,5.3256e-05,-0.23666,-0.25943,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,3.4098e-06,-0.23668,-0.31539,1,0
5,GO ACTIN NUCLEATION,1.3085e-09,-0.23677,-0.32899,1,0
5,GO GASTRIC ACID SECRETION,0.00023667,-0.23684,-0.20057,1,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,9.4341e-06,-0.23702,-0.34963,1,0
5,GO FC RECEPTOR SIGNALING PATHWAY,2.0546e-09,-0.23713,-0.32809,1,0
5,GO DEPHOSPHORYLATION,3.7602e-11,-0.23715,-0.34787,1,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,7.969e-07,-0.23726,-0.3535,1,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.00159,-0.2373,-0.24351,1,0
5,GO PYRUVATE METABOLIC PROCESS,4.7501e-09,-0.23735,-0.34754,1,0
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,3.8983e-07,-0.23735,-0.31349,1,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,1.7706e-05,-0.23736,-0.35871,1,0
5,GO REGULATION OF CELLULAR LOCALIZATION,1.4282e-11,-0.23767,-0.36194,1,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00014362,-0.23767,-0.34038,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,2.4452e-09,-0.23771,-0.31122,1,0
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,3.7602e-11,-0.23772,-0.38194,1,0
5,GO PROTEIN DEPHOSPHORYLATION,5.3602e-11,-0.23783,-0.34777,1,0
5,GO CHROMATIN DISASSEMBLY,7.2414e-06,-0.23785,-0.32345,1,0
5,GO IN UTERO EMBRYONIC DEVELOPMENT,6.1389e-11,-0.23796,-0.34269,1,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00044781,-0.23804,-0.29192,1,0
5,GO GOLGI TO VACUOLE TRANSPORT,1.0169e-05,-0.23807,-0.34739,1,0
5,GO GOLGI VESICLE BUDDING,2.9515e-10,-0.23807,-0.34626,1,0
5,GO HISTONE DEUBIQUITINATION,7.2414e-06,-0.23829,-0.31752,1,0
5,GO T CELL LINEAGE COMMITMENT,0.00024045,-0.23843,-0.23188,1,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,1.1041e-08,-0.2385,-0.2752,1,0
5,GO REGULATION OF PROTEIN STABILITY,1.1706e-10,-0.23854,-0.3127,1,0
5,GO THYMIC T CELL SELECTION,4.1456e-06,-0.23867,-0.24938,1,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,8.9047e-09,-0.23871,-0.28995,1,0
5,GO BLASTOCYST FORMATION,5.6245e-08,-0.23872,-0.28374,1,0
5,GO DEFENSE RESPONSE TO BACTERIUM,5.8856e-08,-0.23872,-0.27707,1,0
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,1.0322e-07,-0.2388,-0.31862,1,0
5,GO PEPTIDE SECRETION,1.2682e-10,-0.23882,-0.35083,1,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.00016629,-0.23893,-0.30492,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,6.1321e-12,-0.23902,-0.37591,1,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,2.538e-07,-0.23905,-0.33048,1,0
5,GO REGULATION OF ODONTOGENESIS,2.6386e-06,-0.23906,-0.33655,1,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.6435e-08,-0.23912,-0.35583,1,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,2.5884e-05,-0.23918,-0.29994,1,0
5,GO VESICLE ORGANIZATION,3.5597e-11,-0.2392,-0.37843,1,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00010673,-0.2392,-0.29864,1,0
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.1245e-09,-0.23924,-0.30004,1,0
5,GO APOPTOTIC PROCESS,5.3186e-12,-0.2393,-0.34173,1,0
5,GO NEURAL RETINA DEVELOPMENT,7.105e-06,-0.2394,-0.31957,1,0
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,9.404e-07,-0.2394,-0.31895,1,0
5,GO ORGANIC ANION TRANSPORT,2.4214e-11,-0.23953,-0.34759,1,0
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.4796e-08,-0.23954,-0.31158,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,1.3948e-05,-0.23958,-0.31342,1,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.7125e-10,-0.23979,-0.31199,1,0
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,4.4807e-06,-0.23985,-0.30706,1,0
5,GO PATTERN SPECIFICATION PROCESS,2.3853e-09,-0.24019,-0.3396,1,0
5,GO MYELOID DENDRITIC CELL ACTIVATION,1.4207e-05,-0.2402,-0.27795,1,0
5,GO LONG CHAIN FATTY ACID TRANSPORT,2.8753e-10,-0.24025,-0.34035,1,0
5,GO PHOSPHOLIPID METABOLIC PROCESS,3.5629e-12,-0.24031,-0.36225,1,0
5,GO SULFUR COMPOUND TRANSPORT,1.7309e-08,-0.24036,-0.37073,1,0
5,GO GANGLION DEVELOPMENT,0.032607,-0.24042,-0.26752,1,0
5,GO NEUROTRANSMITTER SECRETION,1.7706e-05,-0.24046,-0.32277,1,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,8.4877e-09,-0.24052,-0.3099,1,0
5,GO PROTEIN LOCALIZATION TO SYNAPSE,2.011e-05,-0.24057,-0.3469,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.3774e-08,-0.24066,-0.33693,1,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,1.0964e-09,-0.24066,-0.3303,1,0
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,2.0429e-07,-0.2407,-0.33269,1,0
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.0241e-10,-0.24072,-0.32741,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,3.8833e-12,-0.2409,-0.38045,1,0
5,GO NEURON DEATH,1.5277e-10,-0.24095,-0.35682,1,0
5,GO MONOVALENT INORGANIC CATION TRANSPORT,2.1064e-09,-0.24101,-0.30945,1,0
5,GO ALCOHOL BIOSYNTHETIC PROCESS,2.5756e-08,-0.24105,-0.30923,1,0
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,1.1398e-10,-0.24106,-0.31326,1,0
5,GO REGULATION OF T CELL CHEMOTAXIS,1.0361e-05,-0.2411,-0.24924,1,0
5,GO ER NUCLEUS SIGNALING PATHWAY,4.5684e-06,-0.24116,-0.30419,1,0
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,5.9498e-07,-0.24129,-0.28957,1,0
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,1.6994e-06,-0.24133,-0.35508,1,0
5,GO MIDBRAIN DEVELOPMENT,6.586e-10,-0.24154,-0.31995,1,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.00018323,-0.24168,-0.29647,1,0
5,GO GLUCOSE METABOLIC PROCESS,7.8778e-10,-0.24173,-0.34884,1,0
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,2.2505e-06,-0.24185,-0.31392,1,0
5,GO PROTEIN DESTABILIZATION,9.7991e-09,-0.24187,-0.35033,1,0
5,GO REGULATION OF INNATE IMMUNE RESPONSE,5.02e-08,-0.24197,-0.30627,1,0
5,GO HEAD DEVELOPMENT,3.6293e-09,-0.24201,-0.3485,1,0
5,GO RESPONSE TO CATECHOLAMINE,8.8389e-07,-0.24214,-0.31044,1,0
5,GO DETECTION OF ABIOTIC STIMULUS,3.2784e-06,-0.2422,-0.26592,1,0
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,4.0868e-08,-0.24223,-0.30443,1,0
5,GO CARBOHYDRATE PHOSPHORYLATION,2.5884e-05,-0.24224,-0.33762,1,0
5,GO GENETIC IMPRINTING,0.00011218,-0.24238,-0.27827,1,0
5,GO DICARBOXYLIC ACID TRANSPORT,5.1351e-07,-0.24239,-0.3031,1,0
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,2.1812e-12,-0.24251,-0.36433,1,0
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,5.815e-11,-0.24252,-0.31618,1,0
5,GO LYTIC VACUOLE ORGANIZATION,5.3647e-09,-0.24256,-0.37073,1,0
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,2.188e-08,-0.24258,-0.34206,1,0
5,GO VIRAL RNA GENOME REPLICATION,3.152e-06,-0.24262,-0.30923,1,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,4.6359e-05,-0.24268,-0.31297,1,0
5,GO REGULATION OF TRANSPOSITION,0.0019819,-0.24281,-0.28415,1,0
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.2434e-08,-0.24286,-0.3186,1,0
5,GO REGULATION OF MRNA 3 END PROCESSING,5.3562e-07,-0.24289,-0.31455,1,0
5,GO ION TRANSMEMBRANE TRANSPORT,1.9948e-11,-0.2429,-0.34278,1,0
5,GO INTERLEUKIN 10 PRODUCTION,7.0072e-05,-0.24292,-0.24924,1,0
5,GO DEFENSE RESPONSE TO VIRUS,6.2046e-07,-0.24297,-0.36011,1,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,2.0364e-06,-0.24298,-0.32957,1,0
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,6.2169e-06,-0.24299,-0.32206,1,0
5,GO PROTEIN NITROSYLATION,8.5867e-06,-0.24307,-0.26296,1,0
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.3355e-07,-0.24314,-0.37858,1,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,6.6578e-05,-0.24323,-0.29026,1,0
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,2.1624e-06,-0.24326,-0.27444,1,0
5,GO GLYCOPROTEIN METABOLIC PROCESS,1.4686e-11,-0.24332,-0.37845,1,0
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,7.1274e-05,-0.24333,-0.29205,1,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,1.1375e-05,-0.24349,-0.27334,1,0
5,GO IMMUNOGLOBULIN SECRETION,2.9514e-07,-0.24356,-0.32253,1,0
5,GO SECRETION,7.479e-12,-0.2436,-0.35634,1,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00017741,-0.24363,-0.27666,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.2162e-07,-0.2437,-0.32843,1,0
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,2.1624e-06,-0.2438,-0.35277,1,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,2.2926e-08,-0.24385,-0.3505,1,0
5,GO PRIMARY MIRNA PROCESSING,3.5794e-07,-0.24387,-0.32677,1,0
5,GO MONOCARBOXYLIC ACID TRANSPORT,7.8286e-11,-0.24391,-0.34755,1,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,4.8416e-06,-0.24397,-0.30049,1,0
5,GO HORMONE METABOLIC PROCESS,5.2538e-08,-0.24397,-0.27975,1,0
5,GO STEROID CATABOLIC PROCESS,5.9056e-05,-0.24398,-0.30813,1,0
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,8.7316e-05,-0.24404,-0.3116,1,0
5,GO FATTY ACID TRANSPORT,1.2348e-10,-0.24407,-0.35173,1,0
5,GO CEREBRAL CORTEX DEVELOPMENT,1.1794e-07,-0.24412,-0.35672,1,0
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.001422,-0.24413,-0.27306,1,0
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,6.4699e-07,-0.24417,-0.31337,1,0
5,GO METAL ION TRANSPORT,1.3133e-11,-0.24419,-0.34014,1,0
5,GO FATTY ACID CATABOLIC PROCESS,2.0398e-08,-0.24421,-0.3182,1,0
5,GO MUSCLE ORGAN DEVELOPMENT,4.6784e-11,-0.24422,-0.36992,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.5867e-06,-0.24423,-0.29213,1,0
5,GO REGULATION OF INTRACELLULAR TRANSPORT,1.6542e-10,-0.24457,-0.3336,1,0
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,1.0493e-11,-0.24458,-0.32572,1,0
5,GO LIPOSACCHARIDE METABOLIC PROCESS,1.7309e-08,-0.24459,-0.3413,1,0
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,6.895e-08,-0.24461,-0.31039,1,0
5,GO NEUTRAL LIPID METABOLIC PROCESS,8.4871e-11,-0.24462,-0.33611,1,0
5,GO RHYTHMIC BEHAVIOR,4.9069e-08,-0.2447,-0.34896,1,0
5,GO C4 DICARBOXYLATE TRANSPORT,1.9393e-05,-0.24473,-0.29376,1,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,1.3174e-07,-0.24473,-0.29488,1,0
5,GO CELLULAR RESPONSE TO DSRNA,3.1729e-08,-0.24474,-0.37991,1,0
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,3.2146e-06,-0.24479,-0.29901,1,0
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,3.3435e-06,-0.24486,-0.30279,1,0
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,1.6782e-07,-0.24488,-0.28682,1,0
5,GO SEGMENT SPECIFICATION,0.0016575,-0.24493,-0.25472,1,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,1.6158e-05,-0.2451,-0.24527,1,0
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.3891e-06,-0.24515,-0.30274,1,0
5,GO APICAL PROTEIN LOCALIZATION,0.00021857,-0.24515,-0.30732,1,0
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00091404,-0.2452,-0.26807,1,0
5,GO VIRAL LIFE CYCLE,1.4471e-09,-0.24521,-0.34914,1,0
5,GO REGULATION OF HISTONE METHYLATION,1.1086e-06,-0.24521,-0.3013,1,0
5,GO L AMINO ACID TRANSPORT,1.4471e-09,-0.24525,-0.37899,1,0
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,3.9035e-08,-0.24526,-0.31703,1,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,1.0169e-05,-0.24528,-0.34541,1,0
5,GO LIPID EXPORT FROM CELL,1.1535e-07,-0.2453,-0.30636,1,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,6.8396e-06,-0.24535,-0.30253,1,0
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,7.479e-12,-0.24537,-0.39172,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,3.7282e-08,-0.24538,-0.36093,1,0
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.2497e-05,-0.24539,-0.27778,1,0
5,GO PROTEIN CONTAINING COMPLEX REMODELING,2.7668e-07,-0.2454,-0.31603,1,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.6914e-06,-0.24541,-0.25669,1,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.1026e-05,-0.24546,-0.33364,1,0
5,GO NOSE DEVELOPMENT,0.044722,-0.24556,-0.21856,1,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,1.2534e-06,-0.24559,-0.27959,1,0
5,GO RESPONSE TO TEMPERATURE STIMULUS,3.2764e-10,-0.2456,-0.33263,1,0
5,GO HEAT GENERATION,1.8793e-06,-0.2456,-0.24588,1,0
5,GO MULTICELLULAR ORGANISM GROWTH,5.3617e-10,-0.24561,-0.38678,1,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00063314,-0.24561,-0.32563,1,0
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,3.8118e-09,-0.24568,-0.32078,1,0
5,GO POSITIVE REGULATION OF ANION TRANSPORT,6.1583e-08,-0.24573,-0.29894,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,2.538e-07,-0.24585,-0.29731,1,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.0156e-07,-0.24588,-0.32359,1,0
5,GO MAGNESIUM ION HOMEOSTASIS,1.2027e-05,-0.24597,-0.31933,1,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.00014362,-0.246,-0.30529,1,0
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,1.5383e-12,-0.24609,-0.36606,1,0
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,7.5266e-09,-0.24619,-0.31336,1,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,7.6283e-05,-0.24627,-0.30405,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,2.6581e-10,-0.24627,-0.33164,1,0
5,GO NEUTROPHIL CHEMOTAXIS,2.0879e-07,-0.24661,-0.28639,1,0
5,GO UV DAMAGE EXCISION REPAIR,3.2859e-07,-0.24663,-0.30259,1,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00026024,-0.24664,-0.34115,1,0
5,GO ORGANELLE FUSION,9.7991e-09,-0.24672,-0.36205,1,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,3.9102e-06,-0.24683,-0.29328,1,0
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,1.4207e-05,-0.24684,-0.26855,1,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.0019023,-0.24688,-0.25248,1,0
5,GO RESPONSE TO COPPER ION,0.0020929,-0.24693,-0.27749,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,9.404e-07,-0.24701,-0.33436,1,0
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,9.1996e-11,-0.24703,-0.34111,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,1.0792e-11,-0.24704,-0.37724,1,0
5,GO PROTEIN DEPOLYMERIZATION,7.5266e-09,-0.24706,-0.39468,1,0
5,GO NAD BIOSYNTHETIC PROCESS,1.9749e-05,-0.24706,-0.30776,1,0
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,1.0279e-08,-0.24708,-0.3609,1,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.0025617,-0.24708,-0.2393,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION,1.2074e-11,-0.24715,-0.35113,1,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,1.0557e-05,-0.24722,-0.35392,1,0
5,GO EPIDERMIS DEVELOPMENT,1.6782e-07,-0.24724,-0.32547,1,0
5,GO T CELL HOMEOSTASIS,3.5038e-07,-0.24736,-0.28635,1,0
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,1.0557e-05,-0.24739,-0.34542,1,0
5,GO CELL PROJECTION ASSEMBLY,3.9309e-10,-0.2474,-0.3563,1,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,1.3878e-06,-0.24745,-0.31798,1,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0066851,-0.24764,-0.16591,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,1.0791e-07,-0.24765,-0.28443,1,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,7.105e-06,-0.24773,-0.34074,1,0
5,GO TUMOR NECROSIS FACTOR SECRETION,5.77e-09,-0.24791,-0.31873,1,0
5,GO MUSCLE CELL DIFFERENTIATION,1.0202e-11,-0.24794,-0.38831,1,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,1.5576e-05,-0.24796,-0.24985,1,0
5,GO AUTOPHAGIC CELL DEATH,2.1621e-05,-0.24797,-0.30584,1,0
5,GO CELLULAR SENESCENCE,6.8348e-09,-0.24799,-0.30812,1,0
5,GO REGIONALIZATION,5.1101e-09,-0.24803,-0.33844,1,0
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,2.3274e-07,-0.24808,-0.36326,1,0
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,1.3351e-08,-0.24809,-0.277,1,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0042636,-0.24815,-0.26728,1,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0011021,-0.24815,-0.29444,1,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,7.3739e-05,-0.24819,-0.35272,1,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,1.1165e-05,-0.24824,-0.29406,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,1.4112e-09,-0.24829,-0.34835,1,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0057669,-0.2483,-0.26226,1,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,4.5558e-05,-0.24833,-0.30421,1,0
5,GO REPRODUCTIVE BEHAVIOR,1.5037e-07,-0.24839,-0.33211,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00061456,-0.24839,-0.24487,1,0
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,2.1678e-11,-0.24849,-0.38032,1,0
5,GO NEURAL NUCLEUS DEVELOPMENT,3.2146e-06,-0.24851,-0.32138,1,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.00011406,-0.24852,-0.24842,1,0
5,GO RESPONSE TO TOXIC SUBSTANCE,2.3268e-09,-0.24863,-0.27887,1,0
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,2.1678e-11,-0.24876,-0.39787,1,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,5.8856e-08,-0.24877,-0.30543,1,0
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,7.7166e-08,-0.24878,-0.29795,1,0
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.634e-09,-0.24878,-0.32196,1,0
5,GO CARBOHYDRATE METABOLIC PROCESS,2.7041e-11,-0.24881,-0.34773,1,0
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,4.5233e-07,-0.24893,-0.32495,1,0
5,GO ICOSANOID METABOLIC PROCESS,1.3468e-07,-0.24923,-0.30176,1,0
5,GO CYTOSKELETON ORGANIZATION,3.7602e-11,-0.24927,-0.38263,1,0
5,GO HISTONE H3 K9 MODIFICATION,6.9711e-06,-0.24937,-0.31573,1,0
5,GO PROTEIN MATURATION,3.1098e-10,-0.24952,-0.32129,1,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.7385e-05,-0.24954,-0.33763,1,0
5,GO PURINE NUCLEOTIDE TRANSPORT,5.7582e-06,-0.2496,-0.3157,1,0
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,6.757e-10,-0.24962,-0.3561,1,0
5,GO RESPONSE TO INTERLEUKIN 7,3.4003e-08,-0.24967,-0.341,1,0
5,GO REGULATION OF GOLGI ORGANIZATION,2.1338e-07,-0.24978,-0.37383,1,0
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0024609,-0.24985,-0.2727,1,0
5,GO NEGATIVE REGULATION OF DNA BINDING,3.152e-06,-0.24986,-0.2712,1,0
5,GO ISOPRENOID METABOLIC PROCESS,2.7668e-07,-0.24987,-0.27174,1,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.1729e-08,-0.25012,-0.35255,1,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,1.4472e-05,-0.25027,-0.33229,1,0
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,4.8076e-11,-0.25036,-0.32354,1,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,2.188e-08,-0.25045,-0.30176,1,0
5,GO RESPONSE TO UV,1.6907e-08,-0.25052,-0.31476,1,0
5,GO ION HOMEOSTASIS,4.7449e-12,-0.2506,-0.33963,1,0
5,GO CHEMICAL HOMEOSTASIS,3.0856e-12,-0.25063,-0.34354,1,0
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,7.2702e-12,-0.25063,-0.35864,1,0
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,7.479e-12,-0.25074,-0.39046,1,0
5,GO ANATOMICAL STRUCTURE MATURATION,3.5427e-10,-0.25077,-0.33749,1,0
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,6.3088e-12,-0.25081,-0.39255,1,0
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,3.9941e-08,-0.25082,-0.36174,1,0
5,GO NADH METABOLIC PROCESS,5.1446e-05,-0.25087,-0.31341,1,0
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.00063314,-0.25091,-0.28449,1,0
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,1.2253e-05,-0.25097,-0.32592,1,0
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,1.8701e-05,-0.25099,-0.22931,1,0
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.1004e-08,-0.25102,-0.31399,1,0
5,GO CALCIUM MEDIATED SIGNALING,5.815e-11,-0.25115,-0.30434,1,0
5,GO CELLULAR ION HOMEOSTASIS,8.6145e-12,-0.25124,-0.32793,1,0
5,GO NEUTROPHIL MIGRATION,8.8282e-08,-0.25131,-0.29571,1,0
5,GO REGULATION OF NEURON MATURATION,1.0958e-05,-0.25132,-0.35517,1,0
5,GO FATTY ACYL COA METABOLIC PROCESS,6.2175e-05,-0.25139,-0.29088,1,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00012388,-0.25141,-0.32451,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,4.0343e-10,-0.25141,-0.35852,1,0
5,GO REGULATION OF AMINO ACID TRANSPORT,3.5646e-05,-0.25143,-0.29725,1,0
5,GO REGULATION OF CELL CYCLE ARREST,1.4454e-06,-0.25144,-0.26863,1,0
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.00015083,-0.2516,-0.28541,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.2046e-07,-0.25169,-0.37843,1,0
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,4.1948e-11,-0.25171,-0.36213,1,0
5,GO PROGESTERONE METABOLIC PROCESS,0.016205,-0.25175,-0.26469,1,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,5.0323e-06,-0.25178,-0.34336,1,0
5,GO T CELL SELECTION,7.105e-06,-0.25183,-0.25327,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,1.7309e-08,-0.25203,-0.32911,1,0
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,2.559e-11,-0.25214,-0.36509,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,1.2023e-10,-0.25222,-0.32929,1,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.1026e-05,-0.25228,-0.33875,1,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.5386e-08,-0.2523,-0.33846,1,0
5,GO CORNIFICATION,0.026561,-0.25233,-0.17986,1,0
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,8.3066e-07,-0.25234,-0.33694,1,0
5,GO ATP TRANSPORT,4.719e-07,-0.25235,-0.32374,1,0
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.6307e-12,-0.25237,-0.39861,1,0
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,1.2131e-09,-0.25239,-0.33273,1,0
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,2.0509e-11,-0.25247,-0.35384,1,0
5,GO NEPHRON TUBULE FORMATION,0.017894,-0.25249,-0.16642,1,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.007921,-0.25251,-0.36555,1,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.1034e-07,-0.25251,-0.33316,1,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.00010323,-0.25253,-0.30268,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.9014e-08,-0.25263,-0.32116,1,0
5,GO LIPID BIOSYNTHETIC PROCESS,5.815e-11,-0.25264,-0.33601,1,0
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.002702,-0.25272,-0.28571,1,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,4.0657e-06,-0.2528,-0.29989,1,0
5,GO NEGATIVE REGULATION OF TRANSPORT,4.7449e-12,-0.25283,-0.33197,1,0
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.3085e-09,-0.25284,-0.36422,1,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,1.5713e-07,-0.25293,-0.32648,1,0
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00010673,-0.25298,-0.35511,1,0
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,5.3747e-08,-0.25302,-0.29056,1,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,3.5597e-11,-0.2531,-0.38529,1,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,3.7605e-06,-0.2531,-0.34798,1,0
5,GO HISTONE H3 K9 METHYLATION,7.7586e-05,-0.25315,-0.31881,1,0
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,8.0712e-08,-0.25319,-0.37798,1,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00053704,-0.25321,-0.2292,1,0
5,GO CELLULAR HORMONE METABOLIC PROCESS,1.1086e-06,-0.25325,-0.26157,1,0
5,GO MUSCLE FIBER DEVELOPMENT,1.5217e-09,-0.25331,-0.34704,1,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,4.4807e-06,-0.25331,-0.31098,1,0
5,GO MALE SEX DETERMINATION,5.1446e-05,-0.25335,-0.27116,1,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,5.1101e-09,-0.25336,-0.3591,1,0
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,7.8124e-06,-0.25354,-0.29255,1,0
5,GO FOREBRAIN DEVELOPMENT,1.2604e-07,-0.25358,-0.33817,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00029052,-0.25359,-0.26592,1,0
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,6.6774e-12,-0.25369,-0.35805,1,0
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,7.4177e-11,-0.254,-0.34222,1,0
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.5164e-08,-0.25403,-0.33998,1,0
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,5.5016e-10,-0.25405,-0.37221,1,0
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,8.0424e-11,-0.25408,-0.3331,1,0
5,GO TRIGLYCERIDE METABOLIC PROCESS,1.2759e-09,-0.25411,-0.3093,1,0
5,GO THYMUS DEVELOPMENT,1.1282e-07,-0.25414,-0.31155,1,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,1.2954e-05,-0.25415,-0.2572,1,0
5,GO RESPONSE TO INSULIN,2.8299e-12,-0.25417,-0.39213,1,0
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,4.4749e-10,-0.25427,-0.36952,1,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00064263,-0.25428,-0.25587,1,0
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.9717e-11,-0.25431,-0.38608,1,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,7.2129e-08,-0.25447,-0.34599,1,0
5,GO RESPONSE TO UV B,1.9044e-05,-0.2545,-0.34113,1,0
5,GO CELL GROWTH,1.0493e-11,-0.25468,-0.40664,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.7385e-05,-0.25471,-0.32011,1,0
5,GO BILE ACID METABOLIC PROCESS,5.5864e-07,-0.25474,-0.30468,1,0
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,2.7797e-11,-0.25474,-0.35876,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.3806e-05,-0.2548,-0.23409,1,0
5,GO GRANULOCYTE MIGRATION,1.9014e-08,-0.2548,-0.32187,1,0
5,GO PROTEIN K63 LINKED UBIQUITINATION,7.8778e-10,-0.25482,-0.32609,1,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,2.6828e-05,-0.25482,-0.34391,1,0
5,GO POSITIVE REGULATION OF TOR SIGNALING,5.793e-12,-0.25494,-0.37144,1,0
5,GO ERYTHROCYTE MATURATION,1.3468e-07,-0.25496,-0.38076,1,0
5,GO SPECIFICATION OF SYMMETRY,1.2759e-09,-0.25507,-0.33249,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,2.7614e-08,-0.25522,-0.31584,1,0
5,GO MITOCHONDRIAL DEPOLARIZATION,5.2303e-06,-0.25523,-0.32801,1,0
5,GO IRON ION TRANSPORT,4.3606e-10,-0.25529,-0.30905,1,0
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,6.2169e-06,-0.25532,-0.2703,1,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,6.4434e-08,-0.25535,-0.29047,1,0
5,GO POSITIVE REGULATION OF CELL GROWTH,3.7319e-10,-0.25537,-0.36952,1,0
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.2434e-08,-0.25554,-0.34245,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,7.2497e-05,-0.25554,-0.33353,1,0
5,GO REGULATION OF NECROTIC CELL DEATH,9.7998e-07,-0.25565,-0.33578,1,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,1.0036e-08,-0.2557,-0.28232,1,0
5,GO RESPONSE TO MONOSACCHARIDE,5.5078e-11,-0.2557,-0.37334,1,0
5,GO PROTEIN COMPLEX OLIGOMERIZATION,1.887e-11,-0.2558,-0.33063,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,1.9749e-05,-0.25583,-0.31305,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.3186e-12,-0.25589,-0.39711,1,0
5,GO RRNA CATABOLIC PROCESS,6.545e-05,-0.2559,-0.26449,1,0
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,4.6784e-11,-0.25597,-0.38464,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,1.8353e-11,-0.25602,-0.35756,1,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.734e-06,-0.25616,-0.26644,1,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,3.152e-06,-0.2562,-0.3226,1,0
5,GO FATTY ACID BIOSYNTHETIC PROCESS,3.1098e-10,-0.25623,-0.32866,1,0
5,GO HISTONE H3 DEACETYLATION,3.0295e-08,-0.25624,-0.35126,1,0
5,GO INTERLEUKIN 2 PRODUCTION,3.5412e-09,-0.25625,-0.34232,1,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,9.03e-05,-0.25626,-0.26289,1,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,2.8925e-08,-0.25635,-0.37551,1,0
5,GO REGULATION OF GLUCOSE IMPORT,2.8369e-09,-0.25641,-0.34957,1,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0024281,-0.25661,-0.33277,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,7.6937e-12,-0.25664,-0.38092,1,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,6.1119e-05,-0.25672,-0.27017,1,0
5,GO MAGNESIUM ION TRANSPORT,8.3013e-05,-0.25679,-0.31535,1,0
5,GO POSITIVE REGULATION OF GLIOGENESIS,5.6245e-08,-0.25679,-0.29756,1,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0017277,-0.2568,-0.2251,1,0
5,GO NEUROTRANSMITTER TRANSPORT,4.6578e-06,-0.25719,-0.32645,1,0
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,1.7797e-12,-0.25723,-0.39693,1,0
5,GO ACTIN CROSSLINK FORMATION,4.6202e-07,-0.25726,-0.42858,1,0
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,8.9047e-09,-0.25737,-0.33118,1,0
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,4.5922e-10,-0.25744,-0.34941,1,0
5,GO INTERACTION WITH HOST,6.8406e-11,-0.25754,-0.39011,1,0
5,GO PENILE ERECTION,4.1026e-05,-0.25767,-0.28189,1,0
5,GO RESPONSE TO CARBOHYDRATE,1.2074e-11,-0.25769,-0.38361,1,0
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,2.9979e-12,-0.2577,-0.40431,1,0
5,GO RESPONSE TO DSRNA,2.8262e-08,-0.25771,-0.34305,1,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,4.4749e-10,-0.25775,-0.30716,1,0
5,GO REGULATION OF PROTEOLYSIS,1.5968e-11,-0.25778,-0.35974,1,0
5,GO CELL FATE DETERMINATION,1.8032e-05,-0.25793,-0.30907,1,0
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,4.4285e-07,-0.25795,-0.31438,1,0
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,8.6579e-07,-0.25797,-0.3252,1,0
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.7614e-08,-0.258,-0.3319,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00076726,-0.25802,-0.33255,1,0
5,GO ETHANOL OXIDATION,0.00042777,-0.25805,-0.37103,1,0
5,GO RESPONSE TO STARVATION,4.3606e-10,-0.2581,-0.36513,1,0
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,2.2912e-11,-0.25818,-0.3542,1,0
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.634e-09,-0.2582,-0.30293,1,0
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,7.2202e-11,-0.25824,-0.32529,1,0
5,GO MESODERMAL CELL DIFFERENTIATION,9.3415e-09,-0.25825,-0.37501,1,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,7.1726e-09,-0.25828,-0.37963,1,0
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,2.2707e-10,-0.25828,-0.37379,1,0
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,5.2359e-09,-0.25828,-0.34241,1,0
5,GO RESPONSE TO CADMIUM ION,0.00019857,-0.2583,-0.27005,1,0
5,GO REGULATION OF CELL DEATH,6.1321e-12,-0.25839,-0.34979,1,0
5,GO PROSTANOID METABOLIC PROCESS,1.4472e-05,-0.25851,-0.30997,1,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.5865e-05,-0.25858,-0.32295,1,0
5,GO RESPONSE TO MANGANESE ION,1.2328e-07,-0.25859,-0.3385,1,0
5,GO CATION TRANSMEMBRANE TRANSPORT,2.7797e-11,-0.25866,-0.34769,1,0
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00159,-0.25875,-0.27583,1,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,9.8716e-08,-0.25905,-0.37969,1,0
5,GO REGULATION OF STEM CELL PROLIFERATION,1.7534e-07,-0.25907,-0.34067,1,0
5,GO REGULATION OF CELL DIVISION,3.3228e-08,-0.25913,-0.31922,1,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,3.9613e-05,-0.25918,-0.26685,1,0
5,GO ACID SECRETION,7.333e-07,-0.25922,-0.24737,1,0
5,GO EXPLORATION BEHAVIOR,2.2824e-05,-0.25931,-0.3388,1,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,3.152e-06,-0.25942,-0.33566,1,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,2.0853e-05,-0.25945,-0.33213,1,0
5,GO RESPONSE TO LEPTIN,3.6162e-06,-0.25961,-0.32105,1,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,2.538e-07,-0.25962,-0.27465,1,0
5,GO HEXOSE CATABOLIC PROCESS,2.8001e-06,-0.25962,-0.32562,1,0
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,2.1621e-05,-0.25964,-0.33046,1,0
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00029976,-0.2597,-0.27531,1,0
5,GO PROSTAGLANDIN SECRETION,2.1196e-06,-0.25972,-0.28534,1,0
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00011986,-0.25976,-0.28145,1,0
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,7.2702e-12,-0.25993,-0.38183,1,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.001704,-0.25998,-0.31097,1,0
5,GO CHEMOSENSORY BEHAVIOR,7.0522e-08,-0.26,-0.27349,1,0
5,GO STEROID METABOLIC PROCESS,4.8673e-09,-0.26003,-0.31382,1,0
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.5838e-12,-0.2601,-0.37849,1,0
5,GO RESPONSE TO ORGANOPHOSPHORUS,9.9705e-11,-0.26011,-0.34312,1,0
5,GO AMINE CATABOLIC PROCESS,3.2162e-07,-0.26018,-0.33112,1,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,1.2032e-06,-0.26022,-0.28589,1,0
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,2.4491e-12,-0.26028,-0.3892,1,0
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,3.4634e-11,-0.26031,-0.42678,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.2482e-05,-0.26033,-0.3171,1,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,1.1282e-07,-0.26041,-0.28276,1,0
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,3.6361e-10,-0.26051,-0.32475,1,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.4812e-12,-0.26063,-0.35891,1,0
5,GO APOPTOTIC SIGNALING PATHWAY,6.8406e-11,-0.26067,-0.33841,1,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,2.6352e-05,-0.26073,-0.32753,1,0
5,GO GLUCOSE IMPORT,2.0437e-10,-0.26074,-0.36412,1,0
5,GO DIVALENT INORGANIC CATION TRANSPORT,8.1414e-12,-0.26075,-0.35998,1,0
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,4.3549e-12,-0.26084,-0.36801,1,0
5,GO REGULATION OF MEMBRANE POTENTIAL,4.5822e-08,-0.26085,-0.33883,1,0
5,GO REGULATION OF PEPTIDE SECRETION,1.6109e-10,-0.26089,-0.34624,1,0
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.4454e-06,-0.26096,-0.32246,1,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,7.0671e-12,-0.26101,-0.38598,1,0
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,2.8753e-10,-0.26105,-0.3814,1,0
5,GO DEVELOPMENTAL MATURATION,1.1533e-09,-0.26108,-0.35461,1,0
5,GO LYMPHOCYTE APOPTOTIC PROCESS,2.5756e-08,-0.26109,-0.32411,1,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.0322e-07,-0.26109,-0.3741,1,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,2.8001e-06,-0.26121,-0.29642,1,0
5,GO TERPENOID METABOLIC PROCESS,1.4076e-07,-0.26124,-0.29687,1,0
5,GO REGULATION OF ACTIN NUCLEATION,5.1351e-07,-0.26133,-0.32459,1,0
5,GO HORMONE MEDIATED SIGNALING PATHWAY,3.6586e-11,-0.26138,-0.36625,1,0
5,GO ACROSOME REACTION,4.31e-06,-0.26153,-0.32118,1,0
5,GO REGULATION OF LIPID TRANSPORT,9.9705e-11,-0.26153,-0.36077,1,0
5,GO RESPONSE TO METAL ION,7.1121e-10,-0.26154,-0.33569,1,0
5,GO GLUTAMATE SECRETION,4.1026e-05,-0.26155,-0.31415,1,0
5,GO SYNAPTIC VESICLE LOCALIZATION,3.8924e-05,-0.26164,-0.33156,1,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,2.4371e-06,-0.26174,-0.35719,1,0
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,1.3039e-08,-0.2618,-0.36817,1,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,6.5837e-06,-0.26183,-0.2417,1,0
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.9948e-11,-0.26189,-0.38368,1,0
5,GO LIPID CATABOLIC PROCESS,7.0279e-11,-0.26193,-0.33924,1,0
5,GO POSITIVE REGULATION OF EXOCYTOSIS,6.0205e-08,-0.2621,-0.35497,1,0
5,GO RESPONSE TO OXIDATIVE STRESS,1.3888e-11,-0.26211,-0.35388,1,0
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0020367,-0.26221,-0.31339,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,3.3435e-06,-0.26224,-0.31234,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION,3.247e-08,-0.26232,-0.33378,1,0
5,GO GLUCOSE CATABOLIC PROCESS,0.00020178,-0.26232,-0.32244,1,0
5,GO ALCOHOL METABOLIC PROCESS,1.2348e-10,-0.26242,-0.33663,1,0
5,GO V D J RECOMBINATION,0.014494,-0.26248,-0.19746,1,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,1.8142e-08,-0.26248,-0.32251,1,0
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,5.0323e-06,-0.2625,-0.25626,1,0
5,GO PLASMA MEMBRANE FUSION,3.758e-05,-0.26253,-0.3285,1,0
5,GO PIGMENTATION,2.3312e-10,-0.26255,-0.34973,1,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,1.471e-07,-0.26255,-0.42592,1,0
5,GO CELL RECOGNITION,1.6407e-09,-0.26258,-0.32415,1,0
5,GO ETHER METABOLIC PROCESS,3.5794e-07,-0.26265,-0.33501,1,0
5,GO ADULT HEART DEVELOPMENT,0.00032916,-0.26265,-0.30228,1,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,3.0156e-07,-0.26276,-0.30835,1,0
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,4.8359e-10,-0.26279,-0.34491,1,0
5,GO RESPONSE TO PEPTIDE HORMONE,1.5838e-12,-0.26282,-0.39078,1,0
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.00010852,-0.26285,-0.32895,1,0
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,3.6667e-12,-0.26293,-0.38883,1,0
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,7.6657e-06,-0.26299,-0.36514,1,0
5,GO RUFFLE ASSEMBLY,2.8886e-07,-0.26301,-0.35037,1,0
5,GO SECONDARY METABOLIC PROCESS,1.3442e-05,-0.26315,-0.26409,1,0
5,GO ACTIVATION OF MAPK ACTIVITY,9.9185e-12,-0.2632,-0.39533,1,0
5,GO REGULATION OF ANION TRANSPORT,3.1098e-10,-0.2632,-0.3418,1,0
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,9.9803e-06,-0.26333,-0.30552,1,0
5,GO SARCOMERE ORGANIZATION,1.4472e-05,-0.26334,-0.28048,1,0
5,GO NEURON RECOGNITION,3.2146e-06,-0.26339,-0.38515,1,0
5,GO REGULATION OF GLUCONEOGENESIS,1.1533e-09,-0.26349,-0.37309,1,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,1.7706e-05,-0.26355,-0.41143,1,0
5,GO REGULATION OF REPRODUCTIVE PROCESS,2.6306e-11,-0.26359,-0.30645,1,0
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,2.7614e-08,-0.26363,-0.35126,1,0
5,GO COGNITION,1.4471e-09,-0.26366,-0.35856,1,0
5,GO RESPONSE TO ENDOGENOUS STIMULUS,2.9127e-12,-0.26372,-0.38376,1,0
5,GO PROSTATE GLAND GROWTH,4.9694e-05,-0.26374,-0.31646,1,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,5.4701e-07,-0.26377,-0.34512,1,0
5,GO REGULATION OF ATP METABOLIC PROCESS,2.004e-09,-0.26389,-0.32795,1,0
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00053704,-0.26391,-0.27529,1,0
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,7.6205e-11,-0.2642,-0.34075,1,0
5,GO MONOSACCHARIDE METABOLIC PROCESS,4.4749e-10,-0.26424,-0.3464,1,0
5,GO EPITHELIUM DEVELOPMENT,2.2117e-10,-0.26424,-0.365,1,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,3.9872e-06,-0.26425,-0.28834,1,0
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,1.9993e-12,-0.26425,-0.37602,1,0
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,2.7676e-09,-0.26432,-0.36225,1,0
5,GO PALLIUM DEVELOPMENT,1.2534e-06,-0.26434,-0.31621,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.0958e-05,-0.26434,-0.24935,1,0
5,GO NUCLEOTIDE PHOSPHORYLATION,3.3713e-09,-0.26443,-0.34266,1,0
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,3.8924e-05,-0.26461,-0.32885,1,0
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.0712e-08,-0.26465,-0.27293,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,8.8282e-08,-0.26467,-0.36867,1,0
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,8.1623e-05,-0.26474,-0.28124,1,0
5,GO CELLULAR LIPID METABOLIC PROCESS,1.2417e-11,-0.26476,-0.34138,1,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,1.3671e-08,-0.26476,-0.36458,1,0
5,GO RESPONSE TO INTERLEUKIN 4,3.4003e-08,-0.26481,-0.31836,1,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.4749e-10,-0.26482,-0.37411,1,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,2.2697e-09,-0.26488,-0.34601,1,0
5,GO POLYOL BIOSYNTHETIC PROCESS,4.7501e-09,-0.26492,-0.32928,1,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,3.8924e-05,-0.26503,-0.25019,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,3.0395e-05,-0.26508,-0.32703,1,0
5,GO REGULATION OF BINDING,5.9602e-12,-0.26509,-0.35922,1,0
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,6.3359e-07,-0.2651,-0.35751,1,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,4.9694e-05,-0.26519,-0.23391,1,0
5,GO ADAPTIVE THERMOGENESIS,4.9403e-11,-0.26523,-0.36491,1,0
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,3.8149e-08,-0.26527,-0.38704,1,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,5.5412e-06,-0.26529,-0.40153,1,0
5,GO PEROXISOMAL MEMBRANE TRANSPORT,7.0337e-07,-0.26533,-0.30077,1,0
5,GO METAL ION HOMEOSTASIS,8.8611e-12,-0.26535,-0.3388,1,0
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.0322e-07,-0.26546,-0.31299,1,0
5,GO ADULT LOCOMOTORY BEHAVIOR,2.8001e-06,-0.26546,-0.31433,1,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.1316e-06,-0.26553,-0.30599,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,2.7286e-10,-0.2656,-0.3473,1,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,2.1064e-09,-0.26562,-0.35188,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,1.5372e-07,-0.26567,-0.32338,1,0
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,7.5451e-08,-0.2657,-0.35698,1,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,8.2543e-08,-0.26584,-0.33398,1,0
5,GO VESICLE TARGETING,6.0979e-10,-0.26587,-0.36288,1,0
5,GO REGULATION OF SYSTEM PROCESS,1.1415e-11,-0.2659,-0.3835,1,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,3.8347e-06,-0.26591,-0.26966,1,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,2.6828e-05,-0.26593,-0.3089,1,0
5,GO POSITIVE REGULATION OF SIGNALING,2.8299e-12,-0.26594,-0.36186,1,0
5,GO NEURAL TUBE PATTERNING,2.5756e-08,-0.26612,-0.34409,1,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,1.3351e-08,-0.26614,-0.31976,1,0
5,GO LIMBIC SYSTEM DEVELOPMENT,6.2046e-07,-0.26621,-0.32158,1,0
5,GO REGULATION OF CELL KILLING,2.856e-06,-0.26623,-0.31672,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.5037e-07,-0.26626,-0.34093,1,0
5,GO CERAMIDE METABOLIC PROCESS,1.6407e-09,-0.26633,-0.38012,1,0
5,GO MUSCLE STRUCTURE DEVELOPMENT,7.6937e-12,-0.26637,-0.39376,1,0
5,GO REGULATION OF PHOSPHATASE ACTIVITY,3.7319e-10,-0.26645,-0.36145,1,0
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,1.679e-12,-0.26646,-0.37198,1,0
5,GO RESPONSE TO L GLUTAMATE,0.001568,-0.26662,-0.26526,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,3.7602e-11,-0.26663,-0.35487,1,0
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,1.4487e-10,-0.26668,-0.39434,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,1.0519e-10,-0.26672,-0.35272,1,0
5,GO DEVELOPMENTAL INDUCTION,7.6446e-07,-0.26675,-0.31692,1,0
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,5.3617e-10,-0.2668,-0.39249,1,0
5,GO REGULATION OF AUTOPHAGY,5.9602e-12,-0.26695,-0.37325,1,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,1.0527e-08,-0.26696,-0.25876,1,0
5,GO REGULATION OF EXOCYTOSIS,3.9064e-09,-0.26697,-0.36855,1,0
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,2.559e-11,-0.267,-0.3546,1,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.1624e-06,-0.26701,-0.29009,1,0
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,2.0879e-07,-0.26702,-0.33017,1,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.7071e-05,-0.26706,-0.32812,1,0
5,GO MICROTUBULE DEPOLYMERIZATION,6.8396e-06,-0.26706,-0.35898,1,0
5,GO MEMBRANE ORGANIZATION,5.0237e-12,-0.26713,-0.37512,1,0
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,4.8359e-10,-0.26721,-0.35768,1,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.00012594,-0.26728,-0.3125,1,0
5,GO LIPID METABOLIC PROCESS,7.6937e-12,-0.2673,-0.34611,1,0
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,2.3268e-09,-0.26733,-0.3359,1,0
5,GO NEURAL PRECURSOR CELL PROLIFERATION,2.2775e-07,-0.26739,-0.33959,1,0
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.3085e-09,-0.2674,-0.37052,1,0
5,GO RESPONSE TO PEPTIDE,9.6219e-13,-0.26752,-0.40214,1,0
5,GO EMBRYONIC AXIS SPECIFICATION,1.0557e-05,-0.26755,-0.25989,1,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.9078e-09,-0.26764,-0.38251,1,0
5,GO RESPONSE TO NICOTINE,1.5865e-05,-0.26765,-0.27469,1,0
5,GO MANGANESE ION TRANSPORT,4.719e-07,-0.26773,-0.29096,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0017277,-0.26776,-0.27252,1,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0085105,-0.26777,-0.25406,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,2.1234e-05,-0.26778,-0.27896,1,0
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,1.5753e-08,-0.26783,-0.38302,1,0
5,GO CELLULAR LIPID CATABOLIC PROCESS,1.8881e-10,-0.26788,-0.34144,1,0
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.00045468,-0.26796,-0.26327,1,0
5,GO CERAMIDE BIOSYNTHETIC PROCESS,3.2094e-09,-0.26796,-0.37759,1,0
5,GO REGULATION OF PROTEIN IMPORT,7.8778e-10,-0.26802,-0.37098,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.9078e-09,-0.26802,-0.32718,1,0
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,2.7041e-11,-0.26803,-0.36105,1,0
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,5.3617e-10,-0.26805,-0.34291,1,0
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.4967e-09,-0.26809,-0.33462,1,0
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,2.8271e-07,-0.26809,-0.34233,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.8396e-06,-0.2681,-0.34168,1,0
5,GO FEAR RESPONSE,2.8925e-08,-0.26815,-0.30206,1,0
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,2.7e-09,-0.26821,-0.32147,1,0
5,GO PROTEIN PROCESSING,3.7319e-10,-0.26829,-0.3524,1,0
5,GO GROWTH,1.0792e-11,-0.2683,-0.38253,1,0
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.1245e-09,-0.26836,-0.35937,1,0
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,4.8839e-05,-0.2684,-0.28549,1,0
5,GO MESODERM DEVELOPMENT,1.1706e-10,-0.26846,-0.34942,1,0
5,GO NEGATIVE REGULATION OF SIGNALING,2.2453e-12,-0.26868,-0.39114,1,0
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,2.4972e-05,-0.26869,-0.35649,1,0
5,GO AXIS SPECIFICATION,4.6881e-08,-0.2687,-0.30831,1,0
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,1.4741e-05,-0.2688,-0.27894,1,0
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.4487e-10,-0.26882,-0.36228,1,0
5,GO DEMETHYLATION,7.0522e-08,-0.26886,-0.3181,1,0
5,GO CIRCULATORY SYSTEM PROCESS,2.8299e-12,-0.26889,-0.39654,1,0
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.001442,-0.2689,-0.25978,1,0
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,8.2864e-09,-0.26891,-0.3446,1,0
5,GO CARDIOBLAST DIFFERENTIATION,7.5001e-05,-0.26909,-0.32748,1,0
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.00022565,-0.26913,-0.25335,1,0
5,GO OVARIAN FOLLICLE DEVELOPMENT,2.2775e-07,-0.26914,-0.31824,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,8.1138e-06,-0.26925,-0.35546,1,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.1595e-09,-0.26926,-0.33406,1,0
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,1.9387e-10,-0.26926,-0.38174,1,0
5,GO REGULATION OF MACROPHAGE MIGRATION,3.9941e-08,-0.26931,-0.32897,1,0
5,GO THIOESTER BIOSYNTHETIC PROCESS,1.9563e-06,-0.26935,-0.32947,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,1.064e-06,-0.26939,-0.28349,1,0
5,GO EPITHELIAL CELL MATURATION,8.4262e-06,-0.26943,-0.29994,1,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,2.5884e-05,-0.26946,-0.34076,1,0
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,4.5526e-11,-0.26948,-0.35114,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,2.2286e-11,-0.26951,-0.37694,1,0
5,GO STEROL METABOLIC PROCESS,6.3569e-09,-0.26967,-0.33042,1,0
5,GO ALPHA BETA T CELL PROLIFERATION,2.9859e-05,-0.26983,-0.34138,1,0
5,GO RESPONSE TO INSECTICIDE,0.001955,-0.26983,-0.26692,1,0
5,GO SENSORY ORGAN DEVELOPMENT,3.6361e-10,-0.26984,-0.36984,1,0
5,GO ENERGY HOMEOSTASIS,8.2543e-08,-0.26985,-0.4004,1,0
5,GO FATTY ACID METABOLIC PROCESS,1.8389e-10,-0.27001,-0.3168,1,0
5,GO REGULATION OF CHROMATIN BINDING,3.2146e-06,-0.27019,-0.34469,1,0
5,GO REGULATION OF HYDROLASE ACTIVITY,8.1414e-12,-0.27022,-0.38157,1,0
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,8.7502e-06,-0.27027,-0.34289,1,0
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.00020835,-0.27029,-0.26825,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.8142e-08,-0.27036,-0.32715,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,9.7068e-11,-0.27046,-0.35341,1,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,9.6562e-05,-0.2705,-0.35918,1,0
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,8.4262e-06,-0.27055,-0.26542,1,0
5,GO REGULATION OF GROWTH,1.2074e-11,-0.27063,-0.3754,1,0
5,GO SECRETORY GRANULE ORGANIZATION,2.5934e-07,-0.27068,-0.3599,1,0
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,3.9613e-05,-0.27077,-0.30907,1,0
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.00031414,-0.27078,-0.32796,1,0
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,2.3933e-10,-0.27084,-0.40258,1,0
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.8161e-07,-0.27091,-0.33784,1,0
5,GO MONOCYTE CHEMOTAXIS,1.2482e-05,-0.27097,-0.31225,1,0
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,4.0678e-07,-0.27102,-0.32134,1,0
5,GO POSITIVE REGULATION OF CELL KILLING,4.6359e-05,-0.27106,-0.30265,1,0
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.6717e-09,-0.27107,-0.33451,1,0
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,1.3419e-09,-0.27108,-0.32576,1,0
5,GO EMBRYO DEVELOPMENT,1.2074e-11,-0.2711,-0.37627,1,0
5,GO GRANULOCYTE CHEMOTAXIS,1.6129e-08,-0.27111,-0.3195,1,0
5,GO PROTEIN ACTIVATION CASCADE,6.5906e-08,-0.27129,-0.39877,1,0
5,GO SECRETORY GRANULE LOCALIZATION,0.00024819,-0.2713,-0.3941,1,0
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,3.4003e-08,-0.27133,-0.30441,1,0
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,6.0565e-09,-0.27134,-0.3191,1,0
5,GO ACROSOME ASSEMBLY,3.758e-05,-0.27135,-0.28847,1,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,5.2253e-10,-0.27136,-0.33025,1,0
5,GO CEREBELLAR CORTEX DEVELOPMENT,2.8305e-05,-0.27144,-0.30618,1,0
5,GO RESPONSE TO ISCHEMIA,3.7319e-10,-0.27152,-0.43106,1,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,4.1456e-06,-0.27162,-0.31125,1,0
5,GO LIPID OXIDATION,3.5427e-10,-0.2717,-0.33434,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,2.2958e-06,-0.27171,-0.29154,1,0
5,GO REGULATION OF RESPONSE TO TUMOR CELL,7.1819e-07,-0.27175,-0.33577,1,0
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0322e-07,-0.27175,-0.36998,1,0
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.5038e-07,-0.27179,-0.31143,1,0
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,1.9136e-07,-0.2718,-0.30049,1,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.00058763,-0.27181,-0.26336,1,0
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.1828e-09,-0.2719,-0.37564,1,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.00035024,-0.27191,-0.29764,1,0
5,GO MODULATION BY VIRUS OF HOST PROCESS,2.9805e-09,-0.27193,-0.35958,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,7.1274e-05,-0.27198,-0.28812,1,0
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,1.1099e-11,-0.27204,-0.33201,1,0
5,GO VESICLE DOCKING,5.4701e-07,-0.27212,-0.3602,1,0
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,7.2702e-12,-0.27233,-0.37552,1,0
5,GO RESPONSE TO LEAD ION,3.7605e-06,-0.27235,-0.34505,1,0
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,5.2165e-11,-0.27237,-0.39682,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,3.0811e-07,-0.27238,-0.34548,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,4.4807e-06,-0.2724,-0.30902,1,0
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,7.4854e-10,-0.27247,-0.34341,1,0
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.402e-08,-0.27249,-0.33757,1,0
5,GO REGULATION OF TRANSFERASE ACTIVITY,2.1812e-12,-0.27249,-0.37255,1,0
5,GO CARBOHYDRATE HOMEOSTASIS,2.5893e-10,-0.27255,-0.35164,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,2.5756e-08,-0.2726,-0.38065,1,0
5,GO INTERLEUKIN 4 PRODUCTION,5.5864e-07,-0.27267,-0.3009,1,0
5,GO NECROTIC CELL DEATH,3.8983e-07,-0.27268,-0.32039,1,0
5,GO RESPONSE TO ANTIBIOTIC,2.5066e-09,-0.27272,-0.31681,1,0
5,GO REGULATION OF SYMBIOTIC PROCESS,1.0791e-07,-0.27294,-0.33188,1,0
5,GO REGULATION OF PROTEIN TARGETING,1.6407e-09,-0.27295,-0.34199,1,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,7.2129e-08,-0.27296,-0.39617,1,0
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,8.0256e-05,-0.27301,-0.29269,1,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,1.887e-11,-0.27303,-0.35796,1,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.00013451,-0.27303,-0.39564,1,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,5.77e-09,-0.27306,-0.42643,1,0
5,GO PEPTIDYL SERINE MODIFICATION,5.1691e-12,-0.27312,-0.397,1,0
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,2.9805e-09,-0.27332,-0.45393,1,0
5,GO SYNAPTIC SIGNALING,7.892e-08,-0.27334,-0.34575,1,0
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,2.6711e-12,-0.27337,-0.39713,1,0
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,2.2707e-10,-0.2734,-0.36206,1,0
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,9.795e-06,-0.27345,-0.35152,1,0
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,4.3082e-09,-0.27351,-0.37565,1,0
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,8.4871e-11,-0.27353,-0.39015,1,0
5,GO REGULATION OF PHOSPHORYLATION,1.6307e-12,-0.27353,-0.38271,1,0
5,GO EXOCYTIC PROCESS,3.152e-06,-0.27358,-0.33376,1,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,5.5078e-11,-0.27364,-0.37146,1,0
5,GO RESPONSE TO INORGANIC SUBSTANCE,6.4805e-11,-0.27366,-0.3379,1,0
5,GO SECOND MESSENGER MEDIATED SIGNALING,4.5526e-11,-0.27367,-0.33147,1,0
5,GO SEX DIFFERENTIATION,2.0437e-10,-0.27368,-0.33111,1,0
5,GO SEROTONIN TRANSPORT,2.9332e-05,-0.2737,-0.32728,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,1.1478e-12,-0.27381,-0.37659,1,0
5,GO RESPONSE TO REDOX STATE,9.6562e-05,-0.27383,-0.31467,1,0
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0013255,-0.27387,-0.24627,1,0
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,4.3082e-09,-0.27394,-0.34825,1,0
5,GO POSITIVE T CELL SELECTION,2.7312e-05,-0.27396,-0.25672,1,0
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,6.5906e-08,-0.27404,-0.29194,1,0
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,8.6328e-08,-0.27415,-0.36346,1,0
5,GO RNA DESTABILIZATION,4.1552e-07,-0.27418,-0.36346,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,5.3747e-08,-0.27448,-0.32835,1,0
5,GO HEART FORMATION,1.8363e-05,-0.27453,-0.32531,1,0
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,1.2733e-08,-0.27454,-0.32552,1,0
5,GO RESPONSE TO ETHANOL,1.5688e-10,-0.27455,-0.30672,1,0
5,GO REGULATION OF CELL DIFFERENTIATION,5.9602e-12,-0.27456,-0.39075,1,0
5,GO CELLULAR RESPONSE TO VIRUS,2.3784e-07,-0.27461,-0.31514,1,0
5,GO CYTOPLASM ORGANIZATION,1.2954e-05,-0.27464,-0.37206,1,0
5,GO HINDBRAIN MORPHOGENESIS,7.4873e-07,-0.27476,-0.3221,1,0
5,GO NUCLEOTIDE SALVAGE,8.8796e-05,-0.27478,-0.30351,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.5043e-10,-0.27478,-0.31902,1,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,6.2046e-07,-0.27481,-0.29925,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.1307e-08,-0.2749,-0.38958,1,0
5,GO HEART DEVELOPMENT,1.1415e-11,-0.27501,-0.41597,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE,1.2534e-12,-0.27505,-0.40891,1,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,6.1389e-11,-0.27509,-0.40658,1,0
5,GO MEMBRANE LIPID METABOLIC PROCESS,1.4112e-09,-0.27511,-0.35063,1,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,1.0094e-07,-0.27513,-0.33123,1,0
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,1.8594e-09,-0.27515,-0.34043,1,0
5,GO LOCOMOTORY BEHAVIOR,2.6981e-08,-0.27518,-0.37032,1,0
5,GO LABYRINTHINE LAYER DEVELOPMENT,1.1086e-06,-0.2753,-0.37517,1,0
5,GO ACUTE PHASE RESPONSE,2.2286e-07,-0.27532,-0.28367,1,0
5,GO PROTEIN KINASE A SIGNALING,5.6451e-10,-0.27533,-0.34602,1,0
5,GO TELENCEPHALON DEVELOPMENT,1.2886e-07,-0.27534,-0.33825,1,0
5,GO MUSCLE FILAMENT SLIDING,1.6321e-06,-0.27535,-0.26875,1,0
5,GO CELLULAR IRON ION HOMEOSTASIS,5.5016e-10,-0.27537,-0.31091,1,0
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,1.1706e-10,-0.27541,-0.36689,1,0
5,GO RESPONSE TO MINERALOCORTICOID,1.1535e-07,-0.27541,-0.31625,1,0
5,GO SUCKLING BEHAVIOR,0.0016806,-0.27543,-0.30831,1,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.3599e-06,-0.27552,-0.3995,1,0
5,GO SODIUM ION TRANSPORT,1.9546e-09,-0.27554,-0.33371,1,0
5,GO T CELL MEDIATED IMMUNITY,7.8052e-07,-0.27564,-0.33955,1,0
5,GO REGULATION OF PEPTIDASE ACTIVITY,6.586e-10,-0.27568,-0.36959,1,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,3.2631e-05,-0.27572,-0.28888,1,0
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,2.521e-12,-0.27581,-0.38236,1,0
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,9.6431e-12,-0.27587,-0.36955,1,0
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,2.2117e-10,-0.27592,-0.3721,1,0
5,GO ICOSANOID BIOSYNTHETIC PROCESS,1.4076e-07,-0.27599,-0.33597,1,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,5.6245e-08,-0.27603,-0.42231,1,0
5,GO TYPE I INTERFERON PRODUCTION,4.7963e-08,-0.27608,-0.36622,1,0
5,GO RESPONSE TO GLUCAGON,4.7963e-08,-0.2761,-0.36869,1,0
5,GO GLYCEROLIPID METABOLIC PROCESS,4.7449e-12,-0.27612,-0.35427,1,0
5,GO SPINDLE LOCALIZATION,3.0302e-06,-0.27613,-0.31775,1,0
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.3774e-08,-0.27616,-0.33483,1,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,7.5001e-05,-0.27626,-0.31341,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,9.819e-05,-0.2763,-0.31966,1,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.3693e-05,-0.27633,-0.32115,1,0
5,GO MRNA TRANSCRIPTION,4.1751e-05,-0.27639,-0.35573,1,0
5,GO RESPONSE TO X RAY,1.7922e-07,-0.27649,-0.34064,1,0
5,GO CHLORIDE TRANSPORT,9.1996e-11,-0.27649,-0.342,1,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.0323e-06,-0.27655,-0.3196,1,0
5,GO EXTRACELLULAR VESICLE BIOGENESIS,1.4076e-07,-0.27664,-0.34038,1,0
5,GO RESPONSE TO PEPTIDOGLYCAN,2.6362e-08,-0.27668,-0.31889,1,0
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,2.7797e-11,-0.27675,-0.35733,1,0
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,6.3088e-12,-0.27678,-0.40269,1,0
5,GO MODIFIED AMINO ACID TRANSPORT,4.8673e-09,-0.27681,-0.37315,1,0
5,GO REGULATION OF RESPONSE TO STRESS,1.0493e-11,-0.27692,-0.3481,1,0
5,GO MAINTENANCE OF LOCATION,3.6667e-12,-0.27696,-0.36789,1,0
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,1.642e-11,-0.27701,-0.33492,1,0
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,1.2682e-10,-0.27707,-0.36891,1,0
5,GO NOTCH SIGNALING PATHWAY,2.1543e-10,-0.27709,-0.41531,1,0
5,GO ACTIVATED T CELL PROLIFERATION,6.4434e-08,-0.27712,-0.33674,1,0
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.4528e-05,-0.27715,-0.30804,1,0
5,GO REGULATION OF CHROMATIN ASSEMBLY,1.2733e-08,-0.27715,-0.35957,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,2.2926e-08,-0.27722,-0.35783,1,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,3.2162e-07,-0.27749,-0.32546,1,0
5,GO CATECHOLAMINE UPTAKE,0.00010323,-0.27751,-0.29334,1,0
5,GO G2 DNA DAMAGE CHECKPOINT,8.6579e-07,-0.27754,-0.32884,1,0
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,5.7051e-07,-0.27762,-0.33964,1,0
5,GO SKIN DEVELOPMENT,1.2328e-07,-0.27763,-0.34733,1,0
5,GO RESPONSE TO HORMONE,1.8323e-12,-0.27764,-0.38897,1,0
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,4.4812e-12,-0.27768,-0.34861,1,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,6.337e-06,-0.27772,-0.32885,1,0
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00019857,-0.27774,-0.28254,1,0
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,7.9617e-06,-0.27776,-0.3117,1,0
5,GO HYPOTHALAMUS DEVELOPMENT,5.0323e-06,-0.27785,-0.33839,1,0
5,GO BEHAVIOR,1.6001e-09,-0.2779,-0.3591,1,0
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,1.5713e-07,-0.27806,-0.3156,1,0
5,GO TEMPERATURE HOMEOSTASIS,5.6594e-11,-0.27808,-0.36433,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,5.1351e-07,-0.27814,-0.32573,1,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.8142e-08,-0.27814,-0.3957,1,0
5,GO ESTROGEN METABOLIC PROCESS,7.0337e-07,-0.27815,-0.26734,1,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00013451,-0.27819,-0.24648,1,0
5,GO HIPPOCAMPUS DEVELOPMENT,1.9044e-05,-0.27824,-0.28857,1,0
5,GO TUBE FORMATION,4.249e-10,-0.2783,-0.38018,1,0
5,GO HEART GROWTH,3.1896e-11,-0.27833,-0.41833,1,0
5,GO REGULATION OF NEUTROPHIL MIGRATION,7.8124e-06,-0.27839,-0.32745,1,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,8.9558e-11,-0.27847,-0.40924,1,0
5,GO POLYSACCHARIDE METABOLIC PROCESS,3.2785e-11,-0.27854,-0.39137,1,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00031907,-0.27855,-0.28855,1,0
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,9.404e-07,-0.27855,-0.31907,1,0
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,5.3617e-10,-0.27863,-0.32829,1,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00026024,-0.27866,-0.29112,1,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0001803,-0.27871,-0.29333,1,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0020367,-0.27877,-0.26094,1,0
5,GO CELL KILLING,1.0861e-06,-0.27878,-0.28494,1,0
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.7534e-07,-0.27879,-0.33053,1,0
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,9.7068e-11,-0.27884,-0.35644,1,0
5,GO L SERINE METABOLIC PROCESS,0.0051547,-0.27888,-0.2421,1,0
5,GO MYOTUBE DIFFERENTIATION,4.6784e-11,-0.27891,-0.40047,1,0
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.6001e-09,-0.27899,-0.34003,1,0
5,GO ENDOCYTOSIS,1.3291e-12,-0.279,-0.4208,1,0
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.5838e-12,-0.27907,-0.3916,1,0
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,2.0509e-11,-0.2791,-0.40587,1,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,7.8778e-10,-0.27919,-0.35645,1,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,5.332e-06,-0.27923,-0.33561,1,0
5,GO REGULATION OF DEFENSE RESPONSE,3.5427e-10,-0.27926,-0.33173,1,0
5,GO EXTRACELLULAR TRANSPORT,2.2505e-06,-0.27927,-0.31123,1,0
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,5.5016e-10,-0.27937,-0.39365,1,0
5,GO SOMITE DEVELOPMENT,1.8723e-07,-0.27939,-0.325,1,0
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,2.9515e-10,-0.27944,-0.32888,1,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.1316e-06,-0.2795,-0.3905,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,2.0478e-05,-0.27962,-0.27631,1,0
5,GO PANCREATIC JUICE SECRETION,5.8856e-08,-0.27967,-0.32675,1,0
5,GO MAINTENANCE OF LOCATION IN CELL,1.5102e-11,-0.27977,-0.35761,1,0
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,1.9905e-10,-0.27979,-0.35457,1,0
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,8.4262e-06,-0.27999,-0.28644,1,0
5,GO BILE ACID AND BILE SALT TRANSPORT,0.00015331,-0.28,-0.32315,1,0
5,GO MUSCLE CELL DEVELOPMENT,8.4871e-11,-0.28001,-0.38206,1,0
5,GO CYTOKINE METABOLIC PROCESS,2.8753e-10,-0.28009,-0.38607,1,0
5,GO EXOCYTOSIS,1.736e-11,-0.2801,-0.37875,1,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.00076726,-0.2802,-0.3132,1,0
5,GO CALCIUM ION IMPORT,1.2131e-09,-0.28022,-0.36726,1,0
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,2.4452e-09,-0.28026,-0.32789,1,0
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00053704,-0.28029,-0.37238,1,0
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,3.1098e-10,-0.28035,-0.3773,1,0
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,3.9963e-12,-0.28036,-0.39938,1,0
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,3.9064e-09,-0.28037,-0.30748,1,0
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,7.333e-07,-0.2805,-0.32901,1,0
5,GO SYNAPTIC VESICLE MATURATION,0.00057029,-0.28054,-0.36887,1,0
5,GO BILE ACID BIOSYNTHETIC PROCESS,5.3747e-08,-0.28057,-0.3154,1,0
5,GO COPPER ION TRANSPORT,2.4305e-07,-0.28061,-0.31388,1,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0047198,-0.28062,-0.26283,1,0
5,GO REGULATION OF HEAT GENERATION,2.0478e-05,-0.28069,-0.2718,1,0
5,GO MYOTUBE CELL DEVELOPMENT,2.65e-07,-0.2808,-0.29661,1,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.00016098,-0.28082,-0.29546,1,0
5,GO EPITHELIAL TUBE FORMATION,1.7687e-09,-0.28085,-0.37058,1,0
5,GO BICARBONATE TRANSPORT,2.402e-08,-0.28088,-0.31288,1,0
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,1.0241e-10,-0.28094,-0.36743,1,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,2.3853e-09,-0.28097,-0.34838,1,0
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,8.4877e-09,-0.28099,-0.28911,1,0
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.1282e-07,-0.28102,-0.3355,1,0
5,GO RESPONSE TO CORTICOSTERONE,6.2169e-06,-0.28105,-0.33039,1,0
5,GO COENZYME A METABOLIC PROCESS,0.00017741,-0.2811,-0.25901,1,0
5,GO T CELL CHEMOTAXIS,3.1004e-08,-0.28123,-0.31435,1,0
5,GO THALAMUS DEVELOPMENT,0.00094089,-0.28124,-0.27394,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00080175,-0.28129,-0.31708,1,0
5,GO SOMITOGENESIS,1.2733e-08,-0.28137,-0.34688,1,0
5,GO ASSOCIATIVE LEARNING,2.2926e-08,-0.28142,-0.35577,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,9.5677e-09,-0.28146,-0.36942,1,0
5,GO SKIN EPIDERMIS DEVELOPMENT,2.8369e-09,-0.28149,-0.3882,1,0
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,7.892e-08,-0.28152,-0.35995,1,0
5,GO NEGATIVE REGULATION OF CELL DEATH,1.9402e-11,-0.28155,-0.33799,1,0
5,GO REGULATION OF LYASE ACTIVITY,3.4003e-08,-0.28155,-0.32848,1,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.6328e-08,-0.28156,-0.31902,1,0
5,GO REGULATION OF ACTIN FILAMENT LENGTH,7.479e-12,-0.28165,-0.40247,1,0
5,GO REGULATION OF DEPHOSPHORYLATION,2.9515e-10,-0.2817,-0.36974,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,4.3082e-09,-0.28192,-0.37324,1,0
5,GO NEGATIVE REGULATION OF BINDING,5.9748e-11,-0.28195,-0.35373,1,0
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.8753e-10,-0.28199,-0.34422,1,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,6.2169e-06,-0.282,-0.2741,1,0
5,GO RUFFLE ORGANIZATION,4.7963e-08,-0.28203,-0.35279,1,0
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,9.658e-10,-0.28233,-0.33596,1,0
5,GO NEURAL TUBE DEVELOPMENT,4.249e-10,-0.28234,-0.40243,1,0
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,7.892e-08,-0.28237,-0.31422,1,0
5,GO REGULATION OF METAL ION TRANSPORT,7.9144e-12,-0.28239,-0.37194,1,0
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,4.4771e-05,-0.28242,-0.30919,1,0
5,GO REGULATION OF CELL DEVELOPMENT,1.6109e-10,-0.28257,-0.39311,1,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,9.3415e-09,-0.28259,-0.31359,1,0
5,GO MOTILE CILIUM ASSEMBLY,5.4184e-05,-0.28262,-0.33177,1,0
5,GO COCHLEA DEVELOPMENT,4.1815e-08,-0.28265,-0.35691,1,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,1.0036e-08,-0.28267,-0.29674,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.4487e-10,-0.2827,-0.38014,1,0
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,5.3562e-07,-0.28271,-0.36432,1,0
5,GO MUSCLE CELL FATE COMMITMENT,5.3562e-07,-0.28272,-0.33324,1,0
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,2.9979e-12,-0.2829,-0.39037,1,0
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,8.4805e-07,-0.28292,-0.33694,1,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,1.5865e-05,-0.28292,-0.36161,1,0
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,7.969e-07,-0.28294,-0.3532,1,0
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0016122,-0.28295,-0.22576,1,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.7309e-08,-0.28298,-0.37439,1,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0017277,-0.28304,-0.29148,1,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,2.1338e-07,-0.28306,-0.38868,1,0
5,GO REGULATION OF MUSCLE CONTRACTION,5.5078e-11,-0.28308,-0.36272,1,0
5,GO AROMATIC AMINO ACID TRANSPORT,8.4424e-05,-0.28315,-0.43072,1,0
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,3.2162e-07,-0.28321,-0.33511,1,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,1.8723e-07,-0.28324,-0.35742,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,5.0278e-07,-0.28326,-0.35486,1,0
5,GO CARBOHYDRATE CATABOLIC PROCESS,2.8753e-10,-0.28329,-0.35557,1,0
5,GO ERYTHROCYTE DEVELOPMENT,1.3174e-07,-0.28331,-0.40956,1,0
5,GO ENDOCRINE SYSTEM DEVELOPMENT,2.0364e-06,-0.28331,-0.32149,1,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00049053,-0.28334,-0.34256,1,0
5,GO CELLULAR GLUCOSE HOMEOSTASIS,2.801e-10,-0.2834,-0.37064,1,0
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,3.3435e-06,-0.28346,-0.25055,1,0
5,GO THYROID HORMONE METABOLIC PROCESS,2.5868e-06,-0.28355,-0.27846,1,0
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,1.942e-12,-0.28359,-0.38139,1,0
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.001568,-0.28374,-0.31621,1,0
5,GO DIET INDUCED THERMOGENESIS,2.0879e-07,-0.28384,-0.30113,1,0
5,GO NEUROGENESIS,1.069e-09,-0.28387,-0.38015,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,5.7051e-07,-0.28397,-0.28793,1,0
5,GO CELLULAR RESPONSE TO STARVATION,3.6361e-10,-0.28397,-0.37756,1,0
5,GO IMMUNE SYSTEM DEVELOPMENT,1.5968e-11,-0.28398,-0.36452,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,9.1205e-09,-0.28402,-0.36564,1,0
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,3.8347e-06,-0.28406,-0.34652,1,0
5,GO HISTONE H3 K4 TRIMETHYLATION,9.2585e-06,-0.28407,-0.30066,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,2.0478e-05,-0.28408,-0.35561,1,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.4157e-10,-0.28411,-0.35217,1,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,2.5164e-08,-0.28417,-0.3362,1,0
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,1.2682e-10,-0.28426,-0.35152,1,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,4.1751e-05,-0.28434,-0.2739,1,0
5,GO RESPONSE TO BMP,3.192e-10,-0.28446,-0.4386,1,0
5,GO COLLECTING DUCT DEVELOPMENT,1.5674e-06,-0.28456,-0.4662,1,0
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,5.1356e-08,-0.2846,-0.33945,1,0
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.018693,-0.28463,-0.26739,1,0
5,GO FIBROBLAST ACTIVATION,1.064e-06,-0.28471,-0.35637,1,0
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,4.8416e-06,-0.28475,-0.33297,1,0
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,8.0898e-09,-0.28486,-0.38496,1,0
5,GO MATING BEHAVIOR,4.1552e-07,-0.28501,-0.32602,1,0
5,GO NON CANONICAL WNT SIGNALING PATHWAY,4.7501e-09,-0.28501,-0.31728,1,0
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,8.5043e-10,-0.28502,-0.38915,1,0
5,GO MOLTING CYCLE,5.2253e-10,-0.28513,-0.37757,1,0
5,GO TRANSITION METAL ION HOMEOSTASIS,5.6317e-09,-0.28514,-0.31197,1,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,3.5646e-05,-0.28517,-0.37293,1,0
5,GO RESPONSE TO AUDITORY STIMULUS,8.3013e-05,-0.28518,-0.35904,1,0
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,2.5893e-10,-0.28537,-0.43786,1,0
5,GO REGULATION OF SYNAPTIC PLASTICITY,6.2993e-08,-0.2854,-0.38268,1,0
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.5014e-05,-0.28543,-0.39912,1,0
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,3.8833e-12,-0.28548,-0.39323,1,0
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,1.9905e-10,-0.28553,-0.33975,1,0
5,GO LINOLEIC ACID METABOLIC PROCESS,5.7059e-05,-0.28559,-0.36538,1,0
5,GO EOSINOPHIL MIGRATION,0.00044103,-0.28563,-0.32201,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,1.1858e-08,-0.28564,-0.39581,1,0
5,GO CELL PROJECTION ORGANIZATION,9.4499e-11,-0.28565,-0.38943,1,0
5,GO AGING,1.9948e-11,-0.2857,-0.35055,1,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,1.174e-11,-0.28579,-0.40864,1,0
5,GO POSITIVE REGULATION OF CELL DIVISION,9.028e-08,-0.28588,-0.34476,1,0
5,GO INOSITOL METABOLIC PROCESS,6.1119e-05,-0.28591,-0.30752,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,9.6562e-05,-0.28594,-0.27659,1,0
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,1.3351e-08,-0.28595,-0.34025,1,0
5,GO GLAND DEVELOPMENT,2.2912e-11,-0.28616,-0.40096,1,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,6.3074e-11,-0.28616,-0.34088,1,0
5,GO REGULATION OF ISOTYPE SWITCHING,4.0033e-09,-0.28621,-0.40041,1,0
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,7.6792e-10,-0.28627,-0.36825,1,0
5,GO REGULATION OF VIRAL LIFE CYCLE,8.1361e-07,-0.28628,-0.36229,1,0
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,1.0493e-11,-0.28632,-0.43533,1,0
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,1.7909e-10,-0.28643,-0.3786,1,0
5,GO STEM CELL DIFFERENTIATION,7.8778e-10,-0.28643,-0.33147,1,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,7.333e-07,-0.28645,-0.31161,1,0
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.7195e-09,-0.2866,-0.4287,1,0
5,GO REGULATION OF TORC1 SIGNALING,4.6356e-09,-0.28661,-0.41556,1,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,8.0256e-05,-0.28662,-0.28397,1,0
5,GO RESPONSE TO ALCOHOL,1.1415e-11,-0.28662,-0.35989,1,0
5,GO LEFT RIGHT PATTERN FORMATION,1.3325e-06,-0.28666,-0.34694,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.71e-09,-0.28671,-0.36673,1,0
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,3.9717e-11,-0.28676,-0.36818,1,0
5,GO ACTIVATION OF IMMUNE RESPONSE,4.0343e-10,-0.28677,-0.35016,1,0
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00029511,-0.28677,-0.37552,1,0
5,GO THYMOCYTE APOPTOTIC PROCESS,6.5837e-06,-0.28693,-0.34847,1,0
5,GO WATER TRANSPORT,1.5372e-07,-0.28694,-0.31401,1,0
5,GO RETINAL ROD CELL DIFFERENTIATION,0.0005211,-0.28699,-0.27826,1,0
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.484e-09,-0.28705,-0.34176,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,4.0343e-10,-0.28705,-0.32214,1,0
5,GO MEMBRANE FUSION,1.0519e-10,-0.28706,-0.39175,1,0
5,GO TONGUE MORPHOGENESIS,0.013546,-0.2871,-0.19508,1,0
5,GO TISSUE REGENERATION,9.1205e-09,-0.28715,-0.35489,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,3.9941e-08,-0.28718,-0.44881,1,0
5,GO NEURON DIFFERENTIATION,2.3268e-09,-0.2872,-0.37986,1,0
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,2.6828e-05,-0.2872,-0.31783,1,0
5,GO REGULATION OF BLOOD PRESSURE,2.2117e-10,-0.28738,-0.36517,1,0
5,GO CAMERA TYPE EYE MORPHOGENESIS,3.8149e-08,-0.2875,-0.37206,1,0
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,3.9309e-10,-0.28752,-0.39269,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,1.2348e-10,-0.28759,-0.41543,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,3.1004e-08,-0.2876,-0.36981,1,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,2.3793e-12,-0.28771,-0.38371,1,0
5,GO TOXIN METABOLIC PROCESS,0.0003557,-0.28777,-0.29873,1,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,3.4003e-08,-0.2878,-0.43812,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,8.0815e-10,-0.28787,-0.32048,1,0
5,GO ANIMAL ORGAN MORPHOGENESIS,7.6937e-12,-0.28791,-0.40129,1,0
5,GO ALPHA BETA T CELL ACTIVATION,4.6356e-09,-0.28795,-0.36467,1,0
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,2.0776e-06,-0.28801,-0.33595,1,0
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.6717e-09,-0.28801,-0.38567,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS,6.8695e-12,-0.28804,-0.38703,1,0
5,GO TONGUE DEVELOPMENT,0.00044103,-0.28819,-0.26312,1,0
5,GO REGULATION OF T CELL DIFFERENTIATION,1.5277e-10,-0.2882,-0.35625,1,0
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,5.2359e-09,-0.28828,-0.34286,1,0
5,GO LYSOSOMAL TRANSPORT,1.9402e-11,-0.28833,-0.43332,1,0
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,1.5604e-09,-0.28835,-0.38557,1,0
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,3.5427e-10,-0.28838,-0.43614,1,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,1.8573e-08,-0.28845,-0.39959,1,0
5,GO REGULATION OF CELLULAR RESPIRATION,4.0657e-06,-0.28848,-0.29891,1,0
5,GO PHAGOSOME MATURATION,2.0881e-08,-0.28857,-0.35891,1,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,6.895e-08,-0.28861,-0.32827,1,0
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,7.2702e-12,-0.28864,-0.40905,1,0
5,GO SUBSTANTIA NIGRA DEVELOPMENT,1.0527e-08,-0.28865,-0.31168,1,0
5,GO REGULATION OF FEEDING BEHAVIOR,7.105e-06,-0.28873,-0.27205,1,0
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.3948e-05,-0.28873,-0.32118,1,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.404e-07,-0.28879,-0.37504,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,8.6328e-08,-0.28882,-0.36682,1,0
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.4214e-11,-0.2889,-0.42941,1,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,3.8833e-12,-0.28895,-0.39909,1,0
5,GO LEUKOTRIENE METABOLIC PROCESS,3.1729e-08,-0.28905,-0.37659,1,0
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,3.7282e-08,-0.28919,-0.34186,1,0
5,GO DIENCEPHALON DEVELOPMENT,4.0314e-05,-0.28928,-0.30574,1,0
5,GO SKELETAL MUSCLE ADAPTATION,4.4771e-05,-0.28942,-0.28901,1,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,2.801e-10,-0.28942,-0.35237,1,0
5,GO MOVEMENT IN HOST ENVIRONMENT,2.3933e-10,-0.28942,-0.41256,1,0
5,GO IMMUNOGLOBULIN PRODUCTION,6.757e-10,-0.28951,-0.31955,1,0
5,GO MUSCLE CONTRACTION,2.521e-12,-0.28955,-0.39678,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.1807e-07,-0.28961,-0.35464,1,0
5,GO MUSCLE ORGAN MORPHOGENESIS,1.5217e-09,-0.28962,-0.40299,1,0
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,1.9064e-09,-0.28972,-0.37834,1,0
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,1.9465e-08,-0.28979,-0.39205,1,0
5,GO MYELOID LEUKOCYTE MIGRATION,3.1312e-09,-0.28981,-0.33956,1,0
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,1.5052e-06,-0.28984,-0.35687,1,0
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,1.6823e-09,-0.28991,-0.40737,1,0
5,GO REGULATION OF RUFFLE ASSEMBLY,1.9558e-07,-0.29005,-0.38088,1,0
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.484e-09,-0.29005,-0.39556,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,2.2015e-05,-0.29018,-0.28509,1,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.1706e-10,-0.2902,-0.42197,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,1.7286e-12,-0.29022,-0.39824,1,0
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,1.8032e-05,-0.29024,-0.33628,1,0
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,1.1165e-05,-0.29025,-0.3005,1,0
5,GO CELL VOLUME HOMEOSTASIS,1.8594e-09,-0.29025,-0.38435,1,0
5,GO METENCEPHALON DEVELOPMENT,2.5359e-06,-0.29031,-0.31301,1,0
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,5.3617e-10,-0.29043,-0.34327,1,0
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,3.7602e-11,-0.29052,-0.36129,1,0
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,2.4972e-05,-0.29054,-0.31508,1,0
5,GO HAIR CELL DIFFERENTIATION,2.856e-06,-0.29064,-0.36284,1,0
5,GO INTERLEUKIN 17 PRODUCTION,2.9514e-07,-0.29084,-0.36021,1,0
5,GO NEURAL TUBE FORMATION,7.5266e-09,-0.29091,-0.39107,1,0
5,GO PLASMA MEMBRANE TUBULATION,2.2397e-08,-0.29096,-0.45659,1,0
5,GO DENTATE GYRUS DEVELOPMENT,0.00036124,-0.29097,-0.30495,1,0
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,8.8796e-05,-0.29101,-0.31113,1,0
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.00016361,-0.29106,-0.31452,1,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00052901,-0.29106,-0.35261,1,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,5.9432e-10,-0.2911,-0.38511,1,0
5,GO CELL CELL SIGNALING BY WNT,2.559e-11,-0.29111,-0.38055,1,0
5,GO THYROID GLAND DEVELOPMENT,1.3878e-06,-0.29114,-0.36829,1,0
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.05063,-0.29116,-0.19154,1,0
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,8.8389e-07,-0.29121,-0.35897,1,0
5,GO REGULATION OF LIPID METABOLIC PROCESS,1.5838e-12,-0.29127,-0.39304,1,0
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,1.5386e-08,-0.29128,-0.37107,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,4.8198e-07,-0.29136,-0.36994,1,0
5,GO REGULATION OF CYCLASE ACTIVITY,1.0791e-07,-0.29138,-0.33542,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,5.9432e-10,-0.2914,-0.36091,1,0
5,GO SPHINGOLIPID METABOLIC PROCESS,5.0922e-10,-0.29146,-0.38807,1,0
5,GO LYMPHOCYTE CHEMOTAXIS,2.8753e-10,-0.29151,-0.31969,1,0
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,4.719e-07,-0.29158,-0.40251,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.801e-10,-0.29163,-0.38092,1,0
5,GO RESPONSE TO MUSCLE ACTIVITY,9.404e-07,-0.29164,-0.34429,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,6.586e-10,-0.29171,-0.38557,1,0
5,GO NEGATIVE REGULATION OF ION TRANSPORT,2.8753e-10,-0.29173,-0.34448,1,0
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.9078e-09,-0.29181,-0.33908,1,0
5,GO RESPONSE TO AMINO ACID STARVATION,1.471e-07,-0.29184,-0.34824,1,0
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,2.2958e-06,-0.29184,-0.37794,1,0
5,GO CELL MIGRATION IN HINDBRAIN,0.00023294,-0.29201,-0.37796,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.6884e-11,-0.29201,-0.44197,1,0
5,GO NEPHRON MORPHOGENESIS,1.2143e-08,-0.29204,-0.35253,1,0
5,GO TISSUE MORPHOGENESIS,1.3505e-11,-0.29208,-0.3987,1,0
5,GO NEURONAL ACTION POTENTIAL,0.00042777,-0.29213,-0.3071,1,0
5,GO LYMPHOCYTE COSTIMULATION,6.7411e-08,-0.29221,-0.35258,1,0
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,9.2118e-07,-0.29221,-0.41664,1,0
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,2.5893e-10,-0.29226,-0.38195,1,0
5,GO REGULATION OF IMMUNE RESPONSE,2.801e-10,-0.29228,-0.35427,1,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,8.2903e-10,-0.29231,-0.34059,1,0
5,GO VITAMIN TRANSPORT,1.2058e-07,-0.29243,-0.31841,1,0
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,9.9064e-10,-0.2925,-0.34823,1,0
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.00013232,-0.29252,-0.34343,1,0
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,3.8161e-07,-0.29255,-0.3676,1,0
5,GO BODY FLUID SECRETION,8.4871e-11,-0.29265,-0.3521,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,2.402e-08,-0.29267,-0.43002,1,0
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,9.3415e-09,-0.29272,-0.35498,1,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1.8142e-08,-0.29276,-0.34673,1,0
5,GO MITOCHONDRION DISTRIBUTION,2.5868e-06,-0.29278,-0.34735,1,0
5,GO RESPONSE TO BIOTIC STIMULUS,1.8881e-10,-0.29287,-0.34247,1,0
5,GO LYMPHOCYTE HOMEOSTASIS,7.8976e-09,-0.29292,-0.35582,1,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,1.3693e-05,-0.29296,-0.40689,1,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,9.5677e-09,-0.29297,-0.36526,1,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,3.8347e-06,-0.293,-0.44767,1,0
5,GO MUSCLE SYSTEM PROCESS,1.7286e-12,-0.29301,-0.40573,1,0
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.1533e-09,-0.29308,-0.33849,1,0
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.7687e-09,-0.2932,-0.34506,1,0
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,5.0237e-12,-0.29321,-0.38039,1,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,2.971e-06,-0.29332,-0.38973,1,0
5,GO CELLULAR RESPONSE TO X RAY,2.2505e-06,-0.29336,-0.32097,1,0
5,GO STARTLE RESPONSE,0.00081356,-0.29353,-0.28224,1,0
5,GO LIPID DROPLET ORGANIZATION,1.1307e-08,-0.29355,-0.34558,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,2.2453e-12,-0.29358,-0.39312,1,0
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,8.2903e-10,-0.29361,-0.36567,1,0
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.1729e-08,-0.29366,-0.43513,1,0
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,5.7051e-07,-0.29369,-0.31688,1,0
5,GO CARDIOCYTE DIFFERENTIATION,3.7319e-10,-0.29373,-0.40268,1,0
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,7.892e-08,-0.29374,-0.40419,1,0
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,4.3549e-12,-0.29375,-0.41812,1,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,1.0169e-05,-0.2938,-0.34578,1,0
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.0094e-07,-0.29381,-0.40659,1,0
5,GO VACUOLE ORGANIZATION,6.3088e-12,-0.29386,-0.40315,1,0
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,9.1996e-11,-0.29396,-0.3951,1,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,2.7078e-07,-0.29408,-0.3538,1,0
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.7614e-08,-0.2941,-0.34506,1,0
5,GO REGULATION OF GLIAL CELL MIGRATION,2.8753e-10,-0.29412,-0.37154,1,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,1.4877e-10,-0.29419,-0.31871,1,0
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,5.9602e-12,-0.2942,-0.40211,1,0
5,GO REGULATION OF MUSCLE ADAPTATION,1.0161e-09,-0.29439,-0.42155,1,0
5,GO RESPONSE TO INTERLEUKIN 12,4.4807e-06,-0.29464,-0.27951,1,0
5,GO NEGATIVE REGULATION OF GLIOGENESIS,2.2824e-05,-0.2948,-0.27449,1,0
5,GO SMOOTHENED SIGNALING PATHWAY,3.055e-09,-0.2948,-0.35583,1,0
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,1.2143e-08,-0.29498,-0.38899,1,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,4.7449e-12,-0.29499,-0.40063,1,0
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.484e-09,-0.29502,-0.35555,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.5427e-10,-0.29502,-0.38108,1,0
5,GO STRESS GRANULE ASSEMBLY,1.0094e-07,-0.29511,-0.36464,1,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.0678e-07,-0.29516,-0.38047,1,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,8.4877e-09,-0.29522,-0.396,1,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,3.2146e-06,-0.29524,-0.38764,1,0
5,GO NATURAL KILLER CELL ACTIVATION,7.2129e-08,-0.29527,-0.33773,1,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,7.5217e-06,-0.29529,-0.31058,1,0
5,GO MONONUCLEAR CELL MIGRATION,6.1583e-08,-0.29538,-0.33661,1,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.00023667,-0.29547,-0.3442,1,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,3.7282e-08,-0.29547,-0.40034,1,0
5,GO ACUTE INFLAMMATORY RESPONSE,1.0781e-08,-0.29553,-0.32471,1,0
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00020178,-0.29554,-0.31706,1,0
5,GO CELLULAR SODIUM ION HOMEOSTASIS,7.2497e-05,-0.29567,-0.31375,1,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.7676e-09,-0.29579,-0.38756,1,0
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,3.2764e-10,-0.29587,-0.41258,1,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.00014839,-0.29588,-0.28305,1,0
5,GO REGULATION OF T CELL ACTIVATION,4.1403e-10,-0.29588,-0.36011,1,0
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.8053e-06,-0.29591,-0.28867,1,0
5,GO ENDOCARDIUM DEVELOPMENT,3.3806e-05,-0.29601,-0.31631,1,0
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.9546e-09,-0.29619,-0.42829,1,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,9.6538e-08,-0.29626,-0.35106,1,0
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,9.4499e-11,-0.29638,-0.35864,1,0
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.232e-12,-0.29639,-0.41659,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,5.6304e-12,-0.29644,-0.38801,1,0
5,GO PROTEIN HYDROXYLATION,8.5867e-06,-0.29647,-0.3822,1,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,1.642e-11,-0.29649,-0.37846,1,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,7.2414e-06,-0.2965,-0.39324,1,0
5,GO NEGATIVE REGULATION OF CELL GROWTH,9.9185e-12,-0.2965,-0.42233,1,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,7.1819e-07,-0.29653,-0.39661,1,0
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,2.3312e-10,-0.29657,-0.37152,1,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.4112e-09,-0.29658,-0.40837,1,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,8.8389e-07,-0.29658,-0.3635,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,1.439e-07,-0.29662,-0.31835,1,0
5,GO REGULATION OF WNT SIGNALING PATHWAY,1.7442e-10,-0.29664,-0.3709,1,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00017457,-0.29666,-0.33815,1,0
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,9.4407e-08,-0.29668,-0.34648,1,0
5,GO PEPTIDE CROSS LINKING,8.2543e-08,-0.29672,-0.43273,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,2.7312e-05,-0.29676,-0.34717,1,0
5,GO RECEPTOR RECYCLING,4.3606e-10,-0.29681,-0.37004,1,0
5,GO FLUID TRANSPORT,8.2903e-10,-0.29681,-0.345,1,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,3.7282e-08,-0.29684,-0.35672,1,0
5,GO ASTRAL MICROTUBULE ORGANIZATION,1.5994e-06,-0.29689,-0.37602,1,0
5,GO ENGULFMENT OF APOPTOTIC CELL,4.8673e-09,-0.29693,-0.39662,1,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0019819,-0.29695,-0.26211,1,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.2759e-09,-0.29706,-0.39888,1,0
5,GO B CELL ACTIVATION,2.9515e-10,-0.29709,-0.38347,1,0
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,6.7724e-05,-0.29718,-0.3105,1,0
5,GO ORGANELLE MEMBRANE FUSION,1.0964e-09,-0.29723,-0.40904,1,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,3.2894e-09,-0.29728,-0.39122,1,0
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,7.4873e-07,-0.29729,-0.37835,1,0
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,2.65e-07,-0.29732,-0.36245,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,8.3066e-07,-0.29733,-0.36554,1,0
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0007786,-0.29733,-0.29681,1,0
5,GO REGULATION OF LIPID CATABOLIC PROCESS,9.9705e-11,-0.29736,-0.38962,1,0
5,GO RESPONSE TO CAMP,2.3933e-10,-0.29741,-0.37527,1,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,3.2146e-06,-0.29745,-0.29972,1,0
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,7.0279e-11,-0.29747,-0.36034,1,0
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0001803,-0.29747,-0.28485,1,0
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,2.5223e-10,-0.2975,-0.35626,1,0
5,GO SPINAL CORD DEVELOPMENT,1.4454e-06,-0.29751,-0.3245,1,0
5,GO RECEPTOR METABOLIC PROCESS,5.4724e-12,-0.29753,-0.40549,1,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.4967e-09,-0.29754,-0.38232,1,0
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.2534e-06,-0.29757,-0.34433,1,0
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.1125e-12,-0.29765,-0.4124,1,0
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,4.5822e-08,-0.29767,-0.3632,1,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS,2.7797e-11,-0.29772,-0.3843,1,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,5.1356e-08,-0.29773,-0.40148,1,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,1.1533e-09,-0.29778,-0.39502,1,0
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,4.9403e-11,-0.2978,-0.37902,1,0
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,8.3747e-12,-0.29782,-0.42174,1,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,3.9309e-10,-0.29784,-0.3535,1,0
5,GO BROWN FAT CELL DIFFERENTIATION,2.8925e-08,-0.29784,-0.3336,1,0
5,GO NATURAL KILLER CELL DIFFERENTIATION,8.6937e-09,-0.29786,-0.40662,1,0
5,GO DEVELOPMENTAL CELL GROWTH,3.4516e-10,-0.29787,-0.43134,1,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,1.3693e-05,-0.29792,-0.32673,1,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,2.7668e-07,-0.29795,-0.35834,1,0
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,7.892e-08,-0.29799,-0.35822,1,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00010152,-0.298,-0.35848,1,0
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,5.7051e-07,-0.29808,-0.37734,1,0
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.0781e-08,-0.29815,-0.31681,1,0
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,4.3109e-11,-0.29819,-0.3801,1,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.7237e-10,-0.29822,-0.35559,1,0
5,GO RESPONSE TO PROTOZOAN,1.6418e-07,-0.29844,-0.38627,1,0
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,5.7923e-10,-0.29861,-0.41647,1,0
5,GO REGULATION OF HEMOPOIESIS,2.2286e-11,-0.29867,-0.36576,1,0
5,GO POTASSIUM ION TRANSPORT,6.8348e-09,-0.29871,-0.33773,1,0
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,4.3082e-09,-0.29872,-0.34452,1,0
5,GO INNATE IMMUNE RESPONSE,3.2094e-09,-0.29875,-0.35138,1,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.1274e-05,-0.29876,-0.358,1,0
5,GO RETINAL METABOLIC PROCESS,0.0054872,-0.29879,-0.28945,1,0
5,GO REGULATION OF DEVELOPMENTAL GROWTH,6.3074e-11,-0.29884,-0.3937,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,8.1414e-12,-0.2989,-0.4019,1,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.6321e-06,-0.29907,-0.3762,1,0
5,GO MEMORY,1.3376e-10,-0.29913,-0.39896,1,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00032916,-0.29915,-0.3129,1,0
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,2.2117e-10,-0.29922,-0.37956,1,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,9.4499e-11,-0.29928,-0.39938,1,0
5,GO ENDOCYTIC RECYCLING,8.0815e-10,-0.29929,-0.4226,1,0
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00086244,-0.29929,-0.35326,1,0
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,1.887e-11,-0.29936,-0.40801,1,0
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.2348e-10,-0.2994,-0.41146,1,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.6362e-08,-0.29941,-0.35532,1,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,3.8347e-06,-0.29943,-0.33822,1,0
5,GO CELL PROLIFERATION IN HINDBRAIN,5.5127e-05,-0.29946,-0.28812,1,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.00011033,-0.29951,-0.37228,1,0
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.3419e-09,-0.29961,-0.36296,1,0
5,GO ETHANOL CATABOLIC PROCESS,8.2686e-06,-0.29965,-0.3014,1,0
5,GO EMBRYONIC PLACENTA DEVELOPMENT,5.3747e-08,-0.29968,-0.39461,1,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,5.4356e-06,-0.29972,-0.26397,1,0
5,GO DEVELOPMENTAL GROWTH,2.4214e-11,-0.29973,-0.39967,1,0
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.2604e-07,-0.29976,-0.34674,1,0
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,1.6823e-09,-0.29981,-0.333,1,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,8.7237e-10,-0.29982,-0.41761,1,0
5,GO REGULATION OF PROTEIN BINDING,1.0205e-12,-0.29984,-0.42292,1,0
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,4.0817e-11,-0.29987,-0.42834,1,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,3.192e-10,-0.29988,-0.33759,1,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00045468,-0.2999,-0.39348,1,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0013826,-0.29991,-0.34285,1,0
5,GO MALE SEX DIFFERENTIATION,5.2253e-10,-0.30004,-0.36292,1,0
5,GO BRAIN MORPHOGENESIS,9.5677e-09,-0.30016,-0.36548,1,0
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,2.3793e-12,-0.30019,-0.39399,1,0
5,GO MESODERM MORPHOGENESIS,3.192e-10,-0.30025,-0.40302,1,0
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,5.2165e-11,-0.30027,-0.37912,1,0
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.0527e-08,-0.30033,-0.34662,1,0
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,3.5597e-11,-0.30034,-0.40936,1,0
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,4.0678e-07,-0.30036,-0.33233,1,0
5,GO REGULATION OF TUBE SIZE,1.2348e-10,-0.30037,-0.35362,1,0
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,1.5383e-12,-0.30048,-0.39329,1,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,1.8793e-06,-0.30052,-0.29321,1,0
5,GO AMMONIUM ION METABOLIC PROCESS,0.0003557,-0.30064,-0.26745,1,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,2.457e-10,-0.30074,-0.3962,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,4.1751e-05,-0.30074,-0.3489,1,0
5,GO REGULATION OF CELL POPULATION PROLIFERATION,3.9963e-12,-0.30079,-0.37503,1,0
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.0010113,-0.30097,-0.24928,1,0
5,GO REGULATION OF BEHAVIOR,4.2444e-07,-0.30099,-0.30992,1,0
5,GO NAD METABOLIC PROCESS,4.9361e-06,-0.30102,-0.34815,1,0
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,3.1494e-05,-0.30107,-0.28923,1,0
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.0012527,-0.30107,-0.35699,1,0
5,GO RESPONSE TO CYTOKINE,1.3737e-10,-0.30114,-0.37251,1,0
5,GO POSITIVE REGULATION OF HEMOPOIESIS,1.0241e-10,-0.30116,-0.37981,1,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0031247,-0.30131,-0.31504,1,0
5,GO PEPTIDYL THREONINE MODIFICATION,3.4516e-10,-0.30142,-0.38965,1,0
5,GO OLIGODENDROCYTE DIFFERENTIATION,8.6579e-07,-0.30147,-0.31966,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,1.1828e-09,-0.30157,-0.38871,1,0
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,4.9228e-07,-0.30157,-0.32704,1,0
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,4.9228e-07,-0.30159,-0.30365,1,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,6.205e-09,-0.30162,-0.35767,1,0
5,GO MEMBRANE FISSION,2.1196e-06,-0.30162,-0.38143,1,0
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,1.3133e-11,-0.30169,-0.36973,1,0
5,GO LYMPHOCYTE ACTIVATION,5.3602e-11,-0.30169,-0.37388,1,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,1.2281e-06,-0.30169,-0.36193,1,0
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.4592e-06,-0.3017,-0.32362,1,0
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,3.6435e-08,-0.30173,-0.37043,1,0
5,GO DIGESTIVE SYSTEM DEVELOPMENT,1.2131e-09,-0.30181,-0.39395,1,0
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,2.0983e-10,-0.30187,-0.39663,1,0
5,GO IMPORT INTO CELL,6.3074e-11,-0.30197,-0.38859,1,0
5,GO REGULATION OF ERBB SIGNALING PATHWAY,1.4107e-10,-0.30202,-0.42363,1,0
5,GO T CELL DIFFERENTIATION,1.0804e-10,-0.30204,-0.36616,1,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,1.8389e-10,-0.30211,-0.37253,1,0
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,1.4112e-09,-0.30212,-0.34207,1,0
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2759e-09,-0.30213,-0.36572,1,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00054518,-0.30214,-0.29165,1,0
5,GO POTASSIUM ION HOMEOSTASIS,1.6514e-08,-0.30218,-0.35923,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.679e-12,-0.30221,-0.38809,1,0
5,GO MEGAKARYOCYTE DIFFERENTIATION,1.0527e-08,-0.30228,-0.37813,1,0
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2434e-08,-0.30239,-0.38341,1,0
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,8.3026e-13,-0.30242,-0.39554,1,0
5,GO MICROTUBULE ANCHORING,7.892e-08,-0.30256,-0.38394,1,0
5,GO T CELL CYTOKINE PRODUCTION,3.0295e-08,-0.30257,-0.3253,1,0
5,GO MATING,5.9116e-09,-0.30276,-0.32361,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.5867e-06,-0.30281,-0.3329,1,0
5,GO OVULATION CYCLE PROCESS,8.0815e-10,-0.30281,-0.39672,1,0
5,GO APICAL JUNCTION ASSEMBLY,2.5934e-07,-0.30283,-0.39297,1,0
5,GO RESPONSE TO AMPHETAMINE,1.8032e-05,-0.30287,-0.29149,1,0
5,GO REGULATION OF HEART GROWTH,2.9515e-10,-0.30288,-0.39367,1,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,3.4516e-10,-0.30298,-0.32714,1,0
5,GO ACTIN FILAMENT BASED PROCESS,7.6937e-12,-0.30309,-0.44583,1,0
5,GO REGULATION OF MUSCLE HYPERTROPHY,5.5016e-10,-0.3031,-0.44081,1,0
5,GO POSITIVE REGULATION OF T CELL MIGRATION,8.9487e-10,-0.30312,-0.35521,1,0
5,GO GTP METABOLIC PROCESS,2.0364e-06,-0.30313,-0.30719,1,0
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.1896e-11,-0.30315,-0.35867,1,0
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,2.2707e-10,-0.30316,-0.40469,1,0
5,GO AMP METABOLIC PROCESS,7.2497e-05,-0.30319,-0.28043,1,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.734e-06,-0.30321,-0.34593,1,0
5,GO MEMBRANE DISASSEMBLY,5.4356e-06,-0.30321,-0.35524,1,0
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.028e-08,-0.30324,-0.31924,1,0
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,5.9498e-07,-0.30324,-0.44429,1,0
5,GO REGULATION OF CALCIUM ION IMPORT,8.4871e-11,-0.30332,-0.40849,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,1.8881e-10,-0.30335,-0.36095,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.6542e-10,-0.30336,-0.34146,1,0
5,GO LEUKOCYTE CELL CELL ADHESION,1.4877e-10,-0.30343,-0.38618,1,0
5,GO ACIDIC AMINO ACID TRANSPORT,7.0337e-07,-0.30349,-0.33461,1,0
5,GO JNK CASCADE,3.9963e-12,-0.30373,-0.41212,1,0
5,GO MITOPHAGY,1.5604e-09,-0.30373,-0.37331,1,0
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,1.3039e-08,-0.30376,-0.40278,1,0
5,GO MESONEPHROS DEVELOPMENT,1.6129e-08,-0.30382,-0.37571,1,0
5,GO WATER HOMEOSTASIS,6.1583e-08,-0.30387,-0.34679,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.1098e-10,-0.30395,-0.41668,1,0
5,GO ETHANOL METABOLIC PROCESS,5.4356e-06,-0.30399,-0.34173,1,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.0011836,-0.30402,-0.25403,1,0
5,GO AMINO SUGAR CATABOLIC PROCESS,8.2543e-08,-0.30414,-0.33643,1,0
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,9.795e-06,-0.30423,-0.29908,1,0
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,2.8573e-11,-0.30425,-0.37061,1,0
5,GO POSITIVE REGULATION OF ION TRANSPORT,2.9371e-11,-0.3043,-0.3444,1,0
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.2697e-09,-0.30431,-0.36036,1,0
5,GO REGULATION OF GTPASE ACTIVITY,9.3752e-12,-0.30433,-0.45015,1,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,3.7319e-10,-0.30436,-0.41955,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,2.2912e-11,-0.30438,-0.35932,1,0
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,7.0337e-07,-0.30447,-0.40513,1,0
5,GO POSITIVE REGULATION OF GROWTH,7.4177e-11,-0.3045,-0.38558,1,0
5,GO FUCOSE METABOLIC PROCESS,1.1034e-07,-0.30456,-0.35047,1,0
5,GO MYELOID LEUKOCYTE ACTIVATION,7.8778e-10,-0.30457,-0.36744,1,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,1.1828e-09,-0.30459,-0.4124,1,0
5,GO REGULATION OF ION TRANSPORT,4.5526e-11,-0.30465,-0.35247,1,0
5,GO DENDRITIC CELL CHEMOTAXIS,2.8886e-07,-0.30468,-0.32834,1,0
5,GO NEURAL CREST FORMATION,0.00011406,-0.30473,-0.31478,1,0
5,GO REGULATION OF INTEGRIN ACTIVATION,6.2046e-07,-0.30475,-0.37274,1,0
5,GO ADRENAL GLAND DEVELOPMENT,0.00015083,-0.30477,-0.34584,1,0
5,GO TISSUE HOMEOSTASIS,1.7442e-10,-0.30481,-0.35389,1,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,1.3196e-05,-0.30482,-0.31848,1,0
5,GO LIPID LOCALIZATION,5.1691e-12,-0.30508,-0.38538,1,0
5,GO REGULATION OF T CELL MIGRATION,3.7319e-10,-0.30508,-0.36893,1,0
5,GO VASODILATION,1.9989e-07,-0.30509,-0.36447,1,0
5,GO MEMBRANE HYPERPOLARIZATION,5.2445e-07,-0.30521,-0.37084,1,0
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,8.6145e-12,-0.30524,-0.45359,1,0
5,GO ORGANIC CATION TRANSPORT,1.4471e-09,-0.30534,-0.3811,1,0
5,GO MICROTUBULE ANCHORING AT CENTROSOME,3.3435e-06,-0.3054,-0.38169,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.5753e-08,-0.30544,-0.35442,1,0
5,GO REGULATION OF FATTY ACID TRANSPORT,1.3039e-08,-0.30544,-0.37263,1,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.0004e-06,-0.30544,-0.38455,1,0
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,9.4341e-06,-0.30548,-0.3369,1,0
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,6.5125e-09,-0.30561,-0.31792,1,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.5277e-10,-0.30562,-0.37361,1,0
5,GO RESPONSE TO OSMOTIC STRESS,9.658e-10,-0.30578,-0.35686,1,0
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.7923e-10,-0.30578,-0.38294,1,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.6792e-10,-0.30579,-0.36199,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,7.479e-12,-0.3058,-0.41429,1,0
5,GO NEURON CELLULAR HOMEOSTASIS,1.4207e-05,-0.30591,-0.34797,1,0
5,GO LEUKOCYTE CHEMOTAXIS,1.5604e-09,-0.30591,-0.34721,1,0
5,GO RESPONSE TO ESTRADIOL,6.3074e-11,-0.30591,-0.37295,1,0
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,2.2697e-09,-0.30592,-0.3373,1,0
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.887e-11,-0.30593,-0.36481,1,0
5,GO LYMPHOCYTE DIFFERENTIATION,7.2202e-11,-0.30594,-0.37617,1,0
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.1138e-06,-0.30597,-0.27945,1,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.4098e-06,-0.30598,-0.33699,1,0
5,GO REGULATION OF WATER LOSS VIA SKIN,0.00036124,-0.30599,-0.31733,1,0
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,1.3133e-11,-0.30601,-0.39362,1,0
5,GO OSTEOBLAST DEVELOPMENT,7.7166e-08,-0.30605,-0.35081,1,0
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,5.7582e-06,-0.30607,-0.28398,1,0
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,6.0991e-06,-0.30618,-0.44636,1,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,2.65e-07,-0.3062,-0.37433,1,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,4.4749e-10,-0.3062,-0.39808,1,0
5,GO REGULATION OF ANIMAL ORGAN FORMATION,3.3214e-05,-0.30628,-0.29833,1,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.6356e-09,-0.30641,-0.35435,1,0
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.3549e-12,-0.30645,-0.42961,1,0
5,GO L GLUTAMATE IMPORT,1.1245e-09,-0.30654,-0.37354,1,0
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,2.3312e-10,-0.3066,-0.3944,1,0
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,2.9078e-09,-0.30661,-0.36607,1,0
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,1.2441e-09,-0.30661,-0.33446,1,0
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,3.1004e-08,-0.30661,-0.38055,1,0
5,GO NEURON DEVELOPMENT,1.2441e-09,-0.30668,-0.39875,1,0
5,GO IRON ION HOMEOSTASIS,7.4177e-11,-0.30672,-0.35564,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.3249e-05,-0.30675,-0.3242,1,0
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.7319e-10,-0.30675,-0.36408,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.9905e-10,-0.30676,-0.40129,1,0
5,GO PROSTAGLANDIN TRANSPORT,4.3355e-07,-0.30677,-0.33343,1,0
5,GO NEUTRAL LIPID CATABOLIC PROCESS,1.4163e-06,-0.30678,-0.28844,1,0
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.9941e-08,-0.30691,-0.32737,1,0
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,5.2344e-05,-0.30701,-0.34766,1,0
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,1.8419e-06,-0.30708,-0.32346,1,0
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,5.9432e-10,-0.30709,-0.38499,1,0
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,2.9979e-12,-0.30716,-0.39593,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.1245e-09,-0.30718,-0.37527,1,0
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,5.3186e-12,-0.30739,-0.43849,1,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,3.0295e-08,-0.30739,-0.39429,1,0
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.1375e-08,-0.3074,-0.37033,1,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,4.3082e-09,-0.30743,-0.33096,1,0
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.6981e-08,-0.30748,-0.3804,1,0
5,GO RESPONSE TO OXYGEN LEVELS,1.5529e-11,-0.30754,-0.3571,1,0
5,GO TOXIN TRANSPORT,7.2964e-10,-0.30754,-0.39422,1,0
5,GO RESPONSE TO BACTERIUM,7.8286e-11,-0.30755,-0.34828,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.0766e-11,-0.30766,-0.40393,1,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,6.1119e-05,-0.30768,-0.30522,1,0
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.3549e-12,-0.30769,-0.38559,1,0
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.000286,-0.30771,-0.32326,1,0
5,GO SYNAPTIC VESICLE BUDDING,1.0004e-06,-0.30771,-0.37243,1,0
5,GO CELL ACTIVATION,4.9403e-11,-0.30771,-0.37651,1,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.1041e-08,-0.30773,-0.31949,1,0
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,1.8053e-06,-0.30774,-0.38269,1,0
5,GO PROTEIN ADP RIBOSYLATION,1.5753e-08,-0.30782,-0.3803,1,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00037835,-0.30787,-0.29131,1,0
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.0235e-07,-0.30788,-0.33101,1,0
5,GO NOREPINEPHRINE TRANSPORT,4.2271e-06,-0.30791,-0.35489,1,0
5,GO REGULATION OF BONE DEVELOPMENT,6.895e-08,-0.30794,-0.36802,1,0
5,GO NEGATIVE REGULATION OF CELL AGING,8.6937e-09,-0.30797,-0.40317,1,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00015083,-0.30803,-0.34698,1,0
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,5.7059e-05,-0.30808,-0.36722,1,0
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,7.1819e-07,-0.30813,-0.36834,1,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,1.9402e-11,-0.30827,-0.45356,1,0
5,GO RENAL SODIUM EXCRETION,4.8673e-09,-0.30829,-0.35539,1,0
5,GO DEVELOPMENTAL PIGMENTATION,1.7687e-09,-0.30832,-0.35965,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,1.0004e-06,-0.30836,-0.41161,1,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,6.757e-10,-0.30838,-0.33313,1,0
5,GO RESPONSE TO MISFOLDED PROTEIN,3.7195e-09,-0.30842,-0.42742,1,0
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,3.8347e-06,-0.30844,-0.38917,1,0
5,GO GENITALIA DEVELOPMENT,1.6823e-09,-0.30853,-0.36407,1,0
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.021509,-0.30857,-0.22762,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.2032e-06,-0.30868,-0.36672,1,0
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,1.069e-09,-0.30881,-0.38844,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,3.5794e-07,-0.30899,-0.32325,1,0
5,GO RESPONSE TO CALCIUM ION,3.5427e-10,-0.30901,-0.38588,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,1.4472e-05,-0.30903,-0.36928,1,0
5,GO RESPONSE TO DIETARY EXCESS,1.4741e-05,-0.30912,-0.33577,1,0
5,GO POSITIVE REGULATION OF CELL DEATH,2.6711e-12,-0.30915,-0.39052,1,0
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.6586e-11,-0.30922,-0.37378,1,0
5,GO REGULATION OF B CELL DIFFERENTIATION,1.1789e-06,-0.30932,-0.38447,1,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0033799,-0.30936,-0.30741,1,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.00012186,-0.30942,-0.34821,1,0
5,GO REGULATION OF DENDRITE DEVELOPMENT,7.5266e-09,-0.30943,-0.40667,1,0
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,2.2958e-06,-0.30946,-0.37163,1,0
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,5.6245e-08,-0.30952,-0.38459,1,0
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.7237e-10,-0.30964,-0.35882,1,0
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,5.6594e-11,-0.30967,-0.39803,1,0
5,GO NEGATIVE REGULATION OF SECRETION,1.1415e-11,-0.30974,-0.33219,1,0
5,GO REGULATION OF GLIAL CELL PROLIFERATION,2.7668e-07,-0.3099,-0.35711,1,0
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,5.4724e-12,-0.30996,-0.44384,1,0
5,GO T CELL ACTIVATION,2.3312e-10,-0.3101,-0.37451,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,4.1125e-12,-0.31011,-0.42957,1,0
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,1.0791e-07,-0.31016,-0.4084,1,0
5,GO CARDIAC CELL DEVELOPMENT,1.2759e-09,-0.31017,-0.39105,1,0
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,3.019e-11,-0.31021,-0.35934,1,0
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,6.9323e-10,-0.31026,-0.32851,1,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.3468e-07,-0.31038,-0.38252,1,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.2328e-07,-0.31041,-0.31723,1,0
5,GO NEUROMUSCULAR PROCESS,6.0565e-09,-0.31042,-0.35138,1,0
5,GO MORPHOGENESIS OF AN EPITHELIUM,1.785e-11,-0.31043,-0.39721,1,0
5,GO SELECTIVE AUTOPHAGY,3.9717e-11,-0.3105,-0.38899,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,4.0033e-09,-0.31052,-0.36222,1,0
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,2.4528e-05,-0.31066,-0.33588,1,0
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.0079e-05,-0.31066,-0.37133,1,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,4.7999e-05,-0.3107,-0.28644,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,7.6792e-10,-0.31073,-0.39051,1,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,5.2538e-08,-0.31083,-0.36725,1,0
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.2775e-07,-0.3109,-0.39695,1,0
5,GO POSITIVE REGULATION OF CELL ACTIVATION,4.249e-10,-0.31092,-0.36982,1,0
5,GO LUNG CELL DIFFERENTIATION,1.8701e-05,-0.31094,-0.3771,1,0
5,GO CHEMOKINE PRODUCTION,2.7e-09,-0.31111,-0.37659,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,9.5999e-07,-0.31118,-0.38257,1,0
5,GO KETONE BIOSYNTHETIC PROCESS,7.969e-07,-0.31123,-0.3319,1,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.00015583,-0.31123,-0.42248,1,0
5,GO CELLULAR RESPONSE TO DRUG,3.4516e-10,-0.3113,-0.37094,1,0
5,GO DEFENSE RESPONSE,2.0983e-10,-0.31138,-0.35009,1,0
5,GO B CELL PROLIFERATION,7.3476e-09,-0.31142,-0.36891,1,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,1.475e-06,-0.31143,-0.33803,1,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.1398e-10,-0.31154,-0.36269,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,3.8149e-08,-0.31155,-0.38408,1,0
5,GO POLYOL METABOLIC PROCESS,1.6884e-11,-0.31162,-0.36875,1,0
5,GO T CELL PROLIFERATION,3.5412e-09,-0.31163,-0.35125,1,0
5,GO ORGAN GROWTH,1.9402e-11,-0.31167,-0.41608,1,0
5,GO ETHER BIOSYNTHETIC PROCESS,2.8271e-07,-0.3117,-0.42479,1,0
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,7.4854e-10,-0.3118,-0.41319,1,0
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,5.0766e-11,-0.31189,-0.36143,1,0
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,2.5066e-09,-0.31192,-0.38213,1,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.00016901,-0.31192,-0.32114,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.4516e-10,-0.31199,-0.37491,1,0
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,4.5233e-07,-0.31204,-0.39692,1,0
5,GO REGULATION OF PROTEIN DEACETYLATION,6.8348e-09,-0.3121,-0.38228,1,0
5,GO REGULATION OF ENDOCRINE PROCESS,1.5604e-09,-0.3121,-0.38239,1,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00086244,-0.31219,-0.36016,1,0
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,1.1307e-08,-0.31237,-0.39863,1,0
5,GO POLYSACCHARIDE CATABOLIC PROCESS,5.77e-09,-0.31238,-0.36303,1,0
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,3.1479e-07,-0.31238,-0.34549,1,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.2764e-10,-0.31245,-0.38903,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,1.0241e-10,-0.31245,-0.35786,1,0
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.3274e-07,-0.31247,-0.372,1,0
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,4.8416e-06,-0.3125,-0.41794,1,0
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,4.0868e-08,-0.31251,-0.3926,1,0
5,GO PROTEIN LOCALIZATION TO CILIUM,1.0004e-06,-0.31271,-0.34355,1,0
5,GO RESPONSE TO LIPID,2.1188e-12,-0.31275,-0.3872,1,0
5,GO REGULATION OF EXOSOMAL SECRETION,1.7534e-07,-0.31276,-0.3901,1,0
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,7.71e-09,-0.31277,-0.45198,1,0
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,5.3562e-07,-0.3128,-0.32938,1,0
5,GO LIPID MODIFICATION,3.462e-12,-0.31284,-0.38428,1,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,3.758e-05,-0.31287,-0.3057,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.0563e-05,-0.31301,-0.29147,1,0
5,GO REGULATION OF CELLULAR COMPONENT SIZE,5.3186e-12,-0.31305,-0.41982,1,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,3.2094e-09,-0.31322,-0.35093,1,0
5,GO LIPID PHOSPHORYLATION,1.887e-11,-0.31322,-0.4362,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.634e-09,-0.31323,-0.37592,1,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,1.4471e-09,-0.31326,-0.31371,1,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,1.5293e-05,-0.31326,-0.38504,1,0
5,GO PROTEIN LOCALIZATION TO VACUOLE,4.3109e-11,-0.31328,-0.4244,1,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,3.6435e-08,-0.31328,-0.42934,1,0
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,6.9323e-10,-0.31338,-0.38843,1,0
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,1.1579e-08,-0.31341,-0.35282,1,0
5,GO CGMP METABOLIC PROCESS,3.0395e-05,-0.31341,-0.36919,1,0
5,GO SKELETAL SYSTEM DEVELOPMENT,4.6112e-12,-0.31343,-0.43092,1,0
5,GO REGULATION OF VIRAL GENOME REPLICATION,6.4592e-06,-0.31346,-0.35374,1,0
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,7.8052e-07,-0.3136,-0.33813,1,0
5,GO ADAPTATION OF SIGNALING PATHWAY,2.7614e-08,-0.31361,-0.34797,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,5.6451e-10,-0.31363,-0.44205,1,0
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,4.5233e-07,-0.31367,-0.45478,1,0
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,1.1415e-11,-0.31368,-0.36861,1,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,3.8161e-07,-0.31373,-0.36271,1,0
5,GO TRNA CATABOLIC PROCESS,0.00012804,-0.31373,-0.35525,1,0
5,GO EMBRYONIC ORGAN DEVELOPMENT,4.9403e-11,-0.31377,-0.38201,1,0
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.9371e-11,-0.31381,-0.35585,1,0
5,GO URETER DEVELOPMENT,3.7282e-08,-0.31382,-0.37384,1,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,2.1338e-07,-0.31397,-0.3771,1,0
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,6.0759e-07,-0.31401,-0.3506,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.2281e-06,-0.3141,-0.37595,1,0
5,GO RESPONSE TO WATER,5.2303e-06,-0.31412,-0.37255,1,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00011596,-0.31413,-0.36062,1,0
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,7.7586e-05,-0.31415,-0.30279,1,0
5,GO CELLULAR GLUCAN METABOLIC PROCESS,5.9748e-11,-0.31416,-0.40696,1,0
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,3.2785e-11,-0.31421,-0.38444,1,0
5,GO SEROTONIN SECRETION,0.00042777,-0.31421,-0.23639,1,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,2.3784e-07,-0.31424,-0.44656,1,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,4.1815e-08,-0.31441,-0.35665,1,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.7125e-10,-0.31452,-0.42805,1,0
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,5.815e-11,-0.31454,-0.3494,1,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,8.1361e-07,-0.31456,-0.39444,1,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,5.2445e-07,-0.31456,-0.40483,1,0
5,GO RESPONSE TO NERVE GROWTH FACTOR,2.2775e-07,-0.31457,-0.35043,1,0
5,GO MYELOID CELL DIFFERENTIATION,8.3747e-12,-0.31463,-0.40571,1,0
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,1.3039e-08,-0.31463,-0.33267,1,0
5,GO REGULATION OF RECEPTOR INTERNALIZATION,1.3351e-08,-0.31465,-0.38946,1,0
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,5.9432e-10,-0.31471,-0.3749,1,0
5,GO REGULATION OF POTASSIUM ION TRANSPORT,6.5125e-09,-0.31473,-0.34569,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,6.3569e-09,-0.31478,-0.32332,1,0
5,GO REGULATION OF CELL ACTIVATION,5.9748e-11,-0.31485,-0.38024,1,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.6562e-05,-0.31499,-0.2938,1,0
5,GO NEUROTRANSMITTER UPTAKE,3.6567e-07,-0.31517,-0.32992,1,0
5,GO VIRAL GENOME REPLICATION,3.8983e-07,-0.31518,-0.35801,1,0
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,7.1726e-09,-0.31522,-0.38605,1,0
5,GO REGULATION OF BIOMINERALIZATION,1.9402e-11,-0.31527,-0.44861,1,0
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.0437e-10,-0.3154,-0.39371,1,0
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,9.6538e-08,-0.31541,-0.3742,1,0
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,1.4282e-11,-0.31546,-0.41025,1,0
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,2.3554e-11,-0.31548,-0.44247,1,0
5,GO REGULATION OF NEURON DIFFERENTIATION,8.2903e-10,-0.31554,-0.41069,1,0
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,5.6245e-08,-0.31566,-0.38482,1,0
5,GO IMMUNE EFFECTOR PROCESS,4.8359e-10,-0.3157,-0.37037,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.4516e-10,-0.31587,-0.38136,1,0
5,GO RESPONSE TO GROWTH FACTOR,1.0493e-11,-0.316,-0.42831,1,0
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.3761e-09,-0.31608,-0.44484,1,0
5,GO REGULATION OF B CELL ACTIVATION,1.2441e-09,-0.31618,-0.38081,1,0
5,GO FAT CELL DIFFERENTIATION,1.277e-11,-0.31619,-0.41288,1,0
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,1.0036e-08,-0.3162,-0.40371,1,0
5,GO ADIPOSE TISSUE DEVELOPMENT,7.8778e-10,-0.3162,-0.40173,1,0
5,GO REGULATION OF ORGAN GROWTH,6.4805e-11,-0.31622,-0.39136,1,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,2.5893e-10,-0.31625,-0.41661,1,0
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,6.6581e-11,-0.31626,-0.3697,1,0
5,GO REGULATION OF EXCRETION,1.0791e-07,-0.3163,-0.35817,1,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,6.4699e-07,-0.31634,-0.40429,1,0
5,GO OSSIFICATION,4.0817e-11,-0.31635,-0.42286,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,2.9602e-08,-0.31635,-0.37167,1,0
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.4003e-08,-0.31641,-0.40108,1,0
5,GO CONNECTIVE TISSUE DEVELOPMENT,7.9144e-12,-0.31641,-0.46769,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.3629e-10,-0.31651,-0.37611,1,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,1.3039e-08,-0.31651,-0.36143,1,0
5,GO IRON COORDINATION ENTITY TRANSPORT,1.2792e-06,-0.31656,-0.35218,1,0
5,GO FORELIMB MORPHOGENESIS,1.0212e-06,-0.31659,-0.36271,1,0
5,GO REGULATION OF CELL FATE SPECIFICATION,9.9803e-06,-0.3166,-0.34912,1,0
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,4.0817e-11,-0.3166,-0.3941,1,0
5,GO POSITIVE REGULATION OF BINDING,1.0519e-10,-0.31661,-0.34833,1,0
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,8.4262e-06,-0.31664,-0.37907,1,0
5,GO REGULATION OF DENDRITE EXTENSION,0.0020092,-0.31678,-0.25196,1,0
5,GO ERBB2 SIGNALING PATHWAY,1.1041e-08,-0.3169,-0.40897,1,0
5,GO CANONICAL WNT SIGNALING PATHWAY,8.4871e-11,-0.31695,-0.38498,1,0
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.2707e-10,-0.31704,-0.37135,1,0
5,GO RESPONSE TO AMINE,2.2775e-07,-0.31705,-0.31153,1,0
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,4.2487e-05,-0.31715,-0.4064,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,5.2359e-09,-0.31715,-0.3435,1,0
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00030928,-0.31722,-0.40677,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION,2.2697e-09,-0.31745,-0.36429,1,0
5,GO ENSHEATHMENT OF NEURONS,9.9185e-12,-0.31745,-0.42135,1,0
5,GO REGULATION OF CALCIUM ION TRANSPORT,4.3549e-12,-0.31746,-0.38009,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,9.5999e-07,-0.31746,-0.37859,1,0
5,GO MAMMARY GLAND DEVELOPMENT,8.1414e-12,-0.31752,-0.45286,1,0
5,GO GLIAL CELL DIFFERENTIATION,1.2131e-09,-0.31762,-0.38662,1,0
5,GO POST ANAL TAIL MORPHOGENESIS,0.00013899,-0.31765,-0.30958,1,0
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,9.795e-06,-0.31767,-0.30371,1,0
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,3.357e-07,-0.31768,-0.36373,1,0
5,GO CLATHRIN COAT ASSEMBLY,9.6538e-08,-0.31776,-0.41604,1,0
5,GO LEUKOCYTE TETHERING OR ROLLING,1.8135e-09,-0.31778,-0.325,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,9.658e-10,-0.31783,-0.35244,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.5606e-08,-0.31788,-0.33056,1,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,4.5922e-10,-0.31788,-0.38739,1,0
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,6.205e-09,-0.31789,-0.42407,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,6.0759e-07,-0.31792,-0.40826,1,0
5,GO ENDOCRINE HORMONE SECRETION,8.5043e-10,-0.31793,-0.36826,1,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,1.3878e-06,-0.31795,-0.35173,1,0
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,1.0004e-06,-0.31802,-0.2875,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.7923e-10,-0.31805,-0.37817,1,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,2.2416e-05,-0.31805,-0.3407,1,0
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,2.3853e-09,-0.31807,-0.39847,1,0
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,5.2538e-08,-0.3181,-0.42031,1,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.6435e-08,-0.31814,-0.35693,1,0
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00036686,-0.31814,-0.31742,1,0
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,9.2118e-07,-0.31828,-0.40457,1,0
5,GO AUTOPHAGOSOME MATURATION,5.5016e-10,-0.31833,-0.35658,1,0
5,GO LEUKOCYTE DIFFERENTIATION,3.8645e-11,-0.31844,-0.38946,1,0
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,8.2864e-09,-0.31853,-0.40518,1,0
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,5.1101e-09,-0.31855,-0.45205,1,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,7.6205e-11,-0.31857,-0.43906,1,0
5,GO REGULATION OF HISTONE DEACETYLATION,3.2162e-07,-0.31864,-0.35685,1,0
5,GO IMPORT ACROSS PLASMA MEMBRANE,1.0202e-11,-0.31869,-0.40222,1,0
5,GO RETROGRADE AXONAL TRANSPORT,4.9694e-05,-0.31872,-0.39022,1,0
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.484e-09,-0.31887,-0.43558,1,0
5,GO REGULATION OF GASTRULATION,5.4967e-09,-0.3189,-0.43846,1,0
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,8.9558e-11,-0.31902,-0.38665,1,0
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.004e-09,-0.31906,-0.3915,1,0
5,GO RETINA LAYER FORMATION,0.0016122,-0.31907,-0.30967,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.8886e-07,-0.31911,-0.35297,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,5.1101e-09,-0.31922,-0.3429,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,1.2027e-05,-0.31923,-0.3583,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.6306e-11,-0.31926,-0.4664,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.1025e-09,-0.31927,-0.4089,1,0
5,GO B CELL DIFFERENTIATION,2.5066e-09,-0.31936,-0.40028,1,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,1.1579e-08,-0.31939,-0.41054,1,0
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,7.4854e-10,-0.31945,-0.34076,1,0
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00022565,-0.31949,-0.37587,1,0
5,GO LIPID HOMEOSTASIS,1.0202e-11,-0.31952,-0.38551,1,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,8.6328e-08,-0.31958,-0.32028,1,0
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,9.819e-05,-0.31969,-0.3474,1,0
5,GO LYSOSOME LOCALIZATION,1.0036e-08,-0.31972,-0.37353,1,0
5,GO LEUKOCYTE MEDIATED IMMUNITY,8.7237e-10,-0.31975,-0.3606,1,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.0004e-06,-0.3199,-0.38058,1,0
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,2.2286e-07,-0.31991,-0.37183,1,0
5,GO POSITIVE REGULATION OF PROTEIN BINDING,5.3186e-12,-0.31993,-0.43846,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,6.9323e-10,-0.31999,-0.37378,1,0
5,GO HEART MORPHOGENESIS,4.9403e-11,-0.32013,-0.42931,1,0
5,GO RESPONSE TO HYDROGEN PEROXIDE,1.2682e-10,-0.32017,-0.37551,1,0
5,GO REGULATION OF SENSORY PERCEPTION,2.0429e-07,-0.32023,-0.27362,1,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,2.1621e-05,-0.32026,-0.32383,1,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,4.249e-10,-0.3203,-0.40601,1,0
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,7.2414e-06,-0.32033,-0.44261,1,0
5,GO ENTRY INTO HOST,1.7442e-10,-0.32035,-0.45001,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,3.0856e-12,-0.32059,-0.38801,1,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,4.3109e-11,-0.32062,-0.3802,1,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,2.3274e-07,-0.32074,-0.34061,1,0
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,8.9047e-09,-0.32074,-0.38417,1,0
5,GO RESPONSE TO INTERLEUKIN 2,4.6202e-07,-0.32084,-0.38403,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,6.4192e-10,-0.32086,-0.35754,1,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,2.5893e-10,-0.32094,-0.3555,1,0
5,GO PHOSPHOLIPID TRANSPORT,2.0509e-11,-0.321,-0.42844,1,0
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,5.3602e-11,-0.32112,-0.41816,1,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0010408,-0.32118,-0.27188,1,0
5,GO APPENDAGE DEVELOPMENT,3.2094e-09,-0.32119,-0.40614,1,0
5,GO SENSORY PERCEPTION OF PAIN,7.5266e-09,-0.32125,-0.3172,1,0
5,GO CATECHOLAMINE SECRETION,9.3381e-05,-0.32136,-0.31833,1,0
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,8.7502e-06,-0.32148,-0.33246,1,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00010673,-0.32152,-0.3794,1,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00090088,-0.32153,-0.29901,1,0
5,GO AMINE TRANSPORT,5.6085e-05,-0.32166,-0.28375,1,0
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,7.8124e-06,-0.32168,-0.37425,1,0
5,GO RECEPTOR BIOSYNTHETIC PROCESS,6.4192e-10,-0.32169,-0.4106,1,0
5,GO B CELL APOPTOTIC PROCESS,3.8347e-06,-0.32171,-0.36422,1,0
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.7676e-09,-0.32179,-0.38242,1,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,1.6418e-07,-0.32186,-0.39524,1,0
5,GO GLIOGENESIS,3.3629e-10,-0.32189,-0.38706,1,0
5,GO PITUITARY GLAND DEVELOPMENT,0.0053519,-0.32194,-0.25485,1,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,5.5412e-06,-0.32211,-0.3256,1,0
5,GO ERYTHROCYTE HOMEOSTASIS,5.815e-11,-0.32213,-0.40442,1,0
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.3606e-10,-0.32214,-0.41899,1,0
5,GO REGULATION OF LEUKOCYTE MIGRATION,3.9309e-10,-0.32215,-0.39192,1,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0010113,-0.32218,-0.41002,1,0
5,GO MYOBLAST DIFFERENTIATION,2.1064e-09,-0.32222,-0.37405,1,0
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,2.9979e-12,-0.32229,-0.43168,1,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.6109e-10,-0.32241,-0.35142,1,0
5,GO REGULATION OF SODIUM ION TRANSPORT,3.5412e-09,-0.32247,-0.40083,1,0
5,GO REGULATION OF PINOCYTOSIS,3.5412e-09,-0.32247,-0.43026,1,0
5,GO REGULATION OF HORMONE METABOLIC PROCESS,2.7614e-08,-0.32248,-0.47107,1,0
5,GO INTERFERON GAMMA PRODUCTION,6.5906e-08,-0.32252,-0.32952,1,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,6.5125e-09,-0.32253,-0.38918,1,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,5.0323e-06,-0.32254,-0.30754,1,0
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,1.4207e-05,-0.32257,-0.39219,1,0
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,1.0964e-09,-0.32263,-0.33968,1,0
5,GO ACTIN FILAMENT ORGANIZATION,1.1099e-11,-0.32265,-0.43987,1,0
5,GO ANIMAL ORGAN FORMATION,5.6317e-09,-0.32271,-0.3554,1,0
5,GO HORMONE BIOSYNTHETIC PROCESS,1.5037e-07,-0.32271,-0.34565,1,0
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,4.5233e-07,-0.32278,-0.30085,1,0
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.9064e-09,-0.32278,-0.41685,1,0
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,1.7721e-08,-0.32282,-0.38821,1,0
5,GO BONE RESORPTION,8.4877e-09,-0.32306,-0.39482,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.4076e-07,-0.3232,-0.35175,1,0
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,1.475e-06,-0.32324,-0.37232,1,0
5,GO ADAPTIVE IMMUNE RESPONSE,1.9064e-09,-0.32329,-0.38737,1,0
5,GO ENERGY RESERVE METABOLIC PROCESS,3.9717e-11,-0.32338,-0.40008,1,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.1757e-12,-0.32344,-0.43059,1,0
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.2543e-08,-0.32349,-0.38233,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE,1.9387e-10,-0.32352,-0.3569,1,0
5,GO LEARNING,1.1579e-08,-0.32353,-0.37301,1,0
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,4.9624e-10,-0.3236,-0.3591,1,0
5,GO LEUKOCYTE PROLIFERATION,1.4112e-09,-0.32363,-0.3671,1,0
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,3.3629e-10,-0.3237,-0.44133,1,0
5,GO PROTEIN AUTOPHOSPHORYLATION,3.8833e-12,-0.32371,-0.45194,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.4982e-08,-0.32372,-0.34798,1,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,6.6066e-07,-0.32372,-0.50682,1,0
5,GO CELL CELL JUNCTION ASSEMBLY,1.5217e-09,-0.32376,-0.42034,1,0
5,GO GLYCEROLIPID CATABOLIC PROCESS,5.2359e-09,-0.32376,-0.32941,1,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00083767,-0.32387,-0.2857,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,8.2864e-09,-0.32393,-0.37006,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.1041e-08,-0.32397,-0.3095,1,0
5,GO COPII COATED VESICLE CARGO LOADING,7.892e-08,-0.32399,-0.3895,1,0
5,GO RESPONSE TO STEROID HORMONE,2.1188e-12,-0.32403,-0.40214,1,0
5,GO REGULATION OF CARDIAC CONDUCTION,2.9078e-09,-0.32412,-0.37758,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00030449,-0.3242,-0.33582,1,0
5,GO RESPONSE TO VITAMIN A,8.8389e-07,-0.32424,-0.32504,1,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,8.1623e-05,-0.32424,-0.38153,1,0
5,GO GLUCOCORTICOID METABOLIC PROCESS,3.4796e-08,-0.32427,-0.40247,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.6514e-08,-0.32434,-0.38646,1,0
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,1.7721e-08,-0.32436,-0.36596,1,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,2.1375e-08,-0.32445,-0.44263,1,0
5,GO DENDRITIC TRANSPORT,0.00013899,-0.32448,-0.37493,1,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0018764,-0.32462,-0.30824,1,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,2.2824e-05,-0.32468,-0.42786,1,0
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0088198,-0.32476,-0.31246,1,0
5,GO LOCALIZATION WITHIN MEMBRANE,5.6317e-09,-0.32477,-0.40276,1,0
5,GO CELL JUNCTION ASSEMBLY,1.1415e-11,-0.32484,-0.4602,1,0
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,7.0522e-08,-0.32484,-0.36159,1,0
5,GO REGULATION OF LIPASE ACTIVITY,1.3888e-11,-0.32496,-0.36679,1,0
5,GO REGULATION OF STEROID METABOLIC PROCESS,1.1858e-08,-0.32497,-0.35916,1,0
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,2.3891e-06,-0.32498,-0.33093,1,0
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,9.0235e-07,-0.325,-0.33069,1,0
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.000286,-0.32501,-0.30435,1,0
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,1.8353e-11,-0.32502,-0.35967,1,0
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,3.0156e-07,-0.32507,-0.37972,1,0
5,GO REGULATION OF LIPID LOCALIZATION,1.887e-11,-0.32511,-0.37678,1,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,9.404e-07,-0.32512,-0.40743,1,0
5,GO ACTIVATION OF GTPASE ACTIVITY,9.1996e-11,-0.32514,-0.44037,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,7.8052e-07,-0.32514,-0.37492,1,0
5,GO I KAPPAB PHOSPHORYLATION,1.9546e-09,-0.32522,-0.39942,1,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,7.8124e-06,-0.32534,-0.32932,1,0
5,GO BRANCH ELONGATION OF AN EPITHELIUM,1.2716e-05,-0.32544,-0.4003,1,0
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,6.4805e-11,-0.32556,-0.40239,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00063314,-0.32556,-0.29871,1,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,1.484e-09,-0.32567,-0.33542,1,0
5,GO ALPHA BETA T CELL DIFFERENTIATION,6.0565e-09,-0.32568,-0.38554,1,0
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,4.7999e-05,-0.32573,-0.31167,1,0
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,5.6317e-09,-0.32574,-0.34317,1,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,5.7536e-08,-0.32577,-0.38179,1,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,1.6823e-09,-0.32578,-0.38199,1,0
5,GO INTERFERON ALPHA PRODUCTION,2.402e-08,-0.32581,-0.3813,1,0
5,GO REGULATION OF B CELL PROLIFERATION,2.2397e-08,-0.32594,-0.38566,1,0
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.026561,-0.32595,-0.18283,1,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00068191,-0.32596,-0.33348,1,0
5,GO CELLULAR COMPONENT MORPHOGENESIS,1.5217e-09,-0.326,-0.40978,1,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,5.7582e-06,-0.32606,-0.32991,1,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,7.1726e-09,-0.32607,-0.48852,1,0
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,5.3186e-12,-0.32636,-0.42619,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,4.0314e-05,-0.3265,-0.35868,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,1.1099e-11,-0.32655,-0.44033,1,0
5,GO KIDNEY MORPHOGENESIS,1.0279e-08,-0.32661,-0.36238,1,0
5,GO REGULATION OF CELL CELL ADHESION,3.1896e-11,-0.32665,-0.41022,1,0
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,4.1403e-10,-0.32667,-0.38758,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.0241e-10,-0.32669,-0.4789,1,0
5,GO STEROID ESTERIFICATION,9.6538e-08,-0.32671,-0.43014,1,0
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,1.0557e-05,-0.32677,-0.39994,1,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,1.9993e-12,-0.32678,-0.41071,1,0
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.2397e-08,-0.3269,-0.36709,1,0
5,GO ANIMAL ORGAN REGENERATION,1.8594e-09,-0.32698,-0.34911,1,0
5,GO REGULATION OF MAPK CASCADE,2.1188e-12,-0.32698,-0.41656,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.7309e-08,-0.3271,-0.41734,1,0
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.7721e-08,-0.32711,-0.41968,1,0
5,GO REGULATION OF DOPAMINE SECRETION,0.00087508,-0.32711,-0.33123,1,0
5,GO RESPONSE TO PROSTAGLANDIN E,5.5078e-11,-0.32719,-0.39677,1,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,6.8888e-05,-0.32722,-0.31809,1,0
5,GO BONE MATURATION,2.2286e-07,-0.32724,-0.39193,1,0
5,GO REGULATION OF MAP KINASE ACTIVITY,1.0202e-11,-0.32734,-0.43041,1,0
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,8.4415e-08,-0.32737,-0.37043,1,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0032078,-0.32739,-0.40014,1,0
5,GO EMBRYONIC MORPHOGENESIS,2.7041e-11,-0.32743,-0.40542,1,0
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,6.8406e-11,-0.32744,-0.40537,1,0
5,GO OVULATION CYCLE,3.3629e-10,-0.32747,-0.40776,1,0
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,5.6304e-12,-0.32752,-0.42418,1,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,8.5043e-10,-0.32754,-0.3848,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.1375e-05,-0.32755,-0.29446,1,0
5,GO IMMUNOLOGICAL MEMORY PROCESS,9.6562e-05,-0.32757,-0.32524,1,0
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.232e-12,-0.32772,-0.41962,1,0
5,GO CYTOKINE SECRETION,2.5695e-09,-0.32782,-0.3273,1,0
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,5.6085e-05,-0.32787,-0.34583,1,0
5,GO REGULATION OF URINE VOLUME,2.3312e-10,-0.32816,-0.37788,1,0
5,GO REGULATION OF STEM CELL DIVISION,3.5794e-07,-0.32817,-0.35995,1,0
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.00052901,-0.32817,-0.27617,1,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,1.9136e-07,-0.32821,-0.31809,1,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,2.1595e-09,-0.32822,-0.40108,1,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,2.8573e-11,-0.32832,-0.37711,1,0
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,7.5217e-06,-0.32839,-0.39364,1,0
5,GO ALANINE TRANSPORT,3.5606e-08,-0.32846,-0.499,1,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,3.7605e-06,-0.32848,-0.33195,1,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS,3.8246e-05,-0.32855,-0.36596,1,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.4471e-09,-0.32865,-0.42544,1,0
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.462e-12,-0.32873,-0.43795,1,0
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,3.192e-10,-0.32876,-0.36724,1,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,5.332e-06,-0.32878,-0.38479,1,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,3.7195e-09,-0.32881,-0.41851,1,0
5,GO RESPONSE TO ACTIVITY,1.2682e-10,-0.3289,-0.35578,1,0
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,2.5893e-10,-0.32899,-0.3676,1,0
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,5.1691e-12,-0.329,-0.39013,1,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.6654e-06,-0.32914,-0.37999,1,0
5,GO LONG TERM SYNAPTIC POTENTIATION,3.4516e-10,-0.32916,-0.4287,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00024819,-0.32919,-0.29687,1,0
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,6.1119e-05,-0.32924,-0.42297,1,0
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.2117e-10,-0.32933,-0.45448,1,0
5,GO POSITIVE REGULATION OF MAPK CASCADE,1.3685e-12,-0.32943,-0.41643,1,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,4.8198e-07,-0.32943,-0.36041,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.9387e-10,-0.32947,-0.42247,1,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00011218,-0.32952,-0.37497,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.6407e-09,-0.32957,-0.44593,1,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,1.5865e-05,-0.32966,-0.28661,1,0
5,GO REGULATION OF OSSIFICATION,7.4177e-11,-0.32969,-0.43411,1,0
5,GO ACTIN CYTOSKELETON REORGANIZATION,4.5922e-10,-0.32989,-0.42767,1,0
5,GO CYTOKINE PRODUCTION,1.3376e-10,-0.33003,-0.38065,1,0
5,GO MYOFIBRIL ASSEMBLY,2.4586e-08,-0.33005,-0.35871,1,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,2.3239e-05,-0.33006,-0.34395,1,0
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.8318e-07,-0.33008,-0.40932,1,0
5,GO REGENERATION,5.9748e-11,-0.33017,-0.37944,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,8.6328e-08,-0.33036,-0.38696,1,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00029976,-0.33039,-0.30631,1,0
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,9.4499e-11,-0.33039,-0.40915,1,0
5,GO MONOAMINE TRANSPORT,3.5646e-05,-0.3304,-0.30828,1,0
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,3.4296e-07,-0.33044,-0.34616,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.2441e-09,-0.33048,-0.41343,1,0
5,GO INTERLEUKIN 8 PRODUCTION,3.7282e-08,-0.33051,-0.39463,1,0
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.4148e-09,-0.33057,-0.40317,1,0
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,2.0437e-10,-0.33076,-0.44164,1,0
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,1.0322e-07,-0.33077,-0.41719,1,0
5,GO PHOSPHOLIPID CATABOLIC PROCESS,2.004e-09,-0.33082,-0.40123,1,0
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,2.0983e-10,-0.33088,-0.38377,1,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,3.2146e-06,-0.3309,-0.37708,1,0
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00011218,-0.33098,-0.33913,1,0
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,5.6245e-08,-0.33099,-0.34575,1,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,7.105e-06,-0.33112,-0.54363,1,0
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,3.7735e-12,-0.33114,-0.46495,1,0
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,6.2565e-10,-0.33124,-0.43467,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,1.3599e-06,-0.33125,-0.39153,1,0
5,GO NOREPINEPHRINE SECRETION,2.9332e-05,-0.33129,-0.33351,1,0
5,GO CAMERA TYPE EYE DEVELOPMENT,3.5427e-10,-0.33129,-0.39863,1,0
5,GO SUPEROXIDE METABOLIC PROCESS,1.7309e-08,-0.33132,-0.32604,1,0
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,3.9963e-12,-0.33148,-0.41832,1,0
5,GO GLIAL CELL PROLIFERATION,9.1793e-10,-0.33165,-0.38692,1,0
5,GO DIGESTIVE TRACT MORPHOGENESIS,3.6435e-08,-0.33178,-0.37521,1,0
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.7237e-10,-0.33188,-0.37952,1,0
5,GO REGULATION OF MITOPHAGY,2.9602e-08,-0.33189,-0.37934,1,0
5,GO MEMBRANE REPOLARIZATION,1.6514e-08,-0.33191,-0.41285,1,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,5.9056e-05,-0.33191,-0.3814,1,0
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.3999e-08,-0.33204,-0.51375,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.5383e-12,-0.33206,-0.4361,1,0
5,GO POSITIVE CHEMOTAXIS,5.9748e-11,-0.33211,-0.41976,1,0
5,GO CELL PROLIFERATION IN FOREBRAIN,2.4861e-06,-0.33215,-0.38643,1,0
5,GO INTRACELLULAR MRNA LOCALIZATION,2.2958e-06,-0.3322,-0.39031,1,0
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,2.2453e-12,-0.33223,-0.4012,1,0
5,GO RESPONSE TO PARATHYROID HORMONE,3.9102e-06,-0.33236,-0.36693,1,0
5,GO DENDRITE DEVELOPMENT,1.2143e-08,-0.33236,-0.40405,1,0
5,GO SYNAPTIC VESICLE RECYCLING,6.5906e-08,-0.33237,-0.39765,1,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,8.2686e-06,-0.33243,-0.4018,1,0
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,8.9047e-09,-0.33255,-0.4105,1,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.8925e-08,-0.33277,-0.38866,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.064e-06,-0.33278,-0.40338,1,0
5,GO MYELOID CELL HOMEOSTASIS,8.2618e-11,-0.33283,-0.40717,1,0
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,2.9859e-05,-0.33286,-0.47651,1,0
5,GO ENDOCRINE PROCESS,1.7442e-10,-0.3329,-0.39549,1,0
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,6.0759e-07,-0.333,-0.39229,1,0
5,GO TUBULIN DEACETYLATION,2.5934e-07,-0.33303,-0.43629,1,0
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.00016901,-0.33306,-0.30774,1,0
5,GO LYMPHOCYTE MEDIATED IMMUNITY,7.1121e-10,-0.33309,-0.38366,1,0
5,GO TRANSMISSION OF NERVE IMPULSE,3.152e-06,-0.3331,-0.33988,1,0
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,3.1032e-11,-0.33322,-0.39046,1,0
5,GO SYNAPTIC VESICLE DOCKING,0.00076726,-0.33324,-0.36655,1,0
5,GO T HELPER 1 CELL DIFFERENTIATION,3.6877e-06,-0.33331,-0.46856,1,0
5,GO MACROPHAGE DIFFERENTIATION,5.5078e-11,-0.33336,-0.43311,1,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0063654,-0.33337,-0.35336,1,0
5,GO ACYLGLYCEROL HOMEOSTASIS,4.9624e-10,-0.33342,-0.40095,1,0
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,1.5529e-11,-0.33354,-0.38615,1,0
5,GO BASIC AMINO ACID TRANSPORT,8.2543e-08,-0.33359,-0.48427,1,0
5,GO REGULATION OF BLOOD CIRCULATION,3.6586e-11,-0.33377,-0.39581,1,0
5,GO CELL JUNCTION ORGANIZATION,6.8695e-12,-0.33382,-0.46473,1,0
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00015838,-0.33394,-0.39109,1,0
5,GO EMBRYONIC ORGAN MORPHOGENESIS,2.457e-10,-0.33401,-0.38145,1,0
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,1.6782e-07,-0.33403,-0.3681,1,0
5,GO POSITIVE REGULATION OF JNK CASCADE,2.3113e-12,-0.33419,-0.44499,1,0
5,GO HEART PROCESS,4.1948e-11,-0.33426,-0.39174,1,0
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.7706e-05,-0.33426,-0.35704,1,0
5,GO EXCRETION,2.801e-10,-0.33429,-0.36969,1,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.2094e-09,-0.33439,-0.3664,1,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,6.1119e-05,-0.3344,-0.4313,1,0
5,GO MITOTIC CELL CYCLE ARREST,5.0278e-07,-0.33447,-0.36813,1,0
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,7.8286e-11,-0.3345,-0.40704,1,0
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,1.0161e-09,-0.3345,-0.40605,1,0
5,GO EPITHELIAL TUBE MORPHOGENESIS,4.9403e-11,-0.33451,-0.40394,1,0
5,GO CEREBRAL CORTEX CELL MIGRATION,3.9822e-07,-0.33469,-0.39059,1,0
5,GO STEROL HOMEOSTASIS,2.801e-10,-0.33472,-0.39681,1,0
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,1.484e-09,-0.3348,-0.36309,1,0
5,GO VESICLE CARGO LOADING,1.9989e-07,-0.3348,-0.38381,1,0
5,GO SKELETAL MUSCLE CONTRACTION,4.3355e-07,-0.33498,-0.32226,1,0
5,GO MALE GENITALIA DEVELOPMENT,3.4296e-07,-0.33507,-0.36534,1,0
5,GO SENSORY SYSTEM DEVELOPMENT,1.5688e-10,-0.3351,-0.40134,1,0
5,GO MICROVILLUS ORGANIZATION,1.3599e-06,-0.33511,-0.43496,1,0
5,GO SYNAPTIC VESICLE PRIMING,0.00017176,-0.33526,-0.3742,1,0
5,GO PROTEIN PALMITOYLATION,1.1034e-07,-0.33526,-0.37654,1,0
5,GO REGULATION OF SYNAPSE ASSEMBLY,4.3082e-09,-0.33536,-0.40614,1,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,9.4157e-10,-0.33538,-0.35663,1,0
5,GO CELLULAR HYPEROSMOTIC RESPONSE,8.0712e-08,-0.33541,-0.41836,1,0
5,GO METANEPHROS MORPHOGENESIS,5.7051e-07,-0.33545,-0.408,1,0
5,GO NEUROINFLAMMATORY RESPONSE,5.9748e-11,-0.33545,-0.38736,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.5266e-09,-0.33545,-0.398,1,0
5,GO REFLEX,0.00096848,-0.33558,-0.37391,1,0
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,5.2359e-09,-0.33566,-0.41444,1,0
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,1.3761e-09,-0.33576,-0.45412,1,0
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00058763,-0.33581,-0.31268,1,0
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,7.2202e-11,-0.33588,-0.43538,1,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,1.3468e-07,-0.33598,-0.37129,1,0
5,GO REGULATION OF RECEPTOR RECYCLING,1.5386e-08,-0.336,-0.37301,1,0
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,5.9116e-09,-0.33602,-0.42976,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,2.3467e-08,-0.33617,-0.46606,1,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.0212e-06,-0.33624,-0.37135,1,0
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.027401,-0.33639,-0.22602,1,0
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,2.7614e-08,-0.33644,-0.38785,1,0
5,GO DENDRITE MORPHOGENESIS,4.2784e-08,-0.33651,-0.41262,1,0
5,GO PROSTATE GLAND DEVELOPMENT,1.2131e-09,-0.33652,-0.45286,1,0
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,2.1375e-08,-0.33667,-0.36812,1,0
5,GO REGULATION OF ENDOCYTOSIS,1.1478e-12,-0.33671,-0.43819,1,0
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,3.9822e-07,-0.33674,-0.3742,1,0
5,GO SECRETION BY TISSUE,1.4076e-07,-0.33689,-0.30332,1,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,2.8271e-07,-0.33707,-0.33301,1,0
5,GO PLACENTA DEVELOPMENT,2.2697e-09,-0.33722,-0.38897,1,0
5,GO FEMALE GENITALIA DEVELOPMENT,5.7051e-07,-0.33731,-0.32811,1,0
5,GO CELLULAR RESPONSE TO INTERFERON BETA,2.3661e-05,-0.33732,-0.37752,1,0
5,GO B CELL HOMEOSTASIS,1.5604e-09,-0.33746,-0.44751,1,0
5,GO SMOOTH MUSCLE CONTRACTION,5.3602e-11,-0.33757,-0.37817,1,0
5,GO WHITE FAT CELL DIFFERENTIATION,5.9432e-10,-0.33761,-0.38077,1,0
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.7687e-09,-0.3377,-0.37719,1,0
5,GO NEUROTROPHIN SIGNALING PATHWAY,3.3713e-09,-0.33773,-0.4348,1,0
5,GO CARDIAC MUSCLE CELL PROLIFERATION,1.9546e-09,-0.33777,-0.42456,1,0
5,GO C21 STEROID HORMONE METABOLIC PROCESS,1.7385e-05,-0.33779,-0.32404,1,0
5,GO AMINO SUGAR METABOLIC PROCESS,5.7923e-10,-0.33785,-0.36975,1,0
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,3.5794e-07,-0.33789,-0.33573,1,0
5,GO EMBRYONIC HEMOPOIESIS,2.8271e-07,-0.3379,-0.41138,1,0
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,3.2631e-05,-0.33791,-0.35882,1,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,2.5066e-09,-0.33801,-0.4098,1,0
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,6.2046e-07,-0.33807,-0.35493,1,0
5,GO RESPONSE TO ACIDIC PH,7.1819e-07,-0.3381,-0.41942,1,0
5,GO EOSINOPHIL CHEMOTAXIS,0.001776,-0.33814,-0.31039,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,6.4192e-10,-0.33819,-0.3923,1,0
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0042095,-0.33841,-0.3211,1,0
5,GO INFLAMMATORY RESPONSE,1.0519e-10,-0.33842,-0.3711,1,0
5,GO RESPONSE TO FATTY ACID,3.2094e-09,-0.33842,-0.35579,1,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,5.5127e-05,-0.33859,-0.36213,1,0
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.3174e-07,-0.3386,-0.40163,1,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,2.2139e-09,-0.33862,-0.45161,1,0
5,GO BONE MINERALIZATION,2.5223e-10,-0.33863,-0.42295,1,0
5,GO ZYMOGEN INHIBITION,7.4873e-07,-0.33868,-0.37983,1,0
5,GO CELLULAR RESPONSE TO IRON ION,1.0004e-06,-0.33874,-0.37939,1,0
5,GO EMBRYONIC DIGIT MORPHOGENESIS,5.7536e-08,-0.33875,-0.36122,1,0
5,GO SEQUESTERING OF CALCIUM ION,5.0766e-11,-0.33879,-0.39529,1,0
5,GO LEUKOCYTE APOPTOTIC PROCESS,1.0964e-09,-0.33889,-0.37525,1,0
5,GO LACTATION,2.3853e-09,-0.33893,-0.41334,1,0
5,GO MEMBRANE INVAGINATION,6.4805e-11,-0.33893,-0.4589,1,0
5,GO STRIATUM DEVELOPMENT,2.6362e-08,-0.33901,-0.41315,1,0
5,GO PROGRAMMED NECROTIC CELL DEATH,3.9941e-08,-0.33912,-0.36495,1,0
5,GO TUBE DEVELOPMENT,4.3549e-12,-0.33915,-0.44162,1,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.1533e-09,-0.33919,-0.36704,1,0
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,1.1398e-10,-0.33922,-0.40251,1,0
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,9.1996e-11,-0.33931,-0.42502,1,0
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,1.9175e-06,-0.33936,-0.39814,1,0
5,GO RESPIRATORY SYSTEM PROCESS,2.1196e-06,-0.33937,-0.37597,1,0
5,GO POSITIVE REGULATION OF NEURON DEATH,3.3713e-09,-0.33943,-0.40303,1,0
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,2.9371e-11,-0.33945,-0.37285,1,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,7.892e-08,-0.33954,-0.44759,1,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,5.1101e-09,-0.33971,-0.41687,1,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,1.1535e-07,-0.3398,-0.33075,1,0
5,GO PHAGOCYTOSIS RECOGNITION,1.9989e-07,-0.33984,-0.41339,1,0
5,GO RESPONSE TO DRUG,1.9402e-11,-0.33984,-0.38355,1,0
5,GO RECEPTOR INTERNALIZATION,5.3602e-11,-0.33987,-0.40088,1,0
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,2.801e-10,-0.33989,-0.41131,1,0
5,GO MUSCLE HYPERTROPHY,4.9403e-11,-0.33993,-0.45103,1,0
5,GO CELLULAR RESPONSE TO CAMP,8.9558e-11,-0.33993,-0.38488,1,0
5,GO OSTEOBLAST DIFFERENTIATION,8.2618e-11,-0.33994,-0.42607,1,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,3.4003e-08,-0.34001,-0.37447,1,0
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.0295e-08,-0.34008,-0.4395,1,0
5,GO B CELL MEDIATED IMMUNITY,2.801e-10,-0.34017,-0.44017,1,0
5,GO PHOSPHOLIPID HOMEOSTASIS,4.3946e-06,-0.34019,-0.34557,1,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.1274e-05,-0.34019,-0.39551,1,0
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,1.0791e-07,-0.34021,-0.37867,1,0
5,GO CELL PART MORPHOGENESIS,4.6356e-09,-0.34027,-0.41202,1,0
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,7.5451e-08,-0.34029,-0.39134,1,0
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.9822e-07,-0.34034,-0.40717,1,0
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,2.8886e-07,-0.3404,-0.3857,1,0
5,GO REGULATION OF TOLERANCE INDUCTION,7.2414e-06,-0.34062,-0.39902,1,0
5,GO RESPONSE TO NUTRIENT,6.9323e-10,-0.34062,-0.37771,1,0
5,GO CELL CELL JUNCTION ORGANIZATION,2.2707e-10,-0.34077,-0.45898,1,0
5,GO PRESYNAPSE ORGANIZATION,2.1807e-07,-0.34077,-0.38274,1,0
5,GO CENTRIOLE CENTRIOLE COHESION,1.0212e-06,-0.34081,-0.40254,1,0
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,4.0817e-11,-0.34083,-0.40795,1,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,5.3602e-11,-0.3409,-0.39044,1,0
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,8.2686e-06,-0.34095,-0.29424,1,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,1.4092e-12,-0.34098,-0.40598,1,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.77e-09,-0.34105,-0.37787,1,0
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,1.4282e-11,-0.34132,-0.44029,1,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,4.5239e-09,-0.34134,-0.39092,1,0
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,4.4787e-08,-0.34134,-0.4359,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,2.3853e-09,-0.34135,-0.3682,1,0
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,2.9979e-12,-0.34137,-0.419,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,1.3888e-11,-0.3415,-0.48211,1,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,4.0343e-10,-0.34157,-0.38865,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.6293e-09,-0.34163,-0.40081,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.2926e-08,-0.34166,-0.4093,1,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,4.2444e-07,-0.34171,-0.38654,1,0
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.6581e-10,-0.34172,-0.41408,1,0
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,1.0519e-10,-0.3418,-0.38885,1,0
5,GO PARTURITION,1.6418e-07,-0.34181,-0.35166,1,0
5,GO TRIGLYCERIDE CATABOLIC PROCESS,3.6924e-05,-0.34191,-0.25883,1,0
5,GO REGULATION OF LIPID KINASE ACTIVITY,2.9979e-12,-0.34192,-0.44782,1,0
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,1.9558e-07,-0.34192,-0.40662,1,0
5,GO BIOMINERALIZATION,2.1085e-11,-0.34202,-0.44408,1,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,1.3999e-08,-0.34204,-0.40609,1,0
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,1.5372e-07,-0.34206,-0.40359,1,0
5,GO DENDRITIC CELL MIGRATION,3.0295e-08,-0.34214,-0.37666,1,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,4.2444e-07,-0.34215,-0.33018,1,0
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,1.5372e-07,-0.34225,-0.42607,1,0
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.3236e-05,-0.34227,-0.43701,1,0
5,GO T CELL MEDIATED CYTOTOXICITY,0.00017457,-0.34227,-0.3916,1,0
5,GO RESPONSE TO STEROL DEPLETION,6.1583e-08,-0.34228,-0.41187,1,0
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,1.6514e-08,-0.34231,-0.42,1,0
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,1.5102e-11,-0.34243,-0.40764,1,0
5,GO REGULATION OF COLLATERAL SPROUTING,3.7605e-06,-0.34271,-0.43856,1,0
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,1.7693e-06,-0.34275,-0.40858,1,0
5,GO CORTICOSTEROID HORMONE SECRETION,6.7105e-06,-0.3428,-0.3461,1,0
5,GO CARDIAC VENTRICLE MORPHOGENESIS,4.8359e-10,-0.34286,-0.43894,1,0
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.9387e-10,-0.34291,-0.39857,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,2.3467e-08,-0.34292,-0.39599,1,0
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,4.0314e-05,-0.34293,-0.40017,1,0
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,1.725e-09,-0.34299,-0.40512,1,0
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,8.6579e-07,-0.34302,-0.37673,1,0
5,GO RESPONSE TO PROSTAGLANDIN,8.2864e-09,-0.34307,-0.36854,1,0
5,GO GAS TRANSPORT,0.00014599,-0.34309,-0.30393,1,0
5,GO ANIMAL ORGAN MATURATION,1.5027e-08,-0.34311,-0.40688,1,0
5,GO FIBRINOLYSIS,1.5753e-08,-0.34317,-0.50538,1,0
5,GO CELL MOTILITY,3.3639e-12,-0.34317,-0.42839,1,0
5,GO COMPLEMENT ACTIVATION,1.7687e-09,-0.34328,-0.44438,1,0
5,GO UROGENITAL SYSTEM DEVELOPMENT,1.887e-11,-0.34336,-0.438,1,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,2.1595e-09,-0.3435,-0.44807,1,0
5,GO GROWTH HORMONE SECRETION,0.014332,-0.34361,-0.28674,1,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,2.5756e-08,-0.34369,-0.40594,1,0
5,GO RENAL TUBULE DEVELOPMENT,2.801e-10,-0.3437,-0.41986,1,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.8198e-07,-0.3437,-0.43997,1,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,2.0478e-05,-0.34375,-0.33918,1,0
5,GO PRO B CELL DIFFERENTIATION,2.3467e-08,-0.34378,-0.45079,1,0
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,6.8695e-12,-0.34382,-0.43091,1,0
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.8271e-07,-0.34398,-0.42282,1,0
5,GO CELLULAR RESPONSE TO LIPID,3.1757e-12,-0.34402,-0.39399,1,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,1.1041e-08,-0.34458,-0.42171,1,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.9393e-05,-0.34461,-0.40945,1,0
5,GO BONE CELL DEVELOPMENT,1.5713e-07,-0.34471,-0.44536,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,9.4499e-11,-0.34474,-0.45873,1,0
5,GO LYMPH NODE DEVELOPMENT,4.7125e-10,-0.34475,-0.41392,1,0
5,GO RESPONSE TO TESTOSTERONE,4.0678e-07,-0.34476,-0.33017,1,0
5,GO PREPULSE INHIBITION,0.00031414,-0.34477,-0.3853,1,0
5,GO RESPONSE TO COLD,6.5906e-08,-0.3449,-0.39989,1,0
5,GO TYPE 2 IMMUNE RESPONSE,1.6514e-08,-0.34494,-0.43351,1,0
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,1.4334e-08,-0.34498,-0.34677,1,0
5,GO POSITIVE REGULATION OF HEART GROWTH,1.7909e-10,-0.34504,-0.41215,1,0
5,GO EPITHELIAL CELL DEVELOPMENT,8.4871e-11,-0.34526,-0.466,1,0
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,5.9432e-10,-0.34542,-0.34775,1,0
5,GO FIBROBLAST APOPTOTIC PROCESS,3.8149e-08,-0.34546,-0.40317,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.277e-11,-0.34572,-0.4297,1,0
5,GO NEGATIVE REGULATION OF AUTOPHAGY,2.1812e-12,-0.34574,-0.41279,1,0
5,GO MUSCLE ADAPTATION,8.2618e-11,-0.34575,-0.43974,1,0
5,GO LEUKOCYTE HOMEOSTASIS,7.6792e-10,-0.34581,-0.39052,1,0
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00016361,-0.3459,-0.31746,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,6.205e-09,-0.34595,-0.36975,1,0
5,GO RESPONSE TO SALT STRESS,2.0429e-07,-0.34599,-0.34834,1,0
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,4.4285e-07,-0.34605,-0.40162,1,0
5,GO ERBB SIGNALING PATHWAY,2.7797e-11,-0.34612,-0.42732,1,0
5,GO PARENTAL BEHAVIOR,6.1119e-05,-0.34627,-0.33393,1,0
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.0279e-08,-0.34636,-0.41185,1,0
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,3.2784e-06,-0.34639,-0.42304,1,0
5,GO RESPONSE TO MECHANICAL STIMULUS,5.2253e-10,-0.34643,-0.41696,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,1.642e-11,-0.34645,-0.49171,1,0
5,GO RESPONSE TO ESTROGEN,1.6823e-09,-0.34647,-0.39022,1,0
5,GO CIRCULATORY SYSTEM DEVELOPMENT,3.3639e-12,-0.3465,-0.4512,1,0
5,GO NEGATIVE REGULATION OF MAPK CASCADE,6.8695e-12,-0.34665,-0.46045,1,0
5,GO SYNAPSE ASSEMBLY,2.6362e-08,-0.34666,-0.40058,1,0
5,GO NEUROBLAST PROLIFERATION,7.1819e-07,-0.34669,-0.36469,1,0
5,GO EYE MORPHOGENESIS,2.2139e-09,-0.34674,-0.39719,1,0
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.0756e-05,-0.34674,-0.40768,1,0
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.012087,-0.34682,-0.23468,1,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.538e-07,-0.34684,-0.40978,1,0
5,GO FEMALE SEX DIFFERENTIATION,3.3713e-09,-0.34687,-0.35579,1,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,1.6418e-07,-0.34692,-0.4996,1,0
5,GO CGMP MEDIATED SIGNALING,1.5604e-09,-0.34702,-0.40105,1,0
5,GO CARDIAC VENTRICLE FORMATION,0.00012186,-0.34703,-0.38778,1,0
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,2.801e-10,-0.34709,-0.41858,1,0
5,GO CARDIAC VENTRICLE DEVELOPMENT,6.9323e-10,-0.3471,-0.43404,1,0
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,4.3355e-07,-0.34719,-0.37026,1,0
5,GO LEUKOCYTE MIGRATION,1.3737e-10,-0.34746,-0.40993,1,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,8.6579e-07,-0.34747,-0.41192,1,0
5,GO INTERLEUKIN 13 PRODUCTION,1.4163e-06,-0.34749,-0.41909,1,0
5,GO NEURON PROJECTION EXTENSION,2.634e-09,-0.34761,-0.43643,1,0
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,7.4854e-10,-0.34764,-0.39615,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,8.7184e-11,-0.34765,-0.35253,1,0
5,GO KERATINOCYTE MIGRATION,1.5529e-11,-0.34767,-0.43869,1,0
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,2.1375e-08,-0.34769,-0.38387,1,0
5,GO INTERLEUKIN 1 PRODUCTION,2.8262e-08,-0.34777,-0.40191,1,0
5,GO LYMPHOCYTE MIGRATION,2.2912e-11,-0.34781,-0.38612,1,0
5,GO FILOPODIUM ASSEMBLY,2.3268e-09,-0.34783,-0.46417,1,0
5,GO VENTRICULAR SYSTEM DEVELOPMENT,3.2894e-09,-0.34784,-0.41497,1,0
5,GO STORE OPERATED CALCIUM ENTRY,1.0781e-08,-0.34786,-0.43518,1,0
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,4.5922e-10,-0.34788,-0.35937,1,0
5,GO MEGAKARYOCYTE DEVELOPMENT,4.1751e-05,-0.34792,-0.4164,1,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,1.0756e-05,-0.34798,-0.3586,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.2027e-05,-0.34822,-0.33117,1,0
5,GO TORC1 SIGNALING,1.6823e-09,-0.34832,-0.40425,1,0
5,GO LONG TERM SYNAPTIC DEPRESSION,9.086e-06,-0.3484,-0.33706,1,0
5,GO ACTION POTENTIAL,2.1064e-09,-0.34842,-0.40002,1,0
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,1.5277e-10,-0.34846,-0.3813,1,0
5,GO REGULATION OF MAST CELL ACTIVATION,5.5864e-07,-0.34852,-0.37409,1,0
5,GO REGULATION OF CHEMOTAXIS,5.0766e-11,-0.34865,-0.40041,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.634e-09,-0.34891,-0.43788,1,0
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,4.1026e-05,-0.34893,-0.34946,1,0
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,6.1389e-11,-0.34915,-0.50343,1,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,2.7676e-09,-0.34918,-0.37115,1,0
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.2886e-07,-0.34925,-0.36431,1,0
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,2.3467e-08,-0.34926,-0.426,1,0
5,GO CELL MORPHOGENESIS,1.0804e-10,-0.34928,-0.43375,1,0
5,GO OVULATION,1.5753e-08,-0.34934,-0.37669,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,7.2202e-11,-0.34935,-0.43223,1,0
5,GO REGULATORY T CELL DIFFERENTIATION,5.1351e-07,-0.34936,-0.39074,1,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,4.0678e-07,-0.34938,-0.43851,1,0
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.2864e-09,-0.34939,-0.3746,1,0
5,GO RESPONSE TO GONADOTROPIN,3.192e-10,-0.34948,-0.40344,1,0
5,GO T CELL MIGRATION,5.6451e-10,-0.34949,-0.41202,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.4452e-09,-0.34952,-0.47211,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,2.0983e-10,-0.34976,-0.36688,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,5.2359e-09,-0.34982,-0.40439,1,0
5,GO OXYGEN TRANSPORT,0.0011341,-0.34987,-0.3146,1,0
5,GO STEROL TRANSPORT,4.0817e-11,-0.34988,-0.43282,1,0
5,GO ENDOSOME TO LYSOSOME TRANSPORT,1.8389e-10,-0.34988,-0.39718,1,0
5,GO CELLULAR RESPONSE TO VITAMIN D,9.5999e-07,-0.34992,-0.43166,1,0
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,3.8301e-10,-0.35004,-0.3525,1,0
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,1.6307e-12,-0.35015,-0.45869,1,0
5,GO REGULATION OF PHAGOCYTOSIS,1.3505e-11,-0.35036,-0.44504,1,0
5,GO REGULATION OF TRANSPORTER ACTIVITY,5.2165e-11,-0.35043,-0.38791,1,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,3.9941e-08,-0.35048,-0.43466,1,0
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,1.3085e-09,-0.35063,-0.41004,1,0
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,5.6317e-09,-0.35066,-0.44912,1,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,3.0395e-05,-0.35067,-0.36718,1,0
5,GO PRESYNAPTIC ENDOCYTOSIS,7.3772e-08,-0.35067,-0.39828,1,0
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,1.6514e-08,-0.35068,-0.48098,1,0
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,1.3737e-10,-0.35073,-0.44972,1,0
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,4.7125e-10,-0.35078,-0.43285,1,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.357e-07,-0.35089,-0.39824,1,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.2482e-05,-0.35091,-0.38568,1,0
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.00159,-0.35097,-0.24637,1,0
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.9558e-07,-0.35098,-0.36851,1,0
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,7.0671e-12,-0.35104,-0.39788,1,0
5,GO PANCREAS DEVELOPMENT,7.0522e-08,-0.35108,-0.37426,1,0
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,4.3109e-11,-0.35119,-0.44066,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0038478,-0.35133,-0.3125,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,1.0361e-05,-0.35134,-0.37972,1,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,4.4285e-07,-0.35137,-0.33455,1,0
5,GO SKELETAL SYSTEM MORPHOGENESIS,1.5968e-11,-0.35159,-0.43876,1,0
5,GO INTRACELLULAR LIPID TRANSPORT,1.3024e-10,-0.35164,-0.44579,1,0
5,GO RESPONSE TO ACID CHEMICAL,2.0509e-11,-0.35169,-0.40329,1,0
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,1.471e-07,-0.35173,-0.36141,1,0
5,GO LIPID IMPORT INTO CELL,1.3039e-08,-0.35175,-0.41855,1,0
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.77e-09,-0.3518,-0.4228,1,0
5,GO RESPONSE TO CAFFEINE,7.0522e-08,-0.3518,-0.35817,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.3351e-08,-0.35183,-0.43299,1,0
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,9.1205e-09,-0.35184,-0.37077,1,0
5,GO NEPHRON EPITHELIUM DEVELOPMENT,1.1706e-10,-0.35191,-0.42979,1,0
5,GO OSTEOCLAST DIFFERENTIATION,2.4893e-11,-0.35213,-0.41143,1,0
5,GO RESPONSE TO PH,5.7923e-10,-0.35215,-0.43295,1,0
5,GO OLIGODENDROCYTE DEVELOPMENT,2.3784e-07,-0.3522,-0.39791,1,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,8.7184e-11,-0.35226,-0.45963,1,0
5,GO HYPEROSMOTIC RESPONSE,1.1858e-08,-0.35226,-0.37187,1,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,5.3602e-11,-0.35228,-0.39753,1,0
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.6306e-11,-0.35231,-0.40853,1,0
5,GO PINOCYTOSIS,2.3467e-08,-0.35238,-0.43498,1,0
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,6.895e-08,-0.3524,-0.41667,1,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.6581e-10,-0.35241,-0.39143,1,0
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,3.3435e-06,-0.3525,-0.40187,1,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS,7.7166e-08,-0.3526,-0.39861,1,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0002117,-0.35262,-0.42269,1,0
5,GO PARAXIAL MESODERM MORPHOGENESIS,1.1588e-05,-0.35289,-0.38452,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.8925e-08,-0.35291,-0.41628,1,0
5,GO NEGATIVE REGULATION OF GROWTH,5.2165e-11,-0.35291,-0.40762,1,0
5,GO CELL CELL ADHESION,5.0237e-12,-0.35301,-0.42412,1,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00017457,-0.35316,-0.37411,1,0
5,GO CARDIAC CONDUCTION,2.7286e-10,-0.3533,-0.40881,1,0
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,3.1896e-11,-0.35336,-0.47942,1,0
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,4.6784e-11,-0.35351,-0.42619,1,0
5,GO COPPER ION HOMEOSTASIS,4.0033e-09,-0.35354,-0.40365,1,0
5,GO RESPIRATORY BURST,1.9465e-08,-0.35356,-0.38616,1,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,4.2784e-08,-0.3536,-0.38592,1,0
5,GO EPIDERMIS MORPHOGENESIS,1.6418e-07,-0.35364,-0.43416,1,0
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.9064e-09,-0.35374,-0.40582,1,0
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,3.2631e-05,-0.35381,-0.39322,1,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,4.4787e-08,-0.35388,-0.3977,1,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,9.5677e-09,-0.35401,-0.38598,1,0
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,1.0361e-05,-0.35401,-0.39714,1,0
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,2.559e-11,-0.35403,-0.40951,1,0
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,2.4371e-06,-0.35408,-0.37341,1,0
5,GO RESPONSE TO VITAMIN D,1.5674e-06,-0.35413,-0.41247,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0041031,-0.35439,-0.414,1,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,2.5359e-06,-0.35444,-0.38398,1,0
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,2.1621e-05,-0.35448,-0.28067,1,0
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,2.2139e-09,-0.35448,-0.38691,1,0
5,GO NEURON MIGRATION,6.3359e-07,-0.35455,-0.3836,1,0
5,GO MULTICELLULAR ORGANISMAL SIGNALING,2.7e-09,-0.35457,-0.38164,1,0
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00010152,-0.35472,-0.41846,1,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.2057e-05,-0.35481,-0.36768,1,0
5,GO HYALURONAN METABOLIC PROCESS,2.9371e-11,-0.35487,-0.4303,1,0
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.1478e-12,-0.35489,-0.41465,1,0
5,GO GMP METABOLIC PROCESS,7.0337e-07,-0.35493,-0.33555,1,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00058763,-0.35498,-0.36885,1,0
5,GO CELLULAR RESPONSE TO RETINOIC ACID,9.9705e-11,-0.355,-0.46102,1,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,2.2505e-06,-0.35503,-0.40412,1,0
5,GO FOREGUT MORPHOGENESIS,9.7991e-09,-0.35512,-0.38236,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,7.892e-08,-0.35513,-0.37114,1,0
5,GO RESPONSE TO INACTIVITY,1.475e-06,-0.35532,-0.4416,1,0
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.9371e-11,-0.35532,-0.44439,1,0
5,GO AUTOPHAGY OF NUCLEUS,4.3109e-11,-0.35535,-0.42676,1,0
5,GO UTERUS DEVELOPMENT,5.8262e-07,-0.35545,-0.38642,1,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.1101e-09,-0.35545,-0.42015,1,0
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,3.5427e-10,-0.3555,-0.40895,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0018508,-0.35552,-0.37991,1,0
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.1896e-11,-0.35565,-0.41779,1,0
5,GO HISTAMINE SECRETION,0.0040509,-0.3557,-0.27802,1,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,3.7605e-06,-0.35577,-0.39996,1,0
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,9.7991e-09,-0.35594,-0.48438,1,0
5,GO REGULATION OF RECEPTOR CLUSTERING,2.2416e-05,-0.35598,-0.44722,1,0
5,GO MYELOID CELL APOPTOTIC PROCESS,1.484e-09,-0.35602,-0.41787,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,1.3351e-08,-0.35609,-0.42183,1,0
5,GO SYNAPSE ORGANIZATION,9.658e-10,-0.35613,-0.43008,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,3.7282e-08,-0.3562,-0.42013,1,0
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.1098e-10,-0.35621,-0.43341,1,0
5,GO FOREBRAIN CELL MIGRATION,3.4003e-08,-0.35621,-0.38561,1,0
5,GO EPITHELIAL CELL FATE COMMITMENT,4.3997e-05,-0.35621,-0.3855,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,6.8348e-09,-0.35624,-0.40464,1,0
5,GO REGULATION OF STEROL TRANSPORT,2.7e-09,-0.35633,-0.37151,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.8573e-11,-0.35643,-0.48138,1,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,8.8282e-08,-0.35643,-0.41164,1,0
5,GO SPHINGOMYELIN METABOLIC PROCESS,9.404e-07,-0.35644,-0.43098,1,0
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,1.3133e-11,-0.35654,-0.42755,1,0
5,GO APPENDAGE MORPHOGENESIS,1.7309e-08,-0.35658,-0.41242,1,0
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.3312e-10,-0.35662,-0.41443,1,0
5,GO REGULATION OF BONE REMODELING,1.0322e-07,-0.35666,-0.40698,1,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,3.1896e-11,-0.35666,-0.46315,1,0
5,GO ESTABLISHMENT OF CELL POLARITY,1.6001e-09,-0.35667,-0.414,1,0
5,GO CARTILAGE DEVELOPMENT,1.9948e-11,-0.35675,-0.47124,1,0
5,GO CELLULAR EXTRAVASATION,2.5223e-10,-0.35691,-0.41425,1,0
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,2.8369e-09,-0.35694,-0.39957,1,0
5,GO DOPAMINE TRANSPORT,0.00047589,-0.35706,-0.30672,1,0
5,GO COCHLEA MORPHOGENESIS,2.0364e-06,-0.35708,-0.35137,1,0
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,1.8389e-10,-0.35709,-0.39793,1,0
5,GO CALCINEURIN MEDIATED SIGNALING,4.4302e-11,-0.35722,-0.42367,1,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,2.4305e-07,-0.35722,-0.37359,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.4076e-07,-0.35723,-0.35743,1,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,5.7536e-08,-0.35729,-0.42596,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0001179,-0.35735,-0.33018,1,0
5,GO MYELOID CELL DEVELOPMENT,2.5756e-08,-0.35749,-0.41673,1,0
5,GO HISTONE H3 K36 METHYLATION,2.9514e-07,-0.35756,-0.38854,1,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.4749e-10,-0.35758,-0.44109,1,0
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,6.3569e-09,-0.35761,-0.39331,1,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,5.2253e-10,-0.35768,-0.40647,1,0
5,GO RECEPTOR CLUSTERING,2.0398e-08,-0.35776,-0.44332,1,0
5,GO INTERLEUKIN 6 PRODUCTION,7.1121e-10,-0.35779,-0.38577,1,0
5,GO CARTILAGE MORPHOGENESIS,3.152e-06,-0.3578,-0.48707,1,0
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,9.7991e-09,-0.3578,-0.34141,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.2792e-06,-0.3579,-0.40004,1,0
5,GO PEPTIDYL PROLINE HYDROXYLATION,6.7724e-05,-0.35793,-0.36497,1,0
5,GO MECHANORECEPTOR DIFFERENTIATION,5.6245e-08,-0.35799,-0.36298,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,5.3747e-08,-0.35809,-0.4084,1,0
5,GO CHOLESTEROL EFFLUX,1.5688e-10,-0.35819,-0.39573,1,0
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00159,-0.35849,-0.31641,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.5604e-09,-0.35861,-0.42535,1,0
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.1389e-11,-0.35862,-0.43919,1,0
5,GO TAXIS,8.3747e-12,-0.35863,-0.40636,1,0
5,GO TRANSEPITHELIAL TRANSPORT,8.2618e-11,-0.35869,-0.38245,1,0
5,GO SEGMENTATION,4.8359e-10,-0.35874,-0.37918,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.2604e-07,-0.35889,-0.38401,1,0
5,GO ANOIKIS,7.892e-08,-0.35899,-0.44457,1,0
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,3.462e-12,-0.35901,-0.44592,1,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,1.471e-07,-0.35916,-0.39899,1,0
5,GO DENDRITIC CELL DIFFERENTIATION,1.2534e-06,-0.35931,-0.43541,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION,3.2785e-11,-0.35932,-0.43879,1,0
5,GO NEGATIVE REGULATION OF JNK CASCADE,3.9941e-08,-0.35944,-0.40234,1,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,4.9069e-08,-0.35962,-0.42679,1,0
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,7.2964e-10,-0.35971,-0.41667,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.4877e-10,-0.35971,-0.42224,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.2697e-09,-0.35973,-0.43307,1,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,9.658e-10,-0.35974,-0.38486,1,0
5,GO ERK1 AND ERK2 CASCADE,5.9602e-12,-0.35991,-0.44039,1,0
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,1.174e-11,-0.35994,-0.47646,1,0
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,9.6538e-08,-0.35999,-0.39192,1,0
5,GO ACTIN FILAMENT DEPOLYMERIZATION,1.5217e-09,-0.36003,-0.4474,1,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,2.1064e-09,-0.36011,-0.44332,1,0
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,2.4837e-07,-0.36018,-0.50992,1,0
5,GO INTERLEUKIN 5 PRODUCTION,1.5994e-06,-0.36024,-0.41942,1,0
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,8.8389e-07,-0.36024,-0.38639,1,0
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.1494e-05,-0.36027,-0.40262,1,0
5,GO POSITIVE REGULATION OF MYELINATION,2.1595e-09,-0.36037,-0.38839,1,0
5,GO STEM CELL PROLIFERATION,1.6062e-07,-0.3605,-0.37313,1,0
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.3629e-10,-0.36054,-0.42329,1,0
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,7.5451e-08,-0.36072,-0.39915,1,0
5,GO PHAGOLYSOSOME ASSEMBLY,1.2534e-06,-0.36086,-0.45498,1,0
5,GO MAST CELL MIGRATION,3.8246e-05,-0.36091,-0.40906,1,0
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,5.5412e-06,-0.36093,-0.34641,1,0
5,GO REGULATION OF GONAD DEVELOPMENT,3.6293e-09,-0.36103,-0.38577,1,0
5,GO RESPONSE TO HYDROPEROXIDE,7.0337e-07,-0.36106,-0.38805,1,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.6567e-07,-0.36109,-0.48058,1,0
5,GO STRIATED MUSCLE CONTRACTION,7.6205e-11,-0.36117,-0.39913,1,0
5,GO MUSCLE CELL APOPTOTIC PROCESS,3.3713e-09,-0.3613,-0.36881,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,6.0565e-09,-0.36134,-0.39313,1,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,1.2328e-07,-0.36135,-0.37894,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,5.3617e-10,-0.36151,-0.40811,1,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,7.8052e-07,-0.36155,-0.41792,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.793e-12,-0.36156,-0.42388,1,0
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,3.5794e-07,-0.3616,-0.36482,1,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,2.9515e-10,-0.36165,-0.46194,1,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,1.0964e-09,-0.3617,-0.42831,1,0
5,GO REGULATION OF CELL MORPHOGENESIS,1.1398e-10,-0.3617,-0.44771,1,0
5,GO REGULATION OF BODY FLUID LEVELS,5.793e-12,-0.36216,-0.42737,1,0
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,2.3268e-09,-0.36227,-0.46787,1,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0021215,-0.36232,-0.31967,1,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.7154e-07,-0.36256,-0.42095,1,0
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,8.9558e-11,-0.36263,-0.45516,1,0
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,9.9705e-11,-0.36266,-0.38513,1,0
5,GO MEMBRANE DEPOLARIZATION,1.3769e-07,-0.36272,-0.39576,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,3.3697e-11,-0.36276,-0.44574,1,0
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.559e-11,-0.36285,-0.46684,1,0
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,9.1205e-09,-0.36286,-0.38837,1,0
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,6.757e-10,-0.36295,-0.46284,1,0
5,GO REGULATION OF VASOCONSTRICTION,2.457e-10,-0.36304,-0.41536,1,0
5,GO RESPIRATORY SYSTEM DEVELOPMENT,1.4877e-10,-0.3631,-0.44762,1,0
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,1.8353e-11,-0.36312,-0.49058,1,0
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,2.5223e-10,-0.36316,-0.37698,1,0
5,GO AMYLOID BETA CLEARANCE,9.7068e-11,-0.3633,-0.44351,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.7237e-10,-0.36347,-0.47128,1,0
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,3.5412e-09,-0.36352,-0.43922,1,0
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,5.7051e-07,-0.36356,-0.34438,1,0
5,GO IMMUNE RESPONSE TO TUMOR CELL,7.6446e-07,-0.36358,-0.44824,1,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,1.6823e-09,-0.3636,-0.41446,1,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,1.5277e-10,-0.36363,-0.4701,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,7.2129e-08,-0.36368,-0.42081,1,0
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.4487e-10,-0.3637,-0.37814,1,0
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,4.7963e-08,-0.36399,-0.40322,1,0
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,1.1099e-11,-0.36407,-0.45098,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.4076e-07,-0.36411,-0.43637,1,0
5,GO LIPOPROTEIN LOCALIZATION,3.2894e-09,-0.36412,-0.42959,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,4.9228e-07,-0.36427,-0.36054,1,0
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,3.2784e-06,-0.3644,-0.36355,1,0
5,GO MAINTENANCE OF CELL POLARITY,8.0712e-08,-0.36447,-0.37977,1,0
5,GO CARDIAC CHAMBER FORMATION,4.6359e-05,-0.36472,-0.37949,1,0
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,1.6514e-08,-0.36497,-0.39567,1,0
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,2.4305e-07,-0.36536,-0.34813,1,0
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,7.2964e-10,-0.3654,-0.37117,1,0
5,GO PROTEIN TARGETING TO VACUOLE,2.4214e-11,-0.36553,-0.45793,1,0
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0001803,-0.3656,-0.39374,1,0
5,GO RENAL WATER HOMEOSTASIS,3.6293e-09,-0.3656,-0.42522,1,0
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,2.2697e-09,-0.36564,-0.38101,1,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00039622,-0.36589,-0.38677,1,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,4.7172e-05,-0.36589,-0.38683,1,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,1.1794e-07,-0.3659,-0.39205,1,0
5,GO CARDIAC CHAMBER DEVELOPMENT,1.9387e-10,-0.36591,-0.45864,1,0
5,GO CARNITINE SHUTTLE,1.1828e-09,-0.36608,-0.45612,1,0
5,GO EXPORT ACROSS PLASMA MEMBRANE,1.1245e-09,-0.3662,-0.41869,1,0
5,GO RESPONSE TO KETONE,8.8611e-12,-0.36631,-0.39485,1,0
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,8.6579e-07,-0.36632,-0.3829,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,6.8885e-07,-0.36635,-0.40404,1,0
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,5.9116e-09,-0.36637,-0.40108,1,0
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,1.2143e-08,-0.36646,-0.43018,1,0
5,GO CELL AGGREGATION,9.028e-08,-0.36646,-0.38172,1,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.4771e-05,-0.36648,-0.34636,1,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,4.0657e-06,-0.36654,-0.37663,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,2.8886e-07,-0.36658,-0.35099,1,0
5,GO POSITIVE REGULATION OF TISSUE REMODELING,4.0314e-05,-0.36658,-0.34838,1,0
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.3948e-05,-0.36658,-0.35969,1,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,4.9624e-10,-0.36665,-0.41443,1,0
5,GO VITAMIN BIOSYNTHETIC PROCESS,4.0678e-07,-0.36669,-0.38391,1,0
5,GO KIDNEY EPITHELIUM DEVELOPMENT,3.7319e-10,-0.36671,-0.4412,1,0
5,GO XENOBIOTIC TRANSPORT,3.8645e-11,-0.36672,-0.45946,1,0
5,GO EMBRYONIC PATTERN SPECIFICATION,2.2397e-08,-0.36672,-0.34664,1,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.6761e-05,-0.36676,-0.30138,1,0
5,GO PROTEIN KINASE B SIGNALING,1.6884e-11,-0.36696,-0.40647,1,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,2.8001e-06,-0.36706,-0.41474,1,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,6.1583e-08,-0.36707,-0.42356,1,0
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.9371e-11,-0.36715,-0.41291,1,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,9.5677e-09,-0.36719,-0.50551,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,4.4302e-11,-0.36734,-0.46036,1,0
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.00018923,-0.36739,-0.28653,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.6581e-11,-0.3674,-0.4202,1,0
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.0398e-08,-0.3674,-0.39641,1,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,1.4107e-10,-0.36744,-0.46356,1,0
5,GO KERATAN SULFATE METABOLIC PROCESS,6.1389e-11,-0.36761,-0.47775,1,0
5,GO AUTOPHAGOSOME ORGANIZATION,8.8611e-12,-0.36775,-0.42943,1,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,3.2146e-06,-0.36789,-0.39617,1,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.1595e-09,-0.368,-0.40167,1,0
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.9064e-09,-0.36807,-0.47484,1,0
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,2.7614e-08,-0.3682,-0.43218,1,0
5,GO PEPTIDE CATABOLIC PROCESS,8.7237e-10,-0.36827,-0.45839,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,5.1691e-12,-0.36831,-0.44293,1,0
5,GO CARDIAC ATRIUM DEVELOPMENT,5.2538e-08,-0.36835,-0.43286,1,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00070238,-0.36844,-0.35848,1,0
5,GO POSITIVE REGULATION OF CHEMOTAXIS,1.4112e-09,-0.36877,-0.37068,1,0
5,GO CELL JUNCTION MAINTENANCE,6.7461e-07,-0.36879,-0.42304,1,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,4.4148e-09,-0.36894,-0.47791,1,0
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,7.0337e-07,-0.36899,-0.35632,1,0
5,GO VAGINA DEVELOPMENT,4.8198e-07,-0.3691,-0.37373,1,0
5,GO REGULATION OF JUN KINASE ACTIVITY,1.2682e-10,-0.3691,-0.43781,1,0
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0016575,-0.36911,-0.27653,1,0
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,1.642e-11,-0.36916,-0.43776,1,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,8.9047e-09,-0.36926,-0.44753,1,0
5,GO INTERMEMBRANE LIPID TRANSFER,8.6145e-12,-0.36927,-0.46382,1,0
5,GO AMINOGLYCAN METABOLIC PROCESS,1.736e-11,-0.36928,-0.43999,1,0
5,GO FUCOSYLATION,7.7166e-08,-0.36953,-0.3972,1,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0005789,-0.3696,-0.36667,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,1.6782e-07,-0.36967,-0.43482,1,0
5,GO LUNG MORPHOGENESIS,3.1098e-10,-0.36969,-0.47645,1,0
5,GO CELL CHEMOTAXIS,1.8389e-10,-0.36991,-0.3884,1,0
5,GO CERAMIDE TRANSPORT,2.1064e-09,-0.37,-0.43098,1,0
5,GO NOTCH RECEPTOR PROCESSING,0.00020504,-0.37011,-0.35531,1,0
5,GO REGULATION OF VASCULAR PERMEABILITY,2.4893e-11,-0.37011,-0.50793,1,0
5,GO POSITIVE REGULATION OF OSSIFICATION,2.5893e-10,-0.37025,-0.44629,1,0
5,GO SHORT TERM MEMORY,0.00010152,-0.37026,-0.34782,1,0
5,GO TUBE MORPHOGENESIS,4.232e-12,-0.37031,-0.45828,1,0
5,GO AXON DEVELOPMENT,3.4553e-09,-0.37034,-0.42078,1,0
5,GO BIOLOGICAL ADHESION,2.3113e-12,-0.37038,-0.45603,1,0
5,GO HYPOTONIC RESPONSE,1.1041e-08,-0.37043,-0.43028,1,0
5,GO RENAL VESICLE DEVELOPMENT,1.9175e-06,-0.37062,-0.37682,1,0
5,GO REGULATION OF VESICLE FUSION,3.9872e-06,-0.37064,-0.42924,1,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.0791e-07,-0.37068,-0.3897,1,0
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,1.6907e-08,-0.37078,-0.41806,1,0
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,3.3639e-12,-0.3708,-0.48682,1,0
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,1.0792e-11,-0.37092,-0.45896,1,0
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.8301e-10,-0.37101,-0.43132,1,0
5,GO REGULATION OF BONE MINERALIZATION,1.9905e-10,-0.37128,-0.45387,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.0478e-05,-0.37132,-0.44402,1,0
5,GO PLASMINOGEN ACTIVATION,1.5372e-07,-0.37149,-0.4583,1,0
5,GO REGULATION OF FAT CELL DIFFERENTIATION,3.7602e-11,-0.37154,-0.45397,1,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,2.4861e-06,-0.37161,-0.51136,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0071918,-0.3718,-0.30253,1,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,6.0565e-09,-0.37187,-0.43953,1,0
5,GO HISTAMINE TRANSPORT,0.00057029,-0.37195,-0.30663,1,0
5,GO ACTIVATION OF MAPKKK ACTIVITY,8.6328e-08,-0.37204,-0.48639,1,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,2.5223e-10,-0.37207,-0.3916,1,0
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.8723e-07,-0.37242,-0.38579,1,0
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.5461e-06,-0.37245,-0.38926,1,0
5,GO REGULATION OF HAIR CYCLE,2.8925e-08,-0.37247,-0.38095,1,0
5,GO INTEGRIN ACTIVATION,9.3415e-09,-0.37248,-0.44527,1,0
5,GO PROSTATE GLAND MORPHOGENESIS,4.2784e-08,-0.3725,-0.51097,1,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.7721e-08,-0.37253,-0.4105,1,0
5,GO HETEROTYPIC CELL CELL ADHESION,6.5906e-08,-0.37263,-0.40148,1,0
5,GO CARDIAC ATRIUM MORPHOGENESIS,7.892e-08,-0.37268,-0.44487,1,0
5,GO AMINO ACID IMPORT,3.7195e-09,-0.3728,-0.4261,1,0
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,8.8282e-08,-0.37285,-0.43935,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,8.0712e-08,-0.3729,-0.4655,1,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,1.3999e-08,-0.3729,-0.43133,1,0
5,GO ASYMMETRIC CELL DIVISION,1.7721e-08,-0.37292,-0.41445,1,0
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,2.65e-07,-0.37322,-0.50151,1,0
5,GO HINDLIMB MORPHOGENESIS,4.9069e-08,-0.37329,-0.41136,1,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00094089,-0.37335,-0.3982,1,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,3.8983e-07,-0.37345,-0.33795,1,0
5,GO SUPEROXIDE ANION GENERATION,7.969e-07,-0.37362,-0.38046,1,0
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.8573e-08,-0.37369,-0.47032,1,0
5,GO STRIATED MUSCLE ADAPTATION,3.2764e-10,-0.37371,-0.44825,1,0
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0005618,-0.37373,-0.32975,1,0
5,GO SPHINGOID METABOLIC PROCESS,2.4452e-09,-0.37384,-0.45597,1,0
5,GO REGULATION OF CARTILAGE DEVELOPMENT,8.0424e-11,-0.37385,-0.48578,1,0
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.1098e-10,-0.37403,-0.48576,1,0
5,GO RESPONSE TO CORTICOSTEROID,5.0766e-11,-0.37419,-0.38844,1,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,5.4967e-09,-0.37431,-0.42123,1,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,8.7237e-10,-0.37435,-0.42777,1,0
5,GO RESPONSE TO AXON INJURY,4.1025e-09,-0.37446,-0.40601,1,0
5,GO T CELL DIFFERENTIATION IN THYMUS,1.6109e-10,-0.37457,-0.38048,1,0
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,5.6317e-09,-0.37464,-0.45414,1,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,5.0278e-07,-0.37471,-0.40293,1,0
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,8.8611e-12,-0.37473,-0.45365,1,0
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,9.5677e-09,-0.37474,-0.41698,1,0
5,GO DETECTION OF MECHANICAL STIMULUS,2.971e-06,-0.37478,-0.36279,1,0
5,GO NEGATIVE REGULATION OF OSSIFICATION,3.9064e-09,-0.37482,-0.44126,1,0
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,5.3617e-10,-0.37489,-0.45809,1,0
5,GO REGULATION OF CELL SIZE,1.642e-11,-0.37502,-0.45179,1,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,1.5027e-08,-0.37527,-0.4035,1,0
5,GO MECHANOSENSORY BEHAVIOR,0.00024045,-0.37529,-0.41906,1,0
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,8.2618e-11,-0.37531,-0.48866,1,0
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.0094e-07,-0.37535,-0.39529,1,0
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,3.9822e-07,-0.37538,-0.40372,1,0
5,GO CARNITINE METABOLIC PROCESS,3.2146e-06,-0.37541,-0.32821,1,0
5,GO NEUROTRANSMITTER REUPTAKE,2.2958e-06,-0.37544,-0.341,1,0
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.9175e-06,-0.37554,-0.33471,1,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,3.7356e-07,-0.37555,-0.37892,1,0
5,GO ENDOCRINE PANCREAS DEVELOPMENT,9.2321e-08,-0.37564,-0.36518,1,0
5,GO CYSTEINE METABOLIC PROCESS,6.545e-05,-0.37585,-0.35748,1,0
5,GO REGULATION OF CATION CHANNEL ACTIVITY,2.457e-10,-0.37592,-0.38762,1,0
5,GO REGULATION OF MEMBRANE REPOLARIZATION,3.247e-08,-0.37593,-0.4269,1,0
5,GO RESPONSE TO TUMOR CELL,2.1375e-08,-0.37604,-0.45325,1,0
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,5.1101e-09,-0.37622,-0.4255,1,0
5,GO SYNCYTIUM FORMATION,5.6304e-12,-0.37626,-0.48868,1,0
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,1.2441e-09,-0.37626,-0.42221,1,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,4.6784e-11,-0.37627,-0.41735,1,0
5,GO SIALYLATION,2.342e-06,-0.37627,-0.47767,1,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,4.9403e-11,-0.37649,-0.41911,1,0
5,GO GLIAL CELL MIGRATION,2.9515e-10,-0.37655,-0.46001,1,0
5,GO GDP METABOLIC PROCESS,1.8032e-05,-0.37661,-0.3418,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,2.7286e-10,-0.37679,-0.49171,1,0
5,GO INTERFERON BETA PRODUCTION,5.0922e-10,-0.37692,-0.43306,1,0
5,GO PIGMENT ACCUMULATION,2.8886e-07,-0.37749,-0.41427,1,0
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.0004e-06,-0.3776,-0.43567,1,0
5,GO MESENCHYME DEVELOPMENT,1.785e-11,-0.37766,-0.43785,1,0
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,1.1398e-10,-0.37769,-0.44496,1,0
5,GO VITAMIN D METABOLIC PROCESS,1.7154e-07,-0.37771,-0.42448,1,0
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,1.484e-09,-0.37773,-0.42306,1,0
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0055559,-0.3778,-0.36448,1,0
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,2.9371e-11,-0.37782,-0.41015,1,0
5,GO HEART INDUCTION,0.00071283,-0.37783,-0.33657,1,0
5,GO REGULATION OF CAMP MEDIATED SIGNALING,9.658e-10,-0.37792,-0.41132,1,0
5,GO GOLGI RIBBON FORMATION,1.5604e-09,-0.37797,-0.48122,1,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,1.1307e-08,-0.37797,-0.50597,1,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,8.6937e-09,-0.378,-0.41853,1,0
5,GO ANION HOMEOSTASIS,6.8406e-11,-0.37807,-0.41931,1,0
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00092737,-0.37807,-0.33515,1,0
5,GO INTERLEUKIN 1 BETA PRODUCTION,3.247e-08,-0.37829,-0.40898,1,0
5,GO BONE MORPHOGENESIS,2.5223e-10,-0.3783,-0.4601,1,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.7125e-10,-0.3784,-0.44929,1,0
5,GO COPULATION,1.4207e-05,-0.37841,-0.30901,1,0
5,GO REGULATION OF PROTEIN MATURATION,1.4471e-09,-0.37847,-0.40637,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,2.7041e-11,-0.37857,-0.4322,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.1479e-07,-0.37864,-0.41814,1,0
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,4.1403e-10,-0.37882,-0.43602,1,0
5,GO MELANOCYTE DIFFERENTIATION,6.1583e-08,-0.37885,-0.38171,1,0
5,GO COAGULATION,9.6431e-12,-0.3789,-0.45605,1,0
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,9.4499e-11,-0.37903,-0.39844,1,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.3878e-06,-0.37915,-0.40617,1,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,4.4807e-06,-0.3792,-0.42342,1,0
5,GO FIBROBLAST PROLIFERATION,1.5277e-10,-0.3793,-0.44442,1,0
5,GO ACTIN FILAMENT SEVERING,9.5999e-07,-0.37934,-0.47604,1,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.634e-09,-0.37935,-0.40303,1,0
5,GO PLATELET DEGRANULATION,2.0437e-10,-0.37948,-0.48836,1,0
5,GO ARACHIDONIC ACID METABOLIC PROCESS,7.8976e-09,-0.37953,-0.3644,1,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.1858e-08,-0.37963,-0.44449,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,5.9834e-06,-0.37973,-0.46063,1,0
5,GO INTESTINAL ABSORPTION,4.9694e-05,-0.37998,-0.36789,1,0
5,GO REGULATION OF TISSUE REMODELING,8.6937e-09,-0.38002,-0.44255,1,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.2434e-08,-0.38007,-0.45996,1,0
5,GO GRANULOCYTE DIFFERENTIATION,2.65e-07,-0.38026,-0.38426,1,0
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,1.2023e-10,-0.38031,-0.44921,1,0
5,GO LIPID STORAGE,8.8611e-12,-0.3804,-0.42178,1,0
5,GO POSITIVE REGULATION OF URINE VOLUME,1.7721e-08,-0.38045,-0.37089,1,0
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00070238,-0.38049,-0.34944,1,0
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,3.4553e-09,-0.38052,-0.43261,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.8262e-08,-0.38056,-0.41098,1,0
5,GO PROTEIN TRIMERIZATION,1.5753e-08,-0.38067,-0.35767,1,0
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,4.2784e-08,-0.38076,-0.44842,1,0
5,GO PROTEIN DEMETHYLATION,1.4076e-07,-0.38087,-0.40826,1,0
5,GO REGULATION OF POSITIVE CHEMOTAXIS,3.2162e-07,-0.38106,-0.37827,1,0
5,GO INOSITOL LIPID MEDIATED SIGNALING,2.9979e-12,-0.38116,-0.46312,1,0
5,GO CELLULAR RESPONSE TO FATTY ACID,1.3174e-07,-0.38126,-0.36769,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.2785e-11,-0.38141,-0.464,1,0
5,GO LIPID TRANSLOCATION,4.3082e-09,-0.38144,-0.471,1,0
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,1.1307e-08,-0.38145,-0.38585,1,0
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,2.9078e-09,-0.38146,-0.40123,1,0
5,GO FRUCTOSE METABOLIC PROCESS,0.0010865,-0.38148,-0.37766,1,0
5,GO STRIATED MUSCLE CELL PROLIFERATION,1.0422e-09,-0.38154,-0.40487,1,0
5,GO PIGMENT CELL DIFFERENTIATION,2.8369e-09,-0.38156,-0.3925,1,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,7.8052e-07,-0.38169,-0.3411,1,0
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,3.0156e-07,-0.3818,-0.38549,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,9.4157e-10,-0.38191,-0.42612,1,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,4.0868e-08,-0.38197,-0.41719,1,0
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,6.2565e-10,-0.38203,-0.43241,1,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,2.3891e-06,-0.38208,-0.34125,1,0
5,GO PSEUDOPODIUM ORGANIZATION,4.3997e-05,-0.3821,-0.38846,1,0
5,GO REGULATION OF CELL ADHESION,6.8695e-12,-0.38242,-0.46142,1,0
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,3.7282e-08,-0.38245,-0.38682,1,0
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.1789e-06,-0.38246,-0.39151,1,0
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,3.2094e-09,-0.38247,-0.35405,1,0
5,GO RESPONSE TO RETINOIC ACID,9.7068e-11,-0.3827,-0.42981,1,0
5,GO GONADOTROPIN SECRETION,5.5412e-06,-0.3827,-0.35729,1,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,1.6457e-05,-0.38276,-0.36961,1,0
5,GO REGULATION OF SYNAPSE MATURATION,7.0337e-07,-0.38287,-0.46651,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.1356e-08,-0.38294,-0.45565,1,0
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,1.7534e-07,-0.38313,-0.56071,1,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.6293e-09,-0.38317,-0.46669,1,0
5,GO PHAGOCYTOSIS,1.2074e-11,-0.38318,-0.45294,1,0
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.0033e-09,-0.38323,-0.46386,1,0
5,GO BONE DEVELOPMENT,9.1996e-11,-0.38329,-0.45367,1,0
5,GO HEART TRABECULA FORMATION,2.8814e-05,-0.38343,-0.36743,1,0
5,GO SCHWANN CELL DEVELOPMENT,3.1098e-10,-0.38354,-0.47123,1,0
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,2.7452e-06,-0.38359,-0.4627,1,0
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,1.4163e-06,-0.3837,-0.36492,1,0
5,GO ARGININE METABOLIC PROCESS,6.205e-09,-0.38401,-0.445,1,0
5,GO RESPONSE TO TYPE I INTERFERON,3.6924e-05,-0.38405,-0.49178,1,0
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,9.9705e-11,-0.38451,-0.37797,1,0
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,4.4148e-09,-0.38456,-0.42064,1,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,5.1356e-08,-0.38462,-0.44368,1,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,1.0756e-05,-0.38472,-0.3543,1,0
5,GO RESPONSE TO ANGIOTENSIN,3.192e-10,-0.38481,-0.4699,1,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,5.4982e-08,-0.38571,-0.4659,1,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.634e-09,-0.38573,-0.52041,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,2.595e-12,-0.38574,-0.48949,1,0
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.2414e-06,-0.38577,-0.50499,1,0
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,8.2543e-08,-0.38586,-0.36067,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.3376e-10,-0.38587,-0.43153,1,0
5,GO LAMELLIPODIUM ASSEMBLY,1.1099e-11,-0.38612,-0.45782,1,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,4.4787e-08,-0.38615,-0.36922,1,0
5,GO MUSCLE CELL PROLIFERATION,1.174e-11,-0.38617,-0.43882,1,0
5,GO LONG TERM MEMORY,1.2023e-10,-0.38623,-0.4696,1,0
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,1.2886e-07,-0.38641,-0.40817,1,0
5,GO GASTRULATION,3.5597e-11,-0.3865,-0.46764,1,0
5,GO PLASMA MEMBRANE ORGANIZATION,9.6431e-12,-0.38668,-0.521,1,0
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,1.1535e-07,-0.38669,-0.42174,1,0
5,GO RESPONSE TO ACETYLCHOLINE,4.2271e-06,-0.38701,-0.38072,1,0
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,5.1101e-09,-0.38702,-0.43536,1,0
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,3.4773e-06,-0.38707,-0.44854,1,0
5,GO RECEPTOR CATABOLIC PROCESS,4.5922e-10,-0.38716,-0.48828,1,0
5,GO REGULATION OF LYMPHOCYTE MIGRATION,2.0437e-10,-0.38728,-0.41407,1,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,3.5427e-10,-0.38736,-0.51323,1,0
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,1.8389e-10,-0.38737,-0.43903,1,0
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.3196e-05,-0.38751,-0.35714,1,0
5,GO REGULATION OF RESPIRATORY BURST,3.6567e-07,-0.38761,-0.3736,1,0
5,GO ASTROCYTE DIFFERENTIATION,2.5893e-10,-0.38765,-0.4184,1,0
5,GO OSTEOCLAST DEVELOPMENT,1.9014e-08,-0.38766,-0.47111,1,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,5.4967e-09,-0.3877,-0.49603,1,0
5,GO PROTEIN OXIDATION,3.6877e-06,-0.38778,-0.41991,1,0
5,GO MICROVILLUS ASSEMBLY,1.1579e-08,-0.3878,-0.52727,1,0
5,GO RESPONSE TO INTERLEUKIN 15,7.5266e-09,-0.38789,-0.45064,1,0
5,GO GLIAL CELL ACTIVATION,1.4487e-10,-0.38797,-0.41033,1,0
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,1.2434e-08,-0.38818,-0.50514,1,0
5,GO CELL JUNCTION DISASSEMBLY,1.0804e-10,-0.3883,-0.47842,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.2604e-07,-0.38875,-0.47894,1,0
5,GO NEURON MATURATION,6.0759e-07,-0.38902,-0.35903,1,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,2.5893e-10,-0.38918,-0.40727,1,0
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.1234e-05,-0.38918,-0.43117,1,0
5,GO COLLATERAL SPROUTING,5.1356e-08,-0.38923,-0.48226,1,0
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,6.3569e-09,-0.38926,-0.45678,1,0
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,1.8135e-09,-0.38938,-0.41533,1,0
5,GO FORMATION OF PRIMARY GERM LAYER,1.6884e-11,-0.38944,-0.50903,1,0
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00020178,-0.3896,-0.43514,1,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,3.9822e-07,-0.38966,-0.45366,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.1706e-10,-0.39005,-0.43191,1,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,5.3647e-09,-0.39023,-0.40581,1,0
5,GO ACTIVATION OF JUN KINASE ACTIVITY,8.9558e-11,-0.39029,-0.47404,1,0
5,GO ACTIVATION OF MAPKK ACTIVITY,9.4499e-11,-0.39034,-0.47621,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,5.9748e-11,-0.39052,-0.44376,1,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00016629,-0.39067,-0.36806,1,0
5,GO CYTOLYSIS,6.6578e-05,-0.39085,-0.36915,1,0
5,GO RESPONSE TO INTERLEUKIN 6,2.6981e-08,-0.39096,-0.41524,1,0
5,GO FATTY ACID HOMEOSTASIS,1.6514e-08,-0.39102,-0.42815,1,0
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,1.277e-11,-0.39103,-0.49583,1,0
5,GO CHLORIDE ION HOMEOSTASIS,8.9047e-09,-0.3911,-0.47032,1,0
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,2.3793e-12,-0.39128,-0.4581,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,8.8611e-12,-0.39136,-0.4678,1,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,6.2565e-10,-0.39146,-0.47428,1,0
5,GO CARDIAC MUSCLE CONTRACTION,1.3376e-10,-0.39159,-0.41549,1,0
5,GO REGULATION OF TUBULIN DEACETYLATION,1.9136e-07,-0.39159,-0.43605,1,0
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,1.7534e-07,-0.39166,-0.40373,1,0
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,9.9185e-12,-0.39173,-0.47658,1,0
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,2.8305e-05,-0.39174,-0.44832,1,0
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,1.5753e-08,-0.39184,-0.47248,1,0
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.9064e-09,-0.39192,-0.52203,1,0
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,1.6884e-11,-0.39199,-0.47153,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,3.4796e-08,-0.39199,-0.35048,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00052901,-0.392,-0.39258,1,0
5,GO SCHWANN CELL DIFFERENTIATION,1.0161e-09,-0.39205,-0.44129,1,0
5,GO REGULATION OF FATTY ACID OXIDATION,4.5922e-10,-0.39211,-0.41688,1,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,7.6792e-10,-0.39249,-0.4438,1,0
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,8.7237e-10,-0.39249,-0.43477,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.0033e-09,-0.39258,-0.44988,1,0
5,GO STEROID HORMONE SECRETION,1.471e-07,-0.39265,-0.37663,1,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.0546e-09,-0.39267,-0.43753,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.9402e-11,-0.39273,-0.52198,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,4.8359e-10,-0.39273,-0.45687,1,0
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,7.5451e-08,-0.39281,-0.43751,1,0
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,3.9963e-12,-0.39291,-0.49951,1,0
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,1.1398e-10,-0.39304,-0.4422,1,0
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,3.357e-07,-0.39304,-0.40907,1,0
5,GO DIVALENT METAL ION EXPORT,4.4787e-08,-0.39307,-0.42922,1,0
5,GO MYOBLAST FUSION,3.5597e-11,-0.39309,-0.52703,1,0
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,5.7923e-10,-0.39321,-0.45256,1,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.3599e-06,-0.39329,-0.51258,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.6823e-09,-0.39336,-0.41576,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.2538e-08,-0.39337,-0.43016,1,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,1.6542e-10,-0.39352,-0.46442,1,0
5,GO GOLGI TO ENDOSOME TRANSPORT,7.4177e-11,-0.39358,-0.49814,1,0
5,GO MACROPHAGE ACTIVATION,1.1398e-10,-0.39358,-0.42236,1,0
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,8.3747e-12,-0.39393,-0.49096,1,0
5,GO PARAXIAL MESODERM DEVELOPMENT,1.996e-06,-0.39402,-0.37413,1,0
5,GO ARTERY MORPHOGENESIS,5.2253e-10,-0.39407,-0.46151,1,0
5,GO GENITALIA MORPHOGENESIS,7.5451e-08,-0.39417,-0.44855,1,0
5,GO REGULATION OF AXONOGENESIS,3.055e-09,-0.39421,-0.46645,1,0
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,5.3602e-11,-0.39426,-0.44113,1,0
5,GO OPTIC NERVE DEVELOPMENT,1.155e-06,-0.39428,-0.43084,1,0
5,GO PLATELET MORPHOGENESIS,1.6001e-09,-0.39431,-0.5149,1,0
5,GO BONE REMODELING,1.6823e-09,-0.39443,-0.44977,1,0
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,6.4805e-11,-0.39481,-0.44334,1,0
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,7.6792e-10,-0.39507,-0.44208,1,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.0161e-09,-0.39518,-0.41095,1,0
5,GO ATRIAL SEPTUM MORPHOGENESIS,5.8049e-05,-0.39526,-0.41777,1,0
5,GO SYNAPTIC MEMBRANE ADHESION,7.5217e-06,-0.39551,-0.45986,1,0
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,3.4773e-06,-0.3957,-0.41121,1,0
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,3.2859e-07,-0.39571,-0.36894,1,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,5.2359e-09,-0.39584,-0.40019,1,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.0811e-07,-0.39587,-0.47207,1,0
5,GO PEPTIDYL TYROSINE MODIFICATION,1.7797e-12,-0.39592,-0.46084,1,0
5,GO FIBROBLAST MIGRATION,6.2565e-10,-0.39602,-0.46731,1,0
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,4.9228e-07,-0.39612,-0.36319,1,0
5,GO CONVERGENT EXTENSION,8.4805e-07,-0.39645,-0.38538,1,0
5,GO APOPTOTIC CELL CLEARANCE,8.4871e-11,-0.39645,-0.49895,1,0
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,8.5043e-10,-0.39663,-0.43256,1,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.5052e-06,-0.39668,-0.38409,1,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,4.719e-07,-0.39669,-0.4691,1,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,4.1552e-07,-0.3967,-0.45377,1,0
5,GO REGULATION OF LIPID STORAGE,1.3888e-11,-0.3968,-0.43795,1,0
5,GO CALCIUM ION IMPORT INTO CYTOSOL,1.4454e-06,-0.39716,-0.39688,1,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,2.9078e-09,-0.39731,-0.40245,1,0
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,3.3713e-09,-0.39738,-0.40432,1,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.1098e-10,-0.39757,-0.53044,1,0
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,8.2903e-10,-0.39764,-0.47079,1,0
5,GO REGULATION OF VACUOLE ORGANIZATION,4.7125e-10,-0.39764,-0.42405,1,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,9.9705e-11,-0.39771,-0.38939,1,0
5,GO MOTOR NEURON AXON GUIDANCE,1.1086e-06,-0.39775,-0.38806,1,0
5,GO LAMELLIPODIUM ORGANIZATION,9.3752e-12,-0.39788,-0.46955,1,0
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,3.9822e-07,-0.39798,-0.37533,1,0
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,4.2271e-06,-0.3981,-0.40936,1,0
5,GO RESPONSE TO WOUNDING,7.9144e-12,-0.3982,-0.4685,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.9602e-12,-0.39828,-0.52901,1,0
5,GO RESPONSE TO PAIN,6.4434e-08,-0.39846,-0.38852,1,0
5,GO REGULATION OF HEART MORPHOGENESIS,2.8886e-07,-0.39846,-0.39817,1,0
5,GO REGULATION OF PROTEIN GLYCOSYLATION,1.1535e-07,-0.39854,-0.41619,1,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,3.4296e-07,-0.39857,-0.43535,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.725e-09,-0.39858,-0.38969,1,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.5239e-09,-0.3987,-0.51582,1,0
5,GO REGULATION OF MYELINATION,6.205e-09,-0.39876,-0.37003,1,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.4452e-09,-0.3988,-0.55906,1,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,5.2445e-07,-0.39885,-0.49589,1,0
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,9.795e-06,-0.39915,-0.43186,1,0
5,GO REGULATION OF SULFUR METABOLIC PROCESS,7.5217e-06,-0.3993,-0.41481,1,0
5,GO NEPHRIC DUCT DEVELOPMENT,9.404e-07,-0.39936,-0.43854,1,0
5,GO STEM CELL DIVISION,1.3737e-10,-0.39961,-0.48988,1,0
5,GO BLOOD VESSEL MORPHOGENESIS,4.4812e-12,-0.39962,-0.49465,1,0
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,1.7534e-07,-0.39968,-0.47994,1,0
5,GO PIGMENT GRANULE ORGANIZATION,9.8716e-08,-0.39968,-0.36552,1,0
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,1.1858e-08,-0.3997,-0.41301,1,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0011341,-0.40014,-0.39941,1,0
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.6784e-11,-0.40017,-0.48339,1,0
5,GO RESPONSE TO INTERFERON BETA,0.00032916,-0.40021,-0.45562,1,0
5,GO NEPHRON DEVELOPMENT,3.4634e-11,-0.40024,-0.48465,1,0
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,3.0811e-07,-0.4006,-0.41103,1,0
5,GO ENDOTHELIAL CELL PROLIFERATION,5.6304e-12,-0.40063,-0.51099,1,0
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,3.5427e-10,-0.40071,-0.46931,1,0
5,GO RESPONSE TO DEXAMETHASONE,1.7687e-09,-0.40074,-0.41464,1,0
5,GO POSITIVE REGULATION OF COAGULATION,6.4192e-10,-0.40078,-0.46383,1,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,4.6578e-06,-0.40079,-0.37865,1,0
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,1.6907e-08,-0.40086,-0.46921,1,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,1.1579e-08,-0.40102,-0.40656,1,0
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,5.0922e-10,-0.40107,-0.47862,1,0
5,GO RELAXATION OF MUSCLE,2.8925e-08,-0.40119,-0.40534,1,0
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,6.6581e-11,-0.40125,-0.50819,1,0
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,6.4805e-11,-0.40139,-0.43136,1,0
5,GO POSTSYNAPSE ORGANIZATION,7.6792e-10,-0.40141,-0.43973,1,0
5,GO MUCUS SECRETION,0.0073682,-0.4017,-0.32315,1,0
5,GO GLYCINE TRANSPORT,2.7312e-05,-0.40186,-0.44114,1,0
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,5.3562e-07,-0.40194,-0.41477,1,0
5,GO RESPONSE TO FLUID SHEAR STRESS,6.3074e-11,-0.40204,-0.55653,1,0
5,GO SULFATION,2.8262e-08,-0.40204,-0.37064,1,0
5,GO CHONDROCYTE DEVELOPMENT,1.9064e-09,-0.40233,-0.52552,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.2618e-11,-0.40234,-0.45698,1,0
5,GO OSTEOBLAST PROLIFERATION,6.4434e-08,-0.40259,-0.45651,1,0
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,7.4177e-11,-0.40264,-0.4442,1,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,1.2792e-06,-0.40267,-0.39084,1,0
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,4.9069e-08,-0.40272,-0.45823,1,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,2.1624e-06,-0.4032,-0.34289,1,0
5,GO CELLULAR RESPONSE TO CALCIUM ION,3.247e-08,-0.40332,-0.39086,1,0
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,5.3256e-05,-0.40333,-0.4462,1,0
5,GO RESPONSE TO THYROID HORMONE,3.247e-08,-0.4034,-0.45361,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.9465e-08,-0.4034,-0.4951,1,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,2.5756e-08,-0.40342,-0.41387,1,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.9044e-05,-0.40346,-0.36523,1,0
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,9.0235e-07,-0.40349,-0.37408,1,0
5,GO REPLACEMENT OSSIFICATION,5.3617e-10,-0.40377,-0.5108,1,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.4634e-11,-0.404,-0.46452,1,0
5,GO LUNG EPITHELIUM DEVELOPMENT,8.4415e-08,-0.40407,-0.41864,1,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,2.9514e-07,-0.40407,-0.48032,1,0
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,3.9035e-08,-0.40412,-0.49727,1,0
5,GO TOLERANCE INDUCTION,3.6924e-05,-0.40438,-0.47057,1,0
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,4.0343e-10,-0.40441,-0.46933,1,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.8363e-05,-0.40446,-0.40233,1,0
5,GO VITAMIN D BIOSYNTHETIC PROCESS,4.1456e-06,-0.4048,-0.46506,1,0
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00081356,-0.40482,-0.31125,1,0
5,GO CARDIAC CHAMBER MORPHOGENESIS,2.8753e-10,-0.40513,-0.46662,1,0
5,GO CYCLOOXYGENASE PATHWAY,1.536e-06,-0.40513,-0.43414,1,0
5,GO POSITIVE REGULATION OF CELL MATURATION,1.064e-06,-0.40517,-0.41895,1,0
5,GO ACTIVATION OF JNKK ACTIVITY,1.5604e-09,-0.40518,-0.49546,1,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.6994e-06,-0.4054,-0.53833,1,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.0791e-07,-0.40552,-0.4448,1,0
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,7.333e-07,-0.40569,-0.42132,1,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,3.7195e-09,-0.40572,-0.50985,1,0
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,8.6328e-08,-0.40574,-0.41278,1,0
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,7.6446e-07,-0.40577,-0.40742,1,0
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,2.1807e-07,-0.40596,-0.43574,1,0
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,3.8645e-11,-0.40607,-0.48716,1,0
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,6.757e-10,-0.40611,-0.40984,1,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,3.8149e-08,-0.4063,-0.45959,1,0
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.7449e-12,-0.40636,-0.47741,1,0
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,8.4877e-09,-0.40664,-0.42531,1,0
5,GO ESTROUS CYCLE,1.4472e-05,-0.40682,-0.33985,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,3.8833e-12,-0.40688,-0.47564,1,0
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,3.2162e-07,-0.40704,-0.43488,1,0
5,GO ENDOTHELIUM DEVELOPMENT,8.9558e-11,-0.40713,-0.50576,1,0
5,GO HISTONE H3 K9 DEMETHYLATION,6.1583e-08,-0.40734,-0.45292,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.5102e-11,-0.40752,-0.47328,1,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,2.1196e-06,-0.40769,-0.47254,1,0
5,GO ASTROCYTE ACTIVATION,8.4415e-08,-0.40776,-0.40484,1,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.4677e-08,-0.40777,-0.45355,1,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,6.8695e-12,-0.40793,-0.47397,1,0
5,GO PROTEOGLYCAN METABOLIC PROCESS,4.5922e-10,-0.4082,-0.44823,1,0
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,1.0004e-06,-0.40831,-0.42615,1,0
5,GO LEUKOCYTE AGGREGATION,1.6761e-05,-0.40831,-0.4497,1,0
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,5.0278e-07,-0.40844,-0.42631,1,0
5,GO VASCULATURE DEVELOPMENT,2.9979e-12,-0.40861,-0.4917,1,0
5,GO PROTEIN AUTO ADP RIBOSYLATION,5.1356e-08,-0.40863,-0.48594,1,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,9.404e-07,-0.40888,-0.41272,1,0
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,2.402e-08,-0.40898,-0.46293,1,0
5,GO NEPHRIC DUCT MORPHOGENESIS,2.4972e-05,-0.409,-0.39935,1,0
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,7.5451e-08,-0.40909,-0.46683,1,0
5,GO ANATOMICAL STRUCTURE REGRESSION,7.5451e-08,-0.40917,-0.53842,1,0
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.2146e-06,-0.40928,-0.45337,1,0
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,7.6446e-07,-0.40956,-0.39415,1,0
5,GO REGULATION OF SPROUTING ANGIOGENESIS,5.793e-12,-0.40957,-0.51668,1,0
5,GO MITRAL VALVE DEVELOPMENT,3.5794e-07,-0.4097,-0.43867,1,0
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.9498e-07,-0.40973,-0.45476,1,0
5,GO REGULATION OF ANOIKIS,6.4699e-07,-0.40986,-0.48858,1,0
5,GO EPITHELIAL CELL PROLIFERATION,1.2074e-11,-0.40987,-0.44435,1,0
5,GO REGULATION OF MACROPHAGE ACTIVATION,2.3312e-10,-0.40989,-0.45792,1,0
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,8.6145e-12,-0.41007,-0.46687,1,0
5,GO DENDRITIC SPINE DEVELOPMENT,2.5223e-10,-0.41023,-0.45886,1,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,5.4982e-08,-0.4105,-0.42595,1,0
5,GO REGULATION OF VASCULATURE DEVELOPMENT,8.3747e-12,-0.41059,-0.48091,1,0
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,1.536e-06,-0.41116,-0.40131,1,0
5,GO KERATINOCYTE PROLIFERATION,1.3174e-07,-0.41127,-0.43716,1,0
5,GO TYPE B PANCREATIC CELL PROLIFERATION,3.4296e-07,-0.41132,-0.51408,1,0
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00014599,-0.41138,-0.37842,1,0
5,GO AMEBOIDAL TYPE CELL MIGRATION,2.7494e-12,-0.41139,-0.5008,1,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.2143e-08,-0.41146,-0.45387,1,0
5,GO TRABECULA FORMATION,1.0422e-09,-0.41147,-0.50843,1,0
5,GO MYELIN ASSEMBLY,1.0422e-09,-0.41149,-0.53517,1,0
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,6.5837e-06,-0.4115,-0.38169,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.4302e-11,-0.41191,-0.46357,1,0
5,GO NERVE DEVELOPMENT,1.9465e-08,-0.41196,-0.46604,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,4.5233e-07,-0.41212,-0.49669,1,0
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.7319e-10,-0.41226,-0.45143,1,0
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,2.3554e-11,-0.41239,-0.48716,1,0
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,5.9116e-09,-0.41243,-0.41811,1,0
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,3.2162e-07,-0.41243,-0.506,1,0
5,GO RESPONSE TO MAGNESIUM ION,9.2118e-07,-0.41254,-0.48924,1,0
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,2.3467e-08,-0.41255,-0.45964,1,0
5,GO REGULATION OF CHOLESTEROL EFFLUX,2.6581e-10,-0.41256,-0.40478,1,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,7.4177e-11,-0.41264,-0.5072,1,0
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00029976,-0.41268,-0.40022,1,0
5,GO MESENCHYME MORPHOGENESIS,5.4967e-09,-0.41287,-0.44545,1,0
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,1.8389e-10,-0.41306,-0.46441,1,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.4487e-10,-0.41306,-0.52483,1,0
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,1.0824e-12,-0.4131,-0.50928,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,2.3467e-08,-0.4133,-0.47126,1,0
5,GO CELLULAR RESPONSE TO VITAMIN,5.6317e-09,-0.41332,-0.51394,1,0
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,1.9558e-07,-0.41333,-0.54992,1,0
5,GO MESENCHYMAL CELL DIFFERENTIATION,1.5968e-11,-0.41341,-0.47099,1,0
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,7.8286e-11,-0.41375,-0.50894,1,0
5,GO MUSCLE CELL MIGRATION,3.1312e-09,-0.41381,-0.47565,1,0
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,2.3853e-09,-0.4139,-0.4201,1,0
5,GO RESPONSE TO IRON ION,3.5412e-09,-0.41393,-0.42464,1,0
5,GO GANGLIOSIDE METABOLIC PROCESS,1.3769e-07,-0.41404,-0.43663,1,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,1.8594e-09,-0.41425,-0.50142,1,0
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,2.0879e-07,-0.41426,-0.41788,1,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,2.0546e-09,-0.41427,-0.40482,1,0
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,1.6823e-09,-0.41456,-0.50091,1,0
5,GO NEGATIVE REGULATION OF CELL ADHESION,5.1691e-12,-0.41468,-0.4898,1,0
5,GO RESPONSE TO VITAMIN,4.5239e-09,-0.41471,-0.43682,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.7286e-10,-0.41476,-0.46909,1,0
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.3376e-10,-0.41494,-0.52252,1,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,4.2042e-09,-0.41499,-0.44409,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,9.3415e-09,-0.41517,-0.44148,1,0
5,GO ADHERENS JUNCTION ORGANIZATION,8.0815e-10,-0.41521,-0.50683,1,0
5,GO INNER DYNEIN ARM ASSEMBLY,5.1446e-05,-0.41566,-0.37403,1,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,1.2348e-10,-0.41569,-0.49795,1,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,8.9487e-10,-0.41569,-0.46585,1,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,9.1205e-09,-0.41575,-0.43213,1,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,5.8856e-08,-0.41594,-0.42405,1,0
5,GO LIVER MORPHOGENESIS,3.7356e-07,-0.41594,-0.39876,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,3.357e-07,-0.41614,-0.5062,1,0
5,GO REGULATION OF NEURON MIGRATION,1.6418e-07,-0.41638,-0.45488,1,0
5,GO HEART VALVE FORMATION,3.6567e-07,-0.41667,-0.4841,1,0
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,3.7605e-06,-0.41673,-0.46662,1,0
5,GO GLIAL CELL DEVELOPMENT,1.6109e-10,-0.41676,-0.43566,1,0
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,2.4371e-06,-0.41678,-0.47512,1,0
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,8.9047e-09,-0.41678,-0.43345,1,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,1.3671e-08,-0.41678,-0.46118,1,0
5,GO DETECTION OF TEMPERATURE STIMULUS,0.00011218,-0.41683,-0.36482,1,0
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,1.0493e-11,-0.41704,-0.50093,1,0
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,5.6245e-08,-0.41704,-0.42663,1,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,2.3784e-07,-0.4172,-0.4862,1,0
5,GO SNARE COMPLEX ASSEMBLY,3.6293e-09,-0.41739,-0.44207,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,1.8135e-09,-0.41747,-0.53457,1,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.0879e-07,-0.41753,-0.46093,1,0
5,GO PROTEIN LOCALIZATION TO LYSOSOME,1.3376e-10,-0.41763,-0.48011,1,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,8.8282e-08,-0.41764,-0.44546,1,0
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,8.9487e-10,-0.41788,-0.5395,1,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,4.2784e-08,-0.41797,-0.42185,1,0
5,GO REGULATION OF FIBROBLAST MIGRATION,3.8118e-09,-0.41803,-0.47135,1,0
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,2.3853e-09,-0.41807,-0.48179,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,1.1398e-10,-0.41809,-0.4794,1,0
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,9.1205e-09,-0.41817,-0.44484,1,0
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,5.3617e-10,-0.41852,-0.47422,1,0
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,6.586e-10,-0.41856,-0.55478,1,0
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,9.3415e-09,-0.41877,-0.49225,1,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.7534e-07,-0.4188,-0.44171,1,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,3.5412e-09,-0.41926,-0.49413,1,0
5,GO REGULATION OF ACTION POTENTIAL,1.6109e-10,-0.41947,-0.48155,1,0
5,GO REGULATION OF FIBRINOLYSIS,2.5223e-10,-0.41985,-0.4956,1,0
5,GO REGULATION OF HEART RATE,8.4877e-09,-0.41998,-0.38848,1,0
5,GO GALACTOSE METABOLIC PROCESS,2.2286e-07,-0.42009,-0.47268,1,0
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,6.1389e-11,-0.42031,-0.499,1,0
5,GO RESPONSE TO INTERFERON GAMMA,2.6981e-08,-0.42054,-0.46041,1,0
5,GO NEURON PROJECTION REGENERATION,5.1101e-09,-0.42075,-0.46742,1,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,1.0958e-05,-0.42104,-0.42902,1,0
5,GO ENDODERM DEVELOPMENT,7.0671e-12,-0.42112,-0.57934,1,0
5,GO AXIS ELONGATION,3.4296e-07,-0.42149,-0.3976,1,0
5,GO NEURONAL ION CHANNEL CLUSTERING,0.00047589,-0.42156,-0.40281,1,0
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,5.9432e-10,-0.42179,-0.50815,1,0
5,GO LENS FIBER CELL DIFFERENTIATION,7.6205e-11,-0.42195,-0.48581,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,1.642e-11,-0.42197,-0.48076,1,0
5,GO TISSUE REMODELING,2.5893e-10,-0.42204,-0.4913,1,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,2.4091e-05,-0.42215,-0.43265,1,0
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,3.4553e-09,-0.42219,-0.44338,1,0
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,1.3442e-05,-0.4222,-0.42001,1,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,4.5233e-07,-0.42233,-0.41403,1,0
5,GO VENTRICULAR SEPTUM DEVELOPMENT,4.7125e-10,-0.42237,-0.48469,1,0
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,1.8032e-05,-0.42248,-0.41007,1,0
5,GO REGULATION OF HIPPO SIGNALING,4.4787e-08,-0.42268,-0.51389,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,3.9941e-08,-0.42284,-0.44879,1,0
5,GO SPROUTING ANGIOGENESIS,1.2417e-11,-0.42323,-0.51541,1,0
5,GO CELLULAR RESPONSE TO ALCOHOL,9.1996e-11,-0.42324,-0.44038,1,0
5,GO NEGATIVE REGULATION OF LIPID STORAGE,2.9371e-11,-0.42336,-0.47884,1,0
5,GO NEURON REMODELING,5.6245e-08,-0.42344,-0.40516,1,0
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,1.5027e-08,-0.42355,-0.45262,1,0
5,GO RESPONSE TO GROWTH HORMONE,5.4967e-09,-0.42367,-0.471,1,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0037985,-0.42379,-0.28214,1,0
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,2.0881e-08,-0.42388,-0.40662,1,0
5,GO NEURON PROJECTION GUIDANCE,5.6317e-09,-0.42394,-0.44081,1,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,1.6109e-10,-0.42402,-0.4979,1,0
5,GO POST EMBRYONIC DEVELOPMENT,5.3617e-10,-0.42406,-0.44785,1,0
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,4.4148e-09,-0.42411,-0.47086,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.2058e-07,-0.42448,-0.48595,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,8.7184e-11,-0.42462,-0.47591,1,0
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,1.3376e-10,-0.42487,-0.43462,1,0
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,5.1356e-08,-0.42488,-0.47102,1,0
5,GO REGULATION OF ENDOCYTIC RECYCLING,4.5822e-08,-0.42515,-0.46189,1,0
5,GO CELLULAR COMPONENT MAINTENANCE,3.7319e-10,-0.4252,-0.45382,1,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,2.342e-06,-0.42523,-0.45909,1,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,2.7804e-05,-0.42536,-0.34416,1,0
5,GO METANEPHROS DEVELOPMENT,2.2697e-09,-0.42547,-0.41629,1,0
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,3.8161e-07,-0.42551,-0.44005,1,0
5,GO REGULATION OF KIDNEY DEVELOPMENT,3.192e-10,-0.42554,-0.45896,1,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.7166e-08,-0.42559,-0.45724,1,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.0804e-10,-0.42581,-0.52983,1,0
5,GO ROOF OF MOUTH DEVELOPMENT,9.5677e-09,-0.42582,-0.4231,1,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,8.2618e-11,-0.42593,-0.4693,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.4407e-08,-0.42594,-0.46129,1,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,1.5217e-09,-0.42605,-0.42707,1,0
5,GO STRESS FIBER ASSEMBLY,3.9963e-12,-0.42605,-0.54687,1,0
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,3.0296e-10,-0.42618,-0.44727,1,0
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0001803,-0.42641,-0.58988,1,0
5,GO MAST CELL MEDIATED IMMUNITY,3.1479e-07,-0.42645,-0.39927,1,0
5,GO PLATELET ACTIVATION,1.4686e-11,-0.42705,-0.50013,1,0
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,4.7501e-09,-0.42716,-0.56661,1,0
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,7.0279e-11,-0.42733,-0.50136,1,0
5,GO P38MAPK CASCADE,8.7237e-10,-0.42769,-0.48701,1,0
5,GO CELLULAR RESPONSE TO AMYLOID BETA,3.019e-11,-0.42774,-0.52787,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.00010852,-0.42805,-0.33365,1,0
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,1.5277e-10,-0.42809,-0.51403,1,0
5,GO INCLUSION BODY ASSEMBLY,2.342e-06,-0.42818,-0.4447,1,0
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,6.757e-10,-0.42834,-0.51815,1,0
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,3.9309e-10,-0.42873,-0.49919,1,0
5,GO LENS FIBER CELL DEVELOPMENT,2.6581e-10,-0.42884,-0.51032,1,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.634e-09,-0.42887,-0.42727,1,0
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,3.6361e-10,-0.42902,-0.47363,1,0
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,2.2926e-08,-0.42913,-0.5185,1,0
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,3.0811e-07,-0.42944,-0.47446,1,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.8645e-11,-0.42971,-0.56971,1,0
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.7586e-05,-0.42972,-0.45121,1,0
5,GO WOUND HEALING,8.8611e-12,-0.42976,-0.48807,1,0
5,GO DENDRITIC SPINE MORPHOGENESIS,8.4877e-09,-0.43013,-0.44471,1,0
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.3554e-11,-0.43052,-0.45526,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,2.9514e-07,-0.43065,-0.3847,1,0
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,6.586e-10,-0.4311,-0.47899,1,0
5,GO METANEPHRIC NEPHRON DEVELOPMENT,1.3039e-08,-0.43118,-0.47529,1,0
5,GO REGULATION OF CELL SHAPE,1.5688e-10,-0.43125,-0.47764,1,0
5,GO PROTEIN DEGLYCOSYLATION,1.0241e-10,-0.43155,-0.52234,1,0
5,GO PODOSOME ASSEMBLY,1.0279e-08,-0.43164,-0.56851,1,0
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,5.1351e-07,-0.43211,-0.39889,1,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,2.0546e-09,-0.43218,-0.50991,1,0
5,GO ARTERY DEVELOPMENT,5.6594e-11,-0.43237,-0.50313,1,0
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.8135e-09,-0.43253,-0.53988,1,0
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,6.2993e-08,-0.43279,-0.43332,1,0
5,GO MATERNAL PLACENTA DEVELOPMENT,6.7461e-07,-0.43311,-0.42028,1,0
5,GO ACTIN FILAMENT BASED MOVEMENT,1.5529e-11,-0.43312,-0.45844,1,0
5,GO SERTOLI CELL DIFFERENTIATION,2.4452e-09,-0.43317,-0.45437,1,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,1.3769e-07,-0.43326,-0.40518,1,0
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,9.6431e-12,-0.43354,-0.52396,1,0
5,GO GLIAL CELL APOPTOTIC PROCESS,4.8198e-07,-0.43384,-0.47933,1,0
5,GO AMINOGLYCAN CATABOLIC PROCESS,1.5688e-10,-0.434,-0.48233,1,0
5,GO AXON EXTENSION,1.0422e-09,-0.43431,-0.47608,1,0
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,4.4302e-11,-0.43451,-0.48193,1,0
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.277e-11,-0.43463,-0.4978,1,0
5,GO HEPARIN METABOLIC PROCESS,9.2321e-08,-0.43473,-0.46368,1,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,6.895e-08,-0.43476,-0.4742,1,0
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,3.3214e-05,-0.43485,-0.34785,1,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00025215,-0.43497,-0.44366,1,0
5,GO RESPONSE TO FORSKOLIN,1.5994e-06,-0.43499,-0.45397,1,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,6.0565e-09,-0.43507,-0.54485,1,0
5,GO MAST CELL ACTIVATION,1.0554e-07,-0.43514,-0.39124,1,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,1.9989e-07,-0.43532,-0.43774,1,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.5164e-08,-0.43569,-0.48558,1,0
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,9.5677e-09,-0.4357,-0.50107,1,0
5,GO AORTA DEVELOPMENT,8.2903e-10,-0.4357,-0.53092,1,0
5,GO COLLAGEN METABOLIC PROCESS,1.642e-11,-0.43571,-0.57452,1,0
5,GO RENAL SYSTEM PROCESS,2.595e-12,-0.43576,-0.50608,1,0
5,GO RESPONSE TO AMYLOID BETA,4.8824e-12,-0.43577,-0.51433,1,0
5,GO NOTOCHORD DEVELOPMENT,7.7166e-08,-0.43593,-0.49661,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,9.9064e-10,-0.43603,-0.44047,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,2.004e-09,-0.43618,-0.52586,1,0
5,GO TRABECULA MORPHOGENESIS,8.2903e-10,-0.43634,-0.5138,1,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,7.8976e-09,-0.4364,-0.45405,1,0
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.00013451,-0.43642,-0.36043,1,0
5,GO REGULATION OF KERATINOCYTE MIGRATION,4.7449e-12,-0.43685,-0.50835,1,0
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,2.2453e-12,-0.43749,-0.50904,1,0
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,7.8911e-05,-0.43768,-0.43932,1,0
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.0033e-09,-0.43785,-0.52514,1,0
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,1.9064e-09,-0.43811,-0.51425,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,7.2202e-11,-0.43816,-0.46375,1,0
5,GO BARBED END ACTIN FILAMENT CAPPING,2.6914e-06,-0.43819,-0.43298,1,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,2.2775e-07,-0.43855,-0.43689,1,0
5,GO ASTROCYTE DEVELOPMENT,1.6986e-10,-0.43882,-0.48162,1,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,3.357e-07,-0.43897,-0.43571,1,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.2775e-07,-0.43934,-0.51636,1,0
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,7.0017e-09,-0.43936,-0.46551,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,5.3562e-07,-0.43966,-0.48647,1,0
5,GO HYALURONAN BIOSYNTHETIC PROCESS,8.0815e-10,-0.4397,-0.50958,1,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,2.6981e-08,-0.43974,-0.4748,1,0
5,GO RELAXATION OF CARDIAC MUSCLE,1.5713e-07,-0.43985,-0.47955,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,1.3174e-07,-0.4399,-0.40338,1,0
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,1.1588e-05,-0.43991,-0.42145,1,0
5,GO CELLULAR RESPONSE TO KETONE,4.1403e-10,-0.44005,-0.41498,1,0
5,GO AORTA MORPHOGENESIS,5.2538e-08,-0.44007,-0.46738,1,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,1.9014e-08,-0.44017,-0.48466,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,3.1896e-11,-0.44018,-0.5165,1,0
5,GO ENDODERM FORMATION,1.3505e-11,-0.4403,-0.60426,1,0
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,3.4516e-10,-0.44038,-0.51344,1,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,2.6581e-10,-0.44041,-0.48326,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.0964e-09,-0.44047,-0.47456,1,0
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,1.2733e-08,-0.44058,-0.4482,1,0
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00016361,-0.44083,-0.38291,1,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,5.5016e-10,-0.44089,-0.50161,1,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,7.1726e-09,-0.44093,-0.43968,1,0
5,GO REGULATION OF MEMBRANE INVAGINATION,9.1205e-09,-0.44104,-0.50457,1,0
5,GO LUNG ALVEOLUS DEVELOPMENT,2.6581e-10,-0.44107,-0.5317,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,2.0853e-05,-0.44109,-0.38942,1,0
5,GO CELLULAR RESPONSE TO NUTRIENT,9.4157e-10,-0.44133,-0.49865,1,0
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,2.65e-07,-0.44146,-0.48811,1,0
5,GO GAP JUNCTION ASSEMBLY,4.7963e-08,-0.44179,-0.5308,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.471e-07,-0.44209,-0.44344,1,0
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,3.5606e-08,-0.44211,-0.44276,1,0
5,GO DETECTION OF BIOTIC STIMULUS,6.0205e-08,-0.44219,-0.473,1,0
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,2.9602e-08,-0.44223,-0.43155,1,0
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,2.9805e-09,-0.44224,-0.44714,1,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,8.1361e-07,-0.44352,-0.54782,1,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,9.2321e-08,-0.44392,-0.40276,1,0
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.7071e-05,-0.44394,-0.44031,1,0
5,GO SMOOTH MUSCLE CELL PROLIFERATION,1.642e-11,-0.44399,-0.47186,1,0
5,GO POSTSYNAPSE ASSEMBLY,5.332e-06,-0.4441,-0.47942,1,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,7.3476e-09,-0.44426,-0.51681,1,0
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,1.4334e-08,-0.44432,-0.49216,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.5217e-09,-0.44437,-0.45624,1,0
5,GO REGULATION OF MYOBLAST FUSION,8.4415e-08,-0.44446,-0.45754,1,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,4.9624e-10,-0.44466,-0.52954,1,0
5,GO TISSUE MIGRATION,3.462e-12,-0.44477,-0.52976,1,0
5,GO RESPONSE TO PROGESTERONE,1.9387e-10,-0.44484,-0.4593,1,0
5,GO LOCOMOTOR RHYTHM,4.9069e-08,-0.44488,-0.50718,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,4.7172e-05,-0.44503,-0.36919,1,0
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,6.3569e-09,-0.44504,-0.48499,1,0
5,GO REGULATION OF COAGULATION,4.5922e-10,-0.44514,-0.50579,1,0
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,2.4305e-07,-0.4456,-0.54128,1,0
5,GO EPITHELIAL CELL MORPHOGENESIS,7.4873e-07,-0.44566,-0.51578,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.3737e-10,-0.44569,-0.51695,1,0
5,GO PROTEIN LOCALIZATION TO AXON,4.5558e-05,-0.4458,-0.47266,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,3.8161e-07,-0.44582,-0.5052,1,0
5,GO INTRACELLULAR STEROL TRANSPORT,5.1101e-09,-0.44609,-0.45425,1,0
5,GO SMOOTH MUSCLE CELL MIGRATION,6.586e-10,-0.44686,-0.53757,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.4302e-11,-0.44691,-0.45307,1,0
5,GO ODONTOGENESIS,1.0804e-10,-0.44698,-0.4735,1,0
5,GO ACTIN FILAMENT NETWORK FORMATION,0.00049802,-0.44714,-0.41808,1,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,1.0964e-09,-0.44718,-0.50526,1,0
5,GO CELL SUBSTRATE ADHESION,5.6304e-12,-0.44718,-0.55331,1,0
5,GO ENDOTHELIAL CELL MIGRATION,3.7735e-12,-0.44727,-0.54348,1,0
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,4.7963e-08,-0.44761,-0.4678,1,0
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.001118,-0.44762,-0.37779,1,0
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.174e-11,-0.44767,-0.50642,1,0
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,1.1034e-07,-0.44771,-0.48344,1,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,3.4516e-10,-0.44773,-0.5809,1,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.8262e-08,-0.44782,-0.43174,1,0
5,GO CRANIAL NERVE DEVELOPMENT,1.2058e-07,-0.44787,-0.42544,1,0
5,GO LEFT RIGHT AXIS SPECIFICATION,1.734e-06,-0.44795,-0.4378,1,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,3.055e-09,-0.44823,-0.52131,1,0
5,GO ADHERENS JUNCTION ASSEMBLY,2.9514e-07,-0.44902,-0.50433,1,0
5,GO NEURON CELL CELL ADHESION,9.9844e-05,-0.44904,-0.42755,1,0
5,GO HEART VALVE DEVELOPMENT,3.1032e-11,-0.44926,-0.56688,1,0
5,GO MATURE B CELL DIFFERENTIATION,3.1479e-07,-0.44931,-0.49585,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,2.7797e-11,-0.44941,-0.49184,1,0
5,GO NEURON PROJECTION ORGANIZATION,2.1543e-10,-0.44949,-0.48119,1,0
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,1.3761e-09,-0.44996,-0.47189,1,0
5,GO POSITIVE REGULATION OF HEART RATE,2.9332e-05,-0.45005,-0.33356,1,0
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,1.1307e-08,-0.45011,-0.50314,1,0
5,GO RESPONSE TO INTERFERON ALPHA,2.6352e-05,-0.45015,-0.58686,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,5.6451e-10,-0.45022,-0.51517,1,0
5,GO PROTEIN TARGETING TO LYSOSOME,4.0343e-10,-0.45022,-0.54078,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,5.2253e-10,-0.45045,-0.47091,1,0
5,GO COLLAGEN CATABOLIC PROCESS,1.0241e-10,-0.45094,-0.50844,1,0
5,GO RENAL ABSORPTION,1.1789e-06,-0.45112,-0.5129,1,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,1.5102e-11,-0.45129,-0.58843,1,0
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.7452e-06,-0.45164,-0.42405,1,0
5,GO KERATINOCYTE DEVELOPMENT,0.0011836,-0.45174,-0.31727,1,0
5,GO HYALURONAN CATABOLIC PROCESS,9.658e-10,-0.45185,-0.54322,1,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,1.0212e-06,-0.45189,-0.43903,1,0
5,GO ATRIAL SEPTUM DEVELOPMENT,2.6914e-06,-0.45189,-0.43125,1,0
5,GO REGULATION OF DEACETYLASE ACTIVITY,2.6386e-06,-0.45195,-0.44545,1,0
5,GO DORSAL AORTA DEVELOPMENT,4.8416e-06,-0.45197,-0.47798,1,0
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,8.6937e-09,-0.45199,-0.46327,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.8881e-10,-0.45224,-0.49806,1,0
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0089251,-0.4525,-0.28067,1,0
5,GO OUTFLOW TRACT MORPHOGENESIS,5.3617e-10,-0.45273,-0.51261,1,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,4.3355e-07,-0.45323,-0.42661,1,0
5,GO SYNAPSE MATURATION,3.2784e-06,-0.4535,-0.47316,1,0
5,GO DECIDUALIZATION,6.8396e-06,-0.4536,-0.42602,1,0
5,GO CELLULAR RESPONSE TO SALT STRESS,5.6245e-08,-0.45387,-0.47781,1,0
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,1.5277e-10,-0.45408,-0.5081,1,0
5,GO HOMOTYPIC CELL CELL ADHESION,8.7237e-10,-0.45417,-0.51237,1,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,2.7e-09,-0.45438,-0.45769,1,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,6.5125e-09,-0.45446,-0.55351,1,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.1479e-07,-0.45485,-0.55168,1,0
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,9.7998e-07,-0.45559,-0.42508,1,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,2.1375e-08,-0.45562,-0.47974,1,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,2.7078e-07,-0.45564,-0.43692,1,0
5,GO UV PROTECTION,4.8198e-07,-0.45571,-0.42115,1,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,7.0522e-08,-0.45599,-0.41802,1,0
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.4302e-11,-0.45606,-0.56968,1,0
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,9.8716e-08,-0.45613,-0.45452,1,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,5.3747e-08,-0.45659,-0.51214,1,0
5,GO NEGATIVE REGULATION OF WOUND HEALING,1.6884e-11,-0.4566,-0.51388,1,0
5,GO BLOOD VESSEL REMODELING,1.5968e-11,-0.4566,-0.58446,1,0
5,GO REGULATION OF RESPONSE TO WOUNDING,1.1398e-10,-0.45675,-0.46592,1,0
5,GO MIDGUT DEVELOPMENT,8.3066e-07,-0.4569,-0.45377,1,0
5,GO NEGATIVE REGULATION OF COAGULATION,5.9432e-10,-0.45697,-0.53973,1,0
5,GO CARDIAC MUSCLE CELL CONTRACTION,2.7797e-11,-0.45707,-0.5011,1,0
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.8142e-08,-0.4571,-0.48124,1,0
5,GO MEMBRANE BIOGENESIS,4.7125e-10,-0.45724,-0.50842,1,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,8.5043e-10,-0.45726,-0.48982,1,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,1.3351e-08,-0.45729,-0.43592,1,0
5,GO REGULATION OF BMP SIGNALING PATHWAY,1.2682e-10,-0.45729,-0.48323,1,0
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,1.7687e-09,-0.45731,-0.51193,1,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.7041e-11,-0.4574,-0.51823,1,0
5,GO REGULATION OF WOUND HEALING,1.3024e-10,-0.45743,-0.48818,1,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,1.0804e-10,-0.4575,-0.47854,1,0
5,GO POSITIVE REGULATION OF HEART CONTRACTION,4.8416e-06,-0.45763,-0.33599,1,0
5,GO CAMP METABOLIC PROCESS,1.9402e-11,-0.45791,-0.53546,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.6435e-08,-0.45804,-0.44979,1,0
5,GO MAMMARY GLAND MORPHOGENESIS,7.2964e-10,-0.45809,-0.51637,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.004e-09,-0.45829,-0.43122,1,0
5,GO RADIAL GLIAL CELL DIFFERENTIATION,2.8262e-08,-0.45834,-0.47981,1,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,4.31e-06,-0.45843,-0.47986,1,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,1.3948e-05,-0.45866,-0.45747,1,0
5,GO B CELL RECEPTOR SIGNALING PATHWAY,1.1794e-07,-0.4587,-0.45597,1,0
5,GO ACTIN FILAMENT BASED TRANSPORT,1.996e-06,-0.45891,-0.41697,1,0
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,4.7963e-08,-0.45893,-0.49454,1,0
5,GO HAIR FOLLICLE MATURATION,1.3174e-07,-0.459,-0.45314,1,0
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,1.1099e-11,-0.45957,-0.50057,1,0
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,1.642e-11,-0.45983,-0.52202,1,0
5,GO MULTI ORGANISM CELLULAR PROCESS,6.8695e-12,-0.45983,-0.55027,1,0
5,GO DEFINITIVE HEMOPOIESIS,1.6542e-10,-0.45998,-0.53594,1,0
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.7e-09,-0.4602,-0.56706,1,0
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.7909e-10,-0.4608,-0.53383,1,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,2.2697e-09,-0.46098,-0.4571,1,0
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,2.5756e-08,-0.46109,-0.44029,1,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,7.71e-09,-0.46119,-0.54353,1,0
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.0791e-07,-0.46119,-0.47431,1,0
5,GO FOAM CELL DIFFERENTIATION,6.6581e-11,-0.46198,-0.48392,1,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.00028155,-0.46233,-0.39782,1,0
5,GO POSITIVE REGULATION OF MITOPHAGY,4.4148e-09,-0.46245,-0.45258,1,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,2.2775e-07,-0.46259,-0.49164,1,0
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.457e-10,-0.46304,-0.48106,1,0
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,6.5906e-08,-0.46307,-0.503,1,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,3.0296e-10,-0.46355,-0.60088,1,0
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,4.0868e-08,-0.46401,-0.45553,1,0
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,7.0522e-08,-0.46466,-0.53689,1,0
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,3.0856e-12,-0.46502,-0.55204,1,0
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,1.942e-12,-0.46505,-0.54858,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.9047e-09,-0.46522,-0.51368,1,0
5,GO TROPHOBLAST CELL MIGRATION,3.0302e-06,-0.4656,-0.42643,1,0
5,GO EMBRYO IMPLANTATION,1.1307e-08,-0.46587,-0.45962,1,0
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,7.0337e-07,-0.46591,-0.46653,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,1.9546e-09,-0.46597,-0.4793,1,0
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,2.6981e-08,-0.46647,-0.44392,1,0
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,6.5837e-06,-0.46668,-0.43536,1,0
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.6884e-11,-0.46671,-0.49419,1,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,1.0094e-07,-0.46696,-0.46,1,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,2.1678e-11,-0.46752,-0.55424,1,0
5,GO CARDIAC SEPTUM DEVELOPMENT,4.249e-10,-0.46759,-0.51124,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.4677e-08,-0.46768,-0.51864,1,0
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,4.2271e-06,-0.46788,-0.45944,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,2.7494e-12,-0.46813,-0.57228,1,0
5,GO SECONDARY PALATE DEVELOPMENT,4.9872e-09,-0.46816,-0.48658,1,0
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,6.0979e-10,-0.46841,-0.46832,1,0
5,GO CHONDROCYTE DIFFERENTIATION,4.5526e-11,-0.46905,-0.5172,1,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,3.8301e-10,-0.46978,-0.49755,1,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,8.6937e-09,-0.47027,-0.52362,1,0
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,1.0519e-10,-0.47034,-0.50839,1,0
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,6.205e-09,-0.47042,-0.50784,1,0
5,GO RESPONSE TO MUSCLE STRETCH,1.1165e-05,-0.47058,-0.44916,1,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,1.725e-09,-0.4709,-0.57052,1,0
5,GO REGULATION OF CELL SUBSTRATE ADHESION,2.4214e-11,-0.47098,-0.5556,1,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,3.0811e-07,-0.47119,-0.50445,1,0
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,5.2253e-10,-0.47146,-0.48819,1,0
5,GO ENDOTHELIAL CELL DEVELOPMENT,3.2764e-10,-0.4715,-0.56266,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,8.4871e-11,-0.47188,-0.46835,1,0
5,GO GASTRULATION WITH MOUTH FORMING SECOND,4.9228e-07,-0.47221,-0.44558,1,0
5,GO GLAND MORPHOGENESIS,9.7068e-11,-0.47229,-0.53446,1,0
5,GO POSITIVE REGULATION OF WOUND HEALING,2.5066e-09,-0.4726,-0.47973,1,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,8.6328e-08,-0.47263,-0.55552,1,0
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,4.5526e-11,-0.4727,-0.53699,1,0
5,GO VASCULOGENESIS,1.1097e-10,-0.4727,-0.51935,1,0
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,1.7721e-08,-0.47278,-0.62388,1,0
5,GO LYMPH VESSEL MORPHOGENESIS,1.2682e-10,-0.47295,-0.5255,1,0
5,GO ADHESION OF SYMBIONT TO HOST,1.0322e-07,-0.47311,-0.48973,1,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,2.188e-08,-0.47328,-0.46686,1,0
5,GO MESENCHYMAL CELL PROLIFERATION,1.2143e-08,-0.47379,-0.50072,1,0
5,GO CARDIAC SEPTUM MORPHOGENESIS,1.1533e-09,-0.47385,-0.50926,1,0
5,GO ENDODERMAL CELL DIFFERENTIATION,4.9403e-11,-0.47397,-0.6426,1,0
5,GO SOMATIC STEM CELL DIVISION,1.064e-06,-0.47421,-0.54024,1,0
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,3.6293e-09,-0.47422,-0.53615,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.0791e-07,-0.4743,-0.46769,1,0
5,GO NEGATIVE REGULATION OF BONE REMODELING,1.536e-06,-0.47439,-0.43693,1,0
5,GO HIPPO SIGNALING,1.3174e-07,-0.47449,-0.52742,1,0
5,GO ZYMOGEN ACTIVATION,1.4334e-08,-0.47487,-0.50536,1,0
5,GO TRACHEA DEVELOPMENT,1.484e-09,-0.47507,-0.50528,1,0
5,GO PROTEIN DEMANNOSYLATION,4.8359e-10,-0.47544,-0.51651,1,0
5,GO NUCLEAR MIGRATION,6.4434e-08,-0.47557,-0.49557,1,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,7.6792e-10,-0.47587,-0.49918,1,0
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,2.3274e-07,-0.47589,-0.43313,1,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,4.1403e-10,-0.47645,-0.52517,1,0
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,2.5934e-07,-0.47654,-0.43805,1,0
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,3.6435e-08,-0.47658,-0.50781,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,3.8301e-10,-0.47694,-0.5612,1,0
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.6986e-10,-0.47696,-0.5345,1,0
5,GO AMYLOID BETA METABOLIC PROCESS,6.8406e-11,-0.47728,-0.47872,1,0
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,8.7237e-10,-0.47738,-0.48161,1,0
5,GO DISACCHARIDE METABOLIC PROCESS,1.7721e-08,-0.47741,-0.44934,1,0
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,2.538e-07,-0.4781,-0.4796,1,0
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,1.3085e-09,-0.47836,-0.5061,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,3.9941e-08,-0.47852,-0.46126,1,0
5,GO PLATELET AGGREGATION,4.249e-10,-0.47882,-0.50916,1,0
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,6.5125e-09,-0.47889,-0.56521,1,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.1691e-12,-0.47917,-0.57149,1,0
5,GO T CELL EXTRAVASATION,3.7356e-07,-0.47926,-0.48632,1,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,9.7991e-09,-0.47937,-0.57349,1,0
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,2.0853e-05,-0.4799,-0.4257,1,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,7.6205e-11,-0.48011,-0.52704,1,0
5,GO MEMBRANE LIPID CATABOLIC PROCESS,2.8262e-08,-0.48041,-0.47426,1,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,4.8673e-09,-0.48049,-0.44501,1,0
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,3.0811e-07,-0.48053,-0.50171,1,0
5,GO NEGATIVE REGULATION OF ANOIKIS,1.6321e-06,-0.48069,-0.54091,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,3.1098e-10,-0.481,-0.49629,1,0
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,1.9558e-07,-0.48115,-0.53987,1,0
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,2.9371e-11,-0.48158,-0.48719,1,0
5,GO BIOLOGICAL PHASE,7.3803e-06,-0.48259,-0.44112,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,2.1196e-06,-0.48281,-0.47578,1,0
5,GO ELASTIC FIBER ASSEMBLY,2.6362e-08,-0.48327,-0.6879,1,0
5,GO TRACHEA MORPHOGENESIS,4.2042e-09,-0.48334,-0.49353,1,0
5,GO CELL MATRIX ADHESION,1.3505e-11,-0.48335,-0.55854,1,0
5,GO BODY MORPHOGENESIS,1.1097e-10,-0.48337,-0.53062,1,0
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,1.2604e-07,-0.48346,-0.44091,1,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00096848,-0.48348,-0.39651,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,2.7494e-12,-0.48356,-0.56775,1,0
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,1.887e-11,-0.48374,-0.60841,1,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,6.6717e-09,-0.48389,-0.51932,1,0
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,8.2543e-08,-0.48417,-0.49714,1,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,7.5451e-08,-0.48421,-0.5356,1,0
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,2.5893e-10,-0.48422,-0.47063,1,0
5,GO N GLYCAN PROCESSING,5.5016e-10,-0.48431,-0.55925,1,0
5,GO REVERSE CHOLESTEROL TRANSPORT,1.1858e-08,-0.48448,-0.55542,1,0
5,GO CELLULAR RESPONSE TO STEROL,1.4487e-10,-0.48459,-0.51213,1,0
5,GO ACTIN MEDIATED CELL CONTRACTION,2.0509e-11,-0.48492,-0.45118,1,0
5,GO AMELOGENESIS,6.0979e-10,-0.48492,-0.50225,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,7.1274e-05,-0.48496,-0.44444,1,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,2.1338e-07,-0.48515,-0.45542,1,0
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,3.2631e-05,-0.48529,-0.39087,1,0
5,GO EMBRYONIC BODY MORPHOGENESIS,1.2759e-09,-0.48544,-0.51721,1,0
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.3769e-07,-0.48605,-0.50951,1,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,3.8645e-11,-0.48639,-0.59287,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,5.3747e-08,-0.48647,-0.51109,1,0
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,6.586e-10,-0.48653,-0.46994,1,0
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,2.3891e-06,-0.48657,-0.50668,1,0
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.0554e-07,-0.4868,-0.49344,1,0
5,GO BRONCHUS DEVELOPMENT,3.2162e-07,-0.48715,-0.51442,1,0
5,GO NEGATIVE REGULATION OF CELL KILLING,2.4528e-05,-0.48805,-0.52283,1,0
5,GO RESPONSE TO POTASSIUM ION,6.545e-05,-0.48821,-0.36685,1,0
5,GO REGULATION OF PODOSOME ASSEMBLY,6.5906e-08,-0.48823,-0.58156,1,0
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,4.249e-10,-0.48906,-0.5108,1,0
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.1828e-09,-0.48913,-0.57145,1,0
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,6.0979e-10,-0.48958,-0.51565,1,0
5,GO AMYLOID BETA FORMATION,1.642e-11,-0.48959,-0.49113,1,0
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,5.1351e-07,-0.49026,-0.53533,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.6907e-08,-0.49066,-0.55662,1,0
5,GO RESPONSE TO LEUCINE,5.4982e-08,-0.4909,-0.47022,1,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.5968e-11,-0.49164,-0.56889,1,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,4.7963e-08,-0.49182,-0.58461,1,0
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,7.5451e-08,-0.49214,-0.47676,1,0
5,GO ENDOCARDIAL CUSHION FORMATION,9.7991e-09,-0.49253,-0.5285,1,0
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,2.8573e-11,-0.49267,-0.46896,1,0
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.0493e-11,-0.4927,-0.5175,1,0
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,3.6924e-05,-0.49351,-0.3693,1,0
5,GO NUCLEUS LOCALIZATION,4.7501e-09,-0.49357,-0.49542,1,0
5,GO COMMISSURAL NEURON AXON GUIDANCE,7.8124e-06,-0.49393,-0.51322,1,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,3.3713e-09,-0.49408,-0.54108,1,0
5,GO INNERVATION,5.7051e-07,-0.49418,-0.5687,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,3.3629e-10,-0.49445,-0.59847,1,0
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,1.7442e-10,-0.49464,-0.5335,1,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,2.7494e-12,-0.49487,-0.57598,1,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.7605e-06,-0.49535,-0.44299,1,0
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,2.4893e-11,-0.4958,-0.48703,1,0
5,GO NEGATIVE REGULATION OF AXONOGENESIS,1.2759e-09,-0.49643,-0.51817,1,0
5,GO ENTRY OF BACTERIUM INTO HOST CELL,7.5266e-09,-0.49647,-0.59399,1,0
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,9.9064e-10,-0.49672,-0.52444,1,0
5,GO NEURON PROJECTION ARBORIZATION,5.8262e-07,-0.4974,-0.49903,1,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.6352e-05,-0.49762,-0.48259,1,0
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,8.5043e-10,-0.49764,-0.54256,1,0
5,GO LYMPHANGIOGENESIS,4.4787e-08,-0.49806,-0.47429,1,0
5,GO CORONARY VASCULATURE DEVELOPMENT,2.801e-10,-0.49822,-0.5121,1,0
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.6451e-10,-0.4994,-0.49529,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,2.8753e-10,-0.4994,-0.48578,1,0
5,GO RESPONSE TO INTERLEUKIN 18,4.719e-07,-0.49968,-0.58023,1,0
5,GO PROTEIN KINASE C SIGNALING,1.7687e-09,-0.50067,-0.52226,1,0
5,GO NEURAL CREST CELL DIFFERENTIATION,1.7909e-10,-0.5013,-0.47469,1,0
5,GO EPITHELIAL CELL CELL ADHESION,3.0156e-07,-0.50145,-0.58554,1,0
5,GO GERMINAL CENTER FORMATION,1.1579e-08,-0.5015,-0.55526,1,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,1.4076e-07,-0.502,-0.471,1,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,6.757e-10,-0.50349,-0.62789,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,1.9926e-08,-0.5035,-0.5374,1,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,4.0817e-11,-0.50399,-0.5262,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,2.7e-09,-0.50405,-0.50287,1,0
5,GO VOCALIZATION BEHAVIOR,2.8814e-05,-0.50414,-0.46783,1,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,5.4356e-06,-0.5048,-0.46617,1,0
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,1.2886e-07,-0.50512,-0.45779,1,0
5,GO CELLULAR RESPONSE TO CHOLESTEROL,8.4871e-11,-0.50544,-0.53683,1,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,5.02e-08,-0.5055,-0.46676,1,0
5,GO AORTIC VALVE DEVELOPMENT,2.3554e-11,-0.50576,-0.61795,1,0
5,GO RESPONSE TO EPINEPHRINE,2.3891e-06,-0.50608,-0.42865,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.5893e-10,-0.5061,-0.61483,1,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,1.0322e-07,-0.50626,-0.47721,1,0
5,GO DETECTION OF OTHER ORGANISM,2.2958e-06,-0.50633,-0.49817,1,0
5,GO LAMELLIPODIUM MORPHOGENESIS,6.6717e-09,-0.50634,-0.53379,1,0
5,GO FOCAL ADHESION ASSEMBLY,5.6594e-11,-0.50668,-0.58263,1,0
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,3.1032e-11,-0.50669,-0.50098,1,0
5,GO PROSTATIC BUD FORMATION,9.0235e-07,-0.50693,-0.51542,1,0
5,GO GAMMA DELTA T CELL ACTIVATION,8.4262e-06,-0.50699,-0.39005,1,0
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.3196e-05,-0.50805,-0.41659,1,0
5,GO AXONAL FASCICULATION,1.0036e-08,-0.50806,-0.52295,1,0
5,GO NEUROBLAST DIVISION,4.3082e-09,-0.50828,-0.56182,1,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,1.2441e-09,-0.50828,-0.47896,1,0
5,GO HEART TRABECULA MORPHOGENESIS,2.4586e-08,-0.50832,-0.46727,1,0
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.6129e-08,-0.50901,-0.49539,1,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,5.2359e-09,-0.5091,-0.64298,1,0
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,9.3415e-09,-0.50937,-0.55209,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.2281e-06,-0.5099,-0.50064,1,0
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,5.8262e-07,-0.51004,-0.45436,1,0
5,GO T HELPER 2 CELL DIFFERENTIATION,2.6362e-08,-0.51006,-0.54139,1,0
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,3.9822e-07,-0.51007,-0.4492,1,0
5,GO CELL ADHESION MEDIATED BY INTEGRIN,8.4871e-11,-0.51033,-0.56963,1,0
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,6.8406e-11,-0.51045,-0.60102,1,0
5,GO MACROPHAGE PROLIFERATION,1.725e-09,-0.51072,-0.55909,1,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,2.9515e-10,-0.51106,-0.64454,1,0
5,GO REGULATION OF GTP BINDING,9.7991e-09,-0.5123,-0.47574,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,2.2286e-11,-0.51259,-0.59325,1,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,4.8076e-11,-0.51273,-0.52687,1,0
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,7.0522e-08,-0.51417,-0.51762,1,0
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,6.4805e-11,-0.51462,-0.55828,1,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,8.0815e-10,-0.5152,-0.48063,1,0
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,4.3774e-08,-0.5159,-0.55736,1,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,5.2359e-09,-0.51626,-0.5858,1,0
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,5.3747e-08,-0.51653,-0.46942,1,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,6.1389e-11,-0.51656,-0.50847,1,0
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,1.4472e-05,-0.51663,-0.46379,1,0
5,GO PERICARDIUM DEVELOPMENT,1.2604e-07,-0.51717,-0.50252,1,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,5.3647e-09,-0.51727,-0.51034,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00014599,-0.51744,-0.43283,1,0
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,1.3325e-06,-0.51802,-0.52757,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,5.3602e-11,-0.51868,-0.5199,1,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,8.4871e-11,-0.51884,-0.61393,1,0
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,2.1595e-09,-0.51886,-0.50944,1,0
5,GO SERTOLI CELL DEVELOPMENT,7.1726e-09,-0.51906,-0.49504,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,5.3747e-08,-0.51931,-0.50656,1,0
5,GO CHOLESTEROL STORAGE,6.3074e-11,-0.51931,-0.54908,1,0
5,GO SYNAPTIC VESICLE CLUSTERING,0.00015838,-0.51962,-0.46748,1,0
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,2.9805e-09,-0.52035,-0.5687,1,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,6.0759e-07,-0.52087,-0.50617,1,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,4.8076e-11,-0.52162,-0.60898,1,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,2.913e-06,-0.52166,-0.5907,1,0
5,GO RESPONSE TO STEROL,1.0202e-11,-0.5219,-0.54383,1,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,7.8976e-09,-0.52258,-0.59476,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,3.0811e-07,-0.52307,-0.51235,1,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,1.0361e-05,-0.52357,-0.47721,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,1.7385e-05,-0.52361,-0.55883,1,0
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,3.5427e-10,-0.52414,-0.5733,1,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,2.0398e-08,-0.52421,-0.50347,1,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,2.8271e-07,-0.52422,-0.58362,1,0
5,GO CERAMIDE CATABOLIC PROCESS,1.5037e-07,-0.52505,-0.50614,1,0
5,GO POSITIVE REGULATION OF VASCULOGENESIS,7.2129e-08,-0.52526,-0.49345,1,0
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,9.2321e-08,-0.52527,-0.51407,1,0
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,2.559e-11,-0.52643,-0.55452,1,0
5,GO CHONDROCYTE PROLIFERATION,1.3599e-06,-0.52685,-0.46514,1,0
5,GO INACTIVATION OF MAPK ACTIVITY,3.1729e-08,-0.52758,-0.49293,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.1794e-07,-0.52853,-0.49668,1,0
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.2131e-09,-0.52864,-0.57046,1,0
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.6981e-08,-0.52864,-0.6803,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,4.7501e-09,-0.52882,-0.4944,1,0
5,GO FACE DEVELOPMENT,4.4749e-10,-0.52949,-0.54619,1,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.9926e-08,-0.53013,-0.51086,1,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.00018923,-0.53106,-0.40885,1,0
5,GO CELLULAR RESPONSE TO ETHANOL,1.9064e-09,-0.53144,-0.47945,1,0
5,GO RESPONSE TO HYPEROXIA,4.1948e-11,-0.53177,-0.51757,1,0
5,GO COLLAGEN FIBRIL ORGANIZATION,1.3419e-09,-0.53188,-0.62774,1,0
5,GO NEURAL CREST CELL MIGRATION,1.9387e-10,-0.53213,-0.53035,1,0
5,GO LIMB BUD FORMATION,1.9393e-05,-0.53228,-0.48884,1,0
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,1.0322e-07,-0.53236,-0.6595,1,0
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,1.8594e-09,-0.53287,-0.53884,1,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,7.8976e-09,-0.53293,-0.5634,1,0
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,4.4787e-08,-0.53321,-0.55982,1,0
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,7.3476e-09,-0.53359,-0.46634,1,0
5,GO REGULATION OF AXON GUIDANCE,5.6451e-10,-0.53445,-0.53487,1,0
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00069207,-0.53499,-0.60426,1,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,2.2707e-10,-0.53583,-0.52411,1,0
5,GO OLIGOPEPTIDE TRANSPORT,1.0791e-07,-0.53584,-0.47592,1,0
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.9432e-10,-0.53645,-0.51775,1,0
5,GO EPIBOLY,2.2912e-11,-0.53676,-0.61057,1,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,3.2162e-07,-0.53768,-0.63412,1,0
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,1.7721e-08,-0.53844,-0.50953,1,0
5,GO NEGATIVE CHEMOTAXIS,4.4749e-10,-0.53855,-0.56639,1,0
5,GO LYMPH VESSEL DEVELOPMENT,1.4471e-09,-0.53914,-0.56999,1,0
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,6.4192e-10,-0.53952,-0.54479,1,0
5,GO DENDRITIC CELL APOPTOTIC PROCESS,1.5027e-08,-0.53969,-0.61868,1,0
5,GO REGULATION OF CELL MATRIX ADHESION,4.6784e-11,-0.54,-0.58336,1,0
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,1.6407e-09,-0.54002,-0.59783,1,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,2.8753e-10,-0.54042,-0.59864,1,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.4877e-10,-0.541,-0.57887,1,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,1.8881e-10,-0.54127,-0.57988,1,0
5,GO BEHAVIORAL RESPONSE TO PAIN,6.8348e-09,-0.54232,-0.52642,1,0
5,GO NEUTROPHIL HOMEOSTASIS,1.3761e-09,-0.54232,-0.62691,1,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,3.1098e-10,-0.54239,-0.5907,1,0
5,GO REGULATION OF RECEPTOR BINDING,9.9064e-10,-0.54258,-0.59174,1,0
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,6.3569e-09,-0.5427,-0.5829,1,0
5,GO SEQUESTERING OF TRIGLYCERIDE,2.004e-09,-0.54508,-0.46986,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,9.7068e-11,-0.54517,-0.53133,1,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,3.4634e-11,-0.5454,-0.54334,1,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.0881e-08,-0.54541,-0.67901,1,0
5,GO REGULATION OF AMYLOID BETA FORMATION,3.019e-11,-0.54568,-0.52827,1,0
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.6823e-09,-0.54573,-0.5236,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,6.2565e-10,-0.54654,-0.59399,1,0
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,3.2764e-10,-0.54664,-0.56126,1,0
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,2.0546e-09,-0.54713,-0.57393,1,0
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,5.3747e-08,-0.54716,-0.54121,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,2.5934e-07,-0.54808,-0.49324,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.001071,-0.54812,-0.61889,1,0
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,7.71e-09,-0.54844,-0.48888,1,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,3.2785e-11,-0.54888,-0.58835,1,0
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.1356e-08,-0.54986,-0.4981,1,0
5,GO MEMBRANE RAFT ORGANIZATION,2.0429e-07,-0.55035,-0.56124,1,0
5,GO GAMMA DELTA T CELL DIFFERENTIATION,8.5858e-05,-0.55291,-0.4345,1,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.9014e-08,-0.55292,-0.64002,1,0
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.0881e-08,-0.55321,-0.54689,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,3.055e-09,-0.5533,-0.52329,1,0
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,6.5125e-09,-0.55429,-0.53064,1,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,9.7068e-11,-0.55456,-0.61233,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,5.6304e-12,-0.55478,-0.66146,1,0
5,GO PROTEIN LOCALIZATION TO ENDOSOME,4.8198e-07,-0.55543,-0.55112,1,0
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,5.3647e-09,-0.55593,-0.53495,1,0
5,GO EMBRYONIC EYE MORPHOGENESIS,1.6907e-08,-0.55846,-0.48862,1,0
5,GO REGULATION OF VASCULOGENESIS,8.0712e-08,-0.55896,-0.54729,1,0
5,GO BONE GROWTH,2.3853e-09,-0.55916,-0.55136,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.6542e-10,-0.55925,-0.55796,1,0
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,8.4805e-07,-0.55956,-0.54428,1,0
5,GO DERMATAN SULFATE METABOLIC PROCESS,2.9078e-09,-0.56,-0.60213,1,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,3.2146e-06,-0.56082,-0.56491,1,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,8.0898e-09,-0.56096,-0.58171,1,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,7.3476e-09,-0.56111,-0.64302,1,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,1.0422e-09,-0.56116,-0.57434,1,0
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,7.6205e-11,-0.56147,-0.60547,1,0
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,3.1004e-08,-0.56151,-0.55214,1,0
5,GO BONE TRABECULA MORPHOGENESIS,3.5412e-09,-0.56201,-0.64673,1,0
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,5.2253e-10,-0.56288,-0.67122,1,0
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,5.77e-09,-0.56321,-0.55792,1,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,3.1729e-08,-0.56365,-0.55901,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,3.8149e-08,-0.56762,-0.51876,1,0
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,2.6362e-08,-0.56775,-0.59796,1,0
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,5.2359e-09,-0.57047,-0.53114,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,9.028e-08,-0.57054,-0.50992,1,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.00013673,-0.57095,-0.4233,1,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,3.7195e-09,-0.57108,-0.57627,1,0
5,GO EXOCRINE SYSTEM DEVELOPMENT,7.9144e-12,-0.57142,-0.61186,1,0
5,GO FACIAL NERVE MORPHOGENESIS,1.5027e-08,-0.5717,-0.67574,1,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,7.5266e-09,-0.57206,-0.59906,1,0
5,GO CORPUS CALLOSUM DEVELOPMENT,1.3671e-08,-0.57215,-0.54532,1,0
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,2.4586e-08,-0.57223,-0.63349,1,0
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.3713e-09,-0.57226,-0.60059,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.2434e-08,-0.57276,-0.59749,1,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,5.0237e-12,-0.57321,-0.69441,1,0
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,1.3039e-08,-0.57506,-0.55147,1,0
5,GO CRANIAL NERVE MORPHOGENESIS,4.8359e-10,-0.57581,-0.57929,1,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.1706e-10,-0.57621,-0.62466,1,0
5,GO VASCULAR WOUND HEALING,6.7411e-08,-0.5764,-0.4942,1,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,5.02e-08,-0.5773,-0.6548,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,6.3359e-07,-0.57766,-0.57737,1,0
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,3.5427e-10,-0.57769,-0.58504,1,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,4.9624e-10,-0.57832,-0.60508,1,0
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.3505e-11,-0.57861,-0.63962,1,0
5,GO MACROPHAGE CYTOKINE PRODUCTION,7.2202e-11,-0.57959,-0.66909,1,0
5,GO REGULATION OF PLATELET AGGREGATION,3.0295e-08,-0.57997,-0.58189,1,0
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,2.188e-08,-0.58006,-0.57761,1,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,1.5052e-06,-0.58051,-0.54534,1,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,6.9323e-10,-0.58234,-0.60277,1,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,3.1098e-10,-0.58307,-0.66726,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.4302e-11,-0.58417,-0.56775,1,0
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00010852,-0.58525,-0.40778,1,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,5.8262e-07,-0.58572,-0.56592,1,0
5,GO LATERAL VENTRICLE DEVELOPMENT,3.6435e-08,-0.58647,-0.54609,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,7.2202e-11,-0.58694,-0.61042,1,0
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,3.094e-05,-0.59092,-0.60771,1,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,4.5922e-10,-0.59095,-0.66066,1,0
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,1.8419e-06,-0.59251,-0.43983,1,0
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,3.6293e-09,-0.59264,-0.68935,1,0
5,GO BLASTODERM SEGMENTATION,2.5756e-08,-0.59501,-0.53869,1,0
5,GO DENDRITIC SPINE MAINTENANCE,1.785e-11,-0.59526,-0.59423,1,0
5,GO GLYCOLIPID CATABOLIC PROCESS,1.3174e-07,-0.59591,-0.54866,1,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,1.0791e-07,-0.59929,-0.62211,1,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,6.205e-09,-0.5998,-0.61074,1,0
5,GO REGULATION OF PLATELET ACTIVATION,4.7125e-10,-0.60052,-0.58633,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,4.5922e-10,-0.60152,-0.61298,1,0
5,GO SKIN MORPHOGENESIS,1.4112e-09,-0.60198,-0.7464,1,0
5,GO HEAD MORPHOGENESIS,3.8118e-09,-0.60363,-0.53884,1,0
5,GO TOOTH MINERALIZATION,1.2682e-10,-0.60407,-0.62798,1,0
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.6129e-08,-0.60496,-0.61803,1,0
5,GO BASEMENT MEMBRANE ORGANIZATION,3.9963e-12,-0.60531,-0.7235,1,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,6.205e-09,-0.60697,-0.51118,1,0
5,GO CELL CELL JUNCTION MAINTENANCE,3.5038e-07,-0.60776,-0.54441,1,0
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,7.3772e-08,-0.60783,-0.61309,1,0
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,6.9323e-10,-0.60848,-0.57442,1,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,2.4452e-09,-0.609,-0.69204,1,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,1.6823e-09,-0.60964,-0.72698,1,0
5,GO SALIVARY GLAND DEVELOPMENT,2.1085e-11,-0.61058,-0.62825,1,0
5,GO ENDOTHELIAL CELL CHEMOTAXIS,4.3606e-10,-0.6123,-0.56564,1,0
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,3.5597e-11,-0.61268,-0.6076,1,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,2.3113e-12,-0.61396,-0.76843,1,0
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,4.4771e-05,-0.61396,-0.54333,1,0
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,2.188e-08,-0.61401,-0.66237,1,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,7.2202e-11,-0.61449,-0.61674,1,0
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,1.3737e-10,-0.6187,-0.63301,1,0
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,8.8389e-07,-0.61976,-0.54871,1,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.5695e-09,-0.62393,-0.73811,1,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,5.0766e-11,-0.62506,-0.69411,1,0
5,GO AMYLOID FIBRIL FORMATION,1.2759e-09,-0.62756,-0.59706,1,0
5,GO GLOMERULUS DEVELOPMENT,5.793e-12,-0.63129,-0.6743,1,0
5,GO HEMIDESMOSOME ASSEMBLY,3.7605e-06,-0.63235,-0.65246,1,0
5,GO PULMONARY VALVE DEVELOPMENT,3.6293e-09,-0.63738,-0.62863,1,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,6.1389e-11,-0.63971,-0.67005,1,0
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,6.8348e-09,-0.65034,-0.65842,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0016347,-0.65197,-0.70339,1,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,2.5934e-07,-0.65502,-0.58535,1,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,6.3569e-09,-0.65547,-0.75713,1,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,6.3074e-11,-0.65571,-0.66812,1,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,9.1996e-11,-0.66214,-0.71526,1,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,9.8716e-08,-0.66352,-0.63549,1,0
5,GO PULMONARY VALVE MORPHOGENESIS,3.055e-09,-0.67331,-0.67118,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,3.6361e-10,-0.67538,-0.65159,1,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,1.9387e-10,-0.6766,-0.66129,1,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,7.5266e-09,-0.67825,-0.75319,1,0
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,1.3761e-09,-0.67833,-0.62902,1,0
5,GO BLEB ASSEMBLY,2.3274e-07,-0.67845,-0.7084,1,0
5,GO MYELIN MAINTENANCE,2.5066e-09,-0.68053,-0.6246,1,0
5,GO ENDOTHELIAL CELL MORPHOGENESIS,7.8052e-07,-0.68857,-0.68432,1,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,1.4107e-10,-0.68904,-0.70743,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.2074e-11,-0.69359,-0.78763,1,0
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,6.8406e-11,-0.69487,-0.82994,1,0
5,GO BASEMENT MEMBRANE ASSEMBLY,3.7602e-11,-0.70796,-0.82127,1,0
5,GO ENAMEL MINERALIZATION,5.3617e-10,-0.70806,-0.67601,1,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,3.4634e-11,-0.71379,-0.73466,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,4.6784e-11,-0.73389,-0.7603,1,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,4.0817e-11,-0.73544,-0.8046,1,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,1.5688e-10,-0.76382,-0.75733,1,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,3.055e-09,-0.78671,-0.77825,1,0
5,GO REGULATION OF GLOMERULAR FILTRATION,4.9624e-10,-0.80192,-0.80314,1,0
5,GO RENAL FILTRATION,2.1085e-11,-0.85641,-0.85433,1,0
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,2.004e-09,-0.86145,-0.80726,1,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,1.3085e-09,-0.88876,-0.8355,1,0
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,3.1312e-09,-0.92305,-0.91119,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.09714,0.11418,0.0941,0,1
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.11367,0.084633,0.057421,0,1
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.070488,0.077187,0.051292,0,1
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.15802,0.075156,0.050945,0,1
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.1453,0.070989,0.054574,0,1
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.14642,0.056568,0.059937,0,1
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.9693,0.18587,-0.079851,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.86331,0.10288,-0.1198,0,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.15802,0.082908,0.045622,0,0
5,GO MALE MEIOSIS I,0.73212,0.08278,-0.10159,0,0
5,GO PROTEIN NEDDYLATION,0.31021,0.075934,0.027414,0,0
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.43312,0.073185,0.013162,0,0
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.9693,0.069651,-0.040248,0,0
5,GO TRANSLATIONAL TERMINATION,0.30066,0.059028,0.018987,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.19417,0.05742,0.047035,0,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.86331,0.052027,-0.0085823,0,0
5,GO MATURATION OF LSU RRNA,0.40286,0.051181,-0.069886,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.81267,0.047002,-0.046954,0,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.41434,0.045509,0.026307,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.58864,0.043846,0.028663,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.36526,0.042856,0.044283,0,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.2114,0.039833,0.041882,0,0
5,GO MITOCHONDRIAL TRANSLATION,0.61117,0.038344,-0.012502,0,0
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.39156,0.037917,-0.087699,0,0
5,GO PROTEASOME ASSEMBLY,0.17411,0.035351,0.027496,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.797,0.034345,-0.05347,0,0
5,GO NEURON FATE SPECIFICATION,0.95639,0.032936,-0.019971,0,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.51035,0.030715,0.013049,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.83158,0.024701,-0.084169,0,0
5,GO CHROMATIN REMODELING AT CENTROMERE,0.56103,0.021156,0.019555,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.46466,0.01954,-0.080617,0,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.97253,0.019435,-0.03813,0,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.98546,0.017523,-0.037069,0,0
5,GO RIBOSOME ASSEMBLY,0.82842,0.016971,-0.011764,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.51296,0.015027,-0.061135,0,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.89205,0.014623,-0.017348,0,0
5,GO TRNA 5 LEADER REMOVAL,0.99515,0.0090195,-0.021076,0,0
5,GO LACTATE METABOLIC PROCESS,0.22814,0.0081228,-0.11605,0,0
5,GO TRANSLATIONAL ELONGATION,0.8379,0.0044539,-0.021291,0,0
5,GO KINETOCHORE ORGANIZATION,0.35043,0.0019082,-0.074589,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.82842,0.0012665,-0.012546,0,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.26267,-0.0032955,-0.091122,0,0
5,GO REGULATION OF APPETITE,0.49743,-0.003461,-0.04866,0,0
5,GO CYTOPLASMIC TRANSLATION,0.45972,-0.0037295,-0.040404,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.86649,-0.0054167,-0.027569,0,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.38047,-0.007076,-0.071858,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.36098,-0.011094,-0.071505,0,0
5,GO PROTEIN DENEDDYLATION,0.46466,-0.011974,-0.056159,0,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.28578,-0.01251,-0.10571,0,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.13656,-0.013536,-0.093492,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.18866,-0.014333,-0.085694,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.36741,-0.015588,-0.06218,0,0
5,GO TRANSLATIONAL INITIATION,0.9693,-0.015838,-0.0049897,0,0
5,GO HISTONE EXCHANGE,0.40743,-0.016294,-0.050183,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.59424,-0.021036,-0.043801,0,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.43312,-0.021757,-0.03862,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.12721,-0.022235,-0.11822,0,0
5,GO SNORNA 3 END PROCESSING,0.26789,-0.022589,-0.089417,0,0
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.085497,-0.023943,-0.12089,0,0
5,GO TRNA 5 END PROCESSING,0.63697,-0.024586,-0.05234,0,0
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.20992,-0.024598,-0.079184,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.61117,-0.025161,-0.026048,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.24089,-0.026859,-0.15136,0,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.089246,-0.031679,-0.13736,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.088486,-0.033831,-0.091382,0,0
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.29315,-0.034036,-0.056982,0,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.572,-0.036308,-0.049944,0,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.74435,-0.037051,-0.041501,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.065596,-0.038476,-0.16987,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.11183,-0.04077,-0.083368,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.40514,-0.041915,-0.048725,0,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.18062,-0.041966,-0.16138,0,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.21889,-0.042674,-0.10562,0,0
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.10385,-0.045185,-0.084186,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.17283,-0.045328,-0.10204,0,0
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.59705,-0.045393,-0.048304,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.23128,-0.045622,-0.091965,0,0
5,GO KINETOCHORE ASSEMBLY,0.2644,-0.046254,-0.08001,0,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.30255,-0.047607,-0.1122,0,0
5,GO OXIDATIVE PHOSPHORYLATION,0.63697,-0.047939,-0.032702,0,0
5,GO RNA 5 END PROCESSING,0.089246,-0.048031,-0.12179,0,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.27317,-0.048582,-0.076947,0,0
5,GO VIRAL LATENCY,0.44269,-0.049219,-0.061552,0,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.1262,-0.051004,-0.080568,0,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.17029,-0.054934,-0.11852,0,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.076344,-0.055652,-0.10434,0,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.36311,-0.056746,-0.076785,0,0
5,GO VIRAL GENE EXPRESSION,0.2913,-0.056776,-0.042295,0,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.22195,-0.057219,-0.15026,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.32993,-0.058474,-0.031538,0,0
5,GO RNA SURVEILLANCE,0.10385,-0.060197,-0.1041,0,0
5,GO REGULATION OF RESPONSE TO FOOD,0.12224,-0.060922,-0.078197,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.13444,-0.061293,-0.12722,0,0
5,GO RIBOSOME BIOGENESIS,0.062684,-0.063332,-0.11929,0,0
5,GO RRNA 3 END PROCESSING,0.34835,-0.06339,-0.054944,0,0
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.12322,-0.063586,-0.06041,0,0
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.18327,-0.065262,-0.18794,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.25414,-0.065476,-0.090234,0,0
5,GO PIRNA METABOLIC PROCESS,0.26614,-0.067434,-0.094644,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.084034,-0.068873,-0.11289,0,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.13027,-0.068889,-0.12588,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.26789,-0.069981,-0.084001,0,0
5,GO NCRNA 3 END PROCESSING,0.10734,-0.07021,-0.081905,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.20699,-0.072149,-0.21987,0,0
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.06986,-0.072581,-0.087616,0,0
5,GO DNA LIGATION,0.25753,-0.072586,-0.077411,0,0
5,GO MITOTIC DNA REPLICATION,0.080464,-0.073039,-0.17037,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.084763,-0.075665,-0.20618,0,0
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.16904,-0.076725,-0.088656,0,0
5,GO TELOMERASE RNA LOCALIZATION,0.15802,-0.078026,-0.10913,0,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.14983,-0.079491,-0.11367,0,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.14869,-0.079976,-0.075589,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.31215,-0.081018,-0.09317,0,0
5,GO MATURATION OF 5 8S RRNA,0.070488,-0.081371,-0.13211,0,0
5,GO NEURON FATE COMMITMENT,0.38267,-0.082111,-0.10951,0,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.074349,-0.082755,-0.13468,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.21437,-0.083207,-0.068328,0,0
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.086981,-0.08395,-0.068055,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.087731,-0.084316,-0.12064,0,0
5,GO SEQUESTERING OF ACTIN MONOMERS,0.50516,-0.085179,-0.020471,0,0
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.063836,-0.085621,-0.11301,0,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.099614,-0.087394,-0.1458,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.13656,-0.087629,-0.12379,0,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.11183,-0.090645,-0.10419,0,0
5,GO DNA REPLICATION INITIATION,0.1262,-0.093095,-0.097437,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.14197,-0.1072,-0.19664,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.068006,-0.10723,-0.087671,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.36956,-0.10888,-0.20805,0,0
5,GO TELENCEPHALON REGIONALIZATION,0.27495,-0.11147,-0.1133,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.093126,-0.1171,-0.10446,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.14983,-0.12242,-0.14138,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.14642,-0.12253,-0.085466,0,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.27853,-0.12339,-0.10221,0,0
5,GO DNA STRAND ELONGATION,0.096327,-0.12594,-0.11622,0,0
5,GO MYOBLAST MIGRATION,0.11183,-0.13743,-0.16605,0,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.24252,-0.14121,-0.085505,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.32792,-0.14547,-0.079554,0,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.27317,-0.14829,-0.080042,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.090782,-0.15083,-0.10751,0,0
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.090011,-0.15917,-0.17349,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.10299,-0.19195,-0.20863,0,0
5,GO DNA DEAMINATION,0.065005,-0.22006,-0.22433,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.08331,-0.29158,-0.21573,0,0
6,GO REGULATION OF SYNAPSE MATURATION,1.9989e-07,0.70198,0.57028,1,1
6,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,3.9941e-08,0.67842,0.67332,1,1
6,GO SYNAPSE MATURATION,1.4454e-06,0.63456,0.51936,1,1
6,GO VOCALIZATION BEHAVIOR,1.9465e-08,0.63364,0.62568,1,1
6,GO COMMISSURAL NEURON AXON GUIDANCE,4.8673e-09,0.63121,0.62939,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,7.333e-07,0.60563,0.57731,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,4.5822e-08,0.60011,0.65702,1,1
6,GO ANATOMICAL STRUCTURE REGRESSION,2.7452e-06,0.59679,0.46213,1,1
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,4.1815e-08,0.5964,0.59076,1,1
6,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.8723e-07,0.59012,0.58603,1,1
6,GO PREPULSE INHIBITION,4.5233e-07,0.58051,0.51009,1,1
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,8.9166e-06,0.56806,0.54557,1,1
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,2.3933e-10,0.56398,0.6031,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,1.6514e-08,0.56288,0.55966,1,1
6,GO SYNAPTIC MEMBRANE ADHESION,2.5934e-07,0.56033,0.49858,1,1
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,2.5164e-08,0.55529,0.55273,1,1
6,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,5.5127e-05,0.54617,0.46019,1,1
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,7.0522e-08,0.54487,0.51725,1,1
6,GO CARDIAC VENTRICLE FORMATION,5.02e-08,0.53949,0.5413,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,4.5684e-06,0.53844,0.48655,1,1
6,GO PRESYNAPTIC MEMBRANE ORGANIZATION,4.1815e-08,0.53305,0.5734,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,4.719e-07,0.53053,0.52051,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,1.7922e-07,0.52173,0.45712,1,1
6,GO POSTSYNAPSE ASSEMBLY,2.6981e-08,0.51624,0.52812,1,1
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.3039e-08,0.51533,0.54889,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,5.8262e-07,0.51515,0.39429,1,1
6,GO REGULATION OF EPITHELIAL TUBE FORMATION,8.8282e-08,0.50817,0.45463,1,1
6,GO INNER DYNEIN ARM ASSEMBLY,1.2716e-05,0.49972,0.46539,1,1
6,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,1.734e-06,0.49639,0.44609,1,1
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,3.0295e-08,0.49535,0.47046,1,1
6,GO NEURON CELL CELL ADHESION,7.3772e-08,0.49425,0.57075,1,1
6,GO PROSTATE GLAND MORPHOGENESIS,2.1234e-05,0.49161,0.38374,1,1
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.3468e-07,0.48963,0.49847,1,1
6,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.1034e-07,0.48288,0.46332,1,1
6,GO RETINAL ROD CELL DIFFERENTIATION,8.1361e-07,0.48263,0.41643,1,1
6,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,3.2146e-06,0.48039,0.42304,1,1
6,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,1.3999e-08,0.47252,0.48235,1,1
6,GO NEURONAL ION CHANNEL CLUSTERING,1.5674e-06,0.4684,0.47341,1,1
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,3.1479e-07,0.46421,0.37411,1,1
6,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,2.5424e-05,0.46144,0.43943,1,1
6,GO FACIAL NERVE MORPHOGENESIS,2.7804e-05,0.46068,0.41628,1,1
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.8416e-06,0.45935,0.55058,1,1
6,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,1.3693e-05,0.45619,0.43029,1,1
6,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,1.8573e-08,0.45616,0.43748,1,1
6,GO LIMB BUD FORMATION,2.0776e-06,0.45585,0.44881,1,1
6,GO NOSE DEVELOPMENT,7.7166e-08,0.45493,0.51307,1,1
6,GO POSITIVE REGULATION OF NEURON MIGRATION,1.1165e-05,0.45133,0.40558,1,1
6,GO SOMATIC STEM CELL DIVISION,4.0657e-06,0.4504,0.43214,1,1
6,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00014362,0.44899,0.37284,1,1
6,GO CARDIAC CHAMBER FORMATION,1.1794e-07,0.44602,0.4681,1,1
6,GO SPINAL CORD PATTERNING,1.069e-09,0.44584,0.50125,1,1
6,GO REGULATION OF NEUROBLAST PROLIFERATION,1.3761e-09,0.44558,0.41953,1,1
6,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.3196e-05,0.44517,0.38457,1,1
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.6823e-09,0.44439,0.42273,1,1
6,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,1.5293e-05,0.44328,0.39275,1,1
6,GO CELL DIFFERENTIATION IN HINDBRAIN,1.3085e-09,0.44125,0.40418,1,1
6,GO NEURON FATE SPECIFICATION,2.5756e-08,0.43731,0.50144,1,1
6,GO REGULATION OF NEURON MIGRATION,7.3476e-09,0.43142,0.43239,1,1
6,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,3.7195e-09,0.42965,0.41518,1,1
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,4.719e-07,0.42951,0.37323,1,1
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,1.2792e-06,0.42869,0.49138,1,1
6,GO FORELIMB MORPHOGENESIS,6.205e-09,0.4252,0.39803,1,1
6,GO THALAMUS DEVELOPMENT,6.5906e-08,0.42502,0.41609,1,1
6,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,5.2344e-05,0.42473,0.35182,1,1
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,1.1307e-08,0.42079,0.37864,1,1
6,GO CELL PROLIFERATION IN HINDBRAIN,2.5164e-08,0.41999,0.41045,1,1
6,GO CEREBELLAR CORTEX MORPHOGENESIS,3.019e-11,0.41984,0.40992,1,1
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00013673,0.41959,0.31622,1,1
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.9989e-07,0.41896,0.47776,1,1
6,GO SYNAPTIC VESICLE CLUSTERING,6.0991e-06,0.41506,0.49875,1,1
6,GO MALE SEX DETERMINATION,1.1034e-07,0.41481,0.39987,1,1
6,GO CEREBELLAR CORTEX FORMATION,1.6001e-09,0.41432,0.39282,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,9.6538e-08,0.41424,0.41591,1,1
6,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,3.357e-07,0.41415,0.4236,1,1
6,GO DIVALENT METAL ION EXPORT,1.2281e-06,0.41265,0.39616,1,1
6,GO OTIC VESICLE DEVELOPMENT,4.2271e-06,0.41003,0.38993,1,1
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,1.0036e-08,0.40843,0.37835,1,1
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.0811e-07,0.4073,0.42052,1,1
6,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,4.1552e-07,0.40717,0.43796,1,1
6,GO INNERVATION,3.9102e-06,0.4067,0.46803,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.3671e-08,0.4032,0.44135,1,1
6,GO MAST CELL MIGRATION,7.6283e-05,0.40306,0.41228,1,1
6,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,3.7605e-06,0.4018,0.3301,1,1
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.00018323,0.40152,0.35988,1,1
6,GO ATRIAL SEPTUM MORPHOGENESIS,1.0424e-06,0.39874,0.4359,1,1
6,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,1.5037e-07,0.39838,0.39617,1,1
6,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0018006,0.39831,0.28083,1,1
6,GO REGULATION OF RECEPTOR CLUSTERING,5.6085e-05,0.39717,0.35914,1,1
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,1.734e-06,0.39564,0.38108,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,4.6359e-05,0.39523,0.34578,1,1
6,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,5.2303e-06,0.39456,0.37427,1,1
6,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,8.4262e-06,0.39424,0.37859,1,1
6,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,1.0861e-06,0.39392,0.35667,1,1
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.064e-06,0.39317,0.38159,1,1
6,GO MICROTUBULE DEPOLYMERIZATION,3.5461e-06,0.39291,0.32147,1,1
6,GO NEURON FATE COMMITMENT,3.9035e-08,0.38997,0.40234,1,1
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,1.5994e-06,0.38854,0.38113,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.8161e-07,0.38759,0.39782,1,1
6,GO HEART VALVE FORMATION,2.0776e-06,0.38702,0.46622,1,1
6,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,7.8124e-06,0.38484,0.34422,1,1
6,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,3.8246e-05,0.38428,0.38384,1,1
6,GO CORONARY VASCULATURE MORPHOGENESIS,3.3435e-06,0.3842,0.38214,1,1
6,GO REGULATION OF GROWTH HORMONE SECRETION,1.6158e-05,0.38395,0.49655,1,1
6,GO TONGUE DEVELOPMENT,4.2271e-06,0.38388,0.35138,1,1
6,GO ACROSOME ASSEMBLY,1.1579e-08,0.38359,0.35895,1,1
6,GO LATERAL SPROUTING FROM AN EPITHELIUM,8.8796e-05,0.38332,0.42961,1,1
6,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,2.7668e-07,0.38183,0.37682,1,1
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,7.7586e-05,0.3818,0.32098,1,1
6,GO CEREBELLAR CORTEX DEVELOPMENT,8.4871e-11,0.38122,0.37464,1,1
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,3.4773e-06,0.38116,0.41097,1,1
6,GO FOREBRAIN REGIONALIZATION,2.0398e-08,0.38098,0.42823,1,1
6,GO MICROTUBULE ANCHORING AT CENTROSOME,6.1583e-08,0.37834,0.34737,1,1
6,GO REGULATION OF PRESYNAPSE ORGANIZATION,5.4701e-07,0.37769,0.37044,1,1
6,GO AXONAL FASCICULATION,5.4184e-05,0.37582,0.31449,1,1
6,GO CRANIAL NERVE MORPHOGENESIS,1.5576e-05,0.37564,0.32166,1,1
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.8198e-07,0.37528,0.40661,1,1
6,GO TONGUE MORPHOGENESIS,1.5293e-05,0.37502,0.39016,1,1
6,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,2.2015e-05,0.37223,0.32326,1,1
6,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,7.2414e-06,0.37165,0.36676,1,1
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00028155,0.37132,0.38132,1,1
6,GO RESPONSE TO L GLUTAMATE,2.3239e-05,0.37052,0.33203,1,1
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,3.9035e-08,0.3703,0.37612,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,2.3784e-07,0.36917,0.44143,1,1
6,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.996e-06,0.36659,0.36367,1,1
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,3.5794e-07,0.36539,0.42011,1,1
6,GO CENTRIOLE CENTRIOLE COHESION,6.5125e-09,0.36486,0.37405,1,1
6,GO REGULATION OF MESONEPHROS DEVELOPMENT,4.9694e-05,0.36423,0.31077,1,1
6,GO GANGLION DEVELOPMENT,4.9694e-05,0.36372,0.3493,1,1
6,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,1.8053e-06,0.36187,0.31347,1,1
6,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,1.9175e-06,0.36131,0.48046,1,1
6,GO HISTONE H3 K9 DEMETHYLATION,4.3774e-08,0.36071,0.36543,1,1
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,1.734e-06,0.35905,0.29239,1,1
6,GO LEFT RIGHT AXIS SPECIFICATION,4.7488e-06,0.3588,0.33396,1,1
6,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0023637,0.35868,0.31998,1,1
6,GO ECTODERMAL PLACODE DEVELOPMENT,1.536e-06,0.35856,0.41662,1,1
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,3.9822e-07,0.35825,0.34227,1,1
6,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,3.0295e-08,0.35731,0.33731,1,1
6,GO CELLULAR RESPONSE TO VITAMIN D,4.1751e-05,0.35583,0.31715,1,1
6,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,3.0811e-07,0.35138,0.40798,1,1
6,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,3.3806e-05,0.35053,0.31257,1,1
6,GO RESPONSE TO ACETYLCHOLINE,2.0429e-07,0.35049,0.36554,1,1
6,GO HISTONE H3 K27 METHYLATION,2.0429e-07,0.34892,0.28491,1,1
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,2.2926e-08,0.34784,0.40247,1,1
6,GO LONG TERM SYNAPTIC DEPRESSION,3.4296e-07,0.34783,0.35645,1,1
6,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.003166,0.34623,0.2751,1,1
6,GO PROTEIN LOCALIZATION TO AXON,0.00013899,0.34608,0.38444,1,1
6,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0078263,0.34548,0.20406,1,1
6,GO BRAIN MORPHOGENESIS,4.0033e-09,0.34539,0.33619,1,1
6,GO ATRIAL SEPTUM DEVELOPMENT,8.5867e-06,0.34506,0.32801,1,1
6,GO SPINAL CORD DEVELOPMENT,3.1896e-11,0.34477,0.37565,1,1
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,3.3806e-05,0.34409,0.31935,1,1
6,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,5.7582e-06,0.34386,0.33688,1,1
6,GO CELL PROLIFERATION IN FOREBRAIN,2.5868e-06,0.3425,0.32164,1,1
6,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,2.9332e-05,0.3424,0.29599,1,1
6,GO TELENCEPHALON REGIONALIZATION,1.7693e-06,0.34204,0.41582,1,1
6,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0005789,0.34202,0.31113,1,1
6,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.0004e-06,0.34181,0.31682,1,1
6,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,2.913e-06,0.34108,0.31546,1,1
6,GO NEURON CELLULAR HOMEOSTASIS,2.7804e-05,0.34084,0.31064,1,1
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,2.4972e-05,0.34022,0.36983,1,1
6,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,5.5864e-07,0.34006,0.34269,1,1
6,GO RESPONSE TO AUDITORY STIMULUS,4.1026e-05,0.33994,0.37606,1,1
6,GO REGULATION OF SYNAPSE ASSEMBLY,4.1552e-07,0.33961,0.30331,1,1
6,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00047589,0.33936,0.26084,1,1
6,GO COCHLEA MORPHOGENESIS,3.9872e-06,0.3392,0.32953,1,1
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,1.7385e-05,0.33874,0.30211,1,1
6,GO RECEPTOR CLUSTERING,8.8282e-08,0.33857,0.32131,1,1
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,7.1819e-07,0.33845,0.33774,1,1
6,GO DORSAL SPINAL CORD DEVELOPMENT,1.9136e-07,0.33819,0.38411,1,1
6,GO GLIAL CELL FATE COMMITMENT,0.00030928,0.33716,0.34261,1,1
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,1.1165e-05,0.33538,0.34949,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,6.895e-08,0.33379,0.32199,1,1
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00015083,0.33369,0.28099,1,1
6,GO NEURON RECOGNITION,2.5868e-06,0.33367,0.32494,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,1.471e-07,0.33339,0.32401,1,1
6,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0012886,0.33339,0.27535,1,1
6,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,2.9514e-07,0.33291,0.30103,1,1
6,GO CELL FATE SPECIFICATION,9.1793e-10,0.33258,0.33229,1,1
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,3.4796e-08,0.33188,0.34237,1,1
6,GO NEGATIVE REGULATION OF AXONOGENESIS,5.4356e-06,0.33145,0.28953,1,1
6,GO EMBRYONIC FORELIMB MORPHOGENESIS,3.357e-07,0.33064,0.32863,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.5052e-06,0.33025,0.33,1,1
6,GO DORSAL VENTRAL AXIS SPECIFICATION,3.0302e-06,0.32982,0.34875,1,1
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,3.1312e-09,0.32874,0.2995,1,1
6,GO HISTONE H3 K9 METHYLATION,1.4112e-09,0.32848,0.32268,1,1
6,GO NUCLEAR MIGRATION,1.4163e-06,0.32817,0.31164,1,1
6,GO CARDIAC MYOFIBRIL ASSEMBLY,1.4472e-05,0.3281,0.28457,1,1
6,GO NEURON PROJECTION GUIDANCE,1.3999e-08,0.32745,0.32099,1,1
6,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00033955,0.32667,0.32102,1,1
6,GO INHIBITORY SYNAPSE ASSEMBLY,1.6654e-06,0.32663,0.43952,1,1
6,GO EMBRYONIC BRAIN DEVELOPMENT,3.9872e-06,0.32651,0.25347,1,1
6,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00029052,0.32642,0.30991,1,1
6,GO PROTEIN LOCALIZATION TO CILIUM,1.4677e-08,0.32571,0.32198,1,1
6,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00046165,0.32494,0.24266,1,1
6,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,3.9872e-06,0.32483,0.38206,1,1
6,GO NEURON PROJECTION ARBORIZATION,3.1479e-07,0.32457,0.35799,1,1
6,GO EXCITATORY SYNAPSE ASSEMBLY,2.2958e-06,0.32434,0.37968,1,1
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.3948e-05,0.32407,0.29186,1,1
6,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,2.1621e-05,0.32383,0.33757,1,1
6,GO NEURAL TUBE PATTERNING,1.3671e-08,0.32372,0.3083,1,1
6,GO TELENCEPHALON GLIAL CELL MIGRATION,1.2716e-05,0.32309,0.29015,1,1
6,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,5.5864e-07,0.32168,0.32694,1,1
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,3.3806e-05,0.32136,0.30079,1,1
6,GO NEUROBLAST PROLIFERATION,3.9064e-09,0.32031,0.34527,1,1
6,GO ACTIN FILAMENT BASED TRANSPORT,2.2958e-06,0.3203,0.31999,1,1
6,GO SEX DETERMINATION,5.4701e-07,0.31834,0.31205,1,1
6,GO REGULATION OF CENTRIOLE REPLICATION,4.5233e-07,0.31808,0.2978,1,1
6,GO ESTROUS CYCLE,1.2482e-05,0.3179,0.27972,1,1
6,GO MYELIN MAINTENANCE,0.0020092,0.3179,0.26601,1,1
6,GO CELL DIFFERENTIATION IN SPINAL CORD,4.0033e-09,0.31744,0.34415,1,1
6,GO NERVE DEVELOPMENT,1.2534e-06,0.31721,0.34092,1,1
6,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.4076e-07,0.31688,0.35095,1,1
6,GO PROTEIN TRANSPORT ALONG MICROTUBULE,3.7282e-08,0.31654,0.3035,1,1
6,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0087156,0.31636,0.23206,1,1
6,GO ACTIN CROSSLINK FORMATION,1.2886e-07,0.31571,0.36704,1,1
6,GO NEURAL RETINA DEVELOPMENT,7.892e-08,0.31556,0.31478,1,1
6,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.00022208,0.31504,0.33655,1,1
6,GO METENCEPHALON DEVELOPMENT,3.0296e-10,0.31458,0.34557,1,1
6,GO CRANIAL NERVE DEVELOPMENT,6.5837e-06,0.31411,0.30194,1,1
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.0905e-06,0.31341,0.28365,1,1
6,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,5.8049e-05,0.31312,0.2936,1,1
6,GO NEURON MIGRATION,7.8976e-09,0.31187,0.35572,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,9.5677e-09,0.31111,0.3452,1,1
6,GO NUCLEUS LOCALIZATION,2.3891e-06,0.3102,0.28852,1,1
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,9.9803e-06,0.30994,0.29687,1,1
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.00019857,0.3099,0.26976,1,1
6,GO MRNA SPLICE SITE SELECTION,5.0922e-10,0.30951,0.36519,1,1
6,GO EPITHELIAL CELL MATURATION,3.4296e-07,0.30888,0.32277,1,1
6,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0023637,0.30867,0.24762,1,1
6,GO DENDRITIC SPINE MORPHOGENESIS,2.3784e-07,0.30831,0.32253,1,1
6,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.001118,0.30783,0.19301,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,5.0922e-10,0.30754,0.3264,1,1
6,GO PRESYNAPSE ORGANIZATION,1.3325e-06,0.3075,0.30255,1,1
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.007921,0.30746,0.29186,1,1
6,GO STARTLE RESPONSE,1.7071e-05,0.30545,0.33799,1,1
6,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.9558e-07,0.30509,0.33516,1,1
6,GO REGULATION OF COLLATERAL SPROUTING,4.3236e-05,0.30467,0.32203,1,1
6,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,2.2824e-05,0.30464,0.31141,1,1
6,GO MECHANOSENSORY BEHAVIOR,0.0032928,0.30443,0.35123,1,1
6,GO SIALYLATION,3.2146e-06,0.30344,0.35344,1,1
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,3.3435e-06,0.30301,0.41096,1,1
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,4.2271e-06,0.30291,0.24382,1,1
6,GO NEURAL CREST FORMATION,9.6562e-05,0.30192,0.2845,1,1
6,GO OUTER DYNEIN ARM ASSEMBLY,2.7312e-05,0.30178,0.35365,1,1
6,GO RESPONSE TO POTASSIUM ION,1.9393e-05,0.30128,0.31679,1,1
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,2.4861e-06,0.30087,0.3634,1,1
6,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.5684e-06,0.30041,0.30425,1,1
6,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00042128,0.30035,0.25867,1,1
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,7.105e-06,0.30021,0.29868,1,1
6,GO POSTSYNAPSE ORGANIZATION,1.1307e-08,0.2999,0.33405,1,1
6,GO SYNAPSE ORGANIZATION,6.1583e-08,0.29906,0.29164,1,1
6,GO MYOBLAST MIGRATION,0.0007901,0.29873,0.28325,1,1
6,GO CGMP METABOLIC PROCESS,0.001483,0.2987,0.27052,1,1
6,GO DENTATE GYRUS DEVELOPMENT,2.7804e-05,0.29861,0.39724,1,1
6,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,7.2964e-10,0.29794,0.32149,1,1
6,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,5.1351e-07,0.29782,0.29447,1,1
6,GO PHOTORECEPTOR CELL MAINTENANCE,6.5906e-08,0.29698,0.27236,1,1
6,GO GROWTH HORMONE SECRETION,1.7071e-05,0.29655,0.39002,1,1
6,GO HINDBRAIN MORPHOGENESIS,4.8359e-10,0.29637,0.29907,1,1
6,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,7.6446e-07,0.29629,0.30001,1,1
6,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00016361,0.29608,0.25168,1,1
6,GO SYNAPTIC VESICLE DOCKING,0.0025277,0.29567,0.2866,1,1
6,GO INTRACILIARY RETROGRADE TRANSPORT,1.6654e-06,0.29527,0.35439,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.2328e-07,0.29472,0.28131,1,1
6,GO HINDBRAIN DEVELOPMENT,5.2253e-10,0.29445,0.30232,1,1
6,GO HISTONE H3 K36 METHYLATION,7.71e-09,0.29444,0.35086,1,1
6,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,1.8318e-07,0.29435,0.25301,1,1
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,9.7991e-09,0.29434,0.30867,1,1
6,GO HIPPO SIGNALING,2.011e-05,0.29413,0.27159,1,1
6,GO AXONEME ASSEMBLY,2.4305e-07,0.29383,0.34438,1,1
6,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,3.4409e-05,0.29358,0.26194,1,1
6,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00082553,0.29257,0.3002,1,1
6,GO NEPHRON TUBULE FORMATION,4.1751e-05,0.29244,0.30379,1,1
6,GO PHARYNGEAL SYSTEM DEVELOPMENT,7.6283e-05,0.2924,0.2908,1,1
6,GO SPERMATID NUCLEUS DIFFERENTIATION,1.5753e-08,0.29189,0.28904,1,1
6,GO URETER DEVELOPMENT,4.7999e-05,0.2917,0.38112,1,1
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,6.5837e-06,0.29145,0.29558,1,1
6,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,1.6129e-08,0.29143,0.28941,1,1
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,9.8716e-08,0.29138,0.34089,1,1
6,GO ADULT HEART DEVELOPMENT,6.3249e-05,0.29094,0.2618,1,1
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00027284,0.28967,0.22751,1,1
6,GO PROTEIN LOCALIZATION TO SYNAPSE,2.2958e-06,0.2896,0.29253,1,1
6,GO INTRACILIARY TRANSPORT,1.6782e-07,0.28939,0.31898,1,1
6,GO VENTRAL SPINAL CORD DEVELOPMENT,1.6129e-08,0.28875,0.30949,1,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00084997,0.28875,0.20849,1,1
6,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,5.6245e-08,0.28866,0.31393,1,1
6,GO POST ANAL TAIL MORPHOGENESIS,1.3693e-05,0.28776,0.26565,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,5.7051e-07,0.28719,0.27506,1,1
6,GO NON MOTILE CILIUM ASSEMBLY,9.7998e-07,0.28719,0.26021,1,1
6,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,4.3946e-06,0.28709,0.31152,1,1
6,GO REGULATION OF STEM CELL PROLIFERATION,2.2926e-08,0.28698,0.28949,1,1
6,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0014624,0.28664,0.20535,1,1
6,GO THYROID GLAND DEVELOPMENT,4.5684e-06,0.28659,0.2931,1,1
6,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0030038,0.28633,0.2797,1,1
6,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.4334e-08,0.28611,0.32618,1,1
6,GO V D J RECOMBINATION,4.6578e-06,0.28591,0.307,1,1
6,GO HISTONE H3 K9 MODIFICATION,2.3853e-09,0.28558,0.28979,1,1
6,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,4.719e-07,0.28504,0.29056,1,1
6,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,8.5867e-06,0.28503,0.28438,1,1
6,GO REGULATION OF HISTONE H3 K9 METHYLATION,4.249e-10,0.28496,0.32628,1,1
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,1.3056e-06,0.28462,0.30183,1,1
6,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00024045,0.28414,0.26914,1,1
6,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0005618,0.2838,0.3571,1,1
6,GO AXON DEVELOPMENT,2.6981e-08,0.28374,0.28732,1,1
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,6.8885e-07,0.28361,0.3056,1,1
6,GO DETECTION OF TEMPERATURE STIMULUS,0.00043435,0.283,0.30946,1,1
6,GO COCHLEA DEVELOPMENT,3.4796e-08,0.28247,0.3299,1,1
6,GO REGULATION OF SYNAPTIC PLASTICITY,1.1086e-06,0.28062,0.26939,1,1
6,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,1.6129e-08,0.28023,0.29622,1,1
6,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00091404,0.28023,0.24923,1,1
6,GO ASTRAL MICROTUBULE ORGANIZATION,3.2094e-09,0.27983,0.34571,1,1
6,GO SYNAPSE ASSEMBLY,1.3468e-07,0.27968,0.31164,1,1
6,GO RESPONSE TO VITAMIN A,0.00033955,0.27902,0.23421,1,1
6,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,1.2032e-06,0.27896,0.30005,1,1
6,GO MESENCHYMAL CELL PROLIFERATION,2.9859e-05,0.27879,0.28623,1,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,1.6062e-07,0.27852,0.24786,1,1
6,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0044864,0.27849,0.2046,1,1
6,GO REGULATION OF CILIUM ASSEMBLY,8.2543e-08,0.27836,0.25442,1,1
6,GO PROTEIN DEMETHYLATION,2.7668e-07,0.27781,0.27519,1,1
6,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.00027284,0.27697,0.20693,1,1
6,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,6.5837e-06,0.27675,0.25515,1,1
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,8.1138e-06,0.27666,0.27556,1,1
6,GO REGULATION OF GLIAL CELL PROLIFERATION,1.5014e-05,0.27607,0.25984,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,8.8389e-07,0.27602,0.27088,1,1
6,GO NEGATIVE REGULATION OF TORC1 SIGNALING,2.1624e-06,0.27589,0.33034,1,1
6,GO PANCREAS DEVELOPMENT,1.2886e-07,0.27574,0.30476,1,1
6,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.0422e-09,0.27558,0.30469,1,1
6,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,4.2444e-07,0.27539,0.26797,1,1
6,GO MOTILE CILIUM ASSEMBLY,9.03e-05,0.27532,0.307,1,1
6,GO RETROGRADE AXONAL TRANSPORT,1.0958e-05,0.27505,0.27716,1,1
6,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.034984,0.27471,0.19135,1,1
6,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.00020178,0.27464,0.25495,1,1
6,GO TUBE FORMATION,1.3174e-07,0.27462,0.23064,1,1
6,GO DENDRITIC SPINE DEVELOPMENT,1.5037e-07,0.27458,0.29011,1,1
6,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,5.0278e-07,0.2743,0.22889,1,1
6,GO RESPONSE TO NICOTINE,2.0429e-07,0.27401,0.29895,1,1
6,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,1.9465e-08,0.27379,0.3097,1,1
6,GO CELLULAR COMPONENT MAINTENANCE,3.4296e-07,0.27358,0.27053,1,1
6,GO DENDRITE SELF AVOIDANCE,0.00012388,0.27302,0.25633,1,1
6,GO OLIGODENDROCYTE DEVELOPMENT,1.8701e-05,0.27281,0.23779,1,1
6,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.7078e-07,0.2722,0.26283,1,1
6,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,2.2775e-07,0.27217,0.25983,1,1
6,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,1.1579e-08,0.27215,0.27972,1,1
6,GO LEARNING,9.8716e-08,0.27195,0.28349,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00012594,0.27183,0.23173,1,1
6,GO SEROTONIN TRANSPORT,0.00044103,0.27113,0.24528,1,1
6,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00081356,0.27043,0.25174,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00036124,0.27025,0.28408,1,1
6,GO LONG TERM SYNAPTIC POTENTIATION,1.5576e-05,0.2698,0.25004,1,1
6,GO CELLULAR POTASSIUM ION HOMEOSTASIS,3.3806e-05,0.26965,0.27823,1,1
6,GO EMBRYONIC BODY MORPHOGENESIS,2.7804e-05,0.26954,0.27873,1,1
6,GO METANEPHROS MORPHOGENESIS,1.9749e-05,0.26935,0.27219,1,1
6,GO CARDIAC ATRIUM DEVELOPMENT,1.5293e-05,0.2686,0.26665,1,1
6,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,3.0905e-06,0.26741,0.26517,1,1
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,1.0554e-07,0.26707,0.23735,1,1
6,GO REGULATION OF HEART MORPHOGENESIS,0.00022565,0.26699,0.2325,1,1
6,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,4.1552e-07,0.26699,0.30864,1,1
6,GO APPENDAGE MORPHOGENESIS,1.5372e-07,0.26682,0.26807,1,1
6,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,8.8282e-08,0.26677,0.27146,1,1
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.1806e-05,0.26577,0.28431,1,1
6,GO OVARIAN FOLLICLE DEVELOPMENT,1.0322e-07,0.26567,0.30475,1,1
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,7.333e-07,0.26558,0.25648,1,1
6,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00040857,0.26553,0.24422,1,1
6,GO REGULATION OF DENDRITE MORPHOGENESIS,2.8925e-08,0.26513,0.30295,1,1
6,GO POTASSIUM ION HOMEOSTASIS,7.9617e-06,0.26505,0.26735,1,1
6,GO CARDIAC ATRIUM MORPHOGENESIS,7.105e-06,0.26503,0.29298,1,1
6,GO CELL PART MORPHOGENESIS,2.188e-08,0.26453,0.27366,1,1
6,GO REGULATION OF EXTENT OF CELL GROWTH,2.4837e-07,0.26446,0.29764,1,1
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,3.0302e-06,0.26436,0.2724,1,1
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,5.7536e-08,0.26426,0.28041,1,1
6,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,2.9078e-09,0.26412,0.30535,1,1
6,GO DIENCEPHALON DEVELOPMENT,5.6487e-06,0.26406,0.26626,1,1
6,GO SEROTONIN SECRETION,0.00013232,0.26394,0.28837,1,1
6,GO CHLORIDE ION HOMEOSTASIS,0.00037835,0.26393,0.26384,1,1
6,GO TYPE B PANCREATIC CELL DEVELOPMENT,4.5558e-05,0.26354,0.26826,1,1
6,GO HISTONE H3 K9 TRIMETHYLATION,1.7721e-08,0.26322,0.2753,1,1
6,GO MESONEPHRIC TUBULE MORPHOGENESIS,7.5001e-05,0.2631,0.21274,1,1
6,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.1621e-05,0.26306,0.287,1,1
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,7.333e-07,0.26302,0.30511,1,1
6,GO COLLATERAL SPROUTING,3.8246e-05,0.2624,0.28049,1,1
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.00040235,0.26225,0.27921,1,1
6,GO LOCALIZATION WITHIN MEMBRANE,9.404e-07,0.26217,0.2439,1,1
6,GO NEGATIVE REGULATION OF GLIOGENESIS,1.2328e-07,0.26212,0.31534,1,1
6,GO EMBRYONIC APPENDAGE MORPHOGENESIS,7.4873e-07,0.26204,0.24983,1,1
6,GO HEART FORMATION,0.00018323,0.26125,0.2484,1,1
6,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,3.1004e-08,0.26088,0.25589,1,1
6,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00015083,0.26031,0.22198,1,1
6,GO HINDLIMB MORPHOGENESIS,0.00013673,0.2603,0.24187,1,1
6,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,8.4424e-05,0.26017,0.20782,1,1
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00055343,0.26009,0.24669,1,1
6,GO NOREPINEPHRINE SECRETION,7.7586e-05,0.26004,0.29437,1,1
6,GO RENAL VESICLE DEVELOPMENT,0.0001803,0.25998,0.25104,1,1
6,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,2.9859e-05,0.2599,0.24741,1,1
6,GO CARDIAC SEPTUM MORPHOGENESIS,0.00017457,0.25975,0.24388,1,1
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,3.5427e-10,0.25969,0.29434,1,1
6,GO CENTRIOLE ASSEMBLY,1.4076e-07,0.25937,0.28016,1,1
6,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.002631,0.25864,0.23731,1,1
6,GO REGULATION OF NERVOUS SYSTEM PROCESS,5.3747e-08,0.2586,0.30278,1,1
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00038422,0.25829,0.2754,1,1
6,GO REGULATION OF CYCLASE ACTIVITY,7.8124e-06,0.25823,0.23804,1,1
6,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.2032e-06,0.25814,0.2569,1,1
6,GO PROXIMAL DISTAL PATTERN FORMATION,0.00023667,0.25795,0.25148,1,1
6,GO NEURON MATURATION,2.4861e-06,0.25778,0.26272,1,1
6,GO REGULATION OF SYNAPTIC VESICLE CYCLE,1.1588e-05,0.2577,0.28526,1,1
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,6.895e-08,0.25717,0.24934,1,1
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,3.9872e-06,0.25716,0.24233,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,6.8885e-07,0.25693,0.25463,1,1
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0011836,0.25674,0.3495,1,1
6,GO NEGATIVE REGULATION OF DNA REPLICATION,6.8396e-06,0.25664,0.23361,1,1
6,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,1.8793e-06,0.25649,0.25884,1,1
6,GO MICROTUBULE BUNDLE FORMATION,3.7282e-08,0.25647,0.29424,1,1
6,GO EMBRYONIC DIGIT MORPHOGENESIS,5.6487e-06,0.25622,0.21914,1,1
6,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.011151,0.25611,0.18924,1,1
6,GO RESPONSE TO LEUCINE,4.7172e-05,0.25567,0.28443,1,1
6,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,6.337e-06,0.25508,0.24367,1,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.001422,0.25502,0.21616,1,1
6,GO CILIUM ORGANIZATION,3.6293e-09,0.25494,0.25946,1,1
6,GO CORPUS CALLOSUM DEVELOPMENT,3.094e-05,0.25465,0.31305,1,1
6,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0032928,0.25431,0.26592,1,1
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00065224,0.25429,0.26243,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,3.5646e-05,0.2541,0.2057,1,1
6,GO PROTEIN LOCALIZATION TO KINETOCHORE,4.6578e-06,0.25394,0.23816,1,1
6,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.00037835,0.25367,0.2394,1,1
6,GO EPITHELIAL CELL MORPHOGENESIS,0.0095807,0.25236,0.23354,1,1
6,GO REGULATION OF NEURON DIFFERENTIATION,1.8573e-08,0.25228,0.26034,1,1
6,GO REPLICATION FORK PROCESSING,2.0478e-05,0.25183,0.23027,1,1
6,GO MUSCLE FIBER DEVELOPMENT,1.5674e-06,0.25171,0.24226,1,1
6,GO VENTRICULAR SYSTEM DEVELOPMENT,2.5066e-09,0.2513,0.29946,1,1
6,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0032501,0.25105,0.24527,1,1
6,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,5.1304e-06,0.25082,0.26998,1,1
6,GO REGULATION OF DENDRITE DEVELOPMENT,2.2926e-08,0.25078,0.28383,1,1
6,GO MICROTUBULE ANCHORING,1.6321e-06,0.25074,0.24369,1,1
6,GO APICAL PROTEIN LOCALIZATION,1.4207e-05,0.25067,0.266,1,1
6,GO CELLULAR COMPONENT MORPHOGENESIS,2.3467e-08,0.25057,0.25901,1,1
6,GO EMBRYONIC HEMOPOIESIS,6.7105e-06,0.25018,0.27037,1,1
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031414,0.25016,0.21933,1,1
6,GO SOMITE DEVELOPMENT,1.3468e-07,0.24999,0.23838,1,1
6,GO G0 TO G1 TRANSITION,4.7125e-10,0.24982,0.2808,1,1
6,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,5.8856e-08,0.24975,0.22771,1,1
6,GO STEM CELL DIVISION,0.00011033,0.24972,0.22428,1,1
6,GO FOREBRAIN DEVELOPMENT,1.0422e-09,0.24954,0.27424,1,1
6,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,8.8389e-07,0.24945,0.279,1,1
6,GO LATERAL VENTRICLE DEVELOPMENT,4.1751e-05,0.24936,0.29945,1,1
6,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,9.4407e-08,0.24888,0.23053,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.1316e-06,0.24885,0.30407,1,1
6,GO NEURAL TUBE DEVELOPMENT,2.8886e-07,0.24875,0.22454,1,1
6,GO HIPPOCAMPUS DEVELOPMENT,2.3274e-07,0.24869,0.24976,1,1
6,GO RESPONSE TO ELECTRICAL STIMULUS,5.4184e-05,0.2486,0.25658,1,1
6,GO POSITIVE REGULATION OF CHROMATIN BINDING,1.1165e-05,0.24849,0.28461,1,1
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,4.8839e-05,0.24818,0.24656,1,1
6,GO SPERM AXONEME ASSEMBLY,1.5865e-05,0.24816,0.25553,1,1
6,GO NEGATIVE REGULATION OF AXON EXTENSION,1.0958e-05,0.24815,0.27623,1,1
6,GO REGULATION OF TRANSPOSITION,0.0024281,0.24733,0.22317,1,1
6,GO NEGATIVE REGULATION OF NEURON MIGRATION,5.7059e-05,0.24714,0.22023,1,1
6,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0012527,0.24704,0.29229,1,1
6,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0022396,0.24693,0.19634,1,1
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.5293e-05,0.2469,0.21516,1,1
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,7.6657e-06,0.24685,0.2286,1,1
6,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.8723e-07,0.24667,0.24796,1,1
6,GO SYNAPTIC VESICLE EXOCYTOSIS,2.2416e-05,0.24637,0.26845,1,1
6,GO NEUROTRANSMITTER SECRETION,9.6129e-06,0.24635,0.27254,1,1
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,6.2046e-07,0.24585,0.22846,1,1
6,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,6.3249e-05,0.24539,0.36469,1,1
6,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,4.5558e-05,0.24536,0.22213,1,1
6,GO IRON COORDINATION ENTITY TRANSPORT,0.00013899,0.24471,0.24208,1,1
6,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.020828,0.24466,0.20445,1,1
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.00026024,0.24466,0.18585,1,1
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,8.8389e-07,0.24453,0.2568,1,1
6,GO REGULATION OF TRANS SYNAPTIC SIGNALING,8.8282e-08,0.2444,0.28075,1,1
6,GO HISTONE H2A MONOUBIQUITINATION,2.188e-08,0.24372,0.24552,1,1
6,GO ADULT BEHAVIOR,6.0205e-08,0.24372,0.29362,1,1
6,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00031907,0.24365,0.30047,1,1
6,GO EPITHELIAL CELL FATE COMMITMENT,0.0005618,0.24356,0.33741,1,1
6,GO NEURAL CREST CELL DIFFERENTIATION,0.00015083,0.24349,0.21142,1,1
6,GO BONE MORPHOGENESIS,0.00069207,0.24196,0.18831,1,1
6,GO SKELETAL SYSTEM MORPHOGENESIS,1.8419e-06,0.24174,0.21264,1,1
6,GO DORSAL VENTRAL PATTERN FORMATION,1.3085e-09,0.24172,0.29729,1,1
6,GO CONVERGENT EXTENSION,0.00032916,0.24166,0.22156,1,1
6,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.0527e-08,0.24165,0.24594,1,1
6,GO NEURAL PRECURSOR CELL PROLIFERATION,8.7237e-10,0.24146,0.28202,1,1
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,7.8124e-06,0.24146,0.23922,1,1
6,GO ENDOCARDIAL CUSHION DEVELOPMENT,8.0256e-05,0.24118,0.22553,1,1
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,1.7706e-05,0.24117,0.22237,1,1
6,GO MITOTIC RECOMBINATION,0.000286,0.24058,0.20556,1,1
6,GO STRIATUM DEVELOPMENT,0.00022208,0.2405,0.23988,1,1
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,1.5293e-05,0.24044,0.27233,1,1
6,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.0756e-05,0.24038,0.2315,1,1
6,GO PEPTIDYL LYSINE DIMETHYLATION,3.5038e-07,0.24028,0.23042,1,1
6,GO NEGATIVE REGULATION OF DNA BINDING,1.2434e-08,0.24009,0.25389,1,1
6,GO DENDRITIC TRANSPORT,1.2482e-05,0.23989,0.32158,1,1
6,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,9.9844e-05,0.23981,0.24293,1,1
6,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,3.5022e-05,0.23972,0.23344,1,1
6,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.016205,0.23957,0.24823,1,1
6,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,3.2146e-06,0.23913,0.20868,1,1
6,GO PEPTIDYL LYSINE TRIMETHYLATION,7.1819e-07,0.23898,0.21318,1,1
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,2.5066e-09,0.23862,0.25386,1,1
6,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,2.913e-06,0.23858,0.22862,1,1
6,GO EPITHELIAL TUBE FORMATION,2.7078e-07,0.23853,0.21998,1,1
6,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,2.8001e-06,0.23841,0.25414,1,1
6,GO SMAD PROTEIN COMPLEX ASSEMBLY,2.7312e-05,0.2384,0.24506,1,1
6,GO REGULATION OF TUBULIN DEACETYLATION,0.00011218,0.23834,0.26493,1,1
6,GO NEURON DEVELOPMENT,1.9926e-08,0.23828,0.24866,1,1
6,GO SEGMENTATION,3.6162e-06,0.23826,0.20472,1,1
6,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0017277,0.23821,0.22437,1,1
6,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,4.7963e-08,0.2382,0.25358,1,1
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,1.3468e-07,0.23814,0.21645,1,1
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,2.2139e-09,0.23806,0.29236,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,2.0881e-08,0.23798,0.2394,1,1
6,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,2.1375e-08,0.23783,0.25109,1,1
6,GO ENTEROENDOCRINE CELL DIFFERENTIATION,8.8796e-05,0.2375,0.26226,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,4.5558e-05,0.23664,0.21256,1,1
6,GO MICROTUBULE BASED MOVEMENT,2.7614e-08,0.23662,0.22609,1,1
6,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,7.9617e-06,0.23661,0.24854,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,3.2146e-06,0.23632,0.24112,1,1
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,8.9047e-09,0.23632,0.24067,1,1
6,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00041488,0.2363,0.24435,1,1
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00069207,0.23607,0.27879,1,1
6,GO GLIAL CELL PROLIFERATION,0.00013232,0.23602,0.20348,1,1
6,GO STEM CELL PROLIFERATION,2.1338e-07,0.23558,0.24435,1,1
6,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,6.2169e-06,0.2355,0.23357,1,1
6,GO EXPLORATION BEHAVIOR,0.0015038,0.23548,0.22022,1,1
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0080166,0.23545,0.21098,1,1
6,GO NEURON DIFFERENTIATION,7.71e-09,0.23517,0.25043,1,1
6,GO REGULATION OF CHROMATIN BINDING,5.1351e-07,0.23483,0.28933,1,1
6,GO DERMATAN SULFATE METABOLIC PROCESS,0.025743,0.23474,0.17719,1,1
6,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.9069e-08,0.23462,0.2524,1,1
6,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0042636,0.23419,0.183,1,1
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00048316,0.23374,0.24137,1,1
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0005618,0.23362,0.27256,1,1
6,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,4.2444e-07,0.23359,0.23198,1,1
6,GO TRANSPORT ALONG MICROTUBULE,1.439e-07,0.23317,0.21356,1,1
6,GO SMOOTHENED SIGNALING PATHWAY,6.8348e-09,0.23316,0.25702,1,1
6,GO MYOTUBE CELL DEVELOPMENT,8.9166e-06,0.2331,0.23703,1,1
6,GO TRNA CATABOLIC PROCESS,0.021053,0.23307,0.19322,1,1
6,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.00054518,0.23303,0.27919,1,1
6,GO KIDNEY MORPHOGENESIS,4.4807e-06,0.23297,0.22352,1,1
6,GO NEPHRON MORPHOGENESIS,1.3442e-05,0.23275,0.21248,1,1
6,GO KINETOCHORE ORGANIZATION,0.00027284,0.23275,0.21872,1,1
6,GO APPENDAGE DEVELOPMENT,5.1351e-07,0.2325,0.23343,1,1
6,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,4.9069e-08,0.23226,0.26356,1,1
6,GO BEHAVIORAL RESPONSE TO COCAINE,0.0013069,0.23208,0.31808,1,1
6,GO EMBRYONIC EYE MORPHOGENESIS,8.4262e-06,0.23208,0.26403,1,1
6,GO ORGANIC CATION TRANSPORT,0.000286,0.23178,0.19544,1,1
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,9.6129e-06,0.23173,0.2653,1,1
6,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,3.8924e-05,0.23141,0.25008,1,1
6,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00048316,0.23114,0.30395,1,1
6,GO EMBRYONIC ORGAN MORPHOGENESIS,2.8262e-08,0.2311,0.24079,1,1
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00063314,0.23081,0.20736,1,1
6,GO OVULATION CYCLE PROCESS,9.4341e-06,0.23068,0.21752,1,1
6,GO DOSAGE COMPENSATION,2.8305e-05,0.23059,0.20649,1,1
6,GO CELLULAR RESPONSE TO VITAMIN,0.00033955,0.23055,0.25576,1,1
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,3.4003e-08,0.23053,0.23272,1,1
6,GO NEUROGENESIS,1.3039e-08,0.23037,0.23602,1,1
6,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,4.4771e-05,0.23027,0.26197,1,1
6,GO NOREPINEPHRINE TRANSPORT,0.00037835,0.23018,0.25378,1,1
6,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0011341,0.23,0.21338,1,1
6,GO AXIS ELONGATION,0.00019229,0.2296,0.22978,1,1
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00014599,0.22905,0.20459,1,1
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,1.1165e-05,0.22903,0.26333,1,1
6,GO CHONDROCYTE PROLIFERATION,0.0059852,0.2285,0.19276,1,1
6,GO SYNAPTIC TRANSMISSION GABAERGIC,3.1494e-05,0.22842,0.21179,1,1
6,GO REGULATION OF DEVELOPMENTAL GROWTH,1.1282e-07,0.22831,0.21426,1,1
6,GO ROOF OF MOUTH DEVELOPMENT,1.7385e-05,0.2282,0.20915,1,1
6,GO MICROTUBULE BASED TRANSPORT,1.5372e-07,0.22808,0.22153,1,1
6,GO TELENCEPHALON DEVELOPMENT,2.3268e-09,0.22799,0.26675,1,1
6,GO BASIC AMINO ACID TRANSPORT,0.017894,0.22781,0.14739,1,1
6,GO TRACHEA DEVELOPMENT,0.0025961,0.22763,0.21228,1,1
6,GO ANIMAL ORGAN FORMATION,0.00013451,0.22761,0.19424,1,1
6,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00016901,0.22748,0.17869,1,1
6,GO POSITIVE REGULATION OF DNA REPAIR,3.5606e-08,0.22747,0.21779,1,1
6,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,4.6578e-06,0.22738,0.23845,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00012186,0.22732,0.24517,1,1
6,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,4.4285e-07,0.22723,0.24216,1,1
6,GO INNER EAR MORPHOGENESIS,3.357e-07,0.2272,0.26466,1,1
6,GO REGULATION OF BEHAVIOR,1.3948e-05,0.22695,0.2058,1,1
6,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,2.9514e-07,0.22693,0.25279,1,1
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0010408,0.22652,0.1827,1,1
6,GO SECONDARY PALATE DEVELOPMENT,4.9694e-05,0.22647,0.27806,1,1
6,GO PROSTATE GLAND GROWTH,0.0025961,0.22632,0.23032,1,1
6,GO GENITALIA MORPHOGENESIS,0.0022701,0.22626,0.30804,1,1
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,2.402e-08,0.22606,0.20073,1,1
6,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.4972e-05,0.226,0.25129,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.010895,0.22549,0.16606,1,1
6,GO SYNAPTIC SIGNALING,1.9558e-07,0.22534,0.25993,1,1
6,GO REGULATION OF RECEPTOR INTERNALIZATION,6.4699e-07,0.22481,0.22959,1,1
6,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,3.4553e-09,0.22476,0.23831,1,1
6,GO ENERGY HOMEOSTASIS,0.00025617,0.2247,0.21895,1,1
6,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00057029,0.22463,0.2977,1,1
6,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00084997,0.22447,0.1839,1,1
6,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00011033,0.22432,0.19921,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,9.2585e-06,0.22415,0.30108,1,1
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,4.6578e-06,0.22367,0.24234,1,1
6,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,3.8246e-05,0.22352,0.301,1,1
6,GO HEAD DEVELOPMENT,1.4471e-09,0.22342,0.24224,1,1
6,GO SINGLE STRAND BREAK REPAIR,1.9393e-05,0.22342,0.21071,1,1
6,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.7706e-05,0.22341,0.27343,1,1
6,GO MAINTENANCE OF ORGANELLE LOCATION,4.9694e-05,0.22331,0.20824,1,1
6,GO REGULATION OF ANIMAL ORGAN FORMATION,0.00015583,0.22328,0.24203,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,1.4741e-05,0.22326,0.2041,1,1
6,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0061347,0.22307,0.16038,1,1
6,GO L GLUTAMATE IMPORT,0.011544,0.22287,0.14525,1,1
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,5.8049e-05,0.22283,0.22296,1,1
6,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00070238,0.22278,0.26951,1,1
6,GO TRANSPOSITION,0.0016806,0.22275,0.21672,1,1
6,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00043435,0.22274,0.24938,1,1
6,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,1.7309e-08,0.22258,0.25847,1,1
6,GO REGULATION OF HEAT GENERATION,7.0072e-05,0.22256,0.27146,1,1
6,GO CILIUM MOVEMENT,5.0278e-07,0.22245,0.2308,1,1
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00029511,0.22233,0.24777,1,1
6,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,1.5674e-06,0.22208,0.23473,1,1
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,5.8049e-05,0.22199,0.21448,1,1
6,GO LEFT RIGHT PATTERN FORMATION,0.00013232,0.22164,0.23029,1,1
6,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,1.9393e-05,0.22129,0.21966,1,1
6,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,4.5822e-08,0.22121,0.2036,1,1
6,GO REGULATION OF APPETITE,1.1588e-05,0.22098,0.18565,1,1
6,GO EAR MORPHOGENESIS,1.6994e-06,0.22093,0.22782,1,1
6,GO RETINOIC ACID METABOLIC PROCESS,0.00061456,0.22085,0.24629,1,1
6,GO REGULATION OF FATTY ACID BETA OXIDATION,0.001704,0.2207,0.1913,1,1
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.6321e-06,0.22069,0.21461,1,1
6,GO DNA DOUBLE STRAND BREAK PROCESSING,3.8924e-05,0.22069,0.2243,1,1
6,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00030449,0.22059,0.20606,1,1
6,GO SULFATION,0.0050904,0.21955,0.16882,1,1
6,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.00036686,0.21945,0.20201,1,1
6,GO REPRODUCTIVE BEHAVIOR,3.1494e-05,0.21937,0.23338,1,1
6,GO REGULATION OF MRNA PROCESSING,1.5386e-08,0.21936,0.22434,1,1
6,GO HISTONE H4 DEACETYLATION,0.00010852,0.21906,0.20254,1,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,1.3442e-05,0.21872,0.2046,1,1
6,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.001235,0.21833,0.22568,1,1
6,GO OUTFLOW TRACT MORPHOGENESIS,0.00071283,0.21817,0.20788,1,1
6,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,1.4207e-05,0.21814,0.23658,1,1
6,GO MIDGUT DEVELOPMENT,0.016027,0.21798,0.18581,1,1
6,GO MITOTIC G2 M TRANSITION CHECKPOINT,2.65e-07,0.2179,0.23272,1,1
6,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.0024609,0.21771,0.20177,1,1
6,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0057669,0.21768,0.22071,1,1
6,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.00036686,0.21766,0.20844,1,1
6,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,2.0776e-06,0.21742,0.2544,1,1
6,GO ENDOCRINE PANCREAS DEVELOPMENT,1.6761e-05,0.21706,0.23458,1,1
6,GO EPITHELIAL TUBE MORPHOGENESIS,1.0756e-05,0.21703,0.18836,1,1
6,GO PROTEIN PALMITOYLATION,1.4472e-05,0.21701,0.23463,1,1
6,GO HEART VALVE DEVELOPMENT,0.001071,0.21669,0.18611,1,1
6,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,4.3355e-07,0.21653,0.22236,1,1
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,3.4773e-06,0.21636,0.22859,1,1
6,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,4.8416e-06,0.2163,0.218,1,1
6,GO REGULATION OF ORGANELLE ASSEMBLY,2.2926e-08,0.21572,0.20163,1,1
6,GO REGULATION OF SISTER CHROMATID COHESION,1.5994e-06,0.21535,0.24659,1,1
6,GO CELLULAR RESPONSE TO X RAY,5.0563e-05,0.2153,0.18565,1,1
6,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,5.2359e-09,0.21501,0.26373,1,1
6,GO UTERUS DEVELOPMENT,0.00040857,0.21481,0.22902,1,1
6,GO ECTODERM DEVELOPMENT,4.7999e-05,0.2145,0.18274,1,1
6,GO SPERMATID DIFFERENTIATION,6.4434e-08,0.21384,0.20963,1,1
6,GO REGULATION OF MICROTUBULE BASED MOVEMENT,3.6567e-07,0.21383,0.22279,1,1
6,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.00014839,0.21357,0.24261,1,1
6,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0070192,0.21333,0.18439,1,1
6,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,5.6085e-05,0.21328,0.22306,1,1
6,GO MESONEPHROS DEVELOPMENT,0.00016098,0.21325,0.201,1,1
6,GO MITOTIC SPINDLE ORGANIZATION,7.0072e-05,0.21319,0.18023,1,1
6,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,1.2792e-06,0.21311,0.22346,1,1
6,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,6.586e-10,0.21304,0.2421,1,1
6,GO REGULATION OF HISTONE METHYLATION,1.2759e-09,0.21281,0.24173,1,1
6,GO EYE MORPHOGENESIS,4.8198e-07,0.21258,0.2199,1,1
6,GO HISTONE H4 K16 ACETYLATION,1.6761e-05,0.21245,0.19415,1,1
6,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00024819,0.21243,0.18254,1,1
6,GO PROSTATE GLAND DEVELOPMENT,0.0018256,0.21204,0.18196,1,1
6,GO REGULATION OF MICROTUBULE BASED PROCESS,1.6782e-07,0.2117,0.20986,1,1
6,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00013016,0.21156,0.22393,1,1
6,GO SPERM MOTILITY,1.5372e-07,0.21149,0.21677,1,1
6,GO SEX DIFFERENTIATION,1.1282e-07,0.21121,0.19497,1,1
6,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0057669,0.21106,0.16723,1,1
6,GO SENSORY ORGAN MORPHOGENESIS,3.5038e-07,0.21076,0.21391,1,1
6,GO KINETOCHORE ASSEMBLY,0.0017517,0.21007,0.18346,1,1
6,GO LOCOMOTORY BEHAVIOR,8.6579e-07,0.20996,0.26514,1,1
6,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.00012186,0.20974,0.2194,1,1
6,GO EMBRYONIC ORGAN DEVELOPMENT,3.0811e-07,0.20973,0.20899,1,1
6,GO MEMBRANE DISASSEMBLY,0.0054872,0.2095,0.17911,1,1
6,GO EMBRYONIC HEART TUBE MORPHOGENESIS,5.1351e-07,0.20945,0.22168,1,1
6,GO SENSORY SYSTEM DEVELOPMENT,3.9941e-08,0.20943,0.21824,1,1
6,GO SUBPALLIUM DEVELOPMENT,0.0080166,0.20933,0.202,1,1
6,GO MECHANORECEPTOR DIFFERENTIATION,2.3239e-05,0.20898,0.26924,1,1
6,GO OLIGODENDROCYTE DIFFERENTIATION,4.8198e-07,0.20891,0.24975,1,1
6,GO HOMOLOGOUS CHROMOSOME SEGREGATION,1.2716e-05,0.20881,0.20672,1,1
6,GO NEURAL CREST CELL MIGRATION,0.00010852,0.20876,0.26307,1,1
6,GO FUCOSYLATION,0.0020646,0.20862,0.17698,1,1
6,GO WHITE FAT CELL DIFFERENTIATION,1.2253e-05,0.20838,0.23626,1,1
6,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00015583,0.20838,0.21218,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0012705,0.20816,0.13636,1,1
6,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,8.5858e-05,0.20804,0.25758,1,1
6,GO OVULATION CYCLE,1.4741e-05,0.20786,0.20613,1,1
6,GO FEMALE SEX DIFFERENTIATION,2.8886e-07,0.20778,0.22575,1,1
6,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,4.8839e-05,0.20778,0.24292,1,1
6,GO GAMETE GENERATION,5.3617e-10,0.20767,0.20653,1,1
6,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0005789,0.20763,0.24878,1,1
6,GO LUNG CELL DIFFERENTIATION,0.0015038,0.20762,0.27177,1,1
6,GO REGULATION OF GONAD DEVELOPMENT,0.001422,0.20722,0.19268,1,1
6,GO CELL PROJECTION ASSEMBLY,2.3274e-07,0.20708,0.19179,1,1
6,GO HISTONE H4 K5 ACETYLATION,5.5127e-05,0.20694,0.1862,1,1
6,GO NEUROTRANSMITTER TRANSPORT,1.7071e-05,0.20655,0.25271,1,1
6,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.6386e-06,0.20642,0.2138,1,1
6,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,7.7586e-05,0.20639,0.21446,1,1
6,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.01016,0.2063,0.1484,1,1
6,GO CARDIAC SEPTUM DEVELOPMENT,0.00053704,0.20624,0.19103,1,1
6,GO RESPONSE TO FOOD,3.0395e-05,0.20615,0.18238,1,1
6,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,5.0563e-05,0.20596,0.24383,1,1
6,GO G2 DNA DAMAGE CHECKPOINT,8.1361e-07,0.20592,0.22582,1,1
6,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.001071,0.20571,0.19281,1,1
6,GO REGULATION OF PEPTIDE HORMONE SECRETION,3.6162e-06,0.20557,0.2099,1,1
6,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00031414,0.20552,0.17279,1,1
6,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,9.2118e-07,0.20551,0.22127,1,1
6,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.1621e-05,0.20541,0.22611,1,1
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0018006,0.20526,0.17863,1,1
6,GO PATTERN SPECIFICATION PROCESS,7.5266e-09,0.20502,0.23471,1,1
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,5.7582e-06,0.20489,0.23764,1,1
6,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0059852,0.20479,0.2771,1,1
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,3.5461e-06,0.20457,0.21961,1,1
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,3.2784e-06,0.20431,0.24153,1,1
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.00071283,0.20425,0.22005,1,1
6,GO REGULATION OF MICROTUBULE POLYMERIZATION,3.5022e-05,0.20424,0.23453,1,1
6,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0007786,0.20418,0.19564,1,1
6,GO SCHWANN CELL DIFFERENTIATION,3.1494e-05,0.20416,0.21268,1,1
6,GO REGULATION OF ENDOCYTIC RECYCLING,0.0037016,0.20383,0.19811,1,1
6,GO EMBRYONIC HEART TUBE DEVELOPMENT,4.4285e-07,0.20374,0.21697,1,1
6,GO REGULATION OF CAMP MEDIATED SIGNALING,0.00026858,0.20373,0.17591,1,1
6,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,2.8271e-07,0.20356,0.2121,1,1
6,GO CALCINEURIN MEDIATED SIGNALING,2.1621e-05,0.20337,0.21088,1,1
6,GO SERTOLI CELL DEVELOPMENT,0.0027747,0.20316,0.19441,1,1
6,GO CELL JUNCTION ORGANIZATION,3.2784e-06,0.20284,0.21301,1,1
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00043435,0.20253,0.23814,1,1
6,GO POSITIVE REGULATION OF CELL DEVELOPMENT,1.0322e-07,0.20253,0.20563,1,1
6,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.2482e-05,0.20229,0.23382,1,1
6,GO REGULATION OF CHROMATIN ASSEMBLY,6.0991e-06,0.20218,0.22146,1,1
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,6.4434e-08,0.20214,0.22177,1,1
6,GO SCHWANN CELL DEVELOPMENT,9.4959e-05,0.20211,0.22147,1,1
6,GO RECOMBINATIONAL REPAIR,1.4207e-05,0.20206,0.18379,1,1
6,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.041383,0.20163,0.16924,1,1
6,GO PROTEIN LOCALIZATION TO CYTOSKELETON,4.31e-06,0.20119,0.20415,1,1
6,GO MALE SEX DIFFERENTIATION,1.0756e-05,0.20117,0.17506,1,1
6,GO REGULATION OF CILIUM MOVEMENT,5.1304e-06,0.20095,0.22794,1,1
6,GO VENTRICULAR SEPTUM DEVELOPMENT,0.00017741,0.20074,0.1969,1,1
6,GO DEVELOPMENTAL INDUCTION,0.00015838,0.20032,0.20517,1,1
6,GO EPIDERMIS MORPHOGENESIS,0.01585,0.20019,0.14567,1,1
6,GO ENDOCARDIUM DEVELOPMENT,0.00030928,0.19997,0.23083,1,1
6,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,3.5646e-05,0.19993,0.21795,1,1
6,GO STRESS GRANULE ASSEMBLY,0.00043435,0.19979,0.18672,1,1
6,GO MALE GAMETE GENERATION,6.586e-10,0.19979,0.20441,1,1
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,2.6352e-05,0.19942,0.22711,1,1
6,GO REGULATION OF RESPONSE TO FOOD,2.8814e-05,0.19941,0.20655,1,1
6,GO ATP DEPENDENT CHROMATIN REMODELING,7.6657e-06,0.19875,0.19658,1,1
6,GO CATECHOLAMINE UPTAKE,0.0020092,0.19863,0.21947,1,1
6,GO POSITIVE REGULATION OF TORC1 SIGNALING,3.6162e-06,0.19858,0.25305,1,1
6,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.001235,0.19855,0.17414,1,1
6,GO MEMBRANE DOCKING,2.0776e-06,0.1983,0.18215,1,1
6,GO CAMERA TYPE EYE MORPHOGENESIS,5.4701e-07,0.19821,0.22717,1,1
6,GO GERM CELL DEVELOPMENT,7.1121e-10,0.1982,0.22747,1,1
6,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.030368,0.19808,0.13275,1,1
6,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,9.4341e-06,0.19802,0.18697,1,1
6,GO CENTROSOME DUPLICATION,1.3599e-06,0.19775,0.23245,1,1
6,GO NON RECOMBINATIONAL REPAIR,9.4959e-05,0.19758,0.15874,1,1
6,GO NEURAL TUBE FORMATION,2.342e-06,0.19722,0.20592,1,1
6,GO ADIPOSE TISSUE DEVELOPMENT,1.3196e-05,0.19721,0.22109,1,1
6,GO NATURAL KILLER CELL DIFFERENTIATION,0.00011596,0.19718,0.21141,1,1
6,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.00013016,0.19674,0.2246,1,1
6,GO HISTONE H2A UBIQUITINATION,3.5794e-07,0.19671,0.21196,1,1
6,GO SMOOTH MUSCLE CELL DIFFERENTIATION,6.4341e-05,0.1967,0.21571,1,1
6,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,6.895e-08,0.19662,0.20392,1,1
6,GO REGULATION OF EMBRYONIC DEVELOPMENT,9.4959e-05,0.196,0.17359,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,9.4341e-06,0.19578,0.17009,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,4.9361e-06,0.19576,0.21573,1,1
6,GO MICROTUBULE BASED PROCESS,1.0279e-08,0.19551,0.21481,1,1
6,GO CELL PROJECTION ORGANIZATION,1.3999e-08,0.19518,0.21964,1,1
6,GO PROTEIN LOCALIZATION TO CHROMATIN,7.9617e-06,0.19514,0.18689,1,1
6,GO POLYOL CATABOLIC PROCESS,0.0089251,0.19505,0.11933,1,1
6,GO GLIAL CELL DEVELOPMENT,9.3381e-05,0.19497,0.18412,1,1
6,GO ENSHEATHMENT OF NEURONS,3.3214e-05,0.19475,0.17794,1,1
6,GO CELL FATE COMMITMENT,1.3351e-08,0.19453,0.22607,1,1
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00036124,0.19451,0.21324,1,1
6,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00098255,0.19444,0.26243,1,1
6,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,6.7724e-05,0.19436,0.21281,1,1
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0041031,0.19385,0.16705,1,1
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,2.5868e-06,0.1935,0.18638,1,1
6,GO PROSTATIC BUD FORMATION,0.00159,0.19345,0.31161,1,1
6,GO PROTEIN ACETYLATION,2.6362e-08,0.1932,0.18895,1,1
6,GO MORPHOGENESIS OF AN EPITHELIUM,0.00018323,0.19301,0.14304,1,1
6,GO SOMITOGENESIS,1.1375e-05,0.19301,0.18388,1,1
6,GO SMOOTH MUSCLE CONTRACTION,0.00087508,0.19282,0.14081,1,1
6,GO REGULATION OF TORC1 SIGNALING,1.0554e-07,0.19276,0.24842,1,1
6,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0093576,0.19269,0.14341,1,1
6,GO GLAND MORPHOGENESIS,0.0065235,0.19261,0.16753,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,2.0853e-05,0.19239,0.18938,1,1
6,GO TRIPARTITE REGIONAL SUBDIVISION,0.02915,0.19239,0.14813,1,1
6,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.00036124,0.19238,0.20032,1,1
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,1.5674e-06,0.19203,0.17606,1,1
6,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,8.9166e-06,0.19196,0.20488,1,1
6,GO REGULATION OF DNA REPAIR,1.7922e-07,0.19188,0.18929,1,1
6,GO ENDOCRINE SYSTEM DEVELOPMENT,7.3803e-06,0.19186,0.22427,1,1
6,GO P BODY ASSEMBLY,4.7488e-06,0.19162,0.19281,1,1
6,GO SKIN EPIDERMIS DEVELOPMENT,0.00026438,0.19155,0.17455,1,1
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.4741e-05,0.19152,0.19101,1,1
6,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,2.4528e-05,0.19129,0.18883,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00065224,0.19121,0.20002,1,1
6,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,8.5867e-06,0.19108,0.19547,1,1
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION,4.6356e-09,0.19106,0.22771,1,1
6,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00013451,0.19102,0.20743,1,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0050269,0.19097,0.19246,1,1
6,GO RESPONSE TO STEROL,0.00039018,0.19077,0.19961,1,1
6,GO RENAL TUBULE DEVELOPMENT,0.0011668,0.19072,0.16339,1,1
6,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00069207,0.19068,0.20155,1,1
6,GO NEGATIVE REGULATION OF DNA REPAIR,0.00053704,0.1905,0.14509,1,1
6,GO RESPONSE TO UV B,0.012227,0.19046,0.17798,1,1
6,GO CHROMATIN SILENCING,7.3476e-09,0.19039,0.21453,1,1
6,GO CENTROMERE COMPLEX ASSEMBLY,0.0010408,0.1902,0.18414,1,1
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00010852,0.1902,0.2186,1,1
6,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,3.0905e-06,0.1902,0.17344,1,1
6,GO MAMMARY GLAND DEVELOPMENT,0.0021215,0.19019,0.1458,1,1
6,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,6.6066e-07,0.19015,0.18975,1,1
6,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,2.4452e-09,0.19012,0.20575,1,1
6,GO DNA RECOMBINATION,2.8305e-05,0.18977,0.15641,1,1
6,GO SPECIFICATION OF SYMMETRY,4.3774e-08,0.18976,0.19789,1,1
6,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.016938,0.18936,0.1374,1,1
6,GO REGULATION OF CELL CYCLE ARREST,7.3476e-09,0.18922,0.20302,1,1
6,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.043444,0.18919,0.13784,1,1
6,GO REGULATION OF FATTY ACID OXIDATION,0.00040857,0.18917,0.19283,1,1
6,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,6.0565e-09,0.18903,0.19275,1,1
6,GO RENAL FILTRATION,0.0104,0.18869,0.28123,1,1
6,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,4.9694e-05,0.18839,0.1734,1,1
6,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00013673,0.18839,0.18009,1,1
6,GO SECRETORY GRANULE ORGANIZATION,0.00025617,0.18826,0.18175,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,3.4098e-06,0.18817,0.22829,1,1
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00012594,0.18816,0.16555,1,1
6,GO FUCOSE METABOLIC PROCESS,0.0017517,0.18812,0.18188,1,1
6,GO INOSITOL METABOLIC PROCESS,0.0059116,0.18794,0.18116,1,1
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.00040235,0.18778,0.24128,1,1
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.01585,0.18772,0.15673,1,1
6,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0092477,0.18766,0.20394,1,1
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0018508,0.18762,0.17656,1,1
6,GO REGULATION OF SPINDLE CHECKPOINT,3.5646e-05,0.1876,0.2195,1,1
6,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.016568,0.18757,0.19844,1,1
6,GO HETEROCHROMATIN ORGANIZATION,1.6994e-06,0.18743,0.18396,1,1
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,3.5794e-07,0.18735,0.20093,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,2.913e-06,0.18729,0.21099,1,1
6,GO NEGATIVE CHEMOTAXIS,0.0059116,0.18722,0.21886,1,1
6,GO MATING BEHAVIOR,0.00046165,0.18712,0.2051,1,1
6,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,3.4553e-09,0.18699,0.18679,1,1
6,GO REGULATION OF CGMP MEDIATED SIGNALING,0.039406,0.18695,0.15042,1,1
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,2.1621e-05,0.18684,0.24696,1,1
6,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,1.3196e-05,0.1868,0.21178,1,1
6,GO SEXUAL REPRODUCTION,1.2441e-09,0.18665,0.19289,1,1
6,GO REGULATION OF CIRCADIAN RHYTHM,1.2434e-08,0.18664,0.22002,1,1
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,2.1338e-07,0.18658,0.20083,1,1
6,GO SYNAPTIC VESICLE RECYCLING,1.9044e-05,0.18652,0.22246,1,1
6,GO DNA REPLICATION,2.4371e-06,0.18648,0.18731,1,1
6,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.02128,0.18623,0.18034,1,1
6,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,1.2027e-05,0.18618,0.22481,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,8.2864e-09,0.18617,0.19596,1,1
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0018256,0.18605,0.20996,1,1
6,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,9.5999e-07,0.18551,0.19024,1,1
6,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.3997e-05,0.18547,0.1671,1,1
6,GO DETECTION OF MECHANICAL STIMULUS,0.00053704,0.18545,0.2187,1,1
6,GO GLIAL CELL DIFFERENTIATION,3.2784e-06,0.18541,0.20907,1,1
6,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.00018923,0.18526,0.20237,1,1
6,GO DEVELOPMENTAL GROWTH,1.5052e-06,0.18526,0.18872,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,5.0563e-05,0.1852,0.23197,1,1
6,GO POSITIVE REGULATION OF CELL DIVISION,1.0557e-05,0.1852,0.20269,1,1
6,GO PRESYNAPTIC ENDOCYTOSIS,1.4472e-05,0.18505,0.23087,1,1
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00015583,0.18486,0.26176,1,1
6,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00010852,0.18483,0.25263,1,1
6,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.014494,0.18469,0.14721,1,1
6,GO MULTICELLULAR ORGANISM GROWTH,9.7998e-07,0.18435,0.19242,1,1
6,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00026438,0.18433,0.19206,1,1
6,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,4.7172e-05,0.18429,0.22702,1,1
6,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0034243,0.184,0.15582,1,1
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.2253e-05,0.18391,0.18804,1,1
6,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,2.4091e-05,0.18384,0.16386,1,1
6,GO REGULATION OF CELL DIVISION,1.8793e-06,0.18373,0.18193,1,1
6,GO EPITHELIAL CELL DEVELOPMENT,0.00053704,0.18362,0.1706,1,1
6,GO SUBSTANTIA NIGRA DEVELOPMENT,3.2631e-05,0.18362,0.19404,1,1
6,GO SPINDLE ORGANIZATION,1.8363e-05,0.18359,0.17737,1,1
6,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014494,0.18353,0.14366,1,1
6,GO ENDOTHELIAL CELL DEVELOPMENT,0.013546,0.1833,0.14266,1,1
6,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00029511,0.18318,0.21605,1,1
6,GO POST EMBRYONIC DEVELOPMENT,3.5646e-05,0.18315,0.19746,1,1
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00012594,0.183,0.19467,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.00018323,0.18294,0.15729,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,1.5014e-05,0.18286,0.20797,1,1
6,GO MOLTING CYCLE,0.00024045,0.18285,0.1611,1,1
6,GO PEPTIDE HORMONE SECRETION,3.7605e-06,0.18285,0.20463,1,1
6,GO PEPTIDYL LYSINE ACETYLATION,3.9035e-08,0.18275,0.19291,1,1
6,GO HORMONE MEDIATED SIGNALING PATHWAY,3.152e-06,0.18265,0.17098,1,1
6,GO HISTONE H3 K4 METHYLATION,2.6362e-08,0.1826,0.23467,1,1
6,GO REGULATION OF RNA SPLICING,1.1858e-08,0.18259,0.20365,1,1
6,GO LUNG MORPHOGENESIS,0.0056958,0.18252,0.15617,1,1
6,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1.0169e-05,0.18237,0.16518,1,1
6,GO CHROMOSOME LOCALIZATION,0.00012186,0.18234,0.1495,1,1
6,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.00013016,0.18222,0.16418,1,1
6,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.001568,0.18213,0.23652,1,1
6,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00069207,0.18211,0.23423,1,1
6,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0012005,0.18192,0.20526,1,1
6,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,6.545e-05,0.18186,0.2316,1,1
6,GO PROTEIN ACYLATION,8.2864e-09,0.18181,0.19458,1,1
6,GO ASSOCIATIVE LEARNING,1.7071e-05,0.18177,0.19497,1,1
6,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,1.2058e-07,0.18172,0.17667,1,1
6,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.001235,0.1816,0.12831,1,1
6,GO REGULATION OF JUN KINASE ACTIVITY,0.00022565,0.18152,0.15655,1,1
6,GO REGULATION OF SPINDLE ASSEMBLY,0.0023637,0.18151,0.13397,1,1
6,GO DEMETHYLATION,1.3599e-06,0.18143,0.18145,1,1
6,GO SENSORY ORGAN DEVELOPMENT,3.6435e-08,0.18121,0.22313,1,1
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,3.1479e-07,0.1811,0.1965,1,1
6,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,9.0235e-07,0.18075,0.2159,1,1
6,GO CENTROSOME SEPARATION,0.00094089,0.18074,0.16376,1,1
6,GO RECEPTOR INTERNALIZATION,0.00045468,0.18059,0.14727,1,1
6,GO ADHERENS JUNCTION ASSEMBLY,0.0025617,0.18038,0.19202,1,1
6,GO EXTRACELLULAR TRANSPORT,0.00013673,0.18034,0.239,1,1
6,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.014013,0.18024,0.16653,1,1
6,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,5.3256e-05,0.18019,0.19645,1,1
6,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.010895,0.18002,0.15274,1,1
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.2281e-06,0.17995,0.20374,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,2.4528e-05,0.17975,0.19331,1,1
6,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0078263,0.17974,0.19284,1,1
6,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0018256,0.17922,0.21863,1,1
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00088789,0.17921,0.17701,1,1
6,GO HISTONE H4 ACETYLATION,9.2118e-07,0.17884,0.18744,1,1
6,GO RESPIRATORY SYSTEM DEVELOPMENT,0.00062378,0.17881,0.17498,1,1
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.001071,0.17876,0.17618,1,1
6,GO LYMPH VESSEL MORPHOGENESIS,0.026561,0.17861,0.14952,1,1
6,GO CLATHRIN COAT ASSEMBLY,0.017506,0.1786,0.13083,1,1
6,GO MRNA EXPORT FROM NUCLEUS,0.0005056,0.1785,0.13484,1,1
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.040582,0.17816,0.13418,1,1
6,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,1.3325e-06,0.17813,0.20014,1,1
6,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0035146,0.17803,0.175,1,1
6,GO CHROMATIN SILENCING AT TELOMERE,2.3891e-06,0.17795,0.20849,1,1
6,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.00019857,0.17776,0.17217,1,1
6,GO GLIOGENESIS,5.0323e-06,0.17773,0.19328,1,1
6,GO OOGENESIS,1.1858e-08,0.17767,0.21799,1,1
6,GO PEPTIDYL LYSINE METHYLATION,2.5066e-09,0.17756,0.23607,1,1
6,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.2716e-05,0.17756,0.19961,1,1
6,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.00016901,0.17748,0.19135,1,1
6,GO MULTICELLULAR ORGANISM REPRODUCTION,5.4967e-09,0.17736,0.18054,1,1
6,GO RESPONSE TO NERVE GROWTH FACTOR,1.9393e-05,0.17735,0.20823,1,1
6,GO REGULATION OF VASCULOGENESIS,0.037509,0.17711,0.15667,1,1
6,GO REGULATION OF DNA RECOMBINATION,0.00028155,0.17676,0.15042,1,1
6,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0015038,0.17669,0.17221,1,1
6,GO ADULT LOCOMOTORY BEHAVIOR,0.00026858,0.17666,0.19445,1,1
6,GO ODONTOGENESIS,0.014823,0.17664,0.14146,1,1
6,GO REGULATION OF SISTER CHROMATID SEGREGATION,5.4184e-05,0.17634,0.18137,1,1
6,GO GLAND DEVELOPMENT,0.00010497,0.1763,0.15603,1,1
6,GO MATING,4.6359e-05,0.1761,0.18315,1,1
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023919,0.17607,0.12153,1,1
6,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.001704,0.17605,0.17006,1,1
6,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.00099681,0.17601,0.15205,1,1
6,GO TISSUE MORPHOGENESIS,0.0001862,0.17599,0.14,1,1
6,GO LACTATE METABOLIC PROCESS,0.0099244,0.17599,0.13832,1,1
6,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.01995,0.17557,0.13008,1,1
6,GO DOUBLE STRAND BREAK REPAIR,3.3214e-05,0.17555,0.16454,1,1
6,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00016098,0.17536,0.19037,1,1
6,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,5.8698e-06,0.17536,0.16907,1,1
6,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00023667,0.17531,0.18865,1,1
6,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0005056,0.17525,0.18839,1,1
6,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,9.795e-06,0.17492,0.17057,1,1
6,GO REGULATION OF CHROMOSOME SEGREGATION,3.1494e-05,0.17489,0.18122,1,1
6,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0047198,0.17481,0.1523,1,1
6,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,2.8262e-08,0.1748,0.17168,1,1
6,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.014494,0.17477,0.168,1,1
6,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.011813,0.17466,0.13127,1,1
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00059648,0.17454,0.14909,1,1
6,GO INTRACELLULAR MRNA LOCALIZATION,0.0013069,0.17439,0.18807,1,1
6,GO LIPID TRANSLOCATION,0.0039992,0.17438,0.17963,1,1
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.00047589,0.17418,0.19502,1,1
6,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00016361,0.1739,0.15982,1,1
6,GO GAMMA DELTA T CELL DIFFERENTIATION,0.024947,0.17387,0.24329,1,1
6,GO HEART MORPHOGENESIS,8.2686e-06,0.17385,0.19832,1,1
6,GO MEIOSIS I CELL CYCLE PROCESS,8.4262e-06,0.17381,0.18892,1,1
6,GO CELLULAR RESPONSE TO STEROL,9.819e-05,0.17372,0.23473,1,1
6,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0015463,0.17366,0.14685,1,1
6,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00014599,0.17357,0.15205,1,1
6,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.00041488,0.17343,0.22931,1,1
6,GO REGULATION OF MRNA POLYADENYLATION,1.6457e-05,0.17298,0.19378,1,1
6,GO MITOTIC CHROMOSOME CONDENSATION,0.00027284,0.17288,0.22055,1,1
6,GO ANIMAL ORGAN MORPHOGENESIS,1.5576e-05,0.17286,0.16673,1,1
6,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00039018,0.17254,0.14391,1,1
6,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00052901,0.17242,0.25515,1,1
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0062877,0.17237,0.1964,1,1
6,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,3.5461e-06,0.17234,0.18575,1,1
6,GO DNA PACKAGING,1.0557e-05,0.17226,0.17865,1,1
6,GO MISMATCH REPAIR,5.9498e-07,0.17218,0.20099,1,1
6,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0018764,0.17126,0.21412,1,1
6,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,3.2894e-09,0.17126,0.21864,1,1
6,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00029052,0.17124,0.20423,1,1
6,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,7.3739e-05,0.17104,0.16474,1,1
6,GO ACTIVATION OF GTPASE ACTIVITY,0.00024819,0.17093,0.15474,1,1
6,GO TRANSMISSION OF NERVE IMPULSE,0.00075607,0.17092,0.2186,1,1
6,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00028155,0.17085,0.2255,1,1
6,GO NEPHRON EPITHELIUM DEVELOPMENT,0.00072342,0.17077,0.17401,1,1
6,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0072795,0.17068,0.15299,1,1
6,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00031414,0.17055,0.13737,1,1
6,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.043866,0.17048,0.1249,1,1
6,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.027973,0.17034,0.10138,1,1
6,GO CHONDROCYTE DEVELOPMENT,0.0013826,0.17033,0.19515,1,1
6,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00031907,0.1703,0.14455,1,1
6,GO PROTEIN KINASE C SIGNALING,0.0066851,0.17019,0.18565,1,1
6,GO CYTOKINESIS,6.337e-06,0.16993,0.1598,1,1
6,GO CELL CYCLE ARREST,1.9175e-06,0.16982,0.16324,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0028492,0.16975,0.13857,1,1
6,GO MITOTIC DNA INTEGRITY CHECKPOINT,3.1729e-08,0.1697,0.20197,1,1
6,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.011022,0.16965,0.11168,1,1
6,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0023957,0.16962,0.15732,1,1
6,GO CARDIAC CHAMBER MORPHOGENESIS,0.00075607,0.16957,0.17791,1,1
6,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,1.5293e-05,0.16937,0.19876,1,1
6,GO REGULATION OF CELL DIFFERENTIATION,3.9872e-06,0.16929,0.16196,1,1
6,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0011836,0.16923,0.23394,1,1
6,GO HISTONE H3 K4 TRIMETHYLATION,0.00091404,0.16922,0.16015,1,1
6,GO GLIAL CELL MIGRATION,0.018091,0.16902,0.12542,1,1
6,GO HISTONE METHYLATION,3.2094e-09,0.16897,0.23199,1,1
6,GO REGULATION OF PROTEIN DEACETYLATION,0.00059648,0.16896,0.15993,1,1
6,GO THYMUS DEVELOPMENT,5.8262e-07,0.16893,0.22823,1,1
6,GO DNA INTEGRITY CHECKPOINT,1.9558e-07,0.16886,0.1885,1,1
6,GO NEUROMUSCULAR PROCESS,6.8396e-06,0.16882,0.2208,1,1
6,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.0035605,0.16878,0.18048,1,1
6,GO ASYMMETRIC CELL DIVISION,0.0086125,0.16873,0.17768,1,1
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,8.1361e-07,0.16848,0.20939,1,1
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,8.1623e-05,0.16837,0.19949,1,1
6,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0020367,0.16829,0.1557,1,1
6,GO NUCLEOSOME ORGANIZATION,1.3196e-05,0.16827,0.17744,1,1
6,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,3.5038e-07,0.16827,0.19233,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.022686,0.16804,0.17818,1,1
6,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00024045,0.168,0.1593,1,1
6,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00091404,0.168,0.19095,1,1
6,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.1751e-05,0.16788,0.1662,1,1
6,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.016205,0.16777,0.18746,1,1
6,GO EPITHELIAL CELL PROLIFERATION,0.0066851,0.1677,0.12206,1,1
6,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0013069,0.16769,0.13266,1,1
6,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00022208,0.16718,0.15292,1,1
6,GO CANONICAL WNT SIGNALING PATHWAY,0.00037835,0.16715,0.13995,1,1
6,GO REGULATION OF PHOSPHATASE ACTIVITY,5.3562e-07,0.16709,0.18791,1,1
6,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00083767,0.16708,0.17718,1,1
6,GO DNA DEPENDENT DNA REPLICATION,6.2169e-06,0.16694,0.18543,1,1
6,GO CELL CELL SIGNALING,2.4861e-06,0.16687,0.16863,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00018323,0.16671,0.16525,1,1
6,GO DNA CONFORMATION CHANGE,2.4972e-05,0.16667,0.1657,1,1
6,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0038977,0.16663,0.14226,1,1
6,GO RNA DESTABILIZATION,0.00019541,0.16634,0.16039,1,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0027381,0.16609,0.16237,1,1
6,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.016752,0.16609,0.12819,1,1
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,6.2175e-05,0.16588,0.17662,1,1
6,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,8.8389e-07,0.16579,0.17759,1,1
6,GO REPRODUCTION,3.357e-07,0.1657,0.15946,1,1
6,GO REGULATION OF MRNA 3 END PROCESSING,3.4409e-05,0.16529,0.1796,1,1
6,GO NEURON PROJECTION REGENERATION,0.00013673,0.16523,0.21703,1,1
6,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0042095,0.16519,0.14377,1,1
6,GO MEMBRANE BIOGENESIS,0.00036124,0.16515,0.23147,1,1
6,GO MICROTUBULE NUCLEATION,0.0017277,0.16506,0.17112,1,1
6,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0028872,0.16499,0.20378,1,1
6,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,3.152e-06,0.16486,0.16293,1,1
6,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,2.3891e-06,0.16457,0.18548,1,1
6,GO GAMMA DELTA T CELL ACTIVATION,0.014013,0.16437,0.19197,1,1
6,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.016938,0.16436,0.25076,1,1
6,GO REGULATION OF NEURON MATURATION,0.014658,0.16432,0.1651,1,1
6,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0005618,0.16425,0.16055,1,1
6,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,1.6654e-06,0.16418,0.18705,1,1
6,GO ENDOTHELIUM DEVELOPMENT,0.0023637,0.16405,0.16251,1,1
6,GO FERTILIZATION,3.9822e-07,0.16396,0.16978,1,1
6,GO REGULATION OF DNA REPLICATION,3.4098e-06,0.16381,0.17639,1,1
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.5865e-05,0.16378,0.21441,1,1
6,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00034485,0.16349,0.13754,1,1
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00026438,0.16348,0.16231,1,1
6,GO NEUROTRANSMITTER REUPTAKE,0.0059852,0.16347,0.17396,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,5.8049e-05,0.16344,0.14705,1,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.001422,0.1632,0.18166,1,1
6,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0018508,0.16296,0.24155,1,1
6,GO REGULATION OF WNT SIGNALING PATHWAY,0.00015331,0.16273,0.14359,1,1
6,GO ACTIVATION OF JNKK ACTIVITY,0.0058389,0.16255,0.15838,1,1
6,GO REGULATION OF LYASE ACTIVITY,0.00025215,0.16253,0.18224,1,1
6,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.038637,0.16251,0.13958,1,1
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00046872,0.16238,0.27584,1,1
6,GO DEVELOPMENTAL MATURATION,1.996e-06,0.16218,0.18577,1,1
6,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0067673,0.16217,0.13991,1,1
6,GO MRNA PROCESSING,9.819e-05,0.16178,0.14207,1,1
6,GO AXIS SPECIFICATION,4.5684e-06,0.16169,0.19659,1,1
6,GO REGULATION OF CHROMOSOME SEPARATION,0.00030449,0.16145,0.16328,1,1
6,GO REGULATION OF SPINDLE ORGANIZATION,0.0013069,0.16129,0.13352,1,1
6,GO REGULATION OF DNA BINDING,1.7154e-07,0.16122,0.18218,1,1
6,GO EXIT FROM MITOSIS,0.0001179,0.16116,0.1599,1,1
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0012005,0.16074,0.15367,1,1
6,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00022565,0.16063,0.16889,1,1
6,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.00068191,0.16055,0.21651,1,1
6,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0022396,0.1602,0.15784,1,1
6,GO MYOBLAST DIFFERENTIATION,0.0083098,0.16002,0.10699,1,1
6,GO MULTI ORGANISM PROCESS,8.8282e-08,0.15984,0.16032,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.001776,0.15984,0.20727,1,1
6,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00010673,0.15968,0.16748,1,1
6,GO PROTEIN METHYLATION,1.7721e-08,0.15961,0.20477,1,1
6,GO SISTER CHROMATID COHESION,1.3693e-05,0.15951,0.19188,1,1
6,GO ORGANELLE LOCALIZATION,2.1621e-05,0.15946,0.14001,1,1
6,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0011836,0.15944,0.14753,1,1
6,GO ENTRAINMENT OF CIRCADIAN CLOCK,3.5646e-05,0.15938,0.18914,1,1
6,GO NUCLEAR CHROMOSOME SEGREGATION,3.6877e-06,0.15925,0.17661,1,1
6,GO ACTIVATION OF MAPKKK ACTIVITY,0.01128,0.15922,0.17744,1,1
6,GO INTERSTRAND CROSS LINK REPAIR,6.5837e-06,0.15917,0.18729,1,1
6,GO NEUROTROPHIN SIGNALING PATHWAY,0.00099681,0.15915,0.16609,1,1
6,GO PROTEIN AUTO ADP RIBOSYLATION,0.012798,0.15913,0.19158,1,1
6,GO CELLULAR GLUCAN METABOLIC PROCESS,0.001442,0.15825,0.14113,1,1
6,GO HISTONE DEACETYLATION,0.00011406,0.15815,0.16807,1,1
6,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.2414e-06,0.15738,0.18592,1,1
6,GO DNA GEOMETRIC CHANGE,0.00011986,0.1571,0.1554,1,1
6,GO CHROMOSOME SEGREGATION,7.8124e-06,0.157,0.17506,1,1
6,GO REGULATION OF CHROMOSOME ORGANIZATION,1.3056e-06,0.15685,0.15794,1,1
6,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.021509,0.15678,0.18826,1,1
6,GO CELL CYCLE CHECKPOINT,1.7534e-07,0.15649,0.18641,1,1
6,GO HISTONE UBIQUITINATION,2.2505e-06,0.15649,0.16613,1,1
6,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0015249,0.15647,0.21997,1,1
6,GO MITOTIC CYTOKINESIS,0.0011021,0.15632,0.11753,1,1
6,GO BONE DEVELOPMENT,0.0020367,0.1563,0.13439,1,1
6,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,1.9044e-05,0.15619,0.20779,1,1
6,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00030928,0.15619,0.18518,1,1
6,GO SKELETAL MUSCLE CELL DIFFERENTIATION,1.9749e-05,0.1559,0.18339,1,1
6,GO MEIOTIC SPINDLE ORGANIZATION,0.0002117,0.15589,0.20702,1,1
6,GO CYTOSKELETON ORGANIZATION,3.6162e-06,0.15588,0.16209,1,1
6,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,1.475e-06,0.15586,0.17922,1,1
6,GO SKELETAL SYSTEM DEVELOPMENT,0.00029052,0.15568,0.13675,1,1
6,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0011503,0.15554,0.1895,1,1
6,GO RNA POLYADENYLATION,0.010041,0.15545,0.11734,1,1
6,GO NUCLEOSOME ASSEMBLY,6.3249e-05,0.15517,0.18986,1,1
6,GO MITOTIC SPINDLE ASSEMBLY,0.000662,0.15513,0.15453,1,1
6,GO CHROMATIN REMODELING,1.1316e-06,0.1551,0.18573,1,1
6,GO NEURON APOPTOTIC PROCESS,3.4773e-06,0.15507,0.16089,1,1
6,GO REGULATION OF INSULIN SECRETION,2.1234e-05,0.15506,0.1897,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,6.4341e-05,0.15502,0.18387,1,1
6,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0094686,0.15481,0.18951,1,1
6,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00037835,0.15478,0.17952,1,1
6,GO COVALENT CHROMATIN MODIFICATION,8.9487e-10,0.15463,0.20709,1,1
6,GO REGULATION OF GLUCOSE IMPORT,0.0005133,0.15447,0.15943,1,1
6,GO MUSCLE ORGAN MORPHOGENESIS,0.00039622,0.15441,0.15867,1,1
6,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.012798,0.15426,0.15069,1,1
6,GO TELOMERE CAPPING,8.1623e-05,0.15425,0.15109,1,1
6,GO CELL CELL SIGNALING BY WNT,9.6562e-05,0.15415,0.14475,1,1
6,GO DNA REPAIR,6.6578e-05,0.15393,0.13834,1,1
6,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.0073682,0.15383,0.16478,1,1
6,GO GOLGI RIBBON FORMATION,0.00037257,0.15347,0.19321,1,1
6,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,3.094e-05,0.15347,0.20527,1,1
6,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0020092,0.1534,0.15947,1,1
6,GO CHROMATIN ORGANIZATION,2.1064e-09,0.15329,0.20527,1,1
6,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00028155,0.15302,0.13557,1,1
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.9711e-06,0.15278,0.15159,1,1
6,GO REGULATION OF TELOMERE CAPPING,0.0035146,0.1527,0.12601,1,1
6,GO REGULATION OF CENTROSOME CYCLE,2.5884e-05,0.15269,0.18358,1,1
6,GO HORMONE TRANSPORT,4.7999e-05,0.15239,0.16638,1,1
6,GO METAPHASE PLATE CONGRESSION,0.00036124,0.15239,0.13742,1,1
6,GO HEAT GENERATION,0.00045468,0.15212,0.19169,1,1
6,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0005789,0.15167,0.14585,1,1
6,GO SPERM CAPACITATION,0.0074579,0.15133,0.14218,1,1
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0049019,0.15127,0.14223,1,1
6,GO INSULIN SECRETION,2.4972e-05,0.15117,0.19185,1,1
6,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.021053,0.15116,0.13565,1,1
6,GO MAINTENANCE OF CELL POLARITY,0.013093,0.1511,0.15897,1,1
6,GO CELL CYCLE PROCESS,2.6914e-06,0.1508,0.14762,1,1
6,GO RNA SPLICING,7.0072e-05,0.15064,0.14083,1,1
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.2175e-05,0.15058,0.1606,1,1
6,GO HISTONE H3 DEACETYLATION,1.9749e-05,0.15057,0.2037,1,1
6,GO ORGANELLE ASSEMBLY,2.3274e-07,0.15034,0.15966,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.0018508,0.15024,0.13579,1,1
6,GO SISTER CHROMATID SEGREGATION,4.7172e-05,0.15008,0.16552,1,1
6,GO INOSITOL LIPID MEDIATED SIGNALING,0.0063654,0.14999,0.12166,1,1
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00026858,0.14995,0.15231,1,1
6,GO VESICLE DOCKING,0.0021505,0.14971,0.14188,1,1
6,GO FEEDING BEHAVIOR,8.0256e-05,0.14961,0.17672,1,1
6,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00082553,0.14952,0.14466,1,1
6,GO CELL CYCLE G2 M PHASE TRANSITION,0.00074504,0.14951,0.12244,1,1
6,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.013394,0.14943,0.17326,1,1
6,GO ORGANELLE FISSION,4.7488e-06,0.14927,0.15349,1,1
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0015463,0.14915,0.14707,1,1
6,GO REGULATION OF CHROMATIN ORGANIZATION,1.1579e-08,0.14915,0.19173,1,1
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,7.7586e-05,0.14892,0.15294,1,1
6,GO HISTONE H3 K9 ACETYLATION,0.00011596,0.14886,0.17652,1,1
6,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,5.6245e-08,0.14885,0.15996,1,1
6,GO REGULATION OF MEMBRANE PERMEABILITY,0.0002443,0.14883,0.14049,1,1
6,GO POSITIVE REGULATION OF DNA REPLICATION,2.5424e-05,0.14864,0.1596,1,1
6,GO MITOTIC SISTER CHROMATID SEGREGATION,0.0001862,0.14856,0.15232,1,1
6,GO HISTONE DEUBIQUITINATION,0.00028155,0.14835,0.17127,1,1
6,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0054192,0.1483,0.10338,1,1
6,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00014129,0.14825,0.16905,1,1
6,GO REGULATION OF CELL CYCLE PROCESS,1.9175e-06,0.14816,0.14789,1,1
6,GO CHROMOSOME ORGANIZATION,8.0712e-08,0.1481,0.17454,1,1
6,GO CIRCADIAN RHYTHM,2.7452e-06,0.1481,0.16386,1,1
6,GO REGULATION OF FEEDING BEHAVIOR,0.00060545,0.14801,0.18919,1,1
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0050269,0.14795,0.13711,1,1
6,GO LABYRINTHINE LAYER DEVELOPMENT,0.0098086,0.14792,0.16328,1,1
6,GO EATING BEHAVIOR,0.00045468,0.14774,0.15409,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.015159,0.14747,0.11685,1,1
6,GO RHYTHMIC PROCESS,2.1807e-07,0.14729,0.17888,1,1
6,GO TORC1 SIGNALING,7.3803e-06,0.14718,0.19792,1,1
6,GO VIRAL RNA GENOME REPLICATION,0.020605,0.14715,0.10721,1,1
6,GO SINGLE FERTILIZATION,2.4861e-06,0.147,0.15972,1,1
6,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,1.2604e-07,0.14669,0.16333,1,1
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0034692,0.14668,0.1687,1,1
6,GO POSITIVE REGULATION OF CYTOKINESIS,8.8796e-05,0.14667,0.1805,1,1
6,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0078263,0.14666,0.14651,1,1
6,GO PROTEIN AUTOUBIQUITINATION,0.00012594,0.14666,0.13862,1,1
6,GO CELL DIVISION,2.342e-06,0.14661,0.16393,1,1
6,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.012798,0.14652,0.13397,1,1
6,GO ANIMAL ORGAN MATURATION,0.00014839,0.14648,0.20554,1,1
6,GO REGULATION OF HORMONE SECRETION,3.628e-05,0.14647,0.16964,1,1
6,GO NEUROTRANSMITTER UPTAKE,0.0092477,0.14638,0.1397,1,1
6,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0084096,0.1463,0.20435,1,1
6,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0049019,0.14617,0.19803,1,1
6,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0038478,0.14608,0.13351,1,1
6,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0035605,0.14602,0.12908,1,1
6,GO SPINDLE ASSEMBLY,8.3013e-05,0.14593,0.1575,1,1
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0085105,0.14584,0.12247,1,1
6,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00029052,0.14573,0.18515,1,1
6,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0020092,0.14567,0.13231,1,1
6,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0020929,0.14564,0.1198,1,1
6,GO RESPONSE TO COCAINE,3.758e-05,0.14546,0.21953,1,1
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0029645,0.14526,0.13576,1,1
6,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.024428,0.1452,0.11616,1,1
6,GO LIPOPROTEIN LOCALIZATION,0.008211,0.14518,0.14246,1,1
6,GO MAMMARY GLAND MORPHOGENESIS,0.0099244,0.145,0.15856,1,1
6,GO REGULATION OF OOGENESIS,0.00037257,0.14496,0.14601,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0019023,0.14459,0.14923,1,1
6,GO RAC PROTEIN SIGNAL TRANSDUCTION,6.6578e-05,0.14454,0.16865,1,1
6,GO POSITIVE REGULATION OF DNA BINDING,0.00010497,0.14446,0.16093,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE,3.0302e-06,0.14445,0.14128,1,1
6,GO NEGATIVE REGULATION OF OSSIFICATION,0.020166,0.1443,0.11745,1,1
6,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0028492,0.14402,0.13724,1,1
6,GO LIPID PHOSPHORYLATION,5.1446e-05,0.14395,0.15872,1,1
6,GO FEAR RESPONSE,0.00017457,0.14371,0.18104,1,1
6,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,1.6158e-05,0.1436,0.1511,1,1
6,GO REGULATION OF HISTONE MODIFICATION,8.2543e-08,0.14352,0.18371,1,1
6,GO NEGATIVE REGULATION OF NEURON DEATH,1.7385e-05,0.1434,0.15377,1,1
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00016901,0.14339,0.18458,1,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.01829,0.14274,0.16135,1,1
6,GO CELLULAR RESPONSE TO UV,1.4741e-05,0.14273,0.16606,1,1
6,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0014022,0.14268,0.1829,1,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,5.5127e-05,0.14266,0.14698,1,1
6,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.059879,0.14265,0.080526,1,1
6,GO MITOTIC NUCLEAR DIVISION,4.7999e-05,0.14262,0.15547,1,1
6,GO POTASSIUM ION TRANSPORT,7.6283e-05,0.14238,0.19313,1,1
6,GO GANGLIOSIDE METABOLIC PROCESS,0.008211,0.14236,0.15366,1,1
6,GO MITOCHONDRIAL GENOME MAINTENANCE,0.00044103,0.14232,0.1574,1,1
6,GO REGULATION OF MITOCHONDRIAL FISSION,0.0073682,0.14231,0.11674,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00081356,0.1423,0.13351,1,1
6,GO NUCLEAR EXPORT,0.0025277,0.14207,0.11154,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0002443,0.14192,0.13839,1,1
6,GO REGULATION OF CELL CYCLE,3.6567e-07,0.14184,0.1484,1,1
6,GO MRNA METHYLATION,0.008211,0.14184,0.14009,1,1
6,GO MRNA TRANSPORT,0.00031414,0.14179,0.13095,1,1
6,GO JNK CASCADE,0.0057669,0.14178,0.10547,1,1
6,GO RNA EXPORT FROM NUCLEUS,0.0073682,0.14173,0.10607,1,1
6,GO MUSCLE CELL MIGRATION,0.036409,0.1417,0.11285,1,1
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00074504,0.14169,0.1381,1,1
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0027381,0.14153,0.12619,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.9136e-07,0.14097,0.16433,1,1
6,GO DNA METHYLATION OR DEMETHYLATION,7.6283e-05,0.14094,0.13134,1,1
6,GO NEGATIVE REGULATION OF BINDING,0.00011033,0.14094,0.13814,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,2.342e-06,0.14073,0.14761,1,1
6,GO HISTONE PHOSPHORYLATION,0.00042777,0.14069,0.14841,1,1
6,GO MIDBRAIN DEVELOPMENT,9.086e-06,0.14057,0.15714,1,1
6,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,1.2716e-05,0.14054,0.14179,1,1
6,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,1.5293e-05,0.14052,0.14485,1,1
6,GO MRNA 3 END PROCESSING,0.00065224,0.14051,0.14024,1,1
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00033955,0.14026,0.12975,1,1
6,GO REGULATION OF SENSORY PERCEPTION,0.0022095,0.13982,0.12291,1,1
6,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00088789,0.13956,0.13058,1,1
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,7.0072e-05,0.13952,0.17729,1,1
6,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.01585,0.13937,0.11204,1,1
6,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,1.536e-06,0.13928,0.16968,1,1
6,GO CELLULAR RESPONSE TO LIGHT STIMULUS,3.9872e-06,0.13921,0.14341,1,1
6,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,4.0314e-05,0.13898,0.16582,1,1
6,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.038637,0.1388,0.13692,1,1
6,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00098255,0.13869,0.13527,1,1
6,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0015249,0.13861,0.12565,1,1
6,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0032501,0.13861,0.17596,1,1
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00036124,0.13831,0.14123,1,1
6,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0042095,0.13795,0.10254,1,1
6,GO NEGATIVE REGULATION OF RNA SPLICING,3.0395e-05,0.13768,0.15062,1,1
6,GO MUSCLE TISSUE DEVELOPMENT,0.00011596,0.1375,0.13289,1,1
6,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0013826,0.13742,0.13767,1,1
6,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00070238,0.13734,0.14903,1,1
6,GO PROTEIN DEPHOSPHORYLATION,1.3948e-05,0.13721,0.13737,1,1
6,GO T CELL DIFFERENTIATION IN THYMUS,0.0019819,0.13691,0.13037,1,1
6,GO FEMALE GAMETE GENERATION,1.1794e-07,0.13681,0.17449,1,1
6,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.0012886,0.13655,0.10458,1,1
6,GO NEUROTRANSMITTER METABOLIC PROCESS,0.036772,0.13642,0.13026,1,1
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.03429,0.13609,0.13135,1,1
6,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,5.0563e-05,0.13598,0.15713,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,8.0256e-05,0.13579,0.12579,1,1
6,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,4.5558e-05,0.13579,0.14678,1,1
6,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.016027,0.13571,0.15674,1,1
6,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00099681,0.13569,0.1335,1,1
6,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.016386,0.13559,0.13193,1,1
6,GO RESPONSE TO X RAY,0.012653,0.13555,0.10692,1,1
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00015583,0.13553,0.13828,1,1
6,GO REGULATION OF MRNA METABOLIC PROCESS,0.00088789,0.13551,0.11139,1,1
6,GO ONE CARBON METABOLIC PROCESS,0.022686,0.13527,0.10603,1,1
6,GO MITOTIC G1 S TRANSITION CHECKPOINT,7.8124e-06,0.13523,0.18093,1,1
6,GO MUSCLE CELL DEVELOPMENT,0.0038478,0.1352,0.11856,1,1
6,GO DENDRITIC SPINE MAINTENANCE,0.0047198,0.13516,0.20148,1,1
6,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00020504,0.13485,0.13857,1,1
6,GO REGULATION OF DEPHOSPHORYLATION,1.4454e-06,0.13476,0.1679,1,1
6,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00092737,0.13459,0.1863,1,1
6,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0023009,0.13434,0.15833,1,1
6,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0086125,0.13432,0.10781,1,1
6,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.03429,0.13418,0.10752,1,1
6,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.001442,0.13418,0.11414,1,1
6,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00024045,0.13413,0.11839,1,1
6,GO CELL CYCLE,1.6321e-06,0.13407,0.14426,1,1
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0051547,0.13395,0.14379,1,1
6,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,2.4972e-05,0.13384,0.12972,1,1
6,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.040582,0.13375,0.099834,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.01995,0.13365,0.092092,1,1
6,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0033799,0.13356,0.18246,1,1
6,GO BROWN FAT CELL DIFFERENTIATION,0.0023637,0.13352,0.17101,1,1
6,GO GOLGI LOCALIZATION,0.046921,0.13352,0.078864,1,1
6,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.002631,0.13303,0.11673,1,1
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0005211,0.13273,0.14274,1,1
6,GO CYTOSKELETON DEPENDENT CYTOKINESIS,9.4959e-05,0.13265,0.13838,1,1
6,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0020367,0.13262,0.11239,1,1
6,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,5.9056e-05,0.13257,0.17524,1,1
6,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00025215,0.13241,0.11948,1,1
6,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.002702,0.13229,0.16051,1,1
6,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1.3948e-05,0.1322,0.14038,1,1
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0078263,0.13211,0.10703,1,1
6,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,9.819e-05,0.1321,0.1654,1,1
6,GO ANOIKIS,0.028556,0.13204,0.13425,1,1
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,4.1751e-05,0.13196,0.13693,1,1
6,GO ERROR PRONE TRANSLESION SYNTHESIS,2.0853e-05,0.1319,0.17598,1,1
6,GO REGULATION OF CENTROSOME DUPLICATION,9.9844e-05,0.13179,0.17984,1,1
6,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,7.1274e-05,0.13165,0.14626,1,1
6,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.004964,0.13145,0.12069,1,1
6,GO KERATINOCYTE PROLIFERATION,0.046031,0.1313,0.11972,1,1
6,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0030436,0.13116,0.17747,1,1
6,GO REGULATION OF STEM CELL DIVISION,0.018091,0.13108,0.14421,1,1
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0024941,0.13107,0.14304,1,1
6,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.024687,0.13073,0.11133,1,1
6,GO CELL VOLUME HOMEOSTASIS,0.0030436,0.13067,0.14005,1,1
6,GO REGULATION OF VASOCONSTRICTION,0.0028872,0.13053,0.14263,1,1
6,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0088198,0.13046,0.17959,1,1
6,GO INTRACELLULAR LIPID TRANSPORT,0.026838,0.13033,0.12209,1,1
6,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.8419e-06,0.13004,0.14827,1,1
6,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0049019,0.12987,0.10191,1,1
6,GO PROTEIN MONOUBIQUITINATION,0.00083767,0.12987,0.12583,1,1
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00039622,0.12966,0.11566,1,1
6,GO DETECTION OF VISIBLE LIGHT,5.5127e-05,0.12965,0.11491,1,1
6,GO OXIDATIVE DEMETHYLATION,0.0069343,0.12951,0.081359,1,1
6,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00015838,0.12949,0.18173,1,1
6,GO MITOTIC CELL CYCLE,8.3013e-05,0.12938,0.12978,1,1
6,GO DEPHOSPHORYLATION,2.0853e-05,0.12935,0.13407,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.057711,0.12928,0.097462,1,1
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.016027,0.1292,0.15052,1,1
6,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.011949,0.1289,0.099483,1,1
6,GO METANEPHRIC NEPHRON DEVELOPMENT,0.020385,0.12887,0.14912,1,1
6,GO VESICLE LOCALIZATION,0.0059116,0.12883,0.099656,1,1
6,GO POSITIVE REGULATION OF JNK CASCADE,0.023173,0.12871,0.10309,1,1
6,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.024173,0.12847,0.15038,1,1
6,GO EPITHELIUM DEVELOPMENT,0.0020646,0.12828,0.11963,1,1
6,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.010279,0.12818,0.13407,1,1
6,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,7.5001e-05,0.12813,0.14724,1,1
6,GO LACTATION,0.02128,0.128,0.10631,1,1
6,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0034243,0.12781,0.10731,1,1
6,GO POLYSACCHARIDE METABOLIC PROCESS,0.0050904,0.12771,0.11597,1,1
6,GO PLACENTA DEVELOPMENT,0.011544,0.12766,0.11701,1,1
6,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0035605,0.12737,0.18065,1,1
6,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0016122,0.12723,0.14937,1,1
6,GO UV DAMAGE EXCISION REPAIR,0.0016806,0.12685,0.15192,1,1
6,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0054192,0.12666,0.16067,1,1
6,GO REGULATION OF MITOTIC CELL CYCLE,5.0563e-05,0.12651,0.12491,1,1
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0039481,0.12628,0.13441,1,1
6,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.035691,0.12623,0.08854,1,1
6,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00026438,0.1262,0.12024,1,1
6,GO EPITHELIAL STRUCTURE MAINTENANCE,0.004964,0.12614,0.14297,1,1
6,GO REGULATION OF HAIR CYCLE,0.0018006,0.12609,0.16067,1,1
6,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.039795,0.12585,0.07351,1,1
6,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0092477,0.12556,0.11209,1,1
6,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0013826,0.12553,0.10887,1,1
6,GO REGULATION OF CELL AGING,0.0034243,0.12527,0.13113,1,1
6,GO GROOMING BEHAVIOR,0.019104,0.12527,0.15447,1,1
6,GO MUSCLE CELL DIFFERENTIATION,0.00035024,0.12518,0.13732,1,1
6,GO DNA METABOLIC PROCESS,6.0079e-05,0.12517,0.12321,1,1
6,GO CELLULAR RESPONSE TO STARVATION,0.00073415,0.12513,0.12739,1,1
6,GO NUCLEAR TRANSPORT,0.00073415,0.12501,0.11473,1,1
6,GO CELL CYCLE PHASE TRANSITION,0.00040235,0.1249,0.1152,1,1
6,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00017176,0.12482,0.13275,1,1
6,GO REGULATION OF GENE EXPRESSION EPIGENETIC,1.0791e-07,0.12468,0.1651,1,1
6,GO ENERGY RESERVE METABOLIC PROCESS,0.0021215,0.1246,0.13229,1,1
6,GO METANEPHROS DEVELOPMENT,0.008211,0.12448,0.13683,1,1
6,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0080166,0.12442,0.098398,1,1
6,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0032501,0.12376,0.11495,1,1
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0069343,0.12368,0.095685,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00011986,0.12347,0.14414,1,1
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.012367,0.12328,0.062953,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.060432,0.1232,0.084533,1,1
6,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.011151,0.12296,0.15698,1,1
6,GO HYPEROSMOTIC RESPONSE,0.0029256,0.12259,0.14924,1,1
6,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0016806,0.12209,0.13741,1,1
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00011406,0.12198,0.11471,1,1
6,GO SODIUM ION TRANSPORT,0.00069207,0.12183,0.14372,1,1
6,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00091404,0.12169,0.11891,1,1
6,GO PROTEIN K48 LINKED UBIQUITINATION,0.027401,0.12165,0.08806,1,1
6,GO PEPTIDYL AMINO ACID MODIFICATION,0.00016629,0.12153,0.11336,1,1
6,GO REGULATION OF SODIUM ION TRANSPORT,0.0012005,0.12146,0.1576,1,1
6,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.041789,0.12044,0.08313,1,1
6,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0037016,0.12012,0.10676,1,1
6,GO NEURON DEATH,0.00010673,0.12004,0.13579,1,1
6,GO RECEPTOR METABOLIC PROCESS,0.0033361,0.1199,0.11433,1,1
6,GO CHLORIDE TRANSPORT,0.0012177,0.11979,0.13254,1,1
6,GO IMPORT INTO NUCLEUS,0.0012705,0.11973,0.11054,1,1
6,GO ASTROCYTE DIFFERENTIATION,0.0052197,0.11934,0.13988,1,1
6,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0055559,0.11933,0.095934,1,1
6,GO RESPONSE TO AMINO ACID STARVATION,0.0013826,0.11933,0.14799,1,1
6,GO NEGATIVE REGULATION OF SIGNALING,0.0011503,0.11917,0.1112,1,1
6,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.010895,0.11916,0.13577,1,1
6,GO POSITIVE REGULATION OF NUCLEAR DIVISION,8.1138e-06,0.11895,0.14278,1,1
6,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.003654,0.11894,0.11178,1,1
6,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0073682,0.11885,0.10134,1,1
6,GO DETECTION OF LIGHT STIMULUS,0.00049053,0.11883,0.091824,1,1
6,GO RESPONSE TO UV,3.4409e-05,0.1188,0.14957,1,1
6,GO REGULATION OF HORMONE LEVELS,0.0013826,0.11879,0.11899,1,1
6,GO GOLGI ORGANIZATION,0.01829,0.11871,0.078208,1,1
6,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0021798,0.1187,0.12397,1,1
6,GO RESPONSE TO COLD,0.055609,0.11862,0.10544,1,1
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010769,0.11856,0.086105,1,1
6,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.018693,0.11856,0.13149,1,1
6,GO DETECTION OF ABIOTIC STIMULUS,3.628e-05,0.11856,0.15031,1,1
6,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.0019023,0.11847,0.13073,1,1
6,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.033948,0.11844,0.09814,1,1
6,GO PROTEIN AUTOPHOSPHORYLATION,0.0068504,0.11834,0.11292,1,1
6,GO REGULATION OF GLIAL CELL MIGRATION,0.0023637,0.11827,0.12784,1,1
6,GO LIPOPROTEIN METABOLIC PROCESS,0.011411,0.11825,0.0902,1,1
6,GO RNA DECAPPING,0.026286,0.11807,0.095016,1,1
6,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0032928,0.11767,0.10847,1,1
6,GO FAT CELL DIFFERENTIATION,0.0063654,0.11749,0.11804,1,1
6,GO PROTEOGLYCAN METABOLIC PROCESS,0.0071051,0.11739,0.13351,1,1
6,GO RESPONSE TO LIGHT STIMULUS,1.5865e-05,0.11694,0.12947,1,1
6,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.00033432,0.1166,0.13525,1,1
6,GO REGULATION OF DNA METABOLIC PROCESS,1.6158e-05,0.11628,0.13358,1,1
6,GO ACROSOME REACTION,0.0025617,0.11592,0.18156,1,1
6,GO CYTOSOLIC TRANSPORT,0.0052854,0.1159,0.10997,1,1
6,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.016027,0.11545,0.081242,1,1
6,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.049681,0.11535,0.067606,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00091404,0.11531,0.099463,1,1
6,GO REGULATION OF HISTONE DEACETYLATION,0.034984,0.11506,0.11426,1,1
6,GO SENSORY PERCEPTION OF LIGHT STIMULUS,8.7316e-05,0.115,0.12118,1,1
6,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.045155,0.1148,0.080943,1,1
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0056255,0.11479,0.13403,1,1
6,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.052575,0.11466,0.11108,1,1
6,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.007921,0.11455,0.093275,1,1
6,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00025215,0.1141,0.10487,1,1
6,GO REGULATION OF BINDING,0.00052901,0.11394,0.11958,1,1
6,GO EXCRETION,0.0088198,0.11386,0.12202,1,1
6,GO PEPTIDYL LYSINE MODIFICATION,5.02e-08,0.11374,0.17115,1,1
6,GO POSITIVE REGULATION OF NEURON DEATH,0.01499,0.1137,0.10886,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0017517,0.1131,0.10494,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00069207,0.11309,0.10257,1,1
6,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0052197,0.11295,0.098476,1,1
6,GO METHYLATION,0.00018323,0.1129,0.12539,1,1
6,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0013069,0.11286,0.14976,1,1
6,GO POSITIVE REGULATION OF MITOPHAGY,0.053071,0.11283,0.08401,1,1
6,GO REGULATION OF CELL MATURATION,0.010522,0.1128,0.097316,1,1
6,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.03902,0.1127,0.11623,1,1
6,GO RETINA HOMEOSTASIS,0.00013232,0.11265,0.13127,1,1
6,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00037835,0.1126,0.14898,1,1
6,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0017277,0.11242,0.099816,1,1
6,GO STEM CELL DIFFERENTIATION,0.00035024,0.11232,0.11924,1,1
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0076401,0.11228,0.10462,1,1
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.055609,0.11197,0.16804,1,1
6,GO REGULATION OF HISTONE UBIQUITINATION,0.0042095,0.11183,0.11113,1,1
6,GO RNA 3 END PROCESSING,0.037882,0.11157,0.081281,1,1
6,GO RNA LOCALIZATION,0.017699,0.11147,0.08376,1,1
6,GO REGULATION OF MAPK CASCADE,0.05063,0.11136,0.077612,1,1
6,GO REGULATION OF PODOSOME ASSEMBLY,0.052575,0.11134,0.17081,1,1
6,GO SNRNA TRANSCRIPTION,0.012798,0.11108,0.082964,1,1
6,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0011668,0.11052,0.10649,1,1
6,GO DNA METHYLATION,0.00045468,0.11049,0.1316,1,1
6,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.027118,0.11022,0.10567,1,1
6,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.017894,0.11015,0.087053,1,1
6,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.023173,0.11008,0.086789,1,1
6,GO POSITIVE REGULATION OF SIGNALING,0.0061347,0.11002,0.094971,1,1
6,GO REGULATION OF TOR SIGNALING,0.00012186,0.10996,0.14479,1,1
6,GO RESPONSE TO ACTIVITY,0.0059852,0.10986,0.10377,1,1
6,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0072795,0.10981,0.11145,1,1
6,GO PYRUVATE METABOLIC PROCESS,0.023173,0.10969,0.097133,1,1
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.02945,0.10959,0.076567,1,1
6,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0017517,0.10919,0.12944,1,1
6,GO MITOCHONDRIAL FISSION,0.023419,0.10914,0.092071,1,1
6,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,3.3806e-05,0.10909,0.22633,1,1
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0046018,0.10891,0.098176,1,1
6,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00064263,0.1089,0.13654,1,1
6,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.011813,0.10873,0.09606,1,1
6,GO SECOND MESSENGER MEDIATED SIGNALING,0.00086244,0.10853,0.12117,1,1
6,GO PHOTOPERIODISM,0.00029511,0.10833,0.1663,1,1
6,GO REGULATION OF NUCLEAR DIVISION,2.2824e-05,0.10817,0.13847,1,1
6,GO POSITIVE REGULATION OF TOR SIGNALING,5.5127e-05,0.10805,0.16241,1,1
6,GO RHYTHMIC BEHAVIOR,0.0037016,0.10801,0.12872,1,1
6,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00015331,0.10767,0.097207,1,1
6,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0029645,0.10738,0.10308,1,1
6,GO PROTEIN INSERTION INTO MEMBRANE,0.017894,0.10715,0.086788,1,1
6,GO REGULATION OF CELL FATE SPECIFICATION,0.023919,0.10708,0.16421,1,1
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0065235,0.10635,0.10494,1,1
6,GO PROTEIN SUMOYLATION,0.0001179,0.10631,0.14371,1,1
6,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.047372,0.10623,0.1531,1,1
6,GO RESPONSE TO STARVATION,0.00090088,0.1061,0.12588,1,1
6,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0018256,0.10591,0.12253,1,1
6,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.010041,0.10574,0.075953,1,1
6,GO RESPONSE TO ACID CHEMICAL,0.0046018,0.10573,0.1091,1,1
6,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.03068,0.10548,0.075214,1,1
6,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0014022,0.10532,0.12341,1,1
6,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0022095,0.10502,0.10157,1,1
6,GO CELL CELL ADHESION,0.036048,0.10476,0.097436,1,1
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0017277,0.10459,0.10509,1,1
6,GO OSTEOBLAST DIFFERENTIATION,0.061549,0.10443,0.079111,1,1
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0054872,0.10432,0.11278,1,1
6,GO DNA DEMETHYLATION,0.007921,0.10432,0.13846,1,1
6,GO LIPID DROPLET ORGANIZATION,0.006444,0.10425,0.12483,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.036409,0.10402,0.069946,1,1
6,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.054074,0.104,0.12278,1,1
6,GO CELLULAR RESPONSE TO RADIATION,0.00011986,0.10399,0.1097,1,1
6,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.053071,0.10337,0.078177,1,1
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.013856,0.10289,0.17087,1,1
6,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.01849,0.10253,0.083537,1,1
6,GO PROTEIN LOCALIZATION TO VACUOLE,0.024173,0.10188,0.1027,1,1
6,GO ENDOCYTIC RECYCLING,0.0089251,0.10178,0.12151,1,1
6,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.014332,0.10162,0.07074,1,1
6,GO EXOCYTIC PROCESS,0.056128,0.10133,0.10805,1,1
6,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.05063,0.10117,0.075562,1,1
6,GO PROTEIN POLYUBIQUITINATION,0.01829,0.10113,0.079098,1,1
6,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.036409,0.10098,0.10126,1,1
6,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.016386,0.10095,0.10767,1,1
6,GO NCRNA TRANSCRIPTION,0.025743,0.10094,0.073848,1,1
6,GO PROTEIN HOMOOLIGOMERIZATION,0.0052197,0.10092,0.095721,1,1
6,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0061347,0.10076,0.16178,1,1
6,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.058247,0.10066,0.0999,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00086244,0.10034,0.11742,1,1
6,GO MACROMOLECULE DEACYLATION,0.00014839,0.099948,0.14633,1,1
6,GO DNA MODIFICATION,0.00095459,0.099604,0.098394,1,1
6,GO LYMPHOCYTE DIFFERENTIATION,0.039795,0.099507,0.072004,1,1
6,GO NUCLEOTIDE PHOSPHORYLATION,0.013243,0.099407,0.10691,1,1
6,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.013243,0.099119,0.10963,1,1
6,GO REGULATION OF PROTEIN SUMOYLATION,0.0023009,0.0991,0.13225,1,1
6,GO PSEUDOPODIUM ORGANIZATION,0.054582,0.099079,0.1683,1,1
6,GO ENDOSOMAL TRANSPORT,0.014332,0.099074,0.087558,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.016938,0.098972,0.12985,1,1
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0054192,0.098677,0.10177,1,1
6,GO SENSORY PERCEPTION,0.00021511,0.098524,0.12018,1,1
6,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.012227,0.0983,0.10443,1,1
6,GO PEPTIDYL CYSTEINE MODIFICATION,0.0032078,0.097882,0.11897,1,1
6,GO RESPONSE TO ETHER,0.052083,0.097386,0.10056,1,1
6,GO SODIUM ION HOMEOSTASIS,0.0083098,0.096806,0.13639,1,1
6,GO CELLULAR RESPONSE TO ATP,0.020605,0.096642,0.10824,1,1
6,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0022701,0.096635,0.095405,1,1
6,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00028155,0.0966,0.10977,1,1
6,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.017699,0.096547,0.091967,1,1
6,GO BILE ACID BIOSYNTHETIC PROCESS,0.034984,0.09653,0.10064,1,1
6,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0035146,0.095956,0.11318,1,1
6,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.012798,0.095723,0.090604,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.001776,0.095008,0.12455,1,1
6,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0048405,0.094829,0.10042,1,1
6,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0086125,0.094819,0.11152,1,1
6,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.020385,0.094614,0.10452,1,1
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.032938,0.093592,0.11119,1,1
6,GO REGULATION OF PROTEIN BINDING,0.047827,0.093582,0.08719,1,1
6,GO ACTIN CYTOSKELETON REORGANIZATION,0.011151,0.093519,0.10864,1,1
6,GO PROTEIN ADP RIBOSYLATION,0.040582,0.093498,0.10768,1,1
6,GO CALCIUM MEDIATED SIGNALING,0.018091,0.093357,0.074391,1,1
6,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0029256,0.093245,0.099974,1,1
6,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.059879,0.093187,0.075158,1,1
6,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.048285,0.092977,0.074915,1,1
6,GO INTERMEMBRANE LIPID TRANSFER,0.061549,0.092853,0.097862,1,1
6,GO INTRACELLULAR PROTEIN TRANSPORT,0.024947,0.092385,0.064479,1,1
6,GO TRANSLESION SYNTHESIS,0.013394,0.092368,0.091534,1,1
6,GO VACUOLAR TRANSPORT,0.016027,0.092359,0.092729,1,1
6,GO PROTEIN CATABOLIC PROCESS,0.052575,0.092082,0.064499,1,1
6,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.032607,0.091996,0.071378,1,1
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0063654,0.091836,0.063879,1,1
6,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.05063,0.091444,0.063547,1,1
6,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.013243,0.091296,0.093577,1,1
6,GO ERROR FREE TRANSLESION SYNTHESIS,0.037509,0.090996,0.076741,1,1
6,GO PHOTOTRANSDUCTION,0.013546,0.09077,0.055016,1,1
6,GO CARBOHYDRATE PHOSPHORYLATION,0.050154,0.090711,0.098759,1,1
6,GO INTRACELLULAR TRANSPORT,0.011544,0.090402,0.073956,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00087508,0.09022,0.099662,1,1
6,GO MRNA METABOLIC PROCESS,0.011678,0.090065,0.07989,1,1
6,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.0046604,0.090041,0.090824,1,1
6,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.050154,0.089567,0.068988,1,1
6,GO CARNITINE SHUTTLE,0.01016,0.08956,0.17405,1,1
6,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.010895,0.08949,0.099934,1,1
6,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0049019,0.089225,0.07614,1,1
6,GO REGULATION OF MITOPHAGY,0.018898,0.088017,0.10905,1,1
6,GO INORGANIC ANION TRANSPORT,0.020605,0.085531,0.084197,1,1
6,GO PROTEIN COMPLEX OLIGOMERIZATION,0.013546,0.085049,0.083719,1,1
6,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.033271,0.082941,0.088353,1,1
6,GO SENSORY PERCEPTION OF SMELL,0.043866,0.082456,0.067484,1,1
6,GO CARBOHYDRATE HOMEOSTASIS,0.0086125,0.081878,0.10361,1,1
6,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.056128,0.081657,0.062035,1,1
6,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.058787,0.081614,0.077969,1,1
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0068504,0.08138,0.11006,1,1
6,GO DNA CATABOLIC PROCESS,0.0005211,0.081246,0.12143,1,1
6,GO NEGATIVE REGULATION OF SECRETION,0.011022,0.080922,0.087565,1,1
6,GO ORGAN INDUCTION,0.027401,0.0808,0.14267,1,1
6,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.022446,0.080663,0.10476,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.019523,0.080038,0.077547,1,1
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.049681,0.079806,0.078719,1,1
6,GO REGULATION OF ATP METABOLIC PROCESS,0.011678,0.079497,0.098277,1,1
6,GO CELLULAR SENESCENCE,0.0045438,0.078969,0.11131,1,1
6,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.020605,0.077378,0.064923,1,1
6,GO ESTABLISHMENT OF TISSUE POLARITY,0.010279,0.077158,0.093946,1,1
6,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.027973,0.07664,0.10138,1,1
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0038478,0.076481,0.13099,1,1
6,GO REGULATION OF MACROAUTOPHAGY,0.010895,0.07486,0.082283,1,1
6,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.05063,0.074689,0.069817,1,1
6,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.035691,0.074455,0.078733,1,1
6,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0081133,0.073023,0.09558,1,1
6,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.047827,0.069384,0.067821,1,1
6,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.023173,0.068273,0.099651,1,1
6,GO TRANSCRIPTION BY RNA POLYMERASE III,0.039795,0.068026,0.065193,1,1
6,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.033948,0.067525,0.073523,1,1
6,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.02915,0.066977,0.079768,1,1
6,GO REGULATION OF AUTOPHAGY,0.038637,0.066938,0.070535,1,1
6,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.02915,0.065737,0.06621,1,1
6,GO REGULATION OF PROTEIN TARGETING,0.061549,0.063876,0.071756,1,1
6,GO MACROAUTOPHAGY,0.046921,0.059944,0.06303,1,1
6,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,2.6828e-05,0.37634,0.30048,1,0
6,GO RETINAL GANGLION CELL AXON GUIDANCE,7.5001e-05,0.36833,0.37,1,0
6,GO FOREBRAIN NEURON FATE COMMITMENT,0.017506,0.32489,0.3769,1,0
6,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,1.8363e-05,0.31975,0.32652,1,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00014129,0.30848,0.26988,1,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0060595,0.30625,0.28626,1,0
6,GO CELL JUNCTION MAINTENANCE,7.0337e-07,0.30162,0.32883,1,0
6,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,1.7385e-05,0.30061,0.3134,1,0
6,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00015583,0.30017,0.37255,1,0
6,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,5.2303e-06,0.29818,0.28764,1,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.0322e-07,0.29144,0.30729,1,0
6,GO REGULATION OF AXONOGENESIS,8.4415e-08,0.28962,0.30744,1,0
6,GO FOREBRAIN NEURON DEVELOPMENT,0.00022208,0.28748,0.29756,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.015674,0.28622,0.17627,1,0
6,GO DENDRITE MORPHOGENESIS,3.5606e-08,0.28544,0.3104,1,0
6,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.00092737,0.28358,0.2775,1,0
6,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.025475,0.28116,0.32768,1,0
6,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,1.9175e-06,0.2796,0.30165,1,0
6,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.5884e-05,0.2775,0.29052,1,0
6,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,7.3803e-06,0.27719,0.29756,1,0
6,GO COLLECTING DUCT DEVELOPMENT,1.8032e-05,0.27147,0.35321,1,0
6,GO MODIFICATION OF SYNAPTIC STRUCTURE,4.0314e-05,0.27052,0.25898,1,0
6,GO PENILE ERECTION,0.0011668,0.27026,0.22667,1,0
6,GO MICROTUBULE SEVERING,5.02e-08,0.26772,0.29996,1,0
6,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00045468,0.26718,0.23363,1,0
6,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.01585,0.26327,0.30505,1,0
6,GO SECONDARY HEART FIELD SPECIFICATION,0.0021505,0.26204,0.29805,1,0
6,GO CELL MIGRATION IN HINDBRAIN,4.3997e-05,0.26039,0.30104,1,0
6,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.0047198,0.25855,0.24557,1,0
6,GO NEURON PROJECTION ORGANIZATION,1.6321e-06,0.25304,0.27581,1,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,8.4262e-06,0.25197,0.24108,1,0
6,GO PROTEIN POLYGLUTAMYLATION,1.2534e-06,0.25161,0.2812,1,0
6,GO REGULATION OF HIPPO SIGNALING,0.003654,0.2499,0.19976,1,0
6,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,4.1456e-06,0.24989,0.31385,1,0
6,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.00076726,0.2479,0.19615,1,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.5052e-06,0.24729,0.26768,1,0
6,GO SYNAPTIC VESICLE MATURATION,0.00098255,0.24582,0.31749,1,0
6,GO POSITIVE REGULATION OF AXON EXTENSION,1.5014e-05,0.24536,0.25264,1,0
6,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,2.7668e-07,0.24413,0.24782,1,0
6,GO DENDRITE DEVELOPMENT,3.8149e-08,0.24326,0.27937,1,0
6,GO DIGESTIVE TRACT MORPHOGENESIS,1.3693e-05,0.24272,0.24744,1,0
6,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00049802,0.24146,0.24439,1,0
6,GO NOTOCHORD DEVELOPMENT,0.0077327,0.2413,0.20917,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00021857,0.24091,0.23704,1,0
6,GO SUCKLING BEHAVIOR,0.00091404,0.24044,0.28287,1,0
6,GO FOREBRAIN CELL MIGRATION,1.8419e-06,0.23929,0.26337,1,0
6,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.0021215,0.23827,0.25705,1,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.00072342,0.23689,0.24567,1,0
6,GO RETINA LAYER FORMATION,0.00042128,0.23673,0.29293,1,0
6,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.0044298,0.23602,0.20901,1,0
6,GO MITOCHONDRION DISTRIBUTION,1.475e-06,0.23497,0.25156,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.00021511,0.23415,0.23641,1,0
6,GO POSITIVE REGULATION OF AXONOGENESIS,5.4701e-07,0.23274,0.28956,1,0
6,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.0033799,0.23211,0.19229,1,0
6,GO NOREPINEPHRINE METABOLIC PROCESS,0.00086244,0.23205,0.29187,1,0
6,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.00039018,0.22956,0.19453,1,0
6,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00036686,0.22888,0.21494,1,0
6,GO SEGMENT SPECIFICATION,0.00043435,0.22864,0.26229,1,0
6,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0011836,0.22761,0.26733,1,0
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0015038,0.2262,0.29257,1,0
6,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0013069,0.22607,0.23096,1,0
6,GO LAYER FORMATION IN CEREBRAL CORTEX,7.6283e-05,0.22512,0.27781,1,0
6,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,8.1138e-06,0.22503,0.25407,1,0
6,GO CEREBRAL CORTEX DEVELOPMENT,1.8594e-09,0.22334,0.27719,1,0
6,GO PRO B CELL DIFFERENTIATION,5.1446e-05,0.22333,0.26583,1,0
6,GO PROTEIN LOCALIZATION TO CELL JUNCTION,1.3878e-06,0.22258,0.25897,1,0
6,GO MICROTUBULE POLYMERIZATION,1.3948e-05,0.22141,0.22382,1,0
6,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,6.6578e-05,0.2211,0.21346,1,0
6,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00094089,0.22098,0.23469,1,0
6,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.6828e-05,0.21994,0.26831,1,0
6,GO FOREBRAIN NEURON DIFFERENTIATION,0.0001803,0.21935,0.26348,1,0
6,GO LATERAL MESODERM DEVELOPMENT,0.0007786,0.21866,0.25977,1,0
6,GO INCLUSION BODY ASSEMBLY,0.0011341,0.21802,0.22947,1,0
6,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.9563e-06,0.21743,0.23306,1,0
6,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.00029511,0.21735,0.24295,1,0
6,GO NEURON PROJECTION EXTENSION,8.1361e-07,0.21506,0.25606,1,0
6,GO ERYTHROCYTE MATURATION,6.2175e-05,0.21456,0.199,1,0
6,GO COPULATION,0.0016806,0.21453,0.19471,1,0
6,GO TUBULIN DEACETYLATION,0.00014599,0.21445,0.2345,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0013069,0.21418,0.19104,1,0
6,GO PHOTORECEPTOR CELL DEVELOPMENT,2.856e-06,0.21357,0.21469,1,0
6,GO MITOTIC SISTER CHROMATID COHESION,0.00011218,0.21254,0.20826,1,0
6,GO REGULATION OF CELL DEVELOPMENT,6.1583e-08,0.21224,0.21827,1,0
6,GO GABAERGIC NEURON DIFFERENTIATION,0.036048,0.21213,0.2624,1,0
6,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.021973,0.21202,0.24349,1,0
6,GO CELL MORPHOGENESIS,2.2775e-07,0.21186,0.22047,1,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0094686,0.21174,0.22706,1,0
6,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00036124,0.21095,0.19109,1,0
6,GO BONE TRABECULA MORPHOGENESIS,0.044722,0.21074,0.16334,1,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0018764,0.21051,0.19426,1,0
6,GO SYNAPTIC VESICLE LOCALIZATION,8.1623e-05,0.20953,0.24375,1,0
6,GO CARDIOBLAST DIFFERENTIATION,0.0055559,0.20919,0.18969,1,0
6,GO REGULATION OF CELL MORPHOGENESIS,8.4805e-07,0.20856,0.21769,1,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00071283,0.20849,0.2838,1,0
6,GO PALLIUM DEVELOPMENT,5.6317e-09,0.2081,0.25303,1,0
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.014494,0.20565,0.24365,1,0
6,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,5.5864e-07,0.20438,0.21466,1,0
6,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00014599,0.20401,0.20144,1,0
6,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,8.2686e-06,0.20368,0.18908,1,0
6,GO AXON EXTENSION,7.969e-07,0.20358,0.26749,1,0
6,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.001704,0.2033,0.17659,1,0
6,GO CELL FATE DETERMINATION,0.0041031,0.20321,0.16231,1,0
6,GO POSITIVE REGULATION OF BEHAVIOR,0.026013,0.20315,0.15163,1,0
6,GO GENETIC IMPRINTING,2.0478e-05,0.20312,0.22326,1,0
6,GO FAT CELL PROLIFERATION,0.041789,0.20223,0.15326,1,0
6,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.010769,0.20093,0.24107,1,0
6,GO DEVELOPMENTAL CELL GROWTH,1.6654e-06,0.20078,0.22572,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,8.5867e-06,0.20031,0.18136,1,0
6,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.001118,0.19892,0.21379,1,0
6,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,1.6654e-06,0.19889,0.23005,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.014823,0.19888,0.17246,1,0
6,GO MALE MEIOTIC NUCLEAR DIVISION,4.7999e-05,0.19881,0.22745,1,0
6,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0072795,0.19878,0.21146,1,0
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,7.5217e-06,0.198,0.21687,1,0
6,GO CAMERA TYPE EYE DEVELOPMENT,8.2543e-08,0.19794,0.22013,1,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0010865,0.19786,0.1957,1,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0077327,0.19785,0.16853,1,0
6,GO LONG TERM MEMORY,0.0013069,0.19769,0.19074,1,0
6,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,3.8983e-07,0.19666,0.21575,1,0
6,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,7.8911e-05,0.19617,0.23791,1,0
6,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,4.5558e-05,0.19543,0.2066,1,0
6,GO REGULATION OF CELL PROJECTION ORGANIZATION,3.9822e-07,0.19527,0.21518,1,0
6,GO RESPONSE TO FORSKOLIN,0.021509,0.19449,0.18787,1,0
6,GO DNA REPLICATION CHECKPOINT,9.4341e-06,0.19334,0.20743,1,0
6,GO BEHAVIOR,1.6418e-07,0.19312,0.22911,1,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0080166,0.19216,0.16576,1,0
6,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.001704,0.19132,0.18133,1,0
6,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.0069343,0.19129,0.21128,1,0
6,GO NEURAL NUCLEUS DEVELOPMENT,1.0756e-05,0.19116,0.2534,1,0
6,GO PERICARDIUM DEVELOPMENT,0.0032078,0.19085,0.20145,1,0
6,GO BRANCH ELONGATION OF AN EPITHELIUM,0.042197,0.19066,0.14835,1,0
6,GO MITOCHONDRION LOCALIZATION,1.6158e-05,0.19062,0.19547,1,0
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00043435,0.1889,0.20056,1,0
6,GO PROTEIN DEPOLYMERIZATION,5.0563e-05,0.18882,0.17958,1,0
6,GO AXONAL TRANSPORT,6.6578e-05,0.18869,0.19902,1,0
6,GO PITUITARY GLAND DEVELOPMENT,0.00039018,0.18834,0.27891,1,0
6,GO MEIOTIC CHROMOSOME SEPARATION,3.094e-05,0.18787,0.20768,1,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00080175,0.18754,0.35669,1,0
6,GO LYSINE METABOLIC PROCESS,0.060988,0.18684,0.11223,1,0
6,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.031311,0.18601,0.16766,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00080175,0.18554,0.15894,1,0
6,GO CARDIAC VENTRICLE MORPHOGENESIS,4.4771e-05,0.18534,0.19301,1,0
6,GO REGIONALIZATION,6.5906e-08,0.18459,0.22353,1,0
6,GO REVERSE CHOLESTEROL TRANSPORT,0.014172,0.18444,0.19983,1,0
6,GO MEIOTIC CHROMOSOME SEGREGATION,2.0853e-05,0.18392,0.19112,1,0
6,GO REGULATION OF AXON GUIDANCE,0.00015331,0.18357,0.23866,1,0
6,GO MITRAL VALVE DEVELOPMENT,0.0019819,0.18322,0.20153,1,0
6,GO DIGESTIVE SYSTEM DEVELOPMENT,1.5865e-05,0.18192,0.20719,1,0
6,GO MOTOR NEURON AXON GUIDANCE,0.0033361,0.18154,0.17356,1,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00018923,0.18089,0.17891,1,0
6,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.00022208,0.18047,0.23986,1,0
6,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0043184,0.18039,0.18143,1,0
6,GO COGNITION,1.8793e-06,0.17998,0.20448,1,0
6,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,3.9102e-06,0.17904,0.18032,1,0
6,GO EMBRYONIC PATTERN SPECIFICATION,1.5014e-05,0.17879,0.20198,1,0
6,GO BONE MATURATION,7.5001e-05,0.17878,0.22956,1,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.007921,0.17819,0.17889,1,0
6,GO OPTIC NERVE DEVELOPMENT,0.003607,0.17791,0.2584,1,0
6,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0083098,0.17732,0.18315,1,0
6,GO MAINTENANCE OF CELL NUMBER,6.7105e-06,0.17721,0.16848,1,0
6,GO REGULATION OF FILOPODIUM ASSEMBLY,0.00087508,0.17679,0.1951,1,0
6,GO PARENTAL BEHAVIOR,0.00060545,0.1767,0.32313,1,0
6,GO LIMBIC SYSTEM DEVELOPMENT,1.1086e-06,0.1763,0.21426,1,0
6,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0066039,0.17505,0.14671,1,0
6,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,5.9056e-05,0.175,0.1737,1,0
6,GO EMBRYONIC MORPHOGENESIS,3.0905e-06,0.17457,0.18074,1,0
6,GO FOREBRAIN GENERATION OF NEURONS,0.00047589,0.17453,0.2162,1,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.0023957,0.17439,0.16461,1,0
6,GO AXO DENDRITIC TRANSPORT,8.1623e-05,0.17402,0.18658,1,0
6,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0067673,0.17385,0.23949,1,0
6,GO MONOAMINE TRANSPORT,0.00018923,0.17306,0.26049,1,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.002702,0.17279,0.2656,1,0
6,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.6085e-05,0.17229,0.19514,1,0
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00027716,0.17141,0.17526,1,0
6,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00075607,0.17111,0.26394,1,0
6,GO RESPONSE TO BMP,0.00041488,0.17086,0.17611,1,0
6,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.053071,0.17082,0.13224,1,0
6,GO INTRA S DNA DAMAGE CHECKPOINT,0.00054518,0.17068,0.17311,1,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,8.0256e-05,0.17059,0.14354,1,0
6,GO POSITIVE REGULATION OF RNA SPLICING,5.1446e-05,0.17048,0.1665,1,0
6,GO RESPONSE TO INSECTICIDE,0.026561,0.17007,0.17826,1,0
6,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.00044781,0.16975,0.21116,1,0
6,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0001862,0.16936,0.17336,1,0
6,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0010865,0.16894,0.16422,1,0
6,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,1.2253e-05,0.16874,0.19407,1,0
6,GO FOREGUT MORPHOGENESIS,0.00029052,0.16862,0.22252,1,0
6,GO RESPONSE TO VITAMIN D,0.015501,0.16848,0.15911,1,0
6,GO FILOPODIUM ASSEMBLY,0.00064263,0.16812,0.18279,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE ARREST,1.0036e-08,0.16693,0.2203,1,0
6,GO CELLULAR RESPONSE TO NUTRIENT,0.0018006,0.16681,0.19606,1,0
6,GO DOPAMINE TRANSPORT,0.0052854,0.16585,0.25535,1,0
6,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0028492,0.16533,0.24409,1,0
6,GO CHROMATIN DISASSEMBLY,0.00026438,0.16505,0.19121,1,0
6,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0023957,0.16463,0.14973,1,0
6,GO REPRODUCTIVE SYSTEM DEVELOPMENT,9.3381e-05,0.16369,0.15184,1,0
6,GO REGULATION OF BMP SIGNALING PATHWAY,0.00043435,0.16291,0.20187,1,0
6,GO EAR DEVELOPMENT,1.4454e-06,0.16284,0.22668,1,0
6,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.029754,0.16281,0.12869,1,0
6,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.046921,0.16272,0.13763,1,0
6,GO REGULATION OF CYTOKINESIS,4.31e-06,0.16247,0.19222,1,0
6,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00027716,0.1624,0.16635,1,0
6,GO REGULATION OF EXOCYTOSIS,6.1119e-05,0.16214,0.18088,1,0
6,GO REGULATION OF MYELINATION,0.00032916,0.16154,0.16724,1,0
6,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0039481,0.16097,0.13901,1,0
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.012653,0.16079,0.18797,1,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00042777,0.16044,0.21632,1,0
6,GO VASCULOGENESIS,0.001704,0.16022,0.19261,1,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,4.0314e-05,0.16001,0.15061,1,0
6,GO HAIR CELL DIFFERENTIATION,0.0040509,0.15989,0.21994,1,0
6,GO REGULATION OF MICROTUBULE BINDING,0.0029256,0.15953,0.21268,1,0
6,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.1234e-05,0.15936,0.1703,1,0
6,GO ADHERENS JUNCTION ORGANIZATION,0.0016575,0.15895,0.18845,1,0
6,GO REGULATION OF CELL SIZE,1.5994e-06,0.15888,0.21819,1,0
6,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0015249,0.15809,0.15877,1,0
6,GO UROGENITAL SYSTEM DEVELOPMENT,0.0020092,0.15807,0.13725,1,0
6,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0021215,0.15803,0.21648,1,0
6,GO CELL JUNCTION ASSEMBLY,0.00016901,0.15797,0.17977,1,0
6,GO KERATINOCYTE DEVELOPMENT,0.053071,0.15771,0.20181,1,0
6,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,7.5001e-05,0.1577,0.18432,1,0
6,GO ANTEROGRADE AXONAL TRANSPORT,0.00039622,0.1577,0.16977,1,0
6,GO EMBRYO DEVELOPMENT,1.0004e-06,0.15762,0.16563,1,0
6,GO POSITIVE REGULATION OF HEART GROWTH,0.021053,0.15731,0.11202,1,0
6,GO REGULATION OF SYSTEM PROCESS,6.3249e-05,0.15722,0.16767,1,0
6,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,1.0958e-05,0.15706,0.17408,1,0
6,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.014823,0.15695,0.1267,1,0
6,GO MESENCHYMAL CELL DIFFERENTIATION,0.0013255,0.15684,0.15775,1,0
6,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,4.4771e-05,0.1565,0.16405,1,0
6,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0093576,0.15649,0.18519,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0029256,0.15641,0.17263,1,0
6,GO REGULATION OF FIBROBLAST MIGRATION,0.0037498,0.15631,0.14151,1,0
6,GO REGULATION OF VASCULAR PERMEABILITY,0.01499,0.15629,0.12961,1,0
6,GO SPINDLE LOCALIZATION,0.00057029,0.15598,0.14565,1,0
6,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0042095,0.15573,0.17669,1,0
6,GO CEREBRAL CORTEX CELL MIGRATION,2.9859e-05,0.1555,0.23686,1,0
6,GO REGULATION OF MEMBRANE POTENTIAL,8.5858e-05,0.1555,0.18847,1,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,2.6914e-06,0.15528,0.15945,1,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00026438,0.15518,0.17958,1,0
6,GO MITOTIC DNA REPLICATION,0.02945,0.15495,0.14384,1,0
6,GO ARTERY MORPHOGENESIS,0.033271,0.15479,0.10917,1,0
6,GO RESPONSE TO DOPAMINE,5.4184e-05,0.15463,0.18357,1,0
6,GO KIDNEY EPITHELIUM DEVELOPMENT,0.001118,0.15452,0.17152,1,0
6,GO NEGATIVE REGULATION OF CELL AGING,0.010041,0.15444,0.15188,1,0
6,GO REPLACEMENT OSSIFICATION,0.01016,0.15442,0.14998,1,0
6,GO CHROMOSOME SEPARATION,0.00016361,0.15426,0.17099,1,0
6,GO DETERMINATION OF ADULT LIFESPAN,0.025743,0.15418,0.11326,1,0
6,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,4.2444e-07,0.15371,0.17253,1,0
6,GO ESTABLISHMENT OF CELL POLARITY,8.1138e-06,0.15356,0.17461,1,0
6,GO REGULATION OF GLIAL CELL DIFFERENTIATION,4.9694e-05,0.15352,0.19576,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0040509,0.15279,0.15329,1,0
6,GO CARDIAC VENTRICLE DEVELOPMENT,0.00016901,0.15255,0.16704,1,0
6,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0060595,0.15232,0.15203,1,0
6,GO MITOTIC CELL CYCLE CHECKPOINT,1.1282e-07,0.15211,0.18973,1,0
6,GO HISTONE H3 K14 ACETYLATION,3.6877e-06,0.15203,0.20394,1,0
6,GO MEMBRANE HYPERPOLARIZATION,0.00072342,0.15191,0.24844,1,0
6,GO DNA STRAND ELONGATION,0.00030449,0.15183,0.17495,1,0
6,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.00159,0.15182,0.17558,1,0
6,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0092477,0.15162,0.17577,1,0
6,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00034485,0.1512,0.17317,1,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.011411,0.15114,0.14091,1,0
6,GO MESENCHYME DEVELOPMENT,0.00044103,0.15113,0.16042,1,0
6,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0046604,0.15077,0.30713,1,0
6,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0012886,0.15046,0.1929,1,0
6,GO CARDIAC CHAMBER DEVELOPMENT,0.001118,0.15035,0.15113,1,0
6,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00057029,0.1502,0.18206,1,0
6,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00039018,0.14994,0.17972,1,0
6,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00019541,0.14993,0.15426,1,0
6,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.017315,0.14949,0.18664,1,0
6,GO MEIOTIC CELL CYCLE,1.734e-06,0.14942,0.17599,1,0
6,GO GRANULOCYTE DIFFERENTIATION,0.052083,0.14904,0.106,1,0
6,GO CHROMATIN REMODELING AT CENTROMERE,0.0069343,0.14873,0.15807,1,0
6,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0098086,0.14867,0.19231,1,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.003654,0.14863,0.14727,1,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.001704,0.14809,0.1516,1,0
6,GO SHORT TERM MEMORY,0.040582,0.14804,0.13109,1,0
6,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0066039,0.14773,0.13097,1,0
6,GO SENSORY PERCEPTION OF PAIN,0.00044103,0.14769,0.14207,1,0
6,GO RRNA CATABOLIC PROCESS,0.0033799,0.14759,0.14538,1,0
6,GO MEMORY,3.1494e-05,0.14757,0.19298,1,0
6,GO RESPONSE TO GLUCAGON,0.00032408,0.14742,0.18285,1,0
6,GO CATECHOLAMINE SECRETION,0.00045468,0.14738,0.28974,1,0
6,GO STRIATED MUSCLE CELL PROLIFERATION,0.0012177,0.14696,0.14126,1,0
6,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,6.6578e-05,0.14695,0.15956,1,0
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.028852,0.14657,0.1872,1,0
6,GO POSITIVE REGULATION OF HEAT GENERATION,0.0032928,0.14573,0.22805,1,0
6,GO NEGATIVE REGULATION OF TOR SIGNALING,2.7312e-05,0.14569,0.18693,1,0
6,GO CORONARY VASCULATURE DEVELOPMENT,0.0074579,0.14566,0.16451,1,0
6,GO EXOCRINE SYSTEM DEVELOPMENT,0.015329,0.14539,0.16795,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00095459,0.14525,0.15569,1,0
6,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0023009,0.14524,0.14489,1,0
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0046018,0.14511,0.16342,1,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0013255,0.14504,0.14942,1,0
6,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.042197,0.1448,0.11194,1,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0022396,0.14432,0.18875,1,0
6,GO CELL CYCLE DNA REPLICATION,4.1751e-05,0.14422,0.18155,1,0
6,GO REGULATION OF GTPASE ACTIVITY,0.00034485,0.14411,0.14092,1,0
6,GO NUCLEAR BODY ORGANIZATION,0.00062378,0.14387,0.15652,1,0
6,GO HOMOLOGOUS RECOMBINATION,0.00062378,0.1437,0.16521,1,0
6,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0005789,0.14308,0.13492,1,0
6,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.022446,0.14285,0.16329,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,3.1479e-07,0.14243,0.15974,1,0
6,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00019229,0.14232,0.16543,1,0
6,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0056958,0.14208,0.21406,1,0
6,GO CHROMOSOME CONDENSATION,0.0020092,0.14187,0.14531,1,0
6,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0018256,0.14176,0.16881,1,0
6,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.004964,0.14162,0.13585,1,0
6,GO REGULATION OF CELLULAR COMPONENT SIZE,9.3381e-05,0.1416,0.1552,1,0
6,GO CARDIAC CELL FATE COMMITMENT,0.01585,0.14123,0.2236,1,0
6,GO DNA LIGATION,0.025743,0.1401,0.10868,1,0
6,GO HISTONE H2A ACETYLATION,8.4424e-05,0.14003,0.16797,1,0
6,GO ARTERY DEVELOPMENT,0.044292,0.13998,0.10358,1,0
6,GO DEFINITIVE HEMOPOIESIS,0.0059852,0.13987,0.18341,1,0
6,GO 3 UTR MEDIATED MRNA STABILIZATION,0.00088789,0.1398,0.19017,1,0
6,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00074504,0.13952,0.12786,1,0
6,GO NERVOUS SYSTEM PROCESS,3.0302e-06,0.13902,0.16649,1,0
6,GO LENS FIBER CELL DIFFERENTIATION,0.0014624,0.13899,0.1743,1,0
6,GO ENDOCARDIAL CUSHION FORMATION,0.060432,0.13885,0.12305,1,0
6,GO MEMBRANE FISSION,0.0021798,0.1388,0.17653,1,0
6,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.012367,0.13841,0.2083,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.040187,0.13832,0.16162,1,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0018508,0.13783,0.14145,1,0
6,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0026663,0.1377,0.13633,1,0
6,GO ACIDIC AMINO ACID TRANSPORT,0.0011021,0.13753,0.1719,1,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00024819,0.13751,0.17559,1,0
6,GO GROWTH,2.4972e-05,0.13728,0.14759,1,0
6,GO RESPIRATORY SYSTEM PROCESS,0.0063654,0.137,0.14603,1,0
6,GO TUBE MORPHOGENESIS,0.0028118,0.13693,0.12792,1,0
6,GO MALE MEIOSIS I,0.030994,0.13686,0.16009,1,0
6,GO NUCLEUS ORGANIZATION,0.00073415,0.13643,0.11324,1,0
6,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.031311,0.13598,0.13253,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.003166,0.13598,0.1445,1,0
6,GO REGULATION OF GLUTAMATE SECRETION,0.018898,0.13586,0.19275,1,0
6,GO HISTONE H3 ACETYLATION,5.9834e-06,0.13583,0.15914,1,0
6,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,3.2784e-06,0.13582,0.16008,1,0
6,GO REGULATION OF GLIOGENESIS,7.6657e-06,0.13568,0.19235,1,0
6,GO NEGATIVE REGULATION OF LIPID STORAGE,0.023173,0.13555,0.13718,1,0
6,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0017277,0.13543,0.1754,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE,6.895e-08,0.1353,0.15519,1,0
6,GO SIGNAL RELEASE,3.3214e-05,0.13529,0.15926,1,0
6,GO REGULATION OF ACTION POTENTIAL,0.029754,0.13494,0.13179,1,0
6,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.00015838,0.13492,0.17347,1,0
6,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0084096,0.13474,0.18299,1,0
6,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0012177,0.13459,0.1666,1,0
6,GO SYNAPTIC VESICLE TRANSPORT,0.0054872,0.13438,0.15784,1,0
6,GO MEIOTIC CELL CYCLE PROCESS,1.0361e-05,0.13434,0.16584,1,0
6,GO FOCAL ADHESION ASSEMBLY,0.014172,0.13372,0.13033,1,0
6,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.057179,0.13363,0.078647,1,0
6,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0016806,0.13321,0.12352,1,0
6,GO EMBRYONIC AXIS SPECIFICATION,8.7502e-06,0.13309,0.21228,1,0
6,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.001071,0.13304,0.15303,1,0
6,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0043184,0.13288,0.20344,1,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.003607,0.13263,0.15129,1,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.026838,0.13195,0.12824,1,0
6,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.027118,0.13172,0.1365,1,0
6,GO HEART DEVELOPMENT,5.6085e-05,0.13171,0.15704,1,0
6,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0028872,0.13142,0.13411,1,0
6,GO VISUAL BEHAVIOR,0.0005789,0.13134,0.14161,1,0
6,GO DENDRITE EXTENSION,0.00080175,0.13112,0.21984,1,0
6,GO N GLYCAN PROCESSING,0.012798,0.13104,0.1921,1,0
6,GO HISTONE EXCHANGE,0.0028118,0.13101,0.14587,1,0
6,GO POSITIVE REGULATION OF GROWTH,1.8032e-05,0.13089,0.15955,1,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0023009,0.13062,0.17802,1,0
6,GO PODOSOME ASSEMBLY,0.051111,0.13006,0.15248,1,0
6,GO HEART FIELD SPECIFICATION,0.038637,0.13002,0.18934,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,2.6352e-05,0.1298,0.13524,1,0
6,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.0093576,0.12964,0.17077,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0005618,0.12964,0.15104,1,0
6,GO REGULATION OF GROWTH,5.9056e-05,0.12961,0.13773,1,0
6,GO OLFACTORY LOBE DEVELOPMENT,0.0072795,0.12947,0.18435,1,0
6,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0092477,0.12922,0.11134,1,0
6,GO GDP METABOLIC PROCESS,0.027118,0.1292,0.14389,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0027747,0.12914,0.12995,1,0
6,GO PROTEIN TARGETING TO VACUOLE,0.061549,0.12907,0.10159,1,0
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0098086,0.12893,0.14106,1,0
6,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00027284,0.12887,0.1565,1,0
6,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.036409,0.12872,0.10898,1,0
6,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.036048,0.12849,0.091002,1,0
6,GO MUSCLE ORGAN DEVELOPMENT,4.7999e-05,0.12845,0.14185,1,0
6,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.00018923,0.12817,0.11092,1,0
6,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,2.8305e-05,0.12772,0.18639,1,0
6,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0018256,0.12767,0.18752,1,0
6,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.045591,0.12738,0.087553,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0032078,0.12726,0.17382,1,0
6,GO REGULATION OF ORGANELLE ORGANIZATION,6.4341e-05,0.1269,0.12315,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0053519,0.12688,0.23813,1,0
6,GO REGULATION OF DOPAMINE SECRETION,0.011544,0.12684,0.27583,1,0
6,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00092737,0.12659,0.18634,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.02915,0.12655,0.12876,1,0
6,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00010852,0.12654,0.16509,1,0
6,GO NEPHRON DEVELOPMENT,0.0050904,0.12628,0.14351,1,0
6,GO RESPONSE TO GROWTH FACTOR,0.0038478,0.12623,0.11363,1,0
6,GO ACTIN FILAMENT BASED PROCESS,0.0051547,0.12611,0.11735,1,0
6,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,1.2534e-06,0.12605,0.13722,1,0
6,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0030839,0.12602,0.14038,1,0
6,GO BLASTODERM SEGMENTATION,0.022209,0.12599,0.16595,1,0
6,GO REGULATION OF CELLULAR LOCALIZATION,0.00036686,0.12572,0.11631,1,0
6,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0033361,0.12567,0.11955,1,0
6,GO CELL AGGREGATION,0.010769,0.12557,0.133,1,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.011678,0.12544,0.10338,1,0
6,GO WALKING BEHAVIOR,0.0012005,0.12528,0.17967,1,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.023668,0.12521,0.1287,1,0
6,GO REGULATION OF PROTEIN ACETYLATION,2.971e-06,0.12514,0.16405,1,0
6,GO CARDIOCYTE DIFFERENTIATION,0.0083098,0.12503,0.11246,1,0
6,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0059852,0.12501,0.19952,1,0
6,GO BRONCHUS DEVELOPMENT,0.036772,0.12478,0.20197,1,0
6,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.004964,0.12476,0.12251,1,0
6,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.043444,0.12459,0.15708,1,0
6,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0096941,0.12448,0.12268,1,0
6,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0099244,0.12383,0.099125,1,0
6,GO OOCYTE MATURATION,0.03429,0.1236,0.11724,1,0
6,GO PARTURITION,0.040981,0.12324,0.10994,1,0
6,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.012653,0.12311,0.18479,1,0
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0023009,0.12307,0.17333,1,0
6,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0045438,0.12261,0.15011,1,0
6,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0023321,0.12253,0.14274,1,0
6,GO ERYTHROCYTE DEVELOPMENT,0.016386,0.12225,0.11324,1,0
6,GO PIRNA METABOLIC PROCESS,0.015674,0.12219,0.15373,1,0
6,GO ESCRT COMPLEX DISASSEMBLY,0.016386,0.12212,0.12345,1,0
6,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.037139,0.12211,0.10545,1,0
6,GO AMINO ACID BETAINE METABOLIC PROCESS,0.036409,0.12203,0.12753,1,0
6,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0062877,0.12198,0.22186,1,0
6,GO ACTIN FILAMENT ORGANIZATION,0.024947,0.12192,0.10176,1,0
6,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0007786,0.12182,0.11648,1,0
6,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00044781,0.12172,0.13299,1,0
6,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.021973,0.12169,0.10462,1,0
6,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.022686,0.12162,0.12396,1,0
6,GO CHEMOSENSORY BEHAVIOR,0.012367,0.12162,0.12679,1,0
6,GO DNA REPLICATION INITIATION,0.00087508,0.12135,0.15033,1,0
6,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0028118,0.12126,0.17501,1,0
6,GO REGULATION OF PHOSPHORYLATION,0.0033361,0.12113,0.10158,1,0
6,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.002702,0.12093,0.12126,1,0
6,GO TUBE DEVELOPMENT,0.0023957,0.12089,0.12595,1,0
6,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0010113,0.12087,0.19842,1,0
6,GO ORGAN GROWTH,0.0015038,0.1208,0.12141,1,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0013826,0.12063,0.11462,1,0
6,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00070238,0.12054,0.14158,1,0
6,GO RADIAL GLIAL CELL DIFFERENTIATION,0.043444,0.12019,0.16566,1,0
6,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.026286,0.11983,0.12905,1,0
6,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.022209,0.11973,0.11443,1,0
6,GO REGULATION OF TRANSPORTER ACTIVITY,0.001776,0.11965,0.12998,1,0
6,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0005618,0.11965,0.15385,1,0
6,GO GLUCOSE IMPORT,0.0025961,0.11963,0.12258,1,0
6,GO RESPONSE TO IRON ION,0.017125,0.11955,0.13349,1,0
6,GO POSTREPLICATION REPAIR,0.0051547,0.11926,0.091649,1,0
6,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.042609,0.11909,0.20524,1,0
6,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00046165,0.11906,0.15169,1,0
6,GO FIBROBLAST APOPTOTIC PROCESS,0.03902,0.11899,0.11594,1,0
6,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.035336,0.11857,0.1473,1,0
6,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.0011341,0.11854,0.1409,1,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0044864,0.11831,0.10931,1,0
6,GO MESODERM DEVELOPMENT,0.00047589,0.11828,0.13292,1,0
6,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00026858,0.118,0.14462,1,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0029645,0.11764,0.15588,1,0
6,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.01829,0.11764,0.11308,1,0
6,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0088198,0.11761,0.1348,1,0
6,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.014823,0.11754,0.16087,1,0
6,GO AMINE TRANSPORT,0.0031247,0.11721,0.2146,1,0
6,GO MULTICELLULAR ORGANISM AGING,0.023419,0.11711,0.10404,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION,0.00068191,0.1171,0.11071,1,0
6,GO VITAMIN CATABOLIC PROCESS,0.01995,0.11683,0.28953,1,0
6,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0094686,0.11674,0.094223,1,0
6,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.023919,0.11663,0.21884,1,0
6,GO LUNG EPITHELIUM DEVELOPMENT,0.0057669,0.11654,0.20821,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0084096,0.11647,0.13955,1,0
6,GO NEGATIVE REGULATION OF CELL GROWTH,0.0013826,0.11622,0.12283,1,0
6,GO TAXIS,0.00059648,0.11609,0.1409,1,0
6,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.021973,0.11605,0.15738,1,0
6,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.036772,0.11601,0.08682,1,0
6,GO CELL CELL JUNCTION ORGANIZATION,0.023173,0.11585,0.13024,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0044298,0.11585,0.13769,1,0
6,GO REGULATION OF SECRETION,0.00039622,0.11578,0.12704,1,0
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,6.6578e-05,0.11563,0.17147,1,0
6,GO CARDIAC CELL DEVELOPMENT,0.0049019,0.11549,0.12847,1,0
6,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.029754,0.11532,0.1174,1,0
6,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0038478,0.1151,0.14523,1,0
6,GO FIBROBLAST MIGRATION,0.037509,0.1151,0.097863,1,0
6,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,3.094e-05,0.11501,0.13738,1,0
6,GO CHONDROCYTE DIFFERENTIATION,0.012653,0.11488,0.12184,1,0
6,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.0047198,0.1148,0.11074,1,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.030994,0.11471,0.13607,1,0
6,GO POSITIVE REGULATION OF CELL GROWTH,0.0005056,0.11456,0.1345,1,0
6,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0028872,0.11456,0.13874,1,0
6,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0032928,0.11446,0.10756,1,0
6,GO UV PROTECTION,0.0093576,0.11437,0.16801,1,0
6,GO RESPONSE TO CATECHOLAMINE,0.003166,0.11413,0.1384,1,0
6,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0030436,0.11392,0.10938,1,0
6,GO PROTEIN MANNOSYLATION,0.028264,0.1139,0.11968,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00026858,0.11359,0.12664,1,0
6,GO EXPORT ACROSS PLASMA MEMBRANE,0.010041,0.1134,0.13868,1,0
6,GO RESPONSE TO UV C,0.038637,0.11336,0.098576,1,0
6,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.010522,0.11311,0.12829,1,0
6,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.971e-06,0.11309,0.14422,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.5127e-05,0.11307,0.16702,1,0
6,GO MUSCLE STRUCTURE DEVELOPMENT,0.00072342,0.11305,0.12382,1,0
6,GO AORTA MORPHOGENESIS,0.043025,0.11304,0.12969,1,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.021973,0.11303,0.11304,1,0
6,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.00011986,0.11276,0.14413,1,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0018256,0.11275,0.13438,1,0
6,GO REGULATION OF EXIT FROM MITOSIS,0.002631,0.11271,0.16366,1,0
6,GO REGULATION OF MEIOTIC CELL CYCLE,0.001568,0.11269,0.12867,1,0
6,GO VASCULATURE DEVELOPMENT,0.035691,0.11257,0.092883,1,0
6,GO ANATOMICAL STRUCTURE MATURATION,2.7804e-05,0.11194,0.14959,1,0
6,GO RENAL SYSTEM PROCESS,0.01128,0.1119,0.14015,1,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.018091,0.11171,0.09219,1,0
6,GO RESPONSE TO CARBOHYDRATE,0.0046604,0.11169,0.10177,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.042609,0.11168,0.12203,1,0
6,GO PIGMENTATION,0.028556,0.11132,0.088363,1,0
6,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0073682,0.11131,0.10367,1,0
6,GO HEART PROCESS,0.012367,0.11122,0.1204,1,0
6,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.033271,0.11114,0.080615,1,0
6,GO CELL MOTILITY,0.0104,0.11109,0.10634,1,0
6,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.020385,0.11052,0.16212,1,0
6,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0002117,0.11052,0.12083,1,0
6,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.003654,0.11039,0.11367,1,0
6,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0012177,0.1103,0.11271,1,0
6,GO REGULATION OF TRANSFERASE ACTIVITY,0.0035146,0.11026,0.10009,1,0
6,GO REGULATION OF HELICASE ACTIVITY,0.0065235,0.11015,0.15772,1,0
6,GO MRNA TRANSCRIPTION,0.011949,0.11012,0.12779,1,0
6,GO REGULATION OF TRANSPORT,0.00096848,0.10978,0.10868,1,0
6,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.0043737,0.1097,0.14384,1,0
6,GO OOCYTE DIFFERENTIATION,0.0072795,0.10962,0.11806,1,0
6,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.037139,0.10959,0.11303,1,0
6,GO ACTIVATION OF MAPKK ACTIVITY,0.022209,0.10954,0.11728,1,0
6,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0034692,0.10953,0.12737,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.016568,0.10934,0.10013,1,0
6,GO PEPTIDE SECRETION,0.0028872,0.10934,0.11011,1,0
6,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.032938,0.10889,0.10217,1,0
6,GO PLASMA MEMBRANE TUBULATION,0.043444,0.10886,0.11134,1,0
6,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.015159,0.10879,0.11756,1,0
6,GO MELANOCYTE DIFFERENTIATION,0.013856,0.10878,0.13499,1,0
6,GO STRESS FIBER ASSEMBLY,0.032278,0.10811,0.11439,1,0
6,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.013394,0.10795,0.092263,1,0
6,GO MODULATION BY VIRUS OF HOST PROCESS,0.0033361,0.10739,0.12641,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.014172,0.1072,0.090812,1,0
6,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.03006,0.10703,0.096631,1,0
6,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0033361,0.10692,0.11366,1,0
6,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00063314,0.10673,0.11078,1,0
6,GO LENS FIBER CELL DEVELOPMENT,0.027118,0.10644,0.1567,1,0
6,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.0055559,0.10643,0.13666,1,0
6,GO MITOTIC CELL CYCLE ARREST,0.012087,0.10641,0.15575,1,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00096848,0.10637,0.11594,1,0
6,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.02174,0.10635,0.16192,1,0
6,GO CARTILAGE DEVELOPMENT,0.034984,0.10631,0.093226,1,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00014599,0.10599,0.13527,1,0
6,GO RESPONSE TO AXON INJURY,0.0050904,0.10582,0.13697,1,0
6,GO HISTONE MONOUBIQUITINATION,9.9844e-05,0.1057,0.14522,1,0
6,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.01995,0.10567,0.089924,1,0
6,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0029256,0.10561,0.10069,1,0
6,GO REGULATION OF PROTEIN POLYMERIZATION,0.001442,0.10558,0.12199,1,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0028872,0.10542,0.13762,1,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.0070192,0.10527,0.094751,1,0
6,GO PEPTIDYL SERINE MODIFICATION,0.00011218,0.10524,0.13435,1,0
6,GO STRIATED MUSCLE ADAPTATION,0.027401,0.10519,0.11048,1,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.010769,0.10516,0.24121,1,0
6,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0037016,0.105,0.10616,1,0
6,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,1.5014e-05,0.10497,0.14964,1,0
6,GO BLOOD VESSEL MORPHOGENESIS,0.052575,0.10497,0.09191,1,0
6,GO REGULATION OF ENDOCYTOSIS,0.011949,0.10483,0.10622,1,0
6,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.016568,0.1048,0.079752,1,0
6,GO RNA STABILIZATION,0.0025617,0.10464,0.12696,1,0
6,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.014013,0.10457,0.14493,1,0
6,GO BODY MORPHOGENESIS,0.020166,0.10452,0.1287,1,0
6,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.034984,0.10445,0.11381,1,0
6,GO ACTIVATION OF MAPK ACTIVITY,0.027118,0.10441,0.085397,1,0
6,GO REGULATION OF HYDROLASE ACTIVITY,0.039795,0.1043,0.080625,1,0
6,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.012367,0.1043,0.091249,1,0
6,GO PEPTIDYL THREONINE MODIFICATION,0.00013451,0.10418,0.13616,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0013069,0.10402,0.11074,1,0
6,GO BONE GROWTH,0.037882,0.10395,0.14848,1,0
6,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.024687,0.10361,0.10473,1,0
6,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.057179,0.10355,0.088217,1,0
6,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0066039,0.10345,0.095973,1,0
6,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.017506,0.10333,0.085427,1,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00011218,0.10311,0.12378,1,0
6,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.020828,0.10298,0.087206,1,0
6,GO CELL GROWTH,0.00019541,0.10288,0.13841,1,0
6,GO CONNECTIVE TISSUE DEVELOPMENT,0.007921,0.10256,0.11252,1,0
6,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.01128,0.1025,0.1365,1,0
6,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.012653,0.10228,0.095837,1,0
6,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0023009,0.10224,0.11,1,0
6,GO POSITIVE REGULATION OF EXOCYTOSIS,0.019523,0.10222,0.11568,1,0
6,GO CELLULAR RESPONSE TO PEPTIDE,0.013546,0.10219,0.095204,1,0
6,GO REGULATION OF LIPID KINASE ACTIVITY,0.048746,0.10211,0.094295,1,0
6,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0043737,0.10182,0.10592,1,0
6,GO NEGATIVE REGULATION OF JNK CASCADE,0.0059852,0.10164,0.13514,1,0
6,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.037139,0.10149,0.22047,1,0
6,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.025475,0.10114,0.12169,1,0
6,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0081133,0.10109,0.091948,1,0
6,GO CIRCADIAN SLEEP WAKE CYCLE,0.026561,0.10094,0.11059,1,0
6,GO REGULATION OF CELL SHAPE,0.011151,0.10082,0.11991,1,0
6,GO CELL MATURATION,2.9332e-05,0.10072,0.15525,1,0
6,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.048746,0.10063,0.13795,1,0
6,GO NUCLEAR ENVELOPE ORGANIZATION,0.0137,0.10038,0.10157,1,0
6,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.061549,0.10025,0.098649,1,0
6,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.045591,0.10024,0.085182,1,0
6,GO REGULATION OF KIDNEY DEVELOPMENT,0.040582,0.099906,0.10022,1,0
6,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.051595,0.09989,0.081891,1,0
6,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.02128,0.099536,0.11759,1,0
6,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.015674,0.099509,0.16529,1,0
6,GO RESPONSE TO PROSTAGLANDIN E,0.0078263,0.099508,0.12878,1,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00072342,0.099498,0.15422,1,0
6,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.00032916,0.099465,0.15879,1,0
6,GO POSITIVE REGULATION OF BINDING,0.0016122,0.099369,0.10843,1,0
6,GO REGULATION OF PEPTIDE SECRETION,0.0037016,0.099174,0.10712,1,0
6,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.046921,0.098779,0.10158,1,0
6,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0016347,0.098726,0.13612,1,0
6,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0010113,0.098549,0.18026,1,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.034636,0.098085,0.1019,1,0
6,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0035146,0.098041,0.12096,1,0
6,GO RESPONSE TO STEROID HORMONE,0.046474,0.097659,0.081492,1,0
6,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.037509,0.097424,0.10267,1,0
6,GO HISTONE SERINE PHOSPHORYLATION,0.043444,0.097359,0.1009,1,0
6,GO REGULATION OF BLOOD CIRCULATION,0.0077327,0.097329,0.12731,1,0
6,GO SKIN DEVELOPMENT,0.058787,0.097085,0.087481,1,0
6,GO REGULATION OF TELOMERE MAINTENANCE,0.060988,0.097062,0.075218,1,0
6,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0074579,0.097047,0.095653,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.014332,0.097017,0.095531,1,0
6,GO NEGATIVE REGULATION OF BEHAVIOR,0.053071,0.096991,0.11208,1,0
6,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.010522,0.096927,0.11653,1,0
6,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.020605,0.09688,0.19592,1,0
6,GO EPIDERMIS DEVELOPMENT,0.054582,0.096526,0.087426,1,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0001862,0.096305,0.12274,1,0
6,GO REGULATION OF PEPTIDE TRANSPORT,0.0010558,0.096226,0.10401,1,0
6,GO POSITIVE REGULATION OF GLIOGENESIS,0.00074504,0.096128,0.15683,1,0
6,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.01829,0.095993,0.13124,1,0
6,GO LYSOSOMAL TRANSPORT,0.0056958,0.095896,0.11673,1,0
6,GO GMP METABOLIC PROCESS,0.038258,0.095759,0.087126,1,0
6,GO RESPONSE TO MONOSACCHARIDE,0.0032501,0.095621,0.10843,1,0
6,GO REGULATION OF CELL POPULATION PROLIFERATION,0.018091,0.095525,0.089371,1,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0017277,0.095497,0.1183,1,0
6,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0022396,0.09544,0.10437,1,0
6,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.017506,0.094874,0.1504,1,0
6,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.011678,0.09466,0.085746,1,0
6,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.05357,0.094646,0.08595,1,0
6,GO IMPORT INTO CELL,0.007921,0.094504,0.12713,1,0
6,GO BIOLOGICAL ADHESION,0.043444,0.094485,0.096248,1,0
6,GO CELLULAR RESPONSE TO ALCOHOL,0.0068504,0.094408,0.11852,1,0
6,GO RESPONSE TO HORMONE,0.049681,0.09423,0.075147,1,0
6,GO OSSIFICATION,0.045155,0.093716,0.084292,1,0
6,GO LYMPHANGIOGENESIS,0.046921,0.093649,0.13449,1,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION,0.002702,0.093646,0.14275,1,0
6,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0043184,0.093614,0.13302,1,0
6,GO RESPONSE TO ESTRADIOL,0.0033361,0.093429,0.12131,1,0
6,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.060432,0.093136,0.099947,1,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.052083,0.093059,0.084018,1,0
6,GO SPINDLE MIDZONE ASSEMBLY,0.0046604,0.092904,0.16279,1,0
6,GO CIRCULATORY SYSTEM PROCESS,0.020385,0.092234,0.096612,1,0
6,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0066039,0.092205,0.10969,1,0
6,GO EXTRACELLULAR MATRIX ASSEMBLY,0.046474,0.092073,0.13358,1,0
6,GO RESPONSE TO RADIATION,0.00016361,0.091304,0.10893,1,0
6,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0053519,0.091257,0.10091,1,0
6,GO CELL RECOGNITION,0.0025617,0.09125,0.1309,1,0
6,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.019104,0.091054,0.12792,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.01251,0.091036,0.08489,1,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0066039,0.090843,0.13723,1,0
6,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.022686,0.09066,0.196,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0088198,0.090607,0.10086,1,0
6,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.036048,0.090602,0.082756,1,0
6,GO ENDOCRINE HORMONE SECRETION,0.036409,0.090468,0.080007,1,0
6,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.022209,0.090458,0.12375,1,0
6,GO INTERMEDIATE FILAMENT BASED PROCESS,0.049681,0.090035,0.10259,1,0
6,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.01251,0.090004,0.12025,1,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS,0.047372,0.089868,0.07526,1,0
6,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.00011218,0.089795,0.13319,1,0
6,GO POSITIVE REGULATION OF TRANSPORT,0.010769,0.089699,0.09186,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION,0.0090315,0.089637,0.11728,1,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.049212,0.089558,0.13254,1,0
6,GO CARDIAC CONDUCTION,0.0018256,0.08932,0.17545,1,0
6,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0072795,0.089207,0.1258,1,0
6,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.036772,0.089052,0.075431,1,0
6,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.042609,0.088906,0.15932,1,0
6,GO GENE SILENCING,0.00013016,0.088763,0.11767,1,0
6,GO ADAPTIVE THERMOGENESIS,0.028264,0.088711,0.085372,1,0
6,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.027118,0.088421,0.081249,1,0
6,GO NOTCH SIGNALING PATHWAY,0.0069343,0.08794,0.11835,1,0
6,GO MULTI ORGANISM LOCALIZATION,0.056652,0.08794,0.058147,1,0
6,GO RESPONSE TO IONIZING RADIATION,0.046031,0.087935,0.066731,1,0
6,GO NEGATIVE REGULATION OF GROWTH,0.014823,0.087387,0.10107,1,0
6,GO ION TRANSMEMBRANE TRANSPORT,0.0049019,0.087264,0.10599,1,0
6,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,7.7586e-05,0.087197,0.14633,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.02521,0.0871,0.08765,1,0
6,GO RESPONSE TO LEAD ION,0.047827,0.087092,0.10363,1,0
6,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.032607,0.086986,0.088781,1,0
6,GO PROTEIN POLYMERIZATION,0.0030436,0.086967,0.11092,1,0
6,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.012945,0.086847,0.12205,1,0
6,GO RESPONSE TO INSULIN,0.031311,0.08656,0.083724,1,0
6,GO RESPONSE TO ABIOTIC STIMULUS,0.03006,0.086473,0.070715,1,0
6,GO HOMEOSTATIC PROCESS,0.023173,0.086452,0.072183,1,0
6,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0023009,0.086303,0.090393,1,0
6,GO METAL ION TRANSPORT,0.003607,0.086047,0.10535,1,0
6,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0013633,0.085307,0.11422,1,0
6,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.028264,0.084644,0.079688,1,0
6,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.019523,0.084608,0.13419,1,0
6,GO CALCIUM ION IMPORT,0.024687,0.084364,0.1066,1,0
6,GO REGULATION OF CARTILAGE DEVELOPMENT,0.048746,0.084363,0.10804,1,0
6,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.011813,0.084098,0.10354,1,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0044864,0.084086,0.090734,1,0
6,GO MUSCLE CELL APOPTOTIC PROCESS,0.039406,0.083866,0.09553,1,0
6,GO CELLULAR RESPONSE TO CALCIUM ION,0.016568,0.083566,0.1202,1,0
6,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.01016,0.083559,0.11701,1,0
6,GO PROTEIN IMPORT,0.054074,0.083517,0.070146,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0016122,0.083483,0.095504,1,0
6,GO APOPTOTIC DNA FRAGMENTATION,0.00059648,0.083429,0.12329,1,0
6,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0005211,0.083365,0.10237,1,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0018256,0.082931,0.098372,1,0
6,GO SERTOLI CELL DIFFERENTIATION,0.035691,0.082688,0.12393,1,0
6,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.036048,0.082606,0.080556,1,0
6,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.01829,0.082459,0.16121,1,0
6,GO REGULATION OF CATABOLIC PROCESS,0.047827,0.082429,0.06208,1,0
6,GO TOR SIGNALING,0.00076726,0.08222,0.11917,1,0
6,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0029645,0.081838,0.12051,1,0
6,GO AUTOPHAGIC CELL DEATH,0.017125,0.081827,0.13033,1,0
6,GO CATION TRANSPORT,0.0045438,0.081708,0.10473,1,0
6,GO POSITIVE REGULATION OF SECRETION,0.011544,0.081645,0.094359,1,0
6,GO GLUTAMATE SECRETION,0.061549,0.081328,0.14084,1,0
6,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0047798,0.081259,0.10708,1,0
6,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.03429,0.081202,0.12112,1,0
6,GO T CELL DIFFERENTIATION,0.048746,0.081015,0.069101,1,0
6,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.027686,0.080747,0.1176,1,0
6,GO B CELL DIFFERENTIATION,0.056652,0.080724,0.077862,1,0
6,GO CHEMICAL HOMEOSTASIS,0.046031,0.080621,0.07169,1,0
6,GO P38MAPK CASCADE,0.042197,0.080586,0.12235,1,0
6,GO CELLULAR RESPONSE TO RETINOIC ACID,0.040187,0.080447,0.11477,1,0
6,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.020605,0.08039,0.16624,1,0
6,GO EXECUTION PHASE OF APOPTOSIS,0.0037016,0.080362,0.1024,1,0
6,GO MULTI ORGANISM CELLULAR PROCESS,0.026838,0.080302,0.13986,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0046604,0.08009,0.09326,1,0
6,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.014494,0.08007,0.085499,1,0
6,GO REGULATION OF DENDRITE EXTENSION,0.036772,0.080022,0.19674,1,0
6,GO MYOFIBRIL ASSEMBLY,0.041383,0.079996,0.10046,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.056652,0.079909,0.095762,1,0
6,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.053071,0.079759,0.10443,1,0
6,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.033608,0.079576,0.085169,1,0
6,GO TRACHEA MORPHOGENESIS,0.024947,0.079397,0.14185,1,0
6,GO RESPONSE TO PEPTIDE HORMONE,0.059879,0.07933,0.073134,1,0
6,GO RESPONSE TO ALKALOID,0.0063654,0.079324,0.10651,1,0
6,GO ACTIN FILAMENT BASED MOVEMENT,0.025743,0.079075,0.11389,1,0
6,GO POSITIVE REGULATION OF ANION TRANSPORT,0.038637,0.078844,0.087227,1,0
6,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0039481,0.078826,0.11909,1,0
6,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.01585,0.07853,0.10261,1,0
6,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.058247,0.0783,0.067675,1,0
6,GO REGULATION OF ORGAN GROWTH,0.01128,0.078218,0.10248,1,0
6,GO POSITIVE REGULATION OF CELL DEATH,0.042197,0.078133,0.079882,1,0
6,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0057669,0.077851,0.097781,1,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.044722,0.077823,0.060821,1,0
6,GO REGULATION OF ION TRANSPORT,0.0061347,0.077459,0.10992,1,0
6,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.051111,0.077424,0.082478,1,0
6,GO APOPTOTIC PROCESS,0.037139,0.077379,0.07006,1,0
6,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0041031,0.077352,0.11249,1,0
6,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0071051,0.077286,0.10852,1,0
6,GO MUSCLE CONTRACTION,0.060432,0.07728,0.077976,1,0
6,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.043866,0.077094,0.070269,1,0
6,GO DNA BIOSYNTHETIC PROCESS,0.027686,0.076991,0.068487,1,0
6,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.025475,0.076822,0.071366,1,0
6,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0083098,0.076333,0.12838,1,0
6,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0083098,0.076134,0.11002,1,0
6,GO ENDOCYTOSIS,0.060988,0.075996,0.079813,1,0
6,GO DIVALENT INORGANIC CATION TRANSPORT,0.046474,0.07596,0.077677,1,0
6,GO CELLULAR RESPONSE TO ALKALOID,0.011544,0.075714,0.10742,1,0
6,GO BASE EXCISION REPAIR,0.013546,0.075612,0.083132,1,0
6,GO REGULATION OF CARDIAC CONDUCTION,0.017699,0.075507,0.12738,1,0
6,GO TELOMERE ORGANIZATION,0.038637,0.075472,0.077992,1,0
6,GO RESPONSE TO NITROGEN COMPOUND,0.02945,0.075097,0.075873,1,0
6,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.029754,0.075,0.095696,1,0
6,GO IMMUNE SYSTEM DEVELOPMENT,0.046474,0.074979,0.068626,1,0
6,GO REGULATION OF REPRODUCTIVE PROCESS,0.0137,0.074813,0.080862,1,0
6,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.023173,0.074703,0.10746,1,0
6,GO CELL CYCLE G1 S PHASE TRANSITION,0.003607,0.074629,0.10099,1,0
6,GO NEGATIVE REGULATION OF CELL DEATH,0.060432,0.074487,0.063709,1,0
6,GO PROTEIN K63 LINKED UBIQUITINATION,0.040981,0.074416,0.071975,1,0
6,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.017125,0.074379,0.078866,1,0
6,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.010645,0.074258,0.098745,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.052575,0.074226,0.1043,1,0
6,GO REGULATION OF GTP BINDING,0.056652,0.074197,0.14279,1,0
6,GO DICARBOXYLIC ACID TRANSPORT,0.030994,0.074109,0.12278,1,0
6,GO REGULATION OF CELL DEATH,0.058787,0.073909,0.066759,1,0
6,GO ION TRANSPORT,0.012367,0.073339,0.090512,1,0
6,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.058787,0.073102,0.074042,1,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.056652,0.073081,0.075927,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.018898,0.072856,0.11432,1,0
6,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.016027,0.072837,0.10094,1,0
6,GO SPLEEN DEVELOPMENT,0.054074,0.072741,0.089038,1,0
6,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.02915,0.072648,0.12513,1,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.026838,0.07258,0.079003,1,0
6,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0031247,0.072143,0.099842,1,0
6,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.012945,0.072066,0.1513,1,0
6,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0014624,0.071907,0.10246,1,0
6,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.012227,0.071816,0.077504,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.049212,0.071573,0.12896,1,0
6,GO LIPID MODIFICATION,0.02915,0.071371,0.084314,1,0
6,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.046921,0.071274,0.072889,1,0
6,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.033608,0.07126,0.22843,1,0
6,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.055609,0.071028,0.053716,1,0
6,GO CATION TRANSMEMBRANE TRANSPORT,0.0054192,0.071002,0.10754,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.022928,0.070603,0.084221,1,0
6,GO TRANSMEMBRANE TRANSPORT,0.035691,0.070526,0.074555,1,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.012798,0.070124,0.098853,1,0
6,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.03068,0.070049,0.10957,1,0
6,GO DNA DEALKYLATION,0.017315,0.069577,0.11337,1,0
6,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.015674,0.069491,0.13669,1,0
6,GO TEMPERATURE HOMEOSTASIS,0.017699,0.06932,0.092719,1,0
6,GO TISSUE HOMEOSTASIS,0.044292,0.069128,0.077147,1,0
6,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.026561,0.069047,0.089918,1,0
6,GO MEMBRANE ORGANIZATION,0.02174,0.068943,0.083259,1,0
6,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.049212,0.068446,0.090337,1,0
6,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.061549,0.068251,0.069255,1,0
6,GO RESPONSE TO TEMPERATURE STIMULUS,0.043444,0.067055,0.072097,1,0
6,GO REGULATION OF METAL ION TRANSPORT,0.027686,0.06675,0.084032,1,0
6,GO IMPORT ACROSS PLASMA MEMBRANE,0.031311,0.065699,0.10756,1,0
6,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0090315,0.065451,0.1108,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.057711,0.064851,0.078147,1,0
6,GO RESPONSE TO PEPTIDE,0.058787,0.064685,0.074267,1,0
6,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.038258,0.064421,0.11334,1,0
6,GO ANION TRANSMEMBRANE TRANSPORT,0.015674,0.064083,0.090009,1,0
6,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.047827,0.063934,0.078532,1,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.053071,0.063672,0.064265,1,0
6,GO BILE ACID METABOLIC PROCESS,0.044722,0.063565,0.099579,1,0
6,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.016568,0.063401,0.094281,1,0
6,GO RENAL WATER HOMEOSTASIS,0.0089251,0.06312,0.17452,1,0
6,GO HYPEROSMOTIC SALINITY RESPONSE,0.051111,0.062847,0.14241,1,0
6,GO SKELETAL MUSCLE ADAPTATION,0.059331,0.06236,0.11912,1,0
6,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.03068,0.061415,0.071839,1,0
6,GO DETECTION OF STIMULUS,0.023668,0.060809,0.066202,1,0
6,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.035691,0.060774,0.15308,1,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.03068,0.060724,0.08155,1,0
6,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.044292,0.060259,0.083915,1,0
6,GO ACTION POTENTIAL,0.053071,0.059984,0.11144,1,0
6,GO REGULATION OF CELL FATE COMMITMENT,0.049681,0.059418,0.12754,1,0
6,GO REGULATION OF ATPASE ACTIVITY,0.025743,0.059181,0.072232,1,0
6,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.032278,0.057943,0.092898,1,0
6,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.048746,0.057013,0.12845,1,0
6,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.049212,0.056611,0.10889,1,0
6,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.031311,0.05651,0.083704,1,0
6,GO MACROMOLECULE CATABOLIC PROCESS,0.060432,0.055428,0.053321,1,0
6,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.019312,0.050469,0.093207,1,0
6,GO HEART GROWTH,0.051595,0.048787,0.087227,1,0
6,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.026013,0.047871,0.10673,1,0
6,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.054582,0.047688,0.08119,1,0
6,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.043866,0.045517,0.10598,1,0
6,GO CELL AGING,0.040582,0.042465,0.074705,1,0
6,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.019104,0.041632,0.075755,1,0
6,GO ANION HOMEOSTASIS,0.05357,0.040773,0.11171,1,0
6,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0137,0.040679,0.087194,1,0
6,GO SKELETAL MUSCLE CONTRACTION,0.027973,0.039129,0.12737,1,0
6,GO MEGAKARYOCYTE DIFFERENTIATION,0.056652,0.036162,0.083946,1,0
6,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.056652,0.024193,0.07401,1,0
6,GO AMINO ACID ACTIVATION,0.051111,-0.0204,-0.11969,1,0
6,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.024173,-0.041857,-0.089466,1,0
6,GO IRON ION TRANSMEMBRANE TRANSPORT,0.038637,-0.042858,-0.094946,1,0
6,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.017506,-0.045563,-0.1169,1,0
6,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.016568,-0.049602,-0.15556,1,0
6,GO PEPTIDYL PROLINE MODIFICATION,0.026838,-0.050053,-0.098298,1,0
6,GO RIBOSOME ASSEMBLY,0.016027,-0.05285,-0.15435,1,0
6,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.01995,-0.053644,-0.17374,1,0
6,GO PSEUDOURIDINE SYNTHESIS,0.039795,-0.053865,-0.16492,1,0
6,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.040187,-0.05398,-0.13413,1,0
6,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.059879,-0.056775,-0.090154,1,0
6,GO GRANULOCYTE MIGRATION,0.047372,-0.058086,-0.086269,1,0
6,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.046474,-0.062897,-0.067164,1,0
6,GO NEGATIVE T CELL SELECTION,0.051111,-0.062921,-0.10869,1,0
6,GO MITOCHONDRIAL GENE EXPRESSION,0.0023009,-0.062939,-0.16452,1,0
6,GO RESPONSE TO MANGANESE ION,0.060988,-0.063571,-0.073566,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.049681,-0.063719,-0.14395,1,0
6,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.044292,-0.065927,-0.084501,1,0
6,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.052575,-0.069517,-0.089913,1,0
6,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.057711,-0.069777,-0.060303,1,0
6,GO PHOSPHOLIPID CATABOLIC PROCESS,0.060988,-0.071366,-0.087841,1,0
6,GO IRON SULFUR CLUSTER ASSEMBLY,0.025475,-0.073315,-0.12233,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.05063,-0.074698,-0.15756,1,0
6,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.010895,-0.074827,-0.097723,1,0
6,GO RNA 5 END PROCESSING,0.016752,-0.078811,-0.14475,1,0
6,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.009139,-0.079492,-0.082813,1,0
6,GO PIGMENT BIOSYNTHETIC PROCESS,0.044292,-0.079589,-0.081533,1,0
6,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0058389,-0.079818,-0.12555,1,0
6,GO CELLULAR DEFENSE RESPONSE,0.055609,-0.079841,-0.11433,1,0
6,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.040582,-0.080029,-0.090295,1,0
6,GO SULFUR COMPOUND CATABOLIC PROCESS,0.054074,-0.084199,-0.075555,1,0
6,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.058247,-0.085063,-0.13311,1,0
6,GO URONIC ACID METABOLIC PROCESS,0.019104,-0.087868,-0.097964,1,0
6,GO TRANSLATIONAL ELONGATION,0.0015249,-0.088487,-0.14256,1,0
6,GO GRANULOCYTE CHEMOTAXIS,0.043444,-0.089233,-0.082249,1,0
6,GO ICOSANOID BIOSYNTHETIC PROCESS,0.026286,-0.089444,-0.13079,1,0
6,GO PROSTANOID BIOSYNTHETIC PROCESS,0.043444,-0.089774,-0.17593,1,0
6,GO POSITIVE REGULATION OF T CELL MIGRATION,0.041383,-0.091088,-0.093352,1,0
6,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0087156,-0.094553,-0.1077,1,0
6,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.056128,-0.094575,-0.13964,1,0
6,GO CELL ADHESION MEDIATED BY INTEGRIN,0.056652,-0.094878,-0.12346,1,0
6,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.058247,-0.094912,-0.1319,1,0
6,GO CELLULAR COPPER ION HOMEOSTASIS,0.041383,-0.095233,-0.10079,1,0
6,GO MITOCHONDRIAL TRANSLATION,0.00057029,-0.095447,-0.18219,1,0
6,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0060595,-0.095458,-0.094105,1,0
6,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.046921,-0.095784,-0.11806,1,0
6,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.018091,-0.09734,-0.11561,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.014494,-0.099203,-0.12845,1,0
6,GO REGULATION OF TRANSLATIONAL TERMINATION,0.056128,-0.10146,-0.10077,1,0
6,GO CELLULAR RESPIRATION,0.01499,-0.10347,-0.10151,1,0
6,GO PHAGOSOME MATURATION,0.02945,-0.10364,-0.087999,1,0
6,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.016386,-0.10509,-0.12376,1,0
6,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.049681,-0.10518,-0.11914,1,0
6,GO AEROBIC RESPIRATION,0.0085105,-0.10558,-0.10951,1,0
6,GO INTERLEUKIN 8 PRODUCTION,0.03902,-0.10614,-0.11856,1,0
6,GO AMP METABOLIC PROCESS,0.038637,-0.1067,-0.149,1,0
6,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0095807,-0.10699,-0.10743,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.027973,-0.10702,-0.12139,1,0
6,GO RESPONSE TO PEPTIDOGLYCAN,0.010769,-0.11071,-0.14306,1,0
6,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.02945,-0.11098,-0.15297,1,0
6,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.045155,-0.11179,-0.16656,1,0
6,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.043444,-0.11231,-0.14266,1,0
6,GO TRANSLATIONAL TERMINATION,0.00012388,-0.11273,-0.20371,1,0
6,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.012653,-0.11325,-0.17961,1,0
6,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0030038,-0.11375,-0.15858,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.042609,-0.1139,-0.11112,1,0
6,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.018693,-0.11402,-0.14212,1,0
6,GO PROTEASOME ASSEMBLY,0.0035146,-0.11423,-0.13768,1,0
6,GO AMINO SUGAR CATABOLIC PROCESS,0.012087,-0.11448,-0.13298,1,0
6,GO PROSTAGLANDIN SECRETION,0.017506,-0.11449,-0.11601,1,0
6,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.0058389,-0.11513,-0.14723,1,0
6,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.028852,-0.11556,-0.097819,1,0
6,GO MONONUCLEAR CELL MIGRATION,0.016938,-0.11631,-0.11825,1,0
6,GO HEME METABOLIC PROCESS,0.01016,-0.11666,-0.1487,1,0
6,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.012087,-0.11839,-0.13559,1,0
6,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.055093,-0.11883,-0.10181,1,0
6,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.016205,-0.11899,-0.10829,1,0
6,GO TRNA 5 END PROCESSING,0.0045438,-0.11913,-0.14428,1,0
6,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.034984,-0.1198,-0.13365,1,0
6,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0052854,-0.12152,-0.11032,1,0
6,GO CELLULAR RESPONSE TO INTERFERON BETA,0.036409,-0.12153,-0.1451,1,0
6,GO RESPONSE TO PROTOZOAN,0.017315,-0.12209,-0.15206,1,0
6,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.034984,-0.12251,-0.1125,1,0
6,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.024947,-0.12356,-0.12016,1,0
6,GO PROTEIN DENEDDYLATION,0.026838,-0.12359,-0.096386,1,0
6,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.017506,-0.12378,-0.14219,1,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.043444,-0.12383,-0.1276,1,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.059331,-0.12389,-0.10985,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.028556,-0.12438,-0.10692,1,0
6,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.00068191,-0.12442,-0.15174,1,0
6,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0033799,-0.12569,-0.12082,1,0
6,GO CYTOCHROME COMPLEX ASSEMBLY,0.0042095,-0.1261,-0.13555,1,0
6,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0062108,-0.12661,-0.15326,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.052575,-0.12808,-0.16652,1,0
6,GO LIPOXYGENASE PATHWAY,0.030368,-0.12919,-0.20849,1,0
6,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0014022,-0.13053,-0.15928,1,0
6,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.030994,-0.13074,-0.12728,1,0
6,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.031631,-0.13076,-0.12448,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.042197,-0.1312,-0.11558,1,0
6,GO MEMBRANE LIPID CATABOLIC PROCESS,0.02945,-0.13195,-0.12052,1,0
6,GO COPPER ION TRANSPORT,0.012087,-0.13209,-0.13627,1,0
6,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0015038,-0.1323,-0.12333,1,0
6,GO NEUTRAL AMINO ACID TRANSPORT,0.0038977,-0.13264,-0.1333,1,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0030038,-0.13337,-0.17038,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.027973,-0.13578,-0.13885,1,0
6,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.060988,-0.13594,-0.21996,1,0
6,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0073682,-0.136,-0.16505,1,0
6,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.0016347,-0.13648,-0.16026,1,0
6,GO FIBRINOLYSIS,0.016938,-0.1368,-0.19962,1,0
6,GO INTERFERON GAMMA PRODUCTION,0.028264,-0.13713,-0.096468,1,0
6,GO REGULATION OF BONE DEVELOPMENT,0.001704,-0.1378,-0.14129,1,0
6,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.00042128,-0.13937,-0.16901,1,0
6,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,7.7586e-05,-0.13973,-0.21526,1,0
6,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.016752,-0.1406,-0.14256,1,0
6,GO IMP METABOLIC PROCESS,0.056128,-0.14094,-0.13672,1,0
6,GO ELECTRON TRANSPORT CHAIN,0.0013255,-0.14111,-0.12164,1,0
6,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.031311,-0.14115,-0.17622,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.012367,-0.14339,-0.13141,1,0
6,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0055559,-0.14406,-0.20334,1,0
6,GO TRNA 5 LEADER REMOVAL,0.0015463,-0.14418,-0.15639,1,0
6,GO REGULATION OF FIBRINOLYSIS,0.0059116,-0.14469,-0.20219,1,0
6,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0025961,-0.14544,-0.17505,1,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0028492,-0.14554,-0.15845,1,0
6,GO ETHANOL METABOLIC PROCESS,0.027401,-0.14747,-0.15392,1,0
6,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.042197,-0.14802,-0.13223,1,0
6,GO REGULATION OF B CELL PROLIFERATION,0.032607,-0.14817,-0.11035,1,0
6,GO MONOCYTE CHEMOTAXIS,0.0042095,-0.15069,-0.16658,1,0
6,GO CELL REDOX HOMEOSTASIS,0.0033799,-0.15082,-0.13372,1,0
6,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.016752,-0.15227,-0.21134,1,0
6,GO L ASCORBIC ACID METABOLIC PROCESS,0.0071918,-0.15243,-0.18548,1,0
6,GO VITAMIN D METABOLIC PROCESS,0.040981,-0.15304,-0.13019,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.026561,-0.15344,-0.14501,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.041789,-0.15501,-0.12915,1,0
6,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.012945,-0.15515,-0.1083,1,0
6,GO OXIDATIVE PHOSPHORYLATION,0.00019857,-0.15825,-0.14626,1,0
6,GO VITAMIN D BIOSYNTHETIC PROCESS,0.037139,-0.16223,-0.14248,1,0
6,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.01585,-0.16259,-0.20262,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0077327,-0.16401,-0.16941,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.019104,-0.16415,-0.17202,1,0
6,GO VASODILATION,0.011022,-0.16424,-0.14581,1,0
6,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0080166,-0.16442,-0.24224,1,0
6,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.031631,-0.16461,-0.11087,1,0
6,GO INTESTINAL LIPID ABSORPTION,0.059331,-0.16865,-0.19067,1,0
6,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.00096848,-0.1709,-0.15046,1,0
6,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013394,-0.17214,-0.15134,1,0
6,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.047372,-0.17245,-0.21973,1,0
6,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0059116,-0.17251,-0.17767,1,0
6,GO GLYCOLIPID CATABOLIC PROCESS,0.032938,-0.17346,-0.18014,1,0
6,GO MACROMOLECULE DEPALMITOYLATION,0.00032408,-0.17351,-0.16828,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.011022,-0.17588,-0.22145,1,0
6,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,8.7316e-05,-0.17766,-0.17533,1,0
6,GO NUCLEOTIDE SALVAGE,0.0043184,-0.1796,-0.19896,1,0
6,GO HISTAMINE TRANSPORT,0.054074,-0.18291,-0.13162,1,0
6,GO REGULATION OF MYOBLAST FUSION,0.025475,-0.18425,-0.14013,1,0
6,GO T CELL MEDIATED CYTOTOXICITY,0.027401,-0.18435,-0.21055,1,0
6,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00055343,-0.18527,-0.24661,1,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.00016361,-0.1926,-0.17676,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0056958,-0.19432,-0.15495,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.018898,-0.19535,-0.17058,1,0
6,GO PLASMINOGEN ACTIVATION,0.009139,-0.19577,-0.19537,1,0
6,GO AEROBIC ELECTRON TRANSPORT CHAIN,4.1751e-05,-0.19834,-0.20787,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00099681,-0.20122,-0.18845,1,0
6,GO REGULATION OF MICROVILLUS ORGANIZATION,0.046921,-0.20199,-0.17393,1,0
6,GO LIPOPROTEIN CATABOLIC PROCESS,0.0045438,-0.20268,-0.18037,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.050154,-0.2046,-0.15805,1,0
6,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0068504,-0.20592,-0.20202,1,0
6,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.043866,-0.20625,-0.17582,1,0
6,GO CHRONIC INFLAMMATORY RESPONSE,0.0011341,-0.2077,-0.23876,1,0
6,GO INTERLEUKIN 17 PRODUCTION,0.0018764,-0.21071,-0.1863,1,0
6,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.051111,-0.21254,-0.17486,1,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0062877,-0.21275,-0.21226,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.015329,-0.21292,-0.18646,1,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0013633,-0.2132,-0.17619,1,0
6,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0096941,-0.2132,-0.18885,1,0
6,GO KERATAN SULFATE CATABOLIC PROCESS,0.0071051,-0.21434,-0.19884,1,0
6,GO TROPHOBLAST CELL MIGRATION,0.0055559,-0.2144,-0.18149,1,0
6,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0084096,-0.21662,-0.22204,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.021509,-0.21705,-0.1832,1,0
6,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00019857,-0.21836,-0.2778,1,0
6,GO GLUTATHIONE METABOLIC PROCESS,0.0033799,-0.2203,-0.14096,1,0
6,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.039795,-0.2219,-0.20676,1,0
6,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.047827,-0.22201,-0.17851,1,0
6,GO GLYCINE TRANSPORT,0.027118,-0.22761,-0.17917,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00046165,-0.22834,-0.30418,1,0
6,GO PHAGOLYSOSOME ASSEMBLY,0.020166,-0.2287,-0.15173,1,0
6,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.011411,-0.22881,-0.17871,1,0
6,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.060988,-0.22929,-0.12719,1,0
6,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,2.8305e-05,-0.23174,-0.24519,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0001179,-0.23462,-0.244,1,0
6,GO VITAMIN BIOSYNTHETIC PROCESS,0.0024609,-0.2408,-0.15314,1,0
6,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0051547,-0.24212,-0.2366,1,0
6,GO HISTAMINE SECRETION,0.017699,-0.24286,-0.19037,1,0
6,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0017277,-0.24494,-0.24742,1,0
6,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.021973,-0.24601,-0.14133,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.016752,-0.25903,-0.20034,1,0
6,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0011836,-0.2603,-0.26584,1,0
6,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00010152,-0.26087,-0.21443,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00038422,-0.26423,-0.23756,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.001568,-0.26653,-0.24638,1,0
6,GO SIGNAL PEPTIDE PROCESSING,0.00011986,-0.26707,-0.21629,1,0
6,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0083098,-0.27013,-0.35681,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0137,-0.2705,-0.23083,1,0
6,GO CYCLOOXYGENASE PATHWAY,0.039406,-0.27307,-0.17141,1,0
6,GO EOSINOPHIL MIGRATION,0.0041031,-0.28178,-0.2111,1,0
6,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0040509,-0.28384,-0.18958,1,0
6,GO ETHANOL OXIDATION,0.0019285,-0.28413,-0.30979,1,0
6,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.031311,-0.28493,-0.19672,1,0
6,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.019312,-0.29147,-0.20083,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.025475,-0.29224,-0.26308,1,0
6,GO EOSINOPHIL CHEMOTAXIS,0.0059852,-0.32256,-0.2182,1,0
6,GO RESPONSE TO INTERFERON BETA,0.00074504,-0.32275,-0.3414,1,0
6,GO FRUCTOSE METABOLIC PROCESS,0.049212,-0.32647,-0.16941,1,0
6,GO MUCUS SECRETION,0.001118,-0.43148,-0.40002,1,0
6,GO REGULATION OF PLATELET AGGREGATION,0.063258,0.2164,0.16581,0,1
6,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.066192,0.20474,0.19031,0,1
6,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.063258,0.1999,0.17074,0,1
6,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.084034,0.17123,0.13451,0,1
6,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.093918,0.16894,0.093953,0,1
6,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.066792,0.16745,0.13554,0,1
6,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.35253,0.16437,0.090878,0,1
6,GO PROTEIN TARGETING TO LYSOSOME,0.10299,0.16387,0.11247,0,1
6,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.30829,0.16227,0.066397,0,1
6,GO EPITHELIAL CELL CELL ADHESION,0.086981,0.15888,0.15611,0,1
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.11002,0.15531,0.13306,0,1
6,GO CORTICOSTEROID HORMONE SECRETION,0.094715,0.15414,0.11205,0,1
6,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.085497,0.14714,0.082274,0,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.077018,0.14027,0.11967,0,1
6,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.076344,0.13669,0.072172,0,1
6,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.22042,0.13618,0.058737,0,1
6,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.12126,0.1357,0.12028,0,1
6,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.066792,0.13477,0.083531,0,1
6,GO PROTEIN CONTAINING COMPLEX REMODELING,0.19278,0.13445,0.063509,0,1
6,GO MITOCHONDRIAL DNA REPLICATION,0.6515,0.1288,0.012853,0,1
6,GO MYELIN ASSEMBLY,0.073043,0.12668,0.12819,0,1
6,GO LYMPH VESSEL DEVELOPMENT,0.065596,0.12616,0.13703,0,1
6,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.077698,0.12598,0.095461,0,1
6,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.063258,0.123,0.094189,0,1
6,GO LIVER MORPHOGENESIS,0.062114,0.12226,0.10318,0,1
6,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.09796,0.1214,0.087986,0,1
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.23766,0.12075,0.069837,0,1
6,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.076344,0.11867,0.12475,0,1
6,GO REGULATORY T CELL DIFFERENTIATION,0.071756,0.11754,0.10745,0,1
6,GO MAGNESIUM ION TRANSPORT,0.12421,0.11601,0.072187,0,1
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.084034,0.11418,0.10032,0,1
6,GO PHAGOCYTOSIS RECOGNITION,0.12126,0.11335,0.10431,0,1
6,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.069238,0.1122,0.13258,0,1
6,GO RNA INTERFERENCE,0.12126,0.11182,0.06962,0,1
6,GO GLIAL CELL APOPTOTIC PROCESS,0.10558,0.11109,0.12473,0,1
6,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.36526,0.11073,0.038985,0,1
6,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.071119,0.11024,0.089797,0,1
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.25414,0.10946,0.092589,0,1
6,GO CELLULAR RESPONSE TO IRON ION,0.14642,0.10892,0.093202,0,1
6,GO CELLULAR RESPONSE TO FATTY ACID,0.062684,0.10871,0.089923,0,1
6,GO ADAPTATION OF SIGNALING PATHWAY,0.067397,0.10787,0.087011,0,1
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.11183,0.10744,0.061006,0,1
6,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.30066,0.10693,0.069373,0,1
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.18327,0.10595,0.087337,0,1
6,GO LIPID HOMEOSTASIS,0.10558,0.10535,0.071421,0,1
6,GO MESODERMAL CELL DIFFERENTIATION,0.064418,0.10445,0.082256,0,1
6,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.069238,0.10307,0.092067,0,1
6,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.17029,0.10081,0.064542,0,1
6,GO INTRACELLULAR STEROL TRANSPORT,0.14755,0.10054,0.10401,0,1
6,GO NUCLEAR PORE ORGANIZATION,0.094715,0.099697,0.1037,0,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.56103,0.099379,0.01892,0,1
6,GO RNA SURVEILLANCE,0.68689,0.099363,0.002856,0,1
6,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.16654,0.099049,0.066542,0,1
6,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.079071,0.098794,0.10396,0,1
6,GO POSITIVE REGULATION OF MYELINATION,0.075009,0.098666,0.081361,0,1
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.089246,0.098452,0.08097,0,1
6,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.11002,0.098375,0.15404,0,1
6,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.089246,0.097681,0.054177,0,1
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.21738,0.097425,0.062885,0,1
6,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.14308,0.097323,0.055133,0,1
6,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.14869,0.096648,0.067003,0,1
6,GO SMOOTH MUSCLE CELL MIGRATION,0.21587,0.095506,0.07877,0,1
6,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.081168,0.095503,0.0683,0,1
6,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.31997,0.095196,0.031663,0,1
6,GO PHOSPHOLIPID TRANSPORT,0.14088,0.094465,0.076741,0,1
6,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.29877,0.094387,0.070251,0,1
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.86649,0.093954,-0.0048313,0,1
6,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.1793,0.093827,0.061443,0,1
6,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.22658,0.093475,0.12221,0,1
6,GO POSITIVE REGULATION OF PROTEIN BINDING,0.16904,0.093105,0.065523,0,1
6,GO POSITIVE REGULATION OF MAPK CASCADE,0.066792,0.093063,0.076367,0,1
6,GO PIGMENT GRANULE LOCALIZATION,0.10385,0.092824,0.080351,0,1
6,GO RESPONSE TO MUSCLE ACTIVITY,0.11367,0.09225,0.077564,0,1
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.10385,0.086665,0.075416,0,1
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.10734,0.0862,0.093692,0,1
6,GO NEGATIVE REGULATION OF AUTOPHAGY,0.11647,0.085327,0.068955,0,1
6,GO RNA PROCESSING,0.079071,0.084686,0.062348,0,1
6,GO NEUTRAL LIPID CATABOLIC PROCESS,0.28395,0.081839,0.060249,0,1
6,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.093126,0.081608,0.10151,0,1
6,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.077698,0.080915,0.09805,0,1
6,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.068619,0.07979,0.083594,0,1
6,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.16285,0.079074,0.048309,0,1
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.74435,0.077481,0.002623,0,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.37608,0.077417,0.023122,0,1
6,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.15802,0.077208,0.049854,0,1
6,GO POLYOL METABOLIC PROCESS,0.15565,0.076557,0.065294,0,1
6,GO ACTIN FILAMENT DEPOLYMERIZATION,0.3739,0.076132,0.05718,0,1
6,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.22814,0.07328,0.050738,0,1
6,GO ENDOSOME ORGANIZATION,0.19979,0.072796,0.048239,0,1
6,GO NCRNA EXPORT FROM NUCLEUS,0.069238,0.070903,0.083859,0,1
6,GO PROTEIN TETRAMERIZATION,0.075674,0.070548,0.058513,0,1
6,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.30066,0.069495,0.08515,0,1
6,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.5394,0.067243,0.062849,0,1
6,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.22042,0.065469,0.06947,0,1
6,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.18595,0.064145,0.053667,0,1
6,GO RESPONSE TO SALT,0.18461,0.063716,0.054302,0,1
6,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.075674,0.062738,0.058381,0,1
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.45972,0.062195,0.037128,0,1
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.21437,0.059134,0.054183,0,1
6,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.25753,0.058311,0.038584,0,1
6,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.1146,0.056501,0.055227,0,1
6,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.15098,0.053968,0.079274,0,1
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.318,0.053005,0.034728,0,1
6,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.76899,0.052352,0.012303,0,1
6,GO COBALAMIN METABOLIC PROCESS,0.42602,0.048812,0.045118,0,1
6,GO NADH METABOLIC PROCESS,0.19278,0.047419,0.072398,0,1
6,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.24911,0.047075,0.038972,0,1
6,GO SNRNA METABOLIC PROCESS,0.74435,0.047075,-0.017197,0,1
6,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.31997,0.043162,0.047814,0,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.32393,0.034271,0.012622,0,1
6,GO LYSOSOME LOCALIZATION,0.43075,0.033045,0.046132,0,1
6,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.093126,0.23899,0.1407,0,0
6,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.067397,0.22145,0.27436,0,0
6,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.39832,0.20981,0.072878,0,0
6,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.1533,0.20691,0.077836,0,0
6,GO DENSE CORE GRANULE TRANSPORT,0.086237,0.20456,0.15281,0,0
6,GO REFLEX,0.24252,0.18365,0.094158,0,0
6,GO SKIN MORPHOGENESIS,0.11553,0.17512,0.122,0,0
6,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.11183,0.17039,0.091471,0,0
6,GO CARTILAGE MORPHOGENESIS,0.15802,0.16765,0.12418,0,0
6,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.14308,0.16718,0.094427,0,0
6,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.089246,0.16651,0.19952,0,0
6,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.067397,0.1649,0.13074,0,0
6,GO SECRETORY GRANULE LOCALIZATION,0.075674,0.16397,0.1471,0,0
6,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.13549,0.15949,0.09877,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.11647,0.15877,0.15408,0,0
6,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.077698,0.15725,0.15852,0,0
6,GO PULMONARY VALVE MORPHOGENESIS,0.23128,0.14993,0.10738,0,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.092339,0.14827,0.11934,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.15214,0.14731,0.09476,0,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.082591,0.14663,0.10383,0,0
6,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.077018,0.1389,0.13963,0,0
6,GO ENDOTHELIAL CELL MORPHOGENESIS,0.069238,0.1383,0.20489,0,0
6,GO LEYDIG CELL DIFFERENTIATION,0.26095,0.1382,0.11996,0,0
6,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.1146,0.13752,0.11127,0,0
6,GO SYNAPTIC VESICLE PRIMING,0.13763,0.13749,0.14597,0,0
6,GO OSTEOBLAST DEVELOPMENT,0.1146,0.13737,0.077413,0,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.27853,0.13725,0.070705,0,0
6,GO MEGAKARYOCYTE DEVELOPMENT,0.081877,0.13447,0.13913,0,0
6,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.096327,0.13333,0.1059,0,0
6,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.17156,0.13,0.1023,0,0
6,GO NOTCH RECEPTOR PROCESSING,0.082591,0.12919,0.11542,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.09714,0.12908,0.12076,0,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.29689,0.1284,0.071445,0,0
6,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.20699,0.12799,0.13231,0,0
6,GO REGULATION OF ISOTYPE SWITCHING,0.16042,0.12579,0.070785,0,0
6,GO PULMONARY VALVE DEVELOPMENT,0.30829,0.12561,0.081996,0,0
6,GO KIDNEY MESENCHYME DEVELOPMENT,0.065005,0.12524,0.16461,0,0
6,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.16654,0.12471,0.081699,0,0
6,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.13979,0.12348,0.10374,0,0
6,GO AORTIC VALVE DEVELOPMENT,0.1873,0.12348,0.086343,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.2114,0.12249,0.077006,0,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.11837,0.12237,0.084638,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.095518,0.12188,0.10898,0,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.068006,0.12184,0.11099,0,0
6,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.24089,0.12117,0.084963,0,0
6,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.14642,0.11995,0.10081,0,0
6,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.19697,0.11964,0.080525,0,0
6,GO VESICLE FUSION TO PLASMA MEMBRANE,0.1533,0.11842,0.1558,0,0
6,GO ALANINE TRANSPORT,0.31215,0.11836,0.067886,0,0
6,GO REGULATION OF HEART GROWTH,0.067397,0.11588,0.084048,0,0
6,GO DIET INDUCED THERMOGENESIS,0.15802,0.11473,0.069879,0,0
6,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.075009,0.11445,0.11722,0,0
6,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.071756,0.11322,0.077322,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.2913,0.11277,0.074369,0,0
6,GO RECEPTOR RECYCLING,0.09714,0.11243,0.077405,0,0
6,GO STEROID HORMONE SECRETION,0.086237,0.11236,0.09222,0,0
6,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.098784,0.11231,0.074112,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.1252,0.11222,0.081187,0,0
6,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.1146,0.11222,0.13001,0,0
6,GO REGULATION OF PROTEIN IMPORT,0.064418,0.1115,0.071475,0,0
6,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.29502,0.11097,0.11536,0,0
6,GO POSITIVE REGULATION OF CELL MATURATION,0.12421,0.1108,0.11265,0,0
6,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.52082,0.11079,0.046724,0,0
6,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.22971,0.10973,0.085124,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.20699,0.10968,0.073075,0,0
6,GO REGULATION OF DNA METHYLATION,0.11092,0.10948,0.077007,0,0
6,GO NEGATIVE REGULATION OF CELL DIVISION,0.18461,0.10816,0.091462,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.11837,0.10814,0.095853,0,0
6,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.088486,0.10789,0.094946,0,0
6,GO ENDOTHELIAL CELL PROLIFERATION,0.14197,0.10732,0.081545,0,0
6,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.38933,0.10711,0.10014,0,0
6,GO NEUROBLAST DIVISION,0.075674,0.10645,0.13993,0,0
6,GO VIRAL LATENCY,0.065596,0.10626,0.085296,0,0
6,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.35463,0.1062,0.066672,0,0
6,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.085497,0.1062,0.12211,0,0
6,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.2458,0.10606,0.092112,0,0
6,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.2913,0.10597,0.10632,0,0
6,GO REGULATION OF VASCULATURE DEVELOPMENT,0.11275,0.10596,0.079865,0,0
6,GO MANNOSYLATION,0.15565,0.10585,0.067744,0,0
6,GO NEGATIVE REGULATION OF CELL ADHESION,0.084763,0.10566,0.092156,0,0
6,GO RESPONSE TO WATER,0.28395,0.10566,0.065273,0,0
6,GO CYTOPLASM ORGANIZATION,0.24416,0.10565,0.079373,0,0
6,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.16778,0.10561,0.089614,0,0
6,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.09796,0.10552,0.085311,0,0
6,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.13444,0.10549,0.081742,0,0
6,GO AORTA DEVELOPMENT,0.067397,0.10516,0.1038,0,0
6,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.13338,0.10494,0.15058,0,0
6,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.24252,0.10484,0.093755,0,0
6,GO NEPHRIC DUCT MORPHOGENESIS,0.3871,0.10402,0.076074,0,0
6,GO LABYRINTHINE LAYER MORPHOGENESIS,0.22503,0.10393,0.14243,0,0
6,GO CELLULAR RESPONSE TO LIPID,0.068619,0.1037,0.071933,0,0
6,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.098784,0.10362,0.097364,0,0
6,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.178,0.1036,0.13273,0,0
6,GO RESPONSE TO FATTY ACID,0.10129,0.10348,0.069592,0,0
6,GO PRIMARY MIRNA PROCESSING,0.067397,0.10341,0.08297,0,0
6,GO REGULATION OF CELL PROJECTION SIZE,0.14088,0.10255,0.098885,0,0
6,GO TRABECULA MORPHOGENESIS,0.13234,0.10228,0.08316,0,0
6,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.068619,0.10224,0.078448,0,0
6,GO BLEB ASSEMBLY,0.69885,0.10169,-0.0018832,0,0
6,GO MESODERMAL CELL FATE SPECIFICATION,0.091558,0.10155,0.1064,0,0
6,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.12029,0.10155,0.050992,0,0
6,GO REGULATION OF OSSIFICATION,0.094715,0.10146,0.079493,0,0
6,GO ENAMEL MINERALIZATION,0.21288,0.10041,0.10912,0,0
6,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.092339,0.10004,0.10306,0,0
6,GO REGULATION OF CELL MATRIX ADHESION,0.15447,0.099724,0.096832,0,0
6,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.32592,0.099586,0.053506,0,0
6,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.42838,0.099562,0.025525,0,0
6,GO OSTEOBLAST PROLIFERATION,0.25583,0.099329,0.085536,0,0
6,GO EPIBOLY,0.43312,0.099088,0.04533,0,0
6,GO MICROVILLUS ASSEMBLY,0.35886,0.098711,0.082946,0,0
6,GO PEPTIDYL TYROSINE MODIFICATION,0.12721,0.098585,0.074784,0,0
6,GO SEQUESTERING OF TRIGLYCERIDE,0.30637,0.098469,0.092924,0,0
6,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.1453,0.098207,0.091933,0,0
6,GO REGULATION OF STEM CELL DIFFERENTIATION,0.13338,0.098134,0.061015,0,0
6,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.23927,0.098051,0.053822,0,0
6,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.87926,0.097965,-0.0017721,0,0
6,GO REGULATION OF B CELL DIFFERENTIATION,0.073043,0.097858,0.094288,0,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.35674,0.097648,0.070782,0,0
6,GO AUTOPHAGY OF NUCLEUS,0.62545,0.097534,0.029809,0,0
6,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.19417,0.097466,0.08277,0,0
6,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.24089,0.097399,0.053818,0,0
6,GO REGULATION OF CELL SUBSTRATE ADHESION,0.20699,0.097149,0.079608,0,0
6,GO RESPONSE TO CAFFEINE,0.12322,0.096844,0.088044,0,0
6,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.17669,0.096455,0.073542,0,0
6,GO REGULATION OF FATTY ACID TRANSPORT,0.18327,0.096141,0.06125,0,0
6,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.14308,0.096055,0.073314,0,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.062684,0.095821,0.10381,0,0
6,GO RESPONSE TO SALT STRESS,0.076344,0.095786,0.091764,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.077018,0.095683,0.10765,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.066792,0.095582,0.06815,0,0
6,GO LIPID OXIDATION,0.20699,0.095563,0.052962,0,0
6,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.1793,0.095562,0.048569,0,0
6,GO MESENCHYME MORPHOGENESIS,0.096327,0.095507,0.091655,0,0
6,GO MIDDLE EAR MORPHOGENESIS,0.094715,0.095027,0.088771,0,0
6,GO VESICLE ORGANIZATION,0.20409,0.094543,0.050621,0,0
6,GO RESPONSE TO MURAMYL DIPEPTIDE,0.21738,0.09433,0.078146,0,0
6,GO CELL MATRIX ADHESION,0.1252,0.094318,0.087915,0,0
6,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.1252,0.094156,0.093488,0,0
6,GO DORSAL AORTA DEVELOPMENT,0.12421,0.093929,0.1239,0,0
6,GO CELLULAR RESPONSE TO ETHANOL,0.22348,0.093919,0.079527,0,0
6,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.079765,0.093128,0.06921,0,0
6,GO RESPONSE TO OXYGEN LEVELS,0.2114,0.09299,0.051879,0,0
6,GO SNARE COMPLEX ASSEMBLY,0.52082,0.092872,0.042951,0,0
6,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.26964,0.092805,0.065245,0,0
6,GO TUMOR NECROSIS FACTOR SECRETION,0.1262,0.092789,0.062075,0,0
6,GO POSITIVE REGULATION OF OSSIFICATION,0.15565,0.092731,0.073203,0,0
6,GO TRNA METHYLATION,0.69885,0.092647,0.0042816,0,0
6,GO COLLAGEN FIBRIL ORGANIZATION,1,0.092422,-0.017688,0,0
6,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.16407,0.092259,0.081341,0,0
6,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.20122,0.091878,0.10604,0,0
6,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.24911,0.091753,0.057181,0,0
6,GO REGULATION OF BIOMINERALIZATION,0.13549,0.091728,0.079777,0,0
6,GO ERBB2 SIGNALING PATHWAY,0.11183,0.091705,0.07409,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.13979,0.091704,0.093829,0,0
6,GO MYELOID CELL HOMEOSTASIS,0.11002,0.091657,0.076321,0,0
6,GO RRNA TRANSCRIPTION,0.46962,0.091148,0.02162,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.090782,0.090582,0.089915,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.26964,0.090353,0.06322,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.12126,0.090344,0.077339,0,0
6,GO SPROUTING ANGIOGENESIS,0.09796,0.090309,0.09079,0,0
6,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.19557,0.090184,0.06263,0,0
6,GO NEURONAL ACTION POTENTIAL,0.18866,0.090038,0.1051,0,0
6,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.24911,0.089463,0.10677,0,0
6,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.086237,0.089335,0.084622,0,0
6,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.24911,0.089126,0.076783,0,0
6,GO REGULATION OF MRNA BINDING,0.57476,0.089054,0.012692,0,0
6,GO RESPONSE TO PROSTAGLANDIN,0.077018,0.089042,0.092394,0,0
6,GO REGULATION OF RECEPTOR RECYCLING,0.1793,0.088955,0.067743,0,0
6,GO REGULATION OF RNA BINDING,0.27673,0.088853,0.047378,0,0
6,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.25924,0.088716,0.063744,0,0
6,GO PROTEIN KINASE B SIGNALING,0.10045,0.088657,0.073653,0,0
6,GO GENITALIA DEVELOPMENT,0.1146,0.088162,0.074712,0,0
6,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.44269,0.087995,0.056937,0,0
6,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.58307,0.087757,0.029078,0,0
6,GO REGULATION OF MAP KINASE ACTIVITY,0.11553,0.08767,0.070822,0,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.068006,0.087452,0.13099,0,0
6,GO RESPONSE TO VITAMIN,0.19003,0.087379,0.078228,0,0
6,GO STEROL HOMEOSTASIS,0.1252,0.08697,0.068286,0,0
6,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.69586,0.086933,0.034016,0,0
6,GO MUSCLE SYSTEM PROCESS,0.063258,0.086751,0.079303,0,0
6,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.087731,0.086627,0.060646,0,0
6,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.16654,0.086475,0.070022,0,0
6,GO RETINAL CONE CELL DIFFERENTIATION,0.52082,0.086434,0.053657,0,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.11742,0.086354,0.17992,0,0
6,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.31997,0.086306,0.10408,0,0
6,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.21738,0.086305,0.043273,0,0
6,GO RESPONSE TO METAL ION,0.10734,0.086037,0.065216,0,0
6,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.13763,0.085624,0.057246,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.12126,0.085477,0.055451,0,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.48722,0.085459,0.034813,0,0
6,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.11933,0.08538,0.11345,0,0
6,GO BIOMINERALIZATION,0.18866,0.08526,0.076509,0,0
6,GO LAMELLIPODIUM ORGANIZATION,0.22503,0.085148,0.060072,0,0
6,GO REGULATION OF MUSCLE HYPERTROPHY,0.15565,0.084804,0.074832,0,0
6,GO REGULATION OF AMINO ACID TRANSPORT,0.19697,0.084636,0.078538,0,0
6,GO TRIGLYCERIDE CATABOLIC PROCESS,0.17029,0.084562,0.080112,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.1533,0.084024,0.060418,0,0
6,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.24745,0.08396,0.096765,0,0
6,GO REGULATION OF LIPID STORAGE,0.11933,0.083884,0.083431,0,0
6,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.28213,0.083869,0.058111,0,0
6,GO DETECTION OF CALCIUM ION,0.12421,0.083848,0.13971,0,0
6,GO LAMELLIPODIUM ASSEMBLY,0.11933,0.083724,0.077635,0,0
6,GO MYOTUBE DIFFERENTIATION,0.091558,0.083513,0.087679,0,0
6,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.08331,0.083404,0.077184,0,0
6,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.20122,0.083233,0.12153,0,0
6,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.3442,0.083191,0.055068,0,0
6,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.09714,0.083003,0.068388,0,0
6,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.16654,0.08289,0.080582,0,0
6,GO ASTROCYTE DEVELOPMENT,0.10823,0.082757,0.095697,0,0
6,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.50516,0.082556,0.041531,0,0
6,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.14419,0.082304,0.048814,0,0
6,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.25078,0.082085,0.050162,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.15802,0.081932,0.058152,0,0
6,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.39156,0.081806,0.050084,0,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.11837,0.081802,0.1106,0,0
6,GO REGULATION OF EXOSOMAL SECRETION,0.17411,0.081363,0.075567,0,0
6,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.13444,0.081362,0.078645,0,0
6,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.09714,0.081339,0.060906,0,0
6,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.17411,0.081328,0.12577,0,0
6,GO HISTONE MRNA METABOLIC PROCESS,0.19979,0.081283,0.040526,0,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.08331,0.08124,0.11084,0,0
6,GO CELL SUBSTRATE ADHESION,0.14419,0.081121,0.083445,0,0
6,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.09714,0.081061,0.10313,0,0
6,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.066192,0.081023,0.103,0,0
6,GO REGULATION OF PINOCYTOSIS,0.25246,0.080744,0.050955,0,0
6,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.084763,0.080675,0.057073,0,0
6,GO LAMELLIPODIUM MORPHOGENESIS,0.3739,0.080588,0.060622,0,0
6,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.11647,0.080379,0.10493,0,0
6,GO LIVER REGENERATION,0.17283,0.080363,0.048156,0,0
6,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.11092,0.079778,0.076092,0,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.088486,0.079307,0.084749,0,0
6,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.36098,0.079041,0.11147,0,0
6,GO OVULATION,0.36956,0.078984,0.0467,0,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.61687,0.078684,0.02749,0,0
6,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.35463,0.078607,0.048932,0,0
6,GO REGULATION OF DEACETYLASE ACTIVITY,0.20122,0.078537,0.084281,0,0
6,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.19979,0.078515,0.07525,0,0
6,GO REGULATION OF HISTONE H4 ACETYLATION,0.076344,0.078086,0.091789,0,0
6,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.34213,0.077997,0.033426,0,0
6,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13763,0.07782,0.13073,0,0
6,GO THYROID HORMONE METABOLIC PROCESS,0.066192,0.077814,0.13797,0,0
6,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.42838,0.07772,0.061392,0,0
6,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.086981,0.077554,0.10891,0,0
6,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.40058,0.0774,0.060655,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.29315,0.077327,0.080137,0,0
6,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.15921,0.077311,0.076425,0,0
6,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.080464,0.077191,0.16609,0,0
6,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.11367,0.077009,0.10962,0,0
6,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.53406,0.076928,0.032959,0,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17029,0.076665,0.057197,0,0
6,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.13979,0.076539,0.048829,0,0
6,GO CARNITINE METABOLIC PROCESS,0.10912,0.076512,0.099901,0,0
6,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.51557,0.076233,0.044993,0,0
6,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.11002,0.076139,0.10427,0,0
6,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.16285,0.076139,0.064049,0,0
6,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.24416,0.076028,0.065074,0,0
6,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.1653,0.076023,0.096158,0,0
6,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.06986,0.075925,0.1281,0,0
6,GO MYOBLAST PROLIFERATION,0.18062,0.075897,0.050517,0,0
6,GO LIPID STORAGE,0.1754,0.075748,0.073886,0,0
6,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.11183,0.075731,0.16947,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.13027,0.075712,0.059373,0,0
6,GO REGULATION OF ACTIN FILAMENT LENGTH,0.078382,0.075473,0.076634,0,0
6,GO C4 DICARBOXYLATE TRANSPORT,0.31215,0.075428,0.066449,0,0
6,GO ERBB SIGNALING PATHWAY,0.21288,0.075341,0.055776,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.11837,0.075206,0.074143,0,0
6,GO CELL CELL JUNCTION ASSEMBLY,0.09714,0.075205,0.098613,0,0
6,GO RESPONSE TO CALCIUM ION,0.10214,0.075189,0.074152,0,0
6,GO GLOMERULUS DEVELOPMENT,0.40973,0.074992,0.07012,0,0
6,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.13444,0.074991,0.14299,0,0
6,GO SEQUESTERING OF ACTIN MONOMERS,0.19557,0.074976,0.13979,0,0
6,GO RESPONSE TO DRUG,0.11933,0.074166,0.067782,0,0
6,GO RESPONSE TO KETONE,0.099614,0.07411,0.069778,0,0
6,GO RESPONSE TO MECHANICAL STIMULUS,0.15683,0.07406,0.070499,0,0
6,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.76899,0.07398,0.037474,0,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.32993,0.073665,0.046286,0,0
6,GO TRANSCYTOSIS,0.50258,0.073655,0.04221,0,0
6,GO POLYSACCHARIDE CATABOLIC PROCESS,0.13444,0.073598,0.06918,0,0
6,GO GASTRULATION,0.093918,0.073514,0.080379,0,0
6,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.51296,0.073455,0.038407,0,0
6,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.090011,0.073363,0.11157,0,0
6,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.09796,0.073356,0.094005,0,0
6,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.29502,0.073327,0.089612,0,0
6,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.39156,0.073196,0.050628,0,0
6,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.087731,0.07312,0.11632,0,0
6,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.31409,0.072719,0.07346,0,0
6,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.084034,0.072662,0.07071,0,0
6,GO RESPONSE TO PROGESTERONE,0.11183,0.072624,0.094949,0,0
6,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.089246,0.072581,0.075192,0,0
6,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.36956,0.072418,0.049696,0,0
6,GO LYMPHOCYTE ACTIVATION,0.30446,0.072392,0.035613,0,0
6,GO MUSCLE HYPERTROPHY,0.16778,0.072371,0.069508,0,0
6,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.33396,0.072234,0.054515,0,0
6,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.40514,0.07217,0.027215,0,0
6,GO GOLGI TO VACUOLE TRANSPORT,0.34627,0.072141,0.052444,0,0
6,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.072397,0.072005,0.12029,0,0
6,GO HEPARIN METABOLIC PROCESS,0.60834,0.071943,0.016129,0,0
6,GO LEUKOCYTE DIFFERENTIATION,0.16654,0.071834,0.05114,0,0
6,GO MATERNAL PLACENTA DEVELOPMENT,0.27495,0.071725,0.08381,0,0
6,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.28578,0.071611,0.050703,0,0
6,GO GOLGI VESICLE TRANSPORT,0.22348,0.071501,0.044418,0,0
6,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.33194,0.071393,0.051534,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.086237,0.071349,0.092133,0,0
6,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.48215,0.07134,0.028,0,0
6,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.095518,0.071275,0.068691,0,0
6,GO REGULATION OF SPROUTING ANGIOGENESIS,0.21738,0.071193,0.071755,0,0
6,GO BONE MINERALIZATION,0.14755,0.071182,0.07718,0,0
6,GO POSITIVE T CELL SELECTION,0.11837,0.070995,0.064163,0,0
6,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.97576,0.070805,-0.0023613,0,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.71089,0.070702,0.034411,0,0
6,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.47712,0.070659,0.033923,0,0
6,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.59424,0.070618,0.021333,0,0
6,GO REGULATION OF MUSCLE CONTRACTION,0.13234,0.070402,0.064318,0,0
6,GO MESODERMAL CELL FATE COMMITMENT,0.31409,0.070371,0.048433,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.18062,0.070279,0.066147,0,0
6,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.29877,0.070162,0.044486,0,0
6,GO AUTOPHAGOSOME ORGANIZATION,0.090782,0.069948,0.07313,0,0
6,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.23128,0.069734,0.055144,0,0
6,GO ERYTHROCYTE HOMEOSTASIS,0.073043,0.06973,0.079681,0,0
6,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.082591,0.069719,0.083435,0,0
6,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.1653,0.069636,0.0792,0,0
6,GO CHOLESTEROL STORAGE,0.16042,0.069567,0.092117,0,0
6,GO RNA METHYLATION,0.39606,0.069503,0.036937,0,0
6,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.23605,0.069476,0.063872,0,0
6,GO METAL ION HOMEOSTASIS,0.08331,0.069411,0.063787,0,0
6,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.33803,0.069342,0.03364,0,0
6,GO RRNA 3 END PROCESSING,0.61972,0.069341,0.008323,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.41434,0.069197,0.050316,0,0
6,GO MYELOID CELL DEVELOPMENT,0.1146,0.069178,0.074,0,0
6,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.28033,0.069163,0.044991,0,0
6,GO REGULATION OF T CELL DIFFERENTIATION,0.078382,0.069119,0.062739,0,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.25753,0.069109,0.077333,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.23766,0.069046,0.07399,0,0
6,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.065005,0.068968,0.082472,0,0
6,GO ION HOMEOSTASIS,0.086237,0.068923,0.0603,0,0
6,GO REGULATION OF CELL ADHESION,0.34627,0.06881,0.05311,0,0
6,GO RESPONSE TO WOUNDING,0.34213,0.068704,0.056121,0,0
6,GO RESPONSE TO ALCOHOL,0.072397,0.068482,0.074303,0,0
6,GO BONE CELL DEVELOPMENT,0.49487,0.068322,0.041525,0,0
6,GO NEGATIVE REGULATION OF TRANSPORT,0.082591,0.068269,0.058001,0,0
6,GO CAMP METABOLIC PROCESS,0.075009,0.068224,0.11726,0,0
6,GO CELLULAR HOMEOSTASIS,0.068006,0.068157,0.059227,0,0
6,GO TERPENOID BIOSYNTHETIC PROCESS,0.18866,0.068014,0.079857,0,0
6,GO GONADOTROPIN SECRETION,0.19557,0.067935,0.093703,0,0
6,GO HEAD MORPHOGENESIS,0.1653,0.067745,0.087443,0,0
6,GO HORMONE CATABOLIC PROCESS,0.68988,0.067657,0.0096154,0,0
6,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.28395,0.067628,0.11584,0,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.11742,0.06727,0.096407,0,0
6,GO TOOTH MINERALIZATION,0.086981,0.067144,0.14177,0,0
6,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.21587,0.067121,0.067105,0,0
6,GO NUCLEOTIDE EXCISION REPAIR,0.066192,0.067059,0.065986,0,0
6,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.41666,0.067005,0.034103,0,0
6,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.084763,0.066907,0.058743,0,0
6,GO PORE COMPLEX ASSEMBLY,0.1533,0.066856,0.061082,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.14197,0.066545,0.086556,0,0
6,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.16285,0.06639,0.059904,0,0
6,GO ERK1 AND ERK2 CASCADE,0.2714,0.06633,0.052771,0,0
6,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.7814,0.066199,0.0020007,0,0
6,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.22503,0.066093,0.079668,0,0
6,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.20265,0.066092,0.085883,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.8379,0.06598,0.0013698,0,0
6,GO ER OVERLOAD RESPONSE,0.28761,0.065966,0.07082,0,0
6,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.27853,0.0659,0.067632,0,0
6,GO REGULATION OF MRNA CATABOLIC PROCESS,0.2644,0.065884,0.040043,0,0
6,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.10385,0.065879,0.056757,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.70185,0.065831,0.0098108,0,0
6,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.47712,0.065829,0.042105,0,0
6,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.41666,0.065783,0.037919,0,0
6,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.11367,0.065745,0.065725,0,0
6,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.22042,0.065689,0.066924,0,0
6,GO NATURAL KILLER CELL ACTIVATION,0.27853,0.06556,0.041136,0,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.56376,0.06554,0.022632,0,0
6,GO SUPEROXIDE METABOLIC PROCESS,0.30255,0.065523,0.050352,0,0
6,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.10646,0.065392,0.066049,0,0
6,GO REGULATION OF ENDOCRINE PROCESS,0.19417,0.065286,0.056737,0,0
6,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.27317,0.065277,0.080528,0,0
6,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20845,0.064842,0.059767,0,0
6,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.14983,0.064738,0.067316,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.19838,0.064616,0.086401,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.39606,0.064364,0.055509,0,0
6,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.20409,0.064308,0.061489,0,0
6,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.74435,0.064254,-0.027538,0,0
6,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.50776,0.064104,0.041156,0,0
6,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.063836,0.064002,0.077379,0,0
6,GO AMEBOIDAL TYPE CELL MIGRATION,0.21587,0.063855,0.06543,0,0
6,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.099614,0.063749,0.10228,0,0
6,GO WOUND HEALING,0.59705,0.063669,0.03666,0,0
6,GO AMINO SUGAR METABOLIC PROCESS,0.62832,0.063499,0.027053,0,0
6,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.69586,0.063249,0.025268,0,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.97899,0.063207,-0.0025006,0,0
6,GO REGULATION OF GENE SILENCING,0.095518,0.063175,0.061841,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.17156,0.06315,0.052029,0,0
6,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.56925,0.063109,0.036752,0,0
6,GO POSITIVE REGULATION OF ION TRANSPORT,0.069238,0.063033,0.073615,0,0
6,GO LUNG ALVEOLUS DEVELOPMENT,0.16778,0.063028,0.095231,0,0
6,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.077018,0.062987,0.074825,0,0
6,GO POSITIVE REGULATION OF CELL AGING,0.53406,0.062976,0.032396,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.15447,0.06289,0.076709,0,0
6,GO RESPONSE TO NUTRIENT,0.18194,0.062859,0.061987,0,0
6,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.30066,0.062826,0.059819,0,0
6,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.1914,0.062812,0.1241,0,0
6,GO CELL CELL JUNCTION MAINTENANCE,0.11002,0.062737,0.14339,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.12224,0.062697,0.056023,0,0
6,GO CELLULAR HYPEROSMOTIC RESPONSE,0.16285,0.06261,0.084415,0,0
6,GO RESPONSE TO ESTROGEN,0.36741,0.06252,0.047467,0,0
6,GO MRNA CLEAVAGE,0.091558,0.062283,0.074065,0,0
6,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.12822,0.062212,0.088444,0,0
6,GO REGULATION OF BONE MINERALIZATION,0.30066,0.062201,0.061969,0,0
6,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.74128,0.062175,0.02023,0,0
6,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.1453,0.062107,0.074072,0,0
6,GO STRIATED MUSCLE CONTRACTION,0.16163,0.062105,0.076125,0,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.64567,0.062074,0.025908,0,0
6,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.079071,0.06206,0.071578,0,0
6,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.9113,0.061873,-0.019496,0,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.58029,0.061843,0.041414,0,0
6,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.077018,0.061813,0.06831,0,0
6,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.40514,0.061769,0.060164,0,0
6,GO OSTEOCLAST DIFFERENTIATION,0.24911,0.061738,0.058994,0,0
6,GO CARBOHYDRATE CATABOLIC PROCESS,0.096327,0.061686,0.069932,0,0
6,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.41899,0.061559,0.047804,0,0
6,GO GOLGI TO ENDOSOME TRANSPORT,0.47211,0.061304,0.034609,0,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.40058,0.061163,0.055304,0,0
6,GO RESPONSE TO NITRIC OXIDE,0.2458,0.06113,0.044248,0,0
6,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.35463,0.061105,0.065786,0,0
6,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.071756,0.060653,0.068017,0,0
6,GO RESPONSE TO OSMOTIC STRESS,0.20265,0.060629,0.055757,0,0
6,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.27317,0.060491,0.043425,0,0
6,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.27853,0.060491,0.060871,0,0
6,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.17669,0.060445,0.046977,0,0
6,GO CELLULAR RESPONSE TO AMYLOID BETA,0.13549,0.060373,0.09294,0,0
6,GO POSITIVE REGULATION OF HEMOPOIESIS,0.075674,0.060356,0.070214,0,0
6,GO REGULATION OF MUSCLE ADAPTATION,0.11367,0.060316,0.080316,0,0
6,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.32393,0.060271,0.052352,0,0
6,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.25078,0.060221,0.061727,0,0
6,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38047,0.060182,0.10261,0,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS,0.56103,0.060078,0.033004,0,0
6,GO DOPAMINE METABOLIC PROCESS,0.092339,0.060069,0.13144,0,0
6,GO COPII COATED VESICLE CARGO LOADING,0.42602,0.059963,0.04747,0,0
6,GO APICAL JUNCTION ASSEMBLY,0.13763,0.059953,0.10777,0,0
6,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12924,0.059913,0.098876,0,0
6,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.11647,0.059816,0.052175,0,0
6,GO REGULATION OF TUBE SIZE,0.15921,0.059641,0.061474,0,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.15921,0.059445,0.061024,0,0
6,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.74128,0.059411,0.015571,0,0
6,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.12822,0.059391,0.053163,0,0
6,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.16163,0.059381,0.064791,0,0
6,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.087731,0.059352,0.081145,0,0
6,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.178,0.05933,0.050485,0,0
6,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.13234,0.059307,0.14485,0,0
6,GO NCRNA 3 END PROCESSING,0.69286,0.059232,-0.04431,0,0
6,GO MYELOID CELL APOPTOTIC PROCESS,0.24416,0.059214,0.066673,0,0
6,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.45482,0.059032,0.051468,0,0
6,GO REGULATION OF RESPONSE TO STRESS,0.19417,0.058912,0.049176,0,0
6,GO REGULATION OF BLOOD PRESSURE,0.12924,0.05887,0.068396,0,0
6,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.67798,0.058811,0.020779,0,0
6,GO SARCOMERE ORGANIZATION,0.11742,0.058675,0.078376,0,0
6,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.39156,0.058667,0.038493,0,0
6,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.071119,0.058521,0.08122,0,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.24252,0.058288,0.057273,0,0
6,GO CELLULAR RESPONSE TO KETONE,0.11275,0.058273,0.070434,0,0
6,GO MYELOID CELL DIFFERENTIATION,0.10129,0.058177,0.059064,0,0
6,GO CELLULAR ION HOMEOSTASIS,0.11367,0.058167,0.058308,0,0
6,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.16042,0.058161,0.083935,0,0
6,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.88565,0.05813,-0.013007,0,0
6,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.1653,0.058108,0.061732,0,0
6,GO RESPONSE TO LIPID,0.18595,0.058079,0.055093,0,0
6,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.19003,0.058053,0.07696,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION,0.14869,0.057995,0.047774,0,0
6,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.5314,0.057892,0.046355,0,0
6,GO FOAM CELL DIFFERENTIATION,0.49231,0.057714,0.026543,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.12721,0.057711,0.071736,0,0
6,GO LOCOMOTOR RHYTHM,0.35463,0.057562,0.098307,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.12126,0.057547,0.078771,0,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.077018,0.057363,0.069861,0,0
6,GO INNER CELL MASS CELL PROLIFERATION,0.37827,0.057328,0.038857,0,0
6,GO GLYCOPROTEIN METABOLIC PROCESS,0.1653,0.057267,0.056115,0,0
6,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.48722,0.057167,0.035191,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.43075,0.057069,0.031876,0,0
6,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.40058,0.056983,0.056087,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.28945,0.056785,0.056836,0,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.69586,0.05675,0.017046,0,0
6,GO NEGATIVE REGULATION OF MAPK CASCADE,0.23286,0.05675,0.059082,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.19003,0.056727,0.043497,0,0
6,GO REGULATION OF ORGANIC ACID TRANSPORT,0.14869,0.056704,0.068548,0,0
6,GO POSITIVE CHEMOTAXIS,0.32195,0.056696,0.052305,0,0
6,GO ALPHA BETA T CELL DIFFERENTIATION,0.27495,0.056644,0.041901,0,0
6,GO PROTEIN KINASE A SIGNALING,0.073043,0.056637,0.094906,0,0
6,GO SEMI LUNAR VALVE DEVELOPMENT,0.55016,0.056564,0.047098,0,0
6,GO POSITIVE REGULATION OF AUTOPHAGY,0.077018,0.056405,0.085573,0,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.31021,0.056373,0.044023,0,0
6,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.38267,0.056271,0.044853,0,0
6,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.20265,0.05622,0.055377,0,0
6,GO CATECHOLAMINE METABOLIC PROCESS,0.072397,0.056092,0.13929,0,0
6,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.084034,0.056017,0.071609,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.17411,0.055997,0.053787,0,0
6,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.20122,0.055996,0.074125,0,0
6,GO STEROL METABOLIC PROCESS,0.50516,0.055787,0.025541,0,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.87287,0.055785,-0.0032874,0,0
6,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.61972,0.055714,0.017683,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.23286,0.055699,0.08769,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.20845,0.055598,0.053259,0,0
6,GO REGULATION OF LIPID METABOLIC PROCESS,0.41203,0.055317,0.037413,0,0
6,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.24745,0.055286,0.050019,0,0
6,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.46962,0.055255,0.043228,0,0
6,GO MACROPHAGE DIFFERENTIATION,0.28395,0.055251,0.045592,0,0
6,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.10471,0.055205,0.065938,0,0
6,GO ENDODERM DEVELOPMENT,0.21738,0.055136,0.069132,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.36956,0.055116,0.046488,0,0
6,GO FEVER GENERATION,0.28945,0.055113,0.069276,0,0
6,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.52609,0.055009,0.021327,0,0
6,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.076344,0.05499,0.10439,0,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.12224,0.054892,0.080224,0,0
6,GO SYNAPTIC VESICLE BUDDING,0.20409,0.054758,0.081212,0,0
6,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.065596,0.054735,0.057071,0,0
6,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.12126,0.054715,0.068532,0,0
6,GO STEROL TRANSPORT,0.33599,0.054545,0.0495,0,0
6,GO PIGMENT CELL DIFFERENTIATION,0.31409,0.054528,0.060893,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.19003,0.054515,0.060144,0,0
6,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.5394,0.054445,0.022838,0,0
6,GO MUSCLE ADAPTATION,0.29689,0.054393,0.056284,0,0
6,GO GLUCOSE CATABOLIC PROCESS,0.30446,0.054339,0.064461,0,0
6,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.68689,0.05411,0.021491,0,0
6,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.3871,0.0541,0.037333,0,0
6,GO GLYCOSYLATION,0.32592,0.053879,0.037754,0,0
6,GO T CELL SELECTION,0.17156,0.053801,0.056956,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.1653,0.053798,0.044384,0,0
6,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.96284,0.053748,-0.026095,0,0
6,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.31997,0.053548,0.11962,0,0
6,GO PROTEIN HOMOTETRAMERIZATION,0.1793,0.05345,0.049073,0,0
6,GO WATER TRANSPORT,0.24745,0.053334,0.12142,0,0
6,GO TRANSCRIPTION BY RNA POLYMERASE I,0.79075,0.053254,0.0029333,0,0
6,GO MESODERM MORPHOGENESIS,0.10045,0.053145,0.076128,0,0
6,GO T CELL ACTIVATION,0.4355,0.052839,0.024844,0,0
6,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.093126,0.052797,0.065353,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.23128,0.052727,0.056222,0,0
6,GO REGULATION OF HEMOPOIESIS,0.13979,0.052674,0.055317,0,0
6,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.33599,0.052415,0.06327,0,0
6,GO REGULATION OF KERATINOCYTE MIGRATION,0.64858,0.052408,0.035665,0,0
6,GO BLASTOCYST DEVELOPMENT,0.072397,0.052366,0.051906,0,0
6,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.1252,0.05235,0.064848,0,0
6,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.24911,0.052255,0.051115,0,0
6,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.6312,0.052199,0.027424,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.48976,0.052166,0.032213,0,0
6,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.65442,0.051307,0.0084213,0,0
6,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.41666,0.051245,0.027881,0,0
6,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.066792,0.051175,0.066444,0,0
6,GO WATER HOMEOSTASIS,0.09796,0.05117,0.10902,0,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.94026,0.051124,0.00014431,0,0
6,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.15098,0.051046,0.055303,0,0
6,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.85059,0.051035,2.7452e-05,0,0
6,GO FORMATION OF PRIMARY GERM LAYER,0.5394,0.050947,0.04083,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.09714,0.050893,0.11004,0,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.22042,0.050871,0.070382,0,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.53672,0.050806,0.029141,0,0
6,GO TERPENOID METABOLIC PROCESS,0.36526,0.050734,0.046972,0,0
6,GO DENDRITIC CELL CHEMOTAXIS,0.26964,0.050662,0.065194,0,0
6,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.25583,0.050599,0.049008,0,0
6,GO RNA MODIFICATION,0.92416,0.050598,-0.0071433,0,0
6,GO POSITIVE REGULATION OF URINE VOLUME,0.29877,0.050572,0.053174,0,0
6,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.45727,0.050399,0.055575,0,0
6,GO RESPONSE TO CADMIUM ION,0.46218,0.050397,0.032359,0,0
6,GO MODULATION BY HOST OF VIRAL PROCESS,0.9113,0.05037,-0.019155,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.31604,0.050298,0.046179,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.2644,0.050252,0.049492,0,0
6,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.80012,0.050113,0.0012925,0,0
6,GO PROTEIN STABILIZATION,0.062114,0.050052,0.064589,0,0
6,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.78451,0.049994,0.010575,0,0
6,GO T CELL HOMEOSTASIS,0.32195,0.04998,0.055695,0,0
6,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.5583,0.049956,0.026892,0,0
6,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.19697,0.049928,0.05674,0,0
6,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.32592,0.049899,0.056522,0,0
6,GO TETRAHYDROFOLATE INTERCONVERSION,0.9693,0.049881,-0.011067,0,0
6,GO SECRETION,0.21587,0.049845,0.048025,0,0
6,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.20409,0.049839,0.047954,0,0
6,GO NUCLEAR ENVELOPE REASSEMBLY,0.50516,0.049815,0.039816,0,0
6,GO CELLULAR RESPONSE TO VIRUS,0.54477,0.049787,0.022766,0,0
6,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.75664,0.049758,0.010812,0,0
6,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.23927,0.049639,0.053143,0,0
6,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.19557,0.04963,0.050869,0,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.1793,0.049628,0.077402,0,0
6,GO RESPONSE TO ETHANOL,0.14088,0.049598,0.063526,0,0
6,GO REGULATION OF NUCLEASE ACTIVITY,0.21288,0.049509,0.050128,0,0
6,GO NCRNA METABOLIC PROCESS,0.59424,0.049421,-0.035359,0,0
6,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.88565,0.04933,0.0040015,0,0
6,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.086981,0.049282,0.05517,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.53672,0.049266,0.034126,0,0
6,GO THIOESTER METABOLIC PROCESS,0.84424,0.049037,-0.0024922,0,0
6,GO VESICLE TARGETING,0.87926,0.048964,0.012469,0,0
6,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.58585,0.048951,0.029616,0,0
6,GO MEMBRANE LIPID METABOLIC PROCESS,0.41203,0.048896,0.034159,0,0
6,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.27673,0.048867,0.039896,0,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.50258,0.048858,0.0288,0,0
6,GO T CELL EXTRAVASATION,0.67206,0.048748,-0.046352,0,0
6,GO B CELL MEDIATED IMMUNITY,0.73822,0.048724,-0.026128,0,0
6,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.69586,0.048663,-0.036777,0,0
6,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.27673,0.048621,0.056078,0,0
6,GO ENGULFMENT OF APOPTOTIC CELL,0.19557,0.048531,0.070339,0,0
6,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.60268,0.048468,0.053821,0,0
6,GO HEART TRABECULA MORPHOGENESIS,0.29502,0.048421,0.07662,0,0
6,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.61402,0.048376,0.022715,0,0
6,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.89526,0.048228,-0.0041548,0,0
6,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.2913,0.048126,0.047476,0,0
6,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.10045,0.048062,0.071599,0,0
6,GO FIBROBLAST PROLIFERATION,0.19417,0.048061,0.068809,0,0
6,GO T CELL LINEAGE COMMITMENT,0.19557,0.047945,0.076714,0,0
6,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.40058,0.047927,0.02832,0,0
6,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.20699,0.047875,0.074084,0,0
6,GO RESPONSE TO CORTICOSTEROID,0.43075,0.04774,0.040382,0,0
6,GO LIPID BIOSYNTHETIC PROCESS,0.36526,0.047512,0.034223,0,0
6,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.85694,0.047497,0.00052415,0,0
6,GO ALPHA BETA T CELL ACTIVATION,0.48215,0.047472,0.016235,0,0
6,GO SYMBIOTIC PROCESS,0.75048,0.047468,0.0093319,0,0
6,GO RESPONSE TO INTERLEUKIN 6,0.26267,0.047437,0.065948,0,0
6,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.38267,0.047407,0.050199,0,0
6,GO RESPONSE TO INORGANIC SUBSTANCE,0.31409,0.047404,0.044209,0,0
6,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.11933,0.047401,0.065092,0,0
6,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.063258,0.047357,0.066783,0,0
6,GO THYMIC T CELL SELECTION,0.49487,0.047333,0.018269,0,0
6,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.28945,0.047239,0.048743,0,0
6,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.10129,0.047143,0.085744,0,0
6,GO PIGMENT GRANULE ORGANIZATION,0.62832,0.047091,0.024534,0,0
6,GO RECEPTOR BIOSYNTHETIC PROCESS,0.30637,0.047007,0.051814,0,0
6,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.45727,0.046991,0.065119,0,0
6,GO REGULATION OF CHOLESTEROL EFFLUX,0.25078,0.046973,0.06887,0,0
6,GO DEVELOPMENTAL PIGMENTATION,0.18327,0.046956,0.064381,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.080464,0.04692,0.087294,0,0
6,GO AGING,0.15214,0.046872,0.056173,0,0
6,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.2714,0.046819,0.091009,0,0
6,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.78763,0.046719,0.0016629,0,0
6,GO RESPONSE TO ANTIBIOTIC,0.22503,0.046711,0.055733,0,0
6,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.26789,0.046539,0.06018,0,0
6,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.71996,0.046512,0.0073159,0,0
6,GO ENDOTHELIAL CELL CHEMOTAXIS,0.32195,0.046197,0.073336,0,0
6,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.48722,0.046175,-0.069834,0,0
6,GO MAINTENANCE OF LOCATION,0.32792,0.046156,0.045614,0,0
6,GO BLASTOCYST GROWTH,0.59424,0.046155,0.022489,0,0
6,GO AROMATIC AMINO ACID TRANSPORT,0.48468,0.046106,0.05352,0,0
6,GO REGULATION OF CALCIUM ION TRANSPORT,0.45482,0.046105,0.0366,0,0
6,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.3442,0.046031,0.056856,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.29315,0.045845,0.056008,0,0
6,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.39381,0.045747,-0.079305,0,0
6,GO DENDRITIC CELL MIGRATION,0.31409,0.045682,0.061075,0,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.86012,0.04558,-0.0088913,0,0
6,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.92094,0.045575,0.0015396,0,0
6,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.95961,0.045538,-0.0035681,0,0
6,GO MAINTENANCE OF PROTEIN LOCATION,0.20554,0.045502,0.053372,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.68392,0.045342,0.043204,0,0
6,GO AMMONIUM ION METABOLIC PROCESS,0.1914,0.045186,0.078936,0,0
6,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.87926,0.045113,-0.001901,0,0
6,GO CELLULAR RESPONSE TO PH,0.16654,0.04503,0.061655,0,0
6,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.36311,0.045025,0.061348,0,0
6,GO REGENERATION,0.09714,0.045023,0.071362,0,0
6,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.70486,0.045004,0.010017,0,0
6,GO PROTEIN REFOLDING,0.41434,0.04471,0.053029,0,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.50776,0.044694,0.045307,0,0
6,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.56925,0.044692,0.033627,0,0
6,GO AMYLOID FIBRIL FORMATION,0.81896,0.044558,0.02562,0,0
6,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.076344,0.044469,0.066913,0,0
6,GO ISOPRENOID METABOLIC PROCESS,0.5583,0.044334,0.025678,0,0
6,GO INTERFERON BETA PRODUCTION,0.51819,0.044266,0.040778,0,0
6,GO NCRNA CATABOLIC PROCESS,0.16904,0.044133,0.053677,0,0
6,GO GLUCOCORTICOID METABOLIC PROCESS,0.42133,0.044122,0.045422,0,0
6,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.26267,0.044006,0.10199,0,0
6,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.92738,0.04394,-0.011586,0,0
6,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.60268,0.043822,-0.049467,0,0
6,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.18062,0.043798,0.067775,0,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.068619,0.043662,0.06655,0,0
6,GO VIRAL LIFE CYCLE,0.86649,0.043662,0.0017978,0,0
6,GO NEURON REMODELING,0.58864,0.043488,0.044912,0,0
6,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.51296,0.043454,-0.023446,0,0
6,GO GOLGI VESICLE BUDDING,0.77209,0.043423,-0.0096398,0,0
6,GO AMELOGENESIS,0.37827,0.043423,0.060877,0,0
6,GO MAGNESIUM ION HOMEOSTASIS,0.24416,0.043422,0.10793,0,0
6,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.12224,0.043265,0.077821,0,0
6,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.29877,0.043172,0.044412,0,0
6,GO TRNA TRANSPORT,0.14308,0.043136,0.064447,0,0
6,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.82211,0.043128,0.012495,0,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.25753,0.043012,0.064346,0,0
6,GO REPLICATIVE SENESCENCE,0.52874,0.042907,0.030987,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.73822,0.042902,-0.024518,0,0
6,GO TYPE B PANCREATIC CELL PROLIFERATION,0.22195,0.042774,0.11404,0,0
6,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.80639,0.042741,0.011576,0,0
6,GO REGULATION OF RESPIRATORY BURST,0.17156,0.04274,0.085704,0,0
6,GO IMMUNOGLOBULIN PRODUCTION,0.62258,0.042566,0.018871,0,0
6,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.68392,0.042346,0.036095,0,0
6,GO BICARBONATE TRANSPORT,0.2458,0.042154,0.061014,0,0
6,GO AMINO ACID TRANSPORT,0.065596,0.042119,0.088159,0,0
6,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.34213,0.042038,0.053417,0,0
6,GO BODY FLUID SECRETION,0.35886,0.041968,0.037953,0,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.21437,0.041921,0.046655,0,0
6,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.38267,0.041691,0.040732,0,0
6,GO VIRAL GENOME REPLICATION,0.42133,0.041446,0.028837,0,0
6,GO REGULATION OF LIPID LOCALIZATION,0.35463,0.041409,0.047022,0,0
6,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.6312,0.041324,0.023905,0,0
6,GO FATTY ACID BETA OXIDATION,0.39832,0.041266,0.036176,0,0
6,GO POSITIVE REGULATION OF VASCULOGENESIS,0.34835,0.041239,0.079636,0,0
6,GO LIPID EXPORT FROM CELL,0.97576,0.041221,-0.0073498,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.90167,0.041142,0.016463,0,0
6,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.39832,0.041103,0.034538,0,0
6,GO REGULATION OF ANOIKIS,0.52874,0.041062,0.046783,0,0
6,GO PHOSPHOLIPID HOMEOSTASIS,0.18327,0.04103,0.084258,0,0
6,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.50258,0.041022,0.0095978,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.20122,0.040986,0.054986,0,0
6,GO MITOPHAGY,0.1387,0.040964,0.06808,0,0
6,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.17029,0.040735,0.080015,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.77829,0.040654,0.020426,0,0
6,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.27853,0.040639,0.044822,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.81581,0.040637,0.022963,0,0
6,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.093918,0.04062,0.062864,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.75048,0.040443,0.0082521,0,0
6,GO PROTEOLYSIS,0.14869,0.040304,0.047729,0,0
6,GO ASTROCYTE ACTIVATION,0.073694,0.040241,0.1,0,0
6,GO AMINO ACID IMPORT,0.84424,0.04021,0.0097877,0,0
6,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.47963,0.040101,0.035035,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.7659,0.040047,0.025527,0,0
6,GO EPIDERMAL CELL DIFFERENTIATION,0.29315,0.040008,0.052,0,0
6,GO SPHINGOLIPID METABOLIC PROCESS,0.26095,0.039892,0.050465,0,0
6,GO O GLYCAN PROCESSING,0.26095,0.039855,-0.072636,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.48976,0.039835,0.023238,0,0
6,GO LIPID METABOLIC PROCESS,0.36741,0.039786,0.0371,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.17156,0.039641,0.1118,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.21437,0.039577,0.080387,0,0
6,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.2714,0.039525,0.075225,0,0
6,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.32195,0.03948,0.065376,0,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.81581,0.039355,0.016692,0,0
6,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.51035,0.039334,0.027865,0,0
6,GO RESPONSE TO STEROL DEPLETION,0.97253,0.039327,-0.0079736,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.20409,0.039293,0.054017,0,0
6,GO RESPONSE TO DIETARY EXCESS,0.83474,0.03918,0.019994,0,0
6,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.12924,0.039109,0.073371,0,0
6,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.79075,0.03892,0.016321,0,0
6,GO RUFFLE ASSEMBLY,0.22348,0.038794,0.068201,0,0
6,GO RESPONSE TO PARATHYROID HORMONE,0.47211,0.038739,0.041775,0,0
6,GO MRNA MODIFICATION,0.34213,0.038384,0.043301,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.16778,0.038282,0.06729,0,0
6,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.89205,0.038273,0.012486,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15098,0.038153,0.074773,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.81581,0.038132,0.012628,0,0
6,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.43789,0.038071,0.064457,0,0
6,GO PEPTIDYL METHIONINE MODIFICATION,0.75048,0.038025,0.0067949,0,0
6,GO REGULATION OF MEMBRANE REPOLARIZATION,0.54477,0.037984,0.04404,0,0
6,GO CELLULAR RESPONSE TO MANGANESE ION,0.37827,0.037916,0.047,0,0
6,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.86649,0.037875,0.0092794,0,0
6,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.33599,0.037802,0.086026,0,0
6,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.19697,0.037739,0.14722,0,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.51035,0.037641,0.024068,0,0
6,GO ANION TRANSPORT,0.13549,0.037491,0.060816,0,0
6,GO HYPOTHALAMUS DEVELOPMENT,0.58585,0.037394,0.046502,0,0
6,GO REGULATION OF POSITIVE CHEMOTAXIS,0.20265,0.037375,0.10075,0,0
6,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.31409,0.037345,0.057399,0,0
6,GO MAST CELL ACTIVATION,0.5314,0.037266,0.042583,0,0
6,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.42602,0.037247,0.027686,0,0
6,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.77519,0.0371,0.020084,0,0
6,GO PROTEIN DEMANNOSYLATION,0.59986,0.037023,0.018137,0,0
6,GO REGULATION OF VACUOLE ORGANIZATION,0.60834,0.03701,0.035712,0,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS,0.52345,0.036993,0.02881,0,0
6,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.82526,0.036967,0.015888,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.27317,0.036915,-0.087461,0,0
6,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.23927,0.036904,0.059594,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.28761,0.036721,0.034831,0,0
6,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.51557,0.036636,0.036617,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.90167,0.03658,-0.015102,0,0
6,GO MITOCHONDRION MORPHOGENESIS,0.35043,0.036552,0.044741,0,0
6,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.99838,0.036423,-0.024768,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.14088,0.036404,0.072853,0,0
6,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.86331,0.036359,-0.012139,0,0
6,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.90809,0.036281,-0.0041164,0,0
6,GO RESPONSE TO AMYLOID BETA,0.14983,0.036261,0.08578,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.37608,0.036257,0.01979,0,0
6,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.92738,0.03625,0.018456,0,0
6,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.11275,0.036226,0.05345,0,0
6,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.3871,0.03621,0.06442,0,0
6,GO ELASTIC FIBER ASSEMBLY,0.5583,0.03611,0.035101,0,0
6,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.92738,0.036104,-0.0024774,0,0
6,GO ERAD PATHWAY,0.85059,0.036072,-0.00011895,0,0
6,GO FATTY ACID CATABOLIC PROCESS,0.39156,0.036003,0.04267,0,0
6,GO RNA CATABOLIC PROCESS,0.61687,0.035944,0.0056809,0,0
6,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.89526,0.035899,-0.028672,0,0
6,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.53406,0.035859,0.018018,0,0
6,GO POSITIVE THYMIC T CELL SELECTION,0.50776,0.035523,0.016961,0,0
6,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.36098,0.03543,0.034869,0,0
6,GO ACTIVATED T CELL PROLIFERATION,0.46218,0.035386,0.056961,0,0
6,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.30066,0.035298,0.059087,0,0
6,GO HISTONE H2B UBIQUITINATION,0.55287,0.035054,0.037503,0,0
6,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.55016,0.035029,0.030189,0,0
6,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.572,0.034956,0.01474,0,0
6,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.27673,0.034858,0.039232,0,0
6,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.65442,0.034824,0.028261,0,0
6,GO INTERFERON ALPHA PRODUCTION,0.80012,0.034747,0.023759,0,0
6,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.18461,0.034741,0.060838,0,0
6,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.80953,0.034732,0.013986,0,0
6,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.30637,0.034696,0.05467,0,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.86012,0.034691,0.01462,0,0
6,GO CELLULAR LIPID METABOLIC PROCESS,0.44028,0.034669,0.03368,0,0
6,GO CELLULAR RESPONSE TO CAMP,0.34835,0.034551,0.049134,0,0
6,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.24416,0.034543,0.04862,0,0
6,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.84107,0.034514,0.011573,0,0
6,GO NODAL SIGNALING PATHWAY,0.28213,0.034392,0.076373,0,0
6,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.08331,0.034355,0.12694,0,0
6,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.082591,0.034322,0.082105,0,0
6,GO CELLULAR EXTRAVASATION,0.96607,0.034286,0.0044733,0,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.52874,0.034258,0.057729,0,0
6,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.1873,0.034196,0.047702,0,0
6,GO RESPONSE TO INTERLEUKIN 2,0.15802,0.034153,0.099878,0,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.32195,0.034113,0.074249,0,0
6,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.99192,0.033864,-0.0023761,0,0
6,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.70185,0.033794,0.025054,0,0
6,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.91451,0.033767,-0.010947,0,0
6,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.5394,0.033743,0.012287,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.18062,0.033662,0.04822,0,0
6,GO MULTIVESICULAR BODY ORGANIZATION,0.58585,0.033657,0.027244,0,0
6,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.572,0.03362,0.032085,0,0
6,GO IRON ION HOMEOSTASIS,0.82211,0.033413,-0.0039857,0,0
6,GO ENDODERMAL CELL DIFFERENTIATION,0.61687,0.033412,-0.042272,0,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.6312,0.033322,0.024911,0,0
6,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.3871,0.033271,0.047358,0,0
6,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.26614,0.0332,0.0578,0,0
6,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.5583,0.033166,0.026406,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.78763,0.03296,0.022864,0,0
6,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.2714,0.03296,0.056247,0,0
6,GO REGULATION OF BODY FLUID LEVELS,0.53406,0.032881,0.039257,0,0
6,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.68689,0.032814,0.01243,0,0
6,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.6055,0.032663,0.026757,0,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.89846,0.032573,0.0039985,0,0
6,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.58585,0.032519,0.028315,0,0
6,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.46962,0.032447,0.04103,0,0
6,GO REGULATION OF URINE VOLUME,0.072397,0.032425,0.08692,0,0
6,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.10823,0.032343,0.069952,0,0
6,GO MEMBRANE DEPOLARIZATION,0.27317,0.032225,0.07312,0,0
6,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.84107,0.032198,0.01052,0,0
6,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.19557,0.03219,0.06893,0,0
6,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.54477,0.032122,0.024486,0,0
6,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.3871,0.032078,0.036936,0,0
6,GO GLUCOSE METABOLIC PROCESS,0.20699,0.031978,0.059877,0,0
6,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.61117,0.031921,0.023055,0,0
6,GO DRUG CATABOLIC PROCESS,0.4451,0.031697,0.02905,0,0
6,GO ORGANIC ANION TRANSPORT,0.34008,0.031609,0.045445,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.1793,0.031556,0.052378,0,0
6,GO SPHINGOID METABOLIC PROCESS,0.53672,0.031476,0.044158,0,0
6,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.92094,0.031451,0.013309,0,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.76899,0.031436,0.016229,0,0
6,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.46466,0.031346,0.030378,0,0
6,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.66616,0.031336,0.020846,0,0
6,GO RESPONSE TO TESTOSTERONE,0.40973,0.03125,0.04526,0,0
6,GO STORE OPERATED CALCIUM ENTRY,0.35253,0.031249,0.053309,0,0
6,GO REGULATION OF VIRAL TRANSCRIPTION,1,0.03113,7.8007e-05,0,0
6,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.54208,0.031115,0.041626,0,0
6,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.39832,0.03092,0.035013,0,0
6,GO CELLULAR RESPONSE TO SALT STRESS,0.20845,0.030905,0.081227,0,0
6,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.40286,0.030867,0.086592,0,0
6,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.38933,0.030808,0.066978,0,0
6,GO STEROID METABOLIC PROCESS,0.77209,0.030793,0.0073604,0,0
6,GO ORGANELLE FUSION,0.797,0.030695,0.021294,0,0
6,GO REGULATION OF RIBOSOME BIOGENESIS,0.59986,0.030683,-0.050545,0,0
6,GO CARBOHYDRATE METABOLIC PROCESS,0.33803,0.030643,0.042353,0,0
6,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.41203,0.030585,0.07904,0,0
6,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.60834,0.030529,0.01686,0,0
6,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.5394,0.030485,0.046292,0,0
6,GO REGULATION OF LIPID CATABOLIC PROCESS,0.5583,0.030235,0.044211,0,0
6,GO PROTEIN TARGETING TO MEMBRANE,0.83474,0.030094,-0.03462,0,0
6,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.74741,0.030053,0.0017237,0,0
6,GO APOPTOTIC SIGNALING PATHWAY,0.66028,0.030039,0.024594,0,0
6,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.74741,0.029979,0.0055432,0,0
6,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.45727,0.029852,0.041885,0,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.56925,0.029716,0.019048,0,0
6,GO REGULATION OF PROTEIN STABILITY,0.28213,0.029518,0.043983,0,0
6,GO CELLULAR IRON ION HOMEOSTASIS,0.82526,0.029264,-0.0012506,0,0
6,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.7659,0.029138,0.016027,0,0
6,GO RESPONSE TO INACTIVITY,0.15214,0.029128,0.11006,0,0
6,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.54477,0.029111,-0.020551,0,0
6,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.7814,0.029064,0.014413,0,0
6,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.66028,0.02895,0.046232,0,0
6,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.58029,0.028892,-0.01043,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.78763,0.028756,0.012733,0,0
6,GO REGULATION OF PROTEIN MATURATION,0.38488,0.028638,0.042662,0,0
6,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.97253,0.028551,0.009573,0,0
6,GO MEMBRANE REPOLARIZATION,0.3871,0.028369,0.058129,0,0
6,GO LIPOSACCHARIDE METABOLIC PROCESS,0.4451,0.028289,0.0329,0,0
6,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.82526,0.028269,0.0035669,0,0
6,GO SALIVARY GLAND DEVELOPMENT,0.23445,0.028117,0.092286,0,0
6,GO AMINOGLYCAN METABOLIC PROCESS,0.60834,0.028087,0.035604,0,0
6,GO PROTEIN DESTABILIZATION,0.4355,0.028082,0.038908,0,0
6,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.45972,0.028077,0.042288,0,0
6,GO PLASMA MEMBRANE ORGANIZATION,0.11837,0.028071,0.10207,0,0
6,GO FATTY ACID BIOSYNTHETIC PROCESS,0.80639,0.027949,-0.0096032,0,0
6,GO TISSUE REGENERATION,0.21587,0.027829,0.067932,0,0
6,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.5394,0.027805,0.029349,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.22042,0.027546,0.053011,0,0
6,GO LIPID LOCALIZATION,0.5314,0.027437,0.033982,0,0
6,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.093918,0.027318,0.10818,0,0
6,GO EXTRACELLULAR VESICLE BIOGENESIS,0.32993,0.027139,0.053994,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.59424,0.027128,0.026946,0,0
6,GO FACE DEVELOPMENT,0.15565,0.02709,0.08343,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.90488,0.027079,-0.0050427,0,0
6,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.38488,0.027038,0.039763,0,0
6,GO SNRNA PROCESSING,0.797,0.026938,-0.048225,0,0
6,GO PHOSPHOLIPID METABOLIC PROCESS,0.32993,0.026894,0.04204,0,0
6,GO TRNA WOBBLE BASE MODIFICATION,0.98222,0.026893,-0.0013584,0,0
6,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.77829,0.026828,-0.023266,0,0
6,GO ACYLGLYCEROL HOMEOSTASIS,0.42367,0.026745,0.057723,0,0
6,GO B CELL ACTIVATION,0.53672,0.026351,0.023762,0,0
6,GO MITOCHONDRION ORGANIZATION,0.88565,0.026246,0.005711,0,0
6,GO ARGININE METABOLIC PROCESS,0.60834,0.026206,0.032946,0,0
6,GO REGULATION OF STEROID METABOLIC PROCESS,0.88885,0.025978,-0.0032847,0,0
6,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.90488,0.025941,0.0022026,0,0
6,GO REGULATION OF PROTEOLYSIS,0.65442,0.025712,0.016629,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.16778,0.025592,0.047181,0,0
6,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.16778,0.025484,0.060706,0,0
6,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.6312,0.025432,-0.037455,0,0
6,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.48468,0.025358,0.043477,0,0
6,GO REGULATION OF GLOMERULAR FILTRATION,0.24911,0.025242,0.16037,0,0
6,GO GLUTAMATE METABOLIC PROCESS,0.16407,0.025149,0.072405,0,0
6,GO RUFFLE ORGANIZATION,0.65442,0.025086,0.039141,0,0
6,GO VASCULAR WOUND HEALING,0.30829,0.025082,0.10945,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.44028,0.024787,-0.061062,0,0
6,GO CELLULAR KETONE METABOLIC PROCESS,0.88885,0.024769,0.0078979,0,0
6,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.48215,0.024648,0.03273,0,0
6,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.95639,0.024639,0.017467,0,0
6,GO CARBOHYDRATE TRANSPORT,0.3871,0.024525,0.039246,0,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.5,0.024509,0.041976,0,0
6,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.87926,0.024313,-0.011123,0,0
6,GO L AMINO ACID TRANSPORT,0.31409,0.024291,0.045515,0,0
6,GO REGULATION OF LIPID TRANSPORT,0.4451,0.024283,0.037382,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.64858,0.024269,0.019464,0,0
6,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.42602,0.024249,0.034768,0,0
6,GO ORGANELLE INHERITANCE,0.49487,0.02415,0.023626,0,0
6,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.9113,0.024147,-0.024833,0,0
6,GO GLYCEROLIPID METABOLIC PROCESS,0.28033,0.024129,0.047643,0,0
6,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.94026,0.024117,0.026975,0,0
6,GO REGULATION OF ICOSANOID SECRETION,0.51296,0.024096,0.046779,0,0
6,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.81581,0.02409,-0.020673,0,0
6,GO COAGULATION,0.9693,0.024076,0.013589,0,0
6,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.72907,0.024035,0.022448,0,0
6,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.86649,0.024024,0.0076395,0,0
6,GO CYTOKINE SECRETION,0.94993,0.023881,0.006058,0,0
6,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.1754,0.023861,0.082873,0,0
6,GO REGULATION OF ANION TRANSPORT,0.36098,0.02367,0.044662,0,0
6,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.96607,0.023615,0.01283,0,0
6,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.84107,0.023504,0.0077014,0,0
6,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.79387,0.02346,0.017218,0,0
6,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.76899,0.023398,0.015617,0,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.40514,0.023392,0.078693,0,0
6,GO LYMPHOCYTE COSTIMULATION,0.86331,0.023355,0.012364,0,0
6,GO ACTIN FILAMENT NETWORK FORMATION,0.72907,0.023339,0.058855,0,0
6,GO MALE GENITALIA DEVELOPMENT,0.28213,0.023232,0.050839,0,0
6,GO DNA DEAMINATION,0.80953,0.023197,-0.026487,0,0
6,GO CORTICAL CYTOSKELETON ORGANIZATION,0.45727,0.023157,0.048557,0,0
6,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.50516,0.023144,0.011543,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.31409,0.023083,0.056901,0,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.86968,0.022916,0.0012116,0,0
6,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.56376,0.022809,0.035517,0,0
6,GO REGULATION OF T CELL ACTIVATION,0.73822,0.022802,0.011247,0,0
6,GO UBIQUINONE METABOLIC PROCESS,0.87926,0.022788,-0.011656,0,0
6,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.52345,0.022668,0.03013,0,0
6,GO RESPONSE TO MISFOLDED PROTEIN,0.6691,0.022664,0.043497,0,0
6,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.65442,0.022611,0.026176,0,0
6,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.73822,0.0226,0.016644,0,0
6,GO RRNA METABOLIC PROCESS,0.45238,0.022586,-0.055676,0,0
6,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.76899,0.022527,0.016819,0,0
6,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.41434,0.022519,0.040968,0,0
6,GO NEUROINFLAMMATORY RESPONSE,0.61972,0.022482,0.021778,0,0
6,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.22503,0.022379,0.076369,0,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.36098,0.022327,0.055086,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.70486,0.022311,0.022746,0,0
6,GO REGULATION OF INTEGRIN ACTIVATION,0.91772,0.022108,-0.0008258,0,0
6,GO COPII COATED VESICLE BUDDING,0.74435,0.022043,-0.011685,0,0
6,GO HAIR FOLLICLE MATURATION,0.34627,0.021746,0.05723,0,0
6,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.35463,0.02172,0.079963,0,0
6,GO RESPONSE TO HEAT,0.31021,0.021437,0.043729,0,0
6,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.55016,0.021408,0.044206,0,0
6,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.17411,0.021408,0.099863,0,0
6,GO ORGANELLE MEMBRANE FUSION,0.92094,0.021355,0.01616,0,0
6,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.97899,0.021214,-0.0059241,0,0
6,GO THIOESTER BIOSYNTHETIC PROCESS,0.92094,0.021179,0.00488,0,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.94026,0.021114,0.0020976,0,0
6,GO HORMONE BIOSYNTHETIC PROCESS,0.83474,0.021055,-0.0053481,0,0
6,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.23605,0.021028,0.069586,0,0
6,GO RESPONSE TO PH,0.72907,0.020991,-0.0014841,0,0
6,GO ACTIN MEDIATED CELL CONTRACTION,0.40286,0.020912,0.055446,0,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.54208,0.020912,0.023512,0,0
6,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.72907,0.020901,-0.0045653,0,0
6,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.45482,0.020884,0.033031,0,0
6,GO CARDIAC MUSCLE CONTRACTION,0.5,0.020766,0.050647,0,0
6,GO DIGESTIVE SYSTEM PROCESS,0.29502,0.020752,0.048035,0,0
6,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.20699,0.020745,0.053402,0,0
6,GO REGULATION OF CALCIUM ION IMPORT,0.94348,0.020715,-0.00095245,0,0
6,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.34835,0.020651,0.052642,0,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.7814,0.020646,0.0074878,0,0
6,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.77519,0.020617,-0.040844,0,0
6,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.40514,0.020605,0.059019,0,0
6,GO FATTY ACID METABOLIC PROCESS,0.80012,0.020584,0.010259,0,0
6,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.19697,0.02058,0.077996,0,0
6,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.70486,0.020446,0.036103,0,0
6,GO CELL ACTIVATION,0.94026,0.020381,0.00098273,0,0
6,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.45482,0.020377,0.051944,0,0
6,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.79075,0.020294,0.018981,0,0
6,GO HOMOTYPIC CELL CELL ADHESION,0.94026,0.020261,0.011173,0,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.94671,0.020155,0.009491,0,0
6,GO KERATINOCYTE MIGRATION,0.96284,0.020127,0.0014342,0,0
6,GO PANCREATIC JUICE SECRETION,0.33599,0.020041,0.048995,0,0
6,GO FEMALE GENITALIA DEVELOPMENT,0.74128,0.020034,0.015631,0,0
6,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.96607,0.020027,0.0059833,0,0
6,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.79075,0.019976,0.0123,0,0
6,GO RENAL ABSORPTION,0.66616,0.019945,0.045468,0,0
6,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.18866,0.019915,0.058402,0,0
6,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.98869,0.019853,0.010089,0,0
6,GO NCRNA PROCESSING,0.43075,0.019694,-0.05287,0,0
6,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.84741,0.019659,0.01706,0,0
6,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.52609,0.019605,0.031106,0,0
6,GO PLATELET ACTIVATION,0.68988,0.019603,0.035399,0,0
6,GO ORGANELLE DISASSEMBLY,0.79387,0.019471,0.021261,0,0
6,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.6691,0.019408,0.01033,0,0
6,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.572,0.019347,-0.065521,0,0
6,GO TELOMERASE RNA LOCALIZATION,0.31604,0.019332,-0.073244,0,0
6,GO CERAMIDE METABOLIC PROCESS,0.47211,0.019314,0.039882,0,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.84741,0.019281,0.016744,0,0
6,GO POSITIVE REGULATION OF WOUND HEALING,0.67501,0.019257,0.039684,0,0
6,GO TISSUE MIGRATION,0.55016,0.019241,0.038897,0,0
6,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.39832,0.019227,0.095463,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.72907,0.019159,0.029852,0,0
6,GO POSITIVE REGULATION OF CELL ACTIVATION,0.88245,0.01894,-0.0090146,0,0
6,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.55287,0.01889,0.015617,0,0
6,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.53406,0.01887,0.028767,0,0
6,GO RESPONSE TO LEPTIN,0.46466,0.018788,0.05016,0,0
6,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.97576,0.01873,0.010228,0,0
6,GO ATP METABOLIC PROCESS,0.87606,0.01861,-0.0025254,0,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.58029,0.018537,0.025091,0,0
6,GO CELLULAR RESPONSE TO HEAT,0.36311,0.018487,0.040947,0,0
6,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.21587,0.018399,0.08398,0,0
6,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.5314,0.018369,0.034039,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.59144,0.018332,0.079754,0,0
6,GO RESPONSE TO ORGANOPHOSPHORUS,0.5394,0.01831,0.031553,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.32993,0.018246,0.050608,0,0
6,GO MAST CELL MEDIATED IMMUNITY,0.72299,0.018147,0.028612,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.27317,0.018022,0.072276,0,0
6,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.89526,0.017908,0.0074866,0,0
6,GO ACETYL COA METABOLIC PROCESS,0.66321,0.017849,0.02145,0,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.88245,0.017807,0.021795,0,0
6,GO MACROPHAGE PROLIFERATION,0.79387,0.017798,0.031412,0,0
6,GO CYTOKINETIC PROCESS,0.68392,0.017718,0.028559,0,0
6,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.59144,0.017683,0.023478,0,0
6,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.97253,0.017652,0.0013281,0,0
6,GO REGULATION OF TELOMERASE ACTIVITY,0.45482,0.017621,0.039697,0,0
6,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.57752,0.017557,-0.023262,0,0
6,GO RESPONSE TO OXIDATIVE STRESS,0.92094,0.01749,0.015604,0,0
6,GO REGULATION OF HORMONE METABOLIC PROCESS,0.78763,0.017402,0.021074,0,0
6,GO VIRAL RELEASE FROM HOST CELL,0.89205,0.017336,0.014131,0,0
6,GO REGULATION OF ERAD PATHWAY,0.572,0.017264,0.0276,0,0
6,GO CELLULAR COMPONENT DISASSEMBLY,0.91451,0.017244,0.016361,0,0
6,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.43075,0.017198,0.053997,0,0
6,GO RESPONSE TO OXYGEN RADICAL,0.19838,0.017176,0.056836,0,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.65734,0.017036,0.020447,0,0
6,GO INTERACTION WITH HOST,0.93382,0.017024,-0.0082879,0,0
6,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.84741,0.017015,0.0097731,0,0
6,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.85059,0.01699,0.018781,0,0
6,GO ESTROGEN METABOLIC PROCESS,0.36526,0.016988,-0.040041,0,0
6,GO REGULATION OF CELL ACTIVATION,0.66321,0.016837,0.017025,0,0
6,GO EXOCYTOSIS,0.9306,0.016808,0.0059273,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.48468,0.016775,0.035545,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.85376,0.016766,0.018763,0,0
6,GO RESPONSE TO RETINOIC ACID,0.21437,0.016672,0.071892,0,0
6,GO DIGESTION,0.29502,0.016654,0.0417,0,0
6,GO NUCLEOSIDE METABOLIC PROCESS,0.98222,0.016579,-0.00033077,0,0
6,GO PROTEIN NITROSYLATION,0.49487,0.016354,-0.056181,0,0
6,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.88245,0.016256,-0.0032365,0,0
6,GO ALCOHOL METABOLIC PROCESS,0.78451,0.016229,0.0099815,0,0
6,GO CELLULAR LIPID CATABOLIC PROCESS,0.92416,0.016175,0.009199,0,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.68392,0.01594,0.02591,0,0
6,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.84107,0.015819,-0.004236,0,0
6,GO VIRAL GENE EXPRESSION,0.28033,0.015777,-0.069689,0,0
6,GO CELLULAR PIGMENTATION,0.39156,0.015771,0.040867,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.99515,0.015766,0.0011797,0,0
6,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.36311,0.0157,0.056232,0,0
6,GO REGULATION OF TISSUE REMODELING,0.96284,0.0157,0.0020568,0,0
6,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.92416,0.015642,-0.0013677,0,0
6,GO NEUTRAL LIPID METABOLIC PROCESS,0.49231,0.015635,0.035462,0,0
6,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.4451,0.015539,-0.06852,0,0
6,GO LIPID CATABOLIC PROCESS,0.80326,0.015472,0.013284,0,0
6,GO TRNA METABOLIC PROCESS,0.55287,0.01546,-0.033742,0,0
6,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.28945,0.015459,0.055038,0,0
6,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.98222,0.0153,-0.041807,0,0
6,GO MACROPHAGE CYTOKINE PRODUCTION,0.63697,0.015282,-0.04005,0,0
6,GO INACTIVATION OF MAPK ACTIVITY,0.95316,0.015178,0.028098,0,0
6,GO HUMORAL IMMUNE RESPONSE,0.49231,0.01514,-0.042854,0,0
6,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.80012,0.01514,0.0059363,0,0
6,GO PROTEIN O LINKED MANNOSYLATION,0.78451,0.015055,0.022512,0,0
6,GO RNA CAPPING,0.53406,0.015023,0.020454,0,0
6,GO RESPONSE TO BIOTIC STIMULUS,0.55016,0.014966,-0.024764,0,0
6,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.91451,0.01482,0.0024191,0,0
6,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.84107,0.014762,0.0029784,0,0
6,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.74741,0.014756,0.024053,0,0
6,GO POSITIVE REGULATION OF CHEMOTAXIS,0.52609,0.014717,0.041563,0,0
6,GO NEGATIVE REGULATION OF ANOIKIS,0.42133,0.01471,0.072299,0,0
6,GO RESPONSE TO CYTOKINE,0.58864,0.014573,-0.020261,0,0
6,GO MITOCHONDRIAL FUSION,0.77519,0.014326,0.029556,0,0
6,GO INTERMEDIATE FILAMENT ORGANIZATION,0.39606,0.014202,0.04541,0,0
6,GO I KAPPAB PHOSPHORYLATION,0.70787,0.014038,-0.024014,0,0
6,GO RECEPTOR CATABOLIC PROCESS,0.95961,0.01393,0.012367,0,0
6,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.86331,0.013874,0.0069206,0,0
6,GO MATURATION OF 5 8S RRNA,0.2458,0.013805,-0.10124,0,0
6,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.97253,0.013788,0.015123,0,0
6,GO TRNA MODIFICATION,0.70486,0.013732,-0.028173,0,0
6,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.61117,0.013679,-0.032455,0,0
6,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.78763,0.013663,-0.014314,0,0
6,GO REGULATION OF PROTEIN FOLDING,0.94993,0.013625,0.01435,0,0
6,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.60834,0.013621,0.03537,0,0
6,GO REGULATION OF GLUCONEOGENESIS,0.14869,0.013606,0.07989,0,0
6,GO PROTEIN AUTOPROCESSING,0.67798,0.013587,0.024488,0,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.61972,0.013586,0.027752,0,0
6,GO RESPONSE TO ZINC ION,0.69885,0.013484,0.024238,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.9306,0.013483,-0.0018448,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.98869,0.01348,0.0027057,0,0
6,GO REGULATION OF WATER LOSS VIA SKIN,0.62545,0.013416,0.042892,0,0
6,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.96284,0.013392,-0.0005536,0,0
6,GO PARAXIAL MESODERM DEVELOPMENT,0.22814,0.013301,0.08971,0,0
6,GO NEGATIVE REGULATION OF GENE SILENCING,0.52082,0.01309,0.029036,0,0
6,GO REGULATION OF LIPASE ACTIVITY,0.86331,0.013027,0.00079628,0,0
6,GO NIK NF KAPPAB SIGNALING,0.62545,0.012866,-0.027134,0,0
6,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.88565,0.012861,0.01291,0,0
6,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.90488,0.012752,-0.0019994,0,0
6,GO REGULATION OF CHEMOTAXIS,0.51557,0.012667,0.043026,0,0
6,GO DE NOVO PROTEIN FOLDING,0.75048,0.012637,0.017315,0,0
6,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.16778,0.012622,0.083268,0,0
6,GO REGULATION OF CELL CELL ADHESION,0.5583,0.012566,0.030536,0,0
6,GO PLATELET AGGREGATION,0.55558,0.012412,-0.015069,0,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.30066,0.012272,-0.078009,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.94993,0.012264,-0.0037727,0,0
6,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.68988,0.012202,0.032612,0,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.82842,0.012052,0.023959,0,0
6,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.68094,0.012049,-0.037247,0,0
6,GO REGULATION OF CELLULAR EXTRAVASATION,0.84107,0.012038,-0.0030557,0,0
6,GO DEFENSE RESPONSE,0.68392,0.012032,-0.015536,0,0
6,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.71996,0.011993,-0.005441,0,0
6,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.44752,0.011844,0.035379,0,0
6,GO VIRAL TRANSLATION,0.45972,0.011641,-0.0612,0,0
6,GO STEROL BIOSYNTHETIC PROCESS,0.96607,0.011581,0.0030766,0,0
6,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.87926,0.011579,0.01872,0,0
6,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.89526,0.01153,-0.011436,0,0
6,GO PROTEIN TARGETING,0.93382,0.011338,-0.01777,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.83474,0.011174,0.010002,0,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.84741,0.011148,-0.0076468,0,0
6,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.39381,0.011122,0.041821,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.49231,0.010928,0.038312,0,0
6,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.97899,0.010557,0.0020202,0,0
6,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.85376,0.010408,-0.019998,0,0
6,GO POSITIVE REGULATION OF VIRAL PROCESS,0.8379,0.010186,-0.0050065,0,0
6,GO RESPONSE TO GAMMA RADIATION,0.74741,0.010178,0.017171,0,0
6,GO REGULATION OF GOLGI ORGANIZATION,0.79075,0.010156,0.020716,0,0
6,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.9693,0.010133,0.011698,0,0
6,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.5,0.01011,0.031234,0,0
6,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.82526,0.010056,-0.0099094,0,0
6,GO MULTIVESICULAR BODY SORTING PATHWAY,0.51819,0.0098423,0.034906,0,0
6,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.1754,0.0097778,0.12234,0,0
6,GO MIRNA METABOLIC PROCESS,0.99515,0.0097582,-0.0042836,0,0
6,GO NEPHRIC DUCT DEVELOPMENT,0.45238,0.0096115,0.067229,0,0
6,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.70185,0.0095604,0.018183,0,0
6,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.58864,0.0092241,-0.042935,0,0
6,GO GLUTAMINE METABOLIC PROCESS,0.70787,0.0092175,-0.018425,0,0
6,GO MONOCARBOXYLIC ACID TRANSPORT,0.77519,0.0090828,0.01835,0,0
6,GO TOXIN METABOLIC PROCESS,0.68392,0.0090822,0.036367,0,0
6,GO RIBOSOME BIOGENESIS,0.27495,0.0090549,-0.081564,0,0
6,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.9113,0.0089713,0.0055081,0,0
6,GO HYPOTONIC RESPONSE,0.27853,0.0088333,0.10509,0,0
6,GO INTERLEUKIN 4 PRODUCTION,0.78451,0.0088252,-0.019441,0,0
6,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.92738,0.008823,0.0086848,0,0
6,GO RESPONSE TO LITHIUM ION,0.41899,0.0088089,0.10852,0,0
6,GO FATTY ACID HOMEOSTASIS,0.48976,0.0087445,0.06676,0,0
6,GO POSITIVE REGULATION OF FERTILIZATION,0.54208,0.0086172,0.044803,0,0
6,GO STEROID BIOSYNTHETIC PROCESS,0.75972,0.0085983,-0.01035,0,0
6,GO ENDOCRINE PROCESS,0.88245,0.0085315,0.016304,0,0
6,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.81581,0.008484,-0.0038161,0,0
6,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.75048,0.0083905,0.017971,0,0
6,GO POLYOL BIOSYNTHETIC PROCESS,0.66616,0.0082877,0.035241,0,0
6,GO HETEROTYPIC CELL CELL ADHESION,0.5314,0.0082607,0.047049,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.84424,0.0082242,-0.010892,0,0
6,GO RESPONSE TO VIRUS,0.87926,0.0079105,-0.012546,0,0
6,GO TRANSEPITHELIAL TRANSPORT,0.60834,0.0078523,0.024479,0,0
6,GO ALCOHOL BIOSYNTHETIC PROCESS,0.92094,0.0077785,0.011188,0,0
6,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.7814,0.0076956,0.014875,0,0
6,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.89846,0.0076754,0.014093,0,0
6,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.51557,0.0075873,0.041326,0,0
6,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.82842,0.00737,-0.015925,0,0
6,GO RESPONSE TO PAIN,0.71693,0.0073691,-0.027937,0,0
6,GO SECONDARY METABOLIC PROCESS,0.44028,0.0072488,0.04761,0,0
6,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.89846,0.0072466,0.018698,0,0
6,GO POSITIVE REGULATION OF CELL ADHESION,0.92738,0.0072145,0.001384,0,0
6,GO MONOSACCHARIDE METABOLIC PROCESS,0.76281,0.0070216,0.027059,0,0
6,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.85694,0.007014,0.034516,0,0
6,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.85694,0.0069864,-0.0037437,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.89526,0.006944,0.0035906,0,0
6,GO RESPONSE TO AMINE,0.83158,0.0068371,0.0080778,0,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.98869,0.0067859,0.0095865,0,0
6,GO MUSCLE CELL FATE COMMITMENT,0.5394,0.0066971,-0.058399,0,0
6,GO REGULATION OF VIRAL GENOME REPLICATION,0.87606,0.0066117,-0.003945,0,0
6,GO RESPONSE TO TUMOR CELL,0.37608,0.0065902,-0.063607,0,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.68988,0.0065776,-0.030999,0,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.93382,0.0065755,0.0093029,0,0
6,GO MEMBRANE INVAGINATION,0.98869,0.0065452,0.012653,0,0
6,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.40514,0.0064946,0.043724,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.84107,0.0064856,-0.023303,0,0
6,GO VACUOLE ORGANIZATION,0.77519,0.006358,0.025064,0,0
6,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.95961,0.0061692,0.0052956,0,0
6,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.52874,0.0061498,0.079819,0,0
6,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.87606,0.0060384,0.0014541,0,0
6,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.86968,0.0059892,0.0060729,0,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.94993,0.005985,0.0099636,0,0
6,GO PEPTIDYL ASPARAGINE MODIFICATION,0.80012,0.0058566,-0.024502,0,0
6,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.81267,0.0056965,-0.012535,0,0
6,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.84424,0.005639,-0.0060867,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.53406,0.0055885,0.049794,0,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.87287,0.0053424,-0.00035326,0,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.80953,0.0052846,0.012367,0,0
6,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.98222,0.005278,-0.0090006,0,0
6,GO SMALL MOLECULE CATABOLIC PROCESS,0.62832,0.0051368,0.023622,0,0
6,GO RESPONSE TO ATP,0.45727,0.0050156,0.042511,0,0
6,GO FLUID TRANSPORT,0.55287,0.004626,0.06027,0,0
6,GO LEUKOCYTE AGGREGATION,0.92094,0.004427,0.01179,0,0
6,GO HORMONE METABOLIC PROCESS,0.49231,0.0042342,0.033635,0,0
6,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.57752,0.0041313,0.024414,0,0
6,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.51557,0.0040652,-0.036539,0,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.5314,0.0040475,-0.019034,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.67798,0.0040473,-0.025031,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.48468,0.0039691,0.086938,0,0
6,GO MUSCLE CELL PROLIFERATION,0.59144,0.0038847,0.032419,0,0
6,GO REGULATION OF METANEPHROS DEVELOPMENT,0.5665,0.0037475,-0.049421,0,0
6,GO PROTEIN HETEROTETRAMERIZATION,0.84741,0.0037126,0.012643,0,0
6,GO REGULATION OF RENAL SYSTEM PROCESS,0.58864,0.0036866,0.063174,0,0
6,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.70787,0.0036529,-0.026823,0,0
6,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.69286,0.0035654,-0.0090742,0,0
6,GO REGULATION OF BONE REMODELING,0.89205,0.0035414,0.007199,0,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.58585,0.0034674,0.059157,0,0
6,GO NAD METABOLIC PROCESS,0.52874,0.0033596,0.036559,0,0
6,GO METHIONINE BIOSYNTHETIC PROCESS,0.95961,0.0032661,0.01319,0,0
6,GO REGULATION OF ERBB SIGNALING PATHWAY,0.74435,0.0032284,0.021257,0,0
6,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.66028,0.0031843,-0.0075247,0,0
6,GO GLIAL CELL ACTIVATION,0.9693,0.0031748,0.0013213,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.74741,0.0030483,0.035684,0,0
6,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.36311,0.0030265,0.10361,0,0
6,GO MEMBRANE FUSION,0.797,0.0029943,0.027161,0,0
6,GO ORGANIC ACID TRANSPORT,0.50516,0.0029538,0.034037,0,0
6,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.58864,0.0028708,-0.034794,0,0
6,GO IRON ION TRANSPORT,0.84741,0.0028639,0.0022547,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.6691,0.002712,-0.01171,0,0
6,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.85059,0.0026974,-0.010444,0,0
6,GO REGULATION OF PEPTIDASE ACTIVITY,0.50516,0.0026552,-0.027086,0,0
6,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.56103,0.0024605,0.017408,0,0
6,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.81896,0.0024314,-0.0013921,0,0
6,GO LEUKOCYTE TETHERING OR ROLLING,0.82211,0.0024216,0.012361,0,0
6,GO PROGRAMMED NECROTIC CELL DEATH,0.62258,0.0022477,-0.026562,0,0
6,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.80639,0.0022188,-0.023412,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.6055,0.0021465,-0.022377,0,0
6,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.3871,0.0019399,0.040609,0,0
6,GO TRIGLYCERIDE METABOLIC PROCESS,0.72299,0.0019087,0.022949,0,0
6,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.96284,0.0018932,0.011827,0,0
6,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.98869,0.0018438,0.010531,0,0
6,GO PROTEIN FOLDING,0.7814,0.0017967,-0.0099326,0,0
6,GO FATTY ACYL COA METABOLIC PROCESS,0.60834,0.0017954,-0.02532,0,0
6,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.62545,0.0017709,-0.032161,0,0
6,GO PROTEIN NEDDYLATION,0.59144,0.0017051,-0.030036,0,0
6,GO DEFENSE RESPONSE TO VIRUS,0.90488,0.0016287,-0.01436,0,0
6,GO REGULATION OF DEFENSE RESPONSE,0.65734,0.00156,-0.018225,0,0
6,GO AMIDE BIOSYNTHETIC PROCESS,0.45972,0.001509,-0.02794,0,0
6,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.9113,0.001507,0.016685,0,0
6,GO AUTOPHAGY OF MITOCHONDRION,0.71693,0.0014957,0.029742,0,0
6,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.6312,0.001455,-0.033254,0,0
6,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.94993,0.0012914,-0.019465,0,0
6,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.72907,0.001274,0.048783,0,0
6,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.62545,0.0012401,0.029186,0,0
6,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.88565,0.0011577,0.016533,0,0
6,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.82842,0.0010784,0.011764,0,0
6,GO POSITIVE REGULATION OF TRANSLATION,0.47211,0.0010434,-0.021617,0,0
6,GO REGULATION OF HEART RATE,0.70486,0.0008729,0.031323,0,0
6,GO MANGANESE ION TRANSPORT,0.94026,0.0007697,0.0003835,0,0
6,GO RRNA METHYLATION,0.3871,0.00067845,-0.054952,0,0
6,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.72299,0.00067126,0.023398,0,0
6,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.51819,0.00047637,0.051769,0,0
6,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.53672,0.00043675,-0.026286,0,0
6,GO FATTY ACID TRANSPORT,0.66028,0.00036686,-0.0072134,0,0
6,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.70486,0.00025288,-0.030622,0,0
6,GO PROTEIN N LINKED GLYCOSYLATION,0.44994,0.00011993,-0.026079,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.77519,7.9621e-05,0.0038752,0,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.47712,7.7888e-05,0.041833,0,0
6,GO SLEEP,0.73822,3.4808e-05,0.02237,0,0
6,GO ADAPTIVE IMMUNE RESPONSE,0.36311,-5.213e-06,-0.057733,0,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.84424,-3.555e-05,-0.002158,0,0
6,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.76899,-8.0967e-05,-0.00082803,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.87606,-9.7686e-05,0.018346,0,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.54746,-0.00010654,0.035615,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,1,-0.00011179,-4.501e-05,0,0
6,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.52609,-0.00031959,0.060018,0,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.80326,-0.00033529,-0.010588,0,0
6,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.51035,-0.00038586,0.035435,0,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.67501,-0.00041084,0.027469,0,0
6,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.66321,-0.00060502,-0.016595,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.82211,-0.00072287,0.0035281,0,0
6,GO REGULATION OF TRANSLATIONAL FIDELITY,0.38488,-0.00074868,-0.061188,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.87926,-0.00076553,0.0076997,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.5394,-0.00077483,-0.047509,0,0
6,GO REGULATION OF MITOCHONDRIAL FUSION,0.58307,-0.00082756,-0.028884,0,0
6,GO TOXIN TRANSPORT,0.25753,-0.00095959,0.061379,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.95316,-0.0010812,0.025851,0,0
6,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.93382,-0.0011756,0.00091524,0,0
6,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.44028,-0.0012221,0.056745,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.77519,-0.0012403,-0.019753,0,0
6,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.40286,-0.001293,-0.04572,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.25414,-0.0013416,-0.077692,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.74435,-0.0013973,0.012578,0,0
6,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.45238,-0.0014566,-0.019788,0,0
6,GO HYALURONAN METABOLIC PROCESS,0.72907,-0.0015495,-0.011703,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.74128,-0.0015851,-0.0089886,0,0
6,GO ALCOHOL CATABOLIC PROCESS,0.41203,-0.0015938,0.058105,0,0
6,GO PROTEIN HETEROOLIGOMERIZATION,0.66616,-0.001618,0.024241,0,0
6,GO REGULATION OF LIGASE ACTIVITY,0.82526,-0.001696,0.017825,0,0
6,GO REGULATION OF AMYLOID BETA CLEARANCE,0.67206,-0.0017709,0.019983,0,0
6,GO REGULATION OF PHAGOCYTOSIS,0.84741,-0.0018197,0.0093475,0,0
6,GO RESPONSE TO ANGIOTENSIN,0.63986,-0.0020069,-0.022323,0,0
6,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.93704,-0.0021047,0.025125,0,0
6,GO KETONE BODY METABOLIC PROCESS,0.95639,-0.0021806,-0.0015166,0,0
6,GO ER NUCLEUS SIGNALING PATHWAY,0.90167,-0.0023708,0.010218,0,0
6,GO HYALURONAN BIOSYNTHETIC PROCESS,0.90167,-0.0024859,0.018467,0,0
6,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.32592,-0.0025644,-0.059423,0,0
6,GO ENDODERM FORMATION,0.93704,-0.0025849,-0.0059183,0,0
6,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.47211,-0.0026948,0.038174,0,0
6,GO MAINTENANCE OF LOCATION IN CELL,0.91451,-0.0027276,0.017013,0,0
6,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.5583,-0.0027299,-0.030901,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.77829,-0.0027989,0.00044381,0,0
6,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.41434,-0.0028417,-0.016104,0,0
6,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.80953,-0.0028552,-0.016238,0,0
6,GO ZYMOGEN INHIBITION,0.87606,-0.0030469,-0.03194,0,0
6,GO GPI ANCHOR METABOLIC PROCESS,0.81581,-0.0030717,0.0082852,0,0
6,GO NECROTIC CELL DEATH,0.46466,-0.003165,-0.039865,0,0
6,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.68689,-0.0032461,-0.019788,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.70185,-0.0032479,-0.015705,0,0
6,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.69885,-0.0033074,0.031821,0,0
6,GO AMYLOID BETA FORMATION,0.60268,-0.0033951,0.050164,0,0
6,GO CELLULAR AMIDE METABOLIC PROCESS,0.43789,-0.003474,-0.022278,0,0
6,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.67501,-0.0036599,-0.018322,0,0
6,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.79075,-0.0036702,-0.010853,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.8379,-0.0038737,0.010026,0,0
6,GO PEROXISOME ORGANIZATION,0.3871,-0.0039455,-0.034741,0,0
6,GO VIRAL BUDDING,0.77519,-0.0039851,0.026505,0,0
6,GO ORGANIC ACID CATABOLIC PROCESS,0.67798,-0.0040151,0.019449,0,0
6,GO LEUKOCYTE HOMEOSTASIS,0.53672,-0.0040353,-0.013567,0,0
6,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.54746,-0.0041704,-0.059609,0,0
6,GO RESPONSE TO CORTICOSTERONE,0.99838,-0.0041734,0.015021,0,0
6,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.41434,-0.0042059,0.060119,0,0
6,GO TRNA PROCESSING,0.49231,-0.0042692,-0.040061,0,0
6,GO RESPONSE TO IMMOBILIZATION STRESS,0.84741,-0.0042983,-0.009248,0,0
6,GO NUCLEOTIDE TRANSPORT,0.69286,-0.0043882,-0.0048832,0,0
6,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.54746,-0.0044849,0.039045,0,0
6,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.54477,-0.0045466,0.054718,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.85694,-0.004615,0.019955,0,0
6,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.94348,-0.0047017,0.0040945,0,0
6,GO POSITIVE REGULATION OF HAIR CYCLE,0.94026,-0.0047072,-0.002764,0,0
6,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.67501,-0.0047097,-0.011947,0,0
6,GO KETONE BIOSYNTHETIC PROCESS,0.96284,-0.0047282,-0.0052294,0,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.90167,-0.0047339,-0.0012571,0,0
6,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.94993,-0.0047847,0.01844,0,0
6,GO LEUKOCYTE CELL CELL ADHESION,0.86331,-0.0048117,-0.012757,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.52345,-0.0048478,-0.031722,0,0
6,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.84741,-0.0048515,0.010403,0,0
6,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.79387,-0.0050119,-0.0028736,0,0
6,GO LYMPHOCYTE MEDIATED IMMUNITY,0.55558,-0.0052325,-0.042668,0,0
6,GO HEXOSE CATABOLIC PROCESS,0.95316,-0.0052723,0.0061599,0,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.86649,-0.0053775,-0.010997,0,0
6,GO ZINC ION TRANSPORT,0.89846,-0.0053971,0.018436,0,0
6,GO INFLAMMATORY RESPONSE,0.5583,-0.0056336,-0.019776,0,0
6,GO TISSUE REMODELING,0.94026,-0.0056593,0.0029251,0,0
6,GO PEPTIDYL ARGININE MODIFICATION,0.88885,-0.0056646,0.021324,0,0
6,GO REGULATION OF RECEPTOR BINDING,0.82842,-0.0057075,0.047708,0,0
6,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.79387,-0.0057557,0.0019455,0,0
6,GO BASEMENT MEMBRANE ASSEMBLY,0.72299,-0.0057771,0.044726,0,0
6,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.32792,-0.0058016,-0.047813,0,0
6,GO MITOCHONDRIAL TRANSPORT,0.74741,-0.0058321,0.017384,0,0
6,GO CYTOKINE PRODUCTION,0.67206,-0.0059853,-0.019968,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.82526,-0.0060181,0.01868,0,0
6,GO RESPONSE TO FLUID SHEAR STRESS,0.71089,-0.0060364,0.035487,0,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.42133,-0.0060521,0.046421,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,1,-0.0060722,-0.0039064,0,0
6,GO RRNA MODIFICATION,0.19697,-0.006082,-0.086952,0,0
6,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.67501,-0.0061057,0.03455,0,0
6,GO LYMPHOCYTE CHEMOTAXIS,0.93382,-0.0061566,-0.0037181,0,0
6,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.81581,-0.0061899,0.0058412,0,0
6,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.72603,-0.0062764,0.033465,0,0
6,GO SMOOTH MUSCLE CELL PROLIFERATION,0.69286,-0.006297,-0.0042461,0,0
6,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.84424,-0.0063005,0.020497,0,0
6,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.96284,-0.0063016,0.010213,0,0
6,GO BONE RESORPTION,0.47712,-0.006434,-0.035051,0,0
6,GO INTERLEUKIN 6 PRODUCTION,0.94993,-0.0064409,0.0083609,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.82526,-0.0064708,0.01393,0,0
6,GO TRANSITION METAL ION TRANSPORT,0.82526,-0.0064972,0.0035009,0,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.88565,-0.0065403,0.0028786,0,0
6,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.7659,-0.0065649,-0.032841,0,0
6,GO LYMPH NODE DEVELOPMENT,0.95639,-0.006769,0.017077,0,0
6,GO PROTEIN K11 LINKED UBIQUITINATION,0.86968,-0.0067809,0.0004355,0,0
6,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.59144,-0.0068146,-0.035572,0,0
6,GO VESICLE CARGO LOADING,0.82211,-0.0068263,0.01282,0,0
6,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.14419,-0.0068509,-0.075914,0,0
6,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.34835,-0.0068758,0.070218,0,0
6,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.5394,-0.0071358,0.047776,0,0
6,GO ANIMAL ORGAN REGENERATION,0.74128,-0.0071479,0.020891,0,0
6,GO PEPTIDE BIOSYNTHETIC PROCESS,0.34835,-0.0071966,-0.03927,0,0
6,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.85059,-0.0072107,-0.02616,0,0
6,GO KERATINOCYTE DIFFERENTIATION,0.68988,-0.0073349,0.013428,0,0
6,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.1754,-0.0074315,-0.096378,0,0
6,GO RESPONSE TO HYPEROXIA,0.34213,-0.0074511,0.075012,0,0
6,GO RESPONSE TO INTERLEUKIN 18,0.67206,-0.0075456,-0.061428,0,0
6,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.572,-0.0076891,-0.038589,0,0
6,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.74741,-0.0077285,-0.028893,0,0
6,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.95639,-0.007764,0.011741,0,0
6,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.81267,-0.0077883,-0.010122,0,0
6,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.65734,-0.0078088,0.038023,0,0
6,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.46713,-0.0078994,-0.050789,0,0
6,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.84107,-0.0080298,0.024424,0,0
6,GO DOPAMINE BIOSYNTHETIC PROCESS,0.73822,-0.0080548,0.042805,0,0
6,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.46218,-0.0080765,-0.078678,0,0
6,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.6515,-0.0080892,-0.018239,0,0
6,GO PARAXIAL MESODERM MORPHOGENESIS,0.59986,-0.0083108,0.05708,0,0
6,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.8379,-0.0083825,-0.010191,0,0
6,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.86331,-0.0084359,-0.016167,0,0
6,GO ORGANIC ACID METABOLIC PROCESS,0.99838,-0.0084401,0.0090816,0,0
6,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.82526,-0.0084414,-0.01099,0,0
6,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.79075,-0.0084938,-0.002356,0,0
6,GO ACTIN NUCLEATION,0.50776,-0.0085441,-0.016566,0,0
6,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.86968,-0.0085463,0.017599,0,0
6,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.40286,-0.0086352,0.069383,0,0
6,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.31997,-0.0086352,0.048189,0,0
6,GO REGULATION OF STEROL TRANSPORT,0.70185,-0.0086436,-0.018795,0,0
6,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.89526,-0.0086559,0.0056252,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.73517,-0.0087616,0.018108,0,0
6,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.6691,-0.0088344,-0.0094719,0,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.6055,-0.0088373,0.036627,0,0
6,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.46713,-0.0088773,0.064572,0,0
6,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.57476,-0.00892,-0.048806,0,0
6,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.72299,-0.0089216,-0.020062,0,0
6,GO GTP METABOLIC PROCESS,0.62258,-0.0089891,-0.022583,0,0
6,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.797,-0.0091498,0.026792,0,0
6,GO IMMUNOLOGICAL MEMORY PROCESS,0.93704,-0.0091651,0.0012665,0,0
6,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.64567,-0.0092076,-0.015387,0,0
6,GO NEUTROPHIL HOMEOSTASIS,0.78451,-0.009288,-0.035884,0,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.28033,-0.0092987,-0.033767,0,0
6,GO COENZYME A BIOSYNTHETIC PROCESS,0.99515,-0.0093874,0.020053,0,0
6,GO CARDIAC MUSCLE CELL CONTRACTION,0.75356,-0.0094743,0.041388,0,0
6,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.41666,-0.0094831,-0.017713,0,0
6,GO TRANSFERRIN TRANSPORT,0.71391,-0.0094842,-0.0038661,0,0
6,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.59986,-0.009633,0.040074,0,0
6,GO MITOCHONDRIAL PROTEIN PROCESSING,0.7659,-0.0096639,-0.02134,0,0
6,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.70185,-0.0096727,-0.03005,0,0
6,GO SYNCYTIUM FORMATION,0.95639,-0.0097156,0.013383,0,0
6,GO PEPTIDE METABOLIC PROCESS,0.26267,-0.0097201,-0.035485,0,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.572,-0.0097433,-0.014485,0,0
6,GO PHAGOCYTOSIS,0.42367,-0.0098263,-0.022146,0,0
6,GO LEUKOCYTE APOPTOTIC PROCESS,0.6055,-0.0098411,-0.024942,0,0
6,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.42838,-0.0099352,0.072514,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.6691,-0.0099494,-0.012585,0,0
6,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.84741,-0.010033,-0.014736,0,0
6,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.68988,-0.010056,-0.026566,0,0
6,GO CELLULAR RESPONSE TO DSRNA,0.61117,-0.010073,-0.031233,0,0
6,GO AMINE CATABOLIC PROCESS,0.65734,-0.010142,-0.039415,0,0
6,GO LEUKOCYTE PROLIFERATION,0.65442,-0.010178,-0.019526,0,0
6,GO REGULATION OF DNA CATABOLIC PROCESS,0.71391,-0.010247,0.027862,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.093918,-0.010494,-0.12137,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.86968,-0.010526,0.02169,0,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.26267,-0.010588,-0.040065,0,0
6,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.4451,-0.010739,-0.02437,0,0
6,GO RESPONSE TO CAMP,0.63408,-0.010988,0.036331,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.56103,-0.01106,-0.020915,0,0
6,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.24911,-0.011079,-0.037331,0,0
6,GO RESPONSE TO FUNGUS,0.96284,-0.01108,0.022233,0,0
6,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.80326,-0.011088,0.0021258,0,0
6,GO REGULATION OF VIRAL LIFE CYCLE,0.77519,-0.011263,-0.025681,0,0
6,GO LYMPHOCYTE MIGRATION,0.68988,-0.011272,-0.0075371,0,0
6,GO BONE REMODELING,0.89526,-0.011297,0.013426,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.75048,-0.0114,0.047775,0,0
6,GO REGULATION OF PH,0.72907,-0.011472,0.021759,0,0
6,GO ACUTE PHASE RESPONSE,0.67206,-0.011476,-0.022334,0,0
6,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.49487,-0.011557,-0.010264,0,0
6,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.6055,-0.011582,-0.02361,0,0
6,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.3442,-0.011694,-0.039806,0,0
6,GO TRICARBOXYLIC ACID CYCLE,0.15802,-0.011766,-0.081037,0,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.62545,-0.011879,-0.0076337,0,0
6,GO REGULATION OF IMMUNE RESPONSE,0.54477,-0.011911,-0.022856,0,0
6,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.91451,-0.011969,0.0073823,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.72299,-0.011996,0.0088697,0,0
6,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.65734,-0.012088,-0.023579,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.79387,-0.012134,0.0062559,0,0
6,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.68094,-0.012184,0.024867,0,0
6,GO PROTEIN DEGLYCOSYLATION,0.84424,-0.01243,-0.014443,0,0
6,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.96284,-0.012509,0.010877,0,0
6,GO RESPONSE TO ISCHEMIA,0.70486,-0.012517,0.034174,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.81581,-0.012533,0.049036,0,0
6,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.24745,-0.012586,-0.067501,0,0
6,GO MUSCLE FILAMENT SLIDING,0.61402,-0.012638,0.031507,0,0
6,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.94993,-0.012734,0.033392,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.48722,-0.012768,-0.029755,0,0
6,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.61687,-0.012813,-0.013762,0,0
6,GO LONG CHAIN FATTY ACID TRANSPORT,0.5665,-0.012914,-0.011404,0,0
6,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.61402,-0.013192,-0.043079,0,0
6,GO RENAL SODIUM EXCRETION,0.59424,-0.013306,0.045917,0,0
6,GO PEPTIDE CATABOLIC PROCESS,0.49743,-0.013351,-0.02518,0,0
6,GO PROTEIN MATURATION,1,-0.013471,0.0094959,0,0
6,GO CYTOPLASMIC TRANSLATION,0.37608,-0.013596,-0.072199,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.29502,-0.013619,-0.080029,0,0
6,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.51035,-0.013669,-0.034376,0,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.61687,-0.01372,0.034875,0,0
6,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.54477,-0.013745,-0.010154,0,0
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.47963,-0.013747,-0.029434,0,0
6,GO ANTIMICROBIAL HUMORAL RESPONSE,0.42133,-0.013819,-0.038116,0,0
6,GO NUCLEOSIDE SALVAGE,0.57752,-0.013948,-0.019901,0,0
6,GO MOVEMENT IN HOST ENVIRONMENT,0.40514,-0.014043,-0.047947,0,0
6,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.37827,-0.014051,-0.05107,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.88885,-0.014103,0.018295,0,0
6,GO LEUKOTRIENE METABOLIC PROCESS,0.65442,-0.014155,-0.02242,0,0
6,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.74128,-0.014165,-0.01607,0,0
6,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.4451,-0.014184,0.03699,0,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.19557,-0.014208,-0.082525,0,0
6,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.98222,-0.014311,0.0070369,0,0
6,GO REGULATION OF PLATELET ACTIVATION,0.75664,-0.014372,-0.016562,0,0
6,GO MIDBODY ABSCISSION,0.99515,-0.014394,0.020353,0,0
6,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.98222,-0.014414,-0.0062574,0,0
6,GO CERAMIDE BIOSYNTHETIC PROCESS,0.44994,-0.014438,0.043876,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.50516,-0.014512,-0.040682,0,0
6,GO CGMP MEDIATED SIGNALING,0.68988,-0.01452,0.029439,0,0
6,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.43312,-0.014534,-0.034831,0,0
6,GO ENDOTHELIAL CELL MIGRATION,0.95639,-0.014569,0.021393,0,0
6,GO MYOBLAST FUSION,0.46962,-0.014624,-0.030609,0,0
6,GO REGULATION OF MESODERM DEVELOPMENT,0.90809,-0.014639,0.013152,0,0
6,GO RESPONSE TO TOXIC SUBSTANCE,0.67798,-0.014656,0.026786,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.69885,-0.014769,0.0087748,0,0
6,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.73212,-0.014803,-0.026591,0,0
6,GO PROTEIN PROCESSING,0.64567,-0.014842,-0.0065055,0,0
6,GO CARDIOLIPIN METABOLIC PROCESS,0.17411,-0.014866,-0.070787,0,0
6,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.92738,-0.014942,0.0043771,0,0
6,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.63697,-0.015048,-0.023978,0,0
6,GO VESICLE BUDDING FROM MEMBRANE,0.59705,-0.015182,-0.014096,0,0
6,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.082591,-0.0152,-0.092114,0,0
6,GO MITOTIC CYTOKINETIC PROCESS,0.84424,-0.01532,0.021876,0,0
6,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.68094,-0.015345,-0.01872,0,0
6,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.79387,-0.015413,0.01134,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.77209,-0.015429,-0.0078571,0,0
6,GO GAP JUNCTION ASSEMBLY,0.80326,-0.01552,-0.0064333,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.76899,-0.015565,-0.011928,0,0
6,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.49487,-0.015707,0.04655,0,0
6,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.54208,-0.015845,-0.025547,0,0
6,GO MACROPHAGE ACTIVATION,0.53406,-0.015918,-0.019072,0,0
6,GO RESPONSE TO DEXAMETHASONE,0.7814,-0.015921,-0.010468,0,0
6,GO TRANSLATIONAL INITIATION,0.22658,-0.016045,-0.084464,0,0
6,GO OXIDATION REDUCTION PROCESS,0.59705,-0.016086,-0.012847,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.81896,-0.016248,0.024369,0,0
6,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.1387,-0.01625,-0.10891,0,0
6,GO REGULATION OF RESPONSE TO WOUNDING,0.57752,-0.016297,0.042949,0,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.98869,-0.016302,0.0068797,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.95316,-0.016336,0.0076107,0,0
6,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.37827,-0.01643,-0.047758,0,0
6,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.87287,-0.016481,-0.018045,0,0
6,GO REGULATION OF MULTI ORGANISM PROCESS,0.50258,-0.016558,-0.018321,0,0
6,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.80639,-0.016569,0.0039987,0,0
6,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.38267,-0.016626,-0.046572,0,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.4355,-0.01665,-0.012744,0,0
6,GO PINOCYTOSIS,0.71996,-0.016666,-0.019232,0,0
6,GO REGULATION OF CELLULAR RESPIRATION,0.95316,-0.01674,-0.0037984,0,0
6,GO ADRENAL GLAND DEVELOPMENT,0.77829,-0.016857,0.038863,0,0
6,GO RESPONSE TO AMPHETAMINE,0.8379,-0.01686,0.018605,0,0
6,GO MONOSACCHARIDE CATABOLIC PROCESS,0.82842,-0.016994,-0.0017264,0,0
6,GO BLASTOCYST FORMATION,0.54208,-0.017034,-0.0052101,0,0
6,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.96284,-0.017168,-0.0028975,0,0
6,GO TRNA WOBBLE URIDINE MODIFICATION,0.80639,-0.017224,-0.018204,0,0
6,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.5314,-0.017266,-0.055129,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.45972,-0.017398,-0.024381,0,0
6,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.27853,-0.017607,-0.034356,0,0
6,GO CD40 SIGNALING PATHWAY,0.14419,-0.017769,-0.091323,0,0
6,GO POSITIVE REGULATION OF LIPID STORAGE,0.51819,-0.017809,-0.012441,0,0
6,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.92416,-0.017891,0.0087592,0,0
6,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.66028,-0.017891,-0.017446,0,0
6,GO ENTRY INTO HOST,0.34213,-0.017898,-0.065476,0,0
6,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.40058,-0.017973,-0.015271,0,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.73822,-0.017995,0.044476,0,0
6,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.54477,-0.018053,0.026823,0,0
6,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.94026,-0.018301,0.0205,0,0
6,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.80326,-0.018334,0.026979,0,0
6,GO REGULATION OF ODONTOGENESIS,0.98869,-0.018657,-0.014833,0,0
6,GO PROTEIN O LINKED GLYCOSYLATION,0.55016,-0.018697,-0.027753,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.87926,-0.018761,0.0050427,0,0
6,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.24089,-0.018784,-0.046199,0,0
6,GO MITOCHONDRIAL RNA PROCESSING,0.24089,-0.018821,-0.10297,0,0
6,GO T HELPER CELL LINEAGE COMMITMENT,0.51035,-0.018828,-0.018266,0,0
6,GO COLLAGEN BIOSYNTHETIC PROCESS,0.56376,-0.018881,-0.050401,0,0
6,GO STEROID ESTERIFICATION,0.5394,-0.018898,-0.06231,0,0
6,GO NAD BIOSYNTHETIC PROCESS,0.82211,-0.018933,-0.018113,0,0
6,GO MODIFIED AMINO ACID TRANSPORT,0.5394,-0.018974,0.0049967,0,0
6,GO CELLULAR HORMONE METABOLIC PROCESS,0.97576,-0.019044,0.0012461,0,0
6,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.69586,-0.019053,-0.0097949,0,0
6,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.27673,-0.019065,-0.05633,0,0
6,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.32195,-0.019072,-0.058311,0,0
6,GO T HELPER 1 CELL DIFFERENTIATION,0.76899,-0.019239,-0.069643,0,0
6,GO MACROPHAGE CHEMOTAXIS,0.51557,-0.019396,-0.032711,0,0
6,GO GLYCOPROTEIN CATABOLIC PROCESS,0.34008,-0.019491,-0.07186,0,0
6,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.72603,-0.019581,-0.027773,0,0
6,GO SELECTIVE AUTOPHAGY,0.9306,-0.019592,0.0056622,0,0
6,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.72907,-0.019594,0.036146,0,0
6,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.62832,-0.019622,-0.0096948,0,0
6,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.22814,-0.019627,-0.040365,0,0
6,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.45727,-0.019719,-0.045854,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.98222,-0.019772,-0.0044644,0,0
6,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.81581,-0.020118,0.02611,0,0
6,GO CHOLESTEROL EFFLUX,0.61402,-0.020191,0.036243,0,0
6,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.98222,-0.020258,0.013792,0,0
6,GO RESPONSE TO THYROID HORMONE,0.797,-0.020373,-0.01269,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.70486,-0.020516,-0.017744,0,0
6,GO ATP BIOSYNTHETIC PROCESS,0.47461,-0.020628,-0.031196,0,0
6,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.28945,-0.020647,-0.068537,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.23927,-0.020798,-0.060003,0,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.59424,-0.020807,-0.045699,0,0
6,GO POSITIVE REGULATION OF ERAD PATHWAY,0.4451,-0.020888,-0.027481,0,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.39606,-0.020911,-0.05542,0,0
6,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.94026,-0.021035,-0.0054834,0,0
6,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.46962,-0.021092,-0.021674,0,0
6,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.98546,-0.021092,0.016976,0,0
6,GO ATP TRANSPORT,0.87926,-0.021096,0.027333,0,0
6,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.49743,-0.021175,-0.025557,0,0
6,GO AMYLOID BETA METABOLIC PROCESS,0.87606,-0.02171,0.014425,0,0
6,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.70185,-0.021759,-0.0017137,0,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.77829,-0.021812,-0.023379,0,0
6,GO PEPTIDYL ARGININE METHYLATION,0.67206,-0.021984,-0.019836,0,0
6,GO CELL JUNCTION DISASSEMBLY,0.54746,-0.022077,-0.029793,0,0
6,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.73822,-0.022082,-0.027856,0,0
6,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.63697,-0.022169,0.039035,0,0
6,GO REGULATION OF PROTON TRANSPORT,0.83158,-0.022188,0.004233,0,0
6,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.61402,-0.022227,-0.024391,0,0
6,GO REGULATION OF NECROTIC CELL DEATH,0.5314,-0.022394,-0.027999,0,0
6,GO DECIDUALIZATION,0.98222,-0.022422,0.0055831,0,0
6,GO LYMPHOCYTE APOPTOTIC PROCESS,0.2644,-0.022591,-0.052794,0,0
6,GO T CELL PROLIFERATION,0.55016,-0.022639,-0.029082,0,0
6,GO REGULATION OF GASTRULATION,0.81896,-0.022761,0.014933,0,0
6,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.94348,-0.022906,-0.0044992,0,0
6,GO QUINONE METABOLIC PROCESS,0.88245,-0.022991,0.014529,0,0
6,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.8379,-0.023034,-0.023566,0,0
6,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.44994,-0.023045,-0.05025,0,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.75664,-0.023074,-0.024153,0,0
6,GO REGULATION OF ACROSOME REACTION,0.92416,-0.023113,0.00673,0,0
6,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.90167,-0.023193,0.021264,0,0
6,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.88885,-0.023269,0.025807,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.73517,-0.023295,-0.016449,0,0
6,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.43789,-0.023343,-0.031557,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.86649,-0.023367,0.0048579,0,0
6,GO VITAMIN METABOLIC PROCESS,0.33803,-0.023496,-0.021025,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.31021,-0.02351,-0.081085,0,0
6,GO REGULATION OF LYMPHOCYTE MIGRATION,0.68392,-0.02353,-0.010499,0,0
6,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.94348,-0.023543,-1.3971e-05,0,0
6,GO SULFATE TRANSPORT,0.94671,-0.023567,0.011963,0,0
6,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.50516,-0.023585,-0.046431,0,0
6,GO REGULATION OF SYMBIOTIC PROCESS,0.82842,-0.023713,-0.018843,0,0
6,GO REGULATION OF EXCRETION,0.79387,-0.023837,0.026965,0,0
6,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.3739,-0.023925,-0.04087,0,0
6,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.67501,-0.023934,-0.031785,0,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.88885,-0.023977,-0.0047798,0,0
6,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.61687,-0.023992,-0.021661,0,0
6,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.2714,-0.024001,-0.13156,0,0
6,GO REGULATION OF CELLULAR PH,0.80012,-0.024069,0.0043876,0,0
6,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.65734,-0.024148,-0.02394,0,0
6,GO REGULATION OF ACTIN NUCLEATION,0.5665,-0.024351,-0.017734,0,0
6,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.8379,-0.02476,0.018433,0,0
6,GO MEMBRANE PROTEIN PROTEOLYSIS,0.68094,-0.024849,-0.021492,0,0
6,GO ALPHA AMINO ACID METABOLIC PROCESS,0.96607,-0.02506,0.0026156,0,0
6,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.94671,-0.025066,0.0092672,0,0
6,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.71693,-0.025075,0.00029323,0,0
6,GO TYPE I INTERFERON PRODUCTION,0.48976,-0.025324,-0.023569,0,0
6,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.50516,-0.025361,-0.032471,0,0
6,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.37827,-0.025418,-0.047449,0,0
6,GO HEART INDUCTION,0.82526,-0.025499,-0.0069414,0,0
6,GO PEROXISOMAL TRANSPORT,0.28578,-0.025513,-0.042147,0,0
6,GO SULFUR COMPOUND METABOLIC PROCESS,0.31215,-0.025555,-0.027396,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.54746,-0.025614,-0.022512,0,0
6,GO ACUTE INFLAMMATORY RESPONSE,0.4451,-0.026041,-0.038129,0,0
6,GO RESPONSE TO ACIDIC PH,0.45238,-0.026159,-0.040285,0,0
6,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.75972,-0.026569,-0.00047718,0,0
6,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.89526,-0.026602,0.027349,0,0
6,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.96607,-0.026741,0.017637,0,0
6,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.40743,-0.026742,-0.041276,0,0
6,GO AMINOGLYCAN CATABOLIC PROCESS,0.85059,-0.026887,-0.0025629,0,0
6,GO CRISTAE FORMATION,0.20554,-0.026986,-0.06633,0,0
6,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.5665,-0.027184,-0.016333,0,0
6,GO INTERACTION WITH SYMBIONT,0.47211,-0.027206,-0.030321,0,0
6,GO APOPTOTIC CELL CLEARANCE,0.6055,-0.027301,-0.038845,0,0
6,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.66028,-0.027441,-0.02412,0,0
6,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.44028,-0.02751,-0.049416,0,0
6,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.61972,-0.027642,-0.037858,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.64276,-0.027689,-0.016115,0,0
6,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.58307,-0.02778,-0.0047667,0,0
6,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.10385,-0.027801,-0.10294,0,0
6,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.21437,-0.027805,-0.02686,0,0
6,GO REGULATION OF INNATE IMMUNE RESPONSE,0.51557,-0.027902,-0.027203,0,0
6,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.80326,-0.028096,0.033325,0,0
6,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.88885,-0.028152,-0.014924,0,0
6,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.68689,-0.028229,0.027566,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.65734,-0.028245,-0.018349,0,0
6,GO PEROXISOMAL MEMBRANE TRANSPORT,0.92738,-0.02828,0.017884,0,0
6,GO LEUKOCYTE MEDIATED IMMUNITY,0.17669,-0.028302,-0.064843,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.86331,-0.028311,-0.0074802,0,0
6,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.98546,-0.02844,0.011448,0,0
6,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.20265,-0.028741,-0.059469,0,0
6,GO RIG I SIGNALING PATHWAY,0.28033,-0.028798,-0.057543,0,0
6,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.17669,-0.029043,-0.04002,0,0
6,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.88885,-0.029097,0.018798,0,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.33803,-0.02913,-0.0409,0,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.21889,-0.029168,-0.062488,0,0
6,GO T CELL CYTOKINE PRODUCTION,0.28395,-0.029242,-0.060627,0,0
6,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.23927,-0.029276,-0.029724,0,0
6,GO AUTOPHAGOSOME MATURATION,0.53672,-0.0293,-0.012734,0,0
6,GO AMYLOID BETA CLEARANCE,0.79075,-0.029306,-0.017597,0,0
6,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.318,-0.029472,-0.036004,0,0
6,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.16285,-0.029647,-0.071221,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.47963,-0.029797,-0.026162,0,0
6,GO IMMUNE EFFECTOR PROCESS,0.33803,-0.029833,-0.039088,0,0
6,GO RETINOL METABOLIC PROCESS,0.42133,-0.03004,-0.051141,0,0
6,GO ENDODERMAL CELL FATE COMMITMENT,0.54208,-0.030066,-0.014061,0,0
6,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.074349,-0.030154,-0.11271,0,0
6,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.18595,-0.030169,-0.075689,0,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.073694,-0.030189,-0.08071,0,0
6,GO BIOLOGICAL PHASE,0.80639,-0.030497,0.013842,0,0
6,GO REGULATION OF VESICLE FUSION,0.77519,-0.030635,-0.011176,0,0
6,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.18866,-0.030925,-0.13014,0,0
6,GO DEFENSE RESPONSE TO FUNGUS,0.27853,-0.030975,-0.047153,0,0
6,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.23766,-0.030993,-0.052238,0,0
6,GO CHAPERONE MEDIATED AUTOPHAGY,0.80326,-0.031085,-0.016128,0,0
6,GO CELLULAR RESPONSE TO LITHIUM ION,0.74128,-0.031157,0.037683,0,0
6,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.99192,-0.031354,0.0054548,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.40743,-0.031368,-0.049447,0,0
6,GO SEQUESTERING OF CALCIUM ION,0.86012,-0.031507,0.00661,0,0
6,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.75048,-0.031519,0.00067523,0,0
6,GO INNATE IMMUNE RESPONSE,0.37608,-0.031559,-0.047671,0,0
6,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.43789,-0.031684,-0.062977,0,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.24745,-0.03173,-0.047983,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.40058,-0.031792,-0.057279,0,0
6,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.14642,-0.031889,-0.074507,0,0
6,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.51035,-0.032114,-0.021012,0,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.42133,-0.032146,-0.038286,0,0
6,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.14755,-0.03218,-0.065716,0,0
6,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.25078,-0.032195,-0.031395,0,0
6,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.38488,-0.032337,-0.024818,0,0
6,GO REGULATION OF NEUTROPHIL MIGRATION,0.14983,-0.032526,-0.070389,0,0
6,GO TRANSITION METAL ION HOMEOSTASIS,0.37608,-0.032624,-0.021537,0,0
6,GO PH REDUCTION,0.7814,-0.032816,-0.0020166,0,0
6,GO FATTY ACID DERIVATIVE TRANSPORT,0.32592,-0.03311,-0.030546,0,0
6,GO CORNIFICATION,0.64567,-0.033143,-0.056005,0,0
6,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.23286,-0.033148,-0.056163,0,0
6,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.50516,-0.033176,0.1064,0,0
6,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.45238,-0.033207,-0.045784,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.97899,-0.033215,0.0145,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.74435,-0.033273,-0.0028951,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.95639,-0.033305,0.013296,0,0
6,GO CELL CHEMOTAXIS,0.66616,-0.033365,-0.0074452,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.20845,-0.033519,-0.074034,0,0
6,GO PROTEIN TARGETING TO MITOCHONDRION,0.13549,-0.033567,-0.054424,0,0
6,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.69885,-0.033575,0.015213,0,0
6,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.57752,-0.033631,-0.015753,0,0
6,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.40973,-0.033709,-0.044232,0,0
6,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.56376,-0.033746,-0.022821,0,0
6,GO RESPONSE TO HYDROPEROXIDE,0.90488,-0.03375,0.010582,0,0
6,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.93704,-0.033763,0.0048059,0,0
6,GO HEMOGLOBIN METABOLIC PROCESS,0.38047,-0.033772,-0.026555,0,0
6,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.93704,-0.033785,0.02696,0,0
6,GO CELL CELL RECOGNITION,0.19278,-0.033809,-0.03846,0,0
6,GO REGULATION OF MACROPHAGE MIGRATION,0.82842,-0.033868,0.0083101,0,0
6,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.38933,-0.0339,-0.038589,0,0
6,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.91772,-0.034173,0.02135,0,0
6,GO IMMUNOGLOBULIN SECRETION,0.35253,-0.034365,-0.049984,0,0
6,GO GASTRIC ACID SECRETION,0.80012,-0.034407,0.027306,0,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.24089,-0.034435,-0.063696,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.25246,-0.034443,-0.042936,0,0
6,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.33194,-0.034513,-0.024587,0,0
6,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.75356,-0.034517,-0.013014,0,0
6,GO REGULATION OF GASTRIC ACID SECRETION,0.83474,-0.034767,0.0058933,0,0
6,GO CHEMOKINE PRODUCTION,0.46466,-0.035007,-0.040628,0,0
6,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.41666,-0.035211,-0.044694,0,0
6,GO RESPONSE TO NITROSATIVE STRESS,0.9113,-0.035531,-0.01647,0,0
6,GO BASE EXCISION REPAIR AP SITE FORMATION,0.64858,-0.035547,-0.014422,0,0
6,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.77519,-0.035598,-0.020406,0,0
6,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.71089,-0.035784,-0.026699,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.12924,-0.035961,-0.11476,0,0
6,GO CELLULAR RESPONSE TO DRUG,0.50776,-0.036031,-0.0017061,0,0
6,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.49231,-0.036032,-0.059104,0,0
6,GO NEGATIVE REGULATION OF BONE REMODELING,0.75664,-0.036127,-0.018109,0,0
6,GO MYELOID LEUKOCYTE ACTIVATION,0.12322,-0.036138,-0.068473,0,0
6,GO MACROPHAGE MIGRATION,0.74435,-0.036178,-0.0019602,0,0
6,GO RESPONSE TO BACTERIUM,0.20265,-0.036224,-0.050816,0,0
6,GO LEUKOCYTE MIGRATION,0.64276,-0.036267,-0.010062,0,0
6,GO ACID SECRETION,0.31021,-0.036454,0.078397,0,0
6,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.32393,-0.036481,-0.049632,0,0
6,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.23927,-0.036483,-0.05725,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.72603,-0.036616,0.026315,0,0
6,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.41434,-0.036641,-0.046096,0,0
6,GO INTERLEUKIN 12 PRODUCTION,0.28578,-0.036791,-0.055701,0,0
6,GO ACTIVATION OF IMMUNE RESPONSE,0.30829,-0.036836,-0.034168,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.94026,-0.03688,-0.0021803,0,0
6,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.75048,-0.036911,-0.011113,0,0
6,GO RESPONSE TO XENOBIOTIC STIMULUS,0.12126,-0.036963,-0.067689,0,0
6,GO PURINE NUCLEOTIDE TRANSPORT,0.64858,-0.037104,-0.007841,0,0
6,GO REGULATION OF WOUND HEALING,0.78451,-0.037177,-0.0016269,0,0
6,GO ANTIBACTERIAL HUMORAL RESPONSE,0.85059,-0.037178,0.009931,0,0
6,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.17411,-0.037359,-0.080771,0,0
6,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.18194,-0.037389,-0.069569,0,0
6,GO REGULATION OF INFLAMMATORY RESPONSE,0.30066,-0.037486,-0.035131,0,0
6,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.73822,-0.037797,-0.01268,0,0
6,GO PROTEIN HYDROXYLATION,0.23445,-0.037844,-0.089753,0,0
6,GO COMPLEMENT ACTIVATION,0.1914,-0.038063,-0.091473,0,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.47712,-0.038161,-0.034024,0,0
6,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.34627,-0.038277,-0.10152,0,0
6,GO PEPTIDE CROSS LINKING,0.078382,-0.038297,-0.14396,0,0
6,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.89526,-0.038351,-0.0028153,0,0
6,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.75356,-0.038378,0.0010216,0,0
6,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.64858,-0.038434,-0.01499,0,0
6,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.61402,-0.038532,-0.021201,0,0
6,GO NEUTROPHIL MIGRATION,0.12126,-0.038575,-0.067264,0,0
6,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.38488,-0.038802,-0.03196,0,0
6,GO LEUKOCYTE CHEMOTAXIS,0.36741,-0.03881,-0.028195,0,0
6,GO FC RECEPTOR SIGNALING PATHWAY,0.95316,-0.038811,0.0052346,0,0
6,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.4355,-0.038854,-0.027683,0,0
6,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.92094,-0.038875,0.0038753,0,0
6,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.31997,-0.039011,-0.039423,0,0
6,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.27495,-0.03939,-0.084274,0,0
6,GO RESPONSE TO REDOX STATE,0.57476,-0.039401,-0.024267,0,0
6,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.80639,-0.039443,0.0024941,0,0
6,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.83474,-0.039477,0.0098181,0,0
6,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.19278,-0.03949,-0.038285,0,0
6,GO L SERINE METABOLIC PROCESS,0.83158,-0.039551,0.00601,0,0
6,GO T CELL APOPTOTIC PROCESS,0.45238,-0.03963,-0.042962,0,0
6,GO COENZYME A METABOLIC PROCESS,0.91772,-0.039737,0.026433,0,0
6,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.9306,-0.039796,-0.0018049,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.73212,-0.039991,-0.016938,0,0
6,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.67501,-0.04,-0.011679,0,0
6,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.55287,-0.040038,-0.016329,0,0
6,GO REGULATION OF MACROPHAGE ACTIVATION,0.52874,-0.040078,-0.030853,0,0
6,GO PROTON TRANSMEMBRANE TRANSPORT,0.4355,-0.040088,-0.014985,0,0
6,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.4355,-0.040214,-0.019548,0,0
6,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.572,-0.040366,-0.00045932,0,0
6,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.34835,-0.040369,-0.032905,0,0
6,GO EMBRYO IMPLANTATION,0.52345,-0.040401,-0.024597,0,0
6,GO METHIONINE METABOLIC PROCESS,0.75972,-0.040462,0.0033662,0,0
6,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.80639,-0.04047,-0.03162,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.36741,-0.040522,-0.065551,0,0
6,GO LINOLEIC ACID METABOLIC PROCESS,0.60834,-0.040607,-0.032105,0,0
6,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.6515,-0.04074,-0.019434,0,0
6,GO INTERLEUKIN 13 PRODUCTION,0.14088,-0.040747,-0.12442,0,0
6,GO REGULATION OF MAST CELL ACTIVATION,0.58585,-0.040865,-0.022031,0,0
6,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.61687,-0.040912,-0.0096092,0,0
6,GO PHOSPHATE ION TRANSPORT,0.49743,-0.041005,-0.0082762,0,0
6,GO MITOCHONDRIAL DEPOLARIZATION,0.40514,-0.041152,-0.046202,0,0
6,GO SENSORY PERCEPTION OF BITTER TASTE,0.42838,-0.04118,-0.050793,0,0
6,GO RESPONSE TO MAGNESIUM ION,0.37608,-0.041204,-0.065925,0,0
6,GO CELLULAR OXIDANT DETOXIFICATION,0.29689,-0.041445,-0.04299,0,0
6,GO ETHER BIOSYNTHETIC PROCESS,0.24911,-0.041569,-0.12765,0,0
6,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.93382,-0.041705,0.024821,0,0
6,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.55016,-0.041716,0.057571,0,0
6,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.69286,-0.041738,-0.022478,0,0
6,GO OSTEOCLAST DEVELOPMENT,0.26964,-0.042263,-0.045238,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.61972,-0.042444,-0.019834,0,0
6,GO REGULATION OF TOLERANCE INDUCTION,0.97899,-0.04259,-0.018127,0,0
6,GO RESPONSE TO CHEMOKINE,0.42602,-0.042627,-0.02492,0,0
6,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.11275,-0.042669,-0.080685,0,0
6,GO RESPONSE TO INTERLEUKIN 12,0.23128,-0.043041,-0.062276,0,0
6,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.38267,-0.043074,-0.054568,0,0
6,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.67798,-0.043074,-0.0085999,0,0
6,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.50776,-0.043289,-0.040872,0,0
6,GO RELAXATION OF MUSCLE,0.47461,-0.043322,-0.027324,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.25753,-0.043335,-0.065149,0,0
6,GO T CELL RECEPTOR SIGNALING PATHWAY,0.13763,-0.043427,-0.052068,0,0
6,GO COLLAGEN METABOLIC PROCESS,0.99838,-0.043492,0.0081995,0,0
6,GO RESPONSE TO GROWTH HORMONE,0.18327,-0.043518,-0.056792,0,0
6,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.5583,-0.043597,-0.025135,0,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.41434,-0.043907,-0.016224,0,0
6,GO ZINC ION HOMEOSTASIS,0.45482,-0.043976,-0.060597,0,0
6,GO CELLULAR RESPONSE TO CADMIUM ION,0.98222,-0.044268,-0.0062428,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.50776,-0.044344,-0.017946,0,0
6,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.6691,-0.044368,-0.032243,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.093918,-0.04442,-0.061487,0,0
6,GO REGULATION OF AMYLOID BETA FORMATION,0.93704,-0.044461,0.027761,0,0
6,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.23128,-0.044535,-0.057114,0,0
6,GO KERATINIZATION,0.83474,-0.044622,-0.031208,0,0
6,GO REGULATION OF MEMBRANE INVAGINATION,0.59144,-0.044767,-0.041517,0,0
6,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.86331,-0.044821,0.004651,0,0
6,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.51035,-0.044824,-0.010774,0,0
6,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.31409,-0.044871,-0.045971,0,0
6,GO PLATELET DEGRANULATION,0.25246,-0.044955,-0.061185,0,0
6,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.25924,-0.045003,-0.049214,0,0
6,GO DIOL BIOSYNTHETIC PROCESS,0.56103,-0.045079,-0.022648,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.10646,-0.045127,-0.094378,0,0
6,GO B CELL RECEPTOR SIGNALING PATHWAY,0.58307,-0.045221,-0.027825,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.23128,-0.045367,-0.089387,0,0
6,GO BILE ACID AND BILE SALT TRANSPORT,0.47712,-0.045465,-0.063761,0,0
6,GO RESPONSE TO INTERLEUKIN 1,0.14419,-0.045745,-0.056834,0,0
6,GO INTERLEUKIN 1 BETA PRODUCTION,0.54208,-0.045912,-0.032876,0,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.093126,-0.045932,-0.10207,0,0
6,GO ETHANOL CATABOLIC PROCESS,0.46713,-0.046228,-0.02961,0,0
6,GO AMINE METABOLIC PROCESS,0.27495,-0.046433,-0.035924,0,0
6,GO KILLING OF CELLS OF OTHER ORGANISM,0.74128,-0.046448,-0.0014593,0,0
6,GO AMINE BIOSYNTHETIC PROCESS,0.47712,-0.046626,-0.026759,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.31997,-0.046805,-0.049951,0,0
6,GO SNORNA METABOLIC PROCESS,0.63408,-0.046822,-0.033955,0,0
6,GO VIRION ASSEMBLY,0.50776,-0.046955,-0.012871,0,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.81581,-0.047134,0.022965,0,0
6,GO BLOOD VESSEL REMODELING,0.44994,-0.047146,-0.032246,0,0
6,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.57752,-0.04734,-0.029971,0,0
6,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.10129,-0.047374,-0.076155,0,0
6,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.37827,-0.047394,-0.088713,0,0
6,GO GLYCEROLIPID CATABOLIC PROCESS,0.75972,-0.047892,-0.011084,0,0
6,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.66321,-0.048135,-0.012561,0,0
6,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.84107,-0.048422,-0.0044455,0,0
6,GO RESPONSE TO MINERALOCORTICOID,0.61687,-0.048444,-0.01681,0,0
6,GO HEPATOCYTE APOPTOTIC PROCESS,0.70787,-0.048547,0.028991,0,0
6,GO HOMOCYSTEINE METABOLIC PROCESS,0.21437,-0.048802,-0.088338,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.37173,-0.048886,-0.046219,0,0
6,GO POLYAMINE BIOSYNTHETIC PROCESS,0.1754,-0.049369,-0.057314,0,0
6,GO MITOCHONDRIAL TRANSCRIPTION,0.23766,-0.049411,-0.067881,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.27495,-0.049499,-0.055586,0,0
6,GO REGULATION OF LEUKOCYTE MIGRATION,0.69885,-0.049564,-0.0063225,0,0
6,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.41434,-0.049587,-0.023682,0,0
6,GO BASEMENT MEMBRANE ORGANIZATION,0.72603,-0.049601,0.02517,0,0
6,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.39381,-0.049606,-0.017581,0,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.11742,-0.049669,-0.10951,0,0
6,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.24252,-0.050409,-0.04175,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.318,-0.050475,-0.022772,0,0
6,GO OXYGEN TRANSPORT,0.52345,-0.050515,-0.060174,0,0
6,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.41203,-0.050567,-0.024589,0,0
6,GO LYMPHOCYTE HOMEOSTASIS,0.32592,-0.050825,-0.027971,0,0
6,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.30637,-0.050986,-0.069337,0,0
6,GO MYELOID DENDRITIC CELL ACTIVATION,0.37173,-0.051112,-0.046001,0,0
6,GO NEUTROPHIL CHEMOTAXIS,0.095518,-0.051285,-0.062076,0,0
6,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.32993,-0.0515,-0.046746,0,0
6,GO SECRETION BY TISSUE,0.53672,-0.051516,-0.018482,0,0
6,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.19557,-0.051543,-0.068391,0,0
6,GO REGULATION OF RUFFLE ASSEMBLY,0.76899,-0.051583,0.0052892,0,0
6,GO REGULATION OF FERTILIZATION,0.70486,-0.05166,-0.0061104,0,0
6,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.6691,-0.051695,-0.0060334,0,0
6,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.1252,-0.052025,-0.064833,0,0
6,GO INTESTINAL ABSORPTION,0.3871,-0.052037,-0.058793,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.16285,-0.052079,-0.079527,0,0
6,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.28395,-0.052213,-0.081631,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.65734,-0.052222,-0.022538,0,0
6,GO SNORNA 3 END PROCESSING,0.56376,-0.052324,-0.044975,0,0
6,GO SKELETAL MUSCLE TISSUE REGENERATION,0.62545,-0.052612,-0.027756,0,0
6,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.42602,-0.052821,-0.027468,0,0
6,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.7814,-0.05296,-0.0081036,0,0
6,GO ICOSANOID METABOLIC PROCESS,0.14197,-0.053318,-0.08096,0,0
6,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.13763,-0.053421,-0.055087,0,0
6,GO REGULATION OF B CELL ACTIVATION,0.58029,-0.053461,-0.023281,0,0
6,GO FOLIC ACID METABOLIC PROCESS,0.28761,-0.05387,-0.040455,0,0
6,GO MYELOID LEUKOCYTE MIGRATION,0.178,-0.053956,-0.047282,0,0
6,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.32792,-0.054044,-0.034027,0,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.20409,-0.054053,-0.081377,0,0
6,GO DETOXIFICATION,0.2458,-0.054239,-0.039058,0,0
6,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.48722,-0.05445,-0.016597,0,0
6,GO DIOL METABOLIC PROCESS,0.74741,-0.054585,-0.0023111,0,0
6,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.079071,-0.054779,-0.081265,0,0
6,GO POLYAMINE METABOLIC PROCESS,0.23605,-0.054889,-0.032008,0,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.15683,-0.055042,-0.079811,0,0
6,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.33599,-0.055096,-0.052527,0,0
6,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.20699,-0.055342,-0.069422,0,0
6,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.40286,-0.055458,-0.031294,0,0
6,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.56376,-0.055611,-0.031408,0,0
6,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.072397,-0.055615,-0.075014,0,0
6,GO NADPH REGENERATION,0.13234,-0.055787,-0.087836,0,0
6,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.5583,-0.05607,-0.032745,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.72603,-0.056128,-0.043588,0,0
6,GO NEGATIVE REGULATION OF WOUND HEALING,0.55558,-0.056271,-0.035298,0,0
6,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.086981,-0.056387,-0.098414,0,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.35043,-0.056529,-0.045696,0,0
6,GO TETRAPYRROLE METABOLIC PROCESS,0.073694,-0.056594,-0.075353,0,0
6,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.1262,-0.056651,-0.062661,0,0
6,GO C21 STEROID HORMONE METABOLIC PROCESS,0.47963,-0.056668,-0.040057,0,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.44752,-0.05689,-0.032662,0,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.59144,-0.056951,0.0042591,0,0
6,GO RESPONSE TO INTERLEUKIN 7,0.09714,-0.057106,-0.06365,0,0
6,GO VAGINA DEVELOPMENT,0.97899,-0.057399,0.022989,0,0
6,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.10129,-0.057604,-0.098998,0,0
6,GO PROGESTERONE METABOLIC PROCESS,0.92094,-0.057651,-0.0036933,0,0
6,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.27673,-0.057725,-0.0239,0,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.43075,-0.057924,-0.020296,0,0
6,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.068619,-0.057933,-0.05908,0,0
6,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.2644,-0.057945,-0.075856,0,0
6,GO RESPONSE TO HYDROGEN PEROXIDE,0.19557,-0.058036,-0.031372,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.86968,-0.058089,0.11641,0,0
6,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.26267,-0.058144,-0.054757,0,0
6,GO STEROID CATABOLIC PROCESS,0.70787,-0.058324,-0.01644,0,0
6,GO THYMOCYTE APOPTOTIC PROCESS,0.37173,-0.058417,-0.062577,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59705,-0.058492,-0.01132,0,0
6,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.61402,-0.058604,-0.029985,0,0
6,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.12029,-0.058854,-0.0557,0,0
6,GO NUCLEOSIDE CATABOLIC PROCESS,0.28578,-0.058956,-0.057667,0,0
6,GO RESPONSE TO GONADOTROPIN,0.42367,-0.059228,-0.035281,0,0
6,GO SUPEROXIDE ANION GENERATION,0.70787,-0.059347,-0.02553,0,0
6,GO REGULATION OF MIRNA METABOLIC PROCESS,0.15921,-0.059439,-0.079577,0,0
6,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.38047,-0.059586,-0.03349,0,0
6,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.22042,-0.059594,-0.050797,0,0
6,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.12822,-0.059608,-0.10841,0,0
6,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.26267,-0.059804,-0.047276,0,0
6,GO SEQUESTERING OF METAL ION,0.29315,-0.059848,-0.06203,0,0
6,GO HEART TRABECULA FORMATION,0.42367,-0.059982,-0.044623,0,0
6,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.14642,-0.060047,-0.095109,0,0
6,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.28761,-0.060366,-0.05088,0,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.60268,-0.060402,-0.020596,0,0
6,GO ANDROGEN METABOLIC PROCESS,0.28033,-0.060536,-0.067015,0,0
6,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.82842,-0.060585,0.034325,0,0
6,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.59144,-0.060981,-0.016125,0,0
6,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.33396,-0.060997,-0.049975,0,0
6,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.074349,-0.061182,-0.065772,0,0
6,GO T HELPER 2 CELL DIFFERENTIATION,0.75048,-0.061265,-0.064076,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.53672,-0.061423,-0.062466,0,0
6,GO TRABECULA FORMATION,0.97899,-0.061583,0.0068423,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.40286,-0.061612,-0.029612,0,0
6,GO RESPONSE TO INTERLEUKIN 15,0.19838,-0.062067,-0.070281,0,0
6,GO PROSTANOID METABOLIC PROCESS,0.081877,-0.062104,-0.13949,0,0
6,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.43789,-0.062387,-0.036121,0,0
6,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.19838,-0.062422,-0.085013,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.30446,-0.062471,-0.06835,0,0
6,GO REGULATION OF TRANSLATIONAL ELONGATION,0.090011,-0.062609,-0.068703,0,0
6,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.43075,-0.062784,-0.041237,0,0
6,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.20845,-0.062847,-0.072444,0,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.6312,-0.062962,-0.020293,0,0
6,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.091558,-0.063063,-0.079417,0,0
6,GO POSITIVE REGULATION OF COAGULATION,0.45727,-0.063267,-0.036764,0,0
6,GO CERAMIDE TRANSPORT,0.26267,-0.063416,-0.059955,0,0
6,GO SPERM EGG RECOGNITION,0.14869,-0.063617,-0.043502,0,0
6,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.23445,-0.06362,-0.050347,0,0
6,GO ARACHIDONIC ACID SECRETION,0.25753,-0.063629,-0.025949,0,0
6,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.27317,-0.063635,-0.040081,0,0
6,GO PURINE CONTAINING COMPOUND SALVAGE,0.13549,-0.063636,-0.094177,0,0
6,GO MATURATION OF LSU RRNA,0.082591,-0.063698,-0.14131,0,0
6,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.30637,-0.063706,-0.043818,0,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.1146,-0.063836,-0.072426,0,0
6,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.22971,-0.063872,-0.087671,0,0
6,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.64276,-0.063962,-0.032194,0,0
6,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.46713,-0.064044,-0.05444,0,0
6,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.21437,-0.064075,-0.058324,0,0
6,GO POSITIVE REGULATION OF BONE RESORPTION,0.1533,-0.064092,-0.076028,0,0
6,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.18062,-0.064168,-0.12137,0,0
6,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.26267,-0.064174,-0.04349,0,0
6,GO RESPONSE TO DSRNA,0.065005,-0.064279,-0.070965,0,0
6,GO REGULATION OF RESPONSE TO TUMOR CELL,0.58864,-0.064673,-0.04875,0,0
6,GO FIBROBLAST ACTIVATION,0.35886,-0.064677,-0.039113,0,0
6,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.10385,-0.065156,-0.094246,0,0
6,GO CYTOKINE METABOLIC PROCESS,0.10823,-0.065184,-0.080775,0,0
6,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.14308,-0.065262,-0.068557,0,0
6,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.080464,-0.065281,-0.071462,0,0
6,GO DEFENSE RESPONSE TO BACTERIUM,0.096327,-0.065383,-0.072984,0,0
6,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.068619,-0.065507,-0.13096,0,0
6,GO RESPONSE TO INTERFERON GAMMA,0.17029,-0.0656,-0.10597,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION,0.11183,-0.065851,-0.074149,0,0
6,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.25924,-0.066244,-0.079101,0,0
6,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.71693,-0.066433,-0.020236,0,0
6,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.19003,-0.066539,-0.090416,0,0
6,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.22971,-0.066559,-0.081729,0,0
6,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.20122,-0.066787,-0.072487,0,0
6,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.28761,-0.066862,-0.076657,0,0
6,GO INTERLEUKIN 2 PRODUCTION,0.09796,-0.06696,-0.0752,0,0
6,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.47963,-0.067214,-0.011543,0,0
6,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.17283,-0.067284,-0.068109,0,0
6,GO ADHESION OF SYMBIONT TO HOST,0.318,-0.067358,-0.057915,0,0
6,GO REGULATION OF T CELL CHEMOTAXIS,0.1914,-0.067723,-0.052687,0,0
6,GO DETOXIFICATION OF INORGANIC COMPOUND,0.84741,-0.067946,-0.030275,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.53672,-0.068418,-0.0088752,0,0
6,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.10734,-0.068535,-0.098552,0,0
6,GO PROTEIN TRIMERIZATION,0.14755,-0.068731,-0.071607,0,0
6,GO PIGMENT ACCUMULATION,0.27853,-0.068904,-0.059251,0,0
6,GO BARBED END ACTIN FILAMENT CAPPING,0.33803,-0.06896,-0.060002,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.29877,-0.068985,-0.049701,0,0
6,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.85059,-0.069097,0.0048423,0,0
6,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.22503,-0.069156,-0.075175,0,0
6,GO INTERLEUKIN 1 PRODUCTION,0.48215,-0.069289,-0.038314,0,0
6,GO SENSORY PERCEPTION OF TASTE,0.52082,-0.069646,-0.041896,0,0
6,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.44994,-0.069764,-0.085359,0,0
6,GO MICROVILLUS ORGANIZATION,0.41203,-0.069946,-0.053287,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.079071,-0.070193,-0.06856,0,0
6,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.68392,-0.0703,-0.012881,0,0
6,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.096327,-0.070448,-0.15623,0,0
6,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.27317,-0.070571,-0.058114,0,0
6,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.14419,-0.071084,-0.079047,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.572,-0.071233,-0.012582,0,0
6,GO T CELL MIGRATION,0.26964,-0.071377,-0.047206,0,0
6,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.26095,-0.07142,-0.052224,0,0
6,GO HEPATOCYTE DIFFERENTIATION,0.18461,-0.071526,-0.084415,0,0
6,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.24252,-0.071646,-0.05671,0,0
6,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.24911,-0.071697,-0.040965,0,0
6,GO XENOBIOTIC TRANSPORT,0.76281,-0.071796,0.0029772,0,0
6,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.34008,-0.071975,-0.049226,0,0
6,GO RESPONSE TO INTERLEUKIN 4,0.09714,-0.072121,-0.057216,0,0
6,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.16042,-0.072665,-0.07828,0,0
6,GO PIGMENT METABOLIC PROCESS,0.073043,-0.072772,-0.068682,0,0
6,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.16042,-0.07303,-0.11024,0,0
6,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.18062,-0.073048,-0.083665,0,0
6,GO RETINAL METABOLIC PROCESS,0.84741,-0.073086,-0.011017,0,0
6,GO REGULATION OF T CELL MIGRATION,0.1146,-0.073192,-0.065959,0,0
6,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.22042,-0.073198,-0.062459,0,0
6,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.18327,-0.073394,-0.07542,0,0
6,GO PROSTAGLANDIN TRANSPORT,0.13338,-0.073749,-0.072711,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.52082,-0.073784,-0.0074318,0,0
6,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.28033,-0.074633,-0.065813,0,0
6,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.31409,-0.074673,-0.033359,0,0
6,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.16904,-0.074703,-0.056183,0,0
6,GO COPPER ION HOMEOSTASIS,0.093918,-0.07499,-0.071327,0,0
6,GO ALPHA BETA T CELL PROLIFERATION,0.22658,-0.075045,-0.079392,0,0
6,GO PROTEIN OXIDATION,0.15565,-0.07508,-0.11508,0,0
6,GO SULFUR COMPOUND TRANSPORT,0.35674,-0.075089,-0.014597,0,0
6,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.34213,-0.075194,-0.017078,0,0
6,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.27673,-0.075643,-0.033021,0,0
6,GO ENTRY OF BACTERIUM INTO HOST CELL,0.94993,-0.075687,-0.0015429,0,0
6,GO GLYCEROL ETHER METABOLIC PROCESS,0.095518,-0.075721,-0.084851,0,0
6,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.21738,-0.075728,-0.061924,0,0
6,GO DRUG METABOLIC PROCESS,0.23445,-0.075817,-0.054751,0,0
6,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.081168,-0.0762,-0.066092,0,0
6,GO TYPE 2 IMMUNE RESPONSE,0.12822,-0.076249,-0.12009,0,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.11553,-0.076252,-0.05595,0,0
6,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.26095,-0.076391,-0.045159,0,0
6,GO T CELL CHEMOTAXIS,0.3871,-0.076698,-0.032824,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.58864,-0.076742,-0.021397,0,0
6,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.2458,-0.077284,-0.052294,0,0
6,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.1754,-0.077478,-0.11173,0,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.078382,-0.077718,-0.085432,0,0
6,GO CYTOLYSIS,0.25246,-0.078181,-0.094197,0,0
6,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.2913,-0.078191,-0.040642,0,0
6,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.20409,-0.078192,-0.080682,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.44752,-0.078284,-0.033092,0,0
6,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.068006,-0.078638,-0.12163,0,0
6,GO POSITIVE REGULATION OF TISSUE REMODELING,0.063258,-0.078908,-0.086014,0,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.39381,-0.079783,-0.031017,0,0
6,GO INDOLALKYLAMINE METABOLIC PROCESS,0.73212,-0.079966,-0.024105,0,0
6,GO B CELL HOMEOSTASIS,0.1793,-0.08014,-0.064336,0,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.13979,-0.080302,-0.10509,0,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.41203,-0.080386,-0.018374,0,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.085497,-0.080397,-0.08782,0,0
6,GO KERATAN SULFATE METABOLIC PROCESS,0.24416,-0.080543,-0.050849,0,0
6,GO RESPIRATORY BURST,0.36741,-0.080977,-0.043106,0,0
6,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.25246,-0.081011,-0.070898,0,0
6,GO B CELL APOPTOTIC PROCESS,0.073694,-0.081188,-0.088545,0,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1533,-0.081264,-0.042967,0,0
6,GO DISACCHARIDE METABOLIC PROCESS,0.93382,-0.081401,0.0027664,0,0
6,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.81896,-0.081419,0.044429,0,0
6,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.3739,-0.081752,-0.059363,0,0
6,GO LYTIC VACUOLE ORGANIZATION,0.063258,-0.081959,-0.061003,0,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.17669,-0.082027,-0.082732,0,0
6,GO RESPONSE TO TYPE I INTERFERON,0.22971,-0.082039,-0.12563,0,0
6,GO CELLULAR RESPONSE TO ZINC ION,0.87926,-0.082078,-0.021864,0,0
6,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.19557,-0.08218,-0.070068,0,0
6,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.12822,-0.082315,-0.097836,0,0
6,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.12029,-0.082345,-0.049655,0,0
6,GO MONONUCLEAR CELL DIFFERENTIATION,0.30829,-0.082516,-0.056612,0,0
6,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.82526,-0.082621,-0.00084793,0,0
6,GO T CELL MEDIATED IMMUNITY,0.087731,-0.082638,-0.11509,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.48976,-0.082758,-0.065047,0,0
6,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.14088,-0.082948,-0.066575,0,0
6,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.16654,-0.083496,-0.095038,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.17411,-0.083512,-0.044832,0,0
6,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.66616,-0.083656,-0.011289,0,0
6,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.20992,-0.083672,-0.047925,0,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.30255,-0.083753,-0.028742,0,0
6,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.30829,-0.083977,-0.074556,0,0
6,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.073694,-0.084186,-0.07513,0,0
6,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.16407,-0.084203,-0.091358,0,0
6,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.075009,-0.084413,-0.069859,0,0
6,GO MATURATION OF SSU RRNA,0.35463,-0.084489,-0.071058,0,0
6,GO DENDRITIC CELL DIFFERENTIATION,0.1754,-0.084677,-0.10256,0,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.23286,-0.08488,-0.038978,0,0
6,GO DENDRITIC CELL APOPTOTIC PROCESS,0.081168,-0.085121,-0.16294,0,0
6,GO NEGATIVE REGULATION OF CELL KILLING,0.37827,-0.085552,-0.11287,0,0
6,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.089246,-0.085797,-0.073204,0,0
6,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.40743,-0.086079,-0.019492,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.87287,-0.086147,0.035105,0,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.24911,-0.086437,-0.029304,0,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.40286,-0.086578,-0.027263,0,0
6,GO GERMINAL CENTER FORMATION,0.17411,-0.086859,-0.1193,0,0
6,GO VACUOLAR ACIDIFICATION,0.086237,-0.087331,-0.07126,0,0
6,GO RESPONSE TO COPPER ION,0.38047,-0.087535,-0.05313,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.09714,-0.087619,-0.092857,0,0
6,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.178,-0.087941,-0.085029,0,0
6,GO REGULATION OF CELL KILLING,0.10646,-0.087968,-0.092293,0,0
6,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.10214,-0.088031,-0.10576,0,0
6,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.15098,-0.089187,-0.056124,0,0
6,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.1793,-0.089204,-0.045623,0,0
6,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.47712,-0.089807,-0.061857,0,0
6,GO COLLAGEN CATABOLIC PROCESS,0.52874,-0.090058,-0.024903,0,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.46466,-0.090753,-0.082771,0,0
6,GO POSITIVE REGULATION OF CELL KILLING,0.21738,-0.090822,-0.077664,0,0
6,GO NADP METABOLIC PROCESS,0.13234,-0.090996,-0.068258,0,0
6,GO ALDITOL METABOLIC PROCESS,0.25414,-0.091111,-0.046867,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.22814,-0.091149,-0.057093,0,0
6,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.073043,-0.091191,-0.085899,0,0
6,GO PENTOSE METABOLIC PROCESS,0.12924,-0.091253,-0.077588,0,0
6,GO VITAMIN TRANSPORT,0.12721,-0.09153,-0.058357,0,0
6,GO PROTEIN ACTIVATION CASCADE,0.35674,-0.091574,-0.059665,0,0
6,GO ETHER METABOLIC PROCESS,0.20265,-0.091891,-0.079217,0,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.074349,-0.092913,-0.075348,0,0
6,GO CELL KILLING,0.094715,-0.093261,-0.077088,0,0
6,GO B CELL PROLIFERATION,0.11092,-0.0933,-0.078668,0,0
6,GO NUCLEOBASE METABOLIC PROCESS,0.13979,-0.09335,-0.063044,0,0
6,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.21288,-0.093486,-0.063869,0,0
6,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.20845,-0.093648,-0.074113,0,0
6,GO ALDEHYDE CATABOLIC PROCESS,0.08331,-0.093711,-0.069724,0,0
6,GO INTEGRIN ACTIVATION,0.1387,-0.094071,-0.069035,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.098784,-0.094709,-0.079375,0,0
6,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.1754,-0.09491,-0.08249,0,0
6,GO INTERLEUKIN 10 PRODUCTION,0.076344,-0.095574,-0.099775,0,0
6,GO GAS TRANSPORT,0.49487,-0.095874,-0.052443,0,0
6,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.16163,-0.096025,-0.08369,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.10214,-0.096098,-0.054223,0,0
6,GO CELLULAR RESPONSE TO COPPER ION,0.64276,-0.096598,-0.045033,0,0
6,GO PHAGOSOME ACIDIFICATION,0.13763,-0.096954,-0.062827,0,0
6,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.73212,-0.096991,-0.0011681,0,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.2458,-0.097958,-0.036892,0,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.30066,-0.09877,-0.07327,0,0
6,GO ARACHIDONIC ACID METABOLIC PROCESS,0.31604,-0.099436,-0.062327,0,0
6,GO REGULATION OF PROSTAGLANDIN SECRETION,0.095518,-0.10037,-0.07468,0,0
6,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.1252,-0.10042,-0.057639,0,0
6,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.30637,-0.10085,-0.15979,0,0
6,GO HYALURONAN CATABOLIC PROCESS,0.44752,-0.10103,-0.07585,0,0
6,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.073043,-0.1011,-0.11885,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.55016,-0.10196,-0.085315,0,0
6,GO GLYCOSIDE METABOLIC PROCESS,0.31997,-0.10208,-0.061086,0,0
6,GO REGULATION OF COAGULATION,0.14642,-0.10289,-0.084651,0,0
6,GO IMMUNE RESPONSE TO TUMOR CELL,0.092339,-0.10451,-0.135,0,0
6,GO HEMIDESMOSOME ASSEMBLY,0.60834,-0.1046,-0.030731,0,0
6,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.39381,-0.10514,-0.03038,0,0
6,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.51296,-0.1054,-0.053138,0,0
6,GO PLASMA MEMBRANE FUSION,0.33194,-0.10551,-0.078568,0,0
6,GO SULFUR AMINO ACID METABOLIC PROCESS,0.21738,-0.10603,-0.05131,0,0
6,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.70185,-0.1062,0.055116,0,0
6,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.14755,-0.107,-0.11019,0,0
6,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.40514,-0.10714,-0.024036,0,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.25414,-0.1075,-0.10251,0,0
6,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.11002,-0.10753,-0.10952,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.065596,-0.10755,-0.12607,0,0
6,GO PLATELET MORPHOGENESIS,0.27673,-0.10791,-0.032045,0,0
6,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.47712,-0.10837,-0.069871,0,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.7659,-0.10884,0.0096061,0,0
6,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.38047,-0.10962,-0.028157,0,0
6,GO LIPID IMPORT INTO CELL,0.17411,-0.11023,-0.053236,0,0
6,GO GLYCINE METABOLIC PROCESS,0.28395,-0.11132,-0.071329,0,0
6,GO CYSTEINE METABOLIC PROCESS,0.52874,-0.11144,-0.055155,0,0
6,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.15098,-0.11146,-0.057544,0,0
6,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.16163,-0.11189,-0.058336,0,0
6,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.084034,-0.11231,-0.094334,0,0
6,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.1313,-0.11258,-0.10064,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.1453,-0.1126,-0.1091,0,0
6,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15683,-0.11305,-0.095207,0,0
6,GO POSITIVE REGULATION OF HEART RATE,0.09796,-0.11332,-0.082072,0,0
6,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.24252,-0.11395,-0.056511,0,0
6,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.44028,-0.11454,-0.11846,0,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.084763,-0.11568,-0.085377,0,0
6,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.080464,-0.11623,-0.14493,0,0
6,GO RESPONSE TO MUSCLE STRETCH,0.20265,-0.11629,-0.077379,0,0
6,GO SPHINGOMYELIN METABOLIC PROCESS,0.16654,-0.11691,-0.070472,0,0
6,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.086237,-0.1177,-0.085767,0,0
6,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.79075,-0.11845,-0.0022562,0,0
6,GO LIPID DIGESTION,0.06986,-0.11859,-0.17078,0,0
6,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.25414,-0.11864,-0.097359,0,0
6,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.6691,-0.1187,-0.0048945,0,0
6,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.50516,-0.12,-0.055487,0,0
6,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.51296,-0.12028,-0.03682,0,0
6,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.54208,-0.12136,-0.051269,0,0
6,GO MATURE B CELL DIFFERENTIATION,0.15214,-0.12152,-0.10116,0,0
6,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.1914,-0.12306,-0.05997,0,0
6,GO RELAXATION OF CARDIAC MUSCLE,0.18194,-0.12356,-0.083827,0,0
6,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.066192,-0.12381,-0.084065,0,0
6,GO CERAMIDE CATABOLIC PROCESS,0.066192,-0.12411,-0.11612,0,0
6,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.14983,-0.12414,-0.11442,0,0
6,GO TOLERANCE INDUCTION,0.26964,-0.12454,-0.1133,0,0
6,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.90167,-0.12554,0.018894,0,0
6,GO DETECTION OF OTHER ORGANISM,0.18194,-0.12594,-0.11723,0,0
6,GO POSITIVE REGULATION OF HEART CONTRACTION,0.1252,-0.12596,-0.060287,0,0
6,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.38488,-0.12741,-0.036962,0,0
6,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.1793,-0.12843,-0.083652,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.10214,-0.12898,-0.12678,0,0
6,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.11553,-0.12917,-0.096903,0,0
6,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.10129,-0.13051,-0.10341,0,0
6,GO OLIGOPEPTIDE TRANSPORT,0.29315,-0.13461,-0.054422,0,0
6,GO DETECTION OF BIOTIC STIMULUS,0.18327,-0.13476,-0.094133,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.1533,-0.13478,-0.08938,0,0
6,GO ZYMOGEN ACTIVATION,0.094715,-0.13679,-0.11926,0,0
6,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.41899,-0.13917,-0.07382,0,0
6,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.90488,-0.14164,-0.018664,0,0
6,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.15447,-0.14306,-0.11027,0,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.2714,-0.14559,-0.062055,0,0
6,GO PEPTIDYL PROLINE HYDROXYLATION,0.19278,-0.14934,-0.11798,0,0
6,GO ACTIN FILAMENT SEVERING,0.11092,-0.15031,-0.11399,0,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.14419,-0.15084,-0.11427,0,0
6,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.068619,-0.15106,-0.12213,0,0
6,GO RESPONSE TO EPINEPHRINE,0.16407,-0.15231,-0.099972,0,0
6,GO GALACTOSE METABOLIC PROCESS,0.077018,-0.1524,-0.1151,0,0
6,GO NEGATIVE REGULATION OF COAGULATION,0.090011,-0.15302,-0.12805,0,0
6,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.37608,-0.15402,-0.047191,0,0
6,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.16904,-0.15441,-0.081583,0,0
6,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.25583,-0.15493,-0.16083,0,0
6,GO INTERLEUKIN 5 PRODUCTION,0.06986,-0.15524,-0.15746,0,0
6,GO BEHAVIORAL RESPONSE TO PAIN,0.10823,-0.15534,-0.1071,0,0
6,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.25583,-0.15869,-0.044903,0,0
6,GO MEMBRANE RAFT ORGANIZATION,0.16654,-0.1599,-0.13594,0,0
6,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.093126,-0.17029,-0.1056,0,0
6,GO INFLAMMATORY RESPONSE TO WOUNDING,0.1453,-0.17886,-0.14303,0,0
6,GO RESPONSE TO INTERFERON ALPHA,0.10299,-0.17932,-0.21135,0,0
6,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.11742,-0.18337,-0.078046,0,0
6,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.13656,-0.18573,-0.14393,0,0
6,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.081877,-0.19111,-0.15351,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.068006,-0.20329,-0.26051,0,0
6,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.078382,-0.2067,-0.10295,0,0
6,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.12721,-0.21197,-0.1399,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.24911,-0.21452,-0.26707,0,0
6,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.062684,-0.22404,-0.11415,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.22042,-0.24431,-0.24532,0,0
6,GO XENOBIOTIC CATABOLIC PROCESS,0.098784,-0.28738,-0.14356,0,0
6,GO POSITIVE REGULATION OF VESICLE FUSION,0.086981,-0.32314,-0.1833,0,0
